PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Darling, SR; Schaubel, DE; Baker, JG; Leddy, JJ; Bisson, LJ; Willer, B				Darling, Scott R.; Schaubel, Douglas E.; Baker, John G.; Leddy, John J.; Bisson, Leslie J.; Willer, Barry			Intentional versus unintentional contact as a mechanism of injury in youth ice hockey	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							BODY-CHECKING; HIGH-SCHOOL; RATES; BODYCHECKING; SPORTS; SAFETY; RISK	Background Youth ice hockey injury rates and mechanisms have been described by various classification systems. Intentional versus unintentional contact was used to classify mechanisms of injuries. All injuries (n=247) in one youth hockey programme over a 5-year period were recorded and included in the analysis. Purpose To evaluate youth ice hockey injuries and compare programmes that allow body checking versus programmes that do not allow body checking. A primary goal was to determine whether programmes that allow body checking have increased injury rates from intentional body contact. Another goal was to describe the rates of injury across ages, levels of competitive play and during games versus practices. Methods Rates of injury were compared for three levels of competition (house, select and representative) for approximately 3000 boys aged 4-18 years over a 5-year period. This represents 13 292 player years. Data were collected prospectively in this cohort study. All injuries were reported prospectively by a designated team official and verified by a physician. The log injury rate (per 1000 player hours) was modelled via Poisson regression with log player hours used as an offset. Rate ratio was used to explain the covariate-adjusted injury rate for each of three groups (all injuries, intentional injuries, unintentional injuries). Results Unintentional contacts accounted for 66.0% of overall injuries (95% CI 60.0 to 72.0), compared with 34.0% from intentional contacts (p < 0.001; Z=5.25). Serious injuries (fractures, dislocations, concussions) resulted more often from unintentional collisions (p=0.04). Players in more competitive leagues that allow body checking had a greater incidence of total injuries than less competitive leagues. Conclusions Most injuries in the youth hockey programme studied were the result of unintentional contact, and were generally more severe. These findings were not expected given previously published research.	[Darling, Scott R.] SUNY Buffalo, Dept Orthopaed, Buffalo, NY 14214 USA; [Schaubel, Douglas E.] Univ Michigan, Ann Arbor, MI 48109 USA		Darling, SR (corresponding author), SUNY Buffalo, Dept Orthopaed, 160 Farber Hall,3435 Main St, Buffalo, NY 14214 USA.	sdarling@buffalo.edu			Burlington Lions Optimists Minor Hockey Association officials	The authors wish to acknowledge the support of the Burlington Lions Optimists Minor Hockey Association officials, parents and players for allowing access to injury reports. The authors also want to acknowledge this organisation and Hockey Canada for their commitment to the culture of safety in hockey.	Anderson AJ, 2000, PEDIATRICS, V105, P657, DOI 10.1542/peds.105.3.640; Benson Brian W, 2005, Med Sport Sci, V49, P86, DOI 10.1159/000085393; Cantu RC, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.08.945; Cheng T L, 1999, Inj Prev, V5, P59; DAFFNER RH, 1977, J FAM PRACTICE, V4, P225; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Hagel BE, 2006, CAN MED ASSOC J, V175, P155, DOI 10.1503/cmaj.051531; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Macpherson A, 2006, PEDIATRICS, V117, pE143, DOI 10.1542/peds.2005-1163; Marchie A, 2003, CAN MED ASSOC J, V169, P124; Roberts WO, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.11.1102; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; STUART M, 2000, PRINCIPLES ICE HOCKE, P19; STUART MJ, 1995, MAYO CLIN PROC, V70, P350, DOI 10.4065/70.4.350; Sutherland G W, 1976, Am J Sports Med, V4, P264, DOI 10.1177/036354657600400605; Willer B, 2005, MED SCI SPORT EXER, V37, P1658, DOI 10.1249/01.mss.0000181839.86170.06	17	20	20	0	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674			BRIT J SPORT MED	Br. J. Sports Med.	MAY	2011	45	6					492	U194		10.1136/bjsm.2009.063693			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	746XM	WOS:000289282900008	20484317				2022-02-06	
J	Kuo, JR; Lo, CJ; Lu, CL; Chio, CC; Wang, CC; Lin, KC				Kuo, Jinn-Rung; Lo, Chong-Jeh; Lu, Chin-Li; Chio, Chung-Ching; Wang, Che-Chuan; Lin, Kao-Chang			Prognostic Predictors of Outcome in an Operative Series in Traumatic Brain Injury Patients	JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION			English	Article						craniectomy; injury severity score; prognostic factors; pupillary reaction; traumatic brain injury	SEVERE HEAD-INJURY; ACUTE SUBDURAL-HEMATOMA; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; COMA; MULTICENTER; SCALE	Background: Although several prognostic factors for traumatic brain injury (TBI) have been evaluated, a useful predictive scoring model for outcome has yet to be developed for TBI patients. The aim of this study was to determine independent predictors and develop a multivariate logistic regression equation to determine prognosis in TBI patients. Methods: A total of 13 different variables were evaluated. All 84 patients in this study were retrospectively evaluated between October 2003 and January 2008 and all underwent craniectomy or craniotomy for hematoma removal and were fitted with intracranial pressure (ICP) microsensor monitors. By using univariate, multiple logistic regression and prognostic regression scoring equations it was possible to draw Receiver-Operating Characteristic curves (ROC) to predict Glasgow Outcome Scale (GOS) 6 months after TBI. Results: We found that patients over 40 years of age (p<0.001), unresponsive pre-op pupil reaction (p=0.001), pre-op midline shift (p=0.008), higher injury severity score (ISS; p=0.007), and craniectomy (p<0.05) were associated with poor outcome in patients with TBI. Using ROC curve to predict the probability of unfavorable outcome, the sensitivity was 97.5% and the specificity was 90.7%. Conclusion: In our preliminary findings, five variables to predict poor outcomes 6 months after TB! were useful. These sensitive variables can be used as a referential guideline in our daily practice to decide whether or not to perform advanced management or avoid decompressive craniectomy.	[Lin, Kao-Chang] Chi Mei Med Ctr, Dept Neurol, Yung Kang 710, Tainan, Taiwan; [Kuo, Jinn-Rung] Natl Cheng Kung Univ, Sch Med, Inst Clin Med, Tainan 70101, Taiwan; [Kuo, Jinn-Rung; Chio, Chung-Ching; Wang, Che-Chuan] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Lu, Chin-Li] Chi Mei Med Ctr, Clin Res Inst, Tainan, Taiwan; [Kuo, Jinn-Rung; Lin, Kao-Chang] So Taiwan Univ, Dept Biotechnol, Tainan, Taiwan; [Lo, Chong-Jeh] Chang Gung Mem Hosp, Div Trauma & Emergency Surg, Kaohsiung, Taiwan; [Lo, Chong-Jeh] Kaohsiung Med Ctr, Kaohsiung, Taiwan		Lin, KC (corresponding author), Chi Mei Med Ctr, Dept Neurol, 901 Chung Hwa Rd, Yung Kang 710, Tainan, Taiwan.	kuo.ox@msa.hinet.net		Lu, Chin-Li/0000-0002-0818-4823			Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; Carter BG, 2007, ANAESTH INTENS CARE, V35, P984, DOI 10.1177/0310057X0703500623; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; JENNETT B, 1975, LANCET, V1, P480; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kuo JR, 2007, EUR J NEUROL, V14, P1073, DOI 10.1111/j.1468-1331.2007.01908.x; Kuo JR, 2006, J CLIN NEUROSCI, V13, P218, DOI 10.1016/j.jocn.2005.01.012; Kuo JR, 2004, J CLIN NEUROSCI, V11, P710, DOI 10.1016/j.jocn.2003.10.011; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mass AIR, 2007, J TRAUMA, V24, P303; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Ono J, 2001, J CLIN NEUROSCI, V8, P120, DOI 10.1054/jocn.2000.0732; PHUENPATHOM N, 1993, SURG NEUROL, V40, P22, DOI 10.1016/0090-3019(93)90164-V; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Skoglund TS, 2006, J NEUROTRAUM, V23, P1502, DOI 10.1089/neu.2006.23.1502; The Brain TraumaFoundation, 2000, J NEUROTRAUM, V17, P583, DOI [10.1089/neu.2000.17.583, DOI 10.1089/NEU.2000.17.583]; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; WRONSKI J, 2000, NEUROL NEUROCHIR PSY, V6, P80; ZWEIG MH, 1993, CLIN CHEM, V39, P561	25	20	22	0	3	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	0929-6646			J FORMOS MED ASSOC	J. Formos. Med. Assoc.	APR	2011	110	4					258	264		10.1016/S0929-6646(11)60038-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764QB	WOS:000290645900007	21540008	Bronze			2022-02-06	
J	Sundberg, LM; Herrera, JJ; Narayana, PA				Sundberg, Laura M.; Herrera, Juan J.; Narayana, Ponnada A.			Effect of Vascular Endothelial Growth Factor Treatment in Experimental Traumatic Spinal Cord Injury: In Vivo Longitudinal Assessment	JOURNAL OF NEUROTRAUMA			English	Article						behavioral assays; diffusion tensor imaging; magnetic resonance imaging; spinal cord injury; vascular endothelial growth factor	STIMULATES AXONAL OUTGROWTH; VASOGENIC BRAIN EDEMA; BARRIER PERMEABILITY; NERVOUS-SYSTEM; DIFFUSION; RAT; VEGF; MRI; MECHANISMS; BIOLOGY	Vascular endothelial growth factor (VEGF) is thought to provide neuroprotection to the traumatically injured spinal cord. We examined whether supplementing the injured environment with VEGF(165) via direct intraspinal injection into the lesion epicenter during the acute phase of spinal cord injury (SCI) results in improved outcome. The effect of treatment was investigated using longitudinal multi-modal magnetic resonance imaging (MRI), neurobehavioral assays, and end-point immunohistochemistry. We observed on MRI that rats treated with VEGF(165) after SCI had increased tissue sparing compared to vehicle-treated animals at the earlier time points. However, these favorable effects were not maintained into the chronic phase. Histology revealed that VEGF(165) treatment resulted in increased oligodendrogenesis and/or white matter sparing, and therefore may eventually lead to improved functional outcome. The increase in spared tissue as demonstrated by MRI, coupled with the possible remyelination and increased neurosensory sensitivity, suggests that VEGF(165) treatment may play a role in promoting plasticity in the sensory pathways following SCI. However, VEGF-treated animals also demonstrated an increased incidence of persistent allodynia, as indicated on the von Frey filament test.	[Sundberg, Laura M.; Herrera, Juan J.; Narayana, Ponnada A.] Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX 77030 USA		Narayana, PA (corresponding author), Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, 6431 Fannin St, Houston, TX 77030 USA.	ponnada.a.narayana@uth.tmc.edu					BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beattie MS, 2002, PROG BRAIN RES, V137, P37; Benton RL, 2003, NEUROCHEM RES, V28, P1693, DOI 10.1023/A:1026013106016; Bockhorst KH, 2008, J NEUROSCI RES, V86, P1520, DOI 10.1002/jnr.21607; Bockhorst KH, 2010, J NEUROSCI RES, V88, P1146, DOI 10.1002/jnr.22273; BOCKHORST KH, 2010, 18 ANN M INT SOC MAG; BRESNAHAN JC, 1987, EXP NEUROL, V95, P548, DOI 10.1016/0014-4886(87)90299-8; Brockington A, 2004, NEUROPATH APPL NEURO, V30, P427, DOI 10.1111/j.1365-2990.2004.00600.x; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Budde MD, 2009, J NEUROSCI, V29, P2805, DOI 10.1523/JNEUROSCI.4605-08.2009; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Deboy CA, 2007, BRAIN, V130, P2199, DOI 10.1093/brain/awm122; DEMEDIUK P, 1987, NEUROCHEM PATHOL, V7, P79, DOI 10.1007/BF02834293; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Facchiano F, 2002, J NEUROSURG, V97, P161, DOI 10.3171/jns.2002.97.1.0161; Fenyes DA, 1998, MAGN RESON IMAGING, V16, P1249, DOI 10.1016/S0730-725X(98)00093-9; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Goldsmith HS, 1999, SURG NEUROL, V51, P231, DOI 10.1016/S0090-3019(97)00330-3; Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263; HAHN K, 2004, INT SOC MAGNETIC RES, P1208; HAHN K, 2005, INT SOC MAGNETIC RES, P161; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Herrera JJ, 2009, J NEUROTRAUM, V26, P995, DOI [10.1089/neu.2008.0779, 10.1089/neu.2008-0779]; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Madi S, 2005, MAGN RESON MED, V53, P118, DOI 10.1002/mrm.20304; Mihai G, 2008, J NEUROTRAUM, V25, P1, DOI 10.1089/neu.2007.0338; Mills CD, 2001, J NEUROTRAUM, V18, P1091, DOI 10.1089/08977150152693773; NESICTAYLOR DO, 2010, J NEUROTRAUM, V27, P1793; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; NOLAN RT, 1969, BRIT MED J, V1, P710, DOI 10.1136/bmj.1.5645.710; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Peng XM, 2006, ANN NEUROL, V59, P843, DOI 10.1002/ana.20855; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; REULEN HJ, 1976, BRIT J ANAESTH, V48, P741, DOI 10.1093/bja/48.8.741; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Sharma HS, 2005, CURR PHARM DESIGN, V11, P1353, DOI 10.2174/1381612053507837; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Storkebaum E, 2004, BIOESSAYS, V26, P943, DOI 10.1002/bies.20092; Sundberg LM, 2010, J NEUROTRAUM, V27, P1753, DOI 10.1089/neu.2010.1369; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Twisk J, 2002, J CLIN EPIDEMIOL, V55, P329, DOI 10.1016/S0895-4356(01)00476-0; van Neerven S, 2010, J NEUROTRAUM, V27, P1781, DOI 10.1089/neu.2010.1484; WEIRICH SD, 1990, SPINE, V15, P630, DOI 10.1097/00007632-199007000-00004; Widenfalk J, 2003, NEUROSCIENCE, V120, P951, DOI 10.1016/S0306-4522(03)00399-3; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YASHON D, 1973, J NEUROSURG, V38, P693, DOI 10.3171/jns.1973.38.6.0693; YE F, 2007, INT SOC MAGNETIC RES, P1841; Zachary I, 2005, NEUROSIGNALS, V14, P207, DOI 10.1159/000088637; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369	58	20	21	0	8	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2011	28	4					565	578		10.1089/neu.2010.1533			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	746IW	WOS:000289240200007	21299336	Green Published			2022-02-06	
J	Armstead, WM; Raghupathi, R				Armstead, William M.; Raghupathi, Ramesh			Endothelin and the neurovascular unit in pediatric traumatic brain injury	NEUROLOGICAL RESEARCH			English	Article						Cerebral hemodynamics; Pediatric traumatic brain injury; Endothelin; Histopathology	MICROTUBULE-ASSOCIATED PROTEIN-2; ERK MAPK; RAT; ISCHEMIA; INHIBITION; FOREBRAIN; RESPONSES; CHILDREN; SYSTEM; PIG	Objective: This study characterized the association between endothelin-1, cerebral hemodynamics, and histopathology after fluid percussion brain injury in the newborn pig. Methods: Lateral fluid percussion injury was induced in newborn pigs equipped with a closed cranial window. Cerebral blood flow was determined with radiolabeled microspheres and cerebrospinal fluid endothelin-1 was measured by radioimmunoassay. Results: Cerebrospinal fluid endothelin-1 was increased from 26 +/- 4 to 296 +/- 37 pg/ml (similar to 10(-10)M) at 8 hours following fluid percussion injury. Post-injury treatment (30 minutes) with the endothelin-1 antagonist BQ-123 (1 mg/kg, intravenous) blocked pial artery vasoconstriction to topical endothelin-1 (similar to 10(-10)M) and blunted fluid percussion injury-induced reductions in cerebral blood flow at 8 hours post-insult (56 +/- 6 and 26 +/- 4 ml/minute versus 57 +/- 6 and 40 +/- 4 ml/minute; 100 g for cerebral blood flow before injury and 8 hours post-fluid percussion injury in vehicle and BQ-123 post-treated animals, respectively). Fluid percussion injury resulted in neuronal cell loss and decreased microtubule associated protein 2 immunoreactivity in the parietal cortex, which were blunted by BQ-123. Discussion: These data indicate that fluid percussion injury-induced changes in cerebral hemodynamics are associated with neuronal damage and that endothelin-1 contributes to fluid percussion injury-induced histopathologic changes.	[Armstead, William M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Raghupathi, Ramesh] Drexel Univ, Coll Med, Dept Neurobiol & Anat, Philadelphia, PA 19104 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu	Raghupathi, Ramesh/AAX-5538-2021		National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; University of Pennsylvania Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This research was supported by grants from the National Institutes of Health and the University of Pennsylvania Research Foundation.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Armstead WM, 2006, NAT NEUROSCI, V9, P1150, DOI 10.1038/nn1757; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Armstead WM, 1999, AM J PHYSIOL-HEART C, V277, pH1884; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DECAMILLI P, 1984, NEUROSCIENCE, V11, P819, DOI 10.1016/0306-4522(84)90194-5; FRIEDRICH P, 1991, FEBS LETT, V295, P5, DOI 10.1016/0014-5793(91)81371-E; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; HICKS RR, 1995, BRAIN RES, V678, P151, DOI 10.1016/0006-8993(95)00179-T; Lo EH, 2004, STROKE, V35, P354, DOI 10.1161/01.STR.0000115164.80010.8A; Markgraf CG, 1998, STROKE, V29, P152, DOI 10.1161/01.STR.29.1.152; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; MIYAZAWA T, 1993, ACTA NEUROPATHOL, V85, P526; Rafols D, 2004, NEUROSCI LETT, V362, P154, DOI 10.1016/j.neulet.2004.03.021; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; RODRIGUEZ JG, 1990, AM J DIS CHILD, V144, P625, DOI 10.1001/archpedi.1990.02150300019014; SIMONSON MS, 1990, FASEB J, V4, P2989, DOI 10.1096/fasebj.4.12.2168326; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; YAMAURA I, 1993, J NEUROSURG, V79, P537, DOI 10.3171/jns.1993.79.4.0537; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0	23	20	23	0	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAR	2011	33	2					127	132		10.1179/016164111X12881719352138			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	723OM	WOS:000287516600003	21801587	Green Accepted			2022-02-06	
J	Boelen, DHE; Spikman, JM; Fasotti, L				Boelen, D. H. E.; Spikman, J. M.; Fasotti, L.			Rehabilitation of executive disorders after brain injury: Are interventions effective?	JOURNAL OF NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; FRONTAL-LOBE DAMAGE; PAGING SYSTEM; COGNITIVE REHABILITATION; DYSEXECUTIVE SYNDROME; GOAL MANAGEMENT; MEMORY AID; BEHAVIOR; PEOPLE; DEFICITS	In this paper, the effectiveness of interventions for executive disorders was reviewed. The objective was to evaluate the internal and external validity of intervention studies. A total of 46 papers, describing 54 studies, conducted in the last two decades meeting several preset inclusion criteria, was included in this review. The studies were categorized into three treatment approaches in order to enhance comparability. The overall results show that many interventions yield positive outcomes and seem to be effective in reducing executive problems in brain-injured subjects. However, several studies have only an explorative intent and are based on less sophisticated experimental designs. The verification of their results is generally more tenuous. The internal validity, or the set-up of experimental conditions necessary to draw valid conclusions about treatment effectiveness, including the choice of well-matched control groups, or the randomization of patients over treatment and control conditions, is not always strong. The same conclusion can be drawn for the external validity of a number of the intervention studies; often evidence of generalization to real-life situations, long-term follow-up, and transfer to non-trained situations, were (partially) lacking in the studies under review. The authors are aware that the design of proper randomized controlled trials for the investigation of the treatment effectiveness of executive disorders is cumbersome and time consuming. Nonetheless, the provisional results of several well-designed studies described in this review make the effort worthwhile.	[Boelen, D. H. E.; Fasotti, L.] St Maartensklin Res Dev & Educ, NL-6500 GM Nijmegen, Netherlands; [Boelen, D. H. E.; Fasotti, L.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Boelen, D. H. E.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, NL-6525 ED Nijmegen, Netherlands; [Spikman, J. M.] Univ Med Ctr Groningen, Dept Neurol, Neuropsychol Unit, Groningen, Netherlands; [Spikman, J. M.] Univ Groningen, Dept Psychol, NL-9700 AB Groningen, Netherlands		Boelen, DHE (corresponding author), St Maartensklin Res Dev & Educ, POB 9011, NL-6500 GM Nijmegen, Netherlands.	d.boelen@maartenskliniek.nl		Spikman, Jacoba/0000-0002-6477-0763	Netherlands Organization of Health Research and Development (ZonMw)Netherlands Organization for Health Research and Development [1435.0009]	Supported by The Netherlands Organization of Health Research and Development (ZonMw), Rehabilitation Research Programme (Grant No. 1435.0009).	ALDERMAN N, 1995, NEUROPSYCHOL REHABIL, V5, P193, DOI 10.1080/09602019508401467; ALDERMAN N, 1991, Brain Injury, V5, P77, DOI 10.3109/02699059108998516; ALDERMAN N, 1994, NEUROPSYCHOL REHABIL, V4, P31, DOI 10.1080/09602019408401454; Alderman N, 1997, BRAIN INJURY, V11, P79, DOI 10.1080/026990597123683; ALDERMAN N, 1991, NEUROPSYCHOL REHABIL, V1, P65, DOI DOI 10.1080/09602019108401380; Alvarez JB, 2006, GENET RESOUR CROP EV, V53, P1061, DOI 10.1007/s10722-004-7940-9; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess P.W., 2005, EFFECTIVENESS REHABI, P211, DOI DOI 10.1093/ACPROF:OSO/9780198526544.001.0001; Burgess P. W., 2002, PRINCIPLES FRONTAL L, P557, DOI 10.1093/acprof:oso/9780195134971.003.0033; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; BURKE W H, 1991, Brain Injury, V5, P241, DOI 10.3109/02699059109008095; CARAMAZZA A, 1986, BRAIN COGNITION, V5, P41, DOI 10.1016/0278-2626(86)90061-8; Cicerone KD, 2002, BRAIN INJURY, V16, P185, DOI 10.1080/02699050110103959; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 2005, EFFECTIVENESS REHABI, P43; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Coltheart M., 2005, EFFECTIVENESS REHABI, P11, DOI [10.1093/acprof:oso/9780198526544.003.0002, DOI 10.1093/ACPROF:OSO/9780198526544.003.0002]; Darling S, 1998, METACOGNITION AND COGNITIVE NEUROPSYCHOLOGY, P53; Dayus B, 2000, NEUROPSYCHOL REHABIL, V10, P415, DOI 10.1080/096020100411998; Delazer M, 1998, NEUROPSYCHOL REHABIL, V8, P401; Dritschel BH, 1998, BRAIN INJURY, V12, P875; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; Ehlhardt LA, 2005, BRAIN INJURY, V19, P569, DOI 10.1080/002699050400013550; Emslie H, 2007, NEUROPSYCHOL REHABIL, V17, P567, DOI 10.1080/09602010701381933; Evans J, 2005, EFFECTIVENESS REHABI, P247; Evans JJ, 1998, J INT NEUROPSYCH SOC, V4, P399, DOI 10.1017/S1355617798003993; Fasotti L, 2000, NEUROPSYCHOL REHABIL, V10, P47, DOI 10.1080/096020100389291; Fasotti L., 1992, NEUROPSYCHOL REHABIL, V2, P3, DOI DOI 10.1080/09602019208401392; Fish J, 2008, J NEUROL NEUROSUR PS, V79, P930, DOI 10.1136/jnnp.2007.125203; Fish J, 2008, J INT NEUROPSYCH SOC, V14, P154, DOI 10.1017/S1355617708080120; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; HANLON R, 1993, NEUROPSYCHOL REHABIL, V3, P63; Hewitt J, 2006, NEUROPSYCHOLOGIA, V44, P1468, DOI 10.1016/j.neuropsychologia.2005.11.016; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KIRSCH NL, 1992, J HEAD TRAUMA REHAB, V7, P13, DOI DOI 10.1097/00001199-199209000-00004; Knight C, 2002, BRAIN INJURY, V16, P75, DOI 10.1080/02699050110082188; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Luria A.R., 1973, WORKING BRAIN INTRO; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Man DWK, 2006, NEUROREHABILITATION, V21, P205; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Manchester D, 1997, BRAIN INJURY, V11, P605, DOI 10.1080/026990597123296; Manly T, 2004, NEUROPSYCHOL REHABIL, V14, P89, DOI 10.1080/09602010343000110; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Marshall RC, 2004, APHASIOLOGY, V18, P659, DOI 10.1080/02687030444000237; Matthey S, 1996, BRAIN INJURY, V10, P219, DOI 10.1080/026990596124539; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nezu A. M., 2008, EVIDENCE BASED OUTCO; POLLENS RD, 1988, COGNITIVE REHABILITA, V5, P26; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Robertson I., 1996, GOAL MANAGEMENT TRAI; Satish U, 2008, DISABIL REHABIL, V30, P468, DOI 10.1080/09638280701625401; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schweizer TA, 2008, NEUROREHAB NEURAL RE, V22, P72, DOI 10.1177/1545968307305303; Serino A, 2007, BRAIN INJURY, V21, P11, DOI 10.1080/02699050601151811; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; Soong W, 2005, INT J REHABIL RES, V28, P341, DOI 10.1097/00004356-200512000-00006; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stablum F, 2007, NEUROPSYCHOL REHABIL, V17, P1, DOI 10.1080/13506280500411111; Stuss D. T., 2009, REHABILITATION EXECU, P3; Tate RL, 2008, NEUROPSYCHOL REHABIL, V18, P385, DOI 10.1080/09602010802009201; Turkstra LS, 2002, J COMMUN DISORD, V35, P467, DOI 10.1016/S0021-9924(02)00118-1; Turner GR, 2004, SCI PRACT NEUROPSYCH, P224; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Watson C, 2001, BRAIN INJURY, V15, P1003, DOI 10.1080/02699050010022662; WEBB PM, 1994, REHABIL PSYCHOL, V39, P179, DOI 10.1037/h0080321; Westerberg H, 2007, BRAIN INJURY, V21, P21, DOI 10.1080/02699050601148726; Wilson BA, 2005, BRAIN INJURY, V19, P891, DOI 10.1080/02699050400002363; Wilson BA, 1997, J NEUROL NEUROSUR PS, V63, P113, DOI 10.1136/jnnp.63.1.113; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; World Health Organization, 2007, INT CLASS FUNCT DIS; WORTHINGTON A, 2005, EFFECTIVENESS REHABI, P257; Worthington A., 2009, REHABILITATION EXECU, P37; Ylvisaker M. E., 1998, TRAUMATIC BRAIN INJU	86	20	20	0	28	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1748-6645			J NEUROPSYCHOL	J. Neuropsychol.	MAR	2011	5		1				73	113		10.1348/174866410X516434			41	Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	739NK	WOS:000288724600005	21366888				2022-02-06	
J	Dionysus, KE; Denney, RL; Halfaker, DA				Dionysus, Kimberly E.; Denney, Robert L.; Halfaker, Dale A.			Detecting Negative Response Bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Symptom validity testing; Traumatic brain injury; Forensic neuropsychology; Assessment	MMPI-2 VALIDITY SCALES; INJURY LITIGANTS; RBS; VALIDATION; UTILITY	The 28-item Response Bias Scale (RBS) and 15-item Henry-Heilbronner Index (HHI) are new validity scales within the Minnesota Multiphasic Personality Inventory-2, designed to detect over-reporting of cognitive and somatic symptomology, respectively. The 43-item Lees-Haley Fake Bad Scale (FBS) was designed to detect noncredible symptom presentations within a personal injury setting. The current study examined the predictive validity of these scales in a criterion-groups design involving head-injured litigants. Archival data were collected and two groups were created using the Slick, Sherman, and Iverson ([1999]. Diagnostic criteria for malingered neurocognitive dysfunction: Proposed standards for clinical practice and research. The Clinical Neuropsychologist, 13, 545-561) Criteria for Probable Negative Response Bias. Results yielded excellent to acceptable discrimination ability for the validity scales, including an area under the curve of 0.83 for FBS, 0.82 for RBS, and 0.73 for HHI. Findings suggest that the FBS, RBS, and HHI perform as well as the other validity scales in discriminating over-reporting within a head-injured litigant setting.	[Dionysus, Kimberly E.; Denney, Robert L.] Forest Inst, Sch Profess Psychol, Springfield, MO USA; [Halfaker, Dale A.] Neuropsychol Associates SW Missouri, Springfield, MO USA		Dionysus, KE (corresponding author), 73 B Mt Ave, Springfield, NJ 07081 USA.	cheyanne412@hotmail.com					Allen L., 1997, CARB 97 MANUAL COMPU; Ben-Porath Y.S., 2008, MMPI 2 RF MINNESOTA; Butcher J, 1989, MANUAL ADM SCORING M; Butcher JN, 2003, ARCH CLIN NEUROPSYCH, V18, P473, DOI 10.1016/S0887-6177(02)00142-7; FRANZEN MD, 2000, CLIN NEUROPSYCHOLOGY; GERVAIS R, 2010, ARCH CLIN NEUROPSYCH, V25, P1; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Green P, 2004, GREENS MED SYMPTOM V; Green P., 2004, MEMORY COMPLAINTS IN; Greiffenstein M.F., 2007, ASSESSMENT FEIGNED C; Greiffenstein MF, 2002, J CLIN PSYCHOL, V58, P1591, DOI 10.1002/jclp.10077; Hathaway S.R., 1943, MINNESOTA MULTIPHASI; Henry GK, 2008, CLIN NEUROPSYCHOL, V22, P919, DOI 10.1080/13854040701625853; Henry GK, 2006, CLIN NEUROPSYCHOL, V20, P786, DOI 10.1080/13854040500287749; Larrabee GJ, 1998, CLIN NEUROPSYCHOL, V12, P179, DOI 10.1076/clin.12.2.179.2008; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P54, DOI 10.1076/clin.17.1.54.15627; Lees-Haley PR, 2004, ARCH CLIN NEUROPSYCH, V19, P333, DOI 10.1016/j.acn.2003.12.004; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; LEESHALEY PR, 1992, J CLIN PSYCHOL, V48, P681, DOI 10.1002/1097-4679(199209)48:5<681::AID-JCLP2270480516>3.0.CO;2-Q; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Miller LJ, 2001, BRAIN INJURY, V15, P297, DOI 10.1080/026990501750111238; Millis SR., 2001, J FORENSIC NEUROPSYC, V2, P1, DOI [10.1300/J151v02n01_01, DOI 10.1300/J151V02N01_]; Nelson NW, 2007, J CLIN EXP NEUROPSYC, V29, P67, DOI 10.1080/13803390500488546; Nelson NW, 2010, CLIN NEUROPSYCHOL, V24, P701, DOI 10.1080/13854040903482863; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rogers R., 1995, ASSESSMENT, V2, P81, DOI DOI 10.1177/1073191195002001008; Ross SR, 2004, J CLIN EXP NEUROPSYC, V26, P115, DOI 10.1076/jcen.26.1.115.23933; Slick DJ, 1996, J CLIN EXP NEUROPSYC, V18, P911, DOI 10.1080/01688639608408313; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 1997, PSYCHOL ASSESSMENT, V9, P260, DOI 10.1037/1040-3590.9.3.260; Whitney KA, 2008, ARCH CLIN NEUROPSYCH, V23, P777, DOI 10.1016/j.acn.2008.09.001; WYGANT DB, 2010, PSYCHOL ASSESSMENT, V10, P1040; Zhou XH., 2002, STAT METHODS DIAGNOS; [No title captured]	39	20	20	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAR	2011	26	2					81	88		10.1093/arclin/acq096			8	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	726RX	WOS:000287744900001	21148668	Bronze			2022-02-06	
J	Swan, AA; Chandrashekar, R; Beare, J; Hoane, MR				Swan, Alicia A.; Chandrashekar, Rupa; Beare, Jason; Hoane, Michael R.			Preclinical Efficacy Testing in Middle-Aged Rats: Nicotinamide, a Novel Neuroprotectant, Demonstrates Diminished Preclinical Efficacy after Controlled Cortical Impact	JOURNAL OF NEUROTRAUMA			English	Article						aging; CCI; nicotinamide; recovery of function; therapy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; IMPROVES FUNCTIONAL RECOVERY; FLUID PERCUSSION INJURY; COGNITIVE DEFICITS; OXIDATIVE STRESS; CONTUSION INJURY; SENSORIMOTOR; PROGESTERONE; PATHWAYS; NEURONS	Age is a consistent predictor of poor outcome following traumatic brain injury (TBI). Although the elderly population has one of the highest rates of TBI-related hospitalization and death, few preclinical studies have attempted to model and treat TBI in the aged population. Recent studies have indicated that nicotinamide (NAM), a soluble B-group vitamin, improved functional recovery in experimental models of TBI in young animals. The purpose of the present study was to examine the preclinical efficacy of NAM in middle-aged rats. Groups of middle-aged (14-month-old) rats were assigned to NAM (500 mg/kg or 50 mg/kg) or saline alone (1 mL/kg) treatment conditions, and received unilateral cortical contusion injuries (CCI) and injections at 1 h and 24 h following injury. The animals were tested on a variety of tasks to assess vestibulomotor (tapered beam) and cognitive performance (reference and working memory in the Morris water maze), and were evaluated for lesion size, blood-brain barrier compromise, astrocytic activation, and edema formation. In summary, the preclinical efficacy of NAM as a treatment following CCI in middle-aged rats differs from that previously documented in younger rats; while treatment with 50 mg/kg NAM appeared to have no effect, the 500-mg/kg dose worsened performance in middle-aged animals. Histological indicators demonstrated more nuanced group differences, indicating that NAM may positively impact some of the cellular cascades following injury, but were not substantial enough to improve functional recovery. These findings emphasize the need to examine potential treatments for TBI utilizing non-standard populations, and may explain why so many treatments have failed in clinical trials.	[Swan, Alicia A.; Chandrashekar, Rupa; Beare, Jason; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrat Res Cognit & Neural Sci, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrat Res Cognit & Neural Sci, Life Sci 2,MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu	Swan, Alicia A/O-3536-2018; Beare, Jason E/D-2870-2016	Swan, Alicia A/0000-0003-2412-0499; Beare, Jason E/0000-0003-3988-1223; Hoane, Michael/0000-0001-7779-2657	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS045647]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R15NS045647] Funding Source: NIH RePORTER	Funding provided by NIH grant NS045647.	Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; BARNES CA, 1998, NEUROBIOL AGING, P563; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Centers for Disease Control and Prevention, 2010, INJ PREV CONTR TRAUM; Chong ZZ, 2008, CURR NEUROVASC RES, V5, P159, DOI 10.2174/156720208785425666; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1991, J NEUROSURG, V75, P916, DOI 10.3171/jns.1991.75.6.0916; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; KATSURI SB, 2009, RESTOR NEUROL NEUROS, V27, P265; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lindner MD, 1999, BEHAV BRAIN RES, V102, P1, DOI 10.1016/S0166-4328(98)00160-0; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; RUTLANDBROWN W, 2006, J HEAD TRAUMA REHAB, P456; Sandhu SK, 2002, BIOGERONTOLOGY, V3, P161, DOI 10.1023/A:1015643107449; SCHALLERT T, 2005, ORIENTING PLACING BE, P129; SHAO C, 2006, FREE RADIC BIOL MED, P77; UNTERBERG A, 1994, ACTA NEUROCHIR, P431; Xu P, 2010, MECH AGEING DEV, V131, P287, DOI 10.1016/j.mad.2010.03.006; Yang J, 2002, NEUROSCI LETT, V333, P91, DOI 10.1016/S0304-3940(02)01005-4	41	20	20	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2011	28	3					431	440		10.1089/neu.2010.1519			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	734WD	WOS:000288370600008	21083416	Green Published			2022-02-06	
J	Zhao, JA; Zhang, SW; Wu, XJ; Huan, WP; Liu, ZQ; Wei, HX; Shen, AG; Teng, HL				Zhao, Jian; Zhang, Shuangwei; Wu, Xiujie; Huan, Weipeng; Liu, Zhiqiang; Wei, Haixiang; Shen, Aiguo; Teng, Honglin			KPC1 Expression and Essential Role After Acute Spinal Cord Injury in Adult Rat	NEUROCHEMICAL RESEARCH			English	Article						SCI; Astrocyte; Proliferation; KPC1; p27(kip1)	UBIQUITIN-MEDIATED DEGRADATION; CDK INHIBITOR P27; CELL-CYCLE; REGULATES PROTEOLYSIS; REACTIVE ASTROCYTES; GLIAL PROLIFERATION; TRAUMATIC BRAIN; P27(KIP1); REGENERATION; MECHANISMS	KPC1 (Kip1 ubiquitylation-promoting complex 1) is the catalytic subunit of the ubiquitin ligase KPC, which regulates the degradation of the cyclin-dependent kinase inhibitor p27(kip1) at the G1 phase of the cell cycle. To elucidate the expression and role of KPC1 in nervous system lesion and repair, we performed an acute spinal cord contusion injury (SCI) model in adult rats. Western blot analysis showed a significant up-regulation of KPC1 and a concomitant down-regulation of p27(kip1) following spinal injury. Immunohistochemistry and immunofluorescence revealed wide expression of KPC1 in the spinal cord, including expression in neurons and astrocytes. After injury, KPC1 expression was increased predominantly in astrocytes, which highly expressed PCNA, a marker for proliferating cells. Co-immunoprecipitation demonstrated increased interactions between p27(kip1) and KPC1 4 days after injury. To understand whether KPC1 plays a role in astrocyte proliferation, we applied LPS to induce astrocyte proliferation in vitro. Western blot analysis demonstrated that p27(kip1) expression was negatively correlated with KPC1 expression following LPS stimulation. Immunofluorescence analysis showed subcellular localizations of p27(kip1) and KPC1 were also changed following the stimulation of astrocytes with LPS. These results suggest that KPC1 is related to the down-regulation of p27(kip1); this event may be involved in the proliferation of astrocytes after SCI.	[Zhao, Jian; Zhang, Shuangwei; Wu, Xiujie; Huan, Weipeng; Liu, Zhiqiang; Wei, Haixiang; Shen, Aiguo] Nantong Univ, Affiliated Hosp, Dept Orthoped, Nantong 226001, Peoples R China; [Zhao, Jian; Zhang, Shuangwei; Wu, Xiujie; Huan, Weipeng; Liu, Zhiqiang; Wei, Haixiang; Shen, Aiguo] Nantong Univ, Jiangsu Prov Key Lab Neuroregenerat, Nantong 226001, Peoples R China; [Teng, Honglin] Affiliated Hosp 1, Wenzhou Med Coll, Dept Spine Surg, Wenzhou 325000, Zhejiang, Peoples R China		Shen, AG (corresponding author), Nantong Univ, Affiliated Hosp, Dept Orthoped, Nantong 226001, Peoples R China.	shen_aiguo@yahoo.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770488, 30870320, 31070723, 81071487, 81070275]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2009156, BK2009157, BK2009161, BK2009169]; 333 high-level personnel training project of Jiangsu Province [BRA2010137]; Natural Science Foundation of Zhejiang ProvinceNatural Science Foundation of Zhejiang Province [Y2090545]	This work was supported by the National Natural Science Foundation of China (No. 30770488, No. 30870320, No. 31070723, No. 81071487 and No. 81070275), Natural Science Foundation of Jiangsu Province (No. BK2009156, No. BK2009157 and No. BK2009161; BK2009169), the 333 high-level personnel training project of Jiangsu Province (No. BRA2010137) and the Natural Science Foundation of Zhejiang Province (Y2090545).	Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Coats S, 1996, SCIENCE, V272, P877, DOI 10.1126/science.272.5263.877; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Fawcett JW, 1997, CELL TISSUE RES, V290, P371, DOI 10.1007/s004410050943; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Fillies T, 2007, ONCOL REP, V17, P355; Go HS, 2009, NEUROIMMUNOMODULAT, V16, P365, DOI 10.1159/000228911; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; GRUNER JA, 1992, J NEUROTRAUM, V9, P126; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kotoshiba S, 2005, J BIOL CHEM, V280, P17694, DOI 10.1074/jbc.M500866200; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McGraw J, 2001, J NEUROSCI RES, V63, P109, DOI 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J; MCMILLIAN MK, 1994, TRENDS NEUROSCI, V17, P138, DOI 10.1016/0166-2236(94)90086-8; Minamishima YA, 2002, CANCER RES, V62, P995; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nieto-Sampedro M, 1999, ADV EXP MED BIOL, V468, P207; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sgambato A, 2000, J CELL PHYSIOL, V183, P18, DOI 10.1002/(SICI)1097-4652(200004)183:1<18::AID-JCP3>3.0.CO;2-S; Shen AU, 2008, NEUROCHEM INT, V52, P1266, DOI 10.1016/j.neuint.2008.01.011; Shirane M, 1999, J BIOL CHEM, V274, P13886, DOI 10.1074/jbc.274.20.13886; Signoretti S, 2002, J CLIN INVEST, V110, P633, DOI 10.1172/JCI200215795; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sun LL, 2007, J MOL NEUROSCI, V32, P16, DOI 10.1007/s12031-007-0003-x; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Tawfik VL, 2006, GLIA, V54, P193, DOI 10.1002/glia.20365; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Wyndaele M, 2006, SPINAL CORD, V44, P523, DOI 10.1038/sj.sc.3101893; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	43	20	23	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	MAR	2011	36	3					549	558		10.1007/s11064-010-0377-y			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	716RB	WOS:000286990100024	21229311				2022-02-06	
J	Han, BJ; Wang, QG; Cui, GY; Shen, X; Zhu, ZF				Han, Bojun; Wang, Qingguang; Cui, Guiyun; Shen, Xia; Zhu, Zufu			Post-treatment of Bax-inhibiting peptide reduces neuronal death and behavioral deficits following global cerebral ischemia	NEUROCHEMISTRY INTERNATIONAL			English	Article						Cerebral ischemia; Bax-inhibiting peptide; Neuroprotection; Learning and memory	TRAUMATIC BRAIN-INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; TRANSIENT FOREBRAIN ISCHEMIA; DELAYED CELL-DEATH; CYTOCHROME-C; NEURODEGENERATIVE DISORDERS; SELECTIVE VULNERABILITY; SIGNALING PATHWAY; OXIDATIVE DAMAGE; RAT	Cerebral ischemia is a major cause of adult disability and death worldwide. Evidence suggests that Bax-dependent initiation and activation of intrinsic apoptotic pathways contribute to ischemic brain injury. We investigated the Bax-inhibiting peptide VPALR, designed from the rat Ku70-Bax inhibiting domain, on the apoptotic neuronal cell death and behavioral deficits following global cerebral ischemia. The pentapeptide was infused into the left lateral ventricle of the rat brain by intracerebroventricular (icv) injection 1 h after cerebral ischemia, and results showed that it highly permeated hippocampal neurons and bound to Bax protein in vivo. Post-treatment with VPALR reduced the delayed neuronal damage by approximately 78% compared to the non-treated ischemic control and scrambled peptide-treated rats. TUNEL analysis revealed that VPALR markedly reduced the ischemia-induced increase in apoptotic neuronal death in rat hippocampal CA1 region. VPALR post-treatment also significantly attenuated Bax activation and its mitochondrial translocation as compared with scrambled peptide-treated animals. Concomitantly, Bax-inhibiting peptide-treated rats showed reduced cytochrome c release from mitochondria to cytosol and reduced caspase-3 activation in response to cerebral ischemia, indicating that activation of the intrinsic apoptotic pathway was reduced. Furthermore, Bax-inhibiting peptide improved spatial learning and memory performance in the Morris water maze, which was seriously affected by global cerebral ischemia. In conclusion, Bax inhibition by cell-permeable pentapeptides reduced apoptotic neuronal injury in the hippocampal CA1 region and behavioral deficits following global ischemia. These results suggest that Bax is a potential target for pharmacological neuroprotection and that Bax-inhibiting peptide may be a promising neuroprotective strategy for cerebral ischemia. (C) 2010 Elsevier Ltd. All rights reserved.	[Han, Bojun; Wang, Qingguang; Zhu, Zufu] Southeast Univ, Affiliated Jiangyin Hosp, Dept Neurol, Coll Med, Jiangyin 214400, Jiangsu Prov, Peoples R China; [Cui, Guiyun; Shen, Xia] Xuzhou Med Coll, Affiliated Hosp, Dept Neurol, Xuzhou 221002, Jiangsu Prov, Peoples R China		Zhu, ZF (corresponding author), Southeast Univ, Affiliated Jiangyin Hosp, Dept Neurol, Coll Med, 163 Shoushan Rd, Jiangyin 214400, Jiangsu Prov, Peoples R China.	zufuzhu@gmail.com			Educational Commission of Jiangsu Province of China [05KJD320229]	This work was supported by a grant from the Educational Commission of Jiangsu Province of China (no. 05KJD320229).	Amsel AD, 2008, P NATL ACAD SCI USA, V105, P5117, DOI 10.1073/pnas.0706700105; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bakalkin G, 1998, NEUROREPORT, V9, P2147, DOI 10.1097/00001756-199806220-00044; Bazan NG, 2005, ANN NY ACAD SCI, V1053, P137, DOI 10.1196/annals.1344.011; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Cao GD, 2001, J CEREBR BLOOD F MET, V21, P321, DOI 10.1097/00004647-200104000-00001; Cao GD, 2002, J CEREBR BLOOD F MET, V22, P534, DOI 10.1097/00004647-200205000-00005; Chechlacz M, 2001, J NEUROCHEM, V78, P141, DOI 10.1046/j.1471-4159.2001.00380.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dash PK, 2009, NEUROSCIENCE, V163, P1, DOI 10.1016/j.neuroscience.2009.06.028; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Feng YZ, 2003, NEUROSCI LETT, V344, P201, DOI 10.1016/S0304-3940(03)00466-X; Fewell JW, 1996, J CELL SCI, V109, P1937; Flynn RWV, 2008, NEUROPHARMACOLOGY, V55, P250, DOI 10.1016/j.neuropharm.2008.05.031; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Gao YQ, 2010, STROKE, V41, P166, DOI 10.1161/STROKEAHA.109.561852; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P1117, DOI 10.1097/01.WCB.0000089600.87125.AD; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Iriyama T, 2009, NEUROSCI LETT, V451, P11, DOI 10.1016/j.neulet.2008.12.021; Jemmerson R, 2005, ANTIOXID REDOX SIGN, V7, P1158, DOI 10.1089/ars.2005.7.1158; Jin KL, 2001, J CEREBR BLOOD F MET, V21, P1411, DOI 10.1097/00004647-200112000-00005; Kadenbach B, 2004, BBA-BIOENERGETICS, V1655, P400, DOI 10.1016/j.bbabio.2003.06.005; Kim SH, 1999, CANCER RES, V59, P4012; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P201, DOI 10.1007/BF00691853; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Mishra OP, 2001, MENT RETARD DEV D R, V7, P249, DOI 10.1002/mrdd.1034; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouw G, 2002, METAB BRAIN DIS, V17, P143, DOI 10.1023/A:1019921904378; Nishimura M, 2003, J CEREBR BLOOD F MET, V23, P1052, DOI 10.1097/01.WCB.0000084251.20114.65; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Plesnila N, 2004, ACTA NEUROCHIR SUPPL, V89, P15; PLUM F, 1988, NEUROCHEM PATHOL, V9, P139; Polster BM, 2001, J BIOL CHEM, V276, P37887; PULSINELLI WA, 1979, STROKE, V10, P267, DOI 10.1161/01.STR.10.3.267; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rathaus M, 2009, CELL CYCLE, V8, P1843, DOI 10.4161/cc.8.12.8864; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; ROSENTHAL RE, 1987, J CEREBR BLOOD F MET, V7, P752, DOI 10.1038/jcbfm.1987.130; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; SIMS NR, 1991, J NEUROCHEM, V56, P1836, DOI 10.1111/j.1471-4159.1991.tb03438.x; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Sugawara T, 1999, J NEUROSCI, V19, part. no.; Velier JJ, 1999, J NEUROSCI, V19, P5932, DOI 10.1523/JNEUROSCI.19-14-05932.1999; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Wang XY, 2010, STROKE, V41, P2050, DOI 10.1161/STROKEAHA.110.589051; Yoshida T, 2004, BIOCHEM BIOPH RES CO, V321, P961, DOI 10.1016/j.bbrc.2004.07.054; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	58	20	23	1	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	FEB	2011	58	2					224	233		10.1016/j.neuint.2010.12.008			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	718ZV	WOS:000287166800012	21167243				2022-02-06	
J	Harris, RA; Amor, S				Harris, Robert A.; Amor, Sandra			Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders	CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS			English	Article						Oxidative stress; advanced glycation endproducts; advanced oxidation protein products; multiple sclerosis; neurodegeneration	GLYCATION END-PRODUCTS; AMYOTROPHIC-LATERAL-SCLEROSIS; AMYLOID-BETA-PEPTIDE; PROGRESSIVE SUPRANUCLEAR PALSY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; CREUTZFELDT-JAKOB-DISEASE; ENDOPLASMIC-RETICULUM STRESS; TRAUMATIC BRAIN-INJURY; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS	The nervous system is a unique network of different cell types and comprises a variety of proteins, lipids, and carbohydrates that have an important interplay with all major organs in the body. Homeostatic regulation of nervous tissue turnover must be carefully controlled, taking into account interactions of the nervous, endocrine, and immune systems. Clinical conditions affecting the nervous system range from mild cognitive perturbations such as headache, to life-threatening acute courses such as meningitis and glioblastoma, and to chronic neurodegenerative diseases such as multiple sclerosis. One unifying feature in normal developmental or homeostatic functions and clinical dysfunctions within the nervous system is redox regulation, with an imbalance in oxidative/carbonyl stress versus antioxidants being characteristic of pathological conditions. In this review we consider the state of current knowledge regarding structural, genetic, proteomic, histopathological, clinical, and therapeutic perspectives of oxidative and carbonyl stress within the nervous system.	[Harris, Robert A.] Karolinska Hosp Solna, Dept Clin Neurosci, Karolinska Inst, Ctr Mol Med, Solna, Sweden; [Amor, Sandra] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Amor, Sandra] Queen Mary Univ London, Neuroimmunol Unit, Ctr Neurosci, Blizard Inst Cell & Mol Sci,Barts & London Sch Me, London, England		Harris, RA (corresponding author), Karolinska Hosp, Karolinska Inst, Dept Clin Neurosci, Ctr Mol Med L8 04, S-17176 Stockholm, Sweden.	Robert.Harris@ki.se	Harris, Robert A./I-6234-2019	Harris, Robert A./0000-0003-4990-509X; Amor, Sandra/0000-0001-6169-9845	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission; Dutch Multiple Sclerosis society - Stichting MS Research; Multiple Sclerosis society of Great Britain; Multiple Sclerosis society of Northern Ireland; DANA foundation	The authors gratefully acknowledge the support of the Swedish Medical Research Council, the Dutch Multiple Sclerosis society - Stichting MS Research, the Multiple Sclerosis society of Great Britain and Northern Ireland, and the DANA foundation.	Abdul-Majid KB, 2000, J NEUROIMMUNOL, V111, P23, DOI 10.1016/S0165-5728(00)00360-X; Adibhatla RM, 2010, ANTIOXID REDOX SIGN, V12, P125, DOI [10.1089/ars.2009.2668, 10.1089/ARS.2009.2668]; Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Agnello D, 2002, CYTOKINE, V18, P231, DOI 10.1006/cyto.2002.0890; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Albers DS, 2001, TRENDS NEUROSCI, V24, P347, DOI 10.1016/S0166-2236(00)01794-X; Alderson NL, 2004, DIABETOLOGIA, V47, P1385, DOI 10.1007/s00125-004-1474-8; Aldini G, 2007, MED RES REV, V27, P817, DOI 10.1002/med.20073; Andersson A, 2008, J LEUKOCYTE BIOL, V84, P1248, DOI 10.1189/jlb.1207844; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Ando Y, 1997, BIOCHEM BIOPH RES CO, V232, P497, DOI 10.1006/bbrc.1996.5997; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Aoyama K, 2006, EUR J NEUROL, V13, P89, DOI 10.1111/j.1468-1331.2006.01139.x; Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Arbus C, 2010, PSYCHOL NEUROPSYCHIA, V8, P7, DOI 10.1684/pnv.2010.0205; Arlt S, 2002, CURR OPIN LIPIDOL, V13, P289, DOI 10.1097/00041433-200206000-00009; Arlt S, 2002, NEUROBIOL DIS, V10, P150, DOI 10.1006/nbdi.2002.0496; ARMSTRONG JS, 2010, FASEB J IN PRESS; Arnulf I, 2005, SLEEP, V28, P349; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Aycicek A, 2006, BRAIN RES BULL, V69, P666, DOI 10.1016/j.brainresbull.2006.03.014; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Beisswenger PJ, 2003, BIOCHEM SOC T, V31, P1358; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; Biering-Sorensen F, 2009, RESP PHYSIOL NEUROBI, V169, P165, DOI 10.1016/j.resp.2009.08.014; Bizzozero OA, 2005, J NEUROSCI RES, V81, P687, DOI 10.1002/jnr.20587; Bolognesi ML, 2009, NEUROTHERAPEUTICS, V6, P152, DOI 10.1016/j.nurt.2008.10.042; Bolton WK, 2004, AM J NEPHROL, V24, P32, DOI 10.1159/000075627; Bopp C, 2008, CRIT CARE, V12, DOI 10.1186/cc6164; Bostanci MO, 2010, CELL MOL NEUROBIOL, V30, P389, DOI 10.1007/s10571-009-9461-8; Bradley JL, 2004, NEUROCHEM RES, V29, P561, DOI 10.1023/B:NERE.0000014826.00881.c3; Bradley MA, 2010, FREE RADICAL BIO MED, V48, P1570, DOI 10.1016/j.freeradbiomed.2010.02.016; Brass SD, 2010, SLEEP MED REV, V14, P121, DOI 10.1016/j.smrv.2009.07.005; BRETT J, 1993, AM J PATHOL, V143, P1699; BRETT R, 1993, NEUROCHEM INT, V23, P35, DOI 10.1016/0197-0186(93)90141-Q; Bro S, 2008, ATHEROSCLEROSIS, V201, P274, DOI 10.1016/j.atherosclerosis.2008.01.015; BROWN MK, 2010, MOL NEUROBI IN PRESS; BROWNLEE M, 1986, SCIENCE, V232, P1629, DOI 10.1126/science.3487117; Bruce-Keller AJ, 1998, J NEUROPATH EXP NEUR, V57, P257, DOI 10.1097/00005072-199803000-00007; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; CALABRESE V, 1994, INT J CLIN PHARM RES, V14, P119; Calabrese Vittorio, 2006, Ital J Biochem, V55, P263; Calkins MJ, 2005, P NATL ACAD SCI USA, V102, P244, DOI 10.1073/pnas.0408487101; Candido R, 2003, CIRC RES, V92, P785, DOI 10.1161/01.RES.0000065620.39919.20; Capeillere-Blandin C, 2004, BBA-MOL BASIS DIS, V1689, P91, DOI 10.1016/j.bbadis.2004.02.008; Castellani RJ, 2002, NEUROSCI LETT, V319, P25, DOI 10.1016/S0304-3940(01)02514-9; Chavakis T, 2003, J EXP MED, V198, P1507, DOI 10.1084/jem.20030800; Cheng CM, 2005, MODERN PATHOL, V18, P1385, DOI 10.1038/modpathol.3800450; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chou DKH, 2004, J NEUROCHEM, V90, P1389, DOI 10.1111/j.1471-4159.2004.02609.x; COLACO CALS, 1994, NEUROREPORT, V5, P859, DOI 10.1097/00001756-199404000-00001; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Cu XP, 2008, J NUTR SCI VITAMINOL, V54, P321; Dalfo E, 2005, J NEUROPATH EXP NEUR, V64, P816, DOI 10.1097/01.jnen.0000179050.54522.5a; Dalle-Donne I, 2003, TRENDS MOL MED, V9, P169, DOI 10.1016/S1471-4914(03)00031-5; Dasgupta S, 2007, MOL PHARMACOL, V72, P934, DOI 10.1124/mol.106.033787; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Arriba SG, 2006, FREE RADICAL BIO MED, V40, P779, DOI 10.1016/j.freeradbiomed.2005.09.038; Deane R, 2004, STROKE, V35, P2628, DOI 10.1161/01.STR.0000143452.85382.d1; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deepa D, 2008, ANN INDIAN ACAD NEUR, V11, P44, DOI 10.4103/0972-2327.40225; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; DEXTER DT, 1989, J NEUROCHEM, V52, P381, DOI 10.1111/j.1471-4159.1989.tb09133.x; Ding QX, 2005, BBA-MOL CELL RES, V1746, P18, DOI 10.1016/j.bbamcr.2005.08.006; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Dobrowsky RT, 2005, J PHARMACOL EXP THER, V313, P485, DOI 10.1124/jpet.104.079921; Donahue JE, 2006, ACTA NEUROPATHOL, V112, P405, DOI 10.1007/s00401-006-0115-3; Duda JE, 2000, AM J PATHOL, V157, P1439, DOI 10.1016/S0002-9440(10)64781-5; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Espejo C, 2001, NEUROSCIENCE, V105, P1055, DOI 10.1016/S0306-4522(01)00252-4; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FAHN S, 1992, ANN NEUROL, V32, P804, DOI 10.1002/ana.410320616; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Figarola JL, 2003, DIABETOLOGIA, V46, P1140, DOI 10.1007/s00125-003-1162-0; Fitzmaurice PS, 2003, MOVEMENT DISORD, V18, P969, DOI 10.1002/mds.10486; Floor E, 1998, J NEUROCHEM, V70, P268; Forbes JM, 2004, DIABETES, V53, P1813, DOI 10.2337/diabetes.53.7.1813; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Freitas RM, 2009, NEUROSCI LETT, V462, P225, DOI 10.1016/j.neulet.2009.07.037; Freixes M, 2006, NEUROBIOL AGING, V27, P1807, DOI 10.1016/j.neurobiolaging.2005.10.006; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; GOMES R, 2005, BIOCHEM J, V385, P9; Gonsette RE, 2008, J NEUROL SCI, V274, P48, DOI 10.1016/j.jns.2008.06.029; Goodman AOG, 2010, J NEUROL, V257, P882, DOI 10.1007/s00415-010-5517-4; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Guazzi S, 2003, GENE EXPR PATTERNS, V3, P29, DOI 10.1016/S1567-133X(02)00093-5; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Guo ZY, 2008, ANTIOXID REDOX SIGN, V10, P127, DOI 10.1089/ars.2007.1860; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hamanishi T, 2004, DIABETES, V53, P2455, DOI 10.2337/diabetes.53.9.2455; Hartzler AW, 2002, NEUROBIOL AGING, V23, P855, DOI 10.1016/S0197-4580(02)00029-5; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Hedreul MT, 2009, J NEUROIMMUNOL, V210, P30, DOI 10.1016/j.jneuroim.2009.02.010; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Herold K, 2007, J LEUKOCYTE BIOL, V82, P204, DOI 10.1189/jlb.1206751; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horiuchi S, 1996, DIABETES, V45, pS73, DOI 10.2337/diab.45.3.S73; Hudson BI, 2001, DIABETES, V50, pA236; Huizinga R, 2007, J NEUROPATH EXP NEUR, V66, P295, DOI 10.1097/nen.0b013e318040ad5c; Huizinga R, 2008, NEUROBIOL DIS, V32, P461, DOI 10.1016/j.nbd.2008.08.009; Hunot S, 1999, J NEUROSCI, V19, P3440; HUNTER MIS, 1985, NEUROCHEM RES, V10, P1645, DOI 10.1007/BF00988606; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Iacobini C, 2009, J PATHOL, V218, P360, DOI 10.1002/path.2536; Ilzecka J, 2009, ACTA NEUROL SCAND, V120, P119, DOI 10.1111/j.1600-0404.2008.01133.x; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Jang SI, 2003, PLANTA MED, V69, P1057, DOI 10.1055/s-2003-45157; Jang Y, 2007, METABOLISM, V56, P199, DOI 10.1016/j.metabol.2006.09.013; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; JENSEN GE, 1984, J NEUROL SCI, V63, P45, DOI 10.1016/0022-510X(84)90107-2; Jinnouchi Y, 2006, CLIN EXP MED, V6, P191, DOI 10.1007/s10238-006-0115-6; Johnson JA, 2008, ANN NY ACAD SCI, V1147, P61, DOI 10.1196/annals.1427.036; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; Kalea AZ, 2009, CLIN SCI, V116, P621, DOI 10.1042/CS20080494; Kalousova M, 2005, MUTAT RES-FUND MOL M, V579, P37, DOI 10.1016/j.mrfmmm.2005.03.024; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Kaufmann E, 2004, NEUROSCI LETT, V371, P226, DOI 10.1016/j.neulet.2004.08.071; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kearney M, 2009, COCHRANE DB SYST REV, V4; Keller JN, 1997, J NEUROCHEM, V69, P1073; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kimura T, 1996, NEUROSCI LETT, V219, P95, DOI 10.1016/S0304-3940(96)13173-6; Kimura T, 1998, PATHOL INT, V48, P575, DOI 10.1111/j.1440-1827.1998.tb03953.x; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Krapfenbauer K, 2003, BRAIN RES, V967, P152, DOI 10.1016/S0006-8993(02)04243-9; Kreisler A, 2007, BRAIN RES, V1135, P77, DOI 10.1016/j.brainres.2006.12.011; Kruman I, 1997, J NEUROSCI, V17, P5089; Kunz M, 2008, PROG NEURO-PSYCHOPH, V32, P1677, DOI 10.1016/j.pnpbp.2008.07.001; LANGEMANN H, 1992, EUR NEUROL, V32, P248, DOI 10.1159/000116835; Lassmann H, 2003, J NEUROL NEUROSUR PS, V74, P695, DOI 10.1136/jnnp.74.6.695; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; LI JJ, 1995, NEUROBIOL AGING, V16, P69, DOI 10.1016/0197-4580(95)80009-G; LI JJ, 1994, BRAIN RES, V641, P285, DOI 10.1016/0006-8993(94)90156-2; Li KS, 2010, J NEURAL TRANSM, V117, P97, DOI 10.1007/s00702-009-0334-6; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Limousin N, 2009, SLEEP MED, V10, P690, DOI 10.1016/j.sleep.2008.08.003; Liu JSH, 2001, AM J PATHOL, V158, P2057, DOI 10.1016/S0002-9440(10)64677-9; Lo Coco D, 2009, MOVEMENT DISORD, V24, P1555, DOI 10.1002/mds.22629; Lolmede K, 2009, J LEUKOCYTE BIOL, V85, P779, DOI 10.1189/jlb.0908579; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Lovell MA, 2001, NEUROBIOL AGING, V22, P187, DOI 10.1016/S0197-4580(00)00235-9; Lovett-Racke AE, 2004, J IMMUNOL, V172, P5790, DOI 10.4049/jimmunol.172.9.5790; Lu CY, 2009, BBA-MOL BASIS DIS, V1792, P1052, DOI 10.1016/j.bbadis.2009.07.011; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Ma L, 2004, BRAIN RES, V1018, P10, DOI 10.1016/j.brainres.2004.05.052; Ma L, 2003, BRAIN RES, V966, P167, DOI 10.1016/S0006-8993(02)04149-5; Mackic JB, 1998, J CLIN INVEST, V102, P734, DOI 10.1172/JCI2029; Mancuso M, 2010, CURR DRUG TARGETS, V11, P111, DOI 10.2174/138945010790031018; Mangas A, 2009, CURR MED CHEM, V16, P3203, DOI 10.2174/092986709788803259; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Mark RJ, 1997, J NEUROSCI, V17, P1046; Markesbery WR, 1998, NEUROBIOL AGING, V19, P33, DOI 10.1016/S0197-4580(98)00009-8; Martinez A, 2008, J NEURAL TRANSM, V115, P59, DOI 10.1007/s00702-007-0800-y; Matsui T, 2010, PHARMACOL RES, V61, P34, DOI 10.1016/j.phrs.2009.07.004; Matsui T, 2009, BIOCHEM BIOPH RES CO, V385, P269, DOI 10.1016/j.bbrc.2009.05.061; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; McEwen JE, 2005, CURR OPIN CARDIOL, V20, P399, DOI 10.1097/01.hco.0000175517.50181.89; Meiners I, 2004, J NEURAL TRANSM, V111, P441, DOI 10.1007/s00702-003-0066-y; Miller MC, 2008, BRAIN RES, V1230, P273, DOI 10.1016/j.brainres.2008.06.124; Miyata T, 2002, J AM SOC NEPHROL, V13, p218A; Montine KS, 1997, J NEUROPATH EXP NEUR, V56, P866, DOI 10.1097/00005072-199708000-00004; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Moreau C, 2005, NEUROLOGY, V65, P1958, DOI 10.1212/01.wnl.0000188907.97339.76; Muntane G, 2006, J NEUROCHEM, V99, P177, DOI 10.1111/j.1471-4159.2006.04032.x; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; Naidoo N, 2009, REV NEUROSCIENCE, V20, P23; NAIDOO R, 1992, CLIN CHEM, V38, P2449; Navarro A, 2009, FREE RADICAL BIO MED, V46, P1574, DOI 10.1016/j.freeradbiomed.2009.03.007; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; NEWCOMBE J, 1994, NEUROPATH APPL NEURO, V20, P152, DOI 10.1111/j.1365-2990.1994.tb01174.x; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nicholl ID, 1998, CELL MOL BIOL, V44, P1025; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; O'Connor KA, 2003, CYTOKINE, V24, P254, DOI 10.1016/j.cyto.2003.08.001; Odetti P, 1998, BIOCHEM BIOPH RES CO, V243, P849, DOI 10.1006/bbrc.1998.8186; Odetti P, 2000, J NEUROPATH EXP NEUR, V59, P393, DOI 10.1093/jnen/59.5.393; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Ouslimani N, 2007, METABOLISM, V56, P308, DOI 10.1016/j.metabol.2006.10.010; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pamplona R, 2005, J BIOL CHEM, V280, P21522, DOI 10.1074/jbc.M502255200; Pamplona R, 2008, FREE RADICAL BIO MED, V45, P1159, DOI 10.1016/j.freeradbiomed.2008.07.009; PARISI P, 2010, DEV MED CHI IN PRESS; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Passalacqua M, 1998, NEUROSCIENCE, V82, P1021; PATTEN SB, 1992, J AM ACAD CHILD PSY, V31, P100, DOI 10.1097/00004583-199201000-00015; Pedersen MO, 2009, BIOFACTORS, V35, P315, DOI 10.1002/biof.44; Pedersen WA, 1998, ANN NEUROL, V44, P819, DOI 10.1002/ana.410440518; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Penkowa M, 2003, CELL MOL LIFE SCI, V60, P185, DOI 10.1007/s000180300013; Penkowa M, 2003, CELL MOL LIFE SCI, V60, P1258, DOI 10.1007/s00018-003-3021-z; Penkowa M, 2001, J NEUROIMMUNOL, V119, P248, DOI 10.1016/S0165-5728(01)00357-5; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; PETRONILHO F, 2009, J SURG RES IN PRESS; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Pilobello KT, 2007, CURR OPIN CHEM BIOL, V11, P300, DOI 10.1016/j.cbpa.2007.05.002; Pinel-Marie ML, 2009, FREE RADICAL BIO MED, V47, P825, DOI 10.1016/j.freeradbiomed.2009.06.025; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Previtali SC, 2003, J NEUROSCI, V23, P5520; PRIEGOCAPOTE F, 2009, MASS SPECTROM REV, V28; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Puccio H, 2009, J NEUROL, V256, P18, DOI 10.1007/s00415-009-1004-1; Pullerits R, 2009, RHEUMATOLOGY, V48, P785, DOI 10.1093/rheumatology/kep079; Qin JD, 2008, J NEUROSCI RES, V86, P2414, DOI 10.1002/jnr.21692; Ramanan S, 2010, PPAR RES, V2010, DOI 10.1155/2010/234975; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Rezin GT, 2009, NEUROCHEM RES, V34, P1021, DOI 10.1007/s11064-008-9865-8; Rhodes D A, 1999, Rev Immunogenet, V1, P21; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Rockwell P, 2000, ARCH BIOCHEM BIOPHYS, V374, P325, DOI 10.1006/abbi.1999.1646; Rong LL, 2004, FASEB J, V18, P1818, DOI 10.1096/fj.04-1900com; Roriz JS, 2009, BBA-MOL BASIS DIS, V1792, P432, DOI 10.1016/j.bbadis.2008.12.003; Rossi F, 1996, BIOCHEM BIOPH RES CO, V225, P474, DOI 10.1006/bbrc.1996.1197; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; RUULS SR, 1995, J NEUROIMMUNOL, V56, P207, DOI 10.1016/0165-5728(94)00154-G; Salminen A, 2009, J MOL MED, V87, P697, DOI 10.1007/s00109-009-0472-1; SALVI F, 1990, J NEUROL NEUROSUR PS, V53, P522, DOI 10.1136/jnnp.53.6.522; SANTOS R, 2010, ANTIOXID RE IN PRESS; Sasaki N, 2002, NEUROSCI LETT, V326, P117, DOI 10.1016/S0304-3940(02)00310-5; Sasaki N, 2001, BRAIN RES, V888, P256, DOI 10.1016/S0006-8993(00)03075-4; Sasaki N, 1998, AM J PATHOL, V153, P1149, DOI 10.1016/S0002-9440(10)65659-3; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Scott GS, 2005, P NATL ACAD SCI USA, V102, P3483, DOI 10.1073/pnas.0500307102; Selley ML, 2002, NEUROBIOL AGING, V23, P383, DOI 10.1016/S0197-4580(01)00327-X; SHAW PJ, 1995, ANN NEUROL, V38, P691, DOI 10.1002/ana.410380424; Shibata N, 2001, BRAIN RES, V917, P97, DOI 10.1016/S0006-8993(01)02926-2; Shibata T, 2006, J BIOL CHEM, V281, P1196, DOI 10.1074/jbc.M509065200; Shih AY, 2003, J NEUROSCI, V23, P3394, DOI 10.1523/jneurosci.23-08-03394.2003; Shoham S, 2000, CELL MOL BIOL, V46, P743; Shringarpure R, 2000, CELL MOL LIFE SCI, V57, P1802, DOI 10.1007/PL00000660; SHUKLA VKS, 1977, ACTA NEUROL SCAND, V56, P542; Sidoti A, 2007, MULT SCLER J, V13, P446, DOI 10.1177/13524585070130040201; Sitte N, 2000, FASEB J, V14, P2495, DOI 10.1096/fj.00-0209com; Smerjac SM, 2008, J NEUROCHEM, V105, P763, DOI 10.1111/j.1471-4159.2007.05178.x; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; Sousa MM, 2003, PROG NEUROBIOL, V71, P385, DOI 10.1016/j.pneurobio.2003.11.002; Sousa MM, 2001, J NEUROSCI, V21, P7576, DOI 10.1523/JNEUROSCI.21-19-07576.2001; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Spitsin SV, 2002, FREE RADICAL BIO MED, V33, P1363, DOI 10.1016/S0891-5849(02)01048-1; Srikrishna G, 2002, J NEUROCHEM, V80, P998, DOI 10.1046/j.0022-3042.2002.00796.x; Staedt J, 2010, FORTSCHR NEUROL PSYC, V78, P70, DOI 10.1055/s-0028-1109967; Steinbrecher UP, 1999, BBA-MOL CELL BIOL L, V1436, P279, DOI 10.1016/S0005-2760(98)00127-1; Steiner J, 2009, BIOL PSYCHIAT, V65, P1107, DOI 10.1016/j.biopsych.2008.10.044; Sternberg Z, 2008, MULT SCLER J, V14, P759, DOI 10.1177/1352458507088105; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Sturchler E, 2008, J NEUROSCI, V28, P5149, DOI 10.1523/JNEUROSCI.4878-07.2008; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Takazawa T, 2010, INTERNAL MED, V49, P183, DOI 10.2169/internalmedicine.49.2720; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Timmer MSM, 2007, CURR OPIN CHEM BIOL, V11, P59, DOI 10.1016/j.cbpa.2006.11.040; Tiszlavicz Z, 2009, J MOL NEUROSCI, V39, P360, DOI 10.1007/s12031-009-9291-7; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; vanderVeen RC, 1997, J NEUROIMMUNOL, V77, P1, DOI 10.1016/S0165-5728(97)00013-1; Vankova J, 2003, SLEEP, V26, P427, DOI 10.1093/sleep/26.4.427; Vincent AM, 2007, ENDOCRINOLOGY, V148, P548, DOI 10.1210/en.2006-0073; VITEK MP, 1994, P NATL ACAD SCI USA, V91, P4766, DOI 10.1073/pnas.91.11.4766; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Vladimirova O, 1998, MULT SCLER, V4, P413, DOI 10.1177/135245859800400503; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Voss P, 2006, FREE RADICAL RES, V40, P1339, DOI 10.1080/10715760600953859; Vucic S, 2009, CURR MOL MED, V9, P255, DOI 10.2174/156652409787847173; Waldbaum S, 2010, EPILEPSY RES, V88, P23, DOI 10.1016/j.eplepsyres.2009.09.020; Wallberg M, 2007, EUR J IMMUNOL, V37, P1986, DOI 10.1002/eji.200636912; Wang JF, 2009, BIPOLAR DISORD, V11, P523, DOI 10.1111/j.1399-5618.2009.00717.x; Wang L, 2010, BRAIN RES, V1321, P143, DOI 10.1016/j.brainres.2009.12.046; Wang LY, 2008, J NEUROSCI RES, V86, P1254, DOI 10.1002/jnr.21578; Wang MY, 2009, ACTA NEUROPATHOL, V118, P381, DOI 10.1007/s00401-009-0513-4; Wang X, 2009, CNS NEUROSCI THER, V15, P345, DOI 10.1111/j.1755-5949.2009.00105.x; Whitnall Megan, 2006, Semin Pediatr Neurol, V13, P186, DOI 10.1016/j.spen.2006.08.008; Willemsen S, 2010, EUR J HEART FAIL, V12, P294, DOI 10.1093/eurjhf/hfp207; WitkoSarsat V, 1996, KIDNEY INT, V49, P1304, DOI 10.1038/ki.1996.186; Wolfe D, 2009, PAIN MED, V10, P1325, DOI 10.1111/j.1526-4637.2009.00720.x; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xiong YQ, 2009, EXP NEUROL, V216, P105, DOI 10.1016/j.expneurol.2008.11.025; Yamagishi SI, 2008, EXPERT OPIN INV DRUG, V17, P983, DOI 10.1517/13543784.17.7.983 ; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P962, DOI 10.2174/138161208784139729; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; YAN SD, 1995, NAT MED, V1, P693, DOI 10.1038/nm0795-693; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2009, J MOL MED, V87, P235, DOI 10.1007/s00109-009-0439-2; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Yis U, 2009, EPILEPSY RES, V84, P232, DOI 10.1016/j.eplepsyres.2009.02.003; Yokota C, 2009, J NEUROL SCI, V287, P41, DOI 10.1016/j.jns.2009.09.013; Yoritaka A, 1996, P NATL ACAD SCI USA, V93, P2696, DOI 10.1073/pnas.93.7.2696; Yoshida T, 2006, DIABETOLOGIA, V49, P3094, DOI 10.1007/s00125-006-0437-7; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Zarkovic Kamelija, 2003, Molecular Aspects of Medicine, V24, P293, DOI 10.1016/S0098-2997(03)00024-4; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhao JP, 2007, J NEUROSCI, V27, P13649, DOI 10.1523/JNEUROSCI.3153-07.2007; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506; ZIMMERMAN GA, 1995, P NATL ACAD SCI USA, V92, P3744, DOI 10.1073/pnas.92.9.3744	334	20	20	0	8	BENTHAM SCIENCE PUBL	BUSUM	PO BOX 294, BUSUM, 1400 AG, NETHERLANDS	1871-5273	1996-3181		CNS NEUROL DISORD-DR	CNS Neurol. Disord.-Drug Targets	FEB	2011	10	1					82	107					26	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	715HE	WOS:000286872800008	21143140				2022-02-06	
J	McLeod, TCV; Register-Mihalik, JK				McLeod, Tamara C. Valovich; Register-Mihalik, Johna K.			Clinical Outcomes Assessment for the Management of Sport-Related Concussion	JOURNAL OF SPORT REHABILITATION			English	Article						patient report; mild traumatic brain injury; health-related quality of life	QUALITY-OF-LIFE; GENERIC CORE SCALES; MULTIDIMENSIONAL FATIGUE SCALE; TRAUMATIC BRAIN-INJURY; MIGRAINE DISABILITY; PSYCHOMETRIC PROPERTIES; HEAD-INJURY; SYMPTOMS QUESTIONNAIRE; EMOTIONAL RESPONSES; CONSTRUCT-VALIDITY	Patient Scenario: An adolescent female youth soccer athlete, with a previous concussion history, suffered a second concussion 4 wk ago. Her postconcussive symptoms are affecting her school performance and social and family life. Clinical Outcomes Assessment: Concussion is typically evaluated via symptoms, cognition, and balance. There is no specific patient-oriented outcomes measure for concussion. Clinicians can choose from a variety of generic and specific outcomes instruments aimed at assessing general health-related quality of life or various concussion symptoms and comorbidities such as headache, migraine, fatigue, mood disturbances, depression, anxiety, and concussion-related symptoms. Clinical Decision Making: The data obtained from patient self-report instruments may not actively help clinicians make return-to-play decisions; however, these scales may be useful in providing information that may help the athlete return to school, work, and social activities. The instruments may also serve to identify issues that may lead to problems down the road, including depression or anxiety, or serve to further explore the nature of an athlete's symptoms. Clinical Bottom Line: Concussion results in numerous symptoms that have the potential to linger and has been associated with depression and anxiety. The use of outcomes scales to assess health-related quality of life and the effect of other symptoms that present with a concussion may allow clinicians to better evaluate the effects of concussion on physical, cognitive, emotional, social, school, and family issues, leading to better and more complete management.	[McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA; [Register-Mihalik, Johna K.] Univ N Carolina, Chapel Hill, NC USA		McLeod, TCV (corresponding author), AT Still Univ, Athlet Training Program, Mesa, AZ 85206 USA.		Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722			Andrasik F, 2005, HEADACHE, V45, P429, DOI 10.1111/j.1526-4610.2005.05094.x; Bayliss M., 2002, HIT 6 USERS GUIDE; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Connelly M, 2006, J PEDIATR PSYCHOL, V31, P698, DOI 10.1093/jpepsy/jsj063; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Fitzpatrick R, 1998, Health Technol Assess, V2, P1; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Harris CA, 2008, PAIN, V137, P609, DOI 10.1016/j.pain.2007.10.022; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Himanen L, 2009, BRAIN INJURY, V23, P220, DOI 10.1080/02699050902748323; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Hutchison M, 2009, CLIN J SPORT MED, V19, P13, DOI 10.1097/JSM.0b013e318190ba06; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kawata AK, 2005, HEADACHE, V45, P638, DOI 10.1111/j.1526-4610.2005.05130.x; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mailer BJ, 2008, J SPORT REHABIL, V17, P11, DOI 10.1123/jsr.17.1.11; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; MCLEOD TCV, ATHL TRAIN IN PRESS; Osman A, 2008, J CLIN PSYCHOL, V64, P83, DOI 10.1002/jclp.20433; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Parsons JT, 2011, J SPORT REHABIL, V20, P17, DOI 10.1123/jsr.20.1.17; Piebes SK, 2011, J SPORT REHABIL, V20, P129, DOI 10.1123/jsr.20.1.129; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Powers SW, 2004, CEPHALALGIA, V24, P120, DOI 10.1111/j.1468-2982.2004.00652.x; Register-Mihalik JK, 2009, ATHL TRAIN SPORTS HL, V1, P227; Rozen W. M., 2007, INDIVIDUAL DIFFERENC, V5, P73, DOI DOI 10.1136/BJSP0RTS-2017-097791; SMITH AM, 1993, MAYO CLIN PROC, V68, P939, DOI 10.1016/S0025-6196(12)62265-4; SMITH AM, 1990, MAYO CLIN PROC, V65, P38, DOI 10.1016/S0025-6196(12)62108-9; Snyder AR, 2008, J ATHL TRAINING, V43, P428, DOI 10.4085/1062-6050-43.4.428; Snyder AR, 2010, J SPORT REHABIL, V19, P237, DOI 10.1123/jsr.19.3.237; Stalnacke BM, 2009, J REHABIL MED, V41, P353, DOI 10.2340/16501977-0349; Stewart WF, 1999, NEUROLOGY, V53, P988, DOI 10.1212/WNL.53.5.988; Stewart WF, 2000, PAIN, V88, P41, DOI 10.1016/S0304-3959(00)00305-5; Stewart WF, 2001, NEUROLOGY, V56, pS20, DOI 10.1212/WNL.56.suppl_1.S20; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x; Valovich McLeod TC, 2008, J ATHL TRAINING, V43, P437, DOI DOI 10.404/1062-6050-43.4.437; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; Varni JW, 2008, QUAL LIFE RES, V17, P105, DOI 10.1007/s11136-007-9282-5; Varni JW, 2009, J HEALTH PSYCHOL, V14, P611, DOI 10.1177/1359105309103580; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 2004, J RHEUMATOL, V31, P2494; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812; Ware J.E., 2008, USERS MANUAL SF 36V2; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008	60	20	20	0	23	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1056-6716	1543-3072		J SPORT REHABIL	J. Sport Rehabil.	FEB	2011	20	1			SI		46	60		10.1123/jsr.20.1.46			15	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	719AX	WOS:000287172700006	21411822				2022-02-06	
J	Stringer, AY				Stringer, Anthony Y.			Ecologically-oriented neurorehabilitation of memory: Robustness of outcome across diagnosis and severity	BRAIN INJURY			English	Article						Cognitive rehabilitation; traumatic brain injury; stroke; memory	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; IMAGERY; IMPAIRMENT; PROGRAMS	Primary objective: The current study looked for a differential response to memory rehabilitation, testing the hypotheses that outcome would vary significantly as a function of patient diagnosis and severity of memory impairment. Research design: Unblinded, open-label, pre/post-treatment comparison of memory rehabilitation in patients stratified by diagnosis (brain injury, n = 15; stroke, n = 12; other neurological condition, n = 6) and memory impairment severity. Methods and procedures: Patients underwent an ecologically-oriented, strategy-based intervention for memory impairment and were evaluated pre- and post-treatment on seven simulations (four with alternate forms, randomized to the pre- or post-test) of everyday declarative or prospective memory tasks. Main outcomes and results: Patients at all levels of severity and in all three diagnostic groups showed equivalent, statistically significant improvement in memory performance. Neither practice effects from repeat test administration nor spontaneous recovery accounted for the improvement in memory performance. Conclusions: The current study provided evidence of improved performance in everyday memory content domains with compensatory-based cognitive rehabilitation. Comparable improvement was seen across diagnostic groups and severity ranges. Additional case series and randomized clinical trials are needed to evaluate further the efficacy of compensation-based approaches to cognitive rehabilitation.	Emory Univ, Dept Rehabil Med, Div Neuropsychol & Behav Hlth, Atlanta, GA 30322 USA		Stringer, AY (corresponding author), Emory Univ, Dept Rehabil Med, Div Neuropsychol & Behav Hlth, 1441 Clifton Rd NE, Atlanta, GA 30322 USA.	astring@emory.edu					Berg IJ, 1991, NEUROPSYCHOL REHABIL, V1, P97, DOI DOI 10.1080/09602019108401384; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P151, DOI 10.1053/apmr.2003.50123; Cappa SF, 2005, EUR J NEUROL, V12, P665; Chesnut RM, 1999, J HEAD TRAUMA REHAB, V14, P176, DOI 10.1097/00001199-199904000-00007; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; Delis DC, 1987, CALIFORNIA VERBAL LE; Downes JJ, 1997, NEUROPSYCHOL REHABIL, V7, P195, DOI 10.1080/713755535; FREEMAN M R, 1992, Brain Injury, V6, P65, DOI 10.3109/02699059209008124; Hampstead BM, 2008, J INT NEUROPSYCH SOC, V14, P883, DOI 10.1017/S1355617708081009; HAMPSTEAD BM, 2008, J INT NEUROPSYCH SOC, V14, P178; Kaschel R, 2002, NEUROPSYCHOL REHABIL, V12, P127, DOI 10.1080/09602010143000211; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mazmanian Paul E., 1993, Brain Injury, V7, P319, DOI 10.3109/02699059309034958; Milders M, 1998, MEMORY, V6, P21, DOI 10.1080/741941597; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Nadolne MJ, 2001, J INT NEUROPSYCH SOC, V7, P675, DOI 10.1017/S1355617701766039; Patel M, 2003, CLIN REHABIL, V17, P158, DOI 10.1191/0269215503cr596oa; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ryan T V, 1988, Arch Clin Neuropsychol, V3, P165, DOI 10.1016/0887-6177(88)90061-3; Stringer A. Y., 2007, ECOLOGICAL ORIENTED; Stringer AY, 2003, CLIN NEUROPSYCHOL, V17, P34, DOI 10.1076/clin.17.1.34.15625; TOMBAUGH TN, 1992, CLIN NEUROPSYCHOL, V6, P63; TWUM M, 1994, J CLIN EXP NEUROPSYC, V16, P630, DOI 10.1080/01688639408402674; Wechsler D, 1987, MEMORY SCALE REVISED; Winocur G, 2007, J INT NEUROPSYCH SOC, V13, P166, DOI 10.1017/S1355617707070191	27	20	20	0	14	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	2011	25	2					169	178		10.3109/02699052.2010.541894			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JJ	WOS:000288101800004	21219089				2022-02-06	
J	Alderman, N; Wood, RL; Williams, C				Alderman, Nick; Wood, Rodger Li; Williams, Claire			The development of the St Andrew's-Swansea Neurobehavioural Outcome Scale: Validity and reliability of a new measure of neurobehavioural disability and social handicap	BRAIN INJURY			English	Article						Acquired brain injury; neurorehabilitation; outcome measurement	OVERT AGGRESSION SCALE; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; NEUROPSYCHOLOGY BEHAVIOR; AFFECT PROFILE; RATING-SCALE; REHABILITATION; INSTRUMENT; INVENTORY; HEALTH	Primary objective: Neurobehavioural disability (NBD) has a major impact on long-term psychosocial outcome following acquired brain injury (ABI). A recent review highlighted that a reliable and valid measure that can adequately capture the subtle and varied characteristics of NBD has yet to be developed. In this paper, the work underpinning the 'St Andrews-Swansea Neurobehavioural Outcome Scale' (SASNOS) is described using a conceptual framework underpinned by the WHO ICF. The intention is that SASNOS will provide a reliable and valid means of measuring NBD. Methods and procedures: Three hundred and thirty-six sets of ratings were made regarding ABI and neurologically healthy samples. The initial pool of 117 items was subjected to exploratory factor analysis and Rasch analysis. Reliability and validity of the new measure were determined using a range of appropriate statistical methods. Main outcomes: Forty-nine items were retained, falling into five principal factors. Content and construct validity are calculated. SASNOS has excellent discriminant/diagnostic validity. Inter-rater and test re-test reliability are good. Conclusions: SASNOS has a range of clinical and research applications and can be employed when measuring outcome. This new measure will enable neurorehabilitation services to directly compare the clinical populations they serve using the same frame of reference for NBD.	[Alderman, Nick] St Andrews Healthcare, Natl Brain Injury Ctr, Kemsley Unit, Northampton NN1 5DG, England; [Wood, Rodger Li; Williams, Claire] Swansea Univ, Swansea, W Glam, Wales		Alderman, N (corresponding author), St Andrews Healthcare, Natl Brain Injury Ctr, Kemsley Unit, Billing Rd, Northampton NN1 5DG, England.	nalderman@standrew.co.uk		Alderman, Nick/0000-0002-8523-4142; Williams, Claire/0000-0002-0791-744X			Alderman N, 1997, BRAIN INJURY, V11, P503, DOI 10.1080/713802182; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Dickens G, 2007, J FORENSIC PSYCHI PS, V18, P507, DOI 10.1080/14789940701492279; EAMES P, 1985, J NEUROL NEUROSUR PS, V48, P613, DOI 10.1136/jnnp.48.7.613; Eames P, 1996, BRAIN INJURY, V10, P631, DOI 10.1080/026990596124061; Fleminger S, 2005, PSYCHIATR BULL, V29, P53, DOI 10.1192/pb.29.2.53; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Hawley CA, 1999, J NEUROL NEUROSUR PS, V67, P749, DOI 10.1136/jnnp.67.6.749; Knight C, 2008, NEUROPSYCHOL REHABIL, V18, P129, DOI 10.1080/09602010701822381; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; KREUTZER JS, 1999, QUAL LIFE RES, V8, P17; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEVIN H S, 1990, Annales de Readaptation et de Medecine Physique, V33, P35; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Linacre J. M., 1998, USERS GUIDE BIGSTEPS; Linacre JM, 2009, WINSTEPS RASCH MEASU, P46; Nelson LD, 1998, ARCH CLIN NEUROPSYCH, V13, P549, DOI 10.1016/S0887-6177(97)00052-8; RUFF RM, 2003, RUFF NEUROBEHAVIOURA; Satz P, 1996, PSYCHOL ASSESSMENT, V8, P115; SIMBLETT S, 2010, 7 S NEUR REH SPEC IN, V11, P204; SPSS, 2007, SPSS WIND VERS 16 0; Tesio L, 2003, J REHABIL MED, V35, P105, DOI 10.1080/16501970310010448; Turner-Stokes L, 1999, NEUROPSYCHOL REHABIL, V9, P329, DOI 10.1080/096020199389419; TurnerStokes L, 1997, CLIN REHABIL, V11, P306, DOI 10.1177/026921559701100407; URBINA S, 2004, ESSENTIALS PSYCHOL T; Van Lancker D, 1989, PSYCHOL ASSESSMENT, V1, P266, DOI [10.1037/1040-3590.1.4.266, DOI 10.1037/1040-3590.1.4.266]; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wade D. T., 2005, EFFECTIVENESS REHABI; Wade DT, 2003, CLIN REHABIL, V17, P349, DOI 10.1191/0269215503cr619ed; Wing JK, 1998, BRIT J PSYCHIAT, V172, P11, DOI 10.1192/bjp.172.1.11; Wood R. L1., 1990, NEUROBEHAVIOURAL SEQ; Wood RL, 2008, BRAIN INJURY, V22, P905, DOI 10.1080/02699050802491271; Wood RL, 2001, BRAIN DAM B, P3; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; WOOD RLI, 2009, C 30 YEARS NEUR REH; World Health Organization, INT CLASS FUNCT DIS; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35	41	20	20	0	11	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2011	25	1					83	100		10.3109/02699052.2010.532849			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731JI	WOS:000288101700010	21117921				2022-02-06	
J	Baldwin, VN; Powell, T; Lorenc, L				Baldwin, Victoria N.; Powell, Theresa; Lorenc, Louise			Factors influencing the uptake of memory compensations: A qualitative analysis	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Memory compensations; Acquired brain injury (ABI)	TRAUMATIC BRAIN-INJURY; ASSISTIVE DEVICES; EVERYDAY MEMORY; POCKET-COMPUTER; SELF-EFFICACY; PEOPLE; AWARENESS; TECHNOLOGY; AIDS	In 1996, Wilson and Watson stated that it is not always easy to persuade people with memory impairments to use memory strategies, despite the value of using them. To date, there has been no in-depth exploration of what motivates people to use memory compensations from the perspective of the individual with an acquired brain injury. In this study eight people attending an out-patient brain injury rehabilitation service were interviewed. Transcripts were analysed using interpretative phenomenological analysis. Four master themes emerged from the analysis: emotional barriers that need to be overcome before memory compensations are used; factors that may have a reverse effect on motivation, such as the strategy being an unpleasant reminder that one is different; beliefs about memory, such as it is better to use your own memory rather than relying on memory aids otherwise it will become lazy; and the final master theme "It's not in my nature", i.e., it does not fit with the person's lifestyle. The results show that motivation for strategy use depends on complex processes that include social, emotional and practical factors. This study demonstrates the importance of adhering to a biopsychosocial approach within rehabilitation.	[Powell, Theresa] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Lorenc, Louise] Moor Green, W Midlands Rehabil Serv, Birmingham, W Midlands, England		Powell, T (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	t.powell@bham.ac.uk	Powell, Theresa/AAE-4249-2020	Powell, Theresa/0000-0002-3351-9453			Aben L, 2008, J REHABIL MED, V40, P681, DOI 10.2340/16501977-0227; Caprani N., 2007, SUPP HUM MEM INT SYS, P17; Darzi A., 2008, NHS NEXT STAGE REV F HIGH QUALITY CARE AL; Dirette D, 2002, BRAIN INJURY, V16, P861, DOI 10.1080/02699050210131902; Evans JJ, 2003, J INT NEUROPSYCH SOC, V9, P925, DOI 10.1017/S1355617703960127; Gartland D, 2004, NEUROPSYCHOL REHABIL, V14, P61, DOI 10.1080/09602010343000165; Hagger MS, 2003, PSYCHOL HEALTH, V18, P141, DOI 10.1080/088704403100081321; Hollows S. E., 1985, ADULT MEMORY INFORM; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Kit KA, 2007, REHABIL PSYCHOL, V52, P25, DOI 10.1037/0090-5550.52.1.25; Lazarous R. S., 1984, STRESS APPRAISAL COP; Leventhal H., 1984, HDB PSYCHOL HLTH, P219; Leventhal H., 1980, CONTRIB MED PSYCHOL, V2, P7; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Lund ML, 2003, OTJR-OCCUP PART HEAL, V23, P67, DOI 10.1177/153944920302300204; McDougall GJ, 2004, NURS RES, V53, P323, DOI 10.1097/00006199-200409000-00007; McDougall GJ, 2003, NURS RES, V52, P42, DOI 10.1097/00006199-200301000-00006; Moore A. D., 1995, BRAIN INJURY, V6, P89; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Palmer P., 2007, TECHNOLOGY DISABILIT, V19, P17, DOI [10.3233/TAD-2007-19103, DOI 10.3233/TAD-2007-19103]; Pape TLB, 2002, DISABIL REHABIL, V24, P5, DOI 10.1080/09638280110066235; Parette P, 2004, EDUC TRAIN DEV DISAB, V39, P217; Patel D., 2008, THESIS U BIRMINGHAM; Riley GA, 2004, BRAIN INJURY, V18, P871, DOI 10.1080/02699050410001671829; Roelands M, 2002, SOC SCI MED, V54, P1441, DOI 10.1016/S0277-9536(01)00126-5; Roulstone A., 2007, WHAT CAN ASSISTIVE T; Royle J, 2008, DISABIL REHABIL, V30, P114, DOI 10.1080/09638280701223876; Smith J.A., 2008, QUALITATIVE PSYCHOL, V2nd ed., P53, DOI [DOI 10.4135/9781848607927.N11, 10.1002/9780470776278.ch10, DOI 10.1002/9780470776278.CH10]; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; Verhaeghen P, 2000, GERONTOLOGIST, V40, P540, DOI 10.1093/geront/40.5.540; Wilson BA, 1996, MEMORY, V4, P465, DOI 10.1080/741940776; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161; Wright P, 2001, INT J REHABIL RES, V24, P299, DOI 10.1097/00004356-200112000-00006; Yardley L., 2008, QUALITATIVE PSYCHOL, P235, DOI DOI 10.1080/17439760.2016.1262624	35	20	20	1	8	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2011	21	4					484	501		10.1080/09602011.2011.582378			18	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	885OO	WOS:000299788700003	21707468				2022-02-06	
J	Chauhan, NB; Gatto, R				Chauhan, Neelima B.; Gatto, Rodolfo			Restoration of cognitive deficits after statin feeding in TBI	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; controlled cortical impact injury; simvastatin; lovastatin; pravastatin; spontaneous exploratory working memory; learning and memory; morris water maze; Y-maze	TRAUMATIC BRAIN-INJURY; DELAYED NEURONAL DEATH; NITRIC-OXIDE SYNTHASE; BEHAVIORAL DEFICITS; REDUCTASE INHIBITOR; FUNCTIONAL OUTCOMES; ISCHEMIC BRAIN; FOCAL ISCHEMIA; SIMVASTATIN; RATS	Purpose: Traumatic brain injury (TBI) is a global health concern and growing socio-economic burden with limited treatment options. Behavioral assessment in experimental TBI with candidate therapeutic interventions is critical in order to expedite clinical translation. Statins constitute one of the potential treatment options based on their proven beneficial effects in various models of neurotrauma. We compared functional outcome after dietary intervention with representative hydrophilic Pravastatin or lipophilic Simvastatin and Lovastatin to test if different statins will differentially affect cognitive outcomes after injury in a controlled cortical impact injury (CCI) mouse model of TBI. Methods: Mice were subjected to TBI with a controlled cortical impact produced on the left somatosensory-parietal cortex between bregma -1.82 and -2.06, fed with Simvastatin/Lovastatin/Pravastatin (2 mg/kg) for 8 weeks, evaluated for learning, memory and spontaneous exploration behavior followed by immunocytochemistry of an axonal marker. Results: Results indicate that feeding of TBI mice with Simvastatin and Lovastatin significantly improved spatial learning and memory, restored spontaneous exploration and restored axonal integrity (Simvastatin > Lovastatin). On the other hand, Pravastatin failed to improve spatial learning or memory or exploration or axonal damage. Conclusions: Current findings confirm maximum benefits rendered by Simvastatin and reinforce Simvastatin as the candidate therapy for treating TBI.	[Chauhan, Neelima B.; Gatto, Rodolfo] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA; [Chauhan, Neelima B.; Gatto, Rodolfo] Westside Inst Sci & Educ Chicago, Chicago, IL USA; [Chauhan, Neelima B.] Univ Illinois, Dept Pediat, Chicago, IL USA; [Chauhan, Neelima B.] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Gatto, Rodolfo] Univ Illinois, Dept BioEngn, Chicago, IL USA		Chauhan, NB (corresponding author), Jesse Brown VA Med Ctr, R&D 537-151,820 S Damen Ave, Chicago, IL 60612 USA.	nchauhan@uic.edu	Gatto, Rodolfo Gabriel/R-7155-2018	Gatto, Rodolfo Gabriel/0000-0003-2170-6662	Department of Veterans AffairsUS Department of Veterans Affairs [B6285R]; Westside Institute for Science and Education, Chicago; Department of Pediatrics, University of Illinois at Chicago; Department of Anatomy & Cell Biology, University of Illinois at Chicago; Department of BioEngineering, University of Illinois at Chicago; Veterans AffairsUS Department of Veterans Affairs [I01RX000880] Funding Source: NIH RePORTER	This work was supported by the Department of Veterans Affairs (VA MERIT Grant #B6285R, Chauhan NB). Authors are thankful for the support provided by the Westside Institute for Science and Education, Chicago; and by the Departments of Pediatrics, Anatomy & Cell Biology, and BioEngineering, University of Illinois at Chicago.	Balduini W, 2003, STROKE, V34, P2007, DOI 10.1161/01.STR.0000080677.24419.88; Cekic M, 2010, NEUROTHERAPEUTICS, V7, P81, DOI 10.1016/j.nurt.2009.10.017; Chauhan NB, 2004, NEUROCHEM RES, V29, P1897, DOI 10.1023/B:NERE.0000042217.90204.8d; Chauhan NB, 2007, PHYTOTHER RES, V21, P629, DOI 10.1002/ptr.2122; Chauhan NB, 2010, J NEUROSCI METH, V190, P1, DOI 10.1016/j.jneumeth.2010.04.004; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Cheng Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-156; Cimino A, 2005, NEUROTOXICOLOGY, V26, P929, DOI 10.1016/j.neuro.2005.03.009; Cimino M, 2007, NEUROSCIENTIST, V13, P208, DOI 10.1177/1073858406297121; Daimon M, 2004, NEUROSCI LETT, V362, P122, DOI 10.1016/j.neulet.2004.03.012; Farrell R, 2001, NEUROSCIENCE, V107, P585, DOI 10.1016/S0306-4522(01)00386-4; Franklin K, 1998, MOUSE BRAIN STEREOTA; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Guyton JR, 2006, AM J CARDIOL, V97, p95C, DOI 10.1016/j.amjcard.2005.12.016; Kasturi BS, 2009, RESTOR NEUROL NEUROS, V27, P265, DOI [10.3233/RNN-2009-0475, 10.3233/RNN-2009-0476]; Laufs U, 2002, BRAIN RES, V942, P23, DOI 10.1016/S0006-8993(02)02649-5; Li B, 2009, NEUROSURGERY, V65, P179, DOI 10.1227/01.NEU.0000346272.76537.DC; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Lu DY, 2007, J NEUROTRAUM, V24, P1132, DOI 10.1089/neu.2007.0288; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MONTGOMERY KS, 2007, NEUROBIOL AGING; Neal MD, 2009, J TRAUMA, V67, P476, DOI 10.1097/TA.0b013e3181ad66bb; Orr JD, 2008, CURR ATHEROSCLER REP, V10, P11; QUION JA, 2003, CLIN PHARMACOKINET, V27, P94; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Sironi L, 2006, NEUROBIOL DIS, V22, P445, DOI 10.1016/j.nbd.2005.12.004; Sironi L, 2003, ARTERIOSCL THROM VAS, V23, P322, DOI 10.1161/01.ATV.0000044458.23905.3B; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Stepien K, 2005, PHARMACOL REP, V57, P561; Tanaka K, 2009, NEUROSCI LETT, V462, P235, DOI 10.1016/j.neulet.2009.07.024; Turkoglu OF, 2009, SURG NEUROL, V72, P146, DOI 10.1016/j.surneu.2008.07.004; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vree Tom B, 2003, ScientificWorldJournal, V3, P1332; Vuletic S, 2006, DEMENT GERIATR COGN, V22, P392, DOI 10.1159/000095679; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wierzbicki AS, 2003, PHARMACOL THERAPEUT, V99, P95, DOI 10.1016/S0163-7258(03)00055-X; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	45	20	20	1	5	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2011	29	1					23	34		10.3233/RNN-2011-0573			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	722ZZ	WOS:000287476200003	21335666				2022-02-06	
J	Griffen, JA; Rapport, LJ; Bryer, RC; Bieliauskas, LA; Burt, C				Griffen, Julie A.; Rapport, Lisa J.; Bryer, Renee Coleman; Bieliauskas, Linas A.; Burt, Cynthia			Awareness of Deficits and On-Road Driving Performance	CLINICAL NEUROPSYCHOLOGIST			English	Article						Driving; Awareness of deficit; Acquired brain injury	TRAUMATIC BRAIN-INJURY; COMMUNITY INTEGRATION; NEUROPSYCHOLOGICAL ASPECTS; SELF-AWARENESS; OLDER-ADULTS; ABILITY; STROKE; PREDICTORS; FITNESS; REHABILITATION	This study examined the relationship of neuropsychological and on-road driving evaluations among adults with acquired brain injury (ABI), and the extent to which that relationship is moderated by awareness of deficit. Participants were 62 pairs of adults with ABI and significant-other informants and 40 healthy controls (N = 102). Adults with ABI and controls completed neuropsychological and on-road evaluations. Multiple regression indicated that neuropsychological performance and the interaction between awareness of deficit and neuropsychological performance each explained significant variance in driving performance (i.e., the relationship between neuropsychological performance and on-road outcome depends on level of awareness). The moderation effect was illustrated by different relationships between neuropsychological and on-road performances among awareness groups: Among adults with impaired awareness (n = 21), neuropsychological functioning was substantially related to driving outcomes; in contrast, driving outcome showed weak relation to neuropsychological functioning among those with intact awareness (n = 24) or hypervigilance (n = 17) toward deficits. An exception was that processing speed showed modest relation to on-road outcome for all groups, including controls. Awareness of deficit has a considerable influence on driving outcomes both directly and as a moderator between the relationship of neuropsychological functioning and driving performance. When adults with ABI lack appreciation for their impairments, their neuropsychological status is especially important in predicting driving outcomes.	[Griffen, Julie A.; Rapport, Lisa J.; Bryer, Renee Coleman; Burt, Cynthia] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Bieliauskas, Linas A.] Univ Michigan, Psychol Serv, VA Med Ctr, Ann Arbor, MI 48109 USA		Rapport, LJ (corresponding author), Wayne State Univ, Dept Psychol, 7th Floor,5057 Woodward Ave, Detroit, MI 48202 USA.	rapport@wayne.edu		Rapport, Lisa/0000-0001-8014-9523	US Department of Education - National Institute of Disability Research and RehabilitationUS Department of Education [H133G050134]; Wayne State University	This research was supported by grants from the US Department of Education - National Institute of Disability Research and Rehabilitation (H133G050134, L.J. Rapport) and Wayne State University (J.A. Griffen).	Anstey KJ, 2006, J AM GERIATR SOC, V54, P121, DOI 10.1111/j.1532-5415.2005.00471.x; Anstey KJ, 2005, CLIN PSYCHOL REV, V25, P45, DOI 10.1016/j.cpr.2004.07.008; Association for Driver Rehabilitation Specialists (ADED), 2002, MOD PRACT DRIV REH I; Association for Driver Rehabilitation Specialists (ADED), 2009, BEST PRACT DEV DRIV; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Benton A., 1978, CLIN NEUROPSYCHOL, V10, P80; Bieliauskas LA, 1998, CLIN NEUROPSYCHOL, V12, P206, DOI 10.1076/clin.12.2.206.1994; Brouwer W H, 1994, Disabil Rehabil, V16, P149; Burgess P.W., 1997, HAYLING BRIXTON TEST; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Cohen J., 1965, HDB CLIN PSYCHOL, P95; Coleman Bryer R, 2005, DRIVER REHABILITATIO, P165; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Edwards JD, 2009, GERONTOLOGIST, V49, P485, DOI 10.1093/geront/gnp042; Evans L., 1985, HUMAN BEHAV TRAFFIC, P485; Fisk GD, 1998, BRAIN INJURY, V12, P683; FITTEN LJ, 1995, JAMA-J AM MED ASSOC, V273, P1360, DOI 10.1001/jama.273.17.1360; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORDYCE DJ, 1986, REHABIL PSYCHOL, V31, P217, DOI 10.1037//0090-5550.31.4.217; Fox GK, 1997, J AM GERIATR SOC, V45, P949, DOI 10.1111/j.1532-5415.1997.tb02965.x; Fox GK, 1998, ARCH PHYS MED REHAB, V79, P1288, DOI 10.1016/S0003-9993(98)90277-5; GALSKI T, 1992, AM J OCCUP THER, V46, P324, DOI 10.5014/ajot.46.4.324; Golden CJ, 1978, STROOP COLOR WORD TE; Griffen JA, 2009, TOP STROKE REHABIL, V16, P212, DOI 10.1310/tsr1603-212; Hedges LV., 1981, J EDUC STAT, V6, P107, DOI [10.3102/10769986006002107, DOI 10.3102/10769986006002107]; Heikkila VM, 1999, ACTA NEUROL SCAND, V99, P349, DOI 10.1111/j.1600-0404.1999.tb07363.x; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lundqvist A, 2001, NEUROPSYCHOL REHABIL, V11, P171, DOI 10.1080/09602010042000240; Lundqvist A, 2000, APPL COGNITIVE PSYCH, V14, P135, DOI 10.1002/(SICI)1099-0720(200003/04)14:2<135::AID-ACP628>3.0.CO;2-S; Lundqvist A, 2007, BRAIN INJURY, V21, P1109, DOI 10.1080/02699050701651660; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; MARCOTTE T, 2000, J INT NEUROPSYCHOL S, V0006, P00233; Marshall SC, 2007, TOP STROKE REHABIL, V14, P98, DOI 10.1310/tsr1401-98; Mazer BL, 1998, ARCH PHYS MED REHAB, V79, P743, DOI 10.1016/S0003-9993(98)90350-1; Orfei MD, 2008, NEUROSCIENTIST, V14, P203, DOI 10.1177/1073858407309995; Ott BR, 2003, J GERIATR PSYCH NEUR, V16, P151, DOI 10.1177/0891988703255688; Ownsworth T, 2005, J HEAD TRAUMA REHAB, V20, P315, DOI 10.1097/00001199-200507000-00004; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Radford KA, 2004, ARCH PHYS MED REHAB, V85, P324, DOI 10.1016/S0003-9993(03)00765-2; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; RAPPORT LJ, 1993, ARCH PHYS MED REHAB, V74, P621, DOI 10.1016/0003-9993(93)90160-C; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Reitan R, 1988, HALSTEAD REITAN NEUR; Ryan KA, 2009, J CLIN EXP NEUROPSYC, V31, P126, DOI 10.1080/13803390802119922; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Smith, 1973, SYMBOL DIGIT MODALIT; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tabachnick B. G., 2006, USING MULTIVARIATE S, V5th; Trobe JD, 1996, ARCH NEUROL-CHICAGO, V53, P411, DOI 10.1001/archneur.1996.00550050033021; VANZOMEREN AH, 1988, ARCH PHYS MED REHAB, V69, P90; VANZOMEREN AH, 1987, ARCH PHYS MED REHAB, V68, P697; Waldron-Perrine B, 2009, CLIN NEUROPSYCHOL, V23, P462, DOI 10.1080/13854040802279683; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065	58	20	20	0	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2011	25	7					1158	1178		10.1080/13854046.2011.609841			21	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	882JJ	WOS:000299559600005	21951140				2022-02-06	
J	Soeker, MS				Soeker, Mogammad			Occupational Adaptation: A Return to Work Perspective of Persons with Mild to Moderate Brain Injury in South Africa	JOURNAL OF OCCUPATIONAL SCIENCE			English	Article						Traumatic brain injury; Occupational adaptation; Qualitative research; Self efficacy; Return to work		This qualitative study describes the experience of returning to work and the adaptive strategies used by persons with brain injury living in the Western Cape of South Africa. Nine males and one female participated in the study. Face to face, semi structured individual interviews were conducted and data were analyzed using a qualitative approach to explicate patterns and themes. Four themes emerged: 1) A sense of loss of former self; 2) Uncertainty about the future; 3) The road to self acceptance and self belief; and 4) Participation in occupation enables growth. The findings of the study suggest that people with a brain injury undergo a process of reflection and self acceptance before they are ready to adapt to a worker role, and that self efficacy beliefs are instrumental to occupational adaptation. New occupational patterns or routines are formed, based on the functional capacity of the individual with the brain injury. These findings are relevant to occupational science in that they provide insight into the process of occupational adaptation and its link to individual's sense of competence and identity.	[Soeker, Mogammad] Univ Western Cape, Dept Occupat Therapy, Bellville, South Africa		Soeker, MS (corresponding author), Univ Western Cape, Dept Occupat Therapy, Bellville, South Africa.	msoeker@uwc.ac.za			University of the Western Cape; Cannon Collins Educational Trust of South Africa	This project was supported by the University of the Western Cape and the Cannon Collins Educational Trust of South Africa.	BANDURA A, 1991, NEBR SYM MOTIV, V38, P69; Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Bootes Kylie, 2002, Work, V19, P255; Cresswell J.W., 2003, RES DESIGN QUALITATI; FONTANA A, 1994, HDB QUALITATIVE RES; Gutman S. A., 1995, AM J OCCUPATIONAL TH, V50, P535; Gutman SA., 2001, OCCUPATIONAL THERAPY, V5th, P671; GUTMAN SA, 2000, OCCUPATIONAL THERAPY, V15, P1; Holzberg Emily, 2001, Work, V16, P245; Johansson U, 2006, AM J OCCUP THER, V60, P60, DOI 10.5014/ajot.60.1.60; Kielhofner G, 2002, MODEL HUMAN OCCUPATI; Klinger L, 2005, J OCCUP SCI, V12, P9, DOI 10.1080/14427591.2005.9686543; Laliberte-Rudman D., 2001, QUALITATIVE RES OCCU, P24; McCarthy ML, 2006, ARCH PHYS MED REHAB, V87, P953, DOI 10.1016/j.apmr.2006.03.007; Morse J. M., 1996, NURSING RES APPL QUA; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Parsons L, 2008, AUST OCCUP THER J, V55, P231, DOI 10.1111/j.1440-1630.2008.00753.x; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schultz S., 1993, WILLARD SPACKMANS OC, P58; Soeker MS, 2008, WORK, V30, P161; Tipton-Burton M., 2005, PEDRETTIS OCCUPATION, P838; Townsend Elizabeth, 2004, Can J Occup Ther, V71, P75; Wilcock A., 1993, J OCCUP SCI, V1, P17; Wilcock A. A., 2005, OCCUPATIONAL THERAPY, P134; YERXA EJ, 1980, AM J OCCUP THER, V34, P529, DOI 10.5014/ajot.34.8.529; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	26	20	20	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1442-7591			J OCCUP SCI	J. Occup. Sci.		2011	18	1			SI		81	91		10.1080/14427591.2011.554155			11	Social Sciences, Interdisciplinary	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	V76NT	WOS:000211919600007					2022-02-06	
J	Torres, BBJ; Caldeira, FMC; Gomes, MG; Serakides, R; Viott, AD; Bertagnolli, AC; Fukushima, FB; de Oliveira, KM; Gomes, MV; de Melo, EG				Junta Torres, Bruno Benetti; Caetano Caldeira, Fatima Maria; Gomes, Mardelene Geisa; Serakides, Rogeria; Viott, Aline de Marco; Bertagnolli, Angelica Cavalheiro; Fukushima, Fabiola Bono; de Oliveira, Karen Maciel; Gomes, Marcus Vinicius; de Melo, Eliane Goncalves			Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats	INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY			English	Article						apoptosis; caspase-3; dantrolene; immunochemistry; NeuN; spinal cord injury; TUNEL-staining	NEURONAL CELL-DEATH; CA2+ RELEASE; IN-VITRO; CASPASE-3; ACTIVATION; IMPROVEMENT; CONTUSION	P>Dantrolene has been shown to be neuroprotective by reducing neuronal apoptosis after brain injury in several animal models of neurological disorders. In this study, we investigated the effects of dantrolene on experimental spinal cord injury (SCI). Forty-six male Wistar rats were laminectomized at T13 and divided in six groups: GI (n = 7) underwent SCI with placebo and was euthanized after 32 h; GII (n = 7) underwent laminectomy alone with placebo and was euthanized after 32 h; GIII (n = 8) underwent SCI with dantrolene and was euthanized after 32 h; GIV (n = 8) underwent SCI with placebo and was euthanized after 8 days; GV (n = 8) underwent laminectomy alone with placebo and was euthanized after 8 days; and GVI (n = 8) underwent SCI with dantrolene and was euthanized after 8 days. A compressive trauma was performed to induce SCI. After euthanasia, the spinal cord was evaluated using light microscopy, TUNEL staining and immunochemistry with anti-Caspase-3 and anti-NeuN. Animals treated with dantrolene showed a smaller number of TUNEL-positive and caspase-3-positive cells and a larger number of NeuN-positive neurons, both at 32 h and 8 days (P < 0.05). These results showed that dantrolene protects spinal cord tissue after traumatic SCI by decreasing apoptotic cell death.	[Junta Torres, Bruno Benetti; Caetano Caldeira, Fatima Maria; Gomes, Mardelene Geisa; Serakides, Rogeria; Viott, Aline de Marco; Fukushima, Fabiola Bono; de Oliveira, Karen Maciel; de Melo, Eliane Goncalves] Univ Fed Minas Gerais, Sch Vet, Dept Vet Med & Surg, BR-30123970 Belo Horizonte, MG, Brazil; [Gomes, Mardelene Geisa; Serakides, Rogeria; Viott, Aline de Marco] Univ Fed Minas Gerais, Sch Vet, Lab Histopathol, BR-30123970 Belo Horizonte, MG, Brazil; [Bertagnolli, Angelica Cavalheiro] Univ Fed Minas Gerais, Inst Biol Sci, Lab Comparat Pathol, BR-30123970 Belo Horizonte, MG, Brazil; [Gomes, Marcus Vinicius] Univ Fed Minas Gerais, Fac Med, Neurosci Lab, BR-30123970 Belo Horizonte, MG, Brazil		Serakides, R (corresponding author), Univ Fed Minas Gerais, Sch Vet, Dept Vet Med & Surg, Ave Antonio Carlos 6627,Caixa Postal 567,Campus U, BR-30123970 Belo Horizonte, MG, Brazil.	serakide@netuno.lcc.ufmg.br	de Marco Viott, Aline/AAK-9553-2021; Serakides, Rogeria/C-7571-2016; bertagnolli, angelica/U-4762-2019; DE LAVOR, MARIO SERGIO LIMA/Y-4138-2019; Fukushima, Fabiola Bono/ABG-2548-2020; Torres, Bruno Benetti Junta/AAX-9672-2020	de Marco Viott, Aline/0000-0003-1097-2359; Serakides, Rogeria/0000-0001-5374-6242; bertagnolli, angelica/0000-0002-4956-2085; DE LAVOR, MARIO SERGIO LIMA/0000-0003-0795-5320; Fukushima, Fabiola Bono/0000-0001-9843-8374; Torres, Bruno Benetti Junta/0000-0002-6400-046X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Cristalia Lab	The study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Cristalia Lab.	Allen AR., 1911, JAMA-J AM MED ASSOC, V57, P878, DOI DOI 10.1001/JAMA.1911.04260090100008; Aslan A, 2009, EUR SPINE J, V18, P1442, DOI 10.1007/s00586-009-1033-6; Ayar A, 2002, PHYSIOL RES, V51, P341; Barut S, 2005, SURG NEUROL, V64, P213, DOI 10.1016/j.surneu.2005.03.042; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Beattie MS, 2000, J NEUROTRAUM, V17, P915, DOI 10.1089/neu.2000.17.915; Buyukokuroglu ME, 2002, PHARMACOL RES, V45, P455, DOI 10.1006/phrs.2002.0970; Buyukokuroglu ME, 2001, PHARMACOL RES, V44, P491, DOI 10.1006/phrs.2001.0890; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; EIDELBERG E, 1977, EXP NEUROL, V56, P312, DOI 10.1016/0014-4886(77)90350-8; FEHLINGS MG, 1989, J NEUROSURG, V71, P403, DOI 10.3171/jns.1989.71.3.0403; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; FRANDSEN A, 1991, J NEUROCHEM, V56, P1075, DOI 10.1111/j.1471-4159.1991.tb02031.x; Gwak M, 2008, ANESTH ANALG, V106, P227, DOI 10.1213/01.ane.0000287663.81050.38; HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kocogullari CU, 2008, THORAC CARDIOV SURG, V56, P406, DOI 10.1055/s-2008-1038731; Krause T, 2004, ANAESTHESIA, V59, P364, DOI 10.1111/j.1365-2044.2004.03658.x; Li F, 2005, BRAIN RES, V1048, P59, DOI 10.1016/j.brainres.2005.04.058; Liu XZ, 1997, J NEUROSCI, V17, P5395; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; Mori F, 2005, EPILEPSY RES, V65, P59, DOI 10.1016/j.eplepsyres.2005.04.006; Muehlschlegel S, 2009, NEUROCRIT CARE, V10, P103, DOI 10.1007/s12028-008-9133-4; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nakayama R, 2002, ANESTHESIOLOGY, V96, P705, DOI 10.1097/00000542-200203000-00029; Negoescu A, 1996, J HISTOCHEM CYTOCHEM, V44, P959, DOI 10.1177/44.9.8773561; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Popescu BO, 2002, J CELL MOL MED, V6, P555, DOI 10.1111/j.1582-4934.2002.tb00454.x; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; Solaroglu I, 2005, SURG NEUROL, V64, P17, DOI 10.1016/j.surneu.2005.07.058; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 2000, J NEUROSCI, V20, P7246; Takagi T, 2003, NEUROL MED-CHIR, V43, P20, DOI 10.2176/nmc.43.20; Thorell WE, 2002, J NEUROTRAUM, V19, P335, DOI 10.1089/089771502753594909; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Ucuncu H, 2005, HUM EXP TOXICOL, V24, P567, DOI 10.1191/0960327105ht569oa; Wei HF, 2000, J NEUROCHEM, V75, P81, DOI 10.1046/j.1471-4159.2000.0750081.x; Wei HF, 1996, J NEUROCHEM, V67, P2390; Xu GY, 2008, NEUROSCIENCE, V153, P1034, DOI 10.1016/j.neuroscience.2008.02.065; Xu GP, 2002, BRAIN RES, V952, P153, DOI 10.1016/S0006-8993(02)02988-8; Yano T, 2001, RESUSCITATION, V50, P117, DOI 10.1016/S0300-9572(00)00369-5; ZHANG L, 1993, NEUROSCI LETT, V158, P105, DOI 10.1016/0304-3940(93)90623-S; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200	46	20	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0959-9673	1365-2613		INT J EXP PATHOL	Int. J. Exp. Pathol.	DEC	2010	91	6					530	536		10.1111/j.1365-2613.2010.00738.x			7	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	684XV	WOS:000284589500081	21039984	Green Published			2022-02-06	
J	Ranaivo, HR; Patel, F; Wainwright, MS				Ranaivo, Hantamalala Ralay; Patel, Fatima; Wainwright, Mark S.			Albumin activates the canonical TGF receptor-smad signaling pathway but this is not required for activation of astrocytes	EXPERIMENTAL NEUROLOGY			English	Article						Albumin; Astrocyte; Cytokines; TGF beta receptor; Smads	TRAUMATIC BRAIN-INJURY; GROWTH-FACTOR-BETA; NITRIC-OXIDE SYNTHASE; REDUCES NEUROLOGICAL DEFICIT; MATRIX-METALLOPROTEINASE-9 EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; RAT; CYTOKINE; CELLS; NEUROTOXICITY	The use of albumin as a resuscitation fluid is considered safe for most critically ill patients. However, clinical data suggest albumin may increase mortality in neurotrauma, but improve outcome after stroke. Albumin has been shown to activate glia, and to play a role in the mechanisms of epileptogenesis via the TGF beta-receptor (TGF beta R). We have previously shown that albumin induces the production of inflammatory mediators including IL-1 beta via activation of MAPK pathways in primary astrocytes and microglia. The extracellular signaling mechanisms leading to the activation of glial cells in response to albumin are not well understood. Here, we investigated the role of the TGF beta R and the canonical TGF beta receptor-smad signaling pathway in astrocyte activation by albumin. In primary astrocyte cultures, albumin activated the smad pathway downstream of the TGF beta R by increasing the phosphorylation of smad2, and in the level of smad3 and smad4 translocated to the nucleus. Albumin produced an increase in IL-1 beta which was not dependent on smad activation, but was prevented by blockade of the TGF beta R. Increase in the chemokine CX3CL1, and the decrease in S100B produced by albumin were independent of the TGF beta R and smad activation. Albumin induced an increase in LDH release that was inhibited by blockade of the TGF beta R and by inhibition of smad activation. These findings show that albumin activates the canonical TGF beta receptor-smad signaling pathway. The albumin-induced increase in the pro-epileptogenic cytokine IL-1 beta involves the TGF beta R, but is independent of smad activation. Taken together, the effects of albumin on both IL-1 beta and activation of the TGF beta R pathway are further evidence for a role for albumin in neurotrauma-related epileptogenesis. (c) 2010 Elsevier Inc. All rights reserved.	[Ranaivo, Hantamalala Ralay; Patel, Fatima; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Div Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ranaivo, Hantamalala Ralay; Patel, Fatima; Wainwright, Mark S.] Northwestern Univ, Ctr Interdisciplinary Res Pediat Crit Illness & I, Feinberg Sch Med, Chicago, IL 60611 USA		Wainwright, MS (corresponding author), Childrens Mem Hosp, Div Neurol 51, 2300 Childrens Plaza, Chicago, IL 60614 USA.	m-wainwright@northwestern.edu			Davee Foundation; Medical Research Junior Board Foundation; Lyndsey Whittingham Foundation	Dr. Wainwright is supported by the Davee Foundation, the Medical Research Junior Board Foundation, and by the Lyndsey Whittingham Foundation.	Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Boldt J, 2010, BRIT J ANAESTH, V104, P276, DOI 10.1093/bja/aep393; Buisson A, 2003, CELL MOL NEUROBIOL, V23, P539, DOI 10.1023/A:1025072013107; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Cacheaux LP, 2009, J NEUROSCI, V29, P8927, DOI 10.1523/JNEUROSCI.0430-09.2009; Calvo CF, 2005, J NEUROSCI RES, V80, P707, DOI 10.1002/jnr.20511; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Ginsberg MD, 2006, BIOCHEM SOC T, V34, P1323, DOI 10.1042/BST0341323; Hooper C, 2005, J NEUROCHEM, V92, P1363, DOI 10.1111/j.1471-4159.2005.02982.x; Hooper C, 2009, J NEUROCHEM, V109, P694, DOI 10.1111/j.1471-4159.2009.05953.x; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu JR, 1997, J NEUROCHEM, V69, P2294; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kozuka N, 2007, NEUROSCIENCE, V144, P911, DOI 10.1016/j.neuroscience.2006.10.040; Ledeboer A, 2000, GLIA, V30, P134, DOI 10.1002/(SICI)1098-1136(200004)30:2<134::AID-GLIA3>3.0.CO;2-3; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Morganti-Kossmann MC, 1999, J NEUROTRAUM, V16, P617, DOI 10.1089/neu.1999.16.617; Mrak RE, 2005, NEUROBIOL AGING, V26, P349, DOI 10.1016/j.neurobiolaging.2004.05.010; Myburgh J, 2007, NEW ENGL J MED, V357, P874; NADAL A, 2001, BRAIN RES, V132, P367; Palesch YY, 2006, STROKE, V37, P2107, DOI 10.1161/01.STR.0000231389.34701.b5; PREHN JHM, 1993, J CEREBR BLOOD F MET, V13, P521, DOI 10.1038/jcbfm.1993.67; Ranaivo HR, 2010, BRAIN RES, V1313, P222, DOI 10.1016/j.brainres.2009.11.063; Re DB, 2006, NAT NEUROSCI, V9, P859; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Si QS, 1997, GLIA, V21, P413, DOI 10.1002/(SICI)1098-1136(199712)21:4<413::AID-GLIA9>3.0.CO;2-3; Siddiqui SS, 2004, AM J PHYSIOL-LUNG C, V286, pL1016, DOI 10.1152/ajplung.00356.2003; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Tabernero A, 2002, J BIOL CHEM, V277, P4240, DOI 10.1074/jbc.M108760200; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Thornton P, 2008, MOL CELL NEUROSCI, V37, P135, DOI 10.1016/j.mcn.2007.09.002; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Wang Y, 2007, EXP NEUROL, V203, P168, DOI 10.1016/j.expneurol.2006.08.006; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao TZ, 2009, NEUROL SCI, V30, P379, DOI 10.1007/s10072-009-0123-x; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.3.CO;2-M	49	20	20	0	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2010	226	2					310	319		10.1016/j.expneurol.2010.09.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	675MW	WOS:000283835800007	20854815				2022-02-06	
J	Wang, DM; Hazel, AS				Wang, Dongmei; Hazel, Alan S.			Microglial activation is a major contributor to neurologic dysfunction in thiamine deficiency	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						Wernicke encephalopathy; Inflammation; Microglia; Vitamin B-1; Neurologic dysfunction; Oxidative stress	TRAUMATIC BRAIN-INJURY; GLUTAMATE TRANSPORTERS; INDUCED APOPTOSIS; OXIDATIVE STRESS; N-ACETYLCYSTEINE; MILD IMPAIRMENT; GENE-EXPRESSION; MEDIAL THALAMUS; DOWN-REGULATION; MINOCYCLINE	In Wernicke's encephalopathy and thiamine deficiency (TD), the cause of this brain disorder, development of inflammation is an important aspect of the disease process. How this pathological mechanism relates to the neurologic impairment associated with TD, however, remains unclear. A key feature of the inflammatory process is the activation of microglia. In the present study, we evaluated the role of microglial activation in the pathophysiology of TD by examining the relationship between levels of CD11b/c and CD68, two proteins associated with microglial activation, and neurological dysfunction under conditions of TD. Rats with TD showed large increases in expression of both CD11b/c and CD68 in the vulnerable thalamus and inferior colliculus, with no change in mRNA levels in the relatively non-vulnerable frontal cortex. These alterations in CD11b/c and CD68 expression were reflected in dramatic upregulation of both proteins by immunoblotting and immunohistochemical methods. Co-treatment of rats with TD and the anti-inflammatory drug minocycline prevented microglial activation, and onset of neurological changes, including loss of righting reflex, was delayed by approximately 39 h, compared to animals with TD alone. In addition, co-treatment of rats with TD and N-acetylcysteine prevented the increase in CD11b/c and CD68, but did not alter the onset of neurological impairment. These results suggest that microglial activation plays a role in the development of neurological impairment in TD and possibly Wernicke's encephalopathy, and that while development of oxidative stress may be involved in microglial activation, the basis of this neurologic dysfunction is likely to be multifactorial in nature. (C) 2010 Elsevier Inc. All rights reserved.	[Wang, Dongmei; Hazel, Alan S.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada		Hazel, AS (corresponding author), Hop St Luc CHUM, NeuroRescue Lab, 1058 St Denis, Montreal, PQ H2X 3J4, Canada.	alan.stewart.hazell@umontreal.ca			Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP-84497]	This study was supported by a grant from The Canadian Institutes of Health Research (MOP-84497).	Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Carmichael EA, 1931, BRAIN, V54, P189, DOI 10.1093/brain/54.2.189; Chornyy S, 2007, ACTA BIOCHIM POL, V54, P315, DOI 10.18388/abp.2007_3252; COLLINS GH, 1967, AM J PATHOL, V50, P791; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; GIULIAN D, 1989, J NEUROSCI, V9, P4416; Hazell AS, 2010, GLIA, V58, P148, DOI 10.1002/glia.20908; Hazell AS, 2005, J NEUROSCI RES, V79, P200, DOI 10.1002/jnr.20278; Hazell AS, 2001, J NEUROCHEM, V78, P560, DOI 10.1046/j.1471-4159.2001.00436.x; Karuppagounder SS, 2007, NEUROBIOL DIS, V26, P353, DOI 10.1016/j.nbd.2007.01.011; Ke ZJ, 2006, NEUROCHEM INT, V49, P548, DOI 10.1016/j.neuint.2006.04.011; Kruse M, 2004, NEUROCHEM INT, V45, P49, DOI 10.1016/j.neuint.2003.12.007; Langlais PJ, 1997, METAB BRAIN DIS, V12, P137, DOI 10.1007/BF02674735; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsushima K, 1997, NEUROREPORT, V8, P867; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Morimoto N, 2005, BRAIN RES, V1044, P8, DOI 10.1016/j.brainres.2005.02.062; MORIOKA T, 1991, J CEREBR BLOOD F MET, V11, P966, DOI 10.1038/jcbfm.1991.162; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pi RB, 2004, J NEUROCHEM, V91, P1219, DOI 10.1111/j.1471-4159.2004.02796.x; Raivich G, 1999, ACTA NEUROCHIR SUPPL, V73, P21; ROBERTSON DM, 1975, AM J PATHOL, V79, P107; Rozen S, 2000, Methods Mol Biol, V132, P365; Todd KG, 1999, GLIA, V25, P190, DOI 10.1002/(SICI)1098-1136(19990115)25:2<190::AID-GLIA9>3.0.CO;2-B; Vemuganti R, 2006, EUR J NEUROSCI, V23, P1172, DOI 10.1111/j.1460-9568.2006.04651.x; Victor M, 1989, WERNICKE KORSAKOFF S; Wang JJL, 2000, J NUTR BIOCHEM, V11, P208, DOI 10.1016/S0955-2863(00)00067-X; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496	31	20	23	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	NOV 5	2010	402	1					123	128		10.1016/j.bbrc.2010.09.128			6	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	679TB	WOS:000284182600022	20932820				2022-02-06	
J	Tan, IL; Ng, T; Vucic, S				Tan, Ik Lin; Ng, Thomas; Vucic, Steve			Severe Guillain-Barre syndrome following head trauma	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						AMSAN; Guillain-Barre syndrome; Head trauma	T-CELL FUNCTION; IDIOPATHIC POLYNEURITIS; INJURY; PATHOGENESIS; IMPAIRMENT; PATHOLOGY; SURGERY; DEATH; CHINA	Fulminant forms of Guillain-Barre syndrome (GBS) present as acute onset tetraparesis and areflexia with absent brainstem reflexes, simulating brain death. Head trauma as an antecedent to fulminant GBS has been infrequently reported, and recognizing an association between GBS and head trauma may be crucial for patient management. Consequently, we report a patient with fulminant GBS with mixed demyelinating and axonal features preceded by a closed head injury, and discuss the possible pathophysiological mechanisms. (C) 2010 Elsevier Ltd. All rights reserved.	[Tan, Ik Lin; Vucic, Steve] Westmead Hosp, Dept Neurol, Westmead, NSW 2145, Australia; [Ng, Thomas] Westmead Hosp, Dept Anat Pathol, Westmead, NSW 2145, Australia; [Ng, Thomas; Vucic, Steve] Univ Sydney, Westmead Hosp, Western Clin Sch, Westmead, NSW 2145, Australia; [Vucic, Steve] Univ New S Wales, Prince Wales Med Res Inst, Sydney, NSW 2052, Australia		Vucic, S (corresponding author), Westmead Hosp, Dept Neurol, Corner Hawkesbury & Darcy Rd, Westmead, NSW 2145, Australia.	s.vucic@student.unsw.edu.au		Vucic, Steve/0000-0002-8323-873X	Brain Foundation Australia; Motor Neuron Disease Research Institute of Australia	Grant support from Brain Foundation Australia and the Motor Neuron Disease Research Institute of Australia is gratefully acknowledged.	ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001; BALDWIN RT, 1992, J HEART LUNG TRANSPL, V11, P817; DeFreitas GR, 1997, ARQ NEURO-PSIQUIAT, V55, P315, DOI 10.1590/S0004-282X1997000200022; DUNCAN R, 1987, POSTGRAD MED J, V63, P479, DOI 10.1136/pgmj.63.740.479; Friedman Y, 2003, CAN J NEUROL SCI, V30, P397, DOI 10.1017/S0317167100003152; Griffin JW, 1996, ANN NEUROL, V39, P17, DOI 10.1002/ana.410390105; HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Hughes RC, 1985, PERIPHERAL NERVE DIS, P175; Lin TM, 2006, J PLAST RECONSTR AES, V59, P543, DOI 10.1016/j.bjps.2005.10.017; MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402; MCKHANN GM, 1991, LANCET, V338, P593, DOI 10.1016/0140-6736(91)90606-P; MILLER C H, 1991, Neurological Research, V13, P117; PRINEAS JW, 1981, ANN NEUROL, V9, P6, DOI 10.1002/ana.410090704; PRINEAS JW, 1972, LAB INVEST, V26, P133; Pritchard J, 2007, J NEUROIMMUNOL, V183, P232, DOI 10.1016/j.jneuroim.2006.12.002; QUATTROCCHI KB, 1992, J NEUROTRAUM, V9, P1, DOI 10.1089/neu.1992.9.1; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; QUATTROCCHI KB, 1992, J NEUROSURG, V77, P694, DOI 10.3171/jns.1992.77.5.0694; RENLUND DG, 1987, AM HEART J, V113, P844, DOI 10.1016/0002-8703(87)90736-8; Rivas S, 2008, J NEUROSURG, V108, P595, DOI 10.3171/JNS/2008/108/3/0595; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; SHUERT GT, 1972, J ORAL SURG, V30, P913; Vargas F, 2000, INTENS CARE MED, V26, P623, DOI 10.1007/s001340051213; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033	27	20	20	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	NOV	2010	17	11					1452	1454		10.1016/j.jocn.2009.11.037			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	705JF	WOS:000286124000027	20638848				2022-02-06	
J	Zhang, XM; Du, F; Yang, D; Yu, CJ; Huang, XN; Liu, W; Fu, J				Zhang, Xue-mei; Du, Fang; Yang, Dan; Yu, Chun-jiang; Huang, Xiang-nan; Liu, Wei; Fu, Jin			Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral stroke	BMC NEUROSCIENCE			English	Article							TRAUMATIC BRAIN-INJURY; PROGENITOR CELLS; STROMAL CELLS; IN-VIVO; EXPRESSING CELLS; NEUROGENESIS; DOUBLECORTIN; MANIPULATION; WIDESPREAD; INDUCTION	Background: Several studies demonstrate that neurogenesis may be induced or activated following vascular insults, which may be important for neuronal regeneration and functional recovery. Understanding the cellular mechanism underlying stroke-associated neurogenesis is of neurobiological as well as neurological/clinical relevance. The present study attempted to explore potential homing and early development of transplanted bone marrow stem cells in mouse forebrain after focal occlusion of the middle cerebral artery, an experimental model of ischemic stroke. Results: Bone marrow stem cells isolated from donor mice were confirmed by analysis of surface antigen profile, and were pre-labeled with a lipophilic fluorescent dye PKH26, and subsequently transfused into recipient mice with middle cerebral artery coagulation. A large number of PKH26-labeled cells were detected surrounding the infarct site, most of which colocalized with immunolabelings for the proliferating cell nuclear antigen (PCNA) and some also colocalized with the immature neuronal marker doublecortin (DCX) during 1-2 weeks after the bone marrow cells transfusion. Conclusions: The present study shows that transplanted bone morrow cells largely relocate to the infarct penumbra in ischemic mouse cerebrum. These transplanted bone marrow cells appear to undergo a process of in situ proliferation and develop into putative cortical interneurons during the early phase of experimental vascular injury.	[Zhang, Xue-mei; Du, Fang; Yang, Dan; Yu, Chun-jiang; Huang, Xiang-nan; Fu, Jin] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin 150086, Peoples R China; [Liu, Wei] Harbin Med Univ, Affiliated Hosp 2, Ctr Res & Expt, Harbin 150086, Peoples R China		Fu, J (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin 150086, Peoples R China.	fujin198@126.com					Arlotta P, 2003, EXP GERONTOL, V38, P173, DOI 10.1016/S0531-5565(02)00156-0; Atala A, 2004, ANNU REV BIOMED ENG, V6, P27, DOI 10.1146/annurev.bioeng.6.012204.115707; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Crain BJ, 2005, J NEUROL SCI, V233, P121, DOI 10.1016/j.jns.2005.03.017; Fotheringham AP, 2000, NEUROPATH APPL NEURO, V26, P412, DOI 10.1046/j.1365-2990.2000.00265.x; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Grove JE, 2004, STEM CELLS, V22, P487, DOI 10.1634/stemcells.22-4-487; Gu WG, 2010, STEM CELL RES, V4, P148, DOI 10.1016/j.scr.2009.12.001; Hess DC, 2002, TRENDS MOL MED, V8, P452, DOI 10.1016/S1471-4914(02)02404-8; Hess DC, 2002, STROKE, V33, P1362, DOI 10.1161/01.STR.0000014925.09415.C3; Ji KH, 2009, J DERMATOL, V36, P403, DOI 10.1111/j.1346-8138.2009.00666.x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Jin SZ, 2009, WORLD J GASTROENTERO, V15, P2657, DOI 10.3748/wjg.15.2657; JIN SZ, 2010, DIG DIS SCI; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Koh LP, 2004, ANN HEMATOL, V83, P286, DOI 10.1007/s00277-003-0810-2; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Magavi SS, 2002, DEV BRAIN RES, V134, P57, DOI 10.1016/S0165-3806(01)00316-9; Mattiesen WRC, 2009, ACTA NEUROPATHOL, V117, P525, DOI 10.1007/s00401-009-0509-0; Mezey E, 2000, SCIENCE, V290, P1779, DOI 10.1126/science.290.5497.1779; Nadri S, 2007, INT J DEV BIOL, V51, P723, DOI 10.1387/ijdb.072352ns; Ohta T, 2006, NEUROSURGERY, V59, P679, DOI 10.1227/01.NEU.0000229058.08706.88; OKADA S, 1992, BLOOD, V80, P3044; Perin EC, 2004, CIRCULATION, V110, pII213, DOI 10.1161/01.CIR.0000138398.77550.62; Shen CC, 2010, CURR NEUROVASC RES, V7, P6, DOI 10.2174/156720210790820208; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Terai S, 2003, J BIOCHEM, V134, P551, DOI 10.1093/jb/mvg173; Tomita T, 1999, RHEUMATOLOGY, V38, P854, DOI 10.1093/rheumatology/38.9.854; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang YM, 2007, BRAIN RES, V1167, P118, DOI 10.1016/j.brainres.2007.06.065; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yau TM, 2003, ANN THORAC SURG, V75, P169, DOI 10.1016/S0003-4975(02)04290-X; Zhang XM, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.017.2009; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	42	20	23	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2202			BMC NEUROSCI	BMC Neurosci.	OCT 25	2010	11								138	10.1186/1471-2202-11-138			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	675VS	WOS:000283868800001	20973978	gold, Green Published			2022-02-06	
J	Hall, BJ; Lally, JE; Vukmanic, EV; Armstrong, JE; Fell, JD; Gupta, DS; Hubscher, CH				Hall, Bradley J.; Lally, Jason E.; Vukmanic, Eric V.; Armstrong, James E.; Fell, Jason D.; Gupta, Daya S.; Hubscher, Charles H.			Spinal Cord Injuries Containing Asymmetrical Damage in the Ventrolateral Funiculus Is Associated With a Higher Incidence of At-Level Allodynia	JOURNAL OF PAIN			English	Article						Allodynia; neuropathic pain; spinal cord injury; neurotrauma; monofilaments; segmental pain	CHRONIC CENTRAL PAIN; CENTRAL NEUROPATHIC PAIN; VON-FREY MONOFILAMENTS; MU-OPIOID RECEPTOR; THALAMIC NEURONS; RODENT MODEL; DORSAL-HORN; RAT; ACTIVATION; INHIBITION	Approximately 70% of male rats receiving severe T8 spinal contusions develop allodynia in T5-7 dermatomes (at-level) beginning 2 weeks after injury. In contrast, rats having either complete transections or dorsal hemisections do not develop allodynia at-level after chronic spinal cord injury (SCI). In the present study, incomplete laceration and contusion injuries were made to test for neuroanatomical correlates between areas of white matter damage/sparing at the lesion epicenter and the presence/absence of allodynia. After incomplete laceration lesions and 6 weeks of behavioral testing, histological reconstruction and analysis of the lesion epicenters revealed a significant difference (P<.001) in the amount of ventrolateral funiculus (VLF) asymmetry between rats showing pain-like responses evoked by touch (74.5% +/- 8.4% side-to-side difference in VLF damage) versus those not responding to touch (11.3% +/- 4.4% side-to-side difference in VLF damage). A 5-week mean allodynia score for each rat that incorporates a full range of forces that are all innocuous in intact controls revealed that the degree of hypersensitivity at level is related to the extent of VLF asymmetry after SCI. No other damaged spinal white matter or gray matter area was correlated with sensitivity to touch. Similar findings were obtained for rats receiving 18 contusions, a more clinically relevant injury. These data suggest that different extents of damage/sparing between the 2 sides of VLF probably are a requisite for the development of allodynia after SCI. Perspective: A side-to-side lesion asymmetry after chronic SCI in a rodent model was found to be highly correlated with the presence and degree of allodynia. Greater insight of key factors contributing to the development and maintenance of chronic neuropathic pain is important for improving quality of life. (C) 2010 by the American Pain Society	[Hall, Bradley J.; Lally, Jason E.; Vukmanic, Eric V.; Armstrong, James E.; Fell, Jason D.; Gupta, Daya S.; Hubscher, Charles H.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA		Hubscher, CH (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	chhubs01@louisville.edu		Gupta, Daya/0000-0003-1084-9932	National Center for Research Resources (NCRR), NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR015576]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR015576] Funding Source: NIH RePORTER	Supported by grant No. RR015576 from the National Center for Research Resources (NCRR), a component of the NIH.	Abraham KE, 2001, PAIN, V90, P181, DOI 10.1016/S0304-3959(00)00402-4; BERKLEY KJ, 1995, NAT MED, V1, P766, DOI 10.1038/nm0895-766; BOIVIE J, 1992, SYMP PAIN R, P363; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Carson FL, 1990, HISTOTECHNOLOGY SELF; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; Christensen MD, 1996, PAIN, V68, P97, DOI 10.1016/S0304-3959(96)03224-1; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Crown ED, 2006, EXP NEUROL, V199, P397, DOI 10.1016/j.expneurol.2006.01.003; DAVIDOFF G, 1991, SYMP PAIN R, P77; DONOVAN WH, 1982, PARAPLEGIA, V20, P135, DOI 10.1038/sc.1982.27; Eaton MJ, 2006, J NEUROTRAUM, V23, P549, DOI 10.1089/neu.2006.23.549; Finnerup NB, 2007, EXP NEUROL, V207, P139, DOI 10.1016/j.expneurol.2007.06.001; Finnerup NB, 2003, NEUROLOGY, V61, P1569, DOI 10.1212/01.WNL.0000096016.29134.FA; Garcia R, 1998, NEUROSCIENCE, V82, P139; Gerke MB, 2003, NEUROSCIENCE, V117, P715, DOI 10.1016/S0306-4522(02)00961-2; Hains BC, 2003, J NEUROSCI, V23, P8881; HATEM SM, 2007, 2007 NEUR M PLANN SA; HOSOBUCHI Y, 1986, J NEUROSURG, V64, P543, DOI 10.3171/jns.1986.64.4.0543; Hubbard DT, 2007, NEUROSCIENCE, V150, P818, DOI 10.1016/j.neuroscience.2007.10.001; Hubscher CH, 2006, EXP NEUROL, V197, P177, DOI 10.1016/j.expneurol.2005.09.007; Hubscher CH, 2003, J NEUROPHYSIOL, V89, P2, DOI 10.1152/jn.00294.2002; Hubscher CH, 2002, BRAIN RES, V947, P234, DOI 10.1016/S0006-8993(02)02930-X; Hubscher CH, 2001, NEUROREPORT, V12, P2995, DOI 10.1097/00001756-200109170-00048; Hubscher CH, 2008, J NEUROTRAUM, V25, P1241, DOI 10.1089/neu.2008.0515; Hugues S, 2003, J NEUROPHYSIOL, V90, P3224, DOI 10.1152/jn.00895.2002; Hulsebosch CE, 2000, J NEUROTRAUM, V17, P1205, DOI 10.1089/neu.2000.17.1205; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Keizer D, 2007, EUR J ANAESTH, V24, P658, DOI 10.1017/S0265021507000221; Keizer D, 2007, CLIN J PAIN, V23, P85, DOI 10.1097/01.ajp.0000210950.01503.72; Kloos AD, 2005, EXP NEUROL, V191, P251, DOI 10.1016/j.expneurol.2004.09.016; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; LENZ FA, 1994, J NEUROPHYSIOL, V72, P1570, DOI 10.1152/jn.1994.72.4.1570; Luna LG, 1968, MANUAL HISTOLOGIC ST; Markenson Joseph A., 1996, American Journal of Medicine, V101, p6S; MELZACK R, 1982, PAIN, V14, P33, DOI 10.1016/0304-3959(82)90078-1; Merskey H, 1994, CLASSIFICATION CHRON; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Niv David, 2006, Pain Pract, V6, P3, DOI 10.1111/j.1533-2500.2006.00052.x; Oatway MA, 2004, PAIN, V110, P259, DOI 10.1016/j.pain.2004.03.040; Pattany PM, 2002, AM J NEURORADIOL, V23, P901; Porreca F, 2001, J NEUROSCI, V21, P5281, DOI 10.1523/JNEUROSCI.21-14-05281.2001; Reed WR, 2009, J NEUROPHYSIOL, V102, P1062, DOI 10.1152/jn.00165.2009; RICHARDSON RR, 1980, PAIN, V8, P75, DOI 10.1016/0304-3959(80)90091-3; Saade NE, 2006, EXP NEUROL, V197, P157, DOI 10.1016/j.expneurol.2005.09.005; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; SIDDALL P, 1995, NEUROREPORT, V6, P1241, DOI 10.1097/00001756-199506090-00003; Siddall PJ, 2001, SPINAL CORD, V39, P63, DOI 10.1038/sj.sc.3101116; Spennato G, 2008, PSYCHOPHARMACOLOGY, V196, P583, DOI 10.1007/s00213-007-0993-7; Sun H, 2001, PAIN, V90, P105, DOI 10.1016/S0304-3959(00)00392-4; Sved P, 1997, SPINAL CORD, V35, P526, DOI 10.1038/sj.sc.3100443; Villanueva L, 2000, PROG PAIN RES MANAG, V16, P371; Wang GX, 2008, J NEUROSCI, V28, P11959, DOI 10.1523/JNEUROSCI.3296-08.2008; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; WOOLF CJ, 1984, PAIN, V18, P325, DOI 10.1016/0304-3959(84)90045-9; WOOLF CJ, 1984, BRAIN RES, V303, P299, DOI 10.1016/0006-8993(84)91216-2; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yezierski RP, 1998, PAIN, V75, P141, DOI 10.1016/S0304-3959(97)00216-9; Yu CG, 2005, MOL BRAIN RES, V138, P244, DOI 10.1016/j.molbrainres.2005.04.013; Zhang HJ, 2005, BRAIN RES, V1055, P103, DOI 10.1016/j.brainres.2005.06.072; Zhang YP, 2004, J NEUROSURG, V100, P343, DOI 10.3171/spi.2004.100.4.0343; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007	63	20	20	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1526-5900			J PAIN	J. Pain	SEP	2010	11	9					864	875		10.1016/j.jpain.2009.12.008			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	652TW	WOS:000282033900007	20338826	Green Accepted			2022-02-06	
J	Jeong, JH; Kim, YZ; Cho, YW; Kim, JS				Jeong, Jae Hyun; Kim, Young Zoon; Cho, Yong Woon; Kim, Joon Soo			Negative effect of hypopituitarism following brain trauma in patients with diffuse axonal injury	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; diffuse axonal injury; hypopituitarism; functional outcome	HEAD-INJURY; POSTTRAUMATIC HYPOPITUITARISM; COMA	Object. The aim of this prospective observational study was to assess the incidence and pattern of hypopituitarism after diffuse axonal injury (DAI) and to identify its effect on these patients in terms of functional outcome. Methods. Of 1307 patients with traumatic brain injury treated at the authors' institution between March 2005 and June 2008, 65 patients with DAI were enrolled in the present study. The authors determined basal hormone levels, initial Glasgow Coma Scale scores, the Marshall CT grades, the presence of abnormal signal intensity indicating lesions on MR images, and duration of unconsciousness. At the 6-month follow-up visits, functional outcomes were estimated using the Modified Barthel Index. Univariate and multivariate analyses were performed to identify factors that influenced functional outcomes. Results. Twenty-one patients with hypopituitarism (Group A) had more lesions in the body of the corpus callosum, basal ganglia, thalamus, and the gray white matter junction than those without hypopituitarism (Group B). In Group A, growth hormone deficiency (17 patients, 80.9%) was the most common, and multiple pituitary hormone deficiencies were found in 12 patients (57.1%). The mean Modified Barthel Index score at the 6-month follow-up was 64.7 in Group A and 88.5 in Group B (p = 0.027). Duration of unconsciousness (p = 0.035), the Marshall CT grade (p = 0.021), hypopituitarism (p = 0.044), and abnormal signal intensities on MR imaging in midline or deep structures of the brain (p = 0.001) were found to be associated with functional outcome. Conclusions. The findings in this prospective observational study suggest that hypopituitarism in patients with DAI has a relationship not only with injuries in the midline or deep structures of the brain, but also with a poor outcome. (DOI: 10.3171/2009.10.JNS091152)	[Jeong, Jae Hyun; Kim, Young Zoon; Cho, Yong Woon; Kim, Joon Soo] Sungkyunkwan Univ, Sch Med, Masan Samsung Hosp, Dept Neurosurg, Masan 630723, South Korea		Kim, YZ (corresponding author), Sungkyunkwan Univ, Sch Med, Masan Samsung Hosp, Dept Neurosurg, 50,Hapsung 2 Dong, Masan 630723, South Korea.	youngzoon.kim@samsung.com					ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1992, GREENFIELDS NEUROPAT, P123; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; EDWARDS OM, 1986, MEDICINE, V65, P281; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; Hernberg-Stahl E, 2001, J CLIN ENDOCR METAB, V86, P5277, DOI 10.1210/jc.86.11.5277; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Kusanagi Hiroaki, 2000, Journal of Nippon Medical School, V67, P130, DOI 10.1272/jnms.67.130; Lorenzo Monica, 2005, Pituitary, V8, P233, DOI 10.1007/s11102-006-6046-0; MAHONEY F I, 1965, Md State Med J, V14, P61; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Simmonds M, 1914, DEUT MED WOCHENSCHR, V40, P322, DOI 10.1055/s-0029-1190185; Springer J, 2001, LANCET, V357, P1848, DOI 10.1016/S0140-6736(00)04953-9; Sugiyama K, 2007, BRAIN INJURY, V21, P413, DOI 10.1080/02699050701311042; TEASDALE G, 1974, LANCET, V2, P81; Urban RJ, 2005, BRAIN INJURY, V19, P349, DOI 10.1080/02699050400004807; [No title captured]	30	20	20	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2010	113	3					532	538		10.3171/2009.10.JNS091152			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	641FV	WOS:000281111100016	19943735				2022-02-06	
J	Jin, H; Wang, SM; Hou, LJ; Pan, CG; Li, B; Wang, H; Yu, MK; Lu, YC				Jin, Hai; Wang, Sumin; Hou, Lijun; Pan, Chengguang; Li, Bo; Wang, Hui; Yu, Mingkun; Lu, Yicheng			Clinical treatment of traumatic brain injury complicated by cranial nerve injury	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Traumatic brain injury; Cranial nerve injury; Diagnosis; Surgical treatment	OPTIC NEUROPATHY; DECOMPRESSION; DYSFUNCTION; DIAGNOSIS	Objective: To discuss the epidemiology, diagnosis and surgical treatment of cranial nerve injury following traumatic brain injury (TBI) for the sake of raising the clinical treatment of this special category of TBI. Patients and methods: A retrospective analysis was made of 312 patients with cranial nerve injury among 3417 TBI patients, who were admitted for treatment in this hospital. Results: A total of 312 patients (9.1%) involving either a single nerve or multiple nerves among the 12 pairs of cranial nerves were observed. The extent of nerve injury varied and involved the olfactory nerve (66 cases), optic nerve (78 cases), oculomotor nerve (56 cases), trochlear nerve (8 cases), trigeminal nerve (4 cases), abducent nerve (12 cases), facial nerve (48 cases), acoustic nerve (10 cases), glossopharyngeal nerve (8 cases), vagus nerve (6 cases), accessory nerve (10 cases) and hypoglossal nerve (6 cases). Imaging examination revealed skull fracture in 217 cases, complicated brain contusion in 232 cases, epidural haematoma in 194 cases, subarachnoid haemorrhage in 32 cases, nasal cerebrospinal fluid (CSF) leakage in 76 cases and ear CSF leakage in 8 cases. Of the 312 patients, 46 patients died; the mortality rate associated with low cranial nerve injury was as high as 73.3%. Among the 266 surviving patients, 199 patients received conservative therapy and 67 patients received surgical therapy; the curative rates among these two groups were 61.3% (122 patients) and 86.6% (58 patients), respectively. Conclusion: TBI-complicated cranial nerve injury is subject to a high incidence rate, a high mortality rate and a high disability rate. Our findings suggest that the chance of recovery may be increased in cases where injuries are amenable to surgical decompression. It is necessary to study all 12 pairs of cranial nerves systematically. Clinically, it is necessary to standardise surgical indications, operation timing, surgical approaches and methods for the treatment of TBI-complicated cranial nerve injury. (C) 2010 Elsevier Ltd. All rights reserved.	[Jin, Hai; Hou, Lijun; Pan, Chengguang; Li, Bo; Wang, Hui; Yu, Mingkun; Lu, Yicheng] Second Mil Med Univ, Changzheng Hosp, Shanghai Neurosurg Inst, Dept Neurosurg, Shanghai 200003, Peoples R China; [Wang, Sumin] Second Mil Med Univ, Changhai Hosp, Dept Otolaryngol, Shanghai 200003, Peoples R China		Hou, LJ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Shanghai Neurosurg Inst, Dept Neurosurg, 415 Fengyang Rd, Shanghai 200003, Peoples R China.	lhou@partners.org					Acheson JF, 2004, EYE, V18, P1169, DOI 10.1038/sj.eye.6701559; AHMED B, 2006, BR J ORAL MAXILLOFAC, V44, P313; Blomqvist EH, 2004, RHINOLOGY, V42, P189; Carta A, 2006, EUR J OPHTHALMOL, V16, P847, DOI 10.1177/112067210601600610; Cheng YS, 2008, CHINESE MED J-PEKING, V121, P276, DOI 10.1097/00029330-200802010-00020; ENRIQUE U, 1996, J NEUROSURG, V84, P522; Exadaktylos AK, 2005, J TRAUMA, V58, P336, DOI 10.1097/01.TA.0000141874.73520.A6; Kennelly KD, 2006, NEUROLOGIST, V12, P188, DOI 10.1097/01.nrl.0000215784.76741.9e; Leung DYL, 2006, J TRAUMA, V60, P685, DOI 10.1097/01.ta.0000205919.68089.c0; Milbrandt K, 2005, CAN MED ASSOC J, V172, P632, DOI 10.1503/cmaj.1041089; Mine S, 1999, ACTA NEUROCHIR, V141, P27, DOI 10.1007/s007010050262; Ohlsson M, 2007, EXP BRAIN RES, V179, P121, DOI 10.1007/s00221-006-0775-1; Sandford AA, 2006, INT J PEDIATR OTORHI, V70, P1015, DOI 10.1016/j.ijporl.2005.10.013; Shahzadi S, 2007, SURG NEUROL, V68, P464, DOI 10.1016/j.surneu.2006.10.064; SONG WX, 2002, OPHTHALMOLOGY, V11, P286; Wang DH, 2008, ORL-J OTO-RHIN-LARYN, V70, P130, DOI 10.1159/000114537; Wu N, 2008, J INT MED RES, V36, P883, DOI 10.1177/147323000803600503; Zapala Jan, 2005, Klin Oczna, V107, P263	18	20	24	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2010	41	9					918	923		10.1016/j.injury.2010.03.007			6	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	634SL	WOS:000280605500008	20399426				2022-02-06	
J	Sogut, O; Guloglu, C; Orak, M; Sayhan, MB; Gokdemir, MT; Ustundag, M; Akkus, Z				Sogut, O.; Guloglu, C.; Orak, M.; Sayhan, M. B.; Gokdemir, M. T.; Ustundag, M.; Akkus, Z.			Trauma Scores and Neuron-specific Enolase, Cytokine and C-reactive Protein Levels as Predictors of Mortality in Patients with Blunt Head Trauma	JOURNAL OF INTERNATIONAL MEDICAL RESEARCH			English	Article						BLUNT HEAD TRAUMA; NEURON-SPECIFIC ENOLASE; CYTOKINES; C-REACTIVE PROTEIN; GLASGOW COMA SCALE; REVISED TRAUMA SCORE	ACUTE-PHASE RESPONSE; BRAIN-INJURY; CEREBROSPINAL-FLUID; UNITED-STATES; INTERLEUKIN-6; SERUM; EPIDEMIOLOGY; BIOMARKERS; DIAGNOSIS; EMERGENCY	This study evaluated serum neuron-specific enolase (NSE), cytokine and high-sensitivity C-reactive-protein (hs-CRP) levels, along with the Glasgow Coma Scale (GCS) and Revised Trauma Score (RTS), as predictors of mortality in the early post-traumatic period, in 100 Turkish patients with blunt head trauma. Overall patient mortality was 27%. There was a significant association between age and mortality, and mortality was negatively correlated with GCS and RTS. Head injury severity (GCS) was significantly related to NSE, hs-CRP, interleukin (IL)-6, IL-8 and tumour necrosis factor (TNF)-alpha levels. Mortality correlated positively with IL-6, IL-8, TNF-alpha and hs-CRP levels. NSE, hs-CRP, IL-6, IL-8 and TNF-alpha levels were significantly higher in non-survivors compared with survivors. GCS score <= 8, younger age and NSE levels were significant independent predictors of mortality. During the early post-traumatic period, NSE may be an objective alternative criterion to the GCS, in the management of patients with blunt head trauma.	[Sogut, O.] Harran Univ, Fac Med, Dept Emergency Med, TR-63300 Sanliurfa, Turkey; [Guloglu, C.; Orak, M.; Ustundag, M.] Dicle Univ, Fac Med, Dept Emergency Med, Diyarbakir, Turkey; [Akkus, Z.] Dicle Univ, Fac Med, Dept Biostat, Diyarbakir, Turkey; [Sayhan, M. B.] Edirne Publ Hosp, Emergency Serv, Edirne, Turkey; [Gokdemir, M. T.] Sanliurfa Res & Training Hosp, Dept Emergency Med, Sanliurfa, Turkey		Sogut, O (corresponding author), Harran Univ, Fac Med, Dept Emergency Med, Yenisehir Kampusu, TR-63300 Sanliurfa, Turkey.	drosogut@harran.edu.tr			Scientific Research Projects Committee of Dicle University, Diyarbakir, TurkeyDicle University	The study was financially supported by the Scientific Research Projects Committee of Dicle University, Diyarbakir, Turkey and we should like to thank them for their contribution.	ANASTASIADES KD, 1987, AM J CLIN PATHOL, V87, P245, DOI 10.1093/ajcp/87.2.245; Bone RC, 1996, CRIT CARE MED, V24, P163, DOI 10.1097/00003246-199601000-00026; CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P8; Chamoun RB, 2009, J NEUROSURG, V111, P683, DOI 10.3171/2009.2.JNS08817; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; DAY INM, 1984, CLIN CHIM ACTA, V136, P219, DOI 10.1016/0009-8981(84)90295-X; DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517; Faist E, 1996, WORLD J SURG, V20, P454, DOI 10.1007/s002689900071; Gabbe Belinda J, 2003, Emerg Med (Fremantle), V15, P353, DOI 10.1046/j.1442-2026.2003.00474.x; Gabbe BJ, 2003, ANZ J SURG, V73, P944, DOI 10.1046/j.1445-1433.2003.02833.x; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Is M, 2007, J CLIN NEUROSCI, V14, P1163, DOI 10.1016/j.jocn.2006.05.020; Kavalci C, 2007, AM J EMERG MED, V25, P391, DOI 10.1016/j.ajem.2006.10.008; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kuhls DA, 2002, J AM COLL SURGEONS, V194, P695, DOI 10.1016/S1072-7515(02)01211-5; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li Ning, 2004, Chin J Traumatol, V7, P156; Liliang PC, 2010, J SURG RES, V160, P302, DOI 10.1016/j.jss.2008.12.022; Luk SS, 1999, J TRAUMA, V46, P122, DOI 10.1097/00005373-199901000-00020; MCCLAIN C, 1991, J LAB CLIN MED, V118, P225; MEREDITH W, 1995, J TRAUMA, V38, P129, DOI 10.1097/00005373-199501000-00030; NORRIS JG, 1993, J NEUROIMMUNOL, V45, P137; Partrick DA, 1996, AM J SURG, V172, P425, DOI 10.1016/S0002-9610(96)00252-8; Peden M., 2002, INJURY CHART BOOK GR; PULLICINO EA, 1990, LYMPHOKINE RES, V9, P231; Ritchie PD, 2000, J CLIN NEUROSCI, V7, P301, DOI 10.1054/jocn.1999.0198; ROYDS JA, 1981, J NEUROL NEUROSUR PS, V44, P1129, DOI 10.1136/jnnp.44.12.1129; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Simon B, 2001, J TRAUMA, V51, P231, DOI 10.1097/00005373-200108000-00004; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Streetz KL, 2001, CELL MOL BIOL, V47, P661; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Turedi S, 2008, J EMERG MED, V34, P253, DOI 10.1016/j.jemermed.2007.05.055	40	20	20	0	9	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0300-0605	1473-2300		J INT MED RES	J. Int. Med. Res.	SEP-OCT	2010	38	5					1708	1720		10.1177/147323001003800516			13	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	695WT	WOS:000285404000016	21309485				2022-02-06	
J	Sveen, U; Bautz-Holter, E; Sandvik, L; Alvsaker, K; Roe, C				Sveen, Unni; Bautz-Holter, Erik; Sandvik, Leiv; Alvsaker, Kristin; Roe, Cecilie			Relationship between competency in activities, injury severity, and post-concussion symptoms after traumatic brain injury	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Activities of daily living; competency; functioning; instrumental ADL; post-concussion symptoms; traumatic brain injury	MINOR HEAD-INJURY; QUALITY-OF-LIFE; SYSTEMATIC BIAS; RATING-SCALE; FOLLOW-UP; MILD; SATISFACTION; RECOVERY; OUTCOMES; CLASSIFICATION	Objective: To determine to what extent injury severity and post-concussion symptoms after 3 months predict ability in activities 12 months after traumatic brain injury (TBI) and assess the frequency of problems in daily activities. Methods: A one-year cohort of 63 persons with mild to severe TBI was assessed on admission, after three and 12 months. Injury severity was assessed using the Glasgow Coma Scale, Abbreviated Injury Scale for the head and Injury Severity Score. Post-concussion symptoms were reported using the Rivermead Post Concussion Symptoms Questionnaire after three months. The Patient Competency Rating Scale (PCRS), a self-rating scale of ability in activities, was applied 12 months post-injury. The PCRS consists of the domains interpersonal/emotional and cognitive competency, and instrumental ADL. Multiple backward regression models were performed with the three subscales of PCRS as dependent variables. Results: Activity problems at 12 months were related to perceived cognitive and interpersonal/emotional competency. Post-concussion symptoms reported at three-month follow-up were main predictors of cognitive and interpersonal/emotional competency at 12 months. Injury severity predicted only cognitive competency. Conclusion: Symptoms evolving after the trauma seem to be the strongest predictor of perceived ability in activities in this population. This underlines the need for follow-up after TBI to identify persons at risk of developing long-term activity limitations.	[Sveen, Unni; Bautz-Holter, Erik; Alvsaker, Kristin; Roe, Cecilie] Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway; [Sveen, Unni] Univ Oslo, Dept Geriatr Med, Oslo Univ Hosp, Oslo, Norway; [Sveen, Unni] Oslo Univ Coll, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Clin Res Ctr, N-0407 Oslo, Norway		Sveen, U (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway.	unni.sveen@uus.no			Norwegian Foundation for Health and Rehabilitation	The authors would like to thank all the participants in this study, Liv Brathen, Cathrine Advocaat, Malin Mongs, and Inger Seip for helpful assistance with the registrations, and Terje Sprenger for stimulating discussions. They would also like to thank the staff at the Neurosurgical Department for their support during the inclusion period, and Susan Schanche for skilful help with the English language. The Norwegian Foundation for Health and Rehabilitation provided a grant for the study.	[Anonymous], 2009, OXFORD DICT; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Goldstein FC, 2001, J CLIN EXP NEUROPSYC, V23, P739, DOI 10.1076/jcen.23.6.739.1028; Gunstad J, 2004, ARCH CLIN NEUROPSYCH, V19, P391, DOI 10.1016/S0887-6177(03)00073-8; HEILBRONNER RL, 1993, J CLIN EXP NEUROPSYC, V15, P67; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Jacobsson LJ, 2007, ACTA NEUROL SCAND, V116, P300, DOI 10.1111/j.1600-0404.2007.00896.x; Johansson U, 2003, BRAIN INJURY, V17, P991, DOI 10.1080/0269905031000110508; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J, 2005, J HEAD TRAUMA REHAB, V20, P239, DOI 10.1097/00001199-200505000-00007; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; NAKASERICHARDSO.R, 2006, J NEUROL NEUROS 1218; Novack TA, 2000, BRAIN INJURY, V14, P987; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, ACT NEUR S, V93, P39; ROE C, 2009, DISABIL REH IN PRESS; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Stilwell P, 1999, NEUROPSYCHOL REHABIL, V9, P277, DOI 10.1080/096020199389374; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Sundstrom Terje, 2005, Tidsskr Nor Laegeforen, V125, P1310; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; TEASDALE G, 1974, LANCET, V2, P81; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Toschlog EA, 2003, AM SURGEON, V69, P491; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P1103, DOI 10.1016/S0003-9993(97)90135-0	45	20	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.	SEP	2010	17	3					225	232		10.3109/11038120903171295			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	672EQ	WOS:000283566200006	20302448	Green Submitted			2022-02-06	
J	Klimo, P; Ragel, BT; Scott, WH; McCafferty, R				Klimo, Paul, Jr.; Ragel, Brian T.; Scott, William H., Jr.; McCafferty, Randall			Pediatric neurosurgery during Operation Enduring Freedom Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						pediatric neurosurgery; Operation Enduring Freedom; Afghanistan; penetrating brain injury; humanitarian service	COMBAT SUPPORT HOSPITALS; SURGICAL-TEAM; TRAUMATIC BRAIN; IRAQI FREEDOM; AFGHANISTAN; EXPERIENCE; BLAST; MISSION; INJURY	Object. Operation Enduring Freedom (OEF) is the current US military conflict against terrorist elements in Afghanistan. Deepening US involvement in this conflict and increasing coalition casualties prompted the establishment of continuous neurosurgical assets at Craig Joint Theater Hospital (CJTH) at Bagram Airfield, Afghanistan, in September 2007. As part of the military's medical mission, children with battlefield-related injuries and, on a selective case-by-case basis, non war-related pathological conditions are treated at CJTH. Methods. A prospectively maintained record was created in which all rotating neurosurgeons at CJTH recorded their personal procedures:From this record, the authors were able to extract all cases involving patients 18 years of age or younger. Variables recorded included: age, sex, and category of patient (for example, local national, enemy combatant), date, indication and description of the neurosurgical procedure, mechanism of injury, and in-hospital morbidity and mortality data. Results. From September 2007 to October 2009, 296 neurosurgical procedures were performed at CJTH. Fifty-seven (19%) were performed in 43 pediatric patients (16 girls and 27 boys) with an average age of 7.5 years (range 11 days-18 years). Thirty-one of the 57 procedures (54%) were for battlefield-related trauma and 26 for humanitarian reasons (46%). The vast majority of cases were cranial (49/57, 86%) compared with spinal (7/54, 13%), with one peripheral nerve case. Craniotomies or craniectomies for penetrating brain injuries were the most common procedures. There were 5 complications (11.6%) and 4 in-hospital deaths (9.3%). Conclusions. As in previous military conflicts, children are the unfortunate victims of the current Afghanistan campaign. Extremely limited pediatric neurosurgical service and care is rendered under challenging conditions and Air Force neurosurgeons provide valuable, life-saving pediatric treatment for both war-related injuries and humanitarian needs. As the conflict in Afghanistan continues, military neurosurgeons will continue to care for injured children to the best of their abilities. (DOI:10.317112010.3.PEDS109)	[Klimo, Paul, Jr.] 88th Med Grp, Wright Patterson AFB, OH 45433 USA; [Ragel, Brian T.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA; [Scott, William H., Jr.] 99th Med Operat Squadron, Nellis AFB, NV USA; [McCafferty, Randall] Wilford Hall USAF Med Ctr, Lackland AFB, TX 78236 USA		Klimo, P (corresponding author), 88th Med Grp, 4881 Sugar Maple Dr, Wright Patterson AFB, OH 45433 USA.	atomkpnk@yahoo.com					Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Beekley AC, 2004, AM J SURG, V187, P652, DOI 10.1016/j.amjsurg.2004.02.001; Beekley AC, 2009, J TRAUMA, V66, pS129, DOI 10.1097/TA.0b013e31819d85e7; Beitler AL, 2006, MIL MED, V171, P189, DOI 10.7205/MILMED.171.3.189; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bono Christopher M, 2004, Spine J, V4, P230, DOI 10.1016/S1529-9430(03)00178-5; Burnett MW, 2008, PEDIATRICS, V121, P261, DOI 10.1542/peds.2006-3666; Coppola CP, 2006, ARCH PEDIAT ADOL MED, V160, P972, DOI 10.1001/archpedi.160.9.972; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; Djientcheu VD, 2008, J NEUROL SCI, V275, P29, DOI 10.1016/j.jns.2008.07.003; Eastridge BJ, 2009, J TRAUMA, V66, pS48, DOI 10.1097/TA.0b013e31819ce315; Fuenfer MM, 2009, MIL MED, V174, P887, DOI 10.7205/MILMED-D-02-2308; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; KLIMO P, 2009, YOUNG NEUROSURGE SPR, P3; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; Matos RI, 2008, PEDIATRICS, V122, pE959, DOI 10.1542/peds.2008-1244; McGuigan R, 2007, J PEDIATR SURG, V42, P207, DOI 10.1016/j.jpedsurg.2006.09.020; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Nessen SC, 2009, J TRAUMA, V66, pS37, DOI 10.1097/TA.0b013e31819ce302; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Peoples GE, 2005, MIL MED, V170, P462, DOI 10.7205/MILMED.170.6.462; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Warf BC, 2005, J NEUROSURG, V103, P475, DOI 10.3171/ped.2005.103.6.0475	25	20	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	AUG	2010	6	2					107	114		10.3171/2010.3.PEDS109			8	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	632ES	WOS:000280404400001	20672929				2022-02-06	
J	Shen, YC; Hsia, RY				Shen, Yu-Chu; Hsia, Renee Y.			Changes in Emergency Department Access Between 2001 and 2005 Among General and Vulnerable Populations	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							TRAUMATIC BRAIN-INJURY; SAFETY-NET HOSPITALS; RACIAL DISPARITIES; PRIMARY-CARE; HEALTH-INSURANCE; UNITED-STATES; FINANCIAL-PRESSURE; RISK-FACTORS; MORTALITY; TRENDS	Objectives. We analyzed how ease of geographic access to emergency departments (EDs), defined as driving time to the closest ED, changed between 2001 and 2005, and whether access deterioration was more likely to occur in vulnerable communities. Methods. We classified communities on the basis of American Hospital Association and Census data into 3 categories according to driving time to the nearest ED: no increase, less than a 10-minute increase, and a 10-minute or more increase. We estimated a multinomial logit model to examine the relative risk ratio (RRR) of various community characteristics. Results. More than 95% of communities experienced no ED access deterioration. However, 11.4 million people experienced increased driving time to their nearest ED. Low-income communities had a higher risk of facing deteriorating access compared with high-income communities (urban: RRR=3.67; P<.01; rural: RRR= 1.75; P<.10), and communities with higher shares of Hispanics also had higher risks of facing declines (urban: RRR=3.41; P<.10; rural: RRR=2.67; P<.01). Conclusions. Deteriorating access to EDs is more likely to occur in communities with economic hardship and high shares of Hispanic populations. The uneven access to critical services warrants increased attention from policy-making bodies. (Am J Public Health. 2010;100:1462-1469. doi:10.2105/AJPH.2009.175828)	[Shen, Yu-Chu] USN, Grad Sch Business & Publ Policy, Postgrad Sch, Monterey, CA 93943 USA; [Shen, Yu-Chu] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Hsia, Renee Y.] San Francisco Gen Hosp, Emergency Dept, San Francisco, CA 94110 USA		Shen, YC (corresponding author), USN, Grad Sch Business & Publ Policy, Postgrad Sch, 555 Dyer Rd,Code GB, Monterey, CA 93943 USA.	yshen@nps.edu			Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiativeRobert Wood Johnson Foundation (RWJF) [63974]; Robert Wood Johnson FoundationRobert Wood Johnson Foundation (RWJF); National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational ScienceUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)University of California System [KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [KL2RR024130] Funding Source: NIH RePORTER	This project was supported by the Robert Wood Johnson Foundation's Changes in Health Care Financing and Organization initiative (grant 63974). In addition, R.Y. Hsia was supported in part by a grant under the Robert Wood Johnson Foundation's Physician Faculty Scholars Program and the National Institutes of Health/National Center for Research Resources, University of California, San Francisco Clinical and Translational Science (KL2 RR024130).	*AM HOSP ASS, 2001, AHA TREND WATCH, V3, P1; American Hospital Association, 2005, AHA ANN SURV DAT FIS; Arthur M, 2008, MED CARE, V46, P192, DOI 10.1097/MLR.0b013e31815b9d8e; Bazzoll GJ, 2005, HEALTH AFFAIR, V24, P1047, DOI 10.1377/hlthaff.24.4.1047; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Burt Catharine W, 2006, Adv Data, P1; Carr BG, 2009, ANN EMERG MED, V54, P261, DOI 10.1016/j.annemergmed.2008.11.016; Chang DC, 2005, MED CLIN N AM, V89, P945, DOI 10.1016/j.mcna.2005.05.005; Committee on the Future of Emergency Care in the United States Health System Institute of Medicine, 2007, HOSP BAS EM CAR BREA; DALE J, 1995, BRIT MED J, V311, P423, DOI 10.1136/bmj.311.7002.423; Derlet RW, 2001, ACAD EMERG MED, V8, P151, DOI 10.1111/j.1553-2712.2001.tb01280.x; Gaskin DJ, 1999, J URBAN HEALTH, V76, P351, DOI 10.1007/BF02345673; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; *HLTH RES SERV ADM, 2005, AR RES FIL; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; Krause JS, 2006, J SPINAL CORD MED, V29, P17, DOI 10.1080/10790268.2006.11753852; Lambe S, 2002, ANN EMERG MED, V39, P389, DOI 10.1067/mem.2002.122433; LOVE RF, 1979, MANAGE SCI, V25, P130, DOI 10.1287/mnsc.25.2.130; Lucas Jacqueline W, 2005, Vital Health Stat 10, P1; McConnel C E, 1999, Prehosp Disaster Med, V14, P232; McConnel CE, 1998, SOC SCI MED, V46, P1027, DOI 10.1016/S0277-9536(97)10029-6; MELNICK GA, 2004, HLTH AFF MILLWOOD S; Nawar Eric W, 2007, Adv Data, P1; O'Toole TP, 2002, J URBAN HEALTH, V79, P200, DOI 10.1093/jurban/79.2.200; OHARE WP, 1985, POPUL BULL, V40, P1; PHIBBS C, 2010, PAT INC COST EST TRA; Phibbs CS, 1995, MED CARE RES REV, V52, P532, DOI 10.1177/107755879505200406; Pitts Stephen R, 2008, Natl Health Stat Report, P1; Rust G, 2008, ARCH INTERN MED, V168, P1705, DOI 10.1001/archinte.168.15.1705; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Shen YC, 2003, J HEALTH ECON, V22, P243, DOI 10.1016/S0167-6296(02)00124-8; Shen YC, 2009, INT J HEALTH CARE FI, V9, P211, DOI 10.1007/s10754-009-9066-2; Shen YC, 2009, MED CARE, V47, P968, DOI 10.1097/MLR.0b013e31819c9415; Shermer CR, 2007, J TRAUMA, V63, P1268; Sinay UT, 1998, J RURAL HEALTH, V14, P357, DOI 10.1111/j.1748-0361.1998.tb00641.x; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; Suruda A, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-29; Thamer M, 1997, AM J PUBLIC HEALTH, V87, P96, DOI 10.2105/AJPH.87.1.96; U.S. Government Accountability Office, 2009, HOSP EM DEP CROWD CO; *US CENS BUR, 2002, CENS 2000 SUMM FIL 3; Weber EJ, 2005, ANN EMERG MED, V45, P4, DOI 10.1016/j.annemergmed.2004.06.023; WILNER D, 1977, J MAINE MED ASSOC, V68, P401	43	20	20	0	4	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	AUG	2010	100	8					1462	1469		10.2105/AJPH.2009.175828			8	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	656RR	WOS:000282354800025	20558800	Green Published, Green Accepted			2022-02-06	
J	Wang, GS; Zhou, DS; Wang, CZ; Gao, YQ; Zhou, QQ; Qian, GS; DeCoster, MA				Wang, Guansong; Zhou, Deshan; Wang, Changzheng; Gao, Yuqi; Zhou, Qiquan; Qian, Guisheng; DeCoster, Mark A.			Hypoxic preconditioning suppresses group III secreted phospholipase A2-induced apoptosis via JAK2-STAT3 activation in cortical neurons	JOURNAL OF NEUROCHEMISTRY			English	Article						anoxia; cortical neurons; JAK2; pre-conditioning; secreted phospholipase A2; STAT3	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; M-TYPE RECEPTOR; NF-KAPPA-B; UP-REGULATION; SEQUENTIAL ACTIVATION; INTRAVENOUS-INFUSION; GENE-EXPRESSION; CEREBRAL-CORTEX; GROWTH-FACTOR	Our previous studies show that group III secreted phospholipases A(2) (sPLA(2)s III) induces extensive neuronal apoptosis in brain cortical cultures. However, the molecular mechanisms underlying sPLA(2) III-induced neuronal injury/death are still unknown. Also it is not clear whether hypoxic pre-conditioning (HPC) is able to protect neurons from the sPLA(2) III insult. In this report, we demonstrate that sPLA(2) III significantly decreased production of Bcl-xl and the ratio of Bcl-xl/Bax, and increased expression of Bax, cleaved caspase 3, and cleaved alpha-Fodrin in primary neuronal culture. HPC prevented the sPLA(2) III-induced decreases in production of Bcl-xl and the ratio of Bcl-xl/Bax, and increases in expression of Bax, cleaved caspase 3, and alpha-Fodrin. However, the HPC-produced neuronal protection was eliminated or attenuated by AG490, rapamycin, and STAT3 shRNA. Our results suggest that sPLA(2) III-induced neuronal apoptosis is likely because of its alterations in expression and activity of Bcl-xl, Bax, caspase 3, and its target gene fodrin; and that HPC-produced neuroprotection against the sPLA(2) III toxicity is mediated via JAK-STAT signal pathways that regulate the expression of Bcl-xl, Bax, and cleaved caspase 3 in cultured cortical neurons.	[Wang, Guansong; Wang, Changzheng; Qian, Guisheng] Third Mil Med Univ China, Inst Resp Dis, Affiliated Hosp 2, Chongqing 400037, Peoples R China; [Zhou, Deshan; Gao, Yuqi; Zhou, Qiquan] Third Mil Med Univ China, Dept Neurosci Histol & Altitude Mil Med, Chongqing, Peoples R China; [DeCoster, Mark A.] Louisiana Tech Univ, Inst MicroMfg, Ruston, LA 71270 USA		Qian, GS (corresponding author), Third Mil Med Univ China, Inst Resp Dis, Affiliated Hosp 2, Chongqing 400037, Peoples R China.	wanggs2003@hotmail.com; qiangs@mail.tmmu.com.cn; decoster@latech.edu	DeCoster, Mark/AAF-5224-2020		National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30770928, 30971309]; PLA [080093, 06G083]; 973 program of ChinaNational Basic Research Program of China [2006CB504100]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20RR016456]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016456] Funding Source: NIH RePORTER	This work was supported by the National Natural Scientific Foundation of China Grants 30770928 and 30971309 (to G. Wang), the PLA Grants 080093 (to G. Wang) and 06G083 (G. Qian), 973 program of China Grant 2006CB504100 (to Y. Gao), and National Institutes of Health Grant P20RR016456 (M. DeCoster). We are grateful to Dr. Chu Chen from Neuroscience Center, Louisiana State University Health Sciences Center for the critical comments and good suggestions on this manuscript.	Ayala-Grosso C, 2006, NEUROSCIENCE, V141, P863, DOI 10.1016/j.neuroscience.2006.04.041; Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Cao GD, 2002, J NEUROSCI, V22, P5423; Chan SL, 2004, CLIN EXP PHARMACOL P, V31, P119, DOI 10.1111/j.1440-1681.2004.03975.x; Chang AY, 2005, EXP NEUROL, V195, P40, DOI 10.1016/j.expneurol.2004.09.014; CHCNG A, 2007, J NEUROSCI, V27, P1519; Chen HH, 2007, EXP CELL RES, V313, P3106, DOI 10.1016/j.yexcr.2007.04.026; Chong ZZ, 2007, BRIT J PHARMACOL, V150, P839, DOI 10.1038/sj.bjp.0707161; Cunha-Oliveira T, 2007, J NEUROCHEM, V101, P543, DOI 10.1111/j.1471-4159.2006.04406.x; Cupillard L, 1999, J BIOL CHEM, V274, P7043, DOI 10.1074/jbc.274.11.7043; Daniel B, 2004, BRAIN RES PROTOC, V13, P144, DOI 10.1016/j.brainresprot.2004.04.001; DeCoster MA, 2003, BRAIN RES, V988, P20, DOI 10.1016/S0006-8993(03)03326-2; DeCoster MA, 2002, J NEUROSCI RES, V67, P634, DOI 10.1002/jnr.10131; Dey S, 2007, NEUROSCIENCE, V144, P509, DOI 10.1016/j.neuroscience.2006.09.047; Dhandapani KM, 2005, J NEUROCHEM, V95, P9, DOI 10.1111/j.1471-4159.2005.03319.x; Dudley AC, 2005, BIOCHEM J, V390, P427, DOI 10.1042/BJ20050351; Geocadin RG, 2005, BRAIN RES, V1064, P146, DOI 10.1016/j.brainres.2005.04.046; Guaiquil VH, 2004, FREE RADICAL BIO MED, V37, P1419, DOI 10.1016/j.freeradbiomed.2004.06.041; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; Kumar A, 2006, ENDOCRINOLOGY, V147, P4893, DOI 10.1210/en.2006-0027; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Li GH, 2009, J NEURO-ONCOL, V91, P165, DOI 10.1007/s11060-008-9696-0; Liang Zhang, 2007, Genomics Proteomics & Bioinformatics, V5, P25, DOI 10.1016/S1672-0229(07)60011-4; Lin AMY, 2003, ANN NY ACAD SCI, V993, P168, DOI 10.1111/j.1749-6632.2003.tb07527.x; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Lu Y, 2006, J BIOL CHEM, V281, P36683, DOI 10.1074/jbc.M607374200; Ma FY, 2005, ENDOCRINOLOGY, V146, P5112, DOI 10.1210/en.2005-0770; Ma MC, 2005, J BIOL CHEM, V280, P16208, DOI 10.1074/jbc.M408055200; Mascareno E, 2005, VASC PHARMACOL, V43, P327, DOI 10.1016/j.vph.2005.08.023; Nicolas JP, 1997, J BIOL CHEM, V272, P7173, DOI 10.1074/jbc.272.11.7173; Panzeri C, 2006, BRAIN, V129, P1710, DOI 10.1093/brain/awl104; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Raghupathi R, 2003, J NEUROTRAUM, V20, P421, DOI 10.1089/089771503765355504; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Sakanaka M, 2007, J NEUROTRAUM, V24, P1037, DOI 10.1089/neu.2006.0182; Schweizer U, 2002, J CELL BIOL, V156, P287, DOI 10.1083/jcb.200107009; Shou Y, 2002, J NEUROCHEM, V81, P842, DOI 10.1046/j.1471-4159.2002.00880.x; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Terui K, 2004, J HEPATOL, V41, P957, DOI 10.1016/j.jhep.2004.08.019; Titsworth WL, 2007, EXP NEUROL, V207, P150, DOI 10.1016/j.expneurol.2007.06.010; Titsworth WL, 2008, CNS NEUROL DISORD-DR, V7, P254, DOI 10.2174/187152708784936671; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wang GS, 2005, CELL BIOL INT, V29, P598, DOI 10.1016/j.cellbi.2005.03.014; Wang GS, 2005, NEUROREPORT, V16, P1345, DOI 10.1097/01.wnr.0000174403.79020.65; Wang G, 2008, INT J BIOCHEM CELL B, V40, P461, DOI 10.1016/j.biocel.2007.08.008; Wick A, 2002, J NEUROSCI, V22, P6401; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656; Yap YW, 2006, J NEUROCHEM, V98, P1597, DOI 10.1111/j.1471-4159.2006.03996.x; Yata K, 2007, BRAIN RES, V1145, P227, DOI 10.1016/j.brainres.2007.01.144; Yin W, 2007, STROKE, V38, P1017, DOI 10.1161/01.STR.0000258102.18836.ca; Zhang B, 2006, J CEREBR BLOOD F MET, V26, P708, DOI 10.1038/sj.jcbfm.9600225; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Zhu CL, 2003, J NEUROCHEM, V86, P306, DOI 10.1046/j.1471-4159.2003.01832.x; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	57	20	22	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2010	114	4					1039	1048		10.1111/j.1471-4159.2010.00817.x			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	636EC	WOS:000280710100010	20492356				2022-02-06	
J	Wang, T; Zheng, W; Xu, H; Zhou, JM; Wang, ZY				Wang, Tao; Zheng, Wei; Xu, He; Zhou, Jia-Min; Wang, Zhan-You			Clioquinol Inhibits Zinc-Triggered Caspase Activation in the Hippocampal CA1 Region of a Global Ischemic Gerbil Model	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; NEURONAL DEATH; TRANSIENT ISCHEMIA; TRANSGENIC MICE; CANCER-CELLS; IN-VITRO; APOPTOSIS; CHELATOR	Background: Excessive release of chelatable zinc from excitatory synaptic vesicles is involved in the pathogenesis of selective neuronal cell death following transient forebrain ischemia. The present study was designed to examine the neuroprotective effect of a membrane-permeable zinc chelator, clioquinol (CQ), in the CA1 region of the gerbil hippocampus after transient global ischemia. Methodology/Principal Findings: The common carotid arteries were occluded bilaterally, and CQ (10 mg/kg, i.p.) was injected into gerbils once a day. The zinc chelating effect of CQ was examined with TSQ fluorescence and autometallography. Neuronal death, the expression levels of caspases and apoptosis inducing factor (AIF) were evaluated using TUNEL, in situ hybridization and Western blotting, respectively. We were able to show for the first time that CQ treatment attenuates the ischemia-induced zinc accumulation in the CA1 pyramidal neurons, accompanied by less neuronal loss in the CA1 field of the hippocampus after ischemia. Furthermore, the expression levels of caspase-3, -9, and AIF were significantly decreased in the hippocampus of CQ-treated gerbils. Conclusions/Significance: The present study indicates that the neuroprotective effect of CQ is related to downregulation of zinc-triggered caspase activation in the hippocampal CA1 region of gerbils with global ischemia.	[Wang, Tao; Zheng, Wei; Xu, He; Zhou, Jia-Min; Wang, Zhan-You] China Med Univ, Coll Basic Med Sci, Minist Educ China, Key Lab Med Cell Biol, Shenyang, Peoples R China		Wang, T (corresponding author), China Med Univ, Coll Basic Med Sci, Minist Educ China, Key Lab Med Cell Biol, Shenyang, Peoples R China.	zhanyouw@hotmail.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30370452, 30770680]; Program for New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-04-0288]; Department of Education of Liaoning Province [20060948]	The study was supported by the Natural Science Foundation of China (30370452, 30770680), the Program for New Century Excellent Talents in University (NCET-04-0288), and the Research Project for Universities of the Department of Education of Liaoning Province (20060948). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; ARAKI T, 1989, ACTA NEUROL SCAND, V80, P548, DOI 10.1111/j.1600-0404.1989.tb03925.x; BarKalifa R, 2009, EUR J PHARMACOL, V618, P15, DOI 10.1016/j.ejphar.2009.07.019; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Carboni S, 2005, J NEUROCHEM, V92, P1054, DOI 10.1111/j.1471-4159.2004.02925.x; Chen D, 2007, CANCER RES, V67, P1636, DOI 10.1158/0008-5472.CAN-06-3546; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; COLBOURNE F, 1994, BRAIN RES, V654, P265, DOI 10.1016/0006-8993(94)90488-X; DANSCHER G, 1982, HISTOCHEMISTRY, V76, P281, DOI 10.1007/BF00543951; DANSCHER G, 1985, HISTOCHEMISTRY, V83, P419, DOI 10.1007/BF00509203; Danscher G, 2006, PROG HISTOCHEM CYTO, V41, P57, DOI 10.1016/j.proghi.2006.06.001; Diener HC, 2008, STROKE, V39, P1774, DOI 10.1161/STROKEAHA.107.506378; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; FREDERICKSON CJ, 1987, J NEUROSCI METH, V20, P91, DOI 10.1016/0165-0270(87)90042-2; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Gupta S, 2006, BIOL PHARM BULL, V29, P957, DOI 10.1248/bpb.29.957; Hegde ML, 2009, J ALZHEIMERS DIS, V17, P457, DOI 10.3233/JAD-2009-1068; Hetz C, 2005, J BIOL CHEM, V280, P42960, DOI 10.1074/jbc.M505843200; Ibach B, 2005, PHARMACOPSYCHIATRY, V38, P178, DOI 10.1055/s-2005-871241; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Nguyen T, 2005, P NATL ACAD SCI USA, V102, P11840, DOI 10.1073/pnas.0502177102; Nitzan YB, 2003, J MOL MED-JMM, V81, P637, DOI 10.1007/s00109-003-0462-7; OHALLORAN TV, 1993, SCIENCE, V261, P715, DOI 10.1126/science.8342038; Park JA, 2000, J NEUROSCI, V20, P9096; Regland B, 2001, DEMENT GERIATR COGN, V12, P408, DOI 10.1159/000051288; Ritchie CW, 2004, EXPERT OPIN INV DRUG, V13, P1585, DOI 10.1517/13543784.13.12.1585; SMITH ML, 1984, ACTA NEUROPATHOL, V64, P319, DOI 10.1007/BF00690397; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Strosznajder R, 2006, ACTA NEUROBIOL EXP, V66, P15; Suh SW, 2006, J CEREBR BLOOD F MET, V26, P161, DOI 10.1038/sj.jcbfm.9600176; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; VALLEE BL, 1991, P NATL ACAD SCI USA, V88, P999, DOI 10.1073/pnas.88.3.999; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yu HJ, 2009, BIOCHEM J, V417, P133, DOI 10.1042/BJ20081421; Zhang LH, 2010, NEUROBIOL AGING, V31, P74, DOI 10.1016/j.neurobiolaging.2008.02.018	42	20	21	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11888	10.1371/journal.pone.0011888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	WOS:000280520200047	20686690	Green Published, Green Submitted, gold			2022-02-06	
J	Bridges, E; Biever, K				Bridges, Elizabeth; Biever, Kimberlie			Advancing Critical Care Joint Combat Casualty Research Team and Joint Theater Trauma System	AACN ADVANCED CRITICAL CARE			English	Article						biomedical research; critical care; military; nursing; performance improvement; war	OPERATION-IRAQI-FREEDOM; NEAR-INFRARED SPECTROSCOPY; DAMAGE CONTROL RESUSCITATION; ACUTE COMPARTMENT SYNDROME; TYMPANIC-MEMBRANE PERFORATION; EXTREMITY ARTERIAL HEMORRHAGE; PLETH VARIABILITY INDEX; RED-BLOOD-CELL; EN-ROUTE CARE; BRAIN-INJURY	Despite the severity and complexity of injuries, survival rates among combat casualties are equal to or better than those from civilian trauma. This article summarizes the evidence regarding innovations from the battlefield that contribute to these extraordinary survival rates, including preventing hemorrhage with the use of tourniquets and hemostatic dressings, damage control resuscitation, and the rapid evacuation of casualties via MEDEVAC and the US Air Force Critical Care Air Transport Teams. Care in the air for critically injured casualties with pulmonary injuries and traumatic brain injury is discussed to demonstrate the unique considerations required to ensure safe en route care. Innovations being studied to decrease sequelae associated with complex orthopedic and extremity trauma are also presented. The role and contributions of the Joint Combat Casualty Research Team and the Joint Theater Trauma System are also discussed.	[Bridges, Elizabeth] USAFR, NC, Washington, DC USA; [Bridges, Elizabeth] Clin Investigat Facil, Med Grp 60, Travis Afb, CA USA; [Bridges, Elizabeth] US Forces Afghanistan, Deployed Combat Casualty Res Team, Washington, DC USA; [Bridges, Elizabeth] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Bridges, Elizabeth] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Biever, Kimberlie] Joint Theater Trauma Syst, CENTCOM Forward, US Forces Iraq & Afghanistan, Seattle, WA USA		Bridges, E (corresponding author), USAFR, NC, Washington, DC USA.	ebridges@u.washington.edu					Aiken LJ, 2010, DIMENS CRIT CARE NUR, V29, P13, DOI 10.1097/DCC.0b013e3181be4a1a; Aiken Loretta J, 2008, Crit Care Nurs Clin North Am, V20, P31, DOI 10.1016/j.ccell.2007.10.002; Alkins SA, 2002, AVIAT SPACE ENVIR MD, V73, P677; Almogy G, 2005, ARCH SURG-CHICAGO, V140, P390, DOI 10.1001/archsurg.140.4.390; Andersson N, 2003, AVIAT SPACE ENVIR MD, V74, P138; Arbabi S, 1999, J TRAUMA, V47, P829, DOI 10.1097/00005373-199911000-00002; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Arthurs Z, 2006, AM J SURG, V191, P610, DOI 10.1016/j.amjsurg.2006.02.010; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnes SL, 2008, J TRAUMA, V64, pS129, DOI 10.1097/TA.0b013e318160a5b4; Beekley A, 2009, W TRAUM ASS 39 ANN M, P22; Beekley AC, 2008, CRIT CARE MED, V36, pS267, DOI 10.1097/CCM.0b013e31817da7dc; Beekley AC, 2008, J TRAUMA, V64, pS28, DOI 10.1097/TA.0b013e318160937e; Beekley AC, 2006, SURG CLIN N AM, V86, P689, DOI 10.1016/j.suc.2006.02.007; Beilman Greg J, 2009, World J Emerg Surg, V4, P25, DOI 10.1186/1749-7922-4-25; Beilman GJ, 2009, ANN SURG, V249, P845, DOI 10.1097/SLA.0b013e3181a41f6f; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Beninati W, 2009, CHEST, V136; Beninati W, 2008, CRIT CARE MED, V36, pS370, DOI 10.1097/CCM.0b013e31817e3143; Beninati William, 2002, Respir Care Clin N Am, V8, P51, DOI 10.1016/S1078-5337(02)00016-3; Better Gawande A., 2007, SURGEONS NOTE PERFOR, P56; Blackbourne Lorne H, 2007, US Army Med Dep J, P11; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Bridges E, 2005, CRIT CARE MED, V33, pA13, DOI 10.1097/00003246-200512002-00050; Bridges E, 2007, RESUSCITATION CARE C; Bridges E, 2000, AM J CRIT CARE, V9, P218; Bridges E., 2005, THERMAL STRESS HUMAN, P37; Bridges E., 2008, BATTLEFIELD DISASTER; Bridges E, 2009, WART CRIT CAR AIR TR; Bridges E, 2007, MIL MED, V172, P17, DOI 10.7205/MILMED.172.1.17; Bridges E, 2009, MIL MED, V174, P370, DOI 10.7205/MILMED-D-03-9607; Bridges E, 2010, NURS RES, V59, pS75, DOI 10.1097/NNR.0b013e3181c3beac; Bridges Elizabeth J, 2006, Crit Care Nurs Clin North Am, V18, P333, DOI 10.1016/j.ccell.2006.05.005; Bridges Elizabeth J, 2008, Crit Care Nurs Clin North Am, V20, P121, DOI 10.1016/j.ccell.2007.10.011; Brodie Steven, 2007, J R Army Med Corps, V153, P310; Brosch LR, 2008, J TRAUMA, V64, pS9, DOI 10.1097/TA.0b013e31816093a6; Cairns Chris J S, 2002, Curr Opin Crit Care, V8, P106, DOI 10.1097/00075198-200204000-00003; Cannesson M, 2008, BRIT J ANAESTH, V101, P200, DOI 10.1093/bja/aen133; Cannesson M, 2008, ANESTH ANALG, V106, P1189, DOI 10.1213/ane.0b013e318167ab1f; Chen LY, 2009, PREHOSP EMERG CARE, V13, P286, DOI 10.1080/10903120902935298; Clay JG, 2010, MIL MED, V175, P280, DOI 10.7205/MILMED-D-09-00185; Cohen SP, 2010, LANCET, V375, P301, DOI 10.1016/S0140-6736(09)61797-9; Colombo CJ, 2008, CRIT CARE MED, V36, pS388, DOI 10.1097/CCM.0b013e31817e3236; Convertino VA, 2008, J TRAUMA, V64, pS342, DOI 10.1097/TA.0b013e31816c82f4; Cordts PR, 2008, J TRAUMA, V64, pS14, DOI 10.1097/TA.0b013e31816093bd; Covey Dana C, 2009, Instr Course Lect, V58, P117; Cox ED, 2009, TRANSFUSION, V49, p248S, DOI 10.1111/j.1537-2995.2008.01988.x; Creamer K, 2004, CRIT CARE MED, V32, pA63; Creamer KM, 2009, J TRAUMA, V67, P762, DOI 10.1097/TA.0b013e31818b1e15; De Jong M, 2006, COMBINATION READY HE, P28; De Jong Marla J, 2010, J Trauma Nurs, V17, P45, DOI 10.1097/JTN.0b013e3181d914ed; De Jong Marla J, 2008, J Trauma Nurs, V15, P174, DOI 10.1097/01.JTN.0000343322.70334.12; Donovan DJ, 2008, AVIAT SPACE ENVIR MD, V79, P30, DOI 10.3357/ASEM.1893.2008; Dorlac GR, 2009, J TRAUMA, V66, pS164, DOI 10.1097/TA.0b013e31819cdf72; Dougherty AL, 2009, INJURY, V40, P772, DOI 10.1016/j.injury.2009.02.014; Duchesne JC, 2008, J TRAUMA, V65, P272, DOI 10.1097/TA.0b013e31817e5166; Duchesne JC, 2009, J TRAUMA, V67, P33, DOI 10.1097/TA.0b013e31819adb8e; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Eastridge BJ, 2006, J TRAUMA, V61, P1366, DOI 10.1097/01.ta.0000245894.78941.90; Eastridge Brian J, 2009, Am J Surg, V198, P852, DOI 10.1016/j.amjsurg.2009.04.029; Ebbs N L, 2008, Intensive Crit Care Nurs, V24, P51, DOI 10.1016/j.iccn.2007.06.003; Fang R, 2008, CRIT CARE MED, V36, pS383, DOI 10.1097/CCM.0b013e31817e3213; Fecura Stephen E Jr, 2008, J Trauma Nurs, V15, P170, DOI 10.1097/01.JTN.0000343321.70334.c9; Fox CJ, 2008, J TRAUMA, V64, pS99, DOI 10.1097/TA.0b013e3181608c4a; Fuenfer MM, 2009, MIL MED, V174, P887, DOI 10.7205/MILMED-D-02-2308; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garr JL, 1999, J TRAUMA, V46, P613, DOI 10.1097/00005373-199904000-00009; Gentilello LM, 2001, J TRAUMA, V51, P1, DOI 10.1097/00005373-200107000-00001; Giannotti G, 2000, J TRAUMA, V48, P396, DOI 10.1097/00005373-200003000-00005; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Goodman MD, 2010, J SURG RES, V164, P286, DOI 10.1016/j.jss.2009.07.040; Grissom TE, 2002, AEROMEDICAL EVACUATION, P111; GRISSOM TE, 2005, CRIT CARE MED S, V33, P13; Harris C C, 2009, J R Army Med Corps, V155, P157; Harrison CD, 2009, J TRAUMA, V67, P210, DOI 10.1097/TA.0b013e3181a5f1db; Helling E, 2005, MIL MED, V170, P577, DOI 10.7205/MILMED.170.7.577; Higgins RA, 2010, AACN ADV CRIT CARE, V21, P288, DOI 10.1097/NCI.0b013e3181e6741f; Hodgetts T J, 2007, J R Army Med Corps, V153, P12; Holcomb JB, 2005, MIL MED, V170, P7, DOI 10.7205/MILMED.170.1.7; Holcomb JB, 2005, J TRAUMA, V59, P821, DOI 10.1097/01.ta.0000188125.44129.7c; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Holcomb JB, 2007, ANN SURG, V245, P986, DOI 10.1097/01.sla.0000259433.03754.98; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; Johannigman JA, 2008, CRIT CARE MED, V36, pS377, DOI 10.1097/CCM.0b013e31817e31e1; Johannigman JA, 2008, J TRAUMA, V64, pS302, DOI 10.1097/TA.0b013e31816bf4e2; Johannigman JA, 2009, J TRAUMA, V66, P386, DOI 10.1097/TA.0b013e318197a4bb; Joint Theater Trauma System, JTTS CPG MAN PAT SEV; Joint Theater Trauma System, JTTS CLIN PRACT GUID; Katz LM, 2008, CRIT CARE MED, V36, P1756, DOI 10.1097/CCM.0b013e318174d800; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Kenny Deborah J, 2008, Crit Care Nurs Clin North Am, V20, P41, DOI 10.1016/j.ccell.2007.10.013; Kheirabadi BS, 2010, J TRAUMA, V68, P269, DOI 10.1097/TA.0b013e3181c97ef1; Kheirabadi BS, 2009, J TRAUMA, V67, P450, DOI 10.1097/TA.0b013e3181ac0c99; Kheirabadi BS, 2009, J TRAUMA, V66, P316, DOI 10.1097/TA.0b013e31819634a1; Knuth T., 2005, GUIDELINES FIELD MAN; Kragh JF, 2008, J TRAUMA, V64, pS38, DOI 10.1097/TA.0b013e31816086b1; Kragh JF, 2011, J EMERG MED, V41, P590, DOI 10.1016/j.jemermed.2009.07.022; Kragh JF, 2010, FOOT ANKLE CLIN, V15, P23, DOI 10.1016/j.fcl.2009.11.001; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Lakstein D, 2003, J TRAUMA, V54, pS221, DOI 10.1097/01.TA.0000047227.33395.49; Lam DM, 2007, MIL MED, V172, P611, DOI 10.7205/MILMED.172.6.611; Lamb D, 2010, AACN ADV CRIT CARE, V21, P298, DOI 10.1097/NCI.0b013e3181e6f017; Lamb Di, 2003, Intensive Crit Care Nurs, V19, P92, DOI 10.1016/S0964-3397(03)00010-7; Lehman C, 2008, REHABIL NURS, V33, P192, DOI 10.1002/j.2048-7940.2008.tb00227.x; Lehmann R, 2009, J TRAUMA, V66, pS31, DOI 10.1097/TA.0b013e31819d9575; Leibovici D, 1999, ANN EMERG MED, V34, P168, DOI 10.1016/S0196-0644(99)70225-8; Lundy Jonathan B, 2010, J Intensive Care Med, V25, P156, DOI 10.1177/0885066609359588; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; Maegele M, 2008, VOX SANG, V95, P112, DOI 10.1111/j.1423-0410.2008.01074.x; Marshall WB, 2010, AACN ADV CRIT CARE, V21, P279, DOI 10.1097/NCI.0b013e3181e6f913; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; Mason PE, 2011, J EMERG MED, V41, P8, DOI 10.1016/j.jemermed.2008.06.032; McManus J, 2005, ACAD EMERG MED, V12, P1120, DOI 10.1197/j.aem.2005.05.037; McManus J, 2007, SCI ENG ETHICS, V13, P297, DOI 10.1007/s11948-007-9022-9; McManus John, 2005, Prehosp Emerg Care, V9, P423, DOI 10.1080/10903120500255891; McNeill MM, 2010, AACN ADV CRIT CARE, V21, P307, DOI 10.1097/NCI.0b013e3181e59f8e; McQueen MM, 2000, J BONE JOINT SURG BR, V82B, P200, DOI 10.1302/0301-620X.82B2.9799; Meyer Kimberly, 2008, J Trauma Nurs, V15, P185, DOI 10.1097/01.JTN.0000343324.55087.de; Michard F, 2002, CHEST, V121, P2000, DOI 10.1378/chest.121.6.2000; Moore FA, 2009, ANN SURG, V249, P8, DOI 10.1097/SLA.0b013e3181932329; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Olson SA, 2005, J AM ACAD ORTHOP SUR, V13, P436, DOI 10.5435/00124635-200511000-00003; Osman D, 2007, CRIT CARE MED, V35, P64, DOI 10.1097/01.CCM.0000249851.94101.4F; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Owens BD, 2007, J ORTHOP TRAUMA, V21, P254, DOI 10.1097/BOT.0b013e31802f78fb; Parker P J, 2007, J R Army Med Corps, V153, P10; Pierce Penny F, 2003, Crit Care Nurs Clin North Am, V15, P221, DOI 10.1016/S0899-5885(02)00082-5; Pizov R, 1999, CHEST, V115, P165, DOI 10.1378/chest.115.1.165; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Renz EM, 2008, J TRAUMA, V64, pS136, DOI 10.1097/TA.0b013e31816086c9; Ritenour AE, 2008, CRIT CARE MED, V36, pS311, DOI 10.1097/CCM.0b013e31817e2a8c; Ritenour AE, 2008, J TRAUMA, V64, pS153, DOI 10.1097/TA.0b013e3181607750; Sagraves SG, 2009, J TRAUMA, V67, P441, DOI 10.1097/TA.0b013e3181b88de7; Salinas J., 2008, MONITORING TRAUMA PA; Sasser SM, 2006, PREHOSP EMERG CARE, V10, P165, DOI 10.1080/10903120500540912; Scalea TM, 2008, ANN SURG, V248, P578, DOI 10.1097/SLA.0b013e31818990ed; Schmelz J, 2000, AM J CRIT CARE, V9, P218; Schmelz Joseph O, 2003, Crit Care Nurs Clin North Am, V15, P171, DOI 10.1016/S0899-5885(02)00056-4; Schmelz JO, 2007, MIL MED, V172, P322, DOI 10.7205/MILMED.172.3.322; Schreiber MA, 2008, J TRAUMA, V64, pS118, DOI 10.1097/TA.0b013e318160869d; Sihler KC, 2010, CHEST, V137, P209, DOI 10.1378/chest.09-0252; Sihler KC, 2009, CHEST, V136, P1654, DOI 10.1378/chest.09-0251; Singh S, 2004, CURR ORTHOPAED, V18, P468, DOI 10.1016/j.cuor.2004.12.006; Smith KK, 2008, CRIT CARE MED, V36, pS297, DOI 10.1097/CCM.0b013e31817daa01; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Spinella PC, 2008, CRIT CARE MED, V36, pS293, DOI 10.1097/CCM.0b013e31817da99f; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stansbury LG, 2008, J ORTHOP TRAUMA, V22, P43, DOI 10.1097/BOT.0b013e31815b35aa; Stansbury LG, 2009, TRANSFUS MED REV, V23, P255, DOI 10.1016/j.tmrv.2009.06.002; Stuhmiller JH, 2008, TXB MILITARY MED QUA; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Topley DK, 2003, MIL MED, V168, P822, DOI 10.1093/milmed/168.10.822; Ward KR, 2007, J TRAUMA, V63, P276, DOI 10.1097/TA.0b013e3180eea8a5; Wedmore I, 2006, J TRAUMA, V60, P655, DOI 10.1097/01.ta.0000199392.91772.44; White JRM, 2002, CRIT CARE MED, V30, pS478, DOI 10.1097/00003246-200211001-00013; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071	161	20	22	0	3	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	JUL-SEP	2010	21	3					260	276		10.1097/NCI.0b013e3181e67385			17	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF8QR	WOS:000443774200005	20683227				2022-02-06	
J	Wetherington, CE; Hooper, SR; Keenan, HT; Nocera, M; Runyan, D				Wetherington, Crista E.; Hooper, Stephen R.; Keenan, Heather T.; Nocera, Maryalice; Runyan, Desmond			Parent Ratings of Behavioral Functioning After Traumatic Brain Injury in Very Young Children	JOURNAL OF PEDIATRIC PSYCHOLOGY			English	Article						Behavioral ratings post traumatic brain injury; preschool traumatic brain injury; traumatic brain injury	DIATHESIS-STRESS-MODEL; LONG-TERM OUTCOMES; CLOSED-HEAD-INJURY; DEPRESSIVE SYMPTOMS; CHRONIC ILLNESS; ADOLESCENTS; CHILDHOOD; FAMILY; PREVALENCE; PREDICTORS	Objective The behavioral ratings of preschoolers who sustained traumatic brain injury (TBI) prior to the age of 2 years and a typically developing group were compared; predictors of behavioral functioning were examined. Methods Eighty-two 3-year-olds comprised mild TBI (n = 31), moderate/severe TBI (n = 20), and typically developing (n = 31) groups, with Child Behavior Checklist (CBCL) as the primary outcome measure. Results Groups differed on the CBCL Withdrawal Scale. No differences emerged in the proportion of children demonstrating clinical elevations, with average mean scores for each group. Exploratory analyses yielded no differences between inflicted, non-inflicted, and typical groups. Glasgow Coma Scale and Self-Report Family Inventory Leadership predicted Externalizing Problems; developmental level predicted Internalizing Problems. Conclusions After early TBI, preschoolers did not differ from one another or a matched comparison group in behavioral ratings; however, it may be premature to infer that preschoolers do not evidence behavioral dysfunction after early TBI.	[Hooper, Stephen R.] Univ N Carolina, Sch Med, Clin Ctr Study Dev & Learning, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Wetherington, Crista E.] Univ Texas SW Med Ctr, Ctr Pediat Psychiat, Childrens Med Ctr Dallas, Dallas, TX USA; [Wetherington, Crista E.] Univ Texas SW Med Ctr, Dept Psychiat, Dallas, TX USA; [Hooper, Stephen R.] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC 27599 USA; [Hooper, Stephen R.; Runyan, Desmond] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Keenan, Heather T.] Univ Utah, Dept Pediat, Sch Med, Salt Lake City, UT 84112 USA; [Nocera, Maryalice; Runyan, Desmond] Univ N Carolina, Sch Med, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; [Runyan, Desmond] Univ N Carolina, Sch Med, Dept Social Med, Chapel Hill, NC 27599 USA; [Runyan, Desmond] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA		Hooper, SR (corresponding author), Univ N Carolina, Sch Med, Clin Ctr Study Dev & Learning, Carolina Inst Dev Disabil, CB 7255, Chapel Hill, NC 27599 USA.	stephen.hooper@cdl.unc.edu	Runyan, Desmond/S-3974-2016; Hooper, Stephen/X-8171-2019	Runyan, Desmond/0000-0001-5571-9029; 	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD041040, K23 HD041040-01A2] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD041040] Funding Source: NIH RePORTER		Achenbach TM., 2000, CHILD BEHAV CHECKLIS; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2001, PEDIATR NEUROSURG, V34, P138, DOI 10.1159/000056009; Beavers W. R., 1990, SELF REPORT FAMILY I; BEAVERS WR, 1985, FAM PROCESS, V24, P398, DOI 10.1111/j.1545-5300.1985.00398.x; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Burke P, 1999, PSYCHOSOMATICS, V40, P5, DOI 10.1016/S0033-3182(99)71266-1; Carpentier MY, 2007, CHILD HEALTH CARE, V36, P181, DOI 10.1080/02739610701335027; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; Donders J, 1996, J HEAD TRAUMA REHAB, V11, P67, DOI 10.1097/00001199-199606000-00010; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; EWINGCOBBS L, 1995, J HEAD TRAUMA REHAB, V10, P13, DOI 10.1097/00001199-199510000-00004; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fenwick T, 1999, CHILD NEUROPSYCHOL, V5, P213, DOI 10.1076/0929-7049(199912)05:04;1-R;FT213; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; Hampson RB., 1991, J FAM PSYCHOL, V4, P326, DOI [10.1037/0893-3200.4.3.326, DOI 10.1037/0893-3200.4.3.326]; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kesler SR, 2008, J PEDIATR-US, V152, P513, DOI 10.1016/j.jpeds.2007.08.009; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; Kirkwood M, 2000, CHILD NEUROPSYCHOL, V6, P195, DOI 10.1076/chin.6.3.195.3157; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; Morris MC, 2008, J ABNORM PSYCHOL, V117, P719, DOI 10.1037/a0013741; Mullen E.M., 1995, MULLEN SCALES EARLY; QI CH, 1995, LANG SPEECH HEAR SER, V37, P5; Rescorla LA, 2005, MENT RETARD DEV D R, V11, P226, DOI 10.1002/mrdd.20071; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Wagner J, 2007, CHILD HEALTH CARE, V36, P45, DOI 10.1080/02739610701316878; Wagner JL, 2009, J PEDIATR PSYCHOL, V34, P89, DOI 10.1093/jpepsy/jsn052; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093	33	20	20	0	7	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0146-8693	1465-735X		J PEDIATR PSYCHOL	J. Pediatr. Psychol.	JUL	2010	35	6					662	671		10.1093/jpepsy/jsp081			10	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	616EN	WOS:000279191700010	19820170	Bronze, Green Published			2022-02-06	
J	Wilde, EA; McCauley, SR; Kelly, TM; Weyand, AM; Pedroza, C; Levin, HS; Clifton, GL; Schnelle, KP; Shah, MV; Moretti, P				Wilde, Elisabeth A.; McCauley, Stephen R.; Kelly, Tara M.; Weyand, Annie M.; Pedroza, Claudia; Levin, Harvey S.; Clifton, Guy L.; Schnelle, Kathleen P.; Shah, Monika V.; Moretti, Paolo			The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI): I. Construct Validity	JOURNAL OF NEUROTRAUMA			English	Article						Neurological Outcome Scale for Traumatic Brain Injury; outcome; traumatic brain injury; validity	HEALTH STROKE SCALE; CLINICAL-TRIALS; RELIABILITY; VOLUME	The Neurological Outcome Scale for Traumatic Brain Injury (NOS-TBI) is a measure adapted from the National Institutes of Health Stroke Scale (NIHSS), and is intended to capture essential neurological deficits impacting individuals with traumatic brain injury (TBI) (see Wilde et al., 2010). In the present study we evaluate the measure's construct validity via comparison with a quantified neurological examination performed by a neurologist. Spearman rank-order correlation between the NOS-TBI and the neurological examination was rho = 0.76, p<0.0001, suggesting a high degree of correspondence (construct validity) between these two measures of neurological function. Additionally, items from the NOS-TBI compared favorably to the neurological examination items, with correlations ranging from 0.60 to 0.99 (all p<0.0001). On formal neurological examination, some degree of neurological impairment was observed in every participant in this cohort of individuals undergoing rehabilitation for TBI, and on the NOS-TBI neurological impairment was evident in all but one participant. This study documents the presence of measurable neurological sequelae in a sample of patients with TBI in a post-acute rehabilitation setting, underscoring the need for formal measurement of the frequency and severity of neurological deficits in this population. The results suggest that the NOS-TBI is a valid measure of neurological functioning in patients with TBI.	[Wilde, Elisabeth A.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA; [Wilde, Elisabeth A.; Kelly, Tara M.; Levin, Harvey S.; Clifton, Guy L.; Schnelle, Kathleen P.; Shah, Monika V.] Univ Texas Houston Med Sch, Houston, TX USA; [McCauley, Stephen R.; Moretti, Paolo] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Pedroza, Claudia] Univ Texas Med Sch Houston, Ctr Clin Res & Evidence Based Med, Houston, TX USA; [Moretti, Paolo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA		Wilde, EA (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, 1709 Dryden Rd,Suite 1200, Houston, TX 77030 USA.	ewilde@bcm.edu		Pedroza, Claudia/0000-0003-4235-1282	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 43353]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS043353] Funding Source: NIH RePORTER	We would like to extend our gratitude to the participants and their families, whose cooperation and patience helped make this study possible. This study was supported in part by grant NS 43353 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke, to Guy L. Clifton, Principal Investigator. The information in this manuscript and the manuscript itself has never been published either electronically or in print. None of the authors have any financial or other relationships that could be construed as a conflict of interest with respect to the content of this manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bigler ED, 2006, AM J PHYS MED REHAB, V85, P793, DOI 10.1097/01.phm.0000237873.26250.e1; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Derex L, 2004, J NEUROL SCI, V225, P3, DOI 10.1016/j.jns.2004.05.020; DOlhaberriague L, 1996, STROKE, V27, P2331, DOI 10.1161/01.STR.27.12.2331; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Lyden P, 2004, ARCH NEUROL-CHICAGO, V61, P1677, DOI 10.1001/archneur.61.11.1677; LYDEN PD, 1991, STROKE, V22, P1345, DOI 10.1161/01.STR.22.11.1345; Lyden PD, 2001, STROKE, V32, P1310, DOI 10.1161/01.STR.32.6.1310; MCCAULEY SR, 2010, J NEUROTRAUMA, V27; Meyer MA, 1998, STROKE, V29, P1480, DOI 10.1161/01.STR.29.7.1480; Nunnally J.C., 1994, PSYCHOMETRIC THEORY, V3; *SAS I INC, 2008, STAT AN SOFTW WIND; Saver JL, 1999, STROKE, V30, P293, DOI 10.1161/01.STR.30.2.293; Schiemanck SK, 2005, NEUROREHAB NEURAL RE, V19, P133, DOI 10.1177/154596830501900207; TEASDALE G, 1974, LANCET, V2, P81; Urbina S, 1997, PSYCHOL TESTING; Wilde EA, 2010, J NEUROTRAUM, V27, P975, DOI 10.1089/neu.2009.1193; Young FB, 2005, STROKE, V36, P2187, DOI 10.1161/01.STR.0000181089.41324.70	18	20	20	0	3	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUN	2010	27	6					983	989		10.1089/neu.2009.1194			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	612VO	WOS:000278933300002	20210594	Green Published			2022-02-06	
J	Armstead, WM; Kiessling, JW; Kofke, WA; Vavilala, MS				Armstead, William M.; Kiessling, J. Willis; Kofke, W. Andrew; Vavilala, Monica S.			SNP improves cerebral hemodynamics during normotension but fails to prevent sex dependent impaired cerebral autoregulation during hypotension after brain injury	BRAIN RESEARCH			English	Article						Brain injury; Cerebral circulation; Newborn; Autoregulation; Signal transduction	BLOOD-FLOW; CHILDREN; AGE; METABOLISM	Traumatic brain injury (TBI is a leading cause of morbidity in children and boys are disproportionately represented. Hypotension is common and worsens outcome after TBI. Previous studies show that adrenomedullin, a cerebrovasodilator, prevented sex dependent impairment of autoregulation during hypotension after piglet fluid percussion brain injury (FPI). We hypothesized that this concept was generalizable and that administration of another vasodilator, sodium nitroprusside (SNP), may equally improve CBF and cerebral autoregulation in a sex dependent manner after FPI. SNP produced equivalent percent cerebrovasodilation in male and female piglets. Reductions in pial artery diameter, cortical CBF, and cerebral perfusion pressure (CPP) concomitant with elevated intracranial pressure (ICP) after FPI were greater in male compared to female piglets during normotension which was blunted by SNP. During hypotension, pial artery dilation (PAD) was impaired more in the male than the female after FPI. However, SNP did not improve hypotensive PAD after FPI in females and paradoxically caused vasoconstriction in males. SNP did not prevent reductions in CBF, CPP or autoregulatory index during combined hypotension and FPI in either sex. SNP aggravated ERK MAPK upregulation after FPI. These data indicate that despite prevention of reductions in CBF after FPI, SNP does not prevent impairment of autoregulation during hypotension after FPI. These data suggest that therapies directed at a purely hemodynamic increase in CPP will fail to improve outcome during combined TBI and hypotension. (C) 2010 Elsevier B.V. All rights reserved.	[Armstead, William M.; Kiessling, J. Willis; Kofke, W. Andrew] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HD57355]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD057355] Funding Source: NIH RePORTER	This research was funded by a grant from the National Institutes of Health, HD57355 (WMA).	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2009, J CEREBR BLOOD F MET, V29, P524, DOI 10.1038/jcbfm.2008.142; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; Coates BM, 2005, CRIT CARE MED, V33, P2645, DOI 10.1097/01.CCM.0000186417.19199.9B; Coles Jonathan P, 2004, Curr Opin Crit Care, V10, P120, DOI 10.1097/00075198-200404000-00008; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Grande PO, 2006, INTENS CARE MED, V32, P1475, DOI 10.1007/s00134-006-0294-3; Joshi S, 2003, ANESTHESIOLOGY, V98, P412, DOI 10.1097/00000542-200302000-00022; Laher I, 2001, J CEREBR BLOOD F MET, V21, P887, DOI 10.1097/00004647-200108000-00001; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Richards HK, 2001, J CEREBR BLOOD F MET, V21, P779, DOI 10.1097/00004647-200107000-00002; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala Monica S, 2004, Pediatr Crit Care Med, V5, P257, DOI 10.1097/01.PCC.0000123545.69133.C3; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37	20	20	22	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	MAY 12	2010	1330						142	150		10.1016/j.brainres.2010.03.024			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	599FP	WOS:000277896800014	20298682	Green Accepted			2022-02-06	
J	Bian, XX; Yuan, XS; Qi, CP				Bian, Xiao-xing; Yuan, Xue-song; Qi, Chuan-ping			Effect of Recombinant Human Erythropoietin on Serum S100B Protein and Interleukin-6 Levels After Traumatic Brain Injury in the Rat	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						erythropoietin; traumatic brain injury; S100B protein; interleukin-6	NEONATAL HYPOXIA/ISCHEMIA; HEAD TRAUMA; NEUROPROTECTION; NEUROGENESIS; CYTOKINE; RECEPTOR; EDEMA	Erythropoietin (EPO) has a neuroprotective effect in the animal model of ischemia/hypoxia, but the mechanisms underlying the EPO effect in traumatic brain injury (TBI) are not well understood. This study examined the potential neuroprotective mechanisms of recombinant human EPO (rhEPO) in rats after TBI. Sixty healthy adult male Sprague-Dawley rats were randomly divided into 5 groups: 1000 U/kg rhEPO-treated, 3000 U/kg rhEPO-treated, 5000 U/kg rhEPO-treated, citicoline, and normal saline (control) groups. The TBI model was based on the modified Feeney's free falling model. Serum samples were collected at 6 hours, 24 hours, 3 days, 5 days, and 7 days after trauma. The serum S100B protein and interleukin-6 (IL-6) levels were measured after treatment in each group with double antibody sandwich enzyme-linked immunosorbent assay. Both serum S100B protein and IL-6 levels were significantly lower in 3000 U/kg rhEPO-treated and 5000 U/kg rhEPO-treated groups (p < 0.001). The decrease in serum S100B protein level was correlated with the dosage of rhEPO. Medium doses of rhEPO achieved the optimum decreases in the serum IL-6 level. Therefore, inhibition of the composition and secretion of S100B protein and IL-6 levels by EPO might be one of the mechanisms involved in decreasing inflammatory reaction in the brain, and may be responsible for the neuroprotective effect after TBI.	[Bian, Xiao-xing; Yuan, Xue-song] Jiangsu Univ, Affiliated Wujin Hosp, Dept Neurosurg, Changzhou 213002, Jiangsu, Peoples R China; [Qi, Chuan-ping] Jiangsu Univ, Affiliated Wujin Hosp, Dept Ctr Lab, Changzhou 213002, Jiangsu, Peoples R China		Bian, XX (corresponding author), Jiangsu Univ, Affiliated Wujin Hosp, Dept Neurosurg, Changzhou 213002, Jiangsu, Peoples R China.	cedar.y@163.com					Chen Da-qing, 2005, Chin J Traumatol, V8, P245; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Erbayraktar S, 2003, P NATL ACAD SCI USA, V100, P6741, DOI 10.1073/pnas.1031753100; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Folkersma H, 2008, ACTA NEUROCHIR, V150, P1277, DOI 10.1007/s00701-008-0151-y; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Hartley CE, 2008, J NEUROSURG, V109, P708, DOI 10.3171/JNS/2008/109/10/0708; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; King CE, 2007, EXP NEUROL, V205, P48, DOI 10.1016/j.expneurol.2007.01.017; Lima JE, 2006, BRAZ J MED BIOL RES, V39, P129, DOI 10.1590/S0100-879X2006000100015; Liu RQ, 2006, J NEUROCHEM, V96, P1101, DOI 10.1111/j.1471-4159.2005.03597.x; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Okutan O, 2008, SURG NEUROL, V70, P498, DOI 10.1016/j.surneu.2007.07.061; Ozisik K, 2006, TRANSPLANT P, V38, P2784, DOI 10.1016/j.transproceed.2006.08.100; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Sun Y, 2005, STROKE, V36, P1672, DOI 10.1161/01.STR.0000173406.04891.8c; Toth C, 2008, NEUROSCIENCE, V154, P767, DOI 10.1016/j.neuroscience.2008.03.052; van der Kooij MA, 2008, BRAIN RES REV, V59, P22, DOI 10.1016/j.brainresrev.2008.04.007; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	29	20	23	0	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2010	50	5					361	365		10.2176/nmc.50.361			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	596QX	WOS:000277701300003	20505289	Bronze			2022-02-06	
J	Dulou, R; Dagain, A; Delmas, JM; Lambert, E; Blondet, E; Goasguen, O; Pouit, B; Dutertre, G; De Soultrait, F; Pernot, P				Dulou, Renaud; Dagain, Arnaud; Delmas, Jean-Marc; Lambert, Evelyne; Blondet, Eric; Goasguen, Olivier; Pouit, Bruno; Dutertre, Guillaume; De Soultrait, Francois; Pernot, Philippe			The French mobile neurosurgical unit	NEUROSURGICAL FOCUS			English	Article						mobile team; French neurosurgery; war surgery	SURGICAL-TREATMENT; INJURIES; MEDICINE; SURGERY; MISSION; ARMY	The authors present the French concept of a mobile neurosurgical unit (MNSU) as used to provide specific support to remote military medicosurgical units deployed in Africa, South America, Central Europe, and Afghanistan. From 2001 to 2009, 15 missions were performed, for 16 patients. All but 3 of these missions (those in Kosovo, French Guyana, and Afghanistan) concerned Africa. Eleven patients were French soldiers, 3 were civilians, and 2 were Djiboutian soldiers. The conditions that MNSUs were requested for included craniocerebral wounds (2 cases), closed head trauma (7 cases), spinal trauma (5 cases), and spontaneous intracranial hemorrhage (2 cases). In 5 of the 16 cases, neurosurgical treatment was provided on site. All French soldiers and 2 civilians were evacuated to France. The MNSU can be deployed for timely treatment when some delay in neurosurgical management is acceptable. (DOI: 10.3171/2010.2.FOCUS1016)	[Dulou, Renaud; Dagain, Arnaud; Delmas, Jean-Marc; Blondet, Eric; Goasguen, Olivier; Pouit, Bruno; Dutertre, Guillaume; De Soultrait, Francois; Pernot, Philippe] Hop Instruct Armees du Val de Grace, Serv Neurochirurg, F-75230 Paris 05, France; [Lambert, Evelyne] Hop Instruct Armees Percy, Serv Anesthesie Reanimat, Clamart, France		Dulou, R (corresponding author), Hop Instruct Armees du Val de Grace, Serv Neurochirurg, F-75230 Paris 05, France.	renaud.dulou@gmail.com		dagain, arnaud/0000-0001-8416-1976			Amirjamshidi A, 2003, SURG NEUROL, V60, P105, DOI 10.1016/S0090-3019(03)00358-6; CHAUDHRI KA, 1994, ACTA NEUROCHIR, V126, P120, DOI 10.1007/BF01476420; Cushing H, 1918, BRIT J SURG, V5, P558; Department of Defense United States of America, 2004, EM WAR SURG, P121; Donovan DJ, 2006, MIL MED, V171, P12, DOI 10.7205/MILMED.171.1.12; Hughes J T, 2004, J Med Biogr, V12, P18; King B, 2005, J NATL MED ASSOC, V97, P648; Madei WF, 2000, MIL MED, V165, P445, DOI 10.1093/milmed/165.6.445; MEIROWSKY AM, 1953, ANN SURG, V138, P178, DOI 10.1097/00000658-195308000-00003; PERNOT P, 1992, MED ARMEES, V20, P115; PERRIN J, 1950, ONE YEAR WAR NEUROSU; Pitlyk PJ, 1996, MIL MED, V161, P462, DOI 10.1093/milmed/161.8.462; RIGNAULT DP, 1990, MIL MED, V155, P143, DOI 10.1093/milmed/155.4.143; Rosenfeld JV, 1997, MIL MED, V162, P311, DOI 10.1093/milmed/162.5.311; Schurr PH, 2005, J ROY SOC MED, V98, P423, DOI 10.1258/jrsm.98.9.423; SEBESTA D, 1990, MIL MED, V155, P227, DOI 10.1093/milmed/155.5.227; Seet B, 1999, MIL MED, V164, P451, DOI 10.1093/milmed/164.7.451; 1982, MED ARMEES, V10, P873	18	20	22	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2010	28	5							E13	10.3171/2010.2.FOCUS1016			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	589ZU	WOS:000277193600013	20568929				2022-02-06	
J	Mumford, N; Duckworth, J; Thomas, PR; Shum, D; Williams, G; Wilson, PH				Mumford, Nick; Duckworth, Jonathan; Thomas, Patrick R.; Shum, David; Williams, Gavin; Wilson, Peter H.			Upper limb virtual rehabilitation for traumatic brain injury: Initial evaluation of the elements system	BRAIN INJURY			English	Article						Traumatic brain injury; virtual reality; rehabilitation; motor learning; motor control; augmented feedback	COGNITIVE FUNCTION; REALITY; STROKE; FEEDBACK; HAND; ARM; EXERCISE	Primary objective: To evaluate the effectiveness of a tabletop virtual-reality (VR) based upper-limb rehabilitation system (called Elements) for promoting movement skill in patients with TBI. Research design: An ABA case study design with multiple baselines was employed. Baseline performance in this design is contrasted against the results during the treatment phase. Research methods: Three patients with TBI participated in 12 1-hour sessions of VR-based training. The VR system consisted of a 42-inch tabletop LCD, camera tracking system and tangible user interface. The system requires participants to move an object to cued locations while receiving augmented movement feedback to reinforce speed, trajectory and placement. Upper limb performance was assessed using these three system-measured variables and standardized tests. Trends in the time-sequence plots for each patient were assessed by sight inspection of smoothed data and then by statistical analyses. Results: Participants demonstrated improvements on movement accuracy, efficiency and bimanual dexterity and mixed improvement on speed and other measures of movement skill. Conclusion: Taken together, the findings demonstrate that the Elements system shows promise in facilitating motor learning in these TBI patients. Larger scale trials are now deemed a viable step in further validating the system.	[Wilson, Peter H.] RMIT Univ, Sch Hlth Sci, Discipline Psychol, Div Psychol, Melbourne, Vic 3000, Australia; [Mumford, Nick] RMIT Univ, Dept Psychol, Melbourne, Vic 3000, Australia; [Duckworth, Jonathan] RMIT Univ, Sch Creat Media, Melbourne, Vic 3000, Australia; [Thomas, Patrick R.] Griffith Univ, Sch Educ & Profess Studies, Brisbane, Qld 4111, Australia; [Shum, David] Griffith Univ, Sch Psychol, Brisbane, Qld 4111, Australia; [Williams, Gavin] Epworth Med Fdn, Melbourne, Vic, Australia		Wilson, PH (corresponding author), RMIT Univ, Sch Hlth Sci, Discipline Psychol, Div Psychol, POB 2476V, Melbourne, Vic 3000, Australia.	peter.h.wilson@rmit.edu.au	Wilson, Peter H./E-2881-2018; Shum, David/A-3914-2008	Wilson, Peter H./0000-0003-3747-0287; Shum, David/0000-0002-4810-9262; Williams, Gavin/0000-0003-2758-7473	Australian Research Council (ARC)Australian Research Council [LP0562622]; Australia Council for the Arts	This work was supported in part by an Australian Research Council (ARC) Linkage Grant LP0562622, and Synapse Grant awarded by the Australia Council for the Arts. We wish to acknowledge the contributions of other members of the broader Elements project; Ross Eldridge and Dr Heiko Rudolph from the School of Electrical and Computer Engineering, RMIT University, and Mark Guglielmetti, an artist and Lecturer with the School of Art and Design, Monash University.	Armagan O, 2003, AM J PHYS MED REHAB, V82, P856, DOI 10.1097/01.PHM.0000091984.72486.EO; Backman CL, 1999, AM J PHYS MED REHAB, V78, P170, DOI 10.1097/00002060-199903000-00022; Bajo A, 2002, BRAIN INJURY, V16, P385, DOI 10.1080/02699050110119826; Boian R, 2002, STUD HEALTH TECHNOL, V85, P64; Cooper B., 1996, CAN J OCCUP THER, V63, P9, DOI [10.1177/000841749606300103, DOI 10.1177/000841749606300103]; DAVID D, 2007, COGNITION BRAIN BEHA, V11, P299; Eastridge D, 2005, BEHAV INTERVENT, V20, P77, DOI 10.1002/bin.175; EDMANS JA, 2004, 5 INT C DIS VIRT REA, P3; Fischer HC, 2007, TOP STROKE REHABIL, V14, P1, DOI 10.1310/tsr1401-1; Fisher I, 2004, AUST OCCUP THER J, V51, P185, DOI DOI 10.1111/J.1440-1630.2004.00446.X; Gentleman D, 2001, TRAUMA, V3, P193; Gibson JJ., 1966, SENSES CONSIDERED PE; Grealy MA, 1999, ARCH PHYS MED REHAB, V80, P661, DOI 10.1016/S0003-9993(99)90169-7; Henderson A, 2007, TOP STROKE REHABIL, V14, P52, DOI 10.1310/tsr1402-52; HOLDEN MK, 2001, NEUROLOGY REPORT, V25, P129; Hubert V, 2007, HUM BRAIN MAPP, V28, P1415, DOI 10.1002/hbm.20354; Jeannerod M, 2006, CR BIOL, V329, P354, DOI 10.1016/j.crvi.2006.03.017; Jeannerod M., 2006, MOTOR COGNITION WHAT; Kinugasa T, 2004, SPORTS MED, V34, P1035, DOI 10.2165/00007256-200434150-00003; LAYCOCK J, 1992, THESIS U BRADFORD BR; Mastos M, 2007, CLIN REHABIL, V21, P47, DOI 10.1177/0269215506073494; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; Maulucci RA, 2001, NEUROREHABILITATION, V16, P171; MCCARRON LT, 1997, MCCARRON ASSESSMENT; McCrea PH, 2002, DISABIL REHABIL, V24, P534, DOI 10.1080/09638280110115393; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; Morgan DL, 2001, AM PSYCHOL, V56, P119, DOI 10.1037/0003-066X.56.2.119; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; Piron L, 2004, MED INFORM INTERNET, V29, P119, DOI 10.1080/14639230410001723428; Piron L, 2003, ST HEAL T, V94, P265; Piron L, 2007, 2007 VIRTUAL REHABILITATION, P119; Platz T, 2001, ARCH PHYS MED REHAB, V82, P961, DOI 10.1053/apmr.2001.23982; Platz T, 1999, RESTOR NEUROL NEUROS, V14, P161; Platz T, 2005, ARM ARM REHABILITATI; PRIDMORE T, 2004, 5 INT C DIS VIRT REA, P11; RADOMSKI MV, 2000, OCCUPATIONAL THERAPY; Riva G, 2007, 2007 VIRTUAL REHABILITATION, P157; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Rochette A., 1997, CANADIAN J OCCUPATIO, V64, P270, DOI [10.1177/000841749706400504, DOI 10.1177/000841749706400504]; Rose Dorian K, 2004, Top Stroke Rehabil, V11, P20, DOI 10.1310/XAUM-LPBM-0RXD-RLDK; Rosenbaum D. A., 2004, INT J SPORT EXERCISE, V2, P439, DOI DOI 10.1080/1612197X.2004.9671754; Schultheis MT, 2001, PRESENCE-TELEOP VIRT, V10, P431, DOI 10.1162/1054746011470271; Seidler RD, 2004, NEUROIMAGE, V22, P1775, DOI 10.1016/j.neuroimage.2004.05.003; Sideridis GD, 1997, J BEHAV EDUC, V7, P191, DOI DOI 10.1023/a:1022841108508; Siegert R, 2004, DISABIL REHABIL, V26, P1, DOI 10.1080/09638280410001644932; Stewart JC, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-21; Sveistrup H, 2003, CYBERPSYCHOL BEHAV, V6, P245, DOI 10.1089/109493103322011524; Todorov E, 1997, J MOTOR BEHAV, V29, P147, DOI 10.1080/00222899709600829; Turolla A, 2007, 2007 VIRTUAL REHABILITATION, P47; TURVEY MT, 1980, PRELIMINARIES THEORY; Van Vliet PM, 2006, DISABIL REHABIL, V28, P831, DOI 10.1080/09638280500534937; Vaz DV, 2008, CLIN REHABIL, V22, P234, DOI 10.1177/0269215507081578; Wald JL, 2000, CYBERPSYCHOL BEHAV, V3, P643, DOI 10.1089/109493100420232; Whitall J., 2003, PLASTICITY REHABILIT, V9, P77; WILSON BA, 1998, COMPREHENSIVE CLIN P, P463; WILSON PH, 2006, P 5 INT WOR IN PRESS; WILSON PH, 2007, P ANN C VIRT REH VEN, DOI DOI 10.1109/ICVR.2007.4362122; Woollacott, 2007, MOTOR CONTROL TRANSL; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	60	20	20	1	23	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY	2010	24	5					780	791		10.3109/02699051003652807			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	592PJ	WOS:000277391300011	20353283				2022-02-06	
J	Srinivas, R; Brown, SD; Chang, YF; Garcia-Fillion, P; Adelson, PD				Srinivas, Ravi; Brown, S. Danielle; Chang, Yue-Fang; Garcia-Fillion, Pamela; Adelson, P. David			Endocrine function in children acutely following severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Endocrine; Pediatric; Traumatic brain injury; Acute	NEUROENDOCRINE DYSFUNCTION; ABNORMALITIES	Despite the prevalence of frontal injury following traumatic brain injury (TBI) in adults and children with potentially concomitant hypothalamic and pituitary involvement, endocrine dysfunction acutely following TBI has not been well studied in children. To study the acute pediatric endocrine response after severe TBI (Glasgow Coma Scale a parts per thousand currency signaEuro parts per thousand 8), an endocrine panel, including cortisol, ACTH, TSH, T3, T4, free T4, GH, and prolactin levels, were obtained in 37 children (1-17 years) on the day of injury and post-injury days (PID) 3 and 7. Outcome was determined at 6-month follow-up using the Glasgow Outcome Score (GOS) extended modified for pediatric patients (GOS-E Peds) to compare "good" (GOS-E Peds 1-2) to "poor" (GOS-E Peds 3-5) outcomes. Our results showed that following severe TBI in children, cortisol was significantly elevated (24.46 +/- 13.41 mu g/dL) on PID 1 along with ACTH but then returned to normal (10.14-19.92 mu g/dL) by PID 3; 46% and 14% of children had a low cortisol and ACTH (< 10.14 and < 2, respectively) in the acute period. In summary, the cortisol response to trauma and stress in the acute period following severe TBI in the majority of children was altered, though seemingly appropriate cortisol was abnormally low in a significant percentage of children. Further study as to the significance of these findings is needed, but this study provides preliminary insight into the potential impact of severe TBI on the acute response of the hypothalamic-pituitary axis in children.	[Adelson, P. David] Phoenix Childrens Neurosci Inst, Dept Pediat Neurosurg, Phoenix, AZ 85016 USA; [Brown, S. Danielle; Garcia-Fillion, Pamela; Adelson, P. David] Phoenix Childrens Hosp, Childrens Neurosci Inst, Phoenix, AZ USA; [Srinivas, Ravi; Brown, S. Danielle; Chang, Yue-Fang; Adelson, P. David] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA		Adelson, PD (corresponding author), Phoenix Childrens Neurosci Inst, Dept Pediat Neurosurg, Bldg B,4th Floor,1919 E Thomas Rd, Phoenix, AZ 85016 USA.	dadelson@phoenixchildrens.com	Adelson, David/W-2083-2019		Center for Injury and Research Control (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49/CCR323155]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS052478]	We would like to thank the Center for Injury and Research Control (CDC no. R49/CCR323155) for funding this project through their Student Grants section (RS) and the NIH ( no. R01 NS052478) (PDA) for their support in this project.	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Beers SR, 2005, J NEUROTRAUM, V22, P1224; Bettendorf M, 2002, EUR J NUCL MED MOL I, V29, pS439, DOI 10.1007/s00259-002-0905-3; Cernak I, 1999, BRAIN INJURY, V13, P1005; Dimopoulou I, 2004, INTENS CARE MED, V30, P1051, DOI 10.1007/s00134-004-2257-x; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; JENNETT B, 1975, LANCET, V1, P480; KAPTEIN EM, 1981, J CLIN ENDOCR METAB, V53, P764, DOI 10.1210/jcem-53-4-764; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Radovick S, 2003, PEDIAT ENDOCRINOLOGY; Richard I., 2001, Annales de Readaptation et de Medecine Physique, V44, P19, DOI 10.1016/S0168-6054(00)00059-3; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	16	20	22	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	MAY	2010	26	5					647	653		10.1007/s00381-009-1038-9			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	582NV	WOS:000276605600011	19937245				2022-02-06	
J	Thackeray, JD; Scribano, PV; Lindberg, DM				Thackeray, Jonathan D.; Scribano, Philip V.; Lindberg, Daniel M.			Yield of Retinal Examination in Suspected Physical Abuse With Normal Neuroimaging	PEDIATRICS			English	Article						retinal hemorrhages; child physical abuse; abusive head trauma; traumatic brain injury	SHAKEN BABY SYNDROME; TRAUMATIC BRAIN-INJURY; HEAD TRAUMA; YOUNG-CHILDREN; HEMORRHAGES	OBJECTIVE: In some centers, dedicated ophthalmologic examination is performed for all children who are evaluated for potential physical abuse. Although retinal hemorrhages have been reported in rare cases of abused children with normal neuroimaging results, the utility of ophthalmologic examination in this group is currently unknown. The objective of this study was to determine the prevalence of retinal hemorrhages in children younger than 2 years who were evaluated for physical abuse and who had no evidence of traumatic brain injury (TBI) on neuroimaging. PATIENTS AND METHODS: We performed retrospective analysis of data obtained from 1676 children younger than 5 years who were evaluated for potential physical abuse as a part of the Using Liver Transaminases to Recognize Abuse research network. We reviewed results of dedicated ophthalmologic examination in all children younger than 2 years with no evidence of TBI on neuroimaging. RESULTS: Among 282 children who met inclusion criteria, only 2 (0.7% [95% confidence interval: 0.1%-2.5%]) had retinal hemorrhages considered "characteristic" of abuse. Seven other children (2.5% [95% confidence interval: 1.0%-5.1%]) had a nonspecific pattern of retinal hemorrhages. Both children with characteristic retinal hemorrhages in the absence of TBI showed evidence of head or facial injury on physical examination and/or altered mental status. CONCLUSIONS: In children younger than 2 years being evaluated for physical abuse without radiographic evidence of brain injury, retinal hemorrhages are rare. Dedicated ophthalmologic examination should not be considered mandatory in this population. Pediatrics 2010; 125: e1066-e1071	[Thackeray, Jonathan D.; Scribano, Philip V.] Nationwide Childrens Hosp, Ctr Child & Family Advocacy, Columbus, OH 43205 USA; [Lindberg, Daniel M.] Brigham & Womens Hosp, Dept Emergency Med, Boston, MA 02115 USA		Thackeray, JD (corresponding author), Nationwide Childrens Hosp, Ctr Child & Family Advocacy, 655 E Livingston Ave, Columbus, OH 43205 USA.	jonathan.thackeray@nationwidechildrens.org					Aryan HE, 2005, J CLIN NEUROSCI, V12, P624, DOI 10.1016/j.jocn.2005.05.005; Barlow KM, 2000, LANCET, V356, P1571, DOI 10.1016/S0140-6736(00)03130-5; Bechtel K, 2004, PEDIATRICS, V114, P165, DOI 10.1542/peds.114.1.165; BUYS YM, 1992, OPHTHALMOLOGY, V99, P1718; CAFFEY J, 1974, PEDIATRICS, V54, P396; Christian CW, 1999, J PEDIATR-US, V135, P125, DOI 10.1016/S0022-3476(99)70343-4; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Hobbs C, 2005, ARCH DIS CHILD, V90, P952, DOI 10.1136/adc.2003.037739; HOLLENHORST RW, 1958, ARCH OPHTHALMOL-CHIC, V60, P187; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; JOHNSON DL, 1993, NEUROSURGERY, V33, P231; Johnson DL, 1993, NEUROSURGERY, V33, P234; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; Kelly P, 2008, J PAEDIATR CHILD H, V44, P99, DOI 10.1111/j.1440-1754.2007.01234.x; King WJ, 2003, CAN MED ASSOC J, V168, P155; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Laskey AL, 2004, J PEDIATR-US, V144, P719, DOI 10.1016/j.jpeds.2004.02.023; Laskey AL, 2007, CHILD ABUSE NEGLECT, V31, P329, DOI 10.1016/j.chiabu.2006.02.017; Levin AV, 2002, NEUROSURG CLIN N AM, V13, P201, DOI 10.1016/S1042-3680(02)00004-9; Levin AV, 2009, CHILD ABUSE MED DIAG, P211; Lindberg D, 2009, PEDIATRICS, V124, P509, DOI 10.1542/peds.2008-2348; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Reece R.M., 2009, CHILD ABUSE MED DIAG, V3rd; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Trenchs V, 2008, CHILD NERV SYST, V24, P815, DOI 10.1007/s00381-008-0583-y	28	20	20	0	3	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005			PEDIATRICS	Pediatrics	MAY	2010	125	5					E1066	E1071		10.1542/peds.2009-2184			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	590NI	WOS:000277232800038	20385633				2022-02-06	
J	Wang, F; Luo, YM; Ling, F; Wu, H; Chen, J; Yan, F; He, ZY; Goel, GJ; Ji, XM; Ding, YC				Wang, Fei; Luo, Yumin; Ling, Feng; Wu, Hao; Chen, Jian; Yan, Feng; He, Zhongyi; Goel, Gunjan; Ji, Xunming; Ding, Yuchuan			Comparison of neuroprotective effects in ischemic rats with different hypothermia procedures	NEUROLOGICAL RESEARCH			English	Article						Cerebral ischemia; reperfusion damage; hypothermia; infarct; motor behavior	CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOCAL ISCHEMIA; TRAUMATIC BRAIN-INJURY; COLD SALINE INFUSION; ACUTE STROKE; MODERATE HYPOTHERMIA; REPERFUSION INJURY; THERAPEUTIC HYPOTHERMIA; MILD HYPOTHERMIA; TERRITORY	Objective: The neuroprotective effect of hypothermia has long been recognized. The aim of this work was to compare the neuroprotective effect of systemic, head and local vascular cooling hypothermia procedures in ischemic rats. Methods: Stroke in Sprague-Dawley rats (n=64) was induced by a 3 hour right middle cerebral artery occlusion using an intraluminal filament. Before reperfusion, ischemic animals (n=16 in each group) received hypothermia (systemic, head or local vascular) or no treatment. Brain temperature, infarction volume (n=8 in each group) and functional outcome (n=8 in each group) were compared. Results: Regarding brain temperature, vascular cooling significantly reduced the temperature of ischemic territory in cortex from 37.2 +/- 0.1 to 33.4 +/- 0.4 degrees C and in striatum from 37.5 +/- 0.2 to 33.9 +/- 0.4 degrees C within 5 minutes. This hypothermic condition remained for up to 60 minutes after reperfusion. However, systemic cooling reduced brain temperature at a similar level for six times longer. In the head cooling group, the target temperature was reached in 15 minutes, but returned to normal within 5 minutes. Although all hypothermia procedures induced neuroprotection, ischemic rats with vascular cooling showed significantly (p<0.001) better neuroprotection with 10.7 +/- 2.6% infarction, compared to 54.2 +/- 1.9% (no treatment), 37.1 +/- 1.0% (head cooling) and 29.1 +/- 3.4% (systemic cooling). Significantly (p<0.001) better effects on motor function were also detected in vascular cooling groups at 14 and 28 days. Conclusion: Vascular cooling appears to be the most effective in reducing infarct volume and improving functional outcome than the other two hypothermia methods in a rat ischemia/reperfusion model.	[Wang, Fei; Luo, Yumin; Wu, Hao; Yan, Feng; Ji, Xunming; Ding, Yuchuan] Capital Med Univ, Xuanwu Hosp, Key Lab Neurodegenerat Dis, Cerebral Vasc Dis Inst,Minist Educ, Beijing, Peoples R China; [Wang, Fei; He, Zhongyi] Ningxia Med Univ, Yinchuan, Peoples R China; [Ling, Feng; Chen, Jian; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing, Peoples R China; [Goel, Gunjan; Ding, Yuchuan] Wayne State Univ, Sch Med, Detroit, MI USA		Ji, XM (corresponding author), 45 Changchun St, Beijing 100053, Peoples R China.	jixm70@hotmail.com	Ji, Xunming/AAN-3370-2021	yan, feng/0000-0001-8663-6859			Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Balousek PA, 1996, CURR OPIN CARDIOL, V11, P550, DOI 10.1097/00001573-199609000-00015; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; Becker KJ, 2005, STROKE, V36, P400, DOI 10.1161/01.STR.0000153056.25397.ff; CLARK RK, 1994, BRAIN RES BULL, V35, P387, DOI 10.1016/0361-9230(94)90119-8; Colbourne F, 1997, MOL NEUROBIOL, V14, P171, DOI 10.1007/BF02740655; Corbett D, 2000, BRAIN PATHOL, V10, P145; Corbett R, 1998, J NEUROCHEM, V71, P1205; Diao CG, 2003, ANN BIOMED ENG, V31, P346, DOI 10.1114/1.1554924; Ding YC, 2002, STROKE, V33, P2492, DOI 10.1161/01.STR.0000028237.15541.CC; Ding YC, 2002, J NEUROSURG, V96, P310, DOI 10.3171/jns.2002.96.2.0310; Ding YC, 2002, BEHAV BRAIN RES, V132, P29, DOI 10.1016/S0166-4328(01)00405-3; Ding YC, 2001, BRAIN RES, V915, P210, DOI 10.1016/S0006-8993(01)02852-9; Ding YC, 2001, NEUROL RES, V23, P193, DOI 10.1179/016164101101198334; Ding YC, 2004, NEUROSURGERY, V54, P956, DOI 10.1227/01.NEU.0000114513.96704.29; Ding YH, 2004, NEUROSCI LETT, V372, P35, DOI 10.1016/j.neulet.2004.09.010; Feigin V, 2003, LANCET NEUROL, V2, P529, DOI 10.1016/S1474-4422(03)00500-3; Hemmen TM, 2007, STROKE, V38, P794, DOI 10.1161/01.STR.0000247920.15708.fa; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Kammersgaard LP, 2000, STROKE, V31, P2251, DOI 10.1161/01.STR.31.9.2251; Kataoka K, 1998, NEUROSCI RES, V32, P103, DOI 10.1016/S0168-0102(98)00076-5; Konstas AA, 2007, J APPL PHYSIOL, V102, P1329, DOI 10.1152/japplphysiol.00805.2006; KULUZ JW, 1992, STROKE, V23, P1792, DOI 10.1161/01.STR.23.12.1792; Lee SM, 2009, J CEREBR BLOOD F MET, V29, P1589, DOI 10.1038/jcbfm.2009.81; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luan XD, 2004, ACTA NEUROPATHOL, V107, P227, DOI 10.1007/s00401-003-0802-2; Lyden PD, 2006, INT J STROKE, V1, P9, DOI 10.1111/j.1747-4949.2005.00011.x; Schwab S, 1998, STROKE, V29, P2461, DOI 10.1161/01.STR.29.12.2461; Schwab S, 2001, STROKE, V32, P2033, DOI 10.1161/hs0901.095394; Slotboom J, 2004, NEURORADIOLOGY, V46, P923, DOI 10.1007/s00234-004-1286-z; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao WH, 2009, NEUROL RES, V31, P43, DOI 10.1179/174313208X327982	33	20	22	0	2	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0161-6412			NEUROL RES	Neurol. Res.	MAY	2010	32	4					378	383		10.1179/016164110X12670144526183			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	593IJ	WOS:000277446600008	20483004				2022-02-06	
J	Wang, L; Li, ZQ; Shi, ZBA; Zhang, YQ; Shen, JH				Wang, Li; Li, Zhongquan; Shi, Zhanbiao; Zhang, Yuqing; Shen, Jianhuan			Factor structure of acute stress disorder symptoms in Chinese earthquake victims: A confirmatory factor analysis of the acute stress disorder scale	PERSONALITY AND INDIVIDUAL DIFFERENCES			English	Article						Acute stress disorder scale; Factor structure; Confirmatory factor analyses; Earthquake; China	TRAUMATIC BRAIN-INJURY; 2-YEAR PROSPECTIVE EVALUATION; PTSD; PREDICTORS; DISSOCIATION; INTERVIEW; THERAPY; ISSUES	This study examined the factor structure of the acute stress disorder scale (ASDS; Bryant, Moulds, & Guthrie, 2000), a self-report measure for acute stress disorder (ASD). The study was completed 6 to 10 days following an earthquake; it included 353 Chinese earthquake victims (173 women, 180 men; mean age = 29.36, SD = 11.45 years). The results of confirmatory factor analyses indicate that a 4-factor model (dissociation, reexperiencing, avoidance and arousal) is consistent with the conceptualization of ASD, which is defined in the Diagnostic and Statistical Manual of Mental Disorder-Fourth Edition (DSM-IV). Implications and limitations for the results are discussed. (C) 2010 Elsevier Ltd. All rights reserved.	[Li, Zhongquan] Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, Nanjing 210093, Jiangsu, Peoples R China; [Wang, Li] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Shi, Zhanbiao] Chinese Acad Sci, Inst Psychol, Psychol Crisis Intervent Ctr, Beijing 100101, Peoples R China; [Zhang, Yuqing] Chinese Acad Sci, Inst Psychol, Ctr Social & Econ Behav, Beijing 100101, Peoples R China; [Shen, Jianhuan] Univ Toronto, Dept Psychiat, Toronto, ON, Canada		Li, ZQ (corresponding author), Nanjing Univ, Sch Social & Behav Sci, Dept Psychol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	zhongquanl@hotmail.com		Li, Zhongquan/0000-0002-8480-4166; wang, li/0000-0002-1459-3412			AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Brewin CR, 1999, AM J PSYCHIAT, V156, P360; Briere J, 2005, AM J PSYCHIAT, V162, P2295, DOI 10.1176/appi.ajp.162.12.2295; Brooks R, 2008, J TRAUMA STRESS, V21, P352, DOI 10.1002/jts.20333; Bryant R. A., 1999, AUSTR J EMERGENCY MA, V14, P9; Bryant RA, 2000, PSYCHOL ASSESSMENT, V12, P61, DOI 10.1037/1040-3590.12.1.61; Bryant RA, 2005, J CONSULT CLIN PSYCH, V73, P334, DOI 10.1037/0022-006X.73.2.334; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 2003, BEHAV RES THER, V41, P489, DOI 10.1016/S0005-7967(02)00179-1; Bryant RA, 1997, CLIN PSYCHOL REV, V17, P757, DOI 10.1016/S0272-7358(97)00052-4; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2007, J ANXIETY DISORD, V21, P183, DOI 10.1016/j.janxdis.2006.09.012; Byrne B., 2001, STRUCTURAL EQUATION; Ehlers A, 2003, BEHAV RES THER, V41, P1, DOI 10.1016/S0005-7967(01)00126-7; Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; Joreskog K. G., 2005, LISREL 8 72 INTERACT; Kleindorfer S. O., 2006, J TRAUMA PRACTICE, V4, P81, DOI [10.1300/J189v04n01_06, DOI 10.1300/J189V04N01_06]; Marsella AJ, 2004, PSYCHIAT CLIN N AM, V27, P521, DOI 10.1016/j.psc.2004.03.011; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; MERENDA P. F., 1994, CROSS CULTURAL TOPIC, P53; Merenda PF, 2006, PSYCHOL REP, V99, P307, DOI 10.2466/PR0.99.2.307-314; Orsillo S.M., 2001, PRACTITIONERS GUIDE, P255, DOI DOI 10.1007/0-306-47628-2_20; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; Pole Nnamdi, 2005, Cultur Divers Ethnic Minor Psychol, V11, P144, DOI 10.1037/1099-9809.11.2.144; Rhoades Jr G.F., 2006, J TRAUMA PRACTICE, V4, P21; RUBONIS AV, 1991, PSYCHOL BULL, V109, P384, DOI 10.1037/0033-2909.109.3.384; SATORRA A, 1988, ASA 1988 P BUSINESS, P308; TANG CS, 2007, CROSS CULTURAL ASSES, P135; Wang XD, 2000, AM J PSYCHIAT, V157, P1260, DOI 10.1176/appi.ajp.157.8.1260	33	20	25	0	11	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8869			PERS INDIV DIFFER	Pers. Individ. Differ.	MAY	2010	48	7					798	802		10.1016/j.paid.2010.01.027			5	Psychology, Social	Social Science Citation Index (SSCI)	Psychology	591JE	WOS:000277295700004					2022-02-06	
J	Huang, RQ; Cheng, HL; Zhao, XD; Dai, W; Zhuang, Z; Wu, Y; Liu, Y; Shi, JX				Huang, Ren-qiang; Cheng, Hui-lin; Zhao, Xu-dong; Dai, Wei; Zhuang, Zong; Wu, Yi; Liu, Yong; Shi, Ji-xin			Preliminary study on the effect of trauma-induced secondary cellular hypoxia in brain injury	NEUROSCIENCE LETTERS			English	Article						Trauma brain injury; Hypoxia; Cerebral cortex; Sprague-Dawley rat	GROWTH-FACTOR-BETA; FOCAL CEREBRAL-ISCHEMIA; INDUCIBLE FACTOR-1; RAT-BRAIN; EXPRESSION; TISSUE; HOMEOSTASIS; INDUCTION; NEURONS; CELLS	Secondary cerebral hypoxia has recently been shown to play an important role in the outcome of patients suffering from traumatic brain injury (TBI). However, the precise mechanisms underlying secondary cerebral hypoxia are complex and interrelated. In this study, we investigate the effect of hypoxia within a rat model of trauma-induced late cerebral cortex injury. Using the hypoxia marker pimonidazole, we verified and isolated areas of the cortex that had suffered hypoxic damage. Using subsequent reverse-transcriptase PCR analyses, we found that the expressions of both transforming growth factor beta 1 (TGF-beta 1) and hypoxia-inducible factor-1 alpha (HIF-1 alpha) increased significantly under hypoxic conditions induced by TBI compared with uninjured control animals. In addition, the maximum mRNA expression of TGF-beta 1 and HIF-1 alpha was found at 3 days and 12 h after TBI, respectively. Our data suggest that secondary cerebral hypoxia injury involves various cytokines including TGF-beta 1 and HIF-1 alpha. Furthermore, upon immunohistochemical analysis, both TGF-beta 1 and HIF-1 alpha expression were almost localized in the same types of cells by using immunohistochemical study. These results may have important implications in the understanding of trauma-induced secondary cerebral hypoxia injury. (C) 2010 Elsevier Ireland Ltd. All rights reserved.	[Huang, Ren-qiang; Cheng, Hui-lin; Shi, Ji-xin] Second Mil Med Univ Shanghai, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu Prov, Peoples R China; [Cheng, Hui-lin; Zhao, Xu-dong; Dai, Wei; Zhuang, Zong; Wu, Yi; Shi, Ji-xin] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu Prov, Peoples R China; [Liu, Yong] Kyoto Univ, Inst Res Reactor, Particle Radiat Oncol Res Ctr, Osaka 59004, Japan		Shi, JX (corresponding author), Second Mil Med Univ Shanghai, Jinling Hosp, Sch Med, Dept Neurosurg, 305 E Zhongshan Rd, Nanjing 210002, Jiangsu Prov, Peoples R China.	aboo2710@163.com; jxshi@yahoo.cn					Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Ghafar MA, 2002, LAB INVEST, V82, P903, DOI 10.1097/01.LAB.0000021135.87203.92; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; Kiening KL, 1996, J NEUROSURG, V85, P751, DOI 10.3171/jns.1996.85.5.0751; Kim ES, 1998, MOL BRAIN RES, V62, P122, DOI 10.1016/S0169-328X(98)00217-4; KLEMPT ND, 1992, MOL BRAIN RES, V13, P93, DOI 10.1016/0169-328X(92)90048-G; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liu Y, 2009, J RADIAT RES, V50, P233, DOI 10.1269/jrr.08112; Marmarou A, 2005, ACT NEUR S, V95, P277; Martin C, 1998, AM J OBSTET GYNECOL, V178, P527, DOI 10.1016/S0002-9378(98)70433-8; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Mazzeo AT, 2007, J NEUROL SCI, V261, P1, DOI 10.1016/j.jns.2007.04.026; PREHN JHM, 1994, P NATL ACAD SCI USA, V91, P12599, DOI 10.1073/pnas.91.26.12599; Raleigh JA, 1998, INT J RADIAT ONCOL, V42, P727, DOI 10.1016/S0360-3016(98)00329-0; ROBERTS JT, 1986, BRIT J RADIOL, V59, P107, DOI 10.1259/0007-1285-59-698-107; Ruocco A, 1999, J CEREBR BLOOD F MET, V19, P1345, DOI 10.1097/00004647-199912000-00008; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Vincent KA, 2000, CIRCULATION, V102, P2255; WANG XK, 1995, BRAIN RES BULL, V36, P607, DOI 10.1016/0361-9230(94)00243-T; Westbury CB, 2007, BRIT J RADIOL, V80, P934, DOI 10.1259/bjr/25046649; Zhu Y, 2002, J NEUROSCI, V22, P3898, DOI 10.1523/JNEUROSCI.22-10-03898.2002	27	20	22	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	MAR 31	2010	473	1					22	27		10.1016/j.neulet.2010.02.011			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	588MN	WOS:000277074500005	20152885				2022-02-06	
J	Coben, R; Myers, TE				Coben, Robert; Myers, Thomas E.			The Relative Efficacy of Connectivity Guided and Symptom Based EEG Biofeedback for Autistic Disorders	APPLIED PSYCHOPHYSIOLOGY AND BIOFEEDBACK			English	Article						Autism; Quantitative EEG; Neurofeedback; Assessment; Efficacy	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; CORPUS-CALLOSUM; SPECTRUM DISORDER; FUNCTIONAL CONNECTIVITY; NEUROFEEDBACK TREATMENT; RESONANCE SPECTROSCOPY; CORTICAL CONNECTIVITY; EXECUTIVE FUNCTION; INFANTILE-AUTISM	Autism is a neurodevelopmental disorder characterized by deficits in communication, social interaction, and a limited range of interests with repetitive stereotypical behavior. Various abnormalities have been documented in the brains of individuals with autism, both anatomically and functionally. The connectivity theory of autism is a recently developed theory of the neurobiological cause of autisic symptoms. Different patterns of hyper- and hypo-connectivity have been identified with the use of quantitative electroencephalogray (QEEG), which may be amenable to neurofeedback. In this study, we compared the results of two published controlled studies examining the efficacy of neurofeedback in the treatment of autism. Specifically, we examined whether a symptom based approach or an assessment/connectivity guided based approach was more effective. Although both methods demonstrated significant improvement in symptoms of autism, connectivity guided neurofeedback demonstrated greater reduction on various subscales of the Autism Treatment Evaluation Checklist (ATEC). Furthermore, when individuals were matched for severity of symptoms, the amount of change per session was significantly higher in the Coben and Padolsky (J Neurother 11:5-23, 2007) study for all five measures of the ATEC. Our findings suggest that an approach guided by QEEG based connectivity assessment may be more efficacious in the treatment of autism. This permits the targeting and amelioration of abnormal connectivity patterns in the brains of people who are autistic.	[Coben, Robert; Myers, Thomas E.] Neurorehabil Serv, Massapequa Pk, NY 11762 USA; [Coben, Robert; Myers, Thomas E.] Neuropsychol Serv, Massapequa Pk, NY 11762 USA		Coben, R (corresponding author), Neurorehabil Serv, 1035 Pk Blvd,Suite 2B, Massapequa Pk, NY 11762 USA.	robcoben@optonline.net					Alexander AL, 2007, NEUROIMAGE, V34, P61, DOI 10.1016/j.neuroimage.2006.08.032; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Attwood T., 1998, ASPERGERS SYNDROME G; AYERS M, 1995, BIOFEEDBACK SELF-REG, V20, P309; BAILEY A, 1993, LANCET, V341, P1225, DOI 10.1016/0140-6736(93)91065-T; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Boddaert N, 2002, J RADIOL, V83, P1829; Boger-Megiddo I, 2006, J AUTISM DEV DISORD, V36, P733, DOI 10.1007/s10803-006-0121-2; Byers AP., 1995, J NEUROTHERAPY, V1, P22; CANTOR DS, 1986, J AUTISM DEV DISORD, V16, P169, DOI 10.1007/BF01531728; Casanova MF, 2002, J CHILD NEUROL, V17, P692, DOI 10.1177/088307380201700908; *CDCP, 2006, COMM AR AUT SPECTR D; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chung MK, 2004, NEUROIMAGE, V23, P242, DOI 10.1016/j.neuroimage.2004.04.037; Coben R., 2007, J NEUROTHERAPY, V11, P5, DOI DOI 10.1300/J184V11N01_02; COBEN R, 2009, J NEUROTHERAPY; Coben R., 2007, BIOFEEDBACK, V35, P131; Coben R, 2008, CLIN NEUROPHYSIOL, V119, P1002, DOI 10.1016/j.clinph.2008.01.013; Courchesne E, 2005, DEV PSYCHOPATHOL, V17, P577, DOI 10.1017/S0954579405050285; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 1999, NEUROLOGY, V52, P1057, DOI 10.1212/WNL.52.5.1057; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; COURCHESNE E, 1993, AM J ROENTGENOL, V160, P387, DOI 10.2214/ajr.160.2.8424359; COWAN J, 1994, ANN M ASS APPL PSYCH; Davidovitch M, 1996, J CHILD NEUROL, V11, P389, DOI 10.1177/088307389601100509; Dunn, 2007, J NEUROTHERAPY, V10, P3; Frith C, 2003, NOVART FDN SYMP, V251, P149; Fuchs T, 2003, APPL PSYCHOPHYS BIOF, V28, P1, DOI 10.1023/A:1022353731579; Hamilton L. M., 2000, FACING AUTISM GIVING; Hammond D., 2003, J NEUROTHERAPY, V7, P25, DOI DOI 10.1300/J184V07N02_; Hammond D. C., 2004, Journal of Neurotherapy, V8, P5, DOI 10.1300/J184v08n01_02; Heinrich H, 2004, BIOL PSYCHIAT, V55, P772, DOI 10.1016/j.biopsych.2003.11.013; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; HOFFMAN DA, 1996, CLIN ELECTROENCEPHAL, V27, P6; Hughes JR, 2007, EPILEPSY BEHAV, V11, P20, DOI 10.1016/j.yebeh.2007.03.010; Jarusiewicz B., 2002, J NEUROTHERAPY, V6, P39, DOI DOI 10.1300/J184V06N04_05; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kanner L, 1943, NERV CHILD, V2, P217; KELLER I, 2001, J NEUROTHERAPY, V51, P19; Kemper TL, 1998, J NEUROPATH EXP NEUR, V57, P645, DOI 10.1097/00005072-199807000-00001; La Vaque TJ, 2002, APPL PSYCHOPHYS BIOF, V27, P273, DOI 10.1023/A:1021061318355; LUBAR JF, 1981, ARCH NEUROL-CHICAGO, V38, P700, DOI 10.1001/archneur.1981.00510110060009; LUBAR JO, 1984, BIOFEEDBACK SELF-REG, V9, P1, DOI 10.1007/BF00998842; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MCCANDLESS J, 2005, CHILDREN STARVING BR; Mizuno A, 2006, BRAIN RES, V1104, P160, DOI 10.1016/j.brainres.2006.05.064; Monderer RS, 2002, EPILEPSY BEHAV, V3, P214, DOI 10.1016/S1525-5050(02)00001-X; Moore NC, 2000, CLIN ELECTROENCEPHAL, V31, P1, DOI 10.1177/155005940003100105; Murias M, 2007, BIOL PSYCHIAT, V62, P270, DOI 10.1016/j.biopsych.2006.11.012; Murphy DGM, 2002, ARCH GEN PSYCHIAT, V59, P885, DOI 10.1001/archpsyc.59.10.885; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Nunez P.L., 1995, NEOCORTICAL DYNAMICS; OTHMER S, 1997, ASSESSMENT EEG SPECT; Page LA, 2006, AM J PSYCHIAT, V163, P2189, DOI 10.1176/appi.ajp.163.12.2189; Piven J, 1997, AM J PSYCHIAT, V154, P1051; Piven J, 1996, J AM ACAD CHILD PSY, V35, P530, DOI 10.1097/00004583-199604000-00020; Schmitz N, 2006, BIOL PSYCHIAT, V59, P7, DOI 10.1016/j.biopsych.2005.06.007; Schoenberger NE, 2001, J HEAD TRAUMA REHAB, V16, P260, DOI 10.1097/00001199-200106000-00005; Sicile-Kira C., 2004, AUTISM SPECTRUM DISO; SIEGEL B, 1996, WORLD AUTISTIC CHILD; STERMAN MB, 1972, ELECTROEN CLIN NEURO, V33, P89, DOI 10.1016/0013-4694(72)90028-4; Sterman MB, 2000, CLIN ELECTROENCEPHAL, V31, P45, DOI 10.1177/155005940003100111; Thornton KE, 2005, CHILD ADOL PSYCH CL, V14, P137, DOI 10.1016/j.chc.2004.07.001; Tidmarsh L, 2003, CAN J PSYCHIAT, V48, P517, DOI 10.1177/070674370304800803; Trudeau DL, 2005, CHILD ADOL PSYCH CL, V14, P125, DOI 10.1016/j.chc.2004.07.006; Vidal CN, 2006, BIOL PSYCHIAT, V60, P218, DOI 10.1016/j.biopsych.2005.11.011; Walker J. E., 2002, J NEUROTHER, V6, P31, DOI DOI 10.1300/J184v06n02_05; Walker JE, 2005, CHILD ADOL PSYCH CL, V14, P163, DOI 10.1016/j.chc.2004.07.009; Wickelgren A, 2005, SCIENCE, V308, P1856, DOI 10.1126/science.308.5730.1856; [No title captured]	76	20	23	0	31	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1090-0586	1573-3270		APPL PSYCHOPHYS BIOF	Appl. Psychophysiol. Biofeedback	MAR	2010	35	1					13	23		10.1007/s10484-009-9102-5			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	534PV	WOS:000272910500004	19649702				2022-02-06	
J	Finnie, JW; Manavis, J; Blumbergs, PC				Finnie, John W.; Manavis, Jim; Blumbergs, Peter C.			Diffuse neuronal perikaryal amyloid precursor protein immunoreactivity in an ovine model of non-accidental head injury (the shaken baby syndrome)	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Animal model; Neuronal and axonal reactions; Shaken baby syndrome	TRAUMATIC AXONAL INJURY; PERMANENT BRAIN-DAMAGE; INFANT SYNDROME; NEUROPATHOLOGY; CHILDREN; IMPACT; SHAKING	Non-accidental head injury ("shaken baby syndrome") is a major cause if death and disability in infants and young children, but it is uncertain whether shaking alone is sufficient to cause brain damage or an additional head impact is required. Accordingly, we used manual shaking in an ovine model in an attempt to answer this question since lambs have a relatively large gyrencephalic brain and weak neck muscles resembling a human infant. Neuronal perikaryal and axonal reactions were quantified 6 hours after shaking using amyloid precursor protein (APP) immunohistochemistry. Neuronal perikaryal APP was widely distributed in the brain and spinal cord, the first time such a diffuse neuronal stress response after shaking has been demonstrated, but axonal immunoreactivity was minimal a id largely confined to the rostral cervical spinal cord at the site of maximal loading. No ischaemic-hypoxic damage was found in haematoxylin and eosin-stained sections. Crown Copyright (C) 2009 Published by Elsevier Ltd. All rights reserved.	[Finnie, John W.; Manavis, Jim; Blumbergs, Peter C.] Inst Med & Vet Sci, Hanson Inst Ctr Neurol Dis, Adelaide, SA 5000, Australia		Blumbergs, PC (corresponding author), Inst Med & Vet Sci, Hanson Inst Ctr Neurol Dis, POB 14 Rundle Mall, Adelaide, SA 5000, Australia.	peter.blumbergs@imvs.sa.gov.au					BLUMBERGS PC, 2008, GREENFIELDS NEUROPAT, P792; Bonnier C, 2002, BRAIN PATHOL, V12, P320; CAFFEY J, 1974, PEDIATRICS, V54, P396; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Cory CZ, 2003, MED SCI LAW, V43, P317, DOI 10.1258/rsmmsl.43.4.317; Dobbing J., 1981, SCI F PAEDIATRICS, P744; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Finnie JW, 2001, J COMP PATHOL, V124, P159, DOI 10.1053/jcpa.2000.0446; Geddes JF, 2004, FORENSIC SCI INT, V146, P83, DOI 10.1016/S0379-0738(03)00283-4; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gerber P, 2007, CHILD NERV SYST, V23, P499, DOI 10.1007/s00381-006-0267-4; Ghahreman A, 2005, J NEUROSURG, V103, P213, DOI 10.3171/ped.2005.103.3.0213; Gilliland MGF, 1996, J FORENSIC SCI, V41, P114; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Hymel KP, 2006, PEDIATRICS, V118, P421, DOI 10.1542/peds.2006-1245; Jayawant S, 1998, BMJ-BRIT MED J, V317, P1558, DOI 10.1136/bmj.317.7172.1558; Krous HF, 1999, PEDIATR DEVEL PATHOL, V2, P497, DOI 10.1007/s100249900156; KRUGMAN RD, 1993, PEDIATRICS, V92, P872; Leestma JE, 2005, AM J FOREN MED PATH, V26, P199, DOI 10.1097/01.paf.0000164228.79784.5a; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Raghupathi R, 2002, J NEUROTRAUM, V19, P843, DOI 10.1089/08977150260190438; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; Richards PG, 2006, ARCH DIS CHILD, V91, P205, DOI 10.1136/adc.2005.090761; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Smith SL, 1998, J NEUROTRAUM, V15, P693, DOI 10.1089/neu.1998.15.693; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Van Den Heuvel C, 1998, ACT NEUR S, V71, P209; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Ward JD, 1996, NEUROTRAUMA, P859	37	20	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	FEB	2010	17	2					237	240		10.1016/j.jocn.2009.07.001			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	554PC	WOS:000274445900020	20036546				2022-02-06	
J	Lopez-Aguilar, J; Quilez, ME; Marti-Sistac, O; Garcia-Martin, C; Fuster, G; Puig, F; Flores, C; Villar, J; Artigas, A; Blanch, L				Lopez-Aguilar, Josefina; Elisa Quilez, Maria; Marti-Sistac, Octavi; Garcia-Martin, Carolina; Fuster, Gemma; Puig, Ferranda; Flores, Carlos; Villar, Jesus; Artigas, Antonio; Blanch, Lluis			Early physiological and biological features in three animal models of induced acute lung injury	INTENSIVE CARE MEDICINE			English	Article						Ventilator-induced lung injury; Endotoxemia; Lipopolysaccharide; Brain injury; Inflammation; Metalloproteinases	TRAUMATIC BRAIN-INJURY; ULTRASTRUCTURAL-CHANGES; MECHANICAL VENTILATION; PULMONARY; DEATH; DYSFUNCTION; EXPRESSION; CYTOKINES; PRESSURE; RATS	Critically ill patients often develop acute lung injury (ALI) in the context of different clinical conditions. We aimed to explore differences in early local and systemic features in three experimental animal models of ALI. Mechanically ventilated male Sprague-Dawley rats were randomized to high tidal volume (VT) ventilation (HVT) (n = 8, VT 24 ml/kg), massive brain injury (MBI) (n = 8, VT 8 ml/kg) or endotoxemia (LPS) (n = 8, VT 8 ml/kg). Each experimental group had its own control group of eight rats (VT 8 ml/kg). We measured arterial blood gases, mean arterial pressure, lung compliance, inflammatory mediators in plasma and their expression and gelatinase activity in the lungs after 3 h of injury. Despite maintaining relatively normal lung function without evidence of important structural changes, we observed altered lung and systemic inflammatory responses in all three experimental models. LPS triggered the most robust inflammatory response and HVT the lowest systemic proinflammatory response. The HVT group had higher Il6, Tnf and Cxcl2 mRNA in lungs than MBI animals. Metalloproteinase activity/expression and neutrophilic recruitment in the lungs were higher in HVT than in LPS or MBI. The early responses to direct or remote lung insult in our three models of ALI captured different physiological and biological features that could lead to respiratory and/or multiorgan failure.	[Lopez-Aguilar, Josefina; Elisa Quilez, Maria; Marti-Sistac, Octavi; Garcia-Martin, Carolina; Fuster, Gemma; Puig, Ferranda; Artigas, Antonio; Blanch, Lluis] Esfera UAB, Inst Univ, Corp Parc Tauli, Hosp Sabadell,Crit Care Ctr, Sabadell 08208, Spain; [Lopez-Aguilar, Josefina; Elisa Quilez, Maria; Marti-Sistac, Octavi; Fuster, Gemma; Puig, Ferranda; Flores, Carlos; Villar, Jesus; Artigas, Antonio; Blanch, Lluis] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain		Lopez-Aguilar, J (corresponding author), Esfera UAB, Inst Univ, Corp Parc Tauli, Hosp Sabadell,Crit Care Ctr, Parc Tauli S-N, Sabadell 08208, Spain.	jlopeza@tauli.cat	Flores, Carlos/R-1159-2019; Fuster, Gemma/B-5468-2019; Villar, Jesus/R-4526-2019	Fuster, Gemma/0000-0002-4501-2422; Villar, Jesus/0000-0001-5687-3562; Flores, Carlos/0000-0001-5352-069X; antonio, artigas/0000-0002-8029-1017	FISInstituto de Salud Carlos III [CA 05/0138]; Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and Instituto de Salud Carlos [III-FIS PI-04/2365]; Ministerio de Educacion y CienciaSpanish GovernmentEuropean Commission [BFU2006-07124/BFI]; Fundacio Parc Tauli CIR; Programa de Estabilizacion FIS and Health Department of the Generalitat de Catalunya; Instituto de Salud Carlos III and FUNCISInstituto de Salud Carlos III [EMER07/001]	The authors would like to thank Neus Gomez (supported by FIS CA 05/0138) and Milagros Martinez for their technical assistance. The study was supported by Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica and Instituto de Salud Carlos III-FIS PI-04/2365, Ministerio de Educacion y Ciencia BFU2006-07124/BFI, Fundacio Parc Tauli CIR. JLA received support from the Programa de Estabilizacion FIS and Health Department of the Generalitat de Catalunya. CF was supported by a specific agreement between the Instituto de Salud Carlos III and FUNCIS (EMER07/001) under the ENCYT 2015 framework.	Altemeier WA, 2005, J IMMUNOL, V175, P3369, DOI 10.4049/jimmunol.175.5.3369; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Avlonitis VS, 2007, AM J TRANSPLANT, V7, P83, DOI 10.1111/j.1600-6143.2006.01593.x; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Chiari P, 2000, J HEART LUNG TRANSPL, V19, P675, DOI 10.1016/S1053-2498(00)00127-3; dos Santos CC, 2006, ANNU REV PHYSIOL, V68, P585, DOI 10.1146/annurev.physiol.68.072304.113443; Dreyfuss D, 2003, AM J RESP CRIT CARE, V167, P1467, DOI 10.1164/rccm.200206-611CP; Fisher AJ, 2001, AM J RESP CRIT CARE, V163, P259, DOI 10.1164/ajrccm.163.1.2005093; Foda HD, 2001, AM J RESP CELL MOL, V25, P717, DOI 10.1165/ajrcmb.25.6.4558f; Gonzalvo R, 2007, CRIT CARE, V11, DOI 10.1186/cc5930; Haitsma JJ, 2000, INTENS CARE MED, V26, P1515, DOI 10.1007/s001340000648; Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Isowa N, 2001, AM J PHYSIOL-LUNG C, V280, pL762, DOI 10.1152/ajplung.2001.280.4.L762; Kim JH, 2006, AM J PHYSIOL-LUNG C, V291, pL580, DOI 10.1152/ajplung.00270.2005; Lanchou J, 2003, CRIT CARE MED, V31, P536, DOI 10.1097/01.CCM.0000048626.02184.F8; Lewis CC, 2008, AM J RESP CRIT CARE, V177, P376, DOI 10.1164/rccm.200702-333OC; Lopez-Aguilar J, 2006, CRIT CARE MED, V34, P1106, DOI 10.1097/01.CCM.0000205757.66971.DA; Lopez-Aguilar J, 2005, CRIT CARE MED, V33, P1077, DOI 10.1097/01.CCM.0000162913.72479.F7; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Menezes SLS, 2005, J APPL PHYSIOL, V98, P1777, DOI 10.1152/japplphysiol.01182.2004; Nonas SA, 2007, AM J PHYSIOL-LUNG C, V293, pL292, DOI 10.1152/ajplung.00481.2006; Pugin J, 2003, CRIT CARE MED, V31, pS200, DOI 10.1097/01.CCM.0000057844.31307.ED; Skrabal CA, 2005, J SURG RES, V123, P118, DOI 10.1016/j.jss.2004.07.245; Slutsky Arthur S, 2005, Respir Care, V50, P646; Takada M, 1998, TRANSPLANTATION, V65, P1533, DOI 10.1097/00007890-199806270-00001; Tremblay LN, 2005, AM J PHYSIOL-LUNG C, V288, pL596, DOI 10.1152/ajplung.00438.2004; Tremblay LN, 2002, CRIT CARE MED, V30, P1693, DOI 10.1097/00003246-200208000-00003; Villar J, 2009, ANESTHESIOLOGY, V110, P1341, DOI 10.1097/ALN.0b013e31819fcba9; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Yildirim E, 2004, J HEART LUNG TRANSPL, V23, P1423, DOI 10.1016/j.healun.2003.10.006; Yildirim E, 2004, EUR J CARDIO-THORAC, V25, P523, DOI 10.1016/j.ejcts.2003.12.021	34	20	24	1	7	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	FEB	2010	36	2					347	355		10.1007/s00134-009-1695-x			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546KU	WOS:000273810500023	19841895				2022-02-06	
J	van Oorsouw, K; Merckelbach, H				van Oorsouw, Kim; Merckelbach, Harald			Detecting malingered memory problems in the civil and criminal arena	LEGAL AND CRIMINOLOGICAL PSYCHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SYMPTOM VALIDITY TEST; SIMULATING AMNESIA; SCALE; DISSOCIATION; PSYCHOPATHY; ALCOHOL; MMPI-2; VALIDATION; ACCURACY	Feigning a psychiatric or neurological disorder may be an attractive strategy to obtain all sorts of privileges or disability benefits. In the criminal arena, feigning memory loss for a crime (crime-related amnesia) may be a way for defendants to gain sympathy or to promote a diminished capacity defence. Although crime-related amnesia may, under some circumstances, be genuine, in many cases it is more likely to be malingered. Malingered memory problems are a subtle form of deception and what is true for deceptive behaviour in general is also true for malingering memory loss: on the basis of clinical intuition alone, it is difficult to detect. Fortunately, there are methods and tools to evaluate the authenticity of memory problems. It is important that forensic and clinical psychologists familiarize themselves with these techniques.	[van Oorsouw, Kim; Merckelbach, Harald] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands		van Oorsouw, K (corresponding author), Maastricht Univ, Dept Clin Psychol Sci, POB 616, NL-6200 MD Maastricht, Netherlands.	K.vanOorsouw@psychology.unimaas.nl					Arbisi PA, 1995, PSYCHOL ASSESSMENT, V7, P424, DOI 10.1037/1040-3590.7.4.424; Assefi SL, 2003, PSYCHOL SCI, V14, P77, DOI 10.1111/1467-9280.01422; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Berry D., 2008, CLIN ASSESSMENT MALI, P237; BERRY DTR, 2002, CLIN PERSONALITY ASS, P269; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Bourget D, 2007, J AM ACAD PSYCHIATRY, V35, P469; Brown S.C., 2000, OXFORD HDB MEMORY, P93, DOI DOI 10.1016/J.ADOLESCENCE.2017.05.018; Butcher J, 1989, MANUAL ADM SCORING M; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Christianson SA, 1999, APPL COGNITIVE PSYCH, V13, P495, DOI 10.1002/(SICI)1099-0720(199912)13:6<495::AID-ACP615>3.0.CO;2-0; CHRISTIANSON SA, 2006, REACTIVE INSTRUMENTA; Christianson SA, 2006, WITNESS TESTIMONY PS, P105; Christianson SA, 2004, DETECTION DECEPTION, P195, DOI DOI 10.1017/CBO9780511490071.009; Cima M, 2004, INT J LAW PSYCHIAT, V27, P215, DOI 10.1016/j.ijlp.2004.03.007; Cima M, 2003, CLIN NEUROPSYCHOL, V17, P235, DOI 10.1076/clin.17.2.235.16507; Cima M., 2003, FAKING GOOD BAD UGLY; COOPER BS, 2005, THESIS U BRIT COLUMB; CRITCHLOW B, 1986, AM PSYCHOL, V41, P751, DOI 10.1037/0003-066X.41.7.751; Denney RL, 2000, J HEAD TRAUMA REHAB, V15, P804, DOI 10.1097/00001199-200004000-00005; Denney RL, 1996, ARCH CLIN NEUROPSYCH, V11, P589, DOI 10.1016/0887-6177(95)00042-9; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; FAUST D, 1995, MALINGERING CONVERSI, V13, P225; FAUST D, 1996, NEUROPSYCHIATRY; FLOREZ JA, 2002, CURRENT OPINION PSYC, V15, P569; GACONO CB, 1995, B AM ACAD PSYCH LAW, V23, P387; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; GILBERT GM, 1971, NURNBERGER TAGEBUCH; Gorny I., 2005, J FORENSIC NEUROPSYC, V4, P71, DOI DOI 10.1300/J151V04N04_05; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; Green P., 2007, ASSESSMENT FEIGNED C, P50; Greiffenstein MF, 2006, LEGAL CRIMINOL PSYCH, V11, P131, DOI 10.1348/135532505X49828; Greiffenstein MF, 2001, CLIN NEUROPSYCHOL, V15, P162, DOI 10.1076/clin.15.2.162.1895; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Haque Q., 2003, ADV PSYCHIAT TREATME, V9, P144; Holmes EA, 2005, CLIN PSYCHOL REV, V25, P1, DOI 10.1016/j.cpr.2004.08.006; Hopwood JS, 1933, J MENT SCI, V79, P27, DOI 10.1192/bjp.79.324.27; IVERSON GL, 1995, BRAIN INJURY, V9, P35, DOI 10.3109/02699059509004569; Jelicic M., 2007, NETHERLANDS J PSYCHO, V63, P107, DOI [10.1007/BF03061071, DOI 10.1007/BF03061071]; Jelicic M., 2007, OFFENDERS MEMORIES V, P215, DOI [10.1002/9780470713082.ch9, DOI 10.1002/9780470713082.CH9]; Jureidini J, 2004, PSYCHOPATHOLOGY, V37, P259, DOI 10.1159/000081981; KALANT H, 1996, CONTEMP DRUG PROBL, V23, P631; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; KOPELMAN MD, 1995, HDB MEMORY DISORDERS, P427; Kucharski LT, 2006, BEHAV SCI LAW, V24, P633, DOI 10.1002/bsl.661; Kvavilashvili L, 1999, MEMORY, V7, P421, DOI 10.1080/741944922; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lilienfeld SO, 1996, J PERS ASSESS, V66, P488, DOI 10.1207/s15327752jpa6603_3; MacNeil BM, 2006, PERS INDIV DIFFER, V41, P641, DOI 10.1016/j.paid.2006.03.004; MALLESON A, 2002, DUBIOUS DIAGNOSES WH; Marshall WL, 2005, SEX ABUSE-J RES TR, V17, P31; McSherry B, 2004, INT J LAW PSYCHIAT, V27, P445, DOI 10.1016/j.ijlp.2004.06.002; Meijer EH, 2007, PSYCHOPHYSIOLOGY, V44, P814, DOI 10.1111/j.1469-8986.2007.00543.x; Merckelbach H, 2003, BEHAV RES THER, V41, P351, DOI 10.1016/S0005-7967(02)00019-0; Merckelbach H, 2003, ARCH CLIN NEUROPSYCH, V18, P145, DOI 10.1016/S0887-6177(01)00191-3; Merckelbach H, 2003, COMPR PSYCHIAT, V44, P65, DOI 10.1053/comp.2003.50011; MERCKELBACH H, 2007, OFFENDERS MEMORIES V, P165, DOI DOI 10.1002/9780470713082.CH7; MILLER H, 1961, BRIT MED J, V1, P992, DOI 10.1136/bmj.1.5231.992; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morel KR, 2008, J ANXIETY DISORD, V22, P1297, DOI 10.1016/j.janxdis.2008.01.011; Nairne JS, 2008, CURR DIR PSYCHOL SCI, V17, P239, DOI 10.1111/j.1467-8721.2008.00582.x; PAYNE JD, 2004, MEMORY EMOTION, P42; Pollock PH, 1999, LEGAL CRIMINOL PSYCH, V4, P185, DOI DOI 10.1348/135532599167842; Porter S, 2001, INT J LAW PSYCHIAT, V24, P23, DOI 10.1016/S0160-2527(00)00066-2; Porter S., 2006, HDB PSYCHOPATHY, P481; Porter S, 2007, LAW HUMAN BEHAV, V31, P91, DOI 10.1007/s10979-006-9033-0; Pressman MR, 2007, J SLEEP RES, V16, P198, DOI 10.1111/j.1365-2869.2007.00586.x; Pyszora NM, 2003, J FORENSIC PSYCHI PS, V14, P475, DOI 10.1080/14789940310001599785; Rassin E, 1999, BEHAV SCI LAW, V17, P237, DOI 10.1002/(SICI)1099-0798(199904/06)17:2<237::AID-BSL342>3.0.CO;2-5; Rivard JM, 2002, J FORENSIC SCI, V47, P1093; Rogers R., 2008, CLIN ASSESSMENT MALI, P301; Rogers R., 1992, STRUCTURED INTERVIEW; Rogers R, 2008, CLIN ASSESSMENT MALI; Rosen GM, 2004, J AM ACAD PSYCHIATRY, V32, P132; Rosen GM, 2003, J ANXIETY DISORD, V17, P361, DOI 10.1016/S0887-6185(02)00200-1; Ruiz MA, 2002, PROF PSYCHOL-RES PR, V33, P294, DOI 10.1037//0735-7028.33.3.294; Salekin R. T., 2007, CLIN ASSESSMENT MALI, P343; Schagen S, 1997, J CLIN EXP NEUROPSYC, V19, P43, DOI 10.1080/01688639708403835; Schmand B, 1998, J NEUROL NEUROSUR PS, V64, P339, DOI 10.1136/jnnp.64.3.339; SMITH GP, 1992, J AM ACAD PSYCHIAT L, V25, P183; Sweet J.J., 2008, CLIN ASSESSMENT MALI, P218; Swihart G, 1999, INT J LAW PSYCHIAT, V22, P199, DOI 10.1016/S0160-2527(99)00005-9; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tysse JE., 2005, W MITCHELL LAW REV, V32, P353; van Oorsouw K, 2004, J AM ACAD PSYCHIATRY, V32, P364; van Oorsouw K, 2004, APPL COGNITIVE PSYCH, V18, P505, DOI 10.1002/acp.999; Van Oorsouw K., 2007, OFFENDERS MEMORIES V, P191; Van Oorsouw K, 2007, AM J PSYCHOL, V120, P287, DOI 10.2307/20445399; Van Oorsouw K, 2006, PSYCHOL CRIME LAW, V12, P261, DOI 10.1080/10683160500224477; Vanderploeg RD, 2003, J HEAD TRAUMA REHAB, V18, P148, DOI 10.1097/00001199-200303000-00006; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D., 1997, WECHSLER MEMORY SCAL; Woodworth M, 2002, J ABNORM PSYCHOL, V111, P436, DOI 10.1037//0021-843X.111.3.436; [No title captured]; [No title captured]; [No title captured]	98	20	20	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1355-3259	2044-8333		LEGAL CRIMINOL PSYCH	Legal Criminol. Psychol.	FEB	2010	15	1			SI		97	114		10.1348/135532509X451304			18	Criminology & Penology; Law; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Criminology & Penology; Government & Law; Psychology	560RN	WOS:000274919900007					2022-02-06	
J	Ahmed, M; Mostafa, S; Fisher, G; Reynolds, TM				Ahmed, M.; Mostafa, S.; Fisher, G.; Reynolds, T. M.			Comparison between transcutaneous bilirubinometry and total serum bilirubin measurements in preterm infants < 35 weeks gestation	ANNALS OF CLINICAL BIOCHEMISTRY			English	Article							PHOTOTHERAPY; TERM	Background: Neonatal hyperbilirubinaemia is a common treatable cause of brain injury. The treatment for this condition is phototherapy. The decision whether to use phototherapy is currently dependent upon serum bilirubin assay results. However, repeated blood sampling is not only traumatic but may also be a cause of anaemia in neonates. We evaluated a transcutaneous bilirubin assay method to determine whether it was suitable for routine use in preterm infants. Methods: One hundred and eighty-three transcutaneous bilirubin measurements were taken contemporaneously with blood samples for laboratory measurement of serum bilirubin. The study was carried out with informed parental consent and approval by the local research ethics committee. Results: The transcutaneous bilirubin method (BiliChek (R)) exhibited a consistent positive bias compared with the laboratory bilirubin assay. Consequently, for a given detection rate, the transcutaneous method had a higher screen positive rate, i.e. more neonates would be given phototherapy if transcutaneous bilirubin results were used to decide. There was a margin of safety in the transcutaneous bilirubin assay calibration. Conclusion: The BiliChek transcutaneous bilirubin assay is a safe alternative to laboratory bilirubin assay in deciding whether to give preterm neonates phototherapy.	[Ahmed, M.; Mostafa, S.] Queens Hosp, Dept Paediat, Burton Upon Trent, Staffs, England; [Fisher, G.] Queens Hosp, Dept Biochem, Burton Upon Trent, Staffs, England; [Reynolds, T. M.] Univ Leicester, Leicester Med Sch, Leicester, Leics, England		Ahmed, M (corresponding author), Queens Hosp, Belvedere Rd, Burton Upon Trent DE13 0RB, Staffs, England.	mansoor.ahmed@burtonh-tr.wmids.nhs.uk	Reynolds, Tim/AAW-5715-2020; Fisher, Gemma/AAW-8026-2021	Reynolds, Tim/0000-0002-9729-4775; 	RD budget	No external financial support was received for this project (BiliChek disposable probe tips were financed from the R&D budget).	Beck M, 2003, ARCH DIS CHILD-FETAL, V88, P350; Bhutani VK, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.2.e17; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brister BS, 2002, AAPG BULL, V86, P1; De Luca D, 2008, ARCH DIS CHILD-FETAL, V93, pF135, DOI 10.1136/adc.2007.121053; Hinds LE, 2007, ARCH DIS CHILD-FETAL, V92, P378, DOI 10.1136/adc.2006.107771; Knupfer M, 2001, ACTA PAEDIATR, V90, P899; Lin JC, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.2.e19; Maisels MJ, 2004, PEDIATRICS, V114, P297; Maisels MJ, 2004, PEDIATRICS, V113, P1628, DOI 10.1542/peds.113.6.1628; Maisels MJ., 1993, EFFECTIVE CARE NEWBO, P507; Payne RB, 1997, ANN CLIN BIOCHEM, V34, P319, DOI 10.1177/000456329703400317; Rennie JM, 2009, ARCH DIS CHILD-FETAL, V94, pF323, DOI 10.1136/adc.2008.147686; Rubaltelli FF, 2001, PEDIATRICS, V107, P1264, DOI 10.1542/peds.107.6.1264; Sarici SU, 2000, J TROP PEDIATRICS, V46, P36, DOI 10.1093/tropej/46.1.36; Thayyil S, 2005, ARCH DIS CHILD, V90, P1311, DOI 10.1136/adc.2004.070292; Twomey PJ, 2006, ANN CLIN BIOCHEM, V43, P124, DOI 10.1258/000456306776021616; Willems W A, 2004, J Matern Fetal Neonatal Med, V16, P209; Wong CM, 2002, ARCH DIS CHILD-FETAL, V87, pF137, DOI 10.1136/fn.87.2.F137	19	20	20	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0004-5632	1758-1001		ANN CLIN BIOCHEM	Ann. Clin. Biochem.	JAN	2010	47		1				72	77		10.1258/acb.2009.009072			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	567XQ	WOS:000275482400013	19940207	Bronze			2022-02-06	
J	Chen, AS; McEwen, ML; Sun, SX; Ravikumar, R; Springer, JE				Chen, Anshu; McEwen, Melanie L.; Sun, Shixin; Ravikumar, Rangaswamyrao; Springer, Joe E.			Proteomic and Phosphoproteomic Analyses of the Soluble Fraction following Acute Spinal Cord Contusion in Rats	JOURNAL OF NEUROTRAUMA			English	Article						contusion; phosphoproteome; proteome; spinal cord injury; 2-DE	CASPASE-3 APOPTOTIC CASCADE; HEAT-SHOCK PROTEINS; GENE-EXPRESSION; COMPRESSION TRAUMA; SURROGATE MARKERS; ALPHA-CRYSTALLIN; TIME COURSE; CELL-DEATH; INJURY; BRAIN	Traumatic spinal cord injury (SCI) causes marked neuropathological changes in the spinal cord, resulting in limited functional recovery. Currently, there are no effective treatments, and the mechanisms underlying these neuropathological changes are not completely understood. In this study, two-dimensional gel electrophoresis coupled with mass spectrometry was used to investigate injury-related changes in the abundance (SYPRO Ruby stain) and phosphorylation (Pro-Q Diamond stain) of proteins from the soluble fraction of the lesion epicenter at 24 h following SCI. Over 1500 SYPRO Ruby-stained spots and 100 Pro-Q Diamond-stained spots were examined. We identified 26 unique proteins within 38 gel spots that differentially changed in abundance, phosphorylation, or both in response to SCI. Protein redundancies among the gel spots were likely due to differences in proteolysis, post-translational modifications, and the existence of isoforms. The proteins affected were blood-related proteins, heat-shock proteins, glycolytic enzymes, antioxidants, and proteins that function in cell structure, cell signaling, DNA damage, and protein degradation. These protein changes post injury may suggest additional avenues of investigation into the underlying molecular mechanisms responsible for the pathophysiological consequences of SCI.	[Chen, Anshu; McEwen, Melanie L.; Springer, Joe E.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Chen, Anshu; McEwen, Melanie L.; Ravikumar, Rangaswamyrao; Springer, Joe E.] Univ Kentucky, Dept Phys Med & Rehabil, Lexington, KY 40536 USA; [Chen, Anshu; McEwen, Melanie L.; Ravikumar, Rangaswamyrao; Springer, Joe E.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA; [Sun, Shixin] Appl Biosyst Inc, Framingham, MA USA		Springer, JE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B469 BBSRB,741 S Limestone, Lexington, KY 40536 USA.	jspring@uky.edu			PHSUnited States Department of Health & Human ServicesUnited States Public Health Service [NS46380]; Craig H. Neilsen Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046380] Funding Source: NIH RePORTER	The authors would like to thank Anne Stanley and Dr. Bruce A. Stanley in the Proteomics/Mass Spectrometry Core Facility at Pennsylvania State University College of Medicine for helping with the protein identification. This work was supported by PHS grant NS46380 (J.E.S.), an endowment from the Cardinal Hill Rehabilitation Hospital (J.E.S.), and a grant from the Craig H. Neilsen Foundation (M. L. M.).	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; ANDERSON DK, 1980, J NEUROSURG, V53, P375, DOI 10.3171/jns.1980.53.3.0375; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; BANIK NL, 1986, J NEUROL SCI, V73, P245, DOI 10.1016/0022-510X(86)90149-8; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7; COHEN P, 1982, NATURE, V296, P613, DOI 10.1038/296613a0; Cox B, 2005, METHODS, V35, P303, DOI 10.1016/j.ymeth.2004.08.021; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Denslow N, 2003, J NEUROTRAUM, V20, P401, DOI 10.1089/089771503765355487; Ding QX, 2006, PROTEOMICS, V6, P505, DOI 10.1002/pmic.200500296; Fagan A, 2007, PROTEOMICS, V7, P2162, DOI 10.1002/pmic.200600898; Fialho E, 2005, ARCH BIOCHEM BIOPHYS, V436, P246, DOI 10.1016/j.abb.2005.01.005; Ganea E, 2001, CURR PROTEIN PEPT SC, V2, P205, DOI 10.2174/1389203013381107; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Grant P, 2000, J NEUROCYTOL, V29, P843, DOI 10.1023/A:1010999509251; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; GUTIERREZ JA, 1995, BIOCHEM J, V305, P197, DOI 10.1042/bj3050197; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Hwan AY, 2006, BIOCHEM BIOPH RES CO, V348, P560, DOI 10.1016/j.bbrc.2006.07.105; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kaji A, 2007, EMERG MED CLIN N AM, V25, P735, DOI 10.1016/j.emc.2007.06.012; Kang SK, 2006, PROTEOMICS, V6, P2797, DOI 10.1002/pmic.200500621; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Li GL, 1999, ACTA NEUROPATHOL, V98, P473, DOI 10.1007/s004010051112; Ling X, 2007, J NEUROSCI RES, V85, P2175, DOI 10.1002/jnr.21362; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu XZ, 1997, J NEUROSCI, V17, P5395; Loy DN, 2005, NEUROSURGERY, V56, P391, DOI 10.1227/01.NEU.0000148906.83616.D2; Lucas JH, 1998, J NEUROPATH EXP NEUR, V57, P937, DOI 10.1097/00005072-199810000-00006; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; Nishimura RN, 2005, MUSCLE NERVE, V32, P693, DOI 10.1002/mus.20373; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NOBLE LJ, 1987, BRAIN RES, V424, P177, DOI 10.1016/0006-8993(87)91208-X; NOBLE LJ, 1988, EXP NEUROL, V99, P567, DOI 10.1016/0014-4886(88)90173-2; NORDBY HK, 1982, ACTA NEUROCHIR, V65, P93, DOI 10.1007/BF01405445; Ottens AK, 2007, PROG BRAIN RES, V161, P401, DOI 10.1016/S0079-6123(06)61029-7; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Power JHT, 2008, ACTA NEUROPATHOL, V115, P611, DOI 10.1007/s00401-008-0373-3; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Robinson MB, 2005, J NEUROSCI, V25, P9735, DOI 10.1523/JNEUROSCI.1912-05.2005; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schoonheim PJ, 2007, PLANT PHYSIOL, V143, P670, DOI 10.1104/pp.106.090159; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Springer JE, 1997, J NEUROCHEM, V68, P2469; Springer JE, 2000, J NEUROSCI, V20, P7246; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Taylor SW, 2003, TRENDS BIOTECHNOL, V21, P82, DOI 10.1016/S0167-7799(02)00037-9; Tsai MC, 2008, MOL CELL PROTEOMICS, V7, P1668, DOI 10.1074/mcp.M800076-MCP200; Wang KKW, 2004, INT REV NEUROBIOL, V61, P215; Wang LH, 1996, J NEUROSCI, V16, P6197; Wu XF, 2005, J NEUROCHEM, V93, P943, DOI 10.1111/j.1471-4159.2005.03078.x; Wuermser LA, 2007, ARCH PHYS MED REHAB, V88, pS55, DOI 10.1016/j.apmr.2006.12.002; Yan XD, 2009, J NEUROTRAUM, V26, P179, DOI 10.1089/NEU.2008.0533; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Yong C, 1998, J NEUROTRAUM, V15, P459, DOI 10.1089/neu.1998.15.459	72	20	21	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					263	274		10.1089/neu.2009.1051			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200023	19691422	Green Published			2022-02-06	
J	Gauvin-Lepage, J; Lefebvre, H				Gauvin-Lepage, Jerome; Lefebvre, Helene			Social inclusion of persons with moderate head injuries: The points of view of adolescents with brain injuries, their parents and professionals	BRAIN INJURY			English	Article						Traumatic brain injury; social inclusion; adolescents; perceptions; qualitative study	REHABILITATION; CHILDREN; FAMILY; BEHAVIOR; SCHOOL; TERM	Primary objective: This study explores the perceptions of adolescents, their parents and professionals as to the social inclusion of adolescents who have suffered a moderate traumatic brain injury (TBI). Research design: Exploratory descriptive qualitative study. Methods and procedures: Semi-structured interviews were conducted with three adolescents who had suffered a moderate TBI and with their parents. In addition, a focus group was conducted with four professionals. Main outcomes and results: The results show that the perceptions of adolescents, as well as their parents, affect different aspects of their lives, such as the adolescent's personal experiences, the family, friends, the environment and school. A great number of repercussions were indeed noted, which facilitate and sometimes limit the social inclusion of these adolescents. In general, the professionals shared the same perceptions, but added some ideas that did not come up in interviews with the adolescents and their parents. Conclusions: The results of this study should enable health professionals to better understand the social inclusion experienced by these people. They should also provide professionals with guidelines on how to better support the social inclusion of adolescents with TBIs and help families cope with this difficult situation.	[Gauvin-Lepage, Jerome] Jewish Rehabil Hosp, Laval, PQ H7N 1R2, Canada; [Gauvin-Lepage, Jerome; Lefebvre, Helene] Univ Montreal, Fac Nursing, Montreal, PQ, Canada; [Gauvin-Lepage, Jerome; Lefebvre, Helene] Montreal Ctr Interdisciplinary Res Rehabil, Montreal, PQ, Canada		Gauvin-Lepage, J (corresponding author), Jewish Rehabil Hosp, 3205 Alton Goldbloom Pl,Nursing Adm B-1127, Laval, PQ H7N 1R2, Canada.	jerome.gauvin-lepage@umontreal.ca	Gauvin-Lepage, Jerome/AAD-6699-2020				ALBRECHT SL, 1986, SOCIAL PSYCHOL, P696; ALVIN P, 2005, ANNONCE HANDICAP ADO, P127; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; BEE HL, 2008, AGES VIE PSYCHOL DEV, P468; BELANGER ME, 2000, MED QUEBEC, V35, P91; BOURQUE C, 2000, CADRE REFERENCE CLIN, P108; Braga LW, 2005, BRAIN INJURY, V19, P819, DOI 10.1080/02699050500110165; Bragg RM, 1992, J HEAD TRAUMA REHAB, V7, P94; BRONFENBRENNER U, 1986, DEV PSYCHOL, V22, P723, DOI 10.1037/0012-1649.22.6.723; Bronfenbrenner U, 1979, ECOLOGY HUMAN DEV EX, P330; BURNS N, 2009, PRACTICE NURSING RES, P750; Cimon L., 2000, PARTENARIAT RECHERCH, P47; Colantonio A, 1998, ARCH PHYS MED REHAB, V79, P550, DOI 10.1016/S0003-9993(98)90072-7; Crotty M., 1998, FDN SOCIAL RES MEANI, P248; Denzin NK, 2008, COLLECTING INTERPRET, Vx, P701; DePalma J A, 2001, Crit Care Nurs Q, V23, P42; DUBE C, 2001, QUEBEC SCI, V39, P22; EWINGCOBBS L, 1994, NEUROSURGERY, V35, P225, DOI 10.1227/00006123-199408000-00007; Farmer JE, 1996, J LEARN DISABIL-US, V29, P532, DOI 10.1177/002221949602900508; FAWCETT J, 1999, RELATIONSHIP THEORY, P398; FORTIN MF, 2006, FONDEMENTS ETAPES PR, P485; Francois N., 2005, ANNONCE HANDICAP ADO, P58; FRASER SN, 2006, DISS ABSTR INT B, V67, P253; FRIEDMAN D, 1999, COMPRENDRE NEUROTRAU, P43; GARCIA JG, 1998, PROFESSIONAL SCH COU, V2, P33; Guba EG, 1989, 4 GENERATION EVALUAT, P294; Guba EG, 1985, NATURALISTIC INQUIRY, P416; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P991, DOI 10.1016/S0003-9993(99)90049-7; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; HEISS I, 1993, SOCIAL ROLES CONFORM, P11; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Laloua F., 2006, EVALUATION TROUBLES, P109; Lefebvre H., 2004, RECHERCHE SOINS INFI, V78, P14; Lefebvre H., 2002, FAMILLE SITUATION HA, P27; Lefebvre H., 2005, FRONTIERES, V17, P77; Leon-Carrion J, 2006, STUD NEUROPSYCH DEV, P513; LEPAGE C, 2000, PARTENARIAT RECHERCH, P35; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Loiselle CG, 2007, METHODES RECHERCHE S, P591; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; MALEC EA, 1993, DISS ABSTR INT B, V55, P222; MCLEAN A, 1993, ARCH PHYS MED REHAB, V74, P1041, DOI 10.1016/0003-9993(93)90059-J; Mucchielli A., 2009, DICT METHODES QUALIT, P303; NEUMAN W, 2006, SOCIAL RES METHODS Q, P592; OLDS SW, 2005, DEV PERSONNE ADAPTAT, P399; Paquet M, 2005, J ADV NURS, V51, P567, DOI 10.1111/j.1365-2648.2005.03544.x; PATTON MQ, 2002, QUALITATIVE RES EVAL, P598; PELCHAT D, 2004, APPRENDRE ENSEMBLE P, P196; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Poupart J., 1997, RECHERCHE QUALITATIV, P405; PRADATDIEHL P, 2006, EVALUATION TROUBLES, P162; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; SCHWANDT TA, 2001, DICT QUALITATIVE INQ, P322; Shanmukhi S, 2003, NEUROL INDIA, V51, P518; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thompson Matthew D, 2003, Semin Pediatr Neurol, V10, P130, DOI 10.1016/S1071-9091(03)00021-4; TOCHON Francois V., 1996, REV SCI ED, V22, P467, DOI DOI 10.7202/031889AR; Wong SY, 2006, J INTELLECT DISABILI, V10, P165, DOI 10.1177/1744629506064012; Yazicioglu K, 2006, MIL MED, V171, P1083, DOI 10.7205/MILMED.171.11.1083	60	20	20	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2010	24	9					1087	1097		10.3109/02699052.2010.494593			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	636RH	WOS:000280756700005	20569044				2022-02-06	
J	Hawley, LA; Newman, JK				Hawley, Lenore A.; Newman, Jody K.			Group interactive structured treatment (GIST): A social competence intervention for individuals with brain injury	BRAIN INJURY			English	Article						Social skills; brain injury; group therapy; social communication skills; social competence	TRIAL	Background: Impairments in social competence are among the most prevalent sequelae of traumatic brain injury and present a major barrier to a person returning to a productive life. The recent increased incidence of TBI among military personnel and the subsequent difficulties these individuals face reintegrating into society accentuates the need for efficacious social competence treatment interventions for the TBI population. Method and results: This paper outlines the theoretical model and clinical application of Group Interactive Structured Treatment (GIST) for Social Competence. GIST-Social Competence is a structured cognitive-behavioural group therapy model addressing the underlying cognitive, communicative and emotional impairments impeding social competence after TBI. A recent randomized control trial (RCT) funded by the National Institute on Disability and Rehabilitation Research demonstrated the efficacy of this programme. GIST integrates the principles of established cognitive-behavioural therapy, group therapy and holistic neuro-rehabilitation in a manualized 13 week intervention combining a structured curriculum with a group therapy format. The structured cognitive-behavioural approach allows even those with significant underlying deficits (including self-awareness, memory, problem-solving, etc.) to benefit from this intervention. Conclusion: The GIST model can be applied to other treatment areas in TBI rehabilitation. Clinical observations from application of GIST with military personnel are reviewed.	[Hawley, Lenore A.] Craig Hosp, Res Dept, Englewood, CO 80113 USA; [Newman, Jody K.] Univ Colorado, Dept Psychiat, Neurobehav Disorders Program, Sch Med, Aurora, CO USA		Hawley, LA (corresponding author), Craig Hosp, Res Dept, 3425 S Clarkson St, Englewood, CO 80113 USA.	lhawley@craighospital.org; jnewman@craighospital.org			National Institute on Disability and Rehabilitation Research; Colorado TBI Trust	We are grateful to the many clients and families we have worked with through the years who have given us the knowledge and insight to develop this programme. We would like to thank Craig Hospital, especially Cynthia Harrison-Felix, PhD, Gale Whiteneck, PhD, Cynthia Braden, MA, CCC CPHQ, and the entire research team, for believing in the GIST programme and for providing the opportunity to demonstrate its efficacy. The National Institute on Disability and Rehabilitation Research supported the treatment efficacy RCT at Craig Hospital, as part of a TBI Model Systems grant. The Colorado TBI Trust Fund funded the feasibility study, providing further information regarding the application of GIST to individuals with TBI and co-existing diagnoses. Special acknowledgement is given to Don Gerber, PhD, for sharing his expertise and encouraging the authors to further develop the GIST theoretical model, and to Clare Morey, MA, CCC, for her valuable clinical observations, feedback and review. Denver Options is currently supporting the GIST intervention for active duty soldiers and veterans and we would like to acknowledge Jennifer Anderson, Christen Mason and John Lenz of Denver Options for their support in that effort.	[Anonymous], 2008, GULF WAR HLTH, V7; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Beck A.T, 1976, COGNITIVE THERAPY EM; Bellack A.S., 2004, SOCIAL SKILLS TRAINI; BENYISHAY Y, 1985, SEMINARS NEUROLOGY, V5; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Brabender VA, 2004, ESSENTIALS GROUP THE; CICERONE KD, 2000, TRAUMATIC BRAIN INJU, P95; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dobson K.S., 2002, HDB COGNITIVE BEHAV; DZURILLA T, 2002, HDB COGNITIVE BEHAV, P211; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Hawley L., 2008, GROUP INTERACTIVE ST; Lambert M., 2003, BERGIN GARFIELDS HDB, V5; LEZAK M, 1978, AM J PHYS MED, V58, P9; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Meichenbaum, 1977, COGNITIVE BEHAV MODI; PRIGATANO G, 1999, PRINCIPLES NEUROPSYC, P252; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; Rose S. D., 1998, GROUP THERAPY TROUBL; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; WELSH J, 1998, ENCY CHILDHOOD ADOLE; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th; Ylvisaker M., 1998, COLLABORATIVE BRAIN	26	20	20	0	20	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2010	24	11					1292	1297		10.3109/02699052.2010.506866			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	667MY	WOS:000283198800003	20735320				2022-02-06	
J	Nehrt, A; Hamann, K; Ouyang, H; Shi, RY				Nehrt, Ashley; Hamann, Kristin; Ouyang, Hui; Shi, Riyi			Polyethylene Glycol Enhances Axolemmal Resealing following Transection in Cultured Cells and in Ex Vivo Spinal Cord	JOURNAL OF NEUROTRAUMA			English	Article						gap potential; guinea pig; membrane potential; membrane surface tension; membrane tension; plasma membrane; spinal cord white matter; sucrose gap recording; surfactant; white matter	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HYPOTHERMIA; MEMBRANE-PERMEABILITY; NERVE MEMBRANES; IN-VITRO; CUT END; AXONS; REPAIR; CONTUSION; INVOLVEMENT	The integrity of the neuronal membrane is critical for its function as well as survival, and ineffective repair of damaged membranes may be one of the key factors underlying the neuronal degeneration and overall functional loss that occurs after spinal cord injury and traumatic brain injury. Previously, we showed that polyethylene glycol ( PEG) can reseal axonal membranes following compression in isolated guinea pig spinal cord white matter. We now report that 10 mM PEG can also significantly enhance membrane resealing following transection in the clinically relevant conditions of low extracellular Ca2+ and low temperature. Such beneficial effects were demonstrated both functionally, through membrane potential measured by double sucrose gap apparatus, and anatomically, through horseradish peroxidase and tetramethyl rhodamine dextran dye exclusion assays. We further noted that axons with small diameters preferentially benefited from PEG-mediated axolemmal resealing. Using atomic force microscopy, we further showed that PEG can effectively reduce neuronal membrane surface tension. We hypothesize that PEG may promote axolemmal resealing by increasing membrane line tension and reducing membrane tension, thus creating conditions more favorable to membrane resealing. In summary, these studies suggest that PEG is effective under the clinically relevant conditions of low Ca2+ and temperature, and thus has the potential to be used in combination with other more established interventions in spinal cord and traumatic brain injury.	[Nehrt, Ashley; Hamann, Kristin; Ouyang, Hui; Shi, Riyi] Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, Sch Vet Med, W Lafayette, IN 47907 USA; [Ouyang, Hui; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA		Shi, RY (corresponding author), Purdue Univ, Dept Basic Med Sci, Ctr Paralysis Res, Sch Vet Med, 408 S Univ St, W Lafayette, IN 47907 USA.	riyi@purdue.edu			State of Indiana; Purdue University Neuroscience program	We thank Phyllis Zickmund and Gary Leung for their excellent technical support. We also thank Todd Rickett for proofreading and Dr. Richard Borgens for his support and encouragement. This study was supported by funding from the State of Indiana. Ashley Nehrt was supported by the funding provided by Purdue University Neuroscience program.	Borgens RB, 2000, FASEB J, V14, P27, DOI 10.1096/fasebj.14.1.27; BORGENS RB, 1980, P NATL ACAD SCI-BIOL, V77, P1209, DOI 10.1073/pnas.77.2.1209; Casas CE, 2005, J NEUROSURG-SPINE, V2, P308, DOI 10.3171/spi.2005.2.3.0308; Chatzipanteli K, 2000, J NEUROTRAUM, V17, P321, DOI 10.1089/neu.2000.17.321; Choo AM, 2007, J NEUROSURG-SPINE, V6, P255, DOI 10.3171/spi.2007.6.3.255; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2009, J NEUROTRAUM, V26, P393, DOI 10.1089/neu.2008.0556; Dai JW, 1998, J NEUROSCI, V18, P6681; Dietrich WD, 2004, ACTA NEUROCHIR SUPPL, V89, P69; Dine CJ, 2009, EMERG MED CLIN N AM, V27, P137, DOI 10.1016/j.emc.2008.07.003; Eddleman CS, 1997, P NATL ACAD SCI USA, V94, P4745, DOI 10.1073/pnas.94.9.4745; Farkas O, 2006, J NEUROSCI, V26, P3130, DOI 10.1523/JNEUROSCI.5119-05.2006; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Golakani MH, 2019, J NEUROTRAUM, V36, P3410, DOI 10.1089/neu.2019.6421; HAYES KC, 1993, PARAPLEGIA, V31, P730, DOI 10.1038/sc.1993.115; HITT AL, 1994, CURR OPIN CELL BIOL, V6, P120, DOI 10.1016/0955-0674(94)90125-2; Howard MJ, 1999, NEUROSCIENCE, V93, P807, DOI 10.1016/S0306-4522(99)00195-5; Hui OY, 2008, J NEUROTRAUM, V25, P19, DOI 10.1089/neu.2007.0340; Jensen JM, 2003, J NEUROPHYSIOL, V90, P2334, DOI 10.1152/jn.00868.2002; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; KRAUSE TL, 1994, J NEUROSCI, V14, P6638; LEE RC, 1992, P NATL ACAD SCI USA, V89, P4524, DOI 10.1073/pnas.89.10.4524; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lo TP, 2009, J COMP NEUROL, V514, P433, DOI 10.1002/cne.22014; LUCAS JH, 1994, J NEUROTRAUM, V11, P35, DOI 10.1089/neu.1994.11.35; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; Luo J, 2002, J NEUROCHEM, V83, P471, DOI 10.1046/j.1471-4159.2002.01160.x; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; McNeil PL, 2003, ANNU REV CELL DEV BI, V19, P697, DOI 10.1146/annurev.cellbio.19.111301.140101; McNeil PL, 2001, NAT CELL BIOL, V3, pE124, DOI 10.1038/35074652; Peasley MA, 2002, AM J PHYSIOL-CELL PH, V283, pC980, DOI 10.1152/ajpcell.00591.2001; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; PFEIFFER DR, 1995, J BIOL CHEM, V270, P4923, DOI 10.1074/jbc.270.9.4923; Raucher D, 1999, BIOPHYS J, V77, P1992, DOI 10.1016/S0006-3495(99)77040-2; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Robertson CL, 2000, CRIT CARE MED, V28, P3218, DOI 10.1097/00003246-200009000-00017; SCHLAEPFER WW, 1974, BRAIN RES, V69, P203, DOI 10.1016/0006-8993(74)90002-X; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shi R, 1999, J NEUROPHYSIOL, V81, P2406, DOI 10.1152/jn.1999.81.5.2406; Shi R, 2001, J NEUROCYTOL, V30, P829, DOI 10.1023/A:1019645505848; Shi R, 2000, J NEUROCYTOL, V29, P633, DOI 10.1023/A:1010879219775; Shi R, 2002, NEUROSCIENCE, V110, P765, DOI 10.1016/S0306-4522(01)00596-6; Shi R, 1996, J NEUROPHYSIOL, V76, P1572, DOI 10.1152/jn.1996.76.3.1572; Shi R, 2000, NEUROSCIENCE, V98, P157, DOI 10.1016/S0306-4522(00)00096-8; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi RY, 2000, J NEUROPHYSIOL, V84, P1763, DOI 10.1152/jn.2000.84.4.1763; Shi RY, 2004, J NEUROCYTOL, V33, P203, DOI 10.1023/B:NEUR.0000030695.76840.19; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; SPIRA ME, 1993, J NEUROBIOL, V24, P300, DOI 10.1002/neu.480240304; STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2; Togo T, 1999, J CELL SCI, V112, P719; Westergren H, 2000, ACTA NEUROCHIR, V142, P567, DOI 10.1007/s007010050471; Whalen MJ, 2008, J CEREBR BLOOD F MET, V28, P490, DOI 10.1038/sj.jcbfm.9600544; Wieloch T, 2001, IUBMB LIFE, V52, P247, DOI 10.1080/15216540152846064; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17806; Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607; XIE XY, 1991, J NEUROSCI, V11, P3257; YAWO H, 1983, SCIENCE, V222, P1351, DOI 10.1126/science.6658457; YAWO H, 1985, J NEUROSCI, V5, P1626; YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1; Yu ZW, 1998, MOL MEMBR BIOL, V15, P59, DOI 10.3109/09687689809027519	65	20	22	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2010	27	1					151	161		10.1089/neu.2009.0993			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	548RF	WOS:000273983200013	19691421				2022-02-06	
J	Nyakale, NE; Clauss, RP; Nel, W; Sathekge, M				Nyakale, Nozipho E.; Clauss, Ralf P.; Nel, Wally; Sathekge, Mike			Clinical and brain SPECT scan response to zolpidem in patients after brain damage	ARZNEIMITTELFORSCHUNG-DRUG RESEARCH			English	Article						CAS 82626-48-0; Clinical rating scale; SPECT; Stroke; Traumatic brain injury; Zolpidem	TRANSIENT IMPROVEMENT; PERFUSION; AROUSAL; STATE; INJURY; BABOON	Previous reports document transient improvements after daily zolpidem (CAS 82626-48-0) in patients with brain damage. This multi-patient study evaluates the response to zolpidem in neurologically disabled patients, using (99m)TcHMPAO brain SPECT scans and clinical rating scales. Method: 23 of 41 consecutive adult patients, at least 6 months after brain damage were identified as neurologically disabled patients by scoring less than 100/100 on the Barthel Index. Causes of their brain damage included stroke (n = 12), traumatic brain injury (n = 7), anaphylaxis (n = 2), drugs overdose (n = 1) and birth injury (n = 1). The selected 23 patients had a baseline (99m)TcHMPAO brain SPECT scan before starting daily zolpidem therapy and a second within two weeks of therapy, performed 1 h after 10 mg oral zolpidem. Scans were designated as improved when at least two of three assessors detected improvement after zolpidem. The rest were designated non improved. After four months daily zolpidem therapy, patients were rated on the Tinetti Falls Efficacy Scale (TFES) before and after zolpidem. The TFES ratings were compared using a Wilcoxon non parametric signed rank test. Scan improvers were compared with non improvers, using a two sample t test with unequal variance. Results: Mean overall improvement after zolpidem on TFES was 11.3%, from 73.4/100 to 62.1/100 (p = 0.0001). 10/23 (43%) patients improved on SPECT scan after zolpidem. Their mean TFES improvement was 19.4% (+/- 16.75) compared with 5.08% (+/- 5.17) in 13/23 non improvers (p = 0.0081). Conclusion: This prospective study adds further evidence to previous reports of zolpidem efficacy in patients with established brain damage.	[Clauss, Ralf P.] Royal Surrey Cty Hosp, Dept Nucl Med, Guildford GU2 7XX, Surrey, England; [Nyakale, Nozipho E.; Sathekge, Mike] Univ Pretoria, Dept Nucl Med, ZA-0002 Pretoria, South Africa; [Nel, Wally] Pollock Pk Med Ctr, Springs, South Africa		Clauss, RP (corresponding author), Royal Surrey Cty Hosp, Dept Nucl Med, Guildford GU2 7XX, Surrey, England.	rclauss@royalsurrey.nhs.uk	Sathekge, Mike/AAJ-6466-2020	Sathekge, Mike/0000-0002-2806-0625			BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Clauss R, 2006, NEUROREHABILITATION, V21, P23; Clauss R, 2004, NEW ENGL J MED, V351, P511, DOI 10.1056/NEJM200407293510522; Clauss RP, 2000, S AFR MED J, V90, P68; Clauss RP, 2002, ARZNEIMITTELFORSCH, V52, P740; Clauss RP, 2001, ARZNEIMITTEL-FORSCH, V51, P619; CLAUSS RP, 2005, 9 EUR FED NEUR SOC C; Cohen L, 2004, NEW ENGL J MED, V350, P949, DOI 10.1056/NEJM200402263500922; Cohen SI, 2008, AM J PHYS MED REHAB, V87, P229, DOI 10.1097/PHM.0b013e318161971b; FRISTON KJ, 1965, HUM BRAIN MAPP, V2, P165; HALL SD, 2008, NATURE P; Harrison TS, 2005, CNS DRUGS, V19, P65; MAHONEY F I, 1965, Md State Med J, V14, P61; Sanger DJ, 1999, PHARMACOL BIOCHEM BE, V64, P269, DOI 10.1016/S0091-3057(99)00081-7; SANGER DJ, 1986, PSYCHOPHARMACOLOGY, V89, P317; Shadan FF, 2004, SOUTH MED J, V97, P791, DOI 10.1097/00007611-200408000-00025; Shames JL, 2008, ARCH PHYS MED REHAB, V89, P386, DOI 10.1016/j.apmr.2007.08.137; Slomka PJ, 2001, COMPUT MED IMAG GRAP, V25, P153, DOI 10.1016/S0895-6111(00)00044-6; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; Van Laere K, 2001, EUR J NUCL MED, V28, P90, DOI 10.1007/s002590000407; Van Laere KJ, 2002, J NUCL MED, V43, P458	22	20	21	0	3	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0004-4172	1616-7066		ARZNEIMITTELFORSCH	Arzneimittelforschung-Drug Res.		2010	60	4					177	181					5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Chemistry	591XU	WOS:000277339600003	20486466	Green Submitted			2022-02-06	
J	Schroeter, ML; Ettrich, B; Menz, M; Zysset, S				Schroeter, Matthias L.; Ettrich, Barbara; Menz, Mareike; Zysset, Stefan			Traumatic brain injury affects the frontomedian cortex-An event-related fMRI study on evaluative judgments	NEUROPSYCHOLOGIA			English	Article						Diffuse axonal injury; Evaluative judgment; fMRI; Social cognition; Theory of mind; Traumatic head injury	DIFFUSE AXONAL INJURY; MEDIAL PREFRONTAL CORTEX; HEAD-INJURY; NEUROPSYCHIATRIC INVENTORY; EMOTION RECOGNITION; EMPIRICAL ANALYSES; NULL-HYPOTHESIS; FOCAL LESIONS; ACTIVATION; DEFICITS	Traumatic brain injuries represent the leading cause of death and disability in young adults in industrialized countries. Recently, it has been suggested that dysfunctions of the frontomedian cortex, which enables social cognition, are responsible for clinical deficits in the long-term. To validate this hypothesis, we examined brain activation in seven young adults suffering from diffuse axonal injury during a cognitive task that specifically depends on frontomedian structures, namely evaluative judgments, contrasted with semantic memory retrieval. Brain activation in patients was compared with healthy age and gender matched control subjects using event-related functional magnetic resonance imaging. Evaluative judgments were related to a neural network discussed in the context of self-referential processing and theory of mind. More precisely, the neural network consisted of frontomedian regions, the temporal pole, and the posterior superior temporal gyrus and sulcus/angular gyrus. Patients showed higher activations in this network and the inferior frontal gyrus, whereas healthy control subjects activated more dopaminergic structures, namely the ventral tegmental area, during evaluative judgments. One possible interpretation of the data is that deficits in the ventral tegmental area, and consequently the mesocorticolimbic projection system, have to be compensated for by higher brain activations in the frontomedian and anterior cingulate cortex in patients with diffuse axonal injury. In conclusion, our study supports the hypothesis that traumatic brain injury is characterized by frontomedian dysfunctions, which may be responsible for clinical deficits in the long-term and which might be modified by rehabilitative strategies in the future. (C) 2009 Elsevier Ltd. All rights reserved.	[Schroeter, Matthias L.; Ettrich, Barbara; Menz, Mareike; Zysset, Stefan] Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; [Schroeter, Matthias L.] Univ Leipzig, Day Clin Cognit Neurol, D-04103 Leipzig, Germany; [Menz, Mareike] UKE Hamburg, D-20246 Hamburg, Germany; [Menz, Mareike] Univ Hosp Schleswig Holstein, Dept Neurol, D-23538 Lubeck, Germany		Schroeter, ML (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Stephanstr 1A, D-04103 Leipzig, Germany.	schroet@cbs.mpg.de					Abu-Akel A, 2003, MED HYPOTHESES, V60, P382, DOI 10.1016/S0306-9877(02)00406-1; Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; Al-Adawi S, 2000, MED HYPOTHESES, V54, P523, DOI 10.1054/mehy.1999.0890; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bachevalier J, 1997, EXP BRAIN RES, V115, P430, DOI 10.1007/PL00005713; Bara BG, 2001, BRAIN LANG, V77, P72, DOI 10.1006/brln.2000.2430; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; BARNES CL, 1992, J COMP NEUROL, V318, P222, DOI 10.1002/cne.903180207; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Brass M, 2005, NEUROPSYCHOLOGIA, V43, P89, DOI 10.1016/j.neuropsychologia.2004.06.018; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Burgess P, 1996, BEHAV ASSESSMENT DYS; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Cicerone K, 2006, J COGNITIVE NEUROSCI, V18, P1212, DOI 10.1162/jocn.2006.18.7.1212; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; DANNEMILLER E, 1231, EUROPEAN J NUCL MED, V27, P1410; Delis DC, 1987, CALIFORNIA VERBAL LE; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gouick J, 2004, TRAUMA, V6, P285, DOI DOI 10.1191/1460408604TA3230A; HAERTING C, 2000, WMS R DTSCH ADAPTATI; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; LUCAS JA, 1999, CLIN NEUROPSYCHOLOGY, P243; Marit RS, 2005, J HEAD TRAUMA REHAB, V20, P377, DOI 10.1097/00001199-200507000-00009; Maruishi M, 2007, J NEUROL NEUROSUR PS, V78, P168, DOI 10.1136/jnnp.2006.097345; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; Metting Z, 2007, LANCET NEUROL, V6, P699, DOI 10.1016/S1474-4422(07)70191-6; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Milders M, 2006, NEUROPSYCHOLOGY, V20, P400, DOI 10.1037/0894-4105.20.4.400; MORAN MA, 1987, J COMP NEUROL, V256, P88, DOI 10.1002/cne.902560108; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.080523; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Norris DG, 2000, JMRI-J MAGN RESON IM, V11, P445, DOI 10.1002/(SICI)1522-2586(200004)11:4<445::AID-JMRI13>3.0.CO;2-T; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ochsner KN, 2004, J COGNITIVE NEUROSCI, V16, P1746, DOI 10.1162/0898929042947829; Okamoto T, 2007, EUR J NEUROL, V14, P540, DOI 10.1111/j.1468-1331.2007.01742.x; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Salmond CH, 2005, J NEUROTRAUM, V22, P613, DOI 10.1089/neu.2005.22.613; Salmond CH, 2005, CURR OPIN CRIT CARE, V11, P111, DOI 10.1097/01.ccx.0000155358.31983.37; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Schroeter ML, 2008, NEUROBIOL AGING, V29, P418, DOI 10.1016/j.neurobiolaging.2006.10.023; Schroeter ML, 2007, NEUROPSYCHOLOGIA, V45, P3149, DOI 10.1016/j.neuropsychologia.2007.07.004; Schroeter ML, 2007, NEUROIMAGE, V36, P497, DOI 10.1016/j.neuroimage.2007.03.024; Schroeter ML, 2007, NEUROIMAGE, V34, P26, DOI 10.1016/j.neuroimage.2006.09.001; Schroeter ML, 2004, NEUROIMAGE, V22, P341, DOI 10.1016/j.neuroimage.2003.12.041; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; Schroeter ML, 2005, J CEREBR BLOOD F MET, V25, P1675, DOI 10.1038/sj.jcbfm.9600159; Schroeter ML, 2002, HUM BRAIN MAPP, V17, P61, DOI 10.1002/hbm.10052; Stamatakis EA, 2002, J NUCL MED, V43, P476; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Talairach J., 1988, COPLANAR STEREOTAXIC; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; Vogeley K, 1999, CONSCIOUS COGN, V8, P343, DOI 10.1006/ccog.1999.0394; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wilson JTL, 2005, ACTA NEUROCHIR SUPPL, V93, P75; WOLFRAM H, 1986, PSYCHOL LEISTUNGSTES; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yan HQ, 2002, NEUROREPORT, V13, P1899, DOI 10.1097/00001756-200210280-00013; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zimmermann P., 1993, TESTBATTERIE AUFMERK; Zysset S, 2003, NEUROSCI LETT, V335, P183, DOI 10.1016/S0304-3940(02)01196-5; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	87	20	21	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	JAN	2010	48	1					185	193		10.1016/j.neuropsychologia.2009.09.004			9	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	550NU	WOS:000274135500021	19747929				2022-02-06	
J	Schwartz, ES; Edgar, JC; Gaetz, WC; Roberts, TPL				Schwartz, Erin Simon; Edgar, J. Christopher; Gaetz, William C.; Roberts, Timothy P. L.			Magnetoencephalography	PEDIATRIC RADIOLOGY			English	Article						Magnetoencephalography; Epilepsy; Functional imaging; Children	HUMAN SOMATOSENSORY CORTEX; EPILEPSY SURGERY; MEG; PERFORMANCE; STIMULATION; RECORDINGS; CEREBELLUM; ACTIVATION; SIGNALS; FIELDS	Although magnetoencephalography (MEG) may not be familiar to many pediatric radiologists, it is an increasingly available neuroimaging technique both for evaluating normal and abnormal intracranial neural activity and for functional mapping. By providing spatial, temporal, and time-frequency spectral information, MEG affords patients with epilepsy, intracranial neoplasia, and vascular malformations an opportunity for a sensitive and accurate non-invasive preoperative evaluation. This technique can optimize selection of surgical candidates as well as increase confidence in preoperative counseling and prognosis. Research applications that appear promising for near-future clinical translation include the evaluation of children with autism spectrum disorder, traumatic brain injury, and schizophrenia.	[Schwartz, Erin Simon] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA; [Schwartz, Erin Simon; Edgar, J. Christopher; Gaetz, William C.; Roberts, Timothy P. L.] Childrens Hosp Philadelphia, Lurie Family Fdn MEG Imaging Ctr, Dept Radiol, Philadelphia, PA 19104 USA		Schwartz, ES (corresponding author), Childrens Hosp Philadelphia, Dept Radiol, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	simon@email.chop.edu		Roberts, Timothy/0000-0001-7320-4870	Pennsylvania Department of Health	This work has been funded, in part, by a grant from the Pennsylvania Department of Health. The Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions. Dr. Roberts gratefully acknowledges the Oberkircher Family for the Oberkircher Family Chair in Pediatric Radiology at the Children's Hospital of Philadelphia.	Alberstone CD, 2000, J NEUROSURG, V92, P79, DOI 10.3171/jns.2000.92.1.0079; ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Cheyne D, 2006, HUM BRAIN MAPP, V27, P213, DOI 10.1002/hbm.20178; Cheyne D, 2007, CLIN NEUROPHYSIOL, V118, P1691, DOI 10.1016/j.clinph.2007.05.064; Cornwell BR, 2008, J NEUROSCI, V28, P5983, DOI 10.1523/JNEUROSCI.5001-07.2008; DEECKE L, 1978, ELECTROENCEPHALOGR S, V34, P225; ENGEL J, 1988, ACTA NEUROL SCAND, V78, P84, DOI 10.1111/j.1600-0404.1988.tb08008.x; Gaetz W, 2008, CLIN NEUROPHYSIOL, V119, P1923, DOI 10.1016/j.clinph.2008.04.291; Gaetz W, 2009, NEUROSURGERY, V64, pS177, DOI 10.1227/01.NEU.0000316433.10913.32; Garolera M, 2007, NEUROREPORT, V18, P1449, DOI 10.1097/WNR.0b013e3282efa253; HARI R, 1985, PROG NEUROBIOL, V24, P233, DOI 10.1016/0301-0082(85)90007-3; Ioannides AA, 2005, PROG BRAIN RES, V148, P139, DOI 10.1016/S0079-6123(04)48012-1; Knowlton RC, 2006, ANN NEUROL, V59, P835, DOI 10.1002/ana.20857; Knowlton Robert C, 2008, Epilepsy Curr, V8, P1, DOI 10.1111/j.1535-7511.2007.00215.x; Knowlton Robert C, 2003, Curr Neurol Neurosci Rep, V3, P341, DOI 10.1007/s11910-003-0012-2; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Lee D, 2006, EPILEPSY BEHAV, V8, P742, DOI 10.1016/j.yebeh.2006.02.012; LEMON RN, 1979, BRAIN RES, V161, P150, DOI 10.1016/0006-8993(79)90202-6; Lewine J D, 1995, Neuroimaging Clin N Am, V5, P575; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Mamelak AN, 2002, J NEUROSURG, V97, P865, DOI 10.3171/jns.2002.97.4.0865; Martin T, 2006, HUM BRAIN MAPP, V27, P552, DOI 10.1002/hbm.20200; Merrifield WS, 2007, EPILEPSY BEHAV, V10, P120, DOI 10.1016/j.yebeh.2006.10.012; Moses SN, 2009, NEUROIMAGE, V46, P863, DOI 10.1016/j.neuroimage.2009.02.042; Nakasato N, 2000, J CLIN NEUROPHYSIOL, V17, P201, DOI 10.1097/00004691-200003000-00009; Okada Y, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2168672; Okada Y, 1999, CLIN NEUROPHYSIOL, V110, P214, DOI 10.1016/S0013-4694(98)00111-4; Okada YC, 1999, CLIN NEUROPHYSIOL, V110, P230, DOI 10.1016/S0013-4694(98)00099-6; Okada YC, 1997, ELECTROEN CLIN NEURO, V103, P474, DOI 10.1016/S0013-4694(97)00043-6; OKADA YC, 1984, EXP BRAIN RES, V56, P197; Papanicolaou AC, 2004, J NEUROSURG, V100, P867, DOI 10.3171/jns.2004.100.5.0867; Papanicolaou AC, 1999, J NEUROSURG, V90, P85, DOI 10.3171/jns.1999.90.1.0085; Roberson KD, 2000, J APPL ANIM RES, V17, P57, DOI 10.1080/09712119.2000.9706291; Roberts T P, 1995, J Image Guid Surg, V1, P339, DOI 10.1002/(SICI)1522-712X(1995)1:6<339::AID-IGS5>3.3.CO;2-4; ROBINSON SE, 1999, BIOMAG 2000, P302; ROBINSON SE, 2004, NEUROL CLIN NEUROPHY, V74; ROMANI G L, 1988, Brain Topography, V1, P5, DOI 10.1007/BF01129335; Rowley H A, 1995, Neuroimaging Clin N Am, V5, P695; Scherg M, 1996, Electroencephalogr Clin Neurophysiol Suppl, V46, P127; Schiffbauer H, 2002, J NEUROSURG, V97, P1333, DOI 10.3171/jns.2002.97.6.1333; Schiffbauer Hagen, 2003, Neurosurg Focus, V15, pE7; Schwartz ES, 2008, AM J NEURORADIOL, V29, P832, DOI 10.3174/ajnr.A1029; SOBEL DF, 1993, AM J NEURORADIOL, V14, P915; Wada J, 2007, J NEUROSURG, V106, P1117, DOI 10.3171/jns.2007.106.6.1117; Williamson J. S, 1990, ADV AUDIOL, P1, DOI DOI 10.1016/J.IDAIRYJ.2009.07.008; WOOD CC, 1985, SCIENCE, V227, P1051, DOI 10.1126/science.3975600	46	20	20	1	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0301-0449	1432-1998		PEDIATR RADIOL	Pediatr. Radiol.	JAN	2010	40	1					50	58		10.1007/s00247-009-1451-y			9	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Radiology, Nuclear Medicine & Medical Imaging	527RD	WOS:000272383300004	19937237				2022-02-06	
J	Cullen, NK; Crescini, C; Bayley, MT				Cullen, Nora K.; Crescini, Charmagne; Bayley, Mark T.			Rehabilitation Outcomes After Anoxic Brain Injury: A Case-Controlled Comparison With Traumatic Brain Injury	PM&R			English	Article								Objective: To investigate the functional outcomes of patients with anoxic brain injury (AnBI) compared with control patients with traumatic brain injury (TBI) during inpatient rehabilitation. Design: Matched case-controlled design. Setting: Inpatient neurorehabilitation program. Participants: Fifteen patients with AnBI and 15 patients with TBI. Methods: Data of 15 patients with a primary diagnosis of AnBI were retrospectively reviewed and matched to 15 patients with TBI admitted within the same time frame on age, acute care length of stay, and functional status at admission. Main Outcome Measure: Functional outcome was assessed by the use of the Functional Independence Measure (FIM). Results: Compared with the control patients with TBI, patients with AnBI achieved significantly tower FIM motor gain (16.3 +/- 15.6 versus 5.7 +/- 10.7, respectively) and efficiency scores (0.27 +/- 0.28 versus 0.06 +/- 0.13), discharge FIM cognition scores (25.9 +/- 5.9 versus 21.7 +/- 7.3), total FIM gain (22.5 +/- 19.6 versus 9.1 +/- 12.1), and total FIM efficiency scores (0.39 +/- 0.38 versus 0.10 +/- 0.16; all P < .05). Conclusions: Results suggest a slower rate of recovery for patients with AnBI compared with TBI, with physical recovery being slower than cognitive recovery as measured by the FM during inpatient rehabilitation when matched according to preinjury characteristics and functional status at rehabilitation admission. Future studies on larger samples of patients with AnBI and TBI that use a case-controlled design and longer-term outcome measurement are warranted to further clarify the differences in functional outcomes between these groups and to assess whether optimal rehabilitation interventions dale: for these groups.	[Cullen, Nora K.; Crescini, Charmagne; Bayley, Mark T.] Toronto Rehabil Inst, Neuro Rehabil Program, Toronto, ON M5G 2A2, Canada; [Cullen, Nora K.; Bayley, Mark T.] Univ Toronto, Div Physiatry, Toronto, ON M5G 2A2, Canada		Cullen, NK (corresponding author), Toronto Rehabil Inst, Neuro Rehabil Program, 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	cullen.nora@torontorehab.on.co		Bayley, Mark/0000-0001-7860-9463; Cullen, Nora/0000-0001-6359-9418	Physicians' Services Foundation Inc.; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR; Province of Ontario	This research was supported by the Physicians' Services Foundation Inc. Equipment and space were funded with grants from the Canada Foundation for Innovation and the Province of Ontario. The views expressed here do not necessarily reflect those of the Ontario Ministry of Health and Long-Term Care.	Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Bachman D., 1997, NEUROLOGIC REHABILIT, P145; Bigler E D, 1988, Arch Clin Neuropsychol, V3, P383, DOI 10.1016/0887-6177(88)90052-2; BURKE DC, 1995, BRAIN INJURY, V9, P735, DOI 10.3109/02699059509008229; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; Cifu DX, 2003, ARCH PHYS MED REHAB, V84, P1441, DOI 10.1016/S0003-9993(03)00272-7; Cullen N, 2007, BRAIN INJURY, V21, P113, DOI 10.1080/02699050701201540; Cullen N, 2007, J HEAD TRAUMA REHAB, V22, P214, DOI 10.1097/01.HTR.0000281836.54602.6d; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Fertl E, 2000, RESUSCITATION, V47, P231, DOI 10.1016/S0300-9572(00)00239-2; Fiedler RC, 1996, AM J PHYS MED REHAB, V75, P125, DOI 10.1097/00002060-199603000-00010; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Green REA, 2006, BRAIN COGNITION, V60, P199; GROSWASSER Z, 1989, ARCH PHYS MED REHAB, V70, P186; Gualtieri CT, 2002, BRAIN INJURY MENTAL; Hal KM, 1997, J REHABILITATION OUT, V1, P63; Hofgren C, 2008, BRAIN INJURY, V22, P972, DOI 10.1080/02699050802491289; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; National Data and Statistical Center, TRAUM BRAIN INJ MOD; PARKIN AJ, 1987, CORTEX, V23, P655, DOI 10.1016/S0010-9452(87)80055-2; Ravaud JF, 1999, SCAND J REHABIL MED, V31, P31; ROINE RO, 1993, JAMA-J AM MED ASSOC, V269, P237, DOI 10.1001/jama.269.2.237; Schmidt JG, 1997, J NEUROL REHABIL, V11, P189; Shah MK, 2004, BRAIN INJURY, V18, P111, DOI 10.1080/0269905031000149551; Shah MK, 2007, J NEUROL SCI, V260, P95, DOI 10.1016/j.jns.2007.04.012; Stewart DG, 1998, NEUROREHABILITATION, V10, P13, DOI 10.3233/NRE-1998-10103; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; UDS Data Management Service, 1995, GUID UN DAT SYST MED; Wade D T, 1988, Int Disabil Stud, V10, P64; Walker WC, 1996, BRAIN INJURY, V10, P65; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27; [No title captured]	33	20	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482			PM&R	PM&R	DEC	2009	1	12					1069	1076		10.1016/j.pmrj.2009.09.013			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	V24LP	WOS:000208412200004	19926548				2022-02-06	
J	Folkersma, H; Boellaard, R; Vandertop, WP; Kloet, RW; Lubberink, M; Lammertsma, AA; van Berckel, BNM				Folkersma, Hedy; Boellaard, Ronald; Vandertop, W. Peter; Kloet, Reina W.; Lubberink, Mark; Lammertsma, Adriaan A.; van Berckel, Bart N. M.			Reference Tissue Models and Blood-Brain Barrier Disruption: Lessons from (R)-[C-11]PK11195 in Traumatic Brain Injury	JOURNAL OF NUCLEAR MEDICINE			English	Article						blood-brain barrier; craniocerebral trauma; (R)-[C-11]PK11195; humans; positron emission tomography	POSITRON-EMISSION-TOMOGRAPHY; ACTIVATED MICROGLIA; MULTIPLE-SCLEROSIS; IN-VIVO; IMAGE REGISTRATION; PET	(R)-[C-11]PK11195 is a tracer for activated microglia. The purpose of this study was to assess the validity of the simplified reference tissue model for analyzing (R)-[C-11]PK11195 studies in traumatic brain injury (TBI), where blood-brain barrier disruptions are likely. Methods: Dynamic (R)-[C-11]PK11195 scans were acquired at 3 time points after TBI. Plasma input-derived binding potential (BPNDPI), volume of distribution (V-T) and K-1/k(2), and simplified reference tissue model-derived binding potential (BPNDSRTM) were obtained. Simulations were performed to assess the effect of varying K-1/k(2). Results: Early after TBI, an increase in V-T, but not in BPNDPI, was found. Early K-1/k(2) correlated with V-T and BPNDSRTM but not with BPNDPI. One and 6 mo after TBI, BPNDSRTM correlated with BPNDPI. Conclusion: Early after TBI, (R)-[C-11]PK11195 studies should be analyzed using plasma input models.	[Folkersma, Hedy; Vandertop, W. Peter] Vrije Univ Amsterdam, Neurosurg Ctr Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Boellaard, Ronald; Kloet, Reina W.; Lubberink, Mark; Lammertsma, Adriaan A.; van Berckel, Bart N. M.] Vrije Univ Amsterdam, Dept Nucl Med & PET Res, Med Ctr, NL-1081 HV Amsterdam, Netherlands		Folkersma, H (corresponding author), Vrije Univ Amsterdam, Neurosurg Ctr Amsterdam, Med Ctr, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	hedy.folkersma@vumc.nl	Vandertop, William P./K-9288-2018	Vandertop, William/0000-0001-5417-0265; Boellaard, Ronald/0000-0002-0313-5686; Lammertsma, Adriaan/0000-0003-1237-2891	Dutch Brain Foundation [9F01.21]; Netherlands Organisation for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [016.066.09]	We thank the patients, their families, and the control subjects for volunteering for this study, and the personnel of the BV Cyclotron VU and staff of the Department of Nuclear Medicine and PET Research, VU University Medical Center, Amsterdam, for production of (R)-[<SUP>11</SUP>C]PK11195 and technical assistance. This work was made possible by research grant 9F01.21 from the Dutch Brain Foundation and NWO VIDI grant 016.066.09 from the Netherlands Organisation for Scientific Research.	Banati RB, 1999, NEUROLOGY, V53, P2199, DOI 10.1212/WNL.53.9.2199; Banati RB, 2000, BRAIN, V123, P2321, DOI 10.1093/brain/123.11.2321; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Debruyne JC, 2003, EUR J NEUROL, V10, P257, DOI 10.1046/j.1468-1331.2003.00571.x; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Gerhard A, 2003, NEUROLOGY, V61, P686, DOI 10.1212/01.WNL.0000078192.95645.E6; Greuter HNJM, 2005, NUCL MED BIOL, V32, P307, DOI 10.1016/j.nucmedbio.2004.12.005; GROOM GN, 1995, J NUCL MED, V36, P2207; Kropholler MA, 2005, J CEREBR BLOOD F MET, V25, P842, DOI 10.1038/sj.jcbfm.9600092; Kropholler MA, 2006, J CEREBR BLOOD F MET, V26, P1431, DOI 10.1038/sj.jcbfm.9600289; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Price CJS, 2006, STROKE, V37, P1749, DOI 10.1161/01.STR.0000226980.95389.0b; Versijpt J, 2005, MULT SCLER J, V11, P127, DOI 10.1191/1352458505ms1140oa; West J, 1997, J COMPUT ASSIST TOMO, V21, P554, DOI 10.1097/00004728-199707000-00007	16	20	20	0	4	SOC NUCLEAR MEDICINE INC	RESTON	1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA	0161-5505	1535-5667		J NUCL MED	J. Nucl. Med.	DEC	2009	50	12					1975	1979		10.2967/jnumed.109.067512			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	529YM	WOS:000272555300014	19910429	Bronze			2022-02-06	
J	Ochalski, PG; Spiro, RM; Fabio, A; Kassam, AB; Okonkwo, DO				Ochalski, Pawel G.; Spiro, Richard M.; Fabio, Anthony; Kassam, Amin B.; Okonkwo, David O.			FRACTURES OF THE CLIVUS: A CONTEMPORARY SERIES IN THE COMPUTED TOMOGRAPHY ERA	NEUROSURGERY			English	Article						Clivus; Cranial base; Traumatic brain injury	BASILAR ARTERY; LONGITUDINAL FRACTURE; NASOSEPTAL FLAP; SKULL BASE; OCCLUSION; INCARCERATION; INJURY; TRAUMA; CT	OBJECTIVE: We report the morbidity and mortality associated with fractures of the clivus and discuss management approaches specific to this unique diagnostic entity. METHODS: We performed a boolean search of our electronic medical record database to identify patients with fractures of the clivus that were diagnosed using computed tomography of the head. A retrospective imaging and chart analysis was completed to further characterize the fractures and to analyze outcomes. RESULTS: Between January 1999 and December 2007, 41 patients were identified with fractures of the clivus. We found a 0.21% overall incidence among all head-injured patients presenting to our institution and a 2.3% incidence among those patients with a cranial fracture. Ten of 41 patients (24.4%) died, and neurological and vascular complications associated with central cranial base fractures were observed in 19 of 41 patients (46%). Furthermore, associated cranial fractures remote from the central cranial base and associated intracranial hemorrhages were observed in 40 of 41 (97.6%) and 33 of 41 (80.5%) patients, respectively. In terms of outcomes, 26 of 41 patients (63.5%) had a Glasgow Coma Scale score of 12 or greater at the time of discharge from the hospital. CONCLUSION: We demonstrate a lower than previously reported mortality rate in patients with clival fractures. Nevertheless, as a result of location, fractures of the clivus were frequently associated with a high rate of complications and neurological sequelae.	[Ochalski, Pawel G.; Spiro, Richard M.; Fabio, Anthony; Kassam, Amin B.; Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15213 USA		Okonkwo, DO (corresponding author), Univ Pittsburgh, Dept Neurosurg, Med Ctr, 200 Lothrop St,Suite B-400, Pittsburgh, PA 15213 USA.	Okonkwodo@upmc.edu		Fabio, Anthony/0000-0002-6808-4939	NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49CE323155] Funding Source: NIH RePORTER; NCIPC CDC HHS [R49 CE323155] Funding Source: Medline		ANTHONY DC, 1987, J NEUROSURG, V66, P929, DOI 10.3171/jns.1987.66.6.0929; Bala A, 2004, J CLIN NEUROSCI, V11, P660, DOI 10.1016/j.jocn.2003.11.008; Bonilha L, 2002, ARQ NEURO-PSIQUIAT, V60, P636, DOI 10.1590/S0004-282X2002000400023; Carter DA, 1998, J TRAUMA, V44, P230, DOI 10.1097/00005373-199801000-00039; Cho J, 2008, J KOREAN MED SCI, V23, P747, DOI 10.3346/jkms.2008.23.4.747; CORRADINO G, 1990, NEUROSURGERY, V27, P592, DOI 10.1227/00006123-199010000-00015; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; GUHA A, 1989, CAN J NEUROL SCI, V16, P81, DOI 10.1017/S0317167100028560; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; JOSLYN JN, 1988, RADIOLOGY, V166, P817, DOI 10.1148/radiology.166.3.3340778; KAPILA A, 1985, J COMPUT ASSIST TOMO, V9, P1142, DOI 10.1097/00004728-198511000-00033; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Katsuno M, 2007, NEUROL MED-CHIR, V47, P307, DOI 10.2176/nmc.47.307; Khan N, 2000, SURG NEUROL, V54, P171, DOI 10.1016/S0090-3019(00)00284-6; LINDENBERG R, 1966, J NEUROSURG, V24, P908, DOI 10.3171/jns.1966.24.5.0908; LOOP JW, 1964, RADIOLOGY, V83, P36, DOI 10.1148/83.1.36; MEGURO K, 1985, NEUROSURGERY, V16, P666, DOI 10.1227/00006123-198505000-00015; Menku A, 2004, NEUROSURG REV, V27, P194, DOI 10.1007/s10143-004-0320-2; Mizushima H, 1998, J NEUROSURG, V88, P590, DOI 10.3171/jns.1998.88.3.0590; RUSSELL WR, 1949, J NEUROL NEUROSUR PS, V12, P52, DOI 10.1136/jnnp.12.1.52; SANDERS BB, 1973, J NEUROSURG, V39, P610, DOI 10.3171/jns.1973.39.5.0610; Sato S, 2001, NEUROL MED-CHIR, V41, P541, DOI 10.2176/nmc.41.541; SHAW CM, 1972, J NEUROL NEUROSUR PS, V35, P247, DOI 10.1136/jnnp.35.2.247; SIGHTS WP, 1968, J NEUROSURG, V28, P588, DOI 10.3171/jns.1968.28.6.0588; Taguchi Y, 2000, J TRAUMA, V48, P1148, DOI 10.1097/00005373-200006000-00023	26	20	20	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2009	65	6					1063	1069		10.1227/01.NEU.0000360154.18604.28			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	522SQ	WOS:000272019400021	19934965				2022-02-06	
J	Zhang, HT; Luo, J; Sui, LS; Ma, X; Yan, ZJ; Lin, JH; Wang, YS; Chen, YZ; Jiang, XD; Xu, RX				Zhang, Hong-Tian; Luo, Jie; Sui, Li-Sen; Ma, Xu; Yan, Zhong-Jie; Lin, Jian-Hao; Wang, Yu-Sheng; Chen, Yi-Zhao; Jiang, Xiao-Dan; Xu, Ru-Xiang			Effects of Differentiated Versus Undifferentiated Adipose Tissue-derived Stromal Cell Grafts on Functional Recovery After Spinal Cord Contusion	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Adipose tissue-derived stromal cells; Spinal cord injury; Neural differentiation; Neurogenesis; Functional recovery	TRAUMATIC BRAIN-INJURY; BONE-MARROW; STEM-CELLS; ADULT-RAT; TRANSPLANTATION; NEURONS; GROWTH; REPAIR; TRANSDIFFERENTIATION; ARTIFACT	Controversies exist concerning the need for mesenchymal stromal cells (MSCs) to be transdifferentiated prior to their transplantation. In the present study, we compared the results of grafting into the rat contused spinal cord undifferentiated, adipose tissue-derived stromal cells (uADSCs) versus ADSCs induced by two different protocols to form differentiated nervous tissue. Using Basso, Beattie, and Bresnahan scores and grid tests, we found that three cell-treated groups, including uADSCs-treated, dADSCs induced by Protocol 1 (dADSC-P1)-treated, and dADSCs induced by Protocol 2 (dADSC-P2)-treated groups, significantly improved locomotor functional recovery in SCI rats, compared with the saline-treated group. Furthermore, functional recovery was better in the uADSC-treated and dADSC-P2-treated groups than in the dADSC-P1-treated group at week 12 postinjury (P < 0.05 for dADSC-P1 group vs. uADSCs or dADSC-P2 groups). Although both protocols could induce high percentages of cells expressing neural markers in vitro, few BrdU-labeled cells survived at the injury sites in the three cell-treated groups, and only a small percentage of BrdU-positive cells expressed neural markers. On the other hand, the number of NF200-positive axons in the uADSC-treated and dADSC-P2-treated groups was significantly larger than those in the dADSC-P1-treated and saline-treated control groups. Our results indicate that ADSCs are able to differentiate into neural-like cells in vitro and in vivo. However, neural differentiated ADSCs did not result in better functional recovery than undifferentiated ones, following SCI. In vitro neural transdifferentiation of ADSCs might therefore not be a necessary pretransplantation step. Furthermore, cellular replacement or integration might not contribute to the functional recovery of the injured spinal cord.	[Zhang, Hong-Tian; Luo, Jie; Ma, Xu; Yan, Zhong-Jie; Lin, Jian-Hao; Wang, Yu-Sheng; Chen, Yi-Zhao; Jiang, Xiao-Dan; Xu, Ru-Xiang] So Med Univ, Inst Neurosurg, Key Lab Brain Funct Repair & Regenerat Guangdong, Guangzhou 510282, Guangdong, Peoples R China; [Zhang, Hong-Tian; Luo, Jie; Ma, Xu; Yan, Zhong-Jie; Lin, Jian-Hao; Wang, Yu-Sheng; Chen, Yi-Zhao; Jiang, Xiao-Dan; Xu, Ru-Xiang] So Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou 510282, Guangdong, Peoples R China; [Xu, Ru-Xiang] Mil Gen Hosp Beijing PLA, Dept Neurosurg, Beijing 100700, Peoples R China; [Sui, Li-Sen] Guangdong Hosp Tradit Chinese Med, Dept Neurosurg, Guangzhou 510120, Guangdong, Peoples R China		Jiang, XD (corresponding author), So Med Univ, Inst Neurosurg, Key Lab Brain Funct Repair & Regenerat Guangdong, Guangzhou 510282, Guangdong, Peoples R China.	jiangxiao_dan@163.com; zhanghongtian007@126.com			Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [U0632008, 30772232, 30801184, 30500526]; Funds for Key Sci-Tech Research Projects of Guangdong Province [2006Z3-E522, 05/06-7005206, 05/067005213, 258-2008A030201019]; Funds for Key Sci-Tech Research Projects of Guangzhou [3-2008A1-E4011-6]	We thank Associate Professor Rang-ke Wu, Associate Director of the School of Foreign Studies, Southern Medical University, for his diligent revision and proofreading of this article. This research was supported by the Natural Science Foundation of China (NSFC; U0632008, 30772232, 30801184, 30500526), Funds for Key Sci-Tech Research Projects of Guangdong Province [2006Z3-E522, YUE KEJIBAN (2007) 05/06-7005206, 05/067005213, YUECAIJIAO (2008) 258-2008A030201019], and Funds for Key Sci-Tech Research Projects of Guangzhou [YUEKETIAOZI (2008) 3-2008A1-E4011-6].	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Croft AP, 2006, STEM CELLS, V24, P1841, DOI 10.1634/stemcells.2005-0609; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann A, 2006, J NEUROSCI RES, V83, P1502, DOI 10.1002/jnr.20840; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; Kamada T, 2005, J NEUROPATH EXP NEUR, V64, P37, DOI 10.1093/jnen/64.1.37; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Vaquero J, 2006, NEUROSCI LETT, V398, P129, DOI 10.1016/j.neulet.2005.12.072; Vaquero J, 2009, HISTOL HISTOPATHOL, V24, P107, DOI 10.14670/HH-24.107; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yano S, 2005, J NEUROTRAUM, V22, P907, DOI 10.1089/neu.2005.22.907; Ye M, 2007, PARKINSONISM RELAT D, V13, P44, DOI 10.1016/j.parkreldis.2006.07.013; Yoshihara H, 2006, BRAIN RES, V1119, P65, DOI 10.1016/j.brainres.2006.08.080; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zhu RS, 2007, J NEUROSCI RES, V85, P3064, DOI 10.1002/jnr.21426; Zurita M, 2008, NEUROSCI RES, V60, P275, DOI 10.1016/j.neures.2007.11.006	23	20	21	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	DEC	2009	29	8					1283	1292		10.1007/s10571-009-9424-0			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	532WM	WOS:000272781000023	19533335				2022-02-06	
J	Ishibe, N; Pordarczyk, RC; Fulco, C				Ishibe, Naoko; Pordarczyk, Renee C.; Fulco, Carolyn			Overview of the Institute of Medicine's Committee Search Strategy and Review Process for Gulf War and Health: Long-term Consequences of Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						craniocerebral trauma; outcomes; traumatic brain injury		Objectives: To exam I ne the strength of the peer-reviewed literature on the evidence for an association between traumatic brain injury (TBI) and long-term health outcomes using the association categories established and used by previous Institute of Medicine Committees on Gulf War and Health. The health effects that were evaluated were neurologic, cognitive, social functioning, psychiatric, and other (eg, brain tumor, mortality) outcomes. Participants: Not applicable. Design: A comprehensive search using Medline and PsycINFO databases and a critical review of the peer-reviewed literature on human TBI published between 1960 and 2008. Primary Measures: Not applicable. Results: A total of 14 302 citations were identified, of which 1933 were reviewed for further scientific merit; of these, 152 studies met the inclusion/exclusion criteria that form the basis for the findings and recommendations contained, in this topical issue. Conclusion: Based on this review, the committee concluded that there was sufficient evidence of a causal relationship for 3 health outcomes with TBI, sufficient evidence of an association for 13 outcomes, limited/suggestive evidence of an association for 10 outcomes, and inadequate/insufficient evidence to determine whether an association exists for 10 outcomes.	[Ishibe, Naoko] Natl Acad, Inst Med, Board Hlth Select Populat, Washington, DC 20001 USA		Ishibe, N (corresponding author), Natl Acad, Inst Med, Board Hlth Select Populat, 500 5th St NW, Washington, DC 20001 USA.	nishibe@nas.edu			US Department of Veterans AffairsUS Department of Veterans Affairs; National Academies	This study was supported by a contract from the US Department of Veterans Affairs to the Institute of Medicine, the National Academies. We thank Dr George Rutberford for his technical assistance. We also thank Ms Deepali Patel for her assistance with the original literature searches and organizational expertise.	Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; HILL AB, 1965, P ROY SOC MED, V49, P175; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; SUNDERLAND A, 1984, J CLIN NEUROPSYCHOL, V6, P127, DOI 10.1080/01688638408401204; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; 2009, GULF WAR HLTH, V7; 2000, GULF WAR HLTH, V1	8	20	21	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2009	24	6					424	429		10.1097/HTR.0b013e3181c13426			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	528VW	WOS:000272476100002	19940675				2022-02-06	
J	Sookplung, P; Vavilala, MS				Sookplung, Pimwan; Vavilala, Monica S.			What is new in pediatric traumatic brain injury?	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						biomarkers; head injury; hyperglycemia; hypothermia; outcomes; pediatric	INTENSIVE-CARE-UNIT; NERVE GROWTH-FACTOR; CEREBRAL AUTOREGULATION; CLINICAL-TRIAL; THERAPEUTIC HYPOTHERMIA; AIRWAY MANAGEMENT; INSULIN THERAPY; CHILDREN; DEXMEDETOMIDINE; HYPERGLYCEMIA	Purpose of review Pediatric traumatic brain injury (TBI) is associated with significant morbidity and mortality. The purpose of this review is to discuss emerging concepts and to provide an update on the clinical evaluation, management, and predictors of outcome after pediatric TBI. Recent findings We review the epidemiology, patterns of injury, and pathophysiology of pediatric TBI and focus on selective 'hot topics' such as biomarkers, glucose control, and the potential benefits of hypothermia after pediatric TBI. Summary As TBI is the leading cause of death in children, research in this area is needed to advance our knowledge of the sequelae after and improve outcomes of children with TBI.	[Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; [Sookplung, Pimwan] Univ Washington, Dept Anesthesiol, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Dept Anesthesiol Pediat & Neurol Surg Adj, Box 359724, Seattle, WA 98104 USA.	vavilala@u.washington.edu					Adelson P David, 2003, Pediatr Crit Care Med, V4, pS56; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS65; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; *AM COLL SURG COMM, 1993, PED TRAUM ADV TRAUM, P261; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2009, PEDIATR RES, V65, P97, DOI 10.1203/PDR.0b013e31818c7e27; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bullock M Ross, 2006, Neurosurgery, V58, pS7; CARNEY NA, 2003, PEDIAT CRIT CARE M S, V4, pS75; Carollo DS, 2008, CURR OPIN ANESTHESIO, V21, P457, DOI 10.1097/ACO.0b013e328305e3ef; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crosby ET, 2006, ANESTHESIOLOGY, V104, P1293, DOI 10.1097/00000542-200606000-00026; Drummond JC, 2008, ANESTHESIOLOGY, V108, P225, DOI 10.1097/01.anes.0000299576.00302.4c; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Guzel A, 2008, NEUROSURG REV, V31, P439, DOI 10.1007/s10143-008-0148-2; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Klein GW, 2008, J PEDIATR-US, V153, P379, DOI 10.1016/j.jpeds.2008.04.012; Lipshutz AKM, 2009, ANESTHESIOLOGY, V110, P408, DOI 10.1097/ALN.0b013e3181948a80; Marion DW, 2006, NEUROSURGERY, V58, P655; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nishisaki A, 2008, PEDIATR EMERG CARE, V24, P749, DOI 10.1097/PEC.0b013e31818c2665; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Ogawa Y, 2008, ANESTHESIOLOGY, V109, P642, DOI 10.1097/ALN.0b013e3181862a33; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Sharma D, 2009, ANESTH ANALG, V108, P81, DOI 10.1213/ane.0b013e31818a6f32; SYDENHAM E, 2009, COCHRANE DATABASE SY; Tobias JD, 2007, PEDIATR CRIT CARE ME, V8, P115, DOI 10.1097/01.PCC.0000257100.31779.41; Tuggle DW, 2008, AM SURGEON, V74, P195; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vavilala MS, 2006, DEV NEUROSCI-BASEL, V28, P348, DOI 10.1159/000094161; Vavilala MS, 2001, J NEUROSURG ANESTH, V13, P233, DOI 10.1097/00008506-200107000-00009	37	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	OCT	2009	22	5					572	578		10.1097/ACO.0b013e3283303884			7	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	497ID	WOS:000270051500005	19620860				2022-02-06	
J	Drabek, T; Tisherman, SA; Beuke, L; Stezoski, J; Janesko-Feldman, K; Lahoud-Rahme, M; Kochanek, PM				Drabek, Tomas; Tisherman, Samuel A.; Beuke, Lauren; Stezoski, Jason; Janesko-Feldman, Keri; Lahoud-Rahme, Manuella; Kochanek, Patrick M.			Deep Hypothermia Attenuates Microglial Proliferation Independent of Neuronal Death After Prolonged Cardiac Arrest in Rats	ANESTHESIA AND ANALGESIA			English	Article							FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; DELAYED RESUSCITATION; MINOCYCLINE TREATMENT; NEUROLOGICAL DYSFUNCTION; SUSPENDED ANIMATION; FUNCTIONAL DEFICITS; MILD HYPOTHERMIA; TISSUE-DAMAGE	INTRODUCTION: Conventional resuscitation of exsanguination cardiac arrest (CA) victims is generally unsuccessful. Emergency preservation and resuscitation is a novel approach that uses an aortic flush to induce deep hypothermia during CA, followed by delayed resuscitation with cardiopulmonary bypass. Minocycline has been shown to be neuroprotective across a number of brain injury models via attenuating microglial activation. We hypothesized that deep hypothermia and minocycline would attenuate neuronal death and microglial activation and improve outcome after exsanguination CA in rats. METHODS: Using isofluxane anesthesia, rats were subjected to a lethal hemorrhagic shock. After 5 min of no flow, hypothermia was induced with an aortic flush. Three groups were studied: ice-cold (IC) flush, room-temperature (RT) flush, and RT flush followed by minocycline treatment (RT-M). After 20 min of CA, resuscitation was achieved via cardiopulmonary bypass. Survival, Overall Performance Category (1 = normal, 5 = death), Neurologic Deficit Score (0-10% = normal, 100% = max deficit), neuronal death (Fluoro-jade C), and microglial proliferation (Iba1 immunostaining) in hippocampus were assessed at 72 h. RESULTS: Rats in the IC group had lower tympanic temperature during CA versus other groups (IC, 20.9 degrees C +/- 1.3 degrees C; RT, 28.4 degrees C +/- 0.6 degrees C; RT-M, 28.3 degrees C +/- 0.7 degrees C; P < 0.001). Although survival was similar in all groups (RT, 6/9; IC, 6/7; RT-M, 6/11), neurological outcome was better in the IC group versus other groups (Overall Performance Category: IC, 1 +/- 1; RT, 3 1; RT-M, 2 1; P < 0.05; Neurologic Deficit Score: IC, 8% +/- 9%; RT, 55% +/- 19%; RT-M, 27% +/- 16%; P < 0.05). Histological damage assessed in survivors showed selective neuronal death in CA1 and dentate gyrus, similar in all groups (P = 0.15). In contrast, microglial proliferation was attenuated in the IC group versus all other groups (P < 0.01). CONCLUSIONS: Deeper levels of hypothermia induced by the IC versus RT flush resulted in better neurological outcome in survivors. Surprisingly, deep hypothermia attenuated microglial activation but not hippocampal neuronal death. Mino-cycline had modest benefit on neurologic outcome in survivors but did not attenuate microglial activation in brain. Our findings suggest a novel effect of deep hypothermia on microglial proliferation during exsanguination CA. (Anesth Analg 2009;109:914-23)	[Drabek, Tomas; Tisherman, Samuel A.; Beuke, Lauren; Stezoski, Jason; Janesko-Feldman, Keri; Lahoud-Rahme, Manuella; Kochanek, Patrick M.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Drabek, Tomas] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Tisherman, Samuel A.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [Tisherman, Samuel A.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15261 USA; [Lahoud-Rahme, Manuella] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA		Drabek, T (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, 3434 5th Ave, Pittsburgh, PA 15260 USA.	drabekt@anes.upmc.edu	Drabek, Tomas/AAJ-1595-2021; Tisherman, Samuel A./AAK-9377-2020; Kochanek, Patrick M/D-2371-2015	Drabek, Tomas/0000-0002-5702-4498; Tisherman, Samuel A./0000-0003-3810-3729; Kochanek, Patrick M/0000-0002-2627-913X	Society of Cardiovascular Anesthesiologists; Laerdal Foundation for Acute Medicine; Department of Anesthesiology, University of PittsburghUniversity of Pittsburgh	Supported by a Starter Grant from the Society of Cardiovascular Anesthesiologists (to TD), the Laerdal Foundation for Acute Medicine (to TD), and a Seed Grant from the Department of Anesthesiology, University of Pittsburgh (to TD).	Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; Arvin KL, 2002, ANN NEUROL, V52, P54, DOI 10.1002/ana.10242; Behringer W, 2002, J CEREBR BLOOD F MET, V22, P105, DOI 10.1097/00004647-200201000-00013; Bellamy R, 1996, CRIT CARE MED, V24, pS24; BREGMAN D, 1980, AM J CARDIOL, V46, P261, DOI 10.1016/0002-9149(80)90067-3; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Deng H, 2003, STROKE, V34, P2495, DOI 10.1161/01.STR.0000091269.67384.E7; Drabek T, 2007, RESUSCITATION, V75, P114, DOI 10.1016/j.resuscitation.2007.03.012; Drabek T, 2007, LIFE SCI, V81, P543, DOI 10.1016/j.lfs.2007.06.015; Fan LW, 2006, EUR J NEUROSCI, V24, P341, DOI 10.1111/j.1460-9568.2006.04918.x; Fan LW, 2005, NEUROSCIENCE, V133, P159, DOI 10.1016/j.neuroscience.2005.02.016; Festoff BW, 2006, J NEUROCHEM, V97, P1314, DOI 10.1111/j.1471-4159.2006.03799.x; Fukui O, 2006, BRAIN RES, V1121, P35, DOI 10.1016/j.brainres.2006.08.121; GEHRMANN J, 1995, NEUROPATH APPL NEURO, V21, P277, DOI 10.1111/j.1365-2990.1995.tb01062.x; Hayashi Y, 2006, NEUROSCIENCE, V142, P87, DOI 10.1016/j.neuroscience.2006.06.003; Hewlett KA, 2006, NEUROSCIENCE, V141, P27, DOI 10.1016/j.neuroscience.2006.03.071; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Koshinaga M, 2007, HISTOL HISTOPATHOL, V22, P129, DOI 10.14670/HH-22.129; Lai AY, 2008, GLIA, V56, P259, DOI 10.1002/glia.20610; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Maekawa S, 2002, CRIT CARE MED, V30, P2700, DOI 10.1097/00003246-200212000-00014; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Neumann J, 2006, FASEB J, V20, P714, DOI 10.1096/fj.05-4882fje; NEUMAR RW, 1995, RESUSCITATION, V29, P249, DOI 10.1016/0300-9572(94)00827-3; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Rhee PM, 2000, J AM COLL SURGEONS, V190, P288, DOI 10.1016/S1072-7515(99)00233-1; Safar P, 2000, CRIT CARE MED, V28, pN214, DOI 10.1097/00003246-200011001-00012; SAIVIN S, 1988, CLIN PHARMACOKINET, V15, P355, DOI 10.2165/00003088-198815060-00001; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Stirling DP, 2005, NEUROSCIENTIST, V11, P308, DOI 10.1177/1073858405275175; Stirling DP, 2004, J NEUROSCI, V24, P2182, DOI 10.1523/JNEUROSCI.5275-03.2004; TRUNKEY D, 1991, NEW ENGL J MED, V324, P1259; Wang CX, 2002, BMC NEUROL, V2, DOI 10.1186/1471-2377-2-2; Wang CX, 2003, BRAIN RES, V963, P327, DOI 10.1016/S0006-8993(02)04045-3; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769	42	20	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	SEP	2009	109	3					914	923		10.1213/ane.0b013e3181b0511e			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	488EB	WOS:000269330800036	19690267				2022-02-06	
J	Wanger, AK; Sokoloski, JE; Chen, XB; Harun, R; Clossin, DP; Khan, AS; Andes-Koback, M; Michael, AC; Dixon, CE				Wanger, Amy K.; Sokoloski, Joshua E.; Chen, Xiangbei; Harun, Rashed; Clossin, Damian P.; Khan, Amina S.; Andes-Koback, Meghan; Michael, Adrian C.; Dixon, C. Edward			Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission	JOURNAL OF NEUROCHEMISTRY			English	Article						controlled cortical impact; dopamine transporter; electrochemistry; methylphenidate; microdialysis; voltammetry	TRAUMATIC BRAIN-INJURY; C-FOS; EXTRACELLULAR DOPAMINE; NUCLEUS-ACCUMBENS; GENE-EXPRESSION; TISSUE-LEVELS; RAT STRIATUM; COCAINE; MICRODIALYSIS; RELEASE	Traumatic brain injury features deficits are often ameliorated by dopamine (DA) agonists. We have previously shown deficits in striatal DA neurotransmission using fast scan cyclic voltammetry after controlled cortical impact (CCI) injury that are reversed after daily treatment with the DA uptake inhibitor methylphenidate (MPH). The goal of this study was to determine how a single dose of MPH (5 mg/kg) induces changes in basal DA and metabolite levels and with electrically evoked overflow (EO) DA in the striatum of CCI rats. MPH-induced changes in EO DA after a 2-week daily pre-treatment regime with MPH was also assessed. There were no baseline differences in basal DA or metabolite levels. MPH injection significantly increased basal [DA] output in dialysates for control but not injured rats. Also, MPH injection increased striatal peak EO [DA] to a lesser degree in CCI (176% of baseline) versus control rats (233% of baseline). However, daily pre-treatment with MPH resulted in CCI rats having a comparable increase in EO [DA] after MPH injection when compared with controls. The findings further support the concept that daily MPH therapy restores striatal DA neurotransmission after CCI.	[Wanger, Amy K.] Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Wanger, Amy K.; Sokoloski, Joshua E.; Chen, Xiangbei; Harun, Rashed; Clossin, Damian P.; Dixon, C. Edward] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Wanger, Amy K.; Harun, Rashed] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Khan, Amina S.; Andes-Koback, Meghan; Michael, Adrian C.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15213 USA; [Dixon, C. Edward] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA		Wanger, AK (corresponding author), Univ Pittsburgh, Sch Med, Dept Phys Med & Rehabil, 3471 5th Ave,Suite 202, Pittsburgh, PA 15213 USA.	wagnerak@upmc.edu		Harun, Rashed/0000-0003-1843-6710	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K08HD40833, R01NS40125, R21 NS057348]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K08HD040833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS040125, R21NS057348] Funding Source: NIH RePORTER	This work was supported by NIH K08HD40833 (AKW), R01NS40125 (CED), and R21 NS057348 (AKW & ACM). Special thanks to Xiecheng Ma for her technical support on this study.	Abin-Carriquiry JA, 2008, EUR J PHARMACOL, V589, P80, DOI 10.1016/j.ejphar.2008.05.013; Arnsten AFT, 2006, NEUROPSYCHOPHARMACOL, V31, P2376, DOI 10.1038/sj.npp.1301164; Borland LM, 2005, J NEUROSCI METH, V146, P149, DOI 10.1016/j.jneumeth.2005.02.002; Borland LM, 2004, J NEUROCHEM, V91, P220, DOI 10.1111/j.1471-4159.2004.02708.x; Brandon CL, 2003, EUR J NEUROSCI, V18, P1584, DOI 10.1046/j.1460-9568.2003.02892.x; BUTCHER SP, 1991, NEUROSCI LETT, V122, P245, DOI 10.1016/0304-3940(91)90869-U; Chase TD, 2003, NEUROREPORT, V14, P769, DOI 10.1097/00001756-200304150-00022; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DunnMeynell AA, 1997, BRAIN RES, V761, P25, DOI 10.1016/S0006-8993(97)00210-2; Fleckenstein AE, 2009, NEUROPHARMACOLOGY, V56, P133, DOI 10.1016/j.neuropharm.2008.07.002; Gagnaire F, 2006, ARCH TOXICOL, V80, P703, DOI 10.1007/s00204-006-0083-3; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; Greco PG, 2003, EUR J PHARMACOL, V479, P117, DOI 10.1016/j.ejphar.2003.08.062; Hawken CM, 2004, NEUROREPORT, V15, P1045, DOI 10.1097/00001756-200404290-00022; HOPE B, 1992, P NATL ACAD SCI USA, V89, P5764, DOI 10.1073/pnas.89.13.5764; Hope BT, 2006, EUR J NEUROSCI, V24, P867, DOI 10.1111/j.1460-9568.2006.04969.x; Huff JK, 2002, J PHARMACEUT BIOMED, V29, P767, DOI 10.1016/S0731-7085(02)00196-6; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; KAAKKOLA S, 1987, J NEURAL TRANSM, V69, P221, DOI 10.1007/BF01244343; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kuczenski R, 2005, BIOL PSYCHIAT, V57, P1391, DOI 10.1016/j.biopsych.2004.12.036; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; Kulagina NV, 2001, NEUROSCIENCE, V102, P121, DOI 10.1016/S0306-4522(00)00480-2; Lin JS, 1996, P NATL ACAD SCI USA, V93, P14128, DOI 10.1073/pnas.93.24.14128; Lonjon M, 2004, NEUROSCI LETT, V354, P131, DOI 10.1016/j.neulet.2003.10.005; Lu Y, 1998, J NEUROCHEM, V70, P584; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; MCINTOSH TK, 1994, J NEUROCHEM, V63, P1426; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Oechsner M, 2002, J NEURAL TRANSM, V109, P69, DOI 10.1007/s702-002-8237-z; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Sadri-Vakili G, 2008, J PHARMACOL EXP THER, V327, P840, DOI 10.1124/jpet.108.143958; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Smith AD, 2005, EXP NEUROL, V193, P420, DOI 10.1016/j.expneurol.2005.01.010; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Volz TJ, 2008, J PHARMACOL EXP THER, V327, P161, DOI 10.1124/jpet.108.139386; Volz TJ, 2007, J PHARMACOL EXP THER, V323, P738, DOI 10.1124/jpet.107.126888; Wagner AK, 2005, J NEUROCHEM, V95, P457, DOI 10.1111/j.1471-4159.2005.03382.x; Wagner AK, 2005, EXP NEUROL, V195, P475, DOI 10.1016/j.expneurol.2005.06.009; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Yan HQ, 2007, BRAIN RES, V1134, P171, DOI 10.1016/j.brainres.2006.11.087; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; Yano M, 2005, NEUROPSYCHOPHARMACOL, V30, P901, DOI 10.1038/sj.npp.1300613; Youdim MBH, 2004, NEUROLOGY, V63, pS32, DOI 10.1212/WNL.63.7_suppl_2.S32; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; ZETTERSTROM T, 1988, EUR J PHARMACOL, V148, P327, DOI 10.1016/0014-2999(88)90110-0	50	20	21	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2009	110	3					801	810		10.1111/j.1471-4159.2009.06155.x			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	470IP	WOS:000267968700003	19457094	Green Accepted			2022-02-06	
J	Gioia, GA; Isquith, PK; Schneider, JC; Vaughan, CG				Gioia, Gerard A.; Isquith, Peter K.; Schneider, Jillian C.; Vaughan, Christopher G.			New Approaches to Assessment and Monitoring of Concussion in Children	TOPICS IN LANGUAGE DISORDERS			English	Article						assessment; children; concussion; management; mild TBI; pediatric	TRAUMATIC BRAIN-INJURY; SPORTS; MILD; MANAGEMENT; EPIDEMIOLOGY; FOOTBALL; RELIABILITY; SYMPTOMS; RECOVERY	A "mild" traumatic brain injury (TBI) constitutes the overwhelming majority of brain injury cases in children and adolescents. This article focuses on cerebral concussion, which can be viewed as a subset of mild TBI, which, until recently; has received limited attention in the pediatric assessment literature. Few extant measures appropriate to this condition in the developing child are available. A "broadband" approach to the assessment and management of concussion in children is presented, stressing the unique goals of the pediatric postinjury evaluation and treatment process in returning to home life, school, and sports/recreation. This approach calls for standardized assessment using diverse methods that tap multiple domains of the child's functioning, gathering input from key respondents across settings. Neuropsychological testing, together with structured symptom rating scales, provides a multilevel view of the effects of the concussion on the child. Structured data obtained with standardized methods from multiple sources provide more reliable and ecologically valid information to facilitate interventions in the child's key home and school environments. New pediatric assessment measures are presented, providing clinicians with tools to assess and manage this injury effectively. Two clinical cases highlight the use of the battery in guiding recovery. Continued research on the broadband concussion assessment model is needed.	[Gioia, Gerard A.; Schneider, Jillian C.; Vaughan, Christopher G.] Childrens Natl Med Ctr, Div Pediat Neuropsychol, Washington, DC 20010 USA; [Isquith, Peter K.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Psychiat, Hanover, NH 03756 USA		Gioia, GA (corresponding author), Childrens Natl Med Ctr, Div Pediat Neuropsychol, 15245 Shady Grove Rd,Suite 350, Rockville, MD 20850 USA.	ggioia@cnmc.org	Isquith, Peter/AAY-4851-2020				Almquist J, 2001, ATHLET THER TODAY, V6, P13, DOI 10.1123/att.6.1.13; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bailes JE, 2001, J ATHL TRAINING, V36, P236; Barr WB, 2003, ARCH CLIN NEUROPSYCH, V18, P91, DOI 10.1016/S0887-6177(01)00185-8; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bernhardt DT, 2000, PEDIATR ANN, V29, P172, DOI 10.3928/0090-4481-20000301-11; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cassidy JD, 2004, J REHABIL MED, V36, P15, DOI 10.1080/16501960410023688; *CDCP NAT CTR INJ, 2003, C MILD TRAUM BRAIN I; *CDCP NAT CTR INJ, 2007, HEADS BRAIN INJ YOUR; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; De Los Reyes A, 2005, PSYCHOL BULL, V131, P483, DOI 10.1037/0033-2909.131.4.483; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; Echemendia R., 2006, SPORTS NEUROPSYCHOLO; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gioia G, 2006, J INT NEUROPSYCHO S1, V12, P39; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2004, DEV NEUROPSYCHOL, V25, P135, DOI 10.1207/s15326942dn2501&2_8; Gioia GA IP, 2000, BEHAV RATING INVENTO; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Lovell M. R., 2004, TRAUMATIC BRAIN INJU; Lovell M, 2008, NEUROL CLIN, V26, P45, DOI 10.1016/j.ncl.2007.12.001; Lovell MR, 2008, CURR SPORT MED REP, V7, P12, DOI 10.1097/01.CSMR.0000308671.45558.e2; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2005, BRIT J SPORT MED, V39, pI58, DOI 10.1136/bjsm.2005.020776; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McKeever CK, 2003, APPL NEUROPSYCHOL, V10, P4, DOI 10.1207/S15324826AN1001_2; Milroy G, 2008, J PEDIATR PSYCHOL, V33, P242, DOI 10.1093/jpepsy/jsm099; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; Parsons SK, 1999, INT J CANCER, P46; Randolph C, 2005, J ATHL TRAINING, V40, P139; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Schatz P, 2003, APPL NEUROPSYCHOL, V10, P42, DOI 10.1207/S15324826AN1001_6; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; TURKIBENALI Y, 2005, PHYSICA E, V26, P222; Upton P, 2008, QUAL LIFE RES, V17, P895, DOI 10.1007/s11136-008-9350-5; Varni JW, 2004, J RHEUMATOL, V31, P2494; Vincent, 2008, J INT NEUROPSYCH SOC, V1, P204; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; [No title captured]	66	20	20	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0271-8294	1550-3259		TOP LANG DISORD	Top. Lang. Disord.	JUL-SEP	2009	29	3					266	281		10.1097/TLD.0b013e3181b5322b			16	Linguistics; Rehabilitation	Social Science Citation Index (SSCI)	Linguistics; Rehabilitation	488HT	WOS:000269340700007					2022-02-06	
J	Love, PF; Tepas, JJ; Wludyka, PS; Masnita-Iusan, C				Love, Pamela F.; Tepas, Joseph J., III; Wludyka, Peter S.; Masnita-Iusan, Carmen			Fall-Related Pediatric Brain Injuries: The Role of Race, Age, and Sex	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	13th Annual Conference of the Injury Free Coalition for Kids	DEC 12-14, 2008	Ft Lauderdale, FL			Fall related; Traumatic brain injury; Pediatric falls; Pediatric traumatic brain injury; Traumatic brain injury from falls	EPIDEMIOLOGY; PREVENTION	Background: Falls remain a major cause of childhood morbidity and mortality. To improve effectiveness of our prevention program, we used our electronic injury surveillance database to analyze patient variables and the incidence of fall-related brain injury. Methods: The database was queried for all injuries treated in the pediatric emergency department for which the word "fall" was listed as part of the chief complaint. Age, sex, and mechanism variables were cross tabulated for analysis with traumatic brain injury (TBI) codes. Results: Between June 2005 and June 2008, the electronic surveillance system reported 39,718 injury-related visits to the pediatric emergency department. Falls were reported in 3,436 patients (2,107 males, 1,329 females). TBI occurred from falls in 171 patients. Although black children had a higher fall rate (69.24%) than white children (23.75%) and non-black non-white children (7.01%), white children had the highest TBI rate from falls (9.47%). TBI from falls occurred at a lower mean age for females (5.40 +/- 4.45) than males (6.6 +/- 5.15) and for non-whites (5.98 +/- 4.88) than whites (6.21 +/- 4.93). Multiple logistic regression demonstrated a significant influence of age, race, and sex on the likelihood that a fall results in TBI. Females have a higher risk of TBI from falls than males from ages 0 to 11.5. This runs contrary to previous studies suggesting that toddler males are at highest risk for TBI. Conclusion: A disproportionate number of infants, toddlers, and adolescents sustain brain injury from falls. Race and sex group differences mandate enhanced focus on environmental safety and risk-taking behaviors.	[Love, Pamela F.] Univ Florida, Coll Med, Dept Pediat Emergency Med, Jacksonville, FL 32209 USA; [Tepas, Joseph J., III] Univ Florida, Coll Med, Dept Surg Pediat Surg & Pediat, Jacksonville, FL 32209 USA; [Wludyka, Peter S.] Dept Math & Stat, Jacksonville, FL USA; [Masnita-Iusan, Carmen] Univ N Florida, Jacksonville, FL USA		Love, PF (corresponding author), Univ Florida, Coll Med, Dept Pediat Emergency Med, Jacksonville, FL 32209 USA.	jjt@jax.ufl.edu					BERNEY J, CHILDS NERV SYST, V10, P517; Bull MJ, 2001, PEDIATRICS, V107, P1188, DOI 10.1542/peds.107.5.1188; Durkin MS, 1998, NEUROSURGERY, V42, P300, DOI 10.1097/00006123-199802000-00052; Goldstein B, 1994, Pediatr Rev, V15, P213, DOI 10.1542/pir.15-6-213; KRAUS JF, 1986, AM J DIS CHILD, V140, P687, DOI 10.1001/archpedi.1986.02140210085032; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Mathers LJ, 1998, ACAD EMERG MED, V5, P1064, DOI 10.1111/j.1553-2712.1998.tb02663.x; MOSENTHAL AC, 1995, J TRAUMA, V38, P753, DOI 10.1097/00005373-199505000-00013; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Pitone ML, 2006, PEDIATR EMERG CARE, V22, P470, DOI 10.1097/01.pec.0000226869.41803.50; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Wang MY, 2001, J PEDIATR SURG, V36, P1528, DOI 10.1053/jpsu.2001.27037	12	20	22	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	2009	67	1		S			S12	S15		10.1097/TA.0b013e3181ac7f22			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	470DA	WOS:000267953200004	19590346				2022-02-06	
J	Honeybul, S				Honeybul, S.			Decompressive craniectomy: A new complication	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Decompressive craniectomy; Complications; Head injury	TRAUMATIC BRAIN-INJURY; INFARCTION; CHILDREN; TRIAL	There is an increasing amount of published literature Supporting the use of decompressive craniectomy in the management of raised intracranial pressure and it appears that this procedure will become established as a method by which intracranial hypertension can be treated. While technically fairly straightforward, a decompressive craniectomy is not without complications. A further complication is presented here, which has not been previously reported. A 56-year-old male fell backwards from a bar stool and struck his occiput. He had a decompressive craniectomy and was making an excellent recovery when he fell and injured the unprotected craniectomy site. He Suffered further cerebral injury and subsequently died. Following a detailed review of the case a number of recommendations were made and a specific post-decompressive craniectomy operational policy for the assessment and management of these patients was implemented. While we accept that these particular guidelines are specific to a particular institution, this case highlights the need to view these patients as a particularly high risk and recommend that institutions review or establish a specific policy regarding their management. (C) 2008 Elsevier Ltd. All rights reserved.	Sir Charles Gairdner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Nedlands, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au					Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Bostrom S, 2005, ACTA NEUROCHIR, V147, P279, DOI 10.1007/s00701-004-0480-4; Hutchinson Peter, 1800, Neurosurg Focus, V22, pE14; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Schmidt JH, 2007, J NEUROSURG, V107, P678, DOI 10.3171/JNS-07/09/0678; Smith ER, 2002, NEUROSURGERY, V51, P117, DOI 10.1097/00006123-200207000-00018; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235	9	20	20	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	MAY	2009	16	5					727	729		10.1016/j.jocn.2008.06.015			3	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433RQ	WOS:000265223900032	19261473				2022-02-06	
J	Singhi, SC; Tiwari, L				Singhi, Sunit C.; Tiwari, Lokesh			Management of intracranial hypertension	INDIAN JOURNAL OF PEDIATRICS			English	Article						Intracranial pressure; Children; Traumatic brain injury; Cerebral perfusion pressure; Hyperosmolar therapy	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; EARLY DECOMPRESSIVE CRANIECTOMY; NERVOUS-SYSTEM INFECTIONS; INTRA-CRANICAL PRESSURE; CONTROLLED-TRIAL; HEAD-INJURY; SUBARACHNOID HEMORRHAGE; HYPERTONIC SALINE; RANDOMIZED-TRIAL	Raised intracranial pressure (ICP) is a life threatening condition that is common to many neurological and non-neurological illnesses. Unless recognized and treated early it may cause secondary brain injury due to reduced cerebral perfusion pressure (CPP), and progress to brain herniation and death. Management of raised ICP includes care of airway, ventilation and oxygenation, adequate sedation and analgesia, neutral neck position, head end elevation by 20A degrees-30A degrees, and short-term hyperventilation (to achieve PCO(2) 32-35 mm Hg) and hyperosmolar therapy (mannitol or hypertonic saline) in critically raised ICP. Barbiturate coma, moderate hypothermia and surgical decompression may be helpful in refractory cases. Therapies aimed directly at keeping ICP < 20 mmHg have resulted in improved survival and neurological outcome. Emerging evidence suggests that cerebral perfusion pressure targeted therapy may offer better outcome than ICP targeted therapies.	[Singhi, Sunit C.; Tiwari, Lokesh] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Pediat Emergency & Intens Care Units, Chandigarh 160012, India		Singhi, SC (corresponding author), Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Dept Pediat, Pediat Emergency & Intens Care Units, Chandigarh 160012, India.	sunit.singhi@gmail.com	Tiwari, Lokesh/I-5965-2019	Tiwari, Lokesh/0000-0002-2231-0152			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS72; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS34; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS49; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS45; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS28; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS19; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ADLESON PD, 2003, PCCM, V4, P531; Albanese J, 1999, CRIT CARE MED, V27, P407, DOI 10.1097/00003246-199902000-00050; Bader MK, 2005, AACN ADV CRIT CARE, V16, P526, DOI 10.1097/00044067-200510000-00009; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Biousse V, 2003, AM J OPHTHALMOL, V135, P437, DOI 10.1016/S0002-9394(02)02062-7; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Cheung A, 2005, NEUROCRIT CARE, V3, P216, DOI 10.1385/NCC:3:3:216; Coles JP, 2004, BRAIN, V127, P2479, DOI 10.1093/brain/awh268; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cruz J, 2004, J NEUROSURG, V100, P376, DOI 10.3171/jns.2004.100.3.0376; Czosnyka M, 1996, NEUROSURGERY, V38, P219, DOI 10.1097/00006123-199601000-00053; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Edwards P, 2005, LANCET, V365, P1957; Figaji AA, 2003, CHILD NERV SYST, V19, P666, DOI 10.1007/s00381-003-0804-3; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jagannathan J, 2007, J NEUROSURG, V106, P268, DOI 10.3171/ped.2007.106.4.268; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kaal ECA, 2004, CURR OPIN ONCOL, V16, P593, DOI 10.1097/01.cco.0000142076.52721.b3; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; KISHORE PRS, 1981, AM J ROENTGENOL, V137, P829, DOI 10.2214/ajr.137.4.829; Knapp JM, 2005, AACN ADV CRIT CARE, V16, P199, DOI 10.1097/00044067-200504000-00011; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Marchuk G, 2005, CAN J NEUROL SCI, V32, pS22; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; Mazzola CA, 2002, CRIT CARE MED, V30, pS393, DOI 10.1097/00003246-200211001-00003; Ng I, 2004, NEUROSURGERY, V54, P593, DOI 10.1227/01.NEU.0000108639.16783.39; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; Paczynski RP, 1997, CRIT CARE CLIN, V13, P105, DOI 10.1016/S0749-0704(05)70298-0; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; Roth P, 2000, Crit Care Nurs Q, V23, P14; Ruf B, 2003, CRIT CARE, V7, pR133, DOI 10.1186/cc2361; Schramm WM, 1998, ANESTH ANALG, V86, P123, DOI 10.1097/00000539-199801000-00025; Shetty R, 2008, J CHILD NEUROL, V23, P192, DOI 10.1177/0883073807308716; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Valentin A, 2003, CRIT CARE MED, V31, P1539, DOI 10.1097/01.CCM.0000065270.53951.9E; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725	57	20	20	0	6	ALL INDIA INST MEDICAL SCIENCES	NEW DELHI	ANSARI NAGAR, NEW DELHI 110 029, INDIA	0019-5456			INDIAN J PEDIATR	Indian J. Pediatr.	MAY	2009	76	5					519	529		10.1007/s12098-009-0137-7			11	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	449LM	WOS:000266332100011	19466385				2022-02-06	
J	Wei, YT; Sun, XD; Xia, X; Cui, FZ; He, Y; Liu, BF; Xu, QY				Wei, Yue-Teng; Sun, Xiao-Dan; Xia, Xue; Cui, Fu-Zhai; He, Yu; Liu, Bing-Fang; Xu, Qun-Yuan			Hyaluronic Acid Hydrogel Modified with Nogo-66 Receptor Antibody and Poly(L-Lysine) Enhancement of Adherence and Survival of Primary Hippocampal Neurons	JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS			English	Article						hyaluronic acid; hydrogel; antiNgR; poly(L-lysine); cell attachment; tissue engineering; biomaterial; bioengineering; central nervous system injuries; repairing CNS injuries; modified hyaluronic acid hydrogels	SPINAL-CORD-INJURY; TRAUMATIC BRAIN-INJURY; IN-VITRO; AXONAL REGENERATION; POLYETHYLENE-GLYCOL; NERVE REGENERATION; DELIVERY-SYSTEM; CULTURE; RAT; ATTACHMENT	Hyaluronic acid (HA) hydrogel was modified with poly(L-lysine) (PLL) and Nogo-66 Receptor antibody (antiNgR) to enhance the repair of central nervous system (CNS) injuries. The immobilization of PLL was characterized by X-ray photoelectron spectroscopy (XPS) and the immobilization of antiNgR was studied by immunofluorescence. The cytocompatibility of this modified hydrogel was analyzed by culturing primary hippocampal neurons. The quantity and morphology of the neurons were influenced by different modifications; the primary hippocampal neurons cultured with modified HA hydrogel exhibited multipolar and bipolar morphology were compared with unmodified hydrogel cultures. The number of neurons obtained by culturing with HA hydrogel modified with both PLL and antiNgR was almost twice the number of neurons cultured with HA modified with only PLL or antiNgR. This phenomenon was attributed to the collaborative effect of PLL and antiNgR on the neurons. The characteristics of this new hydrogel system, including pore structure, water absorption, hydrolysis degradation did not change much when compared with the hydrogel modified with PLL or antiNgR, respectively. It is expected that this modified HA hydrogel has potential as a CNS tissue engineering material.	[Wei, Yue-Teng; Sun, Xiao-Dan; Xia, Xue; Cui, Fu-Zhai] Tsinghua Univ, Adv Mat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China; [He, Yu; Liu, Bing-Fang; Xu, Qun-Yuan] Capital Med Univ, Beijing Inst Neurosci, Beijing Ctr Neural Regenerat & Repairing, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100069, Peoples R China		Cui, FZ (corresponding author), Tsinghua Univ, Adv Mat Lab, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.	cuifz@mail.tsinghua.edu.cn	Wei, Yueteng/B-4653-2012; liu, bingfang/J-9615-2013		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [50573044, 30670656]; National Basic Research Program of ChinaNational Basic Research Program of China [2005CB623905, 2007CB947704]; National Natural Science Foundation of BeijingBeijing Natural Science Foundation [705001]; Beijing Scientific Committee [20005187040311]; Foundation of Analysis and Testing in Tsinghua University	Yue-Teng Wei and Yu He contributed equally to this work. This work was supported by National Natural Science Foundation of China (Grant No. 50573044, 30670656), National Basic Research Program of China (Grant No. 2005CB623905, 2007CB947704), National Natural Science Foundation of Beijing (Grant No. 705001), Beijing Scientific Committee (Grant No. 20005187040311) and Foundation of Analysis and Testing in Tsinghua University.	Baptiste D, 2007, J NEUROTRAUM, V24, P1285; Borgens RB, 1999, NEUROSCIENCE, V91, P251, DOI 10.1016/S0306-4522(98)00584-3; Brittis PA, 2001, NEURON, V30, P11, DOI 10.1016/S0896-6273(01)00258-6; Cai J, 2007, J BIOMED MATER RES A, V83A, P512, DOI 10.1002/jbm.a.31296; CARBONETTO S, 1983, J NEUROSCI, V3, P2324; Evans MS, 1998, J NEUROSCI METH, V79, P37, DOI 10.1016/S0165-0270(97)00159-3; GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hu M, 2000, TISSUE ENG, V6, P585, DOI 10.1089/10763270050199532; Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088; Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7; Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L; Oerther S, 2000, BIOPOLYMERS, V54, P273, DOI 10.1002/1097-0282(20001005)54:4<273::AID-BIP40>3.0.CO;2-I; Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6; SECKEL BR, 1995, J NEUROSCI RES, V40, P318, DOI 10.1002/jnr.490400305; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025; YAVIN E, 1974, J CELL BIOL, V62, P540, DOI 10.1083/jcb.62.2.540; YONG VW, 1988, DEV NEUROSCI-BASEL, V10, P222, DOI 10.1159/000111972; Zhang T, 2007, J BIOACT COMPAT POL, V22, P19, DOI 10.1177/0883911506074025	25	20	20	3	31	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0883-9115	1530-8030		J BIOACT COMPAT POL	J. Bioact. Compat. Polym.	MAY	2009	24	3					205	219		10.1177/0883911509102266			15	Biotechnology & Applied Microbiology; Materials Science, Biomaterials; Polymer Science	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Materials Science; Polymer Science	443OF	WOS:000265918900001					2022-02-06	
J	Fujii, Y; Tasaki, O; Yoshiya, K; Shiozaki, T; Ogura, H; Kuwagata, Y; Sugimoto, H; Sumi, Y				Fujii, Yoshiyuki; Tasaki, Osamu; Yoshiya, Kazuhisa; Shiozaki, Tadahiko; Ogura, Hiroshi; Kuwagata, Yasuyuki; Sugimoto, Hisashi; Sumi, Yuka			Evaluation of Posttraumatic Venous Sinus Occlusion With CT Venography	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Cerebral venous sinus occlusion; Head trauma; Acute brain swelling; Skull fracture; Intracranial hypertension; Talk and deteriorate	CLOSED-HEAD-INJURY; THROMBOSIS	Background: Although cerebral venous sinus occlusion (CVSO) is reported to be associated with intracranial hypertension, its incidence or significance in head trauma is not clear. This study investigated with CT venography the incidence of posttraumatic CVSO, its clinical course, and relation to intracranial hypertension. Patients: This study comprised 97 consecutive patients admitted to our Trauma Center from 2002 through 2008 with skull fracture of the petrous portion of the temporal bone or that crossed the dural sinus. Patients with CVSO were examined with CT venography and followed up with CT venography or magnetic resonance imaging. The relation of CVSO to patient outcome and incidence of "talk and deteriorate" was also investigated. Results: CVSO was observed in 22 of 97 patients (22.4%). Mortality was significantly higher in the CVSO group versus no-CVSO group (50.0% vs. 9.3%, p < 0.001). Incidence of lethal intracranial hypertension was higher in the CVSO versus no-CVSO group (40.9% vs. 5.3%, p < 0.001), although there was no difference in Glasgow Coma Scale score at admission between the two groups (CVSO group, 8 +/- 5 vs. no-CVSO group, 10 +/- 4). Recanalization without treatment for CVSO occurred by 6 months in 9 of the 11 survivors (81.8%) who could be followed up. Conclusion: CVSO incidence after head injury was much higher than ever thought. It was associated with mortality and lethal intracranial hypertension, indicating that CVSO may induce acute increase in intracranial pressure in some cases. Early recognition of CVSO may be important to predict deterioration after admission and for starting immediate treatment.	[Fujii, Yoshiyuki; Tasaki, Osamu; Yoshiya, Kazuhisa; Shiozaki, Tadahiko; Ogura, Hiroshi; Kuwagata, Yasuyuki; Sugimoto, Hisashi] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Osaka, Japan; [Sumi, Yuka] Juntendo Univ, Urayasu Hosp, Emergency & Crit Care Ctr, Tokyo, Japan		Fujii, Y (corresponding author), Osaka Univ, Sch Med, 2-15 Yamadaoka, Suita, Osaka 5650871, Japan.	jan@v101.vaio.ne.jp			Ministry of Education, Culture, Sports, and Technology in JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19390459]; Labor Science's Research [H19-Iryou-Ippan-006]	Supported by a Grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology in Japan (no. 19390459); by Labor Science's Research Grant (Research on Medical Safety and Health Technology Assessment, H19-Iryou-Ippan-006).	*AM COLL SURG, 1999, ADV TRAUM LIF SUPP P; Barbati G, 2003, Minerva Anestesiol, V69, P919; Ferrera PC, 1998, AM J EMERG MED, V16, P382, DOI 10.1016/S0735-6757(98)90134-6; Ferro JM, 2004, STROKE, V35, P664, DOI 10.1161/01.STR.0000117571.76197.26; Kosinski CM, 2004, STROKE, V35, P2820, DOI 10.1161/01.STR.0000147045.71923.18; Kuether TA, 1998, NEUROSURGERY, V42, P1163, DOI 10.1097/00006123-199805000-00129; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Ochagavia AR, 1996, LANCET, V347, P1564, DOI 10.1016/S0140-6736(96)90721-7; Shigemori Y, 2007, SURG NEUROL, V68, P660, DOI 10.1016/j.surneu.2006.11.037; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Wetzel SG, 1999, AM J NEURORADIOL, V20, P249; Yokota H, 2006, J NEUROSURG, V104, P849, DOI 10.3171/jns.2006.104.5.849	12	20	22	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	APR	2009	66	4					1002	1006		10.1097/TA.0b013e31819a0277			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	431KI	WOS:000265059800009	19359906				2022-02-06	
J	Mercer, J; Erickson-Owens, D; Skovgaard, R				Mercer, J.; Erickson-Owens, D.; Skovgaard, R.			Cardiac asystole at birth: Is hypovolemic shock the cause?	MEDICAL HYPOTHESES			English	Article							UMBILICAL BLOOD-FLOW; TIGHT NUCHAL CORD; SHOULDER DYSTOCIA; CARDIOCEREBRAL RESUSCITATION; NEWBORN-INFANTS; FETAL BLOOD; VOLUME; EXPRESSION; MANAGEMENT; CELLS	A birth involving shoulder dystocia can rapidly deteriorate-from a fetus with a reassuring tracing in the minutes before birth, to a neonate needing aggressive resuscitation. Infants experiencing a traumatic birth involving shoulder dystocia may be severely compromised, even when the preceding labor was uncomplicated. This paper presents two cases in which infants had normal heart beats recorded 510 min before birth and were born with cardiac asystole following shoulder dystocia. Often, in cases of shoulder dystocia, infants shift blood to the placenta due to the tight compressive squeeze of the body in the birth canal (along with cord compression) and thereby may be born hypovolemic. Our hypothesis is that the occurrence of sudden cardiac asystole at birth is due to extreme hypovolemic shock secondary to the loss of blood. At birth, the sudden release of pressure on the infant's body results in hypoperfusion resulting in low central circulation and blood pressure. Severe hypovolemic shock from these effects leads to sudden cardiac arrest. Immediate cord clamping maintains the hypovolemic state by preventing the physiologic and readily available placental blood from returning to the infant. Loss of this blood initiates an inflammatory response leading to seizures, hypoxic-ischemic encephalopathy, and brain damage or death. Animal studies have shown that human umbilical stem cells injected into a rat's abdomen after induced brain damage, can protect the rat's brain from developing permanent injury. To prevent damage to newborns, the infant must receive the blood volume and stem cells lost at the time of descent and immediate cord clamping. Recommended countermeasures for research include: (1) resuscitation at the perineum with intact cord: or (2) milking the cord before clamping; or (3) autologous transfusion of placenta blood after the birth; or (4) rapid transfusion of 0 negative blood after birth and before seizures begin. (C) 2008 Elsevier Ltd. All rights reserved.	[Mercer, J.; Erickson-Owens, D.] Univ Rhode Isl, Coll Nursing, Kingston, RI 02881 USA; [Mercer, J.; Erickson-Owens, D.] Brown Univ, Providence, RI 02912 USA; [Skovgaard, R.] Highland Hosp, Univ Rochester, Dept Obstet & Gynecol, Rochester, NY USA		Mercer, J (corresponding author), 76 Woodbury Rd, Cranston, RI 02905 USA.	jmercer@uri.edu					[Anonymous], 2003, INT J GYNECOL OBSTET, V80, P87; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; BALL RH, 1992, AM J OBSTET GYNECOL, V166, P1683, DOI 10.1016/0002-9378(92)91557-Q; BALLIN A, 1995, ARCH DIS CHILD-FETAL, V73, pF181, DOI 10.1136/fn.73.3.F181; BARKOVICH AJ, 1990, PEDIAT NEUROIMAGING, V1, P355; BLACKBURN S, 2003, MATERNAL FETAL NEONA, P781; CASHORE WJ, 1973, PEDIATR RES, V7, P399; COLOZZI AE, 1954, NEW ENGL J MED, V250, P629, DOI 10.1056/NEJM195404152501502; Copstead L.C, 2000, PATHOPHYSIOLOGY BIOL; Dhar K K, 1995, J Indian Med Assoc, V93, P451; Dildy GA, 2000, CLIN OBSTET GYNECOL, V43, P265, DOI 10.1097/00003081-200006000-00005; Ewy GA, 2006, AM J MED, V119, P6, DOI 10.1016/j.amjmed.2005.06.067; Ewy GA, 2005, CIRCULATION, V111, P2134, DOI 10.1161/01.CIR.0000162503.57657.FA; FAXELIUS G, 1977, J PEDIATR-US, V90, P273, DOI 10.1016/S0022-3476(77)80650-1; GUYTON AC, 2006, TXB MED PHYSL, V1, P1116; Hensleigh PA, 2002, BJOG-INT J OBSTET GY, V109, P1377, DOI 10.1046/j.1471-0528.2002.02197.x; Hope P, 1998, BRIT J OBSTET GYNAEC, V105, P1256, DOI 10.1111/j.1471-0528.1998.tb10003.x; Hosono S, 2008, ARCH DIS CHILD-FETAL, V93, pF14, DOI 10.1136/adc.2006.108902; Iffy L, 2001, Med Law, V20, P627; Iffy L, 2006, MED LAW, V25, P553; Iffy L, 1994, Med Law, V13, P323; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jevitt CM, 2005, J MIDWIFERY WOM HEAL, V50, P485, DOI 10.1016/j.jmwh.2005.07.005; JONES JG, 1990, BRIT J HAEMATOL, V76, P288, DOI 10.1111/j.1365-2141.1990.tb07886.x; Kattwinkel JE, 2006, TXB NEONATAL RESUSCI, V5th; LANZKOWSKY P, 1960, BMJ-BRIT MED J, V5215, P1777; McCAUSLAND A M, 1949, Calif Med, V71, P190; Meier C, 2006, PEDIATR RES, V59, P244, DOI 10.1203/01.pdr.0000197309.08852.f5; MERCER J, 2004, NORMA CHILDBIRTH EVI; Mercer JS, 2005, J MIDWIFERY WOM HEAL, V50, P373, DOI 10.1016/j.jmwh.2005.04.023; Mercer JS, 2002, J PERINAT NEONAT NUR, V15, P56, DOI 10.1097/00005237-200203000-00007; Miller LMJ, 2006, ANIM REPROD SCI, V94, P54, DOI 10.1016/j.anireprosci.2006.03.072; Nelson KB, 1998, AM J OBSTET GYNECOL, V179, P507, DOI 10.1016/S0002-9378(98)70387-4; Nodwell A, 2005, OBSTET GYNECOL, V105, P129, DOI 10.1097/01.AOG.0000146635.51033.9d; Osak R, 1997, EARLY HUM DEV, V49, P193, DOI 10.1016/S0378-3782(97)00030-3; Perlman JM, 2006, CLIN THER, V28, P1353, DOI 10.1016/j.clinthera.2006.09.005; PRENDIVILLE WJ, 1988, BMJ-BRIT MED J, V297, P1295, DOI 10.1136/bmj.297.6659.1295; Rajnik M, 2002, SHOCK, V17, P322, DOI 10.1097/00024382-200204000-00015; Rogers J, 1998, LANCET, V351, P693, DOI 10.1016/S0140-6736(97)09409-9; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; SHEPHERD AJ, 1985, AM J DIS CHILD, V139, P71, DOI 10.1001/archpedi.1985.02140030073033; SIDDALL RS, 1952, AM J OBSTET GYNECOL, V63, P1059, DOI 10.1016/0002-9378(52)90546-2; SIDDALL RS, 1953, OBSTET GYNECOL, V1, P230; STEMBERA ZK, 1965, AM J OBSTET GYNECOL, V91, P568, DOI 10.1016/0002-9378(65)90130-4; STEMBERA ZK, 1968, AM J OBSTET GYNECOL, V101, P546, DOI 10.1016/0002-9378(68)90568-1; Strauss RG, 2003, TRANSFUSION, V43, P1168, DOI 10.1046/j.1537-2995.2003.00454.x; USHER R, 1963, ACTA PAEDIATR, V52, P497, DOI 10.1111/j.1651-2227.1963.tb03809.x; VANHAESEBROUCK P, 1987, ARCH DIS CHILD, V62, P1276, DOI 10.1136/adc.62.12.1276; VOLPE JJ, 2001, NEUROLOGY NEWBORN, P912; WALSH SZ, 1969, BRIT HEART J, V31, P122; WHIPPLE GA, 1957, OBSTET GYNECOL, V10, P603, DOI 10.1097/00006250-195712000-00002; YAO AC, 1969, LANCET, V2, P871; Yao BD, 2002, APPL PHYS LETT, V81, P757, DOI 10.1063/1.1495878	53	20	20	0	6	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	APR	2009	72	4					458	463		10.1016/j.mehy.2008.11.019			6	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	425EM	WOS:000264619800025	19121560	Green Published			2022-02-06	
J	Stuehmer, C; Blum, KS; Kokemueller, H; Tavassol, F; Bormann, KH; Gellrich, NC; Rucker, M				Stuehmer, Constantin; Blum, Katrin S.; Kokemueller, Horst; Tavassol, Frank; Bormann, Kai Hendrik; Gellrich, Nils-Claudius; Ruecker, Martin			Influence of Different Types of Guns, Projectiles, and Propellants on Patterns of Injury to the Viscerocranium	JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY			English	Article							WOUNDS; HEAD; SHOTGUN	Purpose: Gunshot injuries to the Oral and craniomaxillofacial region vary with the type of gun used. Computed tomography (CT) is the standard diagnostic tool for assessing tissue damage in patients with gunshot injuries. Cone-beam computed tomography (CBCT) is a new imaging technique that has recently become available for clinical diagnosis. The objective of this study was to characterize injury patterns with a focus on gun types and identify the imaging modality that is best suited to assessing injuries caused by different gun types. Patients and Methods: We present the cases of 14 patients who sustained gunshot injuries to the viscerocranium during the past 10 years. The injuries were caused by 8 basic combinations of handguns or long guns with soft lead core projectiles, partial or full metal-jacketed bullets, and different propellants. Diagnosis was based on clinical and radiological findings (including CT and CBCT). Results: We found a direct correlation between the gun/projectile combination on the one hand and the diameter of the wound track, tissue contamination, and tissue destruction on the other. Entrance and exit Wounds are indicative of certain gun/projectile combinations. High-density projectiles cause severe artifacts in CT, unlike CBCT, making it difficult to evaluate anatomic structures in close proximity to the projectile. Conclusions: Every gun/projectile combination is associated with a typical pattern of injury. Even in the absence of the offending projectile, it is thus possible to narrow clown the likely gun and/or projectile. In the diagnostic imaging of injuries caused by high-density projectiles, CBCT is more suitable than CT. (C) 2009 American Association of Oral and Maxillofacial Surgeons	[Stuehmer, Constantin; Kokemueller, Horst; Tavassol, Frank; Bormann, Kai Hendrik; Gellrich, Nils-Claudius; Ruecker, Martin] Hannover Med Sch, Ctr Dent Oral & Orthodont Surg, Dept Oral & Maxillofacial Surg, D-30625 Hannover, Germany; [Blum, Katrin S.] Hannover Med Sch, Dept Diagnost Radiol, D-30625 Hannover, Germany		Stuehmer, C (corresponding author), Hannover Med Sch, Ctr Dent Oral & Orthodont Surg, Dept Oral & Maxillofacial Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.	constuehmer@web.de					Betz P, 1997, FORENSIC SCI INT, V86, P155, DOI 10.1016/S0379-0738(97)02121-X; Bowyer GW, 1996, J TRAUMA, V40, pS159, DOI 10.1097/00005373-199603001-00035; HARRUFF RC, 1995, J FORENSIC SCI, V40, P801; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Obajimi M O, 2004, West Afr J Med, V23, P58; Pohlenz P, 2007, ORAL SURG ORAL MED O, V103, P412, DOI 10.1016/j.tripleo.2006.05.008; Rothschild MA, 2000, INT J LEGAL MED, V113, P349; Salzano A, 2000, Radiol Med, V99, P26; Scialpi M, 1995, Radiol Med, V89, P485; STIERNBERG CM, 1992, ARCH OTOLARYNGOL, V118, P592; Vayvada H, 2005, J CRANIOFAC SURG, V16, P794, DOI 10.1097/01.scs.0000180014.06352.65; Verleisdonk E J M M, 2002, Ned Tijdschr Geneeskd, V146, P1271	12	20	23	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0278-2391			J ORAL MAXIL SURG	J. Oral Maxillofac. Surg.	APR	2009	67	4					775	781		10.1016/j.joms.2008.08.036			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	427VZ	WOS:000264808500010	19304034				2022-02-06	
J	Terre, R; Mearin, F				Terre, R.; Mearin, F.			Evolution of tracheal aspiration in severe traumatic brain injury-related oropharyngeal dysphagia: 1-year longitudinal follow-up study	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						aspiration; deglutition; dysphagia; outcome; traumatic brain injury; videofluoroscopy	DISABILITY RATING-SCALE; ACUTE STROKE; INTERRATER RELIABILITY; SWALLOWING DISORDERS; HEAD TRAUMA; PROGRESSION; PREDICTORS	The aims of the article were to ascertain the clinical evolution and prognostic factors of aspiration recovery and feeding outcome in patients with severe traumatic brain injury (TBI) and a videofluoroscopic (VFS) diagnosis of tracheal aspiration. Twenty-six patients with severe TBI and VFS diagnosis of tracheal aspiration were prospectively evaluated. Clinical evaluation of oropharyngeal dysphagia and VFS examination were performed at admission and repeated at 1, 3, 6 and 12 months of follow-up. At admission, all patients had VFS aspiration. During follow-up, an improvement was observed in both oral and pharyngeal function, with the number of patients with aspiration decreasing progressively. The most significant change occurred in the examination made at 3 months. At 1 year, only 23% of patients had aspiration. No patient had clinically significant respiratory infections during the follow-up period. Persistent aspiration at 1 year of follow-up correlated with baseline variables: Rancho Los Amigos Level Cognitive Function Scale score, Disability Rating Scale score, tongue control alteration, velopharyngeal reflex abolition and delay in triggering swallowing reflex. Swallowing physiology in severe TBI greatly improved during follow-up and the number of aspirations decreased progressively, with the most significant reduction at between 3 and 6 months of evolution. This study revealed several prognostic factors for persisting aspiration: neurological involvement (evaluated with the Rancho Los Amigos Level Cognitive Function Scale and Disability Rating Scale), tongue control alteration, oropharyngeal reflex abolition and delay in triggering swallowing reflex at baseline.	[Terre, R.; Mearin, F.] Univ Barcelona, Univ Inst Affiliated Autonomous, Neurorehabil Hosp, Inst Guttmann,Funct Digest Rehabil, Badalona, Spain		Terre, R (corresponding author), Inst Guttmann, Funct Digest Rehabil, Cami Can Ruti S-N, Badalona 08916, Spain.	rterre@gutmann.com					COPE DN, 1982, ARCH PHYS MED REHAB, V63, P433; Daniels SK, 1998, ARCH PHYS MED REHAB, V79, P14, DOI 10.1016/S0003-9993(98)90200-3; Ekberg O, 1988, Dysphagia, V3, P46, DOI 10.1007/BF02406279; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C, 1979, REHABILITATION HEAD, P87; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; HORNER J, 1993, NEUROLOGY, V43, P430, DOI 10.1212/WNL.43.2.430; HORNER J, 1988, NEUROLOGY, V38, P317, DOI 10.1212/WNL.38.2.317; Kim Y, 2005, DYSPHAGIA, V20, P290, DOI 10.1007/s00455-005-0029-6; LAZARUS C, 1987, ARCH PHYS MED REHAB, V68, P79; Lazarus CL, 1989, J HEAD TRAUMA REHAB, V4, P34; LINDEN P, 1983, ARCH PHYS MED REHAB, V64, P281; Linden P., 1993, Dysphagia, V8, P170, DOI 10.1007/BF01354535; Logemann J., 1993, MANUAL VIDEOFLUOROGR, P115; Logemann JA, 2000, J SPEECH LANG HEAR R, V43, P1264, DOI 10.1044/jslhr.4305.1264; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Logemann JA, 1998, EVALUATION TREATMENT, P307; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; McCullough GH, 2005, J SPEECH LANG HEAR R, V48, P1280, DOI 10.1044/1092-4388(2005/089); Morgan A, 2004, BRAIN INJURY, V18, P359, DOI 10.1080/02699050310001617424; Perlman Adrienne L., 1994, Dysphagia, V9, P90, DOI 10.1007/BF00714593; Ramsey D, 2005, DYSPHAGIA, V20, P105, DOI 10.1007/s00455-004-0024-3; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schurr MJ, 1999, J TRAUMA, V46, P817, DOI 10.1097/00005373-199905000-00009; Scott A, 1998, DYSPHAGIA, V13, P223, DOI 10.1007/PL00009576; Smithard DG, 1998, AGE AGEING, V27, P99, DOI 10.1093/ageing/27.2.99; Spechler SJ, 1999, GASTROENTEROLOGY, V117, P233, DOI 10.1016/S0016-5085(99)70573-1; STANNERS JAB, 1993, AGE AGEING, V2, P47; Stoeckli SJ, 2003, DYSPHAGIA, V18, P53, DOI 10.1007/s00455-002-0085-0; Terre R, 2006, NEUROGASTROENT MOTIL, V18, P200, DOI 10.1111/j.1365-2982.2005.00729.x; Terrte R, 2007, BRAIN INJURY, V21, P1411, DOI 10.1080/02699050701785096; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Ward EC, 2007, J HEAD TRAUMA REHAB, V22, P184, DOI 10.1097/01.HTR.0000271119.96780.f5; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992	36	20	24	0	12	WILEY-BLACKWELL PUBLISHING, INC	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	1350-1925			NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	APR	2009	21	4					361	369		10.1111/j.1365-2982.2008.01208.x			9	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	418RD	WOS:000264165200003	19019014				2022-02-06	
J	Ackery, A; Provvidenza, C; Tator, CH				Ackery, Alun; Provvidenza, Christine; Tator, Charles H.			Concussion in Hockey: Compliance with Return to Play Advice and Follow-up Status	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							SPORT-RELATED CONCUSSION; ICE HOCKEY; MANAGEMENT; INJURY; PREVENTION; SCIENCE	Objectives: To determine the compliance rate among hockey players with Concussion of other head injuries who were advised by a physician about return to play. To assess compliance of hockey players with return to play advice and to assess the incidence of long-term post-concussion symptoms. Methods: A retrospective chart review, telephone questionnaire and follow-up analysis of income. level of education and professional aspirations. The study examined 40 hockey players with concussion or other head injury treated at a neurosurgical ambulatory clinic, who had initial visits between 1995 and 2003, and had been seen at least two years prior to completing the questionnaire. Results: There was a 58% (23 of 40) participation rate in the Study. Fifteen (65%) of the 23 participants were advised to never return to play, and 5 (33%) were non-compliant and returned to play. Four (80%) of the five noncompliant players continued to suffer from post concussion Symptoms. Overall, 15 (65%) of the 23 players participating in the Study continued to suffer post concussion symptoms at least two years after the clinic visit. Conclusions: Five (33%) of 15 hockey players advised to never return to play were non-compliant and returned to play, and four continued 10 suffer from post concussion Symptoms two or more years later. After repeated concussions, 65% of hockey players had long-term sequelae that prevented return to play and produced long-term post-concussion symptoms.	[Ackery, Alun; Provvidenza, Christine; Tator, Charles H.] Univ Toronto, ThinFirst Canada, Toronto, ON, Canada; [Ackery, Alun] Univ Toronto, Fac Med, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada		Tator, CH (corresponding author), Toronto Western Hosp, 399 Bathurst St 4W-433, Toronto, ON M5T 2S8, Canada.		Ackery, Alun/B-6634-2016		Dr. Tom Pashby Sport Safety Fund; Tridel Corporation the Ontario Neurotrauma Foundation; Krembil Family Foundation	ThinkFirst gratefully acknowledges support for its injury prevention programs from the Dr. Tom Pashby Sport Safety Fund, Tridel Corporation the Ontario Neurotrauma Foundation and the Krembil Family Foundation.	Bailes JE, 2001, J ATHL TRAINING, V36, P236; Cantu RC, 2003, CLIN SPORT MED, V22, P593, DOI 10.1016/S0278-5919(02)00095-9; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cook DJ, 2003, INJURY PREV, V9, P361, DOI 10.1136/ip.9.4.361; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Goodman D, 2006, J ADOLESCENCE, V29, P351, DOI 10.1016/j.adolescence.2005.07.004; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Grindel SH, 2001, CLIN J SPORT MED, V11, P134, DOI 10.1097/00042752-200107000-00003; Johnston KM, 2001, CLIN J SPORT MED, V11, P150, DOI 10.1097/00042752-200107000-00005; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Leclerc S, 2001, SPORTS MED, V31, P629, DOI 10.2165/00007256-200131080-00007; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2001, CLIN J SPORT MED, V11, P160, DOI 10.1097/00042752-200107000-00006; McCrory P, 1999, BRIT J SPORT MED, V33, P136, DOI 10.1136/bjsm.33.2.136; McCrory Paul, 2005, Clin J Sport Med, V15, P48; *MED CAOS, 2000, CAN J SPORT MED, P10; Oliaro S, 2001, J ATHL TRAINING, V36, P257; Tator CH, 2001, NEUROLOGICAL SPORTS, P261; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832	23	20	20	1	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0317-1671	2057-0155		CAN J NEUROL SCI	Can. J. Neurol. Sci.	MAR	2009	36	2					207	212		10.1017/S0317167100120281			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	421OB	WOS:000264367100015	19378716	Bronze			2022-02-06	
J	Tong, M; Holmes, GM				Tong, M.; Holmes, G. M.			Gastric dysreflexia after acute experimental spinal cord injury in rats	NEUROGASTROENTEROLOGY AND MOTILITY			English	Article						gastric motility; neurotrauma; receptive relaxation reflex; vagovagal reflex	VAGO-VAGAL REFLEX; GASTROINTESTINAL TRANSIT; AUTONOMIC DYSREFLEXIA; AFFERENT-FIBERS; RELAXATION; NEURONS; TRANSECTION; PATHWAYS; MOTILITY; NUCLEUS	Gastric reflexes are mediated mainly by vago-vagal reflex circuits in the caudal medulla. Despite the fact that brainstem vago-vagal circuitry remains intact after spinal cord injury (SCI), patients with SCI at the cervical level most often present gastric stasis with an increased risk of reflux and aspiration of gastric contents. Using a miniature strain gauge sutured to the gastric surface; we tested gastric motility and reflexive gastric relaxation following oesophageal distension (oesophageal-gastric relaxation reflex) in animals 3 days after a severe spinal contusion at either the third or ninth thoracic spinal segment (acute T3- or T9 SCI, respectively). Both basal gastric motility and the oesophageal-gastric relaxation reflex were significantly diminished in animals with T3 SCI. Conversely, both basal gastric motility and the oesophageal-gastric relaxation reflex were not significantly reduced in T9 SCI animals compared to controls. The reduced gastric motility and oesophageal-gastric reflex in T3 SCI rats was not ameliorated by celiac sympathectomy. Our results show that gastric stasis following acute SCI is independent of altered spinal sympathetic input to the stomach caudal to the lesion. Our data suggest that SCI may alter the sensitivity of vagal reflex function, perhaps by interrupting ascending spinosolitary input to brainstem vagal nuclei.	[Tong, M.; Holmes, G. M.] Louisiana State Univ, Pennington Biomed Res Ctr, Neurotrauma & Nutr Lab, Baton Rouge, LA 70808 USA		Holmes, GM (corresponding author), Louisiana State Univ, Pennington Biomed Res Ctr, Neurotrauma & Nutr Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	holmesgm@pbrc.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [49177]; Pennington Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK072476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049177] Funding Source: NIH RePORTER	The authors extend a special note of thanks to Drs R. Alberto Travagli, Kirsteen Browning and Stefany Primeaux for their commentary during the preparation of the manuscript. We thank Emily Creekmore for her assistance with data collection and analysis. We thank Dr Barry Robert, Cynthia Kloster, Hsin (Frank) Hsu and Shannon Sterba for their technical assistance. Grants: This work was supported by NINDS grant #49177 and the Pennington Foundation.	ABRAHAMSSON H, 1973, ACTA PHYSIOL SCAND, P1; ABRAHAMSSON H, 1969, ACTA PHYSIOL SCAND, V77, P172, DOI 10.1111/j.1748-1716.1969.tb04561.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BERLLY MH, 1984, ARCH PHYS MED REHAB, V65, P687; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; BUELKESAM J, 1978, LAB ANIM SCI, V28, P157; Cannon WB, 1911, AM J PHYSIOL, V29, P267, DOI 10.1152/ajplegacy.1911.29.2.267; Cosman B C, 1991, J Am Paraplegia Soc, V14, P175; Dwyer KM, 2002, J TRAUMA, V52, P26, DOI 10.1097/00005373-200201000-00007; EUCHNERWAMSER I, 1993, J NEUROPHYSIOL, V69, P868, DOI 10.1152/jn.1993.69.3.868; FEALEY RD, 1984, GASTROENTEROLOGY, V87, P69; Fukuda H, 2005, NEUROGASTROENT MOTIL, V17, P245, DOI 10.1111/j.1365-2982.2004.00602.x; Gamboa-Esteves FO, 2001, BRAIN RES, V921, P195, DOI 10.1016/S0006-8993(01)03118-3; Gillis R. A., 1989, HDB PHYSL 6, P621; Gondim FAA, 1999, SPINAL CORD, V37, P793, DOI 10.1038/sj.sc.3100923; Gondim FDA, 2001, AUTON NEUROSCI-BASIC, V87, P52; HERMANN G, 1995, NEUROIMMUNOMODULAT, V2, P74, DOI 10.1159/000096874; Hermann GE, 2006, AM J PHYSIOL-REG I, V290, pR1570, DOI 10.1152/ajpregu.00717.2005; Holmes GM, 2005, EXP NEUROL, V193, P29, DOI 10.1016/j.expneurol.2005.01.002; JANSSON G, 1969, ACTA PHYSIOL SCAND, V75, P245, DOI 10.1111/j.1748-1716.1969.tb04376.x; Johnson LR., 1987, PHYSL GASTROINTESTIN, P507; Kabatas S, 2008, NEUROSCIENCE, V154, P1627, DOI 10.1016/j.neuroscience.2008.04.071; Kao CH, 1999, DIGEST DIS SCI, V44, P1512, DOI 10.1023/A:1026690305537; KEWALRAMANI LS, 1979, J TRAUMA, V19, P259, DOI 10.1097/00005373-197904000-00008; Kirshblum SC, 2002, ARCH PHYS MED REHAB, V83, pS50, DOI 10.1053/apmr.2002.32156; Krantis A, 1998, AM J PHYSIOL-GASTR L, V275, pG897, DOI 10.1152/ajpgi.1998.275.5.G897; Krowicki ZK, 1999, J AUTONOM NERV SYST, V77, P83, DOI 10.1016/S0165-1838(99)00033-8; Laird AS, 2006, J PHYSIOL-LONDON, V577, P539, DOI 10.1113/jphysiol.2006.116301; Leal P. R., 2007, Autonomic & Autacoid Pharmacology, V27, P167, DOI 10.1111/j.1474-8673.2007.00408.x; Leal PRL, 2008, AUTON NEUROSCI-BASIC, V141, P66, DOI 10.1016/j.autneu.2008.05.006; Lu WY, 1998, AM J PHYSIOL-REG I, V274, pR1436; Lu WY, 1998, AM J PHYSIOL-REG I, V274, pR1425, DOI 10.1152/ajpregu.1998.274.5.R1425; Maiorov DN, 1997, AM J PHYSIOL-HEART C, V272, pH625, DOI 10.1152/ajpheart.1997.272.2.H625; MCCANN MJ, 1992, J PHYSIOL-LONDON, V453, P401, DOI 10.1113/jphysiol.1992.sp019235; MCCANN MJ, 1994, INNERVATION OF THE GUT, P81; Medeiros BA, 2008, AUTON NEUROSCI-BASIC, V139, P24, DOI 10.1016/j.autneu.2007.12.003; MENETREY D, 1991, EUR J NEUROSCI, V3, P249, DOI 10.1111/j.1460-9568.1991.tb00087.x; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; NEUHUBER W, 1979, ANAT EMBRYOL, V155, P355, DOI 10.1007/BF00317648; NINOMURCIA M, 1992, AM J ROENTGENOL, V158, P279, DOI 10.2214/ajr.158.2.1729781; Oakley PA, 2001, RESUSCITATION, V48, P37, DOI 10.1016/S0300-9572(00)00316-6; ORMSBEE HS, 1976, AM J PHYSIOL, V230, P389; Ozaki N, 2001, AM J PHYSIOL-GASTR L, V281, pG1449, DOI 10.1152/ajpgi.2001.281.6.G1449; Powley TL, 2004, PHYSIOL BEHAV, V82, P69, DOI 10.1016/j.physbeh.2004.04.037; Primeaux SD, 2007, AM J PHYSIOL-REG I, V293, pR1102, DOI 10.1152/ajpregu.00224.2007; Qin C, 2003, AUTON NEUROSCI-BASIC, V109, P10, DOI 10.1016/j.autneu.2003.08.005; Rabchevsky AG, 1999, J NEUROTRAUM, V16, P817, DOI 10.1089/neu.1999.16.817; Rabchevsky AG, 2000, EXP NEUROL, V164, P280, DOI 10.1006/exnr.2000.7399; Rabchevsky AG, 2006, PROG BRAIN RES, V152, P265, DOI 10.1016/S0079-6123(05)52017-X; RAJENDRAN SK, 1992, AM J GASTROENTEROL, V87, P1614; RENEHAN WE, 1995, AM J PHYSIOL-GASTR L, V268, pG780, DOI 10.1152/ajpgi.1995.268.5.G780; Rogers RC, 1999, J PHYSIOL-LONDON, V514, P369, DOI 10.1111/j.1469-7793.1999.369ae.x; Rogers RC, 2003, AM J PHYSIOL-REG I, V285, pR479, DOI 10.1152/ajpregu.00155.2003; Rogers RC, 1996, NEUROSCI BIOBEHAV R, V20, P57, DOI 10.1016/0149-7634(95)00040-L; SEGAL JL, 1995, AM J GASTROENTEROL, V90, P466; Sengupta J. N., 2000, American Journal of Medicine, V108, p87S; SENGUPTA JN, 1989, J NEUROPHYSIOL, V61, P1001, DOI 10.1152/jn.1989.61.5.1001; STINNEFORD JG, 1993, PARAPLEGIA, V31, P384, DOI 10.1038/sc.1993.64; TAKAHASHI T, 1995, J PHYSIOL-LONDON, V484, P481, DOI 10.1113/jphysiol.1995.sp020680; Takahashi T, 1997, J PHYSIOL-LONDON, V504, P479, DOI 10.1111/j.1469-7793.1997.479be.x; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; TRAVAGLI RA, 2004, NEUROGASTROENTEROLOG; Weaver LC, 2006, PROG BRAIN RES, V152, P245, DOI 10.1016/S0079-6123(05)52016-8; Wolf C, 2003, SPINAL CORD, V41, P347, DOI 10.1038/sj.sc.3101440; Yamada M, 2006, NEUROSCI RES, V54, P261, DOI 10.1016/j.neures.2005.12.007; ZAGON A, 1993, NEUROSCIENCE, V54, P729, DOI 10.1016/0306-4522(93)90243-9	66	20	20	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1350-1925	1365-2982		NEUROGASTROENT MOTIL	Neurogastroenterol. Motil.	FEB	2009	21	2					197	206		10.1111/j.1365-2982.2008.01215.x			10	Gastroenterology & Hepatology; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Gastroenterology & Hepatology; Neurosciences & Neurology	397UT	WOS:000262688300013	19126185	Green Accepted			2022-02-06	
J	Aghakhani, N; Durand, P; Chevret, L; Parker, F; Devictor, D; Tardieu, M; Tadie, M				Aghakhani, Nozar; Durand, Philippe; Chevret, Laurent; Parker, Fabrice; Devictor, Denis; Tardieu, Marc; Tadie, Marc			Decompressive craniectomy in children with nontraumatic refractory high intracranial pressure Clinical article	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						craniectomy; intracranial hypertension; outcome; pediatric neurosurgery	HERPES-SIMPLEX ENCEPHALITIS; TRAUMATIC BRAIN-INJURY; SCORE	Object. In this study, the authors investigated the clinical efficacy of decompressive craniectomy treatments for nontraumatic intracranial hypertension in children. Methods. Seven patients with nontraumatic refractory high intracranial pressure (ICP) were enrolled in the study between 1995 and 2005; there were 2 boys and 5 girls with a mean age of 9 years (range 4-14). Decompressive craniectomy was performed in all patients after standard medical therapy had proven insufficient and ICP remained > 50 mm Hg. All patients had a Glasgow Coma Scale score < 8 at admission and a mean Pediatric Risk of Mortality Scale score of 20 (range 10-27). Results. One patient died of persistent high ICP and circulatory failure 48 hours after surgery. Six months later, according to their Glasgow Outcome Scale scores, 3 patients had adequate recoveries, 2 patients recovered with moderate disabilities, and 1 patient had severe disabilities. According to the Pediatric Overall Performance Category Scale, 4 patients received a score of 2 (mild disability), 1 a score of 3 (moderate disability), and 1 a score of 4 (severe disability). Five patients returned to school and normal life. Conclusions. The authors found decompressive craniectomy to be an effective and lifesaving technique in children. This procedure should be included in the arsenal of treatments for nontraumatic intracranial hypertension.	[Aghakhani, Nozar; Parker, Fabrice; Tadie, Marc] Bicetre Univ Hosp, Dept Neurosurg, F-94275 Le Kremlin Bicetre, France; [Tardieu, Marc] Bicetre Univ Hosp, Dept Pediat Neurol, F-94275 Le Kremlin Bicetre, France; [Durand, Philippe; Chevret, Laurent; Devictor, Denis] Bicetre Univ Hosp, Pediat Intens Care Unit, F-94275 Le Kremlin Bicetre, France		Aghakhani, N (corresponding author), Bicetre Univ Hosp, Dept Neurosurg, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	nozar.aghakhani@bct.aphp.fr	aghakhani, nozar/ABF-7908-2021	aghakhani, nozar/0000-0001-8389-8167			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Ausman J I, 1976, Surg Neurol, V6, P97; Bayram N, 2008, EUR J PEDIATR, V167, P821, DOI 10.1007/s00431-007-0566-0; Chesnut Randall M., 1997, Emergency Medicine Clinics of North America, V15, P581, DOI 10.1016/S0733-8627(05)70319-9; CHI C-S, 1990, Acta Paediatrica Japonica, V32, P426; Ebel H, 1999, CHILD NERV SYST, V15, P84, DOI 10.1007/s003810050337; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; GREENGARD J, 1962, JAMA-J AM MED ASSOC, V180, P660, DOI 10.1001/jama.1962.03050210022005; JENNETT B, 1975, LANCET, V1, P480; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Leteurtre S, 2003, LANCET, V362, P192, DOI 10.1016/S0140-6736(03)13908-6; POLLACK MM, 1988, CRIT CARE MED, V16, P1110, DOI 10.1097/00003246-198811000-00006; Schwab S, 1997, NEUROLOGY, V48, P412, DOI 10.1212/WNL.48.2.412; Simma B, 2002, INTENS CARE MED, V28, P1000, DOI 10.1007/s00134-002-1333-3; Taferner E, 2001, INTENS CARE MED, V27, P1426, DOI 10.1007/s001340101027; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Yan HJ, 2002, SURG NEUROL, V57, P20, DOI 10.1016/S0090-3019(01)00688-7	19	20	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707			J NEUROS-PEDIATR	J. Neurosurg.-Pediatr.	JAN	2009	3	1					66	69		10.3171/2008.10.PEDS08116			4	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	388LA	WOS:000262020100013	19119908				2022-02-06	
J	de Andrade, AF; Paiva, WS; de Amorim, RLO; Figueiredo, EG; Neto, ER; Teixeira, MJ				de Andrade, Almir Ferreira; Paiva, Wellingson Silva; Oliveira de Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Rusafa Neto, Eloy; Teixeira, Manoel Jacobsen			THE PATHOPHYSIOLOGICAL MECHANISMS FOLLOWING TRAUMATIC BRAIN INJURY	REVISTA DA ASSOCIACAO MEDICA BRASILEIRA			Portuguese	Article						Trauma; Brain injuries; Physiopathology; Review	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; PLATEAU WAVES; APOPTOSIS; HEMATOMA; METABOLISM; HUMANS; DAMAGE; EDEMA	Traumatic brain injury is the main cause of death and disability in children and adults in Western Countries. The definitive brain injury is a consequence of pathophysiological mechanisms that begin at the moment of an accident and may extend for days or weeks. Traumatic brain injury may be classified as diffuse or focal. These two mechanisms are commonly associated in a patient, however one is generally predominant. Therefore knowledge of the pathophysiological mechanisms or brain injury in head trauma is important to establish the therapeutic, clinical and surgical measures. In this paper the authors present a critical review of the literature on the pathophysiological principles of traumatic brain injury. [Rev Assoc Med Bras 2009; 55(1): 75-81]	[de Andrade, Almir Ferreira; Paiva, Wellingson Silva; Oliveira de Amorim, Robson Luis; Figueiredo, Eberval Gadelha; Rusafa Neto, Eloy; Teixeira, Manoel Jacobsen] Univ Sao Paulo, Fac Med, Hosp Clin, Div Neurocirurgia, Sao Paulo, Brazil		Paiva, WS (corresponding author), Rua Dr Ovidio Pires Campos 171,Apto 511, BR-05403010 Sao Paulo, Brazil.	wellingsonpaiva@yahoo.com.br	Paiva, Wellingson S/G-5517-2013; Figueiredo, Eberval Gadelha/H-3488-2012; Figueiredo, Eberval G/E-2071-2016; Teixeira, Manoel J/E-3110-2012; Amorim, Robson/AAK-1368-2021	Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519			Adekoya N, 2004, PUBLIC HEALTH REP, V119, P486, DOI 10.1016/j.phr.2004.07.006; Aldrich EF, 1996, NEUROLOGICAL SURG, P1719; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; BAYKANER K, 1988, SURG NEUROL, V30, P339, DOI 10.1016/0090-3019(88)90195-4; Bor-Seng-Shu E, 2006, J NEUROSURG, V104, P93, DOI 10.3171/jns.2006.104.1.93; Bor-Seng-Shu Edson, 2004, Neurosurg Focus, V16, pECP1; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Cameron PA, 2004, J TRAUMA, V56, P890, DOI 10.1097/01.TA.0000053398.40463.51; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Engberg AW, 2004, ACTA NEUROL SCAND, V110, P281, DOI 10.1111/j.1600-0404.2004.00323.x; Firsching R, 2001, WORLD J SURG, V25, P1221; FRANCEL P, 1996, NEUROLOGICAL SURG, P1595; Gennarelli, 1998, Semin Clin Neuropsychiatry, V3, P160; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Goodman JC, 1999, TRAUMATIC BRAIN INJU, P143; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kelly DF, 1996, NEUROTRAUMA, P71; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kors EE, 2001, ANN NEUROL, V49, P753, DOI 10.1002/ana.1031; Kraus JF, 1993, HEAD INJURY, P1; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Maragos WF, 2004, J NEUROCHEM, V91, P257, DOI 10.1111/j.1471-4159.2004.02736.x; Marmarou A, 2003, ACT NEUR S, V86, P7; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; McArthur DL, 2004, BRAIN PATHOL, V14, P185, DOI 10.1111/j.1750-3639.2004.tb00052.x; McCrory P, 2001, BRIT J SPORT MED, V35, P380, DOI 10.1136/bjsm.35.6.380; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Meixensberger J, 2001, NEUROL RES, V23, P801, DOI 10.1179/016164101101199379; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; MILLER JD, 1987, TRAUMATIC BRAIN EDEM, P99; MILLER JD, 1993, TRAUMATIC BRAIN SWEL, P331; Nathoo N, 2003, J NEUROSURG, V98, P302, DOI 10.3171/jns.2003.98.2.0302; Nau R, 2002, BRAIN PATHOL, V12, P329; Ng I, 2000, NEUROSURGERY, V46, P949, DOI 10.1097/00006123-200004000-00034; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Polster BM, 2004, J NEUROCHEM, V90, P1281, DOI 10.1111/j.1471-4159.2004.02572.x; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; SAFAR P, 1997, TXB NEUROANESTHESIA, P557; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Sawauchi S, 2007, NEUROL SURG TOKYO, V35, P665; Teasdale G, 1996, NEUROLOGICAL SURG, P1533; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014	50	20	22	1	7	ASSOC MEDICA BRASILEIRA	SAO PAULO	RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL	0104-4230			REV ASSOC MED BRAS	Rev. Assoc. Med. Bras.		2009	55	1					75	81		10.1590/S0104-42302009000100020			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	442GO	WOS:000265829800019	19360283	Green Published, Green Submitted, gold			2022-02-06	
J	Kim, HJ; Craik, FIM; Luo, L; Ween, JE				Kim, Hyun Jung; Craik, Fergus I. M.; Luo, Lin; Ween, Jon Erik			Impairments in prospective and retrospective memory following stroke	NEUROCASE			English	Article						Stroke; Prospective memory; Cognition; Executive function; Retrospective memory	TRAUMATIC BRAIN-INJURY; VASCULAR COGNITIVE IMPAIRMENT; STRATEGY APPLICATION DISORDER; FRONTAL LOBES; AGE; PERFORMANCE; INTENTIONS; DEMENTIA; LESIONS; ADULTS	Prospective memory (PM) is the ability to carry out a planned intention at a future time. We studied PM deficits in a group of community-dwelling stroke survivors compared with normal controls. Twelve stroke patients and 12 matched controls performed a series of tests assessing executive function, prospective (PM) and retrospective memory (RM). Patients performed less well than controls on laboratory measures of PM and associative RM; they also showed deficits on standard tests of RM and executive control. The groups did not differ on more structured clinical measures of executive function, RM, PM or self-rated PM and RM. The results are discussed in terms of an impairment in the ability to 'self-initiate' effortful cognitive processes.	[Kim, Hyun Jung] Eulji Univ, Sch Med, Eulji Gen Hosp, Dept Rehabil Med, Seoul, South Korea; [Craik, Fergus I. M.; Luo, Lin] Univ Toronto, Rotman Res Inst, Baycrest & Dept Psychol, Toronto, ON, Canada; [Ween, Jon Erik] Posluns Ctr Stroke & Cognit, Kunin Lunenfeld Appl Res Unit, Toronto, ON, Canada		Ween, JE (corresponding author), Kimmel Family Bldg,6th Floor,Room 644,Baycrest,35, Toronto, ON M6A 2E1, Canada.	jween@klaru-baycrest.on.ca		Craik, Fergus/0000-0001-8073-3236	Korea Research FoundationKorea Research Foundation [KRF-2006-013-E00133]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	This work was supported by the Korea Research Foundation Grant (KRF-2006-013-E00133) to H. J. Kim and by a grant from the Natural Sciences and Engineering Research Council of Canada to F. I. M. Craik. We also wish to thank HeeSun Lim for research assistance.	Brooks BM, 2004, BRAIN INJURY, V18, P391, DOI 10.1080/02699050310001619855; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 1996, NEUROPSYCHOLOGIA, V34, P263, DOI 10.1016/0028-3932(95)00104-2; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Cohen AL, 2001, AGING NEUROPSYCHOL C, V8, P1, DOI 10.1076/anec.8.1.1.845; COHEN G, 1996, MEMORY INTENTIONS AC, P25; Craik FI., 1986, HUMAN MEMORY COGNITI, V5, P409; CRAIK FIM, 1983, PHILOS T ROY SOC B, V302, P341, DOI 10.1098/rstb.1983.0059; Crawford JR, 2003, MEMORY, V11, P261, DOI 10.1080/09658210244000027; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Delis D.C., 2000, CALIFORNIA VERBAL LE; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; GOLDSTEIN LH, 1993, J NEUROL NEUROSUR PS, V56, P274, DOI 10.1136/jnnp.56.3.274; Grady CL, 2000, CURR OPIN NEUROBIOL, V10, P224, DOI 10.1016/S0959-4388(00)00073-8; Guynn MJ, 2003, INT J PSYCHOL, V38, P245, DOI 10.1080/00207590344000178; Hachinski V, 2007, STROKE, V38, P1396, DOI 10.1161/01.STR.0000260101.08944.e9; HAMILTON BL, 1977, EDUC PSYCHOL MEAS, V37, P701, DOI 10.1177/001316447703700313; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kliegel M, 2004, BRAIN COGNITION, V56, P43, DOI 10.1016/j.bandc.2004.05.005; Kliegel M, 2003, INT J PSYCHOL, V38, P193, DOI 10.1080/00207590344000114; Kvavilashvili L., 1996, PROSPECTIVE MEMORY T, V6, P183; Levine B, 2000, NEUROPSYCHOLOGY, V14, P491, DOI 10.1037/0894-4105.14.4.491; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Martin M, 2003, INT J PSYCHOL, V38, P195, DOI 10.1080/00207590344000123; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McDaniel MA, 1999, NEUROPSYCHOLOGY, V13, P103, DOI 10.1037/0894-4105.13.1.103; McDaniel MA., 1996, PROSPECTIVE MEMORY T, P143; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Reed BR, 2004, ARCH NEUROL-CHICAGO, V61, P1545, DOI 10.1001/archneur.61.10.1545; Reed BR, 2001, ARCH NEUROL-CHICAGO, V58, P493, DOI 10.1001/archneur.58.3.493; Reitan R, 1986, TRAIL MAKING TEST; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Roediger H. L., 1996, PROSPECTIVE MEMORY T, P149; Roman GC, 2004, J NEUROL SCI, V226, P81, DOI 10.1016/j.jns.2004.09.016; Schmitter-Edgecombe M, 2004, NEUROPSYCHOLOGY, V18, P353, DOI 10.1037/0894-4105.18.2.353; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wechsler D., 1997, WECHSLER MEMORY SCAL; West R, 2002, NEUROSCI BIOBEHAV R, V26, P827, DOI 10.1016/S0149-7634(02)00069-6; West R, 2001, NEUROREPORT, V12, P2855, DOI 10.1097/00001756-200109170-00020; West R, 2005, NEUROPSYCHOLOGIA, V43, P418, DOI 10.1016/j.neuropsychologia.2004.06.012; West R, 2007, NEUROCASE, V13, P115, DOI 10.1080/13554790701399247; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO	49	20	21	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1355-4794	1465-3656		NEUROCASE	Neurocase		2009	15	2					145	156	PII 909674187	10.1080/13554790802709039			12	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	425SD	WOS:000264656500009	19296397				2022-02-06	
J	Kuipers, P; Foster, M; Smith, S; Fleming, J				Kuipers, Pim; Foster, Michele; Smith, Sharon; Fleming, Jennifer			Using ICF-Environment factors to enhance the continuum of outpatient ABI rehabilitation: An exploratory study	DISABILITY AND REHABILITATION			English	Article						Acquired Brain Injury; outpatient rehabilitation; ICF Environment factors	TRAUMATIC BRAIN-INJURY; HEALTH; EXPERIENCES; DISCHARGE; FAMILIES; OUTCOMES; NEEDS; MODEL; CARE; HOME	Purpose. This study utilized the Environment dimension of the ICF, to explore needs of outpatients and their family members in the context of system and professional needs in an outpatient rehabilitation unit. Method. A two-phase qualitative exploration comprised structured workshops with outpatient rehabilitation unit professional staff and semi-structured interviews on two occasions with 18 outpatients and their significant others. Data was thematically analysed and categorized according to ICF Environment dimensions. Results. The study found that the ICF Environment dimension was a worthwhile area for research, beneficial for outpatient professionals, relevant to patient and family members' concerns, and useful for conceptualizing intervention. The study found that key foci for outpatient assistance at the Environment level should include: psychosocial support and relationships; information transfer and communication in transition to outpatient rehabilitation; and subsequent connection with community, vocational and support services. Conclusion. Research using the ICF Environment dimension provides a practical means of connecting some of the features of a community-oriented approach with hospital or centre-based outpatient rehabilitation.	[Kuipers, Pim] Univ Queensland, CONROD, Brisbane, Qld, Australia; [Kuipers, Pim] Flinders Univ S Australia, Ctr Remote Hlth, Brisbane, Qld, Australia; [Kuipers, Pim] Charles Darwin Univ, Brisbane, Qld, Australia; [Foster, Michele] Univ Queensland, Sch Social Work & Appl Human Sci, Brisbane, Qld, Australia; [Smith, Sharon] Princess Alexandra Hosp, ABIOS, Brisbane, Qld 4102, Australia; [Fleming, Jennifer] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia; [Fleming, Jennifer] Princess Alexandra Hosp, Occupat Therapy Dept, Brisbane, Qld 4102, Australia			pim.kuipers@flinders.edu.au	Fleming, Jennifer M/B-4436-2011	Kuipers, Pim/0000-0003-0340-2286			Anderson C, 2002, PHARMACOECONOMICS, V20, P537, DOI 10.2165/00019053-200220080-00004; Barnes MP, 2001, J REHABIL MED, V33, P244; Bay Esther, 2006, Res Theory Nurs Pract, V20, P141; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Colantonio A, 2004, DISABIL REHABIL, V26, P253, DOI 10.1080/09638280310001639722; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; DOIG E, 2007, HLTH CARE POLICY PRA; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Koskinen S, 2007, J REHABIL MED, V39, P467, DOI 10.2340/16501977-0077; Kuipers Pim, 2003, Expert Rev Pharmacoecon Outcomes Res, V3, P125, DOI 10.1586/14737167.3.2.125; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Leith KH, 2004, BRAIN INJURY, V18, P1191, DOI 10.1080/02699050410001719943; Mayo NE, 2000, STROKE, V31, P1016, DOI 10.1161/01.STR.31.5.1016; McColl MA, 2001, ARCH PHYS MED REHAB, V82, P429, DOI 10.1053/apmr.2001.22195; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Rice-Oxley M, 1999, CLIN REHABIL, V13, P7, DOI 10.1191/026921599668051623; Stier-Jarmer M, 2005, DISABIL REHABIL, V27, P389, DOI 10.1080/09638280400014022; Stucki G, 2005, DISABIL REHABIL, V27, P349, DOI 10.1080/09638280400013941; Von Koch L, 1998, DISABIL REHABIL, V20, P367, DOI 10.3109/09638289809166095; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; World Health Organization, INT CLASS FUNCT DIS; 2004, QSR QUALITATATIVE SO	22	20	20	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2009	31	2					144	151	PII 792733278	10.1080/01674820701817938			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	402IR	WOS:000263007900010	18608394				2022-02-06	
J	Goldberg, DS				Goldberg, Daniel S.			Concussions, Professional Sports, and Conflicts of Interest: Why the National Football League's Current Policies are Bad for Its (Players') Health	HEC FORUM			English	Article							RECURRENT CONCUSSION; COLLEGIATE; ETHICS; GIFTS		[Goldberg, Daniel S.] Baylor Coll Med, Chron Dis Prevent & Control Ctr, 1709 Dryden,Suite 1025, Houston, TX 77030 USA		Goldberg, DS (corresponding author), Baylor Coll Med, Chron Dis Prevent & Control Ctr, 1709 Dryden,Suite 1025, Houston, TX 77030 USA.	danielg@bcm.tmc.edu					Adams H., 2001, J PUBLIC HLTH POLICY, V2292, P45; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Berkow I., 2006, NY TIMES; Brody H., 2007, HOOKED ETHICMED PR; Calandrillo S, 2005, SLU LAW J, V50, P185; Casson Ira R, 2006, Neurosurgery, V58, pE1003, DOI 10.1227/01.NEY.0000217313.15590.C5; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Ditka M., 2007, TESTIMONY HOUSE SUBC; Erde EL, 1996, CONFLICTS INTEREST C, P12; Flanagin A, 2000, ETHICAL ISSUES IN BIOMEDICAL PUBLICATION, P137; FURROW BR, 2005, ST LOUIS U L J, V50, P165; Garber G., 2005, ESPN            0124; Geertz C., 1972, INTERPRETIVE SOCIAL, P195; Goodman KW, 2005, PERSPECT BIOL MED, V48, P548, DOI 10.1353/pbm.2005.0091; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hecht AN, 2002, SENTON HALL J SPORTS, V12, P17; Kapp M., 2004, SO ILLINOIS U LAW J, V29, P237; Katz D, 2003, AM J BIOETHICS, V3, P39, DOI 10.1162/15265160360706552; Katz J., 2002, SILENT WORLD DOCTOR; Keating P., 2006, ESPN MAGAZINE    OCT; Keating P., 2007, ESPN MAGAZINE   0810; Keating P., 2007, ESPN MAGAZINE   0420; Keim T., 1999, SETON HALL J SPORT L, V9, P196; Krimsky S, 2003, SCI PRIVATE INTEREST; Kuttner K., 2006, NEUROSURGERY, V58, pE1003; Levine C., 2005, SOCIAL MED READER, VII, P299; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; MacMullan J., 2007, BOSTON GLOBE; MARKOWITZ G, 1990, J AM HIST, V77, P525, DOI 10.2307/2079182; McCain J., 2004, STANFORD LAW POLICY, V15, P7; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Mendez CV, 2005, J NEUROPSYCH CLIN N, V17, P297, DOI 10.1176/appi.neuropsych.17.3.297; Nowinski C, 2006, HEAD GAMES FOOTBALLS; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Parker RS, 2003, J BUS ETHICS, V48, P279, DOI 10.1023/B:BUSI.0000005783.58142.6e; Schwarz Alan, 2007, NY TIMES; Singer PA, 2001, BMC MED ETHICS, V2, pE1, DOI DOI 10.1186/1472-6939-2-1; Stark Andrew., 2003, CONFLICT INTEREST AM; Starr Paul, 1982, SOCIAL TRANSFORMATIO; Wojciechowski S., 1988, LOS ANGELES TIMES; 2006, ASS PRESS       0126; [No title captured]	44	20	21	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0956-2737	1572-8498		HEC FORUM	HEC Forum	DEC	2008	20	4					337	355		10.1007/s10730-008-9079-0			19	Ethics	Emerging Sources Citation Index (ESCI)	Social Sciences - Other Topics	VG0MP	WOS:000444638900004	19130254				2022-02-06	
J	Lemon, JA; Rollo, CD; McFarlane, NM; Boreham, DR				Lemon, Jennifer A.; Rollo, C. David; McFarlane, Nicole M.; Boreham, Douglas R.			Radiation-induced apoptosis in mouse lymphocytes is modified by a complex dietary supplement: the effect of genotype and gender	MUTAGENESIS			English	Article							ACETYL-L-CARNITINE; MITOCHONDRIAL OXIDATIVE STRESS; HORMONE INHIBITS APOPTOSIS; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; FREE-RADICAL PROCESSES; GIANT TRANSGENIC MICE; ALPHA-LIPOIC ACID; GROWTH-HORMONE; VITAMIN-E	This study examined whether radiation sensitivity measured by lymphocyte apoptosis could be ameliorated by a complex anti-oxidant/anti-ageing dietary supplement. We also examined lymphocytes from both genders of normal (Nr) mice as well as transgenic growth hormone (Tg) mice that express strongly elevated reactive oxygen species processes and a progeroid syndrome of accelerated ageing. We introduce Tg mice as a potentially valuable new model to study radiation sensitivity. Isolated lymphocytes from all experimental groups were exposed to gamma radiation and the time course of apoptosis was measured in vitro. Kinetics of radiation-induced apoptosis was similar among groups, which peaked at 8 h, but maximal levels differed significantly between groups. Nr male mice had 60% lower levels of radiation-induced apoptosis than Tg males, supporting our hypothesis that Tg mice would be radiation sensitive. The dietary supplement protected lymphocytes in male mice of both strains, with proportionally greater reductions in Tg mice. Lymphocytes from female mice (both Nr and Tg) were highly radiation resistant compared to males and the supplement provided no additional benefit at the doses used in this study. These results highlight that radiation-induced apoptosis is complex and is modified by genotype, dietary supplements and gender.	[Lemon, Jennifer A.; McFarlane, Nicole M.; Boreham, Douglas R.] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4K1, Canada; [Rollo, C. David] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada		Lemon, JA (corresponding author), McMaster Univ, Dept Med Phys & Appl Radiat Sci, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	lemonja@mcmaster.ca			CANDU Owners Group [03.014]; Chemical Biological Radiological Nuclear Research and Technology Initiative [015ssH1021-021608]; National Science and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC) [238495]	CANDU Owners Group (03.014), the Chemical Biological Radiological Nuclear Research and Technology Initiative (015ssH1021-021608) and the National Science and Engineering Research Council (238495).	AGARWAL S, 1994, ARCH BIOCHEM BIOPHYS, V309, P24, DOI 10.1006/abbi.1994.1078; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Blacker D, 2005, NEW ENGL J MED, V352, P2439, DOI 10.1056/NEJMe058086; Boddaert J, 2005, MECH AGEING DEV, V126, P678, DOI 10.1016/j.mad.2005.01.001; Bogazzi F, 2004, ENDOCRINOLOGY, V145, P3353, DOI 10.1210/en.2004-0225; Bolognesi C, 1997, CANCER EPIDEM BIOMAR, V6, P249; Bramlett Helen M, 2005, Pathophysiology, V12, P17, DOI 10.1016/j.pathophys.2005.02.009; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Calder W.A., 1984, SIZE FUNCTION LIFE H, P431; Carlson JC, 1999, AGE, V22, P181, DOI 10.1007/s11357-999-0021-4; Chen DX, 2002, J NEUROCHEM, V81, P1273, DOI 10.1046/j.1471-4159.2002.00916.x; Clutter AC, 1996, GENETICS, V143, P1753; Cui Yu-fang, 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P185; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; Cuzzorcrea S, 2004, CURR MED CHEM, V11, P1147, DOI 10.2174/0929867043365396; Dhitavat S, 2005, BRAIN RES, V1061, P114, DOI 10.1016/j.brainres.2005.05.074; Dulos GJ, 2001, INT IMMUNOPHARMACOL, V1, P321, DOI 10.1016/S1567-5769(00)00029-1; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Evans MJ, 1997, CLIN IMMUNOL IMMUNOP, V82, P258, DOI 10.1006/clin.1996.4300; Garaj-Vrhovac V, 2003, MUTAGENESIS, V18, P265, DOI 10.1093/mutage/18.3.265; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; Geracitano LA, 2004, MAR ENVIRON RES, V58, P1, DOI 10.1016/j.marenvres.2003.09.001; Ginaldi L, 2004, IMMUNOL RES, V30, P81, DOI 10.1385/IR:30:1:081; Gonzalez-Juanatey JR, 2004, J ENDOCRINOL, V180, P325; Guevara Patino JA, 2000, EUR J IMMUNOL, V30, P2586; Haddad JJ, 2004, INT IMMUNOPHARMACOL, V4, P475, DOI 10.1016/j.intimp.2004.02.002; Hagen TM, 2002, P NATL ACAD SCI USA, V99, P1870, DOI 10.1073/pnas.261708898; Hauck SJ, 2002, HORM METAB RES, V34, P481, DOI 10.1055/s-2002-34787; HAUKE SJ, 2001, J GERONTOL BIOL SCI, V56, pB153; Hofmann-Lehmann R, 1998, VET IMMUNOL IMMUNOP, V65, P151, DOI 10.1016/S0165-2427(98)00150-0; Huber SA, 1999, LUPUS, V8, P384, DOI 10.1177/096120339900800511; Joksic G, 2004, BRAZ J MED BIOL RES, V37, P1111, DOI 10.1590/S0100-879X2004000800002; JOKSIC G, 2000, J ENVIRON PATHOL TOX, V23, P195; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Kumari M, 2000, J GERONTOL A-BIOL, V55, pB228, DOI 10.1093/gerona/55.5.B228; Kuo HW, 2003, OCCUP ENVIRON MED, V60, P590, DOI 10.1136/oem.60.8.590; Lang F, 2004, J MOL RECOGNIT, V17, P473, DOI 10.1002/jmr.705; Lee CK, 2004, FREE RADICAL BIO MED, V36, P1043, DOI 10.1016/j.freeradbiomed.2004.01.015; Lemon JA, 2005, J GERONTOL A-BIOL, V60, P275, DOI 10.1093/gerona/60.3.275; Lemon JA, 2003, EXP BIOL MED, V228, P800, DOI 10.1177/15353702-0322807-05; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Lu AG, 2002, J CEREBR BLOOD F MET, V22, P183, DOI 10.1097/00004647-200202000-00006; Ludwig D., 2003, ASIA PAC J CLIN NUTR, V12; Matsuda T, 1998, JPEN-PARENTER ENTER, V22, P368, DOI 10.1177/0148607198022006368; Meliska CJ, 1997, NEUROBIOL LEARN MEM, V68, P1, DOI 10.1006/nlme.1997.3772; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Monget AL, 1996, EUR J CLIN NUTR, V50, P443; Moosmann B, 1999, P NATL ACAD SCI USA, V96, P8867, DOI 10.1073/pnas.96.16.8867; Murata M, 2004, BIOCHEM BIOPH RES CO, V316, P123, DOI 10.1016/j.bbrc.2004.02.022; Ogueta S, 2000, J ENDOCRINOL, V165, P321, DOI 10.1677/joe.0.1650321; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; Palmon SC, 1998, J CEREBR BLOOD F MET, V18, P1248, DOI 10.1097/00004647-199811000-00011; Patten RD, 2004, CIRC RES, V95, P692, DOI 10.1161/01.RES.0000144126.57786.89; Pieters RS, 2006, INT J RADIAT ONCOL, V64, P251, DOI 10.1016/j.ijrobp.2005.04.019; Pollack M, 2002, ANN NY ACAD SCI, V959, P93, DOI 10.1111/j.1749-6632.2002.tb02086.x; Qin XJ, 2008, J APPL TOXICOL, V28, P271, DOI 10.1002/jat.1276; Rafique R, 2004, FREE RADICAL RES, V38, P157, DOI 10.1080/10715760310001643311; Rinaldi P, 2003, NEUROBIOL AGING, V24, P915, DOI 10.1016/S0197-4580(03)00031-9; Rollo CD, 1996, CAN J ZOOL, V74, P606, DOI 10.1139/z96-070; Rollo CD, 1999, CAN J ZOOL, V77, P1874, DOI 10.1139/cjz-77-12-1874; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Sastre J, 2003, FREE RADICAL BIO MED, V35, P1, DOI 10.1016/S0891-5849(03)00184-9; Satoh M, 2007, CIRCULATION, V115, P3197, DOI 10.1161/CIRCULATIONAHA.106.657981; Sener G, 2003, LIFE SCI, V72, P2707, DOI 10.1016/S0024-3205(03)00187-5; Shin DH, 2004, NEUROSCI LETT, V354, P64, DOI 10.1016/j.neulet.2003.09.070; SHIRSHEV SV, 2003, BIOKHIMIYA, V68, P577; Singh M, 2000, J NEUROSCI, V20, P1694; Sonta T, 2004, FREE RADICAL BIO MED, V37, P115, DOI 10.1016/j.freeradbiomed.2004.04.001; STARKEREED PE, 1989, ARCH BIOCHEM BIOPHYS, V275, P559, DOI 10.1016/0003-9861(89)90402-5; Steger R W, 1993, J Reprod Fertil Suppl, V46, P61; Van Remmen H, 2001, EXP GERONTOL, V36, P957; Vedder H, 1999, J NEUROCHEM, V72, P2531, DOI 10.1046/j.1471-4159.1999.0722531.x; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Vilatoba M, 2005, TRANSPL P, V37, P399, DOI 10.1016/j.transproceed.2004.12.053; WOLF E, 1993, MECH AGEING DEV, V68, P71, DOI 10.1016/0047-6374(93)90141-D; Wu LY, 2004, P NATL ACAD SCI USA, V101, P7094, DOI 10.1073/pnas.0402004101; Yaffe K, 2004, NEUROLOGY, V63, P1705, DOI 10.1212/01.WNL.0000142969.19465.8F; Yao XL, 2005, J NEUROTRAUM, V22, P656, DOI 10.1089/neu.2005.22.656	80	20	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0267-8357			MUTAGENESIS	Mutagenesis	NOV	2008	23	6					465	472		10.1093/mutage/gen038			8	Genetics & Heredity; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity; Toxicology	367NE	WOS:000260557900006	18644835	Bronze			2022-02-06	
J	Bolliet, C; Bohn, MC; Spector, M				Bolliet, Catherine; Bohn, Martha C.; Spector, Myron			Non-viral delivery of the gene for glial cell line-derived neurotrophic factor to mesenchymal stem cells in vitro via a collagen scaffold	TISSUE ENGINEERING PART C-METHODS			English	Article							TRAUMATIC BRAIN-INJURY; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; PARKINSONS-DISEASE; NEURAL STEM; ADULT-RAT; GDNF; NEURONS; TRANSFECTION; NERVE	Recent advances in tissue engineering that combine an extracellular matrix-like scaffold with therapeutic molecules, cells, DNA encoding therapeutic proteins, or a combination of the three hold promise for treating defects in the brain resulting from a penetrating injury or tumor resection. The purpose of this study was to investigate a porous sponge-like collagen scaffold for non-viral delivery of a plasmid encoding for glial cell line-derived neurotrophic factor (pGDNF) to rat marrow stromal stem cells (also referred to as mesenchymal stem cells, MSCs). The effects of the following parameters on GDNF synthesis in the three-dimensional (313) constructs were evaluated and compared with results in monolayer culture: initial plasmid load (2-50 mu g pGDNF), ratio of a lipid transfection reagent to plasmid (5: 10), culture environment during the transfection (static and dynamic), and cell density. The level of gene expression in the collagen scaffolds achieved therapeutic levels that had previously been found to support survival of dopaminergic and trigeminal neurons in vitro. For the highest loading of plasmid (50 mu g), the level of GDNF protein remained six to seven times above the control level after 2 weeks, a significant difference. Cell density in the scaffold was of importance for an early increase in GDNF production, with accumulated GDNF being approximately 60% greater after 9 days of culture when scaffolds were initially seeded with 2 million rat MSCs compared to 500,000 cells. Application of orbital shaking during the 4 h of transfection had a positive effect on the production of GDNF on 3D constructs but not of the same magnitude as reported in monolayer studies. Overall, these results demonstrate that the combination of tissue engineering and non-viral transfection of MSCs for the over-expression of GDNF is a promising approach for the long-term production of GDNF and probably for neurotrophic factors in general.	[Bolliet, Catherine; Spector, Myron] Harvard Univ, Sch Med, Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA; [Bolliet, Catherine; Spector, Myron] MIT, Cambridge, MA 02139 USA; [Bohn, Martha C.] Northwestern Univ, Childrens Mem Res Ctr, Chicago, IL 60611 USA		Spector, M (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, 150 S Huntington Ave,MS 151, Boston, MA 02130 USA.	mspector@rics.bwh.harvard.edu		Spector, Myron/0000-0003-3328-4858	Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans AffairsUS Department of Veterans Affairs	This material is based upon work supported by the Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans Affairs. M. Spector is a Veterans Affairs Research Career Scientist.	Arenas E, 1995, NEURON, V15, P1465, DOI 10.1016/0896-6273(95)90024-1; Berry M, 2001, MOL CELL NEUROSCI, V17, P706, DOI 10.1006/mcne.2001.0975; Bjorklund A, 2000, BRAIN RES, V886, P82, DOI 10.1016/S0006-8993(00)02915-2; Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918; Carro E, 2003, MOL NEUROBIOL, V27, P153, DOI 10.1385/MN:27:2:153; Chamberlain LJ, 2000, J NEUROSCI RES, V60, P666, DOI 10.1002/(SICI)1097-4547(20000601)60:5<666::AID-JNR12>3.0.CO;2-0; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779; ChoiLundberg DL, 1997, SCIENCE, V275, P838, DOI 10.1126/science.275.5301.838; Clarkson ED, 1997, CELL TISSUE RES, V289, P207, DOI 10.1007/s004410050867; Cui FZ, 2003, J BIOACT COMPAT POL, V18, P413, DOI 10.1177/0883911503040470; Duvshani-Eshet M, 2007, MOL CANCER THER, V6, P2371, DOI 10.1158/1535-7163.MCT-07-0019; Eglitis MA, 1997, P NATL ACAD SCI USA, V94, P4080, DOI 10.1073/pnas.94.8.4080; Ericson C, 2002, EXP NEUROL, V173, P22, DOI 10.1006/exnr.2001.7829; Feril LB, 2006, CANCER SCI, V97, P1111, DOI 10.1111/j.1349-7006.2006.00286.x; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; HARVEY AR, 1994, RESTOR NEUROL NEUROS, V6, P221, DOI 10.3233/RNN-1994-6306; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Kameda M, 2007, EUR J NEUROSCI, V26, P1462, DOI 10.1111/j.1460-9568.2007.05776.x; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Kordower JH, 1997, EXP NEUROL, V144, P41, DOI 10.1006/exnr.1996.6386; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016; Mahmood A, 2005, NEUROSURGERY, V57, P1026, DOI 10.1227/01.NEU.0000181369.76323.50; Maswood N, 2002, NEUROBIOL AGING, V23, P881, DOI 10.1016/S0197-4580(02)00022-2; Murata R, 2007, OSTEOARTHR CARTILAGE, V15, P1275, DOI 10.1016/j.joca.2007.04.001; Palmer TD, 1999, J NEUROSCI, V19, P8487; Peister A, 2004, GENE THER, V11, P224, DOI 10.1038/sj.gt.3302163; Price TJ, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-4; Samuel RE, 2002, HUM GENE THER, V13, P791, DOI 10.1089/10430340252898975; SHEN RY, 1994, P NATL ACAD SCI USA, V91, P8920, DOI 10.1073/pnas.91.19.8920; Shoichet MS, 2000, ADV DRUG DELIVER REV, V42, P81, DOI 10.1016/S0169-409X(00)00055-7; Tai MH, 2003, EXP NEUROL, V183, P508, DOI 10.1016/S0014-4886(03)00130-4; Tresco PA, 2000, PROG BRAIN RES, V128, P349; Villoslada P, 2004, PROG BRAIN RES, V146, P403; Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200; YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108	43	20	20	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1937-3384	1937-3392		TISSUE ENG PART C-ME	Tissue Eng. Part C-Methods	SEP	2008	14	3					207	219		10.1089/ten.tec.2008.0168			13	Cell & Tissue Engineering; Cell Biology; Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Engineering; Materials Science	354AT	WOS:000259612000005	18721070				2022-02-06	
J	Stravitz, RT; Lee, WM; Kramer, AH; Kramer, DJ; Hynan, L; Blei, AT				Stravitz, R. Todd; Lee, William M.; Kramer, Andreas H.; Kramer, David J.; Hynan, Linda; Blei, Andres T.			Therapeutic hypothermia for acute liver failure: Toward a randomized, controlled trial in patients with advanced hepatic encephalopathy	NEUROCRITICAL CARE			English	Article; Proceedings Paper	5th Annual Meeting of the Neurocritical-Care-Society	NOV 01, 2007	Las Vegas, NV	Neurocrit Care Soc		cerebral edema; hypothermia; acute liver failure	UNCONTROLLED INTRACRANIAL HYPERTENSION; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; ARTERIAL AMMONIA; BODY-TEMPERATURE; CEREBRAL EDEMA; CARDIAC-ARREST; PRESSURE	Acute liver failure (ALF), the abrupt loss of liver function in a patient without previous liver disease, remains a highly mortal condition. Patients with ALF often succumb to their liver injury after the development of cerebral edema, resulting in intracranial hypertension and brain herniation. While the management of cerebral edema in ALF always includes the administration of osmotically active agents, osmotherapy often reduces intracranial pressure (ICP) insufficiently, such that herniation may be delayed but not prevented. Therapeutic hypothermia, the intentional reduction of body core temperature, has been increasingly used to treat cerebral edema in patients with traumatic and hypoxic brain injury. Data in animal models of ALF also suggest that hypothermia is effective in the prevention and treatment of cerebral edema, and case reports in humans have suggested that hypothermia is an effective bridge to orthotopic liver transplantation. A randomized, controlled trial comparing the management of ALF patients under normothermic and hypothermic conditions is a logical extension of these preliminary observations. Herein, we consider the many difficulties which will be encountered in the design of such a trial in patients with ALF at high risk of developing cerebral edema.	[Stravitz, R. Todd] Virginia Commonwealth Univ, Hume Lee Transplant Ctr, Sect Hepatol, Richmond, VA 23298 USA; [Lee, William M.; Hynan, Linda] Univ Texas Dallas, SW Med Ctr, Dallas, TX USA; [Kramer, Andreas H.] Univ Calgary, Calgary, AB, Canada; [Kramer, David J.] Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; [Blei, Andres T.] Northwestern Univ, Chicago, IL USA		Stravitz, RT (corresponding author), Virginia Commonwealth Univ, Hume Lee Transplant Ctr, Sect Hepatol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	rstravit@hsc.vcu.edu	Hynan, Linda S/P-6473-2016	Hynan, Linda/0000-0002-4642-7769	NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [U01 DK058369] Funding Source: Medline		Axelrod YK, 2006, CRIT CARE CLIN, V22, P767, DOI 10.1016/j.ccc.2006.06.001; Bernal W, 2003, SEMIN LIVER DIS, V23, P227; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; Caldwell SH, 2006, HEPATOLOGY, V44, P1039, DOI 10.1002/hep.21303; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Clemmesen JO, 1997, HEPATOLOGY, V26, P1423; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Cordoba J, 1999, GASTROENTEROLOGY, V116, P686, DOI 10.1016/S0016-5085(99)70191-5; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; HANID MA, 1980, GUT, V21, P866, DOI 10.1136/gut.21.10.866; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jalan R, 2003, TRANSPLANTATION, V75, P2034, DOI 10.1097/01.TP.0000066240.42113.FF; Jalan R, 2003, SEMIN LIVER DIS, V23, P271; Jalan R, 1999, LANCET, V354, P1164, DOI 10.1016/S0140-6736(98)12440-6; Jalan R, 2001, HEPATOLOGY, V34, P50, DOI 10.1053/jhep.2001.25386; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee WM, 2003, SEMIN LIVER DIS, V23, P217; LIDOFSKY SD, 1992, HEPATOLOGY, V16, P1, DOI 10.1002/hep.1840160102; MAKIN AJ, 1995, GASTROENTEROLOGY, V109, P1907, DOI 10.1016/0016-5085(95)90758-0; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Munoz SJ, 2005, GASTROENTEROLOGY, V128, P1143, DOI 10.1053/j.gastro.2005.02.048; MUNOZ SJ, 1993, TRANSPLANTATION, V55, P1071, DOI 10.1097/00007890-199305000-00025; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; PEREIRA LMMB, 1992, GUT, V33, P98, DOI 10.1136/gut.33.1.98; Polderman KH, 2004, INTENS CARE MED, V30, P757, DOI 10.1007/s00134-003-2151-y; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Rose C, 2000, HEPATOLOGY, V31, P872, DOI 10.1053/he.2000.5923; Schiodt FV, 2006, LIVER TRANSPLANT, V12, P1776, DOI 10.1002/lt.20886; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shiozaki T, 1999, J NEUROSURG, V91, P185, DOI 10.3171/jns.1999.91.2.0185; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Tofteng F, 2004, J CEREBR BLOOD F MET, V24, P798, DOI 10.1097/01.WCB.0000125648.03213.1D; TRABER P, 1989, GASTROENTEROLOGY, V96, P885; Trey C, 1970, Prog Liver Dis, V3, P282; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; Vaquero J, 2005, J CLIN GASTROENTEROL, V39, pS147, DOI 10.1097/01.mcg.0000155515.94843.55; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; Vaquero J, 2007, NAT CLIN PRACT GASTR, V4, P528, DOI 10.1038/ncpgasthep0927; Vaquero J, 2007, GASTROENTEROLOGY, V132, P372, DOI 10.1053/j.gastro.2006.11.025; WARE AJ, 1971, GASTROENTEROLOGY, V61, P877; WILLIAMS R, 1994, HEPATOLOGY, V20, pS5, DOI 10.1016/0270-9139(94)90265-8; Williams R, 1996, SEMIN LIVER DIS, V16, P343, DOI 10.1055/s-2007-1007247	52	20	20	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2008	9	1					90	96		10.1007/s12028-008-9090-y			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Neurosciences & Neurology	340PM	WOS:000258657500013	18389180				2022-02-06	
J	Abe, C; Tanaka, K; Awazu, C; Morita, H				Abe, Chikara; Tanaka, Kunihiko; Awazu, Chihiro; Morita, Hironobu			Impairment of vestibular-mediated cardiovascular response and motor coordination in rats born and reared under hypergravity	AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY			English	Article						vestibular system; renal sympathetic nerve activity; arterial pressure; rotarod; linear acceleration	TRAUMATIC BRAIN-INJURY; CONSCIOUS RATS; VESTIBULOSYMPATHETIC REFLEX; PRESSOR-RESPONSE; BLOOD-PRESSURE; MICROGRAVITY; SYSTEM; PLASTICITY; LOCOMOTION; CORTEX	It is well known that environmental stimulation is important for the proper development of sensory function. The vestibular system senses gravitational acceleration and then alters cardiovascular and motor functions through reflex pathways. The development of vestibular-mediated cardiovascular and motor functions may depend on the gravitational environment present at birth and during subsequent growth. To examine this hypothesis, arterial pressure (AP) and renal sympathetic nerve activity (RSNA) were monitored during horizontal linear acceleration and performance in a motor coordination task in rats born and reared in 1-G or 2-G environments. Linear acceleration of +/- 1 G increased AP and RSNA. These responses were attenuated in rats with a vestibular lesion, suggesting that the vestibular system mediated AP and RSNA responses. These responses were also attenuated in rats born in a 2-G environment. AP and RSNA responses were partially restored in these rats when the hypergravity load was removed, and the rats were maintained in a 1-G environment for 1 wk. The AP response to compressed air, which is mediated independently of the vestibular system, did not change in the 2-G environment. Motor coordination was also impaired in the 2-G environment and remained impaired even after 1 wk of unloading. These results indicate that hypergravity impaired both the vestibulo-cardiovascular reflex and motor coordination. The vestibulo-cardiovascular reflex was only impaired temporarily and partially recovered following 1 wk of unloading. In contrast, motor coordination did not return to normal in response to unloading.	[Abe, Chikara; Tanaka, Kunihiko; Awazu, Chihiro; Morita, Hironobu] Gifu Univ, Grad Sch Med, Dept Physiol, Gifu 5011194, Japan		Morita, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Physiol, 1-1 Yanagido, Gifu 5011194, Japan.	zunzunmorita@gmail.com	Abe, Chikara/V-6174-2019	Abe, Chikara/0000-0003-3856-7494			Abe C, 2007, EXP BRAIN RES, V181, P639, DOI 10.1007/s00221-007-0961-9; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Buitrago MM, 2004, NEUROBIOL LEARN MEM, V81, P211, DOI 10.1016/j.nlm.2004.01.001; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Clarac F, 1998, BRAIN RES REV, V28, P35, DOI 10.1016/S0165-0173(98)00024-1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gotoh TM, 2004, AM J PHYSIOL-REG I, V286, pR25, DOI 10.1152/ajpregu.00458.2003; Hajjar H, 2005, DRUG AGING, V22, P55; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hess BJM, 2003, J NEUROPHYSIOL, V90, P1996, DOI 10.1152/jn.00302.2003; Holley DC, 2003, J APPL PHYSIOL, V95, P1266, DOI 10.1152/japplphysiol.00707.2002; HUBEL DH, 1967, J NEUROPHYSIOL, V30, P1561, DOI 10.1152/jn.1967.30.6.1561; Iossa S, 1999, J NUTR, V129, P1593, DOI 10.1093/jn/129.8.1593; Jian BJ, 1999, J APPL PHYSIOL, V86, P1552, DOI 10.1152/jappl.1999.86.5.1552; KARHUNEN E, 1973, ACTA OTO-LARYNGOL, V1974, P1; Kerman IA, 1999, AM J PHYSIOL-REG I, V277, pR716; Kihara M, 1998, AGE AGEING, V27, P551, DOI 10.1093/ageing/27.5.551; Kita S, 2006, AVIAT SPACE ENVIR MD, V77, P842; Matsuda T, 2004, BRAIN RES, V1028, P140, DOI 10.1016/j.brainres.2004.09.004; Morita H, 2007, NEUROSCI LETT, V412, P201, DOI 10.1016/j.neulet.2006.11.014; Poo C, 2007, J NEUROSCI, V27, P7553, DOI 10.1523/JNEUROSCI.1786-07.2007; Reschke MF, 1998, BRAIN RES REV, V28, P102, DOI 10.1016/S0165-0173(98)00031-9; RICHARDSON DR, 1977, AVIAT SPACE ENVIR MD, V48, P195; ROYET JP, 1989, J COMP NEUROL, V289, P586, DOI 10.1002/cne.902890405; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Smith PF, 1997, HIPPOCAMPUS, V7, P465, DOI 10.1002/(SICI)1098-1063(1997)7:5<465::AID-HIPO3>3.0.CO;2-G; Takahashi E, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-19; Takei Y, 1997, EXP BRAIN RES, V115, P361, DOI 10.1007/PL00005705; Tanaka K, 2006, NEUROSCI LETT, V397, P40, DOI 10.1016/j.neulet.2005.11.052; Uno Y, 2002, J NEUROCHEM, V81, P1308, DOI 10.1046/j.1471-4159.2002.00933.x; Wade CE, 2002, AVIAT SPACE ENVIR MD, V73, P859; Walton KD, 2005, J PHYSIOL-LONDON, V565, P609, DOI 10.1113/jphysiol.2004.074393; Walton KD, 2005, J PHYSIOL-LONDON, V565, P593, DOI 10.1113/jphysiol.2004.074385; Yamamoto K, 2004, AM J PHYSIOL-HEART C, V286, pH1382, DOI 10.1152/ajpheart.00801.2003; Yates BJ, 2005, J VESTIBUL RES-EQUIL, V15, P119; Yates BJ, 1998, BRAIN RES REV, V28, P73, DOI 10.1016/S0165-0173(98)00028-9	36	20	20	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6119	1522-1490		AM J PHYSIOL-REG I	Am. J. Physiol.-Regul. Integr. Comp. Physiol.	JUL 1	2008	295	1					R173	R180		10.1152/ajpregu.00120.2008			8	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	323VY	WOS:000257477700021	18495837				2022-02-06	
J	McKinlay, J; Chapman, G; Elliot, S; Mallick, A				McKinlay, J.; Chapman, G.; Elliot, S.; Mallick, A.			Pre-emptive Novalung-assisted carbon dioxide removal in a patient with chest, head and abdominal injury	ANAESTHESIA			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; BRAIN-INJURY	A young man sustained traumatic lung, head and abdominal injuries. Despite mechanical ventilation, deteriorating respiratory function resulted in severe hypoxia and hypercapnia, with high P(a)CO(2) compounding an already raised intracranial pressure (ICP). The Novalung was pre-emptively used without anticoagulation, prior to laparotomy, to remove carbon dioxide and to allow for cerebral and lung protective strategies. This facilitated control of ICP thereby limited possible secondary brain injury.	[McKinlay, J.; Chapman, G.; Elliot, S.; Mallick, A.] Gen Infirm, Dept Anaesthet, Leeds LS1 3EX, W Yorkshire, England		Mallick, A (corresponding author), Gen Infirm, Dept Anaesthet, D Floor Jubilee Bldg,Great George St, Leeds LS1 3EX, W Yorkshire, England.	abhiram.mallick@leedsth.nhs.uk					Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Bratton SL, 1997, NEUROSURGERY, V40, P707, DOI 10.1097/00006123-199704000-00009; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Mallick A, 2007, ANAESTHESIA, V62, P72, DOI 10.1111/j.1365-2044.2006.04863.X; Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X	7	20	20	0	0	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0003-2409			ANAESTHESIA	Anaesthesia	JUL	2008	63	7					767	770		10.1111/j.1365-2044.2008.05484.x			4	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	311XE	WOS:000256632900014	18582263	Bronze			2022-02-06	
J	Zaaroor, M; Soustiel, JF; Brenner, B; Bar-Lavie, Y; Martinowitz, U; Levi, L				Zaaroor, M.; Soustiel, J. F.; Brenner, B.; Bar-Lavie, Y.; Martinowitz, U.; Levi, L.			Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy	ACTA NEUROCHIRURGICA			English	Article						brain contusion; brain injury-penetrating; recombinant factor-VIIa	ACTIVATED FACTOR-VII; HEAD TRAUMA; HEMORRHAGE; DEFICIENCY; VASOSPASM; IX	Traumatic brain contusions may increase in size over time or may develop at a delay after injury. This may lead to neurological deterioration, long term morbidity or even death. Coagulation disorders after injury can contribute to progression of haemorrhage. Recombinant activated factor VII (rFVIIa) was used in 12 patients with a severe head injury who had no systemic coagulopathy but who were considered to be at risk of progression of their intracranial lesion. Twelve consecutive patients suffering from life-threatening acute head injuries from blunt (3 cases) and penetrating mechanisms were given with rFVIIa, either to prevent the expected development of brain contusion or to assist in bleeding control during surgery. In 11 patients, rFVIIa was given by the attending neurosurgeon. Two of the patients died of their severe penetrating injuries one of whom had severe vasospasm 2 days after administration of rFVIIa. The other 11 patients did not appear to suffer any treatment-related adverse effects. When the drug was given prophylactically to prevent brain resection (6 cases) or to limit the need for widening resection (5 cases), marked control was achieved in seven cases, and a lesser effect was observed in the other 4 cases. We conclude that, in a small and highly individually selected series of patients with severe head injury, the administration of rFVIIa did not lead to adverse effects. Although the majority of patients were considered to be at high risk of progression of their lesions, this occurred in only one. The early use of rFVIIa in head injured patients without systemic coagulopathy may reduce the occurrence of enlargement of contusions, the requirement of further operation, and adverse outcome. Prospective randomised controlled studies are required to investigate this.	[Zaaroor, M.; Soustiel, J. F.; Brenner, B.; Levi, L.] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel; [Bar-Lavie, Y.] Ramban Med Ctr, Dept Intens Care, IL-31096 Haifa, Israel; [Martinowitz, U.] Tel Hashomer Med Ctr, Natl Haemophilia Ctr, Tel Hashomer, Israel; [Zaaroor, M.; Soustiel, J. F.; Brenner, B.; Levi, L.] Ramban Med Ctr, Dept Neurosurg, Thrombosis & Haemostasis Unit, IL-31096 Haifa, Israel		Levi, L (corresponding author), Ramban Med Ctr, Dept Neurosurg, Thrombosis & Haemostasis Unit, POB 9602, IL-31096 Haifa, Israel.	llevi@rambam.health.gov.il					BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; Dutton RP, 2004, J TRAUMA, V57, P709, DOI 10.1097/01.TA.0000140646.66852.AB; Gerlach R, 2002, J NEUROSURG, V96, P946, DOI 10.3171/jns.2002.96.5.0946; Hoffman M, 1998, BLOOD COAGUL FIBRIN, V9, pS61; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Kluger Y, 2007, CRIT CARE, V11, DOI 10.1186/cc6092; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; Morenski JD, 2003, J NEUROSURG, V98, P611, DOI 10.3171/jns.2003.98.3.0611; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park P, 2003, NEUROSURGERY, V53, P34, DOI 10.1227/01.NEU.0000068830.54968.A8; Scharrer I, 1999, HAEMOPHILIA, V5, P253; Soustiel JF, 2004, SURG NEUROL, V62, P201, DOI 10.1016/j.surneu.2003.10.037; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Wong WY, 2000, HAEMOPHILIA, V6, P50	16	20	22	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.	JUL	2008	150	7					663	668		10.1007/s00701-008-1593-y			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	322HP	WOS:000257366100005	18473114				2022-02-06	
J	Chen, JJS; Ha, JC; Mirvis, SE				Chen, Joseph Jen-Sho; Ha, James C.; Mirvis, Stuart E.			MR imaging of the brain in fat embolism syndrome	EMERGENCY RADIOLOGY			English	Article						Fat embolism; Magnetic resonance imaging; Infarct; Trauma; Diffusion; Imaging		Fat embolism syndrome (FES) is an uncommon but serious complication of traumatic injury and is frequently diagnostically challenging. In this paper, the authors present four patients who sustained lower extremity long bone injury and who had a normal Glasgow Coma Scale before orthopedic surgical intervention. However, postoperatively, significant neurological deterioration developed in these patients. While cranial computed tomography (CT) obtained immediately after surgery for acutely altered mental status was negative in two of the four patients, brain magnetic resonance imaging (MRI) demonstrated white and gray matter abnormalities accounting for the impaired neurological status in all cases. MRI findings in conjunction with clinical presentation established the diagnosis in all patients. MRI is indicated in any patient with orthopedic injuries who manifests an unexplained acute alteration in mental status, despite a normal head CT.	[Chen, Joseph Jen-Sho; Mirvis, Stuart E.] Univ Maryland, Med Ctr, Dept Diagnost Radiol, 22 S Greene St, Baltimore, MD 21201 USA; [Chen, Joseph Jen-Sho; Mirvis, Stuart E.] Univ Maryland, Med Ctr, Maryland Shock Trauma Ctr, Baltimore, MD 21201 USA; [Ha, James C.] Univ Illinois, Coll Med Rockford, Rockford, IL USA		Chen, JJS (corresponding author), Univ Maryland, Med Ctr, Dept Diagnost Radiol, 22 S Greene St, Baltimore, MD 21201 USA.	jchen1@umm.edu					Bardana D, 1998, CAN J SURG, V41, P398; Bokhari S Ismail, 2003, Cardiol Rev, V11, P156, DOI 10.1097/01.CRD.0000053906.65644.A3; Bulger EM, 1997, ARCH SURG-CHICAGO, V132, P435; Butteriss DJA, 2006, AM J NEURORADIOL, V27, P620; Byrick RJ, 2001, ANESTHESIOLOGY, V94, P163, DOI 10.1097/00000542-200101000-00029; Chrysikopoulos H, 1996, CLIN RADIOL, V51, P728, DOI 10.1016/S0009-9260(96)80248-0; CITERIO G, 1995, INTENS CARE MED, V21, P679, DOI 10.1007/BF01711549; Drew PA, 1998, J NEUROL SCI, V156, P138, DOI 10.1016/S0022-510X(98)00039-2; DUDNEY TM, 1994, PROG CARDIOVASC DIS, V36, P447, DOI 10.1016/S0033-0620(94)80053-7; Eguia P, 2007, J NEUROIMAGING, V17, P78, DOI 10.1111/j.1552-6569.2006.00068.x; ERETH MH, 1992, MAYO CLIN PROC, V67, P1066, DOI 10.1016/S0025-6196(12)61121-5; Finlay ME, 1996, CLIN RADIOL, V51, P445; Glover P, 1999, Crit Care Resusc, V1, P276; GOSSLING HR, 1979, JAMA-J AM MED ASSOC, V241, P2740, DOI 10.1001/jama.241.25.2740; GOSSLING HR, 1982, CLIN ORTHOP RELAT R, P68; Habashi NM, 2006, INJURY, V37, pS68, DOI 10.1016/j.injury.2006.08.042; Hagan IG, 2007, RADIOGRAPHICS, V27, P919, DOI 10.1148/rg.274065103; Hofmann S, 1998, ANAESTHESIA, V53, P35; Johnson MJ, 1996, ORTHOPEDICS, V19, P41; KAWANO Y, 1991, NEURORADIOLOGY, V33, P72, DOI 10.1007/BF00593341; Kim HJ, 2003, INVEST RADIOL, V38, P625, DOI 10.1097/01.rli.0000077055.48406.e2; Kim HJ, 2001, INVEST RADIOL, V36, P460, DOI 10.1097/00004424-200108000-00005; LEVY D, 1990, CLIN ORTHOP RELAT R, P281; Malagari K, 2003, CHEST, V123, P1196, DOI 10.1378/chest.123.4.1196; Nakata Y, 1999, J TRAUMA, V47, P111, DOI 10.1097/00005373-199907000-00024; Nastanski F, 2005, J TRAUMA, V58, P372, DOI 10.1097/01.TA.0000108996.10785.0B; OH WH, 1978, ORTHOP CLIN N AM, V9, P769; Parizel PM, 2001, STROKE, V32, P2942, DOI 10.1161/str.32.12.2942; Pinney SJ, 1998, INJURY, V29, P131, DOI 10.1016/S0020-1383(97)00154-X; POLLAK R, 1978, J TRAUMA, V18, P121, DOI 10.1097/00005373-197802000-00008; Ryu CW, 2005, ACTA RADIOL, V46, P528, DOI 10.1080/02841850510021481; SAKAMOTO T, 1983, NEURORADIOLOGY, V24, P283, DOI 10.1007/BF00333182; Sasano N, 2004, CAN J ANAESTH, V51, P875, DOI 10.1007/BF03018883; Satoh H, 1997, J TRAUMA, V43, P345, DOI 10.1097/00005373-199708000-00023; Schemitsch EH, 1998, J TRAUMA, V45, P738, DOI 10.1097/00005373-199810000-00019; Simon AD, 2003, AM J NEURORADIOL, V24, P97; Stoeger A, 1998, EUR RADIOL, V8, P1590, DOI 10.1007/s003300050592; Takahashi M, 1999, J TRAUMA, V46, P324, DOI 10.1097/00005373-199902000-00021; WENDA K, 1993, INJURY, V24, pS73, DOI 10.1016/0020-1383(93)90011-T	39	20	23	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	MAY	2008	15	3					187	192		10.1007/s10140-007-0664-3			6	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	V1X4N	WOS:000217323200007	17934768				2022-02-06	
J	Saltapidas, H; Ponsford, J				Saltapidas, Helen; Ponsford, Jennie			The influence of cultural background on experiences and beliefs about traumatic brain injury and their association with outcome	BRAIN IMPAIRMENT			English	Article						traumatic brain injury; culture; beliefs; emotions; outcome	VOCATIONAL-REHABILITATION CLIENTS; MINOR HEAD-INJURY; PERCEPTION QUESTIONNAIRE; SYMPTOM EXPECTATION; PREDICTORS; ILLNESS; SAMPLE; AGE; PARTICIPATION; ACCULTURATION	The aim of the study was to compare beliefs and experiences of traumatic brain injury (TBI) in patients with TBI from the dominant English-speaking culture in Australia versus those from minority culturally and linguistically diverse (CALD) backgrounds and examine the relative influence of beliefs, acculturation, along with demographic and injury-related variables on outcome. The primary measures included the Illness Perception Questionnaire-Revised (IPQ-R), and the Craig Handicap Assessment and Reporting Technique (CHART). Participants were 70 individuals with mild to severe TBI, including 38 of English-speaking background (ESB) and 32 from CALD backgrounds. Although similar to the ESB participants in education, preinjury employment status, injury severity and experience of TBI, the CALD participants differed significantly from ESB participants on acculturation variables. CALD participants also experienced greater negative emotions and were less likely to have internal locus of control causal beliefs than ESB participants. Regression analyses indicated that describing one's value system as other than Australian, poorer understanding of TBI and greater negative emotional reactions, along with fewer years of education were associated with poorer outcomes on the CHART. Thus, in treating patients from different cultural backgrounds it is important for health professionals to understand beliefs about and responses to TBI, as they could potentially impact on coping, emotional adjustment and long-term outcome.	[Ponsford, Jennie] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Saltapidas, Helen] Monash Univ, Clayton, Vic 3800, Australia		Ponsford, J (corresponding author), Epworth Med Fdn, Dept Psychol, Epworth Rehabil Ctr, 89 Bridge Rd, Richmond, Vic 3121, Australia.	jennie.ponsford@med.monash.edu.au					Armengol CG, 1999, J HEAD TRAUMA REHAB, V14, P233, DOI 10.1097/00001199-199906000-00004; Banja JD, 1996, DISABIL REHABIL, V18, P279, DOI 10.3109/09638289609165881; BATES MS, 1994, SOC SCI MED, V39, P629, DOI 10.1016/0277-9536(94)90020-5; Berry JW, 1997, APPL PSYCHOL-INT REV, V46, P5, DOI 10.1111/j.1464-0597.1997.tb01087.x; Blackmer J, 1999, BRAIN INJURY, V13, P627; BROWN PJ, 1994, HUMAN BEHAV INTRO ME, P84; CAVALLO MM, 1995, J HEAD TRAUMA REHAB, V10, P66, DOI 10.1097/00001199-199504000-00008; Chu C, 1998, Ethn Health, V3, P125; Daniel A., 1983, POWER PRIVILEGE PRES; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P184, DOI 10.1016/S0303-8467(01)00143-3; FITZGERALD MH, 1992, J REHABIL        APR, P38; Gallaher CK, 2001, REHABIL PSYCHOL, V46, P312, DOI 10.1037/0090-5550.46.3.312; Harley D. A., 1996, J APPL REHABILITATIO, V27, P59; HASLAM C, 1995, NEUROPSYCHOLOGY, V9, P599, DOI 10.1037/0894-4105.9.4.599; Heijmans M, 1998, J BEHAV MED, V21, P485, DOI 10.1023/A:1018788427100; Hoofien D, 2002, BRAIN INJURY, V16, P9, DOI 10.1080/02699050110088227; Johnstone B, 2003, BRAIN INJURY, V17, P95, DOI 10.1080/0269905021000010212; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; Man DWK, 2001, BRAIN INJURY, V15, P961, DOI 10.1080/02699050110065664; MELLICK D, 1999, J REHABIL OUTCOMES, V3, P12; MOORE A D, 1992, Brain Injury, V6, P89, DOI 10.3109/02699059209008129; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Padilla, 1980, ACCULTURATION THEORY, P9, DOI DOI 10.1525/AE.1981.8.4.02A00200; Paniagua, 1998, ASSESSING TREATING C; Ponsford J, 1999, NEUROPSYCHOL REHABIL, V9, P517, DOI 10.1080/096020199389563; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Saltapidas H, 2007, J HEAD TRAUMA REHAB, V22, P132, DOI 10.1097/01.HTR.0000265101.75177.8d; Sastry J, 1998, SOC PSYCHOL QUART, V61, P101, DOI 10.2307/2787064; Sherer M, 2003, J HEAD TRAUMA REHAB, V18, P408, DOI 10.1097/00001199-200309000-00003; SHORES EA, 1989, J NEUROL NEUROSUR PS, V52, P126, DOI 10.1136/jnnp.52.1.126-a; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Skeel RL, 2003, REHABIL PSYCHOL, V48, P145, DOI 10.1037/0090-5550.48.3.145; Smart JF, 1997, J REHABIL, V63, P9; Snead SL, 2002, BRAIN INJURY, V16, P947, DOI 10.1080/02699050210147211; Stanhope V, 2002, PSYCHIATR REHABIL J, V25, P273, DOI 10.1037/h0095015; Sue D. W., 1990, COUNSELING CULTURALL; SUINN RM, 1992, EDUC PSYCHOL MEAS, V52, P1041, DOI 10.1177/0013164492052004028; Tabachnick B. G., 2013, USING MULTIVARIATE S, V6th; VICTOR M, 2001, ADAMS VICTORS PRINCI; Walker N, 2003, AM J PHYS MED REHAB, V82, P936, DOI 10.1097/01.PHM.0000098041.42394.9A; Wallace CA, 2000, BRAIN INJURY, V14, P549; Weinman J, 1996, PSYCHOL HEALTH, V11, P431, DOI 10.1080/08870449608400270; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Wilkinson G.S., 1993, WIDE RANGE ACHIEVEME; [No title captured], DOI DOI 10.1080/09602019108520164	49	20	20	1	11	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	MAY	2008	9	1					1	13		10.1375/brim.9.1.1			13	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	325OP	WOS:000257598500001					2022-02-06	
J	Vazquez, JF; Clement, HW; Sommer, O; Schulz, E; van Calker, D				Vazquez, Juan Francisco; Clement, Hans-Willi; Sommer, Olaf; Schulz, Eberhard; van Calker, Dietrich			Local stimulation of the adenosine A(2B) receptors induces an increased release of IL-6 in mouse striatum: an in vivo microdialysis study	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocyte; brain; cytokine; purine	CENTRAL-NERVOUS-SYSTEM; INTERLEUKIN-6 IL-6; CEREBRAL-ISCHEMIA; CYTOKINE ACTIONS; MESSENGER-RNA; RAT-BRAIN; EXPRESSION; ASTROCYTES; PROTEIN; CELLS	Both adenosine and interleukin-6 (IL-6) have been implicated in the pathophysiology of, e.g., epileptic seizures, traumatic brain injury, and affective disorders. Stimulation of adenosine A(2B) receptors on astrocytes in vitro leads to the increased synthesis and secretion of IL-6. We investigated whether or not activation of adenosine receptors evokes an increase of IL-6 release also in vivo. 5'-N-ethylcarboxamidoadenosine, a non-specific adenosine-agonist or vehicle was administered into the striatum of freely moving mice by reverse microdialysis. A statistical significant increase of the IL-6 concentration in the perfusate was detected already 60 min after 5'-N-ethylcarboxamidoadenosine administration. IL-6 increased progressively and reached a maximum after 240 min. This effect appears to be mediated through adenosine A(2B) receptors since it was counteracted by the specific A(2B) receptor antagonist MRS1706 but not by the specific A(1) receptor antagonist DPCPX. We conclude that adenosine via activation of A(2B) receptors evokes IL-6 release also in vivo.	[van Calker, Dietrich] Univ Freiburg, Dept Psychiat & Psychotherapy, Freiburg, Germany; [Vazquez, Juan Francisco; Clement, Hans-Willi; Schulz, Eberhard] Univ Freiburg, Dept Child & Adolescent Psychiat, Freiburg, Germany; [Sommer, Olaf] Univ Freiburg, Dept Gen & Digest Surg, Freiburg, Germany		van Calker, D (corresponding author), Univ Freiburg Klinikum, Abt Psychiat & Psychotherapie, Hauptstr 5, D-79104 Freiburg, Germany.	dietrich.calker@uniklinik-freiburg.de	Vazquez-Costa, Juan F/D-4393-2015	Vazquez-Costa, Juan F/0000-0002-3043-7938			Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Benveniste EN, 1998, CYTOKINE GROWTH F R, V9, P259, DOI 10.1016/S1359-6101(98)00015-X; Biber K, 2001, NEUROPSYCHOPHARMACOL, V24, P86, DOI 10.1016/S0893-133X(00)00169-X; BIBER K, 2007, IN PRESS NEUROPSYCHO; Calker D, 2005, NEUROCHEM RES, V30, P1205, DOI 10.1007/s11064-005-8792-1; Campbell IL, 1998, BRAIN RES REV, V26, P327, DOI 10.1016/S0165-0173(97)00038-6; Choi YH, 1999, PHYSIOL BEHAV, V67, P587, DOI 10.1016/S0031-9384(99)00110-9; Clapp-Lilly KL, 1999, J NEUROSCI METH, V90, P129, DOI 10.1016/S0165-0270(99)00064-3; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Fiebich BL, 2005, NEUROCHEM INT, V46, P501, DOI 10.1016/j.neuint.2004.11.009; Fiebich BL, 1996, J NEUROCHEM, V66, P1426; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Herrmann O, 2003, J CEREBR BLOOD F MET, V23, P406, DOI 10.1097/01.WCB.0000055177.50448.FA; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Huang CC, 2001, REV NEUROSCIENCE, V12, P51; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Juttler E, 2002, NEUROSCIENTIST, V8, P268, DOI 10.1177/1073858402008003012; Kim YC, 2000, J MED CHEM, V43, P1165, DOI 10.1021/jm990421v; Michel PP, 1999, J NEUROCHEM, V72, P2074, DOI 10.1046/j.1471-4159.1999.0722074.x; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pizzi M, 2004, MOL CELL NEUROSCI, V25, P301, DOI 10.1016/j.mcn.2003.10.022; Rosi S, 2003, J NEUROCHEM, V86, P220, DOI 10.1046/j.1471-4159.2003.01825.x; Sallmann S, 2000, J NEUROSCI, V20, P8637; Schwaninger M, 2000, GLIA, V31, P51, DOI 10.1002/(SICI)1098-1136(200007)31:1<51::AID-GLIA50>3.0.CO;2-M; Schwaninger M, 1997, J NEUROCHEM, V69, P1145; Sjogren S, 2002, BRIT J DERMATOL, V146, P375, DOI 10.1046/j.1365-2133.2002.04621.x; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Suzuki S, 2000, NEUROREPORT, V11, P2565, DOI 10.1097/00001756-200008030-00043; Taga T, 2005, CLIN REV ALLERG IMMU, V28, P249, DOI 10.1385/CRIAI:28:3:249; Tawfik HE, 2005, AM J PHYSIOL-HEART C, V288, pH1411, DOI 10.1152/ajpheart.00684.2004; Trincavelli ML, 2004, J NEUROCHEM, V91, P1180, DOI 10.1111/j.1471-4159.2004.02793.x; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; WOODROOFE MN, 1991, J NEUROIMMUNOL, V33, P227, DOI 10.1016/0165-5728(91)90110-S; YAN HQ, 1992, EUR J IMMUNOL, V22, P2963, DOI 10.1002/eji.1830221131	38	20	21	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAY	2008	105	3					904	909		10.1111/j.1471-4159.2007.05191.x			6	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	290RF	WOS:000255139200030	18088370	Bronze			2022-02-06	
J	Baytan, SH; Alkanat, M; Okuyan, M; Ekinci, M; Gedikli, E; Ozeren, M; Akgun, A				Baytan, Sukrucan H.; Alkanat, Mehmet; Okuyan, Mukadder; Ekinci, Murat; Gedikli, Eyup; Ozeren, Mehmet; Akgun, Ahmet			Simvastatin impairs spatial memory in rats at a specific dose level	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						Barnes maze; behavior; statins; brain; locomotor	TRAUMATIC BRAIN-INJURY; D-2 RECEPTOR EXPRESSION; PREFRONTAL CORTEX; DOPAMINE D-1; CHOLESTEROL-SYNTHESIS; REDUCTASE INHIBITORS; COGNITIVE FUNCTION; PYRAMIDAL CELLS; LOWERING DRUGS; ACETYLCHOLINE	Statins, inhibitors of cholesterol synthesis, are used to prevent cardiovascular complications. Moreover, statins have been shown to influence some cognitive functions. The modulating effects of simvastatin, one member of the statin family, on memory-related neurotransmitters and neuronal structures have also been reported. We aimed to investigate the behavioral effects of long-term simvastatin application on daily activity, psychomotor performance and spatial memory using Sprague-Dawley rats. Simvastatin (10 or 30 mg/kg/day) was administered orally to rats, in parallel with a vehicle-treated group. Daily activity test results of both simvastatin groups were found similar to the vehicle group after five weeks of simvastatin or vehicle application. Psychomotor performance was measured with the rotarod test. After 6 weeks of simvastatin or vehicle application, the vehicle-treated group stayed on the rotarod device for a shorter time compared with both simvastatin-treated groups. Spatial memory was evaluated by the Barnes maze test. Four weeks of 10 mg/kg/day simvastatin application led to poorer scores on spatial memory compared to the vehicle group, but surprisingly, this effect was not seen in the 30 mg/kg/day group. Our results revealed that simvastatin administration had no significant effect on daily activity. Psychomotor performance test results suggested that simvastatin alters psychomotor behavior at higher nervous system levels. Spatial memory test results indicate that long-term simvastatin usage impairs spatial memory only at 10 mg/kg/day dose.	[Baytan, Sukrucan H.; Alkanat, Mehmet; Okuyan, Mukadder; Akgun, Ahmet] Karadeniz Tech Univ, Sch Med, Dept Physiol, Trabzon, Turkey; [Ekinci, Murat; Gedikli, Eyup] Karadeniz Tech Univ, Sch Engn, Dept Comp Engn, Trabzon, Turkey; [Ozeren, Mehmet] Karadeniz Tech Univ, Sch Med, Dept Obstet & Gynecol, Trabzon, Turkey		Baytan, SH (corresponding author), KTU Tip Fak, Fizyoloji ABD, TR-61080 Trabzon, Turkey.	cbaytan@gmail.com	Gedikli, Eyup/U-5309-2017; ALKANAT, MEHMET/ABF-3833-2020; OKUYAN, Mukadder/AAV-7932-2021; Karahan, Suleyman Caner/AAL-5846-2021; Ekinci, Murat/A-9653-2012; OZEREN, MEHMET/ABI-7832-2020	Gedikli, Eyup/0000-0002-7212-5457; ALKANAT, MEHMET/0000-0001-8079-3749; OZEREN, MEHMET/0000-0002-4552-9042			Ardevol A, 1998, PFLUG ARCH EUR J PHY, V435, P454, DOI 10.1007/s004240050539; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Baytan SH, 2006, TOHOKU J EXP MED, V209, P311, DOI 10.1620/tjem.209.311; BORER KT, 1977, PHYSIOL BEHAV, V18, P29, DOI 10.1016/0031-9384(77)90089-0; Bosel J, 2005, J NEUROCHEM, V92, P1386, DOI 10.1111/j.1471-4159.2004.02980.x; Cibickova L, 2007, PHYSIOL RES, V56, P765, DOI 10.33549/physiolres.931121; COLE AE, 1983, SCIENCE, V221, P1299, DOI 10.1126/science.6612345; Darvesh S, 2004, CLIN BIOCHEM, V37, P42, DOI 10.1016/j.clinbiochem.2003.09.004; Duriez P, 2003, THERAPIE, V58, P5, DOI 10.2515/therapie:2003002; Fujishiro H, 2005, PSYCHOPHARMACOLOGY, V182, P253, DOI 10.1007/s00213-005-0072-x; Golomb BA, 2004, QJM-INT J MED, V97, P229, DOI 10.1093/qjmed/hch035; Gray JA, 1991, NEUROBIOLOGY LEARNIN; Greig NH, 2005, P NATL ACAD SCI USA, V102, P17213, DOI 10.1073/pnas.0508575102; GUILLOT F, 1993, J CARDIOVASC PHARM, V21, P339, DOI 10.1097/00005344-199302000-00022; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; Johnson-Anuna LN, 2005, J PHARMACOL EXP THER, V312, P786, DOI 10.1124/jpet.104.075028; Kirsch C, 2003, BIOCHEM PHARMACOL, V65, P843, DOI 10.1016/S0006-2952(02)01654-4; Lee RS, 1998, BRAIN RES, V799, P317, DOI 10.1016/S0006-8993(98)00477-6; Li WD, 2005, CURR BIOL, V15, P1961, DOI 10.1016/j.cub.2005.09.043; Lindberg C, 2005, J NEUROSCI RES, V82, P10, DOI 10.1002/jnr.20615; Lutjohann D, 2004, STEROIDS, V69, P431, DOI 10.1016/j.steroids.2004.03.012; Marz P, 2007, GLIA, V55, P1, DOI 10.1002/glia.20422; Mohapel P, 2005, NEUROBIOL AGING, V26, P939, DOI 10.1016/j.neurobiolaging.2004.07.015; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Pahan K, 2006, CELL MOL LIFE SCI, V63, P1165, DOI 10.1007/s00018-005-5406-7; Parle M, 2007, YAKUGAKU ZASSHI, V127, P1125, DOI 10.1248/yakushi.127.1125; Pooler AM, 2006, J NEUROCHEM, V97, P716, DOI 10.1111/j.1471-4159.2006.03763.x; Qu CS, 2005, J NEUROSURG, V103, P695, DOI 10.3171/jns.2005.103.4.0695; SAHEKI A, 1994, PHARMACEUT RES, V11, P305, DOI 10.1023/A:1018975928974; Schulz JG, 2004, J NEUROCHEM, V89, P24, DOI 10.1046/j.1471-4159.2003.02305.x; Snipes G J, 1997, Subcell Biochem, V28, P173; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Summers MJ, 2007, PHARMACOTHERAPY, V27, P183, DOI 10.1592/phco.27.2.183; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; Thiel CM, 1998, NEUROSCIENCE, V85, P1253, DOI 10.1016/S0306-4522(98)00030-X; TSUJI A, 1993, J PHARMACOL EXP THER, V267, P1085; Turner RJ, 2004, J AM COLL NUTR, V23, p534S, DOI 10.1080/07315724.2004.10719397; Vecka M, 2004, TOHOKU J EXP MED, V204, P299, DOI 10.1620/tjem.204.299; Wagstaff LR, 2003, PHARMACOTHERAPY, V23, P871, DOI 10.1592/phco.23.7.871.32720; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang Q, 2005, BRAIN RES, V1045, P229, DOI 10.1016/j.brainres.2005.03.016; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; Wang Q, 2006, NEUROSCI LETT, V408, P189, DOI 10.1016/j.neulet.2006.09.009; Wilkerson A, 1999, NEUROSCIENCE, V89, P743, DOI 10.1016/S0306-4522(98)00346-7	45	20	23	0	5	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	APR	2008	214	4					341	349		10.1620/tjem.214.341			9	Medicine, General & Internal; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Research & Experimental Medicine	296ZN	WOS:000255584600008	18441510	Bronze			2022-02-06	
J	Kovesdi, E; Tamas, A; Reglodi, D; Farkas, O; Pal, J; Toth, G; Bukovics, P; Doczi, T; Buki, A				Kovesdi, Erzsebet; Tamas, Andrea; Reglodi, Dora; Farkas, Orsolya; Pal, Jozsef; Toth, Gabor; Bukovics, Peter; Doczi, Tamas; Buki, Andras			Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats	NEUROTOXICITY RESEARCH			English	Article						traumatic brain injury; PACAP; axonoprotection; APP; RMO	TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; VASOACTIVE-INTESTINAL-PEPTIDE; INTRAAXONAL NEUROFILAMENT COMPACTION; INDUCED RETINAL LESION; AXONAL DAMAGE; SPINAL-CORD; HIPPOCAMPAL-NEURONS; SUBSTANTIA-NIGRA; CYCLOSPORINE-A	Several in vitro and in vivo experiments have demonstrated the neuroprotective effects of pituitary adenylate cyclase activating polypeptide (PACAP) in focal cerebral ischemia, Parkinson's disease and traumatic brain injury (TBI). The aim of the present study was to analyze the effect of PACAP administration on diffuse axonal injury (DAI), an important contributor to morbidity and mortality associated with TBI, in a central fluid percussion (CFP) model of TBI. Rats were subjected to moderate (2 Atm) CFP injury. Thirty min after injury, 100 mu g PACAP was administered intracerebroventricularly. DAI was assessed by immunohistochemical detection of beta-amyloid precursor protein, indicating impaired axoplasmic transport, and RMO-14 antibody, representing foci of cytoskeletal alterations (neurofilament compaction), both considered classical markers of axonal damage. Analysis of damaged, immunoreactive axonal profiles revealed significant axonal protection in the PACAP-treated versus vehicle-treated animals in the corticospinal tract, as far as traumatically induced disturbance of axoplasmic transport and cytoskeletal alteration were considered. Similarly to our former observations in an impact acceleration model of diffuse TBI, the present study demonstrated that PACAP also inhibits DAI in the CFP injury model. The finding indicates that PACAP and derivates can be considered potential candidates for further experimental studies, or purportedly for clinical trials in the therapy of TBI.	[Kovesdi, Erzsebet; Pal, Jozsef; Bukovics, Peter; Doczi, Tamas; Buki, Andras] Univ Pecs, Fac Med, Dept Neurosurg, Pecs, Hungary; [Tamas, Andrea; Reglodi, Dora] Univ Pecs, Fac Med, Dept Anat, Pecs, Hungary; [Farkas, Orsolya] Univ Pecs, Fac Med, Dept Radiol, Pecs, Hungary; [Toth, Gabor] Univ Szeged, Dept Med Chem, Szeged, Hungary; [Bukovics, Peter] Hungarian Acad Sci, Clin Neurosci Res Grp, Pecs, Hungary		Buki, A (corresponding author), Univ Pecs, Fac Med, Dept Neurosurg, Pecs, Hungary.	andras.buki@aok.pte.hu	Buki, Andras/B-1960-2010; Pal, Jozsef/I-3416-2013; Pal, Jozsef/C-4073-2009	Pal, Jozsef/0000-0001-6468-6409			Atlasz T, 2007, GEN COMP ENDOCR, V153, P108, DOI 10.1016/j.ygcen.2006.12.022; Aubert N, 2006, J NEUROCHEM, V99, P1237, DOI 10.1111/j.1471-4159.2006.04148.x; Babai N, 2005, NEUROTOX RES, V8, P227, DOI 10.1007/BF03033976; Beal MF, 2000, NEUROTOX RES, V2, P71, DOI 10.1007/BF03033786; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 2000, J NEUROSCI, V20, P2825; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Chen WH, 2005, NEUROSCI LETT, V384, P117, DOI 10.1016/j.neulet.2005.04.070; Dejda A, 2005, PHARMACOL REP, V57, P307; Delgado M, 2003, J LEUKOCYTE BIOL, V73, P155, DOI 10.1189/jlb.0702372; DEYEBENES JG, 2000, NEUROTOX RES, V2, P115, DOI DOI 10.1007/BF03033789; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Doberer D, 2007, EUR J CLIN INVEST, V37, P665, DOI 10.1111/j.1365-2362.2007.01832.x; Dohi K, 2002, REGUL PEPTIDES, V109, P83, DOI 10.1016/S0167-0115(02)00190-8; Farkas O, 2005, ACTA NEUROCHIR, V147, P855, DOI 10.1007/s00701-005-0559-6; Farkas O, 2004, REGUL PEPTIDES, V123, P69, DOI 10.1016/j.regpep.2004.05.014; Feng SQ, 2005, NEUROTOX RES, V7, P169, DOI 10.1007/BF03033785; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Gasz B, 2006, PEPTIDES, V27, P87, DOI 10.1016/j.peptides.2005.06.022; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gerlach M, 2000, NEUROTOX RES, V2, P99, DOI 10.1007/BF03033788; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Katahira M., 2003, Regulatory Peptides, V115, P49; Kim WK, 2000, J NEUROSCI, V20, P3622, DOI 10.1523/JNEUROSCI.20-10-03622.2000; Li M, 2007, PEPTIDES, V28, P1891, DOI 10.1016/j.peptides.2007.05.002; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; POVISHLOK J, 1996, ACTA NEUROCHIR SUPP, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; RACZ B, 2006, INT J NEUROPROT NEUR, V2, P80; Racz B, 2006, REGUL PEPTIDES, V137, P20, DOI 10.1016/j.regpep.2006.02.009; Racz B, 2007, NEUROTOX RES, V12, P95, DOI 10.1007/BF03033918; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reglodi D, 2006, NEUROPEPTIDES, V40, P265, DOI 10.1016/j.npep.2006.06.001; Reglodi D, 2004, REGUL PEPTIDES, V123, P85, DOI 10.1016/j.regpep.2004.05.016; Reglodi D, 2002, PEPTIDES, V23, P2227, DOI 10.1016/S0196-9781(02)00262-0; Reglodi D, 2005, NEUROTOX RES, V8, P317; Segura-Aguilar J, 2006, NEUROTOX RES, V10, P263, DOI 10.1007/BF03033362; Shioda S, 1998, ANN NY ACAD SCI, V865, P111, DOI 10.1111/j.1749-6632.1998.tb11169.x; Shioda S, 2006, ANN NY ACAD SCI, V1070, P550, DOI 10.1196/annals.1317.080; Skoglosa Y, 1999, NEUROSCIENCE, V90, P235, DOI 10.1016/S0306-4522(98)00414-X; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Stone JR, 2000, BRAIN RES, V871, P288, DOI 10.1016/S0006-8993(00)02485-9; Stone JR, 1999, ACTA NEUROPATHOL, V97, P335, DOI 10.1007/s004010050996; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; Tabuchi A, 2003, J NEUROSCI RES, V71, P504, DOI 10.1002/jnr.10505; Tamas A, 2006, ANN NY ACAD SCI, V1070, P570, DOI 10.1196/annals.1317.083; Tamas A, 2006, J NEUROTRAUM, V23, P686, DOI 10.1089/neu.2006.23.686; van Landeghem FKH, 2007, ACTA NEUROPATHOL, V113, P683, DOI 10.1007/s00401-007-0208-7	60	20	22	1	6	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	APR	2008	13	2					71	78		10.1007/BF03033558			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	313LH	WOS:000256741600001	18515209				2022-02-06	
J	Marwit, SJ; Chibnall, JT; Dougherty, R; Jenkins, C; Shawgo, J				Marwit, Samuel J.; Chibnall, John T.; Dougherty, Rebecca; Jenkins, Chrystal; Shawgo, Jenifer			Assessing pre-death grief in cancer caregivers using the Marwit-Meuser Caregiver Grief Inventory (MM-CGI)	PSYCHO-ONCOLOGY			English	Article						cancer; oncology; caregivers; grief; assessment	ALZHEIMERS-DISEASE; TRAUMATIC GRIEF; DEPRESSION; SCALE; INDIVIDUALS; VALIDATION; EXPERIENCE; SYMPTOMS; DISTRESS; DEMENTIA	The Marwit-Meuser Caregiver Grief Inventory (MM-CGI) was developed and initially validated with caregivers of persons with Alzheimer's disease, and subsequently evaluated with caregivers of persons with brain injury. The present study examined MM-CGI psychometric and validity properties in 75 caregivers of persons with cancer. As with previous studies, high internal consistency reliability of MM-CGI Total Grief and subscale scores (Personal Sacrifice and Burden, Heartfelt Sadness and Longing, and Worry and Felt Isolation) was demonstrated. Construct validity of the subscale scores was supported by differential associations with other caregiver measures of depression, strain, well-being, and family support. Based on these preliminary results, the MM-CGI appears useful for assessing pre-death grief in caregivers of persons with cancer. Copyright (C) 2007 John Wiley & Sons, Ltd.	[Marwit, Samuel J.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA; [Chibnall, John T.; Jenkins, Chrystal; Shawgo, Jenifer] St Louis Univ, Sch Med, Dept Psychiat, St Louis, MO 63103 USA; [Dougherty, Rebecca] St Louis Univ, Ctr Canc, St Louis, MO 63103 USA		Marwit, SJ (corresponding author), 4540 Laclede Ave,306 St, St Louis, MO 63108 USA.	smarwit@yohoo.com					Beery LC, 1997, OMEGA-J DEATH DYING, V35, P261, DOI 10.2190/9QT0-XBD0-V8E9-U650; Berg-Weger M, 2000, HEALTH SOC WORK, V25, P255, DOI 10.1093/hsw/25.4.255; Chen JH, 1999, PSYCHOL MED, V29, P367, DOI 10.1017/S0033291798008137; Ensel WM., 1986, SOCIAL SUPPORT LIFE, P51, DOI [DOI 10.1016/B978-0-12-450660-2.50011-2, 10.1016/B978-0-12-450660-2.50011-2]; Hebert RS, 2006, J PALLIAT MED, V9, P683, DOI 10.1089/jpm.2006.9.683; Kelly B, 1999, PSYCHO-ONCOLOGY, V8, P237, DOI 10.1002/(SICI)1099-1611(199905/06)8:3<237::AID-PON375>3.0.CO;2-C; Loos C, 1997, DEATH STUD, V21, P501; Marwit SJ, 2006, BRAIN INJURY, V20, P1419, DOI 10.1080/02699050601082214; Marwit SJ, 2002, GERONTOLOGIST, V42, P751, DOI 10.1093/geront/42.6.751; MEUSER TM, 2005, LIVING GRIEF ALZHEIM, P169; Prigerson HG, 2003, AM J GERIAT PSYCHIAT, V11, P309, DOI 10.1176/appi.ajgp.11.3.309; Prigerson HG, 1995, PSYCHIAT RES, V59, P65, DOI 10.1016/0165-1781(95)02757-2; PROCIDANO ME, 1983, AM J COMMUN PSYCHOL, V11, P1, DOI 10.1007/BF00898416; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Robinson-Whelen S, 2001, J ABNORM PSYCHOL, V110, P573, DOI 10.1037//0021-843X.110.4.573; Sanders, 2004, DEMENTIA, V3, P195, DOI [DOI 10.1177/1471301204042337, 10.1177/1471301204042337]; Sanders S, 2005, HEALTH SOC WORK, V30, P287, DOI 10.1093/hsw/30.4.287; Sanders S, 2003, SOC WORK HEALTH CARE, V37, P35, DOI 10.1300/J010v37n03_03; Van Doorn C, 1998, J NERV MENT DIS, V186, P566, DOI 10.1097/00005053-199809000-00008; Walker RJ, 1996, HEALTH SOC WORK, V21, P247, DOI 10.1093/hsw/21.4.247	20	20	22	1	10	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND	1057-9249			PSYCHO-ONCOL	Psycho-Oncol.	MAR	2008	17	3					300	303		10.1002/pon.1218			4	Oncology; Psychology; Psychology, Multidisciplinary; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Oncology; Psychology; Biomedical Social Sciences	280GJ	WOS:000254413400012	17518412				2022-02-06	
J	Rivas, S; Douds, GL; Ostdahl, RH; Harbaugh, KS				Rivas, Sharon; Douds, G. Logan; Ostdahl, Roger H.; Harbaugh, Kimberly S.			Fulminant Guillain-Barre syndrome after closed head injury: a potentially reversible cause of an ominous examination - Case report	JOURNAL OF NEUROSURGERY			English	Article						brainstem encephalitis; fulminant Guillain-Barre syndrome; head injury; Miller Fisher syndrome	BRAIN-STEM ENCEPHALITIS; MILLER-FISHER-SYNDROME; CENTRAL PONTINE MYELINOLYSIS; ACUTE AXONAL POLYNEUROPATHY; CRITICAL ILLNESS; ELECTROPHYSIOLOGICAL FINDINGS; CHRONIC-ALCOHOLISM; DEATH; TRAUMA; OPHTHALMOPLEGIA	Fulminant Guillain-Barre syndrome (GBS) is a rapidly progressive form of polyneuropathy in which patients demonstrate eventual flaccid quadriplegia and an absence of brainstem function. Most patients present after a mild upper respiratory or gastrointestinal illness and have nondiagnostic cerebral imaging studies. The authors present a case of fulminant GBS that developed in a 55-year-old alcoholic man 1 week after admission for a closed head injury. The details of this case and a discussion of GBS will be presented. This case provides evidence for combined central and peripheral nervous system involvement in severe cases of GBS. Recognition of fulminant GBS is important to prevent inappropriate declaration of brain death or withdrawal of support in the face of a potentially reversible process.	[Rivas, Sharon; Douds, G. Logan; Harbaugh, Kimberly S.] Penn State Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Ostdahl, Roger H.] Neurol Surg LTD, Mechanicsburg, PA USA		Harbaugh, KS (corresponding author), Penn State Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA.	kharbaugh@psu.edu					ALDIN AN, 1982, BRAIN, V105, P481, DOI 10.1093/brain/105.3.481; ALDIN ASN, 1987, ACTA NEUROL SCAND, V75, P287, DOI 10.1111/j.1600-0404.1987.tb05449.x; AMIT R, 1992, CHILD NERV SYST, V8, P354, DOI 10.1007/BF00296569; Arai M, 2002, EUR J NEUROL, V9, P115, DOI 10.1046/j.1468-1331.2002.00321.x; Berciano J, 1997, MUSCLE NERVE, V20, P846; BERLIT P, 1992, J CLIN NEURO-OPHTHAL, V12, P57; BICKERSTAFF ER, 1957, BRIT MED J, V1, P1384, DOI 10.1136/bmj.1.5032.1384; Bohlega SA, 1997, MUSCLE NERVE, V20, P514, DOI 10.1002/(SICI)1097-4598(199704)20:4<514::AID-MUS19>3.0.CO;2-Y; Bolton CF, 2005, MUSCLE NERVE, V32, P140, DOI 10.1002/mus.20304; BOLTON CF, 1995, NEW ENGL J MED, V333, P1415, DOI 10.1056/NEJM199511233332110; COAD NR, 1990, ANAESTHESIA, V45, P456, DOI 10.1111/j.1365-2044.1990.tb14333.x; DeFreitas GR, 1997, ARQ NEURO-PSIQUIAT, V55, P315, DOI 10.1590/S0004-282X1997000200022; DUNCAN R, 1987, POSTGRAD MED J, V63, P479, DOI 10.1136/pgmj.63.740.479; FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115; FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201; Friedman Y, 2003, CAN J NEUROL SCI, V30, P397, DOI 10.1017/S0317167100003152; Hughes RAC, 2003, J ROY SOC MED, V96, P432, DOI 10.1258/jrsm.96.9.432; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hund E, 2001, CURR OPIN NEUROL, V14, P649, DOI 10.1097/00019052-200110000-00015; Lin TM, 2006, J PLAST RECONSTR AES, V59, P543, DOI 10.1016/j.bjps.2005.10.017; Matsumoto H, 2002, BRAIN DEV-JPN, V24, P98, DOI 10.1016/S0387-7604(01)00409-0; Mochizuki H, 2003, J NEUROL, V250, P1077, DOI 10.1007/s00415-003-0157-6; Mondejar RR, 2002, NEURORADIOLOGY, V44, P411, DOI 10.1007/s00234-001-0733-3; Nishimoto Y, 2004, J NEUROIMMUNOL, V148, P200, DOI 10.1016/j.jneuroim.2003.11.017; Odaka M, 2003, BRAIN, V126, P2279, DOI 10.1093/brain/awg233; Odaka M, 2001, J NEUROL NEUROSUR PS, V70, P50, DOI 10.1136/jnnp.70.1.50; Okumura A, 2002, ARCH DIS CHILD, V86, P304, DOI 10.1136/adc.86.4.304; PASTENA L, 1988, DRUG ALCOHOL DEPEN, V21, P153, DOI 10.1016/0376-8716(88)90062-2; Pulitano S, 2005, CHILD NERV SYST, V21, P473, DOI 10.1007/s00381-005-1144-2; Ragazzoni A, 2000, INT J PSYCHOPHYSIOL, V37, P99, DOI 10.1016/S0167-8760(00)00098-2; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; Ruzek KA, 2004, AM J NEURORADIOL, V25, P210; Sartucci F, 2005, NEUROL SCI, V26, P125, DOI 10.1007/s10072-005-0445-2; Sharma V, 2006, J CLIN NEUROSCI, V13, P277, DOI 10.1016/j.jocn.2005.01.011; SHUERT GT, 1972, J ORAL SURG, V30, P913; Stevenson VL, 2003, EUR J NEUROL, V10, P187, DOI 10.1046/j.1468-1331.2003.00502_1.x; Stojkovic T, 2001, J NEUROL, V248, P430, DOI 10.1007/s004150170190; Susuki K, 2003, J NEUROL SCI, V211, P89, DOI 10.1016/S0022-510X(03)00058-3; TABARAUD F, 1990, J NEUROL SCI, V97, P195, DOI 10.1016/0022-510X(90)90218-C; Tatsumoto M, 2006, J NEUROIMMUNOL, V177, P201, DOI 10.1016/j.jneuroim.2006.04.005; THOMAS PK, 1992, J NEUROL, V239, P361; Thompson D., 2000, DRUG DELIV TECHNOL, V2, P34; Vandenbulcke M, 1999, ACTA NEUROL BELG, V99, P198; Vargas F, 2000, INTENS CARE MED, V26, P623, DOI 10.1007/s001340051213; Vega-Basulto S, 2004, REV NEUROLOGIA, V39, P1194, DOI 10.33588/rn.3912.2003444; Wang De-sheng, 2006, J Zhejiang Univ Sci B, V7, P138, DOI 10.1631/jzus.2006.B0138; Wohrle JC, 1998, ARCH NEUROL-CHICAGO, V55, P1329, DOI 10.1001/archneur.55.10.1329; Yuki N, 1997, J NEUROL SCI, V145, P119, DOI 10.1016/S0022-510X(96)00251-1; Zifko UA, 1998, J NEUROL SCI, V159, P186, DOI 10.1016/S0022-510X(98)00164-6	49	20	21	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	MAR	2008	108	3					595	600		10.3171/JNS/2008/108/3/0595			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	270PM	WOS:000253732700024	18312109				2022-02-06	
J	dela Cruz, GG; Knapik, JJ; Birk, MG				dela Cruz, Georgia G.; Knapik, Joseph J.; Birk, Marcella G.			Evaluation of mouthguards for the prevention of orofacial injuries during United States Army basic military training	DENTAL TRAUMATOLOGY			English	Article							DENTAL INJURIES; MOUTH PROTECTORS; CONCUSSIONS; WEAR	Beginning in January 2000, all individuals participating in basic military training at Fort Leonard Wood, Missouri, were issued boil-and-bite mouthguards. From January 2000 to March 2001, trainees were required to wear mouthguards only for a single activity, pugil stick training. After March 2001, mouthguards were required for four activities including pugil stick training, unarmed combat, rifle/bayonet training, and the confidence/obstacle course. Dentists systematically tracked trainees who reported to the dental clinic with orofacial injuries during three periods: January 2000-March 2001 (phase 1), April-September 2001 (phase 2) and September 2002-June 2003 (phase 3). Orofacial injury rates were 3.35, 1.89 and 1.91 cases/10 000 person-years in phases 1, 2 and 3, respectively. The overall risk of an orofacial injury was 1.76 (95% confidence interval = 1.03-3.02) times higher in phase 1 compared with the combined phases 2 and 3 (P = 0.006). Thus, orofacial injury rates were lower when mouthguards were required for four training activities as opposed to one training activity. Mouthguards are now required at all five Army basic training sites when trainees are performing any of the four training activities.	[dela Cruz, Georgia G.; Knapik, Joseph J.; Birk, Marcella G.] USA, Ctr Hlth Promot & Prevent Med, Aberdeen Proving Ground, MD 21010 USA		dela Cruz, GG (corresponding author), USA, Ctr Hlth Promot & Prevent Med, LTC dela Cruz,5158 Blackhawk Rd, Aberdeen Proving Ground, MD 21010 USA.	georgia.delacruz@us.army.mil					ADAMS JR, 2004, RULES INTERPRETATION; ALEXANDER D, 1995, IOWA DENT J, V40, P41; [Anonymous], 2004, J AM DENT ASSOC, V135, P1061; [Anonymous], 1964, J AM DENT ASSOC, V68, P430; Barbic D, 2005, CLIN J SPORT MED, V15, P294, DOI 10.1097/01.jsm.0000171883.74056.21; Blignaut J B, 1987, Br J Sports Med, V21, P5; *BUR DENT HLTH ED, 1963, J AM DENT ASSOC, V66, P539; CARLOS TA, 1938, ORAL HYG, V28, P1580; Chapman P J, 1985, Br J Sports Med, V19, P34; COHEN A, 1958, J Am Dent Assoc, V56, P863; Cohen A, 1961, B NAT ASS SECONDARY, V45, P145; Cohen A, 1962, PENN DENT J, V29, P6; de Wet F A, 1981, J Dent Assoc S Afr, V36, P249; DUFFY PJ, 2005, ICE HOCKEY RULES INT; Dunbar D, 1962, J MASS DENT SOC, V11, P34; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; GARFIELD S, 1969, TREATISE TEETH RELAT; HEINTZ WD, 1968, J AM DENT ASSOC, V77, P632; HEINTZ WD, 1975, PHYSICIAN SPORTSMED, V3, P61; HUGHSTON JC, 1980, AM J SPORT MED, V8, P61, DOI 10.1177/036354658000800201; Jacobs WH, 1938, ORAL HYGIENE, V28, P1148; *JOINT COMM MOUTH, 1960, REP JOINT COMM MOUTH; Kahn HA, 1989, STAT METHODS EPIDEMI; KATZ RV, 1979, COMMUNITY DENT ORAL, V7, P30, DOI 10.1111/j.1600-0528.1979.tb01182.x; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; MAESTRELLODEMOYA MG, 1989, J DENT CHILD, V56, P36; Marshall SW, 2005, INT J EPIDEMIOL, V34, P113, DOI 10.1093/ije/dyh346; MCNUTT T, 1989, Pediatric Dentistry, V11, P209; MOON DG, 1961, J AM DENT ASSOC, V62, P568, DOI 10.14219/jada.archive.1961.0104; Morton J G, 1979, N Z Dent J, V75, P151; POWERS J M, 1984, Journal of the American Dental Association, V109, P84; Quarrie KL, 2005, BRIT J SPORT MED, V39, P650, DOI 10.1136/bjsm.2004.016022; REED RV, 1994, BRIT DENT J, V176, P478, DOI 10.1038/sj.bdj.4808485; Schoen G, 1956, B NASSAU COUNTY DENT, V30, P12; STEVENS OO, 1963, J AM DENT ASSOC, V67, P521, DOI 10.14219/jada.archive.1963.0330; STOKES ANS, 1987, ENDOD DENT TRAUMATOL, V3, P255; Upson N, 1985, Br J Sports Med, V19, P89; WATTS G, 1954, J AM DENT ASSOC, V49, P7, DOI 10.14219/jada.archive.1954.0132; WINTERS CW, 2005, LACROSSE MENS RULES; Wisniewski JF, 2004, DENT TRAUMATOL, V20, P143, DOI 10.1111/j.1600-4469.2004.00259.x	40	20	22	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2008	24	1					86	90		10.1111/j.1600-9657.2006.00500.x			5	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	242PV	WOS:000251738700018	18173673				2022-02-06	
J	Shein, NA; Grigoriadis, N; Alexandrovich, AG; Simeonidou, C; Spandou, E; Tsenter, J; Yatsiv, I; Horowitz, M; Shohami, E				Shein, Na'ama A.; Grigoriadis, Nikolaos; Alexandrovich, Alexander G.; Simeonidou, Constantina; Spandou, Evangelia; Tsenter, Jeanna; Yatsiv, Ido; Horowitz, Michal; Shohami, Esther			Differential neuroprotective properties of endogenous and exogenous erythropoietin in a mouse model of traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral edema; closed head injury; heat acclimation	CLOSED-HEAD INJURY; RECOMBINANT-HUMAN-ERYTHROPOIETIN; FLUORO-JADE-B; NEURONAL APOPTOSIS; CEREBRAL-ISCHEMIA; CROSS-TOLERANCE; ACCLIMATION INCREASES; COGNITIVE DEFICITS; NERVOUS-SYSTEM; MICE	Both heat acclimation (HA) and post-injury treatment with recombinant human erythropoietin (Epo, rhEpo, exogenous Epo) are neuroprotective against traumatic brain injury (TBI). Our previous data demonstrated that HA-induced neuroprotection includes improved functional recovery and reduced cerebral edema formation. Additionally, in earlier Western-blot analyses, we found that HA mice display increased expression of the specific erythropoietin receptor (EpoR) and of hypoxia-inducible factor-1 alpha (HIF-1 alpha), the inducible subunit of the transcription factor, which regulates Epo gene expression, but not of Epo itself. In light of this, the aim of the current study was threefold: (1) to assess Epo expression in the trauma area and hippocampus following HA, rhEpo administration, or combined HA-rhEpo treatment, using immunohistochemical methods that offer enhanced anatomical resolution; (2) to examine the effects of endogenous and exogenous Epo on edema formation in normothermic (NT) mice; and (3) to evaluate the effects of exogenous Epo administration on neuroprotective outcome measures in HA animals. HA induced enhanced expression of endogenous Epo in the trauma area and the hippocampus. Treatment with anti-Epo antibody given to NT mice increased edema formation, whereas rhEpo induced no beneficial effect. Cognitive performance testing and immunohistochemical findings reinforced HA and rhEpo as separate protective interventions but showed no advantage to combining the two strategies. We therefore suggest that HA-induced neuroprotection is shaped by pre-existing mediators but cannot be modified by post-injury treatment aimed at increasing the levels of neuroprotective agents.	[Shein, Na'ama A.; Alexandrovich, Alexander G.; Shohami, Esther] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-92220 Jerusalem, Israel; [Shein, Na'ama A.; Horowitz, Michal] Hebrew Univ Jerusalem, Dept Physiol, IL-92220 Jerusalem, Israel; [Grigoriadis, Nikolaos] AHEPA Univ, Dept Neurol, Thessaloniki, Greece; [Simeonidou, Constantina; Spandou, Evangelia] AHEPA Univ, Dept Physiol, Thessaloniki, Greece; Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Tsenter, Jeanna] Hadassah Med Ctr, Rehabil Ctr, IL-91120 Jerusalem, Israel; [Yatsiv, Ido] Hadassah Med Ctr, Pediat Crit Care Unit, IL-91120 Jerusalem, Israel		Shohami, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-92220 Jerusalem, Israel.	esty@cc.huji.ac.il					Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Arieli Y, 2003, BRAIN RES, V962, P15, DOI 10.1016/S0006-8993(02)03681-8; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Buemi M, 2002, CLIN SCI, V103, P275, DOI 10.1042/cs1030275; Catania MA, 2002, EUR J PHARMACOL, V437, P147, DOI 10.1016/S0014-2999(02)01292-X; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Czosnyka M, 2006, ACTA NEUROCHIR SUPPL, V96, P114; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Ennaceur A, 2005, BEHAV BRAIN RES, V159, P247, DOI 10.1016/j.bbr.2004.11.006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Genc S, 2004, BRAIN RES, V1000, P19, DOI 10.1016/j.brainres.2003.12.037; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Horowitz M, 2004, J APPL PHYSIOL, V97, P1496, DOI 10.1152/japplphysiol.00306.2004; Horowitz M, 2002, COMP BIOCHEM PHYS A, V131, P475, DOI 10.1016/S1095-6433(01)00500-1; HOROWITZ M, 1985, COMP BIOCHEM PHYS A, V80, P57, DOI 10.1016/0300-9629(85)90678-4; Horowitz M, 1999, AM J PHYSIOL-REG I, V277, pR47, DOI 10.1152/ajpregu.1999.277.1.R47; HOROWITZ M, 1994, TEMPERATURE OSMOREGU, P87; Horowitz M, 2007, PROG BRAIN RES, V162, P373, DOI 10.1016/S0079-6123(06)62018-9; Kumral A, 2003, BIOL NEONATE, V83, P224, DOI 10.1159/000068926; LEVI E, 1993, J APPL PHYSIOL, V75, P833, DOI 10.1152/jappl.1993.75.2.833; Maloyan A, 2005, PHYSIOL GENOMICS, V23, P79, DOI 10.1152/physiolgenomics.00279.2004; Maloyan A, 1999, AM J PHYSIOL-REG I, V276, pR1506, DOI 10.1152/ajpregu.1999.276.5.R1506; Meier U, 2005, ACT NEUR S, V95, P55; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Ray SK, 2002, HISTOL HISTOPATHOL, V17, P1137, DOI 10.14670/HH-17.1137; Reinert M, 2000, Neurosurg Focus, V8, pe10; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; SHOHAMI E, 1994, ACTA NEUROCHIR, P443; Simic G, 2000, EXP NEUROL, V165, P12, DOI 10.1006/exnr.2000.7448; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Stockmann C, 2006, CLIN EXP PHARMACOL P, V33, P968, DOI 10.1111/j.1440-1681.2006.04474.x; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Weber JT, 2004, CURR NEUROVASC RES, V1, P151, DOI 10.2174/1567202043480134; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	48	20	20	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2008	25	2					112	123		10.1089/neu.2007.0358			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	266RZ	WOS:000253456000004	18260794				2022-02-06	
J	Conte, V; Raghupathi, R; Watson, DJ; Fujimoto, S; Royo, NC; Marklund, N; Stocchetti, N; McIntosh, TK				Conte, Valeria; Raghupathi, Ramesh; Watson, Deborah J.; Fujimoto, Scott; Royo, Nicolas C.; Marklund, Niklas; Stocchetti, Nino; McIntosh, Tracy K.			TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						adeno-associated virus; cell death; cognition; in vivo gene therapy; neurotrophins	P75 NEUROTROPHIN RECEPTOR; NEONATAL HYPOXIA-ISCHEMIA; FOCAL CEREBRAL-ISCHEMIA; CENTRAL-NERVOUS-SYSTEM; ADULT-RAT BRAIN; CHOLINERGIC NEURONS; CORTICAL CONTUSION; DOWN-REGULATION; MESSENGER-RNA; FULL-LENGTH	Purpose: The ability of brain-derived neurotrophic factor (BDNF) to attenuate secondary damage and influence behavioral outcome after experimental traumatic brain injury (TBI) remains controversial. Because TBI can result in decreased expression of the trkB receptor, thereby preventing BDNF from exerting potential neuroprotective effects, the contribution of both BDNF and its receptor trkB to hippocampal neuronal loss and cognitive dysfunction were evaluated. Methods: Full-length trkB was overexpressed in the left hippocampus of adult C57BI/6 mice using recombinant adeno-associated virus serotype 2/5 (rAAV 2/5). EGFP (enhanced green fluorescent protein) expression was present at two weeks after AAV-EGFP injection and remained sustained up to four weeks after the injection. At 2 weeks following gene transduction, mice were subjected to parasagittal controlled cortical impact (CCI) brain injury, followed by either BDNF or PBS infusion into the hippocampus. Results: No differences were observed in learning ability at two weeks post-injury or in motor function from 48 hours to two weeks among treatment groups. The number of surviving pyramidal neurons in the CA2-CA3 region of the hippocampus was also not different among treatment groups. Conclusions: These data suggest that neither overexpression of trkB, BNDF infusion or their combination affects neuronal survival or behavioral outcome following experimental TBI in mice.	[Raghupathi, Ramesh] Drexel Univ, Dept Neurobiol & Anat, Coll Med, Philadelphia, PA 19129 USA; [Conte, Valeria; Watson, Deborah J.; Fujimoto, Scott; Royo, Nicolas C.; Marklund, Niklas; McIntosh, Tracy K.] Univ Penn, Traumat Brain Injury Lab, Dept Neurosurg, Philadelphia, PA 19104 USA; [Conte, Valeria; Fujimoto, Scott; Royo, Nicolas C.; Marklund, Niklas; McIntosh, Tracy K.] Vet Adm Med Ctr, Philadelphia, PA 19104 USA; [Conte, Valeria; Stocchetti, Nino] Univ Milan, Neurosurg Intens Care Unit, Dept Anesthesia & Crit Care Med,IRCCS, Osped Maggiore Policlin,Mangiagallie Regina Elena, Milan, Italy		Raghupathi, R (corresponding author), Drexel Univ, Dept Neurobiol & Anat, Coll Med, 2900 Queen Lane, Philadelphia, PA 19129 USA.	Rramesh@drexelmed.edu	Stocchetti, Nino/O-7444-2017; Raghupathi, Ramesh/AAX-5538-2021	Stocchetti, Nino/0000-0003-3250-6834; Marklund, Niklas/0000-0002-9797-5626	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK047757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM034690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS008803, P01NS008803, R01NS040978, R01NS041561] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK47757, P30 DK047757] Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM 34690] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS040978-07, R01 NS041561, NS 08803, NS 40978, NS41561, P50 NS008803, R01 NS040978] Funding Source: Medline		Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Andsberg G, 2002, NEUROBIOL DIS, V9, P187, DOI 10.1006/nbdi.2001.0456; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Baldwin SA, 1996, GLIA, V16, P266; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; BECK T, 1994, J CEREBR BLOOD F MET, V14, P689, DOI 10.1038/jcbfm.1994.86; BELLUARDO N, 1995, NEUROSCI LETT, V196, P1, DOI 10.1016/0304-3940(95)11819-I; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Dietrich WD, 1996, J NEUROTRAUM, V13, P309, DOI 10.1089/neu.1996.13.309; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Endres M, 2000, J CEREBR BLOOD F MET, V20, P139, DOI 10.1097/00004647-200001000-00018; FAN G, 2004, NAT NEUROSCI, V3, P350; Frank L, 1997, EXP NEUROL, V145, P62, DOI 10.1006/exnr.1997.6440; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Griesbach GS, 2004, BRAIN RES, V1016, P154, DOI 10.1016/j.brainres.2004.04.079; Haapasalo A, 2001, BIOCHEM BIOPH RES CO, V280, P1352, DOI 10.1006/bbrc.2001.4296; Han BH, 2000, NEUROBIOL DIS, V7, P38; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hetman M, 1999, J BIOL CHEM, V274, P22569, DOI 10.1074/jbc.274.32.22569; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Hicks RR, 1998, MOL BRAIN RES, V59, P264, DOI 10.1016/S0169-328X(98)00158-2; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; KAPLAN DR, 1994, J NEUROBIOL, V25, P1404, DOI 10.1002/neu.480251108; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim BT, 2001, J NEUROSURG, V95, P674, DOI 10.3171/jns.2001.95.4.0674; Kiprianova I, 1999, EXP NEUROL, V159, P511, DOI 10.1006/exnr.1999.7109; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Knusel B, 1997, NEUROSCIENCE, V78, P851, DOI 10.1016/S0306-4522(96)00616-1; KNUSEL B, 1992, J NEUROSCI, V12, P4391; Kokaia Z, 1998, NEUROSCIENCE, V84, P1113, DOI 10.1016/S0306-4522(97)00579-4; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; McDermott KL, 1997, J NEUROTRAUM, V14, P191, DOI 10.1089/neu.1997.14.191; McKeon RJ, 1997, EXP NEUROL, V148, P558, DOI 10.1006/exnr.1997.6698; Miller FD, 2001, NEURON, V32, P767, DOI 10.1016/S0896-6273(01)00529-3; Minichiello L, 1998, NEURON, V21, P335, DOI 10.1016/S0896-6273(00)80543-7; MORSE JK, 1993, J NEUROSCI, V13, P4146; Murai H, 1998, J COMP NEUROL, V392, P428, DOI 10.1002/(SICI)1096-9861(19980323)392:4<428::AID-CNE2>3.0.CO;2-2; MURAI H, 1995, J NEUROTRAUM, V12, P964; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Passini MA, 2002, J NEUROSCI, V22, P6437; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Saatman KE, 1997, EXP NEUROL, V147, P418, DOI 10.1006/exnr.1997.6629; Schabitz WR, 2004, STROKE, V35, P992, DOI 10.1161/01.STR.0000119754.85848.0D; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Tanaka T, 1997, J NEUROSCI, V17, P2959; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Yan Q, 1997, J COMP NEUROL, V378, P135; Yan Q, 1997, NEUROSCIENCE, V78, P431, DOI 10.1016/S0306-4522(96)00613-6	65	20	21	0	2	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2008	26	1					45	56					12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	306GQ	WOS:000256236700004	18431005				2022-02-06	
B	Karger, B		Tsokos, M		Karger, Bernd			Forensic Ballistics	FORENSIC PATHOLOGY REVIEWS, VOL 5	Forensic Pathology Reviews		English	Article; Book Chapter						Backspatter; Capability to act; Cross sectional area; Deformation; Deposits on bullets; DNA-analysis; Energy deposit; Fragmentation; Gunshots to the head; Incapacitation; Intermediate target; Transfer of trace evidence; Wound ballistics	CLOSE-RANGE SHOTS; CRANIOCEREBRAL MISSILE INJURIES; HIGH-VELOCITY BULLETS; GUNSHOT WOUNDS; TRACE EVIDENCE; TRAJECTORY RECONSTRUCTION; PENETRATING GUNSHOTS; AUTOPSY FINDINGS; SURVIVAL-TIME; SPENT BULLETS	Forensic ballistics is the application of ballistics for forensic purposes. The basis is formed by wound ballistics. Two main mechanisms of injury are differentiated: the crush-mechanism resulting in the permanent cavity and the stretch-mechanism resulting in the temporary cavity. The missile-tissue interactions such as yawing, deformation, fragmentation, and bone contact are explained here and it is shown why the energy deposit or the missile velocity are not the sole or primary factors in determining the severity of a wound. The special wound ballistics of the head including indirect ("remote'') injuries in the brain and skull are discussed. Incapacitation is a necessarily occuring inability to perform complex movements and is therefore based on physiological effects independent of psychological mechanisms such as pain or surprise. Immediate incapacitation can only be caused by direct disruption of brain tissue and thus by penetrating gunshots to the head. Ballistic parameters and intracranial trajectories where sustained capability to act is possible are discussed. Rapid incapacitation is produced by massive blood loss via acute cerebral hypoxemia and subsequent unconsciousness. Targets of rapid incapacitation are the heart, aorta, and the truncus of the pulmonary artery. In cases of considerable ballistic injury to the lungs, liver, kidneys, spleen, large arteries or central veins, the latent period until incapacitation will be in the range of one or several minutes (delayed incapacitation). This potential for physical activity is not always exhausted due to psychological factors. Backspatter is biological material propelled retrogradely out of the entrance wound towards the firearm/the hand of the person shooting. Blood and tissue particles are accelerated by the subcutaneous gas effect, temporary cavitation, and tail splashing. Backspatter therefore is common in close-range gunshots to the head where blood and tissue can travel for several meters. The number of bloodstains can vary greatly and the stains are located in a semicircle of almost 1808 in front of the entrance wound. Characteristic for backspatter are small or tiny droplet or splashing stains with the elongated shapes roughly aiming at the entrance wound. Magnification and appropriate lightning are necessary for investigating backspatter. DNA-analysis of stains can establish a clear link between a person or object and a clearly defined gunshot. Contact of a bullet with an intermediate target can alter the trajectory and stability of the bullet. Contact with fragile materials such as concrete, glass, asphalt, or gypsum-board regularly results in abundant deposits on the bullet, which can be visualized by SEM ( scanning electron microscopy) and determined by X-ray microanalysis. Ductile materials such as wood and car body parts only transfer scarce deposits to the bullet which can be indicative of the intermediate target. This important trace evidence is not eliminated by subsequent perforation of tissue. Individualisation of deposits on FMJ bullets after perforation of a human body can be successfully carried out by PCR-typing of STRs and mitochondrial DNA. In cases of gunfights, this makes it possible to determine who was killed or injured by which bullet. The person shooting can be identified by additional comparison of rifling marks. Cellular material is recovered by swabbing the bullet, which should be protected against contamination and loss of material.	Univ Munster, Inst Legal Med, Munster, Germany		Karger, B (corresponding author), Univ Munster, Inst Legal Med, Munster, Germany.	karger@uni-muenster.de					ALBREHT M, 1979, ACTA CHIR SCAND, P185; ALLEN IV, 1982, INJURY, V14, P183, DOI 10.1016/0020-1383(82)90057-2; AMATO JJ, 1974, AM J SURG, V127, P454, DOI 10.1016/0002-9610(74)90296-7; BERLIN R, 1978, ACTA CHIR SCAND, V144, P213; Berlin R, 1976, Acta Chir Scand Suppl, V459, P1; BERLIN R, 1977, ACTA CHIR SCAND, P5; Betz P, 1995, FORENSIC SCI INT, V76, P47, DOI 10.1016/0379-0738(95)01793-3; BEYER JC, 1962, WOUND BALLISTICS, P135; Black AN, 1941, BRIT MED J, V1941, P872, DOI 10.1136/bmj.2.4224.872; BOWEN TE, 1988, 2 US REVISION EMERGE, P13; Boyer CN, 2005, J TRAUMA, V59, P1463, DOI 10.1097/01.ta.0000195526.27014.c5; BRATZKE H, 1985, Archiv fuer Kriminologie, V175, P31; BURNETT BR, 1991, J FORENSIC SCI, V36, P1745; BUTLER EG, 1945, J NEUROSURG, V2, P358, DOI 10.3171/jns.1945.2.4.0358; Callender GR, 1935, MIL SURG, V77, P177; CAREY ME, 1989, J NEUROSURG, V71, P754, DOI 10.3171/jns.1989.71.5.0754; CLEMEDSON CJ, 1973, Z RECHTSMED, V73, P103, DOI 10.1007/BF01882332; COOPER GJ, 1990, BRIT J SURG, V77, P606, DOI 10.1002/bjs.1800770604; CROCKARD HA, 1977, J NEUROSURG, V46, P784, DOI 10.3171/jns.1977.46.6.0784; CROCKARD HA, 1977, J NEUROSURG, V46, P776, DOI 10.3171/jns.1977.46.6.0776; DiMaio V, 1985, GUNSHOT WOUNDS PRACT; DiMaio V J, 1977, J Forensic Sci, V22, P132; DiMaio V.J.M., 1974, FBI LAW ENFORCE B, V43, P3; DIMAIO VJM, 1987, J FORENSIC SCI, V32, P38; DITTMANN W, 1986, WEHRMED MONATSSCHR, V33, P3; DZIEMIAN A J, 1961, J Trauma, V1, P341; Fackler M.L., 1989, INT DEFEN REV, V22, P59; Fackler M. L., 1991, WOUND BALLISTICS REV, V1, P38; FACKLER ML, 1984, J TRAUMA, V24, P35, DOI 10.1097/00005373-198401000-00005; FACKLER ML, 1985, J TRAUMA, V25, P522, DOI 10.1097/00005373-198506000-00009; FACKLER ML, 1988, J TRAUMA, V28, pS21, DOI 10.1097/00005373-198801001-00007; FACKLER ML, 1988, JAMA-J AM MED ASSOC, V259, P2730, DOI 10.1001/jama.259.18.2730; FACKLER ML, 1984, J TRAUMA, V24, P263, DOI 10.1097/00005373-198403000-00014; Fackler ML, 1992, WOUND BALLISTICS REV, V1, P32; FINNIE JW, 1993, J COMP PATHOL, V108, P93, DOI 10.1016/S0021-9975(08)80231-9; FRAENCKEL P, 1924, ARCH KRIMINOL, V76, P314; FREYTAG E, 1963, ARCH PATHOL, V76, P215; Fryc O, 1979, Beitr Gerichtl Med, V37, P389; GERBER AM, 1972, J NEUROSURG, V36, P43, DOI 10.3171/jns.1972.36.1.0043; Goldsmith W, 1999, INT J IMPACT ENG, V22, P95, DOI 10.1016/S0734-743X(98)00031-1; Goroncy C, 1924, DTSCH Z GERICHTL MED, V4, P145; HABBE D, 1989, AM J FOREN MED PATH, V10, P335, DOI 10.1097/00000433-198912000-00012; HARVEY EN, 1947, SURGERY, V21, P218; Harvey EN, 1945, WAR MED, V8, P91; HENN R, 1969, ARCH KRIMINOL, V143, P188; HERBICH J, 1955, BEITR GERICHTL MED, V20, P22; HOPKINSON DAW, 1963, P ROY SOC MED, V56, P461, DOI 10.1177/003591576305600606; HUDSON P, 1981, AM J FOREN MED PATH, V2, P239, DOI 10.1097/00000433-198109000-00009; INTRONA F, 1989, AM J FOREN MED PATH, V10, P275, DOI 10.1097/00000433-198912000-00001; JASON A, 1991, WOUND BALLISTICS REV, V1, P8; Jussila J, 2005, INJURY, V36, P282, DOI 10.1016/j.injury.2004.09.010; KARGER B, 1995, INT J LEGAL MED, V108, P117, DOI 10.1007/BF01844822; Karger B, 1996, INT J LEGAL MED, V109, P147, DOI 10.1007/BF01369676; Karger B, 1997, INT J LEGAL MED, V110, P101, DOI 10.1007/s004140050041; KARGER B, 1995, INT J LEGAL MED, V108, P53, DOI 10.1007/BF01369905; Karger B, 1996, INT J LEGAL MED, V109, P66, DOI 10.1007/BF01355519; Karger B, 2002, AM J FOREN MED PATH, V23, P211, DOI 10.1097/00000433-200209000-00001; Karger B, 1997, INT J LEGAL MED, V110, P188, DOI 10.1007/s004140050065; Karger B, 2001, INT J LEGAL MED, V115, P16, DOI 10.1007/s004140000202; Karger B, 1996, INT J LEGAL MED, V108, P177, DOI 10.1007/BF01369787; Karger B, 2001, INT J LEGAL MED, V114, P343, DOI 10.1007/s004140000203; Karger B, 1997, INT J LEGAL MED, V110, P27; Karger B, 1998, INT J LEGAL MED, V111, P314, DOI 10.1007/s004140050178; Karger B, 1997, INT J LEGAL MED, V110, P323, DOI 10.1007/s004140050096; KARGER B, 2003, HDB RECHTSMEDIZIN, V1, P593; KAUFMAN HH, 1986, NEUROSURGERY, V18, P689, DOI 10.1227/00006123-198606000-00002; KIRKPATRICK JB, 1978, J NEUROSURG, V49, P185, DOI 10.3171/jns.1978.49.2.0185; KLAGES U, 1975, Z RECHTSMED, V76, P307, DOI 10.1007/BF02114691; KLAUE R, 1949, DTSCH Z NERVENHEILKD, V161, P167; Knight B., 1977, FORENSIC MED, P510; KNUDSEN PJT, 1993, INT J LEGAL MED, V106, P61, DOI 10.1007/BF01225042; KNUDSEN PJT, 1993, INT J LEGAL MED, V106, P15, DOI 10.1007/BF01225018; KOCHER T, 1895, LEHRE SCHUSSWUNDEN D; Kolsky H., 1980, BALLISTIC MAT PENETR, P185; Konig H G, 1989, Beitr Gerichtl Med, V47, P247; KRAULAND W, 1952, ACTA NEUROCHIR, V2, P233; KRAUSS M, 1957, Mil Med, V121, P221; LAMPRECHT K, 1959, ARCH KRIMINOL, V97, P128; LEVY V, 1988, AM J FOREN MED PATH, V9, P215, DOI 10.1097/00000433-198809000-00007; LINDSEY D, 1980, J TRAUMA, V20, P1068, DOI 10.1097/00005373-198012000-00012; LORENZ R, 1948, DTSCH Z GERICHTL MED, V39, P435; MacDonell HL., 1982, BLOODSTAIN PATTERN I, P16; MARSH TO, 1989, J FORENSIC SCI, V34, P491; MAXEINER H, 1986, MED RECHT, P317; METTER D, 1983, Z RECHTSMED, V90, P167, DOI 10.1007/BF02116227; MISSLIWETZ J, 1990, Archiv fuer Kriminologie, V185, P129; NAEGELI O, 1984, VJSCHR GERICHTL MED, V40, P231; Newgard K., 1992, WOUND BALLISTICS REV, V1, P12; NICHOLS CA, 1991, AM J CLIN PATHOL, V95, P660, DOI 10.1093/ajcp/95.5.660; NICHOLS CA, 1990, AM J FOREN MED PATH, V11, P17, DOI 10.1097/00000433-199003000-00003; PAYR E, 1922, HDB ARZTLICHEN ERFAH, P285; PENG L, 1990, J TRAUMA S, V6, P187; Petersohn F, 1967, Dtsch Z Gesamte Gerichtl Med, V59, P259, DOI 10.1007/BF00576905; PETRACO N, 1990, J FORENSIC SCI, V35, P1284; PEX JO, 1987, J FORENSIC SCI, V32, P1587; RAGSDALE BD, 1984, MIL MED, V149, P301; RAGSDALE BD, 1988, J TRAUMA, V28, pS109, DOI 10.1097/00005373-198801001-00024; ROBENS W, 1982, ACTA CHIR SCAND, P223; SCEPANOVIC D, 1982, ACTA CHIR SCAND, P29; Scott R, 1983, Clin Lab Med, V3, P273; SELLIER K, 1971, Z RECHTSMED, V69, P217; SELLIER K, 1982, SCHUSSWAFFEN SCHUSSW, V1; SELLIER K, 1994, WOUND BALLISTICS SCI, P144; SICCARDI D, 1991, SURG NEUROL, V35, P455, DOI 10.1016/0090-3019(91)90179-D; SIGHTS WP, 1969, J NEUROSURG, V31, P25, DOI 10.3171/jns.1969.31.1.0025; SMITH OC, 1987, J FORENSIC SCI, V32, P1416; SMITH S, 1943, POLICE J, V16, P108; Spitz W. U., 1961, J FORENSIC SCI, V6, P290; STEPHENS BG, 1983, J FORENSIC SCI, V28, P437; STONE IC, 1992, AM J FOREN MED PATH, V13, P275, DOI 10.1097/00000433-199212000-00001; STURDIVAN L, 1969, 1447 BALL RES LAB; SUNESON A, 1988, J TRAUMA, V28, pS197, DOI 10.1097/00005373-198801001-00041; TIKKA S, 1988, ANN MED MILIT FENN, V62, P17; Verhoff MA, 2003, INT J LEGAL MED, V117, P229, DOI 10.1007/s00414-003-0383-6; VONHOFFMANN VER, 1898, LEHRBUCH GERICHTLICH, P389; WAGNER H J, 1963, Dtsch Z Gesamte Gerichtl Med, V54, P258, DOI 10.1007/BF00574419; Walcher K., 1929, DTSCH Z GERICHTL MED, V13, P313; WATKINS FP, 1988, J TRAUMA, V28, pS40, DOI 10.1097/00005373-198801001-00011; Weimann W., 1931, DTSCH Z GERICHTL MED, V17, P92, DOI DOI 10.1007/BF02252047; Werkgartner A., 1924, BEITR GERICHTL MED, V6, P148; Wiethold, 1934, DTSCH Z GERICHTL MED, V23, P71, DOI 10.1007/BF01771912; Zhang JY, 2005, J NEUROTRAUM, V22, P1335, DOI 10.1089/neu.2005.22.1335; Zwingli M, 1941, ARCH KRIMINOL, V108, P1; [No title captured]	124	20	20	2	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA			978-1-59745-110-9; 978-1-58829-832-4	FORENSIC PATHOL REV			2008	5						139	172		10.1007/978-1-59745-110-9_9	10.1007/978-1-59745-110-9		34	Medicine, Legal	Book Citation Index – Science (BKCI-S)	Legal Medicine	BLX81	WOS:000271343500009					2022-02-06	
J	Li, G; Wen, L; Zhan, RY; Shen, F; Yang, XF; Fu, WM				Li, G.; Wen, L.; Zhan, R. Y.; Shen, F.; Yang, X. F.; Fu, W. M.			Cranioplasty for patients developing large cranial defects combined with post-traumatic hydrocephalus after head trauma	BRAIN INJURY			English	Article						cranioplasty; post-traumatic hydrocephalus; traumatic brain injury	SINKING SKIN FLAP; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; BLOOD-FLOW	Background: Large cranial defects combined with hydrocephalus after decompressive craniectomy are a common, harsh reality among patients with head trauma. Typically, a shunt is first used to relieve the hydrocephalus. However, subsequently the patients may develop a severe sinking scalp flap over the skull defect before cranioplasty, which would make the procedure difficult. Methods: This problem was overcome by temporarily adjusting the shunt pressure using a programmable ventriculoperitoneal shunt tube, which allowed expansion of the depressed scalp flap and facilitated the subsequent cranioplasty. This study describes two patients who were treated for this problem after severe head trauma. Results: When performing a titanium mesh cranioplasty after a shunt, this new method facilitated the separation of the scalp from the underlying muscle or dura and obliterated the dead space between the titanium mesh and the underlying tissue. Both patients had satisfactory outcomes without complications. Conclusions: This method is easy and safe and it facilitates the cranioplasty, reducing the potential complications, including intracranial haematoma, effusions and infection, and thereby improving the patient outcome.	[Li, G.; Wen, L.; Shen, F.; Yang, X. F.; Fu, W. M.] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Li, G.; Wen, L.; Zhan, R. Y.; Shen, F.; Yang, X. F.] Zhejiang Univ, Inst Brain Med, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Neurosurg, 79 Qingchn Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com	shen, fang/G-8439-2011				Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; CARDOSO ER, 1985, SURG NEUROL, V23, P261, DOI 10.1016/0090-3019(85)90092-8; CARVI Y, 2006, NEUROL RES, V28, P139, DOI DOI 10.1179/016164106X98008; Dujovny M, 1997, SURG NEUROL, V47, P238, DOI 10.1016/S0090-3019(96)00013-4; FODSTAD H, 1984, ACTA NEUROCHIR, V70, P21, DOI 10.1007/BF01406039; Fodstad H, 1979, Acta Neurochir Suppl (Wien), V28, P514; Guyot LL, 2000, NEUROL RES, V22, P25; HENRY H, 2000, OPERATIVE NEUROSURGI, P26; Isago T, 2004, ANN PLAS SURG, V53, P288, DOI 10.1097/01.sap.0000106433.89983.72; Jiao Qing-fang, 2007, Chin J Traumatol, V10, P159; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Miki T, 2006, J TRAUMA, V61, P985, DOI 10.1097/01.ta.0000239665.39237.8c; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Sakamoto S, 2006, CLIN NEUROL NEUROSUR, V108, P583, DOI 10.1016/j.clineuro.2005.03.012; Schaller B, 2003, BRAIN RES, V982, P31, DOI 10.1016/S0006-8993(03)02900-7; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Winkler PA, 2000, J NEUROSURG, V93, P53, DOI 10.3171/jns.2000.93.1.0053; Yang Xue-Jun, 2003, Chin J Traumatol, V6, P99	19	20	26	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2008	22	4					333	337		10.1080/02699050801958353			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	279HS	WOS:000254346900006	18365847				2022-02-06	
J	MacLennan, DL; MacLennan, DC				MacLennan, Don L.; MacLennan, Diane C.			Assessing readiness for post-secondary education after traumatic brain injury using a simulated college experience	NEUROREHABILITATION			English	Article						Traumatic brain injury; rehabilitation; vocational rehabilitation; career counseling; higher education; treatment outcomes	STUDENTS	Approximately 1.4 million Americans sustain a traumatic brain injury (TBI) each year with approximately two-thirds of these injuries affecting people between the ages of 15 and 24 years. Consequently, many adults with brain injury sustain their injuries during a time when they are making important decisions regarding future vocational activities, including return to school. Cognitive impairments resulting from TBI present as a significant barrier to return to school and it is difficult to predict those persons who will succeed in school after a TBI and those who will not. This article presents a college simulation experience currently used in a rehabilitation setting. It involves lectures and examinations that test an individual's ability to learn new material. Lecture content focuses on the nature and effects of brain injury and on study skills. In addition, compensatory strategies commonly used in university settings (note takers, extended time for exams, taped lectures) may be used to assess potential benefit of these services. The simulated college experience provides a realistic appraisal of the individual's ability to learn information in a lecture-oriented class setting. It also provides information regarding the benefits of specific study skills and compensatory strategies. Case studies of three individuals with severe TBI are presented.	[MacLennan, Don L.] Minneapolis VA Med Ctr, Polytrauma Transit Rehabil Program, Minneapolis, MN 55417 USA; [MacLennan, Diane C.] Minneapolis VA Med Ctr, Polytrauma Network Site, Minneapolis, MN 55417 USA		MacLennan, DL (corresponding author), Minneapolis VA Med Ctr, Polytrauma Transit Rehabil Program, 1Veterans Dr 4K TBI, Minneapolis, MN 55417 USA.	donald.maclennan@va.gov					BRIEL LW, 2007, BRAIN INJURY PROFESS, P24; BURSUCK WD, 1989, EXCEPT CHILDREN, V56, P236, DOI 10.1177/001440298905600309; *CDC, TRAUM BRAIN INJ; Cook J, 1991, J HEAD TRAUMA REHAB, V6, P64, DOI [10.1097/00001199-199103000-00011, DOI 10.1097/00001199-199103000-00011]; DAMASIO AR, 1994, DESCARTESERROR; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; ELLIS D, 2007, BECOMING MASTER STUD; HART T, 1986, CLIN NEUROPSYCHOLOGY, P21; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KAY T, 1990, TRAUMATIC BRAIN INJU, P21; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Savage R. C., 1994, ED DIMENSIONS ACQUIR, P3; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg McKay Moore, 2000, Seminars in Speech and Language, V21, P135; Stewart-Scott AM, 1998, BRAIN INJURY, V12, P317, DOI 10.1080/026990598122629; Ward NS, 2006, NEUROREHAB NEURAL RE, V20, P398, DOI 10.1177/1545968306286322; Ylvisaker M., 1998, COLLABORATIVE BRAIN; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR, P35	22	20	20	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135			NEUROREHABILITATION	Neurorehabilitation		2008	23	6					521	528					8	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	391CI	WOS:000262210200008	19127005				2022-02-06	
J	Prins, M				Prins, Mayumi			Diet, ketones, and neurotrauma	EPILEPSIA			English	Article						Ketones; Brain substrate; Metabolism; Injury; Development	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; KETOGENIC DIET; ADULT RATS; JUVENILE; METABOLISM; EXPRESSION; DAMAGE	The annual incidence of traumatic brain injury far exceeds the rates of any other disease in the United States, yet progress toward age-relevant therapies, attention to patients needs, and research funding have all been minimal. Cerebral metabolism of glucose has been shown to be altered after head injury, and increasing cerebral metabolism of alternative substrates (ketones) has been shown to be neuroprotective in several models of traumatic brain injury. This altered dietary approach may have tremendous therapeutic potential for both the pediatric and adult head-injured populations.	[Prins, Mayumi] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA		Prins, M (corresponding author), Univ Calif Los Angeles, Sch Med, Div Neurosurg, Room NPI 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS052406] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS104311, R01 NS052406-03, R01 NS052406] Funding Source: Medline		Appelberg S, 2007, J NEUROTRAUM, V24, P1267; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BERGER NA, 1985, RADIAT RES, V101, P4, DOI 10.2307/3576299; Davis LM, 2008, J NEUROSCI RES, V86, P1812, DOI 10.1002/jnr.21628; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins M, 2007, J NEUROTRAUM, V24, P1267; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; ROBERTSON CS, 1991, J NEUROSURG, V74, P43, DOI 10.3171/jns.1991.74.1.0043; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu A, 2003, NEUROSCIENCE, V119, P365, DOI 10.1016/S0306-4522(03)00154-4; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K	17	20	20	1	3	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	0013-9580			EPILEPSIA	Epilepsia		2008	49			8			111	113		10.1111/j.1528-1167.2008.01852.x			3	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	374QW	WOS:000261059800033	19049605	Bronze, Green Accepted			2022-02-06	
J	Wortzel, HS; Filley, CM; Anderson, CA; Oster, T; Ardnilegas, DB				Wortzel, Hal S.; Filley, Christopher M.; Anderson, C. Alan; Oster, Timothy; Ardnilegas, David B.			Forensic applications of cerebral single photon emission computed tomography in mild traumatic brain injury	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							MINOR HEAD-INJURY; OBSESSIVE-COMPULSIVE PATIENTS; BLOOD-FLOW; TECHNETIUM-99M-HMPAO SPECT; PSYCHIATRIC-ILLNESS; SLEEP; CONCUSSION; NEUROLOGY; PERFUSION; SYMPTOMS	Traumatic brain injury (TBI) is a substantial source of mortality and morbidity world wide. Although most such injuries are relatively mild, accurate diagnosis and prognostication after mild TBI are challenging. These problems are complicated further when considered in medicolegal contexts, particularly civil litigation. Cerebral single photon emission computed tomography (SPECT) may contribute to the evaluation and treatment of persons with mild TBI. Cerebral SPECT is relatively sensitive to the metabolic changes produced by TBI. However, such changes are not specific to this condition, and their presence on cerebral SPECT imaging does not confirm a diagnosis of mild TBI. Conversely, the absence of abnormalities on cerebral SPECT imaging does not exclude a diagnosis of mild TBI, although such findings may be of prognostic value. The literature does not demonstrate consistent relationships between SPECT images and neuropsychological testing or neuropsychiatric symptoms. Using the rules of evidence shaped by Doubert v. Merrell Dow Pharmaceuticals, Inc., and its progeny to analyze the suitability of SPECT for forensic purposes, we suggest that expert testimony regarding SPECT findings should be admissible only as evidence to support clinical history, neuropsychological test results, and structural brain imaging findings and not as stand-alone diagnostic data.	[Wortzel, Hal S.] Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, Denver, CO 80262 USA; [Filley, Christopher M.; Anderson, C. Alan] Univ Colorado, Sch Med, Dept Neurol, Denver, CO USA; [Filley, Christopher M.; Anderson, C. Alan] Denver VA, Denver, CO USA		Wortzel, HS (corresponding author), Univ Colorado, Sch Med, Dept Psychiat, Neurobehav Disorders Program, CPH Room 2508,4200 E 9th Ave,C268-25, Denver, CO 80262 USA.	hal.worrzel@uchsc.edu					*AM C REH MED, 1993, J HEAD INJURY REHABI, V8, P6; ANDERSON KE, 2005, TXB TRAUMATIC BRAIN, P107; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Arlington, 2005, TXB TRAUMATIC BRAIN, P135; ASENBAUM S, 1995, J NUCL MED, V36, P1150; Audenaert Kurt, 2003, Med Sci Monit, V9, pMT112; Barkai G, 2004, PSYCHIAT RES-NEUROIM, V132, P279, DOI 10.1016/j.pscychresns.2004.09.004; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Camargo EE, 2001, J NUCL MED, V42, P611; Davalos Deana B, 2002, Appl Neuropsychol, V9, P92, DOI 10.1207/S15324826AN0902_4; Deb S, 1999, AM J PSYCHIAT, V156, P374; DEVOUS MD, 1992, J CLIN PSYCHIAT, V53, P13; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; DOUGHERTY DD, 2004, ESSENTIALS NEUROIMAG, P75; GOLDSTEIN R, 2003, PRINCIPLES PRACTICE, P789; Gowda NK, 2006, AM J NEURORADIOL, V27, P447; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hicks JW, 2003, PRINCIPLES PRACTICE, P850; HOEHNSARIC R, 1991, AM J PSYCHIAT, V148, P1243; HOLMAN BL, 1991, J NUCL MED, V32, P1206; Ingebrigtsen T, 1998, J NEUROL, V245, P609, DOI 10.1007/s004150050254; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; KRAUS JF, 2005, TXB TRAUMATIC BRAIN, P3; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin H S, 1991, Neurosurg Clin N Am, V2, P457; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; MACHLIN SR, 1991, AM J PSYCHIAT, V148, P1240; Masdeu J C, 1994, J Neuroimaging, V4, P177; Mayberg, 1996, Semin Clin Neuropsychiatry, V1, P195; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Miller Erik C., 1997, Journal of Emergency Medicine, V15, P453, DOI 10.1016/S0736-4679(97)00071-1; Mirza M, 1998, ACTA NEUROL BELG, V98, P190; MONTGOMERY EA, 1991, PSYCHOL MED, V21, P375, DOI 10.1017/S0033291700020481; MOUNTZ JM, 1995, ARTHRITIS RHEUM, V38, P926, DOI 10.1002/art.1780380708; Nakabeppu Y, 2001, ANN NUCL MED, V15, P459, DOI 10.1007/BF02988354; Reeves D, 2003, J AM ACAD PSYCHIATRY, V31, P89; ROPER SN, 1991, J NUCL MED, V32, P1684; ROSEN J, 2007, NY TIMES MAGAZI 0311, P48; SAMSON K, 2007, NEUROLOGY TODAY 0403, P1; Shirakawa S, 2002, PSYCHIAT CLIN NEUROS, V56, P291, DOI 10.1046/j.1440-1819.2002.00961.x; Smith MT, 2002, SLEEP, V25, P325; *SOC NUCL MED, 2002, SOC NUCL MED PROC GU, P113; TEASDALE G, 1974, LANCET, V2, P81; Thurman DA, 1999, TRAUMATIC BRAIN INJU, P1; VANHEERTUM RL, 1991, SEMIN NUCL MED, V21, P24, DOI 10.1016/S0001-2998(05)80077-7; Wilson J, 1996, J NUCL MED, V37, P1256; WOODS SW, 1992, J CLIN PSYCHIAT, V53, P20	52	20	21	0	2	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793			J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2008	36	3					310	322					13	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	356EZ	WOS:000259762800007	18802178				2022-02-06	
J	Qiu, Y; He, YX; Wang, B; Zhu, F; Wang, WJ				Qiu, Yong; He, Yong Xiong; Wang, Bin; Zhu, Feng; Wang, Wei Jun			The anatomical relationship between the aorta and the thoracic vertebral bodies and its importance in the placement of the screw in thoracoscopic correction of Scoliosis	EUROPEAN SPINE JOURNAL			English	Article						aorta; thoracic vertebrae; anatomy; thoracoscopy; scoliosis	ADOLESCENT IDIOPATHIC SCOLIOSIS; ANTERIOR SPINAL-FUSION; FALSE ANEURYSM; INSTRUMENTATION; DEFORMITY; POSITION; SURGERY; TOMOGRAPHY; INJURY	Thoracoscopically-assisted anterior spinal instrumentation is being used widely to treat adolescent idiopathic scoliosis (AIS). Recent studies have showed that screws placed thoracoscopically could counter the aorta or entrance into the spinal canal. There are a few studies defining the anatomic landmarks to identify the relationship between the aorta and the thoracic vertebral body using quantitative measurement for the sake of safe placement of thoracoscopic vertebral screw in anterior correction for AIS. The CT scanning from T4 to T12 in 64 control subjects and 30 AIS patients from mainland China were analyzed manually. Parameters to be measured included the angle for safety screw placement (alpha), the angle of the aorta relative to the vertebral body (beta), the distance from the line between the left and the right rib heads to the anterior wall of the vertebral canal (a), the distance from the left rib head to posterior wall of the aorta (b), the vertebral body transverse diameter (c) and vertebral rotation (gamma). No significant differences were found between the groups with respect to age or sex. Compared with the control group, alpha angle from T7 to T10, beta angle from T5 to T10 and b value at T9, T10 were significantly lower in the scoliotic group. The a value was significantly lower in the scoliotic group. The c value showed no significant difference between the two groups. In conclusion, to place the thoracoscopic vertebral screw safely, at the cephalad thoracic spine (T4-T6), the maximum ventral excursion angle should decrease gradually from 20 degrees to 5 degrees, the entry-point of the screw should be close to the rib head. For apical vertebrae (T7-T9), the maximum ventral excursion angle increased gradually from 5 degrees to 12 degrees. At the caudal thoracic spine (T10-T12), the maximum ventral excursion angle increased, the entry-point should shift 3-5 mm ventrally.	Nanjing Univ, Drum Tower Hosp, Sch Med, Dept Spine Surg, Nanjing 210008, Peoples R China		Qiu, Y (corresponding author), Nanjing Univ, Drum Tower Hosp, Sch Med, Dept Spine Surg, No 321 Zhongsham Rd, Nanjing 210008, Peoples R China.	scoliosis2002@sina.com	Wang, Weijun/A-1438-2016	Wang, Weijun/0000-0001-7191-5548			Ahat E, 1996, INJURY, V27, P225, DOI 10.1016/0020-1383(95)00212-X; Arlet V, 2000, EUR SPINE J, V9, pS17, DOI 10.1007/s005860000186; BAKER JK, 1993, SPINE, V18, P2227, DOI 10.1097/00007632-199311000-00014; Bullmann V, 2005, SPINE, V30, P2078, DOI 10.1097/01.brs.0000179083.84421.64; Choi JB, 2001, J TRAUMA, V50, P140, DOI 10.1097/00005373-200101000-00029; DUNN HK, 1986, ORTHOP CLIN N AM, V17, P113; Ebara S, 2000, SPINE, V25, P876, DOI 10.1097/00007632-200004010-00018; Huitema GC, 2006, SPINE, V31, P1734, DOI 10.1097/01.brs.0000224178.04578.03; Husted DS, 2003, SPINE, V28, P2324, DOI 10.1097/01.BRS.0000085361.32600.63; KRISMER M, 1992, SPINE, V17, P263; Kuklo TR, 2005, J SPINAL DISORD TECH, V18, pS58, DOI 10.1097/01.bsd.0000123424.12852.75; Liljenqvist UR, 2002, J BONE JOINT SURG AM, V84A, P359, DOI 10.2106/00004623-200203000-00005; Maruyama T, 2004, SPINE, V29, P2067, DOI 10.1097/01.brs.0000138409.14577.f0; MATSUZAKI H, 1993, SPINE, V18, P2327, DOI 10.1097/00007632-199311000-00033; Newton PO, 2000, SPINE, V25, P1028, DOI 10.1097/00007632-200004150-00019; Newton PO, 2005, SPINE, V30, P392, DOI 10.1097/01.brs.0000153404.62017.75; Niemeyer T, 2000, EUR SPINE J, V9, P499, DOI 10.1007/s005860000181; Ohnishi T, 2001, J NEUROSURG, V95, P253, DOI 10.3171/spi.2001.95.2.0253; Parent S, 2002, SPINE, V27, P2305, DOI 10.1097/00007632-200211010-00002; Picetti G, 1998, ORTHOPEDICS, V21, P1285; Picetti GD, 2002, NEUROSURGERY, V51, P978, DOI 10.1097/00006123-200210000-00023; Sevastik B, 1996, SURG RADIOL ANAT, V18, P51, DOI 10.1007/BF03207763; Sucato DJ, 2004, SPINE, V29, P554, DOI 10.1097/01.BRS.0000106495.91477.92; Sucato DJ, 2003, J BONE JOINT SURG AM, V85A, P1461, DOI 10.2106/00004623-200308000-00006; WOOLSEY RM, 1986, SURG NEUROL, V25, P267, DOI 10.1016/0090-3019(86)90237-5; Zhang H, 2006, SPINE, V31, P183, DOI 10.1097/01.brs.0000194842.15232.4a	26	20	24	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0940-6719	1432-0932		EUR SPINE J	Eur. Spine J.	SEP	2007	16	9					1367	1372		10.1007/s00586-007-0338-6			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	209QX	WOS:000249404200011	17410383	Green Published			2022-02-06	
J	Wu, XH; Yang, SH; Duan, DY; Cheng, HH; Bao, YT; Zhang, YK				Wu, Xing-Huo; Yang, Shu-Hua; Duan, De-Yu; Cheng, Heng-Hui; Bao, Yu-Ting; Zhang, Yukun			Anti-apoptotic effect of insulin in the control of cell death and neurologic deficit after acute spinal cord injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						apoptosis; insulin; neurological deficit; spinal cord injury (SCI)	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE; VASCULAR MECHANISMS; NERVOUS-SYSTEM; GROWTH-FACTOR; UP-REGULATION; EXPRESSION; CASPASE-3; INFLAMMATION; ANTAGONIST	Recent studies confirmed that the new cell survival signal pathway of Insulin-PI3K-Akt exerted cyto-protective actions involving anti-apoptosis. This study was undertaken to investigate the potential neuroprotective effects of insulin in the pathogenesis of spinal cord injury (SCI) and evaluate its therapeutic effects in adult rats. SCI was produced by extradural compression using modified Allen's stall with damage energy of 40 g-cm force. One group of rats was subjected to SCI in combination with the administration of recombinant human insulin dissolved in 50% glucose solution at the dose of 1 IU / kg center dot day, for 7 days. At the same time, another group of rats was subjected to SCI in combination with the administration of an equal volume of sterile saline solution. Functional recovery was evaluated using open-field walking, inclined plane tests, and motor evoked potentials (MEPs) during the first 14 days post-trauma. Levels of protein for B-cell lymphoma/leukemia-2 gene (Bcl-2), Caspase-3, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) were quantified in the injured spinal cord by Western blot analysis. Neuronal apoptosis was detected by TUNEL, and spinal cord blood flow (SCBF) was measured by laser-Doppler flowmetry (LDF). Ultimately, the data established the effectiveness of insulin treatment in improving neurologic recovery, increasing the expression of anti-apoptotic bcl-2 proteins, inhibiting caspase-3 expression decreasing neuronal apoptosis, reducing the expression of proinflammatory cytokines iNOS and COX-2, and ameliorating microcirculation of injured spinal cord after moderate contusive SCI in rats. In sum, this study reported the beneficial effects of insulin in the treatment of SCI, with the suggestion that insulin should be considered as a potential therapeutic agent.	Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan, Peoples R China; Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China; Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Ultrasonic Diagnost, Wuhan, Peoples R China		Yang, SH (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Orthopaed, Wuhan, Peoples R China.	shuhua196@yahoo.com.cn					Adachi K, 2005, NEUROSCI RES, V52, P295, DOI 10.1016/j.neures.2005.03.002; AUTHES DL, 1996, NEUROSURGERY, V39, P804; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BLIGHT AR, 1991, J NEUROL SCI, V106, P158, DOI 10.1016/0022-510X(91)90253-4; BOBERTSON GS, BRAIN PATHOL, V10, P283; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; David CA, 2002, J BIOMOL SCREEN, V7, P259, DOI 10.1177/108705710200700309; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P265, DOI 10.1097/00002826-200109000-00003; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Garcia-Alias G, 2003, J NEUROTRAUM, V20, P501, DOI 10.1089/089771503765355568; Gerozissis K, 2003, CELL MOL NEUROBIOL, V23, P873, DOI 10.1023/A:1025021529347; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Guizar-Sahagun G, 2005, NEUROSCIENCE, V130, P639, DOI 10.1016/j.neuroscience.2004.09.056; Hamada Y, 1996, FREE RADICAL BIO MED, V20, P1, DOI 10.1016/0891-5849(95)02017-9; Hulsebosch CE, 2000, J NEUROTRAUM, V17, P1205, DOI 10.1089/neu.2000.17.1205; Jonassen AK, 2000, J MOL CELL CARDIOL, V32, P757, DOI 10.1006/jmcc.2000.1118; KIERNAN JA, 1990, TRENDS PHARMACOL SCI, V11, P316, DOI 10.1016/0165-6147(90)90233-X; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Li SX, 2006, TOXICOLOGY, V217, P46, DOI 10.1016/j.tox.2005.08.018; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Meirer R, 2001, J RECONSTR MICROSURG, V17, P625, DOI 10.1055/s-2001-18818; MUHL H, 1994, BRIT J PHARMACOL, V112, P128; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; PETER VW, 2003, SPINE, V28, P941; Popovich PG, 2003, TRENDS PHARMACOL SCI, V24, P13, DOI 10.1016/S0165-6147(02)00006-8; Qiu JX, 2001, J NEUROTRAUM, V18, P1267, DOI 10.1089/089771501317095304; Resnick DK, 1998, J NEUROTRAUM, V15, P1005, DOI 10.1089/neu.1998.15.1005; Satake K, 2000, MOL BRAIN RES, V85, P114, DOI 10.1016/S0169-328X(00)00253-9; Sharma HS, 2000, AMINO ACIDS, V19, P351, DOI 10.1007/s007260070066; Siddle K, 2001, BIOCHEM SOC T, V29, P513, DOI 10.1042/BST0290513; Tator CH, 1997, J NEUROSURG, V86, P483, DOI 10.3171/jns.1997.86.3.0483; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Winkler T, 2000, ACTA NEUROCHIR SUPPL, V76, P291; WOZNIAK M, 1993, NEUROCHEM INT, V22, P1, DOI 10.1016/0197-0186(93)90062-A; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; WRATHALL JR, 1992, J NEUROTRAUM, V9, pS129; YUAN JY, 1993, CELL, V75, P641, DOI 10.1016/0092-8674(93)90485-9; Zhao WQ, 2001, MOL CELL ENDOCRINOL, V177, P125, DOI 10.1016/S0303-7207(01)00455-5	43	20	27	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2007	24	9					1502	1512		10.1089/neu.2006.0228			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	214ZT	WOS:000249777600008	17892411				2022-02-06	
J	Simpson, GK; Tate, RL				Simpson, Grahame K.; Tate, Robyn L.			Preventing suicide after traumatic brain injury: implications for general practice	MEDICAL JOURNAL OF AUSTRALIA			English	Article							REHABILITATION; ASSOCIATION; DEPRESSION	People with traumatic brain injury (TBI) have an increased risk of suicide, suicide attempts and suicide ideation compared with the general population. Most suicide deaths and attempts involve self-poisoning. General practitioners are strategically placed to make a significant contribution to preventing suicide in this group. Assessment approaches need to take into account the chronic nature of suicide risk in people with TBI. The assessment of post-TBI,depression is complicated by the confounding effect of post-TBI motor-sensory and cognitive impairments, but psychological symptoms (feelings of hopelessness, worthlessness, and anhedonia, in particular) suggest the diagnosis of depression after TBI. Management includes close attention to how medications are prescribed, dispensed and administered. Family and community brain injury agencies can be enlisted to provide emotional support and monitoring of people with TBI. GPs can facilitate access to needed mental health services for people with TBI during times of suicidal crisis. Clinical practice guidelines for the care of people living with traumatic brain injury in the community, recently published for general practice, may be of use in managing people with TBI (http://www.maa.nsw.gov.au/default.aspx?MenulD=188).	Liverpool Hlth Serv, Brain Injury Rehabil Unit, Sydney, NSW, Australia; Univ Sydney, Rehabil Studies Unit, Sydney, NSW 2006, Australia; Royal Rehabil Ctr, Sydney, NSW, Australia		Simpson, GK (corresponding author), Liverpool Hlth Serv, Brain Injury Rehabil Unit, Sydney, NSW, Australia.	grahame.simpson@sswahs.nsw.gov.au	Simpson, Grahame K/W-1074-2019	Simpson, Grahame K/0000-0001-8156-9060			ACHTE KA, 1971, ACTA PSYCHIAT SCAND, P1; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Beautrais AL, 2005, CRISIS, V26, P1, DOI 10.1027/0227-5910.26.1.1; *COMM DEP HLTH AG, 2000, LIFE FRAM PREV SUIC; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORTUNE N, 1999, DEFINITION INCIDNENC; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; Haste F, 1998, BRIT J GEN PRACT, V48, P1759; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P47, DOI 10.1097/00001199-199808000-00005; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kuipers P, 2000, J HEAD TRAUMA REHAB, V15, P1275, DOI 10.1097/00001199-200012000-00007; McKelvey RS, 2001, MED J AUSTRALIA, V175, P550, DOI 10.5694/j.1326-5377.2001.tb143718.x; MRAZEK PJ, 1994, COMMITTE PREVENTION; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; SIMPSON GK, 2001, SUICIDE PREVENTION T; Tate R, 1997, J HEAD TRAUMA REHAB, V12, P16, DOI 10.1097/00001199-199712000-00003; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; TREVENA L, 2004, CLIN PRACTICE GUIDEL; Williams WH, 2003, STUD NEUROPSYCHOL DE, P115	24	20	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0025-729X	1326-5377		MED J AUSTRALIA	Med. J. Aust.	AUG 20	2007	187	4					229	232		10.5694/j.1326-5377.2007.tb01206.x			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	206CB	WOS:000249160400009	17708726				2022-02-06	
J	Biegon, A; Gibbs, A; Alvarado, M; Ono, M; Taylor, S				Biegon, Anat; Gibbs, Andrew; Alvarado, Maritza; Ono, Michele; Taylor, Scott			In vitro and in vivo characterization of [H-3]CNS-5161 - A use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain	SYNAPSE			English	Article						glutamate; brain; autoradiography; radiopharmaceutical; PET	EXCITATORY AMINO-ACIDS; CANDIDATE PET TRACER; NMDA ION-CHANNEL; HEAD-INJURY; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; SPECT AGENT; PCP SITE; GLUTAMATE; BINDING	Glutamate is the major excitatory neurotransmitter in the brain. Glutamate activation of the N-methyl-D-aspartate (NMDA) receptor subtype is thought to mediate important physiological and pathological processes, including memory formation and excitotoxicity. The goal of the present work was to characterize and validate a candidate agent for noninvasive positron emission tomography (PET) imaging of this receptor. [H-3]-labeled N-[3-H-3]-methyl-3-(thiomethylphenyl)cyanamide (CNS-5161) was incubated with rat brain homogenates at increasing concentrations, temperatures, and times to establish the binding kinetics and affinity of the ligand in vitro. Nonspecific binding was measured with 100 mu M MK-801. The compound was also injected i.v. in rats pretreated with saline, NMDA, MK801, or a combination, and organ and brain regional uptake was assessed at various times after injection by autoradiography or dissection. Blood and brain samples were assayed for metabolites by high-performance liquid chromatography. CNS-5161 binds brain membranes with high affinity (K-d < 4 nM) and fast association and dissociation kinetics. Specific binding increased in the presence of glutamate and glycine. Intravenous administration in control rats resulted in a heterogeneous brain distribution with hippocampus and cortex > thalamus > striatum > cerebellum, and a cortex/cerebellum ratio of 1.4. Pretreatment with NMDA increased the hippocampus-to-cerebellum ratio to 1.6-1.9 while MK801 abolished this increase, resulting in ratios close to 1. Thus, CNS-5161 binds preferentially to the activated state of the NMDA receptor channel in vitro and in vivo. The high affinity and fast kinetics make it compatible with PET imaging of a carbon-11 labeled CNS-5161.	Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Funct Imaging, Berkeley, CA 94720 USA		Biegon, A (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.	Biegon@bnl.gov					Ametamey SM, 2002, NUCL MED BIOL, V29, P227, DOI 10.1016/S0969-8051(01)00293-1; Ametamey SM, 1999, J RECEPT SIGNAL TR R, V19, P129, DOI 10.3109/10799899909036640; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bisaga A, 2000, DRUG ALCOHOL DEPEN, V59, P1, DOI 10.1016/S0376-8716(99)00107-6; Bressan RA, 2005, BIOL PSYCHIAT, V58, P41, DOI 10.1016/j.biopsych.2005.03.016; Bressan RA, 2004, NUCL MED BIOL, V31, P155, DOI 10.1016/j.nucmedbio.2003.08.008; Brown DRP, 1997, J PSYCHIAT RES, V31, P605, DOI 10.1016/S0022-3956(97)00031-9; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Di X, 1996, J NEUROSURG, V85, P655, DOI 10.3171/jns.1996.85.4.0655; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FOSTER AC, 1987, BRIT J PHARMACOL, V91, P403, DOI 10.1111/j.1476-5381.1987.tb10295.x; Gibbs AR, 2002, J LABELLED COMPD RAD, V45, P395, DOI 10.1002/jlcr.561; GIBSON RE, 1992, NUCL MED BIOL, V19, P319; GLOBUS MYT, 1988, J NEUROCHEM, V51, P1455, DOI 10.1111/j.1471-4159.1988.tb01111.x; GREENAMYRE JT, 1989, NEUROBIOL AGING, V10, P593, DOI 10.1016/0197-4580(89)90143-7; Hu LY, 1997, J MED CHEM, V40, P4281, DOI 10.1021/jm970459c; JEZOVA D, 1992, Endocrine Regulations, V26, P73; Kiesewetter D O, 1990, Int J Rad Appl Instrum A, V41, P139, DOI 10.1016/0883-2889(90)90098-2; KLOOG Y, 1988, BIOCHEMISTRY-US, V27, P843, DOI 10.1021/bi00403a001; Kroppenstedt SN, 1998, J NEUROTRAUM, V15, P191, DOI 10.1089/neu.1998.15.191; Kumlien E, 1999, EPILEPSIA, V40, P30, DOI 10.1111/j.1528-1157.1999.tb01985.x; Lees KR, 1997, NEUROLOGY, V49, pS66, DOI 10.1212/WNL.49.5_Suppl_4.S66; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; MINICK DJ, 1988, J MED CHEM, V31, P1923, DOI 10.1021/jm00118a010; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MUIR KW, 1994, BRIT J CLIN PHARMACO, V38, P33, DOI 10.1111/j.1365-2125.1994.tb04318.x; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; OLNEY JW, 1985, INT REV NEUROBIOL, V27, P337, DOI 10.1016/S0074-7742(08)60561-9; Ouyang XH, 1996, NUCL MED BIOL, V23, P315, DOI 10.1016/0969-8051(95)02086-1; Owens J, 2000, NUCL MED BIOL, V27, P557, DOI 10.1016/S0969-8051(00)00102-5; Owens J, 1997, NUCL MED COMMUN, V18, P149, DOI 10.1097/00006231-199702000-00010; PRICE GW, 1988, EUR J PHARMACOL, V158, P279, DOI 10.1016/0014-2999(88)90080-5; SCHIFFER WK, 2005, DYNAMIC CHANGES NMDA; SMITH DJ, 1980, LIFE SCI, V26, P789, DOI 10.1016/0024-3205(80)90285-4; Tamminga C, 1999, BRIT J PSYCHIAT, V174, P12, DOI 10.1192/S0007125000293598; WALLACE MC, 1992, J NEUROSURG, V76, P127, DOI 10.3171/jns.1992.76.1.0127; Waterhouse RN, 2004, NUCL MED BIOL, V31, P939, DOI 10.1016/j.nucmedbio.2004.03.012; Waterhouse RN, 2003, NUCL MED BIOL, V30, P869, DOI 10.1016/S0969-8051(03)00127-6; Waterhouse RN, 2002, J LABELLED COMPD RAD, V45, P955, DOI 10.1002/jlcr.622; Watson, 1998, RAT BRAIN STEREOTACT; WIELAND DM, 1988, APPL RADIAT ISOTOPES, V39, P1219; Zhao YJ, 2006, J LABELLED COMPD RAD, V49, P163, DOI 10.1002/jlcr.1033	46	20	20	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-4476	1098-2396		SYNAPSE	Synapse	AUG	2007	61	8					577	586		10.1002/syn.20400			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	178CO	WOS:000247199000001	17455246				2022-02-06	
J	Keris, V; Lavendelis, E; Macane, I				Keris, Valdis; Lavendelis, Egils; Macane, Inta			Association between implementation of clinical practice guidelines and outcome for traumatic brain injury	WORLD JOURNAL OF SURGERY			English	Article							SEVERE HEAD-INJURY; NEUROSURGICAL TRAUMA; MANAGEMENT	Background Traumatic brain injury (TBI) is the leading cause of death in the population under 40 years of age in Western countries, and the same was true for Latvia in 1999. This indicated a strong need to improve the management of TBI. The Latvian Society of Neurosurgeons in collaboration with related societies created a dedicated working group, and the Guidelines for Medical Management of TBI in Latvia (Guidelines) were developed in 2001. This study aimed to assess the association between implementation of the Guidelines and the outcome of TBI patients. Methods The Guidelines were printed and distributed to relevant clinical units and teaching institutions. To assess the impact of the Guidelines on the outcome of TBI, Latvian medical statistics were researched. All patients admitted to emergency departments and registered as either discharged or dead with a diagnosis of head trauma from 1998 to 2004 were included in a retrospective survey. The primary endpoint accepted for analysis was the hospital case fatality rate (HCFR). Results The survey included 73,062 consecutive cases. The annual incidence rate of TBI admissions was stable during the period 1998 to 2004 (range 41.5-46.0/10,000), and the incidence of moderate and severe TBI (range 7.2-8.7/10,000) showed no significant trends. There was a reduction of HCFR from 3.7% during 1998-2000 to 2.6% during 2002-2004 (relative risk 0.72; 95% confidence interval 0.67-0.76; p = 0.03). Conclusion Implementation of the Guidelines was associated with a statistically significant decrease of HCFR in TBI patients.	Riga Stradins Univ, Clin Hosp Gailezers, Dept Neurosurg, LV-1038 Riga, Latvia; State Hlth Stat & Med Technol Agcy, Riga, Latvia; Riga Stradins Univ, Dept Sci, Riga, Latvia		Keris, V (corresponding author), Riga Stradins Univ, Clin Hosp Gailezers, Dept Neurosurg, 2 Hipokrata Str, LV-1038 Riga, Latvia.	valker@delfi.lv					Bartlett J, 1998, BRIT J NEUROSURG, V12, P349, DOI 10.1080/02688699844871; Basso A, 2001, WORLD J SURG, V25, P1174; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; FORSYTH R, 2003, COCHRANE DATABASE SY, V1; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Kelly DF, 2001, WORLD J SURG, V25, P1179; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 2000, CRIT CARE MED, V28, P16, DOI 10.1097/00003246-200001000-00003; *NIH, 1998, NIH CONSENSUS STATE, V16, P1; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Valadka AB, 2001, NEUROSURGERY, V48, P17, DOI 10.1097/00006123-200101000-00004	11	20	20	1	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUN	2007	31	6					1352	1355		10.1007/s00268-007-9002-x			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	171UB	WOS:000246759800035	17464541				2022-02-06	
J	Monnerie, H; Le Roux, PD				Monnerie, Hubert; Le Roux, Peter D.			Reduced dendrite growth and altered glutamic acid decarboxylase (GAD) 65-and 67-kDa isoform protein expression from mouse cortical GABAergic neurons following excitotoxic injury in vitro	EXPERIMENTAL NEUROLOGY			English	Article						GABA; neuron; dendrites; cerebral cortex; glutamate; excitotoxicity	MICROTUBULE-ASSOCIATED PROTEIN-2; GAMMA-AMINOBUTYRIC-ACID; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; NMDA RECEPTORS; INDUCED NEURODEGENERATION; REGIONAL DIFFERENCES; PYRAMIDAL NEURONS	The vulnerability of brain cells to neurologic insults varies greatly, depending on their neuronal subpopulation. However, cells surviving pathological insults such as ischemia or brain trauma may undergo structural changes, e.g., altered process growth, that could compromise brain function. In this study, we examined the effect of glutamate excitotoxicity on dendrite growth from surviving cortical GABAergic neurons in vitro. Glutamate exposure did not affect GABAergic neuron viability, however, it significantly reduced dendrite growth from GABAergic neurons. This effect was blocked by the AMPA receptor antagonists NBQX and CFM-2, and mimicked by AMPA, but not NMDA. Glutamate excitotoxicity also caused an NMDA receptor-mediated decrease in the GABA synthesizing enzyme glutamic acid decarboxylase (GAD65/67) immunoreactivity from GABAergic neurons, measured using immunocytochemical and Western blot techniques. GAD is necessary for GABA synthesis; however, reduction of GABA by 3-mercaptopropionic acid (3-MPA), which inhibits GABA synthesis, did not alter dendrite growth. These results suggest that GABAergic cortical neurons are relatively resistant to excitotoxic-induced cell death, but they can display morphological and biochemical alterations which may impair their function. (c) 2007 Elsevier Inc. All rights reserved.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19107 USA		Le Roux, PD (corresponding author), Univ Penn, Dept Neurosurg, 330 S 9th St,4th Floor, Philadelphia, PA 19107 USA.	lerouxp@uphs.upenn.edu					Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Bering R, 1997, EXP BRAIN RES, V115, P423, DOI 10.1007/PL00005712; BRUNO V, 1995, EUR J NEUROSCI, V7, P1906, DOI 10.1111/j.1460-9568.1995.tb00712.x; Bywood PT, 2000, NEUROSCI LETT, V280, P5, DOI 10.1016/S0304-3940(99)00990-8; Bywood PT, 2000, EXP NEUROL, V161, P306, DOI 10.1006/exnr.1999.7259; Centonze D, 2001, PROG NEUROBIOL, V63, P687, DOI 10.1016/S0301-0082(00)00037-X; Chimirri A, 1997, J MED CHEM, V40, P1258, DOI 10.1021/jm960506l; CHOI DW, 1987, J NEUROSCI, V7, P357; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; DAVENPORT CJ, 1990, EPILEPSY RES, V5, P28, DOI 10.1016/0920-1211(90)90063-2; Engel D, 2001, J PHYSIOL-LONDON, V535, P473, DOI 10.1111/j.1469-7793.2001.00473.x; Frahm C, 2004, NEUROSCIENCE, V127, P341, DOI 10.1016/j.neuroscience.2004.05.027; Giorgi S, 1997, NEUROSCIENCE, V80, P793, DOI 10.1016/S0306-4522(97)00114-0; HADDAD GG, 1993, PROG NEUROBIOL, V40, P277, DOI 10.1016/0301-0082(93)90014-J; HARTLEY DM, 1993, J NEUROSCI, V13, P1993; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hasbani MJ, 2000, NEUROSCIENTIST, V6, P110, DOI 10.1177/107385840000600208; HENG JE, 1995, NEUROREPORT, V6, P1890, DOI 10.1097/00001756-199510020-00016; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Holgado A, 2000, J NEUROBIOL, V43, P121, DOI 10.1002/(SICI)1097-4695(200005)43:2<121::AID-NEU2>3.0.CO;2-P; Huang PP, 1999, NEUROSURGERY, V45, P1413, DOI 10.1097/00006123-199912000-00029; Kingston AE, 1999, EUR J PHARMACOL, V377, P155, DOI 10.1016/S0014-2999(99)00397-0; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Laferriere NB, 1999, NEUROL RES, V21, P524, DOI 10.1080/01616412.1999.11740969; Le Roux P, 1999, EXP NEUROL, V160, P151, DOI 10.1006/exnr.1999.7194; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; LEROUX PD, 1995, J NEUROBIOL, V27, P97, DOI 10.1002/neu.480270110; LEROUX PD, 1994, J NEUROSCI, V14, P4639; Lewen A, 1996, BRAIN RES, V719, P161, DOI 10.1016/0006-8993(96)00081-9; Li GL, 2000, APMIS, V108, P98; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Manor D, 1996, NEUROCHEM RES, V21, P1031, DOI 10.1007/BF02532413; Martone ME, 2000, HIPPOCAMPUS, V10, P610, DOI 10.1002/1098-1063(2000)10:5<610::AID-HIPO12>3.3.CO;2-5; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; MATTSON MP, 1988, J NEUROSCI, V8, P2087; MELDRUM BS, 1994, NEUROLOGY, V44, P14; Metzger F, 1998, J NEUROSCI, V18, P1735; Monnerie H, 2003, J NEUROSCI RES, V74, P688, DOI 10.1002/jnr.10797; Monnerie H, 2003, NEUROSCI LETT, V345, P182, DOI 10.1016/S0304-3940(03)00526-3; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Murphy DD, 1998, J NEUROSCI, V18, P2550; NAJLERAHIM A, 1992, EXP NEUROL, V118, P352, DOI 10.1016/0014-4886(92)90193-T; NAJLERAHIM A, 1992, EXP BRAIN RES, V90, P332; Neder L, 2002, CELL MOL NEUROBIOL, V22, P689, DOI 10.1023/A:1021852907068; NETOPILOVA M, 1995, EPILEPSY RES, V20, P179, DOI 10.1016/0920-1211(94)00068-8; Netopilova M, 1997, NEUROSCI LETT, V226, P68, DOI 10.1016/S0304-3940(97)00241-3; NITSCH C, 1989, NEUROSCI LETT, V105, P263, DOI 10.1016/0304-3940(89)90631-9; OBENAUS A, 1993, J NEUROSCI, V13, P4470; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Patz S, 2003, EUR J NEUROSCI, V18, P1, DOI 10.1046/j.1460-9568.2003.02702.x; PULSINELLI WA, 1985, PROG BRAIN RES, V63, P29; RIBAK CE, 1979, SCIENCE, V205, P211, DOI 10.1126/science.109922; RIMVALL K, 1992, J NEUROCHEM, V58, P158, DOI 10.1111/j.1471-4159.1992.tb09291.x; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; SEGAL M, 1995, TRENDS NEUROSCI, V18, P468, DOI 10.1016/0166-2236(95)92765-I; Shetty AK, 2001, EXP NEUROL, V169, P276, DOI 10.1006/exnr.2001.7668; Shetty AK, 2000, J NEUROSCI, V20, P8788; SIMON RP, 1984, J CEREBR BLOOD F MET, V4, P350, DOI 10.1038/jcbfm.1984.52; Sinor AD, 2000, NEUROSCI LETT, V290, P213, DOI 10.1016/S0304-3940(00)01361-6; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; TECOMA ES, 1989, NEUROLOGY, V39, P676, DOI 10.1212/WNL.39.5.676; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Wilson MT, 1998, J NEUROSCI RES, V52, P599, DOI 10.1002/(SICI)1097-4547(19980601)52:5<599::AID-JNR12>3.3.CO;2-X; Yin H z, 1994, Neurobiol Dis, V1, P43, DOI 10.1006/nbdi.1994.0006	66	20	20	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2007	205	2					367	382		10.1016/j.expneurol.2007.02.007			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	176TQ	WOS:000247108200008	17433299				2022-02-06	
J	Bonnier, C; Marique, P; Van Hout, A; Potelle, D				Bonnier, Christine; Marique, Patricia; Van Hout, Anne; Potelle, Dominique			Neurodevelopmental outcome after severe traumatic brain injury in very young children: Role for subcortical lesions	JOURNAL OF CHILD NEUROLOGY			English	Article						pediatric brain injuries; neurodevelopmental outcome; subcortical lesions	SHAKEN BABY SYNDROME; HEAD-INJURY; COMA; EXPERIENCE; INFANTS; AGE	Traumatic brain injury is a major cause of mortality and morbiditv in children younger than 15 years of age. To evaluate the role of subcortical lesions on neurodevelopmental outcomes, longterm outcomes of 50 children with severe traumatic brain injury before 4 years of age (accidental injury, n = 21, nonaccidental injury, n = 29) were reviewed retrospectively and compared with late magnetic resonance imaging (MRI) findings: no visible lesions, cortical lesions, or subcortical lesions. Subcortical lesions occurred in both accidental and nonaccidental traumatic brain injuries. Traumatic brain injury severity (initial Glasgow Coma Scale or coma duration) was significantly associated with subcortical lesions. Long-term motor or visual deficiencies occurred in one third of patients and cognitive deficiencies in 52.1%. Although deficiencies occurred without visible MRI lesions, global outcome scores, motor delay, visual impairment, head growth slowing, global intellectual quotients, and planning performances were significantly worse in patients with subcortical lesions. An alarming deterioration in intellectual quotient over time was noted. It was concluded that neurodevelopmental outcomes are worrisome after severe traumatic brain injury in young children, and subcortical lesions affect the prognosis.	Clin Univ St Luc, Pediat Neurol Serv, B-1200 Brussels, Belgium; Ctr Neurol William Lennox, Louvain, Belgium		Bonnier, C (corresponding author), Clin Univ St Luc, Pediat Neurol Serv, Ave Hippocrate,10-1067, B-1200 Brussels, Belgium.	bonnier@nepe.ucl.ac.be					Ashwal S, 2004, J NEUROTRAUM, V21, P1539, DOI 10.1089/0897715042441756; AUDENAERT K, 2003, MED SCI MONITOR, V10, P112; BANICH MT, 1990, NEUROPSYCHOLOGIA, V28, P35, DOI 10.1016/0028-3932(90)90084-2; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; Bonnier C, 2003, PEDIATRICS, V112, P808, DOI 10.1542/peds.112.4.808; Bonnier C, 2002, BRAIN PATHOL, V12, P320; Bonnier Christine, 2004, Pediatr Rehabil, V7, P165, DOI 10.1080/13638490410001703325; BRENNER SL, 1989, J NATL MED ASSOC, V81, P183; BRUNET O, 1978, ECHELLE DEV PSYCHOMO; CHEVRIEMULLER C, 1981, EPREUVRES EXAMEN LAN; CHEVRIEMULLER C, 1988, BATTERIE EVALUATION; Dennis M, 2000, J COMMUN DISORD, V33, P321, DOI 10.1016/S0021-9924(00)00028-9; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P89; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; EWINGCOBBS L, 1995, J HEAD TRAUMA REHAB, V10, P13, DOI 10.1097/00001199-199510000-00004; Forsyth RJ, 2001, ARCH DIS CHILD, V84, P200, DOI 10.1136/adc.84.3.200; Gennarelli TA, 1985, NEUROSURGERY, V2, P1531; Gil AM, 2003, J SCHOOL PSYCHOL, V41, P337, DOI 10.1016/S0022-4405(03)00085-2; Haviland J, 1997, ARCH DIS CHILD, V77, P504, DOI 10.1136/adc.77.6.504; JENNETT B, 1975, LANCET, V1, P480; Kaufman A., 1983, K ABC KAUFMAN ASSESS; Kemp, 1998, NEPSY DEV NEUROPSYCH; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; MEADOWS AT, 1981, LANCET, V2, P1015; MULHERN RK, 1992, MED PEDIATR ONCOL, V20, P181, DOI 10.1002/mpo.2950200302; MULHERN RK, 1992, J CLIN ONCOL, V10, P1095, DOI 10.1200/JCO.1992.10.7.1095; OSERETSKY L, 1984, ECHELLE DEV MOTEUR L; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; RAIMONDI AJ, 1984, CHILD BRAIN, V11, P12; SINAL SH, 1987, SOUTHERN MED J, V80, P1505, DOI 10.1097/00007611-198712000-00006; TEASDALE G, 1974, LANCET, V2, P81; Umile EM, 2002, ARCH PHYS MED REHAB, V83, P1506, DOI 10.1053/apmr.2002.35092; Wechsler D, 1995, ECHELLE INTELLIGENCE; WECHSLER D, 1992, MANUAL EWCHSLER INTE; ZIMMERMAN P, 1994, TEA TEST EVALUATION	46	20	21	0	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	MAY	2007	22	5					519	529		10.1177/0883073807302604			11	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	179IV	WOS:000247283900001	17690056				2022-02-06	
J	Bay, E; Hagerty, BM; Williams, RA				Bay, Esther; Hagerty, Bonnie M.; Williams, Reg A.			Depressive symptomatology after mild-to-moderate traumatic brain injury: A comparison of three measures	ARCHIVES OF PSYCHIATRIC NURSING			English	Article							NEUROBEHAVIORAL FUNCTIONING INVENTORY; HEAD-INJURY; MOOD; DISABILITY; STRESS	Measurement of posttraumatic brain injury depression is problematic. Disagreement exists about the best screening measure, and symptoms of brain injury often overlap those of depression. In an outpatient sample of 75 persons, we compared aspects of Criterion A of the Diagnostic and Statistical Manual of Mental Disorders-Fourth Revision, Text Revision (2000), with three depression subscales: the Neurobehavioral Functioning (NFI-D), Profile of Moods State (POMS-D), and Center for Epidemiologic Studies (CES-D). Nearly 40% of this outpatient sample had significant levels of depressive symptoms. All measures were internally consistent, reliable, and highly correlated. For persons with mild-to-moderate traumatic brain injury, the CES-D was the best screening instrument because of its ease in administration, sensitivity in detecting probable major depressive disorders, its established categories of severity, and its comprehensiveness. Further effort in the establishment of depression severity categories using the NFI-D is needed. (c) 2007 Elsevier Inc. All rights reserved.	MI State Univ, Coll Nursing, Howell, MI 48843 USA; Univ Michigan, Sch Nursing, Dept Psychiat, Ann Arbor, MI 48109 USA		Bay, E (corresponding author), MI State Univ, Coll Nursing, 4375 Sundance Crossing, Howell, MI 48843 USA.						Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; BAY E, 2001, DISS ABSTR INT; Bay Esther, 2005, J Neurosci Nurs, V37, P4; Bay Esther, 2004, Res Theory Nurs Pract, V18, P213, DOI 10.1891/rtnp.18.2.213.61278; BRESLAU N, 1986, ARCH GEN PSYCHIAT, V43, P309; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Davidson RJ, 2002, BIOL PSYCHIAT, V52, P478, DOI 10.1016/S0006-3223(02)01458-0; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Devins GM, 1985, TEST CRITIQUES, P144; Dikmen SS, 2004, ARCH PHYS MED REHAB, V85, P1457, DOI 10.1016/j.apmr.2003.12.041; EATON W, 2004, CTR EPIDEMIOLOGIC ST, V3; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Jean-Bay E, 2000, J Neurosci Nurs, V32, P169; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kennedy RE, 2005, J HEAD TRAUMA REHAB, V20, P512, DOI 10.1097/00001199-200511000-00004; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LEVIN HS, 1992, J NEUROL NEUROSUR PS, V55, P255, DOI 10.1136/jnnp.55.4.255; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; MCNAIR DM, 1964, J ABNORM SOC PSYCH, V69, P620, DOI 10.1037/h0040902; MCNAIR DM, 2002, PROFILE MOOD STATES; Moldover JE, 2004, NEUROPSYCHOL REV, V14, P143, DOI 10.1023/B:NERV.0000048181.46159.61; Nemeroff CB, 1998, SCI AM, V278, P42, DOI 10.1038/scientificamerican0698-42; NOLENHOEKSEMA S, 1987, PSYCHOL BULL, V101, P259, DOI 10.1037/0033-2909.101.2.259; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; PRIGNATO G, 1991, AWARENESS DEFICIT AF, P10; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rosenthal M, 1998, ARCH PHYS MED REHAB, V79, P90, DOI 10.1016/S0003-9993(98)90215-5; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Sheline YI, 1998, NEUROSCIENTIST, V4, P331, DOI 10.1177/107385849800400514; Sliwinski M, 1998, J HEAD TRAUMA REHAB, V13, P40, DOI 10.1097/00001199-199808000-00004; Smarr K., 2003, ARTHRIT CARE RES, V49, pS134, DOI DOI 10.1002/ART.11410; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Wilhelm K, 2004, PSYCHOSOMATICS, V45, P461, DOI 10.1176/appi.psy.45.6.461; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Willis G.B., 1999, QUESTION APPRAISAL S	48	20	21	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9417	1532-8228		ARCH PSYCHIAT NURS	Arch. Psychiatr. Nurs.	FEB	2007	21	1					2	11		10.1016/j.apnu.2006.07.005			10	Nursing; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Psychiatry	134HS	WOS:000244074700002	17258103				2022-02-06	
J	Chesnut, RM				Chesnut, Randall M.			Care of central nervous system injuries	SURGICAL CLINICS OF NORTH AMERICA			English	Article							CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; POSTTRAUMATIC INTRACRANIAL HYPERTENSION; ARTERIOVENOUS OXYGEN DIFFERENCE; 7.5-PERCENT SODIUM-CHLORIDE; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; HYPERTONIC SALINE	The primary method of improving outcome from traumatic brain injury is through avoiding secondary insults to the injured brain. Although surgery is important, most management is critical care. Evidence-based guidelines continue to be developed to assist in directing care. With modern monitoring systems, a physiologic-based approach is increasingly applicable, allowing focused treatment for intracranial hypertension and ischemia. It is important to balance and integrate the care of the injured brain into the overall care of the polytrauma patient.	Univ Washington, Harborview Med Ctr, Dept Neurosurg, Seattle, WA 98104 USA		Chesnut, RM (corresponding author), Univ Washington, Harborview Med Ctr, Dept Neurosurg, 325 9Th Ave,Box 359766, Seattle, WA 98104 USA.	chesnutr@u.washington.edu					AARABI B, 2001, J TRAUMA S, V51, P86; ADELSON PD, 2003, PEDIAT CRIT CARE M S, V4, P71; ANDREWS BT, 1986, NEUROSURGERY, V19, P408, DOI 10.1227/00006123-198609000-00012; Battison C, 2005, CRIT CARE MED, V33, P196, DOI 10.1097/01.CCM.0000150269.65485.A6; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Bullock RM, 2000, J NEUROTRAUM, V17, P449; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; CHESNUT RM, 1997, J TRAUMA S, V42, P4; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Cooper P R, 1976, Surg Neurol, V5, P25; Cruz J, 1998, CRIT CARE MED, V26, P344, DOI 10.1097/00003246-199802000-00039; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Dutton RP, 2006, J TRAUMA, V60, pS70, DOI 10.1097/01.ta.0000200856.47545.64; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P643, DOI 10.3109/02688699308995093; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FULTON RL, 1993, SURG GYNECOL OBSTET, V176, P327; GAAB MR, 1990, ACT NEUR S, V51, P326; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Ghajar J, 1995, New Horiz, V3, P395; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HORAN MJ, 1987, HYPERTENSION, V10, P115, DOI 10.1161/01.HYP.10.1.115; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hsiang JNK, 1997, J NEUROSURG, V87, P234, DOI 10.3171/jns.1997.87.2.0234; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kellie George, 1824, Trans Med Chir Soc Edinb, V1, P84; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marion DW, 2006, NEUROSURGERY, V58, P655; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; Mathew P, 1996, J NEUROTRAUM, V13, P465, DOI 10.1089/neu.1996.13.465; MENDELOW AD, 1983, BRIT MED J, V287, P1173, DOI 10.1136/bmj.287.6400.1173; Monro A., 1783, OBSERVATIONS STRUCTU; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Napolitano L, 2006, J TRAUMA, V60, pS26, DOI 10.1097/01.ta.0000199979.95789.17; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; RANSOHOFF J, 1971, J NEUROSURG, V34, P70, DOI 10.3171/jns.1971.34.1.0070; Ratilal B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004884.pub2; Robertson C S, 1995, New Horiz, V3, P410; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Schneider GH, 2002, ACT NEUR S, V81, P77; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shiozaki T, 2003, J NEUROSURG, V99, P47, DOI 10.3171/jns.2003.99.1.0047; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vialet R, 2003, CRIT CARE MED, V31, P1683, DOI 10.1097/01.CCM.0000063268.91710.DF; Wade CE, 1997, J TRAUMA, V42, pS61, DOI 10.1097/00005373-199705001-00011; Wakai A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub2; Ware ML, 2005, NEUROSURGERY, V57, P727, DOI 10.1227/01.NEU.0000175726.08903.OA; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	77	20	23	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	FEB	2007	87	1					119	+		10.1016/j.suc.2006.09.018			39	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	123NI	WOS:000243302200009	17127126				2022-02-06	
J	Carpenter, J; Weinstein, S; Myseros, J; Vezina, G; Bell, MJ				Carpenter, Jessica; Weinstein, Steve; Myseros, John; Vezina, Gilbert; Bell, Michael J.			Inadvertent hyponatremia leading to acute cerebral edema and early evidence of herniation	NEUROCRITICAL CARE			English	Article						cerebral edema; hyponatremia; child; hypertonic saline; hyponatremic encephalopathy	INTENSIVE-CARE-UNIT; ENCEPHALOPATHY; SEIZURE; INJURY	Introduction For years, the maintenance of normal or supranormal serum sodium (Na) concentrations has been believed to be beneficial in brain injuries. Recently published guidelines for cerebral trauma recommend the use of hypertonic saline to achieve hypernatremia for the management of increased intracranial pressure and these standards are generally practiced across most diseases in neurocritical care including stroke, hemorrhage and tumors. Severe hyponatremia has long been known to be detrimental, but objective evidence for the harm of mild hyponatremia as a secondary injury has been scarce. Description of Case In this case report, we describe a child with aneurysmal subarachnoid hemorrhage who had a sudden, inadvertent decrease in serum Na (128 meq/l) that was associated with a deterioration of her neurological examination and evidence of early transtentorial herniation on emergent brain CT scan. These findings were quickly reversed after the serum Na was corrected. Discussion This report emphasizes that close monitoring of serum Na and osmolarity in acute head injured children is important, and provides evidence that alterations of these parameters is a substantial risk for cerebral edema in children with evolving brain injuries and briefly reviews the literature regarding the risks of hyponatremia in children.	Childrens Natl Med Ctr, Neurosci Res Ctr, Childrens Res Inst, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Neurol, Childrens Res Inst, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Neurosurg, Childrens Res Inst, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Neuroradiol, Childrens Res Inst, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Crit Care Med, Childrens Res Inst, Washington, DC 20010 USA		Bell, MJ (corresponding author), Childrens Natl Med Ctr, Neurosci Res Ctr, Childrens Res Inst, Washington, DC 20010 USA.	jcarpent@cnmc.org; sweinste@cnmc.org; jmyseros@cnmc.org; gvezina@cnmc.org; mbell@cnmc.org					Arieff AI, 1998, PAEDIATR ANAESTH, V8, P1, DOI 10.1046/j.1460-9592.1998.00730.x; Ashrafian H, 2001, EUR J NEUROL, V8, P103, DOI 10.1046/j.1468-1331.2001.00176.x; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Bennani SL, 2003, REV MED INTERNE, V24, P224, DOI 10.1016/S0248-8663(02)00811-1; DEVITA MV, 1990, CLIN NEPHROL, V34, P163; Donati-Genet PCM, 2001, J PEDIATR SURG, V36, P1094, DOI 10.1053/jpsu.2001.24770; Fedutes BA, 2003, ANN PHARMACOTHER, V37, P1506, DOI 10.1345/aph.1C464; Fraser CL, 1997, AM J MED, V102, P67, DOI 10.1016/S0002-9343(96)00274-4; Frye RE, 2005, PEDIATR NEUROL, V32, P213, DOI 10.1016/j.pediatrneurol.2004.07.012; Ke CS, 2002, EXP NEUROL, V178, P194, DOI 10.1006/exnr.2002.8037; Klein KM, 2004, SEIZURE-EUR J EPILEP, V13, P196, DOI 10.1016/S1059-1311(03)00077-3; Kumar S, 2006, NEUROL RES, V28, P360, DOI 10.1179/016164106X110346; Massieu L, 2004, NEUROCHEM RES, V29, P73, DOI 10.1023/B:NERE.0000010435.06586.e2; Moon G, 1995, HEALTH PLACE, V1, P1, DOI 10.1016/1353-8292(95)90006-V; Moritz ML, 2003, PEDIATRICS, V111, P227, DOI 10.1542/peds.111.2.227; Restuccia T, 2004, HEPATOLOGY, V39, P1613, DOI 10.1002/hep.20237; Singh Sonal, 2005, MedGenMed, V7, P11; STERNS RH, 1989, KIDNEY INT, V35, P69, DOI 10.1038/ki.1989.9; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005	19	20	25	1	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care		2007	6	3					195	199		10.1007/s12028-007-0032-x			5	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	184FO	WOS:000247626700007	17572863				2022-02-06	
J	Chang, TTL; Ciuffreda, KJ; Kapoor, N				Chang, Tina Ting-Li; Ciuffreda, Kenneth Joseph; Kapoor, Neera			Critical flicker frequency and related symptoms in mild traumatic brain injury	BRAIN INJURY			English	Article						traumatic brain injury; mild brain injury; critical flicker frequency; light sensitivity; motion sensitivity; temporal; processing	HEAD-INJURY; LIGHT-SENSE; SENSITIVITY; PERIMETRY; LUMINANCE; MIGRAINE; SOUND	Primary objective: To determine whether critical flicker frequency (CFF) thresholds are abnormal in individuals with mild traumatic brain injury (TBI) and, if so, if they are correlated with the degree of reported motion and light sensitivity. Methods and procedures: The foveal CFF threshold was assessed in individuals with mild TBI ( n = 18) having varying degrees of reported light and motion sensitivity. Mean CFF values were obtained using the ascending and descending psychophysical method of limits with binocular viewing at 40 cm. A 7-item, rating-scale questionnaire was used to assess the degree of light and motion sensitivity. These parameters were also assessed in a large visually-normal, non-TBI cohort. Main outcomes and results: CFF in the mild TBI group was not significantly different across age groups from the visually-normal, non-TBI cohort. However, mean CFF among the mild TBI subjects was significantly higher for the ` light sensitive' and ` motion sensitive' sub-groups when compared to the ` not light sensitive' and ` not motion sensitive' sub-groups. The majority of TBI subjects manifested both light and motion sensitivity. Conclusion: CFF was found to be related to the reported degree of light and motion sensitivity in individuals with mild TBI. Neurological disinhibition as a result of brain injury may be causal of the subjective hypersensitivity to light and motion in the presence of normal CFF.	SUNY Coll Optometry, Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, New York, NY 10036 USA; SUNY Coll Optometry, Raymond J Greenwald Rehabil Ctr, Dept Vis Sci, New York, NY 10036 USA		Ciuffreda, KJ (corresponding author), SUNY Coll Optometry, Raymond J Greenwald Rehabil Ctr, Dept Clin Sci, 33 W 42nd St, New York, NY 10036 USA.	kciuffreda@sunyopt.edu			NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T35EY007079] Funding Source: NIH RePORTER; NEI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [T35 EY07079] Funding Source: Medline		BATTERSBY WS, 1951, J EXP PSYCHOL, V42, P135, DOI 10.1037/h0057037; BATTERSBY WS, 1951, J EXP PSYCHOL, V42, P59, DOI 10.1037/h0063538; BOHNEN N, 1991, J NEUROL, V238, P443, DOI 10.1007/BF00314651; Carmel D, 2006, CURR BIOL, V16, P907, DOI 10.1016/j.cub.2006.03.055; Ceranic BJ, 1998, J NEUROL NEUROSUR PS, V65, P523, DOI 10.1136/jnnp.65.4.523; Chen PC, 2000, J FORMOS MED ASSOC, V99, P45; COIFFREDA KC, 2001, VISUAL VESTIBULAR CO, P77; COLESTON DM, 1995, CEPHALALGIA, V15, P396, DOI 10.1046/j.1468-2982.1995.1505396.x; del Romo GB, 2005, INVEST OPHTH VIS SCI, V46, P1107, DOI 10.1167/iovs.04-1138; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; HARVEY LO, 1970, VISION RES, V10, P55, DOI 10.1016/0042-6989(70)90062-3; HATCH SW, 1998, OPHTHALMIC RES EPIDE, V24, P187; Jackowski MM, 1996, NEUROREHABILITATION, V6, P193, DOI 10.3233/NRE-1996-6305; JACKOWSKI MM, 2001, VISUAL VESTIBULAR CO, P145; Kapoor Neera, 2002, Curr Treat Options Neurol, V4, P271, DOI 10.1007/s11940-002-0027-z; KOERNER F, 1973, EXP BRAIN RES, V18, P88; KOOI KA, 1958, NEUROLOGY, V8, P764, DOI 10.1212/WNL.8.10.764; Kowacs PA, 2005, CEPHALALGIA, V25, P339, DOI 10.1111/j.1468-2982.2004.00861.x; KUYK TK, 1991, OPTOMETRY VISION SCI, V68, P786, DOI 10.1097/00006324-199110000-00005; LACHENMAYR BJ, 1991, GRAEF ARCH CLIN EXP, V229, P246, DOI 10.1007/BF00167877; LACHENMAYR BJ, 1994, INVEST OPHTH VIS SCI, V35, P2741; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; McKendrick A.M., 2003, ADLERS PHYSL EYE, P511; MISIAK H, 1951, SCIENCE, V113, P551, DOI 10.1126/science.113.2941.551; SCHWARTZ SH, 1999, VISUAL PERCEPTION CL, P205; SNELGAR RS, 1985, DOC OPHTHALMOL, V60, P79, DOI 10.1007/BF00164571; Suter P. S., 2004, TRAUMATIC BRAIN INJU, P209; Talcott JB, 1998, NEURO-OPHTHALMOLOGY, V20, P187, DOI 10.1076/noph.20.4.187.3931; WADDELL PA, 1984, ACTA NEUROL SCAND, V69, P270, DOI 10.1111/j.1600-0404.1984.tb07812.x	29	20	20	0	8	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	10					1055	1062		10.1080/02699050701591437			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	222WU	WOS:000250329600008	17891568				2022-02-06	
J	Kuruvilla, M; Murdoch, B; Goozee, J				Kuruvilla, Mili; Murdoch, Bruce; Goozee, Justine			Electromagnetic articulography assessment of articulatory function in adults with dysarthria following traumatic brain injury	BRAIN INJURY			English	Article						EMA assessment; severe TBI; mild TBI; dysarthria; articulation	CLOSED-HEAD-INJURY; KINEMATIC ANALYSIS; SPEECH; TASK; SPEAKERS	Primary objective: To explore articulatory kinematic differences between normal and dysarthric speakers post-traumatic brain injury (TBI) during syllable and sentence productions. Research design: A comparison between the control, mild (MTBI) and severe TBI groups for all measured kinematic parameters was carried out using the Kruskal Wallis test. Methods and procedures: Ten participants with a severe TBI and six post-MTBI formed the experimental group. The control group consisted of 14 age and sex matched non- neurologically impaired speakers. Articulatory kinematic profiles for the three groups were obtained using the Electromagnetic Articulograph (EMA) while repeating sentence and syllable embedded /t/ and /k/ productions at a habitual rate and loudness level. Main outcomes and results: Significant differences between the severe TBI and control group were identified only for the release phase of the /t/ sentence productions wherein an increase in mean maximum acceleration was observed for the severe TBI group. Conclusions: While a simple syllable repetition task at a moderate rate was unable to differentiate the three groups, a complex sentence production task precipitated an increase in mean maximum acceleration which may be indicative of increased articulatory effort and impaired speech motor control even at a convenient rate for the severe group.	Univ Queensland, Motor Speech Res Unit, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia; Univ Queensland, Div Speech Pathol, Brisbane, Qld 4072, Australia		Kuruvilla, M (corresponding author), Univ Queensland, Motor Speech Res Unit, Sch Hlth & Rehabil Sci, Brisbane, Qld 4072, Australia.	m.kuruvilla@shrs.uq.edu.au	Murdoch, Bruce E/C-1397-2012	Kuruvilla-Dugdale, Mili/0000-0001-7900-2364			Brown J.R., 1975, MOTOR SPEECH DISORDE; Goozee JV, 2000, BRAIN INJURY, V14, P153, DOI 10.1080/026990500120817; HARDCASTLE WJ, 1985, BRIT J DISORD COMMUN, V20, P249; Jaeger M, 2000, FOLIA PHONIATR LOGO, V52, P187, DOI 10.1159/000021533; Kent RD, 2000, FOLIA PHONIATR LOGO, V52, P48, DOI 10.1159/000021512; KENT RD, 1975, J SPEECH HEAR DISORD, V40, P467, DOI 10.1044/jshd.4004.467; KLATT DH, 1972, J ACOUST SOC AM, V51, P101, DOI 10.1121/1.1981241; Kuehn D. P., 1976, J PHONETICS, V4, P303, DOI 10.1016/S0095-4470(19)31257-4; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Shaiman S, 2002, EXP BRAIN RES, V146, P411, DOI 10.1007/s00221-002-1195-5; Tasko SM, 2004, J SPEECH LANG HEAR R, V47, P85, DOI 10.1044/1092-4388(2004/008); THEODOROS DG, 1994, BRAIN INJURY, V8, P101, DOI 10.3109/02699059409150963; WEISMER G, 1991, DYSARTHRIA APRAXIA S; ZIEGLER W, 1993, J SPEECH HEAR RES, V36, P683, DOI 10.1044/jshr.3604.683; Ziegler W, 2002, BRAIN LANG, V80, P556, DOI 10.1006/brln.2001.2614; ZYSKI BJ, 1987, J COMMUN DISORD, V20, P367, DOI 10.1016/0021-9924(87)90025-6; [No title captured]	18	20	24	0	11	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.		2007	21	6					601	613		10.1080/02699050701427525			13	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	192LU	WOS:000248204100007	17577711				2022-02-06	
J	Nayak, C; Nayak, D; Bhat, S; Raja, A; Rao, A				Nayak, Chandrika; Nayak, Dinesh; Bhat, Surekha; Raja, Annaswamy; Rao, Anjali			Relationship between neurological outcome and early oxidative changes in erythrocytes in head injury patients	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						erythrocytes; glutathione; lipid peroxidation; outcome; reactive oxygen species	TRAUMATIC BRAIN INJURY; LIPID-PEROXIDATION; SUPEROXIDE-DISMUTASE; FREE-RADICALS; METABOLISM; STRESS; DAMAGE; ISCHEMIA	Background: Experimental data indicate that destructive oxidative events reach their peak within the first 24 h after trauma in head injury (HI) and that brain damage occurring due to this impact can be the cause of death or irreversible permanent disabilities in affected patients. Methods: Venous blood samples were obtained from 50 HI patients within 24 h of trauma onset and from 30 age- and sex-matched normal controls (NC). Patients were divided into three different neurological outcome groups: those who died within 10 days of trauma (D), and those with severe neurological deficits (SD) or mild/no neurological deficits (MD) at 90 days after trauma. Early oxidative changes in erythrocytes were assessed by estimating an indicator of lipid peroxidative damage - thiobarbituric acid-reactive substances (TBARS) - and antioxidants [reduced glutathione (GSH) levels and superoxide dismutase (SOD) activity]. Results: In the D group, erythrocyte TBARS levels were significantly higher compared to the NC, SD and MD groups (p < 0.001); GSH levels were significantly lower compared to the NC (P < 0.061) and MD (p < 0.01) groups and SOD activity was significantly higher than in the NC (p < 0.01) and MD (p < 0.01) groups. In the SD group, TBARS levels were significantly higher than in the NC (p < 0.001) and MD (p < 0.05) groups; GSH levels were significantly lower than in the NC (p < 0.001) and MD (p < 0.01) groups and SOD activity was higher compared to the NC and MD (p < 0.01) groups. In the MD group, TBARS levels were significantly higher and GSH levels significantly lower compared to the NC group (p < 0.001). However,we did not observe any significant change in SOD activity compared to the NC group. Conclusions: These findings indicate that early oxidative changes may reflect the severity of neurological insult and provide an early indication of patient outcome in traumatic HI.	Int Ctr Hlth Sci, Melaka Manipal Med Coll, Dept Biochem, Manipal 576104, Karnataka, India; Kasturba Med Coll & Hosp, Dept Pediat, Manipal 576119, India; Melaka Manipal Med Coll, Dept Biochem, Manipal, India; Kasturba Med Coll & Hosp, Dept Neurosurg, Manipal 576119, India; Kasturba Med Coll & Hosp, Dept Biochem, Manipal 576119, India		Nayak, C (corresponding author), Int Ctr Hlth Sci, Melaka Manipal Med Coll, Dept Biochem, Manipal Campus, Manipal 576104, Karnataka, India.	chandrikadinesh@yahoo.com	Bhat, Malpe Surekha/F-8674-2010	Nayak, Chandrika D/0000-0002-4674-7359; Nayak, Dinesh M/0000-0001-7384-8916; Rao, Anjali/0000-0002-2676-2762			BEAUCHAMP CO, 1971, ANAL BIOCHEM, V44, P276, DOI DOI 10.1016/0003-2697(71)90370-8; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHERUBINI A, 2001, 2 VIRT C CARD SEP 1; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; DISILVESTRO RA, 1989, ARCH BIOCHEM BIOPHYS, V274, P298, DOI 10.1016/0003-9861(89)90442-6; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Giustarini D, 2003, CLIN CHEM, V49, P327, DOI 10.1373/49.2.327; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HALLENBECK JM, 1986, STROKE, V17, P246, DOI 10.1161/01.STR.17.2.246; IKEDA Y, 1994, ACTA NEUROCHIR, P136; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; LAFONCAZAL M, 1993, NATURE, V364, P535, DOI 10.1038/364535a0; LYNCH RE, 1978, J BIOL CHEM, V253, P4697; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1994, ADV EXP MED BIOL, V366, P389; Nayak C, 2006, CLIN CHEM LAB MED, V44, P460, DOI 10.1515/CCLM.2006.068; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Polidori MC, 2001, STROKE, V32, P898, DOI 10.1161/01.STR.32.4.898; Regner A, 2001, J NEUROTRAUM, V18, P783, DOI 10.1089/089771501316919148; REITER RJ, 1995, FASEB J, V9, P526, DOI 10.1096/fasebj.9.7.7737461; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; Said SI, 2000, FREE RADICAL BIO MED, V28, P1300, DOI 10.1016/S0891-5849(00)00289-6; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SHOHAMI E, 1989, J NEUROTRAUM, V16, P365; Siems WG, 2000, CLIN NEPHROL, V53, pS9; SUDHA K, 1998, THESIS MANIPAL ACAD; Tentori L, 1981, Methods Enzymol, V76, P707, DOI 10.1016/0076-6879(81)76152-4; Yamamoto T, 1999, ACT NEUR S, V75, P17	36	20	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.		2007	45	5					629	633		10.1515/CCLM.2007.123			5	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	175HY	WOS:000247005900010	17484625				2022-02-06	
S	Park, E; Ai, JL; Baker, AJ		Weber, JT; Maas, AIR		Park, Eugene; Ai, Jinglu; Baker, Andrew J.			Cerebellar injury: clinical relevance and potential in traumatic brain injury research	NEUROTRAUMA: NEW INSIGHTS INTO PATHOLOGY AND TREATMENT	PROGRESS IN BRAIN RESEARCH		English	Article; Proceedings Paper	8th International Neurotrauma Symposium	MAY 21-25, 2006	Rotterdam, NETHERLANDS			animal models; cerebellum; electrophysiology; FPI; TAI; TBI	LURCHER MUTANT MICE; PENETRATING CRANIOCEREBRAL INJURIES; PURKINJE-CELL VULNERABILITY; PARALLEL FIBER STIMULATION; BERGMANN GLIAL-CELLS; SEVERE HEAD-INJURY; FLUID-PERCUSSION; GUNSHOT INJURIES; AXONAL INJURY; TIME-COURSE	A treatment for traumatic brain injury (TBI) remains elusive despite compelling evidence from animal models for a variety of therapeutic targets. Numerous animal models have been developed to address the wide spectrum of mechanisms involved in the progression of secondary injury after TBI. Evidence from well-established models such as the fluid percussion injury (FPI) device, cortical impact model, and the impact acceleration model has demonstrated diffuse pathophysiological mechanisms throughout various brain structures. More specifically, we have recently extended characterization of the FPI model to include pathophysiological changes in the cerebellum following unilateral fluid percussion. Data suggest that the cerebellum is susceptible to selective Purkinje cell loss as well as white matter dysfunction. Despite the cerebellum's low profile in TBI research, there is evidence to warrant further study of the cerebellum to examine mechanisms of neuronal death and traumatic axonal injury. Furthermore, evidence from clinical literature and basic science suggests that some components of TBI pathophysiology have a basis in cerebellar dysfunction. This review highlights some of the recent findings in cerebellar trauma and builds an argument for including the cerebellum as a model to assess mechanisms of secondary injury and its potential contribution to the pathology of TBI.	[Park, Eugene; Ai, Jinglu; Baker, Andrew J.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada		Baker, AJ (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	bakera@smh.toronto.on.ca		AI, JINGLU/0000-0001-7414-0207			Ai JL, 2002, NEUROSCI LETT, V332, P155, DOI 10.1016/S0304-3940(02)00945-X; Alavi A, 1997, J NUCL MED, V38, P1717; ANDERSON JR, 1973, J NEUROL NEUROSUR PS, V36, P826, DOI 10.1136/jnnp.36.5.826; Armstrong CL, 2000, J COMP NEUROL, V416, P383, DOI 10.1002/(SICI)1096-9861(20000117)416:3<383::AID-CNE9>3.0.CO;2-M; Bellamy TC, 2005, GLIA, V52, P325, DOI 10.1002/glia.20248; Bellamy TC, 2006, CEREBELLUM, V5, P116, DOI 10.1080/14734220600724569; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; BHATIA KP, 1995, BRAIN, V118, P1087, DOI 10.1093/brain/118.5.1087; Bostrom K, 1992, Acta Neurochir Suppl (Wien), V55, P25; *BRAIN TRAUM FDN, 2000, J NEUROTRAUM, V17, P471; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Bullock MR, 1999, NEUROSURGERY, V45, P207, DOI 10.1097/00006123-199908000-00001; CHESTER CS, 1987, ANN NEUROL, V22, P77; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; D'Avella D, 2001, J Neurosurg Sci, V45, P29; Faden AI, 2002, CURR OPIN NEUROL, V15, P707, DOI 10.1097/00019052-200212000-00008; Faden AI, 2001, ARCH NEUROL-CHICAGO, V58, P1553, DOI 10.1001/archneur.58.10.1553; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FOX CA, 1957, J ANAT, V91, P299; Fukuda K, 1996, J NEUROTRAUM, V13, P255, DOI 10.1089/neu.1996.13.255; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Glickstein M, 2000, TRENDS NEUROSCI, V23, P613, DOI 10.1016/S0166-2236(00)01681-7; Gordon N, 1996, EUR J DISORDER COMM, V31, P359; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; HECKROTH JA, 1994, J COMP NEUROL, V343, P173, DOI 10.1002/cne.903430113; HECKROTH JA, 1991, J COMP NEUROL, V312, P641, DOI 10.1002/cne.903120413; HECKROTH JA, 1992, J COMP NEUROL, V315, P85, DOI 10.1002/cne.903150107; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; Hoshino S, 2003, NEUROL MED-CHIR, V43, P165, DOI 10.2176/nmc.43.165; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; KRAUSS JK, 1995, NEUROL RES, V17, P409, DOI 10.1080/01616412.1995.11740353; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Mariotti C, 2005, J NEUROL, V252, P511, DOI 10.1007/s00415-005-0814-z; Mautes AEM, 1996, NEUROSCI LETT, V214, P95, DOI 10.1016/0304-3940(96)12916-5; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MYSIW W J, 1990, Brain Injury, V4, P247, DOI 10.3109/02699059009026174; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nathoo N, 2002, SURG NEUROL, V58, P225, DOI 10.1016/S0090-3019(02)00828-5; Niimura K, 1999, NEUROLOGY, V52, P792, DOI 10.1212/WNL.52.4.792; OHearn E, 1997, J NEUROSCI, V17, P8828; PARK E, 2006, IN PRESS EXP FLUIDS; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Petrosini L, 1998, PROG NEUROBIOL, V56, P191, DOI 10.1016/S0301-0082(98)00036-7; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; RISH BL, 1983, J NEUROSURG, V59, P775, DOI 10.3171/jns.1983.59.5.0775; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Shamoto H, 1997, J CHILD NEUROL, V12, P407, DOI 10.1177/088307389701200701; SHIMA K, 1991, J NEUROSURG, V74, P270, DOI 10.3171/jns.1991.74.2.0270; Sillitoe RV, 2002, J HISTOCHEM CYTOCHEM, V50, P235, DOI 10.1177/002215540205000211; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Unterharnscheidt F, 1995, Rev Neurol, V23, P661; Unterharnscheidt F, 1995, Rev Neurol, V23, P1027; Voogd J, 1998, TRENDS NEUROSCI, V21, P370, DOI 10.1016/S0166-2236(98)01318-6; Welsh JP, 2002, ADV NEUROL, V89, P331; Zanjani HS, 1998, J NEUROSCI, V18, P319, DOI 10.1523/jneurosci.18-01-00319.1998; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	69	20	20	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0079-6123		978-0-444-53017-2	PROG BRAIN RES			2007	161						327	338		10.1016/S0079-6123(06)61023-6			12	Medicine, General & Internal; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	BGY20	WOS:000251295200023	17618988				2022-02-06	
J	Scherer, M				Scherer, Matthew			Gait rehabilitation with body weight-supported treadmill training for a blast injury survivor with traumatic brain injury	BRAIN INJURY			English	Article						blast injury; traumatic brain injury; gait training; body weight-supported treadmill training	NONAMBULATORY HEMIPARETIC PATIENTS; WALK TEST; AMBULATION; RECOVERY; STROKE; LOCOMOTION; THERAPY; SPEED	Background and purpose: Research supports the use of body weight-supported treadmill training (BWSTT) in patients with hemi-paresis and may show promise as a gait training and neuromuscular re-education intervention in the blast-injured, traumatic brain injury (TBI) population. The purpose of this case study is to document the use BWSTT and goal-directed therapy in the improvement of gait quality, gait speed and maximum distance ambulated in a blast injury survivor with TBI. Case description: A 36-year-old male soldier injured by a rocket propelled grenade in Iraq who began physical therapy and gait training incorporating purposeful postural stability and mobility interventions as well as BWSTT. Outcomes: Missouri Assisted Gait scores, six-minute walk distances, and maximum distance ambulated all increased post gait training with BWSTT as a component to PT intervention. Discussion: Intensive gait training including BWSTT may have some efficacy in managing significant blast trauma patients with TBI however, further research is necessary to establish efficacy and appropriateness in this patient population.	Walter Reed Army Med Ctr, Washington, DC 20039 USA		Scherer, M (corresponding author), Walter Reed Army Med Ctr, 6900 Georgia Ave, Washington, DC 20039 USA.	matthew.scherer@us.army.mil					AMIR H, 1999, J HEAD TRAUMA REHAB, V14, P146; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Brown TH, 2005, J HEAD TRAUMA REHAB, V20, P402, DOI 10.1097/00001199-200509000-00002; Grillner S, 1979, Prog Brain Res, V50, P227; Harada ND, 1999, ARCH PHYS MED REHAB, V80, P837, DOI 10.1016/S0003-9993(99)90236-8; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HESSE S, 1994, ARCH PHYS MED REHAB, V75, P1087, DOI 10.1016/0003-9993(94)90083-3; KATZ D, 1997, TRAUMATIC BRAIN INJU, pCH4; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Laufer Y, 2001, J REHABIL RES DEV, V38, P69; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; MOSELEY AM, 2005, COCHRANE DATABASE SY, V1; Mossberg KA, 2003, AM J PHYS MED REHAB, V82, P385, DOI 10.1097/01.PHM.0000052589.96202.BE; Mossberg KA, 2002, BRAIN INJURY, V16, P789, DOI 10.1080/02699050210131894; Platz T, 1999, RESTOR NEUROL NEUROS, V14, P161; Sullivan KJ, 2002, ARCH PHYS MED REHAB, V83, P683, DOI 10.1053/apmr.2002.32488; Visintin M, 1998, STROKE, V29, P1122, DOI 10.1161/01.STR.29.6.1122; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; WERNIG A, 1991, PLASTICITY MOTORNEUR, pCH49; Wilson DJ, 2006, AM J PHYS MED REHAB, V85, P68, DOI 10.1097/01.phm.0000193507.28759.37; Wilson DJ, 2002, BRAIN INJURY, V16, P259, DOI 10.1080/02699050110103922	22	20	21	0	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JAN	2007	21	1					93	100		10.1080/02699050601149104			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	141FQ	WOS:000244564600011	17364524				2022-02-06	
J	Schonberger, M; Humle, F; Teasdale, TW				Schoenberger, Michael; Humle, Frank; Teasdale, Thomas W.			The relationship between clients' cognitive functioning and the therapeutic working alliance in post-acute brain injury rehabilitation	BRAIN INJURY			English	Article						therapeutic working alliance; acquired brain injury; rehabilitation; cognitive functioning; neuropsychological tests; process research	PATIENT COMPLIANCE; HEAD-INJURY; PSYCHOTHERAPY; AWARENESS	Objective: To examine the impact of brain-injured patients' cognitive abilities on their working alliance (WA) with their therapist in post-acute rehabilitation. Design: Cognitive tests were administered to brain-injured individuals at the beginning of post-acute, holistic brain-injury rehabilitation. Clients as well as their primary therapists rated their mutual WA at four time points throughout a 14-week rehabilitation programme. Subjects consisted of 86 clients as well as their primary therapists. Clients had suffered a traumatic brain injury (n=27), a cerebrovascular accident (n = 49) or another neurological insult (n = 10). Measures: (1) Neuropsychological tests of attention, memory and higher cognitive functions; ( 2) the Working Alliance Inventory, client and therapist short form. Results: Overall, the relationships between cognitive tests and WA ratings were weak. The tests of attention, memory and higher cortical functions were differentially related to clients' and therapists' view of their mutual WA at the different stages of their collaborative work. Discussion and conclusion: Clients' cognitive profile affects clients' and therapists' view of their WA in different ways. The weakness of the correlations between cognitive tests and WA ratings may indicate that a good WA is achievable also with clients with severe cognitive difficulties.	Univ Copenhagen, Ctr Rehabil Brain Injury, Copenhagen, Denmark; Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; Monash Univ, Sch Psychol Psychiat & Psychol Med, Melbourne, Vic 3004, Australia; Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia		Schonberger, M (corresponding author), Monash Univ, Sch Psychol Psychiat & Psychol Med, Wellington Rd,Bldg 17, Clayton, Vic 3800, Australia.	michael_schonberger@web.de					Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; Bieman-Copland S, 2000, BRAIN COGNITION, V44, P1; Bordin ES, 1979, PSYCHOTHER THEORY RE, V16, P252, DOI DOI 10.1037/H0085885; Brickenkamp R., 1981, AUFMERKSAMKEITS BELA; CAETANO C, 2000, INT HDB NEUROPSYCHOL, P259; Christensen AL, 1998, J HEAD TRAUMA REHAB, V13, P79, DOI 10.1097/00001199-199810000-00009; Christensen AL, 1996, NEUROPSYCHOL REHABIL, V6, P279, DOI 10.1080/713755511; CHRISTENSEN AL, 1975, NEUROPSYKOLOGISKE UN, P50; Constantino M.J., 2002, COUNSELING BASED PRO, P81; Davis LW, 2004, J NERV MENT DIS, V192, P508, DOI 10.1097/01.nmd.0000131919.60151.a7; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Herman S.M., 1998, J PSYCHOTHERAPY PRAC, V7, P56; HORVATH AO, 1991, J COUNS PSYCHOL, V38, P139, DOI 10.1037/0022-0167.38.2.139; HORVATH AO, 1989, J COUNS PSYCHOL, V36, P223, DOI 10.1037/0022-0167.36.2.223; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Judd D, 2005, BRAIN INJURY, V19, P437, DOI 10.1080/02699050400010994; Kendall E, 1996, NEUROPSYCHOL REHABIL, V6, P101, DOI 10.1080/713755502; Klonoff PS, 1998, ARCH PHYS MED REHAB, V79, P684, DOI 10.1016/S0003-9993(98)90045-4; Klonoff PS, 2001, BRAIN INJURY, V15, P413, DOI 10.1080/02699050010005968; Lewis L., 1991, AWARENESS DEFICIT BR, P223; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Norcross, 2002, PSYCHOTHERAPY RELATI, P17; Prigatano GP., 1988, J HEAD TRAUMA REHAB, V3, P45; PRIGATANO GP, 1994, J HEAD TRAUMA REHAB, V9, P91, DOI DOI 10.1097/00001199-199403000-00011; Raven J., 1998, MANUAL RAVENS ADV PR; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P561, DOI 10.1080/09602010500263084; Schonberger M, 2006, NEUROPSYCHOL REHABIL, V16, P298, DOI 10.1080/09602010500176476; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schonberger M, 2006, BRAIN INJURY, V20, P1271, DOI 10.1080/02699050601049395; SPREEN O, 1968, NEUROSENSORY CTR COM; Stuss D. T., 1999, COGNITIVE NEUROREHAB, P188; TENNANT A, 1995, BRAIN INJURY, V9, P595, DOI 10.3109/02699059509008218; Tracey T.J., 1989, J CONSULT CLIN PSYCH, V1, P207, DOI [10.1037/1040-3590.1.3.207, DOI 10.1037/1040-3590.1.3.207, 10.1037/1040-3590.1.3.207.]; Wechsler, 1997, WECHSLER ADULT INTEL	35	20	20	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2007	21	8					825	836		10.1080/02699050701499433			12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	202YZ	WOS:000248942400004	17676440				2022-02-06	
J	Yang, L; Benardo, LS; Valsamis, H; Ling, DSF				Yang, Lie; Benardo, Larry S.; Valsamis, Helen; Ling, Douglas S. F.			Acute injury to superficial cortex leads to a decrease in synaptic inhibition and increase in excitation in neocortical layer V pyramidal cells	JOURNAL OF NEUROPHYSIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; STATUS EPILEPTICUS MODELS; DEPENDENT PROTEIN-KINASE; NEUROTROPHIN EXPRESSION; POSTTRAUMATIC SEIZURES; RAT NEOCORTEX; AMINO-ACIDS; HEAD-INJURY; IN-VITRO; HIPPOCAMPAL-NEURONS	Injury to the superficial layers of cerebral cortex produces alterations in the synaptic responses of local circuits that promote the development of seizures. To further delineate the specific changes in synaptic strength that are induced by this type of cortical injury, whole cell voltage-clamp recordings were used to examine evoked and spontaneous synaptic events from layer V pyramidal cells in coronal slices prepared from surgically traumatized rat neocortices in which the superficial third of the cortex (layers I, II, and part of III) was removed. Slices from intact neocortices were used as controls. Examinations of fast inhibitory postsynaptic currents (IPSCs) indicated that traumatized slices were disinhibited, exhibiting evoked IPSCs (eIPSCs) with lower peak amplitudes. Measurements of spontaneous IPSCs (sIPSCs) revealed no difference in the mean amplitudes of sIPSCs recorded in traumatized versus control slices. However, the mean sIPSC frequency was lower in traumatized slices, indicative of a decrease in GABA release at these inhibitory synapses. Traumatized slices also displayed an increase in synaptic excitation, exhibiting spontaneous EPSCs (sESPCs) with larger peak amplitudes and higher frequencies. Peak-scaled nonstationary fluctuation analysis of sEPSCs and sIPSCs was used to obtain estimates of the unit conductance and number of functional receptor channels. EPSC and IPSC channel numbers and IPSC unit conductance did not differ between traumatized and intact slices. However, the mean unit conductance of EPSCs was higher (+ 25%) in traumatized slices. These findings suggest that acute injury to the superficial neocortical layers results in a disinhibition of cortical circuits that stems from a decline in GABA release likely due to the loss of superficial inhibitory interneurons and an enhancement of synaptic excitation consequent to an increase in the AMPA receptor unit conductance.	Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA		Yang, L (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, 450 Clarkson Ave,Box 29, Brooklyn, NY 11203 USA.	lie.yang@downstate.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH051677, R29MH051677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS038132] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH 51677] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38132] Funding Source: Medline		Angeleri F, 1999, EPILEPSIA, V40, P1222, DOI 10.1111/j.1528-1157.1999.tb00850.x; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Benardo LS, 1997, J NEUROPHYSIOL, V77, P3134, DOI 10.1152/jn.1997.77.6.3134; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V62, P1149, DOI 10.1152/jn.1989.62.5.1149; CHEN QX, 1990, J PHYSIOL-LONDON, V420, P207, DOI 10.1113/jphysiol.1990.sp017908; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Chu ZG, 2003, J NEUROSCI, V23, P96; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CONNORS BW, 1993, EPILEPSY MODELS MECH, P388; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; DE KONINCK Y, 1994, J NEUROPHYSIOL, V71, P1318, DOI 10.1152/jn.1994.71.4.1318; DOUGLAS RJ, 1990, SYNAPTIC ORG BRAIN, P389; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GALL C, 1991, MOL BRAIN RES, V9, P113, DOI 10.1016/0169-328X(91)90136-L; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; GALL CM, 1992, TRENDS PHARMACOL SCI, V13, P401, DOI 10.1016/0165-6147(92)90123-N; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; GREENGARD P, 1991, SCIENCE, V253, P1135, DOI 10.1126/science.1716001; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Lauterborn JC, 2000, J NEUROSCI, V20, P8, DOI 10.1523/JNEUROSCI.20-01-00008.2000; Li HF, 2005, J NEUROPHYSIOL, V93, P146, DOI 10.1152/jn.00665.2004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2005, CEREB CORTEX, V15, P921, DOI 10.1093/cercor/bhh191; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; LING DSF, 1994, NEUROSCIENCE, V63, P937, DOI 10.1016/0306-4522(94)90561-4; Ling DSF, 1999, J NEUROPHYSIOL, V82, P1793, DOI 10.1152/jn.1999.82.4.1793; Ling DSF, 1998, SYNAPSE, V28, P91, DOI 10.1002/(SICI)1098-2396(199801)28:1<91::AID-SYN11>3.0.CO;2-0; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Lowenstein D H, 1996, Epilepsy Res Suppl, V11, P45; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; MILLER LP, 1990, BRAIN RES, V526, P103, DOI 10.1016/0006-8993(90)90254-9; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; OTIS TS, 1991, BRAIN RES, V545, P142, DOI 10.1016/0006-8993(91)91280-E; POLVISHOCK JT, 2005, J HEAD TRAUMA REHAB, V20, P76; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; RAMAMURTHI B, 1980, SURG NEUROL, V14, P415; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salin P, 1995, J NEUROSCI, V15, P8234; Salin PA, 1996, J NEUROPHYSIOL, V75, P1589, DOI 10.1152/jn.1996.75.4.1589; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WILLMORE LJ, 1990, EPILEPSIA, V31, P67; Yang L, 2002, NEUROSCIENCE, V111, P303, DOI 10.1016/S0306-4522(01)00622-4; Yang L, 1997, J NEUROPHYSIOL, V78, P2804, DOI 10.1152/jn.1997.78.5.2804; Yang L, 1998, NEUROSCI LETT, V257, P33, DOI 10.1016/S0304-3940(98)00798-8; Yang L, 2000, EPILEPSIA, V41, P1507; YANG L, 2004, SOC NEUR ABSTR, V970, P13	67	20	22	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.	JAN	2007	97	1					178	187		10.1152/jn.01374.2005			10	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	126RO	WOS:000243532900018	16987927				2022-02-06	
J	Conn, JM; Annest, JL; Bossarte, RM; Gilchrist, J				Conn, Judith M.; Annest, Joseph L.; Bossarte, Robert M.; Gilchrist, Julie			Non-fatal sports and recreational violent injuries among children and teenagers, United States, 2001-2003	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						violence; injury; sports; child; adolescent; epidemiology	AFRICAN-AMERICAN BOYS; PREVENTION PROGRAMS; CARE-CENTERS; SCHOOL; EPIDEMIOLOGY; INTERVENTION; AGGRESSION; TRIAL	Background: An estimated 2.7 million non-fatat unintentional sports and recreational injuries are treated in U.S. hospital emergency departments (EDs) annually. However, little is known about the number of sports and recreational injuries resulting from violent behavior. Methods: Data for 2001-2003 on sports and recreational injuries were obtained from the National Electronic Injury Surveillance Systern-All Injury Program (NEISS-AIP)-a national sample of 66 U.S. EDs. National estimates and rates of persons treated for violence-related sports and recreational injuries in EDs are compared to those treated for unintentional sports and recreational injuries. Types of injuries and injury circumstances are described. Results: During the study period, an estimated 6705 (8.3 per 100,000; 95% confidence intervals (CI), 6.3-10.3) children and teenagers with violence-related sports and recreational injuries were treated in U.S. EDs annually, compared to 2,698,634 children and teenagers with unintentional sports and recreational injuries. Thus, violent behavior accounted for 0.25% of sports and recreational injuries. The highest incidence rate (13.6 per 100,000) for violence-related sports and recreational injuries was for children aged 10-14 years. Most patients with violence-related sports and recreational injuries were treated and released from the ED. A majority of those with violence-related sports and recreational injuries were injured to the head/neck region (52.2%), of which 24.1% were treated for traumatic brain injuries. Most violent injuries resulted from being pushed or hit (65.6%); the most common sports and recreational activity varied by age: playground (65.2%) for children <=9 years; bicycling (26.7%) for 10-14-year-olds; basketball (45.3%) for 15-19-year-otds. Conclusions: National ED surveillance systems can provide useful information pertaining to prevention programs designed to reduce sports and recreational injuries resulting from violent behavior and unintentional causes. Sports Medicine Australia. Published by Elsevier Ltd.	Ctr Dis Control & Prevent, Off Stat & Programming, Natl Ctr Injury Prevent & Control, Atlanta, GA 30341 USA; Natl Ctr Injury Prevent & Control, Div Violence Prevent, Atlanta, GA USA; Natl Ctr Injury Prevent & Control, Div Unintent Injury Prevent, Atlanta, GA USA		Conn, JM (corresponding author), Ctr Dis Control & Prevent, Off Stat & Programming, Natl Ctr Injury Prevent & Control, 4770 Buford Hwy,MS-K59, Atlanta, GA 30341 USA.	jconn@cdc.gov	Bossarte, Robert/AAF-8571-2019				Alkon A, 1999, ARCH PEDIAT ADOL MED, V153, P1248, DOI 10.1001/archpedi.153.12.1248; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Boden Barry P, 2005, Curr Sports Med Rep, V4, P45; Boulton MJ, 1999, CHILD DEV, V70, P944, DOI 10.1111/1467-8624.00068; *CDCP, EST 1 JUL 2001 1 JUL; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P736; CHANG A, 1989, PEDIATRICS, V83, P272; Cohen L R, 1999, Adolesc Med, V10, P125; Conn JM, 2003, INJURY PREV, V9, P117, DOI 10.1136/ip.9.2.117; *CONS PROD SAF COM, 2002, NAT EL INJ SURV SYST; Cooper WO, 2000, ARCH PEDIAT ADOL MED, V154, P1134, DOI 10.1001/archpedi.154.11.1134; Craig WM, 2000, SCHOOL PSYCHOL INT, V21, P22, DOI 10.1177/0143034300211002; DAHLBERG L, 2005, VIOLENCE GLOBAL HLTH; Dusenbury L, 1997, J SCHOOL HEALTH, V67, P409, DOI 10.1111/j.1746-1561.1997.tb01286.x; Farrell AD, 2001, J CLIN CHILD PSYCHOL, V30, P451, DOI 10.1207/S15374424JCCP3004_02; FOX B, 2005, TEEN KILLED BASEBALL; Greenberg M. T., 1998, BLUEPRINTS VIOLENCE; Grossman DC, 1997, JAMA-J AM MED ASSOC, V277, P1605, DOI 10.1001/jama.277.20.1605; HAMMARSTROM A, 1994, SCAND J SOC MED, V22, P120, DOI 10.1177/140349489402200207; HUDLEY C, 1993, CHILD DEV, V64, P124, DOI 10.1111/j.1467-8624.1993.tb02899.x; Hudley C, 1996, AM J PREV MED, V12, P75, DOI 10.1016/S0749-3797(18)30239-3; HUDLEY C, 1995, APPL PREV PSYCHOL, V4, P185, DOI 10.1016/S0962-1849(05)80057-5; Leff SS, 2003, SCHOOL PSYCHOL REV, V32, P418; LENAWAY DD, 1992, AM J PREV MED, V8, P193, DOI 10.1016/S0749-3797(18)30831-6; Limbos MAP, 2003, J SCHOOL HEALTH, V73, P101, DOI 10.1111/j.1746-1561.2003.tb03582.x; Mattila VM, 2005, SCAND J PUBLIC HEALT, V33, P307, DOI 10.1080/14034940510005851; MCCARTHY B, 2004, PHILADELPHIA IN 0702; *NIH, 1992, C SPORTS INJ YOUTH S; Ranalli Dennis N, 2005, Curr Sports Med Rep, V4, P12; ROSINSKI J, 2004, BOSTON HERALD   0819, pO32; Ryan G, 2005, J INTERPERS VIOLENCE, V20, P132, DOI 10.1177/0886260504268605; Scala CD, 1997, J SCH HLTH, V6, P384; SEYMOUR A, 2004, ATLANTA J CONST 0612, pC1; Spoth RL, 2000, ARCH PEDIAT ADOL MED, V154, P1248, DOI 10.1001/archpedi.154.12.1248; *STAT REG, 2005, POL HOLD CHOCT 14 YE; Tenenbaum G, 1997, SPORT PSYCHOL, V11, P1, DOI 10.1123/tsp.11.1.1; TERRY RC, 1985, QUEST, V37, P27; THORTON T, 2002, BEST PRACTICES YOUTH; 2005, CHICAGO TRIBUNE 0223, P3; [No title captured]; [No title captured]; 2005, SUSPECTS SOUGHT TEEN	43	20	20	0	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2006	9	6					479	489		10.1016/j.jsams.2006.03.004			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	119TY	WOS:000243037800009	16621700				2022-02-06	
J	LeBlanc, J; de Guise, E; Feyz, M; Lamoureux, J				LeBlanc, Joanne; de Guise, Elaine; Feyz, Mitra; Lamoureux, Julie			Early prediction of language impairment following traumatic brain injury	BRAIN INJURY			English	Article						language impairment; communication; traumatic brain injury; prediction	CLOSED-HEAD INJURY; COGNITIVE RESERVE; ELDERLY-PATIENTS; WORKING-MEMORY; VERBAL FLUENCY; ACUTE-CARE; COMA; LEVEL; INTEGRATION; MORTALITY	Primary objective: This study investigated which factors collected early in the acute care setting (age, education, cerebral imaging, Glasgow Coma Scale score) would predict initial impairments of language comprehension and expression in patients with traumatic brain injury (TBI) of all severity. Methods and procedures: Results of language tests carried out during the patients' stay in an acute tertiary trauma centre were obtained. These tests measured performance in the areas of confrontation naming, auditory comprehension, semantic and letter category naming and comprehension of verbal absurdities. Data for the predictive variables were gathered by retrospective chart review. Stepwise multiple linear regressions were carried out on the predictive variables. Main outcomes and results: Education and TBI severity as measured with the GCS score were the most significant factors predicting language deficits in the acute care setting. Conclusions: These findings will serve to guide health care professionals in predicting prognosis for cognitive-communication deficits post-TBI and in planning for appropriate resources in speech-language pathology to meet these patients' needs.	McGill Univ, Montreal Gen Hosp, Hlth Ctr, Traumat Brain Injury Program, Quebec City, PQ H3G 1A4, Canada; Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada		LeBlanc, J (corresponding author), McGill Univ, Montreal Gen Hosp, Hlth Ctr, Traumat Brain Injury Program, Local D13-124,1650 Av Cedar, Quebec City, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca		Lamoureux, Julie/0000-0002-4986-2504			ADAMOVICH BB, 1985, COGNITIVE REHABILITA, P98; *AM SPEECH LANG HE, 1988, ASHA, V30, P29; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Baker H. J., 1965, DETROIT TEST LEARNIN; Balestreri M, 2004, J NEUROL NEUROSUR PS, V75, P161; BAULES KA, 1991, ARIZONA BATTERY COMM; BAYLES KA, 1983, CLIN APHASIOLOGY C P, P304; Bombardier CH, 1998, BRAIN INJURY, V12, P725, DOI 10.1080/026990598122124; Bopp KL, 2005, J GERONTOL B-PSYCHOL, V60, pP223, DOI 10.1093/geronb/60.5.P223; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); COOKE DL, 1995, J CLIN EXP NEUROPSYC, V17, P90, DOI 10.1080/13803399508406585; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; DEGUISE E, UNPUB PEDICTION BEHA; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Duff MC, 2002, BRAIN INJURY, V16, P773, DOI 10.1080/02699050210128870; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Frank EM, 1996, J MED SPEECH-LANG PA, V4, P81; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Goodglass H., 2001, BOSTON DIAGNOSTIC AP; GRUEN AK, 1990, J COMMUN DISORD, V23, P163, DOI 10.1016/0021-9924(90)90020-Y; Hagen C, 1981, TOP LANG DIS, V1, P73; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Harris OA, 2000, J TRAUMA, V49, P1076, DOI 10.1097/00005373-200012000-00017; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; Hartley Leila L., 1992, Seminars in Speech and Language, V13, P264, DOI 10.1055/s-2008-1064202; Henderson LW, 1998, APHASIOLOGY, V12, P901, DOI 10.1080/02687039808249458; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; HUX K, 1997, J MED SPEECH-LANG PA, V5, P181; Jiang JY, 2002, J NEUROTRAUM, V19, P869, DOI 10.1089/08977150260190456; KAKARIEKA A, 1994, ACTA NEUROCHIR, V129, P1, DOI 10.1007/BF01400864; Kaplan E, 1983, BOSTON NAMING TEST; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Lannoo E, 1998, INTENS CARE MED, V24, P236, DOI 10.1007/s001340050556; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; McDonald S., 1999, BRAIN DAM B; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; SHATZ RS, 1998, MED SPEECH LANGUAGE, P243; Snow P, 1997, BRAIN INJURY, V11, P409; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Spreen O., 1969, NEUROSENSORY CTR COM; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Sullivan A, 2001, SOCIOLOGY, V35, P893, DOI 10.1177/0038038501035004006; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; Wehman Paul, 1993, Brain Injury, V7, P31, DOI 10.3109/02699059309008154; Ylvisaker M, 2000, LANGUAGE INTERVENTIO, P745; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	73	20	20	1	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2006	20	13-14					1391	1401		10.1080/02699050601081927			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	130GF	WOS:000243787100009	17378231				2022-02-06	
J	Zhang, J; Zhang, L; Ye, YL; Fang, SH; Zhou, Y; Zhang, WP; Lu, YB; Wei, EQ				Zhang, Jun; Zhang, Lei; Ye, Yi-Lu; Fang, San-Hua; Zhou, Yu; Zhang, Wei-Ping; Lu, Yun-Bi; Wei, Er-Qing			Cysteinyl leukotriene receptors CysLT(1) and CysLT(2) are upregulated in acute neuronal injury after focal cerebral ischemia in mice	ACTA PHARMACOLOGICA SINICA			English	Article						cysteinyl leukotriene receptor; cerebral ischemia; neuronal injury; mRNA expression	TRAUMATIC BRAIN-INJURY; MOLECULAR-CLONING; ARACHIDONIC-ACID; CELL-DEATH; RATS; ANTAGONIST; EXPRESSION; TUMORS; IDENTIFICATION; PROTECTS	Aim: To determine whether cysteinyl leukotriene receptors (CysLT(1) and CysLT(2)) are upregulated in acute neuronal injury after focal cerebral ischemia in mice, and to confirm CysL(T)1 receptor localization. Methods: After permanent focal cerebral ischemia was induced by middle cerebral artery occlusion (MCAO), neurological deficits and neuron loss were determined at various time points within 48 h. The mRNA expressions of CysLT(1) and CysLT(2) receptors in the brain were analyzed by RT-PCR. CysLT(1) receptor localization was detected by double immunofluorescence. Results: Neurological deficits and neuron loss were found 6, 24 and 48 h after MCAO. The mRNA expressions of both CysLT(1) and CysLT(2) receptors were upregulated in the ischemic hemisphere 1, 24, and 48 h after MCAO with peaks at 24 h. The CysLT(1) receptor was selectively localized in neurons 24 h after MCAO. Conclusion: CysLT(1) and CysLT(2) receptors are upregulated in acute neuronal injury after focal cerebral ischemia, and the CysLT(1) receptor is localized in neurons after ischemia.	Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Peoples R China; Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310009, Peoples R China		Wei, EQ (corresponding author), Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310058, Peoples R China.	weieq2001@yahoo.com	Zhang, Lei/F-2603-2011				BLACK KL, 1986, ANN NEUROL, V19, P592, DOI 10.1002/ana.410190613; Brink C, 2003, PHARMACOL REV, V55, P195, DOI 10.1124/pr.55.1.8; CHU LS, 2003, ACTA PHARM SIN, V27, P282; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Dhillon HS, 1996, J NEUROTRAUM, V13, P781, DOI 10.1089/neu.1996.13.781; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Hu H, 2005, ACTA PHARMACOL SIN, V26, P685, DOI 10.1111/j.1745-7254.2005.00092.x; Hui YQ, 2001, J BIOL CHEM, V276, P47489, DOI 10.1074/jbc.M107556200; Kanaoka Y, 2004, J IMMUNOL, V173, P1503, DOI 10.4049/jimmunol.173.3.1503; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lynch KR, 1999, NATURE, V399, P789; Maekawa A, 2001, P NATL ACAD SCI USA, V98, P2256, DOI 10.1073/pnas.041624398; Mazzetti L, 2003, BRIT J PHARMACOL, V138, P707, DOI 10.1038/sj.bjp.0705087; Nothacker HP, 2000, MOL PHARMACOL, V58, P1601, DOI 10.1124/mol.58.6.1601; Ogasawara H, 2002, J BIOL CHEM, V277, P18763, DOI 10.1074/jbc.M109447200; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; OHTSUKI T, 1995, AM J PHYSIOL-HEART C, V268, pH1249, DOI 10.1152/ajpheart.1995.268.3.H1249; Rao AM, 1999, NEUROCHEM RES, V24, P1225, DOI 10.1023/A:1020916905312; Sarau HM, 1999, MOL PHARMACOL, V56, P657, DOI 10.1124/mol.56.3.657; Sheng WW, 2006, BIOCHEM BIOPH RES CO, V346, P19, DOI 10.1016/j.bbrc.2006.05.023; Shishido Y, 2001, PHARMACOL BIOCHEM BE, V69, P469, DOI 10.1016/S0091-3057(01)00572-X; SIMMET T, 1990, BRAIN RES, V515, P79, DOI 10.1016/0006-8993(90)90579-Z; Yonemori F, 1998, J CEREBR BLOOD F MET, V18, P1099, DOI 10.1097/00004647-199810000-00006; Yu GL, 2005, BRAIN RES, V1053, P116, DOI 10.1016/j.brainres.2005.06.046; Yu GL, 2005, PHARMACOLOGY, V73, P31, DOI 10.1159/000081072; ZENG LH, 2001, ACTA PHARMACOL SINIC, V36, P148; Zhang LH, 2003, ACTA PHARMACOL SIN, V24, P1241; Zhang RL, 2003, EXP NEUROL, V184, P746, DOI 10.1016/S0014-4886(03)00296-6; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088; Zhang WP, 2002, ACTA PHARMACOL SIN, V23, P871	31	20	24	1	2	BLACKWELL PUBLISHING	OXFORD	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND	1671-4083			ACTA PHARMACOL SIN	Acta Pharmacol. Sin.	DEC	2006	27	12					1553	1560		10.1111/j.1745-7254.2006.00458.x			8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Pharmacology & Pharmacy	108DU	WOS:000242221300005	17112408	Bronze			2022-02-06	
J	Tecco, S; Salini, V; Calvisi, V; Colucci, C; Orso, CA; Festa, F; D'Attilio, M				Tecco, S.; Salini, V.; Calvisi, V.; Colucci, C.; Orso, C. A.; Festa, F.; D'Attilio, M.			Effects of anterior cruciate ligament (ACL) injury on postural control and muscle activity of head, neck and trunk muscles	JOURNAL OF ORAL REHABILITATION			English	Article						anterior cruciate ligament (ACL) of the knee; body posture; head; neck and trunk muscles; stabilometry; surface electromyography	BODY POSTURE; PROPRIOCEPTION; POSITION; RUPTURE	The aim of the study was to evaluate the effects that an anterior cruciate ligament injury of the knee has on postural control and activity of neck, head and trunk muscles to investigate the existence of connections between the masticatory system and body posture. Surface electromyographic activity of the muscles at mandibular rest position, and during maximal voluntary clenching and posturometric and stabilometric measurements of 25 adult patients having pathology on the left knee were compared with a control non-pathological group. At rest, the patients showed a higher muscular activity of anterior temporalis, masseter, sternocleidomastoid and lower trapezius, compared with the control subjects (P < 0.05). At maximal voluntary clenching, the patients showed a lower muscular activity of the right anterior temporalis and masseter and a higher muscular activity of the lower trapezius, compared with the control subjects. For the stabilometric measurements, all the subjects showed a significant reduction in the postural centre of pressure path length during the test with eyes open and cotton rolls, compared with the test with eyes closed and mandibular rest position (P < 0.05). In addition, the patients showed a significant displacement of the postural centre of pressure in a forward direction (P < 0.05) and into the right side (P < 0.05), compared with the control subjects. Anterior cruciate ligament injury appears to be associated to a change in the activity of head, neck and trunk muscles and to a change in the position of the postural centre of pressure. Cotton rolls seem to improve the stability of the subject.	Univ G DAnnunzio, Dept Oral Sci, Chieti, Italy; Univ G DAnnunzio, Dept Orthopaedy & Traumatol, Chieti, Italy; Univ Aquila, Dept Orthopaedy & Traumatol, I-67100 Laquila, Italy		Tecco, S (corresponding author), Via Mainarde 26, I-65121 Pescara, Italy.	simtecc@tin.it	Salini, Vincenzo/ABB-5842-2021; Festa, Felice/AAC-2761-2022; Tecco, Simona/AAZ-2264-2020; D'ATTILIO, MICHELE/AAF-7920-2020	Salini, Vincenzo/0000-0002-8166-3062; Festa, Felice/0000-0002-5004-7945; Tecco, Simona/0000-0003-2986-1114; D'ATTILIO, MICHELE/0000-0003-1614-4204; Calvisi, Vittorio/0000-0002-8288-2291			BEARD DJ, 1993, J BONE JOINT SURG BR, V75, P311, DOI 10.1302/0301-620X.75B2.8444956; Beynnon BD, 1999, AM J SPORT MED, V27, P150, DOI 10.1177/03635465990270020601; Bracco P, 1998, CRANIO, V16, P252, DOI 10.1080/08869634.1998.11746065; CRAM JR, 1997, INTRO SURFACE ELECTR; DALY P, 1982, AM J ORTHOD DENTOFAC, V82, P157, DOI 10.1016/0002-9416(82)90494-8; Darnell M W, 1983, J Craniomandibular Pract, V1, P49; Donaldson S., 1990, CLIN EMG SURFACE REC, P143; DRENMAN HS, 1963, DENT PROG, V4, P43; FERR FWL, 1961, EXP NEUROL, V4, P134; GANDEVIA SC, 1996, HDB PHYSIOL 12, P128; GAUFFIN H, 1990, INT J SPORTS MED, V11, P73, DOI 10.1055/s-2007-1024766; GOLDIE PA, 1992, ARCH PHYS MED REHAB, V73, P348, DOI 10.1016/0003-9993(92)90008-K; GOLDSTEIN DF, 1984, J PROSTHET DENT, V52, P421, DOI 10.1016/0022-3913(84)90460-8; HAIRSTON LE, 1983, J PROSTHET DENT, V49, P271, DOI 10.1016/0022-3913(83)90514-0; Harner CD., 1992, J SPORT REHABIL, V1, P188; Hefti F, 1993, Knee Surg Sports Traumatol Arthrosc, V1, P226; HUGGARE JA, 1992, CRANIO, V10, P173, DOI 10.1080/08869634.1992.11677908; INGLIS JT, 1994, EXP BRAIN RES, V101, P159; Jerosch J, 1996, ARCH ORTHOP TRAUM SU, V115, P162, DOI 10.1007/BF00434546; JOHANSSON H, 1991, J ELECTROMYOGR KINES, V1, P158, DOI 10.1016/1050-6411(91)90032-Z; KILIARIDIS S, 1995, EUR J ORAL SCI, V103, P127, DOI 10.1111/j.1600-0722.1995.tb00013.x; KRAUS S, 1988, TMJ DISORDERS MANAGE, P380; Kuster MS, 1999, MED SCI SPORT EXER, V31, P368, DOI 10.1097/00005768-199903000-00003; Lund P, 1970, Scand J Dent Res, V78, P417; Lysholm M, 1998, SCAND J MED SCI SPOR, V8, P432; MacDonald PB, 1996, AM J SPORT MED, V24, P774, DOI 10.1177/036354659602400612; MARFURT CF, 1991, J COMP NEUROL, V303, P489, DOI 10.1002/cne.903030313; MCLEAN LF, 1973, J DENT RES, V52, P1041, DOI 10.1177/00220345730520050701; MINTZ VW, 1977, DIS TEMPOROMANDIBULA, P198; MINUTA H, 1992, CLIN J SPORT MED, V2, P235; ROCABADO M, 1984, ABNORMAL JAW MECH DI; Ruf S, 1997, ACTA ODONTOL SCAND, V55, P44, DOI 10.3109/00016359709091940; SHIAU YY, 1990, CRANIO, V8, P244, DOI 10.1080/08869634.1990.11678318; Shiraishi M, 1996, CLIN J SPORT MED, V6, P32, DOI 10.1097/00042752-199601000-00008; TREVOR B, 2001, MED SCI SPORTS EXERC, V33, P1253; TRIPODAKIS AP, 1995, J PROSTHET DENT, V73, P190, DOI 10.1016/S0022-3913(05)80161-1; URBANOWICZ M, 1991, CRANIO, V9, P174, DOI 10.1080/08869634.1991.11678365; van der Bilt A, 2001, EUR J ORAL SCI, V109, P160, DOI 10.1034/j.1600-0722.2001.00030.x; WINTER D, 1996, BIOMECHANICS CONTROL, P5	39	20	21	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-182X	1365-2842		J ORAL REHABIL	J. Oral Rehabil.	AUG	2006	33	8					576	587		10.1111/j.1365-2842.2005.01592.x			12	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	059UO	WOS:000238757900004	16856955				2022-02-06	
J	Geeraerts, T; Ract, C; Tardieu, M; Fourcade, O; Mazoit, JX; Benhamou, D; Duranteau, J; Vigue, B				Geeraerts, Thomas; Ract, Catherine; Tardieu, Marc; Fourcade, Olivier; Mazoit, Jean-Xavier; Benhamou, Dan; Duranteau, Jacques; Vigue, Bernard			Changes in cerebral energy metabolites induced by impact-acceleration brain trauma and hypoxic-hypotensive injury in rats	JOURNAL OF NEUROTRAUMA			English	Article						brain metabolism; hypoxia-hypotension; microdialysis; rat; secondary insult; traumatic brain injury	LASER-DOPPLER FLOWMETRY; MITOCHONDRIAL DYSFUNCTION; HEAD-INJURY; BLOOD-FLOW; MICRODIALYSIS; MODEL; ACID; GLYCOLYSIS; DEPRESSION; SEVERITY	The aim of this study was to describe, in rats, brain energy metabolites changes after different levels of head trauma (T) complicated by hypoxia-hypotension (HH). Male Sprague Dawley rats (n = 7 per groups) were subjected to T by impact-acceleration with 450-g weight drop from 1.50 or 1.80 m (T 1.50 or T 1.80), or to a 15-min period of HH (controlled hemorrhage to mean arterial pressure [MAP] of 40 mm Hg, and mechanical ventilation with N-2 90%/O-2 10%), or to their association (T followed by HH). Invasive MAP, intraparenchymental intracranial pressure (ICP), and cerebral blood flow (CBF using Laser Doppler flowmetry) were recorded during the 5 post-traumatic hours. Cerebral microdialysis was used to measure each hour interstitial brain glucose, lactate, pyruvate, and glutamate. For the entire period, the levels of cerebral glucose, pyruvate, and glutamate were not statistically different between groups. In addition, there were no differences associated with the lactate-glucose ratio. Lactate was significantly higher overtime only in T 1.80 + HH group (p < 0.001 vs. every other groups). The lactate-pyruvate ratio increased with trauma level, and was significantly different vs. sham for the entire study period in T 1.50 + HH, in T 1.80, and in T 1.80 + HH. There was no correlation between CBF variations and the lactate-pyruvate ratio (r(2) = 0.00001). The cerebral perfusion pressure was greater than 70 mm Hg in all groups. The prolonged post-traumatic impairment in brain energy metabolism may be related to traumatic brain injury (TBI) severity. It became worse when T was complicated by HH, but was not related to changes in CBF.	Fac Med Paris Sud, INSERM, Lab Immunol Antivirale Syst & Cerebrale, EMI 0109, F-94276 Le Kremlin Bicetre, France; Fac Med Paris Sud, Lab UPRES 3540, F-94276 Le Kremlin Bicetre, France; Hop Bicetre, Dept Anesthesiol & Intens Care, F-94276 Le Kremlin Bicetre, France; AP HP, Paris, France		Geeraerts, T (corresponding author), Fac Med Paris Sud, INSERM, Lab Immunol Antivirale Syst & Cerebrale, EMI 0109, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	thgeeraerts@hotmail.com	Benhamou, Dan/ABG-7935-2021				ANDERSEN BJ, 1992, BRAIN RES, V585, P184, DOI 10.1016/0006-8993(92)91205-S; Anderson CM, 2002, J NEUROSCI, V22, P9203; Beaumont A, 2002, ACT NEUR S, V81, P217; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Carre E, 2004, J NEUROSCI METH, V140, P23, DOI 10.1016/j.jneumeth.2004.04.037; CHANCE B, 1963, J BIOL CHEM, V238, P418; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; DIRNAGL U, 1989, J CEREBR BLOOD F MET, V9, P589, DOI 10.1038/jcbfm.1989.84; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; FUKUDA O, 1995, NEUROSURGERY, V36, P358, DOI 10.1227/00006123-199502000-00016; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; Hillered L, 1999, ACT NEUR S, V75, P3; Holtzer S, 2001, CRIT CARE MED, V29, P1609, DOI 10.1097/00003246-200108000-00018; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Jones DA, 2000, J NEUROCHEM, V75, P1703, DOI 10.1046/j.1471-4159.2000.0751703.x; KAWAMATA T, 1992, J CEREBR BLOOD F MET, V12, P12, DOI 10.1038/jcbfm.1992.3; KINOSHITA Y, 1970, JPN J PHARMACOL, V20, P599, DOI 10.1254/jjp.20.599; Kristian T, 2004, CELL CALCIUM, V36, P221, DOI 10.1016/j.ceca.2004.02.016; KUHR WG, 1988, J CEREBR BLOOD F MET, V8, P130, DOI 10.1038/jcbfm.1988.17; MAGISTRETTI PJ, 2003, FUNDAMENTAL NEUROSCI, P339; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; NAWASHIRO H, 1995, J NEUROTRAUM, V12, P189, DOI 10.1089/neu.1995.12.189; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Ract C, 2001, J NEUROTRAUM, V18, P1247, DOI 10.1089/089771501317095287; SIESJO BK, 1985, PROG BRAIN RES, V63, P121; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; UNGERSTEDT U, 1991, J INTERN MED, V230, P365, DOI 10.1111/j.1365-2796.1991.tb00459.x; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Yamamoto M, 1999, J NEUROTRAUM, V16, P487, DOI 10.1089/neu.1999.16.487	36	20	20	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2006	23	7					1059	1071		10.1089/neu.2006.23.1059			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	069UG	WOS:000239473200002	16866619				2022-02-06	
J	Lellouche, F; Qader, S; Taille, S; Lyazidi, A; Brochard, L				Lellouche, Francois; Qader, Siham; Taille, Solenne; Lyazidi, Aissam; Brochard, Laurent			Under-humidification and over-humidification during moderate induced hypothermia with usual devices	INTENSIVE CARE MEDICINE			English	Article; Proceedings Paper	17th Annual Congress of the European-Society-of-Intensive-Care-Medicine	OCT 10-13, 2004	Berlin, GERMANY	European Soc Intens Care Med		adverse effects; heated humidifiers; heat and moisture exchangers; humidification devices; hypothermia; mechanical ventilation	TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; MOISTURE EXCHANGERS; THERAPEUTIC HYPOTHERMIA; MECHANICAL VENTILATION; HEATED HUMIDIFIERS; CARDIAC-ARREST; INSPIRED GAS; TEMPERATURE; HUMIDITY	Objective: In mechanically ventilated patients with induced hypothermia, the efficacy of heat and moisture exchangers and heated humidifiers to adequately humidify the airway is poorly known. The aim of the study was to assess the efficacy of different humidification devices during moderate hypothermia. Design: Prospective, cross-over randomized study. Settings: Medical Intensive Care Unit in a University Hospital. Patients and participants: Nine adult patients hospitalized after cardiac arrest in whom moderate hypothermia was induced (33 degrees C for 24 h). Interventions: Patients were ventilated at admission (period designated "normothermia") with a heat and moisture exchanger, and were randomly ventilated during hypothermia with a heat and moisture exchanger, a heated humidifier, and an active heat and moisture exchanger. Measurements and results: Core temperature, inspired and expired gas absolute and relative humidity were measured. Each system demonstrated limitations in its ability to humidify gases in the specific situation of hypothermia. Performances of heat and moisture exchangers were closely correlated to core temperature (r(2) = 0.84). During hypothermia, heat and moisture exchangers led to major under-humidification, with absolute humidity below 25 mgH(2)O/l. The active heat and moisture exchanger slightly improved humidification. Heated humidifiers were mostly adequate but led to over-humidification in some patients, with inspiratory absolute humidity higher than maximal water content at 33 degrees C with a positive balance between inspiratory and expiratory water content. Conclusions: These results suggest that in the case of moderate hypothermia, heat and moisture exchangers should be used cautiously and that heated humidifiers may lead to over-humidification with the currently recommended settings.	Univ Paris 12, Hop Henri Mondor, APHP, Serv Reanimat Med,INSERM,U651, F-94010 Creteil, France		Brochard, L (corresponding author), Univ Paris 12, Hop Henri Mondor, APHP, Serv Reanimat Med,INSERM,U651, 51 Av Marechal de Lattre de Tassigny, F-94010 Creteil, France.	laurent.brochard@hmn.ap-hop-paris.fr	Lyazidi, Aissam/ABC-2618-2021; Lellouche, Francois/AAB-9014-2019	Lyazidi, Aissam/0000-0001-5899-0164; 			*AM ASS RESP CAR, 1992, RESP CARE, V37, P887; Bernard SA, 2003, CRIT CARE MED, V31, P2041, DOI 10.1097/01.CCM.0000069731.18472.61; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Boots RJ, 1997, CRIT CARE MED, V25, P1707, DOI 10.1097/00003246-199710000-00021; BRANSON RD, 1993, CHEST, V104, P1800, DOI 10.1378/chest.104.6.1800; Campbell R S, 2000, Respir Care, V45, P306; CHALON J, 1979, CAN ANAESTH SOC J, V26, P361, DOI 10.1007/BF03006448; COHEN IL, 1988, CRIT CARE MED, V16, P277, DOI 10.1097/00003246-198803000-00013; DREYFUSS D, 1995, AM J RESP CRIT CARE, V151, P986; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jaber S, 2004, ANESTHESIOLOGY, V100, P782, DOI 10.1097/00000542-200404000-00006; Jiang JY, 2000, J NEUROSURG, V93, P718; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kimura A, 2002, CRIT CARE MED, V30, P1499, DOI 10.1097/00003246-200207000-00017; Lacherade JC, 2005, AM J RESP CRIT CARE, V172, P1276, DOI 10.1164/rccm.200408-1028OC; Lellouche F, 2004, AM J RESP CRIT CARE, V170, P1073, DOI 10.1164/rccm.200309-1245OC; Lellouche F, 2003, INTENS CARE MED, V29, pS169; LELLOUCHE L, 2003, AM J RESP CRIT CARE, V167, pA909; Maggiore SM, 2003, AM J RESP CRIT CARE, V167, P1215, DOI 10.1164/rccm.200203-195OC; MARTIN C, 1990, CHEST, V97, P144, DOI 10.1378/chest.97.1.144; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MIYAO H, 1992, CRIT CARE MED, V20, P674, DOI 10.1097/00003246-199205000-00021; NOGUCHI H, 1973, BRIT J ANAESTH, V45, P844, DOI 10.1093/bja/45.8.844; Nolan JP, 2003, CIRCULATION, V108, P118, DOI 10.1161/01.CIR.0000079019.02601.90; PETERSON BD, 1998, HUMIDIFICATION CURRE, P243; Polderman KH, 2004, INTENS CARE MED, V30, P556, DOI 10.1007/s00134-003-2152-x; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Qiu Wu-si, 2005, Chin J Traumatol, V8, P27; Rathgeber J, 2002, INTENS CARE MED, V28, P731, DOI 10.1007/s00134-002-1275-9; Ricard JD, 1999, CHEST, V115, P1646, DOI 10.1378/chest.115.6.1646; Ricard JD, 2000, AM J RESP CRIT CARE, V161, P104, DOI 10.1164/ajrccm.161.1.9902062; ROUSTAN JP, 1992, INTENS CARE MED, V18, P97, DOI 10.1007/BF01705040; SHELLY MP, 1988, INTENS CARE MED, V14, P1, DOI 10.1007/BF00254114; Sterz Fritz, 2003, Curr Opin Crit Care, V9, P205, DOI 10.1097/00075198-200306000-00006; Taille S, 2001, INTENS CARE MED, V27, pS211; Taniguchi T, 2003, CLIN DIAGN LAB IMMUN, V10, P940, DOI 10.1128/CDLI.10.5.940-943.2003; Thomachot L, 1998, CHEST, V114, P1383, DOI 10.1378/chest.114.5.1383; Thomachot L, 1999, CRIT CARE MED, V27, P923, DOI 10.1097/00003246-199905000-00026; Todd DA, 2001, J PAEDIATR CHILD H, V37, P489, DOI 10.1046/j.1440-1754.2001.00750.x; TODD TRJ, 1989, AM REV RESPIR DIS, V140, P1585, DOI 10.1164/ajrccm/140.6.1585; TSUDA T, 1977, BRIT J ANAESTH, V49, P965, DOI 10.1093/bja/49.10.965; WILKES AR, 1998, HUMIDIFICATION CURRE, P261; Williams R, 1996, CRIT CARE MED, V24, P1920, DOI 10.1097/00003246-199611000-00025; Williams R B, 1998, Respir Care Clin N Am, V4, P215; Wu XR, 2005, J TRAUMA, V59, P291, DOI 10.1097/01.ta.0000179445.76729.2c; 2005, HLTH DEVICES, V34, P46	48	20	23	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	JUL	2006	32	7					1014	1021		10.1007/s00134-006-0192-8			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	056CJ	WOS:000238498400010	16791663				2022-02-06	
J	Lefebvre, H; Levert, MJ				Lefebvre, Helene; Levert, Marie Josee			Breaking the news of traumatic brain injury and incapacities	BRAIN INJURY			English	Article						traumatic brain injury (TBI); breaking the news; disclosure; information	BAD-NEWS; PHYSICIANS; FAMILIES; PARENTS; CANCER; CARE	Primary objective: This paper presents research results regarding disclosure of traumatic brain injury (TBI) diagnosis and resulting deficits of a study aiming to investigate the experiences of individuals who had sustained a TBI, their families, the physicians and health professionals involved, from the critical care episodes and subsequent rehabilitation. Research design: Semi-structured interviews were conducted with individuals who had sustained a TBI (n = 8) and their families (n = 8) as well as with the health professionals (or service providers) (n = 22) and physicians (n = 9) who provided them care. Main outcomes and results: Results revealed that the quality of the disclosure is strongly influenced by the medical uncertainty surrounding the TBI and the difficulties of healthcare professionals in dealing with the family's emotions. Conclusions: Delivering bad news is always difficult, but it is possible to make this harrowing experience easier and, in so doing, enhance patient and family resilience.	Univ Montreal, Fac Nursing, Montreal, PQ H3C 3J7, Canada; Montreal Ctr Interdisciplinary Res Rehabil, CRIR, Montreal, PQ, Canada; Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; GIRAFE, Montreal, PQ, Canada		Lefebvre, H (corresponding author), Univ Montreal, Fac Nursing, Downtown Stn,POB 6128, Montreal, PQ H3C 3J7, Canada.	helene.lefebvre@umontreal.ca					Ahmann E, 1998, Pediatr Nurs, V24, P554; Baile W F, 2000, Oncologist, V5, P302, DOI 10.1634/theoncologist.5-4-302; BOLDUC M, 1996, THESIS U MONTREAL QU; BOUCHARD JM, 1994, DEFICIENCE INCAPACIT; BOUCHARD JM, 1999, APPRENTISSAGE SOCIAL, V19, P48; BOUCHARD JM, 1995, LINTEGRATION PERSONN, P379; Boule R, 2005, COMMUNICATION PROFES, P267; BRIERE N, 1996, THESIS U MONTREAL QU; BRZUSTOWSKI M, LANNONCE HANDICAP GR; BURY JA, 1988, ED SANTE CONCEPT ENJ; Campbell EM, 1998, BEHAV MED, V24, P73, DOI 10.1080/08964289809596383; COHADON F, 2002, TRAUMATISES CRANIENS; Cohen M H, 1993, West J Nurs Res, V15, P77, DOI 10.1177/019394599301500106; COHEN MH, 1995, QUAL HEALTH RES, V5, P63, DOI 10.1177/104973239500500105; Cyrulnik B., 2002, MERVEILLEUX MALHEUR; Davies R, 2003, CHILD CARE HLTH DEV, V29, P77, DOI 10.1046/j.1365-2214.2003.00316.x; DELLORTO AE, 2000, HEAD INJURY FAMILY L; DENORMANDIE P, 1999, ESPACE ETHIQUE MISSI; Fallowfield L, 2004, LANCET, V363, P312, DOI 10.1016/S0140-6736(03)15392-5; Farrell M, 2001, J ADV NURS, V36, P765, DOI 10.1046/j.1365-2648.2001.02042.x; FISHER GN, 1994, RESSORT INVISIBLE; Frenisy MC, 1999, ANN MED-PSYCHOL, V157, P159; Frosch S, 1997, BRAIN INJURY, V11, P891; GADOURY M, 1999, CADRE REFERENCE CLIN; GENDRON S, 2000, THESIS U MONTREAL QU; Girgis A, 1998, BEHAV MED, V24, P53, DOI 10.1080/08964289809596381; Girgis A, 1999, BEHAV MED, V25, P69, DOI 10.1080/08964289909595739; Glasser B., 1967, DISCOVERY GROUNDED T; GUBA LG, 1989, FOURTH GENERATION EV; Habermas J., 1987, THEORIE LAGIR COMMUN, VI et II; Horowitz R., 1998, FAMILIES SYSTEMS HLT, V16, P71; KALUBI JC, 1998, INNOVATIONS APPRENTI, P97; Kim MK, 1999, LARYNGOSCOPE, V109, P1064, DOI 10.1097/00005537-199907000-00010; Klein S, 2000, EUR J CANCER, V36, P273; KRIER M, 1997, HANDICAPS INADAPTATI, V75, P33; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; LEFEBVRE H, 2005, PARTENARIAT FAMILLES; Lefebvre H., 2002, FAMILLE SITUATION HA, P27; Lefebvre H., 2005, FRONTIERES, V17, P77; LUCYSHYN JM, 1996, CHILDREN ACQUIRED BR, P99; Maguire P, 1998, EUR J SURG ONCOL, V24, P188, DOI 10.1016/S0748-7983(98)92929-8; Merton R. K., 1990, FOCUSED INTERVIEW MA; Mishel M H, 1997, Annu Rev Nurs Res, V15, P57; MUCCHIELLI A, 2004, DICT METHODES QUALIT; Nolte ML, 1999, DISSERTATION ABSTR I, V60, P4900; Pearson D, 1999, CHILD CARE HLTH DEV, V25, P3, DOI 10.1046/j.1365-2214.1999.00086.x; Pelchat D, 2001, Paediatr Child Health, V6, P365; PELCHAT D, 1996, THESIS U MONTREAL QU; PELCHAT D, 2001, REV INFIRMIERE QUEBE, V9, P26; PELCHAT D, 1994, CAHIERS LAFREE, V6, P81; PELCHAT D, 2002, PRAT PSYCHOL, V1, P41; PELCHAT D, 2000, PROCESSUS LANNOUNCE; Pires A., 1997, RECHERCHE QUALITATIV, P113; PIRES A, 1997, RECHERCHE QUALITATIV, P3; POUPART J., 1997, RECHERCHE QUALITATIV, P173; POURTOIS JP, 1999, LEDUCATION POSTMODER; Ptacek J T, 2000, Crit Care Nurs Q, V23, P51; Ptacek JT, 1999, SUPPORT CARE CANCER, V7, P113, DOI 10.1007/s005200050240; SAINTCHARLES D, 1998, INNOVATIONS APPRENTI, P97; SANDRINEBERTHON B, 2000, LEDUCATION PATIENT S, P7; SCHERZER BP, 1995, LEVEIL, V1, P3; SCHUMACKER KL, 1994, IMAGE J NURSING SCHO, V26, P72; Sohlberg MM, 2001, J HEAD TRAUMA REHAB, V16, P498, DOI 10.1097/00001199-200110000-00008; Sohlberg MM, 1998, BRAIN INJURY, V12, P333; TEASDALE G, 1974, LANCET, V2, P81; TOCHON Francois V., 1996, REV SCI ED, V22, P467, DOI DOI 10.7202/031889AR; VANDERMAREN JM, 1995, METHODES RECHERCHE L	67	20	21	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUN	2006	20	7					711	718		10.1080/02699050600744244			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	062LV	WOS:000238947200005	16809203				2022-02-06	
J	Connelly, J; Chell, S; Tennant, A; Rigby, AS; Airey, CM				Connelly, J.; Chell, S.; Tennant, A.; Rigby, A. S.; Airey, C. M.			Modelling 5-year functional outcome in a major traumatic injury survivor cohort	DISABILITY AND REHABILITATION			English	Article						five year outcome; disability; traumatic brain injury; major traumatic injury	BRAIN-INJURY; MULTIPLE INJURIES; FOLLOW-UP; REHABILITATION; PREDICTION; DISABILITIES; IMPAIRMENTS; PREVALENCE	Aim. To estimate associations between possible predictors of functional disability outcome at 5 years in a working adult population cohort of survivors of major traumatic injury and to develop a prognostic model of outcome. Design. Population based retrospective cohort study. Population. Persons who had experienced major traumatic injury (Injury Seventy Score > 15) in the area of the former Yorkshire Regional Health Authority during the period 30 September 1988 to 1 October 1989 and who survived for 5 years (average 5.3 years). Methods. The same interviewer saw each survivor at their home and used the OPCS Adult Disability Schedule to ascertain levels of functional disability. Disability scores for each survivor were then combined in accordance with the OPCS guidance to calculate a level of disability between 0 ( no disability) to 10 ( maximum disability). The OPCS level was then dichotomised with a cut-point at 4/5. Possible predictor and confounding variables from pre-injury, injury and post-injury periods were modelled in a logistic regression to identify those that predicted outcome level. Two reduced models were developed to allow early prognosis of late outcome. Results. The full model correctly classified 91% of observed outcomes. Inpatient length of stay OR 1.031 (95% CI 1.014,1.048) per day predicted poorer 5-year outcome; Glasgow Coma Score OR 0.790(0.629,0.992) per 1 point increase; stay in Intensive Care Unit OR 0.931 (0.877,0.987) per day; attainment of degree-level education OR 0.014 (0.000,0.707); single civil status OR 0.110 (0.013,0.908); being taken initially to a hospital with a neurosurgical facility OR 0.064(0.010,0.420); being in paid work during the 2 weeks before index injury OR 0.093(0.009,0.969) predicted better 5-year disability outcome. Two reduced models were constructed that included a simple set of variables, one of these models excluded any rehabilitation variables but still correctly classified 85% of the observed outcomes. Conclusion. As well as level of traumatic brain injury (TBI) and total inpatient stay, Pre-injury educational attainment and employment, civil status, immediate care in a hospital with a neurosurgical facility and stay in an Intensive Care Unit determined 5-year outcome. It is possible to efficiently predict outcome at an early stage. Previous work on predictors of disablement have suffered from large selection and attrition biases.	Univ Reading, Sch Hlth & Social Care, Inst Hlth Sci, Reading RG6 1HY, Berks, England; Univ Leeds, Nuffield Inst Hlth, Leeds LS2 9JT, W Yorkshire, England; Univ Leeds, Rehabil Res Unit, Leeds LS2 9JT, W Yorkshire, England; Univ Sheffield, Med Stat Unit, Sheffield S10 2TN, S Yorkshire, England		Connelly, J (corresponding author), Univ Reading, Sch Hlth & Social Care, Inst Hlth Sci, Bulmershe Court, Reading RG6 1HY, Berks, England.	j.b.connelly@reading.ac.uk					Airey CM, 2001, DISABIL REHABIL, V23, P509; AIREY CM, 1995, INJURY, V26, P25, DOI 10.1016/0020-1383(95)90548-C; ANDERSON EM, 2000, ARCH PHYS MED REHAB, V81, P515; Anke AGW, 1997, J TRAUMA, V42, P54, DOI 10.1097/00005373-199701000-00010; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Asikainen I, 1998, BRAIN INJURY, V12, P95, DOI 10.1080/026990598122737; Braithwaite IJ, 1998, INJURY, V29, P55; *COMM TRAUM, 1993, RES OPT CAR INJ PAT; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; DAY RJ, 1994, MED J AUSTRALIA, V160, P675, DOI 10.5694/j.1326-5377.1994.tb125903.x; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; Fleming J, 1999, BRAIN INJURY, V13, P417; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; GRUNDY E, 1998, DISABILITY GREAT BRI; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Hoofien D, 2001, BRAIN INJURY, V15, P189; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Lehmann U, 1999, EUR J SURG, V165, P1116, DOI 10.1080/110241599750007603; Martin J., 1988, PREVALENCE DISABILIT; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCullagh S, 2001, BRAIN INJURY, V15, P489, DOI 10.1080/02699050010007353; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; *ROY COLL SURG ENG, 1988, REP WORK PART MAN PA; Selvin S., 1996, STAT ANAL EPIDEMIOLO; Townsend P.N. Davidson, 1992, INEQUALITIES HLTH BL; VANDERSLUIS CK, 1995, J TRAUMA, V38, P681, DOI 10.1097/00005373-199505000-00001; VanDongen S, 1993, Rehabil Nurs, V18, P76; VARZQUEZ MG, 1996, INFECT CRITICAL CARE, V41, P326; Zafonte RD, 1996, AM J PHYS MED REHAB, V75, P364, DOI 10.1097/00002060-199609000-00012; 1980, OFFICE POPULATIONS C	31	20	21	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.	MAY	2006	28	10					629	636		10.1080/09638280500276513			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	041QO	WOS:000237471000006	16690576				2022-02-06	
J	Rosenbek, JC; Rodriguez, AD; Hieber, B; Leon, SA; Crucian, GP; Ketterson, TU; Ciampitti, M; Singletary, F; Heilman, KM; Rothi, LJG				Rosenbek, John C.; Rodriguez, Amy D.; Hieber, Bethany; Leon, Susan A.; Crucian, Gregory P.; Ketterson, Timothy U.; Ciampitti, Maribel; Singletary, Floris; Heilman, Kenneth M.; Rothi, Leslie J. Gonzalez			Effects of two treatments for aprosodia secondary to acquired brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						aprosodia; cognitive-linguistic treatment; dysarthria; emotional prosody; expressive; imitative treatment; memory; receptive; rehabilitation; right-hemisphere damage; traumatic brain injury	RIGHT-HEMISPHERE; INTERVENTIONS; STROKE	Expressive aprosodia is an impaired ability to change one's voice to express common emotions such as joy, anger, and sadness. Individuals with aprosodia speak in a flat, unemotional voice that often results in miscommunicated emotional messages. This study investigated two conceptually based treatments for expressive aprosodia: imitative treatment and copitive-linguistic treatment. Five women and nine men with expressive aprosodia following right-hemisphere brain damage received the treatments in two phases I month apart in random order. Treatment was received 3 to 4 days a week for a total of 20 sessions each phase. As the outcome measure, sentences that elicited treated (happy, angry, sad, neutral) and untreated (fear) emotional tones of voice were administered during baseline, prior to treatment sessions, following treatment termination, and at 1- and 3-month followups. Effect sizes indicated that treatment effects were modest to substantial and that 12 participants responded to at least one treatment. Four responsive participants who were available for follow-up showed benefit at I and 3 months posttreatment. Most visual and statistical analyses were congruent.	Univ Florida, Dept Commun Disorders, Gainesville, FL 32611 USA; Malcom Randall VA Med Ctr, Dept Vet Affairs Rehabil Res, Gainesville, FL USA; Malcom Randall VA Med Ctr, Dev Brain Rehabil Res Ctr, Gainesville, FL USA; VAMC, Neurol Serv, Gainesville, FL USA; Univ Florida, Dept Commuicat Sci & Disorders, Gainesville, FL USA; Univ Florida, Dept Neurol, Gainesville, FL USA; Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL USA; Univ Florida, Hlth Sci Ctr, Jacksonville, FL 32209 USA; Univ Florida, Brooks Ctr Rehabil Studies, Gainesville, FL USA; VAMC, Ctr Geriatr Res Educ & Clin, Gainesville, FL USA		Rosenbek, JC (corresponding author), Univ Florida, Dept Commun Disorders, POB 100174,101 S Newell Dr,Room 2150, Gainesville, FL 32611 USA.	jrosenbe@phhp.ufl.edu	Rodriguez, Amy/F-8332-2011; Rodriguez, Amy/ABH-8007-2020		PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [P50 DCO3888] Funding Source: Medline		Anderson J., 1999, J INT NEUROPSYCH SOC, V5, P157; Benton A.L., 1983, CONTRIBUTIONS NEUROP; Bowers D., 1998, FLORIDA AFFECT BATTE; Boyd LA, 2001, NEUROSCI LETT, V298, P65, DOI 10.1016/S0304-3940(00)01734-1; Cohen J., 2013, STAT POWER ANAL BEHA; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Leon SA, 2005, J REHABIL RES DEV, V42, P93, DOI 10.1682/JRRD.2003.12.0182; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Robey RR, 1999, APHASIOLOGY, V13, P445, DOI 10.1080/026870399402028; Rosenbek JC, 2004, J INT NEUROPSYCH SOC, V10, P786, DOI 10.1017/S135561770410502X; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; Stringer AY, 1996, BRAIN INJURY, V10, P583, DOI 10.1080/026990596124151; TRYON WW, 1982, J APPL BEHAV ANAL, V15, P423, DOI 10.1901/jaba.1982.15-423; TUCKER DM, 1977, NEUROLOGY, V27, P947, DOI 10.1212/WNL.27.10.947; van der Merwe A, 1997, COMSIG '97 - PROCEEDINGS OF THE 1997 SOUTH AFRICAN SYMPOSIUM ON COMMUNICATIONS AND SIGNAL PROCESSING, P1, DOI 10.1109/COMSIG.1997.629970; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; [No title captured]	17	20	20	2	11	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.	MAY-JUN	2006	43	3					379	390		10.1682/JRRD.2005.01.0029			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	090CR	WOS:000240928700009	17041823	Bronze			2022-02-06	
J	Degeneffe, CE; Lynch, RT				Degeneffe, CE; Lynch, RT			Correlates of depression in adult siblings of persons with traumatic brain injury	REHABILITATION COUNSELING BULLETIN			English	Article							MENTAL-RETARDATION; SOCIAL SUPPORT; FAMILY-MEMBER; HEAD-INJURY; STRESS; INDIVIDUALS; PERCEPTIONS; PARENTS; ILLNESS; BURDEN	Using Pearlin's stress process model, this study examined correlates of depression in 170 adult siblings of persons with traumatic brain injury (TBI). Approximately 39% of adult sibling participants evinced Center for Epidemiologic Studies-Depression (CES-D; Radloff, 1977) scores indicating clinically significant depressive symptoms. Background characteristics found to be related to higher ratings of depression included being female and history of a pre-TBI depressive episode. In addition, results indicated that perceptions of more restrictions in valued family activities and less accessibility to social support were related to higher ratings of depression. Contrary to study hypotheses, an inverse relationship was found between subjective caregiving burden and depression. Practice and research implications of these findings are discussed.	San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, San Diego, CA 92108 USA; Univ Wisconsin, Dept Rehabil Psychol & Special Educ, Madison, WI 53706 USA		Degeneffe, CE (corresponding author), San Diego State Univ, Dept Adm Rehabil & Postsecondary Educ, 3590 Camino Rio N, San Diego, CA 92108 USA.	cdegeneffe@csufresno.edu					ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Bergmann J, 2001, Z SOZIOL, V30, P1; *BRAIN INJ ASS INC, 2000, COSTS CAUS TRAUM BRA; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; Cutrona C, 1987, ADV PERSONAL RELATIO, V1, P33; Degeneffe CE, 2001, HEALTH SOC WORK, V26, P257, DOI 10.1093/hsw/26.4.257; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Elliott TR, 1999, REHABIL PSYCHOL, V44, P104, DOI 10.1037/0090-5550.44.1.104; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; GATZ M, 1990, PSYCHOL AGING, V5, P284, DOI 10.1037/0882-7974.5.2.284; Gill D. J., 2000, REHABILITATION NURSI, V25, P48, DOI [10.1002/j.2048-7940.2000.tb01862.x, DOI 10.1002/J.2048-7940.2000.TB01862.X]; Gray J.M, 1994, CLIN REHABIL, V8, P188, DOI [10.1177/026921559400800302, DOI 10.1177/026921559400800302, DOI 10.1080/09602010902949207]; GRIFFITHS DL, 1994, FAM RELAT, V43, P221, DOI 10.2307/585326; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Harris JKJ, 2001, BRAIN INJURY, V15, P223; HAUSER RM, 2004, WISCONSIN LONGITUDIN; HOLROYD J, 1976, AM J MENT DEF, V80, P431; HOLROYD J, 1986, J CLIN PSYCHOL, V42, P552, DOI 10.1002/1097-4679(198607)42:4<552::AID-JCLP2270420403>3.0.CO;2-8; HOLROYD J, 1985, QUESTIONNAIRE RESOUR; HORWITZ AV, 1993, J MARRIAGE FAM, V55, P623, DOI 10.2307/353343; INANAMI M, 1980, JAPANESE J SPECIAL E, V18, P33; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; KOSCIULEK JF, 1993, THESIS U WISCONSIN M; KREUTZER JS, 1992, ARCH PHYS MED REHAB, V73, P771; Leathem J, 1996, BRAIN INJURY, V10, P27; MARASCUILO L. A., 1983, MULTIVARIATE STAT SO; *NIH, 1999, REP NIH CONS DEV C R; Orsillo SM, 1993, J HEAD TRAUMA REHAB, V8, DOI [10.1097/00001199-199303000-00010, DOI 10.1097/00001199-199303000-00010]; PEARLIN LI, 1989, J HEALTH SOC BEHAV, V30, P241, DOI 10.2307/2136956; PEARLIN LI, 1990, GERONTOLOGIST, V30, P583, DOI 10.1093/geront/30.5.583; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Pruchno RA, 1996, FAM RELAT, V45, P318, DOI 10.2307/585504; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548; SELTZER GB, 1991, FAM RELAT, V40, P310, DOI 10.2307/585017; Seltzer M. M., 1996, AGING FAMILIES ADULT; SELTZER MM, 1989, AM BEHAV SCI, V33, P107, DOI 10.1177/0002764289033001010; Seltzer MM, 1997, FAM RELAT, V46, P395, DOI 10.2307/585099; SPRIGGS VT, 1998, PROMOTING CULTURAL C, P149; STEBBINS P, 1997, AUSTR J REHABILITATI, V3, P30; Willer B, 1999, ARCH PHYS MED REHAB, V80, P399, DOI 10.1016/S0003-9993(99)90276-9; Willer B., 1990, CANADIAN J REHABILIT, V3, P167; [No title captured]	44	20	20	0	1	PRO-ED INC	AUSTIN	8700 SHOAL CREEK BLVD, AUSTIN, TX 78757-6897 USA	0034-3552			REHABIL COUNS BULL	Rehabil. Couns. Bull.	SPR	2006	49	3					130	142		10.1177/00343552060490030101			13	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	027HA	WOS:000236404500001					2022-02-06	
J	Vanderploeg, RD; Collins, RC; Sigford, B; Date, E; Schwab, K; Warden, D				Vanderploeg, RD; Collins, RC; Sigford, B; Date, E; Schwab, K; Warden, D		Defense Veterans Brain Injury Ctr	Practical and theoretical considerations in designing rehabilitation trials - The DVBIC cognitive-didactic versus functional-experiential treatment study experience	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article; Proceedings Paper	Galveston Brain Injury Conference (GBIC)	APR, 2005	Galveston, TX	Moody Fdn		outcome assessment; randomized controlled trials; rehabilitation; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CLOSED-HEAD-INJURY; REORGANIZATION; PROGRAM	This is a descriptive article outlining issues in the development and implementation of a multisite randomized rehabilitation trial for brain injury treatment. The goal of this article is to present practical and theoretical considerations in designing and conducting multicenter rehabilitation trials. Practical issues discussed include (a) treatment setting, (b) patient accessibility in determining the research question of interest, as well as inclusion and exclusion criteria, (c) research protocol development in the context of rehabilitation standard of care, and (d) protocol treatments in the context of realistic cost-benefits analysis. Rehabilitation theory is discussed as playing an important role designing the specifics of the protocol interventions. The Defense and Veterans Brain Injury Center Veterans Health Administration cognitive-didactic versus functional-experiential study methodology is used for illustrative purposes. This study evaluated 2 alternative approaches to treatment: one focusing on underlying cognitive processes and the second on errorless learning in everyday functional situations. Lessons learned over the course of completing the treatment trial are discussed.	Univ S Florida, James A Haley Vet Affairs Med Ctr, Def & Vet Brain Injury Ctr, Tampa, FL USA; Univ S Florida, Dept Psychiat & Behav Sci, Tampa, FL USA; Univ S Florida, Dept Psychol, Tampa, FL 33620 USA; Vet Affairs Med Ctr, Def & Vet Brain Injury Ctr, Minneapolis, MN USA; Def & Vet Brain Injury Ctr, Minneapolis, MN USA; Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN USA; Vet Affairs Palo Alto Hlth Care Syst, Phys Med & Rehabil Serv, Palo Alto, CA USA; Stanford Univ, Dept Phys Med & Rehabil, Sch Med, Palo Alto, CA 94304 USA; Uniformed Serv Univ Hlth Sci, Dept Epidemiol & Stat, Def & Vet Brain Injury Ctr, Bethesda, MD 20814 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; Walter Reed Army Med Ctr, Def & Vet Brain Injury, Washington, DC 20307 USA; Uniformed Serv Univ Hlth Sci, Dept Neurol & Psychiat, Bethesda, MD 20814 USA		Vanderploeg, RD (corresponding author), James A Haley Vet Hosp, Psychol Serv 116B, Tampa, FL 33612 USA.	rodney.vanderploeg@va.gov					Ben-Yishay Y., 1987, NEUROPSYCHOLOGICAL R, P165; BENEDICT RHB, 1989, CLIN PSYCHOL REV, V9, P605; BERROL S, 1990, ARCH NEUROL-CHICAGO, V47, P219, DOI 10.1001/archneur.1990.00530020127025; BUTLER RW, 1988, J NEUROLOGICAL REHAB, V2, P97; Carney N, 1999, J HEAD TRAUMA REHAB, V14, P277, DOI 10.1097/00001199-199906000-00008; Cicerone KD, 1999, J HEAD TRAUMA REHAB, V14, P316, DOI 10.1097/00001199-199906000-00011; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2000, ARCH PHYS MED REHAB, V81, P1596, DOI 10.1053/apmr.2000.19240; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Cramer SC, 2000, NEUROPHARMACOLOGY, V39, P842, DOI 10.1016/S0028-3908(99)00258-0; Duffy, 1991, J HEAD TRAUMA REHAB, V6, P92, DOI DOI 10.1097/00001199-199106000-00011; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; GILES GM, 1993, BRAIN INJURY REHABIL; GORDON WA, 1991, COGNITIVE REHABILITA, P13; Hartley L. L, 1995, COGNITIVE COMMUNICAT; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kaas JH, 1997, NEUROSCIENTIST, V3, P123, DOI 10.1177/107385849700300211; Kessels RPC, 2003, J CLIN EXP NEUROPSYC, V25, P805, DOI 10.1076/jcen.25.6.805.16474; LEVIN HS, 1990, ARCH NEUROL-CHICAGO, V47, P223, DOI 10.1001/archneur.1990.00530020131027; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Malec JF, 1996, ARCH PHYS MED REHAB, V77, P198, DOI 10.1016/S0003-9993(96)90168-9; Mateer CA, 1988, NEUROPSYCHOLOGICAL S, P202; MCDONALD S, 1993, BRAIN LANG, V44, P28, DOI 10.1006/brln.1993.1003; MENTIS M, 1987, J SPEECH HEAR RES, V30, P88, DOI 10.1044/jshr.3001.88; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; PRUTTING CA, 1982, J SPEECH HEAR DISORD, V47, P123, DOI 10.1044/jshd.4702.123; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RATTOK J, 1992, NEUROPSYCHOLOGIA, V6, P395, DOI DOI 10.1037/0894-4105.6.4.395; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1057, DOI 10.1152/jn.1992.67.5.1057; Ricker J H, 1998, Appl Neuropsychol, V5, P184, DOI 10.1207/s15324826an0504_3; ROSENTHAL R, 1963, BEHAV SCI, V8, P183; Rosenthal R, 1976, EXPT EFFECTS BEHAV R, V2nd; ROSENTHAL R, 2002, PREV TREAT; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SEITZ RJ, 1994, HUM BRAIN MAPP, V1, P81; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; SOHLBERG M M, 1992, Brain Injury, V6, P129, DOI 10.3109/02699059209029651; SOHLBERG M M, 1992, Brain Injury, V6, P139, DOI 10.3109/02699059209029652; Sohlberg M. M., 1992, IMPROVING PRAGMATIC; Sohlberg M.M., 1986, ATTENTION PROCESS TR; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; SOHLBERG MM, 1989, J CLIN EXP NEUROPSYC, V11, P871, DOI 10.1080/01688638908400941; SOHLBERG MM, 1994, MANUAL TEACHING PATI; SOHLBERG MM, 1993, ATTENTION PROCESS TR; SOHLBERG MM, 1989, PROSPECTIVE MEMORY T; Spilker B, 1991, GUIDE CLIN TRIALS; Squire LR., 1987, MEMORY BRAIN; Sterr A, 1998, NATURE, V391, P134, DOI 10.1038/34322; Taub E, 1999, J REHABIL RES DEV, V36, P237; TEASDALE G, 1974, LANCET, V2, P81; Terrace H. S., 1966, OPERANT BEHAV AREAS; TERRACE HS, 1963, J EXP ANAL BEHAV, V6, P1, DOI 10.1901/jeab.1963.6-1; VOLPE BT, 1990, ARCH NEUROL-CHICAGO, V47, P220, DOI 10.1001/archneur.1990.00530020128026; VONGIESEN HJ, 1994, EXP BRAIN RES, V99, P94; VONMONAKOW C, 1914, LOKALISATION GROSSBI; Wilson BA, 1996, J HEAD TRAUMA REHAB, V11, P54, DOI 10.1097/00001199-199604000-00006; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P308, DOI 10.1055/s-2008-1064205	61	20	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2006	21	2					179	193		10.1097/00001199-200603000-00010			15	Clinical Neurology; Rehabilitation	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	031PK	WOS:000236716300009	16569991				2022-02-06	
J	Elliott, TR; Bush, BA; Chen, YY				Elliott, TR; Bush, BA; Chen, YY			Social problem-solving abilities predict pressure sore occurrence in the first 3 years of spinal cord injury	REHABILITATION PSYCHOLOGY			English	Article						social problem solving; spinal cord injury; pressure sores	TRAUMATIC BRAIN-INJURY; FAMILY CAREGIVERS; STROKE SURVIVORS; ADJUSTMENT; APPRAISAL; RISK; ULCERS; DEPRESSION; BEHAVIORS; THERAPY	Objective: To test the hypothesis that social problem-solving abilities of persons with recent-onset spinal cord injury (SCI) would be predictive of pressure sore occurrence in the 1st 3 years following discharge from initial inpatient rehabilitation. Design: Prospective study of persons with recently incurred SCI and their subsequent pressure sore evaluations over a 3-year period in annual clinic evaluations. Setting: Inpatient SCI rehabilitation center and outpatient clinic. Participants: 188 persons with recent-onset SCI approaching discharge from initial inpatient SCI rehabilitation, with outpatient pressure sore evaluations for those who returned for pressure sore evaluations. Main Outcome Measure: Pressure sore occurrence as determined in annual outpatient evaluations conducted over the 1st 3 years of SCI. Results: 2 separate statistical models indicated that social problem-solving abilities significantly contributed to the prediction of pressure sore occurrence. Conclusions: Social problem-solving abilities are implicated in the development of pressure sores. Persons with ineffective problem-solving abilities may be at risk for pressure sores; these individuals might require strategic monitoring and training from clinical programs.	Univ Alabama Birmingham, Dept Psychol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL 35294 USA		Elliott, TR (corresponding author), Univ Alabama Birmingham, Dept Psychol, CH 415,1530 3rd Ave S, Birmingham, AL 35294 USA.	telliott@uab.edu	Elliott, Timothy R./I-5301-2012	Elliott, Timothy R./0000-0002-6608-7714			BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bollen K. A., 1989, STRUCTURAL EQUATIONS, DOI 10.1002/9781118619179; Bollen K.A., 1993, TESTING STRUCTURAL E, V154; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Browne, 1993, TESTING STRUCTURAL E, DOI [10.1177/0049124192021002005, DOI 10.1177/0049124192021002005]; Bush BA, 2003, ARCH PHYS MED REHAB, V84, P1803, DOI 10.1016/S0003-9993(03)00367-8; Byrne B. M., 1989, PRIMER LISREL BASIC; Canupp KC, 1997, SPINAL CORD, V35, P314, DOI 10.1038/sj.sc.3100367; Carmines E.G., 1981, SOCIAL MEASUREMENT C, P65, DOI DOI 10.1207/S15327965PLI0404_1; Chen YY, 2005, ARCH PHYS MED REHAB, V86, P1208, DOI 10.1016/j.apmr.2004.12.023; Consortium for Spinal Cord Medicine, 2000, PRESS ULC PREV TREAT; D'Zurilla T.J., 2002, SOCIAL PROBLEM SOLVI; D'Zurilla T.J., 1999, PROBLEM SOLVING THER, V2nd edn; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Dreer LE, 2004, J CLIN PSYCHOL MED S, V11, P7, DOI 10.1023/B:JOCS.0000016265.62022.82; DUGAS MJ, 1995, COGNITIVE THER RES, V19, P109, DOI 10.1007/BF02229679; ELLIOTT T, 2005, ENCY COGNITIVE BEHAV, P324; ELLIOTT TR, 1991, COGNITIVE THER RES, V15, P387, DOI 10.1007/BF01173033; Elliott TR, 2002, REHABIL PSYCHOL, V47, P278, DOI 10.1037//0090-5550.47.3.278; Elliott TR, 2001, J COUNS PSYCHOL, V48, P223, DOI 10.1037//0022-0167.48.2.223; Elliott TR, 1999, REHABIL PSYCHOL, V44, P315, DOI 10.1037/0090-5550.44.4.315; Elliott TR, 2001, J CLIN PSYCHOL MED S, V8, P283, DOI 10.1023/A:1011920914079; Elliott TR, 1996, J COUNS DEV, V74, P645, DOI 10.1002/j.1556-6676.1996.tb02305.x; ELLIOTT TR, 1995, J COUNS PSYCHOL, V42, P105, DOI 10.1037/0022-0167.42.1.105; ELLIOTT TR, 1994, J COUNS DEV, V72, P531, DOI 10.1002/j.1556-6676.1994.tb00987.x; Elliott TR, 2003, COMPREHENSIVE HDB PS, P415; Elliott TR, 2004, SOCIAL PROBLEM SOLVI, V11, P7, DOI DOI 10.1037/10805-007; ENIS JE, 1973, ORTHOPAEDIC REV, V2, P25; FEHRENBACH A, 1989, J CONSULT CLIN PSYCH, V5, P388; Garber SL, 2000, ARCH PHYS MED REHAB, V81, P465, DOI 10.1053/mr.2000.3889; Godshall FJ, 1997, J APPL SOC PSYCHOL, V27, P929, DOI 10.1111/j.1559-1816.1997.tb00279.x; Grant JS, 2004, REHABIL PSYCHOL, V49, P172, DOI 10.1037/0090-5550.49.2.172; Grant JS, 2002, STROKE, V33, P2060, DOI 10.1161/01.STR.0000020711.38824.E3; HEPPNER PP, 1988, PROBLEM SOLVING INVE; HERRICK S, 1994, J CLIN PSYCHOL MED S, V1, P269, DOI 10.1007/BF01989628; Herrick SM, 2001, J CLIN PSYCHOL, V57, P75, DOI 10.1002/1097-4679(200101)57:1<75::AID-JCLP9>3.0.CO;2-6; JOHNSON M, IN PRESS HLTH PSYCHO; Kerns RD, 2002, ANN BEHAV MED, V24, P100, DOI 10.1207/S15324796ABM2402_06; Krause J., 1996, TOP SPINAL CORD INJ, V2, P58; Krause JS, 2004, ARCH PHYS MED REHAB, V85, P1257, DOI 10.1016/j.apmr.2003.08.108; Krause JS, 2001, ARCH PHYS MED REHAB, V82, P107, DOI 10.1053/apmr.2001.18050; Long J.S., 1983, CONFIRMATORY FACTOR; MACNAIR RR, 1992, J RES PERS, V26, P150, DOI 10.1016/0092-6566(92)90051-5; MARSH HW, 1988, PSYCHOL BULL, V103, P391, DOI 10.1037/0033-2909.103.3.391; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; Nezu AM, 2004, BEHAV THER, V35, P1, DOI 10.1016/S0005-7894(04)80002-9; Nezu AM, 2003, J CONSULT CLIN PSYCH, V71, P1036, DOI 10.1037/0022-006X.71.6.1036; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Rimmer JH, 2002, AM J HEALTH PROMOT, V16, P220, DOI 10.4278/0890-1171-16.4.220; Shanmugham K, 2004, NEUROREHABILITATION, V19, P259; Shewchuk RM, 2000, BEHAV RES THER, V38, P727, DOI 10.1016/S0005-7967(99)00122-9; Stover S. L., 1995, SPINAL CORD INJURY C; TURK DC, 1989, HDB CLIN PSYCHOL MED, P249; Yarkony Gary M., 1995, P100; YARKONY GM, 1994, ARCH PHYS MED REHAB, V75, P908, DOI 10.1016/0003-9993(94)90117-1; [No title captured]	57	20	21	0	4	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	FEB	2006	51	1					69	77		10.1037/0090-5550.51.1.69			9	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	022FH	WOS:000236040000010					2022-02-06	
J	Skarbek-Borowska, S; Amanullah, S; Mello, MJ; Linakis, JG				Skarbek-Borowska, S; Amanullah, S; Mello, MJ; Linakis, JG			Emergency department visits for sledding injuries in children in the United States in 2001/2002	ACADEMIC EMERGENCY MEDICINE			English	Article						sledding; injuries; children	ACCIDENTS; ONTARIO; RISK	Objectives: To describe the characteristics of nonfatal sledding-related injuries in U.S. children resulting in emergency department (ED) visits in 2001/2002 and to explore the implications of these findings for injury prevention efforts. Methods: A stratified probability sample of U.S. hospitals providing emergency services in the National Electronic Injury Surveillance System-All Injury Program was utilized for 2001/2002. ED visits resulting from injuries involving sleds, snow discs, snow tubes, and toboggans were analyzed for patients 19 years of age or younger. Results: In 2001/2002, there were an estimated 57,866 ED visits for sledding-related injuries in the United States for all age groups. Of these, 41,272 (71%) occurred in patients 19 years of age or younger, 58% of whom were male. The highest number of injuries occurred in children between five and 14 years of age (74%), and the injuries were most often caused by falls or collisions (75%). The head or neck was the most frequently injured body region among those 0-9 years of age, while the extremities were injured most commonly among those 10-19 years of age. Head and neck injuries occurred in 56% (95% confidence interval [CI] = 32% to 81%) of children 0-4 years of age versus 19% (95%, CI = 9% to 29%) of patients 15-19 years of age. Nine percent (95% Cl = 6% to 12%) of patients sustained a traumatic brain injury. Three percent (95% CI = 1% to 5%) of patients required admission to the hospital. Conclusions: Sledding injuries resulting in ED visits predominantly affect children and are a source of measurable morbidity in this population. An increase in injury prevention efforts for this activity is warranted.	Brown Med Sch, Dept Emergency Med, Providence, RI USA; Brown Med Sch, Dept Pediat, Providence, RI USA; Hasbro Childrens Hosp, Rhode Isl Hosp, Injury Prevent Ctr, Providence, RI USA		Linakis, JG (corresponding author), Hasbro Childrens Hosp, 159 Potter Bldg,593 Eddy St, Providence, RI 02903 USA.	james_linakis_phd@brown.edu					Bernardo L M, 1998, J Trauma Nurs, V5, P34; BJORNSTIG U, 1986, SCAND J SOC MED, V14, P83; DERSHEWITZ R, 1990, AM J DIS CHILD, V144, P1071; Federiuk CS, 2002, WILD ENVIRON MED, V13, P245, DOI 10.1580/1080-6032(2002)013[0245:SSASII]2.0.CO;2; Hackam DJ, 1999, J PEDIATR SURG, V34, P65, DOI 10.1016/S0022-3468(99)90230-0; HEDGES JR, 1980, ANN EMERG MED, V9, P131, DOI 10.1016/S0196-0644(80)80267-8; HERKOWITZ HN, 1978, J TRAUMA, V18, P806, DOI 10.1097/00005373-197812000-00004; KIM PCW, 1995, J PEDIATR SURG, V30, P1135, DOI 10.1016/0022-3468(95)90005-5; Landsman I S, 1987, Pediatr Emerg Care, V3, P277, DOI 10.1097/00006565-198712000-00015; Lee F, 1999, Inj Prev, V5, P198; Major CP, 1999, SOUTHERN MED J, V92, P193, DOI 10.1097/00007611-199902000-00006; MANARY MJ, 1993, PEDIATR EMERG CARE, V9, P155, DOI 10.1097/00006565-199306000-00011; ODOM JA, 1976, J BONE JOINT SURG AM, V58, P733; ROWE BH, 1994, CAN FAM PHYSICIAN, V40, P68; Shorter NA, 1999, AM J EMERG MED, V17, P32, DOI 10.1016/S0735-6757(99)90010-4; SHUGERMAN RP, 1992, PEDIATR EMERG CARE, V8, P283, DOI 10.1097/00006565-199210000-00009; *US DEP HHS, 2003, ICPSR VERS; *US DEP HHS, 2004, ICPSR VERS; Verrees M, 2004, PEDIATR NEUROSURG, V40, P2, DOI 10.1159/000076570; Voaklander DC, 2001, ACAD EMERG MED, V8, P629, DOI 10.1111/j.1553-2712.2001.tb00176.x; WYNNE AD, 1994, J TRAUMA, V37, P820, DOI 10.1097/00005373-199411000-00019	21	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	FEB	2006	13	2					181	185	PII 1069-6563583	10.1197/j.aem.2005.09.009			5	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	010HW	WOS:000235179500010	16436798	Bronze			2022-02-06	
J	Kunz, T; Marklund, N; Hillered, L; Oliw, EH				Kunz, Tina; Marklund, Niklas; Hillered, Lars; Oliw, Ernst H.			Effects of the selective cyclooxygenase-2 inhibitor rofecoxib on cell death following traumatic brain injury in the rat	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						COX-2 inhibitor; fluid percussion brain injury; Fluoro-Jade B; neuroinflammation; prostaglandins; TUNEL staining	GENE-EXPRESSION; FUNCTIONAL RECOVERY; INDUCED SEIZURES; NEURONAL DEATH; METABOLISM; ISCHEMIA; DAMAGE; NEUROPROTECTION; POSTTREATMENT; DEGENERATION	Purpose: Lateral fluid percussion brain injury (FPI) increases cyclooxygenase-2 (COX-2) expression in the cortex and hippocampus. The objective was to investigate whether the selective COX-2 inhibitor rofecoxib (10 mg/kg twice daily) reduces neuronal cell death after FPI in rats, since rofecoxib has been shown to be neuroprotective in other models of CNS injury. Methods: Rofecoxib (n = 23) or vehicle (n = 20) were administered after FPI and for up to 3 days. Cell death was evaluated by Fluoro-Jade B staining and by the TdT-mediated dUTP nick end labelling (TUNEL) assay. Results: COX-2 immunoreactivity increased in the ipsilateral cortex and hippocampus (CA1) and bilaterally in the dentate gyri. Fluoro-Jade B- and TUNEL-positive cells were detected 12-72 It after FPI in the ipsilateral cortex and bilaterally in the dentate gyri. Fluoro-Jade B staining did not indicate a significant neuroprotective effect of rofecoxib (12-72 h) and neither did TUNEL staining. Quantificaton of the TUNEL staining in the ipsilateral cortex was similar to 50% lower in the rofecoxib group at 12 and 24 h, but this did not reach statistical significance (p = 0.06), and appeared unchanged at 72 It. Conclusions: Rofecoxib lacked significant protective effect on early neuronal cell death in the FPI model of traumatic brain injury.	Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden		Oliw, EH (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut Biosci, POB 591, SE-75124 Uppsala, Sweden.	ernst.oliw@farmbio.uu.se		Oliw, Ernst/0000-0002-7986-8130; Marklund, Niklas/0000-0002-9797-5626			Baillie TA, 2001, DRUG METAB DISPOS, V29, P1614; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Bauer MKA, 1997, EUR J BIOCHEM, V243, P726, DOI 10.1111/j.1432-1033.1997.00726.x; Burnier Michel, 2005, Expert Opin Drug Saf, V4, P491; Candelario-Jalil E, 2004, BRAIN RES, V1007, P98, DOI 10.1016/j.brainres.2004.01.078; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chandrasekharan NV, 2002, P NATL ACAD SCI USA, V99, P13926, DOI 10.1073/pnas.162468699; CHEN J, 1995, NEUROREPORT, V6, P245; Chu K, 2004, J CEREBR BLOOD F MET, V24, P926, DOI 10.1097/01.WCB.0000130866.25040.7D; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Gobbo OL, 2005, BRAIN RES, V1046, P224, DOI 10.1016/j.brainres.2005.03.046; Gobbo OL, 2004, NEUROSCIENCE, V125, P317, DOI 10.1016/j.neuroscience.2004.01.045; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Halpin RA, 2000, DRUG METAB DISPOS, V28, P1244; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Kawaguchi K, 2005, BRAIN RES, V1050, P130, DOI 10.1016/j.brainres.2005.05.038; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Kunz T, 2005, COGNITIVE BRAIN RES, V25, P826, DOI 10.1016/j.cogbrainres.2005.09.017; Kunz T, 2001, PHARMACOL TOXICOL, V88, P271, DOI 10.1034/j.1600-0773.2001.d01-116.x; Kunz T, 2001, EUR J NEUROSCI, V13, P569, DOI 10.1046/j.1460-9568.2001.01420.x; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; RINK A, 1995, AM J PATHOL, V147, P1575; Royo NC, 2003, CURR OPIN PHARMACOL, V3, P27, DOI 10.1016/S1471-4892(02)00006-1; Sandrini M, 2002, INFLAMM RES, V51, P154, DOI 10.1007/PL00000287; Sasaki T, 2004, J CEREBR BLOOD F MET, V24, P107, DOI 10.1097/01.WCB.0000100065.36077.4A; Scali C, 2003, NEUROSCIENCE, V117, P909, DOI 10.1016/S0306-4522(02)00839-4; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shaftel SS, 2003, MOL BRAIN RES, V119, P213, DOI 10.1016/j.molbrainres.2003.09.006; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soares HD, 1995, J NEUROSCI, V15, P8223; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436	49	20	20	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2006	24	1					55	63					9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047PU	WOS:000237892000007	16518028				2022-02-06	
J	Wachtel, LE; Hagopian, LP				Wachtel, Lee E.; Hagopian, Louis P.			Psychopharmacology and applied behavioral analysis: Tandem treatment of severe problem behaviors in intellectual disability and a case series	ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES			English	Article							MENTALLY-RETARDED PERSONS; SELF-INJURIOUS-BEHAVIOR; FUNCTIONAL-ANALYSIS; YOUNG-ADULTS; RETARDATION; PSYCHOPATHOLOGY; CHILDREN; PEOPLE; REINFORCEMENT; ADOLESCENTS	Many individuals with intellectual disability will at some time in their lives engage in problem behaviors that may place them and others at risk, and reduce their opportunities for healthy psychosocial functioning. These behaviors may reach severe proportions in both intensity and frequency, necessitating intervention. Both psychiatrists and behaviorists are often approached regarding negative behaviors in intellectual disability, and each discipline offers key tools in behavioral assessment and resolution. We believe that the coordinated effort of these two disciplines affords the most comprehensive and efficacious method of assessing, understanding and treating a wide range of problem behaviors and associated psychiatric pathology in individuals with various forms of intellectual disability. This paper briefly reviews the background of problem behaviors in intellectual disability and treatment of such disturbances through separate psychiatric and applied behavioral modalities, followed by the proposed coordinated neurobehavioral model. A case series ensues, describing the successful application of the neurobehavioral model to the severe problem behaviors demonstrated by three individuals with intellectual disability related to autism, Cornelia de Lange syndrome and traumatic brain injury.	Kennedy Krieger Inst, Neurobehav Unit, Dept Child & Adolescent Psychiat, Baltimore, MD 21205 USA; Kennedy Krieger Inst, Neurobehav Unit, Dept Behav Psychol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA		Wachtel, LE (corresponding author), Kennedy Krieger Inst, Neurobehav Unit, Dept Child & Adolescent Psychiat, 707 N Broadway St, Baltimore, MD 21205 USA.	wachtel@kennedykrieger.org					*AM ASS MENT RET, 2000, TREATM PSYCH BEH PRO, V105, P165; Aman MG, 2000, EUR CHILD ADOLES PSY, V9, P98; American Psychiatric Association, 2000, DIAGN CRIT DSM IV TR; BAUMEISTER AA, 1990, NEUROSCI BIOBEHAV R, V14, P253, DOI 10.1016/S0149-7634(05)80036-3; BorthwickDuffy SA, 1997, RES DEV DISABIL, V18, P415, DOI 10.1016/S0891-4222(97)00020-6; BORTHWICKDUFFY SA, 1994, J CONSULT CLIN PSYCH, V62, P17, DOI 10.1037/0022-006X.62.1.17; Buitelaar JK, 2000, EUR CHILD ADOLES PSY, V9, P85; DeLeon IG, 2000, J APPL BEHAV ANAL, V33, P73, DOI 10.1901/jaba.2000.33-73; EYMAN RK, 1981, AM J MENT DEF, V85, P473; FISHER W, 1992, J APPL BEHAV ANAL, V25, P491, DOI 10.1901/jaba.1992.25-491; Friedlander R, 2001, CAN J PSYCHIAT, V46, P741, DOI 10.1177/070674370104600807; Hagopian LP, 2001, J APPL BEHAV ANAL, V34, P527, DOI 10.1901/jaba.2001.34-527; Hagopian LP, 1998, J APPL BEHAV ANAL, V31, P211, DOI 10.1901/jaba.1998.31-211; Hagopian LP, 2000, J APPL BEHAV ANAL, V33, P433, DOI 10.1901/jaba.2000.33-433; Hanley GP, 2003, J APPL BEHAV ANAL, V36, P147, DOI 10.1901/jaba.2003.36-147; HARRIS JC, 1998, DEVELOPMENTAL NEUROP, V3; IWATA BA, 1994, J APPL BEHAV ANAL, V27, P215, DOI 10.1901/jaba.1994.27-215; IWATA BA, 1994, J APPL BEHAV ANAL, V27, P197, DOI 10.1901/jaba.1994.27-197; Janowsky DS, 2005, INT J NEUROPSYCHOPH, V8, P37, DOI 10.1017/S146114570400481X; Janowsky DS, 2005, J CLIN PSYCHOPHARM, V25, P19, DOI 10.1097/01.jcp.0000150218.51433.7b; Kahng S, 2002, AM J MENT RETARD, V107, P212, DOI 10.1352/0895-8017(2002)107<0212:BTOSIT>2.0.CO;2; Kodak T, 2003, J APPL BEHAV ANAL, V36, P379, DOI 10.1901/jaba.2003.36-379; Kowatch RA, 1998, PEDIATR CLIN N AM, V45, P1173, DOI 10.1016/S0031-3955(05)70068-7; Kraus MF, 1997, J NEUROPSYCH CLIN N, V9, P222; La Malfa G, 2006, HUM PSYCHOPHARM CLIN, V21, P73, DOI 10.1002/hup.748; MacIntyre D, 2003, MOL PSYCHIATR, V8, P275, DOI 10.1038/sj.mp.4001232; MACLEAN WE, 1993, PSYCHOPATHOLOGY MENT; Masi G, 2004, CNS DRUGS, V18, P1031, DOI 10.2165/00023210-200418140-00006; MATSON JL, 1994, J CONSULT CLIN PSYCH, V62, P6, DOI 10.1037/0022-006X.62.1.6; Matson JL, 2000, RES DEV DISABIL, V21, P263, DOI 10.1016/S0891-4222(00)00042-1; MATSON JL, 1984, APPL RES MENT RETARD, V5, P81, DOI 10.1016/S0270-3092(84)80021-1; McClintock K, 2003, J INTELL DISABIL RES, V47, P405, DOI 10.1046/j.1365-2788.2003.00517.x; McDougle CJ, 2005, AM J PSYCHIAT, V162, P1142, DOI 10.1176/appi.ajp.162.6.1142; McIntyre LL, 2002, J INTELL DISABIL RES, V46, P239, DOI 10.1046/j.1365-2788.2002.00371.x; Paclawskyj TR, 2004, BEHAV MODIF, V28, P649, DOI 10.1177/0145445503259834; REISS S, 1994, J CONSULT CLIN PSYCH, V62, P28, DOI 10.1037/0022-006X.62.1.28; RUEDRICH SL, 1990, AM J MENT RETARD, V95, P110; RUTTER M, 1976, PSYCHOL MED, V6, P313, DOI 10.1017/S003329170001388X; Schroeder SR, 2001, MENT RETARD DEV D R, V7, P3, DOI 10.1002/1098-2779(200102)7:1<3::AID-MRDD1002>3.0.CO;2-#; Shore BA, 1997, J APPL BEHAV ANAL, V30, P21, DOI 10.1901/jaba.1997.30-21; Sloman KN, 2005, J APPL BEHAV ANAL, V38, P373, DOI 10.1901/jaba.2005.118-04; Symons FJ, 2004, MENT RETARD DEV D R, V10, P193, DOI 10.1002/mrdd.20031; TUINIER S, 1993, J INTELL DISABIL RES, V37, P16; Wong DF, 1996, P NATL ACAD SCI USA, V93, P5539, DOI 10.1073/pnas.93.11.5539	44	20	20	0	19	MEDIAFARM GROUP	TEL-AVIV	23 ZAMENHOFF ST, TEL-AVIV, 64373, ISRAEL	0333-7308			ISR J PSYCHIATR REL	Isr. J. Psychiatr. Relat. Sci.		2006	43	4					265	274					10	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	133DE	WOS:000243991000006	17338446				2022-02-06	
J	Warren, MW; Kobeissy, FH; Liu, MC; Svetlov, SI; Hayes, RL; Gold, MS; Wang, KKW				Warren, Matthew W.; Kobeissy, Firas H.; Liu, Ming Cheng; Svetlov, Stanislav I.; Hayes, Ronald L.; Gold, Mark S.; Wang, Kevin K. W.			Ecstasy toxicity: A comparison to methamphetamine and traumatic brain injury	JOURNAL OF ADDICTIVE DISEASES			English	Article						ecstasy; neurotoxicity; methamphetamine; MDMA; hepatocytes	RAT-BRAIN; NEURONAL APOPTOSIS; II-SPECTRIN; CALPAIN; CASPASE; CELLS; EXPRESSION; TAU	Ecstasy use is a growing problem in the United States. Techniques to demonstrate and characterize the toxicity associated with its use have been limited and employed infrequently. In this study, we compare the deleterious effects of ecstasy use in rats with that of methamphetamine and traumatic brain injury. Specifically, we investigate the degradation of structural proteins alpha II-spectrin and tau by the pro-necrotic calpain and pro-apoptotic caspase systems. Ecstasy-induced neurotoxicity is shown after 24 hours, although to a much lesser extent than that of methamphetamine or traumatic brain injury. Neurotoxicity is still evident after 72 hours. Furthermore, apoptosis of the liver is seen 72 hours after ecstasy use. Use of protease inhibitors may be useful in preventing ecstasy-induced toxicity.	Univ Florida, Coll Med, Dept Psychiat, Gainesville, FL 32610 USA; Univ Florida, Coll Med, Dept Neurosci, Gainesville, FL 32610 USA		Gold, MS (corresponding author), Univ Florida, Coll Med, Dept Psychiat, POB 100183, Gainesville, FL 32610 USA.	msgold@psychiatry.ufl.edu	Kobeissy, Firas/E-7042-2017	Kobeissy, Firas/0000-0002-5008-6944; Wang, Kevin/0000-0002-9343-6473			Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; *DAWN, 2003, DAWN SER; Deng XL, 2002, MOL PHARMACOL, V62, P993, DOI 10.1124/mol.62.5.993; Hegadoren KM, 1999, NEUROSCI BIOBEHAV R, V23, P539, DOI 10.1016/S0149-7634(98)00046-3; Knoblach SM, 2004, J CEREBR BLOOD F MET, V24, P1119, DOI 10.1097/01.WCB.0000138664.17682.32; Larsen KE, 2002, J NEUROSCI, V22, P8951; Montiel-Duarte C, 2002, BBA-MOL BASIS DIS, V1588, P26, DOI 10.1016/S0925-4439(02)00112-6; Nath R, 1996, BIOCHEM J, V319, P683, DOI 10.1042/bj3190683; NICHOLSON W, 1997, TRENDS BIOCHEM SCI, V22, P299; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Ricaurte George A., 2003, Science (Washington D C), V301, P1479; Stephenson CP, 1999, NEUROSCIENCE, V92, P1011, DOI 10.1016/S0306-4522(99)00049-4; Stumm G, 1999, FASEB J, V13, P1065, DOI 10.1096/fasebj.13.9.1065; Thiriet N, 2001, MOL BRAIN RES, V90, P202, DOI 10.1016/S0169-328X(01)00093-6; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; Yuen Po-Wai, 1998, Drugs of the Future, V23, P741, DOI 10.1358/dof.1998.023.07.858362	19	20	20	0	1	HAWORTH PRESS INC	BINGHAMTON	10 ALICE ST, BINGHAMTON, NY 13904-1580 USA	1055-0887			J ADDICT DIS	J. Addict. Dis.		2006	25	4					115	123		10.1300/J069v25n04_11			9	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	116YN	WOS:000242839800011	17088231				2022-02-06	
J	Gahm, C; Danilov, A; Holmin, S; Wiklund, PN; Brundin, L; Mathiesen, T				Gahm, C; Danilov, A; Holmin, S; Wiklund, PN; Brundin, L; Mathiesen, T			Reduced neuronal injury after treatment with N-G-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) following experimental brain contusion	NEUROSURGERY			English	Article						apoptosis; brain injury; L-NAME; neuronal injury; nitric oxide; nitrotyrosine; S-PBN	FOCAL CEREBRAL-ISCHEMIA; TERT-BUTYL-NITRONE; OXIDE SYNTHASE EXPRESSION; PERIVASCULAR TYROSINE NITRATION; FREE-RADICAL SCAVENGERS; CORTICAL IMPACT INJURY; RAT-BRAIN; PEROXYNITRITE FORMATION; LIPID-PEROXIDATION; ENDOTHELIAL-CELLS	OBJECTIVE: Nitric oxide (NO) and oxygen free radicals are implicated in the pathophysiology of traumatic brain-injury (TBI). Peroxynitrite formation from NO and superoxide contributes to secondary neuronal injury but the neuroprotective effects of nitric oxide synthase (NOS)-inhibitors have been contradictory. This study was undertaken to examine whether PTtic administration of the (NOS)-inhibitor- N-G-nitro-L-arginine methyl ester (L-NAME), and a combination of L-NAME and the nitrone radical scavenger 2-sulfo-phenyl-N-tert-butyl nitrone (S-PBN) favorable affects neuronal injury in a model of TBI. METHODS: A weight-drop model of TBI was used. The animals received L-NAME, S-PBN or a combination of the drugs 15 minutes prothrombin time (PT) and sacrificed after 24 hours or six days. NOS activity was measured by the conversion of L-[U-C-14]arginine to L-[U-C-14] citrulline. Peroxynitrite formation, cellular apoptosis, neuronal degeneration and survival were assessed by nitrotyrosine-, TUNEL-, Fluoro-Jade and NeuN-stainings. RESULTS: eNOS and nNOS activity was significantly reduced in animals that received L-NAME alone or the combination with S-PBN. iNOS activity or iNOS immunoreactivity was not affected. All treatments significantly reduced neuronal degeneration and nitrotyrosine immunoreactivity at 24 hours and increased neuronal survival at six days PT. No differences were detected between L-NAME and L-NAME + S-PBN groups. CONCLUSION: NO from NOS contributes to secondary neuronal injury in this TBI-model. PTtic treatment does not inhibit early beneficial NO-related effects. L-NAME and S-PBN limit peroxynitrite formation, promoting neuronal survival. The combination of L-NAME and S-PBN was neuroprotective; surprisingly no additive effects were found on nitrotyrosine formation, apoptosis or neuronal survival.	Karolinska Inst, Dept Clin Neurosci, Sect Clin CNS Res, Neuroimmunol Grp,Ctr Mol Med, SE-17176 Stockholm, Sweden; Karolinska Inst, Dept Surg, Urol Sect, Stockholm, Sweden		Gahm, C (corresponding author), Karolinska Inst, Dept Clin Neurosci, Sect Clin CNS Res, Neuroimmunol Grp,Ctr Mol Med, SE-17176 Stockholm, Sweden.	Caroline.Gahm@karolinska.se	mathiesen, tiit/ABC-3627-2021	Holmin, Staffan/0000-0002-1628-1615; Mathiesen, Tiit/0000-0001-9463-1919; Brundin, Lou/0000-0003-4408-7817; Wiklund, Peter/0000-0001-6497-4697			Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Beckman J.S., 1994, METHODS ENZYMOL, V233, P229, DOI [DOI 10.1016/S0076-6879(94)33026-3, 10.1016/s0076-6879(94)33026-3]; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; BOLANOS JP, 1995, J NEUROCHEM, V64, P1965; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CARNEY JM, 1991, J MOL NEUROSCI, V3, P47, DOI 10.1007/BF02896848; Catania MV, 2003, NEUROCHEM RES, V28, P607; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Coeroli L, 1998, J NEUROCHEM, V70, P2516; Conti AC, 1998, J NEUROSCI, V18, P5663; DAWSON VL, 1995, CLIN EXP PHARMACOL P, V22, P305, DOI 10.1111/j.1440-1681.1995.tb02005.x; DEMOPOULOS HB, 1980, ACTA PHYSIOL SCAND, P91; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Forster C, 1999, ACTA NEUROPATHOL, V97, P215, DOI 10.1007/s004010050977; Gahm C, 2002, NEUROSURGERY, V50, P1319, DOI 10.1097/00006123-200206000-00024; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Greenberg JH, 1997, NEUROSCI LETT, V229, P1, DOI 10.1016/S0304-3940(97)00395-9; Gursoy-Ozdemir Y, 2000, STROKE, V31, P1974, DOI 10.1161/01.STR.31.8.1974; Gursoy-Ozdemir Y, 2004, STROKE, V35, P1449, DOI 10.1161/01.STR.0000126044.83777.f4; Hall ED, 1999, ANN NY ACAD SCI, V890, P462, DOI 10.1111/j.1749-6632.1999.tb08025.x; HALL ED, 1989, CRIT CARE CLIN, V5, P793; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; HALLIWELL B, 1986, ARCH BIOCHEM BIOPHYS, V246, P501, DOI 10.1016/0003-9861(86)90305-X; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; HILLERED L, 1983, J CEREBR BLOOD F MET, V3, P207, DOI 10.1038/jcbfm.1983.28; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; HOGG N, 1993, FEBS LETT, V326, P199, DOI 10.1016/0014-5793(93)81790-7; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Hooper DC, 2000, FASEB J, V14, P691, DOI 10.1096/fasebj.14.5.691; Huang ZH, 1996, J CEREBR BLOOD F MET, V16, P981, DOI 10.1097/00004647-199609000-00023; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, AM J PHYSIOL-REG I, V268, pR286, DOI 10.1152/ajpregu.1995.268.1.R286; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; Ischiropoulos H, 1996, J CLIN INVEST, V97, P2260, DOI 10.1172/JCI118667; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOTAKE Y, 1998, BIOCHIM BIOPHYS ACTA, V1, P77; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Kuroda S, 1996, NEUROBIOL DIS, V3, P149, DOI 10.1006/nbdi.1996.0015; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lewen A, 2001, J CEREBR BLOOD F MET, V21, P344, DOI 10.1097/00004647-200104000-00003; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lu J, 2003, NEUROPHARMACOLOGY, V44, P253, DOI 10.1016/S0028-3908(02)00380-5; Lu YC, 1997, MOL CHEM NEUROPATHOL, V30, P125, DOI 10.1007/BF02815154; LYNCH DR, 1994, CURR OPIN NEUROL, V7, P510, DOI 10.1097/00019052-199412000-00007; MALIS CD, 1986, J BIOL CHEM, V261, P14201; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marklund N, 2001, J NEUROTRAUM, V18, P821, DOI 10.1089/089771501316919184; MATSUO Y, 1995, J CEREBR BLOOD F MET, V15, P941, DOI 10.1038/jcbfm.1995.119; MAYER B, 1989, BIOCHEM BIOPH RES CO, V164, P678, DOI 10.1016/0006-291X(89)91513-1; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Mesenge C, 1998, EUR J PHARMACOL, V353, P53, DOI 10.1016/S0014-2999(98)00432-4; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; MIYAJIMA T, 1995, BIOCHEM BIOPH RES CO, V215, P114, DOI 10.1006/bbrc.1995.2440; MONCADA S, 1991, PHARMACOL REV, V43, P109; Nagashima T, 2000, ACTA NEUROCHIR SUPPL, V76, P471; Naito Y, 2002, ANTIOXID REDOX SIGN, V4, P195, DOI 10.1089/152308602753625951; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Povlishock J T, 1992, Hum Cell, V5, P345; QUAST MJ, 1995, BRAIN RES, V677, P204, DOI 10.1016/0006-8993(95)00134-C; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; RINK A, 1995, AM J PATHOL, V147, P1575; SALGO MG, 1995, ARCH BIOCHEM BIOPHYS, V322, P500, DOI 10.1006/abbi.1995.1493; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; Samuelsson C, 2003, EPILEPSY RES, V56, P165, DOI 10.1016/j.eplepsyres.2003.09.004; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; SCHULZ JB, 1995, J NEUROCHEM, V64, P2239; SIESJPO B K, 1989, Cerebrovascular and Brain Metabolism Reviews, V1, P165; Singh A, 1996, AM J HYPERTENS, V9, P867, DOI 10.1016/S0895-7061(96)00104-5; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Southan GJ, 1996, BIOCHEM PHARMACOL, V51, P383, DOI 10.1016/0006-2952(95)02099-3; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Yang Y, 2000, EXP NEUROL, V163, P39, DOI 10.1006/exnr.2000.7364; YOUNG W, 1992, J NEUROTRAUM, V9, pS9; YUI Y, 1991, J BIOL CHEM, V266, P12544; ZHANG FY, 1995, J CEREBR BLOOD F MET, V15, P595, DOI 10.1038/jcbfm.1995.73	91	20	24	0	2	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2005	57	6					1272	1281		10.1227/01.NEU.0000187317.32529.06			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	991PQ	WOS:000233826300056	16331176				2022-02-06	
J	Taguchi, A; Kurz, A				Taguchi, Akiko; Kurz, Andrea			Thermal management of the patient: where does the patient lose and/or gain temperature?	CURRENT OPINION IN ANESTHESIOLOGY			English	Article						heat redistribution; perioperative hypothermia; shivering threshold; therapeutic hypothermia; vasoconstriction	TRAUMATIC BRAIN-INJURY; PERIOPERATIVE NORMOTHERMIA; TRANSFUSION REQUIREMENTS; SHIVERING THRESHOLD; CORE-TEMPERATURE; WARMING BLANKETS; WOUND-INFECTION; BLOOD-LOSS; HEAT-FLOW; HYPOTHERMIA	Purpose of review Anesthesia inhibits normal thermoregulatory control, leading to perioperative hypothermia or allowing therapeutic hypothermia. During the last decade many studies have shown the effects of anesthesia on thermoregulation. As a consequence many active warming and cooling devices are available to manipulate patients' core temperature. This review focuses on new findings in the field of temperature management. Recent findings Thermal management of patients has improved tremendously in recent years. Many outcome studies have shown adverse effects of perioperative hypothermia, as well as beneficial effects of therapeutic hypothermia after out-of-hospital cardiac arrest and brain trauma. However, inducing hypothermia is limited by physiologic thermoregulatory responses. Small reductions in core temperature lead to vasoconstriction and shivering, effectively hindering hypothermia. Thus prevention of vasoconstriction and shivering have become major goals during induction of therapeutic hypothermia. All anesthetics, opioids and sedatives lower the vasoconstriction and shivering threshold, thus allowing hypothermia. However, these drugs have side effects, such as respiratory depression, sedation and nausea. Several drugs, alone or in combination, lower the shivering threshold while causing minimal or no side effects. Summary Anesthesia affects thermoregulatory control and leads to perioperative hypothermia. The prevention of perioperative hypothermia improves patient's outcome. Therapeutic hypothermia can be induced and also improves outcome in certain conditions.	[Taguchi, Akiko] Tokyo Womens Med Univ, Dept Anesthesiol, Tokyo, Japan; [Kurz, Andrea] Univ Bern, Dept Anesthesiol, Bern, Switzerland; [Kurz, Andrea] Univ Louisville, Ooucomes Res Inst, Louisville, KY 40292 USA		Kurz, A (corresponding author), Univ Bern, Dept Anesthesiol, Bern, Switzerland.	andrea.kurz@insel.ch		Kurz, Andrea/0000-0001-5887-3099			Alfonsi P, 2004, ANESTHESIOLOGY, V100, P37, DOI 10.1097/00000542-200401000-00010; Bar-Yosef S, 2004, ANESTH ANALG, V99, P641, DOI 10.1213/01.ANE.0000130354.90659.63; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brauer A, 2004, BRIT J ANAESTH, V92, P836, DOI 10.1093/bja/aeh156; CHENG C, 1995, ANESTHESIOLOGY, V82, P1160, DOI 10.1097/00000542-199505000-00011; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CRINO MH, 1968, ANESTHESIOLOGY, V29, P149, DOI 10.1097/00000542-196801000-00038; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Grocott HP, 2004, ANESTH ANALG, V98, P298, DOI [10.1213/01.ANE.0000096242.06561.C0, 10.1213/01.ANE.0000096212.06561.C0]; Guest James D, 2004, Spine J, V4, P130, DOI 10.1016/j.spinee.2003.08.027; Hofer CK, 2005, J THORAC CARDIOV SUR, V129, P838, DOI 10.1016/j.jtcvs.2004.07.002; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hynson J M, 1992, J Clin Anesth, V4, P194, DOI 10.1016/0952-8180(92)90064-8; Janicki PK, 2001, ANESTHESIOLOGY, V95, P868, DOI 10.1097/00000542-200110000-00014; Keller E, 2003, INTENS CARE MED, V29, P939, DOI 10.1007/s00134-003-1685-3; Kimme P, 2004, BRIT J ANAESTH, V93, P343, DOI 10.1093/bja/aeh206; KOKATE JY, 1995, ARCH PHYS MED REHAB, V76, P666, DOI 10.1016/S0003-9993(95)80637-7; Komatsu R, 2005, ANESTH ANAL IN PRESS; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; KURZ A, 1993, ANESTH ANALG, V77, P89; Lenhardt Rainer, 2003, Best Pract Res Clin Anaesthesiol, V17, P569, DOI 10.1016/S1521-6896(03)00048-X; LOPEZ M, 1994, ANESTHESIOLOGY, V80, P780, DOI 10.1097/00000542-199404000-00009; Macario A, 2002, ANESTH ANALG, V94, P215, DOI 10.1097/00000539-200201000-00042; Maglinger PE, 2005, ANESTH ANALG, V100, P738, DOI 10.1213/01.ANE.0000143954.98285.63; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATSUKAWA T, 1995, ANESTHESIOLOGY, V82, P662, DOI 10.1097/00000542-199503000-00008; MATSUKAWA T, 1995, ANESTHESIOLOGY, V83, P961, DOI 10.1097/00000542-199511000-00008; Matsuzaki Y, 2003, BRIT J ANAESTH, V90, P689, DOI 10.1093/bja/aeg106; Melling AC, 2001, LANCET, V358, P876, DOI 10.1016/S0140-6736(01)06071-8; Mokhtarani M, 2001, ANESTH ANALG, V93, P1233, DOI 10.1097/00000539-200111000-00038; MORRIS RH, 1972, ANESTHESIOLOGY, V36, P408, DOI 10.1097/00000542-197204000-00020; MORRIS RH, 1971, ARCH SURG-CHICAGO, V102, P95; Nathan HJ, 2004, J THORAC CARDIOV SUR, V127, P1270, DOI 10.1016/j.jtcvs.2003.07.018; Negishi C, 2003, ANESTH ANALG, V96, P1683, DOI 10.1213/01.ANE.0000062770.73862.B7; Nesher N, 2003, ANESTH ANALG, V96, P328, DOI 10.1097/00000539-200302000-00007; Nesher N, 2001, ANN THORAC SURG, V72, pS1069, DOI 10.1016/S0003-4975(01)02943-5; Passard A, 2004, AM SOC ANESTHESIOL, V101, pA; Playford H, 2004, ANESTH ANALG, P98; Polderman KH, 2004, INTENS CARE MED, V30, P1860, DOI 10.1007/s00134-004-2383-5; Ratnaraj J, 2004, AM SOC ANESTHESIOL, V101; Rohrer K, 2004, AM SOC ANESTHESIOL, V101, pA; Schmied H, 1996, LANCET, V347, P289, DOI 10.1016/S0140-6736(96)90466-3; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; SESSLER DI, 1995, ANESTHESIOLOGY, V82, P674, DOI 10.1097/00000542-199503000-00009; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042; SESSLER DI, 1991, ANESTHESIOLOGY, V74, P875, DOI 10.1097/00000542-199105000-00012; SESSLER DI, 1993, ANESTH ANALG, V77, P73; SESSLER DI, 1990, ANESTHESIOLOGY, V73, P218, DOI 10.1097/00000542-199008000-00005; Stanley TO, 2003, ANN THORAC SURG, V75, P1140, DOI 10.1016/S0003-4975(02)04545-9; Stanley TO, 2005, ANN THORAC IN PRESS; Steinberg GK, 2004, NEUROSURGERY, V55, P307, DOI 10.1227/01.NEU.0000129683.99430.8C; Taguchi A, 2004, ANESTHESIOLOGY, V100, P1058, DOI 10.1097/00000542-200405000-00005; Todd MM, 2005, NEW ENGL J MED, V352, P135, DOI 10.1056/NEJMoa040975; Wadhwa A, 2005, BRIT J ANAESTH, V94, P756, DOI 10.1093/bja/aei105; Woo Y Joseph, 2005, Asian Cardiovasc Thorac Ann, V13, P157; Yamakage M, 2004, AM SOC ANESTHESIOL, V101, pA; Yamakage Michiaki, 2004, Masui, V53, P10; ZWEIFLER RM, 1997, J STROKE CEREBROVASC, V6, P100	58	20	22	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	DEC	2005	18	6					632	639		10.1097/01.aco.0000191890.36691.cc			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	V40ZS	WOS:000209517100008	16534304				2022-02-06	
J	Vinchon, M; Pierrat, V; Tchofo, PJ; Soto-Ares, G; Dhellemmes, P				Vinchon, M; Pierrat, V; Tchofo, PJ; Soto-Ares, G; Dhellemmes, P			Traumatic intracranial hemorrhage in newborns	CHILDS NERVOUS SYSTEM			English	Article						head injury; birth trauma; subdural hematoma; newborn	SUBDURAL-HEMATOMA; MANAGEMENT; DELIVERY; INFANTS; INJURY	Introduction: Neonatal traumatic head injuries (NTHI) can be life-threatening and require aggressive treatment. The indications, techniques, and results of brain decompression are not well defined in the literature. Methods: We studied prospectively cases of NTHI with intracranial traumatic lesions; skull fractures without underlying lesions were not included. We treated 17 cases of NTHI: 7 patients had a subdural hematoma, 3 had an extradural hematoma, and the others had subarachnoid hemorrhage. Surgical evacuation of intracranial clots was performed in 7 cases, by needle aspiration in 5 and by craniotomy in 2 patients with extradural hematomas. Results: The outcome was favorable in all but one patient, who had hemophilia A, and died of rebleeding at the age of 2 months. Conclusion: Surgical decompression of intracranial hematomas due to NTHI is often unnecessary; however, it may be required in emergency because of poor clinical tolerance. Whenever possible, percutaneous needle aspiration is the treatment of choice.	Ctr Hosp Reg & Univ Lille, Serv Neurochirurg Pediat, F-59037 Lille, France; Lille Univ Hosp, Dept Pediat Neurosurg, Lille, France; Lille Univ Hosp, Dept Neonatal Intens Care, Lille, France; Lille Univ Hosp, Dept Neuroradiol, Lille, France		Vinchon, M (corresponding author), Ctr Hosp Reg & Univ Lille, Serv Neurochirurg Pediat, Pl Verdun, F-59037 Lille, France.	m-vinchon@chru-lille.fr	Vinchon, Matthieu/AAH-6845-2021	Vinchon, Matthieu/0000-0002-9122-6165			AOKI N, 1990, ACTA NEUROCHIR, V106, P65, DOI 10.1007/BF01809334; AVRAHAMI E, 1993, NEURORADIOLOGY, V35, P107, DOI 10.1007/BF00593964; CASTILLO M, 1995, AM J NEURORADIOL, V16, P816; Chamnanvanakij S, 2002, PEDIATR NEUROL, V26, P301, DOI 10.1016/S0887-8994(01)00420-9; Duckett S., 1995, PEDIAT NEUROPATHOLOG, P243; GOVAERT P, 1990, ACTA NEUROCHIR, V106, P52, DOI 10.1007/BF01809333; GOVAERT P, 1993, CLIN DEV MED, V129; Harpold TL, 1998, NEUROSURG CLIN N AM, V9, P141; HAYASHI T, 1987, CHILD NERV SYST, V3, P23, DOI 10.1007/BF00707189; HOLLAND E, 1922, J OBSTET GYN BR COMM, V29, P549; Hoskote A, 2002, CHILD NERV SYST, V18, P311, DOI 10.1007/s00381-002-0616-x; Hovind KH, 1986, HEAD INJURIES NEWBOR, P87; Levene M. I., 1995, P335; Myles LM, 2001, PEDIATR NEUROSURG, V34, P94, DOI 10.1159/000056001; Perrin RG, 1997, NEUROSURGERY, V40, P1190, DOI 10.1097/00006123-199706000-00016; PIERREKAHN A, 1970, ANN PEDIAT, V32, P419; Sorensen N., 1986, HEAD INJURIES NEWBOR, P83; Whitby EH, 2004, LANCET, V363, P846, DOI 10.1016/S0140-6736(04)15730-9; WILLIAMS B, 1977, LANCET, V2, P51	19	20	20	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	DEC	2005	21	12					1042	1048		10.1007/s00381-004-1131-z			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	985HQ	WOS:000233368600010	15928969				2022-02-06	
J	Walker, AJ; Onus, M; Doyle, M; Clare, J; McCarthy, K				Walker, AJ; Onus, M; Doyle, M; Clare, J; McCarthy, K			Cognitive rehabilitation after severe traumatic brain injury: A pilot programme of goal planning and outdoor adventure course participation	BRAIN INJURY			English	Article						traumatic brain injury; cognitive rehabilitation; community rehabilitation; goal planning; outward bound		Primary objective: To describe and evaluate a pilot community based rehabilitation programme for severe brain injury. Research design: A prospective repeated-measures design with a single convenience sample was conducted. Methods and procedures: Eleven participants with a history of severe brain injury completed the programme, which featured an outdoor adventure course, skill development and goal-based learning. In the first stage, practical activities facilitated the development of social skills, group cohesiveness and community integration. The second stage was a 9-day outdoor adventure course, which included physically challenging activities such as camping, bushwalking, abseiling, caving and high rope work. The third stage encouraged individuals to work on the personal goals they had developed. Main outcomes and results: Over 80% of stated goals were achieved; suggesting that such a programme may be effective in enabling clients to attain specified goals. Conclusions: The programme shows promise as a form of community rehabilitation.	Westmead Hosp, Brain Injury Rehabil Serv, Sydney, NSW, Australia		Walker, AJ (corresponding author), Westmead Hosp, Brain Injury Rehabil Serv, POB 533, Wentworthville, NSW 2145, Australia.	awalker@biru.wsahs.nsw.gov.au					Bergquist Thomas F., 1993, Brain Injury, V7, P275, DOI 10.3109/02699059309029680; Christensen, 2000, INT HDB NEUROPSYCHOL, P81; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; Deckersbach T, 2000, J CLIN EXP NEUROPSYC, V22, P640, DOI 10.1076/1380-3395(200010)22:5;1-9;FT640; Dupuy HJ, 1987, MEASURING HLTH GUIDE, P125; Heaton R.K., 1990, WISCONSIN CARD SORTI; LEMMON J, 1996, J COGNITIVE REHA JUL, P18; LOVIBOND SH, 1995, MANUAL DEPRESSION AN; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; PONSFORD J, 1995, TRAUMATIC BRAIN INJU, P195; SLOAN S, 1995, TRAUMATIC BRAIN INJU, P103; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Thomas M, 2004, BRAIN INJURY, V18, P1271, DOI 10.1080/02699050410001698776; Wechsler D., 1997, WECHSLER ADULT INTEL, VIII; Wilson BA, 2002, J HEAD TRAUMA REHAB, V17, P542, DOI 10.1097/00001199-200212000-00006; Wilson PN, 2003, REV AGR ECON, V25, P30, DOI 10.1111/1467-9353.00044; Ylvisaker M, 2002, J HEAD TRAUMA REHAB, V17, P191, DOI 10.1097/00001199-200206000-00002; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; Ylvisaker M., 2003, BRAIN IMPAIR, V4, P1, DOI [DOI 10.1375/brim.4.1.1.27031, https://doi.org/10.1375/brim.4.1.1.27031, DOI 10.1375/BRIM.4.1.1.27031]	20	20	20	0	13	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2005	19	14					1237	1241		10.1080/02699050500309411			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	983ZF	WOS:000233270200007	16286339				2022-02-06	
J	Kirkness, CJ				Kirkness, Catherine J.			Cerebral Blood Flow Monitoring in Clinical Practice	AACN ADVANCED CRITICAL CARE			English	Article						cerebral blood flow physiology; clinical measurement	TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; POSITRON-EMISSION-TOMOGRAPHY; STABLE XENON; PERFUSION-PRESSURE; AUTOREGULATION; CT; VASOSPASM; STROKE; HYPERTENSION	The brain depends on a continuous flow of blood to provide it with oxygen and glucose needed to maintain normal function and structural integrity, thus cerebral blood flow is normally tightly regulated. A decrease in cerebral blood flow to ischemic levels may be tolerated for only minutes to hours, depending on the severity of the ischemia. If cerebral blood flow ceases completely, brain cell death occurs within minutes. A variety of conditions are encountered clinically, such as stroke or traumatic brain injury, where an actual or potential alteration in cerebral blood flow puts the brain at risk for ischemia and infarction. In this article, the physiology of cerebral blood flow will be presented as a basis for understanding cerebral blood flow regulation and the rationale for clinical interventions to optimize cerebral blood flow. Techniques currently available to assess cerebral blood flow and clinical situations in which cerebral blood flow is measured will be discussed. Clinical interventions will be presented briefly.	[Kirkness, Catherine J.] Univ Washington, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA		Kirkness, CJ (corresponding author), Univ Washington, 1959 Pacific NE St, Seattle, WA 98195 USA.	kirkness@u.washington.edu					Adams RJ, 1992, TRANSCRANIAL DOPPLER, P41; Bader Mary Kay, 2003, Crit Care Nurse, V23, P29; Bader MK, 2004, AANN CORE CURRICULUL; Bader MK, 2003, CRIT CARE NURSE, V23, P29; Banasiak KJ, 2003, CURR OPIN PEDIATR, V15, P288, DOI 10.1097/00008480-200306000-00011; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Brain Trauma Foundation, GUID MAN SEV TRAUM B; Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P513; Cenic A, 2000, AM J NEURORADIOL, V21, P462; Conrad GR, 2003, SEMIN NUCL MED, V33, P312, DOI 10.1016/S0001-2998(03)00034-5; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Encinas M, 2003, EUR J NUCL MED MOL I, V30, P1473, DOI 10.1007/s00259-003-1277-z; Gur AY, 1996, STROKE, V27, P2188, DOI 10.1161/01.STR.27.12.2188; Hanyu H, 2003, DEMENT GERIATR COGN, V15, P177, DOI 10.1159/000068785; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; Koenig M, 2001, STROKE, V32, P431, DOI 10.1161/01.STR.32.2.431; Kosty T, 2005, CRIT CARE NURS Q, V28, P122, DOI 10.1097/00002727-200504000-00005; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; LATCHAW RE, 1987, RADIOLOGY, V163, P251, DOI 10.1148/radiology.163.1.3823444; Latchaw RE, 2003, STROKE, V34, P1084, DOI 10.1161/01.STR.0000064840.99271.9E; Latchaw Richard E, 2004, J Vasc Interv Radiol, V15, pS29; Lee JD, 2000, EUR J NUCL MED, V27, P1658, DOI 10.1007/s002590000364; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; Lorberboym M, 2002, AM J EMERG MED, V20, P310, DOI 10.1053/ajem.2002.34201; MARION DW, 1991, J CEREBR BLOOD F MET, V11, P347, DOI 10.1038/jcbfm.1991.69; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Nobili F, 2001, DEMENT GERIATR COGN, V12, P89, DOI 10.1159/000051241; Novak V, 2003, NEUROLOGY, V60, P1657, DOI 10.1212/01.WNL.0000068023.14587.06; Okazawa H, 2001, J CEREBR BLOOD F MET, V21, P1472, DOI 10.1097/00004647-200112000-00012; Pindzola RR, 1998, NEUROSURGERY, V43, P1488; PLOUGMANN J, 1994, J NEUROSURG, V81, P822, DOI 10.3171/jns.1994.81.6.0822; Ratsep T, 2001, J NEUROSURG, V95, P393, DOI 10.3171/jns.2001.95.3.0393; ROSENBERG JH, 1995, NEUROLOGY, V45, P1012; Seiler RW, 1992, TRANSCRANIAL DOPPLER; Sen J, 2003, LANCET NEUROL, V2, P614, DOI 10.1016/S1474-4422(03)00531-3; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Smith MJ, 2004, J NEUROSURG, V101, P1, DOI 10.3171/jns.2004.101.1.0001; Soehle M, 2004, ANESTH ANALG, V98, P1133, DOI 10.1213/01.ANE.0000111101.41190.99; Tai YF, 2004, J NEUROL NEUROSUR PS, V75, P669, DOI 10.1136/jnnp.2003.028175; Toole J, 1990, CEREBROVASCULAR DISO; Treggiari MM, 2003, J NEUROSURG, V98, P978, DOI 10.3171/jns.2003.98.5.0978; WEBSTER MW, 1995, J VASC SURG, V21, P338, DOI 10.1016/S0741-5214(95)70274-1; White RP, 1997, STROKE, V28, P1340, DOI 10.1161/01.STR.28.7.1340; Wintermark M, 2004, CRIT CARE MED, V32, P1579, DOI 10.1097/01.CCM.0000130171.08842.72; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; WITT JP, 1994, AM J NEURORADIOL, V15, P847; Wozniak MA, 1996, J NEUROIMAGING, V6, P87, DOI 10.1111/jon19966287; YONAS H, 1993, J NEUROSURG, V79, P483, DOI 10.3171/jns.1993.79.4.0483; YONAS H, 1995, SCI AM, V2, P58	58	20	21	1	4	AMER ASSOC CRITICAL CARE NURSES	ALISO VIEJO	101 COLUMBIA, ALISO VIEJO, CA 92656 USA	1559-7768	1559-7776		AACN ADV CRIT CARE	AACN Adv. Crit. Care	OCT-DEC	2005	16	4					476	487		10.1097/00044067-200510000-00005			12	Nursing	Emerging Sources Citation Index (ESCI)	Nursing	VF0BG	WOS:000441621700005	16269893				2022-02-06	
J	Yehuda, R; Bryant, R; Marmar, C; Zohar, J				Yehuda, R; Bryant, R; Marmar, C; Zohar, J			Pathological responses to terrorism	NEUROPSYCHOPHARMACOLOGY			English	Article						terrorism; posttraumatic stress disorder; risk factors; biological studies; prospective studies	POSTTRAUMATIC-STRESS-DISORDER; MOTOR-VEHICLE ACCIDENTS; 2-YEAR PROSPECTIVE EVALUATION; AUDITORY STARTLE RESPONSE; TRAUMATIC BRAIN-INJURY; ROAD TRAFFIC ACCIDENTS; DELAYED-ONSET PTSD; NEW-YORK-CITY; PERITRAUMATIC DISSOCIATION; PREDICTING PTSD	Many important gains have been made in understanding PTSD and other responses to trauma as a result of neuroscience- based observations. Yet there are many gaps in our knowledge that currently impede our ability to predict those who will develop pathologic responses. Such knowledge is essential for developing appropriate strategies for mounting a mental health response in the aftermath of terrorism and for facilitating the recovery of individuals and society. This paper reviews clinical and biological studies that have led to an identification of pathologic responses following psychological trauma, including terrorism, and highlights areas of future-research. It is important to not only determine risk factors for the development of short-and long-term mental health responses to terrorism, but also apply these risk factors to the prediction of such responses on an individual level. It is also critical to consider the full spectrum of responses to terrorism, as well as the interplay between biological and psychological variables that contribute to these responses. Finally, it is essential to remove the barriers to collecting data in the aftermath of trauma by creating a culture of education in which the academic community can communicate to the public what is and is not known so that survivors of trauma and terrorism will understand the value of their participation in research to the generation of useful knowledge, and by maintaining the acquisition of knowledge as a priority for the government and those involved in the immediate delivery of services in the aftermath of large-scale disaster or trauma.	Bronx Vet Affairs Med Ctr, Psychiat OOMH, Bronx, NY 10468 USA		Yehuda, R (corresponding author), Bronx Vet Affairs Med Ctr, Psychiat OOMH, 130 W Kingsbridge Rd, Bronx, NY 10468 USA.	Rachel.Yehuda@med.va.gov	Marmar, Charles R./O-1902-2017; Bryant, Richard/AAA-6479-2019	Marmar, Charles R./0000-0001-8427-5607; Bryant, Richard/0000-0002-9607-819X			*AM PSYCH ASS, 1994, DIAGN STAT MAN 4 R; Andrews B, 2000, J ABNORM PSYCHOL, V109, P69, DOI 10.1037/0021-843X.109.1.69; BOHUS B, 1968, INT J NEUROPHARMACOL, V7, P301; Boscarino JA, 1996, J CONSULT CLIN PSYCH, V64, P191, DOI 10.1037/0022-006X.64.1.191; BRESLAU N, 1991, ARCH GEN PSYCHIAT, V48, P216; Breslau N, 1999, AM J PSYCHIAT, V156, P902, DOI 10.1176/ajp.156.6.902; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brewin CR, 1999, AM J PSYCHIAT, V156, P360; Brunet A, 2001, AM J PSYCHIAT, V158, P1480, DOI 10.1176/appi.ajp.158.9.1480; Bryant RA, 2003, BIOL PSYCHIAT, V53, P789, DOI 10.1016/S0006-3223(02)01895-4; Bryant RA, 2000, J ABNORM PSYCHOL, V109, P341, DOI 10.1037/0021-843X.109.2.341; Bryant RA, 2001, BEHAV RES THER, V39, P961, DOI 10.1016/S0005-7967(00)00086-3; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Bryant RA, 2002, AUST NZ J PSYCHIAT, V36, P205, DOI 10.1046/j.1440-1614.2002.01009.x; Buckley TC, 1996, J ABNORM PSYCHOL, V105, P617, DOI 10.1037/0021-843X.105.4.617; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; Dancu CV, 1996, J TRAUMA STRESS, V9, P253, DOI 10.1007/BF02110659; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Delahanty DL, 1997, J CONSULT CLIN PSYCH, V65, P560, DOI 10.1037/0022-006X.65.4.560; Delahanty DL, 2000, BIOL PSYCHIAT, V48, P940, DOI 10.1016/S0006-3223(00)00896-9; Difede J, 2002, PSYCHOSOM MED, V64, P826, DOI 10.1097/01.PSY.0000024237.11538.08; Dunmore E, 2001, BEHAV RES THER, V39, P1063, DOI 10.1016/S0005-7967(00)00088-7; Ehlers A, 1998, J ABNORM PSYCHOL, V107, P508, DOI 10.1037/0021-843X.107.3.508; Galea S, 2002, NEW ENGL J MED, V346, P982, DOI 10.1056/NEJMsa013404; Galea S, 2003, AM J EPIDEMIOL, V158, P514, DOI 10.1093/aje/kwg187; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; GREEN BL, 1990, AM J ORTHOPSYCHIAT, V60, P43, DOI 10.1037/h0079168; Guthrie RM, 2005, AM J PSYCHIAT, V162, P283, DOI 10.1176/appi.ajp.162.2.283; Harvey AG, 1999, J CONSULT CLIN PSYCH, V67, P985, DOI 10.1037/0022-006X.67.6.985; Harvey AG, 1998, J CONSULT CLIN PSYCH, V66, P507, DOI 10.1037/0022-006X.66.3.507; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Harvey AG, 2002, PSYCHOL BULL, V128, P886, DOI 10.1037//0033-2909.128.6.886; Holeva V, 2001, BEHAV THER, V32, P65, DOI 10.1016/S0005-7894(01)80044-7; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Keane T., 2001, DISSOCIATIVE STATES, P21; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; KOOPMAN C, 1995, J TRAUMA STRESS, V8, P29, DOI 10.1007/BF02105405; KOOPMAN C, 1994, AM J PSYCHIAT, V151, P888; Maes M, 2001, J AFFECT DISORDERS, V63, P113, DOI 10.1016/S0165-0327(00)00173-7; MARMAR C, 2003, UNPUB IMPACT WORLD T; MARMAR CR, 1994, AM J PSYCHIAT, V151, P902; Marmar CR, 1999, J NERV MENT DIS, V187, P15, DOI 10.1097/00005053-199901000-00004; Marshall GN, 2002, J ABNORM PSYCHOL, V111, P626, DOI 10.1037//0021-843X.111.4.626; MAYOU R, 1993, BRIT MED J, V307, P647, DOI 10.1136/bmj.307.6905.647; MCFARLANE AC, 1989, BRIT J PSYCHIAT, V154, P221, DOI 10.1192/bjp.154.2.221; McNally RJ, 2003, BIOL PSYCHIAT, V53, P779, DOI 10.1016/S0006-3223(02)01663-3; Murray J, 2002, BRIT J PSYCHIAT, V180, P363, DOI 10.1192/bjp.180.4.363; Neylan TC, 2003, NEUROPSYCHOPHARMACOL, V28, P1666, DOI 10.1038/sj.npp.1300215; Nietzel MT, 1996, CONTEMP PSYCHOL, V41, P642; Nishith P, 2000, J ABNORM PSYCHOL, V109, P20, DOI 10.1037/0021-843X.109.1.20; North Carol S, 2002, CNS Spectr, V7, P580; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; Orr SP, 1997, ANN NY ACAD SCI, V821, P114, DOI 10.1111/j.1749-6632.1997.tb48273.x; Ozer EJ, 2003, PSYCHOL BULL, V129, P52, DOI 10.1037//0033-2909.129.1.52; PACAK K, 1995, FRONT NEUROENDOCRIN, V16, P89, DOI 10.1006/frne.1995.1004; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Pitman RK, 2000, NEW COGNITIVE NEUROS, P687; RAUSCH LS, 1997, PSYCHOL TRAUMA ANN R, V17, P67; RESNICK HS, 1995, AM J PSYCHIAT, V152, P1675; Schnyder U, 2001, AM J PSYCHIAT, V158, P594, DOI 10.1176/appi.ajp.158.4.594; Schuster MA, 2001, NEW ENGL J MED, V345, P1507, DOI 10.1056/NEJM200111153452024; SHALEV AY, 1992, J NERV MENT DIS, V180, P505, DOI 10.1097/00005053-199208000-00005; Shalev AY, 1998, ARCH GEN PSYCHIAT, V55, P553, DOI 10.1001/archpsyc.55.6.553; Shalev AY, 1997, BRIT J PSYCHIAT, V170, P558, DOI 10.1192/bjp.170.6.558; Shalev AY, 1998, AM J PSYCHIAT, V155, P630, DOI 10.1176/ajp.155.5.630; Shalev AY, 2000, AM J PSYCHIAT, V157, P255, DOI 10.1176/appi.ajp.157.2.255; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Silva RR, 2000, AM J PSYCHIAT, V157, P1229, DOI 10.1176/appi.ajp.157.8.1229; Simeon D, 2003, PSYCHIAT RES, V121, P93, DOI 10.1016/S0165-1781(03)00205-1; Smith K, 2000, BEHAV RES THER, V38, P709, DOI 10.1016/S0005-7967(99)00096-0; SOLOMON Z, 1989, PSYCHIATRY, V52, P428, DOI 10.1080/00332747.1989.11024467; Southwick SM, 1997, ARCH GEN PSYCHIAT, V54, P749; SOUTHWICK SM, 1993, ARCH GEN PSYCHIAT, V50, P266; Staab JP, 1996, ANXIETY, V2, P219, DOI 10.1002/(SICI)1522-7154(1996)2:5<219::AID-ANXI3>3.0.CO;2-H; Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675; TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002; Vaiva G, 2004, BIOL PSYCHIAT, V55, P250, DOI 10.1016/j.biopsych.2003.08.009; Wong CM, 2002, PSYCHIAT CLIN N AM, V25, P369, DOI 10.1016/S0193-953X(01)00006-5; Yehuda R, 2000, AM J PSYCHIAT, V157, P1252, DOI 10.1176/appi.ajp.157.8.1252; Yehuda R, 1998, BIOL PSYCHIAT, V44, P1305, DOI 10.1016/S0006-3223(98)00276-5; Yehuda R, 1999, CAN J PSYCHIAT, V44, P34, DOI 10.1177/070674379904400104; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; YEHUDA R, 1995, AM J PSYCHIAT, V152, P1705; Yehuda R, 2001, J PSYCHIAT RES, V35, P261, DOI 10.1016/S0022-3956(01)00032-2; YEHUDA R, 1999, RISK FACTORS POSTRAU; Zangrossi H, 1999, EUR J PHARMACOL, V369, P267, DOI 10.1016/S0014-2999(99)00075-8	89	20	20	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	OCT	2005	30	10					1793	1805		10.1038/sj.npp.1300816			13	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	965VJ	WOS:000231978200003	16012535	Bronze			2022-02-06	
J	Aimaretti, G; Ghigo, E				Aimaretti, Gianluca; Ghigo, Ezio			Traumatic brain injury and hypopituitarism	THESCIENTIFICWORLDJOURNAL			English	Article						traumatic brain injury (TBI); hypopituitarism; pituitary deficits	ANEURYSMAL SUBARACHNOID HEMORRHAGE; HEAD-INJURY; NEUROENDOCRINE DYSFUNCTION; PITUITARY DYSFUNCTION; EPIDEMIOLOGY; PREVALENCE; LESIONS	Results of recent and ongoing studies have made it clear that brain injuries like traumatic brian injury (TBI) pose substantial risk to pituitary function, perhaps even greater risk than previously believed. Patients with TBI should be screened both prospectively and retrospectively for isolated, multiple, and even total pituitary deficits. It is well known that patients with "classical" hypopituitarism (due to primary hypothalamic-pituitary pathologies) do benefit from hormonal replacement therapy. It has been suggested that patients with TBI-induced hypopituitarism may benefit with appropriate hormonal replacement receiving replacement therapy such as antidiuretic hormone (ADH), glucocorticoid, and thyroid hormones when needed. Gonadal and recombinant human growth hormone (rhGH) replacement therapy should also be introduced if there are deficiencies demonstrated and even reconfirmed in a second step. The signs and symptoms of post-TBI hypopituitarism may be masked by what has been assumed to be merely the post-traumatic syndrome. By increasing awareness among physicians of the risks of brain injuries-induced endocrinopathies and the need for appropriate endocrinological testing, it may be possible to improve the quality of life and enhance the rehabilitation prospects for these patients. In most instances, these patients are first seen and treated by trauma surgeons and neurosurgeons, and subsequently by rehabilitation physicians; they must be knowledgeable about the risks of hypopituitarism so that they can determine which patients are candidates for screening for hypopituitarism. In addition, endocrinologists and internists must be educated about TBI-induced hypopituitarism and encouraged to actively share their expertise with other physicians.	Univ Turin, Dept Internal Med, Div Endocrinol & Metab, I-10126 Turin, Italy		Ghigo, E (corresponding author), Univ Turin, Dept Internal Med, Div Endocrinol & Metab, Corso Dogliotti 14, I-10126 Turin, Italy.	gianluca.aimaretti@unito.it; ezio.ghigo@unito.it					Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; AIMARETTI G, 2005, UNPUB J CLIN ENDOCRI; ALTMAN R, 1961, ANN INTERN MED, V55, P149, DOI 10.7326/0003-4819-55-1-149; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Brandt L, 2004, ACTA NEUROL SCAND, V109, P91, DOI 10.1046/j.0001-6314.2003.00189.x; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; DANIEL PM, 1959, LANCET, V2, P927; De Marinis L, 1999, CLIN ENDOCRINOL, V50, P741; EDWARDS OM, 1986, MEDICINE, V65, P281; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Hillier SL, 1997, BRAIN INJURY, V11, P649; JENNETT B, 1981, BRIT MED J, V282, P101, DOI 10.1136/bmj.282.6258.101; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Kreitschmann-Andermahr I, 2004, J CLIN ENDOCR METAB, V89, P4986, DOI 10.1210/jc.2004-0146; KUSUNAGI H, 2000, J NIPPON MED SCH, V67, P130; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; NELL V, 1991, SOC SCI MED, V33, P289, DOI 10.1016/0277-9536(91)90363-H; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Servadei F, 2002, NEUROEPIDEMIOLOGY, V21, P297, DOI 10.1159/000065523; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; VAZQUEZBARQUERO A, 1992, EUR J EPIDEMIOL, V8, P832, DOI 10.1007/BF00145328	27	20	20	0	9	THESCIENTIFICWORLD LTD	NEWBURY	29-34, VENTURE WEST, NEW GREENHAM PARK, NEWBURY, BERKSHIRE RG19 6HX, ENGLAND	1537-744X			THESCIENTIFICWORLDJO	TheScientificWorldJOURNAL	SEP	2005	5						777	781		10.1100/tsw.2005.100			5	Environmental Sciences; Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Science & Technology - Other Topics	110NL	WOS:000242385500009	16170439	gold, Green Published, Green Submitted			2022-02-06	
J	Card, JP; Santone, DJ; Gluhovsky, MY; Adelson, PD				Card, JP; Santone, DJ; Gluhovsky, MY; Adelson, PD			Plastic reorganization of hippocampal and neocortical circuitry in experimental traumatic brain injury in the immature rat	JOURNAL OF NEUROTRAUMA			English	Article						development; head trauma; pseudorabies virus; transneuronal tracing	CONTROLLED CORTICAL IMPACT; PSEUDORABIES VIRUS-INFECTION; CENTRAL AUTONOMIC CIRCUITS; CENTRAL-NERVOUS-SYSTEM; ADULT-RAT; NEURAL PATHWAYS; HEAD-INJURY; APOPTOSIS; MODELS; DEATH	The reorganization of circuitry in the immature forebrain resulting from controlled cortical impact was examined with viral transneuronal tracing. Animals injured on postnatal day (PND) 17 and sham controls from the same litters received an intracerebral injection of a recombinant strain of pseudorabies virus (PRV) into the entorhinal cortex on PND 45. Fifty hours following injection of virus the animals were perfused and infected neurons were localized immunohistochemically with antisera specific for PRV. Prior studies have demonstrated that the PRV recombinant used in this analysis moves exclusively in the retrograde direction through synaptically linked neurons. CCI induced a necrotic loss of cortex at the site of impact and variable damage to the underlying corpus callosum and rostral (dorsal) hippocampus that was not present in sham controls. Analysis of viral transport in sham controls revealed retrograde transport of virus through hippocampal and neocortical circuitry in a pattern consistent with established patterns of connectivity and topography. Injured animals exhibited preservation of topographically organized connections in both the hippocampus and neocortex. However, the magnitude of labeling in the injured hemisphere was significantly increased relative to control animals and correlated with the magnitude of the injury. The distribution of infected neurons in the contralateral uninjured hemisphere also conformed to known connections. However differences in the involvement of the corpus callosum in the injury resulted in greater variability in the number of infected neurons among cases. These data provide novel insights into trauma induced reorganization of the developing brain and add to the experimental tools that can be used to assess the basis for functional recovery in animal models of developmental traumatic brain injury.	Univ Pittsburgh, Dept Neurosurg, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA		Card, JP (corresponding author), Univ Pittsburgh, Dept Neurosurg, 446 Crawford Hall, Pittsburgh, PA 15260 USA.	card@bns.pitt.edu	Adelson, David/W-2083-2019	Card, John/0000-0002-6148-7364			Adelson PD, 1998, ACT NEUR S, V71, P104; Adelson PD, 1996, J NEUROSURG, V85, P877, DOI 10.3171/jns.1996.85.5.0877; Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Adelson PD, 1999, EXP TOXICOL PATHOL, V51, P130; Amaral David G., 1995, P443; Billig I, 2000, J NEUROSCI, V20, P7446; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Cano G, 2004, J COMP NEUROL, V471, P462, DOI 10.1002/cne.20040; Card J.P., 1999, CURRENT PROTOCOLS NE, P151; Card JP, 1995, J NEUROVIROL, V1, P349, DOI 10.3109/13550289509111024; CARD JP, 1990, J NEUROSCI, V10, P1974; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Card JP, 2001, ADV VIRUS RES, V56, P39, DOI 10.1016/S0065-3527(01)56004-2; Clark RSB, 1997, J NEUROSCI, V17, P9172; Conti AC, 1998, J NEUROSCI, V18, P5663; Dixon C. E., 1995, CENTRAL NERVOUS SYST, P255; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Enquist LW, 1999, ADV VIRUS RES, V51, P237; GALL C, 1980, J COMP NEUROL, V193, P1047, DOI 10.1002/cne.901930416; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HOFF SF, 1986, NEUROSCIENCE, V19, P1227, DOI 10.1016/0306-4522(86)90136-3; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Kempermann G, 2004, CURR OPIN NEUROBIOL, V14, P186, DOI 10.1016/j.conb.2004.03.001; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Keyvani K, 2002, J NEUROPATH EXP NEUR, V61, P831, DOI 10.1093/jnen/61.10.831; Kim ES, 2002, J NEUROTRAUM, V19, P787, DOI 10.1089/08977150260139156; Kovac AD, 2004, BRAIN PATHOL, V14, P249; KRISTT DA, 1987, J NEUROPATH EXP NEUR, V46, P668, DOI 10.1097/00005072-198711000-00006; Lee JW, 2000, J COMP NEUROL, V418, P484; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; MARCHAND CF, 1986, BRAIN RES, V383, P262, DOI 10.1016/0006-8993(86)90024-7; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; O'Dell DM, 2000, J NEUROSCI, V20, P4821; Pickard GE, 2002, J NEUROSCI, V22, P2701, DOI 10.1523/JNEUROSCI.22-07-02701.2002; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Prins ML, 1996, DEV BRAIN RES, V95, P272, DOI 10.1016/S0165-3806(96)00098-3; Rinaman L, 1999, DEV BRAIN RES, V114, P207, DOI 10.1016/S0165-3806(99)00039-5; Rinaman L, 2000, J NEUROSCI, V20, P2731; SAUNDERS JW, 1966, SCIENCE, V154, P604, DOI 10.1126/science.154.3749.604; Singleton RH, 2004, J NEUROSCI, V24, P3543, DOI 10.1523/JNEUROSCI.5048-03.2004; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; STEVENSON HW, 2000, J PSYCHOL CHINESE SO, V1, P1; Sugaya K, 1997, NEUROSCI LETT, V223, P197, DOI 10.1016/S0304-3940(97)13433-4; VAHLNE A, 1980, INFECT IMMUN, V28, P675; VAHLNE A, 1978, J GEN VIROL, V40, P359, DOI 10.1099/0022-1317-40-2-359; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; Yakovlev AG, 1997, J NEUROSCI, V17, P7415	51	20	20	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2005	22	9					989	1002		10.1089/neu.2005.22.989			14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	967HP	WOS:000232082600006	16156714				2022-02-06	
J	Fuller, DA; Mark, A; Keenan, MAE				Fuller, DA; Mark, A; Keenan, MAE			Excision of heterotopic ossification from the knee - A functional outcome study	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article							TRAUMATIC BRAIN-INJURY; FLEXION CONTRACTURES; BONE-FORMATION; HEAD TRAUMA; RESECTION; PROPHYLAXIS; RADIATION; ADULTS; GAIT	We retrospectively reviewed 17 consecutive patients with neurologic injuries (22 knees) who had excision of heterotopic ossification (22 knees, five bilateral) of the knees. Our primary research goal was to determine the change in range of motion at the knee after resection of heterotopic ossification in patients with neurologic injuries. Our secondary research goal was to determine the mobility gains measured regarding ambulatory and sitting functions for these patients. Diagnoses included traumatic brain injury (15 patients), anoxia (one patient), and spinal cord injury (one patient). The average age of the patients was 33 years (range, 19-51 years). Data were collected by an independent observer and included range of motion of the knee, ambulatory ability according to a five-level scale, and sitting ability according to a three-level scale. The average followup was 32 months. Range of motion improved by 65 degrees postoperatively. Extension improved from a preoperative mean of 16 degrees to a postoperative mean of 2 degrees. Flexion improved from a preoperative mean of 57 degrees to a postoperative mean of 107 degrees. Ambulatory and sitting function improved as a result of treatment. Surgical excision of heterotopic ossification of the knee is an effective procedure to increase joint mobility and function.	Moss Rehab Hosp, Philadelphia, PA USA		Fuller, DA (corresponding author), Univ Med & Dent New Jersey, Cooper Hosp, 3 Cooper Plaza,Suite 411, Camden, NJ 08103 USA.	dafuller1230@hotmail.com	Keenan, Mary Ann/ABB-1551-2020				BONTKE CB, 1988, J HEAD TRAUMA REHAB, V3, P86; Botte MJ, 1997, ORTHOPEDICS, V20, P335; CERNY K, 1994, ORTHOPEDICS, V17, P501; Charnley G, 1996, INJURY, V27, P125, DOI 10.1016/0020-1383(95)00180-8; Chidel MA, 2001, J ARTHROPLASTY, V16, P1, DOI 10.1054/arth.2001.16492; CITTAPIETROLUNGO TJ, 1992, ARCH PHYS MED REHAB, V73, P258; FREED JH, 1982, PARAPLEGIA, V20, P208, DOI 10.1038/sc.1982.39; GACON G, 1978, REV CHIR ORTHOP, V64, P375; GACON G, 1975, REV CHIR ORTHOP, V61, P269; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P59; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GARLAND DE, 1991, CLIN ORTHOP RELAT R, P13; Gennarelli T A, 1988, Brain Inj, V2, P175, DOI 10.3109/02699058809150942; HERNANDEZ GR, 2000, REV ESP MED NUCL, V19, P495; HOFFINGER SA, 1993, J PEDIATR ORTHOPED, V13, P722, DOI 10.1097/01241398-199311000-00006; Ippolito E, 1999, J BONE JOINT SURG AM, V81A, P783, DOI 10.2106/00004623-199906000-00005; Johns JS, 1999, J HEAD TRAUMA REHAB, V14, P269, DOI 10.1097/00001199-199906000-00007; Keenan M A, 1988, Orthop Rev, V17, P1185; KEENAN MA, 1984, FOOT ANKLE, V5, P35, DOI 10.1177/107110078400500105; Kolessar DJ, 1996, J HEAD TRAUMA REHAB, V11, P78, DOI 10.1097/00001199-199608000-00010; MALONEY WJ, 1992, CLIN ORTHOP RELAT R, P230; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; PETERS WJ, 1990, J BURN CARE REHABIL, V114, P318; POTTER PJ, 1991, AM J PHYS MED REHAB, V70, P301; Rubenstein J H, 1992, J Fla Med Assoc, V79, P828; Subbarao J V, 1999, J Spinal Cord Med, V22, P273; Subbarao J V, 1987, J Am Paraplegia Soc, V10, P3	28	20	22	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	SEP	2005		438					197	203		10.1097/01.blo.0000170718.86747.da			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	962HN	WOS:000231721800033	16131891				2022-02-06	
J	Schmitter-Edgecombe, M; Bales, JW				Schmitter-Edgecombe, M; Bales, JW			Understanding text after severe closed-head injury: Assessing inferences and memory operations with a think-aloud procedure	BRAIN AND LANGUAGE			English	Article						traumatic brain injury; closed-head injury; think-aloud; protocol analysis; language; discourse; comprehension; inferences; memory; working memory	TRAUMATIC BRAIN-INJURY; DIFFUSE AXONAL INJURY; RIGHT-HEMISPHERE; COMPREHENSION; DEFICITS; ABILITIES; COHERENCE; CAPACITY; LESIONS; SKILL	A think-aloud method was used to examine. the content of information available to working memory during narrative comprehension in a CHI population. Twenty severe CHI participants (> 1 year post-injury) and 20 controls talked aloud after they read each sentence of story narratives. Trabasso and Magliano's (1996a) verbal protocol analysis was then used to code for the production of inferential and non-inferential clauses and the memory operations that supported inferential clause, production. We found that CHI and control groups produced a comparable number of clauses, that inferences dominated narrative comprehension, and that both groups produced more, explanatory inferences than predictive or associative inferences. Despite these qualitative similarities, the CHI group demonstrated poorer comprehension, generated proportionately fewer inferences, relied less on retrieval as a memory source for explanatory inferences, and produced more non-inferential clauses and associative inferences. (c) 2005 Elsevier Inc. All rights reserved.	Washington State Univ, Dept Psychol, Pullman, WA 99164 USA		Schmitter-Edgecombe, M (corresponding author), Washington State Univ, Dept Psychol, Pullman, WA 99164 USA.	schmitter-a@wsu.edu					ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BARONA A, 1984, J CONSULT CLIN PSYCH, V52, P885, DOI 10.1037/0022-006X.52.5.885; BEEMAN M, 1993, BRAIN LANG, V44, P80, DOI 10.1006/brln.1993.1006; Benton A., 1976, MULTILINGUAL APHASIA; BIHRLE AM, 1986, BRAIN COGNITION, V5, P399, DOI 10.1016/0278-2626(86)90042-4; BRITTON BK, 1983, DISCOURSE PROCESS, V6, P39, DOI 10.1080/01638538309544553; BROWNELL HH, 1986, BRAIN LANG, V27, P310, DOI 10.1016/0093-934X(86)90022-2; Channon S, 2000, NEUROPSYCHOLOGIA, V38, P1006, DOI 10.1016/S0028-3932(99)00154-2; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; COELHO CA, 1995, APHASIOLOGY, V9, P409, DOI 10.1080/02687039508248707; Cote N, 1999, CONSTRUCTION OF MENTAL REPRESENTATIONS DURING READING, P169; Delis DC, 1987, CALIFORNIA VERBAL LE; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Ferstl EC, 2001, COGNITIVE BRAIN RES, V11, P325, DOI 10.1016/S0926-6410(01)00007-6; Fonteyn M.E., 1993, QUAL HEALTH RES, V3, DOI [DOI 10.1177/104973239300300403, https://doi.org/10.1177/104973239300300403]; German D.J., 1991, TEST WORD FINDING DI; GERNSBACHER MA, 1990, J EXP PSYCHOL LEARN, V16, P430, DOI 10.1037/0278-7393.16.3.430; Gernsbacher MA, 1997, AGING NEUROPSYCHOL C, V4, P175, DOI 10.1080/13825589708256646; Golden J. C., 1978, STROOP COLOR WORD TE; Graesser A, 1991, HDB READING RES, P171; GRAESSER AC, 1993, DISCOURSE PROCESS, V16, P145, DOI 10.1080/01638539309544833; GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371; Graesser Arthur, 1985, STRUCTURES PROCEDURE; HARTLEY L L, 1991, Brain Injury, V5, P267, DOI 10.3109/02699059109008097; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; Haut MW, 1991, NEUROPSYCHOLOGY, V5, P81, DOI 10.1037/0894-4105.5.2.81; Heaton RK, 1981, MANUAL WISCONSIN CAR; Laing SP, 2002, J LEARN DISABIL-US, V35, P436, DOI 10.1177/00222194020350050401; Langston MC, 1999, LANG SPEECH & COMMUN, P181; Lehman-Blake MT, 2001, J SPEECH LANG HEAR R, V44, P639, DOI 10.1044/1092-4388(2001/052); LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LILES BZ, 1989, J SPEECH HEAR DISORD, V54, P356, DOI 10.1044/jshd.5403.356; Magliano JP, 2003, COGNITION INSTRUCT, V21, P251, DOI 10.1207/S1532690XCI2103_02; Magliano JP, 1999, J EDUC PSYCHOL, V91, P615, DOI 10.1037/0022-0663.91.4.615; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Nicholas L.E., 1995, AM J SPEECH LANGUAGE, V4, P69, DOI [DOI 10.1044/1058-0360.0403.69, 10.1044/1058-0360.0403.69]; Pressley M., 1995, VERBAL PROTOCOLS REA; Simon, 1993, PROTOCOL ANAL VERBAL; Smith A., 1991, SYMBOL DIGIT MODALIT; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; TEASDALE G, 1974, LANCET, V2, P81; TRABASSO T, 1993, DISCOURSE PROCESS, V16, P3, DOI 10.1080/01638539309544827; Trabasso T, 1996, DISCOURSE PROCESS, V21, P255, DOI 10.1080/01638539609544959; TRABASSO T, 1985, J MEM LANG, V24, P612, DOI 10.1016/0749-596X(85)90049-X; Trabasso T., 1984, LEARNING COMPREHENSI; TRABASSO T, 1996, 1 R EVERY CHILDS RIG; Vanderploeg RD, 2001, J CLIN EXP NEUROPSYC, V23, P185, DOI 10.1076/jcen.23.2.185.1210; Wechsler D., 1997, WECHSLER MEMORY SCAL; WHITNEY P, 1991, DISCOURSE PROCESS, V14, P133, DOI 10.1080/01638539109544779; WILSON JTL, 1995, J NEUROL NEUROSUR PS, V59, P328, DOI 10.1136/jnnp.59.3.328; Zwaan RA, 1996, DISCOURSE PROCESS, V21, P289, DOI 10.1080/01638539609544960	52	20	21	0	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	SEP	2005	94	3					331	346		10.1016/j.bandl.2005.01.007			16	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	959NO	WOS:000231524900007	16098381				2022-02-06	
J	Egan, J; Worrall, L; Oxenham, D				Egan, J; Worrall, L; Oxenham, D			An Internet training intervention for people with traumatic brain injury: Barriers and outcomes	BRAIN INJURY			English	Article						TBI; brain injury; aphasia-friendly; digital divide; accessibility; disability; Internet; training; computers	CLOSED HEAD-INJURY	Primary objective: To test whether people with cognitive-linguistic impairments following traumatic brain injury could learn to use the Internet using specialized training materials. Research design: Pre-post test design. Methods and procedures: Seven participants were each matched with a volunteer tutor. Basic Internet skills were taught over six lessons using a tutor's manual and a student manual. Instructions used simple text and graphics based on Microsoft Internet Explorer 5.5. Students underwent Internet skills assessments and interviews pre- and post-training. Tutors completed a post-training questionnaire. Main outcomes and results: Six of seven participants reached moderate-to-high degrees of independence. Literacy impairment was an expected training barrier; however, cognitive impairments affecting concentration, memory and motivation were more significant. Conclusions: Findings suggest that people with cognitive-linguistic impairments can learn Internet skills using specialized training materials. Participants and their carers also reported positive outcomes beyond the acquisition of Internet skills.	Univ Queensland, Commun Disabil Ageing Res Unit, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia		Worrall, L (corresponding author), Univ Queensland, Commun Disabil Ageing Res Unit, Dept Speech Pathol & Audiol, Brisbane, Qld 4072, Australia.	l.worrall@uq.edu.au	Worrall, Linda/D-2579-2010	Worrall, Linda/0000-0002-3283-7038			BODDY G, 1997, HIGHER ED RES DEV, V16, P342; Crisp R., 1994, J APPL REHABILITATIO, V25, P16; Egan J, 2004, APHASIOLOGY, V18, P265, DOI 10.1080/02687030344000562; FIFIELD MG, 1997, TECHNOLOGY DISABILIT, V6, P77; FRANCIK E, 2001, TELECOMMUNICATION PR; HARTLEY LL, 1990, APHASIOLOGY, V4, P353, DOI 10.1080/02687039008249088; HARTLEY LL, 1995, NEUROGENIC COMMUNICA, V2, P289; Kertesz A., 1982, W APHASIA BATTERY; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; King NS, 2003, HDB CLIN NEUROPSYCHO, P487; Lezak MD, 1995, NEUROPSYCHOLOGICAL A, P17; Nochi M, 1998, QUAL HEALTH RES, V8, P665, DOI 10.1177/104973239800800507; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; OWENS J, 2001, LIT REV COMPUTER INT; RAPPAPORT M, 1989, ARCH PHYS MED REHAB, V70, P885; Rowlands A, 2001, FAM SOC-J CONTEMP H, V82, P273, DOI 10.1606/1044-3894.201; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; Simpson G, 2000, BRAIN INJURY, V14, P125, DOI 10.1080/026990500120790; Simpson G., 2002, AUST SOC WORK, V55, P24, DOI [10.1080/03124070208411669, DOI 10.1080/03124070208411669]; SNOW P, 1995, TRAUMATIC BRAIN INJU, P137; SNOW P, 1995, TRAUMATIC BRAIN INJU, P65; Sohlberg MM, 2003, BRAIN INJURY, V17, P609, DOI 10.1080/0269905031000070189; Swift TL, 2001, BRAIN INJURY, V15, P149, DOI 10.1080/026990501458380; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Togher L., 2000, BRAIN DAM B, P1; Webb D, 1998, SOCIOLOGY, V32, P541, DOI 10.1177/0038038598032003008; WILLIAMS BW, 1989, NEUROPSYCHOLOGIA, V27, P1073, DOI 10.1016/0028-3932(89)90186-3	27	20	20	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2005	19	8					555	568		10.1080/02699050400013659			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	933IS	WOS:000229622700001	16175810				2022-02-06	
J	Zaltzman, R; Alexandrovich, A; Trembovler, V; Shohami, E; Gozes, I				Zaltzman, R; Alexandrovich, A; Trembovler, V; Shohami, E; Gozes, I			The influence of the peptide NAP on Mac-1-deficient mice following closed head injury	PEPTIDES			English	Article; Proceedings Paper	4th Peptide Receptors Symposium	JUL 31-AUG 04, 2004	Montreal, CANADA			activity-dependent neuroprotective protein (ADNP); NAP; Mac-1; closed head injury (CHI); neurological severity score (NSS)	DEPENDENT NEUROPROTECTIVE PROTEIN; TRAUMATIC BRAIN-INJURY; INTERCELLULAR-ADHESION MOLECULE-1; NITRIC-OXIDE PRODUCTION; MAC-1 CD11B CD18; TRANSENDOTHELIAL MIGRATION; INFLAMMATORY RESPONSE; MEDIATES ADHERENCE; HUMAN MONOCYTES; RECEPTOR	A single administration of the neuroprotective peptide NAP was previously shown to protect against death associated with closed head injury (CHI) and enhance recovery of the surviving mice. The protective effect was accompanied by down-regulation of the relative mRNA content of the complement receptor 3 (Mac-1, a marker for inflammation) as measured about a month after the injury. In contrast, the mRNA transcripts for activity-dependent neuroprotective protein (ADNP, the NAP containing protein) were shown to increase 29 days post CHI in the injured hemisphere of Mac-1 expressing mice. The present study was set out to investigate: (1) are Mac-l-deficient mice less susceptible to the adverse outcome of traumatic head injury; (2) does NAP treatment affect Mac-l-deficient mice subjected to head injury; and (3) is Mac-1 expression associated with ADNP expression. Results showed that (1) Mac-l-deficient mice were partially protected against death associated with severe head injury as compared to Mac-1 expressing mice. (2) Significant protection against death was observed in NAP-treated mice and an increase in recovery was observed in the NAP-treated Mac-1 mice 4 weeks after injury. (3) ADNP expression did not change in the Mac-1-deficient mice following head injury. Our working hypothesis is that a month following injury, gene expression in the injured brain is altered and competing proteins are expressed such as Mac-1 that is associated with inflammation and ADNP that is associated with neuroprotection. Obviously, this plasticity in gene expression is intimately interwoven with the genetic background of the animal. NAP treatment tilts the balance toward neuroprotection. (c) 2005 Elsevier Inc. All rights reserved.	Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91905 Jerusalem, Israel		Gozes, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Biochem, IL-69978 Tel Aviv, Israel.	igozes@post.tau.ac.il					ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893; ALTIERI DC, 1988, P NATL ACAD SCI USA, V85, P7462, DOI 10.1073/pnas.85.20.7462; ANDERSON DC, 1990, BLOOD, V76, P2613; Bassan M, 1999, J NEUROCHEM, V72, P1283, DOI 10.1046/j.1471-4159.1999.0721283.x; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Benimetskaya L, 1997, NAT MED, V3, P414, DOI 10.1038/nm0497-414; Benirschke SK, 2004, J ORTHOP TRAUMA, V18, P1, DOI 10.1097/00005131-200401000-00001; Brenneman DE, 2000, BIOCHEM SOC T, V28, P983; CAMPBELL MJ, 1995, MED STAT; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Delgado M, 2003, FASEB J, V17, P1922, DOI 10.1096/fj.02-1029fje; Delgado M, 2002, J MOL MED, V80, P16, DOI 10.1007/s00109-001-0291-5; DIAMOND MS, 1990, J CELL BIOL, V111, P3129, DOI 10.1083/jcb.111.6.3129; Divinski I, 2004, J BIOL CHEM, V279, P28531, DOI 10.1074/jbc.M403197200; FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000; FURMAN S, 2005, IN PRESS NEURON GLIA; GLADWIN AM, 1990, BIOCHIM BIOPHYS ACTA, V1052, P166, DOI 10.1016/0167-4889(90)90072-L; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; GOODRUM KJ, 1994, INFECT IMMUN, V62, P3102, DOI 10.1128/IAI.62.8.3102-3107.1994; Gozes I, 2001, TRENDS NEUROSCI, V24, P700, DOI 10.1016/S0166-2236(00)01931-7; GOZES I, IN PRESS CURR ALZHEI; Hailer NP, 2001, NEUROSCI LETT, V298, P33, DOI 10.1016/S0304-3940(00)01711-0; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Ilschner S, 1996, GLIA, V18, P129, DOI 10.1002/(SICI)1098-1136(199610)18:2<129::AID-GLIA5>3.3.CO;2-G; Kipnis J, 2003, J NEUROTRAUM, V20, P559, DOI 10.1089/089771503767168483; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Leker RR, 2002, STROKE, V33, P1085, DOI 10.1161/01.STR.0000014207.05597.D7; Matsuno R, 1998, BIOCHEM BIOPH RES CO, V244, P115, DOI 10.1006/bbrc.1998.8231; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Neumann H, 2001, GLIA, V36, P191, DOI 10.1002/glia.1108; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Penkowa M, 1999, GLIA, V25, P343; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Reichert F, 2001, NEUROBIOL DIS, V8, P504, DOI 10.1006/nbdi.2001.0383; Romano J, 2002, J MOL NEUROSCI, V18, P37, DOI 10.1385/JMN:18:1-2:37; Salimi K, 2002, BRAIN RES, V946, P283, DOI 10.1016/S0006-8993(02)02896-2; SCHOLZ KH, 1990, ORG SYNTH, V7, P4; SHAPPELL SB, 1990, J IMMUNOL, V144, P2702; Shohami E, 1997, J NEUROIMMUNOL, V72, P169, DOI 10.1016/S0165-5728(96)00181-6; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SMITHSWINTOSKY VL, 2000, SOC NEUR ABST, V26, P843; Soriano SG, 1999, STROKE, V30, P134, DOI 10.1161/01.STR.30.1.134; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Stein SC, 2004, NEUROSURGERY, V54, P687, DOI 10.1227/01.NEU.0000108641.98845.88; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Stoll G, 2002, ADV EXP MED BIOL, V513, P87; Takeuchi A, 1998, EUR J NEUROSCI, V10, P1613, DOI 10.1046/j.1460-9568.1998.00168.x; Tan SM, 2000, J IMMUNOL, V165, P2574, DOI 10.4049/jimmunol.165.5.2574; Ugarova TP, 2001, ANN NY ACAD SCI, V936, P368; van Spriel AB, 2001, BLOOD, V97, P2478, DOI 10.1182/blood.V97.8.2478; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; Zaltzman R, 2004, J MOL NEUROSCI, V24, P181, DOI 10.1385/JMN:24:2:181; Zaltzman R, 2003, NEUROREPORT, V14, P481, DOI 10.1097/01.wnr.0000058036.29600.ff; Zamostiano R, 2001, J BIOL CHEM, V276, P708, DOI 10.1074/jbc.M007416200; Zemlyak I, 2000, REGUL PEPTIDES, V96, P39, DOI 10.1016/S0167-0115(00)00198-1	59	20	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0196-9781	1873-5169		PEPTIDES	Peptides	AUG	2005	26	8					1520	1527		10.1016/j.peptides.2005.03.014			8	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism; Pharmacology & Pharmacy	954UX	WOS:000231181700032	16042992				2022-02-06	
J	Baker, F; Wigram, T; Gold, C				Baker, F; Wigram, T; Gold, C			The effects of a song-singing programme on the affective speaking intonation of people with traumatic brain injury	BRAIN INJURY			English	Article						intonation; song singing; music therapy; mood	PARKINSONS-DISEASE; ACOUSTIC MEASURES; MUSIC-THERAPY; VOCAL FATIGUE; SPEECH; DEPRESSION; MOOD; INDIVIDUALS; RELAXATION; EMOTION	Primary objective: To examine changes in the relationship between intonation, voice range and mood following music therapy programmes in people with traumatic brain injury. Research design: Data from four case studies were pooled and effect size, ANOVA and correlation calculations were performed to evaluate the effectiveness of treatment. Methods and procedures: Subjects sang three self-selected songs for 15 sessions. Speaking fundamental frequency, fundamental frequency variability, slope, voice range and mood were analysed pre- and post-session. Results: Immediate treatment effects were not found. Long-term improvements in affective intonation were found in three subjects, especially in fundamental frequency. Voice range improved over time and was positively correlated with the three intonation components. Mood scale data showed that immediate effects were in the negative direction whereas there weres increases in positive mood state in the longer-term. Conclusions: Findings suggest that, in the long-term, song singing can improve vocal range and mood and enhance the affective intonation styles of people with TBI.	Univ Queensland, Brisbane, Qld, Australia; Univ Aalborg, Aalborg, Denmark; Sogn & Fjordane Univ Coll, Sandane, Norway		Baker, F (corresponding author), Univ Queensland, Brisbane, Qld, Australia.	f.bakr1@mailbox.uq.edu.au	Gold, Christian/K-1774-2015				Alpert M, 2001, J AFFECT DISORDERS, V66, P59, DOI 10.1016/S0165-0327(00)00335-9; APPLE W, 1979, J PERS SOC PSYCHOL, V37, P715, DOI 10.1037/0022-3514.37.5.715; Aronson A. E, 1990, CLIN VOICE DISORDERS; AUSTIN D, 1998, DYNAMICS MUSIC PSYCH, P315; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; Baker C, 2004, AIRL BUS, V20, P32; BAKER F, UNPUB BRIT J MUSIC T; Beblo T., 1999, COGN NEUROPSYCHIATRY, V4, P333, DOI [DOI 10.1080/135468099395864, 10.1080/135468099395864]; Benke T, 1998, BRAIN COGNITION, V38, P36, DOI 10.1006/brcg.1998.1013; Brown S, 2000, ORIGINS OF MUSIC, P271; BUNCH M, 1997, DYNAMICS SINGING VOI; COHEN NS, 1992, J MUSIC THER, V29, P87, DOI 10.1093/jmt/29.2.102; Darrow A. A., 1991, CASE STUDIES MUSIC T, P193; DARROW AA, 1986, J MUSIC THER, V23, P194, DOI 10.1093/jmt/23.4.194; Davis P., 1998, AUSTR VOICE, V4, P13; DAVITZ JR, 1959, J COMMUN, V9, P6, DOI 10.1111/j.1460-2466.1959.tb00286.x; Fairbanks G., 1960, VOICE ARTICULATION D; Fricchione C., 1986, BRAIN LANG, V71, P75; Frolov M. V., 1999, HUM PHYSL, V25, P42; Garcia-Toro M, 2000, J NERV MENT DIS, V188, P824, DOI 10.1097/00005053-200012000-00006; Haneishi E, 2001, J MUSIC THER, V38, P273, DOI 10.1093/jmt/38.4.273; Husain G, 2002, MUSIC PERCEPT, V20, P151, DOI 10.1525/mp.2002.20.2.151; Iwanaga M, 1996, J MUSIC THER, V33, P219, DOI 10.1093/jmt/33.3.219; KATSCH S, 1985, MUSIC YOU; Kent RD, 1999, AM J SPEECH-LANG PAT, V8, P129, DOI 10.1044/1058-0360.0802.129; KITCH JA, 1994, J VOICE, V8, P207, DOI 10.1016/S0892-1997(05)80291-7; Kolb B., 1999, COGNITIVE NEUROREHAB, P9; KUNY S, 1995, PSYCHOPATHOLOGY, V28, P190, DOI 10.1159/000284922; LEONARD RJ, 1988, J SPEECH HEAR RES, V31, P54, DOI 10.1044/jshr.3101.54; Livingston F., 1996, AUSTR J NEUROSCI, V9, P12; Morris RJ, 1996, J VOICE, V10, P159, DOI 10.1016/S0892-1997(96)80043-9; Mozziconacci S.J., 1997, IPO ANN PROGR REPORT, V32, P154; MURRAY IR, 1993, J ACOUST SOC AM, V93, P1097, DOI 10.1121/1.405558; Naarding P, 2003, J NEUROLINGUIST, V16, P37, DOI 10.1016/S0911-6044(01)00043-4; Nayak S, 2000, REHABIL PSYCHOL, V45, P274, DOI 10.1037/0090-5550.45.3.274; NEWHAM P, 1998, FDN EXPRESSIVE ARTS, P89; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Pittman J., 1994, VOICE SOCIAL INTERAC; Robb SL, 2000, J MUSIC THER, V37, P2, DOI 10.1093/jmt/37.1.2; Scherer K., 1991, MUSIC LANGUAGE SPEEC, P146; Stern R. A., 1997, VISUAL ANALOG MOOD S; THAUT MH, 1993, J MUSIC THER, V30, P210, DOI 10.1093/jmt/30.4.210; TURRY A, 1999, CLIN APPL MUSIC THER, P13; Welham NV, 2003, J VOICE, V17, P21, DOI 10.1016/S0892-1997(03)00033-X; Wigram T., 1993, HDB INQUIRY ARTS THE, P177; ZHANG SP, 1994, J NEUROPHYSIOL, V72, P1337, DOI 10.1152/jn.1994.72.3.1337; [No title captured]	48	20	21	0	20	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	2005	19	7					519	528		10.1080/02699050400005150			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology; Rehabilitation	933IQ	WOS:000229622500006	16134740				2022-02-06	
J	Casas, F; Alam, H; Reeves, A; Chen, Z; Smith, WA				Casas, F; Alam, H; Reeves, A; Chen, Z; Smith, WA			A portable cardiopulmonary bypass/extracorporeal membrane oxygenation system for the induction and reversal of profound hypothermia: Feasibility study in a swine model of lethal injuries	ARTIFICIAL ORGANS			English	Article; Proceedings Paper	12th Congress of the International-Society-for-Rotary-Blood-Pumps	OCT 07-10, 2004	Cleveland, OH	Int Soc Rotary Blood Pump		hypothermia; suspended animation; rotary blood pump	UNCONTROLLED HEMORRHAGIC-SHOCK; PROLONGS SURVIVAL-TIME; CARDIAC-ARREST; CIRCULATORY ARREST; MILD HYPOTHERMIA; BRAIN-DAMAGE; RESUSCITATION; RATS; DOGS; EPIDEMIOLOGY	The Cleveland Clinic Foundation's (CCF) cardiopulmonary bypass/extracorporeal membrane oxygenation (CPB/ECMO) system capabilities were tested in a hypothermia trauma management feasibility study in a porcine animal model at the Uniformed Services University of the Health Sciences (USUHS, Bethesda, MD, U.S.A.). In this survival series, the CCF system was used in a simulated forward lines combat casualty application where lethal uncontrolled hemorrhage from major vascular injuries was repaired under a state of profound hypothermic arrest (suspended animation), followed by recovery and monitoring in an intensive care unit (ICU) setting. The animals were monitored for survival, neurological impact, cognitive functions, organ damage, and delayed complications over 3 weeks. A survival rate of 83% matched rates previously found using conventional equipment. Neurological findings, organ dysfunction, and complication rates also were no different from previous studies using standard equipment. Successful survival results demonstrated that the CCF CPB/ECMO system could be used to induce a period of profound hypothermic arrest for the repair of lethal traumatic injuries. The logistical advantages of this system make it an attractive choice for use in austere settings and during transport.	Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA; Uniformed Serv Univ Hlth Sci, Trauma Res & Readiness Inst Surg, Bethesda, MD 20814 USA		Casas, F (corresponding author), Cleveland Clin Fdn, Dept Biomed Engn, Lerner Res Inst, ND20,9500 Euclid Ave, Cleveland, OH 44195 USA.	casasf@ccf.org			NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K01HL073076] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K01HL073076] Funding Source: NIH RePORTER		Acosta JA, 1998, J AM COLL SURGEONS, V186, P528, DOI 10.1016/S1072-7515(98)00082-9; ALAM H, IN PRESS J TRAUMA; Alam HB, 2002, SURGERY, V132, P278, DOI 10.1067/msy.2002.125787; Alam HB, 2002, J TRAUMA, V52, P18, DOI 10.1097/00005373-200201000-00006; APRAHAMIAN C, 1985, ANN EMERG MED, V14, P583, DOI 10.1016/S0196-0644(85)80785-X; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Behringer W, 2003, CRIT CARE MED, V31, P1523, DOI 10.1097/01.CCM.0000063450.73967.40; Behringer W, 2000, ANESTHESIOLOGY, V93, P1491, DOI 10.1097/00000542-200012000-00022; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; COLE SL, 1956, JAMA-J AM MED ASSOC, V161, P1454, DOI 10.1001/jama.1956.02970150022005; *COMM FLUID RES CO, 1999, JFLUID RES STAT SCI, P1; JENNINGS RB, 1988, CRIT CARE MED, V16, P988, DOI 10.1097/00003246-198810000-00010; Kim SH, 1998, J TRAUMA, V44, P485, DOI 10.1097/00005373-199803000-00010; Leonov Y, 2002, RESUSCITATION, V52, P193, DOI 10.1016/S0300-9572(01)00453-1; MATTOX KL, 1982, J TRAUMA, V22, P934, DOI 10.1097/00005373-198211000-00008; Norio H, 2002, J TRAUMA, V52, P1056, DOI 10.1097/00005373-200206000-00006; RADOVSKY A, 1995, STROKE, V26, P2127, DOI 10.1161/01.STR.26.11.2127; Rhee P, 2000, J TRAUMA, V48, P439, DOI 10.1097/00005373-200003000-00011; Safar Peter J, 2002, Curr Opin Anaesthesiol, V15, P203, DOI 10.1097/00001503-200204000-00010; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Shoemaker WC, 1996, CRIT CARE MED, V24, pS12; Takasu A, 1999, CRIT CARE MED, V27, P1557, DOI 10.1097/00003246-199908000-00025; Takasu A, 2003, RESUSCITATION, V56, P319, DOI 10.1016/S0300-9572(02)00405-7; Takasu A, 2002, RESUSCITATION, V54, P303, DOI 10.1016/S0300-9572(02)00148-X; Talbott JH, 1941, NEW ENGL J MED, V224, P281, DOI 10.1056/NEJM194102132240705; Taylor MJ, 2005, TRANSPL P, V37, P303, DOI 10.1016/j.transproceed.2004.12.024; TISHERMAN SA, 1991, J TRAUMA, V31, P1051, DOI 10.1097/00005373-199131080-00002; TISHERMAN SA, 1990, J TRAUMA, V30, P836, DOI 10.1097/00005373-199007000-00014; VANDAM LD, 1959, NEW ENGL J MED, V261, P595, DOI 10.1056/NEJM195909172611206; VANDAM LD, 1959, NEW ENGL J MED, V261, P546, DOI 10.1056/NEJM195909102611106; Wu XR, 2003, CRIT CARE MED, V31, P195, DOI 10.1097/00003246-200301000-00030	31	20	22	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	JUL	2005	29	7					557	563		10.1111/j.1525-1594.2005.29092.x			7	Engineering, Biomedical; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Engineering; Transplantation	939EX	WOS:000230056300008	15982284				2022-02-06	
J	Lobato, RD; Alen, JF; Perez-Nunez, A; Alday, R; Gomez, PA; Pascual, B; Lagares, A; Miranda, P; Arrese, I; Kaen, A				Lobato, RD; Alen, JF; Perez-Nunez, A; Alday, R; Gomez, PA; Pascual, B; Lagares, A; Miranda, P; Arrese, I; Kaen, A			Value of serial CT scanning and intracranial pressure monitoring for detecting new intracranial mass effect in severe head injury patients showing lesions type I-II in the initial CT scan	NEUROCIRUGIA			Spanish	Article						head injury; postraumatic coma; brain contusion epidural hematoma; axonal injury; computerized tomography; intracranial pressure	TRAUMATIC INTRACEREBRAL HEMATOMA; COMPUTERIZED-TOMOGRAPHY; BRAIN-INJURY; HEMORRHAGE; COAGULATION; MANAGEMENT; FIBRINOLYSIS; COMA	Objective. To determine the incidence of pathological and intracranial pressure (ICP) changes during the acute posttraumatic period in severe head injury patients presenting with lesions Types I-II (TCDB classification) in the admission CT scan with the aim of defining the most appropriate strategy of sequential CT scanning and ICP monitoring for detecting new intracranial mass effect and improving the final outcome. Material and methods. 56 patients (ages 15-80 years) consecutively admitted during a 2 years period were included. All had the initial CT scan < 24 hours after injury (mean interval = 150 min), several CT controls within the first days of the course and ICP monitoring after admission. Different epidemiological, clinical and radiological variables were recorded and deterioration defined as the development of sustained ICP over 20 mmHg requiring aggressive medical and/or surgical treatment was considered the dependent variable. Uni and multivariate analyses were made for determining the correlation between different parameters and the occurrence of deterioration and the final outcome as assessed with the GOS. Results. The mean GCS score was 5 and 37% of the patients showed pupillary changes; 52.3% had peritraumatic hypotension-hypoxemia, 16.1% anemia and 12.3% coagulation changes. 50% of the patients showed petechial hemorrhages in the white matter or the brainstem, 66% SAH, 40% HIV, 39.3% brain contusion and 21.4% small extraxial hematomas. 57.1% of the patients showed CT changes through the acute posttraumatic period consisting of new contusion (26.8% of the cases), growing of previous contusion (68.2%) or previous extraaxial hematoma (10.7%), and generalized brain swelling (10.7%). 64.9% of the patients made a favourable and 35.7% an unfavourable outcome. Overall, 27 (48.9%) patients developed deterioration, 21 (37.5%) with concurrent CT changes and 6 (10,7%) without new pathology as seen by the CT control. The remaining 29 (51.7%) patients in this series did not develop deterioration in spite that 11(19.6%) showed CT changes. The age, the initial score, the occurrence of peritraumatic hypotension-hypoxemia and coagulation disorders did not correlate with the risk of deterioration. By contrast, the presence of contusion at the initial CT scan (p= 0.01) and the occurrence of CT change (only generalized brain swelling, p= 0.003) significantly correlated with the risk of deterioration; in his turn deterioration increased by a factor of 10 (OR = 9,8) the risk of death and 7 out of the 8 patients who died developed intractable intracranial hypertension. The 8 (14.2%) patients requiring surgery showed simultaneous ICP deterioration and CT changes, but another 11 patients in a similar condition could be managed without surgery. With or without ICP deterioration, patients showing CT changes had a worse outcome than those without new pathologies, but the difference did not reach statistical significance, Discussion and conclusions. Over 50% of the patients with initial Type I-II lesions developed new CT changes and nearly 50% showed intracranial hypertension during the acute posttraumatic period. Considering the high incidences of ICP and CT deterioration through the course, along with the absence of strong predictors and the discordances between CT and ICP changes (which were seen in 30.3% of the cases) we recommend ICP monitoring after admission in all patients and serial CT scanning at 2-4, 12, 24, 48 and 72 hours after injury with additional controls as indicated by clinical or ICP changes in all cases. Though it is clear that the presence of severe intracranial hypertension significantly increased the risk of death, the small size of the sample in this series prevented to assess to what extent the occurrence of new mass effect and/or raised ICP contributed to the development of moderate and severe disability in the survivors which were mainly due to the occurrence of diffuse axonal injury. Finally, demonstrating that sequential CT scanning and ICP monitoring improve the final outcome in this type of patients would require a prospective randomized trial which is impracticable for different reasons, among them the ethical ones.	Hosp 12 Octubre, Serv Neurocirugia, E-28041 Madrid, Spain		Lobato, RD (corresponding author), Hosp 12 Octubre, Serv Neurocirugia, Avda Cordoba SN, E-28041 Madrid, Spain.		KAEN, ARIEL/F-1338-2015; ALEN, JOSE A FERNANDEZ/G-4990-2018; Lagares, Alfonso/B-2969-2011; Perez-Nunez, Angel/AAG-4422-2020; Gomez, Pedro/N-5051-2019; kaen, ariel/G-3786-2015	ALEN, JOSE A FERNANDEZ/0000-0002-3321-983X; Lagares, Alfonso/0000-0003-3996-0554; Perez-Nunez, Angel/0000-0002-2391-6586; Gomez, Pedro/0000-0002-4185-5238; KAEN, ARIEL/0000-0002-0595-9515			BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; CLIFTON GL, 1980, J NEUROSURG, V52, P611, DOI 10.3171/jns.1980.52.5.0611; CORDOBES F, 1986, ACTA NEUROCHIR, V81, P27, DOI 10.1007/BF01456261; CORDOBES F, 1983, J NEUROSURG, V58, P217, DOI 10.3171/jns.1983.58.2.0217; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; JENNETT B, 1975, LANCET, V1, P480; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KOBAYASHI S, 1983, SURG NEUROL, V20, P25, DOI 10.1016/0090-3019(83)90101-5; KUMURA E, 1987, ACTA NEUROCHIR, V85, P23, DOI 10.1007/BF01402365; LAGARES A, 2005, PATOLOGIA APARATO LO, V3, P41; LEE ST, 1991, ACTA NEUROCHIR, V113, P121, DOI 10.1007/BF01403196; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; LOBATO RD, 1986, J NEUROSURG, V65, P784, DOI 10.3171/jns.1986.65.6.0784; Lobato RD, 1997, ACTA NEUROCHIR, V139, P385, DOI 10.1007/BF01808871; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Marshall LF, 2000, NEUROSURGERY, V46, P77; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; ROBERSON FC, 1979, SURG NEUROL, V12, P161; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; SAWADA Y, 1984, J NEUROL NEUROSUR PS, V47, P1125, DOI 10.1136/jnnp.47.10.1125; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; TEASDALE G, 1974, LANCET, V2, P81; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; VANDERSANDE JJ, 1981, J NEUROSURG, V54, P21, DOI 10.3171/jns.1981.54.1.0021	32	20	30	0	5	ELSEVIER ESPANA SLU	BARCELONA	AV JOSEP TARRADELLAS, 20-30, 1ERA PLANTA, BARCELONA, CP-08029, SPAIN	1130-1473	2340-6305		NEUROCIRUGIA	Neurocirugia	JUN	2005	16	3					217	234					18	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	943JG	WOS:000230349100001	16007322				2022-02-06	
J	Agha, A; Ryan, J; Sherlock, M; Thompson, CJ				Agha, A; Ryan, J; Sherlock, M; Thompson, CJ			Spontaneous recovery from posttraumatic hypopituitarism	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						hypopituitarism; growth hormone; somatotroph recovery; adrenocorticotropin hormone; cortisol; rehabilitation	TRAUMATIC BRAIN-INJURY; GROWTH-HORMONE; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; PITUITARY DYSFUNCTION; GLUCAGON; ADULTS; DEFICIENCY; DIAGNOSIS; LESIONS	Hypopituitarism is an increasingly recognized complication of traumatic brain injury that can have significant potential to impair recovery and rehabilitation in affected survivors, Although posttraumatic cranial diabetes insipidus is known to be transient in many cases, recovery of established anterior pituitary hormone deficiency is thought to be a very rare event. We report the case of a 25-yr-old man who incurred severe traumatic brain injury in 1997. Sixteen months later, dynamic pituitary stimulation tests revealed severe growth hormone and adrenocorticotropin hormone deficiency. He was treated with recombinant human growth hormone and hydrocortisone. Five years after traumatic brain injury, repeat neuroendocrine assessment, prompted by an increasing serum insulin-like growth factor-1 level, showed normal growth hormone and adrenocorticotropin hormone responses. This is the first case report, to our knowledge, to show that adult posttraumatic growth hormone deficiency can be reversible. The recognition that anterior pituitary dysfunction can recover after traumatic brain injury has implications for the follow-up of patients with hypopituitarism secondary to head trauma to avoid unnecessary, expensive, and potentially harmful therapy.	Beaumont Hosp, Dept Endocrinol, Dublin 9, Ireland		Agha, A (corresponding author), Beaumont Hosp, Dept Endocrinol, Beaumont Rd, Dublin 9, Ireland.						Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379; Benvenga S, 1997, J ENDOCRINOL INVEST, V20, P675, DOI 10.1007/BF03348031; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; CACCIARI E, 1992, J CLIN ENDOCR METAB, V74, P1284, DOI 10.1210/jc.74.6.1284; Ceballos R, 1966, Ala J Med Sci, V3, P185; COCKRELL JR, 1988, PSYCHOPHARMACOL BULL, V24, P689; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; CROMPTON MR, 1971, BRAIN, V94, P165, DOI 10.1093/brain/94.1.165; DANIEL PM, 1959, LANCET, V2, P927; DOWARD LC, 1995, QUAL LIFE RES, V4, P420; EDWARDS OM, 1986, MEDICINE, V65, P281; EIHOLZER U, 1986, EUR J PEDIATR, V145, P128, DOI 10.1007/BF00441873; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; HOFFMAN DM, 1994, LANCET, V343, P1065; Iglesias P, 1996, J ENDOCRINOL INVEST, V19, P320, DOI 10.1007/BF03347870; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; KORNBLUM RN, 1969, ARCH PATHOL, V88, P242; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; MONSON JP, 2003, EUR J ENDOCRINOL S2, V148, P9; PIERUCCI G, 1971, Pathologica (Genoa), V63, P71; RAO RH, 1987, METABOLISM, V36, P658, DOI 10.1016/0026-0495(87)90150-8; VANCE ML, 1994, NEW ENGL J MED, V330, P1651, DOI 10.1056/NEJM199406093302306; YUAN XQ, 1991, FRONT NEUROENDOCRIN, V12, P209	27	20	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	MAY	2005	84	5					381	385		10.1097/01.PHM.0000156898.47097.93			5	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	921NF	WOS:000228770600009	15829786				2022-02-06	
J	Giugni, E; Sabatini, U; Hagberg, GE; Formisano, R; Castriota-Scanderbeg, A				Giugni, E; Sabatini, U; Hagberg, GE; Formisano, R; Castriota-Scanderbeg, A			Fast detection of diffuse axonal damage in severe traumatic brain injury: Comparison of gradient-recalled echo and turbo Proton Echo Planar Spectroscopic Imaging MRI sequences	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							PERSISTENT VEGETATIVE STATE; MAGNETIC-RESONANCE; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; PRACTICAL SCALE; LESIONS; AMANTADINE; IMAGES; COMA	BACKGROUND AND PURPOSE: Diffuse axonal injury (DAI) is a common type of primary neuronal injury in patients with severe traumatic brain injury (TBI), and is frequently accompanied by tissue tear hemorrhage. T2*-weighted gradient-recalled echo (GRE) sequences are more sensitive than T2-weighted spin-echo images for detection of hemorrhage. The purpose of this study is to compare turbo Proton Echo Planar Spectroscopic Imaging (t-PEPSI), an extremely fast sequence, with GRE sequence in the detection of DAI. METHODS: Twenty-one patients (mean age 26.8 years) with severe TBI occurred at least 3 months earlier, underwent a brain MR Imaging study on a 1.5-T scanner. A qualitative evaluation of the t-PEPSI sequences was performed by identifying the optimal echo time and in-plane resolution. The number and size of DAI lesions, as well as the signal intensity contrast ratio (SI CR), were computed for each set of GRE and t-PEPSI images, and divided according to their anatomic location as lobar and/or deep brain. RESULTS: There was no significant difference between GRE and t-PEPSI sequences in the detection of the total number of DAI lesions (291 vs. 230, respectively). GRE sequence delineated a higher number of DAI in the temporal lobe compared to the t-PEPSI sequence (74 vs. 37, P < .004), while no differences were found for the other regions. The SI CR was significantly lower with the t-PEPSI than the GRE sequence (P < .00001). CONCLUSION. Owing to its very short scan time and high sensitivity to the hemorrhage foci, the t-PEPSI sequence may be used as an alternative to the GRE to assess brain DAI in severe TBI patients, especially if uncooperative and medically unstable.	IRCCS, Fdn S Lucia, I-00179 Rome, Italy		Giugni, E (corresponding author), IRCCS, Fdn S Lucia, Via Ardeatina 306, I-00179 Rome, Italy.		Sabatini, Umberto/A-8484-2010; Sabatini, Umberto/K-4659-2016; Hagberg, Gisela E/A-2134-2010	Sabatini, Umberto/0000-0001-5321-8626; Hagberg, Gisela E/0000-0003-2176-7086; Bastianello, Stefano/0000-0002-8414-9077			ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Besenski N, 2002, EUR RADIOL, V12, P1237, DOI 10.1007/s00330-002-1355-9; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; DELAPAZ RL, 1994, RADIOGRAPHICS, V14, P1045, DOI 10.1148/radiographics.14.5.7991813; EDELMAN RR, 1994, RADIOLOGY, V192, P600, DOI 10.1148/radiology.192.3.8058920; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Garnett MR, 2001, CURR OPIN NEUROL, V14, P753, DOI 10.1097/00019052-200112000-00012; GEAN AD, 1994, IMAGING HEAD TRAUMA, P207; GENTRY LR, 1994, RADIOLOGY, V297, P1; GOLDSTEIN LB, 1991, J NEUROL REHABIL, V5, P129; Graham D.I., 1996, NEUROTRAUMA, P43; Hagberg GE, 2002, MAGNET RESON MED, V48, P877, DOI 10.1002/mrm.10283; JENNETT B, 1975, LANCET, V1, P480; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Kampfl A, 1998, J NEUROSURG, V88, P809, DOI 10.3171/jns.1998.88.5.0809; Kinoshita T, 2000, STROKE, V31, P1646, DOI 10.1161/01.STR.31.7.1646; Kuzma BB, 2000, SURG NEUROL, V53, P400; Lee BCP, 1999, AM J NEURORADIOL, V20, P1239; Liang LX, 1999, AM J NEURORADIOL, V20, P1527; Lin DDM, 2001, AM J NEURORADIOL, V22, P1275; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; MCLELLAN DR, 1990, COMA EMERGING PATIEN, P389; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Patel MR, 1999, AM J ROENTGENOL, V173, P479, DOI 10.2214/ajr.173.2.10430158; Patel MR, 1996, STROKE, V27, P2321, DOI 10.1161/01.STR.27.12.2321; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Posse S, 1997, MAGN RESON MED, V37, P858, DOI 10.1002/mrm.1910370609; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Reichenbach JR, 1998, MAGN RESON MATER PHY, V6, P62, DOI 10.1016/S1352-8661(98)00011-8; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Takaoka M, 2002, J NEUROL NEUROSUR PS, V73, P289, DOI 10.1136/jnnp.73.3.289; TEASDALE G, 1974, LANCET, V2, P81; TOIDE K, 1990, PHARMACEUT RES, V7, P670, DOI 10.1023/A:1015890800131; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wardlaw JM, 2000, NEURORADIOLOGY, V42, P81, DOI 10.1007/s002340050019; Wolansky LJ, 2000, J NEUROIMAGING, V10, P131, DOI 10.1111/jon2000103131; Yanagawa Y, 2000, J TRAUMA, V49, P272, DOI 10.1097/00005373-200008000-00013	43	20	21	0	6	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	MAY	2005	26	5					1140	1148					9	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	928XV	WOS:000229306100028	15891173				2022-02-06	
J	Bell, MDD				Bell, MDD			Non-heartbeating organ donation: clinical process and fundamental issues	BRITISH JOURNAL OF ANAESTHESIA			English	Article						complications, death; organ donation, consent; organ donation, futility; organ donation, legal problems	DEATH; TRANSPLANTATION; DONORS	This case report outlines the clinical process whereby a patient with severe traumatic brain injury became a non-heartbeating organ donor after a withdrawal-of-care decision. This process raises a series of ethical questions regarding decision-making on grounds of futility, the role of the next of kin, informed consent, the accommodation of manoeuvres directed towards organ retrieval at maximal viability, and the timing and determination of death. Although many aspects of the process can be accommodated within fundamental ethical principles and a broad interpretation of the concept of the 'best interests', the variance with established law requires authoritative clarification if a need for transplantable organs is to be responded to without compromising the reputation of practitioners involved in this area of care. Therefore, this recruitment strategy warrants wide public and professional debate to achieve longer-term sustainability and ensure the protection of all parties.	Gen Infirm Leeds, Leeds LS1 3EX, W Yorkshire, England		Bell, MDD (corresponding author), Gen Infirm Leeds, Great George St, Leeds LS1 3EX, W Yorkshire, England.	dominic.bell@leedsth.nhs.uk					[Anonymous], 1968, JAMA, V205, P337; Bell D, 2004, CRIT CARE MED, V32, P1241, DOI 10.1097/01.CCM.0000124856.92699.25; Bell John C., 2003, Cancer Cell, V4, P7, DOI 10.1016/S1535-6108(03)00170-3; Bell MDD, 2003, J MED ETHICS, V29, P176, DOI 10.1136/jme.29.3.176; BELL MDD, 2004, CARE CRITICALLY ILL, V20, P1; *BRIT MED ASS, 1999, WITHH WITHDR LIF PRO; *BRIT MED ASS, 1993, B MED ETHICS, V3, P8; Childress JF, 1994, PRINCIPLES BIOMEDICA; *DEP HLTH, 2001, 2001023 HSC DEP HLTH; *DEP HLTH, 2001023 HSC DEP HLTH; *DEP HLTH, 2003, IS REP; *DEP HLTH, 2003, SAV LIV VAL DON TRAN; *DEP HLTH GREAT BR, 1983, CAD ORG TRANSPL COD; Devita Michael A., 1993, Kennedy Institute of Ethics Journal, V3, P113; FEEST TG, 1990, LANCET, V335, P1133, DOI 10.1016/0140-6736(90)91134-V; General Medical Council, 2002, WITHH WITHDR LIF PRO; General Medical Council, 1998, SEEK PAT CONS ETH CO; *HOUS LORD SEL COM, 1993, 211 HL SEL COMM MED; KENNEDY I, 2000, MED LAW; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; McConnell JR, 1999, J MED ETHICS, V25, P322, DOI 10.1136/jme.25.4.322; *NAT HLTH SERV, 2001, MOR TRANSPL NEW LIV; *NAT HLTH SERV, 2003, UK TRANSPL POT DON A; *NAT HLTH SERV, UK TRANSPL; *NAT HLTH SERV AC, 1994, 9441 NHS EX HSG AC S; PALLIS C, 1982, BRIT MED J, V285, P1409, DOI 10.1136/bmj.285.6352.1409; Re F, 1990, AC, V2, P1; RUERS TJM, 1986, TRANSPLANT P, V18, P408; Steen S, 2001, LANCET, V357, P825, DOI 10.1016/S0140-6736(00)04195-7; Truog RD, 2003, CRIT CARE MED, V31, P2391, DOI 10.1097/01.CCM.0000090869.19410.3C; Weber M, 2002, NEW ENGL J MED, V347, P248, DOI 10.1056/NEJMoa020274; WILLIAMS M, 2003, BJA CEPD REV, V3, P163	32	20	20	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	APR	2005	94	4					474	478		10.1093/bja/aei048			5	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	905JJ	WOS:000227564100012	15591330	Bronze			2022-02-06	
J	Delaney, JS; Al-Kashmiri, A				Delaney, JS; Al-Kashmiri, A			Neck injuries presenting to emergency departments in the United States from 1990 to 1999 for ice hockey, soccer, and American football	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							SPINE INJURIES; BRAIN-INJURY; HEAD; CONCUSSIONS; EPIDEMIOLOGY; PLAYERS; IMPACT; CANADA	Objective: To examine the number and rate of neck injuries in the community as a whole for ice hockey, soccer, and American football by analysing data from patients presenting to emergency departments in the United States from 1990 to 1999. Methods: Data compiled for the US Consumer Product Safety Commission were used to generate estimates for the total number of neck injuries and the more specific diagnoses of neck fractures, dislocations, contusions, sprains, strains, and lacerations occurring nationally from 1990 to 1999. These data were combined with yearly participation figures to generate rates of injury presenting to emergency departments for each sport. Results: There were an estimated 5038 neck injuries from ice hockey, 19 341 from soccer, and 114 706 from American football. These could be broken down as follows: 4964 contusions, sprains, or strains from ice hockey, 17 927 from soccer, and 104 483 from football; 105 neck fractures or dislocations from ice hockey, 214 from soccer, and 1588 from football; 199 neck lacerations for ice hockey, 0 for soccer, and 621 for football. The rates for total neck injuries and combined neck contusions, sprains, or strains were higher for football than for ice hockey or soccer in all years for which data were available. Conclusion: The rate of neck injury in the United States was higher in football than in ice hockey or soccer in the time period studied.	McGill Univ, Ctr Hlth, Montreal, PQ, Canada; McGill Univ, Royal Coll Emergency Med Residency Training Progr, Montreal, PQ H3A 2T5, Canada		Delaney, JS (corresponding author), McGill Sport Med Clin, Montreal, PQ H2W 1S4, Canada.	j.delaney@mcgill.ca	Al-Kashmiri, Ammar/AAG-4008-2020				Barnes BC, 1998, AM J SPORT MED, V26, P433, DOI 10.1177/03635465980260031601; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Benson BW, 2002, BRIT J SPORT MED, V36, P27, DOI 10.1136/bjsm.36.1.27; BIASCA N, 1995, UNFALLCHIRURG, V98, P283; Boden BP, 1998, AM J SPORT MED, V26, P238, DOI 10.1177/03635465980260021301; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; Cantu RC, 2003, NEUROSURGERY, V53, P358, DOI 10.1227/01.NEU.0000073422.01886.88; Clarke KS, 1998, CLIN SPORT MED, V17, P1, DOI 10.1016/S0278-5919(05)70056-9; Clarke KS, 1998, CLIN SPORT MED, V17, P83, DOI 10.1016/S0278-5919(05)70063-6; Delaney JS, 1999, CLIN J SPORT MED, V9, P121; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; Delaney JS, 2001, CLIN J SPORT MED, V11, P234, DOI 10.1097/00042752-200110000-00005; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; Gillogly S D, 2000, J Med Assoc Ga, V89, P39; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Honey CR, 1998, CLIN J SPORT MED, V8, P43, DOI 10.1097/00042752-199801000-00010; Jorgensen U, 1986, Br J Sports Med, V20, P7; MARZO JM, 1991, NEW YORK STATE J MED, V91, P46; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Mueller FO, 1998, CLIN SPORT MED, V17, P169, DOI 10.1016/S0278-5919(05)70071-5; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Roberts WO, 1996, ARCH PEDIAT ADOL MED, V150, P140, DOI 10.1001/archpedi.1996.02170270022003; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; TATOR CH, 1987, CLIN SPORT MED, V6, P101; Tator CH, 2000, CAN MED ASSOC J, V162, P787; Tator CH, 1998, CLIN SPORT MED, V17, P183, DOI 10.1016/S0278-5919(05)70072-7; Tegner Y, 1996, BRIT J SPORT MED, V30, P251, DOI 10.1136/bjsm.30.3.251; TORG JS, 1991, AM J SPORT MED, V19, P6, DOI 10.1177/036354659101900103; TYSVAER AT, 1992, SPORTS MED, V14, P200, DOI 10.2165/00007256-199214030-00006; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109	33	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	APR 1	2005	39	4							e21	10.1136/bjsm.2004.015735			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	911CV	WOS:000227980000006	15793079	Green Published, Bronze			2022-02-06	
J	Helgeland, MI; Torgersen, S				Helgeland, MI; Torgersen, S			Stability and prediction of schizophrenia from adolescence to adulthood	EUROPEAN CHILD & ADOLESCENT PSYCHIATRY			English	Article						schizophrenia; adolescent psychiatry; long-term follow-up	CHILDHOOD-ONSET SCHIZOPHRENIA; LONG-TERM COURSE; FOLLOW-UP; HIGH-RISK; 1ST-DEGREE RELATIVES; BIRTH COHORT; DISORDERS; DIAGNOSIS; CHILDREN; AGE	Stability of schizophrenia diagnosis from adolescence to adulthood, antecedents of schizophrenia, and differences in developmental and behavioural histories between subjects with early onset schizophrenia (EOS) and with adult onset schizophrenia (AOS) were investigated in 145 adult subjects diagnosed with mental disorders in adolescence and rediagnosed on the basis of medical records according to DSM-IV. A very high diagnostic stability schizophrenia was demonstrated at the 28-year follow-up. Several factors, including neurological adversities, delayed language development, low IQ, and congenital functional disability, differentiated significantly between schizophrenic subjects and nonschizophrenic subjects. Histories of concussion, physical abuse, parental divorce, and unstable familial context differentiated significantly between EOS and AOS subjects. Our findings support earlier evidence of schizophrenia being a chronic disorder with high diagnostic stability, and confirm the importance of neurological adversities, delayed language development, and low IQ as factors predictive of schizophrenia. Exploration of four case histories of AOS subjects delineates "pre-schizophrenic warning cluster" where combination of neurological adversities, temperamental problems, antisocial behaviour, preference for solitary play, and unstable family system constitute main factors.	Univ Oslo, Inst Psychol, N-0317 Oslo, Norway; Sogn Ctr Child & Adolescent Psychiat, Oslo, Norway		Helgeland, MI (corresponding author), Bjerkelundgaten 5, N-0553 Oslo, Norway.						AMBELAS A, 1992, BRIT J PSYCHIAT, V160, P401, DOI 10.1192/bjp.160.3.401; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANGST J, 1988, SCHIZOPHRENIA BULL, V14, P501, DOI 10.1093/schbul/14.4.501; ASARNOW JR, 1994, SCHIZOPHRENIA BULL, V20, P599, DOI 10.1093/schbul/20.4.599; AYLWARD E, 1984, SCHIZOPHRENIA BULL, V10, P430, DOI 10.1093/schbul/10.3.430; BLAND RC, 1976, ARCH GEN PSYCHIAT, V33, P949; Bleuler E., 1911, DEMENTIA PRAECOX GRO; Bleuler M., 1978, SCHIZOPHRENIC DISORD; Cannon M, 2002, ARCH GEN PSYCHIAT, V59, P449, DOI 10.1001/archpsyc.59.5.449; CAWTHRON P, 1994, J CHILD PSYCHOL PSYC, V35, P1321, DOI 10.1111/j.1469-7610.1994.tb01237.x; Chen YR, 1996, AM J PSYCHIAT, V153, P682; CIOMPI L, 1980, SCHIZOPHRENIA BULL, V6, P606, DOI 10.1093/schbul/6.4.606; Davidson L, 1997, CAN J PSYCHIAT, V42, P34, DOI 10.1177/070674379704200105; Davidson M, 2000, ACTA PSYCHIAT SCAND, V101, P7, DOI 10.1111/j.0065-1591.2000.007s021[dash]2.x; DELISI LE, 1992, SCHIZOPHRENIA BULL, V18, P209, DOI 10.1093/schbul/18.2.209; EATON WW, 1992, SCHIZOPHRENIA BULL, V18, P229, DOI 10.1093/schbul/18.2.229; Ericson E. H., 1968, IDENTITY YOUTH CRISI; Falloon IRH, 1998, BRIT J PSYCHIAT, V172, P33, DOI 10.1192/S0007125000297638; First M.B., 1996, STRUCTURED CLIN INTE; FISH B, 1992, ARCH GEN PSYCHIAT, V49, P221; HAAS GL, 1990, BIOL PSYCHIAT, V27, P179; HARDING CM, 1987, AM J PSYCHIAT, V144, P718; HARTMANN E, 1984, ARCH GEN PSYCHIAT, V41, P1050; HEGARTY JD, 1994, AM J PSYCHIAT, V151, P1409; Hollis C, 2000, AM J PSYCHIAT, V157, P1652, DOI 10.1176/appi.ajp.157.10.1652; HOLLIS C, 1995, BRIT J PSYCHIAT, V166, P489, DOI 10.1192/bjp.166.4.489; JANES CL, 1994, CHILDREN RISK SCHIZO, P160; JONES P, 1994, LANCET, V344, P1398, DOI 10.1016/S0140-6736(94)90569-X; KENDLER KS, 1985, ARCH GEN PSYCHIAT, V42, P770; KRAUSZ M, 1993, SCHIZOPHRENIA BULL, V19, P831, DOI 10.1093/schbul/19.4.831; Lewis SW, 1989, SCHIZOPHRENIA SCI FO, P56; Malmberg A, 1998, BRIT J PSYCHIAT, V172, P308, DOI 10.1192/bjp.172.4.308; MARCUS J, 1985, SCHIZOPHRENIA BULL, V11, P85, DOI 10.1093/schbul/11.1.85; MARENGO J, 1991, AM J PSYCHIAT, V148, P606; MARNEROS A, 1991, EUR ARCH PSY CLIN N, V241, P187, DOI 10.1007/BF02219720; MASON P, 1995, BRIT J PSYCHIAT, V167, P596, DOI 10.1192/bjp.167.5.596; Maziade M, 1996, BRIT J PSYCHIAT, V169, P361, DOI 10.1192/bjp.169.3.361; MCGLASHAN TH, 1988, SCHIZOPHRENIA BULL, V14, P515, DOI 10.1093/schbul/14.4.515; MCGLASHAN TH, 1990, SCHIZOPHR B, V14, P515; Miller PM, 2002, PSYCHOL MED, V32, P173, DOI 10.1017/S0033291701004779; MURRAY RM, 1992, SCHIZOPHRENIA BULL, V18, P319, DOI 10.1093/schbul/18.2.319; ONSTAD S, 1991, ACTA PSYCHIAT SCAND, V83, P463, DOI 10.1111/j.1600-0447.1991.tb05577.x; ONSTAD S, 1993, PSYCHOL MED, V23, P335, DOI 10.1017/S0033291700028439; PARNAS J, 1982, ARCH GEN PSYCHIAT, V39, P658; Pfohl B., 1994, STRUCTURED INTERVIEW; RAM R, 1992, SCHIZOPHRENIA BULL, V18, P185, DOI 10.1093/schbul/18.2.185; Robins L.N., 1966, DEVIANT CHILDREN GRO; SALOKANGAS RKR, 1990, SCHIZOPHR RES, V3, P333, DOI 10.1016/0920-9964(90)90019-4; Schaeffer JL, 2002, J AM ACAD CHILD PSY, V41, P538, DOI 10.1097/00004583-200205000-00011; SCHMIDT M, 1995, EUR ARCH PSY CLIN N, V245, P93, DOI 10.1007/BF02190735; SEEMAN MV, 1983, COMPR PSYCHIAT, V24, P125, DOI 10.1016/0010-440X(83)90100-1; SHAPIRO R, 1979, WHO SCHIZOPHRENIA IN; TRAINOR D, 1979, PSYCHIATR NEWS  0406, P30; TSUANG MT, 1981, ARCH GEN PSYCHIAT, V38, P535; VAILLANT GE, 1978, SCHIZOPHRENIA BULL, V4, P78, DOI 10.1093/schbul/4.1.78; VETTER P, 1993, PSYCHOPATHOLOGY, V26, P173, DOI 10.1159/000284819; WALKER E, 1990, AM J PSYCHIAT, V147, P1052; WATKINS JM, 1988, J CHILD PSYCHOL PSYC, V29, P865, DOI 10.1111/j.1469-7610.1988.tb00759.x; WATT NF, 1982, J CONSULT CLIN PSYCH, V50, P171; WATT NF, 1972, J NERV MENT DIS, V155, P42, DOI 10.1097/00005053-197207000-00006; WATT NF, 1978, ARCH GEN PSYCHIAT, V35, P160; WEINTRAUB S, 1978, J ABNORM CHILD PSYCH, V6, P461, DOI 10.1007/BF00926056; WERRY JS, 1991, J AM ACAD CHILD PSY, V30, P457, DOI 10.1097/00004583-199105000-00017; ZEITLIN H, 1986, MAUDSLEY MONOGRAPH, V29; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	65	20	21	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1018-8827	1435-165X		EUR CHILD ADOLES PSY	Eur. Child Adolesc. Psych.	MAR	2005	14	2					83	94		10.1007/s00787-005-0436-0			12	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	910RI	WOS:000227949500004	15793687				2022-02-06	
J	Yoon, SJ; Lee, JH; Kim, ST; Chun, MH				Yoon, SJ; Lee, JH; Kim, ST; Chun, MH			Evaluation of traumatic brain injured patients in correlation with functional status by localized H-1-MR spectroscopy	CLINICAL REHABILITATION			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; DIFFUSE AXONAL INJURY; HEAD-INJURY; METABOLITE	Objective: To determine whether proton magnetic resonance spectroscopy (H-1-MRS) could be a useful tool for detecting microscopic diffuse axonal injury to evaluate the functional status of patients with traumatic brain injury (TBI). Design: A comparative study. Setting: An inpatient rehabilitation unit in Korea. Subjects: We examined eight adult patients who had severe TBI approximately five months before. Fourteen normal controls were employed for comparison. Main measures: Image-guided localized in vivo H-1-MRS was performed in the parietal white matter and occipital grey matter regions in brain in which no definite abnormalities in MR imaging were found at the time of H-1-MRS examination. We evaluated functional status for all patients with the Functional Independence Measure (FIM) on the same day as the H-1-MRS examination and compared the results. Results: In the parietal white matter, the [N-acetyl aspartate/creatine] ratios were significantly lower, and the [choline/creatine] and [myo-inositol/creatine] ratios were significantly higher than those of normal controls. Significant correlations of the [N-acetyl aspartate/creatine] and [myo-inositol/creatine] ratios in the parietal white matter with FIM scores were observed (p < 0.05). Conclusions: A spectral feature of the decreased [N-acetyl aspartate/creatine] and increased [choline/creatine] and [myo-inositol/creatine] ratios in parietal white matter may be a marker for diffuse axonal injury in patients with TBI and has a significant correlation with the functional status of the patients. Localized H-1-MRS has the potential to be used for detecting diffuse axonal injury in vivo in TBI patients, which can be used to guide evaluation of the functional status of TBI patients receiving rehabilitation.	Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, Seoul 138736, South Korea; Univ Ulsan, Coll Med, Asan Inst Life Sci, NMR Lab, Seoul 138736, South Korea		Chun, MH (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Rehabil Med, 388-1 Poongnap Dong, Seoul 138736, South Korea.	mhchun@amc.seoul.kr	lee, jung hee/H-8107-2018				ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Cecil KM, 1998, J NEUROSURG, V88, P795, DOI 10.3171/jns.1998.88.5.0795; Chan YL, 1999, J MAGN RESON IMAGING, V10, P130, DOI 10.1002/(SICI)1522-2586(199908)10:2<130::AID-JMRI4>3.0.CO;2-R; Chang L, 1996, LIFE SCI, V58, P2049, DOI 10.1016/0024-3205(96)00197-X; CHOE BY, 1995, INVEST RADIOL, V30, P502, DOI 10.1097/00004424-199508000-00008; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Friedman SD, 1999, NEUROLOGY, V52, P1384, DOI 10.1212/WNL.52.7.1384; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; GRAHAM GD, 1993, STROKE, V24, P1891, DOI 10.1161/01.STR.24.12.1891; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; HELPERN JA, 1993, NEUROLOGY, V43, P1577, DOI 10.1212/WNL.43.8.1577; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; LEE JH, 1994, NEW ENGL J MED, V331, P439, DOI 10.1056/NEJM199408183310704; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; RANGO M, 1995, MAGNET RESON MED, V33, P595, DOI 10.1002/mrm.1910330503; ROSS B, 1994, MAGN RESON QUART, V10, P191; Saunders DE, 1999, JMRI-J MAGN RESON IM, V9, P711, DOI 10.1002/(SICI)1522-2586(199905)9:5<711::AID-JMRI14>3.0.CO;2-3; SMITH DH, 1995, J NEUROTRAUM, V12, P573, DOI 10.1089/neu.1995.12.573; VINK R, 1987, J CEREBR BLOOD F MET, V7, P563, DOI 10.1038/jcbfm.1987.106; Vink R, 1996, J NEUROCHEM, V66, P2477	22	20	25	0	3	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	MAR	2005	19	2					209	215		10.1191/0269215505cr813oa			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	901TY	WOS:000227306000012	15759537				2022-02-06	
J	Chapman, SS; Ewing, CB; Mozzoni, MP				Chapman, SS; Ewing, CB; Mozzoni, MP			Precision teaching and fluency training across cognitive, physical, and academic tasks in children with traumatic brain injury: A multiple baseline study	BEHAVIORAL INTERVENTIONS			English	Article								Children with traumatic brain injuries present significant challenges in terms of interrupted development and loss of previously mastered skills. The sequelae of pediatric brain injury develop in time whereas injury to an adult brain tends to create static deficits. Children with brain injuries present unique problems in their ability to form enduring memories of verbal material and performance strategies. Precision teaching and fluency training methodologies present teachers with powerful tools to capitalize upon over learning as a method of improving persistence of a new repertoire. In this series of studies precision teaching and fluency training were used across academic, communicative, and physical skill repertoires, to demonstrate the utility, efficiency, and efficacy of these methodologies. Significant improvements were reached in all functional target areas. By utilizing data-based decision methods therapists can rapidly assess and adjust treatment to keep clients progressing. In this age of limited length of stay within the therapeutic treatment environment fast and effective treatment is a mandate. Copyright (C) 2005 John Wiley Sons, Ltd.	Univ Nevada, Reno, NV 89557 USA; Timber Ridge Ranch, Little Rock, AR USA		Mozzoni, MP (corresponding author), Timber Ridge Grp Inc, 4500 W Commercial Dr, N Little Rock, AR 72116 USA.	mikeaba@ix.netcom.com					Binder C, 1996, BEHAV ANALYST, V19, P163, DOI 10.1007/BF03393163; Hartnedy SL, 2005, BEHAV INTERVENT, V20, P27, DOI 10.1002/bin.167; Haughton E.C., 1980, J PRECISION TEACHING, V1, P2; JOHNSON KR, 1994, BEHAVIOR ANALYSIS IN EDUCATION, P173; KOENIG CH, 1980, CLASSROOM LEARNING S; Kubina R. M., 2000, BEHAV SOCIAL ISSUES, V10, P83; Kubina RM, 2000, BEHAV INTERVENT, V15, P189; Lindsley OR, 1995, J PRECISION TEACHING, V13, P2; McGreevy P, 1983, TEACHING LEARNING PL; Merbitz CT, 2000, BEHAV INTERVENT, V15, P169, DOI 10.1002/1099-078X(200007/09)15:3<169::AID-BIN54>3.0.CO;2-5; PENNYPACKER HS, 1972, HDB STANDARD CELERAT; *REG RES CTR, 1971, DIAGN MATH INT; WHITE OR, 1986, EXCEPT CHILDREN, V52, P522, DOI 10.1177/001440298605200605	13	20	20	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1072-0847	1099-078X		BEHAV INTERVENT	Behav. Intervent.	FEB	2005	20	1					37	49		10.1002/bin.168			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	899IR	WOS:000227138600005					2022-02-06	
J	Solbakk, AK; Reinvang, I; Svebak, S; Nielsen, CS; Sundet, K				Solbakk, AK; Reinvang, I; Svebak, S; Nielsen, CS; Sundet, K			Attention to affective pictures in closed head injury: Event-related brain potentials and cardiac responses	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							MILD HEAD; DEFICITS; CORTEX; P300; COMPLAINTS; COMPONENT; AROUSAL; INDEXES; TASK	We examined whether closed head injury patients show altered patterns of selective attention to stimulus categories that naturally evoke differential responses in healthy people. Self-reported rating and electrophysiological (event-related potentials [ERPs], heart rate [HR]) responses to affective pictures were studied in patients with mild head injury (n = 20; CT/MRI negative), in patients with predominantly frontal brain lesions (n = 12; CT/MRI confirmed), and in healthy controls (n = 20). Affective valence similarly modulated HR and ERP responses in all groups, but group differences occurred that were independent of picture valence. The attenuation of P3-slow wave amplitudes in the mild head injury group indicates a reduction in the engagement of attentional resources to the task. In contrast, the general enhancement of ERP amplitudes at occipital sites in the group with primarily frontal brain injury may reflect disinhibition of input at sensory receptive areas, possibly due to a deficit in top-down modulation performed by anterior control systems.	Univ Oslo, Dept Psychol, N-0317 Blindern, Norway; Univ Oslo, Rikshosp, Dept Psychosomat & Behav Med, N-0316 Oslo, Norway; Norwegian Univ Sci & Technol, MTFS, Dept Neurosci, N-7034 Trondheim, Norway		Solbakk, AK (corresponding author), Univ Oslo, Dept Psychol, PB 1094, N-0317 Blindern, Norway.	a.k.solbakk@psykologi.uio.no					Barcelo F, 2000, NAT NEUROSCI, V3, P399, DOI 10.1038/73975; Belin P, 1998, J NEUROSCI, V18, P6388; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Bigler ED, 2003, ARCH CLIN NEUROPSYCH, V18, P595; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; BOHNEN N, 1992, NEUROSURGERY, V30, P692, DOI 10.1097/00006123-199205000-00007; Butcher J.N., 1989, MMPI2 MINNESOTA MULT; CAMPBELL KB, 1995, HDB NEUROPSYCHOLOGY, P269; Chan RCK, 2003, BRAIN INJURY, V17, P131, DOI 10.1080/0269905021000010168; Chan RCK, 2002, J CLIN EXP NEUROPSYC, V24, P1081, DOI 10.1076/jcen.24.8.1081.8371; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Coull JT, 1998, J NEUROSCI, V18, P7426; *CSEA NIMH, 1995, INT AFF PICT SYST; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dupuis F, 2000, NEUROREPORT, V11, P4087, DOI 10.1097/00001756-200012180-00035; Gaetz M, 2000, BRAIN INJURY, V14, P815; Hartikainen KA, 2001, BRAIN COGNITION, V47, P339; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Knight RT, 1997, J COGNITIVE NEUROSCI, V9, P75, DOI 10.1162/jocn.1997.9.1.75; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Lang PJ, 1995, INT AFFECTIVE PICTUR; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; LEVIN HS, 1987, NEUROBEHAVIORAL RECO, P221; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Naatanen R, 1992, ATTENTION BRAIN FUNC; NIELSEN CS, 1997, READPEAK DATA PROGRA; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; POSNER MI, 1995, BEHAV BRAIN SCI, V18, P327, DOI 10.1017/S0140525X0003870X; Potter DD, 2001, NEUROPSYCHOLOGIA, V39, P1464, DOI 10.1016/S0028-3932(01)00057-4; PRATAPCHAND R, 1988, ACTA NEUROL SCAND, V78, P185, DOI 10.1111/j.1600-0404.1988.tb03643.x; Reinvang I, 1999, NEUROPSYCHOL REV, V9, P231, DOI 10.1023/A:1021638723486; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; Sangal RB, 1996, BIOL PSYCHIAT, V39, P305, DOI 10.1016/0006-3223(95)00447-5; Satz P, 1999, J CLIN EXP NEUROPSYC, V21, P620, DOI 10.1076/jcen.21.5.620.870; Segalowitz SJ, 2001, BRAIN COGNITION, V45, P342, DOI 10.1006/brcg.2000.1263; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Solbakk AK, 2000, J CLIN EXP NEUROPSYC, V22, P743, DOI 10.1076/jcen.22.6.743.953; Solbakk AK, 1999, PSYCHOPHYSIOLOGY, V36, P802; Stablum F, 1996, CORTEX, V32, P261, DOI 10.1016/S0010-9452(96)80050-5; YAMAGUCHI S, 1990, BRAIN RES, V521, P281, DOI 10.1016/0006-8993(90)91553-S	52	20	20	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	2005	27	2					205	223		10.1080/13803390490515739			19	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	908NP	WOS:000227794000005	15903151				2022-02-06	
J	Long, JB; Yourick, DL; Slusher, BS; Robinson, MB; Meyerhoff, JL				Long, JB; Yourick, DL; Slusher, BS; Robinson, MB; Meyerhoff, JL			Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						NMDA; (N-methyl-D-asparune); NAAG; (N-acetylasparlylglutamate); neuroprotection; GCP II; (glutamate carboxypeptidase II); NAALADase; (N-acetylated-ot-linked acidic dipeptidase); dynorphin A	ACETYL-ASPARTYL-GLUTAMATE; TRAUMATIC BRAIN-INJURY; N-ACETYLASPARTYLGLUTAMATE; NEUROPROTECTIVE ACTIVITY; BLOOD-FLOW; RECEPTORS; ACID; RESPONSES; BINDING; MOTOR	Glutamate carboxypeptidase (GCP) II (EC 3.4.17.21), which is also known as N-acetylated-alpha-linked acidic dipeptidase (NAALADase), hydrolyses the endogenous acidic dipeptide N-acetylaspartylglutamate (NAAG), yielding N-acetyl-aspartate and glutamate. Inhibition of this enzyme by 2-(phosphonomethyl) pentanedioic acid (2-PMPA) has been shown to protect against ischemic injury to the brain and hypoxic and metabolic injury to neuronal cells in culture, presumably by increasing and decreasing the extracellular concentrations of NAAG and glutamate, respectively. Since both NAAG and GCP II are found in especially high concentrations in the spinal cord, injuries to the spinal cord involving pathophysiological elevations in extracellular glutamate might be particularly responsive to GCP II inhibition. Lumbar subarachnoid injections of dynorphin A in rats cause ischernic spinal cord injury, elevated extracellular glutamate and a persistent hindlimb paralysis that is mediated through excitatory amino acid receptors. We therefore used this injury model to evaluate the protective effects of 2PMPA. When coadministered with dynorphin A, 2-PMPA significantly attenuated the dynorphin A-induced elevations in cerebrospinal fluid glutamate levels and by 24 h postinjection caused significant dose-dependent improvements in motor scores that were associated with marked histopathological improvements. These results indicate that 2-PMPA provides effective protection against excitotoxic spinal cord injury. Published by Elsevier B.V.	Walter Reed Army Inst Res, Dept Polytrauma & Resucitat Res, Div Mil Casualty Res, Silver Spring, MD 20910 USA; Walter Reed Army Inst Res, Div Neurosci, Silver Spring, MD 20910 USA; Guildford Pharmaceut Inc, Baltimore, MD 21224 USA; Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA		Long, JB (corresponding author), Walter Reed Army Inst Res, Dept Polytrauma & Resucitat Res, Div Mil Casualty Res, Silver Spring, MD 20910 USA.	joseph.long@na.amedd.army.mil	Yourick, Debra/A-2121-2011				BAKSHI R, 1990, BRAIN RES, V507, P1, DOI 10.1016/0006-8993(90)90512-A; BAKSHI R, 1990, NEUROSCI LETT, V110, P113, DOI 10.1016/0304-3940(90)90797-D; Berman Y, 1999, J BIOCHEM, V125, P641, DOI 10.1093/oxfordjournals.jbchem.a022331; Bruno V, 1998, NEUROSCIENCE, V85, P751, DOI 10.1016/S0306-4522(97)00531-9; Bruno V, 1998, J NEUROSCI, V18, P9594; Bruno V, 1997, J NEUROSCI, V17, P1891; BUISSON A, 1995, NEUROPHARMACOLOGY, V34, P1081, DOI 10.1016/0028-3908(95)00073-F; BURLINA AP, 1994, J NEUROCHEM, V63, P1174; CAUDLE RM, 1988, BRAIN RES, V443, P329, DOI 10.1016/0006-8993(88)91628-9; Chen L, 1998, J PHARMACOL EXP THER, V284, P826; CHESNEAU V, 1994, J BIOL CHEM, V269, P2056; Coyle JT, 1997, NEUROBIOL DIS, V4, P231, DOI 10.1006/nbdi.1997.0153; FADEN AI, 1984, BRIT J PHARMACOL, V81, P271, DOI 10.1111/j.1476-5381.1984.tb10074.x; GILLAN MGC, 1985, J NEUROCHEM, V45, P1034, DOI 10.1111/j.1471-4159.1985.tb05520.x; HERMAN BH, 1985, J PHARMACOL EXP THER, V232, P27; ISAAC L, 1990, BRAIN RES, V531, P83, DOI 10.1016/0006-8993(90)90760-9; KOENIG ML, 1994, NEUROREPORT, V5, P1063, DOI 10.1097/00001756-199405000-00012; KOLLER KJ, 1985, J NEUROSCI, V5, P2882; KOLLER KJ, 1984, DEV BRAIN RES, V15, P137, DOI 10.1016/0165-3806(84)90150-0; LONG JB, 1987, BRAIN RES, V436, P374, DOI 10.1016/0006-8993(87)91683-0; LONG JB, 1988, J PHARMACOL EXP THER, V246, P1167; LONG JB, 1988, EUR J PHARMACOL, V149, P287, DOI 10.1016/0014-2999(88)90659-0; LONG JB, 1994, J PHARMACOL EXP THER, V269, P358; LONG JB, 1992, J PHARMACOL EXP THER, V260, P1425; LONG JB, 1994, EUR J PHARMACOL, V261, P295, DOI 10.1016/0014-2999(94)90120-1; McIntosh TK, 1996, LAB INVEST, V74, P315; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MIYAKE M, 1981, J NEUROCHEM, V36, P804, DOI 10.1111/j.1471-4159.1981.tb01665.x; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Obrenovitch TP, 1997, J NEUROTRAUM, V14, P677, DOI 10.1089/neu.1997.14.677; OLNEY JW, 1989, SCIENCE, V244, P1360, DOI 10.1126/science.2660263; PUTTFARCKEN PS, 1993, J PHARMACOL EXP THER, V266, P796; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; ROBINSON MB, 1993, J NEUROCHEM, V61, P2099, DOI 10.1111/j.1471-4159.1993.tb07447.x; SanchezPrieto J, 1996, TRENDS NEUROSCI, V19, P235, DOI 10.1016/0166-2236(96)10031-X; SCHOEPP DD, 1993, TRENDS PHARMACOL SCI, V14, P13, DOI 10.1016/0165-6147(93)90107-U; SEKIGUCHI M, 1989, BRAIN RES, V482, P87, DOI 10.1016/0006-8993(89)90545-3; Shukla VK, 1997, J PHARMACOL EXP THER, V283, P604; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; STEVENS CW, 1986, J PHARMACOL EXP THER, V238, P833; Tang QB, 1999, J PHARMACOL EXP THER, V291, P760; Thomas AG, 2001, EUR J PHARMACOL, V426, P35, DOI 10.1016/S0014-2999(01)01198-0; Thomas AG, 2001, EUR J PHARMACOL, V430, P33, DOI 10.1016/S0014-2999(01)01239-0; THORNHILL JA, 1989, BRAIN RES, V490, P174, DOI 10.1016/0006-8993(89)90447-2; Tortella FC, 2000, EUR J PHARMACOL, V402, P31, DOI 10.1016/S0014-2999(00)00519-7; VALIVULLAH HM, 1994, J NEUROCHEM, V63, P1714; Wroblewska B, 1997, J NEUROCHEM, V69, P174; Wroblewska B, 1998, GLIA, V24, P172, DOI 10.1002/(SICI)1098-1136(199810)24:2<172::AID-GLIA2>3.0.CO;2-6; WROBLEWSKA B, 1993, J NEUROCHEM, V61, P943, DOI 10.1111/j.1471-4159.1993.tb03606.x	49	20	20	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0014-2999	1879-0712		EUR J PHARMACOL	Eur. J. Pharmacol.	JAN 31	2005	508	1-3					115	122		10.1016/j.ejphar.2004.12.008			8	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	895WF	WOS:000226894000014	15680261				2022-02-06	
J	Hoane, MR				Hoane, MR			Treatment with magnesium improves reference memory but not working memory while reducing GFAP expression following traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						MgCl2; recovery of function; rat; sensorimotor; cognition; neurotrauma; neuroprotection; gliosis	FACILITATE RECOVERY; SENSORIMOTOR CORTEX; FUNCTIONAL RECOVERY; COGNITIVE DEFICITS; NMDA ANTAGONISTS; RATS; THERAPY; LESIONS; EFFICACY; CHLORIDE	Purpose: Previous studies have shown that administration of MgCl2 in animal models of brain injury significantly improves functional recovery: however, few studies have examined cognitive recovery. The present study evaluated the effect of MgCl2 pharmacotherapy on recovery of function following medial frontal cortex contusion injury. Methods: Groups of rats were assigned to either MgCl2 (1.0 mmol/kg) or saline treatment conditions and prepared with contusion injuries or shams. Drug treatment was administered 15 min and 24 hr following injury. Rats were examined on tests of sensorimotor performance (bilateral tactile adhesive removal) and cognitive ability (reference and working memory). Results: Administration of MgCl2 following injury significantly reduced the behavioral impairments observed on the bilateral tactile removal test. The acquisition of reference memory was also significantly improved compared to saline-treated rats; however, treatment did not improve working memory performance. Lesion analysis revealed that administration of MgCl2 did not significantly reduce lesion size compared to saline-treatment. Examination of glial fibrillary acidic protein (GFAP) expression showed that MgCl2 did significantly reduce the number of GFAP(+) cells. Conclusion: These results indicate that MgCl2 administration significantly improved behavioral outcome following injury in a task dependent manner and reduced GFAP expression.	So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Brain & Cognit Sci Program, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Brain & Cognit Sci Program, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657			ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Badan I, 2003, J CEREBR BLOOD F MET, V23, P845, DOI 10.1097/01.WCB.0000071883.63724.A7; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Bareyre FM, 1999, J NEUROCHEM, V73, P271, DOI 10.1046/j.1471-4159.1999.0730271.x; BARTH TM, 1990, STROKE, V21, P153; Browne KD, 2004, J NEUROSCI RES, V77, P878, DOI 10.1002/jnr.20215; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Esen F, 2003, J NEUROSURG ANESTH, V15, P119, DOI 10.1097/00008506-200304000-00009; Feldman Z, 1996, J NEUROSURG, V85, P131, DOI 10.3171/jns.1996.85.1.0131; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; Guluma KZ, 1999, J NEUROTRAUM, V16, P311, DOI 10.1089/neu.1999.16.311; Heath DL, 1996, BRAIN RES, V738, P150, DOI 10.1016/0006-8993(96)00957-2; Heath DL, 1999, J PHARMACOL EXP THER, V288, P1311; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, MAGNESIUM RES, V12, P269; Hoane Michael R, 2004, Clin Calcium, V14, P65; Hoane MR, 2000, BRAIN RES BULL, V53, P175, DOI 10.1016/S0361-9230(00)00327-0; Hoane MR, 1998, BRAIN RES BULL, V45, P45, DOI 10.1016/S0361-9230(97)00288-8; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 2003, BRAIN RES BULL, V60, P105, DOI 10.1016/S0361-9230(03)00022-4; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; Hoane MR, 2002, PHYSIOL BEHAV, V76, P271, DOI 10.1016/S0031-9384(02)00714-X; Hoane MR, 2001, MAGNESIUM RES, V14, P51; Janis LS, 1998, J NEUROTRAUM, V15, P105, DOI 10.1089/neu.1998.15.105; Kramer JH, 2003, EXP BIOL MED, V228, P665, DOI 10.1177/153537020322800604; Lee JS, 2004, J NEUROTRAUM, V21, P549, DOI 10.1089/089771504774129883; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCINTOSH TK, 1989, BRAIN RES, V482, P252, DOI 10.1016/0006-8993(89)91188-8; McIntosh TK, 1988, J NEUROTRAUM, V5, P17, DOI 10.1089/neu.1988.5.17; Muir JK, 1999, EXP NEUROL, V159, P584, DOI 10.1006/exnr.1999.7187; Paxinos G, 1997, RAT BRAIN STEREOTAXI; Saatman KE, 2001, J NEUROPATH EXP NEUR, V60, P183, DOI 10.1093/jnen/60.2.183; SMITH DH, 1993, NEUROSCI LETT, V157, P211, DOI 10.1016/0304-3940(93)90739-8; Statler KD, 2001, J NEUROTRAUM, V18, P1195, DOI 10.1089/089771501317095232; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van den Heuvel Corinna, 2004, Clin Calcium, V14, P9; VINK R, 1993, MOL CHEM NEUROPATHOL, V18, P279, DOI 10.1007/BF03160120; Vink R, 1990, Magnes Res, V3, P163; Vink R, 2003, NEUROSCI LETT, V336, P41, DOI 10.1016/S0304-3940(02)01244-2; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; Vink R, 1996, J NEUROCHEM, V66, P2477; VINK R, 1988, J BIOL CHEM, V263, P757	45	20	20	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2005	23	2					67	77					11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	963UP	WOS:000231831900002	15990413				2022-02-06	
J	Lew, HL; Poole, JH; Chiang, JYP; Lee, EH; Date, ES; Warden, D				Lew, HL; Poole, JH; Chiang, JYP; Lee, EH; Date, ES; Warden, D			Event-related potential in facial affect recognition: Potential clinical utility in patients with traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						affect recognition; brain injury; cognition; electroencephalograph; emotional processing; event-related potential; social perception	EMOTIONAL EXPRESSION; P300; STIMULI; LATENCY; TIME; TASK	Traumatic brain injury (TBI) frequently leads to deficits in social behavior Prior research suggests that such deficits may result from impaired perception of basic social Cues. However. these social-emotional deficits have not been studied eelectrophysiologically. We measured the P300 event-related potential (ERP), which has been shown to be a sensitive index of cognitive efficiency, in 13 patients with a history of moderate to severe TBI and in 13 healthy controls. The P300 response was measured during detection of 30 pictures of angry faces (rare target) randomly distributed among 120 neutral faces (frequent nontarget). Compared to control subjects, the TBI group's P300 responses were significantly delayed in latency (p = 0.002) and lower in amplitude (p = 0.003). TBI patients also showed slower reaction times and reduced accuracy when manually signaling their detection of angry faces. Coefficients of variation (CVs) for the facial P300 response compared faborably to those of many standard clinical assays, Suggesting. potential clinical utility. For this study, we demonstrated the feasibility of studying TBI patients P300 responses during the recognition of facial affect. Compared to controls. TBI patients showed significantly impaired electrophysiological and behavioral responses while attempting to detect affective facial cues. Additional studies are required for clinicians to determine whether this measure is related to patients' psychosocial function in the community.	VA Palo Alto Hlth Care Syst, PM&R Serv, Palo Alto, CA 94304 USA; Def & Vet Brain Injury Ctr, Palo Alto, CA USA; Stanford Univ, Sch Med, Stanford, CA 94305 USA; Walter Reed Army Med Ctr, Def & Vet Brain Injury Ctr, Washington, DC 20307 USA		Lew, HL (corresponding author), VA Palo Alto Hlth Care Syst, PM&R Serv, MS-B117,3801 Miranda Ave, Palo Alto, CA 94304 USA.	henry.lew@med.va.gov					Birch DG, 2002, ARCH OPHTHALMOL-CHIC, V120, P1045; Campanella S, 2002, BIOL PSYCHOL, V59, P171, DOI 10.1016/S0301-0511(02)00005-4; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Ekman P., 1976, PICTURES FACIAL AFFE; Espino DV, 2004, J AM GERIATR SOC, V52, P822, DOI 10.1111/j.1532-5415.2004.52226.x; Fowler B, 1997, BIOL PSYCHOL, V46, P113, DOI 10.1016/S0301-0511(97)05253-8; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Ilan AB, 1999, CLIN NEUROPHYSIOL, V110, P367; JACKSON HF, 1987, CORTEX, V23, P293, DOI 10.1016/S0010-9452(87)80039-4; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; Kubu CS, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P451; LANG SF, 1990, J CLIN EXP NEUROPSYC, V12, P946, DOI 10.1080/01688639008401033; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Lew HL, 2002, AM J PHYS MED REHAB, V81, P524, DOI 10.1097/00002060-200207000-00011; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Morita Y, 2001, NEUROSCI RES, V41, P89, DOI 10.1016/S0168-0102(01)00248-6; NISHIMURA N, 1995, PSYCHIAT CLIN NEUROS, V49, P79, DOI 10.1111/j.1440-1819.1995.tb01863.x; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Polich J., 1997, ELECTROENCEPHALOGRAP, V104, P228, DOI DOI 10.1016/S0168-5597(97)96139-6; Viggiano MP, 1996, J CLIN EXP NEUROPSYC, V18, P631, DOI 10.1080/01688639608408288	23	20	21	0	5	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711			J REHABIL RES DEV	J. Rehabil. Res. Dev.	JAN-FEB	2005	42	1					29	34		10.1682/JRRD.2004.05.0056			6	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	914DL	WOS:000228205100006	15742247				2022-02-06	
J	Quinn, TJ; Smith, C; Murray, L; Stewart, J; Nicoll, JAR; Graham, DI				Quinn, TJ; Smith, C; Murray, L; Stewart, J; Nicoll, JAR; Graham, DI			There is no evidence of an association in children and teenagers between the apolipoprotein E epsilon 4 allele and post-traumatic brain swelling	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						apolipoprotein E polymorphism; brain swelling; traumatic brain injury	HEAD-INJURED CHILDREN; CEREBRAL BLOOD-FLOW; E GENOTYPE; E POLYMORPHISM; INTRACEREBRAL HEMORRHAGE; CEREBROVASCULAR-DISEASE; COGNITIVE DECLINE; APOE GENOTYPE; SURVIVAL; EDEMA	Traumatic brain injury (TBI) is an important cause of mortality and disability in children and teenagers. A particular feature of the neuropathology at post-mortem is brain swelling. The cause of the swelling in some cases is not known, while in others it is associated with traumatic axonal injury or hypoxia. Apolipoprotein E (APOE) epsilon4 allele is known to be an important genetic determinant of outcome in children after TBI. We hypothesized a relationship between possession of APOEepsilon4 and diffuse traumatic brain swelling. A total of 165 cases aged between 2 and 19 years were identified from the department's tissue archive. APOE genotype was determined by polymerase chain reaction (PCR) in 106 cases. Bilateral swelling was present in 44 cases (11 with APOEepsilon4), unilateral swelling in 25 cases (7 with APOEepsilon4) and in 36 cases (9 with APOEepsilon4) there was no evidence of brain swelling. There was no significant relationship between possession of APOEepsilon4 and the presence of cerebral swelling (chi(2) = 0.09, df = 2, P = 0.96). The 95% confidence interval for difference in proportions with swelling in those with and without the APOE epsilon4 is -19% to 22%. Thus, a significant relationship was not found between diffuse brain swelling and possession of APOEepsilon4, and in this cohort of patients there was an identifying cause of the brain swelling in all cases.	Univ Glasgow, So Gen Hosp, Acad Unit Neuropathol, Glasgow, Lanark, Scotland; Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland; Univ Southampton, Div Clin Neurosci, Southampton, Hants, England		Graham, DI (corresponding author), S Glasgow Univ Hosp NHS Trust, So Gen Hosp, Inst Neurol Sci, Dept Neuropathol, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	D.Graham@clinmed.gla.ac.uk	Quinn, Terence Joseph/H-7000-2019; Nicoll, James/I-9253-2017	Quinn, Terence Joseph/0000-0003-1401-0181; Nicoll, James/0000-0002-9444-7246			ADAMS JH, 1976, NEUROPATH APPL NEURO, V2, P323, DOI 10.1111/j.1365-2990.1976.tb00506.x; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Barger SW, 1997, NATURE, V388, P878, DOI 10.1038/42257; BRUCE DA, 1981, J NEUROSURG, V54, P170, DOI 10.3171/jns.1981.54.2.0170; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; Duhaime Ann-Christine, 1996, P1553; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Gorrie C, 2001, J NEUROTRAUM, V18, P849, DOI 10.1089/089771501750451776; GRAHAM DI, 1989, J CLIN PATHOL, V42, P18, DOI 10.1136/jcp.42.1.18; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kraus J, 2000, HEAD INJURY, P1; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; KUHL DE, 1980, J NEUROSURG, V52, P309, DOI 10.3171/jns.1980.52.3.0309; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Liaquat I, 2002, J NEUROSURG, V96, P90, DOI 10.3171/jns.2002.96.1.0090; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Luerssen T G, 1991, Neurosurg Clin N Am, V2, P399; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; McCarron MO, 1999, NEUROLOGY, V53, P1308, DOI 10.1212/WNL.53.6.1308; McCarron MO, 2000, ARCH NEUROL-CHICAGO, V57, P1480, DOI 10.1001/archneur.57.10.1480; McCarron MO, 1998, STROKE, V29, P1882, DOI 10.1161/01.STR.29.9.1882; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1989, J NEUROSURG, V71, P72, DOI 10.3171/jns.1989.71.1.0072; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; Nicoll JAR, 1997, ANN NEUROL, V41, P716, DOI 10.1002/ana.410410607; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; Prins ML, 2003, J NEUROTRAUM, V20, P123, DOI 10.1089/08977150360547053; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; Schiefermeier M, 2000, STROKE, V31, P2068, DOI 10.1161/01.STR.31.9.2068; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Teasdale GM, 1997, LANCET, V350, P1069, DOI 10.1016/S0140-6736(97)04318-3; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Tolar M, 1999, J NEUROSCI, V19, P7100, DOI 10.1523/JNEUROSCI.19-16-07100.1999; Weiner H. L., 2000, HEAD INJURY, P419; Weir CJ, 2001, NEUROLOGY, V57, P1097, DOI 10.1212/WNL.57.6.1097; [No title captured]	43	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	DEC	2004	30	6					569	575		10.1111/j.1365-2990.2004.00581.x			7	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	870RJ	WOS:000225075200001	15540997				2022-02-06	
J	Iohom, G; Szarvas, S; Larney, V; O'Brien, J; Buckley, E; Butler, M; Shorten, G				Iohom, G; Szarvas, S; Larney, V; O'Brien, J; Buckley, E; Butler, M; Shorten, G			Perioperative plasma concentrations of stable nitric oxide products are predictive of cognitive dysfunction after laparoscopic cholecystectomy	ANESTHESIA AND ANALGESIA			English	Article							NEURON-SPECIFIC ENOLASE; TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; GENERAL-ANESTHESIA; CARDIAC-SURGERY; NEUROBIOCHEMICAL MARKERS; SERUM CONCENTRATION; S-100 PROTEIN; SYNTHASE; ISCHEMIA	In this study our objectives were to determine the incidence of postoperative cognitive dysfunction (POCD) after laparoscopic cholecystectomy under sevoflurane anesthesia in patients aged >40 and <85 yr and to examine the associations between plasma concentrations of i) S-100beta protein and ii) stable nitric oxide (NO) products and POCD in this clinical setting. Neuropsychological tests were performed on 42 ASA physical status I-II patients the day before, and 4 days and 6 wk after surgery. Patient spouses (n = 13) were studied as controls. Cognitive dysfunction was defined as deficit in one or more cognitive domain(s). Serial measurements of serum concentrations of S-1000 protein and plasma concentrations of stable NO products (nitrate/nitrite, NOx) were performed perioperatively. Four days after surgery, new cognitive deficit was present in 16 (40%) patients and in 1 (7%) control subject (P = 0.01). Six weeks postoperatively, new cognitive deficit was present in 21 (53%) patients and 3 (23%) control subjects (P = 0.03). Compared with the "no deficit" group, patients who demonstrated a new cognitive deficit 4 days postoperatively had larger plasma NOx at each perioperative time point (P < 0.05 for each time point). Serum S-100beta protein concentrations were similar in the 2 groups. In conclusion, preoperative (and postoperative) plasma concentrations of stable NO products (but not S-100beta) are associated with early POCD. The former represents a potential biochemical predictor of POCD.	Cork Univ Hosp, Dept Anesthesia & Intens Care Med, Cork, Ireland; Cork Univ Hosp, Dept Clin Biochem, Cork, Ireland		Shorten, G (corresponding author), Cork Univ Hosp, Dept Anesthesia & Intens Care Med, Cork, Ireland.	shorteng@shb.ie					ABERG T, 1982, LANCET, V1, P1139; AURELL A, 1991, STROKE, V22, P1254, DOI 10.1161/01.STR.22.10.1254; Ayata C, 1997, J NEUROSCI, V17, P6908; Bruggemans EF, 1997, J CLIN EXP NEUROPSYC, V19, P543, DOI 10.1080/01688639708403743; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Cockroft KM, 1996, STROKE, V27, P1393, DOI 10.1161/01.STR.27.8.1393; DENIS R, 1984, ANESTH ANALG, V63, P653; ENDOH M, 1994, BRAIN RES, V651, P92, DOI 10.1016/0006-8993(94)90683-1; FORSTERMANN U, 1994, HYPERTENSION, V23, P1121, DOI 10.1161/01.HYP.23.6.1121; Fujioka S, 2000, SURG TODAY, V30, P871, DOI 10.1007/s005950070036; Granger DL, 1999, METHOD ENZYMOL, V301, P49; HARMON D, IN PRESS EUR J ANAES; Herrmann M, 1999, RESTOR NEUROL NEUROS, V14, P109; Iadecola C, 1997, J NEUROSCI, V17, P9157; Iadecola C, 1997, TRENDS NEUROSCI, V20, P132, DOI 10.1016/S0166-2236(96)10074-6; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Johnson T, 2002, ANESTHESIOLOGY, V96, P1351, DOI 10.1097/00000542-200206000-00014; Johnsson P, 1995, J CARDIOTHOR VASC AN, V9, P694, DOI 10.1016/S1053-0770(05)80231-9; Linstedt U, 2002, ACTA ANAESTH SCAND, V46, P384, DOI 10.1034/j.1399-6576.2002.460409.x; Linstedt U, 2000, ANAESTHESIST, V49, P887, DOI 10.1007/s001010070042; Martin R, 2002, EPILEPSIA, V43, P1551, DOI 10.1046/j.1528-1157.2002.23602.x; McKeating EG, 1998, ACT NEUR S, V71, P117; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Troy Anne Marie, 2002, Curr Opin Anaesthesiol, V15, P647, DOI 10.1097/00001503-200212000-00008; Tzabar Y, 1996, BRIT J ANAESTH, V76, P194, DOI 10.1093/bja/76.2.194; Wunderlich MT, 1999, STROKE, V30, P1190, DOI 10.1161/01.STR.30.6.1190; YOSHIDA T, 1994, J CEREBR BLOOD F MET, V14, P924, DOI 10.1038/jcbfm.1994.123; ZHANG ZG, 1994, BRAIN RES, V654, P85; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	20	25	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	OCT	2004	99	4					1245	1252		10.1213/01.ANE.0000132971.00206.4A			8	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	856IW	WOS:000224039900053	15385384				2022-02-06	
J	Bor-Seng-Shu, E; Teixeira, MJ; Hirsch, R; de Andrade, AF; Marino, R				Bor-Seng-Shu, E; Teixeira, MJ; Hirsch, R; de Andrade, AF; Marino, R			Transcranial doppler sonography in two patients who underwent decompressive craniectomy for traumatic brain swelling - Report of two cases	ARQUIVOS DE NEURO-PSIQUIATRIA			English	Article						brain swelling; cerebral hemodynamics; decompressive craniectomy; head injury; intracranial hypertension; transcranial Doppler sonography	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; FLOW VELOCITY; HEAD-INJURY; ULTRASONOGRAPHY; MANAGEMENT; VASOSPASM; ULTRASOUND; DIAGNOSIS; CHILDREN	The role of decompressive craniectomy in the treatment of severe posttraumatic cerebral swelling remains quite a controversial issue. To the best of our knowledge, there is no study demonstrating the effect of decompressive craniectomy on cerebral blood flow (CBF) velocity by means of transcranial Doppler sonography (TCD). We present two patients who developed traumatic brain swelling and uncontrollable intracranial hypertension with coma and signs of transtentorial herniation. One patient underwent bifrontal, while the second, unilateral, frontotemporoparietal decompressive craniectomy with dural expansion. In both patients, TCD examinations were performed immediately before and after surgery to study the cerebral hemodynamic changes related to the operations. Pre and postoperative TCD examinations demonstrated a significant increase in blood flow velocity in the intracranial arteries in both subjects. In conclusion, our cases suggest that decompressive craniectomy with dural expansion may result in elevation of CBF velocity in patients with massive brain swelling. The increase in CBF velocity appears to occur not only in the decompressed hemisphere, but also on the opposite side.	Univ Sao Paulo, Sch Med, Hosp Clin, Div Neurosurg, Sao Paulo, Brazil		Bor-Seng-Shu, E (corresponding author), Rua Loefgreen 1272, BR-04040001 Sao Paulo, Brazil.	edsonshu@hotmail.com	BOR-SENG-SHU, EDSON/AAC-9762-2019; Teixeira, Manoel J/E-3110-2012; BOR-SENG-SHU, EDSON/H-7784-2013	BOR-SENG-SHU, EDSON/0000-0002-6713-8974; BOR-SENG-SHU, EDSON/0000-0002-6713-8974			AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Babikian VL, 2000, J NEUROIMAGING, V10, P101, DOI 10.1111/jon2000102101; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Coplin WM, 2001, J TRAUMA, V50, P1050, DOI 10.1097/00005373-200106000-00013; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Ducrocq X, 1998, J NEUROL SCI, V159, P145, DOI 10.1016/S0022-510X(98)00158-0; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; HASSLER W, 1988, J NEUROSURG, V68, P745; HOMBURG AM, 1993, ACTA NEUROL SCAND, V87, P488; KIRKHAM FJ, 1986, ULTRASOUND MED BIOL, V12, P15, DOI 10.1016/0301-5629(86)90139-0; KLINGELHOFER J, 1991, J NEUROSURG, V75, P752, DOI 10.3171/jns.1991.75.5.0752; KUNZE E, 1998, ACTA NEUROCHIR SUPP, V71, pS16; Lee JH, 1997, J NEUROSURG, V87, P221, DOI 10.3171/jns.1997.87.2.0221; LINDEGAARD KF, 1989, ACTA NEUROCHIR, V100, P12, DOI 10.1007/BF01405268; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Martin N A, 1994, Neurosurg Clin N Am, V5, P607; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Meier U, 2000, ACTA NEUROCHIR SUPPL, V76, P475; MORGALLA MH, 1995, SURG NEUROL, V43, P583, DOI 10.1016/0090-3019(95)00034-8; MUIZELAAR JP, 1984, ADV NEUROTRAUMATOLOG, P92; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Newell D W, 1994, Neurosurg Clin N Am, V5, P619; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; RINALDI A, 1990, ACTA NEUROCHIR SUPP, V51, pS394; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Sloan MA, 1996, NEUROSONOLOGY, P156; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Whitfield PC, 2001, NEUROSURGERY, V49, P225, DOI 10.1097/00006123-200107000-00042; Yamakami Iwao, 1993, Neurologia Medico-Chirurgica, V33, P616, DOI 10.2176/nmc.33.616; Yoo DS, 1999, J NEUROSURG, V91, P953, DOI 10.3171/jns.1999.91.6.0953	34	20	20	0	1	ASSOC ARQUIVOS NEURO- PSIQUIATRIA	SAO PAULO SP	PR AMADEU AMARAL 47/33, 01327-010 SAO PAULO SP, BRAZIL	0004-282X	1678-4227		ARQ NEURO-PSIQUIAT	Arq. Neuro-Psiquiatr.	SEP	2004	62	3A					715	721		10.1590/S0004-282X2004000400028			7	Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	853AV	WOS:000223799400028	15334237	gold, Green Published, Green Submitted			2022-02-06	
J	Kontos, AP; Collins, M; Russo, SA				Kontos, AP; Collins, M; Russo, SA			An introduction to sports concussion for the sport psychology consultant	JOURNAL OF APPLIED SPORT PSYCHOLOGY			English	Article							APOLIPOPROTEIN-E EPSILON-4; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; FOOTBALL PLAYERS; MILD; PERFORMANCE; ADOLESCENTS; PREVENTION; GUIDELINES; SYMPTOMS	This paper was designed to introduce the sport psychology consultant (SPC) to the relevant practical and theoretical information pertaining to sports concussion. The paper discusses four key areas related to sports concussion: I) recognition, 2) management, 3) psychological issues following a concussion, and 4) prevention and education. Throughout the paper, the authors emphasize the role of the SPC in each of these four areas. An integrated review of the sport concussion literature and current research and guidelines regarding the definition, pathophysiology, symptoms, neuropsychological testing, and risk factors for concussion is presented. The SPC's roles in educating and helping athletes deal with post-concussion issues such as the pressure to return to play and fear of reinjury are examined. The authors highlight the need for baseline neuropsychological testing of athletes; and advocate a multidimensional team approach to sport concussion, involving the SPC as a key member of that team.	Univ New Orleans, Behav Performance Lab, New Orleans, LA 70148 USA; Univ Pittsburgh, Med Ctr, Dept Orthopaed Surg, Pittsburgh, PA 15260 USA; UPMC, Sports Med Concuss Program, Pittsburgh, PA 15260 USA		Kontos, AP (corresponding author), Univ New Orleans, Behav Performance Lab, 109 Human Performance Ctr, New Orleans, LA 70148 USA.	akontos@uno.edu		Kontos, Anthony/0000-0002-3749-4310			American Psychiatric Association, 1997, DIAGN STAT MAN MENT; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Bailes JE, 2001, NEUROSURGERY, V48, P26, DOI 10.1097/00006123-200101000-00005; BAILES JE, 2001, NEUROLOGICAL SPORTS, P1; Bandura A., 1997, SELF EFFICACY EXERCI; Barth JT, 1989, MILD HEAD INJURY, P257; BOHENEN N, 1992, NEUROSURGERY, V30, P692; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; CANTU RC, 2001, NEUROLOGICAL SPORTS, P25; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins Michael W, 2002, Curr Sports Med Rep, V1, P12; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; COLLINS MW, 2001, ANN NEW DEV SPORTS R; COLLINS MW, 2002, ORTH SOC SPORTS MED; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; EVANS L, 1995, J SPORT EXERCISE PSY, V17, P227, DOI 10.1123/jsep.17.3.227; FELER CA, 1992, HDB HEAD TRAUMA ACUT, P19; FIELD M, 2002, ANN NEW DEV SPORTS R; Gasquoine PG, 1997, NEUROPSYCHOL REV, V7, P77, DOI 10.1023/B:NERV.0000005945.58251.c0; Giza CC, 2001, J ATHL TRAINING, V36, P228; GONZALEZ J, 1994, ADOLESCENCE, V29, P701; Green GA, 1998, CLIN SPORT MED, V17, P795, DOI 10.1016/S0278-5919(05)70120-4; Gronwall D, 1989, MILD HEAD INJURY, P153; Groveman AM, 1987, NEUROPSYCHOLOGY, V1, P19, DOI 10.1037//0894-4105.1.1.19; Harre N, 2000, DEV REV, V20, P206, DOI 10.1006/drev.1999.0498; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Jordan BD, 1998, PHYSICIAN SPORTSMED, V26, P25, DOI 10.3810/psm.1998.02.928; Jordan BD, 1996, PHYSICIAN SPORTSMED, V24, P87, DOI 10.3810/psm.1996.05.1358; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly JP, 1998, J HEAD TRAUMA REHAB, V13, P53, DOI 10.1097/00001199-199804000-00008; King NS, 1999, BRIT J CLIN PSYCHOL, V38, P15, DOI 10.1348/014466599162638; KONTOS AP, 2002, ANN NEW DEV SPORTS R; KONTOS AP, IN PRESS J PEDIAT PS; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Larson GA, 1996, SPORT PSYCHOL, V10, P37, DOI 10.1123/tsp.10.1.37; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; LOVELL MR, 2001, NEUROLOGICAL SPORTS, P169; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; MAROON JC, 2001, ANN NEW DEV SPORTS R; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; MITTENBERG W, 1994, BRAIN INJURY, V8, P429, DOI 10.3109/02699059409150994; Petitpas A., 1995, Sport psychology interventions., P255; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rotella RJ, 1999, PSYCHOL BASES SPORT, P111; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Sturmi JE, 1998, SPORTS MED, V25, P351, DOI 10.2165/00007256-199825060-00001; Tysvaer A, 1981, Br J Sports Med, V15, P163; Walton G. L., 1881, BOSTON MED SURG J, V109, P337, DOI 10.1056/NEJM188310111091501; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; WILLIAMS JM, 1993, HDB RES SPORT PSYCHO, P815; YARNELL PR, 1970, LANCET, V1, P863	57	20	20	1	11	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-3200			J APPL SPORT PSYCHOL	J. Appl. Sport Psychol.	SEP	2004	16	3					220	235		10.1080/10413200490485568			16	Hospitality, Leisure, Sport & Tourism; Psychology, Applied; Psychology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Psychology; Sport Sciences	852VN	WOS:000223785000002					2022-02-06	
J	Meyerhoff, JL; Lee, JK; Rittase, BW; Tsang, AY; Yourick, DL				Meyerhoff, JL; Lee, JK; Rittase, BW; Tsang, AY; Yourick, DL			Lipoic acid pretreatment attenuates ferric chloride-induced seizures in the rat	BRAIN RESEARCH			English	Article						seizure; brain injury; hemoglobin; iron; antioxidant; lipoic acid; free radical	INTENSIVE-CARE-UNIT; POSTTRAUMATIC EPILEPSY; CEREBRAL-ISCHEMIA; CONTINUOUS EEG; EPILEPTIFORM DISCHARGES; RECURRENT SEIZURES; IRON INJECTION; BRAIN-INJURY; HEAD-INJURY; ACUTE-PHASE	Traumatic brain injury (TBI) is often complicated by the occurrence of seizures, which adversely affect clinical outcome. The risk of seizures increases to the extent that the injury is associated with sub-arachnoid hemorrhage and hematoma. A likely mechanism of seizure development post-TBI is decompartmentalization of iron from extravasated hemoglobin (Hb). It is well known that iron can catalyze formation of reactive oxygen species (ROS). Based on this proposed mechanism, a descriptive model of TBI-induced seizures, using intracortical injection of iron salts, was developed by Willmore. We have added modifications to enhance the quantifiability of seizure activity and have used the model to examine the therapeutic efficacy of lipoic acids (ROS-scavenging antioxidants). Male SD rats were pretreated with alpha-lipoic acid (ALA) and dihydrolipoic acid (DHLA) or appropriate vehicles. Under anesthesia, unilateral intracortical infusions of ferric choride were performed stereotaxically. EEG was recorded via extradural electrodes. EEG was sampled for 10 s of every 60-s interval over a 24-h period following injection of ferric chloride. We measured the number of seconds of epileptiform discharges or seizure activity in every 10-s EEG sample during the 24 h. The EEGs of rats pretreated with ALA and DHLA exhibited 55% less seizure activity than vehicle-treated ferric chloride-injected animals, suggesting that lipoic acids may be Of use in preventing or attenuating TBI-induced seizures.	Walter Reed Army Inst Res, Div Neurosci, Silver Spring, MD 20910 USA		Meyerhoff, JL (corresponding author), Walter Reed Army Inst Res, Div Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	james.meyerhoff@na.amedd.army.mil					Biewenga GP, 1997, GEN PHARMACOL, V29, P315, DOI 10.1016/S0306-3623(96)00474-0; CELESIA GG, 1976, JAMA-J AM MED ASSOC, V235, P1571, DOI 10.1001/jama.235.15.1571; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DUGAN LL, 1994, ANN NEUROL, V35, pS17, DOI 10.1002/ana.410350707; Engstrom ER, 2001, EPILEPSY RES, V43, P135, DOI 10.1016/S0920-1211(00)00191-1; Han D, 1997, AM J PHYSIOL-REG I, V273, pR1771, DOI 10.1152/ajpregu.1997.273.5.R1771; JENNETT B, 1974, J NEUROSURG, V41, P208, DOI 10.3171/jns.1974.41.2.0208; Jordan KG, 1999, J CLIN NEUROPHYSIOL, V16, P14, DOI 10.1097/00004691-199901000-00002; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Koenig M. L., 1999, Society for Neuroscience Abstracts, V25, P2093; KUCHIWAKI H, 1989, NEUROCHIRURGIA, V32, P116; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; MEYERHOFF JL, 2000, SOC NEUR ABSTR, V26, P2304; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R; Packer L, 1997, FREE RADICAL BIO MED, V22, P359, DOI 10.1016/S0891-5849(96)00269-9; Panigrahi M, 1996, BRAIN RES, V717, P184, DOI 10.1016/0006-8993(96)00009-1; PAYAN H, 1970, EPILEPSIA, V11, P81, DOI 10.1111/j.1528-1157.1970.tb03869.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; ROSEN AD, 1979, EXP NEUROL, V66, P277, DOI 10.1016/0014-4886(79)90080-3; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; SHIVAKUMAR BR, 1995, J PHARMACOL EXP THER, V274, P1167; Suzer T, 2000, RES EXP MED, V199, P223; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; Treiman DM, 1998, NEW ENGL J MED, V339, P792, DOI 10.1056/NEJM199809173391202; Ueda Y, 1998, EXP NEUROL, V153, P123, DOI 10.1006/exnr.1998.6869; WILLMORE LJ, 1983, BRAIN RES, V277, P393, DOI 10.1016/0006-8993(83)90954-X; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; WILLMORE LJ, 1978, SCIENCE, V200, P1501, DOI 10.1126/science.96527; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; Wolz P, 1996, NEUROPHARMACOLOGY, V35, P369, DOI 10.1016/0028-3908(95)00172-7; Young GB, 1996, NEUROLOGY, V47, P83; ZIEGLER D, 1995, DIABETOLOGIA, V38, P1425, DOI 10.1007/BF00400603	35	20	22	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	AUG 6	2004	1016	2					139	144		10.1016/j.brainres.2004.03.019			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	841IH	WOS:000222923000001	15246849				2022-02-06	
J	DeKosky, ST; Abrahamson, EE; Taffe, KM; Dixon, CE; Kochanek, PM; Ikonomovic, MD				DeKosky, ST; Abrahamson, EE; Taffe, KM; Dixon, CE; Kochanek, PM; Ikonomovic, MD			Effects of post-injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapies	JOURNAL OF NEUROCHEMISTRY			English	Article						catalase; glutathione peroxidase; hippocampus; reactive oxygen species; superoxide dismutase; traumatic brain injury	TRAUMATIC BRAIN-INJURY; GLUTATHIONE-PEROXIDASE ACTIVITY; CORTICAL IMPACT INJURY; NGF RESTORES DECREASE; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; CATALASE; INCREASE; DEFICITS; RNA	The pathological sequelae of traumatic brain injury (TBI) include increased oxidative stress due to the production of reactive oxygen species (ROS). Regulation of ROS levels following TBI is determined primarily by antioxidant enzyme activity that in turn can be influenced by nerve growth factor (NGF). Hypothermia is one of the current therapies designed to combat the deleterious effects of TBI. However, it has been shown to suppress post-trauma increases in NGF levels in rat brain. The present study sought to determine whether post-injury hypothermia also impairs the antioxidant response to injury, and if such an effect could be reversed by infusion of exogenous NGF. We employed a lateral controlled cortical impact injury model in rat, followed by moderate hypothermia treatment with supplemental intracerebroventricular infusion of NGF or vehicle. The time course of changes in post-injury/intervention levels of NGF and activity of three major enzymes responsible for ROS scavenging, catalase (CAT), glutathione peroxidase (GPx) and superoxide dismutase (SOD), was determined in the hippocampus. Relative to levels in injured, normothermic animals, hypothermia treatment not only suppressed NGF levels, but also attenuated CAT and GPx activity, and increased SOD activity. Infusion of NGF in injured, hypothermia-treated animals was ineffective in restoring hippocampal antioxidant enzymes activity to levels produced after injury under normothermic conditions, although it was able to increase septal cholinergic (choline acetyltransferase) enzyme activity. These results have implications for clinical treatment of TBI, demonstrating that moderate hypothermia suppresses NGF and the antioxidant response after TBI; the latter cannot be countered by exogenous NGF administration.	Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Brain Trauma Res Ctr, Pittsburgh, PA 15213 USA		DeKosky, ST (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, 3471 5th Ave,Suite 811, Pittsburgh, PA 15213 USA.	DeKoskyST@upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; DeKosky, Steven/0000-0003-3743-2758	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG05133] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS07391, NS30318] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030318, P01NS030318, P50NS030318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005133] Funding Source: NIH RePORTER		AEBI H, 1984, METHOD ENZYMOL, V105, P121; ANDERSON KD, 1995, J COMP NEUROL, V357, P296, DOI 10.1002/cne.903570209; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; CHAN PH, 1992, J NEUROTRAUM, V9, pS417; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; Clerch LB, 1996, BIOCHEM BIOPH RES CO, V222, P590, DOI 10.1006/bbrc.1996.0788; Clerch LB, 1996, AM J PHYSIOL-LUNG C, V270, pL790, DOI 10.1152/ajplung.1996.270.5.L790; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; DeKosky ST, 2004, J NEUROTRAUM, V21, P491, DOI 10.1089/089771504774129838; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; FRIM DM, 1994, EXP NEUROL, V128, P172, DOI 10.1006/exnr.1994.1125; FUKUHARA T, 1994, BRAIN RES, V657, P333, DOI 10.1016/0006-8993(94)90987-3; GAROFALO L, 1994, EXP NEUROL, V125, P195, DOI 10.1006/exnr.1994.1024; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Goss JR, 1998, EXP NEUROL, V149, P301, DOI 10.1006/exnr.1997.6712; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; HALL ED, 1993, RES P ARNMD, V71, P81; JACKSON GR, 1990, J NEUROSCI RES, V25, P360, DOI 10.1002/jnr.490250313; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mikawa S, 1996, J NEUROSURG, V85, P885, DOI 10.3171/jns.1996.85.5.0885; Ninkovic M B, 2000, Vojnosanit Pregl, V57, P257; NISTICO G, 1991, NEUROSCI LETT, V130, P117, DOI 10.1016/0304-3940(91)90241-K; NISTICO G, 1992, FREE RADICAL BIO MED, V12, P177, DOI 10.1016/0891-5849(92)90024-B; PALMER AM, 1993, J NEUROTRAUM, V10, P363, DOI 10.1089/neu.1993.10.363; PAN ZH, 1993, J NEUROCHEM, V61, P1713, DOI 10.1111/j.1471-4159.1993.tb09808.x; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Povlishock J T, 1992, Hum Cell, V5, P345; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; SAMPATH D, 1994, J NEUROCHEM, V62, P2476; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Yunoki M, 1997, J NEUROTRAUM, V14, P739, DOI 10.1089/neu.1997.14.739	40	20	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2004	90	4					998	1004		10.1111/j.1471-4159.2004.02575.x			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	842WC	WOS:000223034200026	15287906				2022-02-06	
J	Goethals, I; Audenaert, K; Jacobs, F; Lannoo, E; Van de Wiele, C; Ham, H; Otte, A; Oostra, K; Dierckx, R				Goethals, I; Audenaert, K; Jacobs, F; Lannoo, E; Van de Wiele, C; Ham, H; Otte, A; Oostra, K; Dierckx, R			Cognitive neuroactivation using SPECT and the Stroop Colored Word test in patients with diffuse brain injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral perfusion; cognitive activation; diffuse brain injury; single photon emission computed tomography	CLOSED-HEAD-INJURY; PREFRONTAL ACTIVATION PROBE; CEREBRAL-BLOOD-FLOW; NEUROPSYCHOLOGICAL RECOVERY; TECHNETIUM-99M-HMPAO SPECT; INTERFERENCE TASK; COUNTING STROOP; FRONTAL-LOBE; PERFORMANCE; VALIDATION	Psychomotor slowing in patients with diffuse brain injury frequently underlies impaired cognitive performance on neuropsychological tests, for example, the Stroop Colored Word test. The aim of the present study was to determine the neural basis associated with performance on the Stroop interference subtask in patients with diffuse brain injury. We hypothesized that patients would be slower than healthy controls, and that this would be associated with brain activations other than those seen in healthy subjects. Brain perfusion, using a split-dose activation paradigm with single photon emission tomography (SPECT) and the Stroop test, was assessed in 9 patients with diffuse brain injury. The Stroop interference score was calculated as a behavioral parameter, and functional imaging data were analyzed with statistical parametrical mapping (SPM99) to determine significant voxel-wise differences of activation between the control and the activation condition. Patients were impaired on the interference subtask of the Stroop test. Comparison of the SPECT data obtained during the activation condition with those obtained during the control condition by means of SPM showed significant activations in the left inferior parietal lobe, the right anterior cingulate extending into the right middle frontal gyrus and the right caudate, and the left posterior cingulate cortex. Patients with diffuse brain injury were slower than healthy controls on the interference subtask of the Stroop test, suggesting difficulty with resistance to distractions This finding was associated with activation effects in posterior (mainly parietal) brain areas in addition with activation of previously observed anterior (mainly anterior cingulate) brain regions.	Ghent Univ Hosp, Poliklin 7, Div Nucl Med, B-9000 Ghent, Belgium; Ghent Univ Hosp, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium; Ghent Univ Hosp, Ctr Locomotor & Neurol Rehab, B-9000 Ghent, Belgium		Goethals, I (corresponding author), Ghent Univ Hosp, Poliklin 7, Div Nucl Med, De Pintelaan 185, B-9000 Ghent, Belgium.	ingeborg.goethals@ugent.be	Oostra, Kristine/AAI-7317-2020	Otte, Andreas/0000-0002-6290-6786			ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Asikainen I, 1999, EUR J NEUROL, V6, P179, DOI 10.1111/j.1468-1331.1999.tb00011.x; Audenaert K, 2001, NUCL MED COMMUN, V22, P135, DOI 10.1097/00006231-200102000-00004; Audenaert K, 2000, EUR J NUCL MED, V27, P1800, DOI 10.1007/s002590000351; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; Brown GG, 1999, J INT NEUROPSYCH SOC, V5, P308, DOI 10.1017/S1355617799544020; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.3.CO;2-H; Carter CS, 1995, NEUROIMAGE, V2, P264, DOI 10.1006/nimg.1995.1034; DAMASIO AR, 1983, NEUROLOGY, V33, P1573, DOI 10.1212/WNL.33.12.1573; DAMASIO AR, 1979, BRAIN LANG, V7, P74, DOI 10.1016/0093-934X(79)90007-5; DAVID AS, 1992, NEUROPSYCHOLOGIA, V30, P161, DOI 10.1016/0028-3932(92)90025-H; Derbyshire SWG, 1998, EXP BRAIN RES, V118, P52, DOI 10.1007/s002210050254; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; DUNBAR K, 1984, J EXP PSYCHOL HUMAN, V10, P622, DOI 10.1037/0096-1523.10.5.622; Fuster, 2015, PREFRONTAL CORTEX; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; George M S, 1994, Hum Brain Mapp, V1, P194, DOI 10.1002/hbm.460010305; Goethals I, 2002, J NUCL MED, V43, P1426; GOLDENBERG G, 1992, J NEUROL NEUROSUR PS, V55, P362, DOI 10.1136/jnnp.55.5.362; Gruber SA, 2002, NEUROIMAGE, V16, P349, DOI 10.1006/nimg.2002.1089; Hammes J., 1971, STROOP KLEUR WOORDTE; ICHISE M, 1994, J NUCL MED, V35, P217; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lannoo E, 1997, PSYCHOL BELG, V37, P141; Lannoo E, 2001, BRAIN INJURY, V15, P1, DOI 10.1080/02699050150209084; LEVIN HS, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P89; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, P171; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; LINDSAY DS, 1994, J EXP PSYCHOL HUMAN, V20, P219, DOI 10.1037/0096-1523.20.2.219; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; Newberg AB, 2003, SEMIN NUCL MED, V33, P136, DOI 10.1053/snuc.2003.127299; ODER W, 1992, J NEUROL NEUROSUR PS, V55, P475, DOI 10.1136/jnnp.55.6.475; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Peterson BS, 1999, BIOL PSYCHIAT, V45, P1237, DOI 10.1016/S0006-3223(99)00056-6; PRAYER L, 1993, ACTA RADIOL, V34, P593; ROPER SN, 1991, J NUCL MED, V32, P1684; SILVER SM, 1992, AM PSYCHIAT TXB NEUR, P363; Stamatakis EA, 1999, NEUROIMAGE, V10, P397, DOI 10.1006/nimg.1999.0477; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; TAYLOR SF, 1994, NEUROPSYCHOLOGIA, V32, P249, DOI 10.1016/0028-3932(94)90010-8; Taylor SF, 1997, NEUROIMAGE, V6, P81, DOI 10.1006/nimg.1997.0285; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; Van Laere K, 2001, EUR J NUCL MED, V28, P873, DOI 10.1007/s002590100549; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0	53	20	21	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG	2004	21	8					1059	1069		10.1089/0897715041651051			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	846AK	WOS:000223286800008	15319005				2022-02-06	
J	Harmsen, M; Geurts, ACH; Fasotti, L; Bevaart, BJW				Harmsen, M; Geurts, ACH; Fasotti, L; Bevaart, BJW			Positive behavioural disturbances in the rehabilitation phase after severe traumatic brain injury: an historic cohort study	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; DIFFUSE AXONAL INJURY; AGITATION; HALOPERIDOL; RESTLESSNESS; COGNITION; RECOVERY; AMNESIA; AGENTS	Primary objective: To investigate the association of post-traumatic amnesia (PTA) with positive behavioural disturbances (PBD) in an historic cohort of patients with severe traumatic brain injury (TBI) and to evaluate the use and effects of neuroleptic drugs in this cohort. Research design: Historic cohort study. Methods: The medical files of 60 patients with severe TBI, selected for inpatient rehabilitation during a period of 5.5 years, were independently examined for the presence of PTA and PBD at admission in the rehabilitation centre as well as for the concomitant use of neuroleptic drugs. All TBI patients with PBD at admission were subjected to special nursing measures consisting of a structured and safe environment, a minimum number of caregivers and provision of simple and consistent feedback. As a basic policy, the use of neuroleptic medication was minimized or stopped. Results: Of the 28 patients suffering from PTA at admission, 16 demonstrated PBD (positive predictive value 0.57 (95% CI 0.45-0.70)). In contrast, all the 32 patients without PTA but one did not show PBD (negative predictive value 0.97 (95% CI 0.93-1.00)). Seven of the 17 patients with PBD (41%) had been prescribed neuroleptic medication, of whom five patients (81%) experienced undesired side effects. Because of the special nursing measures, these drugs could be stopped or substituted by non-neuroleptic behaviour-modifying drugs in all patients within 3 weeks, without aggravation of their PBD. Conclusions: These results suggest that impaired attention and memory may play a critical role in the development of PBD in patients with severe TBI. From this perspective, maximum effort must be made to improve TBI patients' level of attention, memory and orientation instead of using mechanical or chemical restraints.	St Maartens Clin, Dept Rehabil Med, NL-6500 GM Nijmegen, Netherlands; Rehabil Ctr Tolbrug, Shertogenbosch, Netherlands		Geurts, ACH (corresponding author), St Maartens Clin, Dept Rehabil Med, POB 9011, NL-6500 GM Nijmegen, Netherlands.	a.geurts@maartenskliniek.nl	Geurts, Alexander/H-8032-2014	Geurts, Alexander/0000-0001-7478-1119			Ahmed S, 2000, BRAIN INJURY, V14, P765; ARTIOLAIFORTUNY L, 1980, J NEUROL NEUROSUR PS, V43, P377, DOI 10.1136/jnnp.43.5.377; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Byerly MJ, 2001, DRUG AGING, V18, P45, DOI 10.2165/00002512-200118010-00004; CORRIGAN J D, 1992, Brain Injury, V6, P155, DOI 10.3109/02699059209029653; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; Ducharme JM, 1999, BRAIN INJURY, V13, P645, DOI 10.1080/026990599121232; Fasotti L., 2003, HDB NEUROPSYCHOLOGY, V9, P67; Fugate LP, 1997, ARCH PHYS MED REHAB, V78, P924, DOI 10.1016/S0003-9993(97)90051-4; GOLDSTEIN LB, 1993, J NEURAL TRANSP PLAS, V4, P175, DOI 10.1155/NP.1993.175; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; HAMM RJ, 1994, J NEUROSURG, V81, P267, DOI 10.3171/jns.1994.81.2.0267; JENNET B, 1981, MANAGEMENT HEAD INJU; Legangneux E, 2000, J PSYCHOPHARMACOL, V14, P164, DOI 10.1177/026988110001400206; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Maryniak O, 2001, BRAIN INJURY, V15, P167, DOI 10.1080/026990501458399; McLean A. J., 1997, HEAD INJURY, P25; Meythaler JM, 2002, J HEAD TRAUMA REHAB, V17, P300, DOI 10.1097/00001199-200208000-00004; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mysiw WJ, 1997, ARCH PHYS MED REHAB, V78, P213, DOI 10.1016/S0003-9993(97)90266-5; Pike BR, 1997, PHARMACOL BIOCHEM BE, V57, P785, DOI 10.1016/S0091-3057(96)00453-4; POLING A, 1990, J PHARMACOL EXP THER, V255, P1240; RAO N, 1985, ARCH PHYS MED REHAB, V66, P30; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Stanislav SW, 2000, BRAIN INJURY, V14, P261; Teng CJ, 2001, BRAIN INJURY, V15, P463, DOI 10.1080/02699050010005931; van der Naalt J, 2000, BRAIN INJURY, V14, P781; Whyte J, 2002, J HEAD TRAUMA REHAB, V17, P284, DOI 10.1097/00001199-200208000-00003; Wilkinson R, 1999, BRAIN INJURY, V13, P1025; [No title captured]	34	20	20	0	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2004	18	8					787	796		10.1080/02699050410001671757			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	826AN	WOS:000221801300005	15204319				2022-02-06	
J	Metz, M; Kross, M; Abt, P; Bankey, P; Koniaris, LG				Metz, M; Kross, M; Abt, P; Bankey, P; Koniaris, LG			Tree stand falls: A persistent cause of sports injury	SOUTHERN MEDICAL JOURNAL			English	Article						deer tree stands; injury; public health	TRAUMA; EXPERIENCE	Objective: Tree stand falls are a well-known cause of hunting-related injury. Spine and brain injuries associated with these falls result in a significant incidence of permanent disability. Prior studies indicate that hunting tree stand injuries are largely preventable with the proper use of safety belts; however, compliance with safety belt use is variable. The purposes of this study were to determine 1) current compliance with safety belt use, 2) alterations in the spectrum of injury, and 3) causes of the falls. Methods: From January 1996 to October 2001, 51 tree stand-related injuries referred to either of two regional trauma centers or their region's medical examiner's office were reviewed. Data had been recorded in each hospital's trauma registry, and the registries were searched for falls. Medical records were reviewed for additional data retrospectively, with an emphasis on determining the use of safety belts, and mechanisms contributing to the fall. Results: Fifty-one cases of tree stand-associated injuries were identified. These injuries all occurred in men, with a mean age of 42.6 years (range, 22-69 years). Alcohol use was present in 10% of patients and in two of the three deaths. The mean Injury Severity Score was 18.1 (range, 2-75). The most common injuries were spinal fractures (51% of series) and extremity fractures (41% of series). Closed head injuries were identified in 24% and lung injuries were identified in 22% of patients. Abdominal visceral injuries were present in 8% and genitourinary injuries were present in 4%. Three patients died. In addition to injury from the fall, a significant number (six patients [12%]) had additional morbidity from exposure. Only two patients reported the use of a safety belt (4% of series). There were no cases of gunshot wounds in this review, either self-inflicted or hunter-related. The chief reasons reported for these falls were errors in placement that resulted in structural failure of the stand, or errors made while climbing into or out of the stand (50% of falls). Conclusion: Devastating spine and brain injuries continue to occur after falls from tree stands during recreational hunting when safety belts are not used. Our results suggest a continuing need for the education of hunters concerning safe tree stand hunting practices, including proper methods of stand placement, assessment of tree branch strength, avoidance of fatigue and alcohol, anticipation of firearm recoil, and proper methods of stand entrance and exit. Trauma prevention programs directed toward heightened public awareness of these injuries during hunting season are still needed.	Miami Univ, Sch Med, DeWitt Daughtry Dept Surg 310T, Miami, FL 33156 USA; Univ Rochester, Sch Med & Dent, Dept Surg, Rochester, NY USA; Washington Cty Hosp, Dept Surg, Hagerstown, MD USA		Koniaris, LG (corresponding author), Miami Univ, Sch Med, DeWitt Daughtry Dept Surg 310T, 1475 NW 12th St, Miami, FL 33156 USA.	lkoniaris@med.miami.edu	Abt, Peter/AAD-6856-2019				Brandes SB, 1999, J TRAUMA, V47, P643, DOI 10.1097/00005373-199910000-00007; *CDCP, 1989, MMWR-MORBID MORTAL W, V38, P697; Crites B M, 1998, J South Orthop Assoc, V7, P241; Gates RL, 2002, J TRAUMA, V53, P705, DOI 10.1097/00005373-200210000-00014; Goodacre S, 1999, J TRAUMA, V46, P1055, DOI 10.1097/00005373-199906000-00014; Kennedy RL, 2001, J TRAUMA, V51, P717, DOI 10.1097/00005373-200110000-00016; Lawrence D W, 1996, J La State Med Soc, V148, P77; Morey AF, 2001, J TRAUMA, V51, P683, DOI 10.1097/00005373-200110000-00010; Price C, 1994, J Okla State Med Assoc, V87, P270; Thomas B, 1997, J TRAUMA, V42, P384, DOI 10.1097/00005373-199703000-00004; URQUHART CK, 1991, SOUTHERN MED J, V84, P686, DOI 10.1097/00007611-199106000-00003; Wilson S, 2001, INJURY, V32, P525, DOI 10.1016/S0020-1383(00)00199-6	12	20	20	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0038-4348	1541-8243		SOUTH MED J	South.Med.J.	AUG	2004	97	8					715	719		10.1097/00007611-200408000-00003			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847BB	WOS:000223362600003	15352662				2022-02-06	
J	Prigatano, GP; Johnson, SC; Gale, SD				Prigatano, GP; Johnson, SC; Gale, SD			Neuroimaging correlates of the Halstead Finger Tapping Test several years post-traumatic brain injury	BRAIN INJURY			English	Article							IMPAIRED AWARENESS; ACTIVATION	Eight healthy volunteers and seven post-acute patients with a history of severe traumatic brain injury (TBI) performed the Halstead Finger Tapping Test while undergoing functional magnetic resonance imaging (fMRI). Patients with TBI were on average 18.5 years post-trauma and at that time had normal or near normal tapping speeds. The fMRI analysis revealed greater bilateral frontal activation in healthy controls while tapping only in the right hand compared to patients with TBI. The maximum area of activation differences involved the supplementary motor area. Voxel-based morphometry (VBM) failed to reveal signs of atrophy to explain these findings. Different patterns of brain activation in patients with TBI compared to healthy controls may be seen even when the level of behavioural performance of patients is generally within normal limits.	St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA		Prigatano, GP (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol, 350 W thomas Rd, Phoenix, AZ 85013 USA.	gprigat@chw.edu					Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; DETTMERS C, 1995, J NEUROPHYSIOL, V74, P802, DOI 10.1152/jn.1995.74.2.802; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead WC, 1947, BRAIN INTELLIGENCE Q; HEATON RK, 1978, J NERV MENT DIS, V166, P408, DOI 10.1097/00005053-197806000-00004; Heaton RK, 1991, COMPREHENSIVE NORMS; Holmes AP, 1998, NEUROIMAGE, V7, pS754, DOI [10.1016/S1053-8119(18)31587-8, DOI 10.1016/S1053-8119(18)31587-8]; Johnson M. T., 2000, Information Display, V16, P12; Johnson SC, 2001, J INT NEUROPSYCH SOC, V7, P55, DOI 10.1017/S135561770171106X; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Mead LA, 2002, J INT NEUROPSYCH SOC, V8, P735, DOI 10.1017/S1355617702860015; Mesulam M., 1985, PRINCIPLES BEHAV NEU; Passingham RE, 1997, HUMAN BRAIN FUNCTION, P243; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano GP, 1999, REHABIL PSYCHOL, V44, P145, DOI 10.1037/0090-5550.44.2.145; PRIGATANO GP, 1976, J CONSULT CLIN PSYCH, V44, P527, DOI 10.1037/0022-006X.44.4.527; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Prigatano GP, 1997, ARCH PHYS MED REHAB, V78, P847, DOI 10.1016/S0003-9993(97)90198-2; REITAN RM, 1994, CLIN NEUROPSYCHOL, V8, P193, DOI 10.1080/13854049408401557; REITAN RM, 1956, J NERV MENT DIS, V123, P536; Rosen HJ, 2002, NEUROLOGY, V58, P198, DOI 10.1212/WNL.58.2.198; VEGA A, 1967, J CONSULT PSYCHOL, V31, P619, DOI 10.1037/h0025112; Winterer G, 2002, NEUROIMAGE, V17, P851, DOI 10.1006/nimg.2002.1232; WORSLEY KJ, 1995, UNIFIED STAT APPROAC	28	20	20	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL	2004	18	7					661	669		10.1080/02699050310001646170			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	821HJ	WOS:000221450700003	15204327				2022-02-06	
J	Enblad, P; Nilsson, P; Chambers, I; Citerio, G; Fiddes, H; Howells, T; Kiening, K; Ragauskas, A; Sahuquillo, J; Yau, YH; Contant, C; Piper, I				Enblad, P; Nilsson, P; Chambers, I; Citerio, G; Fiddes, H; Howells, T; Kiening, K; Ragauskas, A; Sahuquillo, J; Yau, YH; Contant, C; Piper, I			R3-Survey of traumatic brain injury management in European Brain IT centres year 2001	INTENSIVE CARE MEDICINE			English	Article						head injury; management; survey	SEVERE HEAD-INJURY; CARE MANAGEMENT; INTENSIVE-CARE; UNITED-KINGDOM; GUIDELINES; CONSORTIUM	Objective. To obtain knowledge about the conditions and management of traumatic brain injury (TBI) in a collaborative network of Brain Information Technology centres. Design. The Brain IT (Brain monitoring with Information Technology) survey comprised two parts: local conditions and policies (part A), and a case study part (part B). The information was gathered by written questionnaires followed by telephone interviews. Participants. Twenty-four Brain IT centres participated (two respondents from 18 sites). Results. The average proportion of agreement between duplicate respondents was 0.79 (range 0.44-1.00). All Brain IT centres monitored ICP. The reported order of treatment for intracranial hypertension was: evacuation of mass-lesions and head elevation (1), increase of sedation and Mannitol scheme (2), hyperventilation (3), ventricular drainage (4), craniectomy and pentothal coma (5), and decompressive lobectomy (6). The respondents were less prone to evacuate expansive contusions in relation to extra cerebral hematomas. The most common suggested interventions (alone or in combination) for treatment of intracranial hypertension without mass lesions was the Mannitol scheme (included in 71% of the suggestions), CSF drainage (included in 56%), hyperventilation (included in 32%), and pentothal coma (included in 22%). Conclusions. The suggested management of TBI was mainly in accordance with published guidelines, although a minor proportion of the answers deviated to some extent. The suggested order and combinations of different treatment interventions varied. Variation of treatment within the range of prescribed standards provides optimal conditions for an interesting future analysis of treatment and monitoring data as collected prospectively in a Brain IT database.	Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, S-75185 Uppsala, Sweden; Newcastle Gen Hosp, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Osped San Gerardo, Dept Anaesthesia, Monza, Italy; S Glasgow Univ Hosp NHS Trust, Dept Neurosurg, Glasgow, Lanark, Scotland; Virchow Hosp, Charite, Dept Neurosurg, Berlin, Germany; Kaunas Univ Technol, Dept Bioengn, Kaunas, Lithuania; Vall Hebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; S Glasgow Univ Hosp NHS Trust, Dept Clin Phys, Glasgow, Lanark, Scotland		Enblad, P (corresponding author), Univ Uppsala Hosp, Neurosurg Sect, Dept Neurosci, S-75185 Uppsala, Sweden.	Per.Enblad@neurokir.uu.se	Sahuquillo, Juan/B-3577-2008; Citerio, Giuseppe/B-1839-2015; Ragauskas, Art/J-7486-2016	Sahuquillo, Juan/0000-0003-0713-5875; Citerio, Giuseppe/0000-0002-5374-3161; Ragauskas, Art/0000-0002-3536-554X			Bullock MR, 1996, J NEUROTRAUM, V13, P643; GHAJAR J, 1995, CRIT CARE MED, V23, P560, DOI 10.1097/00003246-199503000-00023; Jeevaratnam DR, 1996, BRIT MED J, V312, P944; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Matta B, 1996, CRIT CARE MED, V24, P1743, DOI 10.1097/00003246-199610000-00023; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Piper I, 2003, ACTA NEUROCHIR, V145, P615, DOI 10.1007/s00701-003-0066-6; Stocchetti N, 2001, INTENS CARE MED, V27, P400, DOI 10.1007/s001340000825	8	20	20	0	2	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	JUN	2004	30	6					1058	1065		10.1007/s00134-004-2206-8			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825BF	WOS:000221730300010	15024565				2022-02-06	
J	Lepeintre, JF; D'Arbigny, P; Mathe, JF; Vigue, B; Loubert, G; Delcour, J; Kempf, C; Tadie, M				Lepeintre, JF; D'Arbigny, P; Mathe, JF; Vigue, B; Loubert, G; Delcour, J; Kempf, C; Tadie, M			Neuroprotective effect of gacyclidine - A multicenter double-blind pilot trial in patients with acute traumatic brain injury	NEUROCHIRURGIE			English	Article						clinical trial design; traumatic brain injury; gacyclidine; N-methyl-D-aspartate; NMDA; neuroprotection; favorable outcome; Glasgow outcome scale	SPINAL-CORD-INJURY; SEVERE HEAD-INJURY; AMINO-ACIDS; EXTRACELLULAR LEVELS; ADULT-RATS; GLUTAMATE; SECONDARY; ANTAGONISTS; NIMODIPINE; RECEPTORS	The aim of this study was to assess the safety and efficacy of intravenous (IV) injections of gacyclidine, a novel NMDA receptor antagonist, for neurological and functional recovery following acute traumatic brain injury. This multicenter, prospective, randomized, placebo-controlled, double-blind study compared four parallel groups. Two IV doses were administrated (placebo, 2x0.005mg/kg, 2x0.001mg/kg, 2x0.02mg/kg): the first dose was given within 2 hours following the trauma, and the second dose 4 hours after the first. Fifty-one patients were enrolled and 48 studied between March 1995 and June 1997 in France. Evaluation criteria for safety were physical examination, cardiovascular parameters, blood chemistry, hematology, ECG, and neuropsychological changes monitored after medication. Primary evaluation criteria for efficacy was the Glasgow coma scale complemented by the initial CT-scan and Glasgow outcome scale, motor deficiencies, neuropsychological changes, and functional indenpendence at D90 and D365 or endpoint. Intracranial pressure (ICP) monitoring was not taken into account because all the clinical centers participating in this study did not use this technique in daily practice during the inclusion period. Twelve patients died during the follow-up period, none of these deaths being related to the drug. Serious adverse events (181) were reported by most of the patients with no significant differences between groups. Only 10 of these adverse events were considered to be drug-related. Safety-related laboratory tests did not show any relevant. Concerning efficacy, the predefined prognostic factors (initial CT-scan score, initial Glasgow Coma Scale and occurrence of low systolic blood pressure during the first 24 hours) largely determinated the patient's outcome. When the prognostic factors were taken into account together with the dose level in a logistic regression model, gacyclidine showed a beneficial long-term effect and a best dose-result in the 0.04mg/kg treated group. Data obtained in this clinical trial appeared sufficient to warrant a European multicenter study on gacyclidine using the same evaluation criteria and ICP monitoring.	CHU Bicetre, Serv Neurochirurg, AP HP, F-94275 Le Kremlin Bicetre, France; Beaufour Ipsen Pharma, Res & Dev, F-75781 Paris, France; CHU Nantes, Hop St Jacques, Serv Reeduc Fonctionnelle, F-44035 Nantes 01, France; CHU Bicetre, Serv Anesthesie Reanimat, AP HP, F-94275 Le Kremlin Bicetre, France; Hop Raymond Poincare, Dept Anesthesie, AP HP, F-92380 Garches, France; CHU Amiens, Serv Neurochirurg Neurotraumatol B, F-80054 Amiens 01, France; Integrated Clin Data, F-67530 Ottrott, France		Lepeintre, JF (corresponding author), CHU Bicetre, Serv Neurochirurg, AP HP, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	jf.lepeintre@bct.ap-hop-paris.fr					BAILEY I, 1991, ACTA NEUROCHIR, V110, P97, DOI 10.1007/BF01400674; BRAAKMAN R, 1994, J NEUROSURG, V80, P797; CHAUDIEU I, 1987, EUR J MED CHEM, V22, P359, DOI 10.1016/0223-5234(87)90274-1; CHOI D, 1989, TRENDS NEUROSCI, V11, P21; CHOI DW, 1987, J NEUROSCI, V7, P369; Drian MJ, 1999, J NEUROSCI RES, V57, P927, DOI 10.1002/(SICI)1097-4547(19990915)57:6<927::AID-JNR18>3.0.CO;2-C; DRIAN MJ, 1991, J NEUROSCI RES, V29, P133, DOI 10.1002/jnr.490290116; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Farooque M, 1996, J NEUROTRAUM, V13, P537, DOI 10.1089/neu.1996.13.537; Gaviria M, 2000, J NEUROTRAUM, V17, P19, DOI 10.1089/neu.2000.17.19; Gaviria M, 2000, BRAIN RES, V874, P200, DOI 10.1016/S0006-8993(00)02581-6; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; Hirbec H, 2001, CNS DRUG REV, V7, P172; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KAMENKA JM, 1982, J MED CHEM, V25, P431, DOI 10.1021/jm00346a019; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Lallement G, 1997, NEUROTOXICOLOGY, V18, P851; Lallement G, 1999, ARCH TOXICOL, V73, P115, DOI 10.1007/s002040050595; LEVALLOIS C, 1995, CELL BIOL TOXICOL, V11, P155, DOI 10.1007/BF00756517; LEVALLOIS C, 1992, BRAIN RES, V573, P327, DOI 10.1016/0006-8993(92)90782-5; Li S, 1999, SPINAL CORD, V37, P820, DOI 10.1038/sj.sc.3100941; Lu YM, 1996, J NEUROSCI, V16, P5457; Machado SG, 1999, J NEUROTRAUM, V16, P1131, DOI 10.1089/neu.1999.16.1131; MAIER CM, 1995, J NEUROCHEM, V65, P652; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MICHAUD M, 1994, EUR J MED CHEM, V29, P869, DOI 10.1016/0223-5234(94)90109-0; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; Murray GD, 1996, ACTA NEUROCHIR, V138, P1163, DOI 10.1007/BF01809745; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; PENCALET P, 1993, J NEUROSURG, V78, P603, DOI 10.3171/jns.1993.78.4.0603; Ribotta MGY, 1998, CURR OPIN NEUROL, V11, P647, DOI 10.1097/00019052-199812000-00007; RONDOUIN G, 1988, NEUROSCI LETT, V91, P199, DOI 10.1016/0304-3940(88)90768-9; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Young B, 1996, JAMA-J AM MED ASSOC, V276, P538, DOI 10.1001/jama.276.7.538	43	20	21	0	0	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0028-3770	1773-0619		NEUROCHIRURGIE	Neurochirurgie	JUN	2004	50	2-3	1				83	95					13	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	832KR	WOS:000222266900001	15213636				2022-02-06	
J	Morgan, A; Ward, E; Murdoch, B				Morgan, A; Ward, E; Murdoch, B			Clinical progression and outcome of dysphagia following paediatric traumatic brain injury: a prospective study	BRAIN INJURY			English	Article							HEAD-INJURY; REHABILITATION	Objectives : To provide a preliminary clinical profile of the resolution and outcomes of oral-motor impairment and swallowing function in a group of paediatric dysphagia patients post-traumatic brain injury (TBI). To document the level of cognitive impairment parallel to the return to oral intake, and to investigate the correlation between the resolution of impaired swallow function versus the resolution of oral-motor impairment and cognitive impairment. Participants : Thirteen children admitted to an acute care setting for TBI. Main outcome measures : A series of oral-motor (Verbal Motor Production Assessment for Children, Frenchay Dysarthria Assessment, Schedule for Oral Motor Assessment) and swallowing (Paramatta Hospital's Assessment for Dysphagia) assessments, an outcome measure for swallowing (Royal Brisbane Hospital's Outcome Measure for Swallowing), and a cognitive rating scale (Rancho Level of Cognitive Functioning Scale). Results : Across the patient group, oral-motor deficits resolved to normal status between 3 and 11 weeks post-referral (and at an average of 12 weeks post-injury) and swallowing function and resolution to normal diet status were achieved by 3-11 weeks post-referral (and at an average of 12 weeks post-injury). The resolution of dysphagia and the resolution of oral-motor impairment and cognitive impairment were all highly correlated. Conclusion : The provision of a preliminary profile of oral-motor functioning and dysphagia resolution, and data on the linear relationship between swallowing impairment and cognition, will provide baseline information on the course of rehabilitation of dysphagia in the paediatric population post-TBI. Such data will contribute to more informed service provision and rehabilitation planning for paediatric patients post-TBI.	Univ Queensland, Dept Speech Pathol & Audiol, Brisbane, Qld, Australia		Morgan, A (corresponding author), Inst Child Hlth, Dev Cognit Neurosci Sci, 30 Guilford St, London WC1N, England.		Ward, Elizabeth/F-9652-2010; Murdoch, Bruce E/C-1397-2012; Morgan, Angela/J-5235-2017	Ward, Elizabeth/0000-0002-2680-8978; Morgan, Angela/0000-0003-1147-7405			Barnes MP, 1999, BRIT MED BULL, V55, P927, DOI 10.1258/0007142991902727; Cherney LR, 1989, J HEAD TRAUMA REHAB, V4, P42; Christensen J R, 1989, Dysphagia, V3, P131, DOI 10.1007/BF02407131; COPPENS P, 1995, BRAIN INJURY, V9, P195, DOI 10.3109/02699059509008192; Eker C, 2000, BRAIN INJURY, V14, P605; Enderby P, 1983, FRENCHAY DYSARTHRIA; Field L H, 1989, Brain Inj, V3, P19, DOI 10.3109/02699058909008069; Gisel E G, 1998, Int J Orofacial Myology, V24, P27; Gisel EG, 1996, DYSPHAGIA, V11, P48, DOI 10.1007/BF00385800; Gisel Erika G., 1994, Dysphagia, V9, P180, DOI 10.1007/BF00341263; Hagen C., 1972, LEVELS COGNITIVE FUN; Halper AS, 1999, J HEAD TRAUMA REHAB, V14, P486, DOI 10.1097/00001199-199910000-00009; HANSWORTH DS, 1997, J NEUROSCIENCE NURSI, V29, P156; Hayden D., 1999, VERBAL MOTOR PRODUCT; Logemann JA, 1994, J HEAD TRAUMA REHAB, V9, P43; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Mcilvoy L, 2001, J Neurosci Nurs, V33, P72; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Morgan AT, 2001, ASIA PACIFIC J SPEEC, V6, P9; Morris S E, 1989, Dysphagia, V3, P135, DOI 10.1007/BF02407132; REILLY S, 1995, DYSPHAGIA, V10, P177, DOI 10.1007/BF00260975; Rowe LA, 1999, J HEAD TRAUMA REHAB, V14, P497, DOI 10.1097/00001199-199910000-00010; STARR S, 1998, FEEDING ASSESSMENT R, V2; Ward E, 1999, ASIA PACIFIC J SPEEC, V4, P109, DOI DOI 10.1179/136132899805577051; *WESTM HOSP COMM H, 1998, PARR HOSP ASS DYSPH; WINSTEIN CJ, 1983, PHYS THER, V63, P1992, DOI 10.1093/ptj/63.12.1992; YLVISAKER M, 1989, J HEAD TRAUMA REHAB, V4, P51; YLVISAKER M, 1986, MANAGEMENT HEAD INJU; YORKSTON KM, 1989, J HEAD TRAUMA REHAB, V4, P52	30	20	21	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2004	18	4					359	376		10.1080/02699050310001617424			18	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	765VB	WOS:000188304100003	14742150				2022-02-06	
J	Vespa, P; McArthur, DL; Alger, J; O'Phelan, K; Hattori, N; Wu, C; Glenn, T; Bergsneider, M; Martin, NI; Hovda, DA				Vespa, P; McArthur, DL; Alger, J; O'Phelan, K; Hattori, N; Wu, C; Glenn, T; Bergsneider, M; Martin, NI; Hovda, DA			Regional heterogeneity of post-traumatic brain metabolism as studied by microdialysis, magnetic resonance Spectroscopy and positron emission tomography	BRAIN PATHOLOGY			English	Article							CEREBRAL-BLOOD-FLOW; HUMAN HEAD-INJURY; GLUCOSE; LACTATE		Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Neurosurg, Los Angeles, CA 90095 USA		Vespa, P (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Div Neurosurg, 10833 Le Conte Ave,CHS 18-218,Mail Code 713909, Los Angeles, CA 90095 USA.	Pvespa@mednet.ucla.edu	Hattori, Naoya/AAR-6405-2020; McArthur, David/E-6442-2013; Hattori, Naoya/G-2298-2012	McArthur, David/0000-0003-3385-1314; Martin, Neil/0000-0002-6565-4131; Glenn, Thomas/0000-0003-4273-3408			Alessandri B, 1999, ACT NEUR S, V75, P21; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bergsneider M, 2001, J HEAD TRAUMA REHAB, V16, P135, DOI 10.1097/00001199-200104000-00004; Bergsneider M, 2000, J NEUROTRAUM, V17, P389, DOI 10.1089/neu.2000.17.389; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Condon B, 1998, J NEUROTRAUM, V15, P563, DOI 10.1089/neu.1998.15.563; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Garnett MR, 2001, J NEUROTRAUM, V18, P231, DOI 10.1089/08977150151070838; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; MARION DW, 1991, NEUROSURGERY, V29, P869, DOI 10.1227/00006123-199112000-00011; MARSHALL LF, 1992, J NEUROTRAUMA, V9, P287; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Ross BD, 1998, J MAGN RESON IMAGING, V8, P829, DOI 10.1002/jmri.1880080412; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; VANDERKNAAP MS, 1990, RADIOLOGY, V176, P509, DOI 10.1148/radiology.176.2.2164237; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF	19	20	20	0	1	INT SOC NEUROPATHOLOGY	LOS ANGELES	UCLA MEDICAL CENTER, SECTION NEUROPATHOLGY, C H S 18-126, LOS ANGELES, CA 90095-1732 USA	1015-6305			BRAIN PATHOL	Brain Pathol.	APR	2004	14	2					210	214		10.1111/j.1750-3639.2004.tb00055.x			5	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	820SZ	WOS:000221410900012	15193034	Green Published			2022-02-06	
J	Wassenberg, R; Max, JE; Koele, SL; Firme, K				Wassenberg, R; Max, JE; Koele, SL; Firme, K			Classifying psychiatric disorders after traumatic brain injury and orthopaedic injury in children: adequacy of K-SADS versus CBCL	BRAIN INJURY			English	Article							CLOSED-HEAD-INJURY; BEHAVIOR PROBLEM SYNDROMES; ADOLESCENTS; DIAGNOSES; OUTCOMES; LIFETIME; TERM; MILD; PSYCHOPATHOLOGY; COMORBIDITY	Primary objective : To evaluate the convergence between the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) for the diagnosis of psychiatric disorders and the Child Behavior Checklist (CBCL). Research design : Cross-sectional psychiatric study of 72 children with traumatic brain injuries or orthopaedic injuries aged 5-14. Methods and procedures : Sensitivity, specificity, total predictive value and odds ratio were calculated to evaluate the association between CBCL summary scores and K-SADS diagnosis of at least one psychiatric disorder (K-SADS-1), and of CBCL subscales and K-SADS diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD). Lowered cut-off scores of t greater than or equal to 60 were used. Main outcomes and results : Convergence between the CBCL total problem scale and K-SADS-1 was poor. Convergence between 'at least one elevated CBCL subscale' and K-SADS-1, and between CBCL attention problems and social problems scales and K-SADS diagnosis of ADHD was excellent. Conclusions : Caution is needed when using the total problem scale of CBCL in predicting global psychological impairment because underestimation of problems is likely. The attention and social problems scales of CBCL can be used to estimate ADHD.	Childrens Hosp & Hlth Ctr, San Diego, CA 92123 USA; Univ Hosp Maastricht, Maastricht, Netherlands; Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA		Max, JE (corresponding author), Childrens Hosp & Hlth Ctr, 3020 Childrens Way,MC 5033, San Diego, CA 92123 USA.	jmax@ucsd.edu			NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08MH001800] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [K08 MH 01800] Funding Source: Medline		Achenbach TM, 1991, MANUAL CHILD BEHAV C; American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BIEDERMAN J, 1993, J CHILD PSYCHOL PSYC, V34, P1241, DOI 10.1111/j.1469-7610.1993.tb01785.x; BIJUR PE, 1990, PEDIATRICS, V86, P337; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Boyle MH, 1997, ARCH GEN PSYCHIAT, V54, P793; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Ciccetti D., 1984, VINELAND ADAPTIVE BE; Cohen J., 2013, STAT POWER ANAL BEHA; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; EDELBROCK C, 1988, J ABNORM CHILD PSYCH, V16, P219, DOI 10.1007/BF00913597; FILLEY CM, 1987, ARCH NEUROL-CHICAGO, V44, P194, DOI 10.1001/archneur.1987.00520140058018; Fletcher JM, 1996, J CHILD NEUROL, V11, P283, DOI 10.1177/088307389601100404; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Gerring JP, 2002, J AM ACAD CHILD PSY, V41, P157, DOI 10.1097/00004583-200202000-00009; GOULD MS, 1993, J ABNORM CHILD PSYCH, V21, P287, DOI 10.1007/BF00917536; Green ML, 1998, J PEDIATR PSYCHOL, V23, P289, DOI 10.1093/jpepsy/23.5.289; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; Herskovits EH, 2002, RADIOLOGY, V224, P345, DOI 10.1148/radiol.2242011439; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Hornyak J E, 1997, Pediatr Rehabil, V1, P15; JENSEN PS, 1993, J AM ACAD CHILD PSY, V32, P397, DOI 10.1097/00004583-199303000-00022; Kasius MC, 1997, J CHILD PSYCHOL PSYC, V38, P625, DOI 10.1111/j.1469-7610.1997.tb01689.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kinsella G, 1999, J CONSULT CLIN PSYCH, V67, P116, DOI 10.1037/0022-006X.67.1.116; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LACHAR D, 1986, ASSESSMENT CHILD ADO; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Light R, 1998, J CONSULT CLIN PSYCH, V66, P1023; Mahalick DM, 1998, PEDIATR NEUROSURG, V29, P121, DOI 10.1159/000028705; Max JE, 1998, J AM ACAD CHILD PSY, V37, P832, DOI 10.1097/00004583-199808000-00013; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; Max JE, 1998, J NEUROPSYCH CLIN N, V10, P290, DOI 10.1176/jnp.10.3.290; Max JE, 1998, ARCH PHYS MED REHAB, V79, P893, DOI 10.1016/S0003-9993(98)90084-3; McGuire RJ, 2000, EUR CHILD ADOLES PSY, V9, P263, DOI 10.1007/s007870070029; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; Reich W., 1988, REVISED VERSION DIAG; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; STEINGARD R, 1992, J AM ACAD CHILD PSY, V31, P449, DOI 10.1097/00004583-199205000-00010; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Taylor HG, 2001, J INT NEUROPSYCH SOC, V7, P755, DOI 10.1017/S1355617701766118; TEASDALE G, 1974, LANCET, V2, P81; Williams SE, 1998, J HEAD TRAUMA REHAB, V13, P73, DOI 10.1097/00001199-199806000-00007; WIRT RD, 1977, MULTIDIMENSIONAL DES; YEATES KO, 2001, JINS, V3, P617	52	20	20	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	2004	18	4					377	390		10.1080/02699050310001617325			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	765VB	WOS:000188304100004	14742151				2022-02-06	
J	Dixon, MR; Falcomata, TS				Dixon, MR; Falcomata, TS			Preference for progressive delays and concurrent physical therapy exercise in an adult with acquired brain injury	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article						brain injury; impulsivity; physical therapy; self-control	SELF-CONTROL; REINFORCEMENT; CHILDREN	The purpose of this study was to increase self-control and engagement in a physical therapy task (head holding) for a man with acquired traumatic brain injury. Once impulsivity was observed (i.e., repeated impulsive choices), an experimental condition was introduced that consisted of choices between a small immediate reinforcer, a large fixed-delay reinforcer, and a large progressive-delay reinforcer. The participant showed a preference for the progressive-delay option, even when the duration of the delay exceeded that of the fixed delay. The results have implications for establishing optimal choice making and teaching life-enhancing skills.	So Illinois Univ, Behav Analtsis & Therapy Program, Carbondale, IL 62901 USA		Dixon, MR (corresponding author), So Illinois Univ, Behav Analtsis & Therapy Program, Carbondale, IL 62901 USA.	mdixon@siu.edu					DeLeon IG, 1996, J APPL BEHAV ANAL, V29, P519, DOI 10.1901/jaba.1996.29-519; Dixon MR, 2003, J APPL BEHAV ANAL, V36, P371, DOI 10.1901/jaba.2003.36-371; Dixon MR, 2001, J APPL BEHAV ANAL, V34, P491, DOI 10.1901/jaba.2001.34-491; Dixon MR, 2000, J APPL BEHAV ANAL, V33, P611, DOI 10.1901/jaba.2000.33-611; Stromer R, 2000, J APPL BEHAV ANAL, V33, P359, DOI 10.1901/jaba.2000.33-359; Vollmer TR, 1999, J APPL BEHAV ANAL, V32, P451, DOI 10.1901/jaba.1999.32-451	6	20	20	1	5	JOURNAL APPL BEHAV ANAL	LAWRENCE	DEPT HUMAN DEVELOPMENT, UNIV KANSAS, LAWRENCE, KS 66045 USA	0021-8855			J APPL BEHAV ANAL	J. Appl. Behav. Anal.	SPR	2004	37	1					101	105		10.1901/jaba.2004.37-101			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	808CG	WOS:000220546600013	15154223	Green Published, Bronze			2022-02-06	
J	Wang, Q; Wang, Z; Zhu, PF; Jiang, JX				Wang, Q; Wang, Z; Zhu, PF; Jiang, JX			Alterations of myelin basic protein and ultrastructure in the limbic system at the early stage of trauma-related stress disorder in dogs	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						myelin basic protein (MBP); ultrastructure; trauma; stress disorder; cerebrospinal fluid (CSF); limbic system	MISSILE EXTREMITY IMPACT; PRESSURE WAVE INJURIES; SPINAL-CORD-INJURY; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; PIGS; EXPRESSION; MARKERS; LIGHT	Background: The secondary injury and related complications after trauma are still the focus of trauma research. However, whether the remote effects on the central nervous system could be induced by high-energy missile extremity impact remains unclear. Also, the possible biomarker for brain damage in traumatic stress disorder has not been determined. Methods: Forty-two healthy adult dogs were divided into three groups: the control group (n = 12), the high-speed trauma group (n = 15), and the low-speed trauma group (n = 15). Bilateral thighs of dogs were wounded with a smoothbore 6.2-mm rifle at a speed of 1,368 m/s (1.03-g steel bullet) for the high-speed trauma group and 625 m/s for the low-speed trauma group. The expression of myelin basic protein (MBP) in cerebrospinal fluid (CSF), hypothalamus and hippocampus of the limbic system, and temporoparietal cortex was investigated by enzyme-linked immunosorbent assay and dot-blot analysis. Also, the ultrastructure of the above areas was observed with light and electron microscopy. Results: Neuronal degeneration and nerve fiber demyelination were seen in the hypothalamus and hippocampus in the high-speed trauma group at 8 hours after impact. The MBP level was markedly increased in the CSF (p < 0.01) in the two trauma groups, in the hypothalamus of the low-speed trauma group (p < 0.05), and in both the hypothalamus and the hippocampus of the high-speed trauma group (p < 0.01). The expression of MBP mRNA was also significantly enhanced in these areas at the same time. The increase of MBP content in the CSF was positively correlated with the elevation of MBP concentration in the hypothalamus and hippocampus. Conclusion: The hypothalamus and hippocampus of the limbic system in the central nervous system are vulnerable to damage after high-energy missile extremity impact, indicating that it might be one of the important pathologic bases involved in the development of trauma-related complications. Meanwhile, the MBP level in the CSF may be a sensitive biological indicator for brain damage at the early stage of trauma-related stress disorder.	Third Mil Med Univ, Daping Hosp, Dept 4, Inst Surg Res, Chongqing 400042, Peoples R China		Wang, Q (corresponding author), Third Mil Med Univ, Daping Hosp, Dept 4, Inst Surg Res, Chongqing 400042, Peoples R China.	wqs832001@sina.com					Danzer SC, 2002, J NEUROSCI, V22, P9754; de Vries J, 2001, J NEUROL NEUROSUR PS, V71, P671, DOI 10.1136/jnnp.71.5.671; Fackler ML, 1996, ANN EMERG MED, V28, P194, DOI 10.1016/S0196-0644(96)70062-8; Gustafsson U., 1997, Annals Academy of Medicine Singapore, V26, P22; GUSTAFSSON U, 1988, ANN ACAD MED SINGAP, V28, P3; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Jin Y, 2002, EXP NEUROL, V177, P265, DOI 10.1006/exnr.2002.7980; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lathe R, 2001, J ENDOCRINOL, V169, P205, DOI 10.1677/joe.0.1690205; Marshall RD, 2002, PSYCHIAT RES, V110, P219, DOI 10.1016/S0165-1781(02)00126-9; Massaro AR, 1998, MULT SCLER J, V4, P1; Michalowska-Wender G, 2001, FOLIA NEUROPATHOL, V39, P1; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Ohta M, 2000, CLIN CHEM, V46, P1326; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; Reindl M, 1999, BRAIN, V122, P2047, DOI 10.1093/brain/122.11.2047; Sarchielli P, 2002, J NEUROIMMUNOL, V132, P180, DOI 10.1016/S0165-5728(02)00319-3; SCHANTZ B, 1982, ACTA CHIR SCAND, P159; SUNESON A, 1987, J TRAUMA, V27, P782, DOI 10.1097/00005373-198707000-00016; SUNESON A, 1990, J TRAUMA, V30, P295, DOI 10.1097/00005373-199003000-00007; SUNESON A, 1990, J TRAUMA, V30, P281, DOI 10.1097/00005373-199003000-00006; Suneson A, 2000, MIL MED, V165, P119, DOI 10.1093/milmed/165.2.119; Vasterling JJ, 2002, NEUROPSYCHOLOGY, V16, P5, DOI 10.1037//0894-4105.16.1.5; Wang JZ, 1997, RARE METAL MAT ENG, V26, P54; Wrathall JR, 1998, J NEUROSCI, V18, P8780; Xiang XY, 2001, J VIROL METHODS, V94, P129, DOI 10.1016/S0166-0934(01)00284-1; Zhang XH, 2002, NEURON, V36, P675, DOI 10.1016/S0896-6273(02)01023-1	28	20	23	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	2004	56	3					604	610		10.1097/01.TA.0000058122.57737.0E			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	808CM	WOS:000220547200029	15128132				2022-02-06	
J	Mitchell, P; Tseng, M; Mendelow, AD				Mitchell, P; Tseng, M; Mendelow, AD			Decompressive craniectomy with lattice duraplasty	ACTA NEUROCHIRURGICA			English	Article						decompressive craniectomy; dura; duraplasty	TRAUMATIC BRAIN INJURY	A method of opening dura for decompressive craniectomies is described. Numerous cuts intersecting in a lattice pattern allow the dura to expand in a gradual and controlled manner minimising the chances of cortical laceration or venous kinking on the craniectomy edge.	Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England		Mitchell, P (corresponding author), Newcastle Gen Hosp, Dept Neurosurg, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	patrick.mitchell@ncl.ac.uk	Mendelow, Alexander/AAW-2878-2021				Alves OL, 2003, ACTA NEUROCHIR, V145, P583, DOI 10.1007/s00701-003-0055-9; Csokay A, 2001, NEUROSURG REV, V24, P209, DOI 10.1007/s101430100158; Csokay A, 2001, ACTA NEUROCHIR, V143, P173, DOI 10.1007/s007010170125; Schneider GH, 2002, ACT NEUR S, V81, P77; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110	6	20	26	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	FEB	2004	146	2					159	160		10.1007/s00701-003-0186-z			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	773NB	WOS:000188928900020	14963748				2022-02-06	
J	Branca, B; Lake, AE				Branca, B; Lake, AE			Psychological and neuropsychological integration in multidisciplinary pain management after TBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic pain; neuropsychology; pain management; post-concussion syndrome; posttraumatic headache; psychotherapy; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; DISABILITY INDEX; NEUROPATHIC PAIN; OPIOID USE; HEADACHE; INVENTORY; QUESTIONNAIRE; PERSONALITY	The intersection of traumatic brain injury and posttraumatic chronic pain poses a significant challenge for the health practitioner. Effective intervention requires psychological and neuropsychological evaluation, multidisciplinary teamwork, and an understanding of a wide range of pain disorders and their relationship to traumatic brain injury. Assessment must include documentation of both current functioning and premorbid history. Pain interacts with cognitive impairment, mood and anxiety disorders, dysinhibition syndromes, and personality disorders, posing significant diagnostic dilemmas and treatment challenges. Coordinated care requires multiple, ongoing interventions from a variety of specialists. Patient involvement, focusing on internal locus of control, mediates successful treatment.	Michigan Head Pain & Neurol Inst, Ann Arbor, MI 48104 USA		Branca, B (corresponding author), Michigan Head Pain & Neurol Inst, 3120 Profess Dr, Ann Arbor, MI 48104 USA.	bbranca@mhni.com					[Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001822; ARONOFF GM, 1992, EVALUATION TREATMENT; Barclay S, 2003, PALLIATIVE MED, V17, P27, DOI 10.1191/0269216303pm665oa; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bezner JR, 2001, ARCH PHYS MED REHAB, V82, P787, DOI 10.1053/apmr.2001.23269; Blomqvist K, 2003, J ADV NURS, V41, P575, DOI 10.1046/j.1365-2648.2003.02569.x; BRANCA B, 1992, 34 ANN M AM ASS STUD, V32, P260; BRESLAU N, 1994, NEUROLOGY, V44, P17; Breslau N, 2001, NEUROLOGY, V56, P350, DOI 10.1212/WNL.56.3.350; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant RA, 2003, AM J PSYCHIAT, V160, P585, DOI 10.1176/appi.ajp.160.3.585; Bryant RA, 1999, J HEAD TRAUMA REHAB, V14, P588, DOI 10.1097/00001199-199912000-00007; BRYANT RA, 1998, AM J PSYCHIAT, V13, P31; Burgess CP, 2000, ASTROPART PHYS, V14, P1, DOI 10.1016/S0927-6505(00)00102-X; Burns JW, 2003, J CONSULT CLIN PSYCH, V71, P81, DOI 10.1037/0022-006X.71.1.81; Carlson J, 2003, J PAIN SYMPTOM MANAG, V25, P264, DOI 10.1016/S0885-3924(02)00677-2; Chandler CC, 2001, APPL COGNITIVE PSYCH, V15, P3, DOI 10.1002/1099-0720(200101/02)15:1<3::AID-ACP669>3.0.CO;2-1; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; De Benedittis G, 1983, J Neurosurg Sci, V27, P177; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Deb S, 1999, AM J PSYCHIAT, V156, P374; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Dewar Anne, 2003, Health Expect, V6, P44, DOI 10.1046/j.1369-6513.2003.00208.x; Dikmen S, 2001, J NEUROTRAUM, V18, P127, DOI 10.1089/08977150150502578; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Fillingim RB, 2003, SPINE, V28, P143, DOI 10.1097/00007632-200301150-00010; Flashman LA, 2002, NEUROREHABILITATION, V17, P285; FLOR H, 1992, PAIN, V49, P221, DOI 10.1016/0304-3959(92)90145-2; Folzer SM, 2001, AM J ORTHOPSYCHIAT, V71, P245, DOI 10.1037/0002-9432.71.2.245; Frazier SK, 2003, AM J CRIT CARE, V12, P19, DOI 10.4037/ajcc2003.12.1.19; Gatchel RJ, 2002, CLIN J PAIN, V18, P139, DOI 10.1097/00002508-200205000-00001; Gilron I, 2003, CAN J ANAESTH, V50, P42, DOI 10.1007/BF03020185; Goldfinch EP, 2002, RADIAT PROT DOSIM, V102, P3; Greve KW, 2001, BRAIN INJURY, V15, P255; Gustafsson M, 2002, J REHABIL MED, V34, P119, DOI 10.1080/165019702753714147; Hart RP, 2000, NEUROPSYCHOL REV, V10, P131, DOI 10.1023/A:1009020914358; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; Haythornthwaite JA, 1998, PAIN, V77, P33, DOI 10.1016/S0304-3959(98)00078-5; Haythornthwaite JA, 2000, CLIN J PAIN, V16, pS101, DOI 10.1097/00002508-200006001-00017; Hill J, 2003, RHEUMATOLOGY, V42, P280, DOI 10.1093/rheumatology/keg079; International Headache Society, 1988, CEPHALALGIA S7, V8, P9; JENSEN MP, 1992, PAIN, V50, P157, DOI 10.1016/0304-3959(92)90156-6; Johnston MV, 2002, ARCH PHYS MED REHAB, V83, pS26, DOI 10.1053/apmr.2002.37100; Klein E, 2003, CAN J PSYCHIAT, V48, P28, DOI 10.1177/070674370304800106; Klepstad P, 2002, J PAIN SYMPTOM MANAG, V24, P517, DOI 10.1016/S0885-3924(02)00526-2; Kolitz BP, 2003, ARCH PHYS MED REHAB, V84, P277, DOI 10.1053/apmr.2003.50100; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kosinski M., 2001, CEPHALALGIA, V21, P334; Kramer BJ, 2002, ARTHRIT RHEUM-ARTHR, V47, P588, DOI 10.1002/art.10795; Lake AE, 1999, J HEAD TRAUMA REHAB, V14, P70, DOI 10.1097/00001199-199902000-00008; Lane Judy C., 2002, Curr Treat Options Neurol, V4, P89, DOI 10.1007/s11940-002-0007-3; Lemstra M, 2002, HEADACHE, V42, P845, DOI 10.1046/j.1526-4610.2002.02202.x; Linehan MM., 1993, COGNITIVE BEHAV TREA; Manias E, 2003, J ADV NURS, V41, P585, DOI 10.1046/j.1365-2648.2003.02570.x; Martelli MF, 1999, J HEAD TRAUMA REHAB, V14, P49, DOI 10.1097/00001199-199902000-00007; Martin PG, 2000, ACCIDENT ANAL PREV, V32, P541, DOI 10.1016/S0001-4575(99)00076-7; Max JE, 1998, BRAIN INJURY, V12, P41; McCracken LM, 2002, SPINE, V27, P2564, DOI 10.1097/00007632-200211150-00033; McIntosh Aileen, 2003, Health Expect, V6, P19, DOI 10.1046/j.1369-6513.2003.00197.x; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; MERIKANGAS KR, 1997, NEUROLOGIC CLIN ADV, P115; Mersky H, 1994, CLASSIFICATION CHRON; Mickeviciene D, 2002, EUR J NEUROL, V9, P581, DOI 10.1046/j.1468-1331.2002.00497.x; Nicholson K, 2000, NEUROREHABILITATION, V14, P95; OKIFUJI A, 1999, HDB PAIN SYNDROMES B; Potter M, 2003, AUST J PHYSIOTHER, V49, P53, DOI 10.1016/S0004-9514(14)60188-4; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Saper JR, 2002, HEADACHE, V42, P663, DOI 10.1046/j.1526-4610.2002.02156.x; SAPER JR, 1999, HDB HEADACHE MANAGME; Schofield Patricia, 2003, Prof Nurse, V18, P276; Sherer M, 1999, BRAIN INJURY, V13, P973; SILBERSTEIN SD, 2003, 45 ANN SCI M AM HEAD; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Stewart WF, 1999, CEPHALALGIA, V19, P107, DOI 10.1046/j.1468-2982.1999.019002107.x; Stroud MW, 2000, PAIN, V84, P347, DOI 10.1016/S0304-3959(99)00226-2; TAIT RC, 1990, PAIN, V40, P171, DOI 10.1016/0304-3959(90)90068-O; TSUSHIMA WT, 1993, HEADACHE, V33, P139, DOI 10.1111/j.1526-4610.1993.hed3303139.x; TUSA RJ, 1994, NEUROLOGY, V44, P528, DOI 10.1212/WNL.44.3_Part_1.528; Verri AP, 1998, CEPHALALGIA, V18, P45, DOI 10.1177/0333102498018S2112; Viguier D, 2001, BRAIN INJURY, V15, P263; Vodopiutz J, 2002, J WOMEN HEALTH GEN-B, V11, P719, DOI 10.1089/15409990260363670; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Walker Barbara B, 2002, Med Health R I, V85, P269; WEISSMAN MM, 1993, J PERS DISORD, V7, P44	87	20	20	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2004	19	1					40	57		10.1097/00001199-200401000-00005			18	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	768UT	WOS:000188554000005	14732830				2022-02-06	
J	Dosemeci, L; Yilmaz, M; Cengiz, M; Dora, B; Ramazanoglu, A				Dosemeci, L; Yilmaz, M; Cengiz, M; Dora, B; Ramazanoglu, A			Brain death and donor management in the intensive care unit: Experiences over the last 3 years	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	Joint Meeting of the Turkish-Transplantation-Society and Eurotransplant	JUN 25-27, 2003	ANKARA, TURKEY	Turkish Transplantat Soc, Eurotransplant				We sought to examine the frequency of brain death in the ICU, the donation rate, and the problems encountered during donor management between the years of January 2000, the date we began treating patients with neurologic pathologies and traumatic brain injury, and March 2003. Between January 2000 and March 2003, 134 patients diagnosed with brain death in our ICU were studied prospectively for the reason of brain death, the time between admission to ICU, and the diagnosis of brain death, the frequency of diabetes insipidus, the inotrope requirement, hypothermia, electrolyte imbalance, arrhythmia, and cardiac arrest. Among the approximately 2600 patients admitted to the general 24-bed ICU, 940 had cerebral injuries. In this group, the mortality rate was 33.5% (315 out of 940 patients) including brain-dead patients. Donor care was performed in 94 patients with organs suitable for transplantation out of 134 brain-dead patients. Fifty (53.2%) out of 94 patients became organ donors. The donor ratio was 12 per million-population per year as a mean value of the study period, which was approximately 10 times higher than the average ratio in Turkey. Although we observed many life-threatening problems during donor management, none of these patients died or had acute organ dysfunction.	Akdeniz Univ Hosp, Dept Anesthesiol & Intens Care, Antalya, Turkey		Dosemeci, L (corresponding author), Akdeniz Univ Hosp, Dept Anesthesiol & Intens Care, Dumlupinar Bulvar,Kampus Alani,B Blok, Antalya, Turkey.	leventege@yahoo.com	Yilmaz, Murat/I-6629-2017; Dora, Babur/C-1053-2016				MOLLARET P., 1959, REV NEUROL [PARIS], V101, P3; POWNER DJ, 2000, TXB CRITICAL CARE, P1894; TROPPMANN C, 1999, INTENS CARE MED, P2184; 2001, ORGANS TISSUES, V3, P143	4	20	22	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0041-1345	1873-2623		TRANSPL P	Transplant. Proc.	JAN-FEB	2004	36	1					20	21		10.1016/j.transproceed.2003.11.050			2	Immunology; Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Immunology; Surgery; Transplantation	770YC	WOS:000188758100005	15013289				2022-02-06	
J	Landry, SH; Swank, P				Landry, SH; Swank, P			Social competence in young children with inflicted traumatic brain injury	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							SHAKEN-BABY SYNDROME; BIRTH-WEIGHT CHILDREN; CLOSED-HEAD INJURY; 1ST 2 YEARS; PHYSICAL ABUSE; EMOTIONAL EXPRESSION; SOCIOECONOMIC-STATUS; MALTREATED CHILDREN; PRACTICAL SCALE; IMPACT SYNDROME	As infants develop skills that allow for increasing independence in social and cognitive domains, they acquire the ability to identify goals, sequence behaviors to carry out goals, and to flexibly use strategies for attaining goals in both social and independent play contexts. Little is known about how brain injury in young children may disrupt the precursors to such executive processes. In this study, we examined social and cognitive competence in 25 infants ages 3 to 23 months who sustained moderate to severe traumatic brain injury (TBI) secondary to physical abuse and in 22 healthy community comparison children. Children with TBI were evaluated an average of 1.6 months after the injury. A toy-centered activity with the examiner was used to capture joint attention and social behavior and an exploratory toy play situation was used to measure independent goal-directed play. The inflicted TBI group showed significant reduction in both social and cognitive domains relative to the comparison group. Canonical correlation analyses disclosed that inflicted TBI was associated with reduction in (a) initiation of social interactions, (b) responsiveness to interactions initiated by the examiner, (c) positive affect, and (d) compliance. The groups performed comparably on indexes of gestural and verbal communication and for the occurrence of negative affect. Joint attention was an area of vulnerability for the TBI group in both social initiation and response contexts. Although general cognitive and motor scores were lower in the inflicted TBI group, the complexity of independent toy play did not differ across groups. Early brain injury causes significant disruption in behaviors regulating initiation and responsiveness in social contexts. Longitudinal follow-up will characterize the long-term consequences of early disruption in joint attention and other behaviors on the development of social and cognitive precursors to executive processes.	Univ Texas, Hlth Sci Ctr, Div Dev Pediat, Houston, TX 77030 USA; FSD Data Serv, Houston, TX USA		Landry, SH (corresponding author), Univ Texas, Hlth Sci Ctr, Div Dev Pediat, 7400 Fannin,Suite 2300, Houston, TX 77030 USA.	susan.h.landry@uth.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS029462] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS 29462-07] Funding Source: Medline		ABER JL, 1987, DEV PSYCHOL, V23, P406, DOI 10.1037/0012-1649.23.3.406; ADAMS KM, 1985, J CLIN EXP NEUROPSYC, V7, P445, DOI 10.1080/01688638508401276; Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; APPELBAUM AS, 1977, J ABNORM CHILD PSYCH, V5, P417, DOI 10.1007/BF00915089; BARAHAL RM, 1981, J CONSULT CLIN PSYCH, V49, P508, DOI 10.1037/0022-006X.49.4.508; Barkley R.A., 1997, ADHD NATURE SELF CON; Bayley N., 2006, BAYLEY SCALES INFANT, V3rd; Block JH, 1980, MINNESOTA S CHILD PS, V13, P39; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Bonnier C, 1995, DEV MED CHILD NEUROL, V37, P943; BRADLEY RH, 1995, J PEDIATR PSYCHOL, V20, P347, DOI 10.1093/jpepsy/20.3.347; Brown A. L., 1978, CHILDRENS THINKING W, P3; BRUCE DA, 1989, PEDIATR ANN, V18, P482, DOI 10.3928/0090-4481-19890801-07; BULLOCK M, 1988, CHILD DEV, V59, P664, DOI 10.2307/1130566; Butterworth G., 1995, JOINT ATTENTION ITS, P29; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CAMRAS LA, 1983, J CLIN CHILD PSYCHOL, V12, P325, DOI 10.1207/s15374424jccp1203_16; Carlson E., 1995, DEV PSYCHOPATHOL, V1, P581; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; CICCHETTI D, 1994, DEV PSYCHOPATHOL, V6, P533, DOI 10.1017/S0954579400004673; Darwish D, 2001, CHILD ABUSE NEGLECT, V25, P13, DOI 10.1016/S0145-2134(00)00228-3; De Bellis MD, 2001, DEV PSYCHOPATHOL, V13, P539, DOI 10.1017/S0954579401003078; DENEKLA MB, 1996, ATTENTION MEMORY EXE, P263; Dennis M, 2001, J INT NEUROPSYCH SOC, V7, P683, DOI 10.1017/S1355617701766040; *DIV INJ CONTR CTR, 1969, AM J DIS CHILD, V144, P627; DODGE KA, 1995, J ABNORM PSYCHOL, V104, P632, DOI 10.1037/0021-843X.104.4.632; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Duhaime AC, 1996, PEDIATR NEUROSURG, V24, P292, DOI 10.1159/000121058; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; DUHAIME AC, 1987, J NEUROSURG, V66, P409, DOI 10.3171/jns.1987.66.3.0409; DURING SM, 1991, J CLIN CHILD PSYCHOL, V20, P132, DOI 10.1207/s15374424jccp2002_4; Eisenberg N, 1997, CHILD DEV, V68, P642, DOI 10.2307/1132116; ELMER E, 1977, PEDIATRICS, V59, P273; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Ewing-Cobbs L, 1999, PEDIATR NEUROSURG, V31, P251, DOI 10.1159/000028872; FENSON L, 1976, CHILD DEV, V47, P232; FISCHER H, 1994, CLIN PEDIATR, V33, P696, DOI 10.1177/000992289403301113; Fleiss JL, 1986, RELIABILITY MEASUREM, DOI DOI 10.1002/9781118032923; FRICK T, 1978, REV EDUC RES, V48, P157, DOI 10.2307/1169913; GAENSBAUER TJ, 1982, J AM ACAD CHILD PSY, V21, P163, DOI 10.1016/S0002-7138(09)60915-8; GAENSBAUER TJ, 1981, DEV NEUROPSYCHOL, V20, P673; GARNER PW, 1991, INFANT BEHAV DEV, V14, P489, DOI 10.1016/0163-6383(91)90035-Q; GOLDSON E, 1978, AM J DIS CHILD, V132, P790, DOI 10.1001/archpedi.1978.02120330062016; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P1328, DOI 10.1097/00003246-199309000-00016; Green MB, 1998, J HIGH ENERGY PHYS; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HERRENKOHL EC, 1995, CHILD ABUSE NEGLECT, V19, P191, DOI 10.1016/0145-2134(94)00116-C; Hinshaw SP, 1997, CHILD DEV, V68, P880, DOI 10.1111/j.1467-8624.1997.tb01968.x; HOFFMANPLOTKIN D, 1984, CHILD DEV, V55, P794, DOI 10.2307/1130130; HOLMBERG MC, 1980, CHILD DEV, V51, P448; JENNETT B, 1975, LANCET, V1, P480; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; KOPP CB, 1982, DEV PSYCHOL, V18, P199, DOI 10.1037/0012-1649.18.2.199; KOSKINIEMI M, 1995, ARCH PEDIAT ADOL MED, V149, P249, DOI 10.1001/archpedi.1995.02170150029004; KUCZYNSKI L, 1990, DEV PSYCHOL, V26, P398, DOI 10.1037/0012-1649.26.3.398; Landry SH, 1997, J CLIN EXP NEUROPSYC, V19, P261, DOI 10.1080/01688639708403856; LANDRY SH, 1990, CHILD DEV, V61, P1605, DOI 10.2307/1130768; Landry SH, 1998, CHILD DEV, V69, P105, DOI 10.1111/j.1467-8624.1998.tb06137.x; Landry SH, 1997, DEV PSYCHOL, V33, P1040, DOI 10.1037/0012-1649.33.6.1040; Landry SH, 2000, CHILD DEV, V71, P358, DOI 10.1111/1467-8624.00150; Landry SH, 2002, DEV NEUROPSYCHOL, V21, P15, DOI 10.1207/S15326942DN2101_2; LEUNG EHL, 1981, DEV PSYCHOL, V17, P215, DOI 10.1037/0012-1649.17.2.215; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; LUDWIG S, 1984, ANN EMERG MED, V13, P104, DOI 10.1016/S0196-0644(84)80571-5; LYONS TJ, 1993, PEDIATRICS, V92, P125; MARLOWE WB, 1992, BRAIN COGNITION, V20, P205, DOI 10.1016/0278-2626(92)90070-3; Masten AS, 1999, DEV PSYCHOPATHOL, V11, P143, DOI 10.1017/S0954579499001996; Maughan A, 2002, CHILD DEV, V73, P1525, DOI 10.1111/1467-8624.00488; MITCHELL SK, 1979, PSYCHOL BULL, V86, P376, DOI 10.1037/0033-2909.86.2.376; OKUN A, 1994, DEV PSYCHOPATHOL, V6, P77, DOI 10.1017/S0954579400005897; PARPAL M, 1985, CHILD DEV, V56, P1326, DOI 10.2307/1130247; PLUNKETT JW, 1989, INFANT MENT HEALTH J, V10, P117, DOI 10.1002/1097-0355(198922)10:2<117::AID-IMHJ2280100205>3.0.CO;2-B; ROGOSCH FA, 1995, DEV PSYCHOPATHOL, V7, P591, DOI 10.1017/S0954579400006738; SALZINGER S, 1993, CHILD DEV, V64, P169, DOI 10.1111/j.1467-8624.1993.tb02902.x; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; TEASDALE G, 1974, LANCET, V2, P81; Toth SL, 1996, J CONSULT CLIN PSYCH, V64, P32, DOI 10.1037/0022-006X.64.1.32; TRICKETT PK, 1991, DEV PSYCHOL, V27, P148, DOI 10.1037/0012-1649.27.1.148; VONDRA JI, 1990, CHILD ABUSE NEGLECT, V14, P525, DOI 10.1016/0145-2134(90)90101-X; WERTSCH JV, 1979, HUM DEV, V22, P1, DOI 10.1159/000272425; ZAHNWAXLER C, 1995, DEV PSYCHOPATHOL, V7, P27, DOI 10.1017/S0954579400006325; [No title captured]; [No title captured]; [No title captured]	91	20	20	1	12	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2004	26	3					707	733		10.1207/s15326942dn2603_4			27	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	876KQ	WOS:000225496100004	15525566				2022-02-06	
J	Poirrier, ALML; Ngosso-Tetanye, I; Mouchamps, M; Misson, JP				Poirrier, ALML; Ngosso-Tetanye, I; Mouchamps, M; Misson, JP			Spontaneous arachnoid cyst rupture in a previously asymptomatic child: a case report	EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY			English	Article						arachnoid cyst; subdural hygroma; intracranial hypertension; cerebrospinal fluid derivation	MIDDLE CRANIAL FOSSA; EXPERIENCE; VALVE	Arachnoid cysts are benign congenital cavities arising in the subarachnoid space. Non-traumatic subdural effusion of cerebrospinal fluid is a rare complication requiring surgical treatment. Case Report: A 15-year-old boy was admitted to the hospital because of symptoms related to acute intracranial hypertension (headache and vomiting). The cerebral CT-scan revealed a subdural hygroma adjoining a voluminous Sylvian arachnoid cyst. Two arachnoid cysts were incidentally discovered 11 years before this dramatic complication. Moreover, the patient had suffered a cerebral concussion 2 years earlier, but interestingly did not develop cystic hemorrhage or rupture, contrary to numerous cases previously described in the literature. The location of the cysts and their regular follow-up did not allow foreseeing a cystic rupture. Hygroma evacuation was first performed after which a subdural peritoneal. shunting, using a programmable opening pressure valve, was implanted. Spontaneous rupture into the subdural space represents an unusual complication of arachnoid cysts. Clinical aspects, radiographic findings, pathogenesis and surgical management are described. It is important to point out that subdural hygroma or haematoma should never be excluded in the absence of trauma history, even in the case of small non-progressive cysts regularly supervised. (C) 2004 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.	Univ Liege, Dept Neuropediat, CHR Citadelle, B-4000 Liege, Belgium		Misson, JP (corresponding author), Univ Liege, Dept Neuropediat, CHR Citadelle, 12E Ligne Blvd,1, B-4000 Liege, Belgium.	jeanpaul.misson@skynet.be		Poirrier, Anne-Lise/0000-0002-1247-2334			Albuquerque FC, 1997, NEUROSURGERY, V41, P951, DOI 10.1097/00006123-199710000-00036; Arai H, 1996, NEUROSURGERY, V39, P1108, DOI 10.1097/00006123-199612000-00007; Cayli SR, 2000, BRIT J NEUROSURG, V14, P568, DOI 10.1080/02688690050206738; Di Rocco C, 2003, SURG NEUROL, V60, P211, DOI 10.1016/S0090-3019(03)00064-8; Dodd RL, 2002, PEDIATR NEUROSURG, V37, P152, DOI 10.1159/000064394; Germano A, 2003, CHILD NERV SYST, V19, P166, DOI 10.1007/s00381-002-0702-0; Gosalakkal JA, 2002, PEDIATR NEUROL, V26, P93, DOI 10.1016/S0887-8994(01)00329-0; Kang JK, 2000, CHILD NERV SYST, V16, P111, DOI 10.1007/s003810050024; Mazurkiewicz-Beldzinska Maria, 2002, Med Sci Monit, V8, pCR462; Mori K, 2002, J NEUROTRAUM, V19, P1017, DOI 10.1089/089771502760341938; Parsch CS, 1997, NEUROSURGERY, V40, P483, DOI 10.1097/00006123-199703000-00010; Wester K, 1999, NEUROSURGERY, V45, P775, DOI 10.1097/00006123-199910000-00008; Yamauchi T, 1999, ACTA NEUROCHIR, V141, P537, DOI 10.1007/s007010050338; Zemack G, 2000, J NEUROSURG, V92, P941, DOI 10.3171/jns.2000.92.6.0941	14	20	21	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1090-3798	1532-2130		EUR J PAEDIATR NEURO	Eur. J. Paediatr. Neurol.		2004	8	5					247	251		10.1016/j.ejpn.2004.04.005			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	856CP	WOS:000224021500003	15341907				2022-02-06	
J	Catroppa, C; Anderson, V				Catroppa, C; Anderson, V			Recovery and predictors of intellectual ability two years following paediatric traumatic brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article							CLOSED-HEAD-INJURY; CHILDREN; SEQUELAE; COHORT; SEVERITY; ADOLESCENTS; CHILDHOOD; AGE	While a number of research papers have reported findings on intellectual skills following traumatic brain injury (TBI), only limited studies have monitored the recovery of these skills over time. The present study examined intellectual skills in a group of 70 children who had sustained a mild, moderate, or severe traumatic brain injury (TBI). Results showed that, while the severe TBI group exhibited greatest recovery of intellectual ability over 24 months, they continued to perform more poorly than children who had sustained a mild and moderate injury. Further, domain-specific Index Scores, derived from intellectual measures, provided additional insight regarding the development and/or recovery of specific cognitive areas following TBI. Best predictor of intellectual outcome was socio-economic status.	Royal Childrens Hosp, Melbourne, Vic, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia		Catroppa, C (corresponding author), Royal Childrens Hosp, Dept Psychol, Flemington Rd, Parkville, Vic 3052, Australia.	catroppc@cryptic.rch.unimelb.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436			Anderson V, 1998, NEUROPSYCHOL REHABIL, V8, P283; Anderson V, 1995, CHILD NEUROPSYCHOL, V1, P187, DOI 10.1080/09297049508400224; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; ANDERSON V, 2001, J CLIN EXPT NEUROPSY; ANDERSON V, 2001, IN PRESS DEV NEU DEC; Anderson V A, 1999, Pediatr Rehabil, V3, P159; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anderson VA, 2000, BRAIN INJURY, V14, P679; BASSETT SS, 1990, J PEDIATR PSYCHOL, V15, P225, DOI 10.1093/jpepsy/15.2.225; BIJUR PE, 1995, TRAUMATIC HEAD INJUR, P147; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; Catroppa C, 1999, J INT NEUROPSYCH SOC, V5, P48, DOI 10.1017/S1355617799511077; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; Ciccetti D., 1984, VINELAND ADAPTIVE BE; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; Daniel A., 1983, POWER PRIVILEGE PRES; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Donders J, 1997, CHILD NEUROPSYCHOL, V3, P71, DOI 10.1080/09297049708401369; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; GULBRANDSEN GB, 1984, J CLIN NEUROPSYCHOL, V6, P257, DOI 10.1080/01688638408401217; HOLMESBERNSTEIN J, 1990, NEUROMETHODS, V17, P311, DOI DOI 10.1385/0896031330; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P587, DOI 10.1016/0003-9993(93)90156-5; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Levin H S, 1997, J Int Neuropsychol Soc, V3, P598; Morse S, 1999, Pediatr Rehabil, V3, P139; Ong LC, 1998, J PAEDIATR CHILD H, V34, P363, DOI 10.1046/j.1440-1754.1998.00239.x; PRIOER M, 1994, AUST PSYCHOL, V29, P116, DOI 10.1080/00050069408257334; RIVARA JB, 1994, ARCH PHYS MED REHAB, V75, P369, DOI 10.1016/0003-9993(94)90157-0; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Tremont G, 1999, CHILD NEUROPSYCHOL, V5, P104, DOI 10.1076/chin.5.2.104.3166; Wechsler D., 1991, MANUAL WECHSLER INTE, V3rd; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; WRIGHTSON P, 1995, J NEUROL NEUROSUR PS, V59, P375, DOI 10.1136/jnnp.59.4.375; [No title captured]	41	20	20	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	DEC	2003	13	5					517	536		10.1080/09602010343000084			20	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	742PB	WOS:000186525500002					2022-02-06	
J	Power, PW; Hershenson, DB				Power, PW; Hershenson, DB			Work adjustment and readjustment of persons with mid-career onset traumatic brain injury	BRAIN INJURY			English	Article							RETURN; EMPLOYMENT; REHABILITATION; DISABILITY	This study investigated the effects of mid-career onset traumatic brain injury on work adjustment, as well as examining the utility of Hershenson's model of work adjustment. Ten clients in a head injury rehabilitation programme were intensively interviewed and completed questionnaires concerning the effect of their mid-career onset disability on their work adjustment. Information about post-traumatic work adjustment and coping was identified, collated and summarized. Results indicated that for this population work adjustment assumes a special meaning and career development becomes a redevelopment and planning process, rather than an unbroken, linear process. Results also suggested the utility of the Hershenson model for structuring studies on this specific topic and further emphasized that work adjustment development must be studied in the context of personal, family and social development.	Univ Maryland, Coll Educ, Dept Counseling & Personnel Serv, College Pk, MD 20742 USA		Power, PW (corresponding author), Univ Maryland, Coll Educ, Dept Counseling & Personnel Serv, College Pk, MD 20742 USA.	pp21@umail.umd.edu					Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; CORTHELL DW, 1985, REHABILITATION TRAUM; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; FRASER RT, 1995, NEUROREHABILITATION, V5, P39, DOI 10.3233/NRE-1995-5104; Gollaher K, 1998, BRAIN INJURY, V12, P255, DOI 10.1080/026990598122557; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HACKETT G, 1981, J VOCAT BEHAV, V18, P326, DOI 10.1016/0001-8791(81)90019-1; HERSHENSON DB, 1981, REHABIL COUNS BULL, V25, P91; Hershenson DB, 1996, REHABIL COUNS BULL, V40, P2; HOWELL L, 1978, DISABILITY REHABILIT, P67; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; KOSCIULEK JF, 1991, VOCATIONAL EVALUATIO, V24, P137; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Marshall C., 1995, DESIGNING QUALITATIV; Moore R.L., 1990, J APPL REHABILITATIO, V21, P3; PARKER RS, 1987, EAP DIGEST, V7, P55; Possl O, 2001, BRAIN INJURY, V15, P15; ROCCHIO C, 2001, BRAIN INJURY SOURCE, V5, P44; Super D. E., 1990, CAREER CHOICE DEV AP; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Wagner AK, 2002, ARCH PHYS MED REHAB, V83, P107, DOI 10.1053/apmr.2002.27470; WEHMAN P, 1993, AM J PHYS MED REHAB, V72, P355; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; [No title captured]	27	20	20	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC	2003	17	12					1021	1034		10.1080/0269905031000110526			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	731WR	WOS:000185909900002	14555362				2022-02-06	
J	Bergemalm, PO				Bergemalm, PO			Progressive hearing loss after closed head injury: A predictable outcome?	ACTA OTO-LARYNGOLOGICA			English	Article						audiometry; closed head injury; contusion; fracture; progression; Swedish Reaction Level Scale; tinnitus	TEMPORAL BONE-FRACTURES; TRAUMA; CHILDREN	Objectives-To evaluate the prevalence of progression of closed head injury (CHI)-induced hearing impairment, defined as greater than or equal to 15 dB HL deterioration at 1 or more frequencies, and to identify risk factors in patient history and initial status that could predict progression. Material and Methods-A total of 600 patients with major CHI were admitted to 2 Swedish medical centres during a 14-year period. The type of injury was established by means of CT and the severity of head injury was measured using the Swedish Reaction Level Scale (RLS). In 62 of these patients, pure-tone audiometry was performed soon after the injury. Forty-three patients agreed to participate in the present investigation, which was carried out 2-13 years after the injury. Each participant was evaluated using pure-tone audiometry and an itemized anamnesis was obtained. Results-There was a higher prevalence of hearing impairments in the study group compared to a control group. Thirty-two subjects (74%) showed a progression of greater than or equal to 15 dB, which was significantly greater than the spontaneous progression in the control group. Age and temporal bone fracture were risk factors for progression but not brain contusion only or RLS. There was an association between early pure-tone average (PTA) and progression as well as regression, i.e. the poorer the initial PTA the greater the progression as well as regression, indicating increased instability in the auditory system. Examination of patient histories did not reveal any single risk factors for progression. A serendipitous finding was a higher prevalence of reported memory shortcomings among those with post-traumatic tinnitus. Conclusion-Especially for those with fracture of the temporal bone the present results stress the importance of audiometric evaluation and follow-up, from both rehabilitation and medicolegal perspectives.	Orebro Univ Hosp, Ahlsen Res Inst, SE-70185 Orebro, Sweden; Lindesberg Cty Hosp, ENT Dept, Lindesberg, Sweden		Bergemalm, PO (corresponding author), Orebro Univ Hosp, Ahlsen Res Inst, SE-70185 Orebro, Sweden.	per-olof.bergemalm@orebroll.se					Bergemalm PO, 2001, ACTA OTO-LARYNGOL, V121, P724, DOI 10.1080/00016480152583674; Berrettini S, 1998, SEMIN ARTHRITIS RHEU, V27, P301, DOI 10.1016/S0049-0172(98)80051-6; BROWNSON RJ, 1986, LARYNGOSCOPE, V96, P166; Dahiya R, 1999, J TRAUMA, V47, P1079, DOI 10.1097/00005373-199912000-00014; FELDMANN H, 1987, ACTA OTO-LARYNGOL, V103, P379; Fitzgerald DC, 1996, J TRAUMA, V40, P488, DOI 10.1097/00005373-199603000-00034; FUKUDA S, 1994, ACTA OTO-LARYNGOL, P108; GRIFFITHS MV, 1979, J LARYNGOL OTOL, V93, P253, DOI 10.1017/S0022215100086990; ILBERG CV, 1977, LARYNG RHINOL OTOL V, V56, P323; JACOBSON CA, 1989, EAR HEARING, V10, P178, DOI 10.1097/00003446-198906000-00007; LYOS AT, 1995, ARCH OTOLARYNGOL, V121, P795; MAKISHIMA K, 1975, ARCH OTOLARYNGOL, V101, P426; MCGUIRT WF, 1992, CLIN PEDIATR, V31, P12, DOI 10.1177/000992289203100103; NEUBERGER M, 1992, AUDIOLOGY, V31, P45; Niklasson M, 1998, SCAND AUDIOL, V27, P131, DOI 10.1080/010503998422629; PAULSEN K, 1971, Z LARYNGOL RHINO, V5, P297; PODOSHIN L, 1975, ARCH OTOLARYNGOL, V101, P15; Roizen NJ, 1999, PEDIATR CLIN N AM, V46, P49, DOI 10.1016/S0031-3955(05)70080-8; Scholer W, 1990, Z Unfallchir Versicherungsmed, V83, P237; SCHUKNECHT HF, 1969, ANN OTO RHINOL LARYN, V78, P253, DOI 10.1177/000348946907800205; SCHUKNECHT HF, 1991, ADV OTO-RHINO-LARYNG, V46, P50; Segal S, 2002, OTOL NEUROTOL, V23, P312, DOI 10.1097/00129492-200205000-00014; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; TONKIN JP, 1975, J LARYNGOL OTOL, V89, P733, DOI 10.1017/S0022215100080944; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	25	20	22	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0001-6489	1651-2251		ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	OCT	2003	123	7					836	845		10.1080/00016480310002474			10	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	718GR	WOS:000185137200008	14575399				2022-02-06	
J	Riley, GA; Simmonds, LV				Riley, GA; Simmonds, LV			How robust is performance on the National Adult Reading Test following traumatic brain injury?	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; DEMOGRAPHIC-VARIABLES; PREMORBID INTELLIGENCE; NART PERFORMANCE; REGRESSION; IQ; RELIABILITY; EQUATION; APHASIA	Objective. To investigate whether National Adult Reading Test (NART) performance may be impaired by severe traumatic brain injury (TBI). Method. A sample of 26 people who had been given a NART within 12 months of a severe TBI was given a second NART at least 12 months after the first NART. Results. Mean performance on the second NART was significantly better than performance on the first NART. Of the participants, 11 (42%) showed an improvement of more than 5 IQ points in respect of the verbal IQ estimates based on their NART scores, with three participants showing an improvement of 20 points. In applying the NART to determine the presence of an acquired intellectual impairment, use of the first NART scores alone would have resulted in such impairments being missed in at least 25% of a subsample of 16 participants for whom an actual verbal IQ had been obtained at the time of the first NART. Conclusion. An NART given within 12 months of a severe TBI runs the risk of significantly underestimating pre-morbid IQ. If applied in this context, it is recommended that the NART score is used in conjunction with other methods of estimation, such as those based on demographic data.	Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England		Riley, GA (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.		riley, gerard/AAP-1439-2020; Riley, Gerard/A-4328-2008; Riley, Gerard Anthony/J-1646-2012	Riley, Gerard Anthony/0000-0002-1167-8023			Alcott D, 1999, BRIT J CLIN PSYCHOL, V38, P431, DOI 10.1348/014466599162926; Basso MR, 2000, CLIN NEUROPSYCHOL, V14, P325, DOI 10.1076/1385-4046(200008)14:3;1-P;FT325; Crawford JR, 1997, CLIN NEUROPSYCHOL, V11, P192, DOI 10.1080/13854049708407050; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P97, DOI 10.1348/014466501163517; CRAWFORD JR, 1989, BRIT J CLIN PSYCHOL, V28, P267, DOI 10.1111/j.2044-8260.1989.tb01376.x; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; CRAWFORD JR, 1988, BRIT J CLIN PSYCHOL, V27, P181, DOI 10.1111/j.2044-8260.1988.tb00770.x; Freeman J, 2001, BRIT J CLIN PSYCHOL, V40, P221, DOI 10.1348/014466501163562; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Howell DC., 1997, STAT METHODS PSYCHOL, V4th ed; Joseph J, 2001, J LEARN DISABIL-US, V34, P566, DOI 10.1177/002221940103400609; KERR C, 1995, BRAIN INJURY, V9, P777, DOI 10.3109/02699059509008234; Kiyosawa M, 1996, GRAEF ARCH CLIN EXP, V234, P110, DOI 10.1007/BF00695250; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; LAMBONRALPH MA, 2000, NEUROCASE, V6, P141; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P229, DOI 10.1111/j.2044-8260.1987.tb01352.x; ODONNELL JP, 1990, J CLIN PSYCHOL, V46, P310, DOI 10.1002/1097-4679(199005)46:3<310::AID-JCLP2270460311>3.0.CO;2-G; RIMNEL RW, 1990, REHABILITATION ADULT, P8; SEGALOWITZ SJ, 1995, J LEARN DISABIL, V28, P309, DOI 10.1177/002221949502800507; Syder D, 1993, SHEFFIELD SCREENING; THOMSEN IV, 1975, J NEUROL NEUROSUR PS, V38, P713, DOI 10.1136/jnnp.38.7.713; Veiel HOF, 2001, PSYCHOL ASSESSMENT, V13, P356, DOI 10.1037/1040-3590.13.3.356; Watt KJ, 1999, J NEUROL NEUROSUR PS, V66, P474, DOI 10.1136/jnnp.66.4.474; Wechsler, 1997, WECHSLER ADULT INTEL; Wilson B., 1999, BEHAVIOURAL INATTENT BEHAV INATTENTION TE; WILSON BA, 1994, J CLIN EXP NEUROPSYC, V16, P354, DOI 10.1080/01688639408402646; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	20	20	0	4	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	SEP	2003	42		3				319	328		10.1348/01446650360703410			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	730TY	WOS:000185847300008	14565896				2022-02-06	
J	Herskovits, EH; Gerring, JP				Herskovits, EH; Gerring, JP			Application of a data-mining method based on Bayesian networks to lesion-deficit analysis	NEUROIMAGE			English	Article							CLOSED-HEAD INJURY; HYPERACTIVITY DISORDER; ANATOMIC CHARACTERISTICS; PROBABILISTIC NETWORKS; CORPUS-CALLOSUM; BRAIN; PREVALENCE; CHILDREN; IMAGES	Although lesion-deficit analysis (LDA) has provided extensive information about structure-function associations in the human brain, LDA has suffered from the difficulties inherent to the analysis of spatial data, i.e., there are many more variables than subjects, and data may be difficult to model using standard distributions, such as the normal distribution. We herein describe a Bayesian method for LDA; this method is based on data-mining techniques that employ Bayesian networks to represent structure-function associations. These methods are computationally tractable, and can represent complex, nonlinear structure-function associations. When applied to the evaluation of data obtained from a study of the psychiatric sequelae of traumatic brain injury in children, this method generates a Bayesian network that demonstrates complex, nonlinear associations among lesions in the left caudate, right globus pallidus, right side of the corpus callosum, right caudate, and left thalamus, and subsequent development of attention-deficit hyperactivity disorder, confirming and extending our previous statistical analysis of these data. Furthermore, analysis of simulated data indicates that methods based on Bayesian networks may be more sensitive and specific for detecting associations among categorical variables than methods based on chi-square and Fisher exact statistics. (C) 2003 Elsevier Science (USA). All rights reserved.	Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Johns Hopkins Bayview Med Ctr, Dept Psychiat, Baltimore, MD 21224 USA		Herskovits, EH (corresponding author), Hosp Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA.	herskovits@rad.upenn.edu			NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG 13743] Funding Source: Medline; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG013743] Funding Source: NIH RePORTER		Baumgardner TL, 1996, NEUROLOGY, V47, P477, DOI 10.1212/WNL.47.2.477; BERKER EA, 1986, ARCH NEUROL-CHICAGO, V43, P1065, DOI 10.1001/archneur.1986.00520100069017; Boling W, 1999, NEUROCHIRURGIE, V45, P208; Bouckaert R. R., 1994, Uncertainty in Artificial Intelligence. Proceedings of the Tenth Conference (1994), P110; Bryan RN, 1999, AM J NEURORADIOL, V20, P1273; Bryan RN, 1997, RADIOLOGY, V202, P47, DOI 10.1148/radiology.202.1.8988191; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; CAPUTI F, 1995, J NEUROSURG, V83, P933, DOI 10.3171/jns.1995.83.5.0933; CHENG J, 1997, P 6 ACM INT C INF KN, P325; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1023/A:1022649401552; Cowie SE, 2000, J INVEST SURG, V13, P297, DOI 10.1080/089419300750059334; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Damasio H., 1989, LESION ANAL NEUROPSY; Davatzikos C, 1997, COMPUT VIS IMAGE UND, V66, P207, DOI 10.1006/cviu.1997.0605; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P206; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; GENTRY LR, 1994, RADIOLOGY, V191, P1; Gerring J, 2000, BRAIN INJURY, V14, P205; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; Giedd JN, 2001, ANN NY ACAD SCI, V931, P33; Harris LJ, 1999, SCHIZOPHRENIA BULL, V25, P11, DOI 10.1093/oxfordjournals.schbul.a033359; Heckerman D, 1997, DATA MIN KNOWL DISC, V1, P79, DOI 10.1023/A:1009730122752; Hejlesen OK, 1995, LECT NOTES ARTIF INT, V934, P151; Henrion M., 1988, UNCERTAINTY ARTIFICI, V5, P149, DOI 10.1016/B978-0-444-70396-5.50019-4; Herskovits EH, 1999, RADIOLOGY, V213, P389, DOI 10.1148/radiology.213.2.r99nv45389; Herskovits EH, 2000, METHOD INFORM MED, V39, P291; HERSKOVITS EH, 1991, COMPUTER BASED PROBA; HOWARD RA, 1984, READINGS PRINCIPLES; KIIVERI H, 1984, J AUST MATH SOC A, V36, P30, DOI 10.1017/S1446788700027312; LAURITZEN SL, 1992, J AM STAT ASSOC, V50, P157; Lyoo IK, 1996, BIOL PSYCHIAT, V40, P1060; Max JE, 2002, J AM ACAD CHILD PSY, V41, P563, DOI 10.1097/00004583-200205000-00014; MEGA MS, 1994, J NEUROPSYCH CLIN N, V6, P358; PEARL J, 1986, ARTIF INTELL, V29, P241, DOI 10.1016/0004-3702(86)90072-X; Pearl J., 1988, PROBABILISTIC REASON; REY D, 2001, MED IMAGE COMPUTING, P1232; ROBINSON RW, 1977, LECT NOTES MATH, V0622, P00028, DOI DOI 10.1007/BFB0069178; SHACHTER RD, 1989, MANAGE SCI, V35, P527, DOI 10.1287/mnsc.35.5.527; Shen DG, 2002, IEEE T MED IMAGING, V21, P1421, DOI 10.1109/TMI.2002.803111; Shen DG, 2001, IEEE T MED IMAGING, V20, P257, DOI 10.1109/42.921475; SHOCK NW, 1984, US PUBLIC HLTH SERVI; Suzuki J, 1999, IEICE T INF SYST, VE82D, P356; Tyler KL, 2000, NEUROLOGY, V55, P1015, DOI 10.1212/WNL.55.7.1015; ZAMETKIN AJ, 1993, ARCH GEN PSYCHIAT, V50, P333	46	20	23	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8119	1095-9572		NEUROIMAGE	Neuroimage	AUG	2003	19	4					1664	1673		10.1016/S1053-8119(03)00231-3			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	717GK	WOS:000185079000036	12948721				2022-02-06	
J	Page, S; Levine, P				Page, S; Levine, P			Forced use after TBI: promoting plasticity and function through practice	BRAIN INJURY			English	Article							CONSTRAINT-INDUCED THERAPY; INDUCED MOVEMENT THERAPY; UPPER-LIMB FUNCTION; UPPER-EXTREMITY; PHYSICAL REHABILITATION; INTERRATER RELIABILITY; STROKE PATIENTS; INJURY	Objective: To review the literature supporting, and determine the efficacy of, modified constraint-induced therapy ( mCIT) in improving more affected upper limb use and function in patients with traumatic brain injury ( TBI). Design: Multiple-baseline, pre-post, case series. Setting: Outpatient clinic. Patients: Three patients with TBI occurring >1 year ago and exhibiting stable upper limb hemiparesis and learned non-use. Intervention: Patients participated in 10 sessions of 30 minute, structured physical and occupational therapy, emphasizing more affected arm use in valued, functional activities, three times/week for 10 weeks and using shaping techniques. Their less affected upper limbs were also restrained 5 days/week during 5 hours identified as times of frequent use during the same 10-week period. Main outcome measures: The Action Research Arm Test (ARA), Wolf Motor Function Test (WMFT) and Motor Activity Log ( MAL). Results: Following intervention, subjects exhibited improvements > 2.0 in their amount and quality of more affected limb use, as measured by the MAL. Subjects 1, 2 and 3 also displayed functional improvements on the ARA (14.0, 5.5 and 6.0, respectively), improvements in ratings of WMFT task performance (1.15, 1.7 and 1.35, respectively) and diminished time needed to perform all WMFT tasks. Conclusions: mCIT is a promising approach by which improved more affected limb use and function can be realized following TBI.	Univ Cincinnati, Coll Med, Dept Phys Med & Rehabil, Cincinnati, OH 45267 USA		Page, S (corresponding author), Univ Cincinnati, Coll Med, Dept Phys Med & Rehabil, 202 Goodman Dr,Suite 275, Cincinnati, OH 45267 USA.	stephen.page@uc.edu	LEVINE, PETER/AAS-2067-2020				Blanton S, 1999, PHYS THER, V79, P847, DOI 10.1093/ptj/79.9.847; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BRINKMANN JR, 1979, PHYS THER, V59, P859, DOI 10.1093/ptj/59.7.859; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; KEITH RA, 1987, SOC SCI MED, V24, P529, DOI 10.1016/0277-9536(87)90342-X; Liepert J, 1999, EXP BRAIN RES, V125, P435, DOI 10.1007/s002210050700; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lincoln NB, 1996, STROKE, V27, P18, DOI 10.1161/01.STR.27.1.18; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MACKAY LE, 1992, ARCH PHYS MED REHAB, V73, P635; Mackey F, 1996, ARCH PHYS MED REHAB, V77, P1066, DOI 10.1016/S0003-9993(96)90070-2; Miller T.R., 1995, DATABOOK NONFATAL IN; Miltner WHR, 1999, STROKE, V30, P586, DOI 10.1161/01.STR.30.3.586; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Newell A., 1981, COGN SKILLS ACQUISIT, V1, P1; Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791; Page SJ, 2002, ARCH PHYS MED REHAB, V83, P286, DOI 10.1053/apmr.2002.28007; Page SJ, 2002, AM J PHYS MED REHAB, V81, P870, DOI 10.1097/00002060-200211000-00013; Page SJ, 2002, CLIN REHABIL, V16, P55, DOI 10.1191/0269215502cr473oa; Page SJ, 2001, J REHABIL RES DEV, V38, P583; Reynolds WE, 2001, J HEAD TRAUMA REHAB, V16, P34, DOI 10.1097/00001199-200102000-00006; SCHAUMBURG S, 1999, ANN M AM C REH MED O; Taub E, 1999, J REHABIL RES DEV, V36, pVII; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Taub E, 1999, J REHABIL RES DEV, V36, P237; Taub E., 1976, NEURAL CONTROL LOCOM, P676; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van der Lee JH, 1999, STROKE, V30, P2369, DOI 10.1161/01.STR.30.11.2369; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620; Winstein CJ, 2001, J STROKE CEREBROVASC, V10, P197; Wolf S L, 1997, Top Stroke Rehabil, V3, pv, DOI 10.1080/10749357.1997.11754125; WOLF SL, 1989, EXP NEUROL, V104, P125, DOI 10.1016/S0014-4886(89)80005-6	34	20	21	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2003	17	8					675	684		10.1080/0269905031000107160			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	691MF	WOS:000183609500005	12850952				2022-02-06	
J	Singh, P				Singh, P			Missile injuries of the brain: Results of less aggressive surgery	NEUROLOGY INDIA			English	Article						missile injury; cerebral contusion; skull bone fracture; Glasgow-coma scale	PENETRATING CRANIOCEREBRAL INJURIES; INTRACRANIAL INFECTION; LEBANESE CONFLICT; BONE FRAGMENTS; VIETNAM; WOUNDS; HEAD; WAR	Sixty cases of missile injuries (59 males, average age 25 years) were studied over a period of one year. Forty-three patients had suffered splinter injuries, 12 had gunshot wounds and 5 had suffered injuries from improvised explosive devices. The Glasgow coma scale was <5 in 8 patients, 5-8 in 14, 8-12 in 30 and 13-15 in 8 patients. Extensive comminution of skull bones was found in 10 patients. Thirty-five patients had penetration of the skull and the rest had orbito-cranial or facio-cranial wounds. CT scan revealed small hemorrhagic contusion with in-driven bones without mass effect in 15, contusion with mass effect in 36 cases, cortical contusions without in-driven bones (tangential injuries) in 3, distant intracranial contusions in 4, intraventricular hemorrhages in 5, multilobar injuries in 14, and unilobar injury in 40. Fifty-two patients were operated upon at our center, of which 30 were operated within 24 hrs, 10 between 24 to 48 hrs, and 12 between 48 to 72 hrs. Six patients were treated conservatively and 2 underwent only a simple closure of scalp wound. Craniectomy was done in 10 and craniotomy in 42 patients. Two patients developed wound sepsis, one had aspiration pneumonia, one had septicemia and one had deep vein thrombosis while one had post-traumatic hydrocephalus. On follow-up at 6 months, the outcome as per the Glasgow outcome scale was as follows: Good outcome in 42, moderate disability in 7, severe disability in 6 and death of 5 patients. Retained bone fragments were found in 36.3 % on follow-up CT scan but no one had brain abscess.	Army Hosp R&R, Neurosurg Ctr, Delhi 110010, India		Singh, P (corresponding author), Army Hosp R&R, Neurosurg Ctr, Delhi 110010, India.						ARABI B, 1987, NEUROSURGERY, V20, P61; Ascroft PB, 1943, LANCET, V2, P211; BRANDVOLD B, 1990, J NEUROSURG, V72, P15, DOI 10.3171/jns.1990.72.1.0015; Cairns H, 1944, Br Med J, V1, P33; COOPER WL, 1979, P SOC THERIOGENOLOGY, V1, P1; Cushing H, 1918, BRIT J SURG, V5, P558; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; HADDAD FS, 1978, CAN J SURG, V21, P233; HAMMON WM, 1971, J NEUROSURG, V34, P127, DOI 10.3171/jns.1971.34.2part1.0127; MALTBY GL, 1946, J NEUROSURG, V3, P239, DOI 10.3171/jns.1946.3.3.0239; MATSON DD, 1958, NEUROSURGERY, V1, P123; MEIRWOSKY AM, 1968, MIL MED, V33, P887; MYERS PW, 1989, J NEUROSURG, V70, pA319; PITLYK PJ, 1970, J NEUROSURG, V33, P19, DOI 10.3171/jns.1970.33.1.0019; RISH BL, 1981, NEUROSURGERY, V9, P535, DOI 10.1227/00006123-198111000-00008; RISH BL, 1980, J NEUROSURG, V53, P772, DOI 10.3171/jns.1980.53.6.0772; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Splavski B, 2000, INJURY, V31, P233, DOI 10.1016/S0020-1383(99)00273-9; TAHA JM, 1991, NEUROSURGERY, V29, P864, DOI 10.1227/00006123-199112000-00010; Tudor M, 1998, MIL MED, V163, P486, DOI 10.1093/milmed/163.7.486; Vrankovic D, 1996, J Neurosurg Sci, V40, P107; WANNAMAKER GT, 1958, J NEUROSURG, V15, P512, DOI 10.3171/jns.1958.15.5.0512; WEBSTER JE, 1946, J NEUROSURG, V3, P7, DOI 10.3171/jns.1946.3.1.0007	23	20	21	0	2	NEUROL SOC INDIA	CHANDIGARH	C/O J S CHOPRA, PGIMER, DEPT NEUROLOGY, CHANDIGARH 160 012, INDIA	0028-3886			NEUROL INDIA	Neurol. India	JUN	2003	51	2					215	219					5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	743BT	WOS:000186553100012	14571007				2022-02-06	
J	Swartz, CM; Acosta, D; Bashir, A				Swartz, CM; Acosta, D; Bashir, A			Diminished ECT response in catatonia due to chronic neurologic condition	JOURNAL OF ECT			English	Article						delirium; catatonia; neurologic disease; traumatic brain injury; dementia	SYSTEMIC LUPUS-ERYTHEMATOSUS; DEPRESSION	A series of four clinical cases suggests that catatonic disorder due to a chronic neurologic condition does not respond as reliably to electroconvulsive therapy (ECT) as functional catatonia does. Cases reported in the medical literature show a similar pattern. Presumably this form of catatonia is intrinsically less responsive to ECT, although the possibility remains that a more intense quality of treatment and prophylaxis is needed. Conversely, catatonia resistant to ECT suggests an underlying medical condition.	So Illinois Univ, Sch Med, Dept Psychiat, Springfield, IL 62794 USA; E Carolina Univ, Sch Med, Dept Psychiat, Greenville, NC USA		Swartz, CM (corresponding author), So Illinois Univ, Sch Med, Dept Psychiat, POB 19642, Springfield, IL 62794 USA.						BARNES MP, 1986, J NEUROL NEUROSUR PS, V49, P991, DOI 10.1136/jnnp.49.9.991; BRASIC JR, 2000, GERMAN J PSYCHIAT, V3, P13; DITMORE BG, 1992, CONVULSIVE THER, V8, P33; Folkerts HW, 1998, J ECT, V14, P53; KESSING L, 1994, CONVULSIVE THER, V10, P232; Lance JW, 1998, MOVEMENT DISORD, V13, P835, DOI 10.1002/mds.870130515; Lee J W, 2000, Ann Clin Psychiatry, V12, P89, DOI 10.1023/A:1009072130267; MAC DS, 1983, J CLIN PSYCHIAT, V44, P155; Malur C, 2001, J ECT, V17, P55, DOI 10.1097/00124509-200103000-00012; MATTINGLY G, 1992, J NEUROPSYCH CLIN N, V4, P145; ROHLAND BM, 1993, J AFFECT DISORDERS, V29, P255, DOI 10.1016/0165-0327(93)90015-C; Swartz C, 2002, J ECT, V18, P167, DOI 10.1097/00124509-200209000-00012; Swartz CM, 2001, J ECT, V17, P180, DOI 10.1097/00124509-200109000-00006; SWARTZ CM, 1994, NEUROPSYCHOBIOLOGY, V29, P174; TAYLOR MA, 1982, ELECTROCONVULSIVE TH, P7	15	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1095-0680			J ECT	J. ECT	JUN	2003	19	2					110	114		10.1097/00124509-200306000-00010			5	Behavioral Sciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Psychiatry	687FB	WOS:000183364500010	12792461				2022-02-06	
J	Thornton, K				Thornton, K			The electrophysiological effects of a brain injury on auditory memory functioning - The QEEG correlates of impaired memory	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						QEEG; auditory memory; brain damage; memory; electrophysiology	CLOSED-HEAD-INJURY; EEG	The effect of a brain injury on the quantitative EEG (QEEG) variables during an auditory memory activation condition was examined with 56 normal subjects and 85 mild traumatic brain-injured (MTBI) subjects. An analysis was conducted on the different response patterns of the two groups, the variables which were correlated with memory performance in the brain-injured group, and the variables which predicted the memory score for the combined two groups (normal and brain injured). The three conditions included the input task, the immediate recall, and the delayed recall task. The consistent effect of a brain injury was a lowering of the connectivity patterns in the betal and beta2 frequencies (phase and coherences) and increases predominantly in the relative power of beta1 (13-32 Hz), which were correlated with the differences in recall. There is a subtle shift to right hemisphere/right temporal functioning and employment of the higher beta1 and beta2 frequencies (phase and coherence) in the response pattern of the MTBI subject. Memory functioning is predominantly positively correlated with connection activity (phase and coherence) and negatively correlated with beta activation at specific locations. (C) 2002 National Academy of Neuropsychology. Published by Elsevier Science Ltd. All rights reserved.	Ctr Hlth Psychol, S Plainfield, NJ 07080 USA		Thornton, K (corresponding author), Ctr Hlth Psychol, Ste 2A,2509 Pk Ave, S Plainfield, NJ 07080 USA.			thornton, kirtley/0000-0002-3303-4747			HOOSHMAND H, 1989, CLIN ELECTROENCEPHAL, V20, P235, DOI 10.1177/155005948902000411; HUGHES JR, 1999, IN PRESS J NEUROPSYC; Moran John E., 1993, Brain Topography, V5, P229, DOI 10.1007/BF01128990; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; PAULSON MJ, 1970, J CLIN PSYCHOL, V26, P453, DOI 10.1002/1097-4679(197010)26:4<453::AID-JCLP2270260415>3.0.CO;2-V; PRICHEP L S, 1992, Brain Topography, V4, P249, DOI 10.1007/BF01135562; RANDOLPH C, 1988, NEUROPSYCHOBIOLOGY, V20, P43, DOI 10.1159/000118471; TABANO MT, 1988, ELECTROENCEPHALOGRAP, V70, P185; Thatcher RW, 1998, NEUROIMAGE, V7, P352, DOI 10.1006/nimg.1998.0330; THATCHER RW, 1989, ELECTROENCEPHALOGRAP, V73, P10; THORNTON K, 2001, J NEUROTHERAPY, V4, P45; Thornton KE, 1999, BRAIN INJURY, V13, P477, DOI 10.1080/026990599121395; THORNTON KE, 1999, J NEUROTHERAPY   FAL, P1	13	20	20	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0887-6177			ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2003	18	4					363	378	PII S0887-6177(02)00139-7	10.1016/S0887-6177(02)00139-7			16	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	678GA	WOS:000182857100003	14591452				2022-02-06	
J	Kumar, R; Gupta, RK; Husain, M; Vatsal, DK; Chawla, S; Rathore, RKS; Pradhan, S				Kumar, R; Gupta, RK; Husain, M; Vatsal, DK; Chawla, S; Rathore, RKS; Pradhan, S			Magnetization transfer MR imaging in patients with posttraumatic epilepsy	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article; Proceedings Paper	10th Annual Meeting of the International-Society-for-Magnetic-Resonance-in-Medicine (ISMRM)	MAY 18-24, 2002	HONOLULU, HAWAII	Int Soc Magnet Resonance Med			DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN-INJURY; HEAD-INJURY; INTRACTABLE EPILEPSY; PERILESIONAL GLIOSIS; SEIZURES; NEUROCYSTICERCOSIS; CALCIFICATION; PROPHYLAXIS	BACKGROUND AND PURPOSE: Intractable epilepsy is a well-recognized complication following head trauma, and many factors have been implicated in its pathogenesis. This study was performed to determine the severity of tissue damage after severe head injury as assessed with magnetization transfer (MT) MR imaging and the relationship of this damage with seizure intractability. METHODS: Forty-four patients, 13 without seizures (disease controls) and 31 with seizures, underwent T1-weighted MT MR imaging 1-10 years after head trauma. Phase-corrected gradient-echo (GRE) imaging was also performed in all patients to look for the presence of hemosiderin. All patients were evaluated for the presence of an MT abnormality beyond an abnormality seen on T2-weighted images, an MT abnormality within a T2 abnormality, and hemosiderin deposition. RESULTS: Patients with an MT abnormality beyond a T2 abnormality had a significantly higher intractability of seizures compared with those with an MT abnormality within a T2 abnormality (P <.05). In addition, the mere presence of hemosiderin deposit was not associated with seizure intractability; however, gliosis around the hemosiderin as seen on T1-weighted MT images was associated with seizure intractability. CONCLUSIONS: T1-weighted MT imaging may be of value in predicting the intractability of the seizure in delayed posttraumatic epilepsy.	Sanjay Gandhi Postgrad Inst Med Sci, Dept Radiol, Lucknow 226014, Uttar Pradesh, India; Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Lucknow 226014, Uttar Pradesh, India; King Georges Med Coll, Dept Neurosurg, Lucknow, Uttar Pradesh, India; Indian Inst Technol, Dept Math, Kanpur 208016, Uttar Pradesh, India		Gupta, RK (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, MR Sect, Dept Radiodiag, Lucknow 226014, Uttar Pradesh, India.			Pradhan, Sunil/0000-0003-3324-3626			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF., 1996, TREATMENT EPILEPSY P, P165; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; CAVENESS WF, 1976, EPILEPSIA, V17, P207, DOI 10.1111/j.1528-1157.1976.tb03398.x; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; CROOKS DA, 1991, NEUROPATH APPL NEURO, V17, P421, DOI 10.1111/j.1365-2990.1991.tb00742.x; De Santis A, 1992, Acta Neurochir Suppl (Wien), V55, P64; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; DUNN LT, 1994, ANN ROY COLL SURG, V76, P147; Gupta RK, 1999, LANCET, V354, P44, DOI 10.1016/S0140-6736(99)00881-8; Gupta RK, 2001, J COMPUT ASSIST TOMO, V25, P698, DOI 10.1097/00004728-200109000-00006; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; JENNET WB, 1975, EPILEPSY NONMISSILE; Kabuto H, 1996, EPILEPSY RES, V25, P65, DOI 10.1016/0920-1211(96)00063-0; Kazemi NJ, 1997, EPILEPSIA, V38, P670, DOI 10.1111/j.1528-1157.1997.tb01236.x; Kimura H, 1996, J COMPUT ASSIST TOMO, V20, P540, DOI 10.1097/00004728-199607000-00007; Kumar R, 2002, NEUROIMAGE, V15, P1015, DOI 10.1006/nimg.2001.1036; Lee ST, 1995, ACTA NEUROCHIR, V137, P151, DOI 10.1007/BF02187187; MARKS DA, 1995, NEUROLOGY, V45, P2051, DOI 10.1212/WNL.45.11.2051; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; NIEMI PT, 1992, JMRI-J MAGN RESON IM, V2, P197, DOI 10.1002/jmri.1880020213; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Pradhan S, 2000, ANN NEUROL, V48, P181, DOI 10.1002/1531-8249(200008)48:2&lt;181::AID-ANA7&gt;3.0.CO;2-C; RATHORE RKS, 2001, P 9 M INT SOC MAGN R, P794; RUBIN JJ, 1980, EXP NEUROL, V67, P472, DOI 10.1016/0014-4886(80)90119-3; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Semah F, 1998, NEUROLOGY, V51, P1256, DOI 10.1212/WNL.51.5.1256; WILLMORE LJ, 1978, ANN NEUROL, V4, P329, DOI 10.1002/ana.410040408; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Yamada N, 1996, RADIOLOGY, V198, P171, DOI 10.1148/radiology.198.1.8539373	31	20	22	0	2	AMER SOC NEURORADIOLOGY	OAK BROOK	2210 MIDWEST RD, OAK BROOK, IL 60521 USA	0195-6108			AM J NEURORADIOL	Am. J. Neuroradiol.	FEB	2003	24	2					218	224					7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	738UT	WOS:000186306800011	12591637				2022-02-06	
J	Bayir, H; Kochanek, TM; Liu, SX; Arroyo, A; Osipov, A; Jiang, TF; Wisniewski, S; Adelson, PD; Graham, SH; Kagan, VE				Bayir, H; Kochanek, TM; Liu, SX; Arroyo, A; Osipov, A; Jiang, TF; Wisniewski, S; Adelson, PD; Graham, SH; Kagan, VE			Increased S-nitrosothiols and S-nitrosoalbumin in cerebrospinal fluid after severe traumatic brain injury in infants and children: Indirect association with intracranial pressure	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						nitric oxide; nitrosative stress; oxidative stress; head injury; ascorbate; DAF-2	NITRIC-OXIDE SYNTHASE; ANTIPLATELET PROPERTIES; PLATELET-AGGREGATION; OXIDATIVE STRESS; MICE DEFICIENT; SMOOTH-MUSCLE; ALBUMIN; INHIBITION; PLASMA; NITROSOGLUTATHIONE	Nitric oxide (NO) is implicated in both secondary damage and recovery after traumatic brain injury (TBI). Transfer of NO groups to cysteine sulfhydryls on proteins produces S-nitrosothiols (RSNO). S-nitrosothiols may be neuroprotective after TBI by nitrosylation of N-methyl-D-aspartate receptor and caspases. S-nitrosothiols release NO on decomposition for which endogenous reductants (i.e., ascorbate) are essential, and ascorbate is depleted in cerebrospinal fluid (CSF) after pediatric TBI. This study examined the presence and decomposition of RSNO in CSF and the association between CSF RSNO level and physiologic parameters after severe TBI. Cerebrospinal fluid samples (n = 72) were obtained from 48 infants and children on days I to 3 after severe TBI (Glasgow Coma Scale score < 8) and 18 controls. Cerebrospinal fluid RSNO levels assessed by fluorometric assay peaked on day 3 versus control (1.42 +/- 0.11 mu mol/L vs. 0.86 +/- 0.04, P < 0.05). S-nitrosoalbumin levels were also higher after TBI (n = 8, 0.99 +/- 0.09 mumol/L on day 3 vs. n = 6, 0.42 +/- 0.02 in controls, P < 0.05). S-nitrosoalbumin decomposition was decreased after TbI. Multivariate analysis showed an inverse relation between CSF RSNO and intracranial pressure and a direct relation with barbiturate treatment. Using a novel assay, the presence of RSNO and S-nitrosoalbumin in human CSF, an similar to 1.7-fold increase after TBI, and an association with low intracranial pressure are reported, supporting a possible neuroprotective role for RSNO. The increase in RSNO may result from increased NO production and/or decreased RSNO decomposition.	Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth & Pharmacol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Epidemiol & Publ Hlth, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Kagan, VE (corresponding author), Univ Pittsburgh, Sch Med, Dept Environm & Occupat Hlth & Pharmacol, 3343 Forbes Ave, Pittsburgh, PA 15213 USA.	kagan@pitt.edu	Adelson, David/W-2083-2019; Kochanek, Patrick M/D-2371-2015; Osipov, Andreyan N/G-4791-2010	Kochanek, Patrick M/0000-0002-2627-913X; Osipov, Andreyan N/0000-0001-5921-9056; Wisniewski, Stephen/0000-0002-3877-9860	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS030318, P01NS030318, P20NS030318] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL64145] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS30318] Funding Source: Medline		Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; AMANO M, 1994, J CARDIOVASC PHARM, V24, P860, DOI 10.1097/00005344-199424060-00002; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Belayev L, 1998, STROKE, V29, P2587, DOI 10.1161/01.STR.29.12.2587; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Boje KMK, 2000, J PHARMACOL EXP THER, V293, P545; Bullock MR, 1996, J NEUROTRAUM, V13, P667; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; CLANCY RM, 1994, P NATL ACAD SCI USA, V91, P3680, DOI 10.1073/pnas.91.9.3680; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Clark RSB, 1996, PEDIATR RES, V39, P784, DOI 10.1203/00006450-199605000-00007; Clark RSB, 1997, J NEUROSCI, V17, P9172; DAWSON TM, 1994, PROG BRAIN RES, V103, P365; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; Gaston B, 1998, BIOCHEM BIOPH RES CO, V253, P899, DOI 10.1006/bbrc.1998.9865; GASTON B, 1993, P NATL ACAD SCI USA, V90, P10957, DOI 10.1073/pnas.90.23.10957; Gaston B, 1999, BBA-BIOENERGETICS, V1411, P323, DOI 10.1016/S0005-2728(99)00023-7; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P11482, DOI 10.1073/pnas.97.21.11482; Gluckman TL, 2000, J TOXICOL ENV HEAL A, V61, P9, DOI 10.1080/00984100050116753; Goodman JC, 1996, J NEUROTRAUM, V13, P549, DOI 10.1089/neu.1996.13.549; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Hogg N, 1999, ANAL BIOCHEM, V272, P257, DOI 10.1006/abio.1999.4199; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Holscher C, 1997, TRENDS NEUROSCI, V20, P298, DOI 10.1016/S0166-2236(97)01065-5; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P378, DOI 10.1038/jcbfm.1995.47; IGNARRO LJ, 1981, J PHARMACOL EXP THER, V218, P739; ILLI OE, 1983, HELV PAEDIATR ACTA, V38, P323; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Ji YB, 1999, ARCH BIOCHEM BIOPHYS, V362, P67, DOI 10.1006/abbi.1998.1013; Johnson MA, 2001, J BIOL CHEM, V276, P39872, DOI 10.1074/jbc.M102781200; Jourd'heuil D, 2000, FREE RADICAL BIO MED, V28, P409, DOI 10.1016/S0891-5849(99)00257-9; KashibaIwatsuki M, 1997, ARCH BIOCHEM BIOPHYS, V345, P237, DOI 10.1006/abbi.1997.0258; Kastenbauer S, 1999, J INFECT DIS, V180, P1164, DOI 10.1086/315048; KEANEY JF, 1993, J CLIN INVEST, V91, P1582, DOI 10.1172/JCI116364; Kelm M, 1999, BBA-BIOENERGETICS, V1411, P273, DOI 10.1016/S0005-2728(99)00020-1; Kluge I, 1997, J NEUROCHEM, V69, P2599; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Kochanek PM, 2001, PEDIATR CLIN N AM, V48, P661, DOI 10.1016/S0031-3955(05)70333-3; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; KOWALUK EA, 1990, J PHARMACOL EXP THER, V255, P1256; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Marks DS, 1995, J CLIN INVEST, V96, P2630, DOI 10.1172/JCI118328; Marley R, 2000, FREE RADICAL RES, V32, P1, DOI 10.1080/10715760000300011; Marmarou A, 2000, J NEUROSURG, V93, P183, DOI 10.3171/jns.2000.93.2.0183; MELLION BT, 1983, MOL PHARMACOL, V23, P653; MORRIS SL, 1981, J BACTERIOL, V148, P465, DOI 10.1128/JB.148.2.465-471.1981; Murphy MP, 1999, BBA-BIOENERGETICS, V1411, P401, DOI 10.1016/S0005-2728(99)00029-8; PARK JW, 1988, BIOCHEM BIOPH RES CO, V152, P916, DOI 10.1016/S0006-291X(88)80127-X; Pfeiffer S, 1998, ANAL BIOCHEM, V258, P68, DOI 10.1006/abio.1998.2562; Rauhala P, 1996, SYNAPSE, V23, P58, DOI 10.1002/(SICI)1098-2396(199605)23:1<58::AID-SYN7>3.0.CO;2-G; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sambrook J., 1989, MOL CLONING LAB MANU; SCHARFSTEIN JS, 1994, J CLIN INVEST, V94, P1432, DOI 10.1172/JCI117480; Schulz JB, 1995, J NEUROSCI, V15, P8419; SIMON DI, 1993, ARTERIOSCLER THROMB, V13, P791, DOI 10.1161/01.ATV.13.6.791; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P8087, DOI 10.1073/pnas.89.17.8087; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Tannock GW, 1992, LACTIC ACID BACTERIA, V1, P21; TOMITA H, 1994, ACTA NEUROCHIR, P547; TRAVIS J, 1976, BIOCHEM J, V157, P301, DOI 10.1042/bj1570301; Tyurin VA, 2002, METHOD ENZYMOL, V352, P347; Tyurin VA, 2001, CIRC RES, V88, P1210, DOI 10.1161/hh1101.092179; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Whalen MJ, 1999, J CEREBR BLOOD F MET, V19, P835, DOI 10.1097/00004647-199908000-00002; Xu AM, 2000, HYPERTENSION, V36, P291, DOI 10.1161/01.HYP.36.2.291	71	20	21	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JAN	2003	23	1					51	61		10.1097/01.WCB.0000040399.30600.E3			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	629LW	WOS:000180052000006	12500091	Bronze			2022-02-06	
J	Johnstone, B; Mount, D; Gaines, T; Goldfader, P; Bounds, T; Pitts, O				Johnstone, B; Mount, D; Gaines, T; Goldfader, P; Bounds, T; Pitts, O			Race differences in a sample of vocational rehabilitation clients with traumatic brain injury	BRAIN INJURY			English	Article								Objective : To evaluate race differences in demographics, injury severity, and vocational outcomes for persons with TBI. Participants : Seventy-five individuals with TBI (13 African American, 62 Caucasian) who requested services from the Missouri Division of Vocational Rehabilitation (VR) over a 2-year period. Measures : Demographics (i.e. age, race, level of education), injury severity (i.e. LOC, PTA, length of hospitalization, neuropsychological test scores), VR services provided (e.g. transportation, maintenance, on-the-job training, etc.), and VR outcomes (successfully vs unsuccessfully employed; cost per case). Procedure : All participants completed a standard neuropsychological evaluation and completed VR services (i.e. were followed from enrolment to case closure). Hypotheses : African Americans and Caucasians would not differ in demographics or injury severity, although fewer African Americans would be successfully employed through DVR. Analyses : Chi-squares and non-parametric MANOVAs to evaluate race differences in terms of demographics, injury severity, vocational services provided and vocational outcomes. Results : As hypothesized, there were few race differences in demographics or injury severity, although African Americans received significantly more transportation services (62 vs 21%). Contrary to hypotheses, there was no difference in the number of successfully employed African Americans (23%) vs Caucasians (18%). Conclusions : African Americans and Caucasians with TBI achieve similar vocational successes if they receive state VR services.	Univ Missouri, Columbia, MO USA; Div Vocat Rehabil, Jefferson City, MO USA; Div Vocat Rehabil, St Charles, MO USA		Johnstone, B (corresponding author), Dept Hlth Psychol, DC046-46, Columbia, MO 65212 USA.	johnstoneg@health.missouri.edu		Johnstone, Brick/0000-0001-8845-9649			Abrams D., 1993, J HEAD TRAUMA REHAB, V8, P59; Arnold B. R., 1994, ASSESSMENT, V1, P239, DOI DOI 10.1177/107319119400100303; Belgrave FZ, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P585, DOI 10.1037/10361-028; BOUNDS T, IN PRESS NEUROREHABI; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burnett DM, 2000, BRAIN INJURY, V14, P713; Curl RM, 1996, J HEAD TRAUMA REHAB, V11, P75, DOI 10.1097/00001199-199602000-00009; DEFILIPPIS NA, 1991, MANUAL BOOKLET CATEG; GOODALL P, 1994, J HEAD TRAUMA REHAB, V9, P61; Heaton RK, 1996, NEUROPSYCHOLOGICAL A, P141; HURT GD, 2000, NEUROPSYCHOLOGICAL M, P215; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Johnstone B, 2002, J RURAL HEALTH, V18, P109, DOI 10.1111/j.1748-0361.2002.tb00882.x; Johnstone B, 1999, J HEAD TRAUMA REHAB, V14, P220, DOI 10.1097/00001199-199906000-00003; JOHNSTONE B, IN PRESS ARCH PHYSIC; *KESSL MED REH RES, 2000, TRAUM BRAIN INJ MOD; KLOVE H, CLIN NEUROPSYCHOLOGY, P211; MCMORDIE W R, 1990, Brain Injury, V4, P57, DOI 10.3109/02699059009026149; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Reitan RM, 1992, TRAIL MAKING TEST MA; Reitan RM, 1985, HALSTEADREITAN NEURO; Rosenthal M, 1996, J HEAD TRAUMA REHAB, V11, P40, DOI 10.1097/00001199-199610000-00005; Sander AM, 1996, J HEAD TRAUMA REHAB, V11, P70, DOI 10.1097/00001199-199610000-00007; SEELMAN KD, 1998, PLEN SESS TIDE 3 C A; US Census Bureau, 2000, STAT COUNT QUICK FAC; Wechsler D, 1997, ADM SCORING MANUAL; WEHMAN P, 1989, J APPL BEHAV ANAL, V22, P395, DOI 10.1901/jaba.1989.22-395; WHITMAN S, 1984, AM J EPIDEMIOL, V119, P570, DOI 10.1093/oxfordjournals.aje.a113774; [No title captured]; [No title captured]	30	20	20	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2003	17	2					95	104		10.1080/0269905021000010212			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	633LL	WOS:000180284700001	12519638				2022-02-06	
J	Zemlan, FP; Mulchahey, JJ; Gudelsky, GA				Zemlan, FP; Mulchahey, JJ; Gudelsky, GA			Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: Cleaved microtubule-associated protein-tau (C-tau)	NEUROSCIENCE			English	Article						kainic acid; neurotoxicity; C-tau; ELISA; immunohistochemistry; neurodegeneration	RAT-BRAIN; AMYGDALOID PROJECTIONS; EFFERENT CONNECTIONS; CORTICAL PROJECTIONS; NUCLEUS-ACCUMBENS; NEURONAL DAMAGE; BINDING-SITES; ORGANIZATION; INJURY; AUTORADIOGRAPHY	Previous studies of neuronal degeneration induced by the neurotoxin, kainic acid, employed silver stain techniques that are non-quantitative or ELISA measurement of the non-neuronal protein, glial fibrillary acidic protein. As previous studies employed biomarkers that were either non-quantitative or non-neuronal, the present study employed a new neuronally localized biomaker of neuronal damage, cleaved microtubule-associated protein (MAP)-tau (C-tau). The time course of kainate neurotoxicity was quantitatively determined in several brain regions in the present study employing a C-tau specific ELISA. Differences in ELISA determined regional brain levels of C-tau were compared with the density of somatodendritic C-tau labeling qualitatively determined in immunohistochemical anatomical mapping studies of kainic acid-treated animals. Immunoblot studies revealed that the C-tau antibodies employed in the present study were highly specific for proteolytic cleaved C-tau. Immunolabeling of 45 kD-50 kD C-tau proteins was observed only in brain samples from kainic acid-treated but not vehicle-treated rats. Time course studies revealed that C-tau levels determined by ELISA were maximal 3 days after kainic acid with C-tau levels increasing 26-fold in hippocampus, 16-fold in cortex and four-fold in both striatum and hypothalamus. These statistical differences in maximal C-tau levels observed in the ELISA studies were similar to differences qualitatively observed in C-tau immunohistochemical studies. C-tau immunohistochemistry revealed extensive damage in hippocampal regions CA1 and 3, moderate damage in several cortical regions and mild damage in striatum and hypothalamus. Similar cleavage of rat MAP-tau to C-tau has been reported after neuronal degeneration induced by neurotoxic doses of methamphetamine and neuronal degeneration resulting from bacterial meningitis. In humans, C-tau proteolysis has been demonstrated to be a reliable biomarker of neuronal damage in traumatic brain injury and stroke where cerebrospinal C-tau levels are correlated with patient clinical outcome. These data suggest that C-tau proteolysis may prove a reliable species independent biomarker of neuronal degeneration regardless of source of injury. (C) 2003 IBRO. Published by Elsevier Ltd. All rights reserved.	Univ Cincinnati, Coll Med, Dept Psychiat, Cincinnati, OH 45267 USA; Univ Cincinnati, Coll Pharm, Cincinnati, OH 45267 USA		Zemlan, FP (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat, 231 Sabin Ave, Cincinnati, OH 45267 USA.				NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA007427, R43DA013300, R44DA013300] Funding Source: NIH RePORTER; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA13300, DA07427] Funding Source: Medline		BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BROADWELL RD, 1975, J COMP NEUROL, V163, P329, DOI 10.1002/cne.901630306; Crawford N, 1999, J PHARMACOL TOXICOL, V42, P121, DOI 10.1016/S1056-8719(00)00040-X; DollemanVanderWeel MJ, 1996, J COMP NEUROL, V364, P637; Friedman LK, 1998, HIPPOCAMPUS, V8, P511, DOI 10.1002/(SICI)1098-1063(1998)8:5<511::AID-HIPO9>3.0.CO;2-W; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Hampson David R., 1998, Natural Toxins, V6, P153, DOI 10.1002/(SICI)1522-7189(199805/08)6:3/4<153::AID-NT16>3.0.CO;2-1; HEGGLI DE, 1981, BRAIN RES, V230, P253, DOI 10.1016/0006-8993(81)90405-4; Irazuzta JE, 2000, BRAIN RES, V881, P88, DOI 10.1016/S0006-8993(00)02894-8; Irazuzta JE, 2001, BRAIN RES, V913, P95, DOI 10.1016/S0006-8993(01)02764-0; Kaasinen K, 2000, EUR J NEUROSCI, V12, P540, DOI 10.1046/j.1460-9568.2000.00940.x; KOSIK KS, 1987, J NEUROSCI, V7, P3142; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; KRETTEK JE, 1978, J COMP NEUROL, V178, P225, DOI 10.1002/cne.901780204; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P15, DOI 10.1016/0306-4522(91)90248-M; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; MULCHAHEY JJ, 2002, SOC NEUR ABSTR, V606, P1; NADLER JV, 1979, LIFE SCI, V24, P289, DOI 10.1016/0024-3205(79)90325-4; PATEL S, 1986, NEUROSCI LETT, V70, P301, DOI 10.1016/0304-3940(86)90569-0; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Risold PY, 1996, SCIENCE, V272, P1484, DOI 10.1126/science.272.5267.1484; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Shaw GJ, 2002, ANN EMERG MED, V39, P254, DOI 10.1067/mem.2002.121214; Shibata H, 2000, NEUROSCI RES, V38, P303, DOI 10.1016/S0168-0102(00)00174-7; SWANSON LW, 1977, J COMP NEUROL, V172, P49, DOI 10.1002/cne.901720104; Tarazi FI, 1998, SYNAPSE, V30, P227, DOI 10.1002/(SICI)1098-2396(199810)30:2<227::AID-SYN13>3.3.CO;2-F; Tarazi FI, 1999, J NEUROSCI RES, V55, P401, DOI 10.1002/(SICI)1097-4547(19990215)55:4<401::AID-JNR1>3.0.CO;2-H; Vertes RP, 2002, J COMP NEUROL, V442, P163, DOI 10.1002/cne.10083; Wallace TL, 2003, NEUROSCIENCE, V116, P1063, DOI 10.1016/S0306-4522(02)00795-9; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zhang JW, 1998, EUR J NEUROSCI, V10, P3358, DOI 10.1046/j.1460-9568.1998.00347.x	32	20	22	0	4	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522			NEUROSCIENCE	Neuroscience		2003	121	2					399	409		10.1016/S0306-4522(03)00459-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	729YW	WOS:000185803300015	14521998				2022-02-06	
J	Stander, S; Bone, HG; Machens, HG; Aberle, T; Burchard, W; Prien, T; Luger, TA; Metze, D				Stander, S; Bone, HG; Machens, HG; Aberle, T; Burchard, W; Prien, T; Luger, TA; Metze, D			Hydroxyethyl starch does not cross the blood-brain or the placental barrier but the perineurium of peripheral nerves in infused animals	CELL AND TISSUE RESEARCH			English	Article						hydroxyethyl starch; pruritus; nerve fibers; blood-brain barrier; placental barrier; rat (Sprague Dawley); sheep	CLOSED-HEAD TRAUMA; RETICULOENDOTHELIAL SYSTEM; LONG-TERM; PERSISTENT PRURITUS; REPERFUSION INJURY; CELL-DEATH; ALBUMIN; HEMODILUTION; HES; HETASTARCH	Therapy with hydroxyethyl starch (HES) is associated with a high incidence of persistent pruritus due to HES storage in cutaneous nerves. Up to now it has been unknown if HES also accumulates in the extracutaneous peripheral or central nervous system. To study this, five rats including one pregnant one were infused with a single dose (34-150 mg) of HES (70/200/450 kDa molecular weight) conjugated with fluorescein isothiocyanate (FITC). In addition, four sheep were infused with a cumulative dosage of 30 g, 120 g, and 420 g HES (200 kDa), respectively. After 7-13 days, biopsies from the adult rats, four fetal rats and sheep were taken from various organs. The specimens were analyzed by light, electron, and confocal laser scanning microscopy. Typical HES storage vacuoles were found in macrophages of the skin, liver, spleen, lung, and kidney. HES storage in healthy animals was not associated with signs of either inflammation or apoptosis contrary to a previously described animal hemorrhagic shock model. Beyond that, fetus biopsies did not show any storage phenomenon, confirming that HES does not cross the placental barrier. Deposits of HES could be detected in Schwann cells of cutaneous nerve fibers as well as in perineural and endo-neural cells of sciatic nerve in one rat (HES 450 kDa) and three of four sheep. No HES storage was found in the central nervous system. Our findings clearly demonstrate that storage of HES is detectable only in small peripheral nerves, suggesting a cutaneous origin of the HES-induced pruritus.	Univ Munster, Dept Anesthesiol & Intens Care Med, Munster, Germany; Hannover Med Sch, Clin Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany; Univ Freiburg, Inst Macromol Chem, D-7800 Freiburg, Germany; Univ Munster, Dept Dermatol, D-4400 Munster, Germany; Univ Munster, Ludwig Boltzmann Inst Cell Biol & Immunobiol Skin, Munster, Germany		Stander, S (corresponding author), Univ Munster, Dept Dermatol, Von Esmarch Str 56, D-4400 Munster, Germany.	sonja.staender@uni-muenster.de		Stander, Sonja/0000-0003-3612-7786			Chi OZ, 1996, ANESTH ANALG, V83, P336, DOI 10.1097/00000539-199608000-00023; Chorny I, 1999, J NEUROSURG ANESTH, V11, P273, DOI 10.1097/00008506-199910000-00008; Chrysomali E, 1997, ORAL SURG ORAL MED O, V83, P272, DOI 10.1016/S1079-2104(97)90016-0; De Belder A, 1973, CARBOHYD RES, V30, P375, DOI DOI 10.1016/S0008-6215(00)81824-8; Eilig I, 2001, ANESTH ANALG, V92, P669, DOI 10.1213/00000539-200103000-00023; Forster H, 1999, INFUSIONSTHERAPIE, V26, P45; FORSTER H, 1989, HYDROXYETHYLSTARKE A, P15; Gall H, 1996, DERMATOLOGY, V192, P222, DOI 10.1159/000246370; GALL H, 1993, HAUTARZT, V44, P713; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; HEILMANN L, 1989, Z GEBURTSH PERINATOL, V193, P219; HEILMANN L, 1991, INFUSIONSTHERAPIE, V18, P236; HULSE JD, 1983, DRUG INTEL CLIN PHAR, V17, P334, DOI 10.1177/106002808301700503; JURECKA W, 1993, ARCH DERMATOL RES, V285, P13, DOI 10.1007/BF00370817; KARINEN J, 1994, BRIT J ANAESTH, V73, P751, DOI 10.1093/bja/73.6.751; KIESEWETTER H, 1990, J INTERN MED, V227, P107, DOI 10.1111/j.1365-2796.1990.tb00127.x; Kimme P, 2001, ACTA ANAESTH SCAND, V45, P686, DOI 10.1034/j.1399-6576.2001.045006686.x; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; KRAFT D, 1992, EUR SURG RES, V24, P138, DOI 10.1159/000129200; LENZ G, 1986, ANAESTHESIST, V35, P423; LEUNIG A, 1995, LARYNGO RHINO OTOL, V74, P135, DOI 10.1055/s-2007-997706; MESSMER K, 1986, EUR SURG RES, V18, P254, DOI 10.1159/000128533; Metze D, 1997, BRIT J DERMATOL, V136, P553, DOI 10.1111/j.1365-2133.1997.tb02140.x; Murphy M, 2001, BRIT J DERMATOL, V144, P973, DOI 10.1046/j.1365-2133.2001.04184.x; PARKER NE, 1982, BRIT MED J, V284, P385, DOI 10.1136/bmj.284.6313.385-a; PARTH E, 1992, EUR SURG RES, V24, P13, DOI 10.1159/000129184; RICHTER W, 1983, HDB EXPT PHARM, V63, P581; SAKAKI T, 1990, NEUROSURGERY, V27, P268, DOI 10.1227/00006123-199008000-00016; SALING P, 1990, PERINATALE MED, P233; SCHELL RM, 1992, ANESTHESIOLOGY, V77, P86, DOI 10.1097/00000542-199207000-00013; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; SHATNEY CH, 1984, CIRC SHOCK, V13, P21; Sirtl C, 1999, BRIT J ANAESTH, V82, P510, DOI 10.1093/bja/82.4.510; Stander S, 2001, CELL TISSUE RES, V304, P261, DOI 10.1007/s004410000324; Subrato D, 2000, J TRAUMA, V49, P47, DOI 10.1097/00005373-200007000-00007; SZEIMIES RM, 1994, BRIT J DERMATOL, V131, P380, DOI 10.1111/j.1365-2133.1994.tb08529.x; Thompson J., 1979, T AM CRYSTALLOGRAPHI, V15, P1; UNGER M, 1990, PERINATALE MED, P235; WHITE KL, 1986, DRUG CHEM TOXICOL, V9, P305, DOI 10.3109/01480548608998282; ZIKRIA BA, 1989, CRIT CARE MED, V17, P1306, DOI 10.1097/00003246-198912000-00012	40	20	20	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	DEC	2002	310	3					279	287		10.1007/s00441-002-0644-6			9	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	628XQ	WOS:000180021700003	12457226				2022-02-06	
J	Hains, BC; Black, JA; Waxman, SG				Hains, BC; Black, JA; Waxman, SG			Primary motor neurons fail to up-regulate voltage-gated sodium channel Na(v)1.3/brain type III following axotomy resulting from spinal cord injury	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						spasticity; seizure; trauma; hyperexcitability	NERVE GROWTH-FACTOR; RAT CORTICOSPINAL NEURONS; SENSORY NEURONS; MESSENGER-RNAS; NEUROTROPHIC FACTOR; PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPTOGENESIS; DOWN-REGULATION; ALPHA-SNS; EXPRESSION	Epilepsy occurs in a small proportion of patients with spinal cord injury (SCI), but whether it is due to concomitant traumatic head injury or to changes in cortical motor neurons secondary to axotomy within the spinal cord is not known. Na(v)1.3/brain type Ill sodium channel expression is up-regulated following peripheral axotomy of dorsal root ganglion (DRG) and facial motor neurons, but, to date, Na(v)1.3 expression has not been examined in upper (cortical) motor neurons following axotomy associated with SCI. In the present study, we examine Na(v)1.3 expression in upper motor neurons within rat primary motor cortex following midthoracic (T9) dorsal column transection, which severs the axons of those cells. Axotomized pyramidal cells were identified by retrograde transport of fluorogold. Immunolabeled cells were confined to layer V of the primary motor cortex and exhibited low levels of Na(v)1.3 staining. After axotomy, no significant changes were detected in Na(v)1.3 density or distribution in injured or uninjured cells, compared with control brains, in contrast to up-regulation of Na(v)1.3 in ipsilateral DRG neurons after sciatic nerve transection. These results do not preclude a role for voltage-gated sodium channels in post-SCI epilepsy but suggest that up-regulated expression of Na(v)1.3 channel is not involved. (C) 2002 Wiley-Liss, Inc.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Paralyzed Vet Amer Eastern Paralyzed Vet Assoc Ct, New Haven, CT 06510 USA; VA Connecticut Healthcare Syst, Rehabil Res & Dev Ctr, West Haven, CT USA		Waxman, SG (corresponding author), Yale Univ, Sch Med, Dept Neurol, 333 Cedar St, New Haven, CT 06510 USA.	stephen.waxman@yale.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS007224] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5 T32 NS07224] Funding Source: Medline		AGUAYO LG, 1992, BRAIN RES, V570, P61, DOI 10.1016/0006-8993(92)90564-P; ARONIADOU VA, 1993, J NEUROPHYSIOL, V70, P1553, DOI 10.1152/jn.1993.70.4.1553; Barth JL, 2001, TRENDS CARDIOVAS MED, V11, P26, DOI 10.1016/S1050-1738(01)00080-9; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; Black JA, 1997, NEUROREPORT, V8, P2331, DOI 10.1097/00001756-199707070-00046; Bonatz H, 2000, J NEUROSCI METH, V100, P105, DOI 10.1016/S0165-0270(00)00238-7; BRYSCH W, 1991, EXP BRAIN RES, V86, P562; Bush PC, 1999, J NEUROPHYSIOL, V82, P1748, DOI 10.1152/jn.1999.82.4.1748; Chen YH, 2000, EUR J NEUROSCI, V12, P4281, DOI 10.1111/j.1460-9568.2000.01336.x; Coward K, 2001, NEUROREPORT, V12, P495, DOI 10.1097/00001756-200103050-00014; Cummins TR, 1997, J NEUROSCI, V17, P3503; Cummins TR, 2001, J NEUROSCI, V21, P5952, DOI 10.1523/JNEUROSCI.21-16-05952.2001; Deng LLYS, 2000, NEUROSCI RES, V38, P183; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; DEVOR M, 1992, PAIN, V48, P261, DOI 10.1016/0304-3959(92)90067-L; Dib-Hajj SD, 1998, J NEUROPHYSIOL, V79, P2668, DOI 10.1152/jn.1998.79.5.2668; DibHajj S, 1996, P NATL ACAD SCI USA, V93, P14950, DOI 10.1073/pnas.93.25.14950; Elliott EJ, 1997, BRAIN RES, V755, P221, DOI 10.1016/S0006-8993(97)00100-5; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Fjell J, 1999, J NEUROPHYSIOL, V81, P803, DOI 10.1152/jn.1999.81.2.803; Fjell J, 1999, J NEUROSCI RES, V57, P39, DOI 10.1002/(SICI)1097-4547(19990701)57:1<39::AID-JNR5>3.0.CO;2-M; FRANCESCHETTI S, 1995, BRAIN RES, V696, P127, DOI 10.1016/0006-8993(95)00807-3; FURUYAMA T, 1993, MOL BRAIN RES, V17, P169, DOI 10.1016/0169-328X(93)90087-6; Giehl KM, 1996, EUR J NEUROSCI, V8, P1167, DOI 10.1111/j.1460-9568.1996.tb01284.x; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Hablitz JJ, 2000, EPILEPSIA, V41, P1082, DOI 10.1111/j.1528-1157.2000.tb00309.x; IWAHASHI Y, 1994, MOL BRAIN RES, V22, P341, DOI 10.1016/0169-328X(94)90064-7; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; Kharazia VN, 2001, NEUROSCIENCE, V102, P23, DOI 10.1016/S0306-4522(00)00467-X; Kim CH, 2001, MOL BRAIN RES, V95, P153, DOI 10.1016/S0169-328X(01)00226-1; Kolb B, 1997, NEUROSCIENCE, V76, P1139, DOI 10.1016/S0306-4522(96)00448-4; Kolb B, 1997, BRAIN RES, V751, P289, DOI 10.1016/S0006-8993(96)01410-2; KORSCHING S, 1985, NEUROSCI LETT, V54, P201, DOI 10.1016/S0304-3940(85)80079-3; KORSCHING S, 1985, EMBO J, V4, P1389, DOI 10.1002/j.1460-2075.1985.tb03791.x; Landy HJ, 1998, HUM REPROD UPDATE, V4, P177, DOI 10.1093/humupd/4.2.177; LESSER SS, 1995, J NEUROSCI, V15, P253; Liebl DJ, 2001, EXP NEUROL, V167, P15, DOI 10.1006/exnr.2000.7548; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MATZNER O, 1992, BRAIN RES, V597, P92, DOI 10.1016/0006-8993(92)91509-D; MCBRIDE RL, 1989, J NEUROPATH EXP NEUR, V48, P568, DOI 10.1097/00005072-198909000-00007; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; NAGATA Y, 1987, J NEUROCHEM, V49, P296, DOI 10.1111/j.1471-4159.1987.tb03429.x; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; NISHIO T, 1994, NEUROSCIENCE, V60, P67, DOI 10.1016/0306-4522(94)90204-6; Novakovic SD, 2001, TRENDS NEUROSCI, V24, P473, DOI 10.1016/S0166-2236(00)01884-1; OMRI G, 1990, J MEMBRANE BIOL, V115, P13, DOI 10.1007/BF01869102; Oyelese AA, 1997, J NEUROPHYSIOL, V78, P31, DOI 10.1152/jn.1997.78.1.31; Pasikova N V, 2001, Neurosci Behav Physiol, V31, P497, DOI 10.1023/A:1010470730416; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PIORO EP, 1990, NEUROSCIENCE, V34, P57, DOI 10.1016/0306-4522(90)90304-M; Pitts AF, 1995, SOMATOSENS MOT RES, V12, P329, DOI 10.3109/08990229509093666; Prince DA, 1998, EPILEPSY RES, V32, P83, DOI 10.1016/S0920-1211(98)00042-4; Ragsdale DS, 1998, BRAIN RES REV, V26, P16, DOI 10.1016/S0165-0173(97)00054-4; RUDY B, 1987, J NEUROSCI, V7, P1613; Schutte A, 2000, NEUROSCI LETT, V290, P185, DOI 10.1016/S0304-3940(00)01351-3; TOPKA H, 1991, NEUROLOGY, V41, P1276, DOI 10.1212/WNL.41.8.1276; TSENG GF, 1993, J COMP NEUROL, V335, P92, DOI 10.1002/cne.903350107; Tuszynski MH, 1996, NEUROSCIENCE, V71, P761, DOI 10.1016/0306-4522(95)00440-8; WAXMAN SG, 1994, J NEUROPHYSIOL, V72, P466, DOI 10.1152/jn.1994.72.1.466; Whitaker WRJ, 2000, J COMP NEUROL, V422, P123, DOI 10.1002/(SICI)1096-9861(20000619)422:1<123::AID-CNE8>3.0.CO;2-X; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3; White HS, 1999, EPILEPSIA, V40, P28; ZHOU XF, 1994, J NEUROSCI METH, V54, P95, DOI 10.1016/0165-0270(94)90163-5	67	20	20	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV 15	2002	70	4					546	552		10.1002/jnr.10402			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	610RX	WOS:000178975500002	12404508				2022-02-06	
J	Smith, DH; Meaney, DF				Smith, DH; Meaney, DF			Roller coasters, G forces, and brain trauma: On the wrong track?	JOURNAL OF NEUROTRAUMA			English	Article						G force; head rotational acceleration; roller coaster; traumatic brain injury	DIFFUSE AXONAL INJURY; COMA	There has been enormous attention in the general press on the possibility that high G force roller coasters are inducing brain injury in riders. Armed with a handful of anecdotal case reports of brain injuries, the U.S. Congress has recently proposed legislation to regulate the level of G forces of roller coasters. However, high G forces are well tolerated during many activities and, therefore, are a poor measure for the risk of brain injury. Rather, accelerations of the head that can be caused by G forces are the key to producing injury. To determine the extent of head accelerations during roller coaster-rides, we acquired G force data from three popular high G roller coasters. We used the highest recorded G forces in a simple mathematical model of head rotational acceleration, with the head rigidly pivoting from the base of the skull at a radius representing typical men and women. With this model, we calculated peak head rotational accelerations in three directions. Even for a conservative worst-case scenario, we found that the highest estimated peak head accelerations induced by roller coasters were far below conventional levels that are predicted for head injuries. Accordingly, our findings do not support the contention that current roller coaster rides produce high enough forces to mechanically deform and injure the brain.	Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Smith, DH (corresponding author), Univ Penn, Dept Neurosurg, 105 Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.		smith, douglas/A-1321-2007	Meaney, David/0000-0002-0954-4122	NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG21527] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS38104, NS35712, NS41699, NS08803] Funding Source: Medline; ODCDC CDC HHS [CCR312712] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS035712, R01NS038104, P01NS008803, F32NS041699, P50NS008803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K08AG021527] Funding Source: NIH RePORTER		ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ALLEN ME, 1994, SPINE, V19, P1285, DOI 10.1097/00007632-199405310-00017; Braksiek RJ, 2002, ANN EMERG MED, V39, P65, DOI 10.1067/mem.2002.120127; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; METZ H, 1970, J BIOMECH, V3, P453, DOI 10.1016/0021-9290(70)90017-5; PINCEMAILLE Y, 1988, DTRS5786C00037 DOT; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; WHINNERY JE, 1990, ARCH NEUROL-CHICAGO, V47, P764, DOI 10.1001/archneur.1990.00530070058012; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	13	20	20	0	8	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	OCT	2002	19	10					1117	1120		10.1089/08977150260337921			4	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	605MJ	WOS:000178681400001	12427321				2022-02-06	
J	Mobbs, RJ; Yang, MO				Mobbs, RJ; Yang, MO			The dangers of diagnostic laparoscopy in the head injured patient	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						ICP; laparoscopy; head injury	INTRACRANIAL-PRESSURE; INTRAABDOMINAL PRESSURE; PNEUMOPERITONEUM	Pneumoperitoneum during laparoscopy has been known to result in a rise in intracranial pressure (ICP) in experimental studies. There are no reports of the effect of pneumoperitoneum during diagnostic laparoscopy in patients suffering closed head injuries. We present the case of a 39 year old male with a closed head injury. Diagnostic laparoscopy was performed while intracranial pressure was monitored. ICP increased from 9 mmHg to over 60 mmHg within 10 min of pneumoperitoneum. Laparoscopy was terminated and the ICP returned to normal levels within 35 min. The authors recommend that pneumoperitoneum laparoscopy should not be used in the trauma setting where head injury is suspected. (C) 2002 Published by Elsevier Science Ltd.	Univ New S Wales, Sydney, NSW 2033, Australia		Mobbs, RJ (corresponding author), 3 Wansey Rd, Randwick, NSW 2031, Australia.		Mobbs, Ralph/G-5254-2014	Mobbs, Ralph/0000-0001-6542-6836			Ben-Haim M, 2000, J SURG RES, V91, P101, DOI 10.1006/jsre.2000.5903; ESTEMCDONALD JR, 1995, ARCH SURG-CHICAGO, V130, P362; Halverson AL, 1999, SURG ENDOSC-ULTRAS, V13, P797, DOI 10.1007/s004649901102; JOSEPHS LG, 1994, J TRAUMA, V36, P815, DOI 10.1097/00005373-199406000-00011; Moncure M, 1999, AM SURGEON, V65, P168; Rosenthal RJ, 1998, J AM COLL SURGEONS, V187, P32, DOI 10.1016/S1072-7515(98)00126-4; Rosenthal RJ, 1997, SURG ENDOSC, V11, P376, DOI 10.1007/s004649900367; Schob OM, 1996, AM J SURG, V172, P248, DOI 10.1016/S0002-9610(96)00101-8; Uzzo RG, 1997, UROLOGY, V49, P753, DOI 10.1016/S0090-4295(97)00233-1	9	20	20	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0967-5868			J CLIN NEUROSCI	J. Clin. Neurosci.	SEP	2002	9	5					592	593		10.1054/jocn.2001.1070			2	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	609YL	WOS:000178933900024	12383425				2022-02-06	
J	Wang, CX; Reece, C; Wrathall, JR; Shuaib, A; Olschowka, JA; Hao, CH				Wang, CX; Reece, C; Wrathall, JR; Shuaib, A; Olschowka, JA; Hao, CH			Expression of tumor necrosis factor alpha and its mRNA in the spinal cord following a weight-drop injury	NEUROREPORT			English	Article						bioassay; contusion; cytokine; polymerase chain reaction	TRAUMATIC INJURY; GENE-EXPRESSION; RAT; INFLAMMATION; CYTOKINES; BRAIN; INTERLEUKIN-1-BETA; ASTROCYTES; INCREASE; PROTEIN	The effect of traumatic spinal cord injury (SCI) on the expression of tumor necrosis factor (TNFalpha) and its mRNA was examined. Quantitative reverse transcription polymerase chain reaction assay showed TNFalpha mRNA level increased > 20-fold at the lesion site by 1 h after the injury compared to that in uninjured controls. The TNFalpha mRNA level was still significantly higher than in the controls 72 h after the injury TNFalpha mRNA in the samples collected immediately caudal to the lesion site was also increased. Levels of TNFalpha protein, determined by a cytotoxic bioassay, were also significantly increased at the lesion site. The TNFalpha protein level was maximal 1 and 8 h after the injury and still significantly higher than in the controls 24 h post-injury. The present results demonstrate that TNFalpha is rapidly induced in the spinal cord after the injury, and it may play a significant role in secondary events in SCI.	Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; Georgetown Univ, Dept Cell Biol, Washington, DC 20057 USA; Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14627 USA		Wang, CX (corresponding author), Univ Alberta, Dept Med, Room 533 HMRC, Edmonton, AB T6G 2S2, Canada.						BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; ENG LF, 1992, PROG BRAIN RES, V94, P353; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; FAJARDO LF, 1992, AM J PATHOL, V140, P539; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; FORSTER E, 1992, BIOTECHNIQUES, V16, P8; GADIENT RA, 1990, NEUROSCI LETT, V117, P335, DOI 10.1016/0304-3940(90)90687-5; HEREMANS H, 1992, EUR J IMMUNOL, V22, P2395, DOI 10.1002/eji.1830220932; LOTZ M, 1996, CELLULAR RESPONSES C, P47; Merrill E, 1996, CYTOKINES CNS, P151; METHA VK, 1994, EUR J ENDOCRINOL, V130, P208; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; NUTTIN B, 1994, ACTA NEUROL BELG, V94, P64; SCHOBITZ B, 1994, PROG NEUROBIOL, V44, P397, DOI 10.1016/0301-0082(94)90034-5; SELMAJ KW, 1990, J IMMUNOL, V144, P129; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; SIMMONS RD, 1990, J NEUROL SCI, V100, P37, DOI 10.1016/0022-510X(90)90010-K; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TCHELINGERIAN JL, 1994, NEUROREPORT, V5, P585, DOI 10.1097/00001756-199401000-00013; Wang CX, 1997, BRAIN RES, V759, P190, DOI 10.1016/S0006-8993(97)00254-0; Wang CX, 1996, J NEUROIMMUNOL, V69, P151; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; YOSHIDA K, 1992, J NEUROCHEM, V59, P919, DOI 10.1111/j.1471-4159.1992.tb08331.x	24	20	23	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	AUG 7	2002	13	11					1391	1393		10.1097/00001756-200208070-00008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	593GU	WOS:000177983300004	12167759				2022-02-06	
J	Haan, JM; Kramer, ME; Scalea, TM				Haan, JM; Kramer, ME; Scalea, TM			Pattern of injury from personal watercraft	AMERICAN SURGEON			English	Article; Proceedings Paper	Annual Meeting of the Southeastern-Surgical-Congress	FEB 01-05, 2002	NASHVILLE, TENNESSEE				JET-SKI ACCIDENT	Injury from personal watercraft has continued to increase. Prior attempts to delineate patterns of injury and relative frequencies have yielded varied results. We retrospectively reviewed Trauma Registry data and charts of all patients who suffered personal watercraft injury treated at the R. Adams Cowley Shock Trauma Center between August 1996 and January 2001. Patient demographics included mechanism of injury, injuries sustained, and outcomes. Attempts were made to correlate events around the injury and injury pattern. During the study period 24 patients were treated. Mechanisms consisted of direct collision, fails from the watercraft, handlebar straddle injuries, axial loading, and hydrostatic jet injury. Traumatic brain injury was most common occurring in 54 per cent of patients. Spinal injury was also common occurring in 29 per cent of patients. Axial loading from falls while wave jumping seemed to correlate with skeletal injury. Thoracolumbar spine injury were often skeletally unstable requiring either brace or operative fixation. Inexperience and reckless behavior were found to be the greatest contributing factors. Substance abuse did not influence injury.	Univ Maryland, Dept Surg Crit Care, Baltimore, MD 21231 USA		Haan, JM (corresponding author), Univ Maryland, Dept Surg Crit Care, 22 S Greene St, Baltimore, MD 21231 USA.						Branche CM, 1997, JAMA-J AM MED ASSOC, V278, P663, DOI 10.1001/jama.278.8.663; Francis R A, 1994, Mo Med, V91, P241; HAEFNER HK, 1991, OBSTET GYNECOL, V78, P986; HAMMAN BL, 1993, J PEDIATR SURG, V28, P920, DOI 10.1016/0022-3468(93)90697-J; Jones C S, 1997, J Ark Med Soc, V94, P111; Morrison DM, 1998, J TRAUMA, V45, P816, DOI 10.1097/00005373-199810000-00037; Philpott JM, 1999, J TRAUMA, V47, P385, DOI 10.1097/00005373-199908000-00031; SCALEA T, 1986, J TRAUMA, V26, P706, DOI 10.1097/00005373-198608000-00005; Shatz DV, 1998, J TRAUMA, V44, P198, DOI 10.1097/00005373-199801000-00029; SODERSTROM C, RECENT ARTICLE EPIDE; Swinburn EEL, 1996, MED J AUSTRALIA, V165, P606, DOI 10.5694/j.1326-5377.1996.tb138662.x; Tyler B C, 1997, N C Med J, V58, P284; WEIN P, 1990, AUST NZ J OBSTET GYN, V30, P384, DOI 10.1111/j.1479-828X.1990.tb02038.x; White MW, 1999, AM SURGEON, V65, P865	14	20	20	0	0	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA	0003-1348			AM SURGEON	Am. Surg.	JUL	2002	68	7					624	627					4	Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Surgery	573AN	WOS:000176807300014	12132746				2022-02-06	
J	Belayev, L; Becker, DA; Alonso, OF; Liu, YT; Busto, R; Ley, JJ; Ginsberg, MD				Belayev, L; Becker, DA; Alonso, OF; Liu, YT; Busto, R; Ley, JJ; Ginsberg, MD			Stilbazulenyl nitrone, a novel azulenyl nitrone antioxidant: improved neurological deficit and reduced contusion size after traumatic brain injury in rats	JOURNAL OF NEUROSURGERY			English	Article						oxygen radicals; reactive oxygen species; neuroprotection; traumatic brain injury; histopathological study; neurobehavioral outcome; rat	CEREBRAL-ARTERY OCCLUSION; RADICAL-TRAPPING AGENT; PHARMACOLOGICAL STRATEGIES; HISTOPATHOLOGICAL DAMAGE; COLORIMETRIC DETECTION; DELAYED TREATMENT; HEAD-INJURY; BLOOD-FLOW; ISCHEMIA; PBN	Object. Stilbazulenyl nitrone (STAZN) is a second-generation azulenyl nitrone that has markedly enhanced antioxidant properties compared with those of conventional alpha-phenyl nitrones. In this study, the authors assessed the potential efficacy of STAZN in a rodent model of fluid-percussion brain injury, which results in a consistent cortical contusion. Methods. After anesthesia had been induced in normothermic Sprague-Dawley rats (brain temperature 36-36.5degreesC) by halothane-nitrous oxide, the animals were subjected to a right parietooccipital parasagittal fluid-percussion injury (1.5-2 atm). The agent (STAZN, 30 mg/kg; eight animals) or vehicle (dimethyl sulfoxide; eight animals) was administered intraperitoneally at 5 minutes and 4 hours after trauma. The neurological status of each rat was evaluated on Days 1, 2, and 7 postinjury (normal score 0, maximum injury 12). Seven days after trauma, the rat brains were perfusion fixed, coronal sections at various levels were digitized, and areas of contusion were measured. Treatment with STAZN significantly improved neurological scores on Days 2 and 7 postinjury compared with vehicle-treated rats. Administration of STAZN also significantly reduced the total contusion area by 63% (1.8 +/- 0.5 mm(2) in STAZN-treated animals compared with 4.8 +/- 2.1 mm(2) in vehicle-treated animals; p = 0.04) and the deep cortical contusion area by 60% (1.2 +/- 0.2 mm(2) in STAZN-treated animals compared with 2.9 +/- 1.2 mm(2) in vehicle-treated animals; p = 0.03). By contrast, hippocampal cell loss in the CA3 sector was unaffected by STAZN treatment. Conclusions. Therapy with STAZN, a novel potent antioxidant, administered following traumatic brain injury, markedly improves neurological and histological outcomes. Azulenyl nitrones appear to represent a promising class of neuroprotective agents for combating this devastating condition.	Univ Miami, Sch Med, Dept Neurol D45, Cerebral Vasc Dis Res Ctr, Miami, FL 33101 USA; Florida Int Univ, Dept Chem, Miami, FL 33199 USA		Ginsberg, MD (corresponding author), Univ Miami, Sch Med, Dept Neurol D45, Cerebral Vasc Dis Res Ctr, POB 016960, Miami, FL 33101 USA.	mdginsberg@stroke.med.miami.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 38221, NS 30291, NS 05820] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS005820, P50NS030291, P50NS005820, R01NS038221] Funding Source: NIH RePORTER		Althaus JS, 1998, FREE RADICAL BIO MED, V24, P738, DOI 10.1016/S0891-5849(97)00338-9; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Bareyre FM, 2000, J NEUROTRAUM, V17, P1029, DOI 10.1089/neu.2000.17.1029; Becker DA, 1999, CELL MOL LIFE SCI, V56, P626, DOI 10.1007/s000180050457; Becker DA, 1998, ORG SYN TH, V4, P155; Becker DA, 1996, J AM CHEM SOC, V118, P905, DOI 10.1021/ja952895z; Becker DA, 1998, J CHEM SOC PERK T 2, P1289, DOI 10.1039/a708702k; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, NEUROREPORT, V8, P55, DOI 10.1097/00001756-199612200-00012; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Belayev L, 1999, J NEUROTRAUM, V16, P445, DOI 10.1089/neu.1999.16.445; Bentzer P, 2001, J NEUROTRAUM, V18, P275, DOI 10.1089/08977150151070919; BUSTO R, 1984, ANN NEUROL, V15, P441, DOI 10.1002/ana.410150507; CAO XH, 1994, BRAIN RES, V644, P267, DOI 10.1016/0006-8993(94)91689-6; CARNEY JM, 1991, J MOL NEUROSCI, V3, P47, DOI 10.1007/BF02896848; Castagna V, 1999, NEUROSCIENCE, V93, P313, DOI 10.1016/S0306-4522(99)00138-4; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; FOLBERGROVA J, 1995, P NATL ACAD SCI USA, V92, P5057, DOI 10.1073/pnas.92.11.5057; Gido G, 2000, ACTA PHYSIOL SCAND, V168, P277; Ginsberg MD, 2001, J NEUROSURG, V94, P499, DOI 10.3171/jns.2001.94.3.0499; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; HALL ED, 1994, FREE RADICAL DAMAGE, P217; HALL ED, 1998, CEREBROVASC DIS, P710; Hensley K, 1997, INT REV NEUROBIOL, V40, P299; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Klivenyi P, 1998, EXP NEUROL, V152, P163, DOI 10.1006/exnr.1998.6824; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Kuroda S, 1996, NEUROBIOL DIS, V3, P149, DOI 10.1006/nbdi.1996.0015; Lees KR, 2001, STROKE, V32, P675, DOI 10.1161/01.STR.32.3.675; LEMKE M, 1990, NEUROSCI LETT, V108, P201, DOI 10.1016/0304-3940(90)90731-N; Leoni MJ, 2000, EXP NEUROL, V166, P442, DOI 10.1006/exnr.2000.7513; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Lewen A, 1998, J NEUROTRAUM, V15, P521, DOI 10.1089/neu.1998.15.521; Marklund N, 2001, ACTA NEUROCHIR, V143, P73, DOI 10.1007/s007010170141; Marshall JWB, 2001, STROKE, V32, P190, DOI 10.1161/01.STR.32.1.190; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; National Institutes of Health, 1998, NIH CONSENSUS STATEM, V16, P1; Novelli G P, 1986, Free Radic Res Commun, V1, P321, DOI 10.3109/10715768609080971; Passineau MJ, 2000, AM J PHYSIOL-HEART C, V279, pH924, DOI 10.1152/ajpheart.2000.279.3.H924; Peeling J, 2001, NEUROPHARMACOLOGY, V40, P433, DOI 10.1016/S0028-3908(00)00170-2; PHILLIS JW, 1990, NEUROSCI LETT, V116, P315, DOI 10.1016/0304-3940(90)90093-O; Povlishock J T, 1992, Hum Cell, V5, P345; SEN S, 1994, FREE RADICAL BIO MED, V16, P685, DOI 10.1016/0891-5849(94)90183-X; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Truettner J, 1999, J NEUROTRAUM, V16, P471, DOI 10.1089/neu.1999.16.471; Zhang C, 1998, J NEUROSCI RES, V52, P342, DOI 10.1002/(SICI)1097-4547(19980501)52:3<342::AID-JNR10>3.0.CO;2-8; ZHAO Q, 1994, ACTA PHYSIOL SCAND, V152, P349, DOI 10.1111/j.1748-1716.1994.tb09816.x; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510; Zink BJ, 2001, ANN EMERG MED, V37, P318, DOI 10.1067/mem.2001.113505	56	20	20	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2002	96	6					1077	1083		10.3171/jns.2002.96.6.1077			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	559LD	WOS:000176026900024	12066910				2022-02-06	
J	Aoyama, N; Katayama, Y; Kawamata, T; Maeda, T; Mori, T; Yamamoto, T; Kikuchi, T; Uwahodo, Y				Aoyama, N; Katayama, Y; Kawamata, T; Maeda, T; Mori, T; Yamamoto, T; Kikuchi, T; Uwahodo, Y			Effects of antioxidant, OPC-14117, on secondary cellular damage and behavioral deficits following cortical contusion in the rat	BRAIN RESEARCH			English	Article						cerebral contusion; edema formation; tissue osmolality; cognitive behavior; free radical scavenger; rat	TRAUMATIC BRAIN INJURY; CEREBRAL-ISCHEMIA; LIPID-PEROXIDATION; IMPACT INJURY; FREE-RADICALS; HEAD-INJURY; BLOOD; DEATH; EDEMA; GENERATION	In the present study, we examined the effects of OPC-14117, a superoxide radical scavenger, on the secondary cellular damage and cognitive dysfunction occurring in a rat model of cerebral contusion induced by a controlled cortical impact (CCI). Histological examinations revealed that the contusion necrosis volume reached 13.6 +/- 5.3 mm(3) in non-treated animals and declined to 1.9 +/- 0.6 mm(3) in OPC-14117-treated animals (P < 0.01). The cell number of the CA3 region was 120.0 +/- 12.4 cells/mm in the normal controls, 73.6 +/- 19.9 cells/min in the non-treated animals, and 111.2 +/- 10.2 cells/mm in the OPC-14117-treated animals, indicating that CCI-induced selective neuronal cell death in the CA3 region was attenuated by the OPC-14117 administration (P < 0.01). The tissue osmolality, as determined with a vapor pressure osmometer, was 314.5 +/- 15.4 mmol/kg in the normal brain and increased to 426.0 +/- 20.1 mmol/kg at 12 h following CCI. The increase in tissue osmolality was significantly attenuated by OPC-14117 administration (P < 0.01). The OPC-14117 administration also attenuated the CCI-induced cognitive deficits. The OPC-14117-treated animals showed a tendency to improve on the Morris water maze performance test. The impairment of the habituation of exploratory activity elicited by CCI was significantly attenuated by OPC-14117 administration (P < 0.05). In conclusion, OPC-14117 may have a potential for decreasing secondary cellular damage due to traumatic brain injury since it is as efficacious as any other compound tested in this model. (C) 2002 Elsevier Science B.V. All rights reserved.	Nihon Univ, Sch Med, Dept Neurol Surg, Tokyo, Japan; Otsuka Pharmaceut Co Ltd, Tokushima Inst New Drug Res 3, Tokushima 77101, Japan		Aoyama, N (corresponding author), 30-1 Oyaguchikamimachi,Itabashi Ku, Tokyo 1738610, Japan.	aonao17@dream.com					ALEXANDER MJ, 1994, ACTA NEUROCHIR, P479; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; BULLOCK R, 1990, ACT NEUR S, V51, P286; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark RSB, 1997, J NEUROTRAUM, V14, P179, DOI 10.1089/neu.1997.14.179; DIXON CE, 1991, J NEUROSCI METH, V39, P253; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FISHER M, 1992, J NEUROL SCI, V109, P107, DOI 10.1016/0022-510X(92)90102-Q; FLAMM ES, 1978, STROKE, V9, P445, DOI 10.1161/01.STR.9.5.445; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HOSSMANN KA, 1976, EXP NEUROL, V51, P124, DOI 10.1016/0014-4886(76)90057-1; HOVDA DA, 1992, J NEUROTRAUM, V9, pS47; JESBERGER JA, 1991, INT J NEUROSCI, V57, P1, DOI 10.3109/00207459109150342; Katayama Y, 1998, ACT NEUR S, V71, P289; KATAYAMA Y, 1992, NEURORADIOLOGY, V34, P381, DOI 10.1007/BF00596494; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KATAYAMA Y, 1995, NEUROCHEMICAL MONITO, P72; Katayama Yoichi, 1995, Journal of Neurotrauma, V12, P358; KINUTA Y, 1989, J NEUROSURG, V71, P421, DOI 10.3171/jns.1989.71.3.0421; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maeda T, 1997, ACT NEUR S, V70, P102; MAEDA T, 1995, ADV NEUROTRAUMA RES, V6, P10; MARMAROU A, 1978, J NEUROSURG, V49, P530, DOI 10.3171/jns.1978.49.4.0530; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; NELSON CW, 1992, AM J PHYSIOL, V263, pH1356, DOI 10.1152/ajpheart.1992.263.5.H1356; NISANTHA MB, 1978, STROKE, V9, P249; OSHIRO Y, 1991, J MED CHEM, V34, P2014, DOI 10.1021/jm00111a014; PLATEL A, 1982, PSYCHOPHARMACOLOGY, V78, P346, DOI 10.1007/BF00433739; RINK A, 1995, AM J PATHOL, V147, P1575; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Soares HD, 1995, J NEUROTRAUM, V12, P1059, DOI 10.1089/neu.1995.12.1059; Stein DG, 1991, J NEUROTRAUM, V8, P281, DOI 10.1089/neu.1991.8.281; TOTTORI K, 1995, JPN J PHARM S1, V67, P144; TRUELOVE D, 1994, FREE RADICAL BIO MED, V17, P445, DOI 10.1016/0891-5849(94)90171-6	45	20	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 3	2002	934	2					117	124	PII S0006-8993(02)02366-1	10.1016/S0006-8993(02)02366-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	557FL	WOS:000175897600004	11955474				2022-02-06	
J	Sellars, C; Hughes, T; Langhorne, P				Sellars, C; Hughes, T; Langhorne, P			Speech and language therapy for dysarthria due to nonprogressive brain damage: a systematic Cochrane review	CLINICAL REHABILITATION			English	Article							INTELLIGIBILITY; STROKE	Background: Dysarthria is a common sequel of nonprogressive brain damage (typically stroke and traumatic brain damage). Impairment-based therapy and a wide variety of compensatory management strategies are undertaken by speech and language therapists with this patient population. Objective: To determine the efficacy of speech and language therapy interventions for adults with dysarthria following nonprogressive brain damage. Design: Systematic review. Search strategy: This review has drawn on the search strategies developed for the following Cochrane Groups as a whole: Stroke, Injuries, and Infectious Diseases. Relevant trials were identified in the Specialised Registers of Controlled Trials. We also searched the trials register of the Cochrane Rehabilitation and Related Therapies Field. The Cochrane Controlled Trials Register, MEDLINE, EMBASE, CINAHL, PsycLIT, and Linguistics and Language Behavior Abstracts were electronically searched. Hand-searching of the International Journal of Language and Communication Disorders and of reference lists from relevant articles and conference proceedings was also undertaken. Colleagues were approached to identify other possible published and unpublished studies. Selection criteria: Unconfounded randomized controlled trials. Data collection and analysis: One reviewer assessed trial quality. Two co-reviewers were available to examine any potential trials for possible inclusion in the review. Main results: No trials of the required standard were identified. Reviewers' conclusions: There is no evidence of the quality required by this review to support or refute the effectiveness of speech and language therapy interventions for dysarthria following nonprogressive brain damage. There is an urgent need for good quality research in this area.	Glasgow Royal Infirm, Acad Sect Geriatr Med, STEP Project, Glasgow G4 0SF, Lanark, Scotland; Glasgow Royal Infirm, Dept Speech & Language Therapy, Glasgow G4 0SF, Lanark, Scotland; Rookwood Hosp, Welsch Spinal Injuries & Neurol Rehabil Unit, Cardiff, S Glam, Wales		Sellars, C (corresponding author), Glasgow Royal Infirm, Acad Sect Geriatr Med, STEP Project, 3rd Floor,Ctr Block,Castle St, Glasgow G4 0SF, Lanark, Scotland.						ARBOIX A, 1990, STROKE, V21, P842, DOI 10.1161/01.STR.21.6.842; Baum HM, 1999, MED CARE RES REV, V56, P139; Berry W., 1983, CLIN DYSARTHRIA, P203; COHEN NS, 1993, J MUSIC THER, V30, P81, DOI 10.1093/jmt/30.2.81; CROW E, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P99; ENDERBY P, 1990, BRIT J DISORD COMMUN, V25, P341; Fukusako Y., 1989, ANN B RILP, V23, P119; GREENER J, 2000, COCHRANE LIB; INCE LP, 1973, ARCH PHYS MED REHAB, V54, P233; Keenan J, 1993, AUGMENTATIVE ALTERNA, V9, P184, DOI DOI 10.1080/07434619312331276591; Kent RD, 1999, J MED SPEECH-LANG PA, V7, P83; MCNAMARA RD, 1983, CLIN DYSARTHRIA, P191; MELO TP, 1992, NEUROLOGY, V42, P789, DOI 10.1212/WNL.42.4.789; NETSELL R, 1984, SEMINARS LANGUAGE, P279; Pilon MA, 1998, BRAIN INJURY, V12, P793, DOI 10.1080/026990598122188; Robey RR, 1999, APHASIOLOGY, V13, P445, DOI 10.1080/026870399402028; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; TUDOR C, 1974, BRIT J DISORD COMMUN, V9, P117; WARLOW CP, 1996, STROKE PRACTICAL GUI; Weismer, 1998, J MED SPEECH-LANG PA, V6, P165; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398, DOI 10.1044/jshd.4604.398; YORKSTON KM, 1990, J SPEECH HEAR DISORD, V55, P550, DOI 10.1044/jshd.5503.550; Yorkston KM, 1996, J SPEECH HEAR RES, V39, pS46, DOI 10.1044/jshr.3905.s46; YORKSTON KM, 1987, CLIN MANAGEMENT DYSA; Yorkston KM, 1989, J HEAD TRAUMA REHAB, V4, P1	25	20	21	0	11	ARNOLD, HODDER HEADLINE PLC	LONDON	338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND	0269-2155			CLIN REHABIL	Clin. Rehabil.	FEB	2002	16	1					61	68		10.1191/0269215502cr468oa			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	517FH	WOS:000173600100008	11837527				2022-02-06	
J	Azcoitia, I; Doncarlos, LL; Garcia-Segura, LM				Azcoitia, Inigo; Doncarlos, Lydia L.; Garcia-Segura, Luis M.			Estrogen and brain vulnerability	NEUROTOXICITY RESEARCH			English	Article						Apoptosis; Neuroprotection; Estrogen; Estrogen receptor; Neurotrophins; Insulin-like growth factor I; Alzheimer's disease; Stroke; Schizophrenia		Accumulated clinical and basic evidence suggests that gonadal steroids affect the onset and progression of several neurodegenerative diseases and schizophrenia, and the recovery from traumatic neurological injury such as stroke. Thus, our view on gonadal hormones in neural function must be broadened to include not only their function in neuroendocrine regulation and reproductive behaviors, but also to include a direct participation in response to degenerative disease or injury. Recent findings indicate that the brain up-regulates both estrogen synthesis and estrogen receptor expression at sites of injury. Genetic or pharmacological inactivation of aromatase, the enzyme involved in estrogen synthesis, indicates that the induction of this enzyme in the brain after injury has a neuroprotective role. Some of the mechanisms underlying the neuroprotective effects of estrogen may be independent of the classically defined nuclear estrogen receptors (ERs). Other neuroprotective effects of estrogen do depend on the classical nuclear ERs, through which estrogen alters expression of estrogen responsive genes that play a role in apoptosis, axonal regeneration, or general trophic support. Yet another possibility is that non-classical ERs in the membrane or cytoplasm alter phosphorylation cascades, such as those involved in the signaling of insulin-like growth factor-I (IGF-I). Indeed, ERs and IGF-I receptor interact in the activation of PI3K and MAPK signaling cascades and in the promotion of neuroprotection. The decrease in estrogen and IGF-I levels with aging may thus result in an increased risk for neural pathological alterations after different forms of brain injury.	[Azcoitia, Inigo] Univ Complutense, Fac Biol, Dept Biol Celular, E-28040 Madrid, Spain; [Doncarlos, Lydia L.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell Biol Neurobiol & Anat, Maywood, IL 60153 USA; [Garcia-Segura, Luis M.] Inst Cajal, CSIC, Ave Dr Arce 37, E-28002 Madrid, Spain		Garcia-Segura, LM (corresponding author), Inst Cajal, CSIC, Ave Dr Arce 37, E-28002 Madrid, Spain.	lmgs@cajal.csic.es	Azcoitia, Inigo/A-6208-2011; Garcia-Segura, Luis M/U-3711-2017	Azcoitia, Inigo/0000-0002-5791-9144; Garcia-Segura, Luis M/0000-0002-2450-2916	Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission [01/1214]; Comunidad de MadridComunidad de Madrid [08.5/0047.1/2000]; DEGESIC [PM98-0110]; Commission of the European Communities, specific RTD programme "Quality of Life and Management of Living Resources" [QLK6-CT-2000-00179]; USPHSUnited States Department of Health & Human ServicesUnited States Public Health Service [MH 48794]	Supported by grants from the Instituto de Salud Carlos III (01/1214), Comunidad de Madrid (08.5/0047.1/2000), DEGESIC (PM98-0110), Commission of the European Communities, specific RTD programme "Quality of Life and Management of Living Resources" (QLK6-CT-2000-00179) and USPHS MH 48794.	Akama K.T, 2000, SOC NEUR ABSTR, V26, P409; Alkayed NJ, 2001, J NEUROSCI, V21, P7543, DOI 10.1523/JNEUROSCI.21-19-07543.2001; ARIMATSU Y, 1986, DEV BRAIN RES, V26, P151, DOI 10.1016/0165-3806(86)90017-9; Asthana S, 2001, NEUROLOGY, V57, P605, DOI 10.1212/WNL.57.4.605; Azcoitia I, 1998, NEUROREPORT, V9, P3075, DOI 10.1097/00001756-199809140-00029; Azcoitia I, 1999, J NEUROSCI RES, V58, P815, DOI 10.1002/(SICI)1097-4547(19991215)58:6<815::AID-JNR8>3.0.CO;2-R; Azcoitia I, 1999, GLIA, V26, P260; Azcoitia I, 2001, Prog Brain Res, V132, P469; Azcoitia I, 1999, J NEUROCYTOL, V28, P699, DOI 10.1023/A:1007025219044; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Baulieu EE, 1998, PSYCHONEUROENDOCRINO, V23, P963, DOI 10.1016/S0306-4530(98)00071-7; Behl C, 1999, TRENDS PHARMACOL SCI, V20, P441, DOI 10.1016/S0165-6147(99)01392-9; Behl C, 2000, J NEUROCYTOL, V29, P351, DOI 10.1023/A:1007109222673; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Bogdanov MB, 1999, NEUROSCI LETT, V262, P33, DOI 10.1016/S0304-3940(99)00047-6; Brinton RD, 1997, NEUROCHEM RES, V22, P1339, DOI 10.1023/A:1022015005508; Callier S, 2001, SYNAPSE, V41, P131, DOI 10.1002/syn.1067; Cardona-Gomez G.P., 2000, SOC NEUR ABSTR, V26, P1095; Cardona-Gomez GP, 2000, NEUROSCIENCE, V99, P751, DOI 10.1016/S0306-4522(00)00228-1; Cardona-Gomez GP, 2001, BRAIN RES REV, V37, P320, DOI 10.1016/S0165-0173(01)00137-0; Chan SL, 1999, J NEUROCHEM, V73, P502, DOI 10.1046/j.1471-4159.1999.0730502.x; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chen J, 1998, NEUROSCIENCE, V87, P817, DOI 10.1016/S0306-4522(98)00198-5; Chowen JA, 2000, J PEDIATR ENDOCR MET, V13, P1045; CHOWEN JA, 1992, NEUROENDOCRINOLOGY, V56, P895, DOI 10.1159/000126321; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Costa MM, 1999, BIOL PSYCHIAT, V46, P182, DOI 10.1016/S0006-3223(98)00355-2; Culmsee C, 1999, J CEREBR BLOOD F MET, V19, P1263, DOI 10.1097/00004647-199911000-00011; Culmsee C, 2001, J CEREBR BLOOD F MET, V21, P334, DOI 10.1097/00004647-200104000-00002; Dluzen DE, 2000, J NEUROCYTOL, V29, P387, DOI 10.1023/A:1007117424491; Dodel RC, 1999, J NEUROCHEM, V73, P1453, DOI 10.1046/j.1471-4159.1999.0731453.x; Drew PD, 2000, J NEUROIMMUNOL, V111, P77, DOI 10.1016/S0165-5728(00)00386-6; Duan WZ, 1999, ANN NEUROL, V46, P587, DOI 10.1002/1531-8249(199910)46:4<587::AID-ANA6>3.0.CO;2-M; Duan WZ, 1999, J NEUROCHEM, V72, P2312, DOI 10.1046/j.1471-4159.1999.0722312.x; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Duenas M, 1996, NEUROSCIENCE, V74, P531, DOI 10.1016/0306-4522(96)00142-X; FALKEBORN M, 1993, ARCH INTERN MED, V153, P1201, DOI 10.1001/archinte.153.10.1201; Finley SK, 1999, J NEUROBIOL, V40, P446; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 1998, NEUROREPORT, V9, P593, DOI 10.1097/00001756-199803090-00006; Garcia-Segura LM, 2000, J NEUROCYTOL, V29, P425, DOI 10.1023/A:1007125626308; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; GarciaSegura LM, 1996, FRONT NEUROENDOCRIN, V17, P180, DOI 10.1006/frne.1996.0005; Garnier M, 1997, J NEUROSCI, V17, P4591; Gibbs RB, 2000, NEUROSCIENCE, V101, P931, DOI 10.1016/S0306-4522(00)00433-4; Gollapudi L, 1999, J NEUROSCI RES, V56, P471, DOI 10.1002/(SICI)1097-4547(19990601)56:5<471::AID-JNR3>3.3.CO;2-T; Gollapudi L, 1999, J NEUROSCI RES, V56, P99, DOI 10.1002/(SICI)1097-4547(19990401)56:1<99::AID-JNR13>3.0.CO;2-G; GOMEZMANCILLA B, 1992, NEUROSCI LETT, V135, P129, DOI 10.1016/0304-3940(92)90152-W; Grandbois M, 2000, NEUROREPORT, V11, P343, DOI 10.1097/00001756-200002070-00024; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Gudino-Cabrera G, 1999, J NEUROBIOL, V40, P458, DOI 10.1002/(SICI)1097-4695(19990915)40:4<458::AID-NEU4>3.0.CO;2-9; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Harms C, 2001, J NEUROSCI, V21, P2600, DOI 10.1523/JNEUROSCI.21-08-02600.2001; Henderson VW, 2000, NEUROLOGY, V54, P295, DOI 10.1212/WNL.54.2.295; HENDERSON VW, 1994, ARCH NEUROL-CHICAGO, V51, P896, DOI 10.1001/archneur.1994.00540210068014; Hoff AL, 2001, AM J PSYCHIAT, V158, P1134, DOI 10.1176/appi.ajp.158.7.1134; Hogervorst E, 2000, NEUROSCIENCE, V101, P485, DOI 10.1016/S0306-4522(00)00410-3; Holm K, 1999, TRENDS NEUROSCI, V22, P269, DOI 10.1016/S0166-2236(98)01352-6; Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K; Honda K, 2001, J NEUROSCI RES, V64, P466, DOI 10.1002/jnr.1098; Hosli E, 2001, INT J DEV NEUROSCI, V19, P11, DOI 10.1016/S0736-5748(00)00082-4; Ishunina TA, 2001, NEUROBIOL AGING, V22, P417, DOI 10.1016/S0197-4580(00)00255-4; Jakab RL, 2001, J COMP NEUROL, V430, P396, DOI 10.1002/1096-9861(20010212)430:3<396::AID-CNE1039>3.0.CO;2-0; Jones KJ, 1999, J NEUROBIOL, V40, P560, DOI 10.1002/(SICI)1097-4695(19990915)40:4<560::AID-NEU11>3.0.CO;2-I; Jordan CL, 1999, J NEUROBIOL, V40, P434, DOI 10.1002/(SICI)1097-4695(19990915)40:4<434::AID-NEU2>3.0.CO;2-T; Kulkarni J, 2001, SCHIZOPHR RES, V48, P137, DOI 10.1016/S0920-9964(00)00088-8; LANGUB MC, 1992, ENDOCRINOLOGY, V130, P364, DOI 10.1210/en.130.1.364; Lindamer LA, 2001, BIOL PSYCHIAT, V49, P47, DOI 10.1016/S0006-3223(00)00995-1; LONGSTRETH WT, 1994, ANN INTERN MED, V121, P168, DOI 10.7326/0003-4819-121-3-199408010-00002; MA ZQ, 1994, MOL ENDOCRINOL, V8, P910, DOI 10.1210/me.8.7.910; Meda C, 2000, J NEUROENDOCRINOL, V12, P1051, DOI 10.1046/j.1365-2826.2000.00541.x; Melcangi RC, 1999, J NEUROBIOL, V40, P471, DOI 10.1002/(SICI)1097-4695(19990915)40:4<471::AID-NEU5>3.3.CO;2-G; Mong JA, 1999, J NEUROBIOL, V40, P602, DOI 10.1002/(SICI)1097-4695(19990915)40:4<602::AID-NEU14>3.0.CO;2-O; Mor G, 1999, J NEUROBIOL, V40, P484, DOI 10.1002/(SICI)1097-4695(19990915)40:4<484::AID-NEU6>3.0.CO;2-C; Mulnard RI, 2000, JAMA-J AM MED ASSOC, V283, P1007, DOI 10.1001/jama.283.8.1007; Nichols NR, 1999, J NEUROBIOL, V40, P585, DOI 10.1002/(SICI)1097-4695(19990915)40:4<585::AID-NEU13>3.0.CO;2-1; Ojeda SR, 1999, J NEUROBIOL, V40, P528, DOI 10.1002/(SICI)1097-4695(19990915)40:4<528::AID-NEU9>3.0.CO;2-V; Paganini-Hill A, 2001, MATURITAS, V38, P243, DOI 10.1016/S0378-5122(01)00167-0; PAGANINIHILL A, 1988, BMJ-BRIT MED J, V297, P519, DOI 10.1136/bmj.297.6647.519; PAGANINIHILL A, 1995, PROG CARDIOVASC DIS, V38, P223, DOI 10.1016/S0033-0620(95)80014-X; PaganiniHill A, 1996, ARCH INTERN MED, V156, P2213, DOI 10.1001/archinte.156.19.2213; Patrone C, 1999, P NATL ACAD SCI USA, V96, P10905, DOI 10.1073/pnas.96.19.10905; Pelligrino DA, 1998, NEUROREPORT, V9, P3285, DOI 10.1097/00001756-199810050-00026; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x; Rabbani O, 1997, EXP NEUROL, V146, P179, DOI 10.1006/exnr.1997.6516; Regan RF, 1997, BRAIN RES, V764, P133, DOI 10.1016/S0006-8993(97)00437-X; Reibel S, 2000, NEUROSCI LETT, V281, P79, DOI 10.1016/S0304-3940(00)00784-9; Rusa R, 1999, STROKE, V30, P1665, DOI 10.1161/01.STR.30.8.1665; SANDYK R, 1987, PEDIATR NEUROL, V3, P122, DOI 10.1016/0887-8994(87)90042-7; Saunders-Pullman R, 1999, NEUROLOGY, V52, P1417, DOI 10.1212/WNL.52.7.1417; Sawada H, 1998, J NEUROSCI RES, V54, P707, DOI 10.1002/(SICI)1097-4547(19981201)54:5<707::AID-JNR16>3.0.CO;2-T; Sawada M, 2000, J CEREBR BLOOD F MET, V20, P112, DOI 10.1097/00004647-200001000-00015; Schonknecht P, 2001, NEUROSCI LETT, V307, P122, DOI 10.1016/S0304-3940(01)01896-1; Schumacher M, 2000, J NEUROCYTOL, V29, P307, DOI 10.1023/A:1007152904926; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Singer CA, 1999, J NEUROSCI, V19, P2455; Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025; Singer CA, 1996, NEUROSCI LETT, V212, P13, DOI 10.1016/0304-3940(96)12760-9; Singh M, 1999, J NEUROSCI, V19, P1179; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Slooter AJC, 1999, J NEUROL NEUROSUR PS, V67, P779, DOI 10.1136/jnnp.67.6.779; Soares CD, 2001, ARCH GEN PSYCHIAT, V58, P529; Stone DJ, 1997, EXP NEUROL, V143, P313, DOI 10.1006/exnr.1996.6360; Stone DJ, 1998, ENDOCRINOLOGY, V139, P3202, DOI 10.1210/en.139.7.3202; Sudo S, 1997, NEUROSCI RES, V29, P345, DOI 10.1016/S0168-0102(97)00106-5; Tang MX, 1996, LANCET, V348, P429, DOI 10.1016/S0140-6736(96)03356-9; TEIXEIRA C, 1995, CANCER RES, V55, P3902; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; Tsang KL, 2000, NEUROLOGY, V54, P2292, DOI 10.1212/WNL.54.12.2292; Vedder H, 1999, J NEUROCHEM, V72, P2531, DOI 10.1046/j.1471-4159.1999.0722531.x; Vegeto E, 2001, J NEUROSCI, V21, P1809, DOI 10.1523/JNEUROSCI.21-06-01809.2001; Vegeto E, 1999, FASEB J, V13, P793, DOI 10.1096/fasebj.13.8.793; Wang Q, 1999, STROKE, V30, P630, DOI 10.1161/01.STR.30.3.630; Waring SC, 1999, NEUROLOGY, V52, P965, DOI 10.1212/WNL.52.5.965; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; Wilson M.E, 2000, SOC NEUR ABSTR, V26, P923; Wilson ME, 2000, BRAIN RES, V873, P235, DOI 10.1016/S0006-8993(00)02479-3; Wise PM, 2000, J NEUROCYTOL, V29, P401, DOI 10.1023/A:1007169408561; Wise PM, 2001, ENDOCRINOLOGY, V142, P969, DOI 10.1210/en.142.3.969; Wise PM, 2001, FRONT NEUROENDOCRIN, V22, P33, DOI 10.1006/frne.2000.0207; Wise PM, 2000, J PEDIATR ENDOCR MET, V13, P1425; Yaffe K, 1998, JAMA-J AM MED ASSOC, V279, P688, DOI 10.1001/jama.279.9.688; Zaulyanov LL, 1999, CELL MOL NEUROBIOL, V19, P705, DOI 10.1023/A:1006948921855; Zhang L, 2001, NEUROREPORT, V12, P1919, DOI 10.1097/00001756-200107030-00030; Zhang Y, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0007.2001; Zhang YQ, 1998, BRAIN RES, V784, P321, DOI 10.1016/S0006-8993(97)00502-7	133	20	21	1	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1029-8428	1476-3524		NEUROTOX RES	Neurotox. Res.	JAN	2002	4	3					235	245		10.1080/10298420290033232			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	VJ3BG	WOS:000574981300007	12829404				2022-02-06	
J	McDonald, JW; Stefovska, VG; Liu, XZ; Shin, H; Liu, S; Choi, DW				McDonald, JW; Stefovska, VG; Liu, XZ; Shin, H; Liu, S; Choi, DW			Neurotrophin potentiation of iron-induced spinal cord injury	NEUROSCIENCE			English	Article						nerve growth factor; brain-derived neurotrophic factor; neurotrophin-3; neurotrophin-4/5; excitotoxicity; free radicals	NERVE GROWTH-FACTOR; ASPARTATE RECEPTOR SUBUNIT-1; STRIATAL CHOLINERGIC NEURONS; PARTIAL FUNCTIONAL RECOVERY; TRAUMATIC BRAIN INJURY; RETINAL GANGLION-CELLS; NITRIC-OXIDE SYNTHASE; REDUCES INFARCT SIZE; CORTICAL-NEURONS; ADULT-RAT	Previous studies have shown that pretreatment with neurotrophins can potentiate the vulnerability of cultured neurons to excitotoxic and free radical-induced necrosis, in contrast to their well known neuroprotective effects against apoptosis. Here we tested the hypothesis that this unexpected injury-potentiating effect of neurotrophins would also take place in the adult rat spinal cord. Fe3+-citrate was injected stereotaxically into spinal cord gray matter in adult rats in amounts sufficient to produce minimal tissue injury 24 It later. Twenty-four-hour pretreatment with brain-derived neurotrophic factor, neurotrophin-3, or neurotrophin-4/5, but not nerve growth factor, markedly enhanced tissue injury in the gray matter as evidenced by an increase in the damaged area, as well as the loss of neurons and oligodendrocytes. Consistent with maintained free radical mediation, the neurotrophin-potentiated iron-induced spinal cord damage was blocked by co-application of the antioxidant N-tert-butyl-(2-sulfophenyl)-nitrone. These data support the hypothesis that the overall neuroprotective properties of neurotrophins in models of acute injury to the spinal cord may be limited by an underlying potentiation of free radical-mediated necrosis. (C) 2002 IBRO. Published by Elsevier Science Ltd. All rights reserved.	Washington Univ, Sch Med, Ctr Study Nervous Syst Injury, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA		Choi, DW (corresponding author), Merck Sharp & Dohme Ltd, Res Labs, West Point, PA 19486 USA.	wildersp@neuro.wustl.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS032636, R01NS036265, K08NS001931] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS01931, NS36265, NS32636] Funding Source: Medline		ALDERSON RF, 1990, NEURON, V5, P297, DOI 10.1016/0896-6273(90)90166-D; Andsberg G, 1998, EUR J NEUROSCI, V10, P2026, DOI 10.1046/j.1460-9568.1998.00214.x; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Atamna H, 2000, J BIOL CHEM, V275, P6741, DOI 10.1074/jbc.275.10.6741; Bai G, 1997, J BIOL CHEM, V272, P5936, DOI 10.1074/jbc.272.9.5936; Chan KM, 1996, NEUROCHEM RES, V21, P763, DOI 10.1007/BF02532298; CHENG B, 1994, BRAIN RES, V650, P331, DOI 10.1016/0006-8993(94)91801-5; CHENG B, 1994, BRAIN RES, V640, P56, DOI 10.1016/0006-8993(94)91857-0; Cheng Y, 1997, ANN NEUROL, V41, P521, DOI 10.1002/ana.410410416; DAVIES SW, 1992, NEUROSCI LETT, V140, P161, DOI 10.1016/0304-3940(92)90092-L; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dreyfus CF, 1999, J NEUROSCI RES, V56, P1, DOI 10.1002/(SICI)1097-4547(19990401)56:1<1::AID-JNR1>3.0.CO;2-3; FERNANDEZSANCHEZ MT, 1993, FEBS LETT, V335, P124, DOI 10.1016/0014-5793(93)80453-2; FRIM DM, 1993, NEUROREPORT, V4, P367, DOI 10.1097/00001756-199304000-00006; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Grill R, 1997, J NEUROSCI, V17, P5560; Gwag BJ, 1995, NEUROREPORT, V7, P93, DOI 10.1097/00001756-199512000-00022; HEFTI F, 1986, J NEUROSCI, V6, P2155; Heppenstall PA, 2001, P NATL ACAD SCI USA, V98, P8107, DOI 10.1073/pnas.141015098; Houle JD, 1999, NEUROSCIENCE, V94, P929, DOI 10.1016/S0306-4522(99)00359-0; Houweling DA, 1998, NEUROSCI LETT, V251, P193, DOI 10.1016/S0304-3940(98)00536-9; Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Isenmann S, 1998, EUR J NEUROSCI, V10, P2751, DOI 10.1046/j.1460-9568.1998.00325.x; Jakeman LB, 1998, EXP NEUROL, V154, P170, DOI 10.1006/exnr.1998.6924; Jarvis CR, 1997, J NEUROPHYSIOL, V78, P2363, DOI 10.1152/jn.1997.78.5.2363; Johnson EM, 1996, BRAIN PATHOL, V6, P397, DOI 10.1111/j.1750-3639.1996.tb00872.x; Johnston M V, 2000, Semin Neonatol, V5, P75, DOI 10.1053/siny.1999.0116; Kirschner PB, 1996, BRAIN RES, V713, P178, DOI 10.1016/0006-8993(95)01513-2; Klocker N, 1998, J NEUROSCI, V18, P1038; Kobayashi H, 1997, BRAIN RES BULL, V43, P17, DOI 10.1016/S0361-9230(96)00343-7; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Lever IJ, 2001, J NEUROSCI, V21, P4469, DOI 10.1523/JNEUROSCI.21-12-04469.2001; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Lobner D, 1996, NEUROSCIENCE, V72, P335, DOI 10.1016/0306-4522(95)00561-7; MCDONALD JW, 1989, EXP NEUROL, V106, P289, DOI 10.1016/0014-4886(89)90162-3; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Novikova LN, 2000, EUR J NEUROSCI, V12, P776, DOI 10.1046/j.1460-9568.2000.00978.x; Park EC, 1998, NEUROREPORT, V9, P687, DOI 10.1097/00001756-199803090-00023; Pitts AF, 2000, J COMP NEUROL, V418, P241, DOI 10.1002/(SICI)1096-9861(20000313)418:3<241::AID-CNE1>3.0.CO;2-M; Prehn JHM, 1996, EUR J PHARMACOL, V306, P81, DOI 10.1016/0014-2999(96)00225-7; Samdani AF, 1997, J NEUROSCI, V17, P4633; Scarisbrick IA, 1999, J NEUROSCI, V19, P7757; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schutte A, 2000, NEUROSCI LETT, V290, P185, DOI 10.1016/S0304-3940(00)01351-3; SENGSTOCK GJ, 1992, BRAIN RES BULL, V28, P645, DOI 10.1016/0361-9230(92)90118-H; SHIGENO T, 1991, J NEUROSCI, V11, P2914; Sinson G, 1997, J NEUROSURG, V86, P511, DOI 10.3171/jns.1997.86.3.0511; Small DL, 1998, NEUROSCI LETT, V252, P211, DOI 10.1016/S0304-3940(98)00587-4; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Takei N, 1998, J BIOL CHEM, V273, P27620, DOI 10.1074/jbc.273.42.27620; TUSZYNSKI MH, 1990, J NEUROSCI, V10, P3604; Won SJ, 2000, NEUROBIOL DIS, V7, P251, DOI 10.1006/nbdi.2000.0284; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; Yan Q, 1997, J COMP NEUROL, V378, P135	57	20	20	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience		2002	115	3					931	939	PII S0306-4522(02)00342-1	10.1016/S0306-4522(02)00342-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	620FV	WOS:000179524100027	12435430				2022-02-06	
J	Moor, E; Kohen, R; Reiter, RJ; Shohami, E				Moor, E; Kohen, R; Reiter, RJ; Shohami, E			Closed head injury increases extracellular levels of antioxidants in rat hippocampus in vivo: an adaptive mechanism?	NEUROSCIENCE LETTERS			English	Article						head trauma; closed head injury; microdialysis; antioxidants; oxidative stress; uric acid; ascorbic acid	URIC-ACID; IN-VIVO; ISCHEMIA-REPERFUSION; ASCORBIC-ACID; BRAIN INJURY; RELEASE; GLUTAMATE; STRIATUM	Reactive oxygen species (ROS) are a major cause of secondary brain injury following head trauma. Low molecular weight antioxidants (LMWA) protect the tissue against oxidative damage caused by ROS. In the present study, we measured the extracellular levels of the LMWA ascorbic acid and uric acid in the rat brain before, during and after experimental closed head injury (CHI). A dialysis probe was inserted into the right ventral hippocampus through a chronically implanted guide. CHI was applied to the left hemisphere using a weight-drop device. CHI induced a rapid but transient increase in ascorbic acid levels. Uric acid levels increased to 250% of baseline shortly after CHI and remained elevated at 2 h after CHI. Previous results show that the overall reducing power of brain tissue decreases following CHI. Together with previous results, the current findings suggest that ascorbic acid and uric acid are mobilized from brain cells to the extracellular space. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.	Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel; Univ Texas, Hlth Sci Ctr, Dept Cellular & Struct Biol, San Antonio, TX 78284 USA		Moor, E (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel.						AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BeitYannai E, 1997, J CEREBR BLOOD F MET, V17, P273, DOI 10.1097/00004647-199703000-00004; Benzie IFF, 1996, REDOX REP, V2, P231, DOI 10.1080/13510002.1996.11747055; Berry EM, 1999, MED HYPOTHESES, V53, P397, DOI 10.1054/mehy.1998.0786; Elangovan V, 2000, J NEUROTRAUM, V17, P1013, DOI 10.1089/neu.2000.17.1013; Enrico P, 1997, PHARMACOL RES, V35, P577, DOI 10.1006/phrs.1997.0193; GHASEMZEDAH B, 1991, BRAIN RES, V547, P162; HILLERED L, 1990, NEUROSCI LETT, V113, P328, DOI 10.1016/0304-3940(90)90606-A; HILLERED L, 1988, NEUROSCI LETT, V95, P1; Islekel S, 1999, RES EXP MED, V199, P167, DOI 10.1007/s004330050121; Krishnappa IK, 1999, J NEUROTRAUM, V16, P213, DOI 10.1089/neu.1999.16.213; Lomnitski L, 2000, EXP TOXICOL PATHOL, V52, P177; MAJEWSKA MD, 1990, BRAIN RES, V537, P328, DOI 10.1016/0006-8993(90)90379-P; Miele M, 2000, BRIT J PHARMACOL, V129, P582, DOI 10.1038/sj.bjp.0703066; MIELE M, 1994, NEUROSCIENCE, V62, P87, DOI 10.1016/0306-4522(94)90316-6; MOTCHNIK PA, 1994, METHOD ENZYMOL, V234, P115; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; RYAN M, 1997, ANN CLIN BIOCHEM, V35, P553; SEVANIAN A, 1991, AM J CLIN NUTR, V54, pS1129, DOI 10.1093/ajcn/54.6.1129s; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Tayag EC, 1996, BRAIN RES, V733, P287, DOI 10.1016/0006-8993(96)00669-5; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Yusa T, 2000, NEUROSCI LETT, V293, P123, DOI 10.1016/S0304-3940(00)01501-9; Yusa T, 2001, BRAIN RES, V897, P104, DOI 10.1016/S0006-8993(01)02099-6	25	20	20	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	DEC 28	2001	316	3					169	172		10.1016/S0304-3940(01)02394-1			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	511MT	WOS:000173268200011	11744229				2022-02-06	
J	Ract, C; Vigue, B; Bodjarian, N; Mazoit, JX; Samii, K; Tadie, M				Ract, C; Vigue, B; Bodjarian, N; Mazoit, JX; Samii, K; Tadie, M			Comparison of dopamine and norepinephrine after traumatic brain injury and hypoxic-hypotensive insult	JOURNAL OF NEUROTRAUMA			English	Article						catecholamines; cerebral perfusion pressure; dopamine; head trauma; hypoxic-hypotensive injury; intracranial pressure; norepinephrine	CEREBRAL BLOOD-FLOW; DIFFUSE AXONAL INJURY; HEAD-INJURY; PERFUSION-PRESSURE; HEMORRHAGIC-SHOCK; IMPACT INJURY; RATS; PHENYLEPHRINE; METABOLISM; ARTERIES	After severe brain trauma, blood-brain barrier disruption and alteration of cerebral arteriolar vasoreactive properties may modify the cerebral response to catecholamines. Therefore, the goal of the present study was to compare the effects of dopamine and norepinephrine in a model of brain injury that consisted of a weight-drop model of injury complicated by a 15-min hypoxic-hypotensive insult (HH). Sprague-Dawley rats (n = 7 in each group) received, after brain injury, an infusion of either norepinephrine (TNE group) or dopamine (TDA group) in order to increase cerebral perfusion pressure (CPP) above 70 mm Hg. In addition, a control group (C group, no trauma) and a trauma group (T group, brain injury, no catecholamine infusion) were studied. Mean arterial pressure (MAP), intracranial pressure (ICP, intraparenchymal fiberoptic device), and local cerebral blood flow (LCBF, extradural laser-Doppler fiber) were measured throughout the protocol. In T group, brain injury and RH induced a decrease in CPP (by an increase of ICP and a decrease of MAP), and a decrease of LCBF. Both norepinephrine and dopamine failed to increase CPP, and ICP was significantly higher in TNE and TDA groups than in T group. Interestingly, norepinephrine was not able to alleviate the decrease in MAP. Neither norepinephrine or dopamine could induce an increase of MAP. LCBF decreased similarly in T, TNE and TDA groups. In conclusion, norepinephrine and dopamine are not able to restore values of CPP above 70 mm Hg in a model of severe brain trauma. Furthermore, their systemic vasopressor properties are altered.	Hop Bicetre, Dept Anesthesie Reanimat, Lab Neurochirurg, F-94275 Le Kremlin Bicetre, France; Hop Broussais, F-75674 Paris, France; Univ Paris Sud, Fac Med, Lab Anesthesiol, F-94275 Le Kremlin Bicetre, France		Vigue, B (corresponding author), Hop Bicetre, Dept Anesthesie Reanimat, Lab Neurochirurg, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.						ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; BANDRES J, 1992, J NEUROSURG ANESTH, V4, P250, DOI 10.1097/00008506-199210000-00004; BARZO P, 1993, NEUROSURGERY, V32, P611; BAUKNIGHT GC, 1992, STROKE, V23, P1522, DOI 10.1161/01.STR.23.10.1522; BRYAN RM, 1990, AM J PHYSIOL, V259, pH269, DOI 10.1152/ajpheart.1990.259.2.H269; Cherian L, 1999, CRIT CARE MED, V27, P2512, DOI 10.1097/00003246-199911000-00031; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CROOKS DA, 1991, J PATHOL, V165, P5, DOI 10.1002/path.1711650103; DARBY JM, 1994, J NEUROSURG, V80, P857, DOI 10.3171/jns.1994.80.5.0857; EDVINSSON L, 1979, ACTA PHYSIOL SCAND, V107, P289, DOI 10.1111/j.1748-1716.1979.tb06478.x; FARACI FM, 1990, CIRC RES, V66, P8, DOI 10.1161/01.RES.66.1.8; Fulton R L, 1993, J Invest Surg, V6, P117, DOI 10.3109/08941939309141603; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HARPER SL, 1984, AM J PHYSIOL, V246, pH17, DOI 10.1152/ajpheart.1984.246.1.H17; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; Kroppenstedt SN, 1999, J NEUROSURG, V90, P520, DOI 10.3171/jns.1999.90.3.0520; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; Law MM, 1996, SHOCK, V6, P213, DOI 10.1097/00024382-199609000-00010; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P483, DOI 10.1152/ajplegacy.1976.231.2.483; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MERTES PM, 1994, TRANSPLANTATION, V58, P414, DOI 10.1097/00007890-199408270-00004; MONTASSER A, 1994, J NEUROSURG, V80, P301; OLESEN J, 1972, NEUROLOGY, V22, P978, DOI 10.1212/WNL.22.9.978; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; PILATI CF, 1992, AM J PHYSIOL, V263, pH784, DOI 10.1152/ajpheart.1992.263.3.H784; POPP AJ, 1982, J SURG RES, V32, P416, DOI 10.1016/0022-4804(82)90121-4; ROGERS AT, 1988, ANESTHESIOLOGY, V69, P547, DOI 10.1097/00000542-198810000-00015; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; SAMORAJSKI T, 1962, J HISTOCHEM CYTOCHEM, V10, P392, DOI 10.1177/10.4.392; SERCOMBE R, 1990, J CEREBR BLOOD F MET, V10, P808, DOI 10.1038/jcbfm.1990.137; SHIVALKAR B, 1993, CIRCULATION, V87, P230, DOI 10.1161/01.CIR.87.1.230; SOKRAB TEO, 1989, ACTA PHYSIOL SCAND, V137, P101, DOI 10.1111/j.1748-1716.1989.tb08725.x; TODA N, 1983, EXPERIENTIA, V39, P1131, DOI 10.1007/BF01943144; TUOR UI, 1986, AM J PHYSIOL, V251, pH824, DOI 10.1152/ajpheart.1986.251.4.H824; URSINO M, 1991, CRIT REV BIOMED ENG, V18, P255; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1975, STROKE, V6, P654, DOI 10.1161/01.STR.6.6.654; WEILMALHERBE H, 1959, SCIENCE, V129, P1226, DOI 10.1126/science.129.3357.1226; WEILMALHERBE H, 1961, J NEUROCHEM, V8, P55, DOI 10.1111/j.1471-4159.1961.tb13526.x; WHITE M, 1995, CIRCULATION, V92, P2183, DOI 10.1161/01.CIR.92.8.2183; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408	43	20	22	0	2	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	NOV	2001	18	11					1247	1254		10.1089/089771501317095287			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	491KC	WOS:000172106700006	11721743				2022-02-06	
J	Levin, HS; Song, J; Ewing-Cobbs, L; Roberson, G				Levin, HS; Song, J; Ewing-Cobbs, L; Roberson, G			Porteus maze performance following traumatic brain injury in children	NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; POSITRON-EMISSION-TOMOGRAPHY; SPATIAL WORKING-MEMORY; FRONTAL-LOBE LESIONS; PREFRONTAL CORTEX; COGNITIVE-DEVELOPMENT; DEVELOPMENTAL-CHANGES; ORBITOFRONTAL CORTEX; SUSTAINED ATTENTION; ADOLESCENTS	To investigate planning in traumatically brain injured children, the authors gave the Porteus Maze Test (PMT; S. D. Porteus, 1959) to 276 pediatric patients who had sustained a traumatic brain injury (TBI) at least 3 years previously. Sensitivity of the PMT to TBI severity, age at test, and volume of focal brain lesions detected by magnetic resonance imaging was also studied. The Peabody Picture Vocabulary Test-Revised (L. M. Dunn & L. M. Dunn, 1981) was also administered as a control measure. Results indicated that the PMT was highly sensitive to TBI severity and to volume of circumscribed prefrontal lesions. In contrast to the PMT data, receptive vocabulary was related to injury severity but not to discrete prefrontal lesions, Implications for mechanisms of cognitive deficit after TBI in children are discussed.	Baylor Coll Med, Cognit Neurosci Lab, Dept Psychiat, Houston, TX 77030 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Dept Pediat, San Antonio, TX 78284 USA		Levin, HS (corresponding author), Baylor Coll Med, Cognit Neurosci Lab, Dept Psychiat, 6560 Fannin St,Box 67,Suite 1144, Houston, TX 77030 USA.	hlevin@bcm.tmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-21889] Funding Source: Medline		Anderson P, 1996, CLIN NEUROPSYCHOL, V10, P54, DOI 10.1080/13854049608406663; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; BENCH CJ, 1993, NEUROPSYCHOLOGIA, V31, P907, DOI 10.1016/0028-3932(93)90147-R; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; BJORKLUND DF, 1990, DEV REV, V10, P48, DOI 10.1016/0273-2297(90)90004-N; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Brookshire BL, 2000, J INT NEUROPSYCH SOC, V6, P741, DOI 10.1017/S1355617700677019; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; CANAVAN AGM, 1983, NEUROPSYCHOLOGIA, V21, P375, DOI 10.1016/0028-3932(83)90024-6; CASE R, 1992, BRAIN COGNITION, V20, P51, DOI 10.1016/0278-2626(92)90061-P; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; DAMASIO HC, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P92; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; DENNIS M, 1991, DEV NEUROPSYCHOL, V7, P327, DOI 10.1080/87565649109540497; DENNIS M, 1990, DISCOURSE ABILITY BR, P199; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; DIAMOND A, 1990, P394; DREWE E A, 1975, Cortex, V11, P8; Dunn LM., 1981, PEABODY PICTURE VOCA; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Eslinger P. J, 1996, ATTENTION MEMORY EXE, P367; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 1998, CHILD NEUROPSYCHOL, V4, P35, DOI 10.1076/chin.4.1.35.3194; Fuster J., 1989, PREFRONTAL CORTEX AN; Gerring JP, 1998, J AM ACAD CHILD PSY, V37, P647, DOI 10.1097/00004583-199806000-00015; GERSTADT CL, 1994, COGNITION, V53, P129, DOI 10.1016/0010-0277(94)90068-X; GOLDMAN PS, 1971, EXP NEUROL, V32, P366, DOI 10.1016/0014-4886(71)90005-7; GOLDMAN PS, 1970, EXP NEUROL, V27, P291, DOI 10.1016/0014-4886(70)90222-0; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; HILLMAN GR, 1991, J COMPUT ASSIST TOMO, V15, P640, DOI 10.1097/00004728-199107000-00021; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Krikorian R, 1998, CLIN NEUROPSYCHOL, V12, P305, DOI 10.1076/clin.12.3.305.1984; KRIKORIAN R, 1994, J CLIN EXP NEUROPSYC, V16, P840, DOI 10.1080/01688639408402697; Levin HS, 1996, DEV NEUROPSYCHOL, V12, P17, DOI 10.1080/87565649609540638; Levin HS, 1996, CORTEX, V32, P461, DOI 10.1016/S0010-9452(96)80004-9; LEVIN HS, 1991, DEV NEUROPSYCHOL, V7, P377, DOI 10.1080/87565649109540499; LEVIN HS, 1993, ARCH NEUROL-CHICAGO, V50, P897, DOI 10.1001/archneur.1993.00540090008004; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; Levin HS, 1997, NEUROSURGERY, V40, P432, DOI 10.1097/00006123-199703000-00002; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lorsbach TC, 1997, J EXP CHILD PSYCHOL, V64, P317, DOI 10.1006/jecp.1996.2350; Luciana M, 1998, NEUROPSYCHOLOGIA, V36, P273, DOI 10.1016/S0028-3932(97)00109-7; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Machin D., 1997, SAMPLE SIZE TABLES C; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; MILNER B, 1965, NEUROPSYCHOLOGIA, V3, P317, DOI 10.1016/0028-3932(65)90005-9; Owen AM, 1996, EUR J NEUROSCI, V8, P353, DOI 10.1111/j.1460-9568.1996.tb01219.x; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Passler MA, 1985, DEV NEUROPSYCHOL, V1, P349, DOI 10.1080/87565648509540320; Pennington B., 1996, ATTENTION MEMORY EXE, P327; PENNINGTON BF, 1994, MAC FDN MEN, P243; Porteus S. D, 1959, MAZE TEST CLIN PSYCH; Porteus S.D., 1965, PORTEUS MAZE TEST 50; Porteus SD, 1944, GENET PSYCHOL MONOGR, V29, P3; RAIZNER RD, IN PRESS DEV NEUROPS; Roberts RJ, 1996, DEV NEUROPSYCHOL, V12, P105, DOI 10.1080/87565649609540642; Rolls E.T., 1999, BRAIN EMOTION; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; TEASDALE G, 1974, LANCET, V2, P81; WELSH MC, 1988, DEV NEUROPSYCHOL, V4, P199, DOI 10.1080/87565648809540405; WELSH MC, 1991, DEV NEUROPSYCHOL, V7, P131, DOI 10.1080/87565649109540483; Yeates K O, 1995, J Int Neuropsychol Soc, V1, P78; Zacks R. T., 1994, INHIBITORY PROCESSES	74	20	24	0	8	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2001	15	4					557	567		10.1037//0894-4105.15.4.557			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	494KQ	WOS:000172281800015	11761045				2022-02-06	
J	Logan, SM; Bell, GW; Leonard, JC				Logan, SM; Bell, GW; Leonard, JC			Acute subdural hematoma in a high school football player after 2 unreported episodes of head trauma: A case report	JOURNAL OF ATHLETIC TRAINING			English	Article						second-impact syndrome; head injury; concussion; seizure	CONCUSSION; GUIDELINES; SPORTS; MANAGEMENT; DIAGNOSIS; INJURIES	Objective: To discuss the association between 2 unreported episodes of head trauma and an acute subdural hematoma in a high school football player; to address the role of the sport health care team in secondary schools when caring for an athlete with head trauma; and to recognize the importance of educating athletes and coaches about this condition. Background. A previously healthy athlete experienced 2 unreported episodes of head trauma during a single game. The athlete was conscious and oriented to person, time, and place, but he vomited and complained of severe headache, nausea, and vertigo. During transfer, the athlete appeared to have a seizure. Differential Diagnosis: Subdural hematoma, epidural hematoma, intracerebral hemorrhage, second-impact syndrome, cervical spine injury, or epilepsy. Treatment: Computed tomography scan indicated fluid over the left frontal temporal fossa. Conservative treatment was begun, and the fluid resolved without incident. Uniqueness: A single episode of blunt trauma has been thought to cause an acute subdural hematoma. However, multiple concussions can also result in this condition. Conclusion: Single or multiple episodes of head trauma can lead to an acute subdural hematoma. This case study reflects the importance of proper education in the recognition and care of head trauma and return-to-play guidelines for athletes and coaches. A sport health care team in all secondary schools can provide the immediate and appropriate intervention for such injuries.	Univ Illinois, Champaign, IL 61820 USA; Carle Sports Med, Urbana, IL USA		Logan, SM (corresponding author), 4434 Smokerise Dr, Stow, OH 44224 USA.	Smlogan21@aol.com					ALBRIGHT L, 1983, HLTH CARE YOUNG ATHL, P263; *AM SPORT ED PROGR, 1998, RAIS STAND 1998 NAT; BRUNO LA, 1987, CLIN SPORT MED, V6, P17; Cantu RC, 1999, PHYSICIAN SPORTSMED, V27, P35, DOI 10.3810/psm.1999.08.945; CANTU RC, 1995, PHYSICIAN SPORTSMED, V23, P27, DOI 10.1080/00913847.1995.11947799; Cantu RC, 1998, CLIN SPORT MED, V17, P45, DOI 10.1016/S0278-5919(05)70060-0; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P2283, DOI 10.1001/jama.282.24.2283; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kersey RD, 1998, J ATHL TRAINING, V33, P264; Lyznicki JM, 1999, J ATHL TRAINING, V34, P272; MCLATCHIE G, 1994, BRIT MED J, V308, P1624; Mueller F O, 1991, Exerc Sport Sci Rev, V19, P261; Narayan RK, 1996, NEUROTRAUMA; *NCCA NEWS, 2000, NEWS FEAT; NELSON W, 1984, J ATHL TRAINING, V19, P95; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Ransone J, 1999, J ATHL TRAINING, V34, P267; Report of the Sports Medicine Committee, 1990, GUID MAN CONC SPORTS; SHELL D, 1993, PHYSICIAN SPORTSMED, V21, P74, DOI 10.1080/00913847.1993.11710364; Sturmi JE, 1998, SPORTS MED, V25, P351, DOI 10.2165/00007256-199825060-00001; TORG JS, 1981, ATHLETIC INJURIES HE; Warren WL, 1998, CLIN SPORT MED, V17, P13, DOI 10.1016/S0278-5919(05)70057-0	27	20	21	0	8	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	OCT-DEC	2001	36	4					433	436					4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	554QK	WOS:000175747800017	12937485				2022-02-06	
J	Fleming, PRI; Crompton, JL; Simpson, DA				Fleming, PRI; Crompton, JL; Simpson, DA			Neuro-ophthalmological sequelae of horse-related accidents	CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						equestrian; helmets; horse riding; injury; neuro-ophthalmological injuries	RIDING INJURIES	Purpose: The aim of this study was to highlight the neuro-ophthalmological dangers associated with horse riding, and working around horses, and the importance of wearing adequate headgear to protect the rider from neuro- ophthalmic injuries. It raises the questions of whether the current laws regarding helmet use are satisfactory, and whether helmets currently used are of an adequate standard. Methods: The records over a 20-year period of one neuro-ophthalmologist in Adelaide were reviewed producing 22 patients with neuro-ophthalmological sequelae of head injuries as a result of horse-related accidents. Results: There were 22 patients (16 female, six male), one of whom was involved in three separate accidents. Of these, seven were professional riders and 15 amateur. In 20 of the 24 accidents, patients were either thrown or fell from the horse. Helmets were worn in 15 of the accidents. All the patients had closed head injuries of varying severity. The most common neuro-ophthalmological complication found was a fourth-nerve palsy in 11 patients. Five patients had a significant loss of vision and two of these were severe enough to warrant a blind pension. Conclusions: Horse riding and working around horses constitute an occupation or recreation with inherent dangers. Previous studies have shown that wearing of protective headgear reduces the risk and severity of head injuries, and helmet use should be vigorously promoted. The current laws and practices regarding helmet use are not uniform and seem to be inadequate. The current standard for equestrian safety helmets (AS/NZS 3838:1998) embodies improvements on earlier helmet standards and certainly increases the rider's chances of surviving a severe impact. Nevertheless, serious brain injuries have occurred in wearers of approved helmets, and further research is desirable to ensure the optimum degree of protection compatible with rider acceptance.	Univ Adelaide, Royal Adelaide Hosp, Adelaide, SA, Australia; Univ Adelaide, Rd Accid Res Unit, Adelaide, SA, Australia		Crompton, JL (corresponding author), 22 Walter St, Adelaide, SA 5006, Australia.						BARBER HM, 1973, BRIT MED J, V3, P532, DOI 10.1136/bmj.3.5879.532; BARONE GW, 1989, J TRAUMA, V29, P245, DOI 10.1097/00005373-198902000-00019; BIXBYHAMMETT DM, 1987, AM FAM PHYSICIAN, V36, P209; BROOKS WH, 1988, PHYSICIAN SPORTSMED, V16, P84, DOI 10.1080/00913847.1988.11709646; BUCKLEY SM, 1993, AUST J PUBLIC HEALTH, V17, P269; Chapman M A, 1991, Br J Sports Med, V25, P121; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; CHRISTEY GL, 1994, J FAM PRACTICE, V39, P148; CONDIE C, 1993, PUBLIC HEALTH REP, V108, P121; DABREU F, 1976, LANCET, V1, P1241; GIERUP J, 1976, ACTA CHIR SCAND, V142, P57; GROSSMAN JAI, 1978, JAMA-J AM MED ASSOC, V240, P1881, DOI 10.1001/jama.240.17.1881; HAMILTON MG, 1993, J TRAUMA, V34, P227, DOI 10.1097/00005373-199302000-00008; ILGREN EB, 1984, CLIN NEUROPATHOL, V3, P253; INGEMARSON H, 1989, J TRAUMA, V29, P25, DOI 10.1097/00005373-198901000-00005; Kriss TC, 1997, J TRAUMA, V43, P97, DOI 10.1097/00005373-199707000-00022; Lloyd R G, 1987, Br J Sports Med, V21, P22; MAHALEY MS, 1976, P 18 C MED ASP SPORT; MCLATCHIE GB, 1979, BRIT J SPORT MED, V13, P632; MILLS NJ, 1990, P INT RES C BIOM IMP, P155; MUWANGA LC, 1985, ARCH EMERG MED, V2, P85; NELSON DE, 1994, PHYSICIAN SPORTSMED, V10, P53; NELSON DE, 1994, PHYSICIAN SPORTSMED, V10, P59; NICHOLL JP, 1990, BRIT MED J, V301, P496, DOI 10.1136/bmj.301.6750.496-b; Paix BR, 1999, BRIT J SPORT MED, V33, P46, DOI 10.1136/bjsm.33.1.46; POUNDER DJ, 1984, MED J AUSTRALIA, V141, P632, DOI 10.5694/j.1326-5377.1984.tb113173.x; RANDALLBOND G, 1995, PEDIATRICS, V95, P487; *STAND AUSTR, 1998, 3838 ASNZS; Whitlock M R, 1987, Br J Sports Med, V21, P25	29	20	20	0	2	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	1442-6404			CLIN EXP OPHTHALMOL	Clin. Exp. Ophthalmol.	AUG	2001	29	4					208	212		10.1046/j.1442-9071.2001.00430.x			5	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	482ZE	WOS:000171606500002	11545416				2022-02-06	
J	Freeman, J; Godfrey, HPD; Harris, JKJ; Partridge, FM				Freeman, J; Godfrey, HPD; Harris, JKJ; Partridge, FM			Utility of a demographic equation in detecting impaired NART performance after TBI	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							ADULT READING TEST; PREMORBID INTELLIGENCE; HEAD-INJURY; VALIDITY; DEMENTIA; HOLD	Objectives. This study applies a demographic regression equation devised by Crawford, Allan, Cochrane, and Parker (1990) to determine its utility in New Zealand, and to determine the proportion of persons with traumatic brain injury (TBI) with impaired performance on the National Adult Reading Test (NART). Method. The NART was administered to 80 community participants, 65 people with traumatic brain injury (TBI), and 27 orthopaedic controls. The Crawford et al. (1990) equation was applied to all three samples. Results. The Crawford er al. (1990) equation was applicable in the New Zealand community sample. It was found that 30% of the TDI sample had impaired performance on the NART. Using corrected NART scores, a significantly larger proportion of the TBI sample was detected as intellectually impaired than in the control sample. Conclusion. Nearly one-third of the TBI sample evidenced impaired performance on the NART. Consequently, clinicians that use the NART in assessing people with TBI should use the demographic equation to check the accuracy of NART performances, and correct the NART scores if this is indicated.	Univ Otago, Dept Psychol, Dunedin, New Zealand		Godfrey, HPD (corresponding author), Univ Otago, Dept Psychol, POB 56, Dunedin, New Zealand.						CRAWFORD JR, 1992, BRIT J PSYCHIAT, V161, P69, DOI 10.1192/bjp.161.1.69; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; CRAWFORD JR, 1987, BRIT J CLIN PSYCHOL, V26, P313, DOI 10.1111/j.2044-8260.1987.tb01366.x; Freeman J, 2000, BRIT J CLIN PSYCHOL, V39, P95, DOI 10.1348/014466500163130; FROMM D, 1991, CORTEX, V27, P367, DOI 10.1016/S0010-9452(13)80032-9; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; MOSS AR, 1991, BRIT J CLIN PSYCHOL, V30, P179, DOI 10.1111/j.2044-8260.1991.tb00934.x; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; Nelson L. S., 1982, High Temperatures - High Pressures, V14, P259; OCARROLL RE, 1987, BRIT J CLIN PSYCHOL, V26, P315, DOI 10.1111/j.2044-8260.1987.tb01367.x; Raven J. C., 1960, GUIDE STANDARD PROGR; Stebbins Glenn T, 1990, Clin Neuropsychol, V4, P18, DOI 10.1080/13854049008401493; VANDENBROEK MD, 1994, BRIT J CLIN PSYCHOL, V33, P509	13	20	20	0	4	BRITISH PSYCHOLOGICAL SOC	LEICESTER	ST ANDREWS HOUSE, 48 PRINCESS RD EAST, LEICESTER LE1 7DR, LEICS, ENGLAND	0144-6657			BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	JUN	2001	40		2				221	224		10.1348/014466501163562			4	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	444ZV	WOS:000169433200012	11446244				2022-02-06	
J	Zink, BJ; Schultz, CH; Stern, SA; Mertz, M; Wang, X; Johnston, P; Keep, RF				Zink, BJ; Schultz, CH; Stern, SA; Mertz, M; Wang, X; Johnston, P; Keep, RF			Effects of ethanol and naltrexone in a model of traumatic brain injury with hemorrhagic shock	ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						ethanol; naltrexone; brain injury; hemorrhagic shock	SEVERE HEAD-INJURY; ALCOHOL-INTOXICATION; OPIATE ANTAGONISTS; ENDOGENOUS OPIOIDS; IMPROVES SURVIVAL; BLOOD-FLOW; NALOXONE; RATS; RESPONSES; ENDORPHINS	Background: Ethanol predisposes to traumatic injury and causes respiratory depression and cardiovascular compromise in models of traumatic brain injury (TBI) and hemorrhagic shock (IIS). Endogenous opioids may play a role in ethanol intoxication and TBI. We studied the effects of ethanol and the opiate antagonist agent naltrexone (NTX) in a TBI/HS model. Methods: Fifty-six pigs (20 kg) were anesthetized with isoflurane, intubated, instrumented, and subjected to fluid percussion TBI with concurrent 30 ml/kg hemorrhage over 30 min. Seven groups were studied: Control, EtOH, NTX, INJ, INJ/EtOH, INJ/NTX, and INJ/EtOH/NTX. Ethanol (2 g/kg IV) was given preinjury, followed by infusion of 0.4 g/kg/hr. NTX 0.3 mg/kg intravenous was given 5 min postinjury. Parameters monitored for 120 min postinjury included minute ventilation (V,), blood pressure (MAP), cerebral perfusion pressure (CPP), cerebral venous lactate (Lac), arterial and cerebral venous blood gases, and brain tissue PtiO2. Results: Ethanol levels at injury were 220 mg/dL. Ethanol-treated animals had depression of hypercapnic ventilatory response, which was reversed by administration of naltrexone. MAP and CPP were significantly lower in injured animals, but were not significantly improved by NTX. Cerebral venous pH was lower and lactate was higher in ethanol-treated animals. Conclusion: In this TBI/HS model, NTX reverses ethanol-induced depression of hypercapnic ventilatory response but does not improve MAP, CPP, or metabolic acidosis. This suggests that the respiratory effects of ethanol in TBI, but not the hemodynamic effects, may be mediated by opiate receptor activation.	Univ Michigan, Dept Emergency Med, Emergency Med Res Lab, Ann Arbor, MI 48109 USA; Univ Michigan, Crosby Neurosurg Lab, Ann Arbor, MI 48109 USA		Zink, BJ (corresponding author), Univ Michigan, Dept Emergency Med, Emergency Med Res Lab, Ann Arbor, MI 48109 USA.			Keep, Richard/0000-0001-6441-5334	NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [5 K08 AA00184-03] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K08AA000184] Funding Source: NIH RePORTER		ALBIN MS, 1986, CRIT CARE MED, V14, P841, DOI 10.1097/00003246-198610000-00001; ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; Atkinson JLD, 2000, MAYO CLIN PROC, V75, P37, DOI 10.4065/75.1.37; BAROR D, 1982, NEW ENGL J MED, V306, P1363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 1998, J TRAUMA, V44, P958, DOI 10.1097/00005373-199806000-00003; CURTIS MT, 1980, AM J PHYSIOL, V239, pH416, DOI 10.1152/ajpheart.1980.239.3.H416; Dereeper E, 1998, RESUSCITATION, V36, P15, DOI 10.1016/S0300-9572(97)00080-4; DeWitt DS, 1997, J NEUROTRAUM, V14, P931, DOI 10.1089/neu.1997.14.931; EVANS L, 1993, J STUD ALCOHOL, V54, P441, DOI 10.15288/jsa.1993.54.441; FELL JC, 1990, 34 ANN P ASS ADV AUT, P69; FLAMM ES, 1977, J NEUROSURG, V46, P328, DOI 10.3171/jns.1977.46.3.0328; FRANCO CD, 1988, J NATL MED ASSOC, V80, P63; GURLL NJ, 1981, SURGERY, V89, P364; GURLL NJ, 1982, J PHARMACOL EXP THER, V220, P625; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; JAGGER J, 1984, NEUROSURGERY, V15, P303, DOI 10.1227/00006123-198409000-00002; JEFFCOATE WJ, 1979, LANCET, V1, P1157; JEFFERYS DB, 1980, LANCET, V1, P308; Kelly DF, 1997, J NEUROSURG, V86, P876, DOI 10.3171/jns.1997.86.5.0876; Komjati K, 1997, SHOCK, V7, P288, DOI 10.1097/00024382-199704000-00008; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Lightfoot JT, 2000, CRIT CARE MED, V28, P684, DOI 10.1097/00003246-200003000-00014; LYETH BG, 1995, NEUROPEPTIDES, V29, P11, DOI 10.1016/0143-4179(95)90051-9; Masse J, 2000, J NEUROTRAUM, V17, P421, DOI 10.1089/neu.2000.17.421; MAYFIELD KP, 1992, BRAIN RES, V582, P226, DOI 10.1016/0006-8993(92)90137-X; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1986, J SURG RES, V40, P265, DOI 10.1016/0022-4804(86)90160-5; MCINTOSH TK, 1985, CIRC SHOCK, V17, P313; McMahon CG, 1999, J TRAUMA, V47, P891, DOI 10.1097/00005373-199911000-00013; MICHIELS TM, 1983, J APPL PHYSIOL, V55, P929, DOI 10.1152/jappl.1983.55.3.929; MOSS IR, 1981, J APPL PHYSIOL, V50, P1001; NEWSOME HH, 1988, J TRAUMA, V28, P1, DOI 10.1097/00005373-198801000-00001; PETROZZINO JJ, 1993, AM REV RESPIR DIS, V147, P607, DOI 10.1164/ajrccm/147.3.607; REYNOLDS DG, 1989, RESUSCITATION, V18, P243, DOI 10.1016/0300-9572(89)90026-9; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; SAHN SA, 1975, CLIN SCI MOL MED, V49, P33, DOI 10.1042/cs0490033; SALERNO TA, 1981, SURG GYNECOL OBSTET, V152, P773; SANTIAGO TV, 1985, J APPL PHYSIOL, V59, P1675, DOI 10.1152/jappl.1985.59.6.1675; Shapira Y, 1997, J NEUROSURG ANESTH, V9, P118, DOI 10.1097/00008506-199704000-00003; TOTH PD, 1986, CIRC SHOCK, V20, P35; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1990, J NEUROSCI, V10, P3524; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; Wichmann MW, 2000, CRIT CARE MED, V28, P184, DOI 10.1097/00003246-200001000-00030; Winchell RJ, 1997, ARCH SURG-CHICAGO, V132, P592; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; YAMAKAMI I, 1995, J NEUROSURG, V82, P813, DOI 10.3171/jns.1995.82.5.0813; Zhang LX, 1999, J NEUROTRAUM, V16, P243, DOI 10.1089/neu.1999.16.243; Zink B J, 1994, Acad Emerg Med, V1, P171; ZINK BJ, 1995, J NEUROSURG, V82, P822, DOI 10.3171/jns.1995.82.5.0822; ZINK BJ, 1993, J NEUROTRAUM, V10, P275, DOI 10.1089/neu.1993.10.275; Zink BJ, 1996, ALCOHOL CLIN EXP RES, V20, P1518, DOI 10.1111/j.1530-0277.1996.tb01693.x; Zink BJ, 1999, BRAIN RES, V837, P1, DOI 10.1016/S0006-8993(99)01646-7; Zink BJ, 1998, J NEUROSURG, V89, P983, DOI 10.3171/jns.1998.89.6.0983	56	20	20	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0145-6008			ALCOHOL CLIN EXP RES	Alcoholism (NY)	JUN	2001	25	6					916	923					8	Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse	442YN	WOS:000169312700018	11410729				2022-02-06	
J	Suominen, E; Tukiainen, E				Suominen, E; Tukiainen, E			Close-range shotgun and rifle injuries to the face	CLINICS IN PLASTIC SURGERY			English	Article							FREE-FLAP RECONSTRUCTION; GUNSHOT WOUNDS; HIGH-ENERGY; MANDIBULAR RECONSTRUCTION; HEAD; MANAGEMENT; DEFECTS; NECK; BONE; LIP	This article addresses the reconstructive approach to close-range shotgun and rifle injuries to the face. Emergency management, acute surgical management, secondary management, and case reports are reviewed.	Univ Helsinki, Cent Hosp, Toolo Hosp, Dept Plast Surg, SF-00260 Helsinki, Finland		Suominen, E (corresponding author), Univ Helsinki, Cent Hosp, Toolo Hosp, Dept Plast Surg, Topeliuksenkatu 5, SF-00260 Helsinki, Finland.						AVIV JE, 1991, ARCH OTOLARYNGOL, V117, P1242; Clark N, 1996, PLAST RECONSTR SURG, V98, P583, DOI 10.1097/00006534-199609001-00001; COLEMAN JJ, 1991, PLAST RECONSTR SURG, V87, P682, DOI 10.1097/00006534-199104000-00013; COSTA H, 1993, BRIT J PLAST SURG, V46, P223, DOI 10.1016/0007-1226(93)90172-8; Demetriades D, 1998, J TRAUMA, V45, P39, DOI 10.1097/00005373-199807000-00007; DEMUTH WE, 1971, J TRAUM, V11, P219, DOI 10.1097/00005373-197103000-00003; DENNY AD, 1992, ANN PLAS SURG, V29, P564, DOI 10.1097/00000637-199212000-00014; GRUSS JS, 1991, PLAST RECONSTR SURG, V87, P436, DOI 10.1097/00006534-199103000-00008; GRUSS JS, 1989, BRIT J PLAST SURG, V42, P385, DOI 10.1016/0007-1226(89)90003-9; HENRIKSSON TG, 1990, SCAND J PLAST RECONS, V24, P81, DOI 10.3109/02844319009004525; HIDALGO DA, 1994, CLIN PLAST SURG, V21, P27; Kuzon WM, 1998, MICROSURG, V18, P372, DOI 10.1002/(SICI)1098-2752(1998)18:6<372::AID-MICR6>3.0.CO;2-F; Lorenzetti F, 1999, MICROSURG, V19, P196, DOI 10.1002/(SICI)1098-2752(1999)19:4<196::AID-MICR6>3.3.CO;2-X; MANSON PN, 1985, PLAST RECONSTR SURG, V76, P1; MLADICK RA, 1970, PLAST RECONSTR SURG, V45, P186, DOI 10.1097/00006534-197002000-00017; OLDING M, 1993, ANN PLAS SURG, V31, P82; ORDOG GJ, 1988, J TRAUMA, V28, P624, DOI 10.1097/00005373-198805000-00011; ORIGITANO TC, 1992, NEUROSURGERY, V30, P570; Pribaz JJ, 1999, PLAST RECONSTR SURG, V104, P357, DOI 10.1097/00006534-199908000-00005; SADOVE RC, 1993, PLAST RECONSTR SURG, V92, P141, DOI 10.1097/00006534-199307000-00022; SHEPARD GH, 1980, J TRAUMA, V20, P1065, DOI 10.1097/00005373-198012000-00011; Shvyrkov MB, 1999, BRIT J ORAL MAX SURG, V37, P261, DOI 10.1054/bjom.1999.0120; SUOMINEN EA, 1995, T 11 C INT CONF PLAS, P13; THORNE CH, 1992, CLIN PLAST SURG, V19, P233; Vasconez HC, 1996, ANN PLAS SURG, V36, P18, DOI 10.1097/00000637-199601000-00005; VITKUS K, 1990, J RECONSTR MICROSURG, V6, P279, DOI 10.1055/s-2007-1006831; Vrankovic D, 1998, INJURY, V29, P369, DOI 10.1016/S0020-1383(98)00054-0; WALKER ML, 1990, SURG GYNECOL OBSTET, V170, P97; WEINZWEIG N, 1994, PLAST RECONSTR SURG, V94, P685, DOI 10.1097/00006534-199410000-00017	29	20	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0094-1298			CLIN PLAST SURG	Clin. Plast. Surg.	APR	2001	28	2					323	+					16	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	437LX	WOS:000168994100009	11400826				2022-02-06	
J	Friedmann, I; Yoles, E; Schwartz, M				Friedmann, I; Yoles, E; Schwartz, M			Thrombin attenuation is neuroprotective in the injured rat optic nerve	JOURNAL OF NEUROCHEMISTRY			English	Article						CNS; injury; NAPAP; prothrombin; tissue repair; wound healing	PROTHROMBIN MESSENGER-RNA; NEURITE OUTGROWTH; NEURONAL CELLS; BRAIN EDEMA; SYSTEM; RECEPTOR; ASTROCYTES; ACTIVATION; DEGENERATION; REPAIR	The functional loss that often follows injury of the mammalian CNS has been attributed not only to the immediate neural loss, but also to secondary neuronal degeneration caused by toxic biochemical mediators in the environment of the injured nerve. We report here that a high thrombin content, produced as a result of injury-induced activation of prothrombin, appears to be an important mediator of secondary damage. Measurement of post-traumatic neuronal survival in vivo revealed that post-traumatic local application of the thrombin inhibitor N-alpha-(2-naphthylsulphonylglycyl)-4-(D,L)-amidinophenylalanine piperidide acetate in the rat optic nerve subjected to mild partial crush injury left twice as many retinal ganglion cells with functioning axons as in controls. Thus, by readjusting thrombin activity, thereby possibly obtaining a moderate post-traumatic increase and thus gaining the benefit of thrombin without its toxic effects, it may be possible to create an environment that is more favourable towards post-traumatic survival.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel		Schwartz, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.						BEHRMANN DL, 1994, EXP NEUROL, V126, P61, DOI 10.1006/exnr.1994.1042; BENEZRA M, 1993, SEMIN THROMB HEMOST, V19, P405, DOI 10.1055/s-2007-993292; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; Debeir T, 1996, BRAIN RES, V708, P159, DOI 10.1016/0006-8993(95)01237-0; DESCHEPPER CF, 1991, MOL BRAIN RES, V11, P355, DOI 10.1016/0169-328X(91)90045-Y; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; Donovan FM, 1998, J BIOL CHEM, V273, P12746, DOI 10.1074/jbc.273.21.12746; Donovan FM, 1997, J NEUROSCI, V17, P5316; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; FADEN AI, 1993, CRIT REV NEUROBIOL, V7, P175; Friedmann I, 1999, FASEB J, V13, P533, DOI 10.1096/fasebj.13.3.533; GRABHAM PW, 1991, EUR J NEUROSCI, V3, P663, DOI 10.1111/j.1460-9568.1991.tb00852.x; GRIFFIN JH, 1995, NATURE, V378, P337, DOI 10.1038/378337a0; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; Hauptmann J, 1999, THROMB RES, V93, P203, DOI 10.1016/S0049-3848(98)00192-3; Kubo Y, 2000, J NEUROTRAUM, V17, P163, DOI 10.1089/neu.2000.17.163; LazarovSpiegler O, 1996, FASEB J, V10, P1296, DOI 10.1096/fasebj.10.11.8836043; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Masada T, 2000, BRAIN RES, V867, P173, DOI 10.1016/S0006-8993(00)02302-7; Moalem G, 1999, NAT MED, V5, P49, DOI 10.1038/4734; MONARD D, 1983, PROG BRAIN RES, V58, P359, DOI 10.1016/S0079-6123(08)60037-0; Motohashi O, 1997, J NEUROTRAUM, V14, P747, DOI 10.1089/neu.1997.14.747; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; Ramon y Cajal S., 1959, DEGENERATION REGENER; Schwartz M, 1999, TRENDS NEUROSCI, V22, P295, DOI 10.1016/S0166-2236(99)01405-8; STIERNBERG J, 1993, THROMB HAEMOSTASIS, V70, P158; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; WEINSTEIN JR, 1995, J NEUROSCI, V15, P2906; Xi GH, 1999, STROKE, V30, P1247, DOI 10.1161/01.STR.30.6.1247; Xi GH, 1998, STROKE, V29, P2580, DOI 10.1161/01.STR.29.12.2580; Yamazaki Y, 1999, J BIOCHEM-TOKYO, V126, P655, DOI 10.1093/oxfordjournals.jbchem.a022499; Yoles E, 1998, EXP NEUROL, V153, P1, DOI 10.1006/exnr.1998.6811	35	20	21	0	1	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0022-3042			J NEUROCHEM	J. Neurochem.	FEB	2001	76	3					641	649		10.1046/j.1471-4159.2001.00001.x			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	397UG	WOS:000166715300001	11158234	Bronze			2022-02-06	
J	Markgraf, CG; Clifton, GL; Aguirre, M; Chaney, SF; Knox-du Bois, C; Kennon, K; Verma, N				Markgraf, CG; Clifton, GL; Aguirre, M; Chaney, SF; Knox-du Bois, C; Kennon, K; Verma, N			Injury severity and sensitivity to treatment after controlled cortical impact in rats	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; motor deficit; cognitive deficit; hypothermia; recovery	TRAUMATIC BRAIN INJURY; CEREBRAL-ARTERY OCCLUSION; FLUID-PERCUSSION MODEL; MODERATE HYPOTHERMIA; POSTTRAUMATIC HYPOTHERMIA; HEAD-INJURY; DEFICITS; ISCHEMIA; DAMAGE; TEMPERATURE	We sought to determine sensitivity of the cortical impact injury model of traumatic brain injury (TBI) to severity of injury and to treatment. We examined the pattern of motor and cognitive deficits and recovery following TBI over a range of injury severities, and examined the efficacy of surface-induced moderate hypothermia at three disparate injury levels. In experiment I, Sprague-Dawley rats were injured at one of eight injury severity levels from 0 mm (sham) to 2.5 mm depth of penetration. On postinjury day 1, balance beam, rotorod performance, and posture reflexes were evaluated. Motor outcome was increasingly impaired with increasing injury levels, with the pattern of deficits showing a step-like function. Cognitive deficits, assessed using water maze on day 7, were more severe for the 2.5-mm group than for the 1.6-mm injury group, while the 1.0-mm group did not differ from the sham controls. In experiments II-IV, hypothermia, 30 degreesC for 3-h duration or normothermia was applied to three injury levels: 1.0 mm, the least cortical deformation; 2.5 mm, the most deformation; and 1.6 mm, representing a level in-between. Neurologic outcome was assessed relative to shams on postinjury days 1, 3, and 5. The 1.0-mm group exhibited small deficits that recovered completely by day 3; the 1.6-mm group recovered to the level of shams by day 5, and the 2.5-mm group did not show significant recovery during the testing period. Hypothermia effectively attenuated behavioral deficits for the 1.6-mm group, but had no effect on the other two groups. These three observations-that increasing injury severity is associated with increasing motor and cognitive deficits, that injury severity is related to recovery time, and that hypothermia treatment is selectively effective-have each been reported in the human TBI population; thus, moderate cortical impact injury in rats may be a model with clinical predictability for evaluating neuroprotective therapies.	Univ Texas, Dept Neurosurg, Vivian L Smith Fdn Neurol Res, Sch Med, Houston, TX 77030 USA		Markgraf, CG (corresponding author), Univ Texas, Dept Neurosurg, Vivian L Smith Fdn Neurol Res, Sch Med, 6431 Fannin St,Ste 7-136, Houston, TX 77030 USA.						BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; BULLOCK R, 1996, NEUROTRAUMA, P375; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; CLIFTON GL, 1989, STROKE, V20, P1545, DOI 10.1161/01.STR.20.11.1545; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; CLIFTON GL, 1983, CLIN NEUROSCIENCES, P1269; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; DIXON CE, 1991, J NEUROSCI METH, V39, P253; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOODMAN JC, 1994, J NEUROTRAUM, V11, P587, DOI 10.1089/neu.1994.11.587; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; LEVIN HS, 1992, J NEUROTRAUM, V9, pS359; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MUIZELAAR JP, 1989, TXB HEAD INJURY, P221; ONESTI ST, 1991, NEUROSURGERY, V29, P369, DOI 10.1227/00006123-199109000-00005; PERSSON L, 1989, STROKE, V20, P641, DOI 10.1161/01.STR.20.5.641; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; RIDENOUR TR, 1992, STROKE, V23, P733, DOI 10.1161/01.STR.23.5.733; Saatman KE, 1996, P NATL ACAD SCI USA, V93, P3428, DOI 10.1073/pnas.93.8.3428; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Smith SL, 1996, J NEUROTRAUM, V13, P1, DOI 10.1089/neu.1996.13.1; WARNER DS, 1993, ANESTHESIOLOGY, V79, P985, DOI 10.1097/00000542-199311000-00017; WELSH FA, 1990, J CEREBR BLOOD F MET, V10, P557, DOI 10.1038/jcbfm.1990.98	34	20	20	0	6	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	FEB	2001	18	2					175	186		10.1089/08977150150502604			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	402PW	WOS:000166998200005	11229710				2022-02-06	
J	Walker, R; Staton, M; Leukefeld, CG				Walker, R; Staton, M; Leukefeld, CG			History of head injury among substance users: Preliminary findings	SUBSTANCE USE & MISUSE			English	Article						service utilization; incarcerated males; drug abuse	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; SHORT-TERM-MEMORY; ABUSE; IMPAIRMENT; ALCOHOLICS; DEFICITS	Traumatic brain injury is associated with a variety of problems in cognitive functioning that may be related to substance use and that may influence recovery. This pilot study of 591 inmates in medium and minimum-security prisons examined self-reports of head injury, mental health problems, and health service utilization in three groups: no head injury, one head injury, and two or more head injuries. The group with multiple head injuries reported significantly more emergency room visits, more hospital admission, and number of hospital stays when compared with those with no head injury. This preliminary analysis reflects a need for additional research on brain injury among substance misusers.	Ctr Drug & Alcohol Res, Lexington, KY 40506 USA		Walker, R (corresponding author), Ctr Drug & Alcohol Res, 333 Bowman Hall, Lexington, KY 40506 USA.	jrwalkO@pop.uky.edu			NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [DA 11309-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA011309] Funding Source: NIH RePORTER		AMEN DG, 1992, J PSYCHOACTIVE DRUGS, V29, P307; BOND MR, 1986, NEUROPSYCHOLOGICAL A, P347; BOYLE MJ, 1991, J ROY SOC MED, V84, P608; BREMNER JD, 1993, AM J PSYCHIAT, V150, P1015; Bremner JD, 1995, PSYCHIAT RES, V59, P97; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Brown BS, 1997, TREATING DRUG ABUSER, P99; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; DIKMEN SS, 1993, J HEAD TRAUMA REHAB, V8, P30, DOI DOI 10.1097/00001199-199309000-00005; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; DUFFY JD, 1994, J NEUROPSYCH CLIN N, V6, P379; FOGEL BS, 1994, J NEUROPSYCH CLIN N, V6, P343; Halgren Eric, 1995, P1137; HARDEN PW, 1997, ADDICTIVE BEHAV READ, P488; Hart T, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P133; HESTAD K, 1995, SCAND J PSYCHOL, V36, P246, DOI 10.1111/j.1467-9450.1995.tb00984.x; Kaplan HI, 1998, SYNOPSIS PSYCHIAT BE; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; Kraus Jess F., 1994, P3; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Malec JF, 1999, EVALUATION AND TREATMENT OF MILD TRAUMATIC BRAIN INJURY, P15; MCALLISTER TW, 1994, EVALUATION TREATMENT, P347; MEEK PS, 1989, J PSYCHOACTIVE DRUGS, V21, P153, DOI 10.1080/02791072.1989.10472155; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; Moes Elisabeth, 1994, P217; Morse Philip A., 1994, P107; Nixon SJ, 1999, PSYCHOL SCI, V10, P181, DOI 10.1111/1467-9280.00130; PIHL RO, 1995, ALCOHOL HEALTH RES W, V19, P142; Raine A, 1993, PSYCHOPATHOLOGY CRIM; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; SAPOLSKY RM, 1990, PROG BRAIN RES, V86, P13; Shallice T., 1998, FRONTAL CORTEX, P22; SILVER JM, 1997, AM PSYCHIAT PRESS TX, P521; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; SOLOMON RA, 1992, NEUROSURG QUART, V2, P1; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; SPARADEO FR, 1992, NEUROREHABILITATION, V2, P65; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Volavka J., 1995, NEUROBIOLOGY VIOLENC; WEINBERGER NM, BRAIN ORG MEMORY CEL, P285	40	20	20	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1082-6084	1532-2491		SUBST USE MISUSE	Subst. Use Misuse		2001	36	6-7					757	770		10.1081/JA-100104089			14	Substance Abuse; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Substance Abuse; Psychiatry; Psychology	455PH	WOS:000170034900006	11697609				2022-02-06	
J	McCluskey, AE				McCluskey, AE			Paid attendant carers hold important and unexpected roles which contribute to the lives of people with brain injury	BRAIN INJURY			English	Article							CAREGIVER; SERVICES	Objective: Paid attendant carers spend many hours assisting people with a brain injury. Despite this considerable responsibility, most carers receive little support or training and their roles are often ill-defined. This exploratory study set out to define the key roles of paid carers. Method: Ten semi-structured interviews were conducted. Perspectives were sought from 10 participants: five people with a traumatic brain injury and five paid carers. A computer software package, NUD*IST was used during analysis to help identify and categorize commonly recurring themes. Results: Five major roles were identified: Attendant, Protector, Friend, Coach and Negotiator. Friendship was the most important aspect of the care relationship for three of the people with a brain injury, most of whom had lost their pre-injury friends and associates. Carers were required to negotiate frequently with clients and their families, and with other service providers. Sound communication skills were required. Conclusion: In addition to further research, industry guidelines are required which take account of the wider suite of roles fulfilled by paid carers, address training and support needs, and occupational health and safety issues.	Univ Western Sydney Macarthur, Fac Hlth, Div Occupat Therapy, Campbelltown, NSW 2560, Australia		McCluskey, AE (corresponding author), Univ Western Sydney Macarthur, Fac Hlth, Div Occupat Therapy, POB 555, Campbelltown, NSW 2560, Australia.						*ALL OEH I, 1990, MAK FRIENDS DEV REL; AMADO AN, 1990, FRIENDS MANUAL CONNE; ATKINS BJ, 1982, J REHABIL, V48, P20; Beatty PW, 1998, ARCH PHYS MED REHAB, V79, P674, DOI 10.1016/S0003-9993(98)90043-0; Bell, 1981, WORLDS FRIENDSHIP; Carr J, 1998, NEUROLOGICAL REHABIL, P23; Cichon E. J., 1993, COMMUNICATION Q, V41, P477, DOI [10.1080/01463379309369907, DOI 10.1080/01463379309369907]; FISHER CB, 1989, FAM RELAT, V38, P83, DOI 10.2307/583615; *FOC LEARN SYST, 1998, TRAIN NEEDS ATT CAR; Frosch S, 1997, BRAIN INJURY, V11, P891; Gilson S F, 1997, J Case Manag, V6, P13; Hardy ME, 1988, ROLE THEORY PERSPECT, P159; HUTCHINS RK, 1978, AM REHABILITATION, V4, P18; Law MJS, 1998, CLIENT CTR OCCUPATIO; Lutfiya Z. M., 1993, FRIENDSHIPS COMMUNIT, P97; Magill R. A., 1993, MOTOR LEARNING CONCE; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McColl MA, 1998, BRAIN INJURY, V12, P15, DOI 10.1080/026990598122827; Miller E L, 1987, Rehabil Nurs, V12, P185; MORSE JM, 1991, J ADV NURS, V16, P455, DOI 10.1111/j.1365-2648.1991.tb03436.x; NOSEK MA, 1991, REHABIL COUNS BULL, V35, P105; Nosek MA, 1990, J APPLIED REHABILITA, V21, P3, DOI [10.1891/0047-2220.21.4.3, DOI 10.1891/0047-2220.21.4.3]; Opie N D, 1989, Arch Psychiatr Nurs, V3, P205; Parsons T., 1951, SOCIAL SYSTEM; Perske R., 1988, CIRCLES FRIENDS PEOP; PRINCE JM, 1995, ARCH PHYS MED REHAB, V76, P919, DOI 10.1016/S0003-9993(95)80067-0; Rees RJ, 1996, AUST J SOC ISSUES, V31, P392, DOI 10.1002/j.1839-4655.1996.tb01286.x; RICHARDS T, 1991, QUALITATIVE SOCIOLOG, V14, P289; SHOULTZ B, 1995, VARIETY COMMUNITY EX, P9; SMITH NK, 1981, REHABIL LIT, V42, P258; Stake R., 1995, ART CASE STUDY RES; STAMP GH, 1994, COMMUN MONOGR, V61, P89, DOI 10.1080/03637759409376327; STELMACH M, 1981, REHABIL LIT, V42, P130; Strauss A., 1998, BASICS QUALITATIVE R, V2nd Edition; WELLS J, 1993, FRIENDSHIPS COMMUNIT, P197; WILLER B, 1994, BRAIN INJURY, V8, P647, DOI 10.3109/02699059409151017; Zencius AH, 1999, BRAIN INJURY, V13, P723; [No title captured]	38	20	20	0	0	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2000	14	11					943	957		10.1080/02699050050191896			15	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	373UC	WOS:000165306800001	11104135				2022-02-06	
J	Dawson, DR; Levine, B; Schwartz, M; Stuss, DT				Dawson, DR; Levine, B; Schwartz, M; Stuss, DT			Quality of life following traumatic brain injury: A prospective study	BRAIN AND COGNITION			English	Article							STATE	The purpose of this study was to describe QOL following TBI and to determine whether early signs of injury severity predict QOL at 4 years postinjury. Early measures included Glasgow Coma Scale, loss of consciousness (LOC), and a measure of PTA (days to recall of three words (REC)). Quality of life measures included the Reintegration to Normal Living Index, Flanagan's QOL Scale, and a single QOL item. Subjects (n = 49) seen at follow-up (mean 4.4 years postinjury) had a significantly longer LOC than those lost to follow-up (n = 43). Results showed that 70 to 80% of subjects reported a good QOL. Multivariate regression showed REC to be the only significant predictor of QOL. These findings suggest that factors other than injury severity and PTA contributing to QOL. (C) 2000 Academic Press.	Univ Toronto, Toronto, ON, Canada		Dawson, DR (corresponding author), Univ Toronto, 100 Coll St, Toronto, ON, Canada.		Dawson, Deirdre R/I-8882-2014; Levine, Brian/O-2725-2019	Dawson, Deirdre R/0000-0001-7517-6121; Levine, Brian/0000-0003-4343-811X			FLANAGAN JC, 1982, ARCH PHYS MED REHAB, V63, P56; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; WOODDAUPHINEE SL, 1988, ARCH PHYS MED REHAB, V69, P583	5	20	20	0	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					35	39					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300009					2022-02-06	
J	Pelletier, PM; Alfano, DP				Pelletier, PM; Alfano, DP			Depression, social support, and family coping following traumatic brain injury	BRAIN AND COGNITION			English	Article							CAREGIVERS	Relationships among variables related to patients' psychological functioning and family coping following traumatic brain injury (TBI) were investigated in a sample of 13 matched pairs of patients and family members. Patient depression and perceived stress were examined in relation to perceived social support from family/friends, family coping, and perceived family stress. Greater perceived social support from family was related to lower reported levels of patient depression and perceived stress. Family coping style was also related to patient perceived stress and depression. Family stress due to greater patient physical limitations was related to lower patient depression and perceived stress. The findings of this study clearly suggest an important link between family environment and patient functioning following TBI which has implications For intervention with patients and families. (C) 2000 Academic Press.	London Hlth Sci Ctr, London, ON, Canada; Univ Regina, Regina, SK S4S 0A2, Canada		Pelletier, PM (corresponding author), London Hlth Sci Ctr, London, ON, Canada.						Florian V, 1991, NEUROPSYCHOLOGY, V5, P267, DOI DOI 10.1037/0894-4105.5.4.267; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Pelletier P M, 1994, Appl Neuropsychol, V1, P38, DOI 10.1207/s15324826an0101&2_8; Sander AM, 1997, BRAIN INJURY, V11, P235, DOI 10.1080/026990597123548	5	20	21	0	4	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0278-2626			BRAIN COGNITION	Brain Cogn.	OCT	2000	44	1					45	49					5	Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	358FJ	WOS:000089547300012					2022-02-06	
J	Yamaguchi, S; Nakahara, K; Miyagi, T; Tokutomi, T; Shigemori, M				Yamaguchi, S; Nakahara, K; Miyagi, T; Tokutomi, T; Shigemori, M			Neurochemical monitoring in the management of severe head-injured patients with hypothermia	NEUROLOGICAL RESEARCH			English	Article						severe head injury; glutamate; aspartate; NO2; microdialysis; hypothermia	TRAUMATIC BRAIN INJURY; EXCITATORY AMINO-ACIDS; FOCAL CEREBRAL-ISCHEMIA; NITRIC-OXIDE; MILD HYPOTHERMIA; MODERATE HYPOTHERMIA; INTRACEREBRAL MICRODIALYSIS; NEURONAL DEATH; RAT-BRAIN; GLUTAMATE	The neuroprotective action and effect of hypothermia on the neurochemical system is not well understood. The present study was performed using six patients with GCS scores of 5 or less to clarify the relationship between monitored brain temperature, intracranial pressure (ICP) cerebral perfusion pressure (CPP) and oxygen saturation of the jugular venous blood (SjO(2)). Changes in concentration of excitatory amino acids, glutamate (GLU) and aspartate (ASP) and NO2 were studied using intracerebral microdialysis as well as in jugular venous blood and cerebrospinal fluid (CSF). Changes in brain temperature, CPP and SjO(2) resulting from hypothermia and brain death associated with markedly higher concentrations of and fluctuations in the concentrations of GLU, ASP and NO2 were observed in the dialysate than in the jugular venous blood or CSF. Hypothermic treatment significantly reduces excitatory amino acid and NO2 concentrations, a finding which was associated with an improvement in CPP and SjO(2). Measurement of GLU and ASP using intracerebral microdialysis is a clinically useful method for clarifying abnormal neurochemical events associated with severe head injury and for evaluating the effects of hypothermia.	Kurume Univ, Sch Med, Dept Neurosurg, Kurume, Fukuoka 830, Japan		Yamaguchi, S (corresponding author), Kurume Univ, Sch Med, Dept Neurosurg, 67 Asahi Machi, Kurume, Fukuoka 830, Japan.						ALBINA JE, 1993, J IMMUNOL, V150, P5080; ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; BUCHAN A, 1990, J NEUROSCI, V10, P311; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHAO CC, 1992, J IMMUNOL, V149, P2736; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOPP M, 1989, J CEREBR BLOOD F MET, V9, P141, DOI 10.1038/jcbfm.1989.21; CHRISTOPH M, 1996, J NEUROSURG, V85, P533; CLERK RSB, 1996, CRIT CARE MED, V24, P1243; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; DAWSON TM, 1992, ANN NEUROL, V32, P297, DOI 10.1002/ana.410320302; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HAGBERG H, 1987, NEUROSCI LETT, V78, P311, DOI 10.1016/0304-3940(87)90379-X; HILLERED L, 1990, J CEREBR BLOOD F MET, V10, P149; ICHIMORI K, 1994, REV SCI INSTRUM, V65, P2714, DOI 10.1063/1.1144674; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KADER A, 1994, NEUROSURGERY, V35, P272, DOI 10.1227/00006123-199408000-00013; KANTHAN R, 1995, J NEUROL NEUROSUR PS, V59, P326, DOI 10.1136/jnnp.59.3.326; KEHR J, 1988, J NEUROCHEM, V51, P1308, DOI 10.1111/j.1471-4159.1988.tb03101.x; KORF J, 1985, J NEUROCHEM, V45, P1341, DOI 10.1111/j.1471-4159.1985.tb07198.x; LINDROTH P, 1979, ANAL CHEM, V51, P1667, DOI 10.1021/ac50047a019; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; MITANI A, 1991, NEUROSCIENCE, V42, P661, DOI 10.1016/0306-4522(91)90035-M; MONCADA S, 1992, ACTA PHYSIOL SCAND, V145, P201, DOI 10.1111/j.1748-1716.1992.tb09359.x; NAKAHARA K, 1994, J KURUME MED ASS, V57, P1131; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; Saveland H, 1996, NEUROSURGERY, V38, P12, DOI 10.1097/00006123-199601000-00004; Shiozaki T, 1998, J NEUROSURG, V89, P206, DOI 10.3171/jns.1998.89.2.0206; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Wieloch T, 1985, Neurol Res, V7, P24	41	20	20	0	0	FOREFRONT PUBL GROUP	WILTON	C/O MARY J RAWLINS, 5 RIVER RD, STE 113, WILTON, CT 06897 USA	0161-6412			NEUROL RES	Neurol. Res.	OCT	2000	22	7					657	664					8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	373LH	WOS:000165290600002	11091969				2022-02-06	
J	Zafonte, RD; Lexell, J; Cullen, N				Zafonte, RD; Lexell, J; Cullen, N			Possible applications for dopaminergic agents following traumatic brain injury: Part 1	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							LEVODOPA; PERGOLIDE; APHASIA; AGONIST		Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; UPMC Hlth Syst, Clin Rehabil Serv, Pittsburgh, PA 15260 USA; Univ Lund Hosp, Dept Rehabil Med, Brain Injury Unit, S-22185 Lund, Sweden; Univ Toronto, Toronto, ON, Canada; Toronto Rehabil Program, Neurorehab Program, Toronto, ON, Canada		Zafonte, RD (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.			Lexell, Jan/0000-0001-5294-3332; Cullen, Nora/0000-0001-6359-9418			ALBERT ML, 1988, NEUROLOGY, V38, P877, DOI 10.1212/WNL.38.6.877; Barbier P, 1997, J NEURAL TRANSM, V104, P867, DOI 10.1007/BF01285554; DOBKIN BH, 1993, ANN NEUROL, V33, P313, DOI 10.1002/ana.410330315; Durif F, 1999, DRUG AGING, V14, P337, DOI 10.2165/00002512-199914050-00002; Gupta SR, 1995, NEUROLOGY, V45, P2170, DOI 10.1212/WNL.45.12.2170; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; KRAUS M, 1887, BRIAN INJURY, V11, P455; Kulisevsky J, 1996, BRAIN, V119, P2121, DOI 10.1093/brain/119.6.2121; Lal S, 1988, Brain Inj, V2, P225, DOI 10.3109/02699058809150946; McDowell S, 1998, BRAIN, V121, P1155, DOI 10.1093/brain/121.6.1155; Shaunak S, 1999, J NEUROL NEUROSUR PS, V66, P79, DOI 10.1136/jnnp.66.1.79; Tang YP, 1997, BEHAV BRAIN RES, V83, P189, DOI 10.1016/S0166-4328(97)86067-6	12	20	21	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704 USA	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	2000	15	5					1179	1182		10.1097/00001199-200010000-00014			4	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	359DT	WOS:000089596800014	10970937				2022-02-06	
J	Duncan, MA; Dowd, N; Rawluk, D; Cunningham, AJ				Duncan, MA; Dowd, N; Rawluk, D; Cunningham, AJ			Traumatic bilateral internal carotid artery dissection following airbag deployment in a patient with fibromuscular dysplasia	BRITISH JOURNAL OF ANAESTHESIA			English	Article						complications, accidents; complications, trauma; complications, fibromuscular dysplasia; arteries, carotid		This case describes a 39-yr-old male, presenting with left hemiplegia after a road traffic accident involving frontal deceleration and airbag deployment. Brain computerized tomography (CT) scan revealed a right parietal lobe infarct. Contrast angiography demonstrated bilateral internal carotid artery dissection and fibromuscular dysplasia. The patient was treated with systemic heparinization. Neurological improvement, evidenced by full return of touch sensation, proprioception and nociception began 10 days after the injury. To our knowledge, this is the first case report of carotid artery dissection associated with airbag deployment. Forced neck extension in such settings may result in carotid artery dissection because of shear force injury at the junction of the extracranial and intrapetrous segments of the vessel. Clinicians should consider carotid artery injury when deterioration in neurological status occurs after airbag deployment, We propose that the risk of carotid artery dissection was increased by the presence of fibromuscular dysplasia.	Beaumont Hosp, Dept Anaesthesia Intens Care Med & Neurosurg, Dublin 9, Ireland		Duncan, MA (corresponding author), Beaumont Hosp, Dept Anaesthesia Intens Care Med & Neurosurg, Beaumont Rd, Dublin 9, Ireland.						BIOUSSE V, 1995, STROKE, V26, P235, DOI 10.1161/01.STR.26.2.235; Eachempati SR, 1998, J TRAUMA, V44, P406, DOI 10.1097/00005373-199802000-00035; Fabian TC, 1996, ANN SURG, V223, P513, DOI 10.1097/00000658-199605000-00007; HACKE W, 1995, INTENS CARE MED, V21, P856, DOI 10.1007/BF01700973; Hart R G, 1983, Neurol Clin, V1, P155; Maxeiner H, 1997, J TRAUMA, V42, P1148, DOI 10.1097/00005373-199706000-00029; Mikhail J N, 1997, J Emerg Nurs, V23, P439, DOI 10.1016/S0099-1767(97)90138-0; MOKRI B, 1986, ANN NEUROL, V19, P126, DOI 10.1002/ana.410190204; Perez J, 1996, ANN EMERG MED, V28, P722, DOI 10.1016/S0196-0644(96)70099-9; PERRY MO, 1995, VASCULAR SURG, P705; PORTER JM, 1993, VASCULAR SURG COMPRE, P108; Schievink WI, 1996, CLIN NEUROPATHOL, V15, P2	12	20	20	0	2	PROF SCI PUBL	LONDON	TAVISTOCK HOUSE EAST, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-0912			BRIT J ANAESTH	Br. J. Anaesth.	SEP	2000	85	3					476	478		10.1093/bja/85.3.476			3	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	351UL	WOS:000089176500027	11103196	Bronze			2022-02-06	
J	Passineau, MJ; Zhao, W; Busto, R; Dietrich, WD; Alonso, O; Loor, JY; Bramlett, HM; Ginsberg, MD				Passineau, MJ; Zhao, W; Busto, R; Dietrich, WD; Alonso, O; Loor, JY; Bramlett, HM; Ginsberg, MD			Chronic metabolic sequelae of traumatic brain injury: prolonged suppression of somatosensory activation	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						deoxyglucose; autoradiography; trauma; barrel circuit; vibrissae	CEREBRAL GLUCOSE-UTILIZATION; BLOOD-FLOW; POSTTRAUMATIC HYPOTHERMIA; INTRALUMINAL SUTURE; DISPARITY ANALYSIS; ARTERY OCCLUSION; DYNAMIC CHANGES; RAT; APOPTOSIS; AUTORADIOGRAPHY	Injuries to the brain acutely disrupt normal metabolic function and may deactivate functional circuits. It is unknown whether these metabolic abnormalities improve over time. We used 2-deoxyglucose (2-DG) autoradiographic image-averaging to assess local cerebral glucose utilization (1CMR(Glc)) of the rat brain 2 mo after moderate (1.7-2.1 atm) fluid-percussion traumatic brain injury (FPI). Four animal groups (n = 5 each) were studied: sham-injured rats with and without stimulation of the vibrissae-barrel field ipsilateral to injury; and animals with prior FPI, with or without this stimulation. In sham-injured rats, resting 1CMR(Glc) was normal, and vibrissae stimulation produced right-sided metabolic activation of the ventrolateral thalamic and somatosensory-cortical projection areas. In rats with prior injury, 1CMR(Glc) contralateral to injury was normal, but 1CMR(Glc) of the ipsilateral forebrain was depressed by similar to 38-45% compared with shams. Whisker stimulation in rats with prior trauma failed to induce metabolic activation of either cortex or thalamus. Image-mapping of histological material obtained in the same injury model was undertaken to assess the possible influence of injury-induced regional brain atrophy on computed 1CMR(Glc); an effect was found only in the lateral cortex at the trauma epicenter. Our results show that, 2 mo after trauma, resting cerebral metabolic perturbations persist, and the whisker-barrel somatosensory circuit shows no signs of functional recovery.	Univ Miami, Sch Med, Cerebral Vasc Dis Res Ctr, Dept Neurol D4 5, Miami, FL 33101 USA; Univ Miami, Sch Med, Cerebral Vasc Dis Res Ctr, Dept Neurol Surg, Miami, FL 33101 USA; Univ Miami, Sch Med, Program Neurosci, Miami, FL 33101 USA; Univ Miami, Sch Med, Neurotrauma Res Ctr, Miami, FL 33101 USA		Ginsberg, MD (corresponding author), Univ Miami, Sch Med, Cerebral Vasc Dis Res Ctr, Dept Neurol D4 5, POB 016960, Miami, FL 33101 USA.	mdginsberg@stroke.med.miami.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS-30291, NS-05820] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS005820, P50NS030291, P01NS005820] Funding Source: NIH RePORTER		Belayev L, 1997, J CEREBR BLOOD F MET, V17, P1266, DOI 10.1097/00004647-199712000-00002; BELFORD GR, 1979, J COMP NEUROL, V183, P305, DOI 10.1002/cne.901830207; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Bramlett HM, 1997, BRAIN RES, V762, P195, DOI 10.1016/S0006-8993(97)00387-9; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Conti AC, 1998, J NEUROSCI, V18, P5663; COX SB, 1993, J CEREBR BLOOD F MET, V13, P899, DOI 10.1038/jcbfm.1993.113; DIETRICH WD, 1994, J NEUROTRAUM, V11, P629, DOI 10.1089/neu.1994.11.629; DIETRICH WD, 1986, J CEREBR BLOOD F MET, V6, P405, DOI 10.1038/jcbfm.1986.73; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; GINSBERG MD, 1989, J CEREBR BLOOD F MET, V9, P329, DOI 10.1038/jcbfm.1989.51; Ginsberg MD, 1997, AM J PHYSIOL-HEART C, V272, pH2859, DOI 10.1152/ajpheart.1997.272.6.H2859; GINSBERG MD, 1987, NEUROLOGY, V37, P11, DOI 10.1212/WNL.37.1.11; HOVDA DA, 1991, BRAIN RES, V567, P1, DOI 10.1016/0006-8993(91)91429-5; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Sasaki M, 1993, Nihon Ika Daigaku Zasshi, V60, P215; SAVAKI HE, 1980, J NEUROCHEM, V35, P495, DOI 10.1111/j.1471-4159.1980.tb06293.x; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Thatte U, 1997, DRUGS, V54, P511, DOI 10.2165/00003495-199754040-00002; VANDERLOOS H, 1976, NEUROSCI LETT, V2, P1, DOI 10.1016/0304-3940(76)90036-7; WELKER C, 1974, J COMP NEUROL, V158, P437, DOI 10.1002/cne.901580405; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yang XJ, 1996, P NATL ACAD SCI USA, V93, P475, DOI 10.1073/pnas.93.1.475; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; ZHAO WZ, 1995, J CEREBR BLOOD F MET, V15, P552, DOI 10.1038/jcbfm.1995.69; Zhao WZ, 1999, J NEUROSURG, V90, P510, DOI 10.3171/jns.1999.90.3.0510; Zhao WZ, 1997, J CEREBR BLOOD F MET, V17, P1281, DOI 10.1097/00004647-199712000-00003; ZHAO WZ, 1993, IEEE T MED IMAGING, V12, P782, DOI 10.1109/42.251130; Zilles K, 1985, CORTEX RAT	34	20	20	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	SEP	2000	279	3					H924	H931		10.1152/ajpheart.2000.279.3.H924			8	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Physiology	355HC	WOS:000089379400007	10993751				2022-02-06	
J	Vinall, PE; Kramer, MS; Heinel, LA; Rosenwasser, RH				Vinall, PE; Kramer, MS; Heinel, LA; Rosenwasser, RH			Temporal changes in sensitivity of rats to cerebral ischemic insult	JOURNAL OF NEUROSURGERY			English	Article						cerebral infarction; circadian rhythm; middle cerebral artery occlusion; brain swelling; rat	PERMANENT FOCAL ISCHEMIA; TRAUMATIC BRAIN INJURY; MILD HYPOTHERMIA; INFLAMMATORY RESPONSE; CIRCADIAN VARIATION; INFARCT SIZE; MODEL; TEMPERATURE; RHYTHMS; ONSET	Object. Experimental rat models are often used to study cerebral ischemia, yet rats are nocturnal animals that have activity cycles that are the opposite of those of humans. In the following study the authors examined the circadian rhythm of sensitivity to an ischemic insult in rats by using an intraluminal thread technique to produce reversible middle cerebral artery occlusion. Methods. Ischemia (2 hours of blockage followed by 22 hours of reperfusion) was induced in rats according to the 24-hour clock at either 100, 400, 700, 1000, 1300, 1600, 1900, or 2200 hours (11-14 rats per time period). The rat brains were removed, coronally sectioned, stained with 3,3,5-triphenyltetrazolium chloride and analyzed using commercially available software. Analysis of variance and cosinor-rhythmometry statistical tests were used for analysis of data. The time of day when the ischemic infarct was induced had a significant (p = 0.011) influence on the volume of the lesion. The volume of total brain infarct produced at 400 hours (7.65 +/- 1.31%) was more than three times greater than the volume produced at 1600 hours (2.1 +/- 0.34%). Cosinor-rhythm analysis indicated a peak occurrence of infarct volume at 6:02 (95% confidence interval 5:49-6:16). The size of the infarct correlated with core body temperature rhythms, which varied by 1.3 +/- 0.62 degrees C (mean +/- standard deviation). Conclusions. Circadian rhythms, as well as the reversed natural body rhythms of the rat compared with humans, should be considered when extrapolating data to human or other animal studies. Temporal rhythms may also provide information concerning the cascading disease processes associated with cerebral ischemia.	Thomas Jefferson Univ, Dept Neurosurg, Field Lab Cerebrovasc Res, Philadelphia, PA 19107 USA; Penn Hosp, Neurosci Res Inst, Philadelphia, PA 19107 USA		Heinel, LA (corresponding author), Thomas Jefferson Univ, Dept Neurosurg, Field Lab Cerebrovasc Res, 305 Coll Bldg,1025 Walnut St, Philadelphia, PA 19107 USA.	Lynn.Heinel@mail.tju.edu	ROSENWASSER, ROBERT H/L-2482-2014				AHLERSOVA E, 1986, PHYSIOL BOHEMOSLOV, V35, P233; ARONOWSKI J, 1994, STROKE, V25, P2235, DOI 10.1161/01.STR.25.11.2235; BAKER CJ, 1995, NEUROSURGERY, V36, P994, DOI 10.1227/00006123-199505000-00016; Barone FC, 1997, NEUROSCI BIOBEHAV R, V21, P31, DOI 10.1016/0149-7634(95)00080-1; BRUGUEROLLE B, 1994, BIOL RHYTHMS CLIN LA, P114; BUCHAN AM, 1992, STROKE, V23, P273, DOI 10.1161/01.STR.23.2.273; BUREAU JP, 1991, INT J TISSUE REACT, V13, P203; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CICCIARELLO R, 1993, CHILD NERV SYST, V9, P25, DOI 10.1007/BF00301931; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; COHEN M, 1978, THROMB RES, V12, P965, DOI 10.1016/0049-3848(78)90052-X; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; DIETRICH WD, 1990, J NEUROPATH EXP NEUR, V49, P486, DOI 10.1097/00005072-199009000-00004; DUVERGER D, 1988, J CEREBR BLOOD F MET, V8, P449, DOI 10.1038/jcbfm.1988.86; Escott KJ, 1998, J CEREBR BLOOD F MET, V18, P281, DOI 10.1097/00004647-199803000-00006; FOX G, 1993, STROKE, V24, P2087, DOI 10.1161/01.STR.24.12.2087; FRAZZINI VI, 1994, NEUROSURGERY, V34, P1040, DOI 10.1227/00006123-199406000-00013; Ginsberg MD, 1996, ARCH NEUROL-CHICAGO, V53, P1065, DOI 10.1001/archneur.1996.00550100151024; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; KADER A, 1992, NEUROSURGERY, V31, P1056, DOI 10.1227/00006123-199212000-00011; KADER A, 1993, STROKE, V24, P1709, DOI 10.1161/01.STR.24.11.1709; KUSUMOTO K, 1992, BRAIN RES, V576, P147, DOI 10.1016/0006-8993(92)90621-F; LABRECQUE G, 1995, PHARMACOL THERAPEUT, V66, P285, DOI 10.1016/0163-7258(94)00082-E; LABRECQUE G, 1988, ANN REV CHRONOPHARMA, V5, P445; LEMMER B, 1974, N-S ARCH PHARMACOL, V282, P75, DOI 10.1007/BF00647404; LEMMER B, 1994, BIOL RHYTHMS CLIN LA, P418; LEMMER B, 1989, CHRONOPHARMACOLOGY C, P252; LEVI F, 1991, ANN NY ACAD SCI, V618, P312, DOI 10.1111/j.1749-6632.1991.tb27251.x; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; Manev H, 1996, FASEB J, V10, P1546, DOI 10.1096/fasebj.10.13.8940301; Manev H, 1998, J Stroke Cerebrovasc Dis, V7, P165, DOI 10.1016/S1052-3057(98)80002-5; MARSHALL J, 1977, STROKE, V8, P230, DOI 10.1161/01.STR.8.2.230; MARSHALL SB, 1956, ARCH SURG-CHICAGO, V72, P98; MASUKAWA T, 1993, JPN J PHARMACOL, V61, P197, DOI 10.1254/jjp.61.197; MINEMATSU S, 1995, EXP ANIM TOKYO, V44, P223, DOI 10.1538/expanim.44.223; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Park CK, 1998, ACT NEUR S, V71, P225; RIDENOUR TR, 1992, STROKE, V23, P733, DOI 10.1161/01.STR.23.5.733; SCHEVING LE, 1967, ANAT REC, V157, P657, DOI 10.1002/ar.1091570411; SLOAN MA, 1992, STROKE, V23, P1420, DOI 10.1161/01.STR.23.10.1420; SMOLENSKY MH, 1976, CHRONOBIOLOGIA, V3, P337; Soares HD, 1995, J NEUROSCI, V15, P8223; SOLOMON GD, 1992, CLEV CLIN J MED, V59, P326, DOI 10.3949/ccjm.59.3.326; SOULBAN G, 1989, LIFE SCI, V45, P2485, DOI 10.1016/0024-3205(89)90015-5; THOMAS G, 1986, J PHARM PHARMACOL, V38, P936, DOI 10.1111/j.2042-7158.1986.tb03390.x; TONI D, 1991, CHRONOBIOL INT, V8, P321, DOI 10.3109/07420529109059168; TURNERWARWICK M, 1988, AM J MED, V85, P6, DOI 10.1016/0002-9343(88)90231-8	48	20	20	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2000	93	1					82	89		10.3171/jns.2000.93.1.0082			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	327UW	WOS:000087813100012	10883909				2022-02-06	
J	Keller, M; Hiltbrunner, B; Dill, C; Kesselring, J				Keller, M; Hiltbrunner, B; Dill, C; Kesselring, J			Reversible neuropsychological deficits after mild traumatic brain injury	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article						brain injury; attention; neuropsychology	HEAD-INJURY; WHIPLASH INJURY; FOLLOW-UP; ATTENTION	Objectives-To determine the influence of motivation on performance in a divided attention test of patients after mild traumatic brain injury (MBI). Methods-Comparison of the performance of 12 patients with MBI with 10 patients with severe brain injury (SBI) and 11 healthy controls in a computer supported divided attention task before (T1) and after (T2) verbal motivation. Results-At T1, the MBI group performed the same as the SBI group but significantly worse than the controls in all variables. At T2, the MBI group performed worse than the controls at T2 but the results were equal to the results of the controls at T1 and significantly better than the SBI group at T1 or T2. At T2 the MBI group performed at the level of published norms for the rest. Conclusion-Before verbal motivation the MBI group's results in the divided attention task were comparable with those from patients with severe brain injury. They failed to exploit their performance potential when it depended on self motivation but were able to perform at the level of the control group when external motivation was applied.	Rehabil Ctr Valens, Dept Neurol, CH-7317 Valens, Switzerland; Suva, CH-6002 Luzern, Switzerland		Keller, M (corresponding author), Rehabil Ctr Valens, Dept Neurol, CH-7317 Valens, Switzerland.	b.rutz@klinik-valens.ch					ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; ANDERSON SW, 1996, HEAD INJURY POSTCONC, V23, P457; BATCHELOR J, 1995, CLIN NEUROPSYCHOL, V9, P180, DOI 10.1080/13854049508401600; BERG M, 1992, BENUTZERHANDBUCH ZUM; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; BRENNER H, 1981, Z KLIN PSYCHOL-FORSC, V10, P167; Cassens G, 1990, J Neuropsychiatry Clin Neurosci, V2, P202; Cicerone KD, 1996, BRAIN INJURY, V10, P79, DOI 10.1080/026990596124566; DEBRUNNER HU, 1996, SUMEST MED STAT SUVA; FISCHER R, 1998, SUMEST MED STAT SUVA; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Goldstein G, 1998, HUMAN BRAIN FUNCT, P63; Goldstein K, 1942, EFFECTS BRAIN INJURI; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; KEIDEL M, 1992, NERVENARZT, V63, P731; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A, V7, P170; Mcclelland D.C., 1969, MOTIVATING EC ACHIEV; Mesulam M -M, 1985, PRINCIPLES BEHAV NEU, P125; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; MossMorris R, 1996, J NEUROL NEUROSUR PS, V60, P474, DOI 10.1136/jnnp.60.5.474; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Parker RS, 1996, BRAIN INJURY, V10, P287, DOI 10.1080/026990596124467; PEARCE JMS, 1994, NEUROLOGY, V44, P1993, DOI 10.1212/WNL.44.11.1993; *QUEB TASK FORC WH, 1995, SPINE S8, V20, pS12; RADANOV BP, 1993, ARCH NEUROL-CHICAGO, V50, P87, DOI 10.1001/archneur.1993.00540010081022; Seligman MEP., 1975, HELPLESSNESS DEPRESS; STURM W, 1982, NERVENARZT, V53, P395; STUSS DT, 1995, NEUROLOGY, V45, P1251, DOI 10.1212/WNL.45.7.1251; World Health Organization, 1992, ICD 10 CLASSIFICATIO	31	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2000	68	6					761	764		10.1136/jnnp.68.6.761			4	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	316NY	WOS:000087174900014	10811701	Bronze, Green Published			2022-02-06	
J	Golding, EM; Robertson, CS; Bryan, RM				Golding, EM; Robertson, CS; Bryan, RM			L-arginine partially restores the diminished CO2 reactivity after mild controlled cortical impact injury in the adult rat	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						carbon dioxide reactivity; free radicals; L-arginine; nitric oxide; rat; traumatic brain injury	CEREBRAL BLOOD-FLOW; TRAUMATIC BRAIN INJURY; NITRIC-OXIDE SYNTHASE; SENSITIVE POTASSIUM CHANNELS; CEREBROVASCULAR REACTIVITY; HYPERTENSIVE RATS; CARBON-DIOXIDE; K+ CHANNELS; HYPERCAPNIA; SUPEROXIDE	Using an open cranial window technique, The authors investigated the mechanisms associated with the suppressed CO2 reactivity after mild controlled cortical impact (CCI) injury in rats. The dilation of arterioles (n = 7) to hypercapnia before injury was 38 +/- 12%, which was significantly reduced both at 1 hour (23 +/- 15% dilation) and at 2 hours after injury (11 +/- 19% dilation). In the presence of L-arginine (10 mmol/L topical suffusion, 300 mg/kg intravenous infusion), the dilation of pial arterioles (n = 6) to hypercapnia was partially restored to 30 +/- 6% at 2 hours after injury. In the presence of the nitric ox ide (NO) donor, S-nitroso-N-acetylpenicillamine (SNAP) (10(-8) mol/L topical suffusion), the dilation of pial arterioles (n = 5) to hypercapnia remained diminished (5 +/- 7%) at 2 hours after injury. The dilation of pial arterioles (n = 4) to hypercapnia also remained suppressed (5 +/- 6%) with topical suffusion of the free radical scavengers, polyethylene glycol-superoxide dismutase (60 units/mL) and polyethylene glycol-catalase (40 units/mL). The authors have shown that L-arginine at least partially restores the diminished response to hypercapnia after mild CCI injury. Furthermore, these data suggest that the beneficial effects of L-arginine are mediated by a combination of providing substrate for NO synthase and scavenging free radicals.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA		Golding, EM (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin St,Suite 944, Houston, TX 77030 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [PHS P01-NS27616] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER		AOKI E, 1991, BRAIN RES, V547, P190, DOI 10.1016/0006-8993(91)90961-T; BAUMBACH GL, 1989, J PHYSIOL-LONDON, V416, P123, DOI 10.1113/jphysiol.1989.sp017753; Brian JE, 1998, ANESTHESIOLOGY, V88, P1365, DOI 10.1097/00000542-199805000-00029; Cherian L, 1999, CRIT CARE MED, V27, pA52, DOI 10.1097/00003246-199901001-00091; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; COLD GE, 1977, ACTA ANAESTH SCAND, V21, P359, DOI 10.1111/j.1399-6576.1977.tb01232.x; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; FABRICIUS M, 1994, AM J PHYSIOL, V266, pH1457; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FARACI FM, 1994, STROKE, V25, P1679, DOI 10.1161/01.STR.25.8.1679; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; HARPER SL, 1984, HYPERTENSION, V6, P408, DOI 10.1161/01.HYP.6.3.408; HEINZEL B, 1992, BIOCHEM J, V281, P627, DOI 10.1042/bj2810627; Holm P, 1998, EUR J PHARMACOL, V346, P97, DOI 10.1016/S0014-2999(98)00009-0; IADECOLA C, 1992, P NATL ACAD SCI USA, V89, P3913, DOI 10.1073/pnas.89.9.3913; JACOB TD, 1993, J TRAUMA, V35, P590, DOI 10.1097/00005373-199310000-00015; KJALLQUIST A, 1969, ACTA PHYSIOL SCAND, V76, P485; KLATT P, 1993, J BIOL CHEM, V268, P14781; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; Kontos HA, 1996, AM J PHYSIOL-HEART C, V271, pH1498, DOI 10.1152/ajpheart.1996.271.4.H1498; LEWELT W, 1982, J NEUROSURG, V56, P332, DOI 10.3171/jns.1982.56.3.0332; MUIR JK, 1995, J NEUROTRAUM, V12, P179, DOI 10.1089/neu.1995.12.179; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pelligrino DA, 1995, BRAIN RES, V704, P61, DOI 10.1016/0006-8993(95)01105-6; POU S, 1992, J BIOL CHEM, V267, P24173; Rehman A, 1997, BRIT J PHARMACOL, V122, P1702, DOI 10.1038/sj.bjp.0701556; REID JM, 1995, AM J PHYSIOL-HEART C, V269, pH916, DOI 10.1152/ajpheart.1995.269.3.H916; Reis DJ, 1999, ANN NY ACAD SCI, V881, P65, DOI 10.1111/j.1749-6632.1999.tb09343.x; SAUNDERS ML, 1979, J NEUROSURG, V51, P18, DOI 10.3171/jns.1979.51.1.0018; Sobey CG, 1997, STROKE, V28, P392, DOI 10.1161/01.STR.28.2.392; Sobey CG, 1997, STROKE, V28, P2290, DOI 10.1161/01.STR.28.11.2290; WADA K, 1997, J NEUROTRAUM, V14, P760; WANG Q, 1992, J CEREBR BLOOD F MET, V12, P947, DOI 10.1038/jcbfm.1992.131; Wang QO, 1998, BRAIN RES, V793, P187, DOI 10.1016/S0006-8993(98)00173-5; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	39	20	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2000	20	5					820	828		10.1097/00004647-200005000-00008			9	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	312WM	WOS:000086967000008	10826532	Bronze			2022-02-06	
J	Bhatt, M; Desai, J; Mankodi, A; Elias, M; Wadia, N				Bhatt, M; Desai, J; Mankodi, A; Elias, M; Wadia, N			Posttraumatic akinetic-rigid syndrome resembling Parkinson's disease: A report on three patients	MOVEMENT DISORDERS			English	Article						parkinsonism; trauma; imaging; MRI	POSITRON EMISSION TOMOGRAPHY; HEAD TRAUMA; MOVEMENT-DISORDERS; BRAIN; PAIRS; TWINS	We describe three patients who developed a rapidly evolving posttraumatic akinetic-rigid syndrome (ARS), the clinical manifestations of which were similar to Parkinson's disease, including response to levodopa. Despite initial imaging studies showing traumatic damage to the substantia nigra, the ARS appeared after a delay of 1-5 months after the injury. We stress the importance of magnetic resonance imaging to illustrate nigral damage in all patients in whom head trauma precedes an ARS.	Jaslok Hosp & Res Ctr, Movement Disorders Clin, Dept Neurol, Bombay 400026, Maharashtra, India		Bhatt, M (corresponding author), Jaslok Hosp & Res Ctr, Movement Disorders Clin, Dept Neurol, 15 G Deshmukh Marg, Bombay 400026, Maharashtra, India.			Mankodi, Ami/0000-0002-5131-7767; Bhatt, Mohit/0000-0002-5233-3371			BenShlomo Y, 1996, J NEUROL NEUROSUR PS, V61, P4, DOI 10.1136/jnnp.61.1.4; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; BHARUCHA NE, 1986, NEUROLOGY, V36, P284, DOI 10.1212/WNL.36.2.284; BHATT MH, 1993, NEUROLOGY, V43, P314, DOI 10.1212/WNL.43.2.314; BURN DJ, 1992, NEUROLOGY, V42, P1894, DOI 10.1212/WNL.42.10.1894; CALNE DB, 1985, NATURE, V317, P246, DOI 10.1038/317246a0; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; GOETZ CG, 1992, NEUROL CLIN, V10, P907, DOI 10.1016/S0733-8619(18)30187-7; GOETZ CG, 1991, ANN NEUROL, V29, P191, DOI 10.1002/ana.410290213; HORNYKIE.O, 1973, FED PROC, V32, P183; JENNER P, 1992, ANN NEUROL, V32, pS82, DOI 10.1002/ana.410320714; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; KRAUSS JK, 1992, MOVEMENT DISORD, V7, P263, DOI 10.1002/mds.870070313; MARSDEN CD, 1985, BRAIN, V108, P463, DOI 10.1093/brain/108.2.463; SAINTHILAIRE MH, 1991, NEUROLOGY, V41, P216; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; WARD CD, 1983, NEUROLOGY, V33, P815, DOI 10.1212/WNL.33.7.815; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; YOUDIM MBH, 1989, ACTA NEUROL SCAND, V80, P47, DOI 10.1111/j.1600-0404.1989.tb01782.x	20	20	21	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0885-3185	1531-8257		MOVEMENT DISORD	Mov. Disord.	MAR	2000	15	2					313	317		10.1002/1531-8257(200003)15:2<313::AID-MDS1017>3.0.CO;2-P			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	293WT	WOS:000085878500017	10752583				2022-02-06	
S	Han, SH; Chung, SY		Kalaria, RN; Ince, P		Han, SH; Chung, SY			Marked hippocampal neuronal damage without motor deficits after mild concussive-like brain injury in apolipoprotein E-deficient mice	VASCULAR FACTORS IN ALZHEIMER'S DISEASE	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	Conference on Vascular Factors in Alzheimers Disease	MAY 25-28, 1999	NEWCASTLE TYNE, ENGLAND	Bayer AG, Eisai Ltd, GJ Livanos Trust, Alzheimers Report, Hoechst Marrion Roussel, Janssen Pharmaceut, Novartis Pharma AG, Parke Davis, Pfizer Inc, SmithKline Beecham Pharmaceut, Zeneca, Med Res Council, Inst Brain & Blood Vessels, Akita, Inst Hlth Elderly, Univ Newcastle Upon Tyne			CLOSED-HEAD INJURY; FAMILIAL ALZHEIMERS-DISEASE; E EPSILON-4; RAT HIPPOCAMPUS; TYPE-4 ALLELE; AMYLOID-BETA; RISK	Of various biological factors, only allele epsilon 4 of apolipoprotein E (apoE, protein; APOE4, gene) has been thus far suggested as a major determinant of genetic risk for sporadic and late-onset familial Alzheimer's disease (AD), Environmental influences such as lack of education, traumatic brain injury, oxidative stress, environmental toxins, hormonal imbalances, and alterations in immune or inflammatory responses may also contribute to the pathogenesis of AD. Thus genetic susceptibility and environmental risk factors may have synergistic effects on the development of AD. The purpose of present report was to assess whether the gene (APOE) and the environmental risk factor (traumatic brain injury) could interact in hippocampal neuronal degeneration, We investigated the histopathological changes of hipoccampal regions after mild concussive-like brain injury without motor deficits in apoE-deficient mice using the recently described novel weight-drop device, Control mice revealed minimal neurodegenerative changes limited to CA2 and CA3, while apoE-deficient mice showed widespread neuronal degeneration throughout hippocampal subfields and part of dentate gyrus, We also observed widespread glial fibrillary acidic protein (GFAP) immunoreactivity throughout the hippocampus, which was more intense in apoE-deficient mice, The results of this study indicate that even very mild traumatic brain injury could result in widespread hippocampal damage in apoE-deficient mice, This again supports the hypothesis that apoE might play a neurotrophic or neuroprotective function in the central nervous system.	Chungbuk Natl Univ Hosp, Dept Neurol, Chungbuk 361711, South Korea; Catholic Univ, Dept Pediat, Our Lady Mercy Hosp, Med Ctr,Bupyong Ku, Inchon 403016, South Korea		Han, SH (corresponding author), Chungbuk Natl Univ Hosp, Dept Neurol, 62 Gaeshin Dong, Chungbuk 361711, South Korea.						ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Bodjarian N, 1997, NEUROREPORT, V8, P3951, DOI 10.1097/00001756-199712220-00020; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; HOLZMAN DM, 1995, P NATL ACAD SCI USA, V92, P9480; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; KAKU Y, 1993, J CEREBR BLOOD F MET, V13, P402, DOI 10.1038/jcbfm.1993.54; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Matthews RT, 1996, BRAIN RES, V718, P181, DOI 10.1016/0006-8993(95)01576-0; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; MAYEUX R, 1993, ANN NEUROL, V34, P752, DOI 10.1002/ana.410340527; NATHAN BP, 1994, SCIENCE, V264, P850, DOI 10.1126/science.8171342; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; NICOLL JAR, 1995, NAT MED, V1, P135, DOI 10.1038/nm0295-135; ROSES AD, 1995, NAT MED, V1, P603, DOI 10.1038/nm0795-603; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Slooter AJC, 1997, JAMA-J AM MED ASSOC, V277, P818, DOI 10.1001/jama.277.10.818; Small GW, 1998, J CLIN PSYCHIAT, V59, P7; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Tang YP, 1997, J NEUROTRAUM, V14, P851, DOI 10.1089/neu.1997.14.851; TEASDALE MCG, 1977, LANCET, V350, P1069; VANDUIJN CM, 1991, LANCET, V20, P337; Veinbergs I, 1999, NEUROSCI LETT, V265, P218, DOI 10.1016/S0304-3940(99)00243-8	26	20	20	0	5	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-251-7	ANN NY ACAD SCI	Ann.NY Acad.Sci.		2000	903						357	365		10.1111/j.1749-6632.2000.tb06387.x			9	Multidisciplinary Sciences; Clinical Neurology; Peripheral Vascular Disease	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Neurosciences & Neurology; Cardiovascular System & Cardiology	BQ26Z	WOS:000087756800046	10818526				2022-02-06	
J	Goldstein, FC; Levin, HS; Goldman, WP; Kalechstein, AD; Clark, AN; Kenehan-Altonen, T				Goldstein, FC; Levin, HS; Goldman, WP; Kalechstein, AD; Clark, AN; Kenehan-Altonen, T			Cognitive and behavioral sequelae of closed head injury in older adults according to their significant others	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							TRAUMATIC BRAIN INJURY; FOLLOW-UP; INITIAL FINDINGS; RELATIVES VIEW; CONSEQUENCES; RECOVERY	This study examined the neurobehavioral effects Of closed head injury (CHI) in older adults according to their significant of others. Informants of 17 mild and moderate CHI patients greater than or equal to 50 years old when injured completed the Geriatric Evaluation of Relative's Rating Instrument, a questionnaire inquiring about the patient's cognition, affect, interpersonal relations, and daily activities. The significant others provided retrospective ratings of preinjury functioning and completed the same instrument an average of 4 and 13 months post-injury. The significant others of 10 community-residing, normal control subjects completed the questionnaire at comparable intervals between each rating. Compared with their preinjury functioning, and unlike the control subjects, patients showed declines in cognition and moon. The possible impact of these changes, including their effect on subjective burden in caregivers, is discussed.	Wesley Woods Hlth Ctr, Dept Neurol, Atlanta, GA 30329 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; Baylor Coll Med, Dept Psychiat, Houston, TX 77030 USA; Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA		Goldstein, FC (corresponding author), Wesley Woods Hlth Ctr, Dept Neurol, 1841 Clifton Rd NE, Atlanta, GA 30329 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BORNSTEIN RA, 1989, J NEUROSURG, V70, P509, DOI 10.3171/jns.1989.70.4.0509; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Brooks N, 1984, CLOSED HEAD INJURY P, P123; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; GOLDSTEIN FC, 1995, J HEAD TRAUMA REHAB, V10, P57, DOI 10.1097/00001199-199502000-00007; GOLDSTEIN FC, 1994, J NEUROL NEUROSUR PS, V57, P961, DOI 10.1136/jnnp.57.8.961; GOLDSTEIN FC, 1997, J NEUROPSYCHIATRY CL, V9, P173; GOLDSTEIN FC, 1998, J INT NEUROPSYCH SOC, V4, P9; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; HOLBROOK TL, 1994, J TRAUMA, V36, P74, DOI 10.1097/00005373-199401000-00011; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JENNETT B, 1975, LANCET, V1, P480; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Kraus JF, 1987, HEAD INJURY, V2, P1; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Levin, 1997, Semin Clin Neuropsychiatry, V2, P207; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MACNIVEN E, 1993, BRAIN INJURY, V7, P241, DOI 10.3109/02699059309029676; MAZZUCCHI A, 1992, J NEUROL, V239, P256; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; PRIGATANO GP, 1986, NEUROPSYCHOLOGICAL R, P29; SCHALEN W, 1994, BRAIN INJURY, V8, P49, DOI 10.3109/02699059409150958; SCHWARTZ GE, 1983, PSYCHOL REP, V53, P479, DOI 10.2466/pr0.1983.53.2.479; TEASDALE G, 1974, LANCET, V2, P81; VOLLMER DG, 1991, J NEUROSURG, V75, P537; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	36	20	20	0	2	AMER PSYCHIATRIC PRESS, INC	WASHINGTON	1400 K ST, N W, STE 1101, WASHINGTON, DC 20005 USA	0895-0172			J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	WIN	1999	11	1					38	44		10.1176/jnp.11.1.38			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	162PC	WOS:000078354800006	9990554				2022-02-06	
J	Hemphill, JC; Gress, DR; Halbach, VV				Hemphill, JC; Gress, DR; Halbach, VV			Endovascular therapy of traumatic injuries of the intracranial cerebral arteries	CRITICAL CARE CLINICS			English	Article							INTERNAL CAROTID-ARTERY; ELECTROLYTICALLY DETACHABLE COILS; TRANSVENOUS EMBOLIZATION; CAVERNOUS FISTULAS; VASCULAR-LESIONS; SIGMOID SINUSES; ANEURYSMS; OCCLUSION; DIAGNOSIS; PSEUDOANEURYSM	Dissections, pseudoaneurysms, and fistulas may result from traumatic injuries to the intracranial arteries in the setting of closed head injury, penetrating skull trauma, or angiography. Endovascular therapy with particle or coil embolization, balloon occlusion, or stent deployment are potential treatments for this heterogeneous group of lesions. These arterial injuries usually manifest in a delayed fashion with intracranial hemorrhage, cerebral ischemia, or epistaxis. Principles of neurologic critical care that minimize secondary brain injury are essential adjuncts in patient management. This article emphasizes a coordinated approach to the endovascular treatment and neurologic critical care of these patients.	San Francisco Gen Hosp, Dept Neurol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA		Hemphill, JC (corresponding author), San Francisco Gen Hosp, Dept Neurol, Room 4M62,1001 Potrero Ave, San Francisco, CA 94110 USA.		Demchuk, Andrew M/E-1103-2012; Hemphill, Claude/AAY-5630-2021	Demchuk, Andrew M/0000-0002-4930-7789; Hemphill, Claude/0000-0003-4019-7525			ACOSTA C, 1972, J NEUROSURG, V36, P531, DOI 10.3171/jns.1972.36.5.0531; Bavinzski G, 1997, NEURORADIOLOGY, V39, P81, DOI 10.1007/s002340050371; BENOIT BG, 1973, J NEUROL NEUROSUR PS, V36, P127, DOI 10.1136/jnnp.36.1.127; BERGER MS, 1984, J NEUROSURG, V61, P882, DOI 10.3171/jns.1984.61.5.0882; BRUGIERES P, 1989, J NEURORADIOLOGY, V16, P1; Bullock R, 1995, GUIDELINES MANAGEMEN; Chen DS, 1998, LARYNGOSCOPE, V108, P326, DOI 10.1097/00005537-199803000-00004; Cooper A., 1836, GUYS HOSP REP, V1, P53; DALISE M, 1997, CEREBROVASC DIS, P1169; DOLENC V, 1983, J NEUROSURG, V58, P824, DOI 10.3171/jns.1983.58.6.0824; DRATZ HM, 1947, J NEUROPATH EXP NEUR, V6, P286, DOI 10.1097/00005072-194707000-00009; ENDO S, 1980, CHILD BRAIN, V6, P131; FELDGES A, 1989, INTENS CARE MED, V15, P400; FELDMAN RA, 1980, NEUROSURGERY, V6, P670, DOI 10.1227/00006123-198006000-00013; FERRY DJ, 1972, J NEUROSURG, V36, P503, DOI 10.3171/jns.1972.36.4.0503; FEUERMAN TF, 1984, ARCH OTOLARYNGOL, V110, P412; FLEISCHER A S, 1975, Surgical Neurology, V4, P233; GELBERT F, 1991, NEURORADIOLOGY, V33, P111, DOI 10.1007/BF00588245; GILLER CA, 1994, J NEUROSURG, V81, P15, DOI 10.3171/jns.1994.81.1.0015; Goto K, 1986, Acta Radiol Suppl, V369, P576; GRAVES VB, 1995, NEUROSURGERY, V37, P640, DOI 10.1227/00006123-199510000-00006; GREATZ KW, 1991, INT J ORAL MAXILLOF, V20, P280; HALBACH VV, 1987, AM J ROENTGENOL, V149, P587, DOI 10.2214/ajr.149.3.587; HALBACH VV, 1988, AM J NEURORADIOL, V9, P741; HALBACH VV, 1989, AM J NEURORADIOL, V10, P377; HALBACH VV, 1987, RADIOLOGY, V163, P437, DOI 10.1148/radiology.163.2.3562823; HALBACH VV, 1989, AM J NEURORADIOL, V10, P385; HALBACH VV, 1987, RADIOLOGY, V163, P443, DOI 10.1148/radiology.163.2.3562824; HALBACH VV, 1991, AM J NEURORADIOL, V12, P429; HAN MH, 1994, LARYNGOSCOPE, V104, P370; HIESHIMA GB, 1978, SURG NEUROL, V9, P293; Higashida R T, 1986, Acta Radiol Suppl, V369, P580; HIGASHIDA RT, 1989, AM J ROENTGENOL, V153, P577, DOI 10.2214/ajr.153.3.577; HIGASHIDA RT, 1990, J NEUROSURG, V72, P857, DOI 10.3171/jns.1990.72.6.0857; HOLMES B, 1993, J TRAUMA, V35, P855, DOI 10.1097/00005373-199312000-00009; HUND E, 1995, NEUROL CLIN, V13, P511, DOI 10.1016/S0733-8619(18)30032-X; JACKSON F, 1976, HDB CLIN NEUROLOGY, P381; JOHNSON AC, 1977, SURG NEUROL, V7, P49; JOSEPH S, 1983, ACTA NEUROL SCAND, V88, P320; KIECK CF, 1984, J NEUROSURG, V60, P42, DOI 10.3171/jns.1984.60.1.0042; KING MA, 1989, PEDIATRICS, V84, P128; Lempert TE, 1998, AM J NEURORADIOL, V19, P907; Lylyk P, 1986, Acta Radiol Suppl, V369, P584; Malek AM, 1998, NEUROIMAG CLIN N AM, V8, P445; MATHIS JM, 1995, AM J NEURORADIOL, V16, P749; McDougall CG, 1996, J NEUROSURG, V84, P393, DOI 10.3171/jns.1996.84.3.0393; MENDEL R, 1995, NEUROVASCULAR SURG, P1301; MOAR JJ, 1987, FORENSIC SCI INT, V34, P227, DOI 10.1016/0379-0738(87)90036-3; PATEL AN, 1971, J NEUROSURG, V35, P571, DOI 10.3171/jns.1971.35.5.0571; Polin RS, 1996, J NEUROSURG, V84, P755, DOI 10.3171/jns.1996.84.5.0755; PROLO DJ, 1971, J NEUROSURG, V35, P237, DOI 10.3171/jns.1971.35.2.0237; Quintana F, 1996, AM J NEURORADIOL, V17, P283; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; SERBINENKO FA, 1974, J NEUROSURG, V41, P125, DOI 10.3171/jns.1974.41.2.0125; SHAW CM, 1968, J NEUROSURG, V28, P475, DOI 10.3171/jns.1968.28.5.0475; STEHBENS WE, 1989, J NEUROSURG, V70, P823, DOI 10.3171/jns.1989.70.6.0823; Teitelbaum GP, 1998, NEUROSURGERY, V42, P1394, DOI 10.1097/00006123-199806000-00134; THOMPSON JR, 1973, AM J ROENTGENOL, V118, P163, DOI 10.2214/ajr.118.1.163; TSAI F, 1984, NEURORADIOLOGY HEAD, P243; VENTUREYRA ECG, 1994, CHILD NERV SYST, V10, P361, DOI 10.1007/BF00335125; YONAS H, 1980, NEUROSURGERY, V7, P499, DOI 10.1227/00006123-198011000-00016; YONAS H, 1977, SURG NEUROL, V8, P407; YOUNG WL, 1994, ANESTHESIOLOGY, V80, P427	63	20	22	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0749-0704			CRIT CARE CLIN	Crit. Care Clin.	OCT	1999	15	4					811	+		10.1016/S0749-0704(05)70089-0			21	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	256CU	WOS:000083709000010	10569123				2022-02-06	
J	Mechoulam, R				Mechoulam, R			Recent advances in cannabinoid research	FORSCHENDE KOMPLEMENTARMEDIZIN			English	Article						tetrahydrocannabinol (THC) arachidonylethanolamide (anandamide); 2-arachidonylglycerol (2-AG); HU-211; emesis; appetite enhancement; multiple sclerosis; spinal injury; closed head injury	RECEPTOR; BRAIN; BINDS	Although the active component of cannabis Delta(9)-THC was isolated by our group 35 years ago, until recently its mode of action remained obscure. In the last decade it was established that Delta(9)-THC acts through specific receptors - CB1 and CB2 and mimics the physiological activity of endogenous cannabinoids of two types, the best known representatives being arachidonoytethanolamide (anandamide) and 2-arachidonoylglycerol (2-AG). THC is officially used against vomiting caused by cancer chemotherapy and for enhancing appetite, particularly in AIDS patients. Illegally, usually by smoking marijuana, it is used for ameliorating the symptoms of multiple sclerosis, against pain, and in a variety of other diseases. A synthetic cannabinoid, HU-211, is in advanced clinical tests against brain damage caused by closed head injury. It may prove to be valuable against stroke and other neurological diseases.	Hebrew Univ Jerusalem, Fac Med, IL-91120 Jerusalem, Israel		Mechoulam, R (corresponding author), Hebrew Univ Jerusalem, Fac Med, IL-91120 Jerusalem, Israel.						ABRAHAMOV A, 1995, LIFE SCI, V56, P2097, DOI 10.1016/0024-3205(95)00194-B; Consroe P, 1997, EUR NEUROL, V38, P44, DOI 10.1159/000112901; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 1998, PROGR MED CHEM, V35, P199, DOI 10.1016/S0079-6468(08)70037-7; Mechoulam R, 1998, EUR J PHARMACOL, V362, pR1, DOI 10.1016/S0014-2999(98)00777-8; MECHOULAM R, 1994, CNS DRUGS, V2, P255, DOI 10.2165/00023210-199402040-00001; Mechoulam R, 1987, Prog Med Chem, V24, P159, DOI 10.1016/S0079-6468(08)70422-3; MECHOULAM R, 1973, CHEM PHARM METABOLIS; MECHOULAM R, 1992, MARIJUANA CANNABINOI, P1; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; PLASSE TF, 1991, PHARMACOL BIOCHEM BE, V40, P695, DOI 10.1016/0091-3057(91)90385-F; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Varga K, 1998, FASEB J, V12, P1035, DOI 10.1096/fasebj.12.11.1035	17	20	20	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7096			FORSCH KOMPLEMENTMED	Forsch. Komplement.med.	OCT	1999	6			3			16	20		10.1159/000057151			5	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Integrative & Complementary Medicine	262EW	WOS:000084053500004	10575284				2022-02-06	
J	Klein, BY; Shohami, E; Reikhinshtein, Y; Ben-Bassat, H; Liebergall, M				Klein, BY; Shohami, E; Reikhinshtein, Y; Ben-Bassat, H; Liebergall, M			Serum-mediated osteogenic effects of head injury on cultured rat marrow stromal cells	CALCIFIED TISSUE INTERNATIONAL			English	Article						osteoprogenitors; closed head injury; marrow-stroma; alkaline phosphatase; mineralization; cell proliferation	BONE-FORMATION; MINERALIZATION; COMMITMENT; FRACTURE; INVITRO; TISSUE	Central nervous system (CNS) injuries in humans are frequently associated with heterotopic ossification (HO) and with enhanced fracture healing. In search for an experimental HO model we tested sera, from an established rat model of closed head injury (CHI), for their osteogenic effects on rat marrow stromal cells. Most normal pat sera increased cell proliferation not discriminating between osteoprogenitors and other stromal cells. Rats followed longitudinally by sequential blood sampling were bled 24 hours before and 24 hours, 48 hours, and 7 days after CHI. Sera obtained 24 and 48 hours after CHI progressively decreased cell proliferation and specific alkaline phosphatase (ALP) activity compared with pre-CHI sera of the same rats. Sera obtained from these rats, 7 days post-CHI, partially recovered proliferation induction, more than recovering induction of specific ALP activity. A positive correlation between day 11 ALP activity and day 21 mineralization was found under stimulation by pre-CHI sera. However, no correlation was found on stimulation with sera obtained 48 hours after CHI. Correlation between ALP and mineralization partially recovered in cultures exposed to sera obtained 7 days after CHI. In cross-sectional experiments where rats were subjected to single blood sampling, sera of 24 hours and 7 days post-CHI induced proliferation, whereas sera of 48 hours and 14 days post-CHI did not. The results indicate that 48 hours post-CHI, the mitogenicity of sera decreased in both cross-sectional and longitudinal blood sampling. In addition, 48 hours post-CHI, the specific ALP activity increases in cultured marrow stromal cells. Thus, changes in bone-seeking factors, causing serum-mediated osteogenic activity in rats, are expected close on 48 hour post-CNS injury.	Hadassah Med Ctr, Expt Surg Lab, IL-91120 Jerusalem, Israel; Hadassah Med Ctr, Dept Orthoped, IL-91120 Jerusalem, Israel; Hadassah Med Ctr, Dept Anesthesiol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel		Klein, BY (corresponding author), Hadassah Med Ctr, Expt Surg Lab, Ein Kerem POB 12000, IL-91120 Jerusalem, Israel.						Assaf Y, 1997, MAGN RESON IMAGING, V15, P77, DOI 10.1016/S0730-725X(96)00246-9; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; DEJERINE A, 1991, CLIN ORTHOP RELAT R, P3; Garland D E, 1992, J Bone Joint Surg Am, V74, P152; GARLAND DE, 1980, CLIN ORTHOP RELAT R, P198; JABER S, 1995, BONE, V16, P81; KLEIN BY, 1995, J CELL BIOCHEM, V57, P530, DOI 10.1002/jcb.240570318; KLEIN BY, 1993, J CELL BIOCHEM, V53, P114, DOI 10.1002/jcb.240530204; KLEIN BY, 1993, J CELL BIOCHEM, V51, P190, DOI 10.1002/jcb.240510211; KLEIN BY, 1994, J CELL BIOCHEM, V54, P354, DOI 10.1002/jcb.240540311; Klein BY, 1997, J CELL BIOCHEM, V65, P420; Klein BY, 1996, J CELL BIOCHEM, V63, P115; KLEIN BY, 1994, CELL MATER, V4, P73; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; MOHAN S, 1991, CLIN ORTHOP RELAT R, P30; ORZEL JA, 1985, J NUCL MED, V26, P125; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; POKWINSE SM, 1992, J CELL BIOCHEM, V49, P310; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; RODAN SB, 1987, CANCER RES, V47, P4961; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157	26	20	22	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0171-967X			CALCIFIED TISSUE INT	Calcif. Tissue Int.	SEP	1999	65	3					217	222		10.1007/s002239900686			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	224GJ	WOS:000081889400008	10441654				2022-02-06	
J	Hak, DJ; Goulet, JA				Hak, DJ; Goulet, JA			Severity of injuries associated with traumatic hip dislocation as a result of motor vehicle collisions	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						hip dislocation; multiple trauma	AIRBAG; ACCIDENTS; CRASHES	Background: Previous reports have shown a high rate of associated injuries in patients who sustain traumatic hip dislocation. Since these earlier reports appeared, improvements have been made in passenger safety systems and the rate of restraint usage has increased. The purpose of this study was to review the associated injuries present in a current series of patients who sustained traumatic hip dislocation as a result of motor vehicle collisions. Methods: We retrospectively reviewed our trauma registry and identified 66 patients who sustained traumatic hip dislocation as a result of motor vehicle collisions. Thirty patients (45%) were restrained and 36 (55%) were unrestrained. Airbags were known to have deployed in 14 cases. Results: The incidence of associated injuries was 95% (63 patients), Orthopedic injuries alone were seen in 22 patients (33%), whereas associated injuries were seen in 44 patients (67%), Abdominal injuries were present in 10 patients (15%), thoracic injuries were present in 14 patients (21%), closed head injuries were present in 16 patients (24%), and craniofacial injuries were present in 14 patients (21%). Acetabular fractures were seen in 46 patients (70%), femoral head fractures were identified in 9 patients (14%), and other extremity fractures occurred in 26 patients (39%), The average Injury Severity Score for all patients was 17.4 (range, 9-59), The average Injury Severity Score of the restrained patients was not statistically different from that of the unrestrained patients (p = 0.491). Conclusion: Although improvements in automotive safety features and restraint usage have occurred since previous reports appeared, there continues to be a high rate of severe injuries associated with traumatic hip dislocation that occur in motor vehicle collisions, We believe that all patients who sustain traumatic hip dislocation warrant a general surgery trauma evaluation to rule out any potential associated injuries.	Univ Michigan, Sect Orthopaed Surg, Ann Arbor, MI 48109 USA		Hak, DJ (corresponding author), 2914G Taubman Ctr, Sect Orthopaed Surg, Ann Arbor, MI 48105 USA.						BRAV EA, 1962, J BONE JOINT SURG AM, V44, P1115, DOI 10.2106/00004623-196244060-00007; BURGESS AR, 1995, J TRAUMA, V38, P509, DOI 10.1097/00005373-199504000-00008; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P229, DOI 10.1016/0001-4575(86)90007-2; HOUGAARD K, 1987, J BONE JOINT SURG AM, V69A, P679, DOI 10.2106/00004623-198769050-00007; JACOB JR, 1987, CLIN ORTHOP RELAT R, P249; Kuner EH, 1996, INJURY, V27, P185, DOI 10.1016/0020-1383(95)00211-1; Loo GT, 1996, J TRAUMA, V41, P935, DOI 10.1097/00005373-199612000-00001; PIETRAFESA CA, 1983, JAMA-J AM MED ASSOC, V249, P3342; ROEDER LF, 1980, CLIN ORTHOP RELAT R, P121; ROSENTHAL RE, 1979, J TRAUMA, V19, P572, DOI 10.1097/00005373-197908000-00005; SHIM SS, 1979, CLIN ORTHOP RELAT R, V140, P155; SURACI AJ, 1986, J TRAUMA, V26, P458, DOI 10.1097/00005373-198605000-00008; Sutyak JP, 1997, SOUTHERN MED J, V90, P915, DOI 10.1097/00007611-199709000-00011; VIANO DC, 1995, J TRAUMA, V38, P538, DOI 10.1097/00005373-199504000-00013; YANG RS, 1991, CLIN ORTHOP RELAT R, P218	15	20	21	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JUL	1999	47	1					60	63		10.1097/00005373-199907000-00014			4	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	216ZQ	WOS:000081474700012	10421188				2022-02-06	
J	Ippolito, E; Formisano, R; Caterini, R; Farsetti, P; Penta, F				Ippolito, E; Formisano, R; Caterini, R; Farsetti, P; Penta, F			Resection of elbow ossification and continuous passive motion in postcomatose patients	JOURNAL OF HAND SURGERY-AMERICAN VOLUME			English	Article						heterotopic ossification; surgical treatment; coma; elbow; continuous passive motion	HETEROTOPIC OSSIFICATION	Heterotopic periarticular ossifications were surgically excised in 16 elbows of 14 traumatic brain injury patients an average of 18.9 months (range, 4-67 months) after the end of coma. In 11 elbows the ulnohumeral joint was ankylosed in a position that ranged from 0 degrees to 100 degrees of flexion (group 1); in 5 elbows the arc of flexion ranged from 10 degrees to 25 degrees (group 2). Full pronation and supination were present in 15 of the elbows; in 1 the radiocapitellar joint was fixed at 30 degrees of pronation by a partial ossification of the interosseous membrane. The are of flexion attained after surgery averaged 115 degrees (range, 90 degrees to 145 degrees) in the group 1 elbows and 128 degrees (range, 115 degrees to 140 degrees) in the group 2 elbows. In an attempt to prevent postoperative loss of motion and recurrence of ossification, continuous passive motion was applied to the affected elbow for 6 weeks before starting a fully active rehabilitation program. All the patients were examined at regular intervals after the surgery. The follow-up period ranged from 12 to 60 months (average, 30.7 months). During the follow-up period, all the elbows showed improvement in range of motion and the are of flexion averaged 95 degrees (range, 30 degrees to 135 degrees) in the group 1 elbows and 116 degrees (range, 80 degrees to 145 degrees) in the group 2 elbows. Patients with poor neuromuscular control lost part of their postoperative range of motion and partial recurrence was observed in 3 elbows. We believe that our improved results, compared with those obtained by previous investigators, may have been due to the prolonged application of continuous passive motion after surgery. Copyright (C) 1999 by the American Society for Surgery of the Hand.	Univ Roma Tor Vergata, Dept Orthoped Surg, Rome, Italy		Ippolito, E (corresponding author), Via Cattaro 28, I-00198 Rome, Italy.						GACON G, 1978, REV CHIR ORTHOP, V64, P375; GARLAND DE, 1985, J BONE JOINT SURG AM, V67A, P1261, DOI 10.2106/00004623-198567080-00019; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; GATES HS, 1992, J BONE JOINT SURG AM, V74A, P1229, DOI 10.2106/00004623-199274080-00013; McAuliffe JA, 1997, J BONE JOINT SURG AM, V79A, P749, DOI 10.2106/00004623-199705000-00015; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P872, DOI 10.2106/00004623-198163060-00002; ROBERTS JB, 1979, J BONE JOINT SURG AM, V61, P760, DOI 10.2106/00004623-197961050-00018; SAZBON L, 1981, J BONE JOINT SURG BR, V63, P120, DOI 10.1302/0301-620X.63B1.7204466; VASEN AP, 1995, J HAND SURG A, V20, P289	10	20	20	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0363-5023			J HAND SURG-AM	J. Hand Surg.-Am. Vol.	MAY	1999	24A	3					546	553					8	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	197AU	WOS:000080343100016	10357534				2022-02-06	
J	Capitani, E; Laiacona, M; Barbarotto, R; Cossa, FM				Capitani, E; Laiacona, M; Barbarotto, R; Cossa, FM			How can we evaluate interference in attentional tests? A study based on bi-variate non-parametric tolerance limits	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD INJURY; DEFICITS	In attentional tasks a basic performance is often contrasted with the same task administered with some additional load, defined here as "interference". However, it is questionable how interference should be quantified. The raw difference between the interference-loaded ("complex") task and the basic task is marred by measurement artefacts. There are alternative ways, but the choice of which solution to employ appears arbitrary. Bivariate non-parametric tolerance limits were introduced as they retain the information linked to the bivariate nature of the observation, and in this study we compared the different approaches for evaluating interference using real data from 209 normal participants who performed Visual Reaction Times (basic and go / no-go) and the Stroop Test. Our analysis indicated that, among the univariate indices, the use of the complex score covaried for the basic score yields the most satisfactory evaluation of interference; however, its use can be decided only after data inspection. Bivariate non-parametric tolerance limits offer advantages in terms of generality of use.	Univ Milan, S Paolo Hosp, Clin Nervous Dis, I-20122 Milan, Italy; S Maugeri Fdn, Dept Neurol, Neuropsychol Unit, Clin Lavoro & Riabilitaz, Veruno, Novara, Italy; Ist Disabili Psich Villa S Ambrogio, Ist Fatebenefratelli, Milan, Italy		Capitani, E (corresponding author), Osped S Paolo, Neurol Clin, Via di Rudini 8, I-20142 Milan, Italy.						ACKERMANN H, 1985, MEHRDIMENSIONALE NIC; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; FRASER DAS, 1953, ANN MATH STAT, V24, P44, DOI 10.1214/aoms/1177729081; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; MURPHY RB, 1948, ANN MATH STAT, V19, P79; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Spikman JM, 1996, J CLIN EXP NEUROPSYC, V18, P755, DOI 10.1080/01688639608408298; Uttl B, 1997, J CLIN EXP NEUROPSYC, V19, P405, DOI 10.1080/01688639708403869; Venturini R., 1983, COLOR WORD TEST TEST; Wald A, 1943, ANN MATH STAT, V14, P45, DOI 10.1214/aoms/1177731491; Wilks SS, 1941, ANN MATH STAT, V12, P91, DOI 10.1214/aoms/1177731788	11	20	20	0	2	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	APR	1999	21	2					216	228		10.1076/jcen.21.2.216.934			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	226CL	WOS:000082002700006	10425518				2022-02-06	
J	Di, X; Gordon, J; Bullock, R				Di, X; Gordon, J; Bullock, R			Fluid percussion brain injury exacerbates glutamate-induced focal damage in the rat	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; glutamate; fluid percussion; excitotoxicity	EXCITATORY AMINO-ACIDS; EXTRACELLULAR GLUTAMATE; BLOOD-FLOW; CELL-DEATH; RELEASE; REDUCTION; ISCHEMIA	The role of glutamate-mediated neuronal damage in neurotrauma remains controversial. The cerebral levels measured in patients by microdialysis are sufficient to kill neurons in culture, but not in the intact brain of the normal rat. A synergistic effect between excitatory amino acid-mediated damage and other posttrauma mechanisms must therefore be proposed, if glutamate is indeed a significant cause of posttraumatic brain damage. The presence of such a synergistic mechanism was therefore investigated by combining in vivo glutamate perfusion and fluid percussion injury (FPI). Twenty-four adult male Sprague Dawley rats were randomly assigned to three groups: (1) vehicle (n = 9): mock cerebrospinal fluid (CSF) perfusion plus FPI; (2) glutamate + FPI (n = 9): 0.1 M glutamate intracortical perfusion plus FPI; and (3) glutamate without FPI (n = 6), After preparation for central FPI, at a moderate level of injury (2 +/- 0.5 atm), glutamate or mock CSF perfusion was performed via a CMA/12 microdialysis probe (3 mm), Animals were then perfusion fixed, under deep anesthesia, after 3-h survival, for volumetric histopathology, The glutamate perfusion + FPI group (2.42 +/- 1.63 mm(3)) produced a significantly bigger lesion than mock CSF perfusion + FPI (0.063 +/- 0.41 mm(3)) and glutamate perfusion alone (1.00 +/- 0.47 mm(3)). Traumatic brain injury thus seems to enhance glutamate-mediated brain damage, and this may be due to qualitative changes induced in ion channels and receptors, such as the N-methyl-D-aspartate channel, after shear injury.	Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Richmond, VA 23298 USA		Bullock, R (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Div Neurosurg, Box 980631,MCV Stn, Richmond, VA 23298 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12587] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS012587, P01NS012587] Funding Source: NIH RePORTER		BENVENISTE H, 1991, CEREBROVAS BRAIN MET, V3, P213; BULLOCK R, 1995, STROKE, V26, P2187, DOI 10.1161/01.STR.26.11.2187; BULLOCK R, 1991, J NEUROSURG, V74, P794, DOI 10.3171/jns.1991.74.5.0794; BULLOCK R, 1993, GLUTAMATE TRANSMITTE, P113; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CHOI DW, 1991, EXCITATORY AMINO ACI, P216; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FUJISAWA H, 1993, J CEREB BLOOD FLO S1, V13, pS784; HAGBERG H, 1985, J CEREBR BLOOD F MET, V5, P413, DOI 10.1038/jcbfm.1985.56; Huang R, 1997, NEUROSCI BIOBEHAV R, V21, P129, DOI 10.1016/S0149-7634(96)00002-4; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Landolt H, 1998, J CLIN NEUROSCI, V5, P193, DOI 10.1016/S0967-5868(98)90037-6; LANDOLT H, 1993, J CEREB BLOOD FLO S1, V13, pS644; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; Zauner A, 1996, ACT NEUR S, V67, P40; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	17	20	20	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	MAR	1999	16	3					195	201		10.1089/neu.1999.16.195			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	178QQ	WOS:000079277800001	10195467				2022-02-06	
J	Moorthi, S; Schneider, WN; Dombovy, ML				Moorthi, S; Schneider, WN; Dombovy, ML			Rehabilitation outcomes in encephalitis - a retrospective study 1990-1997	BRAIN INJURY			English	Article							HERPES-SIMPLEX ENCEPHALITIS; RAPID RECOVERY	Background: Encephalitis is an uncommon clinical entity compared to traumatic brain injury, and stroke. Many encephalitis survivors have disabling seqeulae. There is scant information in the literature addressing outcome following inpatient rehabilitation for encephalitis. Further, it is unclear which of these patients will benefit from acute in-patient rehabilitation. Purpose: The purposes of this study are to (1) describe the outcome following in-patient rehabilitation in a cohort of patients with encephalitis, and (2) develop preliminary; criteria to guide the selection of patients with encephalitis who may benefit from inpatient rehabilitation. Method: The demographic, clinical, functional (functional independence measure-FIM) and neuropsychological data were retrospectively abstracted for eight subjects with a clinical diagnosis of encephalitic aged 5 to 75 years, who were admitted to a brain injury rehabilitation unit between 1990 and 1997. Results: In the eight subjects, the mean age was 38 years, mean acute hospital stay (ALOS) was 40.3 days, and mean rehabilitation length of stay (RLOS) was 75.9 days. Mean admission FIM (AFIM) was 40.1, mean discharge FIM (DFIM) was 69.9. Mean FIM gain was 29.8 and mean FIM efficiency was 0.39. Adult subjects with an AFIM > 30 at 5 weeks from onset of illness (n = 4) had a FIM LOS efficiency of 0.64 and all four were discharged home. None of the adult subjects with an AFIM < 30 at 5 weeks from onset of illness (n = 3, FIM efficiency = 0.14) were discharged home. A child with an AFIM < 30 (n = 1) had a FIM LOS efficiency of 1.24, made good recovery and was discharged home. FIM LOS efficiency of 0.64 in encephalitis is less, as compared to traumatic brain injury (TBI -1.27) and stroke (1.06). Conclusions: The results of this study showed that, although subjects with encephalitis make functional gains in rehabilitation, the rate of recovery varies and is generally less than that for TBI and stroke. The study also suggests chat FIM scores can he used for screening adult patients after encephalitis for admission to inpatient rehabilitation. Adult patients with an AFIM > 30, 3 weeks post onset of illness are likely to make reasonable progress and be discharged home. If replicated, these results suggest that despite low AFIM scores at 5 weeks from onset of illness (AFIM < 30), children may still make good progress and should be given a trial of in-patient rehabilitation.	Univ Rochester, Dept Phys Med & Rehabil, Rochester, NY USA; Univ Rochester, Dept Neurol, Rochester, NY USA; Unity Hlth Syst, Dept Phys Med & Rehabil, Rochester, NY USA		Dombovy, ML (corresponding author), Univ Rochester, St Marys Hosp, 89 Genesee St, Rochester, NY 14611 USA.						BALE JF, 1996, CLIN NEUROLOGY, V2, P1; Dombovy ML, 1998, BRAIN INJURY, V12, P443, DOI 10.1080/026990598122412; EARNEST MP, 1971, NEUROLOGY, V21, P969, DOI 10.1212/WNL.21.9.969; EWINGCOBBS L, 1990, NEUROSURGERY, V27, P683, DOI 10.1227/00006123-199011000-00003; FIELDER RC, 1996, AM J PHYSICAL MED RE, V75, P125; FIELDER RC, 1998, AM J PHYS MED REHABI, V77, P69; Gutierrez KM, 1998, POSTGRAD MED, V103, P123, DOI 10.3810/pgm.1998.03.413; HAMILTON BB, 1994, SCAND J REHABIL MED, V26, P115; HEINEMANN AW, 1994, ARCH PHYS MED REHAB, V75, P133; Hokkanen L, 1997, J NEUROL NEUROSUR PS, V63, P222, DOI 10.1136/jnnp.63.2.222; Johnson RT, 1996, CLIN INFECT DIS, V23, P219, DOI 10.1093/clinids/23.2.219; Kolski H, 1998, CLIN INFECT DIS, V26, P398, DOI 10.1086/516301; LOWERY PW, 1997, J LAB CLIN MED, V129, P405; Marton R, 1996, ACTA NEUROL SCAND, V93, P149; McCarthy, 1972, MCCARTHY SCALES CHIL; McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321; *NO CAL NEUR GROUP, 1995, NEUR COGN STAT EX NC; PARTINGTON JE, 1949, PSYCHOL SERVICE CTR, V1, P9; Reitan R, 1985, HALSTEAD REITAN NEUR; Tong CYW, 1997, LANCET, V349, P470, DOI 10.1016/S0140-6736(96)09320-8; Wechsler D, 1987, MEMORY SCALE REVISED; WHITLEY RJ, 1989, JAMA-J AM MED ASSOC, V262, P24; Zifroni A, 1997, LANCET, V349, P1328, DOI 10.1016/S0140-6736(05)62546-9	23	20	20	0	5	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1999	13	2					139	146		10.1080/026990599121809			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	167HQ	WOS:000078626800007	10079959				2022-02-06	
J	Emond, SD; Tayoun, P; Bedolla, JP; Camargo, CA				Emond, SD; Tayoun, P; Bedolla, JP; Camargo, CA			Injuries in a 1-day recreational cycling tour: Bike New York	ANNALS OF EMERGENCY MEDICINE			English	Article							BICYCLE SAFETY HELMETS; ACCIDENTS; PREVENTION; TRAUMA; CARE	Study objective: To describe injuries during a 1-day urban cycling tour. Methods: During the May 1996 "Bike New York" tour, we monitored EMS calls to identify injuries in a cohort of helmeted cyclists shielded from traffic. We collected demographic information from entry records, injury data from ambulance call reports, and follow-up on transported patients from telephone interviews with emergency physicians. Data were summarized using proportions, relative risks (RRs), 95% confidence intervals (Cls), and chi(2) test. Results: Approximately 28,000 cyclists participated, of which 23,502 (84%) were officially registered. Sixty-eight percent of registered bicyclists were male, and 92% were between 18 and 55 years old. Of the 140 EMS calls made during the tour, 136 (97%) involved participants; this yielded an injury incidence of 5 per 1,000 riders, or 12 to 13 per 100,000 person-miles. Injury was more common among younger cyclists (RR=1.4 for age less than or equal to 35 years versus age >35 years; 95% CI, 1.0 to 2.0; P<.05), and possibly women (RR=1.3; 95% CI, .9 to 1.8, P=.11). Injuries were mostly minor, but there were 7 concussions and 6 clavicle fractures; none of the 140 injuries was fatal. Thirty-eight calls resulted in ED transport, and 5 of these patients were admitted. Although EMS units were evenly distributed along the route, most EMS calls occurred in only 3 of the 7 zones (P<.001). Conclusion: Injuries during the largest 1-day US cycling tour were uncommon, More data are needed to determine the relative importance of injury risk factors. Data collection during mass events may help guide distribution of EMS personnel.	Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Emergency Med, New York, NY 10025 USA		Emond, SD (corresponding author), Columbia Univ, St Lukes Roosevelt Hosp Ctr, Dept Emergency Med, New York, NY 10025 USA.		Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654	NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL-03533] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K14HL003533] Funding Source: NIH RePORTER		AULT MJ, 1996, YOUR PATIENT FITNESS, V10, P23; BALLHAM A, 1985, INJURY, V16, P405, DOI 10.1016/0020-1383(85)90057-9; Dannenberg AL, 1996, AM J SPORT MED, V24, P747, DOI 10.1177/036354659602400608; FRANK E, 1995, ACAD EMERG MED, V2, P200, DOI 10.1111/j.1553-2712.1995.tb03198.x; Friedman LJ, 1998, ANN EMERG MED, V31, P219, DOI 10.1016/S0196-0644(98)70310-5; HEMS TEJ, 1992, J TRAUMA, V32, P683, DOI 10.1097/00005373-199206000-00002; KIBURZ D, 1986, AM J SPORT MED, V14, P416, DOI 10.1177/036354658601400516; KULUND D, 1978, PHYSICIAN SPORTSMED, V6, P75; LOFTHOUSE GA, 1994, CLIN SPORT MED, V13, P113; MAIMARIS C, 1994, BRIT MED J, V308, P1537, DOI 10.1136/bmj.308.6943.1537; MONTALTO NJ, 1994, CLIN SPORT MED, V13, P249; Nyberg P, 1996, SCAND J SOC MED, V24, P293, DOI 10.1177/140349489602400410; RIVARA FP, 1989, JAMA-J AM MED ASSOC, V261, P566, DOI 10.1001/jama.261.4.566; Rivara FP, 2015, INJURY PREV, V21, P47, DOI 10.1136/injprev-00002-0038rep; SANDERS AB, 1986, ANN EMERG MED, V15, P515, DOI 10.1016/S0196-0644(86)80984-2; SIMPSON AHRW, 1992, INJURY, V23, P171, DOI 10.1016/S0020-1383(05)80038-5; SPAITE DW, 1995, J TRAUMA, V38, P287, DOI 10.1097/00005373-199502000-00028; THOMPSON DC, 1990, AM J PUBLIC HEALTH, V80, P1388, DOI 10.2105/AJPH.80.11.1388; Thompson DC, 1996, JAMA-J AM MED ASSOC, V276, P1974, DOI 10.1001/jama.276.24.1974; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; TINSWORTH DK, 1994, BICYCLE USE HAZARD P; TUCCI JJ, 1988, AM J SPORT MED, V16, P181, DOI 10.1177/036354658801600216; WEISS BD, 1985, AM J SPORT MED, V13, P187, DOI 10.1177/036354658501300308; YELON JA, 1995, AM SURGEON, V61, P202	24	20	20	0	3	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	JAN	1999	33	1					56	61		10.1016/S0196-0644(99)70417-8			6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	154RC	WOS:000077901700010	9867887				2022-02-06	
J	Geisler, MW; Schlotfeldt, CR; Middleton, CB; Dulay, MF; Murphy, C				Geisler, MW; Schlotfeldt, CR; Middleton, CB; Dulay, MF; Murphy, C			Traumatic brain injury assessed with olfactory event-related brain potentials	JOURNAL OF CLINICAL NEUROPHYSIOLOGY			English	Article						head trauma; olfactory; trigeminal; olfactory event-related potential (OERP)	CLOSED-HEAD-INJURY; CHEMOSENSORY EVOKED-POTENTIALS; CONTINGENT NEGATIVE-VARIATION; INDIVIDUAL-DIFFERENCES; CHEMICAL-STIMULATION; ODOR IDENTIFICATION; ALZHEIMERS-DISEASE; NASAL-MUCOSA; P300; AGE	Olfactory event-related potentials (OERPs) were evaluated to develop an objective, quantitative assessment of sensory and cognitive olfactory loss following traumatic brain injury (TBI). Subjects included 25 TBI patients and 25 age/gender-matched healthy controls. Following standard clinical evaluation of smell function, TBI patients were divided into three groups: 12 anosmics (loss of smell), 6 hyposmics (reduced smell), and 7 normosmics (normal smell). Cognitive ability was assessed using the Trail Making Test (A and B). OERPs were recorded monopolarly from midline electrode sites using an amyl acetate stimulus with a 60-second interstimulus interval; subjects estimated the magnitude of each odor stimulus. Anosmic TBI patients were also tested with OERPs using ammonia to ensure trigeminal nerve function. Amyl acetate OERPs demonstrated that the sensory N1 and P2 amplitudes and the cognitive P3 amplitudes were absent in the anosmic TBI patients and greatly reduced in the hyposmic and normosmic TBI patients compared to healthy controls. The trigeminal OERPs from the anosmic TBI patients were within normal limits, indicating that the primary olfactory deficits were objectively measured with OERPs. The relationship between the OERPs and neuropsychologic test performance supports the cognitive loss associated with TBI. The present study lends support to the utility of OERPs as an objective tool for measuring sensory and cognitive loss after traumatic brain injury.	San Diego State Univ, Dept Psychol, San Diego, CA 92120 USA; Univ Calif San Diego, Ctr Med, San Diego, CA 92103 USA		Murphy, C (corresponding author), San Diego State Univ, Dept Psychol, 6363 Alvarado Ct,Suite 101, San Diego, CA 92120 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC002064, T32DC000032] Funding Source: NIH RePORTER; NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC00032, DC02064] Funding Source: Medline		Army Individual Test Battery, 1944, MAN DIR SCOR; AUFFERMANN H, 1993, ANN OTO RHINOL LARYN, V102, P6, DOI 10.1177/000348949310200102; BICKERSTAFF ER, 1973, NEUROLOGICAL EXAMINA, P33; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; COMETTOMUNIZ JE, 1991, PHARMACOL BIOCHEM BE, V39, P983, DOI 10.1016/0091-3057(91)90063-8; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; COSTANZO RM, 1987, NY ACAD SCI, V510, P242; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; Cui LY, 1997, ELECTROEN CLIN NEURO, V102, P303, DOI 10.1016/S0013-4694(96)96109-X; DAVIDSON TM, 1995, POSTGRAD MED, V98, P107, DOI 10.1080/00325481.1995.11946020; Davidson TM, 1997, ARCH OTOLARYNGOL, V123, P591; DAVIDSON TM, 1987, WESTERN J MED, V146, P434; Donchin E., 1986, PSYCHOPHYSIOL SYST P, P244; DONCHIN E, 1988, BEHAV BRAIN SCI, V59, P238; Doty R. L., 1992, J HEAD TRAUMA, V7, P47; DOTY RL, 1975, PHYSIOL BEHAV, V14, P855, DOI 10.1016/0031-9384(75)90081-5; DOTY RL, 1989, ANN NY ACAD SCI, V561, P76, DOI 10.1111/j.1749-6632.1989.tb20971.x; DOTY RL, 1984, SCIENCE, V226, P1441, DOI 10.1126/science.6505700; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; DOTY RL, 1984, PHYSIOL BEHAV, V32, P489, DOI 10.1016/0031-9384(84)90269-5; DOTY RL, PHYSL BEHAV, V20, P175; ESON ME, 1978, J NEUROL NEUROSUR PS, V41, P1036, DOI 10.1136/jnnp.41.11.1036; Etcoff LM, 1996, NEUROPSYCHOL REV, V6, P171, DOI 10.1007/BF01874896; EVANS WJ, 1995, ELECTROEN CLIN NEURO, V95, P293; EVANS WJ, 1993, CHEM SENSES, V18, P751, DOI 10.1093/chemse/18.6.751; Frederick R. I., 1991, PSYCHOL ASSESSMENT J, V3, P596, DOI DOI 10.1037/1040-3590.3.4.596; GEISLER MW, 1990, BIOL PSYCHOL, V31, P117, DOI 10.1016/0301-0511(90)90012-L; Geisler MW, 1996, J NEUROL REHABIL, V10, P17; GEISLER MW, 1992, PSYCHOPHYSIOLOGY, V29, P76, DOI 10.1111/j.1469-8986.1992.tb02017.x; GEISLER MW, 1992, PSYCHOPHYSIOLOGY, V29, P86, DOI 10.1111/j.1469-8986.1992.tb02019.x; GEISLER MW, IN PRESS J CLIN EXP; GORKE W, 1991, BRAIN DYSFUNCT, V4, P147; Haines ME, 1995, NEUROPSYCHOL REV, V5, P125, DOI 10.1007/BF02208438; Halstead W.C., 1947, BRAIN INTELLIGENCE; JAFEK BW, 1989, ARCH NEUROL-CHICAGO, V46, P300, DOI 10.1001/archneur.1989.00520390066018; KOBAL G, 1985, PAIN, V22, P151, DOI 10.1016/0304-3959(85)90175-7; KOBAL G, 1992, CHEM SENSES, V17, P233, DOI 10.1093/chemse/17.3.233; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; Kobal G, 1981, ELEKTROPHYSIOLOGISCH; KOBAL G, 1989, CHEM SENSES, V2, P123; KOBAL G, 1991, SMELL TASTE HLTH DIS, P255; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LORIG TS, 1995, PSYCHOPHYSIOLOGY, V32, P393, DOI 10.1111/j.1469-8986.1995.tb01222.x; Lorig TS, 1996, INT J PSYCHOPHYSIOL, V23, P199, DOI 10.1016/S0167-8760(96)00061-X; Morgan CD, 1997, EVOKED POTENTIAL, V104, P351, DOI 10.1016/S0168-5597(97)00020-8; MORGAN CD, 1995, J CLIN EXP NEUROPSYC, V17, P793, DOI 10.1080/01688639508405168; MORGAN CD, IN PRESS PSYCHOPHYSI; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; MURPHY C, 1994, CHEM SENSES, V19, P47, DOI 10.1093/chemse/19.1.47; MURPHY C, 1990, NEUROBIOL AGING, V11, P465, DOI 10.1016/0197-4580(90)90014-Q; MURPHY C, 1986, PHYSIOL BEHAV, V37, P177, DOI 10.1016/0031-9384(86)90402-6; MURPHY C, 1992, J HEAD TRAUMA REHAB, V7, P76; MURPHY C, 1994, OLFACTION TASTE, V11, P609; NATIV A, 1994, ARCH PHYS MED REHAB, V75, P1322; ODONNELL BF, 1992, INT J PSYCHOPHYSIOL, V12, P187, DOI 10.1016/0167-8760(92)90010-9; ODONNELL BF, 1987, BIOL PSYCHOL, V24, P23, DOI 10.1016/0301-0511(87)90097-4; ODONNELL BF, 1990, NEUROPSY NEUROPSY BE, V3, P164; Parker RS, 1996, NEUROPSYCHOL REV, V6, P135, DOI 10.1007/BF01874895; Pause BM, 1996, PSYCHOPHYSIOLOGY, V33, P376, DOI 10.1111/j.1469-8986.1996.tb01062.x; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 1998, J CLIN NEUROPHYSIOL, V15, P14, DOI 10.1097/00004691-199801000-00004; POLICH J, 1994, ELECTROEN CLIN NEURO, V92, P253, DOI 10.1016/0168-5597(94)90068-X; POLICH J, 1985, J GERONTOL, V40, P721, DOI 10.1093/geronj/40.6.721; PONTIUS AA, 1980, J NERV MENT DIS, V168, P111, DOI 10.1097/00005053-198002000-00008; Rauh C, 1967, HNO, V15, P271; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; REITEN RM, 1974, CLIN NEUROPSYCHOLOGY; ROSENFELD JP, 1995, INT J PSYCHOPHYSIOL, V19, P1, DOI 10.1016/0167-8760(94)00057-L; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; RUTHERFORD WH, 1977, LANCET, V1, P1; SOUSTIEL JF, 1995, BRAIN INJURY, V9, P805, DOI 10.3109/02699059509008236; Sumner D, 1975, HDB CLIN NEUROLOGY, P1; Trueblood W, 1997, ARCH CLIN NEUROPSYCH, V12, P13, DOI 10.1016/S0887-6177(96)00027-3	77	20	22	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0736-0258	1537-1603		J CLIN NEUROPHYSIOL	J. Clin. Neurophysiol.	JAN	1999	16	1					77	86		10.1097/00004691-199901000-00008			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	176TW	WOS:000079168700008	10082095				2022-02-06	
J	Uchiyama, H; Nishizawa, S; Satoh, A; Yokoyama, T; Uemura, K				Uchiyama, H; Nishizawa, S; Satoh, A; Yokoyama, T; Uemura, K			Post-traumatic pituitary apoplexy - Two case reports	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						head injury; pituitary apoplexy; pituitary tumor; transsphenoidal surgery		A 60-year-old Female and a 66-year-old male presented with post-traumatic pituitary apoplexy associated with clinically asymptomatic pituitary macroadenoma manifesting as severe visual disturbance that had not developed immediately after the head injury. Skull radiography showed a unilateral linear occipital fracture. Magnetic resonance imaging revealed pituitary tumor with dumbbell-shaped suprasellar extension and fresh intratumoral hemorrhage. Transsphenoidal surgery was performed in the first patient, and the visual disturbance subsided. Decompressive craniectomy was performed in the second patient to treat brain contusion and part of the tumor was removed to decompress the optic nerves. The mechanism of post-traumatic pituitary apoplexy may occur as follows. The intrasellar part of the tumor ir; fixed by the bony structure forming the sella, and the suprasellar part is free to move, so a rotational force acting on the occipital region on one side will create a shearing strain between the intra- and suprasellar part of the tumor, resulting in pituitary apoplexy. Recovery of visual function, no matter how severely impaired, can be expected if an emergency operation is performed to decompress the optic: nerves. Transsphenoidal surgery is the most advantageous procedure, as even partial removal of the tumor may be adequate to decompress the optic nerves in the acute stage. Staged transsphenoidal surgery is indicated to achieve total removal later.	Hamamatsu Univ Sch Med, Dept Neurosurg, Hamamatsu, Shizuoka 4313192, Japan; Hamamatsu Red Cross Hosp, Dept Neurosurg, Hamamatsu, Shizuoka, Japan		Nishizawa, S (corresponding author), Hamamatsu Univ Sch Med, Dept Neurosurg, 3600 Handa Cho, Hamamatsu, Shizuoka 4313192, Japan.						BROUGHAM M, 1950, J NEUROSURG, V7, P421, DOI 10.3171/jns.1950.7.5.0421; CARDOSO ER, 1984, NEUROSURGERY, V14, P363, DOI 10.1227/00006123-198403000-00021; JOLLEY GL, 1958, J MED ASS GA, V47, P75; Nishizawa S, 1998, NEUROL MED-CHIR, V38, P213, DOI 10.2176/nmc.38.213; OKUDA O, 1994, SURG NEUROL, V42, P19, DOI 10.1016/0090-3019(94)90244-5; Perpetuo F O, 1976, Arq Neuropsiquiatr, V34, P298; REICHENTHAL E, 1980, ACTA NEUROCHIR, V54, P251, DOI 10.1007/BF01407092; SACHDEV Y, 1976, BRIT MED J, V1, P942, DOI 10.1136/bmj.1.6015.942; VanWagenen WP, 1932, ANN SURG, V95, P625; WAKAI S, 1981, J NEUROSURG, V55, P187, DOI 10.3171/jns.1981.55.2.0187; WEISBERG LA, 1977, AM J MED, V63, P109, DOI 10.1016/0002-9343(77)90122-X; WRIGHT RL, 1965, ARCH NEUROL-CHICAGO, V12, P326, DOI 10.1001/archneur.1965.00460270102013	12	20	20	0	4	JAPAN NEUROSURGICAL SOC	TOKYO	7-3-1 HONGO BUNKYO-KU, TOKYO, 113-8655, JAPAN	0470-8105			NEUROL MED-CHIR	Neurol. Med.-Chir.	JAN	1999	39	1					36	39		10.2176/nmc.39.36			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	168XM	WOS:000078718500015	10093459	Bronze			2022-02-06	
J	Piek, J				Piek, J		Working Grp Neurosurgical Intensive Care Europe	Guidelines for the pre-hospital care of patients with severe head injuries	INTENSIVE CARE MEDICINE			English	Article							CEREBRAL PERFUSION-PRESSURE; HYPERTONIC SALINE; HEMORRHAGIC-SHOCK; INTRACRANIAL HYPERTENSION; BRAIN INJURY; MILD HYPOTHERMIA; CLINICAL-TRIAL; TRAUMATIC COMA; BLOOD-FLOW; RESUSCITATION		European Soc Intens Care Med, B-1070 Brussels, Belgium		Piek, J (corresponding author), European Soc Intens Care Med, Av J Wybran 40, B-1070 Brussels, Belgium.	esicm@pophost.eunet.be					BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; BERGER S, 1994, ACT NEUR S, V60, P494; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOWERS SA, 1980, NEUROSURGERY, V6, P237; BUSTO R, 1989, STROKE, V20, P904, DOI 10.1161/01.STR.20.7.904; Chesnut R M, 1995, New Horiz, V3, P366; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CHESNUT RM, 1993, HEAD INJURY, P225; CHEVRET S, 1993, INTENS CARE MED, V19, P256, DOI 10.1007/BF01690545; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; COTTRELL JE, 1977, ANESTHESIOLOGY, V47, P28, DOI 10.1097/00000542-197707000-00006; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; DUHAIME AC, NEUROTRAUMA, P365; FELDMAN Z, 1992, J NEUROSURG, V76, P207, DOI 10.3171/jns.1992.76.2.0207; FRESHMAN SP, 1993, J TRAUMA, V35, P344, DOI 10.1097/00005373-199309000-00003; GAAB MR, 1989, NEUROCHIRURGIA, V32, P93; GAAB MR, 1995, ZBL NEUROCHIR, V55, P135; GENTLEMAN D, 1986, BRIT MED J, V292, P449, DOI 10.1136/bmj.292.6518.449; GENTLEMAN D, 1992, INT SURG, V77, P297; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRUMME T, 1995, RES EXP MED, V195, P217, DOI 10.1007/BF02576791; GUNNAR WP, 1986, ANN SURG, V204, P686, DOI 10.1097/00000658-198612000-00012; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; HARTL R, 1995, SHOCK, V3, P274; HILLS MW, 1993, J TRAUMA, V34, P549, DOI 10.1097/00005373-199304000-00011; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; JENNETT B, 1978, INJURY, V10, P31; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; MACIVER IN, 1958, LANCET, V1, P390; MANINGAS PA, 1989, AM J SURG, V157, P528, DOI 10.1016/0002-9610(89)90654-5; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MCQUEEN JD, 1964, J NEUROSURG, V21, P118, DOI 10.3171/jns.1964.21.2.0118; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1975, J NEUROSURG, V42, P274, DOI 10.3171/jns.1975.42.3.0274; MILLER JD, 1978, JAMA-J AM MED ASSOC, V4, P439; MOSKOPP D, 1990, UNFALLCHIRURG, V93, P120; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; NAKAYAMA S, 1984, CIRC SHOCK, V13, P149; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; PAGNI CA, 1991, ACTA NEUROCHIR, V111, P1, DOI 10.1007/BF01402506; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; PIEK J, 1993, ADV NEUROS, V21, P192; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; ROCHAESILVA M, 1986, CIRC SHOCK, V19, P165; ROSE J, 1977, BRIT MED J, V21, P615; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; Sheikh AA, 1996, CRIT CARE MED, V24, P1226, DOI 10.1097/00003246-199607000-00027; SHENKIN HA, 1962, J NEUROSURG, V19, P897, DOI 10.3171/jns.1962.19.10.0897; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; SINGBARTL G, 1985, ANASTH INTENSIV NOTF, V20, P251, DOI 10.1055/s-2007-1003119; Taylor G, 1996, J PEDIATR SURG, V31, P65, DOI 10.1016/S0022-3468(96)90321-8; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TOMMASINO C, 1988, CRIT CARE MED, V16, P862, DOI 10.1097/00003246-198809000-00009; VALESCO IT, 1980, AM J PHYSIOL, V239, pH664; VAN WAGONER F H, 1961, J Trauma, V1, P401; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37; WAHJOEPRAMONO EJ, 1993, ADV NEUROS, V21, P184; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WISE BL, 1962, J NEUROSURG, V19, P1038, DOI 10.3171/jns.1962.19.12.1038; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	67	20	20	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	1998	24	11					1221	1225		10.1007/s001340050748			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	144XU	WOS:000077341700017	9876987				2022-02-06	
J	Harbrecht, BG; Moraca, RJ; Saul, M; Courcoulas, AP				Harbrecht, BG; Moraca, RJ; Saul, M; Courcoulas, AP			Percutaneous endoscopic gastrostomy reduces total hospital costs in head injured patients	AMERICAN JOURNAL OF SURGERY			English	Article							COMPLICATIONS	BACKGROUND: Gastrostomies provide reliable long-term enteral access in patients with traumatic brain injuries. The impact of technique of gastrostomy on total hospital cost is not known. METHODS: A retrospective analysis of patients who sustained head trauma and required gastrostomies for long-term enteral access between 1 July 1990 and 1 July 1996 was performed. RESULTS: The patients who received percutaneous endoscopic gastrostomies (PEG) were similar to patients who received Stamm gastrostomies (OPEN) with respect to age, injury severity score, mechanism of injury, associated injuries, complication rates, and deaths. Total hospital costs ($ x 10(3)) were lower for patients who had PEGs placed in the intensive care unit (78.2 +/- 37.4) or endoscopy suite (71.9 +/- 37.7) compared with PEGs placed in the operating room (122.4 +/- 75.7) or OPEN gastrostomies (119.8 +/- 65.1). CONCLUSIONS: In head-injured patients, PEGs are a reliable method of obtaining long-term enteral access with a complication rate equivalent to Stamm gastrostomies. If performed in either the intensive care unit or the endoscopy suite, PEGs are associated with significantly reduced total hospital costs. (C) 1998 by Excerpta Medica, Inc.	Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; Univ Pittsburgh, Dept Biomed Infomat, Pittsburgh, PA USA		Harbrecht, BG (corresponding author), Univ Pittsburgh, Presbyterian Univ Hosp A1010, 200 Lothrop St, Pittsburgh, PA 15213 USA.						Carrillo EH, 1997, SURG ENDOSC, V11, P1068, DOI 10.1007/s004649900531; Chowdhury MA, 1996, J GASTROEN HEPATOL, V11, P835, DOI 10.1111/j.1440-1746.1996.tb00089.x; DAMELIO LF, 1992, J TRAUMA, V33, P435; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; KIRBY DF, 1991, JPEN-PARENTER ENTER, V15, P298, DOI 10.1177/0148607191015003298; LARSON DE, 1987, GASTROENTEROLOGY, V93, P48, DOI 10.1016/0016-5085(87)90312-X; Lowe JB, 1997, AM J SURG, V174, P624, DOI 10.1016/S0002-9610(97)00177-3; SAXE JM, 1994, J TRAUMA, V37, P581, DOI 10.1097/00005373-199410000-00010; SHELLITO PC, 1985, ANN SURG, V201, P180, DOI 10.1097/00000658-198502000-00008; STIEGMANN GV, 1990, GASTROINTEST ENDOSC, V36, P1, DOI 10.1016/S0016-5107(90)70911-X; WEBSTER MW, 1975, ARCH SURG-CHICAGO, V110, P658	11	20	21	0	0	CAHNERS PUBL CO	NEW YORK	249 WEST 17 STREET, NEW YORK, NY 10011 USA	0002-9610			AM J SURG	Am. J. Surg.	OCT	1998	176	4					311	314		10.1016/S0002-9610(98)00206-2			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	135DL	WOS:000076785500004	9817245				2022-02-06	
J	Golding, EM; Steenberg, ML; Cherian, L; Marrelli, SP; Robertson, CS; Bryan, RM				Golding, EM; Steenberg, ML; Cherian, L; Marrelli, SP; Robertson, CS; Bryan, RM			Endothelial-mediated dilations following severe controlled cortical impact injury in the rat middle cerebral artery	JOURNAL OF NEUROTRAUMA			English	Article						endothelium; middle cerebral artery; nitric oxide; purinoceptors; traumatic brain injury; vascular smooth muscle	TRAUMATIC BRAIN INJURY; NITRIC-OXIDE; DEPENDENT RELAXATION; STIMULATED ACTIVITY; ACUTE HYPERTENSION; BASILAR ARTERY; L-ARGININE; BASAL; AORTA; CATS	The mechanisms associated with dysfunction of the cerebral vasculature following head trauma have not yet been fully elucidated. In an attempt to shed more light on the matter, we investigated the endothelial-mediated dilations in the rat middle cerebral artery (MCA) following severe traumatic brain injury (TBI). Rats were subjected to severe controlled cortical impact injury (CCI; 5 m/s, 130 ms duration, 3 mm deformation) over the right parietal cortex. At 24 h postinjury, ipsilateral segments of MCA and corresponding contralateral segments were isolated, mounted in a vessel chamber, and pressurized. The responses to 2 methylthio-ATP (2MeSATP), a selective agonist for the P2Y(1) purinoceptors, NW-nitro-L-arginine (L-NAME), an NO synthase inhibitor, and S-nitroso-N-acetylpenicillamine (SNAP), an exogenous NO donor,were determined. 2MeSATP elicited concentration dependent dilations in all MCAs studied. Ipsilateral MCAs harvested following TBI or sham-TBI, showed similar maximum dilations to 2MeSATP [70 +/- 4% (n = 17) and 72 +/- 6% (n = 13), respectively]. However, TBI reduced the concentration of 2MeSATP necessary to elicit one-half of the maximum dilation (EC50) from 15 to 9 nM (p < 0.05). Inhibition of NO synthase with 10(-5) M L-NAME abolished the dilation to 2MeSATP in both TBI and sham-TBI MCAs. The constriction to L-NAME was significantly reduced in TBI MCAs compared to sham vessels. Dilations to SNAP, an NO donor, were not altered by TBI indicating that the mechanisms of dilation involving NO in the vascular smooth muscle were not affected. Unlike other pathological conditions which often diminish endothelial-mediated responses, severe TBI enhanced the sensitivity to 2MeSATP without altering the maximum response.	Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; Baylor Coll Med, Dept Anesthesiol, Houston, TX 77030 USA; Baylor Coll Med, Cardiovasc Sci Program, Houston, TX 77030 USA		Golding, EM (corresponding author), Baylor Coll Med, Dept Neurosurg, 6560 Fannin St,Ste 944, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS027616] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [HL07816] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01-NS27616] Funding Source: Medline		ARMSTEAD WM, 1996, AM J PHYSIOL, V270, pH2172; Betz AL, 1996, ADV NEUROL, V71, P301; BRUHWYLER J, 1993, NEUROSCI BIOBEHAV R, V17, P373, DOI 10.1016/S0149-7634(05)80114-9; Bryan RM, 1996, ANESTHESIOLOGY, V85, P82, DOI 10.1097/00000542-199607000-00012; BRYAN RM, 1995, AM J PHYSIOL-HEART C, V269, pH1171; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; CHERIAN L, 1994, J NEUROTRAUM, V11, P573, DOI 10.1089/neu.1994.11.573; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1991, J NEUROSCI METH, V39, P253; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; FARACI FM, 1992, PHARMACOL THERAPEUT, V56, P1, DOI 10.1016/0163-7258(92)90035-X; FREW JD, 1993, BRIT J PHARMACOL, V110, P1003, DOI 10.1111/j.1476-5381.1993.tb13913.x; HATAKE K, 1992, STROKE, V23, P1111, DOI 10.1161/01.STR.23.8.1111; JOHANSSON B, 1989, J HYPERTENS, V7, pS5; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; Marrelli Sean P., 1997, Society for Neuroscience Abstracts, V23, P1379; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; Mayhan WG, 1996, J CEREBR BLOOD F MET, V16, P500, DOI 10.1097/00004647-199605000-00017; MAYHAN WG, 1995, BRAIN RES, V686, P99, DOI 10.1016/0006-8993(95)00460-8; MIAN KB, 1995, BRIT J PHARMACOL, V115, P993, DOI 10.1111/j.1476-5381.1995.tb15909.x; MONCADA S, 1991, PHARMACOL REV, V43, P109; PAULSON OB, 1970, NEUROLOGY, V20, P63, DOI 10.1212/WNL.20.1.63; POVLISHOCK JT, 1994, J NEUROTRAUM, V11, P723, DOI 10.1089/neu.1994.11.723; RUBANYI GM, 1991, J CELL BIOCHEM, V46, P27, DOI 10.1002/jcb.240460106; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1985, CIRC RES, V57, P781, DOI 10.1161/01.RES.57.5.781; You JP, 1997, AM J PHYSIOL-HEART C, V273, pH1472, DOI 10.1152/ajpheart.1997.273.3.H1472	28	20	20	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	AUG	1998	15	8					635	644		10.1089/neu.1998.15.635			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	111KP	WOS:000075436500007	9726262				2022-02-06	
J	Childers, MK; Holland, D; Ryan, MG; Rupright, J				Childers, MK; Holland, D; Ryan, MG; Rupright, J			Obsessional disorders during recovery from severe head injury: report of four cases	BRAIN INJURY			English	Article							GLUCOSE METABOLIC RATES; COMPULSIVE DISORDER	Four cases of transient obsessional disorders following severe head injury are described within the context of recovery from acute traumatic brain injury (TBI). obsessional features following TBI have important treatment implications in brain injury rehabilitation settings, since emergence of this disorder in the acutely brain injured patient poses a significant obstacle to interdisciplinary rehabilitation. Although the numbers of patients described here and in previous reports are too small to draw conclusions about the incidence of obsessional disorders following TBI, these cases illustrate the importance of correctly identifying and treating obsessional symptoms in the brain injured patient.	Univ Missouri, Dept Phys Med & Rehabil, Howard A Rusk Rehabil Ctr, Columbia, MO 65212 USA; Missouri Rehabil Ctr, Mt Vernon, MO USA		Childers, MK (corresponding author), Univ Missouri, Dept Phys Med & Rehabil, Howard A Rusk Rehabil Ctr, DC046-00 1 Hosp Dr, Columbia, MO 65212 USA.			Childers, Martin/0000-0003-4754-0883			BACTER LR, 1987, ARCH GEN PSYCHIAT, V44, P800; BAXTER LR, 1988, AM J PSYCHIAT, V145, P1560; BAXTER LR, 1992, ARCH GEN PSYCHIAT, V49, P681; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; BEHAR D, 1984, AM J PSYCHIAT, V141, P363; Bond M. R., 1990, REHABILITATION ADULT, P179; DRUMMOND LM, 1988, BRIT J PSYCHIAT, V153, P839, DOI 10.1192/bjp.153.6.839; Goldstein K, 1942, EFFECTS BRAIN INJURI; GOLDSTEIN K, 1930, ORGANISM; LISHMAN WA, 1968, BRIT J PSYCHIAT, V114, P373, DOI 10.1192/bjp.114.509.373; MAX JE, 1995, J AM ACAD CHILD PSY, V34, P45, DOI 10.1097/00004583-199501000-00012; MCKEON J, 1984, BRIT J PSYCHIAT, V144, P190, DOI 10.1192/bjp.144.2.190; WALKER VJ, 1973, BRIT J PSYCHIAT, V123, P675, DOI 10.1192/bjp.123.6.675; YARYURATOBIA JA, 1997, OBSESSIVE COMPULSIVE; 1994, DIAGNOSTIC STAT MANU, P417	15	20	20	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON EC4A 3DE, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	JUL	1998	12	7					613	616					4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	ZX249	WOS:000074495200007	9653524				2022-02-06	
J	Hogg, S; Perron, C; Barneoud, P; Sanger, DJ; Moser, PC				Hogg, S; Perron, C; Barneoud, P; Sanger, DJ; Moser, PC			Neuroprotective effect of eliprodil: Attenuation of a conditioned freezing deficit induced by traumatic injury of the right parietal cortex in the rat	JOURNAL OF NEUROTRAUMA			English	Article						conditioned emotional response; conditioned fear response; neuroprotection; NMDA receptor antagonist; traumatic brain injury	RECEPTOR ANTAGONIST ELIPRODIL; GLOBAL CEREBRAL-ISCHEMIA; BRAIN INJURY; NMDA RECEPTOR; CA2+ CHANNELS; CORTICAL-NEURONS; POLYAMINE SITE; ANIMAL-MODELS; IFENPRODIL; SL-82.0715	We have previously demonstrated that a lateral fluid percussion-induced traumatic lesion of the right parietal cortex can lead to a deficit in a conditioned freezing response and that this deficit can be attenuated by both pre- and postlesion administration of the NMDA receptor antagonist dizocilpine. In the present study, we investigated the effects of eliprodil, a noncompetitive NMDA receptor antagonist acting at the polyamine modulatory site, which also acts as a Ca2+ channel blocker, on the trauma-induced conditioned freezing deficit, Eliprodil produced a 50% reduction in this deficit when administered as three 1 mg/kg injections i.v. at 15 min, 6 h, and 24 h following the lesion. Approximately the same degree of protection was afforded when 2 x 1.5 mg/kg were administered 6 and 24 h and equally at 12 and 24 h after surgery (56% and 59%, respectively). A single treatment (3 mg/kg) at 24 h was ineffective against the deficit. The protection afforded with treatment at 6 and 24 h after lesion was dose dependent, with a minimal active dose of 2 x 0.75 mg/kg, These data complement those previously published on the ability of eliprodil to reduce lesion volume following traumatic brain injury and show, in addition, that the neuroprotective effect has functional consequences.	Synthelabo Rech, F-92500 Rueil Malmaison, France; Synthelabo Rech, Bagneux, France		Moser, PC (corresponding author), Synthelabo Rech, 10 Rue Carrieres, F-92500 Rueil Malmaison, France.			Moser, Paul/0000-0002-6887-3508			Avenet P, 1997, NEUROSCI LETT, V223, P133, DOI 10.1016/S0304-3940(97)13422-X; Bath CP, 1996, EUR J PHARMACOL, V299, P103, DOI 10.1016/0014-2999(95)00846-2; BENAVIDES J, 1990, BRAIN RES, V522, P275, DOI 10.1016/0006-8993(90)91472-S; BENAVIDES J, 1992, J PHARMACOL EXP THER, V260, P896; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; BITON B, 1994, EUR J PHARMACOL, V257, P297, DOI 10.1016/0014-2999(94)90142-2; Biton B, 1995, EUR J PHARMACOL, V294, P91, DOI 10.1016/0014-2999(95)00511-0; CARTER C, 1989, EUR J PHARMACOL, V164, P611, DOI 10.1016/0014-2999(89)90275-6; CARTER C, 1988, J PHARMACOL EXP THER, V247, P1222; CARTER CJ, 1990, J PHARMACOL EXP THER, V253, P475; DECOSTER MA, 1995, BRAIN RES, V671, P45, DOI 10.1016/0006-8993(94)01294-R; Doppenberg EMR, 1997, J NEUROTRAUM, V14, P71, DOI 10.1089/neu.1997.14.71; DUVAL D, 1992, NEUROSCI LETT, V137, P193, DOI 10.1016/0304-3940(92)90402-S; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GOTTI B, 1990, BRAIN RES, V522, P290, DOI 10.1016/0006-8993(90)91473-T; GOTTI B, 1988, J PHARMACOL EXP THER, V247, P1211; HAMM RJ, 1993, COGNITIVE BRAIN RES, V1, P223, DOI 10.1016/0926-6410(93)90006-Q; Hogg S, 1998, BEHAV BRAIN RES, V93, P143, DOI 10.1016/S0166-4328(97)00146-0; Hogg S, 1998, BEHAV BRAIN RES, V93, P157, DOI 10.1016/S0166-4328(97)00145-9; HOVDA DA, 1995, J NEUROTRAUM, V12, P903, DOI 10.1089/neu.1995.12.903; Ikonomidou C, 1996, METAB BRAIN DIS, V11, P125, DOI 10.1007/BF02069500; KATAYAMA Y, 1995, BRAIN PATHOL, V5, P427, DOI 10.1111/j.1750-3639.1995.tb00621.x; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P215, DOI 10.1089/neu.1993.10.215; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; McIntosh TK, 1996, EUR J ANAESTH, V13, P291, DOI 10.1046/j.1365-2346.1996.00981.x; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; Novack TA, 1996, J CLIN EXP NEUROPSYC, V18, P685, DOI 10.1080/01688639608408292; ONeill MJ, 1996, EUR J PHARMACOL, V310, P115, DOI 10.1016/0014-2999(96)00387-1; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Paxinos G., 1982, RAT BRAIN STEREOTAXI, V1st ed.; POIGNET H, 1992, BRAIN RES, V596, P320, DOI 10.1016/0006-8993(92)91565-V; PONCELET M, 1993, NEUROPHARMACOLOGY, V32, P605, DOI 10.1016/0028-3908(93)90057-A; SANGER DJ, 1991, PSYCHOPHARMACOLOGY, V104, P27, DOI 10.1007/BF02244550; SCATTON B, 1994, DIRECT ALLOSTERIC CO, P139; SHALABY IA, 1992, J PHARMACOL EXP THER, V260, P925; SHAPIRA Y, 1990, Journal of Neurotrauma, V7, P131, DOI 10.1089/neu.1990.7.131; TOULMOND S, 1993, BRAIN RES, V620, P32, DOI 10.1016/0006-8993(93)90267-Q	38	20	20	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	1998	15	7					545	553		10.1089/neu.1998.15.545			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ZY374	WOS:000074614700008	9674557				2022-02-06	
J	Minassian, AT; Melon, E; Leguerinel, C; Lodi, CA; Bonnet, F; Beydon, L				Minassian, AT; Melon, E; Leguerinel, C; Lodi, CA; Bonnet, F; Beydon, L			Changes in cerebral blood flow during PaCO2 variations in patients with severe closed head injury: comparison between the Fick and transcranial Doppler methods	JOURNAL OF NEUROSURGERY			English	Article						Doppler ultrasonography; head injury; cerebral hemodynamics; cerebral vasoreactivity	CARBON-DIOXIDE; SUBARACHNOID HEMORRHAGE; HYPEREMIA; VELOCITY; ARTERY; AUTOREGULATION; HYPERTENSION; ULTRASOUND; VASOSPASM; PRESSURE	Object. The aim of this study was to reassess whether middle cerebral artery blood flow velocity (MCAv) variations measured by transcranial Doppler ultrasonography during acute PaCO2 manipulation adequately reflect cerebral blood flow (CBF) changes in patients with severe closed head injury. Methods. The study was performed by comparing MCAv variations to changes in CBF as assessed by measurements of the difference in the arteriovenous content in oxygen (AVDO(2)). The authors initiated 35 CO2 challenges in 12 patients with severe closed head injury during the acute stage. By simultaneous recording of systemic and cerebral hemody namic parameters, 105 AVDO(2) measurements were obtained. Patients were stratified into two groups, "high" and "low," with respect to whether their resting values of MCAv were greater than 100 cm/second during moderate hyperventilation. Four patients displayed an elevated MCAv, which was related to vasospasm in three cases and to hyper emia in one case. The PaCO2 and intracranial pressure levels were not different between the two groups. The slope of the regression line between 1 divided by the change in (Delta)AVDO(2) and Delta MCAv was not different from identity in the low group (1/Delta AVDO(2) = 1.08 x Delta MCAv -0.07, r = 0.93, p < 0.001) and significantly differed (p < 0.05) from the slope of the high group (1/Delta AVDO(2) = 1.46 X Delta MCAv -0.4, r = 0.83, p < 0.001). Conclusions. In patients with severe closed head injury, MCAv variations adequately reflect CBF changes as assessed by AVDO, measurements in the absence of a baseline increase in MCAv. These observations indicate that both moderate variations in PaCO2 and variations in cerebral perfusion pressure do not act noticeably on the diameter of the MCA. The divergence from the expected relationship in the high group seems to be due to the heterogeneity of CO2-induced changes in cerebrovascular resistance between differing arterial territories.	Hop Henri Mondor, Surg Intens Care Unit, F-94010 Creteil, France; Hop Henri Mondor, Dept Anesthesia, F-94010 Creteil, France; Hop Henri Mondor, Dept Neurosurg, F-94010 Creteil, France; Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy		Minassian, AT (corresponding author), Hop Larrey, Dept Anesthesie Reanimat Chirurg, 4 Rue Larrey, F-49033 Angers 01, France.	lBeydon.angers@invivo.edu					AUER L, 1978, EUR NEUROL, V17, P351, DOI 10.1159/000114974; BISHOP CCR, 1986, STROKE, V17, P913, DOI 10.1161/01.STR.17.5.913; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; BRASS LM, 1988, STROKE, V19, P1466, DOI 10.1161/01.STR.19.12.1466; CHAN KH, 1992, NEUROSURGERY, V30, P697; DEARDEN NM, 1991, CURR OPIN ANESTHESIO, V4, P279; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GIBBS EL, 1945, AM J PSYCHIAT, V102, P184, DOI 10.1176/ajp.102.2.184; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; GREENBERG JH, 1978, CIRC RES, V43, P324, DOI 10.1161/01.RES.43.2.324; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; LAM JMK, 1994, INTRACRANIAL PRESSUR, V9, P38; Lindegaard K F, 1988, Acta Neurochir Suppl (Wien), V42, P81; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; ROBERTSON CS, 1987, J NEUROSURG, V67, P361, DOI 10.3171/jns.1987.67.3.0361; Romner B, 1996, J NEUROSURG, V85, P90, DOI 10.3171/jns.1996.85.1.0090; SADOSHIMA S, 1980, BRAIN RES, V189, P115, DOI 10.1016/0006-8993(80)90011-6; Sahuquillo J, 1994, INTRACRANIAL PRESSUR, P48; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; Steiger HJ, 1996, STROKE, V27, P2048, DOI 10.1161/01.STR.27.11.2048; STOCCHETTI N, 1994, NEUROSURGERY, V34, P38; TAKEUCHI H, 1991, NEUROSURGERY, V28, P41, DOI 10.1227/00006123-199101000-00007; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762	24	20	20	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	1998	88	6					996	1001		10.3171/jns.1998.88.6.0996			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZP267	WOS:000073735200009	9609293				2022-02-06	
J	Sturmi, JE; Smith, C; Lombardo, JA				Sturmi, JE; Smith, C; Lombardo, JA			Mild brain trauma in sports - Diagnosis and treatment guidelines	SPORTS MEDICINE			English	Article							CLOSED HEAD-INJURY; CEREBRAL CONCUSSION; PREVENTION; FOOTBALL; MANAGEMENT; SYMPTOMS; SEQUELAE; PLAYERS; DAMAGE; BOXERS	Much has been written about the evaluation and management of mild brain trauma in sports. No less than 10 different 'guidelines' have been proposed and published to aid the clinician in the diagnosis of this condition. Too often, these guidelines have creating confusion instead of promoting an understanding of the spectrum of brain injury. As the understanding of the basic science of mild brain injury evolves, so must the approach to the concussed athlete. This article presents an up-to-date and clinically useful approach to the management of the athlete with a mild brain injury. The definition of 'concussion' is discussed and clarified and pertinent epidemiological data which highlight the importance of management skills as applied to athletes in a wide variety of sports are also reviewed. There is really no such thing as a 'mild concussion' if one considers the rare but catastrophic outcome of the second impact syndrome. For this reason, we review and expand upon the mechanisms of injury and pathophysiology. The accurate diagnosis of mild brain injury requires considerable experience, a high index of suspicion, a careful history and a series of examinations of the athlete, and a working knowledge of the athlete's personality and the likelihood of minimising their symptoms. The value of orientation questions pertinent to the athlete is now well established. Any focal neurological deficit or the deterioration of an athlete's condition warrants immediate hospitalisation, brain imaging and neurosurgical consultation. More commonly, athletes present with a brief alteration of consciousness, headache and amnesia and require careful examination and observation before returning to competition. The astute clinician will always err on the side of conservative management. The complete resolution of all symptoms before a return to play is imperative. Computerised tomography is very sensitive in the imaging of mild brain injuries. Neuropsychological testing is also very sensitive in the evaluation of brain injuries in athletes, and may become more clinically useful in the future.	Ohio State Univ, Athlet Dept, Columbus, OH 43210 USA		Sturmi, JE (corresponding author), Ohio State Univ Sports Med, 97b E Main St, New Albany, OH 43054 USA.						ALVES WM, 1991, ATHLETIC INJURIES HE; Archer P, 1996, JAMA-J AM MED ASSOC, V275, P1072; Barth JT, 1989, MILD HEAD INJURY, P257; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bruce D A, 1982, Clin Sports Med, V1, P495; BRUNO LA, 1987, CLIN SPORT MED, V6, P17; BUCKLEY WE, 1988, AM J SPORT MED, V16, P51, DOI 10.1177/036354658801600109; CANTU RC, 1992, SPORTS MED, V14, P64, DOI 10.2165/00007256-199214010-00005; CANTU RC, 1995, CLIN SPORT MED, V14, P517; CASSON IR, 1984, JAMA-J AM MED ASSOC, V251, P2663, DOI 10.1001/jama.251.20.2663; *CDCP, 1997, MMWR-MORBID MORTAL W, V46, P224; *CMS SPORTS MED CO, 1990, GUID MAN CONC SPORTS; Committee on Head Injury Nomenclature of Congress of Neurological Surgeons, 1966, CLIN NEUROSURG, V12, P386; ECHEMENDIA RJ, 1997, AM MED SOC SPORTS ME; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; FEKETE JF, 1968, CAN MED ASSOC J, V99, P1234; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GERBERICH SG, 1987, CHILD NERV SYST, V3, P59, DOI 10.1007/BF00271123; GIBBS N, 1993, AM J SPORT MED, V21, P696, DOI 10.1177/036354659302100510; GIERUP J, 1976, ACTA CHIR SCAND, V142, P57; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GUTHKELCH AN, 1980, EUR NEUROL, V19, P91, DOI 10.1159/000115133; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HOVDA D, 1997, AM MED SOC SPORTS ME, P127; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Jorgensen U, 1986, Br J Sports Med, V20, P7; KARZMARK P, 1995, BRAIN INJURY, V9, P21, DOI 10.3109/02699059509004567; KASTE M, 1982, LANCET, V2, P1186; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kelly JP, 1997, NEUROLOGY, V48, P581; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; LEVIN HS, 1988, J NEUROSURG, V69, P861, DOI 10.3171/jns.1988.69.6.0861; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LOVELL MR, 1997, AM MED SOC SPORTS ME, P147; MADDOCKS DL, 1995, CLIN J SPORT MED, V5, P32, DOI 10.1097/00042752-199501000-00006; Maroon J C, 1980, Clin Neurosurg, V27, P414; MASTERS SJ, 1987, NEW ENGL J MED, V316, P84, DOI 10.1056/NEJM198701083160205; MCKEAG DB, 1996, CONCUSSION SYLLABUS; MCLATCHIE G, 1987, J NEUROL NEUROSUR PS, V50, P96, DOI 10.1136/jnnp.50.1.96; Nelson W. E., 1984, PHYSICIAN SPORTSMED, V12, P103; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; SALAZAR AM, 1996, SCI AM, V11, P1; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Shawdon A, 1994, Aust J Sci Med Sport, V26, P59; TEASDALE G, 1974, LANCET, V2, P81; TORG JS, 1994, ORTHOPEDIC SPORTS ME, P422; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; WILBERGER JE, 1989, CLIN SPORT MED, V8, P1; WILBERGER JE, 1993, SPORTS MED, V15, P338, DOI 10.2165/00007256-199315050-00005; YARNELL PR, 1973, NEUROLOGY, V23, P196, DOI 10.1212/WNL.23.2.196; YARNELL PR, 1970, LANCET, V1, P863	53	20	20	0	6	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	0112-1642			SPORTS MED	Sports Med.	JUN	1998	25	6					351	358		10.2165/00007256-199825060-00001			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	101HC	WOS:000074862700001	9680657				2022-02-06	
J	Marion, DW				Marion, DW			Head and spinal cord injury	NEUROLOGIC CLINICS			English	Article							CEREBRAL BLOOD-FLOW; CIVILIAN GUNSHOT WOUNDS; TRAUMATIC BRAIN INJURY; INTRACRANIAL HYPERTENSION; COMPUTERIZED-TOMOGRAPHY; POSTTRAUMATIC SEIZURES; SURGICAL INTERVENTION; SUBDURAL-HEMATOMA; COMATOSE PATIENTS; EARLY DIAGNOSIS	Traumatic brain and spinal cord injuries remain the leading cause of death and disability for individuals under 50 years of age. This article describes common causes of primary and secondary central nervous system injuries. Particular emphasis is placed on the initial evaluation of trauma patients, detection of head and spinal cord injuries, and critical care of these patients. Definitive management of central nervous system injuries and prognosis and long-term management issues are also discussed.	Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Ctr Injury Res & Control, Pittsburgh, PA 15213 USA		Marion, DW (corresponding author), Univ Pittsburgh, Dept Neurol Surg, Brain Trauma Res Ctr, 200 Lothrop St,Suite B400, Pittsburgh, PA 15213 USA.		Marion, Donald/AAR-5749-2021	Marion, Donald/0000-0003-4627-7702			ARABI B, 1990, NEUROSURGERY, V27, P692; BACHULIS BL, 1987, AM J SURG, V153, P473, DOI 10.1016/0002-9610(87)90796-3; BECKER DP, 1977, J NEUROSURG, V47, P491, DOI 10.3171/jns.1977.47.4.0491; BEERS GJ, 1988, J COMPUT ASSIST TOMO, V12, P755, DOI 10.1097/00004728-198809010-00007; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BINGHAM WF, 1986, SURG NEUROL, V25, P340, DOI 10.1016/0090-3019(86)90207-7; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; BURNEY RE, 1993, ARCH SURG-CHICAGO, V128, P596; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; CLARK RSB, 1997, J NEUROSURG; COOPER A, 1987, J PEDIATR SURG, V22, P24, DOI 10.1016/S0022-3468(87)80008-8; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; DEKOSKY ST, 1994, J NEUROTRAUMA, V11, P106; DEVIVO MJ, 1992, ARCH PHYS MED REHAB, V73, P424; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; GERBERICH SG, 1983, AM J PUBLIC HEALTH, V73, P1370, DOI 10.2105/AJPH.73.12.1370; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1988, J CLIN PATHOL, V41, P34, DOI 10.1136/jcp.41.1.34; GRAHM TW, 1990, NEUROSURGERY, V27, P696, DOI 10.1227/00006123-199011000-00005; GRONWALL D, 1975, LANCET, V2, P995; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; HAHN YS, 1988, CHILD NERV SYST, V4, P34; HELLING TS, 1992, J TRAUMA, V32, P398, DOI 10.1097/00005373-199203000-00019; HERNESNIEMI J, 1979, ACTA NEUROCHIR, V49, P199, DOI 10.1007/BF01808959; HOFFMAN JR, 1992, ANN EMERG MED, V21, P1454, DOI 10.1016/S0196-0644(05)80059-9; HOWELL DA, 1959, BRAIN, V82, P525, DOI 10.1093/brain/82.4.525; HSU CY, 1985, NEUROLOGY, V35, P1003, DOI 10.1212/WNL.35.7.1003; Ingebrigtsen T, 1996, ACTA NEUROL SCAND, V93, P207; JANSSEN L, 1989, SPINE, V14, P23, DOI 10.1097/00007632-198901000-00005; JORGE RE, 1993, J NEUROPSYCH CLIN N, V5, P43; KAUFMAN HH, 1991, NEUROSURGERY CLIN N, P387; KIWERSKI JE, 1993, PARAPLEGIA, V31, P192, DOI 10.1038/sc.1993.36; KLAUBER MR, 1985, J NEUROSURG, V62, P528, DOI 10.3171/jns.1985.62.4.0528; KREIPKE DL, 1989, J TRAUMA, V29, P1438, DOI 10.1097/00005373-198910000-00024; LEWIS LM, 1991, ANN EMERG MED, V20, P117, DOI 10.1016/S0196-0644(05)81205-3; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MARION DW, 1994, SPORTS INJURIES MECH, P813; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MARSHALL LF, 1987, J NEUROSURG, V66, P400, DOI 10.3171/jns.1987.66.3.0400; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1983, J NEUROSURG, V58, P566, DOI 10.3171/jns.1983.58.4.0566; McLaughlin MR, 1996, J NEUROSURG, V85, P871, DOI 10.3171/jns.1996.85.5.0871; *MED RES COUNC, 1986, AIDS EX PER NERV SYS, P1; MILLER J, 1994, JAMA-J AM MED ASSOC, V240, P439; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MILLER JD, 1982, CLIN NEUR, V29, P162; MORAN SG, 1994, AM SURGEON, V60, P533; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OSULLIVAN MG, 1994, J NEUROSURG, V80, P46, DOI 10.3171/jns.1994.80.1.0046; PALMER AM, 1994, NEUROREPORT, V6, P153, DOI 10.1097/00001756-199412300-00039; PANTER SS, 1990, ANN NEUROL, V27, P96, DOI 10.1002/ana.410270115; PENNEY MD, 1979, INTENS CARE MED, V5, P23, DOI 10.1007/BF01738998; POLLANEN MS, 1992, CAN J NEUROL SCI, V19, P196, DOI 10.1017/S0317167100042256; PRZYBYLSKI GJ, 1996, TRAUMA, P307; RESNICK DK, 1994, NEUROSURGERY, V34, P252, DOI 10.1227/00006123-199402000-00007; Resnick DK, 1997, NEUROSURGERY, V40, P1177, DOI 10.1097/00006123-199706000-00012; RIMOLDI RL, 1992, SPINE, V17, P1443, DOI 10.1097/00007632-199212000-00001; ROBERGE R J, 1992, Journal of Emergency Medicine, V10, P539, DOI 10.1016/0736-4679(92)90133-E; ROBERGE RJ, 1988, J TRAUMA, V28, P784, DOI 10.1097/00005373-198806000-00010; SALVANT JB, 1993, NEUROSURGERY, V33, P387; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SIESJO BK, 1985, CENTRAL NERVOUS SYST, P513; STEIN SC, 1991, ANN EMERG MED, V20, P1286, DOI 10.1016/S0196-0644(05)81066-2; STONE JL, 1995, NEUROSURGERY, V37, P1104, DOI 10.1227/00006123-199512000-00010; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; TEAL JS, 1973, J NEUROSURG, V38, P568, DOI 10.3171/jns.1973.38.5.0568; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983; YOUNG W, 1986, BRAIN RES, V365, P42, DOI 10.1016/0006-8993(86)90720-1	78	20	21	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0733-8619			NEUROL CLIN	Neurol. Clin.	MAY	1998	16	2					485	+		10.1016/S0733-8619(05)70073-6			20	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZN686	WOS:000073671500012	9537971				2022-02-06	
J	Smirnova, IV; Salazar, A; Arnold, PM; Glatt, S; Handler, M; Festoff, BW				Smirnova, IV; Salazar, A; Arnold, PM; Glatt, S; Handler, M; Festoff, BW			Thrombin and its precursor in human cerebrospinal fluid	THROMBOSIS AND HAEMOSTASIS			English	Article							PROTEASE-NEXIN-I; NERVOUS-SYSTEM INJURY; NEURITE OUTGROWTH; RECEPTOR ACTIVATION; ALZHEIMERS-DISEASE; ALTERNATIVE PATHWAY; COAGULATION CASCADE; ANTITHROMBIN-III; SERINE PROTEASES; PROTHROMBIN	The blood coagulation cascade proteolytic enzyme, thrombin, affects many cell types, including neurons and astrocytes, in which it prevents process outgrowth and induces significant morphological degeneration and even cell death. Since thrombin may contribute significantly to pathological conditions in the central nervous system (CNS), where it is synthesized locally, we measured the levels of thrombin and its precursor, prothrombin, in the cerebrospinal fluid (CSF) of 67 individuals from 6 groups: non-neurologic controls (NNC); spinal degenerative disease (SDD); peripheral nerve disease (PND); cerebrovascular, neuroimmune and seizure disorders and tumor (CNSD); traumatic brain injury (TBI) and neurodegenerative disorders (NDD). We employed a sensitive chromogenic assay utilizing the thrombin specific tripeptide substrate, S-2238, to evaluate CSF levels of thrombin and prothrombin. The latter estimated after its conversion to active enzyme by the snake venom prothrombinase, ecarin. No measurable active thrombin was detected in these CSF samples. However, activatable prothrombin was measured in all groups. The mean activatable prothrombin concentrations (in nM) were 7.26 +/- 3.39 (NNC); 8.85 +/- 3.09 (SDD); 6.78 +/- 2.58 (PND); 6.33 +/- 3.87 (CNSD); 5.10 +/- 1.86 (TBI), and 7.80 +/- 3.27 (NDD). Duncan's multiple comparison test showed significant reduction (p <0.05) in prothrombin levels of the TBI group. Our data suggests that the prothrombin zymogen gains access to the CSF, likely across either an intact or compromised blood-brain barrier (BBB), in increased amounts with age. Reduced levels in TBI patients may have diagnostic and/or prognostic value.	VET ADM MED CTR, NEUROBIOL RES LAB 151R, KANSAS CITY, MO 64128 USA; UNIV KANSAS, MED CTR, DEPT NEUROL, KANSAS CITY, KS 66103 USA; UNIV KANSAS, MED CTR, DEPT SURG NEUROSURG, KANSAS CITY, KS 66103 USA; UNIV KANSAS, MED CTR, DEPT PATHOL & ONCOL NEUROPATHOL, KANSAS CITY, KS 66103 USA; WALTER REED ARMY MED CTR, DEPT CLIN INVEST, WASHINGTON, DC 20307 USA								ABRAHAM CR, 1992, RES IMMUNOL, V143, P631, DOI 10.1016/0923-2494(92)80047-O; Akenami FOT, 1996, J CLIN PATHOL, V49, P577, DOI 10.1136/jcp.49.7.577; AKIYAMA H, 1992, NEUROSCI LETT, V146, P152, DOI 10.1016/0304-3940(92)90065-F; BAKER JB, 1986, RECEPTORS, P153; BEECHER KL, 1994, J NEUROSCI RES, V37, P108, DOI 10.1002/jnr.490370115; Benzakour O, 1995, J CELL BIOCHEM, V59, P514, DOI 10.1002/jcb.240590411; CAVANAUGH KP, 1990, J NEUROCHEM, V54, P1735, DOI 10.1111/j.1471-4159.1990.tb01228.x; COLOVER J, 1991, J CLIN PATHOL, V44, P69, DOI 10.1136/jcp.44.1.69; CUNNINGHAM DD, 1993, THROMB HAEMOSTASIS, V70, P168; DESCHEPPER CF, 1991, MOL BRAIN RES, V11, P355, DOI 10.1016/0169-328X(91)90045-Y; DIHANICH M, 1991, NEURON, V6, P575, DOI 10.1016/0896-6273(91)90060-D; DUBE RK, 1980, INDIAN J MED RES, V72, P454; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; FENTON JW, 1986, ANN NY ACAD SCI, V485, P5, DOI 10.1111/j.1749-6632.1986.tb34563.x; FENTON JW, 1988, SEMIN THROMB HEMOST, V14, P234, DOI 10.1055/s-2007-1002783; FENTON JW, 1991, HAEMOSTASIS, V21, P27; FESTOFF BW, 1992, NEUROLOGY, V42, P1361, DOI 10.1212/WNL.42.7.1361; Festoff BW, 1996, SEMIN THROMB HEMOST, V22, P267, DOI 10.1055/s-2007-999018; FORSYTH KD, 1994, CLIN EXP IMMUNOL, V95, P277; GARTON MJ, 1991, J NEUROL SCI, V104, P74, DOI 10.1016/0022-510X(91)90218-V; GIJBELS K, 1993, J NEUROSCI RES, V36, P432, DOI 10.1002/jnr.490360409; GRABHAM P, 1995, J NEUROCHEM, V64, P583; GRABHAM PW, 1991, EUR J NEUROSCI, V3, P663, DOI 10.1111/j.1460-9568.1991.tb00852.x; GURWITZ D, 1988, P NATL ACAD SCI USA, V85, P3440, DOI 10.1073/pnas.85.10.3440; HARRINGTON MG, 1985, CLIN CHEM, V31, P722; HO GJ, 1994, BIOMED PHARMACOTHER, V48, P296, DOI 10.1016/0753-3322(94)90175-9; LEE KR, 1995, J NEUROSURG, V83, P1045, DOI 10.3171/jns.1995.83.6.1045; Lee KR, 1996, J NEUROSURG, V84, P91, DOI 10.3171/jns.1996.84.1.0091; LINDAHL U, 1989, ARCH BIOCHEM BIOPHYS, V273, P180, DOI 10.1016/0003-9861(89)90177-X; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; MATSUBARA E, 1990, ANN NEUROL, V28, P561, DOI 10.1002/ana.410280414; Monard D, 1993, Perspect Dev Neurobiol, V1, P165; NISHINO A, 1994, ACT NEUR S, V60, P86; NISHINO A, 1993, J NEUROTRAUM, V10, P167, DOI 10.1089/neu.1993.10.167; POUYSSEGUR J, 1993, NOUV REV FR HEMATOL, V35, P263; RAYFORD A, 1992, J NEUROCHEM, V58, P88, DOI 10.1111/j.1471-4159.1992.tb09281.x; ROZNIECKI JJ, 1995, ANN NEUROL, V37, P63, DOI 10.1002/ana.410370112; Schisano G, 1994, J Neurosurg Sci, V38, P77; SCHWAGERL AL, 1995, J NEUROCHEM, V64, P443; SCHWARTZ BS, 1982, J EXP MED, V155, P1464, DOI 10.1084/jem.155.5.1464; SEKIYA F, 1994, J BIOL CHEM, V269, P32441; SMIRNOVA IV, 1994, SEMIN THROMB HEMOST, V20, P426, DOI 10.1055/s-2007-1001931; Smirnova IV, 1996, J NEUROCHEM, V67, P2188; SMITHSWINTOSKY VL, 1995, J NEUROSCI, V15, P5840; STONE SR, 1987, ARCH BIOCHEM BIOPHYS, V252, P237, DOI 10.1016/0003-9861(87)90028-2; SUIDAN HS, 1992, NEURON, V8, P363, DOI 10.1016/0896-6273(92)90302-T; SUZUKI M, 1994, THROMB HAEMOSTASIS, V71, P155; SUZUKI M, 1992, STROKE, V23, P1181, DOI 10.1161/01.STR.23.8.1181; TURNELL AS, 1995, BIOCHEM J, V308, P965, DOI 10.1042/bj3080965; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; VAUGHAN PJ, 1994, BRAIN RES, V668, P160, DOI 10.1016/0006-8993(94)90521-5; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; WAGNER SL, 1989, P NATL ACAD SCI USA, V86, P8284, DOI 10.1073/pnas.86.21.8284	53	20	20	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0340-6245	2567-689X		THROMB HAEMOSTASIS	Thromb. Haemost.	DEC	1997	78	6					1473	1479					7	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	YK789	WOS:A1997YK78900011	9423797				2022-02-06	
J	OFlaherty, CA; Douglas, JM				OFlaherty, CA; Douglas, JM			Living with cognitive-communicative difficulties following traumatic brain injury: using a model of interpersonal communication to characterize the subjective experience	APHASIOLOGY			English	Article							CLOSED HEAD-INJURY; FAMILY; RELATIVES; ADULTS; LIFE	This study was undertaken to better understand the subjective experience of long-term cognitive-communicative impairments following severe cerebral insult. An additional aim was to explore the utility of a model of interpersonal communication in elucidating how such difficulties affect communicative interactions. Participants in the study were five dyads in which one member had sustained a severe traumatic brain injury (TBI). Data collection and analysis utilized both qualitative and quantitative methodology. It was found that individuals with long-term TBT continue to experience significant communication difficulties, which in combination with problems of memory, fatigue and irritability commonly generate unsatisfactory interpersonal communication experiences. The model of interpersonal communication provided a useful framework for considering why these interactions are ineffective or unsatisfactory. It is felt that the methodology outlined in this paper may offer a useful means of investigating the relationship between neurogenic communication impairments/disabilities and interpersonal communication difficulties experienced by individuals from a variety of clinical populations.	LA TROBE UNIV,MELBOURNE,VIC,AUSTRALIA				Douglas, Jacinta M/C-2380-2009	Douglas, Jacinta/0000-0003-0940-6624			Adamovich BL, 1991, COGNITIVE REHABILITA, P75; Argyle M, 1986, SOCIAL INTERACTION; BATESON G, 1951, COMMUNICATION SOCIAL; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BOWMAN ML, 1990, J MARRIAGE FAM, V52, P463, DOI 10.2307/353040; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Chwalisz K, 1996, Appl Neuropsychol, V3, P28, DOI 10.1207/s15324826an0301_5; COOK M, 1981, BASES HUMAN SEXUAL A; Damico J. S., 1985, COMMUNICATION SKILLS, P165; DANZIGER K, 1976, INTERPERSONAL COMMUN; DEPOMPEI R, 1989, TOP LANG DISORD, V9, P78, DOI 10.1097/00011363-198903000-00008; DIRMEN S, 1993, BRAIN INJURY, V7, P113; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; DOUGLAS JM, 1997, UNPUB DEV EVALUATION; EHRLICH JS, 1988, J COMMUN DISORD, V21, P1, DOI 10.1016/0021-9924(88)90006-8; Grice H. P., 1975, SYNTAX SEMANTICS, P41; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; Hagen C, 1984, LANGUAGE DISORDERS A, P245; HARTLEY LL, 1995, COGNITIVE COMMUNICAT, P21; HARTLEY P, 1993, INTERPERSONAL COMMUN; KELLEY HH, 1973, AM PSYCHOL, V28, P107, DOI 10.1037/h0034225; KENNY DA, 1994, INTERPERSONAL PERCEP, P16; KLONOFF PS, 1986, NEUROSURGERY, V19, P735, DOI 10.1227/00006123-198611000-00004; Kozloff R., 1987, J HEAD TRAUMA REHAB, V2, P14, DOI [DOI 10.1097/00001199-198709000-00004, 10.1097/00001199-198709000-00004]; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; LEDORZE G, 1995, APHASIOLOGY, V9, P239; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Marquardt TP, 1990, TRAUMATIC BRAIN INJU, P181; MARSH NV, 1991, J CLIN EXP NEUROPSYC, V13, P729, DOI 10.1080/01688639108401086; NICOTERA AM, 1993, INTERPERSONAL COMMUN; ODDY M, 1984, CLOSED HEAD INJURY P, P108; Panting A, 1972, REHABILITATION, V38, P33; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; PONSFORD JL, 1995, TRAUMATIC BRAIN INJU, P15; Prigatano GP, 1986, NEUROPSYCHOL REHABIL, P18; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; SDOROW L, 1990, PSYCHOLOGY, P590; Swann W. B, 1990, HDB MOTIVATION COGNI, V2, P408; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P117; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Watzlawick P., 1967, PRAGMATICS HUMAN COM; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; [No title captured]	48	20	20	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0268-7038			APHASIOLOGY	Aphasiology	SEP	1997	11	9					889	911		10.1080/02687039708250463			23	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	XW027	WOS:A1997XW02700005					2022-02-06	
J	Diringer, MN; Edwards, DF				Diringer, MN; Edwards, DF			Does modification of the innsbruck and the Glasgow Coma Scales improve their ability to predict functional outcome?	ARCHIVES OF NEUROLOGY			English	Article							REACTION-LEVEL-SCALE; HEAD-INJURY; CONSCIOUSNESS; SURVIVAL	Background: The accurate prediction of functional outcome requires the development of multivariate models. To enhance their contribution to such models, the predictive power of each component must be optimized. Objectives: To improve the predictive power of coma scales as the first step in building more sophisticated multivariate models to predict specific levels of functional outcome. Design: Prospective descriptive study. Setting: Neurology and neurosurgery intensive care unit (NNICU) in a tertiary care academic center. Patients: Eighty-four patients with acute traumatic brain injury, intracerebral hemorrhage, subarachnoid hemorrhage, or ischemic stroke. Interventions: None. Main Outcome Measures: The Glasgow Coma Scale (GCS) and Innsbruck Coma Scale (ICS) were administered within 24 hours of admission to the NNICU and then at 48-hour intervals until discharge of the patient from the NNICU. The assessments were performed by 3 occupational therapy graduate students working under the supervision of the medical director of the NNICU. The functional outcome at 3 months after discharge from the hospital was assessed by telephone by the same nurse using the following categories: (1) dead, (2) receiving nursing home or custodial care, (3) home with help, or (4) independent. Cronbach's alpha estimates of reliability for each scale were computed using all scores obtained during the study. The analyses indicated that the verbal response item of the GCS and the oral automatisms item of the ICS were less reliable in this patient population. The scales were modified by deleting those items, and predictive validity for the original and modified scales was computed using a discriminant function of the admission scores. Results: Before modification, both scales were best at predicting independence (GCS and ICS, 71% correct) and mortality (GCS, 60% correct, ICS, 56% correct). The modifications produced a modest improvement in the ability of both scales to better predict levels of outcome (modified GCS: home with help, 33% correct, independent, 71% correct; modified ICS: home with help, 0% correct, independent, 74% correct). Conclusions: By deleting items with low reliability from the ICS and the GCS we achieved improved reliability and predictive validity. The improvement in predictive power, however, was inadequate to accurately predict functional outcome. Combining clinical scales with other demographic, physiological, functional, and radiographic data will be needed to achieve useful predictions of functional outcome.	WASHINGTON UNIV,SCH MED,PROGRAM OCCUPAT THERAPY,ST LOUIS,MO 63110		Diringer, MN (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL,660 S EUCLID AVE,BOX 8111,ST LOUIS,MO 63110, USA.		Diringer, Michael N/C-1165-2008	Diringer, Michael N/0000-0003-2337-5537			BASTOS PG, 1993, CRIT CARE MED, V21, P1459, DOI 10.1097/00003246-199310000-00012; BENZER A, 1991, LANCET, V338, P977, DOI 10.1016/0140-6736(91)91840-Q; BORN JD, 1988, ACTA NEUROCHIR, V91, P1, DOI 10.1007/BF01400520; DISNEY L, 1988, NEUROSURGERY, V23, P1; EDWARDS DF, 1995, STROKE, V26, P1852, DOI 10.1161/01.STR.26.10.1852; Ellis A, 1992, Intensive Crit Care Nurs, V8, P94, DOI 10.1016/0964-3397(92)90037-K; JAGGER J, 1983, LANCET, V2, P97; JOHNSTONE AJ, 1993, BRAIN INJURY, V7, P501, DOI 10.3109/02699059309008177; KLECKA WR, 1980, DISCRIMINANT ANAL, P67; LANGFITT TW, 1978, J NEUROSURG, V48, P673, DOI 10.3171/jns.1978.48.5.0673; MENEGAZZI JJ, 1993, J TRAUMA, V34, P46, DOI 10.1097/00005373-199301000-00008; NUNNALLY JC, 1979, PSYCHOMETRIC THEORY, P229; Price D J, 1986, Acta Neurochir Suppl (Wien), V36, P106; Robinson S, 1992, Axone, V14, P21; SARLE WS, 1991, SAS STAT USERS GUIDE, P360; SEGATORE M, 1992, HEART LUNG, V21, P548; SOUSTIEL JF, 1993, ELECTROEN CLIN NEURO, V87, P277, DOI 10.1016/0013-4694(93)90180-4; *SPSS, 1990, SPSS ADV STAT US GUI, P245; STANCZAK DE, 1984, J NEUROSURG, V60, P955, DOI 10.3171/jns.1984.60.5.0955; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TUHRIM S, 1988, ANN NEUROL, V24, P258, DOI 10.1002/ana.410240213	24	20	21	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	MAY	1997	54	5					606	611		10.1001/archneur.1997.00550170078017			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WY809	WOS:A1997WY80900014	9152117				2022-02-06	
J	Johannes, S; Weber, A; MullerVahl, KR; Kolbe, H; Dengler, R; Munte, TF				Johannes, S; Weber, A; MullerVahl, KR; Kolbe, H; Dengler, R; Munte, TF			Event-related brain potentials show changed attentional mechanisms in Gilles de la Tourette Syndrome	EUROPEAN JOURNAL OF NEUROLOGY			English	Article						Gilles de la Tourette Syndrome; attention; even-related brain potentials; basal ganglia; frontal lobes	CLOSED HEAD-INJURY; DEFICIT HYPERACTIVITY DISORDER; AUDITORY ODDBALL TASK; ELECTROPHYSIOLOGICAL EVIDENCE; VISUAL-SEARCH; BASAL GANGLIA; DYSFUNCTION; PERFORMANCE; INFORMATION; CHILDREN	In many patients the Gilles de la Tourette Syndrome (TS) is associated with the childhood Attention Deficit Hyperactivity Disorder. To gain a general view of attentional processes in TS we recorded event-related brain potentials (ERPs) in 12 TS patients and in a matched control group. Four visual attention experiments with different levels of complexity were done (oddball task, pop-out experiment, figure extraction and figure conjunction task). The reaction times did not differ significantly between groups. The Tourette patients' event-related brain potentials showed an increased amplitude of the N2 component to targets in the simple oddball and pop-out experiments. While both groups had similar P3b latencies to targets in the figure extraction experiment, Tourette patients responded less accurately in the most complex figure conjunction task and had increased P3b latencies. This is interpreted as evidence for a stronger attentional effort of the Tourette patients to obtain behavioural results similar to control subjects in easy attentional tasks. Consequently, Tourette patients show a reduced performance in complex attentional tasks.					Munte, Thomas/C-2077-2014	Muller-Vahl, Kirsten/0000-0002-7181-7419			American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; Bornstein R A, 1991, J Neuropsychiatry Clin Neurosci, V3, P157; BORNSTEIN RA, 1991, AM J PSYCHIAT, V148, P468; BRAUN AR, 1993, NEUROPSYCHOPHARMACOL, V9, P277, DOI 10.1038/npp.1993.64; BROOKSHIRE BL, 1994, J CLIN EXP NEUROPSYC, V16, P289, DOI 10.1080/01688639408402639; BURD L, 1992, J LEARN DISABIL, V25, P598, DOI 10.1177/002221949202500909; CATH DC, 1992, ADV NEUROL, V58, P33; Cohen D. J., 1988, TOURETTES SYNDROME T; COMINGS DE, 1990, J CLIN PSYCHIAT, V51, P275; DUNCAN J, 1986, COGNITIVE NEUROPSYCH, V3, P271, DOI 10.1080/02643298608253360; FITZGERALD PG, 1983, BIOL PSYCHOL, V17, P241, DOI 10.1016/0301-0511(83)90003-0; GEDYE A, 1991, J CLIN PSYCHOL, V47, P233, DOI 10.1002/1097-4679(199103)47:2<233::AID-JCLP2270470209>3.0.CO;2-N; GEORGE MS, 1992, PSYCHIAT RES-NEUROIM, V45, P143, DOI 10.1016/0925-4927(92)90022-V; GEORGIOU N, 1995, J NEUROL NEUROSUR PS, V58, P184, DOI 10.1136/jnnp.58.2.184; HEINZE HJ, 1992, NEUROPSYCHOLOGIA, V30, P495, DOI 10.1016/0028-3932(92)90054-P; HILLYARD SA, 1993, CURR OPIN NEUROBIOL, V3, P217, DOI 10.1016/0959-4388(93)90213-I; HILLYARD SA, 1983, ANNU REV PSYCHOL, V34, P33, DOI 10.1146/annurev.ps.34.020183.000341; HILLYARD SA, 1990, MACHINERY OF THE MIND, P186; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; JOHANNES S, 1996, UNPUB GILLES TOURETT; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; KNELL ER, 1993, J CLIN PSYCHIAT, V54, P331; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; LANSER JBK, 1993, BRIT J PSYCHIAT, V163, P116, DOI 10.1192/bjp.163.1.116; LUCK S J, 1988, Society for Neuroscience Abstracts, V14, P1013; LUCK SJ, 1990, PERCEPT PSYCHOPHYS, V48, P603, DOI 10.3758/BF03211606; MANGUN GR, 1993, ATTENTION PERFORMANC, V14; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; NAATANEN R, 1986, CEREBRAL PSYCHOPHYSI, P169; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERSON B, 1993, NEUROLOGY, V43, P941, DOI 10.1212/WNL.43.5.941; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; ROBERTSON MM, 1989, BRIT J PSYCHIAT, V154, P147, DOI 10.1192/bjp.154.2.147; RUGG MD, 1988, J NEUROL NEUROSUR PS, V51, P691, DOI 10.1136/jnnp.51.5.691; RUGG MD, 1993, NEUROPSYCHOLOGIA, V31, P373, DOI 10.1016/0028-3932(93)90161-R; SEGALOWITZ SJ, 1993, PSYCHOPHYSIOLOGY, V30, P451, DOI 10.1111/j.1469-8986.1993.tb02068.x; Shapiro A., 1988, GILLES TOURETTE SYND; SIEG KG, 1993, CLIN NUCL MED, V18, P255, DOI 10.1097/00003072-199303000-00022; SINGER HS, 1993, NEUROLOGY, V43, P950, DOI 10.1212/WNL.43.5.950; SINGER HS, 1991, MEDICINE, V70, P15, DOI 10.1097/00005792-199101000-00002; STOETTER B, 1992, ADV NEUROL, V58, P213; *TOUR SYNDR CLASS, 1993, ARCH NEUROL-CHICAGO, V50, P1013; VANWOERKOM TCAM, 1994, ACTA NEUROL SCAND, V90, P116; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; WEATE SJ, 1993, CLIN ELECTROENCEPHAL, V24, P188, DOI 10.1177/155005949302400410; WICKENS C, 1983, SCIENCE, V221, P1080, DOI 10.1126/science.6879207	47	20	20	0	3	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	1351-5101			EUR J NEUROL	Eur. J. Neurol.	MAR	1997	4	2					152	161		10.1111/j.1468-1331.1997.tb00321.x			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	XC957	WOS:A1997XC95700012	24283908				2022-02-06	
J	Max, JE; Dunisch, DL				Max, JE; Dunisch, DL			Traumatic brain injury in a child psychiatry outpatient clinic: A controlled study	JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY			English	Article						traumatic brain injury; children and adolescents; psychiatric outpatients	HEAD-INJURIES; SEQUELAE	Objective: To demonstrate the similarity of children with a history of traumatic brain injury (TBI), particularly mild TBI, to matched children without such a history, within a child psychiatry outpatient clinic. Method: This is a chart review of patients presenting to a child psychiatry outpatient clinic over a 3-year period. Children with TBI were matched by age, sex, race, and social class to children with no history of TBI. Axis I and II diagnoses, use of special education services, and IQ scores were compared. Results: Seventy-four (5.6%) of 1,333 consecutive clinic cases had a definite TBI. Of these, 64 were mild. Only 3 of 59 comparisons that were made between TBI and control subjects were significant. A developmental communication disorder cluster was significantly more frequent in the TBI group. Autism and a pervasive developmental disorder cluster were significantly more frequent in the control group. Conclusion: In a child psychiatry clinic, patients with a history of TBI are virtually indistinguishable from matched children without TBI. Caution should be exercised before attributing the child's problems, especially long-term problems, to the TBI unless the injury was severe or the child is exhibiting related phobic or posttraumatic stress symptomatology.	UNIV IOWA,DEPT PSYCHIAT,IOWA CITY,IA 52242								American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; ASARNOW RF, 1995, TRAUMATIC HEAD INJUR, P117; BLACK P, 1981, BRAIN DYSFUNCTION CH, P171; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DONDERS J, 1992, J ABNORM CHILD PSYCH, V20, P233, DOI 10.1007/BF00916690; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; GILLBERG C, 1995, CLIN CHILD NEUROPSYC, P274; HARRINGTON JA, 1958, J MENT SCI, V104, P1205, DOI 10.1192/bjp.104.437.1205; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; Kraus JF, 1995, TRAUMATIC HEAD INJUR, P22; LEMKUHL G, 1990, BRAIN BEHAV CHILD PS, P267; MARTINI DR, 1992, SCI P 39 ANN M AM AC, V8; Max JE, 1997, J AM ACAD CHILD PSY, V36, P94, DOI 10.1097/00004583-199701000-00022; MAX JE, IN PRESS J NERV MENT; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; RIVARA JB, 1993, ARCH PHYS MED REHAB, V74, P1047, DOI 10.1016/0003-9993(93)90060-N; *SPSS, 1993, SPSS WIND PROOF STAT; Taylor H.G., 1995, TRAUMATIC HEAD INJUR, P188; TEASDALE G, 1974, LANCET, V2, P81	23	20	20	0	2	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0890-8567			J AM ACAD CHILD PSY	J. Am. Acad. Child Adolesc. Psychiatr.	MAR	1997	36	3					404	411		10.1097/00004583-199703000-00020			8	Psychology, Developmental; Pediatrics; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Pediatrics; Psychiatry	WK274	WOS:A1997WK27400020	9055522				2022-02-06	
J	Wilson, DJ; Childers, MK; Cooke, DL; Smith, BK				Wilson, DJ; Childers, MK; Cooke, DL; Smith, BK			Kinematic changes following botulinum toxin injection after traumatic brain injury	BRAIN INJURY			English	Article							SPASTICITY; GAIT; HEMIPLEGIA; VARIABLES; PERFORMANCE; MANAGEMENT; STROKE; FOOT	The objectives of this study were to: (1) demonstrate the use of computerized, three-dimensional gait analysis as a functional assessment instrument following clinical intervention; and (2) objectively quantify the effects of focal muscle denervation via botulinum toxin type A (BTXA) injection in a hemiparetic patient with lower extremity spasticity following traumatic brain injury (TBI). A desired outcome of this intervention was to realize kinematics more closely resembling those reported for normal patients. The design was a single-subject case study. Ten trials of walking gait were analysed pre-injection (PI), 1 week post-injection (1PO) and 4 weeks post-injection(4PO). The PI and 1PO sessions were found to be appreciably different from the 1PO on the joint angles of the ankle and knee at each phase of the gait cycle. These differences resulted in a reduced asymmetry of ambulation. Stride time, stance time, percentage stance time, percentage swing rime and walking speed improved, showing progress towards a more efficient gait pattern. Decreased stride time and increased walking speed supported improved functional ability. The inter-trial variability of the gait parameters showed the analysis to be a consistently reproducible protocol. Conclusions based on the results included encouraging findings for the efficacy of botulinum toxin A as a therapy for the reduction of spasticity.	UNIV MISSOURI,DEPT PHYS MED & REHABIL,COLUMBIA,MO 65212; UNIV MISSOURI,DEPT HLTH & EXERCISE SCI,COLUMBIA,MO 65212					Childers, Martin/0000-0003-4754-0883	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD 07460-03] Funding Source: Medline		Abdel-Aziz YI., 1971, P S CLOS RANG PHOT U, P1, DOI 10.14358/PERS.81.2.103; BEER FP, 1977, VECTOR MECH ENG STAT, P1; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BORGSTEIN J, 1993, AM J PHYS MED REHAB, V72, P364; BRANDSTATER ME, 1983, ARCH PHYS MED REHAB, V64, P583; DAS TK, 1989, BRIT J CLIN PRACT, V43, P401; DAS TK, 1989, POSTGRAD MED J, V65, P208, DOI 10.1136/pgmj.65.762.208; DENGLER R, 1992, J NEUROL, V239, P375; DETTMANN MA, 1987, AM J PHYS MED REHAB, V66, P77; DUNNE JW, 1995, J NEUROL NEUROSUR PS, V58, P232, DOI 10.1136/jnnp.58.2.232; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; HESSE S, 1994, J NEUROL NEUROSUR PS, V57, P1312; KAO I, 1976, SCIENCE, V193, P1256, DOI 10.1126/science.785600; KERRIGAN DC, 1994, AM J PHYS MED REHAB, V73, P421, DOI 10.1097/00002060-199411000-00007; KNUTZEN KM, 1987, MED SCI SPORT EXER, V19, P303; KOMAN LA, 1993, J PEDIATR ORTHOPED, V13, P489, DOI 10.1097/01241398-199307000-00013; LEHMANN JF, 1987, ARCH PHYS MED REHAB, V68, P763; MEMIN B, 1992, REV NEUROL, V148, P212; OLNEY SJ, 1994, PHYS THER, V74, P872, DOI 10.1093/ptj/74.9.872; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; VONSCHROEDER HP, 1995, J REHABIL RES DEV, V32, P25; WALL JC, 1986, ARCH PHYS MED REHAB, V67, P550	23	20	21	0	6	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR	1997	11	3					157	167		10.1080/026990597123610			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WL158	WOS:A1997WL15800001	9057998				2022-02-06	
J	Nguyen, C; Katner, HP				Nguyen, C; Katner, HP			Myeloperoxidase deficiency manifesting as pustular candidal dermatitis	CLINICAL INFECTIOUS DISEASES			English	Article							DISSEMINATED CANDIDIASIS; CEFTRIAXONE; MENINGITIS	Myeloperoxidase deficiency is the most common neutrophilic lysosomal enzyme deficiency. Case studies indicate that individuals with myeloperoxidase deficiency are not susceptible to serious infection in the absence of coexisting conditions such as diabetes mellitus. We present a case of myeloperoxidase deficiency manifesting as disseminated pustular candidal dermatilis in a nondiabetic male, Ceftriaxone therapy was administered to the patient for 8 days after he received a closed head injury and before the development of fever and pustular dermatitis. Candida albicans was isolated from the skin lesion. His neutrophils demonstrated a qualitative lack of myeloperoxidase. Patients who develop rapidly disseminated fungal dermatitis while they are receiving antimicrobial therapy that is relatively limited in coverage should be evaluated for myeloperoxidase deficiency.	MERCER UNIV,SCH MED,DEPT INTERNAL MED,INFECT DIS SECT,MACON,GA 31207					Katner, Harold/0000-0002-2529-9817			ADU A, 1995, DRUGS, V50, P423, DOI 10.2165/00003495-199550030-00002; BODEY GP, 1974, JAMA-J AM MED ASSOC, V229, P1466, DOI 10.1001/jama.229.11.1466; CARLSON J, 1987, SCAND J INFECT DIS, V19, P687, DOI 10.3109/00365548709117205; GROSSMAN ME, 1980, J AM ACAD DERMATOL, V2, P111, DOI 10.1016/S0190-9622(80)80388-4; LEHRER RI, 1969, J CLIN INVEST, V48, P1478, DOI 10.1172/JCI106114; LUDVIKSSON BR, 1993, PEDIATR INFECT DIS J, V12, P162, DOI 10.1097/00006454-199302000-00015; MOSKOVITZ BL, 1984, AM J MED, V77, P84; NAUSEEF WM, 1988, HEMATOL ONCOL CLIN N, V2, P135; OKUDA T, 1991, J ORAL MAXIL SURG, V49, P183, DOI 10.1016/0278-2391(91)90108-X; PARRY MF, 1981, ANN INTERN MED, V95, P293, DOI 10.7326/0003-4819-95-3-293; TSAKONAS DP, 1994, CLIN LAB HAEMATOL, V16, P337	11	20	20	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	1058-4838			CLIN INFECT DIS	Clin. Infect. Dis.	FEB	1997	24	2					258	260		10.1093/clinids/24.2.258			3	Immunology; Infectious Diseases; Microbiology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases; Microbiology	WH302	WOS:A1997WH30200030	9114158	Bronze			2022-02-06	
J	Dave, JR; Bauman, RA; Long, JB				Dave, JR; Bauman, RA; Long, JB			Hypoxia potentiates traumatic brain injury-induced expression of c-fos in rats	NEUROREPORT			English	Article						c-fos mRNA; fluid percussion; hypoxia; immediate-early genes; ischemia; oncogene activation; rat brain; traumatic brain injury	CORTICAL IMPACT INJURY; MESSENGER-RNA; ACCUMULATION; INDUCTION; CALCIUM; NMDA	HALOTHANE-anesthetized male rats were subjected to either moderately severe parasagittal fluid percussion-induced traumatic brain injury (TBI) or sham injury, and for 30 min immediately after injury hypoxia was induced in half the rats from each group by substituting a 13% O-2, source to deliver halothane for continued anesthesia. At 60 min post-TBI, Northern blot analysis showed a significant increase in c-fos mRNA levels, by 60-100% above sham control levels in the frontal cortex, cerebellum and hippocampus. Although hypoxia in sham-injured rats did not by itself alter c-fos mRNA levels, it did significantly potentiate the TBI-induced changes in c-fos mRNA in all three brain regions. These findings show that hypoxia is an important factor influencing genomic responses to TBI.			Dave, JR (corresponding author), WALTER REED ARMY MED CTR,WALTER REED ARMY INST RES,DIV NEUROSCI,BLDG 40,WASHINGTON,DC 20307, USA.						BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Dave J. R., 1993, Society for Neuroscience Abstracts, V19, P1771; DAVE JR, 1992, PHARM COMMUN, V1, P319; DRAGUNOW M, 1990, NEUROSCI LETT, V109, P128, DOI 10.1016/0304-3940(90)90550-S; EUMANNHAEFELIN T, 1994, J CEREBR BLOOD FLOW, V14, P206; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; ISHIGE N, 1987, NEUROSURGERY, V20, P854, DOI 10.1227/00006123-198706000-00006; ISHIGE N, 1987, J CEREBR BLOOD F MET, V7, P759, DOI 10.1038/jcbfm.1987.131; ISHIGE N, 1987, NEUROSURGERY, V20, P848, DOI 10.1227/00006123-198706000-00005; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KINOUCHI H, 1994, J CEREBR BLOOD F MET, V14, P808, DOI 10.1038/jcbfm.1994.101; LUTZ HA, 1982, HEAD INJURY BASIC CL, P221; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MORGAN PF, 1991, NEUROREPORT, V2, P251, DOI 10.1097/00001756-199105000-00009; PHILLIPS LL, 1992, J NEUROTRAUM, V9, P323, DOI 10.1089/neu.1992.9.323; Raghupathi R, 1996, MOL BRAIN RES, V37, P134, DOI 10.1016/0169-328X(95)00289-5; Raghupathi Ramesh, 1994, Society for Neuroscience Abstracts, V20, P542; SMEYNE RJ, 1993, NATURE, V363, P166, DOI 10.1038/363166a0; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; TANNO H, 1992, J NEUROTRAUM, V9, P335, DOI 10.1089/neu.1992.9.335; YANG K, 1995, J NEUROSCI RES, V42, P571, DOI 10.1002/jnr.490420415; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X	25	20	23	0	0	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-4965			NEUROREPORT	Neuroreport	JAN 20	1997	8	2					395	398		10.1097/00001756-199701200-00002			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	WX340	WOS:A1997WX34000003	9080414				2022-02-06	
J	DunnMeynell, AA; Yarlagadda, Y; Levin, BE				DunnMeynell, AA; Yarlagadda, Y; Levin, BE			alpha(1)-adrenoceptor blockade increases behavioral deficits in traumatic brain injury	JOURNAL OF NEUROTRAUMA			English	Article						contusion; desmethylimipramine; head trauma; norepinephrine; pharmacology; prazosin; somatosensory cortex	SENSORIMOTOR CORTEX INJURY; RAT-BRAIN; NORADRENERGIC DENERVATION; FUNCTIONAL RECOVERY; INCOMPLETE ISCHEMIA; NEURONAL DAMAGE; MOTOR RECOVERY; LOCUS-CERULEUS; NOREPINEPHRINE; NEUROTRANSMITTER	Experimental enhancement of noradrenergic activity following traumatic brain injury (TBI) accelerates behavioral recovery if performed at a time when brain norepinephrine (NE) turnover is decreased. But, since NE turnover is markedly increased immediately after TBI, the present study was undertaken to evaluate the effect of modulating these early changes in NE metabolism on recovery of function. Rats were pretrained on a modified beam walking task. Thirty minutes prior to unilateral somatosensory cortex contusion they were treated with a NE reuptake blocker [desmethylimipramine (DMI); 10 mg/kg, ip, n = 6] or an alpha(1)-adrenoreceptor antagonist [prazosin (PRZ); 3 mg/kg, ip, n = 6]. PRZ pretreatment markedly worsened beam walking performance throughout the 3 weeks following injury, whilst DMI pretreatment did not affect performance compared to injured controls (n = 4). Despite the marked behavioral deficits, PRZ-treated animals showed no apparent worsening of histological damage (n = 11 per group) and lesion size was the same in all groups. In separate experiments (n = 4 per group), PRZ lowered basal blood pressure and prevented the rise in pressure immediately following TBI. However, blood pressures in the three groups came to the same level within 20 sec following TBI. This suggests that the action of PRZ was not simply due to hypotension-induced ischemia. It is possible that blockade of al-adrenoreceptors in the immediate posttrauma period leads to enhancement of excitatory neurotransmission, which exacerbates behavioral deficits.	UNIV MED & DENT NEW JERSEY,DEPT NEUROSCI,NEWARK,NJ 07103		DunnMeynell, AA (corresponding author), DEPT VET AFFAIRS MED CTR,NEUROL SERV 127C,BLDG 7,385 TREMONS AVE,E ORANGE,NJ 07018, USA.						ARAKI T, 1989, ACTA NEUROL SCAND, V80, P451, DOI 10.1111/j.1600-0404.1989.tb03908.x; BOYESON MG, 1993, AM J PHYS MED REHAB, V72, P286, DOI 10.1097/00002060-199310000-00007; BOYESON MG, 1992, PHARMACOL BIOCHEM BE, V43, P771, DOI 10.1016/0091-3057(92)90407-7; BOYESON MG, 1992, BEHAV NEUROSCI, V106, P964, DOI 10.1037/0735-7044.106.6.964; CAVERO I, 1980, LIFE SCI, V27, P1525, DOI 10.1016/0024-3205(80)90561-5; CLINESCHMIDT BV, 1979, ARCH INT PHARMACOD T, V242, P59; Cooper JR, 1991, BIOCH BASIS NEUROPHA; CROWDER JM, 1987, EUR J PHARMACOL, V143, P343, DOI 10.1016/0014-2999(87)90458-4; DAVIS JN, 1989, CEREBROVASC DIS, P109; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; DUNNMEYNELL AA, 1995, BRAIN RES, V675, P143, DOI 10.1016/0006-8993(95)00050-Z; DUNNMEYNELL AA, 1994, BRAIN RES, V600, P88; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1993, J NEURAL TRANSP PLAS, V4, P199, DOI 10.1155/NP.1993.199; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; FEENEY DM, 1988, PHARM APPROACHES TRE, P121; GOLDSTEIN LB, 1993, RESTOR NEUROL NEUROS, V5, P371, DOI 10.3233/RNN-1993-55608; GOLDSTEIN LB, 1991, RESTOR NEUROL NEUROS, V3, P41, DOI 10.3233/RNN-1991-3105; GUSTAFSON I, 1991, EXP BRAIN RES, V86, P555; HALONEN T, 1995, BRAIN RES, V693, P217, DOI 10.1016/0006-8993(95)00744-B; HARIK SI, 1984, ANN NEUROL, V15, P568, DOI 10.1002/ana.410150609; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HOFFMAN WE, 1991, ANESTHESIOLOGY, V75, P328, DOI 10.1097/00000542-199108000-00022; INOUE M, 1991, J CEREBR BLOOD F MET, V11, P242, DOI 10.1038/jcbfm.1991.56; ITO U, 1975, ACTA NEUROPATHOL, V32, P209, DOI 10.1007/BF00696570; JIANG JY, 1991, J NEUROSURG, V74, P492, DOI 10.3171/jns.1991.74.3.0492; KAMISAKI Y, 1992, EUR J PHARMACOL, V217, P57, DOI 10.1016/0014-2999(92)90511-2; KO KH, 1984, EXPERIENTIA, V40, P70, DOI 10.1007/BF01959107; Kobayashi H, 1990, Adv Neurol, V52, P127; KOIDE T, 1986, J CEREBR BLOOD F MET, V6, P559, DOI 10.1038/jcbfm.1986.102; Krobert K. A., 1992, Society for Neuroscience Abstracts, V18, P172; LAWTHO D, 1993, EUR J NEUROSCI, V5, P1494, DOI 10.1111/j.1460-9568.1993.tb00217.x; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; LYETH BG, 1988, BRAIN RES, V448, P88, DOI 10.1016/0006-8993(88)91104-3; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; LYNCH MA, 1988, NEUROPHARMACOLOGY, V25, P493; MANIAS B, 1983, EUR J PHARMACOL, V95, P305, DOI 10.1016/0014-2999(83)90652-0; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MENKES DB, 1981, N-S ARCH PHARMACOL, V317, P273, DOI 10.1007/BF00503830; MOURADIAN RD, 1991, BRAIN RES, V546, P83, DOI 10.1016/0006-8993(91)91162-T; NEVANDER G, 1986, EXP BRAIN RES, V63, P439; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PAPPIUS HM, 1991, NEUROCHEM RES, V16, P941, DOI 10.1007/BF00965837; Pappius HM, 1995, NEUROCHEM RES, V20, P1311, DOI 10.1007/BF00992506; PAPPIUS HM, 1988, METAB BRAIN DIS, V3, P303, DOI 10.1007/BF00999542; PI F, 1992, N-S ARCH PHARMACOL, V345, P653, DOI 10.1007/BF00164579; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; PRASAD MR, 1994, J NEUROCHEM, V63, P1086; Prasad RM, 1995, RESTOR NEUROL NEUROS, V9, P65, DOI 10.3233/RNN-1995-9201; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; RADISAVLJEVIC Z, 1994, INT J DEV NEUROSCI, V12, P353, DOI 10.1016/0736-5748(94)90085-X; READER TA, 1983, BRAIN RES BULL, V11, P687, DOI 10.1016/0361-9230(83)90012-6; REID JL, 1986, CARDIOLOGY, V73, P164, DOI 10.1159/000174002; RUFFOLO RR, 1994, PHARMACOL THERAPEUT, V61, P1, DOI 10.1016/0163-7258(94)90058-2; SARMENTO A, 1991, N-S ARCH PHARMACOL, V343, P633; SHIBATA M, 1993, J NEUROSURG, V79, P696, DOI 10.3171/jns.1993.79.5.0696; SUTIN J, 1985, NEUROSCIENCE, V14, P973, DOI 10.1016/0306-4522(85)90269-6; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SUTTON RL, 1993, J NEUROTRAUM, V10, pS181; SUTTON RL, 1994, NEUROLOGICAL REHABIL, P469; WERNER C, 1990, ANESTHESIOLOGY, V73, P923, DOI 10.1097/00000542-199011000-00021; WOOD AJ, 1975, CLIN EXP PHARMACOL P, V2, P297, DOI 10.1111/j.1440-1681.1975.tb01836.x; WU HQ, 1987, EUR J PHARMACOL, V138, P309, DOI 10.1016/0014-2999(87)90468-7	63	20	20	0	0	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538	0897-7151			J NEUROTRAUM	J. Neurotrauma	JAN	1997	14	1					43	52		10.1089/neu.1997.14.43			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WK032	WOS:A1997WK03200005	9048310				2022-02-06	
J	Hartl, R; Ghajar, J; Hochleuthner, H; Mauritz, W				Hartl, R; Ghajar, J; Hochleuthner, H; Mauritz, W			Treatment of refractory intracranial hypertension in severe traumatic brain injury with repetitive hypertonic/hyperoncotic infusions	ZENTRALBLATT FUR CHIRURGIE			English	Article						head injury; hypertonic saline; small-volume resuscitation; colloids; intracranial pressure	7.5-PERCENT SODIUM-CHLORIDE; CEREBRAL BLOOD-FLOW; HYPERTONIC HYPERONCOTIC SOLUTIONS; SMALL-VOLUME RESUSCITATION; HEMORRHAGIC-SHOCK; SALINE DEXTRAN; HEAD-INJURY; FLUID RESUSCITATION; MULTICENTER TRIAL; WATER-CONTENT	Rapid resuscitation of clinical and experimental traumatic brain injury (TBI) with hypertonic saline (HS) has been shown to improve neurological function and decrease intracranial pressure (ICP). The purpose of the present study was to test the efficacy of administration of HS (7,5 %) combined with 6 % hydroxyethyl starch (molecular weight 200,000/0.60-0.66; HHES) for the treatment of intracranial hypertension refractory to standard therapy in patients with severe TBI. With approval of the Institutional Ethics Committee six consecutive patients with severe TBI (GCS < 8) between 22 and 47 years of age (mean 32) who met the inclusion criteria (therapy resistant ICP > 25 mmHg, cerebral perfusion pressure (CPP) < 60 mmHg, plasma-Na+ < 150 mOsm and > 4 hours since the last HS/HHES treatment) were proepectively enrolled in the study. Patients received between one and ten bolus infusions of maximal 250ml HS/HHES at a rate of 20 ml/min. A total of 32 infusions were given. ICP and CPP before treatment were 45 +/- 15 and 52 +/- 18 mmHg, respectively. Administration of HS/HHES significantly lowered ICP to 25 +/- 14 mmHg and improved CPP to 72 +/- 16 mmHg at 30 min without affecting arterial blood pressure or blood gases. Plasma sodium normalized within 30 min. HS/HES might become an interesting addition to conventional treatment maneuvers currently used for ICP therapy. It reduces otherwise therapy-resistant intracranial hypertension without negatively affecting blood pressure, blood gases and cerebral perfusion.	TRAUMA HOSP,VIENNA,AUSTRIA								BATTISTELLA F, 1992, CIRC SHOCK, V37, P16; BATTISTELLA FD, 1991, J TRAUMA, V31, P182, DOI 10.1097/00005373-199131020-00005; BERGER S, 1995, NEUROSURGERY, V37, P98, DOI 10.1227/00006123-199507000-00015; Bullock R, 1995, GUIDELINES MANAGEMEN; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; GUNNAR WP, 1986, ANN SURG, V204, P686, DOI 10.1097/00000658-198612000-00012; HARTL R, 1995, SHOCK, V3, P274; Hartl R., 1995, Journal of Neurotrauma, V12, P416; HARTL R, 1993, INTRACRANIAL PRESSUR, V8, P612; KRAMER GC, 1986, SURGERY, V100, P239; KREIMEIER U, 1990, J SURG RES, V49, P493, DOI 10.1016/0022-4804(90)90174-Z; MATTOX KL, 1991, ANN SURG, V213, P482, DOI 10.1097/00000658-199105000-00014; Meier-Hellmann A, 1990, EUR SURG RES, V22, P303; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; MURR R, 1992, CURR OPIN ANAESTH, V5, P285; PROUGH D S, 1991, Anesthesia and Analgesia, V73, P738; PROUGH DS, 1991, ANESTHESIOLOGY, V75, P319, DOI 10.1097/00000542-199108000-00021; PROUGH DS, CRIT CARE MED, V13, P407; SCHACKFORD SR, 1988, SURGERY, V104, P553; SCHURER L, 1992, EUR SURG RES, V24, P1, DOI 10.1159/000129183; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1994, J TRAUMA, V37, P899, DOI 10.1097/00005373-199412000-00005; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, J TRAUMA, V34, P622, DOI 10.1097/00005373-199305000-00003; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; Vassar MJ, 1991, ARCH SURG-CHICAGO, V126, P43; VELASCO IT, 1989, CRIT CARE MED, V17, P261, DOI 10.1097/00003246-198903000-00012; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9; WISNER DH, 1990, J TRAUMA, V30, P75, DOI 10.1097/00005373-199001000-00011; WORTHLEY LIG, 1988, J NEUROSURG, V68, P478, DOI 10.3171/jns.1988.68.3.0478; ZORNOW MH, 1989, J TRAUMA, V29, P484, DOI 10.1097/00005373-198904000-00011	34	20	22	0	0	JOHANN AMBROSIUS BARTH VERLAG	HEIDELBERG	IM WEIHER 10, D-69121 HEIDELBERG, GERMANY	0044-409X			ZBL CHIR	Zent.bl. Chir.		1997	122	3					181	185					5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	WU705	WOS:A1997WU70500010	9128912				2022-02-06	
J	Vitale, AE; Jankowski, LW; Sullivan, SJ				Vitale, AE; Jankowski, LW; Sullivan, SJ			Reliability of a walk/run test to estimate aerobic capacity in a brain-injured population	BRAIN INJURY			English	Article							WALKING TEST; RESPIRATORY-DISEASE; TREADMILL WALKING; DISABILITY	The purpose of this study was to establish the test-retest reliability of a modified 20 m shuttle walk/run test of aerobic capacity for adults with traumatic brain injuries (TBI). A convenience sample of 18 TBI patients (16 males, two females) between 19 and 58 years of age, was tested using an externally paced, progressive, maximal shuttle walk/run, on two separate occasions, within a 1-week period. The test involved walking or running a 20 m shuttle course while maintaining the pace determined by signals from a prerecorded audiotape. The initial slow walking pace (2.4 km/h) was increased gradually, each minute, until the patient could not continue. Statistical analyses revealed excellent reliability for the number of levels completed (ICC = 0.976), total walk/run test time (S)(ICC = 0.983) and maximal heart rate attained during the final level (bpm) (ICC = 0.964). Although small but significant increases were noted for the number of levels completed during the second test, the modified 20 m shuttle walk/run seems to be a reliable field test which may be useful for assessing the aerobic capacity of brain-injured adults.	CONCORDIA UNIV,DEPT EXERCISE SCI,MONTREAL,PQ H4B 1R6,CANADA; UNIV MONTREAL,FAC MED,MONTREAL,PQ H3C 3J7,CANADA; INST READAPTAT MONTREAL,CTR RECH,MONTREAL,PQ,CANADA								*AM COLL SPORTS ME, 1991, GUID EX TEST PRESCR; AUERBACH SH, 1989, PHYSICAL MED REHABIL, V3, P1; BEAUMONT A, 1985, THORAX, V40, P459, DOI 10.1136/thx.40.6.459; BECKER E, 1978, SCAND J REHABIL MED, V10, P47; BUTLAND RJA, 1982, BRIT MED J, V284, P1607, DOI 10.1136/bmj.284.6329.1607; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; EVANS RM, 1979, ACTA NEUROCHIRURGI S, V28, P52; FROST EAM, 1989, NEUROTRAUMA TREATMEN, V1, P29; Greenleaf J E, 1982, Exerc Sport Sci Rev, V10, P84; Guyton AC, 1991, TXB MED PHYSL, V8th; JANKOWSKI LW, 1990, ARCH PHYS MED REHAB, V71, P500; KOTTKE FJ, 1966, J AMER MED ASSOC, V196, P825, DOI 10.1001/jama.196.10.825; Leger L, 1980, Can J Appl Sport Sci, V5, P77; LEGER L, 1988, PHYSICIAN SPORTSMED, V16, P143, DOI 10.1080/00913847.1988.11709511; Leger L, 1984, Can J Appl Sport Sci, V9, P64; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Leger L A, 1983, Can J Appl Sport Sci, V8, P47; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; LEIPZIG TJ, 1986, NEUROSURGERY, V19, P356, DOI 10.1227/00006123-198609000-00004; LIPKIN DP, 1986, BRIT MED J, V292, P653, DOI 10.1136/bmj.292.6521.653; LOWENSOHN RI, 1977, LANCET, V1, P626; MCGAVIN CR, 1978, BRIT MED J, V2, P241, DOI 10.1136/bmj.2.6132.241; MONTGOMERY DL, 1992, CAN J SPORT SCI, V17, P309; ROSSI C, IN PRESS ARCH PHYSIC; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; SULLIVAN S J, 1990, Brain Injury, V4, P407, DOI 10.3109/02699059009026194; SWERTS PMJ, 1990, PHYS THER, V70, P439, DOI 10.1093/ptj/70.7.439; Vitale AE, 1996, BRAIN INJURY, V10, P367, DOI 10.1080/026990596124377; VITALE AE, 1995, PERCEPT MOTOR SKILL, V80, P57, DOI 10.2466/pms.1995.80.1.57; Whyte J, 1993, REHABILITATION MED P, P825; Wolman RL, 1994, CLIN REHABIL, V8, P253	31	20	20	0	7	TAYLOR & FRANCIS LTD	LONDON	ONE GUNPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1997	11	1					67	76		10.1080/026990597123827			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	WB723	WOS:A1997WB72300007	9012553				2022-02-06	
J	Chappell, JE; McBride, WJ; Shackford, SR				Chappell, JE; McBride, WJ; Shackford, SR			Diaspirin cross-linked hemoglobin resuscitation improves cerebral perfusion after head injury and shock	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						diaspirin cross-linked hemoglobin; head injury; shock; cerebral perfusion pressure	FLUID-PERCUSSION MODEL; BRAIN-INJURY; BLOOD-FLOW; INTRACRANIAL-PRESSURE; OXYGEN DELIVERY; HEMODYNAMICS; EPIDEMIOLOGY; HYPOTENSION; DISABILITY; HEMORRHAGE	Background: Shock associated with traumatic brain injury (TBI) doubles the mortality of TBI alone by inducing a secondary ischemic injury, Rapid correction of cerebral perfusion pressure (CPP) is thought to be essential to improving outcome, Diaspirin cross-linked hemoglobin (DCLHb) has been shown to improve cerebral blood flow, increase mean arterial pressure (MAP), and reduce lesion size in models of occlusive cerebral ischemia but has not been evaluated in a model of TBI combined with hemorrhagic shock. Methods: We studied the effects of DCLHb resuscitation in a porcine model of cryogenic TBI and hemorrhagic shock (MAP = 50 mmHg). After combined insults, animals were randomized to receive a bolus of 4 mL/kg of either lactated Ringer's solution (n = 5) or DCLHb (n = 6), Lactated Ringer's solution was then infused in both groups to maintain MAP at baseline, Shed blood was returned 1 hour after the initiation of resuscitation (R1), Animals were studied for 24 hours. Results: DCLHb infusion resulted in a significantly greater MAP at R1 and R24 (95 +/- 4 vs, 82 +/- 2 and 99 +/- 3 vs, 85 +/-3 mm Hg, respectively) and a significantly greater CPP at R1 and R24 (83 +/- 10 vs, 68 +/- 5 and 89 +/- 6 vs, 71 +/- 11 mm Hg, respectively), Intracranial pressure was lower in the DCLHb group, but this difference was not significant, There was no significant difference between the groups in cerebral oxygen delivery, DCLHb animals required less fluid to maintain MAP (12,094 +/- 552 vs, 15,542 +/- 1094 mL, p < 0.05). Conclusion: These data suggest that DCLHb is beneficial in the early resuscitation of head injury and shock and that further investigation is warranted.	UNIV VERMONT, DEPT SURG, BURLINGTON, VT 05401 USA						NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20-NS30324-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P20NS030324] Funding Source: NIH RePORTER		ALI J, 1993, HEAD TRAUMA, P159; AUKLAND K, 1964, CIRC RES, V14, P164, DOI 10.1161/01.RES.14.2.164; BROWN MM, 1985, BRAIN, V108, P81, DOI 10.1093/brain/108.1.81; BUCCI E, 1992, J BIOMAT ARTIF CELLS, V20, P76; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLASEN RA, 1953, SURG GYNECOL OBSTET, V96, P605; COLE DJ, 1993, ANESTHESIOLOGY, V78, P335, DOI 10.1097/00000542-199302000-00018; COLE DJ, 1990, ACTA NEUROPATHOL, V80, P152, DOI 10.1007/BF00308918; GUYTON AC, 1996, TXB MED PHYSL, V9, P516; KAIEDA R, 1989, NEUROSURGERY, V24, P671, DOI 10.1227/00006123-198905000-00003; KIEPERT PE, 1992, J BIOMAT ARTIF CELLS, V20, P516; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; NELSON D, 1992, BIOMAT ARTIF CELL IM, V20, P423, DOI 10.3109/10731199209119662; NELSON SR, 1971, J APPL PHYSIOL, V30, P268, DOI 10.1152/jappl.1971.30.2.268; PIETROPAOLI JA, 1992, J TRAUMA, V33, P403, DOI 10.1097/00005373-199209000-00011; PRZYBELSKI RJ, 1990, J LAB CLIN MED, V115, P579; PRZYBELSKI RJ, 1991, J LAB CLIN MED, V117, P143; SCHMOKER JD, 1991, J TRAUMA, V31, P1607, DOI 10.1097/00005373-199112000-00007; SCHMOKER JD, 1992, J TRAUMA, V32, P714, DOI 10.1097/00005373-199206000-00007; SCHMOKER JD, 1993, J TRAUMA, V35, P627; SCHULTZ SC, 1993, J TRAUMA, V35, P619, DOI 10.1097/00005373-199310000-00019; SHACKFORD SR, 1992, J NEUROSURG, V76, P91, DOI 10.3171/jns.1992.76.1.0091; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; SHACKFORD SR, 1989, J TRAUMA, V29, P1392, DOI 10.1097/00005373-198910000-00018; SHACKFORD SR, 1992, J INTENSIVE CARE MED, V7, P170; SHARMA AC, 1994, J LAB CLIN MED, V123, P299; SIEGEL JH, 1991, CRIT CARE MED, V19, P1252, DOI 10.1097/00003246-199110000-00007; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; THIBAULT LE, 1992, J NEUROTRAUM, V9, P311, DOI 10.1089/neu.1992.9.311; TODA N, 1990, AM J PHYSIOL, V258, pH57, DOI 10.1152/ajpheart.1990.258.1.H57; WALD SL, 1993, J TRAUMA, V34, P377, DOI 10.1097/00005373-199303000-00012; WALSH JC, 1991, J SURG RES, V50, P284, DOI 10.1016/0022-4804(91)90192-O; ZHUANG J, 1995, CRIT CARE MED, V23, P140, DOI 10.1097/00003246-199501000-00023; Zornow M H, 1995, New Horiz, V3, P488; ZORNOW MH, 1988, ANESTHESIOLOGY, V69, P180, DOI 10.1097/00000542-198808000-00005	36	20	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	1996	41	5					781	788		10.1097/00005373-199611000-00003			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	VR635	WOS:A1996VR63500003	8913204				2022-02-06	
J	Bigler, ED				Bigler, ED			Brain imaging and behavioral outcome in traumatic brain injury	JOURNAL OF LEARNING DISABILITIES			English	Article							INDUCED DEGENERATIVE CHANGES; HEAD-INJURY; MEMORY; CT; MORPHOLOGY; INDEX; MODEL; MRI	Brain imaging studies have become an essential diagnostic assessment procedure in evaluating the effects of traumatic brain injury (TBI). Such imaging studies provide a wealth of information about structural and functional deficits following TBI. But how pathologic changes identified by brain imaging methods relate to neurobehavioral outcome is not as well known. Thus, the focus of this article is on brain imaging findings and outcome following TBI. The article starts with an overview of current research dealing with the cellular pathology associated with TBI. Understanding the cellular elements of pathology permits extrapolation to what is observed with brain imaging. Next, this article reviews the relationship of brain imaging findings to underlying pathology and how that pathology relates to neurobehavioral outcome. The brain imaging techniques of magnetic resonance imaging, computerized tomography, and single photon emission computed tomography are reviewed. Various image analysis procedures, and how such findings relate to neuropsychological testing, are discussed. The importance of brain imaging in evaluating neurobehavioral deficits following brain injury is stressed.			Bigler, ED (corresponding author), BRIGHAM YOUNG UNIV, DEPT PSYCHOL, 1086 KIMBALL TOWER, PROVO, UT 84602 USA.						ADAM C, 1994, ARCH NEUROL-CHICAGO, V51, P130, DOI 10.1001/archneur.1994.00540140036012; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ANDERSON CV, 1994, BRAIN INJURY, V8, P565, DOI 10.3109/02699059409151008; Bigler E. D., 1990, TRAUMATIC BRAIN INJU; Bigler E. D., 1989, NEUROPSYCHOLOGICAL F; BIGLER ED, 1992, BRAIN RES BULL, V28, P651, DOI 10.1016/0361-9230(92)90119-I; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BIGLER ED, 1992, ARCH CLIN NEUROPSYCH, V7, P449, DOI 10.1016/0887-6177(92)90158-J; BIGLER ED, 1994, BRAIN INJURY, V8, P231, DOI 10.3109/02699059409150975; BIGLER ED, 1994, PERSP INDIV, P1; BIGLER ED, 1987, J LEARN DISABIL, V20, P454, DOI 10.1177/002221948702000803; BIGLER ED, 1994, FUNCTIONAL NEUROIMAG, P121; Bigler Erin D., 1993, Brain Injury, V7, P125, DOI 10.3109/02699059309008166; COURCHESNE E, 1994, NEUROLOGY, V44, P203, DOI 10.1212/WNL.44.2.203; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FISHMAN PS, 1993, J NEUROTRAUM, V10, P457, DOI 10.1089/neu.1993.10.457; Fishman R. A., 1992, CEREBROSPINAL FLUID, V2nd; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; GALE SD, 1994, NEUROPSY NEUROPSY BE, V7, P160; GALE SD, 1995, J NEUROTRAUM, V12, P151, DOI 10.1089/neu.1995.12.151; GALE SD, 1993, BRAIN RES BULL, V32, P345, DOI 10.1016/0361-9230(93)90198-K; HAYES RL, 1989, HEAD INJURY, P427; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; ICHISE M, 1994, J NUCL MED, V35, P217; JOHNSON SC, 1994, BRAIN RES BULL, V35, P373, DOI 10.1016/0361-9230(94)90116-3; Johnson SC, 1994, NEUROPSYCHOLOGY, V8, P307, DOI DOI 10.1037/0894-4105.8.3.301; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; KOSSLYN SM, 1993, CEREB CORTEX, V3, P567, DOI 10.1093/cercor/3.6.567; KURTH SM, 1994, BRAIN INJURY, V8, P489, DOI 10.3109/02699059409151001; LANDIS DMD, 1994, ANNU REV NEUROSCI, V17, P133, DOI 10.1146/annurev.ne.17.030194.001025; Levin Harvey S, 1987, NEUROBEHAVIORAL RECO; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1994, J CHILD NEUROL, V9, P81, DOI 10.1177/088307389400900121; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; NEUWELT EA, 1989, IMPLICATIONS MOOD BR, V1; NEUWELT EA, 1989, IMPLICATIONS BLOOD B, V2; POVLISHOCK JT, 1993, ANN EMERG MED, V22, P980, DOI 10.1016/S0196-0644(05)82738-6; POVLISHOCK JT, 1993, ANN M INT ASS STUD T; SALAZAR AM, 1992, CHALLENGES NEUROLOGY, P55; SCHMIDT RH, 1993, J NEUROTRAUMA, V10, P425; STEWARD O, 1989, Journal of Neurotrauma, V6, P99, DOI 10.1089/neu.1989.6.99	41	20	20	1	2	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-2194			J LEARN DISABIL-US	J. Learn. Disabil.	SEP	1996	29	5					515	530		10.1177/002221949602900507			16	Education, Special; Rehabilitation	Social Science Citation Index (SSCI)	Education & Educational Research; Rehabilitation	VJ057	WOS:A1996VJ05700007	8870522				2022-02-06	
J	Freitas, J; Puig, J; Rocha, AP; Lago, P; Teixeira, J; Carvalho, MJ; Costa, O; deFreitas, AF				Freitas, J; Puig, J; Rocha, AP; Lago, P; Teixeira, J; Carvalho, MJ; Costa, O; deFreitas, AF			Heart rate variability in brain death	CLINICAL AUTONOMIC RESEARCH			English	Article						brain death; heart rate variability; autonomic central reflexes	POWER SPECTRUM ANALYSIS; INJURY	The sensitivity and specificity of heart rare variability (HRV) in the corroboration of brain death diagnosis in patients with acute traumatic intracranial lesions was evaluated in 20 patients with clinical criteria of brain death, nine patients in deep coma (Glasgow scale < 7) and 18 normal controls, all age marched. The electrocardiogram was sampled at 650 Hz and several parameters of HRV were calculated, in both rime and frequency domains. The HRV parameters were significantly lower in the brain death group compared with the deep coma group. Linear discriminant analysis between brain death and deep coma patients was performed on a data set made of nine randomly selected patients with clinical criteria of brain death and nine patients in deep coma. Cross-validation was performed on the remaining 11 patients with clinical criteria of brain death. All patients in the data set were correctly classified (sensitivity and specificity of 100%). All patients in the cross-validation set were correctly classified (sensitivity of 100%). Further studies are necessary to evaluate the specificity of the method in the independent set: of deep coma patients and in the follow-up of comatose and vegetative patients to identify irreversibility of HRV. Nevertheless, these results suggest that HRV analysis constitutes a fully sensitive and specific method for assessing brain death in potential organ donors with acute traumatic lesions of the brain. This fast, quantitative and bedside method seems very promising for the early confirmation of brain death, which is an important factor for the success of transplantation procedures and could have a high predictive value of brain death in comatose patients with brain injuries without fully diagnostic criteria.	UNIV PORTO, HOSP SAO JOAO, FDN AUTON CORINO ANDRADE & CIRURG VASC, CTR ESTUDOS, P-4200 OPORTO, PORTUGAL; UNIV PORTO, GRP MATEMAT APLICADA, P-4200 OPORTO, PORTUGAL				Rocha, Ana Paula/D-2813-2012; Costa, Ovidio/L-7319-2014; Freitas, Joao/AAT-6698-2020	Rocha, Ana Paula/0000-0003-3218-7001; Costa, Ovidio/0000-0001-7279-3706; Freitas, Joao/0000-0001-7478-3042			AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; BERNARDI L, 1993, BLOOD PRESSURE HEART, P143; CARVALHO MJ, 1991, J HYPERTENS, V9, pS62; CLIFTON GL, 1983, J NEUROSURG, V59, P637; COSTA O, 1994, J ELECTROCARDIOL, V27, P251, DOI 10.1016/S0022-0736(94)80009-X; FRANK JI, 1992, ARCH NEUROL-CHICAGO, V49, P1200, DOI 10.1001/archneur.1992.00530350122028; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; KITA Y, 1993, J AUTONOM NERV SYST, V44, P101, DOI 10.1016/0165-1838(93)90022-M; KLEIGER R E, 1992, Cardiology Clinics, V10, P487; LACQUANITI LG, 1993, INT J CLIN MONIT COM, V10, P181, DOI 10.1007/BF01246453; ORI Z, 1992, Cardiology Clinics, V10, P499; RUBENSTEIN E, SCI AM MED, P1; SANDS KEF, 1989, CIRCULATION, V79, P76, DOI 10.1161/01.CIR.79.1.76; SCWARTZ G, 1987, FUNCTIONAL NEUROLOGY, V2, P149; TEASDALE G, 1974, LANCET, V2, P81; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875	16	20	20	0	2	RAPID SCIENCE PUBLISHERS	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8NH	0959-9851			CLIN AUTON RES	Clin. Auton. Res.	JUN	1996	6	3					141	146		10.1007/BF02281900			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UZ057	WOS:A1996UZ05700002	8832122				2022-02-06	
J	Ham, LP; Packard, RC				Ham, LP; Packard, RC			A retrospective, follow-up study of biofeedback-assisted relaxation therapy in patients with posttraumatic headache	BIOFEEDBACK AND SELF-REGULATION			English	Article						post-traumatic headache; EMG biofeedback; thermal biofeedback; mild head injury; relaxation training	TENSION HEADACHE; BRAIN INJURY; PSYCHOTHERAPY; EFFICACY	Although biofeedback in the treatment of migraine and tension-type headache has been widely researched, there is little research examining biofeedback therapy in posttraumatic headache (PTH). In this retrospective study, 40 subjects with PTH who had received biofeedback-assisted relaxation at our headache clinic were questioned at least 3 months following the completion of therapy. Subjects were queried about improvements in headache increases in ability to relax and cope with pain, and overall benefits, lasting effectiveness, and continued use of biofeedback in daily life. Results indicate 53% reported at least moderate improvement in headaches; 80% reported at least moderate improvement in ability to relax and cope with pain; 93% found biofeedback helpful to some degree; 85% felt headache relief achieved through biofeedback had continued at least somewhat; and 95% stared they were continuing to use biofeedback skills in daily life. A correlation analysis revealed a negative relationship between response to biofeedback and increased chronicity of the disorder. In other words, the more chronic the disorder, the poorer the response to treatment. A stepwise regression analysis found that chronicity of the disorder and number of treatment sessions significantly affected response to treatment. Data suggest that biofeedback-assisted relaxation should at least be considered when planning treatment strategies for posttraumatic headache.			Ham, LP (corresponding author), HEADACHE MANAGEMENT & NEUROL,5500 N DAVIS HIGHWAY,SUITE 1,PENSACOLA,FL 32503, USA.						ADLER CS, 1976, HEADACHE, V16, P189, DOI 10.1111/j.1526-4610.1976.hed1604189.x; ADLER CS, 1987, PSYCHIAT ASPECTS HEA, P349; ADLER CS, 1985, UPDATING HEADACHE, P246; ANDRASIK F, 1984, J CONSULT CLIN PSYCH, V52, P609, DOI 10.1037/0022-006X.52.4.609; ANDRASIK F, 1987, BIOFEEDBACK STUDIES, P281; BELL NW, 1983, HEADACHE, V23, P162, DOI 10.1111/j.1526-4610.1983.hed2304162.x; BLANCHARD EB, 1982, J CONSULT CLIN PSYCH, V50, P562, DOI 10.1037/0022-006X.50.4.562; BLANCHARD EB, 1985, HEADACHE, V25, P214, DOI 10.1111/j.1526-4610.1985.hed2504214.x; BLANCHARD EB, 1981, BEHAV THER, V12, P711, DOI 10.1016/S0005-7894(81)80142-6; BLANCHARD EB, 1982, BEHAV RES THER, V20, P469, DOI 10.1016/0005-7967(82)90068-7; BLANCHARD EB, 1987, BIOFEEDBACK STUDIES, P1; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; BROWN SJ, 1994, J NEUROPSYCH CLIN N, V6, P15; BUDZYNSKI T, 1970, J BEHAV THER EXP PSY, V1, P205, DOI 10.1016/0005-7916(70)90004-2; CAHN T, 1980, BIOFEEDBACK SELF-REG, V5, P265, DOI 10.1007/BF00998602; DIAMOND S, 1979, HEADACHE, V19, P90, DOI 10.1111/j.1526-4610.1979.hed1902090.x; DIAMOND S, 1984, HEADACHE, V24, P5, DOI 10.1111/j.1526-4610.1984.hed2401005.x; DIAMOND S, 1979, HEADACHE, V19, P180, DOI 10.1111/j.1526-4610.1979.hed1903180.x; DUCKRO PN, 1985, HEADACHE, V25, P328; ELKIND AH, 1992, PRACTICING PHYSICIAN, P146; EVANS RW, 1994, SEMIN NEUROL, V14, P32, DOI 10.1055/s-2008-1041056; EVANS RW, 1992, NEUROL CLIN, V10, P975, DOI 10.1016/S0733-8619(18)30191-9; Headache Classification Committee of the International Headache Society, 1988, CEPHALALGIA S7, V8, P1; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; McGrady AV, 1983, J HOLISTIC MED, V5, P130; MEDINA JL, 1992, HEADACHE, V32, P180, DOI 10.1111/j.1526-4610.1992.hed3204180.x; MORGAN AS, 1989, J NATL MED ASSOC, V81, P1133; OLSON RP, 1988, BIOFEEDBACK SELF-REG, V13, P331; PACKARD RC, 1993, HEADACHE, V33, P133, DOI 10.1111/j.1526-4610.1993.hed3303133.x; PACKARD RC, 1992, HEADACHE, V32, P496, DOI 10.1111/j.1526-4610.1992.hed3210496.x; PACKARD RC, 1994, SEMIN NEUROL, V14, P40, DOI 10.1055/s-2008-1041057; PACKARD RC, 1994, J NEUROPSYCH CLIN N, V6, P229; SCHWARTZ MS, 1995, BIOFEEDBACK PRACTITI, P313; SPEED WG, 1986, PRACTICING PHYSICIAN, P113; [No title captured]	35	20	20	2	3	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	0363-3586			BIOFEEDBACK SELF-REG	Biofeedback Self-Regul.	JUN	1996	21	2					93	104		10.1007/BF02284689			12	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	UT735	WOS:A1996UT73500001	8805960				2022-02-06	
J	Richard, I; Giraud, M; PerrouinVerbe, B; Hiance, D; delaGreve, IM; Mathe, JF				Richard, I; Giraud, M; PerrouinVerbe, B; Hiance, D; delaGreve, IM; Mathe, JF			Laryngotracheal stenosis after intubation or tracheostomy in patients with neurological disease	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							TRAUMATIC BRAIN INJURY; INTENSIVE-CARE UNIT; ENDOTRACHEAL INTUBATION; AIRWAY COMPLICATIONS; ASSISTED VENTILATION; PROLONGED INTUBATION; PATHOGENESIS; TRACHEOTOMY	Objective: This retrospective study evaluated the incidence of ah-way complications in neurological patients following translaryngeal intubation, tracheostomy, or both. Design: The medical records of 315 consecutive patients (200 with traumatic brain injuries, 31 traumatic tetraplegics, and 84 with other neurological disorders) were reviewed. The type of artificial airway, duration of intubation, and use of nocturnal ventilation were recorded. Eighty-six percent of the patients underwent some combination of tracheal tomograms, flow-volume loop analysis, and fiberoptic tracheolaryngoscopy. Stenosis was classified as severe if it required surgery, if it required maintaining the tracheostomy, or was lethal. It was classified as benign if it was successfully treated by medical or local means. Results: Fifty-five percent of the patients were intubated translaryngeally only (mean = 17 days). Three percent underwent tracheostomy only, and 42% underwent tracheostomy after intubation for a mean of 13 days. The overall incidence of airway stenosis was 20%, 1/4 of which was severe, Fifteen percent of these patients died as a result of tracheal complications. The incidence of stenosis was higher following tracheostomy than following intubation only (29% vs 13%,p <.01). The incidence of severe stenosis in intubated-only patients was low (1%) compared with that following tracheostomy (10%, p <.01). No significant relationship was found between the length of intubation or the timing of tracheostomy. Conclusion: Fewer complications are associated with transtracheal intubation than with tracheostomy. The data suggest that longer periods of intubation be used when attempting ventilator weaning before resorting to tracheostomy if weaning fails. (C) 1996 by the American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation	CHRU NANTES,HOP ST JACQUES,CLIN OTORHINOLAYNGOL & CHIRURG CERVICOFACIAL,F-44035 NANTES,FRANCE		Richard, I (corresponding author), CHRU NANTES,HOP ST JACQUES,SERV REEDUC FONCT,85 RUE ST JACQUES,F-44035 NANTES,FRANCE.						ANDREWS MJ, 1971, ANN SURG, V173, P249, DOI 10.1097/00000658-197102000-00012; AROLA MK, 1981, ACTA CHIR SCAND, V147, P183; Bach J R, 1991, J Am Paraplegia Soc, V14, P158; BACH JR, 1993, CHEST, V104, P1553, DOI 10.1378/chest.104.5.1553; BISHOP MJ, 1984, ANESTH ANALG, V63, P335; CITTAPIETROLUNGO TJ, 1993, ARCH PHYS MED REHAB, V74, P905; COLICE GL, 1989, CHEST, V96, P877, DOI 10.1378/chest.96.4.877; COMBES P, 1991, REAN SOINS INTENS ME, V7, P254; DANE TEB, 1975, CHEST, V67, P398, DOI 10.1378/chest.67.4.398; DAYAL VS, 1986, LARYNGOSCOPE, V96, P58; DUNHAM CM, 1984, J TRAUMA, V24, P120, DOI 10.1097/00005373-198402000-00005; ENRIQUE VR, 1981, CRIT CARE MED, V9, P637; GAYNOR EB, 1985, LARYNGOSCOPE, V95, P1461; HEFFNER JE, 1986, CHEST, V90, P269, DOI 10.1378/chest.90.2.269; HEFFNER JE, 1986, CHEST, V90, P430, DOI 10.1378/chest.90.3.430; KASTANOS N, 1983, CRIT CARE MED, V11, P362, DOI 10.1097/00003246-198305000-00009; KIRCHNER JC, 1988, LARYNGOSCOPE, V98, P1165; KLINGBEIL GEG, 1988, ARCH PHYS MED REHAB, V69, P493; LEWIS FR, 1970, AM J SURG, V135, P452; LEWIS RJ, 1992, CLIN CHEST MED, V13, P137; MARSH HM, 1989, CHEST, V96, P190, DOI 10.1378/chest.96.1.190; MCCAFFREY TV, 1992, LARYNGOSCOPE, V102, P1335, DOI 10.1288/00005537-199212000-00004; MILLER JD, 1984, SURG NEUROL, V22, P186, DOI 10.1016/0090-3019(84)90050-8; NOWAK P, 1987, AM J OTOLARYNG, V8, P91, DOI 10.1016/S0196-0709(87)80030-3; PINGLETON SK, 1988, AM REV RESPIR DIS, V137, P1463, DOI 10.1164/ajrccm/137.6.1463; RASHKIN MC, 1986, CHEST, V89, P165, DOI 10.1378/chest.89.2.165; Richard I., 1993, Annales de Readaptation et de Medecine Physique, V36, P401; SQUIRE R, 1990, LARYNGOSCOPE, V100, P765; STAUFFER JL, 1981, AM J MED, V70, P65, DOI 10.1016/0002-9343(81)90413-7; STREITZ JM, 1991, SURG CLIN N AM, V71, P1211; VOGELHUT MM, 1979, CHEST, V76, P110, DOI 10.1378/chest.76.1.110; WAIN JC, 1990, ANN THORAC SURG, V49, P881, DOI 10.1016/0003-4975(90)90860-9; WHITED RE, 1984, LARYNGOSCOPE, V94, P364; WOO P, 1989, LARYNGOSCOPE, V99, P725	34	20	22	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0003-9993			ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	1996	77	5					493	496		10.1016/S0003-9993(96)90039-8			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	UM466	WOS:A1996UM46600013	8629927				2022-02-06	
J	Kopke, R; Staecker, H; Lefebvre, P; Malgrange, B; Moonen, G; Ruben, RJ; VandeWater, TR				Kopke, R; Staecker, H; Lefebvre, P; Malgrange, B; Moonen, G; Ruben, RJ; VandeWater, TR			Effect of neurotrophic factors on the inner ear: Clinical implications	ACTA OTO-LARYNGOLOGICA			English	Article						auditory neurons; brain derived neurotrophic factor (BDNF); neuritogenesis; neuronal survival; neurotrophin-3 (NT-3); sensorineural deafness	ADULT AUDITORY NEURONS; TRANSLABYRINTHINE APPROACH; HEARING PRESERVATION; EXPRESSION; GANGLION; SURVIVAL; CULTURE	Loss of auditory neurons is commonly associated with sensorineural deafness, and may result from either direct neuronal injury or be a consequence of sensory hair cell loss (i.e. loss of a source of trophic factors). Developmental studies and in vitro studies of adult auditory neurons have begun to identify growth factors important for the development, maintenance, and rescue/repair of auditory neurons. Specific neurotrophic factors have been shown to enhance the auditory neurons' ability to withstand traumatic loss of target tissue connections and toxic injury. Promising initial in vivo studies confirm that specific neurotrophins are able to support neuronal survival and promote neuronal repair in an intact animal following injury to the cochlea. Further study into unique methods and routes of growth factor delivery will provide insights into the possibility of neurotrophic growth factors to act as drugs for the treatment of injured or stressed auditory neurons.	YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT OTOLARYNGOL,BRONX,NY 10461; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT NEUROSCI,BRONX,NY 10461; UNIV LIEGE,DEPT HUMAN PHYSIOL & PATHOPHYSIOL,LIEGE,BELGIUM				; Malgrange, Brigitte/A-4887-2019	Staecker, Hinrich/0000-0002-0348-3015; Malgrange, Brigitte/0000-0002-8957-2528	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC00008] Funding Source: Medline		ARD MD, 1985, NEUROSCIENCE, V16, P151, DOI 10.1016/0306-4522(85)90053-3; BROWN JN, 1993, HEARING RES, V70, P167, DOI 10.1016/0378-5955(93)90155-T; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; FISHMAN JB, 1987, J NEUROSCI RES, V18, P299, DOI 10.1002/jnr.490180206; HIRSCH BE, 1993, AM J OTOL, V14, P533; JUHN SK, 1981, ANN OTO RHINOL LARYN, V90, P135, DOI 10.1177/000348948109000208; LEFEBVRE PP, 1992, NEUROREPORT, V3, P295, DOI 10.1097/00001756-199204000-00001; LEFEBVRE PP, 1994, NEUROREPORT, V5, P865, DOI 10.1097/00001756-199404000-00003; LEFEBVRE PP, 1992, HEARING RES, V58, P185, DOI 10.1016/0378-5955(92)90127-9; LEFEBVRE PP, 1991, BRAIN RES, V567, P306, DOI 10.1016/0006-8993(91)90809-A; LEFEBVRE PP, 1991, NEUROREPORT, V2, P305, DOI 10.1097/00001756-199106000-00001; LUO L, 1993, HEARING RES, V69, P182; MARSH MA, 1991, 26 ANN SCI M AM NEUR; MCELVEEN JT, 1993, OTOLARYNG HEAD NECK, V108, P671, DOI 10.1177/019459989310800608; MONSELL EM, 1993, OTOLARYNG CLIN N AM, V26, P737; NADOL JB, 1989, ANN OTO RHINOL LARYN, V98, P411, DOI 10.1177/000348948909800602; SPEONDLIN H, 1988, OTOLOGIC MED SURG, P117; STAECKER H, 1995, NEUROREPORT, V6, P1533, DOI 10.1097/00001756-199507310-00017; STAECKER H, 1996, IN PRESS AM J OTOL; STAECKER H, 1995, MIDW M ASS RES OT FE; VANDEWATER TR, 1995, CLIN ASPECTS HEARING; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; ZHANG JL, 1995, J NEUROSCI, V15, P5079; ZHOU XN, 1987, ACTA OTO-LARYNGOL, V104, P90, DOI 10.3109/00016488709109052	25	20	21	0	1	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0001-6489			ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	MAR	1996	116	2					248	252		10.3109/00016489609137834			5	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Otorhinolaryngology	UF493	WOS:A1996UF49300024	8725525				2022-02-06	
J	Jordan, FM; Ashton, R				Jordan, FM; Ashton, R			Language performance of severely closed head injured children	BRAIN INJURY			English	Article							ADOLESCENTS; CHILDHOOD	The language functioning of a group of children who had sustained a severe closed head injury (CHI) was evaluated. The subjects were administered a battery of language assessments including measures of syntax, semantics and pragmatics. Performance of the experimental group was compared with that of a control group matched for age and sex. Results indicated that all areas of language competence assessed (syntax, semantics, pragmatics) appeared to be compromised by the childhood CHI. The findings of this study are considered in light of the implications for the existence of different language components (syntax, semantics, pragmatics) as opposed to a unified concept of language. Also considered is the evidence of a specific linguistic impairment in the childhood CHI population as opposed to a more generalized cognitive decline expressed as an overall decrease in performance across all domains of language skill.			Jordan, FM (corresponding author), UNIV QUEENSLAND,DEPT PSYCHOL,BRISBANE,QLD 4072,AUSTRALIA.						Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; Bishop D. V., 1989, TEST RECEPTION GRAMM; BRUCE DA, 1983, PAEDIATRIC HEAD TRAU, P27; CHADWICK O, 1981, J CHILD PSYCHOL PSYC, V22, P117, DOI 10.1111/j.1469-7610.1981.tb00538.x; CHADWICK O, 1981, Journal of Clinical Neuropsychology, V3, P101, DOI 10.1080/01688638108403117; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DENNIS M, 1981, BRAIN LANG, V12, P33, DOI 10.1016/0093-934X(81)90004-3; DENNIS M, 1987, J CLIN EXP NEUROPSYC, V9, P723, DOI 10.1080/01688638708405213; Dennis M., 1988, CLIN NEUROPSYCHOLOGY, P85; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; FISHER J, 1992, HUNDRED PICTURES NAM; FLETCHER JM, 1988, HDB PEDIATRIC PSYCHO, P258; JORDAN F M, 1990, Brain Injury, V4, P147, DOI 10.3109/02699059009026159; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; Levin H., 1979, J PEDIATR PSYCHOL, V4, P389, DOI DOI 10.1093/JPEPSY/4.4.389; Murdoch B. E., 1990, ACQUIRED SPEECH LANG; PAQUIER P, 1993, APHASIOLOGY, V7, P421, DOI 10.1080/02687039308248618; Secord, 1991, TEST WORD KNOWLEDGE; TEASDALE G, 1974, LANCET, V2, P81; Wiig EH, 1985, TEST LANGUAGE COMPET; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218; [No title captured]	22	20	20	0	8	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	FEB	1996	10	2					91	97		10.1080/026990596124575			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	UB726	WOS:A1996UB72600002	8696319				2022-02-06	
J	ODell, MW; Jasin, P; Lyons, N; Stivers, M; Meszaros, F				ODell, MW; Jasin, P; Lyons, N; Stivers, M; Meszaros, F			Standardized assessment instruments for minimally-responsive, brain-injured patients	NEUROREHABILITATION			English	Article						traumatic brain injury; vegetative state; functional assessment; rehabilitation; health status; minimally responsive	HEAD-INJURY; RECOVERY; SCALE; COMA	Among the most significant advances in the care and rehabilitation of severely brain injured, minimally-responsive patients (MRP) has been the development of standardized assessment scales. Currently available instruments include the Coma/Near Coma Scale (CNC), Coma Recovery Scale (CRS), Sensory Stimulation Assessment Measure (SSAM), and the Western Neuro Sensory Stimulation Profile (WNSSP). Each scale is reviewed in terms of content, psychometric properties, and clinical attributes. Data is then presented comparing converted, percentile admission scores for the CRS, WNSSP, and CNC in a group of ten MRP at Rancho Levels II-IV, with a mean age of 31 years and mean time from injury of 37.5 days. Admission CNC and CRS scores tended to group in the middle range, while WNSSP scores tended to group in the lower quartile. This suggests the potential concern for 'floor effect' with the WNSSP. At admission, none of the three scales was able to effectively distinguish between dichotomized outcome variables: disposition (home vs. nursing home), advancement to active rehabilitation, or discharge Functional Independence Measure score (> 80 vs. < 80). The data indicate the CRS demonstrates moderately strong relationships with both the CNC and WNSSP. Full delineation of how these scales relate to one another awaits both cross-sectional and longitudinal analyses in larger samples and should include the SSAM.	DRAKE CTR INC,DEPT PSYCHOL,BRAIN INJURY REHABIL PROGRAM,CINCINNATI,OH; DRAKE CTR INC,DEPT SPEECH PSYCHOL,BRAIN INJURY REHABIL PROGRAM,CINCINNATI,OH; DRAKE CTR INC,DEPT THERAPEUT RECREAT,BRAIN INJURY REHABIL PROGRAM,CINCINNATI,OH		ODell, MW (corresponding author), UNIV CINCINNATI,COLL MED,DEPT PHYS MED & REHABIL,5161 MED SCI BLDG,MAIL LOCAT 530,CINCINNATI,OH 45267, USA.						Ansell B. J., 1993, J HEAD TRAUMA REHAB, V8, P88, DOI DOI 10.1097/00001199-199309000-00011; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; BINDMAN AB, 1990, MED CARE, V28, P1142, DOI 10.1097/00005650-199012000-00003; DIKMEN S, 1983, ARCH NEUROL-CHICAGO, V40, P333, DOI 10.1001/archneur.1983.04050060033004; ELSTON RC, 1987, ESSENTIALS BIOSTATIS, P196; GIACINO J T, 1991, Archives of Physical Medicine and Rehabilitation, V72, P798; GIACINO JT, 1991, ARCH PHYS MED REHAB, V72, P897, DOI 10.1016/0003-9993(91)90008-7; GIACINO JT, 1995, J HEAD TRAUMA REHAB, V10, P40; Giacino JT, 1993, ARCH PHYS MED REHAB, V74, P662; GIACINO JT, 1994, ARCH PHYS MED REHAB, V75, P723; GRANGER CV, 1988, DEV UNIFORM NATL DAT; Hagen C, 1979, REHABILITATION HEAD, P87; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; HALL M E, 1992, Brain Injury, V6, P435, DOI 10.3109/02699059209008139; ODELL MW, MED REHABILITATION T; ODELL MW, 1992, 54 ANN M AM AC PHYS; ODELL MW, IN PRESS J HEAD TRAU; Rader M A, 1989, Brain Inj, V3, P141, DOI 10.3109/02699058909004545; RADER MA, 1994, BRAIN INJURY, V8, P309, DOI 10.3109/02699059409150982; RAPPAPORT M, 1992, ARCH PHYS MED REHAB, V73, P628; TALBOT LR, 1994, BRAIN INJURY, V8, P689, DOI 10.3109/02699059409151023; TEASDALE G, 1974, LANCET, V2, P81; 1995, ARCH PHYS MED REHAB, V76, P205	23	20	20	0	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	FEB	1996	6	1					45	55		10.1016/1053-8135(95)00147-6			11	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TZ377	WOS:A1996TZ37700006	24525685				2022-02-06	
J	VecchieriniBlineau, MF; Nogues, B; Louvet, S; Desfontaines, O				VecchieriniBlineau, MF; Nogues, B; Louvet, S; Desfontaines, O			Positive temporal sharp waves in electroencephalograms of the premature newborn	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			English	Article						prematurity; EEG; waves	INTRAVENTRICULAR HEMORRHAGE; EEG RECORDINGS; NEONATAL EEG; FULL-TERM; INFANTS; PRETERM	Positive temporal sharp waves (PTS) were studied in electroencephalograms (EEG) of 92 premature infants born either at 31 and 32 weeks of gestational age, recorded during the first week of life. The infants were assigned either to a reference group (asymptomatic) or to one of three pathologic groups (neonatal asphyxia, hypoglycemia or hypocalcemia, or periventricular leukomalacia with rolandic positive sharp waves), Regardless of the group, no significant differences in PTS criteria (morphology, frequency, amplitude, duration and lateralization) were Found between 31- and 32-week infants. The PTS observed in 558 of the asymptomatic infants were characterized by low frequency (0.13 +/- 0.12/min), a mean amplitude of 109.8 +/- 25.8 mu V and a mean duration of 148.7 +/- 35.4 ms. For PTS recorded in 72 to 758 of pathologic infants, mean duration and amplitude were significantly greater in all groups than in asymptomatic infants, whereas frequency was significantly greater only in the group presenting with asphyxia. Discriminant analysis based un the three PTS criteria frequency, amplitude and duration) allowed correct classification for only 30 to 54% of infants in the four groups. The frequency of PTS decreased rapidly during the second week of life in asymptomatic infants, but persisted in a larger number of infants in the pathologic groups. This study shows that PTS have no negative significant with they are few in number, short in duration, moderate in amplitude and rapidly regressive, thus probably reflecting the vulnerability of the temporal lobe during the traumatic period of birth. However, they require attention when they are abundant and/or slow, ample or tend to persist. They may thus constitute a nonspecific response to injury to an immature brain.			VecchieriniBlineau, MF (corresponding author), LAB PHYSIOL APPL EXPLORAT FONCT,1 RUE GASTON VEIL,F-44035 NANTES,FRANCE.						BLUME WT, 1982, ELECTROEN CLIN NEURO, V53, P277, DOI 10.1016/0013-4694(82)90085-2; CHUNG HJ, 1991, ELECTROEN CLIN NEURO, V79, P256; CLANCY RR, 1984, NEUROLOGY, V34, P583, DOI 10.1212/WNL.34.5.583; CLANCY RR, 1984, ELECTROEN CLIN NEURO, V57, P395, DOI 10.1016/0013-4694(84)90068-3; Cukier F, 1972, Rev Electroencephalogr Neurophysiol Clin, V2, P318, DOI 10.1016/S0370-4475(72)80037-6; CURZIDASCALOVA L, 1993, PEDIATR RES, V34, P624, DOI 10.1203/00006450-199311000-00013; HUGHES JR, 1991, CLIN ELECTROENCEPHAL, V22, P30, DOI 10.1177/155005949102200108; HUGUES JR, 1987, ELECTROENCEPHALOGR C, V67, P7; JAMMES JL, 1983, DEV HUMAN BRAIN GROW, P87; KELLAWAY P, 1982, PRACTICE PEDIAT NEUR, P96; LACEY DJ, 1986, NEUROLOGY, V36, P1084, DOI 10.1212/WNL.36.8.1084; LOMBROSO CT, 1985, J CLIN NEUROPHYSIOL, V2, P105, DOI 10.1097/00004691-198504000-00002; MARRET S, 1992, ARCH DIS CHILD, V67, P948, DOI 10.1136/adc.67.7.948; MARRET S, 1986, NEUROPEDIATRICS, V17, P199, DOI 10.1055/s-2008-1052529; MARRET S, 1989, ARCH FR PEDIATR, V46, P249; NOVOTNY EJ, 1987, NEUROLOGY, V37, P1481, DOI 10.1212/WNL.37.9.1481; NOWACK W J, 1987, Journal of Clinical Neurophysiology, V4, P315; NOWACK WJ, 1989, CLIN ELECTROENCEPHAL, V20, P196, DOI 10.1177/155005948902000314; Nowack WJ, 1990, AM J EEG TECHNOL, V30, P211; POPE JE, 1992, ATLAS NEONATAL ELECT; SCHER MS, 1994, ELECTROEN CLIN NEURO, V90, P173, DOI 10.1016/0013-4694(94)90088-4; SCHER MS, 1994, ELECTROEN CLIN NEURO, V90, P179, DOI 10.1016/0013-4694(94)90089-2; VECCHIERINI-BLINEAU M F, 1990, Neurophysiologie Clinique, V20, p11S; VECCHIERINIBLIN.MF, 1993, ELECTROENCEPHALOGR C, V86; VecchieriniBlineau MF, 1996, NEUROPHYSIOL CLIN, V26, P102, DOI 10.1016/0987-7053(96)83150-9; Werner SS, 1977, ATLAS NEONATAL ELECT	26	20	21	0	1	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	141 RUE JAVEL, 75747 PARIS, FRANCE	0987-7053			NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.		1996	26	6					350	362		10.1016/S0987-7053(97)89149-6			13	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	WA726	WOS:A1996WA72600003	9018697				2022-02-06	
J	Yamaki, T; Yoshino, E; Fujimoto, M; Ohmori, Y; Imahori, Y; Ueda, S				Yamaki, T; Yoshino, E; Fujimoto, M; Ohmori, Y; Imahori, Y; Ueda, S			Chronological positron emission tomographic study of severe diffuse brain injury in the chronic stage	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							COMPUTERIZED-TOMOGRAPHY; TRAUMATIC COMA; HEAD-INJURY; DISORDERS; PET; MRI	Cerebral blood flow and metabolism were investigated in five patients with severe diffuse brain injury in the chronic stage, using positron emission tomography (PET). Regional cerebral blood flow, regional oxygen extraction fraction, regional cerebral blood volume, regional cerebral metabolic rate for oxygen, and regional cerebral metabolic rate for glucose were measured bilaterally in the frontal, temporal, occipital, and parietal gray matter, as well as the white matter of the centrum semiovale. In 4 of 5 patients, a follow-up PET study was also performed. In three cases, below-normal regional cerebral blood flow and regional cerebral metabolic rate for oxygen values accompanied by above-normal regional oxygen extraction fraction values, as well as low metabolism, were demonstrated in the initial PET studies. In two of three cases, clinical improvements were observed, and follow-up PET data also improved. These findings suggest that chronological PET studies may he able to assess quantitatively clinical improvements in patients with diffuse brain injury.	SAISEIKAI SHIGA HOSP, DEPT NEUROSURG, SAISEIKAI, JAPAN		Yamaki, T (corresponding author), KYOTO PREFECTURAL UNIV MED, DEPT NEUROSURG, KAMIGYO KU, KAWARAMACHI HIROKOJI, KYOTO 602, JAPAN.						ALAVI A, 1986, J NUCL MED, V27, P919; ALAVI A, 1987, J CEREB BLOOD FLO S1, V7, pS646; ANSELL BJ, 1989, ARCH PHYS MED REHAB, V70, P104; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; FRACKOWIAK RSJ, 1980, J COMPUT ASSIST TOMO, V4, P727, DOI 10.1097/00004728-198012000-00001; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; HUTCHINS GD, 1984, J CEREBR BLOOD F MET, V4, P35, DOI 10.1038/jcbfm.1984.5; JAMIESON D, 1988, RADIOL CLIN N AM, V26, P1075; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, MANAGEMENT HEAD INJU, P153; JOLLES PR, 1989, J NUCL MED, V30, P1589; JONES T, 1976, BRIT J RADIOL, V49, P339, DOI 10.1259/0007-1285-49-580-339; LANGFITT TW, 1986, J NEUROSURG, V64, P760, DOI 10.3171/jns.1986.64.5.0760; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NAKAGAWA Y, 1991, NEUROTRAUMATOLOGY, V14, P127; RAO N, 1984, ARCH PHYS MED REHAB, V65, P780; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; TEASDALE G, 1974, LANCET, V2, P81; TENJIN H, 1990, NEUROSURGERY, V26, P971, DOI 10.1227/00006123-199006000-00009; VOLLMER DG, 1991, J NEUROSURG, V75, pS37, DOI 10.3171/sup.1991.75.1s.0s37	23	20	20	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	JAN	1996	40	1					50	56		10.1097/00005373-199601000-00010			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	TU074	WOS:A1996TU07400011	8576999				2022-02-06	
J	BOGNER, J; CORRIGAN, JD				BOGNER, J; CORRIGAN, JD			EPIDEMIOLOGY OF AGITATION FOLLOWING BRAIN INJURY	NEUROREHABILITATION			English	Article						BRAIN INJURY; AGITATION; INCIDENCE; AGGRESSION; LABILITY; DISINHIBITION	CLOSED HEAD-INJURY; SCALE	Agitation, while considered an important factor influencing outcome following traumatic brain injury (TBI), has been a poorly defined construct. As a result, the literature on agitation has been confusing and incomplete in regard to incidence rates, causes and correlates, intervention methods, and long-term outcomes. In this article, we review previous research on incidence rates, concluding that differences in definition have greatly limited current knowledge. We then review how agitation has been operationalized in previous clinical and research efforts, and we recommend a definition that we believe will allow future studies to proceed in a more systematic manner.	OHIO STATE UNIV,DEPT PHYS MED & REHABIL,COLUMBUS,OH 43210				Corrigan, John D./E-2921-2011				BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; CORRIGAN JD, 1994, J CLIN EXP NEUROPSYC, V16, P386, DOI 10.1080/01688639408402649; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; FICHERA SM, 1993, J CLIN EXP NEUROPSYC, V15, P105; FUGATE LP, 1994, THESIS OHIO STATE U; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; MALKMUS D, 1980, PROFESSIONAL STAFF A; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; YUDOFSKY SC, 1986, AM J PSYCHIAT, V143, P35; ZIELINSKI R, 1994, 10IND ANN APA CONV L	13	20	20	0	4	ELSEVIER SCI PUBL IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	OCT	1995	5	4					293	297		10.1016/1053-8135(95)00128-X			5	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	TJ211	WOS:A1995TJ21100002	24525573				2022-02-06	
J	EMORY, LE; COLE, CM; MEYER, WJ				EMORY, LE; COLE, CM; MEYER, WJ			USE OF DEPO-PROVERA TO CONTROL SEXUAL AGGRESSION IN PERSONS WITH TRAUMATIC BRAIN INJURY	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							MEDROXYPROGESTERONE ACETATE; THERAPY; PARAPHILIAS; MEN; ANTIANDROGEN; OFFENDERS	Objective: To determine the effectiveness of medroxyprogesterone acetate (Depo-Provera) treatment in conjunction with psychological counseling on the hypersexual behavior seen in individuals with traumatic brain injury. Design: A retrospective review of the use of Depo-Provera in adult male patients who sustained a traumatic brain injury from blunt trauma and subsequently exhibited hypersexual behavior. Ah individuals were treated with a combination of weekly Depo-Provera injections and psychological counseling; the latter was educational/behavioral in nature and took into account such problems as deficits in awareness and empathy, poor memory, concreteness, and rigidity. Follow-up examinations were done every 3 months for at least 2 years and every 6 months thereafter. Setting: Individuals were seen in outpatient treatment and reside in community environments. Patients: Eight males (average age = 17.5 years at the time of head trauma) who developed problematic hypersexual behavior approximately 3 years later. These individuals were consecutive referrals to a psychiatric practice with expertise in the treatment of hypersexual behavior. Intervention: Weekly intramuscular Depo-Provera injections were used in conjunction with counseling. Main Outcome Measures: Incidence of hypersexual behavior; change in testosterone level. Results: In all cases, cessation of the unacceptable sexual behavior was noted while the men received treatment (mean duration = 42 months). Three individuals remain on Depo-Provera, and two have successfully discontinued treatment for 2 and 10 years, respectively, with no further problems. The remaining three reoffended when medication was discontinued, a decision made unilaterally by their families. Conclusions: The use of Depo-Provera in conjunction with counseling may offer an opportunity to control aberrant sexual behaviors after brain injury. However, only a minority of individuals stay in good control after discontinuing Depo-Provera.	UNIV TEXAS,MED BRANCH,GALVESTON,TX 77550		EMORY, LE (corresponding author), ROSENBERG CLIN,GALVESTON,TX, USA.						BENYISHAY Y, 1989, NEUROPSYCHOLOGY TREA; BERLIN FS, 1981, JOHNS HOPKINS MED J, V149, P119; BLACKERBY W, 1989, PHYSICAL MED REHABIL; BLUMER D, 1975, J NERV MENT DIS, V160, P127, DOI 10.1097/00005053-197502000-00007; BRADFORD JMW, 1988, ANN NY ACAD SCI, V58, P193; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; Garden F. H., 1990, J HEAD TRAUMA REHAB, V5, P52, DOI DOI 10.1097/00001199-199005020-00009; GEE KW, 1988, MOL NEUROBIOL, V2, P291, DOI 10.1007/BF02935636; GOTTESMAN HG, 1993, J CLIN PSYCHIAT, V54, P182; Griffith ER, 1993, SEXUALITY PERSON TRA; Gronwall Dorothy, 1990, HEAD INJURY FACTS GU; HARVEY JA, 1987, PSYCHOPHARMACOLOGY 3; KAFKA MP, 1992, J CLIN PSYCHIAT, V53, P351; KOSTELJANETZ M, 1981, ACTA NEUROL SCAND, V63, P169; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; KRUESI MJP, 1992, ARCH SEX BEHAV, V21, P587, DOI 10.1007/BF01542257; LEFEBVRE KA, 1990, J HEAD TRAUMA REHABI, V5, P25; LEHNE G, 1986, SEX DISABIL, V7, P145; Levin HS., 1982, NEUROBEHAVIORAL CONS; MEYER J, 1971, J NEUROVISCERAL RE S, V10, P519; Meyer W J 3rd, 1992, Bull Am Acad Psychiatry Law, V20, P249; MEYER WJ, 1992, RES COMMUN CHEM PATH, V75, P69; MEYER WJ, 1985, FERTIL STERIL, V43, P102; MILLER BL, 1986, J NEUROL NEUROSUR PS, V49, P867, DOI 10.1136/jnnp.49.8.867; MILLER L, 1993, PSYCHOTHERAPY BRAIN; MONEY J, 1987, J SEX MARITAL THER, V13, P219; MONEY J, 1981, INT J MENT HEALTH, V10, P122, DOI 10.1080/00207411.1981.11448890; MONEY J, 1975, PSYCHONEUROENDOCRINO, V1, P165, DOI 10.1016/0306-4530(75)90008-6; Pithers W, 1990, HDB SEXUAL ASSAULT I; UZZELL BP, 1988, NEUROPSYCHOLOGICAL R; WALKER PA, 1984, GUIDELINES USE PSYCH; ZASLER ND, 1990, J HEAD TRAUMA REHAB, V5, P14, DOI DOI 10.1097/00001199-199005020-00004	32	20	20	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUN	1995	10	3					47	58					12	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RC717	WOS:A1995RC71700005					2022-02-06	
J	NAGERIS, B; HANSEN, MC; LAVELLE, WG; VANPELT, FA				NAGERIS, B; HANSEN, MC; LAVELLE, WG; VANPELT, FA			TEMPORAL BONE-FRACTURES	AMERICAN JOURNAL OF EMERGENCY MEDICINE			English	Article						TEMPORAL BONE FRACTURE; CSF OTORRHEA; FACIAL NERVE PARALYSIS		The diagnosis and monitoring of patients presenting to an emergency department with blunt temporal bone fracture and complications requiring acute management were reviewed for a four-month period, Of 104 trauma patients with closed head injury, 15 patients were diagnosed with temporal bone fracture, 12 of whom survived their injuries. Four patients developed cerebrospinal fluid (CSF) otorrhea and two patients developed facial nerve paralysis; all patients had resolution of complications with conservative management. Significant shortcomings in the initial evaluation and monitoring of patients with temporal bone fracture were identified. Specific and thorough facial nerve examinations were not initially conducted on temporal bone fracture patients and subsequent inpatient monitoring for facial nerve paralysis and CSF otorrhea was incomplete. The outcome of temporal bone fracture is discussed. This article reminds the emergency physician of the importance of initial diagnosis and documentation of temporal bone fractures. ((C) 1995 by W.B. Saunders Company)			NAGERIS, B (corresponding author), UNIV MASSACHUSETTS,SCH MED,DEPT OTOLARYNGOL HEAD & NECK SURG,55 LAKE AVE N,WORCESTER,MA 01655, USA.							0	20	21	0	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0735-6757			AM J EMERG MED	Am. J. Emerg. Med.	MAR	1995	13	2					211	214		10.1016/0735-6757(95)90096-9			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	QQ147	WOS:A1995QQ14700021	7893311				2022-02-06	
J	COOKE, DL; KAUSLER, DH				COOKE, DL; KAUSLER, DH			CONTENT MEMORY AND TEMPORAL MEMORY FOR ACTIONS IN SURVIVORS OF TRAUMATIC BRAIN INJURY	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							ADULT AGE-DIFFERENCES; ACTION EVENTS; FRONTAL-LOBE; HEAD-INJURY; FREQUENCY; LESIONS; WORDS	Memory for performed actions, a rehearsal-independent form of memory, was compared to verbal memory in 30 survivors of traumatic brain injury (TBI) and 30 demographically matched controls. Subjects were tested on recognition and recall memory for the content of recently performed actions in the laboratory, as well as the ability to reconstruct the temporal order in which the actions were performed. Each subject performed actions under incidental and intentional memory instructions. Half of the subjects performed 12 actions, the other half 24 actions, with an equal number of usual and unusual actions in each list. Verbal memory was assessed with paired-associate and temporal order tests, Although recall was more proficient overall for the control compared to the brain-injured subjects on both content and temporal memory for actions, memory for actions was better than verbal memory in both groups. Both groups performed better overall on the short compared to the long list of actions and recalled unusual actions better than usual actions. The rehearsal-independent nature of action memory was supported, with no advantage for the intentional instruction. It is proposed that a retrieval deficit may be in part responsible for deficits in memory for actions following TBI. However, preserved ability to benefit from the abundant contextual cues available through motor actions may account for the better recall of actions compared to words.			COOKE, DL (corresponding author), UNIV MISSOURI,RUSK REHABIL CTR 501,DEPT PHYS MED & REHABIL,COLUMBIA,MO 65211, USA.				NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG008214] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG08214] Funding Source: Medline		BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; COHEN RL, 1983, MEM COGNITION, V11, P575, DOI 10.3758/BF03198282; COHEN RL, 1987, PSYCHOL AGING, V2, P280, DOI 10.1037/0882-7974.2.3.280; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; DIAMOND A, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P339; DICK MB, 1989, BRAIN COGNITION, V9, P71, DOI 10.1016/0278-2626(89)90045-6; EAKMAN AM, 1992, THESIS W MICHIGAN U; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Haut MW, 1991, NEUROPSYCHOLOGY, V5, P81, DOI 10.1037/0894-4105.5.2.81; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; KAUSLER DH, 1990, EXP AGING RES, V16, P147, DOI 10.1080/07340669008251542; KAUSLER DH, 1990, PSYCHOL AGING, V5, P530, DOI 10.1037/0882-7974.5.4.530; KAUSLER DH, 1988, COGNITIVE DEV ADULTH, P93, DOI DOI 10.1007/978-1-4612-3852-2_4; KNOPF M, 1989, DEV PSYCHOL, V25, P780, DOI 10.1037/0012-1649.25.5.780; LARSSON C, 1987, SCAND J REHABIL MED, V19, P99; LEVIN HS, 1988, BRAIN COGNITION, V7, P283, DOI 10.1016/0278-2626(88)90003-6; LICHTY W, 1986, THESIS U MISSOURI CO; Milner B., 1964, FRONTAL GRANULAR COR, P313; ODONNELL JP, 1988, J GEN PSYCHOL, V115, P355, DOI 10.1080/00221309.1988.9710572; OLTON DS, 1989, NEUROPSYCHOLOGIA, V27, P121, DOI 10.1016/0028-3932(89)90094-8; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; SALTHOUSE TA, 1988, PSYCHOL AGING, V3, P29, DOI 10.1037/0882-7974.3.1.29; SANDERS RE, 1990, PSYCHOL AGING, V5, P172, DOI 10.1037/0882-7974.5.2.172; SCHACTER DL, 1987, PSYCHOBIOLOGY, V15, P21; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; SHIMAMURA AP, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P173; TULVING E, 1989, AM SCI, V77, P361; TWEEDY JR, 1988, J CLIN EXP NEUROPSYC, V10, P664, DOI 10.1080/01688638808402803; Wechsler, 1997, WECHSLER ADULT INTEL; WIEGERSMA S, 1990, NEUROPSYCHOLOGIA, V28, P95, DOI 10.1016/0028-3932(90)90089-7; WILKINS AJ, 1986, ACTA NEUROL SCAND, V74, P109, DOI 10.1111/j.1600-0404.1986.tb04869.x	32	20	22	1	3	SWETS ZEITLINGER BV	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	FEB	1995	17	1					90	99		10.1080/13803399508406585			10	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	QJ150	WOS:A1995QJ15000011	7608307				2022-02-06	
J	BEHRMAN, SW; KUDSK, KA; BROWN, RO; VEHE, KL; WOJTYSIAK, SL				BEHRMAN, SW; KUDSK, KA; BROWN, RO; VEHE, KL; WOJTYSIAK, SL			THE EFFECT OF GROWTH-HORMONE ON NUTRITIONAL MARKERS IN ENTERALLY FED IMMOBILIZED TRAUMA PATIENTS	JOURNAL OF PARENTERAL AND ENTERAL NUTRITION			English	Article							POSITIVE NITROGEN-BALANCE; SEVERE HEAD-INJURY; PARENTERAL-NUTRITION; GASTROINTESTINAL SURGERY; CATABOLIC RESPONSE; PROTEIN; METABOLISM; SUPPORT; CELLS	Background: Earlier clinical studies have demonstrated improved nitrogen balance in nonstressed patients receiving hypocaloric feedings and growth hormone (GH). This study investigates the effect of GH on nitrogen balance, on serum protein concentrations, and on other indices of nutrition when combined with enteral feeding in immobilized patients after closed-head injury or spinal cord injury. Methods: Sixteen patients who tolerated enteral feedings and remained nonseptic were randomized to receive either placebo or 0.2 mg/kg recombinant human GH for 7 to 13 days. Nitrogen balances were collected daily, and serum proteins were measured at study entrance and exit. Results: GH treatment resulted in higher GH and insulin-like growth factor-1 concentrations but did not improve nitrogen balance. GH treatment also resulted in increased transferrin and serum albumin levels and total lymphocyte count during the study period. Conclusions: Adjuvant recombinant human GH has no effect on nitrogen balance in highly stressed, totally immobilized patients after head or spinal cord injury, but it significantly enhances constitutive serum protein concentrations and other indices of nutritional repletion.	UNIV TENNESSEE,CTR HLTH SCI,DEPT SURG,MEMPHIS,TN 38163; UNIV TENNESSEE,CTR HLTH SCI,DEPT CLIN PHARM,MEMPHIS,TN 38163								BROWN RO, 1990, J AM COLL NUTR, V9, P523; CARRICO CJ, 1986, ARCH SURG-CHICAGO, V121, P196; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; Cuthbertson DP, 1929, BIOCHEM J, V23, P1328, DOI 10.1042/bj0231328; CUTHBERTSON DP, 1969, MAMMALIAN PROTEIN ME, P373; DAHN MS, 1984, JPEN-PARENTER ENTER, V8, P690, DOI 10.1177/0148607184008006690; FELDMAN Z, 1993, J TRAUMA, V34, P806, DOI 10.1097/00005373-199306000-00010; GATZEN C, 1992, SURGERY, V112, P181; INGENBLEEK Y, 1985, INT J VITAM NUTR RES, V55, P91; JIANG ZM, 1989, ANN SURG, V210, P513, DOI 10.1097/00000658-198910000-00012; KOLPEK JH, 1993, JPEN, V15, P277; KUDSK KA, 1994, ARCH SURG-CHICAGO, V129, P66; MADDAIAH VT, 1973, J BIOL CHEM, V248, P4263; MANSON JM, 1986, SURGERY, V100, P188; MANSON JM, 1988, ANN SURG, V208, P136, DOI 10.1097/00000658-198808000-00002; MARIMEE TJ, 1973, METABOLISM, V22, P1235; NIEDERMAN MS, 1984, ANN INTERN MED, V100, P795, DOI 10.7326/0003-4819-100-6-795; OKAMURA K, 1989, JPEN-PARENTER ENTER, V13, P450, DOI 10.1177/0148607189013005450; PHILLIPS LS, 1980, NEW ENGL J MED, V302, P371, DOI 10.1056/NEJM198002143020704; PHILLIPS LS, 1980, NEW ENGL J MED, V438, P446; PONTING GA, 1988, LANCET, V1, P438, DOI 10.1016/S0140-6736(88)91232-9; RAPAPORT R, 1987, LIFE SCI, V41, P2319, DOI 10.1016/0024-3205(87)90545-5; SOROFF HS, 1967, ANN SURG, V166, P739, DOI 10.1097/00000658-196711000-00002; SOROFF HS, 1967, J TRAUM, V7, P130; STREAT SJ, 1987, J TRAUMA, V27, P262, DOI 10.1097/00005373-198703000-00006; THORSSON AV, 1977, BIOCHEM BIOPH RES CO, V74, P1566, DOI 10.1016/0006-291X(77)90621-0; VARATHORBECK R, 1993, WORLD J SURG, V17, P530, DOI 10.1007/BF01655116; VARATHORBECK R, 1992, HEPATO-GASTROENTEROL, V39, P270; VOERMAN HJ, 1992, ANN SURG, V216, P648, DOI 10.1097/00000658-199212000-00006; WARD HC, 1987, ANN SURG, V206, P56, DOI 10.1097/00000658-198707000-00009; WILMORE DW, 1974, SURG GYNECOL OBSTET, V138, P875; ZIEGLER TR, 1988, ANN SURG, V208, P6, DOI 10.1097/00000658-198807000-00002; ZIEGLER TR, 1990, JPEN-PARENTER ENTER, V14, P574, DOI 10.1177/0148607190014006574	33	20	20	0	0	AMER SOC PARENTERAL & ENTERAL NUTRITION	SILVER SPRING	8630 FENTON STREET SUITE 412, SILVER SPRING, MD 20910	0148-6071			JPEN-PARENTER ENTER	J. Parenter. Enter. Nutr.	JAN-FEB	1995	19	1					41	46		10.1177/014860719501900141			6	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	QA886	WOS:A1995QA88600008	7658599				2022-02-06	
J	PATIR, R; SOOD, S; BHATIA, R				PATIR, R; SOOD, S; BHATIA, R			POSTTRAUMATIC BRAIN-ABSCESS - EXPERIENCE OF 36 PATIENTS	BRITISH JOURNAL OF NEUROSURGERY			English	Article						ABSCESS; CLOSED HEAD INJURY; COMPOUND HEAD INJURY	MANAGEMENT; FRACTURE; WOUNDS	Thirty-six patients with post-traumatic brain abscess were managed over 18 years. They constituted 9.3% of all brain abscesses encountered during the same period. The head injury was associated with an external compound fracture in 20, internal compounding in three and was closed in 13 patients. The mean interval between the time of injury to presentation with an abscess was 113 days. This did not differ significantly in patients with closed and compound head injury, and amongst patients who had wound sepsis and with clean wounds after the injury. The occurrence of focal neurological deficit was more frequent in patients with a dosed injury (p<0.05). Twenty patients underwent primary excision of the abscess with recurrence of the abscess in one patient. Of the 14 patients in whom the abscess was initially aspirated, eight patients required a subsequent excision. Excision was required in 18 patients (94.7%) with external compound injury, five (50%) of those with closed injury and in all patients with internally compound injuries. Two patients had 'coned' and died before they could be operated upon. The operative mortality in the absence of signs of herniation preoperatively was 12.5% in patients with compound injury and none among patients with dosed head injury.	ALL INDIA INST MED SCI,CTR NEUROSCI,DEPT NEUROSURG,NEW DELHI 110029,INDIA								Bhatia R, 1983, Indian J Pediatr, V50, P591, DOI 10.1007/BF02957724; Bhatia R, 1973, Int Surg, V58, P565; BLACK P, 1975, J NEUROSURG, P705; CAIRNS H, 1947, BR J SURG WAR SURG S, V1, P198; CAREY ME, 1971, J NEUROSURG, V34, P145, DOI 10.3171/jns.1971.34.2part1.0145; DETRIBOLET N, 1979, SURG NEUROL, V11, P187; Dinakar I, 1971, J Postgrad Med, V17, P137; Evans W, 1931, LANCET, V1, P1231; EVERETT ED, 1980, NEUROSURGERY, V6, P691; GILLINGHAM FJ, 1947, BR J SURG WAR SURG S, V1, P80; HAGAN RE, 1971, J NEUROSURG, V34, P132, DOI 10.3171/jns.1971.34.2part1.0132; JENNETT B, 1972, J NEUROSURG, V36, P333, DOI 10.3171/jns.1972.36.3.0333; LEGG NJ, 1973, BRAIN, V96, P259, DOI 10.1093/brain/96.2.259; MAMPALAM TJ, 1988, NEUROSURGERY, V23, P451, DOI 10.1227/00006123-198810000-00008; MEIROWSKY AM, 1965, NEUROLOGICAL SURGYER; MOSKOPP D, 1985, NEUROCHIRURGIA, V28, P147; RATH SA, 1989, CHILD NERV SYST, V5, P121, DOI 10.1007/BF00571124; SANDERMANN J, 1986, CHILD NERV SYST, V2, P49, DOI 10.1007/BF00274036; WEBSTER JE, 1950, SURG GYNECOL OBSTET, V90, P209; YANG SY, 1981, J NEUROSURG, V55, P794, DOI 10.3171/jns.1981.55.5.0794	20	20	20	0	0	CARFAX PUBL CO	ABINGDON	PO BOX 25, ABINGDON, OXON, ENGLAND OX14 3UE	0268-8697			BRIT J NEUROSURG	Br. J. Neurosurg.		1995	9	1					29	35					7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	QQ175	WOS:A1995QQ17500005	28168911				2022-02-06	
J	BRAZZELLI, M; COCCHINI, G; DELLASALA, S; SPINNLER, H				BRAZZELLI, M; COCCHINI, G; DELLASALA, S; SPINNLER, H			ALZHEIMER PATIENTS SHOW A SENSITIVITY DECREMENT OVER TIME ON A TONIC ALERTNESS TASK	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article							CLOSED-HEAD-INJURY; SUSTAINED-ATTENTION; DIVIDED ATTENTION; WORKING MEMORY; DISEASE; DEMENTIA; DIAGNOSIS; DEFICITS	Tonic alertness was investigated in Alzheimer patients and normal elderly subjects. Sensitivity acid criterion shifts were investigated across 45 min of continuous testing using a high event rate test with very low target probability. Alzheimer patients showed a significant sensitivity decrement over time that was unrelated to dementia severity. These results suggest that tonic alertness is impaired by Alzheimer's disease even in its early stages.	UNIV MILAN,OSPED SAN PAOLO BARONA,NEUROL CLIN 3,I-20142 MILAN,ITALY; MED CTR VERUNO,FDN CLIN LAVORO,DEPT NEUROL,NEUROPSYCHOL UNIT,NOVARA,ITALY; UNIV ABERDEEN,DEPT PSYCHOL,ABERDEEN,SCOTLAND; UNIV MILAN,DEPT NEUROL 3,MILAN,ITALY								ALEXANDER DA, 1973, PSYCHOL REP, V32, P229, DOI 10.2466/pr0.1973.32.1.229; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Bock R. D., 1968, MEASUREMENT PREDICTI; BRAZZELLI M, UNPUB NEUROPSYCHOLOG; BROUWER WH, 1985, CORTEX, V21, P111, DOI 10.1016/S0010-9452(85)80019-8; CAPITANI E, 1988, J GERONTOL, V43, P157; COSSA FM, 1989, NEUROPSYCHOLOGIA, V27, P887, DOI 10.1016/0028-3932(89)90012-2; DAVIES DR, 1984, VARIETIES ATTENTION, P418; Davies DR., 1982, PSYCHOL VIGILANCE; DEESE J, 1955, PSYCHOL REV, V62, P359, DOI 10.1037/h0042393; DELLASALA S, 1986, ITAL J NEUROL SCI, V7, P27, DOI 10.1007/BF02230415; DELLASALA S, 1992, PSYCHOL MED, V22, P885, DOI 10.1017/S0033291700038460; GRADY CL, 1989, ARCH NEUROL-CHICAGO, V46, P317, DOI 10.1001/archneur.1989.00520390083021; Guilford J.P., 1954, PSYCHOMETRIC METHODS, V2d ed; JORM AF, 1986, PSYCHOL MED, V16, P77, DOI 10.1017/S0033291700002567; LANZETTA TM, 1987, HUM FACTORS, V29, P625, DOI 10.1177/001872088702900602; Mackworth J.F., 1970, VIGILANCE ATTENTION; MACKWORTH NH, 1950, MRC268 SPEC REP; Mackworth NH., 1957, ADV SCI, V53, P389; MAYEUX R, 1987, NEUROLOGY, V37, P1130, DOI 10.1212/WNL.37.7.1130; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nebes R. D., 1992, HDB AGING COGNITION, P373; NEBES RD, 1989, CORTEX, V25, P305, DOI 10.1016/S0010-9452(89)80045-0; NEBES RD, 1993, CORTEX, V29, P77, DOI 10.1016/S0010-9452(13)80213-4; NESTOR PG, 1991, NEUROPSYCHOLOGIA, V29, P379, DOI 10.1016/0028-3932(91)90026-5; NEUCHTERLEIN KH, 1983, SCIENCE, V220, P327; PARASURAMAN R, 1979, SCIENCE, V205, P924, DOI 10.1126/science.472714; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; PARASURAMAN R, 1989, PSYCHOL AGING, V4, P339, DOI 10.1037/0882-7974.4.3.339; Parasuraman R, 1984, VARIETIES ATTENTION, P243; Parasuraman R, 1985, ATTENTION PERFORM, P493; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI [10.1037/0894-4105.7.3.242, DOI 10.1037/0894-4105.7.3.242]; Parasuraman R, 1977, VIGILANCE THEORY OPE, P559; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Posner, 1978, CHRONOMETRIC EXPLORA; Posner M.I., 1975, HDB PSYCHOBIOLOGY, P441, DOI [DOI 10.1016/B978-0-12-278656-3.50019-3, 10.3758/BF03333099, DOI 10.3758/BF03333099]; SALMASO D, 1982, PERCEPT MOTOR SKILL, V55, P127; SPINNLER H, 1988, J NEUROL, V235, P258, DOI 10.1007/BF00314172; SPINNLER H, 1991, HDB NEUROPSYCHOLOGY, V5, P79; VANZOMEREN AH, 1981, REACTION TIME ATTENT, P69	41	20	20	0	3	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	1380-3395			J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	DEC	1994	16	6					851	860		10.1080/01688639408402698			10	Psychology, Clinical; Clinical Neurology; Psychology	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology; Neurosciences & Neurology	PV080	WOS:A1994PV08000004	7890820				2022-02-06	
J	DIAMOND, BJ; VALENTINE, T; MAYES, AR; SANDEL, ME				DIAMOND, BJ; VALENTINE, T; MAYES, AR; SANDEL, ME			EVIDENCE OF COVERT RECOGNITION IN A PROSOPAGNOSIC PATIENT	CORTEX			English	Article							UNDERSTANDING FACE RECOGNITION; FACIAL RECOGNITION; OVERT RECOGNITION; AGNOSIA; DISSOCIATION; FAMILIAR	This is a case-study of a patient (ET) who suffers from prosopagnosia, in the context of impairment to cognitive functions, following traumatic brain injury. Despite severe perceptual difficulties in tests involving non-face stimuli and matching unfamiliar faces, ET showed evidence of ''covert'' recognition of familiar faces in a number of tasks. Although densely prosopagnosic, she performed at normal levels in word and object recognition tasks, and is unimpaired in her ability to recognise names of celebrities. She performed at the same level as controls in her ability to make a forced-choice of the correct name for a famous face, even though it evoked no feeling of familiarity for her. She performed at chance in a forced-choice face familiarity decision task, but showed evidence of covert recognition in a ''true'' versus ''untrue'' face-name learning task. ET showed overt recognition of some famous faces using a procedure based on Sergent and Poncet's (1990) semantic activation task. The pattern of impariment of ET's face processing abilities is interpreted in terms of an interactive activation model of face processing.	UNIV DURHAM,DEPT PSYCHOL,DURHAM DH1 3LE,ENGLAND; UNIV LIVERPOOL,DEPT PSYCHOL,LIVERPOOL L69 3BX,ENGLAND; UNIV PENN,DEPT REHABIL MED,DIV NEUROREHABIL,PHILADELPHIA,PA		DIAMOND, BJ (corresponding author), KESSLER INST REHABIL,DEPT RES,PLEASANT VALLEY WAY,W ORANGE,NJ 07052, USA.		Valentine, Tim/A-5761-2012	Valentine, Tim/0000-0001-6049-6229			Bauer R.M., 1986, ASPECTS FACE PROCESS, P253, DOI 10.1007/978-94-009-4420-6_27.; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; BENTON A, 1990, CORTEX, V26, P491, DOI 10.1016/S0010-9452(13)80299-7; Benton A.L., 1983, CONTRIBUTIONS NEUROP; BENTON AL, 1980, AM PSYCHOL, V35, P176, DOI 10.1037/0003-066X.35.2.176; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BRUYER R, 1983, BRAIN COGNITION, V2, P257, DOI 10.1016/0278-2626(83)90014-3; BRUYER R, 1991, BRAIN COGNITION, V15, P223, DOI 10.1016/0278-2626(91)90027-6; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; BURTON AM, 1990, BRIT J PSYCHOL, V81, P361, DOI 10.1111/j.2044-8295.1990.tb02367.x; BURTON AM, 1993, IN PRESS BRIT J PSYC; CAMPBELL R, 1986, BRAIN, V109, P509, DOI 10.1093/brain/109.3.509; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; DAMASIO AR, 1985, TRENDS NEUROSCI, V8, P132, DOI 10.1016/0166-2236(85)90051-7; De Haan E. H., 1991, EUROPEAN J COGNITIVE, V3, P51, DOI DOI 10.1080/09541449108406219; DEHAAN EHF, 1987, COGN NEUROPSYCHOL, V4, P385, DOI 10.1080/02643298708252045; DEHAAN EHF, 1991, BRAIN, V114, P2575, DOI 10.1093/brain/114.6.2575; DEHAAN EHF, 1987, CORTEX, V23, P309, DOI 10.1016/S0010-9452(87)80041-2; DERENZI E, 1986, NEUROPSYCHOLOGIA, V24, P385; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; Ekman P, 1975, UNMASKING FACE; FLUDE BM, 1993, IN PRESS BRAIN COGNI; KURUCZ J, 1979, J AM GERIATR SOC, V27, P225, DOI 10.1111/j.1532-5415.1979.tb06037.x; LANDIS T, 1988, BRAIN, V111, P1287, DOI 10.1093/brain/111.6.1287; MALONE DR, 1982, J NEUROL NEUROSUR PS, V45, P820, DOI 10.1136/jnnp.45.9.820; MEADOWS JC, 1974, J NEUROL NEUROSUR PS, V37, P489, DOI 10.1136/jnnp.37.5.489; NEWCOMBE F, 1989, NEUROPSYCHOLOGIA, V27, P179, DOI 10.1016/0028-3932(89)90170-X; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; SERGENT J, 1990, BRAIN, V113, P989, DOI 10.1093/brain/113.4.989; SHUTTLEWORTH EC, 1982, BRAIN COGNITION, V1, P302, DOI DOI 10.1016/0278-2626(82)90031-8; Valentine T., 1991, EUROPEAN J COGNITIVE, V3, P147, DOI DOI 10.1080/09541449108406224; WALLACE MA, 1992, J COGNITIVE NEUROSCI, V4, P150, DOI 10.1162/jocn.1992.4.2.150; Young A. W, 1989, HDB RES FACE PROCESS; YOUNG AW, 1988, COGNITIVE NEUROPSYCH, V5, P317, DOI 10.1080/02643298808252938; YOUNG AW, 1991, NEUROPSYCHOLOGY CONS	35	20	21	1	7	MASSON DIVISIONE PERIODICI	MILAN	VIA FRATELLI BRESSAN 2, 20126 MILAN, ITALY	0010-9452			CORTEX	Cortex	SEP	1994	30	3					377	393		10.1016/S0010-9452(13)80336-X			17	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	PH095	WOS:A1994PH09500002	7805381				2022-02-06	
J	HEYER, NJ; FRANKLIN, GM				HEYER, NJ; FRANKLIN, GM			WORK-RELATED TRAUMATIC BRAIN INJURY IN WASHINGTON-STATE, 1988 THROUGH 1990	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							HEAD-INJURY	Objectives. Brain trauma is a major cause of disability in the United States, especially among young adults. Work-related brain trauma cases represent a subpopulation that may be amenable to intervention efforts, but largely because of unavailability of data, this group has not previously been studied. Methods. Washington State workers' compensation data were used to identify brain trauma cases and to describe incidence rates with respect to age, gender, and industrial classification. Cause of injury was evaluated for industrial classifications with numerous cases. Results. Washington State workers experienced 301 brain traumas over a 3-year period (9.4/100000 full-time-equivalent workers per year). One third of all traumatic brain injury claims were concentrated among seven industrial classifications, Cause of injury was highly correlated with specific industrial classifications. Conclusions. This study demonstrates the usefulness of diagnosis-related group codes to identify cases of traumatic brain injury. These injuries are concentrated among a few industries, with a dominant specific cause for each industry. This suggests that intervention methods may be efficiently introduced to reduce traumatic brain injuries in the workplace.	UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,DEPT ENVIRONM HLTH,SEATTLE,WA 98103; UNIV WASHINGTON,SCH MED NEUROL,SEATTLE,WA 98195; WASHINGTON STATE DEPT LABOR & IND,OLYMPIA,WA								ANNEGERS JF, 1980, NEUROLOGY, V30, P912, DOI 10.1212/WNL.30.9.912; BRESLOW NE, 1987, STATISTICAL METHODS, V2, P91; EDNA TH, 1984, SCAND J SOC MED, V12, P7, DOI 10.1177/140349488401200103; FIFE D, 1986, AM J PUBLIC HEALTH, V76, P773, DOI 10.2105/AJPH.76.7.773; FRANKLIN GM, 1991, AM J PUBLIC HEALTH, V81, P741, DOI 10.2105/AJPH.81.6.741; HEYER NJ, 1992, AM J PUBLIC HEALTH, V82, P557, DOI 10.2105/AJPH.82.4.557; JAMESON KG, 1974, AUST NZ J SURG, V44, P241; JENNETT B, 1977, Lancet, V2, P696; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KERR TA, 1971, BRIT J PREV SOC MED, V25, P179; KLONOFF H, 1969, CAN MED ASSOC J, V100, P235; KRAUS JF, 1985, J OCCUP ENVIRON MED, V27, P757; KRAUS JF, 1991, NEUROEPIDEMIOLOGY TR, P333; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; STEADMAN JH, 1970, P ROY SOC MED, V63, P23, DOI 10.1177/003591577006300109; TANAKA S, 1988, J OCCUP ENVIRON MED, V30, P488, DOI 10.1097/00043764-198806000-00010	16	20	20	0	1	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	1015 FIFTEENTH ST NW, WASHINGTON, DC 20005	0090-0036			AM J PUBLIC HEALTH	Am. J. Public Health	JUL	1994	84	7					1106	1109		10.2105/AJPH.84.7.1106			4	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	PB870	WOS:A1994PB87000011	8017533	Bronze, Green Published			2022-02-06	
J	NEISTADT, ME				NEISTADT, ME			A MEAL PREPARATION TREATMENT PROTOCOL FOR ADULTS WITH BRAIN INJURY	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						ACTIVITIES OF DAILY LIVING; BRAIN INJURIES; INDEPENDENT LIVING SKILLS	OCCUPATIONAL-THERAPY; PERCEPTUAL DEFICITS	Adults with acquired brain injury often demonstrate dysfunction in meal preparation due to deficits in component cognitive-perceptual skills. Although occupational therapy for these clients routinely includes meal preparation training, there are no protocols in the occupational therapy literature to help structure that activity to address clients' cognitive-perceptual deficits. This paper describes a meal preparation treatment protocol based on cognitive-perceptual information processing theory that has been pilot tested in a treatment outcome study with adult men with traumatic or anoxic acquired brain injury. In that study, the group of 23 subjects treated with this meal preparation protcol showed significant improvement in their meal preparation skill, as measured by the Rabideau Kitchen Evaluation-Revised (RKE-R), a test of meal preparation skill, and in their cognitive-perceptual skill, as measured by the WAIS-R Block Design Test. The treatment protocol includes descriptions of the structure, grading, and cuing methods for light meal preparation activities.			NEISTADT, ME (corresponding author), UNIV NEW HAMPSHIRE,SCH HLTH & HUMAN SERV,DEPT OCCUPAT THERAPY,DURHAM,NH 03824, USA.						ABREU BC, 1987, AM J OCCUP THER, V41, P439, DOI 10.5014/ajot.41.7.439; BEN-YISHAY Y, 1970, Journal of Abnormal Psychology, V76, P378, DOI 10.1037/h0030404; Ben-Yishay Y, 1974, Cortex, V10, P121; BENYISHAY Y, 1970, J ABNORM PSYCHOL, V75, P248, DOI 10.1037/h0029368; FLEISHMAN EA, 1963, J EXP PSYCHOL, V66, P6, DOI 10.1037/h0046677; Hopkins H. L., 1993, WILLARD SPACKMANS OC; KANTOWITZ BH, 1980, THEOR LEARN, P332; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; NEISTADT ME, 1990, AM J OCCUP THER, V44, P299, DOI 10.5014/ajot.44.4.299; NEISTADT ME, 1992, OCCUP THER J RES, V12, P242, DOI 10.1177/153944929201200404; NEISTADT ME, 1993, AM J OCCUP THER, V47, P154, DOI 10.5014/ajot.47.2.154; NEISTADT ME, 1992, AM J OCCUP THER, V46, P141, DOI 10.5014/ajot.46.2.141; NEISTADT ME, 1988, AM J OCCUP THER, V42, P434, DOI 10.5014/ajot.42.7.434; NEISTADT ME, 1994, AM J OCCUP THER, V48, P62, DOI 10.5014/ajot.48.1.62; NEISTADT ME, 1989, AM J OCCUP THER, V43, P448, DOI 10.5014/ajot.43.7.448; NEISTADT ME, 1991, OCCUPATIONAL THERAPY; Pedretti LW., 1990, OCCUPATIONAL THERAPY, V3rd; RABIDEAU GM, 1986, THESIS TUFTS U MEDFO; Singer R. N., 1985, QUEST, V37, P103, DOI [DOI 10.1080/00336297.1985.10483824, 10.1080/00336297.1985.10483824]; TOGLIA JP, 1991, AM J OCCUP THER, V45, P505, DOI 10.5014/ajot.45.6.505; Trombly C., 1989, OCCUPATIONAL THERAPY; ZOLTAN B, 1986, PERCEPTUAL COGNITIVE	22	20	20	1	5	AMER OCCUPATION THERAPY ASSN	ROCKVILLE	1383 PICCARD DRIVE PO BOX ROCKVILLE, MD 20850-4375	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	MAY	1994	48	5					431	438		10.5014/ajot.48.5.431			8	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	NF247	WOS:A1994NF24700006	8042686				2022-02-06	
J	ADESUNKANMI, K; OYELAMI, OA				ADESUNKANMI, K; OYELAMI, OA			THE PATTERN AND OUTCOME OF BURN INJURIES AT WESLEY-GUILD-HOSPITAL, ILESHA, NIGERIA - A REVIEW OF 156 CASES	JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article						BURN INJURIES; PATTERN AND OUTCOME	INFECTION; PATIENT; HONEY; UNIT	A review of 156 patients with burn injuries admitted over a 5-year period (January 1988-December 1992) at Wesley Guild Hospital, Ilesha, was undertaken. The male:female ratio was 1.6:1. About 70% of the cases were between 1 and 10 years of age (mean 9 years). Scalds were responsible for 50.6% of the cases while naked flames, including kerosine explosion and burns at road traffic accidents, were responsible for 43.5%. Seventy-one per cent were due to domestic accidents. The burns were categorized as major in 70% of cases. The trunk accounted for 56.4% of anatomical areas involved, upper limbs 51.3%, lower limbs 48%, while head and neck accounted for 28.8%. Open dressings were used in 70.5% of the cases, combined open and closed dressings in 22.4% and closed dressings in 10.3%. In about 90% of cases, silver sulphadiazine was used as a topical antimicrobial agent while natural honey was used on the rest. Wound infection was the commonest complication occurring in 24.4%, while mortality was recorded in 7.7% of cases.	OBAFEMI AWOLOWO UNIV, COLL HLTH SCI, DEPT PAEDIAT, IFE, NIGERIA		ADESUNKANMI, K (corresponding author), OBAFEMI AWOLOWO UNIV, COLL HLTH SCI, DEPT SURG, IFE, NIGERIA.						AKHTAR M, 1981, BURNS, V7, P1; BANERJEE AK, 1991, BRIT J SURG, V78, P248, DOI 10.1002/bjs.1800780240; BANG RL, 1988, BURNS, V14, P194, DOI 10.1016/0305-4179(88)90038-1; BURKE JF, 1991, ARCH SURG-CHICAGO, V126, P677; CHAURASIA AR, 1982, BURNS, V9, P184; CIOFFI WG, 1991, ARCH SURG-CHICAGO, V126, P74; DEMLING RH, 1985, NEW ENGL J MED, V313, P1389, DOI 10.1056/NEJM198511283132205; EFEM SEE, 1988, BRIT J SURG, V75, P679, DOI 10.1002/bjs.1800750718; HEGAZY MM, 1991, ANN SAUDI MED, V11, P255, DOI 10.5144/0256-4947.1991.255; MCMANUS AT, 1985, ARCH SURG-CHICAGO, V120, P217; MUIR IFK, 1978, CURRENT SURGICAL PRA, V2, P230; Oluwasanmi J O, 1969, Br J Plast Surg, V22, P216, DOI 10.1016/S0007-1226(69)80110-4; OLUWASANMI JO, 1989, PRINCIPLE PRACTICE S, P160; OLUWASANMI JO, 1979, PLASTIC SURGERY TROP, P44; PRUITT BA, 1990, BRIT J SURG, V77, P1081, DOI 10.1002/bjs.1800771002; PURDUE GF, 1985, J TRAUMA, V25, P216, DOI 10.1097/00005373-198503000-00008; SOWEMIMO GOA, 1982, BURNS, V9, P280; SUBRAHMANYAM M, 1991, BRIT J SURG, V78, P497, DOI 10.1002/bjs.1800780435	18	20	21	0	7	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0022-5304			J TROP MED HYG	J. Trop. Med. Hyg.	APR	1994	97	2					108	112					5	Public, Environmental & Occupational Health; Tropical Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Tropical Medicine	NF895	WOS:A1994NF89500009	8170000				2022-02-06	
J	GALSKI, T; PALASZ, J; BRUNO, RL; WALKER, JE				GALSKI, T; PALASZ, J; BRUNO, RL; WALKER, JE			PREDICTING PHYSICAL AND VERBAL AGGRESSION ON A BRAIN TRAUMA UNIT	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							MINI-MENTAL STATE; CLOSED HEAD-INJURY; PRACTICAL SCALE; RELIABILITY; DEMENTIA; ORIENTATION; INSTRUMENTS; IMPAIRMENT; PHENYTOIN		UMDNJ, NEW JERSEY MED SCH, NEWARK, NJ USA		GALSKI, T (corresponding author), KESSLER INST REHABIL, BRAIN INJURY PROGRAM, 240 CENT AVE, E ORANGE, NJ 07018 USA.		BRUNO, RISELANE DE LUCENA ALCANTARA/AAX-7486-2021	BRUNO, RISELANE DE LUCENA ALCANTARA/0000-0002-4206-6417			ANTHONY JC, 1982, PSYCHOL MED, V12, P397, DOI 10.1017/S0033291700046730; BIRD HR, 1987, J NERV MENT DIS, V175, P731, DOI 10.1097/00005053-198712000-00005; BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; Brooks D N, 1979, Int Rehabil Med, V1, P160; CORRIGAN JD, 1988, ARCH PHYS MED REHAB, V69, P487; DENNYBROWN D, 1945, JAMA-J AM MED ASSOC, V127, P429, DOI 10.1001/jama.1945.02860080001001; DICK JPR, 1984, J NEUROL NEUROSUR PS, V47, P496, DOI 10.1136/jnnp.47.5.496; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; FILLENBAUM GG, 1987, ARCH NEUROL-CHICAGO, V44, P924, DOI 10.1001/archneur.1987.00520210026014; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; Holland N J, 1988, Rehabil Nurs, V13, P244; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; Johnston MarkV., 1992, NEUROREHABILITATION, V2, P72; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; LESHER EL, 1986, J CONSULT CLIN PSYCH, V54, P726, DOI 10.1037/0022-006X.54.5.726; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; MASSAGLI TL, 1991, ARCH PHYS MED REHAB, V72, P219; MCCULLA MM, 1989, ARCH NEUROL-CHICAGO, V46, P1210, DOI 10.1001/archneur.1989.00520470070029; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NELSON A, 1986, J NERV MENT DIS, V174, P73, DOI 10.1097/00005053-198602000-00002; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Ozuna J, 1985, J Neurosurg Nurs, V17, P66; PRUITT AW, 1985, PEDIATRICS, V76, P644; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; UOMOTO JM, 1992, ARCH PHYS MED REHAB, V73, P674; WILKINSON L, 1990, SYSTAT SYSTEM STATIS; WILLIAMS JM, 1987, COGNITIVE BEHAVIOR R; ZILLMER EA, 1989, STAFF RES PHYS, V35, P79	32	20	20	0	5	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	1994	75	4					380	383		10.1016/0003-9993(94)90158-9			4	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	NH535	WOS:A1994NH53500002	8172494				2022-02-06	
J	FRICKER, R; GACHTER, A				FRICKER, R; GACHTER, A			LATERAL FLEXION EXTENSION RADIOGRAPHS - STILL RECOMMENDED FOLLOWING CERVICAL SPINAL-INJURY	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article							CORD CONCUSSION	We present the case of a patient who sustained a cervical spinal injury and subsequent transient quadriplegia with full recovery from the spinal cord concussion. Initial plain X-ray films and magnetic resonance imaging did not show any pathological findings, but lateral radiographs in flexion and extension performed 10 days later revealed a fracture of the C4 spinous process without ligamentous instability, confirming significant injury to the cervical spine.			FRICKER, R (corresponding author), UNIV BASEL,KANTONSSPITAL,DEPT SURG,DIV ORTHOPED & TRAUMA SURG,CH-4031 BASEL,SWITZERLAND.						DELBIGIO MR, 1989, SPINE, V14, P37, DOI 10.1097/00007632-198901000-00007; HIRSH LF, 1991, J NEUROSURG, V75, P131, DOI 10.3171/jns.1991.75.1.0131; TORG JS, 1986, J BONE JOINT SURG AM, V68A, P1354, DOI 10.2106/00004623-198668090-00008; ZWIMPFER TJ, 1990, J NEUROSURG, V72, P894, DOI 10.3171/jns.1990.72.6.0894	4	20	20	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	FEB	1994	113	2					115	116		10.1007/BF00572919			2	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	MY878	WOS:A1994MY87800015	8186047				2022-02-06	
J	SCHALEN, W; NORDSTROM, G; NORDSTROM, CH				SCHALEN, W; NORDSTROM, G; NORDSTROM, CH			ECONOMIC-ASPECTS OF CAPACITY FOR WORK AFTER SEVERE TRAUMATIC BRAIN-LESIONS	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; REHABILITATION	During 1981-84310 patients with severe traumatic brain lesions were treated at the Department of Neurosurgery in Lund, Sweden. A total of 161 patients were treated after the introduction of a more aggressive management protocol in 1983. In this first part of a long-term follow-up study we concentrate on the economic aspects. Two questions were addressed: first, what was the vocational outcome after severe head injuries? and second, what were the long-term effects of the new protocol? Out of 147 patients classified as good recovery/moderate disability (GR/MD) 6-months after injury, 106 patients agreed to participate in the study. Five to 8 years after injury 70 patients were classified as capable of working: 57 of these patients were actually at work, nine were studying and four were unemployed. Twenty-two patients had received disability pension and 14 patients had retired because of old age. In the age groups up to 60 years, 70% of patients had returned to work or school. The number of patients who returned to work was significantly higher after introduction of the more aggressive management protocol: 38 of 57 patients who had returned to work were in the group treated between 1983 and 1984. Mean income for patients who had returned to work was close to the average for the corresponding age groups in Sweden. Mean sick leave 5-8 years after severe head injuries was only slightly higher than average in Sweden. Our data show that a majority of the patients classified as GR/MD 6 months after severe traumatic brain lesions have the capacity to return to work. The improvements in the primary management of patients with severe head injuries introduced in 1983 increased the number of patients who work and thus increased the number of patients who favourably contributed to the economy of the community.	UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT PSYCHIAT,S-22185 LUND,SWEDEN								BENGTSSON K, 1990, OPINIONS SWEDISH NAT, V5; Bond M R, 1975, Ciba Found Symp, P141; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; HEISKANEN O, 1970, ACTA NEUROL SCAND, V46, P343, DOI 10.1111/j.1600-0404.1970.tb05798.x; HUMPHREY M, 1980, INJURY, V12, P107, DOI 10.1016/0020-1383(80)90133-3; JENNETT B, 1975, LANCET, V1, P480; LEWIN W, 1968, BMJ-BRIT MED J, V1, P465, DOI 10.1136/bmj.1.5590.465; LUNDBERG N, 1960, ACTA PSYCHIATRICA  S, V149, P1; MELLARGARD P, 1990, J SWEDISH MED ASS, V87, P1348; MESSETER K, 1986, J NEUROSURG, V64, P231, DOI 10.3171/jns.1986.64.2.0231; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; Nordstrom C H, 1989, Brain Inj, V3, P267, DOI 10.3109/02699058909029640; Nordstrom C H, 1989, Brain Inj, V3, P247, DOI 10.3109/02699058909029639; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; SCHALEN W, BRAIN INJURY, V8, P49; Sundbarg G, 1989, Brain Inj, V3, P283, DOI 10.3109/02699058909029641; SUNDBARG G, 1987, J NEUROSURG, V67, P841, DOI 10.3171/jns.1987.67.6.0841; SUNDBARG G, 1989, BRIT J NEUROSURG, V2, P485; UZZELL BP, 1987, SURG NEUROL, V27, P419, DOI 10.1016/0090-3019(87)90247-3; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; 1990, BE20 SM9002 STAT SWE, P15	21	20	21	0	1	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1994	8	1					37	47		10.3109/02699059409150957			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MQ291	WOS:A1994MQ29100005	8124316				2022-02-06	
J	MILLER, L				MILLER, L			FAMILY-THERAPY OF BRAIN INJURY - SYNDROMES, STRATEGIES, AND SOLUTIONS	AMERICAN JOURNAL OF FAMILY THERAPY			English	Article							SEVERE HEAD-INJURY; MOOD DISORDERS; DEPRESSION; MANAGEMENT; RELATIVES; DIAGNOSIS; DAMAGE	Brain injury presents the family therapist with some unique problems and challenges. This paper describes the effects that the brain-injured patient may be expected to have on the family system and the kinds of reactions typically seen in the family members. It then describes strategies of family therapy in brain injury, including education, supportive counseling, and more intensive family therapy modalities. Finally, the paper closes with some thoughts on the goals and outcomes of family therapy with this group and recommendations for improving the family therapy process.									BENSON DF, 1977, APHASIA ASSESSMENT T; BOND MR, 1984, CLOSED HEAD INJURY P, P148; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; BROOKS N, 1984, CLOSED HEAD INJURY P, P123; Doherty W.J., 1992, MED FAMILY THERAPY B; FAHY TJ, 1967, LANCET, V2, P475; GALASKO CSB, 1974, INJURY, V6, P107, DOI 10.1016/0020-1383(74)90004-7; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; JAMIESON KG, 1971, HEAD INJURIES, P12; LEFTOFF S, 1983, J CLIN NEUROPSYCHOL, V5, P51, DOI 10.1080/01688638308401150; LEZAK MD, 1988, J CLIN EXP NEUROPSYC, V10, P111, DOI 10.1080/01688638808405098; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; LONDON P S, 1967, Annals of the Royal College of Surgeons of England, V41, P460; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; McKinlay WW, 1988, J HEAD TRAUMA REHAB, p[3, 64]; McLaughlin A. M., 1985, COGNITIVE REHABILITA, V3, P14; MILLER L, 1992, INT J LAW PSYCHIAT, V15, P303, DOI 10.1016/0160-2527(92)90005-L; Miller L., 1990, COGN REHABIL, V8, P14; MILLER L, 1989, COGNITIVE REHABILITA, V7, P26; MILLER L, 1990, PSYCHOTHERAPY PRIVAT, V8, P12; MILLER L, 1993, PSYCHOTHERAPY BRAIN; MILLER L, 1991, J COGNITIVE REHABILI, V9, P24; MILLER L, 1990, COGNITIVE REHABILITA, V8, P12; MILLER L, 1990, INNER NATURES BRAIN; MILLER L, 1992, J COGNITIVE REHABILI, V10, P14; ODDY M, 1980, J NEUROL NEUROSUR PS, V43, P798, DOI 10.1136/jnnp.43.9.798; Panting A, 1972, REHABILITATION, V38, P33; PARKER R, 1990, TRAUMATIC BRAIN INJU; PASNAU RO, 1981, FAMILY THERAPY MAJOR, P301; POTTER JM, 1967, POSTGRAD MED J, V43, P574, DOI 10.1136/pgmj.43.503.574; ROBINSON RG, 1985, PSYCHOSOMATICS, V26, P769, DOI 10.1016/S0033-3182(85)72790-9; ROBINSON RG, 1984, BRAIN, V107, P81, DOI 10.1093/brain/107.1.81; ROBINSON RG, 1986, HOSP PRACT, V21, P83; ROMANO MD, 1974, SCAND J REHABIL MED, V6, P1; ROSENBAUM A, 1989, AM J PSYCHIAT, V146, P1048; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; Rosenthal M, 1988, J HEAD TRAUMA REHAB, V3, P42; ROSS ED, 1981, ARCH NEUROL-CHICAGO, V38, P561, DOI 10.1001/archneur.1981.00510090055006; ROSS ED, 1981, ARCH GEN PSYCHIAT, V38, P1344; ROSS ED, 1987, J NERV MENT DIS, V175, P165, DOI 10.1097/00005053-198703000-00007; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; Thomsen I V, 1974, Scand J Rehabil Med, V6, P180; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	45	20	20	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0192-6187	1521-0383		AM J FAM THER	Am. J. Fam. Ther.	SUM	1993	21	2					111	121		10.1080/01926189308250910			11	Psychology, Clinical; Family Studies	Social Science Citation Index (SSCI)	Psychology; Family Studies	LK370	WOS:A1993LK37000002					2022-02-06	
J	KAUFMAN, HH				KAUFMAN, HH			HISTORICAL VIGNETTE - TREATMENT OF HEAD-INJURIES IN THE AMERICAN CIVIL-WAR	JOURNAL OF NEUROSURGERY			English	Article						HEAD INJURY; GUNSHOT WOUND; NEUROSURGICAL HISTORY; INFECTION		At the time of the American Civil War (1861-1865), a great deal was known about closed head injury and gunshot wounds to the head. Compression was differentiated from concussion, but localization of lesion's was not precise. Ether and especially chloroform were used to provide anesthesia. Failure to understand how to prevent infection discouraged physicians from aggressive surgery. Manuals written to educate inexperienced doctors at the onset of the war provide an overview of the advice given by senior surgeons. The Union experiences in the treatment of head injury in the Civil War were discussed in the three surgical volumes of The Medical and Surgical History of the War of the Rebellion. Wounds were divided into incised and puncture wounds, blunt injuries, and gunshot wounds, which were analyzed separately. Because the patients were not stratified by severity of injury and because there was no neuroimaging, it is difficult to understand the clinical problems and the effectiveness of surgery. Almost immediately after the war, increased knowledge about cerebral localization and the development of antisepsis (and then asepsis) permitted the development of modern neurosurgery.			KAUFMAN, HH (corresponding author), W VIRGINIA UNIV,MED CTR,SCH MED,DEPT NEUROSURG,MORGANTOWN,WV 26506, USA.						Adams George Worthington, 1952, DOCTORS BLUE MED HIS; CHISOLM JJ, 1861, MANUAL MILITARY SURG, P237; Coco Gregory A., 1988, VAST SEA MISERY HIST; Cunningham H. H, 1958, DOCTORS GRAY CONFEDE; DAMMANN G, 1988, PICTORIAL ENCY CIVIL, V2; DAMMANN G, 1983, PICTORIAL ENCY CIVIL, V1; DONAHUE MP, 1985, NURSING FINEST ART; FORMENTO F, 1963, NOTES OBSERVATIONS A, P37; GILLETT MC, 1987, ARMY MED DEPT 1818 1; GROSS SD, 1859, SYSTEM SURGERY PATHO, V2, P254; GROSS SD, 1861, MANUAL MILITARY SURG, P98; Guthrie GJ, 1842, INJURIES HEAD AFFECT; HALL COURTNEY R., 1952, BULL HIST MED, V26, P231; HAMILTON FH, 1864, AM MED TIMES    0213, P73; HAMILTON FH, 1864, AM MED TIMES    0227, P97; HAMILTON FH, 1864, AM MED TIMES    0206, P61; HAMILTON FH, 1864, AM MED TIMES    0220, P85; HAMILTON FH, 1861, PRACTICAL TREATISE M, P152; HAMILTON FH, 1865, TREATISE MILITARY SU, P228; HOGG IV, 1985, ILLUSTRATED ENCY AMM; KEEN WW, 1922, BOSTON MED SURG J, V187, P592; MAHER MD, 1989, BLIND WOUNDS CATHOLI; MCAULAY JD, 1987, CIVIL WAR BREECH LOA; MCLEOD GHB, 1858, NOTES SURGERY WAR CR; Middleton W S, 1966, Bull Hist Med, V40, P14; Mitchell Silas Weir, 1905, T COLL PHYS PHILA, V27, P87; Paget S., 1920, V HORSLEY STUDY HIS; SMITH S, 1862, HDB SURGICAL OPERATI, P237; THOMPSON CJS, 1942, HIST EVOLUTION SURGI; TRIPLER CS, 1861, HDB MILITARY SURGEON, P90; WARREN E, 1863, EPITOME PRACTICAL SU, P1369; ZELLEM RT, 1985, NEUROSURGERY, V17, P850, DOI 10.1227/00006123-198511000-00024; 1870, MED SURGICAL HIST WA, V1; 1877, MED SURGICAL HIST WA, V2; 1883, MED SURGICAL HIST WA, V3; 1863, MANUAL MILITARY SURG, P49	36	20	20	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	MAY	1993	78	5					838	845		10.3171/jns.1993.78.5.0838			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Neurosciences & Neurology; Surgery	KY468	WOS:A1993KY46800024	8468618				2022-02-06	
J	WAALAND, PK; BURNS, C; COCKRELL, J				WAALAND, PK; BURNS, C; COCKRELL, J			EVALUATION OF NEEDS OF HIGH-INCOME AND LOW-INCOME FAMILIES FOLLOWING PEDIATRIC TRAUMATIC BRAIN INJURY	BRAIN INJURY			English	Article							HEAD-INJURIES; CHILDREN; SEQUELAE; ILL	This paper assesses the needs of high- and low-income caregivers shortly after the traumatic brain injury of their child. The Family Needs Questionnaire [1], developed to assess the priorities and satisfaction of needs among family members, was administered to 49 caregivers. Surprisingly, caregivers from both groups displayed similar patterns of priorities and rated their most important needs as met. Caregivers' most important needs included clear information, therapy input, and understanding from professionals and classroom teachers. Personal needs, family support, and fixture patient-related concerns were devalued by both groups. These results are discussed as having implications for identification of high-risk families, treatment goals, and community reintegration needs.	VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,CTR REHABIL RES & TRAINING,CHILDRENS NEUROL SERV,RICHMOND,VA 23298; VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,CHILDRENS HOSP,RICHMOND,VA 23298								Annegers J. F., 1983, PEDIATRIC HEAD TRAUM, P1; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FARBER B, 1959, MONOGRAPHS SOC RES C, V21; FLETCHER JM, IN PRESS J CONSULTIN; GARDNER RA, 1973, FAMILY BOOK MINIMAL; HELM DT, 1986, J AUTISM DEV DISORD, V16, P1, DOI 10.1007/BF01531574; KALSBEEK WD, 1980, J NEUROSURG, V53, P819; Kreutzer J. S., 1988, FAMILY NEEDS QUESTIO; Kreutzer J.S., 1990, COMMUNITY INTEGR TRA, P249; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Marcus LM., 1984, EFFECTS AUTISM FAMIL, P311, DOI [10.1007/978-1-4899-2293-9_18, DOI 10.1007/978-1-4899-2293-9_18]; Mathis M, 1984, J Neurosurg Nurs, V16, P36; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; MCKINNEY B, 1987, J PEDIATR PSYCHOL, V12, P133; MOLTER NC, 1979, HEART LUNG, V8, P332; POLINKO PR, 1985, HEAD INJURY REHABILI, P91; Rosen CD, 1986, HEAD TRAUMA ED REINT; ROSENBAUM M, 1976, J CONSULT CLIN PSYCH, V44, P881, DOI 10.1037/0022-006X.44.6.881; RUTTER M, 1980, PSYCHOL MED, V10, P633, DOI 10.1017/S0033291700054933; RUTTER M, 1983, DEV NEUROPSYCHIATRY, P83; SAVAGE R, 1985, SURVEY TRAUMATICALLY, P1; WAALAND P, 1991, JUN POSTGR COURS REH; WAALAND PK, 1990, COMMUNITY INTEGRATIO, P225; WALLANDER JL, 1989, J PEDIATR PSYCHOL, V14, P157, DOI 10.1093/jpepsy/14.2.157; WEINRAUB M, 1977, HUM DEV, V20, P31, DOI 10.1159/000271546	26	20	20	0	4	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR-APR	1993	7	2					135	146		10.3109/02699059309008167			12	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KZ726	WOS:A1993KZ72600005	8453412				2022-02-06	
J	GOLDSTEIN, FC; MCKENDALL, RR; HAUT, MW				GOLDSTEIN, FC; MCKENDALL, RR; HAUT, MW			GIST RECALL IN MULTIPLE-SCLEROSIS	ARCHIVES OF NEUROLOGY			English	Article							CLOSED-HEAD INJURY; MEMORY DISTURBANCE; IMPAIRMENT; DEFICITS; AMNESIA; DISABILITY; DISEASE; PROSE; UNITS	This study examined gist recall (memory for important story ideas) in patients with multiple sclerosis. Twelve patients with clinically probable or definite multiple sclerosis and 10 neurologically intact control subjects were read prose passages from the Wechsler Memory Scale-Revised Logical Memory subtest. The idea units from these passages contained low, medium, and high information content to the stories. In comparison with the control subjects, the patients recalled fewer total elements over immediate and delayed conditions. However, similar to controls, they recalled more ideas that were of high rather than low or medium importance. These results suggest that semantic sensitivity to important ideas of narratives is a relatively preserved feature in multiple sclerosis.	UNIV TEXAS,MED BRANCH,DEPT NEUROL,GALVESTON,TX 77550; UNIV TEXAS,MED BRANCH,DEPT MICROBIOL,GALVESTON,TX 77550; W VIRGINIA UNIV,MED CTR,SCH MED,DEPT PSYCHIAT,MORGANTOWN,WV 26506; W VIRGINIA UNIV,MED CTR,SCH MED,DEPT NEUROL,MORGANTOWN,WV 26506; W VIRGINIA UNIV,MED CTR,SCH MED,DEPT BEHAV MED,MORGANTOWN,WV 26506; EMORY UNIV,SCH MED,DEPT NEUROL,NEUROBEHAV PROGRAM,ATLANTA,GA 30322		GOLDSTEIN, FC (corresponding author), WESLEY WOODS HLTH CTR,DEPT NEUROL,1841 CLIFTON RD NE,ATLANTA,GA 30329, USA.			Haut, Marc/0000-0003-0235-362X			Bartlett FC, 1932, REMEMBERING; BEATTY WW, 1988, ARCH NEUROL-CHICAGO, V45, P611, DOI 10.1001/archneur.1988.00520300029013; BROWN AL, 1977, CHILD DEV, V48, P1, DOI 10.2307/1128873; CAINE ED, 1986, ARCH NEUROL-CHICAGO, V43, P249, DOI 10.1001/archneur.1986.00520030039009; CARROLL M, 1984, NEUROPSYCHOLOGIA, V22, P297, DOI 10.1016/0028-3932(84)90076-9; FREEDMAN M, 1986, BRAIN COGNITION, V5, P108, DOI 10.1016/0278-2626(86)90063-1; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GRAFMAN J, 1991, ARCH NEUROL-CHICAGO, V48, P1072, DOI 10.1001/archneur.1991.00530220094025; Grafman J, 1990, NEUROBEHAVIORAL ASPE, P102; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; Haut MW, 1991, NEUROPSYCHOLOGY, V5, P81, DOI 10.1037/0894-4105.5.2.81; JOHNSON RE, 1970, J VERB LEARN VERB BE, V9, P12, DOI 10.1016/S0022-5371(70)80003-2; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P281, DOI 10.1001/archneur.1988.00520270059021; LITVAN I, 1988, ARCH NEUROL-CHICAGO, V45, P607, DOI 10.1001/archneur.1988.00520300025012; Moscovitch M., 1982, HUMAN MEMORY AMNESIA, P337; PETERSEN RC, 1991, MEMORY DISORDERS, P457; PREVEY ML, 1988, CORTEX, V24, P301, DOI 10.1016/S0010-9452(88)80038-8; RAO SM, 1989, J CLIN EXP NEUROPSYC, V11, P699, DOI 10.1080/01688638908400926; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1984, ARCH NEUROL-CHICAGO, V41, P625, DOI 10.1001/archneur.1984.04210080033010; RUBIN DC, 1981, INT J NEUROSCI, V13, P81, DOI 10.3109/00207458109043304; SQUIRE LR, 1982, J EXP PSYCHOL LEARN, V8, P560, DOI 10.1037/0278-7393.8.6.560; VANDENBURG W, 1987, ARCH NEUROL-CHICAGO, V44, P494, DOI 10.1001/archneur.1987.00520170024017; Wechsler D, 1987, MEMORY SCALE REVISED; WEINGARTNER H, 1981, J ABNORM PSYCHOL, V90, P187, DOI 10.1037/0021-843X.90.3.187; WEINGARTNER H, 1981, ARCH GEN PSYCHIAT, V38, P42; ZELINSKI EM, 1985, NEW DIRECTIONS AGING, P519	29	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0003-9942			ARCH NEUROL-CHICAGO	Arch. Neurol.	OCT	1992	49	10					1060	1064		10.1001/archneur.1992.00530340080021			5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JR326	WOS:A1992JR32600013	1417514				2022-02-06	
J	MARKIANOS, M; SERETIS, A; KOTSOU, S; BALTAS, I; SACHAROGIANNIS, H				MARKIANOS, M; SERETIS, A; KOTSOU, S; BALTAS, I; SACHAROGIANNIS, H			CSF NEUROTRANSMITTER METABOLITES AND SHORT-TERM OUTCOME OF PATIENTS IN COMA AFTER HEAD-INJURY	ACTA NEUROLOGICA SCANDINAVICA			English	Article						HEAD INJURY; COMA; CSF; METHOXYHYDROXYPHENYLGLYCOL; HOMOVANILLIC ACID; 5-HYDROXYINDOLEACETIC ACID; OUTCOME	CEREBROSPINAL-FLUID; BRAIN; RECOVERY; RELEASE	The main metabolites of the neurotransmitters noradrenalin, dopamin, and serotonin, methoxyhydroxyphenylglycol (MHPG), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5HIAA) respectively, were estimated by HPLC with electrochemical detection in CSF samples from 24 patients in coma after head injury, 1 to 12 (mean 3.0) days from accident, and from 24 age- and sex-matched subjects undergoing myelography for possible herniated disk. Analysis of variance with-age as covariate, revealed significantly elevated levels of all three metabolites in the patients group. The concentrations of 5HIAA were negatively correlated to the score in the Glasgow Coma Scale. Fourteen patients who recovered with no or minor neurological deficits, had significantly lower CSF 5HIAA levels compared to the ten patients who had a bad outcome (death), while there were no differences regarding HVA or MHPG concentrations. The possibility of a connection of the high neurotransmitter turnover during coma to the development of post-traumatic depression is discussed.	ASCLEPEION HOSP,DEPT NEUROSURG,VOULA ATHENS,GREECE		MARKIANOS, M (corresponding author), UNIV ATHENS,EGINIT HOSP,MED SCH,PSYCHIAT CLIN,VAS SOPHIAS 74,GR-11528 ATHENS,GREECE.			Markianos, Manolis/0000-0002-4751-1014			ALTAR CA, 1987, J NEUROCHEM, V48, P390, DOI 10.1111/j.1471-4159.1987.tb04106.x; BUSTO R, 1985, ANN NEUROL, V18, P329, DOI 10.1002/ana.410180310; INAGAWA T, 1980, J NEUROSURG, V52, P635, DOI 10.3171/jns.1980.52.5.0635; JEQUIER E, 1974, SURG NEUROL, V2, P247; MOHABAYED M, 1990, J AFFECT DISORDERS, V19, P237; ODINK J, 1989, ACTA NEUROL SCAND, V80, P6, DOI 10.1111/j.1600-0404.1989.tb03834.x; PAPPIUS HM, 1987, J NEUROCHEM, V49, P321, DOI 10.1111/j.1471-4159.1987.tb03433.x; PAPPIUS HM, 1988, J CEREBR BLOOD F MET, V8, P324, DOI 10.1038/jcbfm.1988.67; WESTER P, 1990, J NEUROCHEM, V54, P1148, DOI 10.1111/j.1471-4159.1990.tb01942.x; WESTER P, 1987, ACTA NEUROL SCAND, V76, P473, DOI 10.1111/j.1600-0404.1987.tb03605.x; YATES CM, 1979, J NEUROL NEUROSUR PS, V42, P887, DOI 10.1136/jnnp.42.10.887; ZHANG WQ, 1988, BRAIN RES, V461, P335, DOI 10.1016/0006-8993(88)90264-8; 1990, BRIT J PHARMACOL, V99, P741	13	20	21	1	2	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	AUG	1992	86	2					190	193		10.1111/j.1600-0404.1992.tb05064.x			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JL205	WOS:A1992JL20500015	1384260				2022-02-06	
J	SCHWINGER, RHG; BOHM, M; LAROSEE, K; SCHMIDT, U; SCHULZ, C; ERDMANN, E				SCHWINGER, RHG; BOHM, M; LAROSEE, K; SCHMIDT, U; SCHULZ, C; ERDMANN, E			NA+-CHANNEL ACTIVATORS INCREASE CARDIAC GLYCOSIDE SENSITIVITY IN FAILING HUMAN MYOCARDIUM	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						CARDIAC GLYCOSIDES; NA+-CHANNEL ACTIVATOR; BDF-9148; HEART FAILURE; POSITIVE INOTROPIC AGENTS; HUMAN MYOCARDIUM	HUMAN VENTRICULAR MYOCARDIUM; SODIUM-CALCIUM EXCHANGE; DPI 201-106; HEART-FAILURE; STROPHANTHIDIN INOTROPY; DILATED CARDIOMYOPATHY; INTRACELLULAR SODIUM; DOWN-REGULATION; PUMP ACTIVITY; MUSCLE	Na+-channel activators increase intracellular Na+ and thereby enhance the transport rate of sarcolemmal Na+, K+-ATPase. We investigated the interaction of the new Na+-channel activator BDF 9148 (BDF) with the cardiac glycoside ouabain (OUA) in human myocardium. The influence of OUA (0.01-0.1-mu-M) and of OUA after prestimulation with BDF (0.1-mu-M, 1-mu-M; BDF + OUA) on isometric force of contraction (FOC, force of contraction; +T/-T, peak rate of tension increase/decay) of electrically driven (1 Hz, 37-degrees-C) papillary muscle strips from terminally failing [New York Heart Association classification IV (NYHA IV) heart transplants, n = 19] human myocardium was studied. We also examined the effects of BDF and OUA on nonfailing human myocardium (brain death resulting from traumatic injury, n = 5). 0.01-mu-M OUA enhanced FOC only after prestimulation with BDF (NYHA IV + 2.9 +/- 0.4 mN; p < 0.01). The time until maximal (T(max): BDF + OUA 117 min, OUA 166 min), half-maximal (T1/2max: BDF + OUA 47 min, OUA 85 min) inotropic effects and time until toxic signs (contracture, extrasystoles) occurred were significantly shorter with BDF + OUA as compared with OUA alone. BDF influenced T(max), T1/2max, and time until toxic side effects occurred (T(tox)) of the OUA-mediated inotropism in a concentration-dependent manner. Both OUA and BDF enhanced +T and -T. The effectiveness of OUA and BDF in increasing FOC was similar to that of Ca2+ (1.8-15 mM) but significantly (p < 0.01) higher as compared with the beta-adrenoceptor-agonist isoprenaline in NYHA IV. In myocardial membranes, [H-3]ouabain binding (B(max), K(d)) was not affected by BDF. These results suggest that BDF enhances the potency of OUA to increase FOC in human myocardium but also enhances toxicity of OUA. The influence of BDF on the effects of OUA is probably indirect and may be related to cellular Na+ load. Because BDF 9148 can decrease the inotropic and toxic concentration for cardiac glycosides, great caution appears to be necessary when these compounds are used simultaneously to treat human heart failure.			SCHWINGER, RHG (corresponding author), UNIV MUNICH,KLINIKUM GROSSHADERN,MED KLIN 1,MARCHIONINISTR 15,W-8000 MUNICH 70,GERMANY.						AKERA T, 1981, BIOCHIM BIOPHYS ACTA, V640, P779, DOI 10.1016/0005-2736(81)90108-5; Akera T, 1978, PHARMACOL REV, V29, P187; ALSEN C, 1982, J CARDIOVASC PHARM, V4, P63, DOI 10.1097/00005344-198201000-00011; ARMAH B I, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR50; BARCENASRUIZ L, 1987, SCIENCE, V238, P1720, DOI 10.1126/science.3686010; BOHM M, 1988, J CARDIOVASC PHARM, V12, P726; BOHM M, 1989, AM J CARDIOL, V64, P812, DOI 10.1016/0002-9149(89)90773-X; BORCHARD M, 1986, EUR J PHARMACOL, V131, P269, DOI 10.1016/0014-2999(86)90581-9; BRASCH H, 1991, BRIT J PHARMACOL, V103, P1939, DOI 10.1111/j.1476-5381.1991.tb12356.x; BRIGGS GM, 1987, CIRCULATION S4, V76, P613; BRISTOW MR, 1986, CIRC RES, V59, P297, DOI 10.1161/01.RES.59.3.297; BRISTOW MR, 1982, NEW ENGL J MED, V307, P205, DOI 10.1056/NEJM198207223070401; BUGGISCH D, 1985, EUR J PHARMACOL, V118, P303, DOI 10.1016/0014-2999(85)90141-4; ERDMANN E, 1983, EUR HEART J, V4, P61, DOI 10.1093/eurheartj/4.suppl_A.61; ERDMANN E, 1973, BIOCHIM BIOPHYS ACTA, V307, P386, DOI 10.1016/0005-2736(73)90104-1; FELDMAN AM, 1988, J CLIN INVEST, V82, P189, DOI 10.1172/JCI113569; FELDMAN MD, 1987, CIRCULATION, V75, P331, DOI 10.1161/01.CIR.75.2.331; GRUPP I, 1985, J PHYSIOL-LONDON, V360, P149, DOI 10.1113/jphysiol.1985.sp015609; GWATHMEY JK, 1990, CIRCULATION, V82, P1266, DOI 10.1161/01.CIR.82.4.1266; GWATHMEY JK, 1988, J CLIN INVEST, V82, P1592, DOI 10.1172/JCI113771; HAJJAR RJ, 1988, J CLIN INVEST, V82, P1578, DOI 10.1172/JCI113769; HERZIG S, 1988, J PHYSIOL-LONDON, V396, P105, DOI 10.1113/jphysiol.1988.sp016953; HERZIG S, 1991, J CARDIOVASC PHARM, V18, P182, DOI 10.1097/00005344-199108000-00002; HONERJAEGER P, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR51; HONERJAGER P, 1975, N-S ARCH PHARMACOL, V289, P1, DOI 10.1007/BF00498026; KENNEDY RH, 1983, EUR J PHARMACOL, V89, P199, DOI 10.1016/0014-2999(83)90495-8; LEBLANC N, 1990, SCIENCE, V248, P372, DOI 10.1126/science.2158146; LEE CO, 1985, J MOL CELL CARDIOL, V17, P1043, DOI 10.1016/S0022-2828(85)80120-6; LI T, 1986, CAN J PHYSIOL PHARM, V64, P1385, DOI 10.1139/y86-235; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NEUMANN J, 1988, LANCET, V2, P936; PACKER M, 1988, CIRCULATION, V77, P721, DOI 10.1161/01.CIR.77.4.721; PFEIFER T, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR51; PORT JD, 1988, FASEB J, V2, pA602; RAVENS U, 1989, J CARDIOVASC PHAR S3, V14, pS3; SCHMITZ W, 1989, J CARDIOVASC PHARM, V14, pS11, DOI 10.1097/00005344-198914003-00003; SCHOLTYSIK G, 1985, N-S ARCH PHARMACOL, V329, P316, DOI 10.1007/BF00501887; SCHOLTYSIK G, 1989, J CARDIOVASC PHARM, V14, pS24, DOI 10.1097/00005344-198914003-00006; SCHOLTYSIK G, 1989, J CARDIOVASC PHARM, V13, P342, DOI 10.1097/00005344-198902000-00026; SCHOLTYSIK G, 1986, TRIANGLE, V25, P105; SCHWINGER RHG, 1991, J MOL CELL CARDIOL, V23, P461, DOI 10.1016/0022-2828(91)90170-Q; SCHWINGER RHG, 1990, J CARDIOVASC PHARM, V15, P692, DOI 10.1097/00005344-199005000-00002; SCHWINGER RHG, 1990, AM HEART J, V119, P889; SHEU SS, 1982, J GEN PHYSIOL, V80, P325, DOI 10.1085/jgp.80.3.325; SMITH TW, 1984, PROG CARDIOVASC DIS, V26, P413, DOI 10.1016/0033-0620(84)90012-4; SMITH TW, 1989, THERAPIE, V44, P431; THORMANN J, 1986, J CARDIOVASC PHARM, V8, P749; YAJIMA M, 1984, JPN J PHARMACOL, V36, pP277	48	20	20	0	0	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0160-2446			J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	APR	1992	19	4					554	561		10.1097/00005344-199204000-00012			8	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	HK716	WOS:A1992HK71600012	1380598				2022-02-06	
J	RIBAS, GC; JANE, JA				RIBAS, GC; JANE, JA			TRAUMATIC CONTUSIONS AND INTRACEREBRAL HEMATOMAS	JOURNAL OF NEUROTRAUMA			English	Article							SEVERE HEAD-INJURY; DIFFUSE AXONAL INJURY; INTRA-CEREBRAL HEMATOMAS; COMA DATA-BANK; COMPUTERIZED-TOMOGRAPHY; CT SCAN; INTRACRANIAL-PRESSURE; CRANICAL PRESSURE; CORPUS-CALLOSUM; BRAIN-DAMAGE	The authors review acute and delayed traumatic intracerebral hemorrhages. Based on recent experimental and clinical data, these injuries' clinical presentation, pathologic characteristics, and treatment are discussed. A description of traumatic hemorrhage based on biomechanics is emphasized.	UNIV VIRGINIA, HLTH SCI CTR, DEPT NEUROL SURG, BOX 212, CHARLOTTESVILLE, VA 22908 USA; HOSP ALBERT EINSTEIN, SAO PAULO, BRAZIL								Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1986, ARCH PATHOL LAB MED, V110, P485; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; Adams JH, 1975, HDB CLIN NEUROLOGY, V23, P35; AMACHER AL, 1987, NEUROSURGERY, V20, P954; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; ANTTINEN EE, 1957, ACTA PSYCH NEUROL, V32, P103; AUSTARHEIM KR1STEN, 1956, ACTA PATHOL ET MICROBIOL SCAND, V38, P177; BARATHAM G, 1972, J NEUROL NEUROSUR PS, V35, P698, DOI 10.1136/jnnp.35.5.698; BECKER DP, 1982, NEUROLOGICAL SURGERY, V4, P1938; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; BROADDUS WC, 1989, INTRACRANIAL PRESSUR, V7, P41; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; BRUNETTI J, 1979, NEURORADIOLOGY, V18, P43, DOI 10.1007/BF00346211; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; BULLOCK R, 1990, J NEUROSURG, V72, P9, DOI 10.3171/jns.1990.72.1.0009; CLARK JM, 1974, J NEUROL NEUROSUR PS, V37, P463, DOI 10.1136/jnnp.37.4.463; CLASEN RA, 1987, HEAD INJURY, P285; COLQUHOUN IR, 1989, CLIN RADIOL, V40, P619, DOI 10.1016/S0009-9260(89)80324-1; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Courville CB, 1940, ARCH SURG-CHICAGO, V41, P1; CROWE NW, 1989, NEUROLOGY, V39, P863, DOI 10.1212/WNL.39.6.863; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAWSON SL, 1980, HUM PATHOL, V11, P155, DOI 10.1016/S0046-8177(80)80136-5; De Vet AC, 1976, HDB CLIN NEUROLOGY, V24, P351; DeJong RN, 1942, ARCH NEURO PSYCHIATR, V48, P257, DOI 10.1001/archneurpsyc.1942.02290080103004; DEMIERRE B, 1987, NEUROCHIRURGIE, V33, P12; DIAZ FG, 1979, J NEUROSURG, V50, P217, DOI 10.3171/jns.1979.50.2.0217; DOHRMANN PJ, 1983, AUST NZ J SURG, V53, P169, DOI 10.1111/j.1445-2197.1983.tb02421.x; DUBLIN AB, 1977, RADIOLOGY, V122, P365, DOI 10.1148/122.2.365; ELSNER H, 1990, J NEUROSURG, V72, P813, DOI 10.3171/jns.1990.72.5.0813; EVANS JP, 1946, J NEUROSURG, V3, P101, DOI 10.3171/jns.1946.3.2.0101; FRENCH BN, 1977, SURG NEUROL, V7, P171; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; FUKAMACHI A, 1985, J TRAUMA, V25, P145, DOI 10.1097/00005373-198502000-00010; GALBRAITH S, 1987, BRIT MED J, V294, P325, DOI 10.1136/bmj.294.6568.325; GALBRAITH S, 1981, J NEUROSURG, V55, P75, DOI 10.3171/jns.1981.55.1.0075; Gennarelli T A, 1983, Acta Neurochir Suppl (Wien), V32, P1; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENNARELLI TA, 1979, 23RD P STAPP CAR CRA, P561; GENNARELLI TA, 1985, TRAUMA CENTRAL NERVO, P169; GENTRY LR, 1988, AM J NEURORADIOL, V9, P101, DOI 10.2214/ajr.150.3.663; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; Graham D. I., 1987, HEAD INJURY, P72; GRAHAM DI, 1971, LANCET, V1, P265; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; GUDEMAN SK, 1979, J NEUROSURG, V51, P301, DOI 10.3171/jns.1979.51.3.0301; Gurdjian E S, 1980, Surg Annu, V12, P223; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; GURDJIAN ES, 1975, IMAPCT HEAD INJURY; HEISKANEN O, 1972, ACTA NEUROCHIR, V27, P29, DOI 10.1007/BF01402170; HIRSH LF, 1979, NEUROSURGERY, V5, P653, DOI 10.1227/00006123-197912000-00001; Holbourn AHS, 1943, LANCET, V2, P438; HOLBOURN AHS, 1945, BRIT MED BULL, V3, P147, DOI 10.1093/oxfordjournals.bmb.a071895; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; JAMIESON KG, 1972, J NEUROSURG, V37, P528, DOI 10.3171/jns.1972.37.5.0528; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KAUFMAN HH, 1980, NEUROSURGERY, V7, P445, DOI 10.1227/00006123-198011000-00003; KLATZO I, 1958, J NEUROPATH EXP NEUR, V17, P548, DOI 10.1097/00005072-195810000-00002; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KOMATSU S, 1979, NEUROSURGERY, V5, P32, DOI 10.1227/00006123-197907010-00005; KUROKAWA Y, 1989, Neurological Surgery, V17, P335; LANGFITT TW, 1982, CLIN NEUR, V29, P353; LARA VV, 1974, THESIS LIMA; LARSON S J, 1965, J Trauma, V5, P482, DOI 10.1097/00005373-196507000-00006; LEVINTHAL R, 1977, SURG NEUROL, V7, P269; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LINDENBERG R, 1955, AM J PATHOL, V31, P297; LIPPER MH, 1979, RADIOLOGY, V133, P645, DOI 10.1148/133.3.645; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; LONG DM, 1982, CLIN NEUR, V29, P174; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MACPHERSON P, 1986, J NEUROL NEUROSUR PS, V49, P29, DOI 10.1136/jnnp.49.1.29; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LR, 1985, ANN M AM ASS NEUROLO; MCLAURIN RL, 1965, J NEUROSURG, V23, P296, DOI 10.3171/jns.1965.23.3.0296; MCLAURIN RL, 1956, ANN SURG, V143, P294, DOI 10.1097/00000658-195603000-00002; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; MILLER JD, 1982, CLIN NEUR, V29, P103; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MIZUTANI T, 1990, SURG NEUROL, V33, P178, DOI 10.1016/0090-3019(90)90181-N; MODESTI LM, 1982, NEUROSURGERY, V10, P689, DOI 10.1227/00006123-198206010-00002; MORIN MA, 1970, J NEUROSURG, V33, P542, DOI 10.3171/jns.1970.33.5.0542; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NEVIN NC, 1967, J NEUROPATH EXP NEUR, V26, P77, DOI 10.1097/00005072-196701000-00006; NICHONJI T, 1984, ACTA NEUROCHIR, V71, P69; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; REILLY PL, 1975, LANCET, V2, P375; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; RIETH KG, 1980, RADIOLOGY, V135, P343, DOI 10.1148/radiology.135.2.6768102; ROBERSON FC, 1979, SURG NEUROL, V12, P161; ROCKSWOLD GL, 1987, NEUROSURGERY, V21, P51, DOI 10.1227/00006123-198707000-00010; ROESSMAN U, 1968, ACTA NEUROPATHOL, V10, P151, DOI 10.1007/BF00691309; ROSS DA, 1989, J NEUROSURG, V71, P498, DOI 10.3171/jns.1989.71.4.0498; ROWBOTHAM GF, 1964, ACUTE INJURIES HEAD; SACKETT JF, 1975, RADIOLOGY, V116, P95, DOI 10.1148/116.1.95; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; Schonauer M, 1979, J Neurosurg Sci, V23, P279; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHIGEMORI M, 1986, ACTA NEUROCHIR, V81, P36, DOI 10.1007/BF01456262; SMITH D R, 1969, Journal of Neurosurgery, V30, P664, DOI 10.3171/jns.1969.30.6.0664; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; SOLONIUK D, 1986, J TRAUMA, V26, P787, DOI 10.1097/00005373-198609000-00003; SOSIN DM, 1989, JAMA-J AM MED ASSOC, V262, P2251, DOI 10.1001/jama.262.16.2251; STATHAM PF, 1989, J NEUROL NEUROSUR PS, V52, P351, DOI 10.1136/jnnp.52.3.351; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; STRICH SJ, 1970, J CLIN PATHOL S4, V23, P166; TANEDA M, 1979, ACTA NEUROCHIR, V51, P73, DOI 10.1007/BF01401796; TEASDALE E, 1984, J NEUROL NEUROSUR PS, V47, P600, DOI 10.1136/jnnp.47.6.600; Tornheim P A, 1976, Surg Neurol, V5, P171; TORNHEIM PA, 1985, CENTRAL NERVOUS SYST, P431; TORNHEIM PA, 1985, TRAUMA NERVOUS SYSTE, P141; TORRES H, 1972, NEUROCHIRURGIA, V15, P62; TOUTANT SM, 1984, J NEUROSURG, V61, P691, DOI 10.3171/jns.1984.61.4.0691; TSAI FY, 1978, NEURORADIOLOGY, V16, P314, DOI 10.1007/BF00395286; VANDONGEN KJ, 1983, J NEUROSURG, V59, P951, DOI 10.3171/jns.1983.59.6.0951; VOIGT GE, 1977, ACTA NEUROPATHOL, V39, P201, DOI 10.1007/BF00691698; WEAVER DD, 1982, J NEUROSURG, V56, P660, DOI 10.3171/jns.1982.56.5.0660; WINN HR, 1977, SURG NEUROL, V8, P41; Yashon D, 1978, Neurosurgery, V2, P103; YOUNG HA, 1984, NEUROSURGERY, V14, P22, DOI 10.1227/00006123-198401000-00006; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZIMMERMAN RA, 1978, NEURORADIOLOGY, V16, P320, DOI 10.1007/BF00395288; ZUCCARELLO M, 1980, ACTA NEUROCHIR, V54, P265, DOI 10.1007/BF01407094	135	20	20	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	1992	9			1			S265	S278					14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HN806	WOS:A1992HN80600025	1588615				2022-02-06	
J	WROBLEWSKI, BA; JOSEPH, AB				WROBLEWSKI, BA; JOSEPH, AB			THE USE OF INTRAMUSCULAR MIDAZOLAM FOR ACUTE SEIZURE CESSATION OR BEHAVIORAL EMERGENCIES IN PATIENTS WITH TRAUMATIC BRAIN INJURY	CLINICAL NEUROPHARMACOLOGY			English	Article						MIDAZOLAM; SEIZURES; BEHAVIOR; AGGRESSION; BRAIN INJURY		Brain-injured patients involved in rehabilitation programs are susceptible to the occurrence of acute seizures or severe behavioral episodes. Effective pharmacological management in this setting should ideally include rapid onset without severe adverse effects. Previous treatments have generally included intramuscular diazepam or lorazepam, as well as intramuscular antipsychotic drugs. These options have proved problematic due to poor absorption, slow onset of activity, or potential for unacceptable side effects. We report 10 cases involving the use of intramuscular midazolam, a rapid-acting, short half-life benzodiazepine, in treating acute seizures or behavioral problems. We conclude that this drug demonstrates great promise for the rapid, effective treatment of these conditions without significant adverse effects and deserves further study in these areas.	GREENERY REHABIL CTR, 99 CHESTNUT HILL AVE, BRIGHTON, MA 02135 USA; TUFTS UNIV, SCH MED, DEPT REHABIL MED, BOSTON, MA 02111 USA; MASSACHUSETTS COLL PHARM & ALLIED HLTH SCI, DEPT PHARM, BOSTON, MA 02115 USA; HARVARD UNIV, MCLEAN HOSP, SCH MED, DEPT PSYCHIAT, BELMONT, MA 02178 USA; CTR NEUROBEHAV REHABIL MIDDLESEX HOSP, WALTHAM, MA USA; HARVARD UNIV, SCH MED, DEPT PSYCHIAT, BOSTON, MA 02115 USA								BOND WS, 1989, AM J PSYCHIAT, V146, P925; DUNDEE JW, 1984, DRUGS, V28, P519, DOI 10.2165/00003495-198428060-00002; EGLI M, 1981, 12TH WORLD C NEUR KY, P144; GALVIN GM, 1987, ARCH EMERG MED, V4, P169; JAWAD S, 1986, J NEUROL NEUROSUR PS, V49, P1050, DOI 10.1136/jnnp.49.9.1050; MAYHUE FE, 1988, ANN EMERG MED, V17, P643, DOI 10.1016/S0196-0644(88)80408-6; MENDOZA R, 1987, J CLIN PSYCHIAT, V48, P291; VONALBERT HH, 1986, MIDAZOLAM ANESTHESIO, P255; 1986, VERSED PRODUCT INFOR	9	20	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-5664	1537-162X		CLIN NEUROPHARMACOL	Clin. Neuropharmacol.	FEB	1992	15	1					44	49		10.1097/00002826-199202000-00006			6	Clinical Neurology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	GZ748	WOS:A1992GZ74800006	1576597				2022-02-06	
J	SCHURER, L; DAUTERMANN, C; HARTL, R; MURR, R; BERGER, S; ROHRICH, F; MESSMER, K; BAETHMANN, A				SCHURER, L; DAUTERMANN, C; HARTL, R; MURR, R; BERGER, S; ROHRICH, F; MESSMER, K; BAETHMANN, A			TREATMENT OF HEMORRHAGIC HYPOTENSION WITH HYPERTONIC HYPERONCOTIC SOLUTIONS - EFFECTS ON REGIONAL CEREBRAL BLOOD-FLOW AND BRAIN SURFACE OXYGEN-TENSION	EUROPEAN SURGICAL RESEARCH			English	Article						HYPERTONIC HYPERONCOTIC; NACL DEXTRAN; SMALL-VOLUME RESUSCITATION; CEREBRAL BLOOD FLOW; CEREBRAL O2 SUPPLY; HEMORRHAGIC HYPOVOLEMIA	SMALL-VOLUME RESUSCITATION; INTRACRANIAL-PRESSURE; TRAUMATIC SHOCK; SALINE DEXTRAN; HEAD-INJURY; TISSUE; MICROCIRCULATION; TRANSPORT; PROTEINS; BARRIER	Hypertonic/hyperoncotic solutions (e.g. HHS: 7.2% NaCl/10% dextran-60) are highly effective to normalize cardiovascular function in hemorrhagic shock due to rapid mobilization of fluid from the extravascular compartment. Since experiences are limited with regard to potential side effects of this treatment on the central nervous system, the present studies were carried out under particular consideration of the cerebral blood flow and O2 supply. HHS was administered in albino rabbits subjected to alpha-chloralose anesthesia and artificial ventilation with and without hemorrhagic hypovolemia. Hemorrhagic hypovolemia of 30 min duration was induced by withdrawal of approximately one third of the circulating blood volume resulting in a decrease in arterial blood pressure to 40 mm Hg. HHS was studied in addition in normovolemic animals. Cardiac output was rapidly normalized by infusion of HHS in animals with hypovolemia, while it increased intermittently in normovolemic animals. In animals with hemorrhagic shock arterial blood pressure recovered by treatment to approximately 70% of normal, whereas blood pressure remained unchanged after infusion of HHS in normovolemic controls. Cerebral blood flow, which was assessed by H2 clearance at the brain surface, had a range of 43.0-50.3 ml/100 g/min under control conditions. It remained virtually unchanged during hemorrhagic hypovolemia and also after infusion of HHS in normovolemic animals. Treatment of shock by HHS was followed 90 or 120 min later by a moderate increase in regional cerebral blood flow to 61 ml/100 g/min. Local tissue P(O2) at the brain surface was obtained by an O2 multiwire electrode in the vicinity of the H2 clearance measurements using a weightless suspension system to avoid compression of the brain surface. Infusion of HHS in normovolemic animals did not affect the O2 supply of the brain. Hemorrhagic hypovolemia which led to a left shift of the cerebral P(O2) histogram was followed by gradual normalization after fluid resuscitation. The current findings taken together do not indicate adverse side effects of this efficient method of fluid resuscitation with regard to the cerebral blood and O2 supple. The results make worthwhile further investigations on HHS in the presence of a focal brain lesion causing brain edema to find out whether the HHS are useful also for the treatment of intracranial hypertension.	LUDWIG MAXIMILIANS UNIV, KLINIKUM GROSSHADERN, DEPT NEUROSURG, W-8000 MUNICH 70, GERMANY; LUDWIG MAXIMILLIAN UNIV, KLINIKUM GROSSHADERN, INST ANESTHESIOL, W-8000 MUNICH 70, GERMANY		SCHURER, L (corresponding author), LUDWIG MAXIMILIANS UNIV, KLINIKUM GROSSHADERN, INST SURG RES, MARCHIONINISTR 15, W-8000 MUNICH 70, GERMANY.						ALBRIGHT AL, 1984, J NEUROSURG, V60, P481, DOI 10.3171/jns.1984.60.3.0481; ARVIDSSON S, 1981, ACTA ANAESTH SCAND, V25, P153, DOI 10.1111/j.1399-6576.1981.tb01626.x; AUKLAND DK, 1964, CIRC RES, V17, P85; BITTERMAN H, 1987, CIRC SHOCK, V21, P271; CHAN R, 1983, INT J MICROCIRC, V2, P297; GAAB M, 1978, ACTA NEUROCHIR, V40, P203, DOI 10.1007/BF01774747; Groger U, 1990, Adv Neurol, V52, P215; GUNNAR W, 1988, SURGERY, V103, P398; HOLCROFT JW, 1987, ANN SURG, V206, P279, DOI 10.1097/00000658-198709000-00006; IVANOV KP, 1979, MICROVASC RES, V18, P434, DOI 10.1016/0026-2862(79)90049-9; Jennett B, 1981, MANAGEMENT HEAD INJU; KESSLER M, 1976, ANESTHESIOLOGY, V45, P184, DOI 10.1097/00000542-197608000-00007; KOZNIEWSKA E, 1987, J CEREBR BLOOD F MET, V7, P464, DOI 10.1038/jcbfm.1987.89; KRAMER GC, 1986, SURGERY, V100, P239; KREIMEIER U, 1990, CIRC SHOCK, V32, P83; KREIMEIER U, 1988, EUR SURG RES, V20, P277, DOI 10.1159/000128773; KREIMEIER U, 1987, SURGICAL RES RECENT, P39; KUROIWA T, 1985, ACTA NEUROPATHOL, V68, P122, DOI 10.1007/BF00688633; KUROIWA T, 1985, ACTA NEUROPATHOL, V66, P3, DOI 10.1007/BF00698288; LUBBERS DW, 1972, HIRNKREISLAUF, P214; MAEKAWA T, 1979, ANESTHESIOLOGY, V51, P313, DOI 10.1097/00000542-197910000-00007; MANINGAS PA, 1987, CRIT CARE MED, V15, P1121, DOI 10.1097/00003246-198712000-00009; Mattar J A, 1973, Crit Care Med, V1, P293; MATTAR JA, 1989, CRIT CARE MED, V17, P297, DOI 10.1097/00003246-198903000-00020; MAZZONI MC, 1988, AM J PHYSIOL, V255, pH629, DOI 10.1152/ajpheart.1988.255.3.H629; MAZZONI MC, 1987, MICROCIRCULATION UPD, V1, P289; MCKEE AC, 1988, NEUROLOGY, V38, P1211, DOI 10.1212/WNL.38.8.1211; PRAZMA J, 1978, J APPL PHYSIOL, V44, P977, DOI 10.1152/jappl.1978.44.6.977; PROUGH DS, 1985, CRIT CARE MED, V13, P407, DOI 10.1097/00003246-198505000-00008; PROUGH DS, 1986, J NEUROSURG, V64, P627, DOI 10.3171/jns.1986.64.4.0627; RUBIN MJ, 1985, AM J PHYSIOL, V249, pH540, DOI 10.1152/ajpheart.1985.249.3.H540; SHACKFORD SR, 1990, CRIT CARE MED, V5, P59; SILVA PA, 1986, J LEARN DISABIL, V19, P165, DOI 10.1177/002221948601900307; SMITH GJ, 1985, J SURG RES, V39, P517, DOI 10.1016/0022-4804(85)90120-9; SMITH RH, 1977, MICROVASC RES, V13, P233, DOI 10.1016/0026-2862(77)90088-7; VASSAR MJ, 1990, ARCH SURG-CHICAGO, V125, P1309; WADE CE, 1989, CIRC SHOCK, V29, P193; WIERNSPERGER N, 1981, EUR NEUROL, V20, P200, DOI 10.1159/000115234; WIERNSPERGER N, 1978, DRUG RES, V28, P768; WISNER D, 1989, J SURG RES, V46, P49, DOI 10.1016/0022-4804(89)90181-9	40	20	21	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0014-312X	1421-9921		EUR SURG RES	Eur. Surg. Res.	JAN-FEB	1992	24	1					1	12		10.1159/000129183			12	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	HT026	WOS:A1992HT02600001	1375157				2022-02-06	
J	GOLDSTEIN, FC; LEVIN, HS				GOLDSTEIN, FC; LEVIN, HS			QUESTION-ASKING STRATEGIES AFTER SEVERE CLOSED HEAD-INJURY	BRAIN AND COGNITION			English	Article							SCALE		EMORY UNIV,SCH MED,DEPT NEUROL,ATLANTA,GA 30322; UNIV TEXAS,MED BRANCH,DIV NEUROSURG,GALVESTON,TX 77550		GOLDSTEIN, FC (corresponding author), WESLEY WOODS GERIATR HOSP,EMORY NEUROBEHAV PROGRAM,1821 CLIFTON RD NE,ATLANTA,GA 30329, USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 21889] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS021889] Funding Source: NIH RePORTER		Benson D.F., 1986, FRONTAL LOBES; BENYISHAY Y, 1983, REHABILITATION HEAD; CICERONE KD, 1987, ARCH PHYS MED REHAB, V68, P111; DENNEY DR, 1973, DEV PSYCHOL, V9, P275, DOI 10.1037/h0035092; DENNEY NW, 1979, HUM DEV, V22, P23, DOI 10.1159/000272426; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Luria A.R., 1973, WORKING BRAIN; LURIA AR, 1964, FRONTAL GRANULAR COR; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mosher F., 1966, STUDIES COGNITIVE GR; ODDY M, 1984, CLOSED HEAD INJURY P; OLVER RR, 1966, STUDIES COGNITIVE GR; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TEASDALE G, 1974, LANCET, V2, P81; [No title captured]	18	20	20	0	0	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	SEP	1991	17	1					23	30		10.1016/0278-2626(91)90063-E			8	Neurosciences; Psychology, Experimental	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GV410	WOS:A1991GV41000002	1781978				2022-02-06	
J	HORVAT, JC				HORVAT, JC			TRANSPLANTS OF FETAL NEURAL TISSUE AND AUTOLOGOUS PERIPHERAL-NERVES IN AN ATTEMPT TO REPAIR SPINAL-CORD INJURIES IN THE ADULT-RAT - AN OVERALL VIEW	PARAPLEGIA			English	Article						SPINAL CORD INJURY; TRANSPLANTATION; FETAL NEURAL TISSUE; PERIPHERAL NERVE AUTOGRAFTS; ADULT RAT; EXPERIMENTAL RESEARCH		Embryonic neurons and autologous peripheral nerve segments constitute selected materials for studying central nervous system plasticity and repair in adult mammals. Transplanted to the brain or the spinal cord, the former are possible substitutes designed to replace lost or deficient host neurons while the latter have useful stimulating and guiding effects upon axonal regrowth from surviving axotomized neurons. Consequently, these techniques give rise to interesting prospects for short and medium range fundamental research as well as for possible medium and long-term clinical applications. From a basic viewpoint, utilisation of such transplants is designed to study the survival, the morphological and biochemical differentiation, the reafferentation, the expression of potentialities for plasticity, axomal growth or regeneration, synaptogenesis, of host as well as of transplanted embryonic neurons. From a clinical viewpoint these studies should attempt at finding solutions to counteract the effects of severe traumatic or neurodegenerative lesions of the brain and of the spinal cord which until now appear quite refractory to therapeutic approaches.			HORVAT, JC (corresponding author), DESCARTES UNIV 45,NEUROBIOL RENE LAB,RUE ST PERES,F-75270 PARIS 06,FRANCE.							0	20	21	0	2	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0031-1758			PARAPLEGIA	Paraplegia	JUN	1991	29	5					299	308		10.1038/sc.1991.44			10	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	FR564	WOS:A1991FR56400003	1886729	Bronze			2022-02-06	
J	LANG, DA; HADLEY, DM; TEASDALE, GM; MACPHERSON, P; TEASDALE, E				LANG, DA; HADLEY, DM; TEASDALE, GM; MACPHERSON, P; TEASDALE, E			GADOLINIUM DTPA ENHANCED MAGNETIC-RESONANCE-IMAGING IN ACUTE HEAD-INJURY	ACTA NEUROCHIRURGICA			English	Article						HEAD INJURY; MAGNETIC RESONANCE IMAGING; GADOLINIUM DTPA; BLOOD BRAIN BARRIER	GD-DTPA; COMPUTED-TOMOGRAPHY; CEREBRAL INFARCTION; BRAIN INFARCTS; HEMORRHAGE	We studied the effect of contrast enhancement on magnetic resonance imaging (Gadolinium DTPA Magnetic REsonance) in 10 patients with a recent head injury. The use of contrast did not increase the number of traumatic lesions identified and we did not detect evidence of altered blood brain barrier permeability in any of the 7 patients, who had a total of 27 lesions, imaged between one and 4 days after injury. Enhancement was found in each of 3 patients imaged 6 or more days after injury. These findings suggest that traumatic cortical and intraparenchymal lesions are not associated with increased cerebrovascular permeability within the first 96 hours of a head injury.	UNIV GLASGOW,SO GEN HOSP,INST NEUROL SCI,DEPT NEUROSURG,GLASGOW G51 4TF,SCOTLAND								ADAMS JH, 1982, RECENT ADV NEUROPATH, V2, pCH7; BARSCH RC, 1983, RADIOLOGY, V147, P781; BECKER H, 1988, DIAGNOSTIC IMAGING S, V1, P18; BULLOCK R, 1989, INTRACRANIAL PRESSUR, P637; CAILLE JM, 1983, AM J NEURORADIOL, V4, P1041; ENZMANN DR, 1981, AM J NEURORADIOL, V2, P517; GARCIA JH, 1974, J NEUROPATH EXP NEUR, V33, P408, DOI 10.1097/00005072-197407000-00007; HADLEY DM, 1988, CLIN RADIOL, V39, P131; HOSSMANN KA, 1980, STROKE, V11, P583, DOI 10.1161/01.STR.11.6.583; IMAKITA S, 1987, NEURORADIOLOGY, V29, P422, DOI 10.1007/BF00341737; JENKINS A, 1986, LANCET, V2, P445; KILGORE DP, 1986, RADIOLOGY, V160, P757, DOI 10.1148/radiology.160.3.3488563; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Klatzo I, 1967, BRAIN EDEMA, P554; LEVIN HS, 1985, ARCH NEUROL-CHICAGO, V42, P963, DOI 10.1001/archneur.1985.04060090045012; MACPHERSON P, 1989, NEURORADIOLOGY, V31, P293, DOI 10.1007/BF00344169; MAUSER HW, 1984, NEURORADIOLOGY, V26, P31, DOI 10.1007/BF00328200; MCNAMARA MT, 1987, MAGNETIC RESONANCE I, P97; NATH FP, 1987, J NEUROSURG, V66, P555, DOI 10.3171/jns.1987.66.4.0555; NATH FP, 1985, INTRACRANIAL PRESSUR, V6, P581; OLSSON Y, 1971, ACTA NEUROPATHOL, V18, P89, DOI 10.1007/BF00687597; PETITO CK, 1979, J NEUROPATH EXP NEUR, V38, P222, DOI 10.1097/00005072-197905000-00003; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TORNHEIM PA, 1984, J NEUROSURG, V60, P473, DOI 10.3171/jns.1984.60.3.0473; VIRAPONGSE C, 1986, RADIOLOGY, V161, P785, DOI 10.1148/radiology.161.3.3786734; WILBERGER JE, 1987, NEUROSURGERY, V20, P571, DOI 10.1227/00006123-198704000-00011	27	20	21	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1991	109	1-2					5	11		10.1007/BF01405689			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FJ152	WOS:A1991FJ15200002	2068967				2022-02-06	
J	RIEGER, H; PENNIG, D; KLEIN, W; GRUNERT, J				RIEGER, H; PENNIG, D; KLEIN, W; GRUNERT, J			TRAUMATIC DISLOCATION OF THE HIP IN YOUNG-CHILDREN	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article								Traumatic dislocation of the hip joint is an uncommon injury in children. The present report on this traumatic emergency is based on the authors' own observations of three cases and a review of the literature. The main problem is the possible development of avascular necrosis of the femoral head. The crucial therapeutic intervention to avoid this seious complication seems to be immediate, usually closed, reduction under general anaesthesia. A management protocol is presented.			RIEGER, H (corresponding author), UNIV MUNSTER,UNFALL & HANDCHIRURG KLIN & POLIKLIN,JUNGEBLODTPL 1,W-4400 MUNSTER,GERMANY.						BRUG E, 1974, MUNCHEN MED WOCHEN, V116, P315; BRUNNER C, 1988, Z KINDERCHIR, V43, P174; CHUNG SMK, 1976, J BONE JOINT SURG AM, V58, P961, DOI 10.2106/00004623-197658070-00011; FINESCHI G, 1956, Arch Orthop Unfallchir, V48, P225, DOI 10.1007/BF00418688; FINKE W, 1976, ZENTRALBL CHIR, V101, P177; FUNK FJ, 1962, J BONE JOINT SURG AM, V44, P1135, DOI 10.2106/00004623-196244060-00008; GLASS A, 1961, J BONE JOINT SURG BR, V43, P29; HELBING G, 1986, PRAXIS ORTHOPADIE, P310; HIPP E, 1986, LEHBRUCH ORTHOPADIE, V3, P344; JONASCH E, 1981, LEBENSJAHR, P84; JUNGBLUTH KH, 1978, BG SCHRIFTENREIHE, P69; LUGGER LJ, 1974, ZBL CHIR, V99, P340; OFFIERSKI CM, 1981, J BONE JOINT SURG BR, V63, P194, DOI 10.1302/0301-620X.63B2.7217141; PIGGOT J, 1961, J BONE JOINT SURG BR, V43, P38; REEEINHARDT R, 1975, BG SCHRIFTENREIHE, P177; RITTER G, 1984, UNFALLHEILKUNDE, V87, P24; SEILER JG, 1989, J BONE JOINT SURG AM, V671, P28; SLAVIK M, 1986, ARCH ORTHOP TRAUM SU, V104, P385, DOI 10.1007/BF00454438; TRUETA J, 1957, J BONE JOINT SURG BR, V39, P358, DOI 10.1302/0301-620X.39B2.358; VONLAER L, 1986, FRAKTUREN LUXATIONEN, P142; Weigand H, 1979, Hefte Unfallheilkd, P239; 1988, J BONE JOINT SURG AM, V50, P79	22	20	22	0	1	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0936-8051			ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.		1991	110	2					114	117		10.1007/BF00393886			4	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Surgery	EZ001	WOS:A1991EZ00100011	2015133				2022-02-06	
J	WEHMAN, P; WEST, M; FRY, R; SHERRON, P; GROAH, C; KREUTZER, J; SALE, P				WEHMAN, P; WEST, M; FRY, R; SHERRON, P; GROAH, C; KREUTZER, J; SALE, P			EFFECT OF SUPPORTED EMPLOYMENT ON THE VOCATIONAL OUTCOMES OF PERSONS WITH TRAUMATIC BRAIN INJURY	JOURNAL OF APPLIED BEHAVIOR ANALYSIS			English	Article											WEHMAN, P (corresponding author), VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,BOX 2011,RICHMOND,VA 23284, USA.						Ben-Yishay Y., 1987, J HEAD TRAUMA REHAB, V2, P35, DOI [10.1097/00001199-198703000-00007, DOI 10.1097/00001199-198703000-00007]; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; ELLARD D, IN PRESS VOCATIONAL; FRASER RT, 1988, REHABILITATION ED, V2, P179; HEGEL T, 1988, BRAIN INJURY, V2, P333; HERSEN M, 1976, SINGLE CASE EXPT DES; HILL M, 1988, VOCATIONAL REHABILIT, P31; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; KAY T, 1986, ANNOTATED BIBLIOGRAP; KREUTZER J, IN PRESS COMMUNITY I; Kreutzer J S, 1989, Brain Inj, V3, P177, DOI 10.3109/02699058909004550; KREUTZER JS, 1989, REHABIL PSYCHOL, V34, P117; Levin HS., 1982, NEUROBEHAVIORAL CONS; MCMORDIE W, 1988, BRAIN INJURY, V2, P359; MOON S, 1986, SUPPORTED WORK MODEL; PECK E, 1984, ANN M INT NEUROPSYCH; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Rosen CD, 1986, HEAD TRAUMA ED REINT; RUSCH F, 1986, COMPETITIVE EMPLOYME; STAPLETON M, IN PRESS VOCATIONAL; STAPLETON MC, 1986, COGNITIVE REHABIL, V4, P34; STONNINGTON HH, 1987, AM REHABILITATION, V10, P66; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; Wehman P., 1988, VOCATIONAL REHABILIT; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012; WEHMAN P, IN PRESS BRAIN INJUR; WEHMAN P, IN PRESS VOCATIONAL; Wehman P., 1989, J HEAD TRAUMA REHAB, V4, P66, DOI [10.1097/00001199-198909000-00010, DOI 10.1097/00001199-198909000-00010]; Wehman P, 1985, J ASSOC PERS SEVERE, V10, P3; Ylvisaker M., 1985, HEAD INJURY REHABILI; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	32	20	20	0	1	JOURNAL APPL BEHAV ANAL	LAWRENCE	DEPT HUMAN DEVELOPMENT, UNIV KANSAS, LAWRENCE, KS 66045	0021-8855			J APPL BEHAV ANAL	J. Appl. Behav. Anal.	WIN	1989	22	4					395	405		10.1901/jaba.1989.22-395			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	CV433	WOS:A1989CV43300006	2515185	Green Published			2022-02-06	
J	SAHGAL, V; HEINEMANN, A				SAHGAL, V; HEINEMANN, A			RECOVERY OF FUNCTION DURING INPATIENT REHABILITATION FOR MODERATE TRAUMATIC BRAIN INJURY	SCANDINAVIAN JOURNAL OF REHABILITATION MEDICINE			English	Article											SAHGAL, V (corresponding author), REHABIL INST CHICAGO,BRAIN TRAUMA PROGRAM,345 E SUPER ST,CHICAGO,IL 60611, USA.		Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326				0	20	20	0	2	SCANDINAVIAN UNIVERSITY PRESS	OSLO	PO BOX 2959 TOYEN, JOURNAL DIVISION CUSTOMER SERVICE, N-0608 OSLO, NORWAY	0036-5505			SCAND J REHABIL MED	Scand. J. Rehabil. Med.		1989	21	2					71	79					9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	AB880	WOS:A1989AB88000002	2749197				2022-02-06	
J	Wilson, JTL; Wiedmann, KD; Hadley, DM; Brooks, DN				Wilson, J. T. L.; Wiedmann, K. D.; Hadley, D. M.; Brooks, D. N.			The Relationship between Visual Memory Function and Lesions Detected by Magnetic Resonance Imaging after Closed Head Injury	NEUROPSYCHOLOGY			English	Article						Head injury; magnetic resonance imaging; visual and verbal memory		Forty-five patients with closed head injuries were followed up 6 months postinjury with magnetic resonance imaging (MRl) and neuropsychological assessment. Patients were tested on visual and verbal measures of short-term memory and learning: Pattern Span, Pattern Learning, Path Span, Path Learning, Digit Span, and Digit Learning. Visual memory for patterns and paths was tested using a recall procedure. Compared with a matched control group (n = 22), patients were significantly impaired on pattern span but not on path span or digit span. Patients were also significantly impaired on measures of path learning and digit learning. Performance on the visual memory tasks, but not measures of verbal memory, was related to a rating of ventricular enlargement derived from MRI. There was some evidence for differential relationships between pattern span and pattern learning and lesions in hemispheric sites. However, despite the sensitivity of MRl to focal lesions, it appears that diffuse damage remains of importance in predicting neuropsychological impairment in head injury.	[Wilson, J. T. L.; Wiedmann, K. D.] Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland; [Hadley, D. M.] So Gen Hosp, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; [Brooks, D. N.] Univ Glasgow, Dept Psychol Med, Glasgow, Lanark, Scotland		Wilson, JTL (corresponding author), Univ Stirling, Dept Psychol, Stirling FK9 4LA, Scotland.		Wilson, Lindsay/O-8883-2019; Wilson, Lindsay/A-3659-2009	Wilson, Lindsay/0000-0003-4113-2328; Wilson, Lindsay/0000-0003-4113-2328	Medical Research Council of Great BritainUK Research & Innovation (UKRI)Medical Research Council UK (MRC)	This study was supported by the Medical Research Council of Great Britain.	ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ALEXANDRE A, 1983, J NEUROSURG, V59, P751, DOI 10.3171/jns.1983.59.5.0751; Baddeley A.D., 1986, WORKING MEMORY; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; DERENZI E, 1977, CORTEX, V13, P424, DOI 10.1016/S0010-9452(77)80022-1; DRACHMAN DA, 1966, ARCH NEUROL-CHICAGO, V15, P52, DOI 10.1001/archneur.1966.00470130056005; FRICK RW, 1985, MEM COGNITION, V13, P346, DOI 10.3758/BF03202502; HADLEY DM, 1988, CLIN RADIOL, V39, P131; JENNETT WB, 1969, SPECIAL PUBLICATION, V4; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P14, DOI 10.1136/jnnp.51.1.14; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; PHILLIPS WA, 1983, PHILOS T ROY SOC B, V302, P295, DOI 10.1098/rstb.1983.0056; Rey A, 1941, ARCH PSYCHOL, V28; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; WARRINGTON EK, 1967, NEUROPSYCHOLOGIA, V5, P253, DOI 10.1016/0028-3932(67)90040-1; Wechsler D., 1955, MANUAL WECHSLER ADUL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILSON JTL, 1987, BRIT J DEV PSYCHOL, V5, P249, DOI 10.1111/j.2044-835X.1987.tb01060.x; [No title captured]; [No title captured]	28	20	20	0	1	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology		1989	3	4					255	265		10.1037//0894-4105.3.4.255			11	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V44JW	WOS:000209746300005					2022-02-06	
J	ADOUR, KK; BOYAJIAN, JA; KAHN, ZM; SCHNEIDER, GS				ADOUR, KK; BOYAJIAN, JA; KAHN, ZM; SCHNEIDER, GS			SURGICAL AND NONSURGICAL MANAGEMENT OF FACIAL PARALYSIS FOLLOWING CLOSED HEAD-INJURY	LARYNGOSCOPE			English	Article									KAISER PERMANENTE MED CTR,OAKLAND,CA 94611								ADOUR KK, 1974, NEUROLOGY, V24, P1112, DOI 10.1212/WNL.24.12.1112; ADOUR KK, 1972, NEW ENGL J MED, V287, P1268, DOI 10.1056/NEJM197212212872503; ALFORD BR, 1971, LARYNGOSCOPE, V81, P620, DOI 10.1288/00005537-197105000-00002; Binns P M, 1967, Trans Am Acad Ophthalmol Otolaryngol, V71, P665; BOONE P C, 1959, Acta Neurochir (Wien), V7, P221, DOI 10.1007/BF01405890; BOYLE WF, 1967, LARYNGOSCOPE, V77, P1168, DOI 10.1288/00005537-196707000-00009; BUNNELL S, 1952, AMA ARCH OTOLARYNGOL, V55, P417; DEVRIESE PP, 1972, ARCHIV OTOLARYNGOL, V95, P350; FISCH U, 1974, LARYNGOSCOPE, V84, P2141, DOI 10.1288/00005537-197412000-00005; GREER JA, 1974, ANN OTO RHINOL LARYN, V83, P582, DOI 10.1177/000348947408300503; GROVES J, 1973, P ROY SOC MED, V66, P545, DOI 10.1177/003591577306600625; POTTER J M, 1964, J Laryngol Otol, V78, P654, DOI 10.1017/S0022215100062563	12	20	21	1	1	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0023-852X			LARYNGOSCOPE	Laryngoscope		1977	87	3					380	390		10.1288/00005537-197703000-00011			11	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	CY646	WOS:A1977CY64600011	839932	Bronze			2022-02-06	
J	GOVONS, SR; GOVONS, RB; HEUSNER, WW; VANHUSS, WD				GOVONS, SR; GOVONS, RB; HEUSNER, WW; VANHUSS, WD			BRAIN CONCUSSION IN RAT	EXPERIMENTAL NEUROLOGY			English	Article																	Denny-Brown D, 1941, BRAIN, V64, P7; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; FRIEDE RL, 1961, ARCH NEUROL-CHICAGO, V4, P449, DOI 10.1001/archneur.1961.00450100097012; GOVONS SR, 1968, CONFIN NEUROL, V30, P77; GOVONS SR, 1971, AEROSPACE MED, V42, P421; GOVONS SR, 1947, J NEUROPATH EXP NEUR, V6, P95, DOI 10.1097/00005072-194702000-00008; GRANIT R, 1955, RECEPTORS SENSORY PE; Magnus R, 1926, LANCET, V2, P531; Magnus R, 1926, LANCET, V2, P585; Roberts TDM, 1967, NEUROPHYSIOLOGY POST; Sherrington CS, 1906, INTEGRATIVE ACTION N; SYMONDS CP, 1943, INJURIES SKULL BRAIN, P65; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WALKER AE, 1966, HEAD INJURY C P, P13; WARD AA, 1958, J NEUROSURG, V15, P129, DOI 10.3171/jns.1958.15.2.0129; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561; WITKOWSKI L, 1877, VIRCHOWS ARCH, V69, P498; 1968, 1024 PUBL HEALTH SCI, P10; [No title captured]	19	20	20	1	1	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0014-4886			EXP NEUROL	Exp. Neurol.		1972	34	1					121	&		10.1016/0014-4886(72)90193-8			0	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	L5514	WOS:A1972L551400012	5009503				2022-02-06	
J	BROWN, GW; BROWN, ML				BROWN, GW; BROWN, ML			CARDIOVASCULAR RESPONSES TO EXPERIMENTAL CEREBRAL CONCUSSION IN THE RHESUS MONKEY - DISCUSSION OF SIMILARITY OF RESPONSES TO ELECTROCONVULSIVE SHOCK AND CEREBRAL CONCUSSION IN DOGS, MONKEYS, AND MAN	AMA ARCHIVES OF NEUROLOGY AND PSYCHIATRY			English	Article																	Batson OV, 1944, FED PROC, V3, P139; BROWN GW, 1952, AM J PHYSIOL, V170, P294, DOI 10.1152/ajplegacy.1952.170.2.294; BROWN ML, 1952, AM J PSYCHIAT, V109, P27, DOI 10.1176/ajp.109.1.27; BROWN ML, 1953, AMA ARCH NEUROL PSY, V69, P609, DOI 10.1001/archneurpsyc.1953.02320290061007; BROWN ML, 1953, AMA ARCH NEUROL PSY, V69, P601, DOI 10.1001/archneurpsyc.1953.02320290053006; Davis E. W., 1944, AMER JOUR PSYCHIATRY, V100, P825; Heymans C, 1937, ARCH NEURO PSYCHIATR, V38, P304, DOI 10.1001/archneurpsyc.1937.02260200076006; KOENIG H, 1945, STAIN TECHNOL, V20, P13, DOI 10.3109/10520294509107124; RICHARDSON AW, 1949, J LAB CLIN MED, V34, P1706; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Walker AE, 1945, A RES NERV MENT DIS, V24, P437	11	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0096-6886			AMA ARCH NEUROL PSY			1954	71	6					707	713		10.1001/archneurpsyc.1954.02320420035004			7	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	UF344	WOS:A1954UF34400004	13157700				2022-02-06	
J	Davies, H; Falconer, MA				Davies, H; Falconer, MA			Ventricular changes after closed head injury	JOURNAL OF NEUROLOGY AND PSYCHIATRY			English	Article																	Abramowitsch D, 1930, Z GESAMTE NEUROL PSY, V127, P454, DOI 10.1007/BF02864217; Bagley C, 1928, ARCH SURG-CHICAGO, V17, P18, DOI 10.1001/archsurg.1928.01140070021002; Bennett AE, 1933, ARCH SURG-CHICAGO, V26, P397, DOI 10.1001/archsurg.1933.01170030054004; Bielschowsky P, 1928, Z GESAMTE NEUROL PSY, V117, P55, DOI 10.1007/BF02876518; Cairns H, 1941, BRIT MED J, V1941, P465, DOI 10.1136/bmj.2.4213.465; Dyke CG., 1937, NORMAL ENCEPHALOGRAM; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; Fischer M, 1928, ARCH PSYCHIAT NERVEN, V82, P403, DOI 10.1007/BF01828873; FRIEDMAN ED, 1932, ARCH NEUROL PSYCHIAT, V27, P791; HASSIN GB, 1940, INJURIES SKULL BRAIN; Hauptmann A, 1932, ARCH PSYCHIAT NERVEN, V96, P84, DOI 10.1007/BF02064325; LIPPENS A, 1934, PR MED, V42, P455; LYSHOLM E, 1935, ACTA RADIOL STOCKH S, V24; MONEY RA, 1932, AUST N Z J SURG, V2, P47; Schwab O, 1926, Z GESAMTE NEUROL PSY, V102, P294, DOI 10.1007/BF02962279; SCHWAB O, 1926, DTSCH Z NERVENHEILK, V89, P44; SWIFT GW, 1931, SURG GYNECOL OBSTET, V52, P576; TRAVERS JT, 1937, RADIOLOGY, V28, P704; Winkelman NW, 1934, ARCH NEURO PSYCHIATR, V31, P956, DOI 10.1001/archneurpsyc.1934.02250050074002; [No title captured]	20	20	20	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0368-329X			J NEUROL PSYCHIATRY	J. Neurol. Psychiatry	JAN-APR	1943	6	1/2					52	68		10.1136/jnnp.6.1-2.52			17	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V21BH	WOS:000201422900007	21611417	Green Published, Bronze			2022-02-06	
J	Bieniek, KF; Cairns, NJ; Crary, JF; Dickson, DW; Folkerth, RD; Keene, CD; Litvan, I; Perl, DP; Stein, TD; Vonsattel, JP; Stewart, W; Dams-O'Connor, K; Gordon, WA; Tripodis, Y; Alvarez, VE; Mez, J; Alosco, ML; McKee, AC				Bieniek, Kevin F.; Cairns, Nigel J.; Crary, John F.; Dickson, Dennis W.; Folkerth, Rebecca D.; Keene, C. Dirk; Litvan, Irene; Perl, Daniel P.; Stein, Thor D.; Vonsattel, Jean-Paul; Stewart, William; Dams-O'Connor, Kristen; Gordon, Wayne A.; Tripodis, Yorghos; Alvarez, Victor E.; Mez, Jesse; Alosco, Michael L.; McKee, Ann C.		TBI CTE Res Grp	The Second NINDS/NIBIB Consensus Meeting to Define Neuropathological Criteria for the Diagnosis of Chronic Traumatic Encephalopathy	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Brain trauma; Chronic traumatic encephalopathy; Neurodegenerative disorders; Tauopathy; Traumatic brain injury		Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder associated with exposure to head trauma. In 2015, a panel of neuropathologists funded by the NINDS/NIBIB defined preliminary consensus neuropathological criteria for CTE, including the pathognomonic lesion of CTE as "an accumulation of abnormal hyperphosphorylated tau (p-tau) in neurons and astroglia distributed around small blood vessels at the depths of cortical sulci and in an irregular pattern," based on review of 25 tauopathy cases. In 2016, the consensus panel met again to review and refine the preliminary criteria, with consideration around the minimum threshold for diagnosis and the reproducibility of a proposed pathological staging scheme. Eight neuropathologists evaluated 27 cases of tauopathies (17 CTE cases), blinded to clinical and demographic information. Generalized estimating equation analyses showed a statistically significant association between the raters and CTE diagnosis for both the blinded (OR = 72.11, 95% CI = 19.5-267.0) and unblinded rounds (OR = 256.91, 95% CI = 63.6-1558.6). Based on the challenges in assigning CTE stage, the panel proposed a working protocol including a minimum threshold for CTE diagnosis and an algorithm for the assessment of CTE severity as "Low CTE" or "High CTE" for use in future clinical, pathological, and molecular studies.	[Bieniek, Kevin F.] UT Hlth San Antonio, Dept Pathol, San Antonio, TX USA; [Bieniek, Kevin F.] UT Hlth San Antonio, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX USA; [Cairns, Nigel J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Crary, John F.] Mt Sinai Sch, Icahn Sch Med, Dept Pathol, Ronald M Loeb Ctr Alzheimers Dis,Freidman Brain I, New York, NY USA; [Crary, John F.] Mt Sinai Sch, Icahn Sch Med, Dept Neurosci, Ronald M Loeb Ctr Alzheimers Dis,Freidman Brain I, New York, NY USA; [Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Folkerth, Rebecca D.] NYU, New York City Off Chief Med Examiner, Sch Med, New York, NY USA; [Folkerth, Rebecca D.] NYU, Dept Forens Med, Sch Med, New York, NY USA; [Keene, C. Dirk] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Litvan, Irene] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Stein, Thor D.; Alvarez, Victor E.; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02118 USA; [Tripodis, Yorghos; Alvarez, Victor E.; Mez, Jesse; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Stein, Thor D.; Tripodis, Yorghos; Alvarez, Victor E.; Mez, Jesse; Alosco, Michael L.; McKee, Ann C.] Boston Univ, Alzheimers Dis Ctr, Sch Med, CTE Program, Boston, MA 02118 USA; [Stein, Thor D.; Alvarez, Victor E.; Alosco, Michael L.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Vonsattel, Jean-Paul] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Stewart, William] Univ Glasgow, Dept Neuropathol, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Stewart, William] Queen Elizabeth Univ Hosp, Glasgow, Lanark, Scotland; [Dams-O'Connor, Kristen; Gordon, Wayne A.] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA		McKee, AC (corresponding author), Boston Univ, Sch Med, 72 East Concord St,Robinson 7800, Boston, MA 02118 USA.	amckee@bu.edu		Stewart, William/0000-0003-2199-2582	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01, 1U01NS086625-01, R01NS078337, R56NS078337, R01NS095252]; Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064, W81XWH-14-1-0399]; Department of Veterans Affairs, the Veterans Affairs BiorepositoryUS Department of Veterans Affairs [CSP 501]; National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [1R01AG061028-01]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP) [13267017]; National Institute of Aging Boston University Framingham Heart Study [R01AG1649]; National Operating Committee on Standards for Athletic Equipment; Concussion Legacy Foundation; Andlinger Foundation; World Wrestling Entertainment; National Football League; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50 AG05681, P01 AG03991]	This study was supported by the National Institute of Neurological Disorders and Stroke (1U01NS086659-01, 1U01NS086625-01, R01NS078337, R56NS078337, R01NS095252), Department of Defense (W81XWH-13-2-0064, W81XWH-14-1-0399), Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging (1R01AG061028-01), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), Department of Defense Peer Reviewed Alzheimer's Research Program (DoD-PRARP #13267017), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), the National Operating Committee on Standards for Athletic Equipment and the Concussion Legacy Foundation. This study was also supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment and the National Football League. This study was also supported by grants P50 AG05681 and P01 AG03991 from the National Institute on Aging (NJC).	Bieniek KF, 2020, BRAIN PATHOL, V30, P63, DOI 10.1111/bpa.12757; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bowman KM, 1940, INJURIES SKULL BRAIN, P309; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Buckland ME, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0772-9; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Forrest SL, 2019, J NEUROPATH EXP NEUR, V78, P398, DOI 10.1093/jnen/nlz017; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; HOF PR, 1991, ACTA NEUROPATHOL, V82, P321, DOI 10.1007/BF00308819; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Iacono D, 2020, J NEUROPATH EXP NEUR, V79, P144, DOI 10.1093/jnen/nlz122; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Keene CD, 2018, ACTA NEUROPATHOL, V135, P303, DOI 10.1007/s00401-017-1801-z; Koga S, 2016, J NEUROPATH EXP NEUR, V75, P963, DOI 10.1093/jnen/nlw073; Kouri N, 2011, NAT REV NEUROL, V7, P263, DOI 10.1038/nrneurol.2011.43; Kovacs GG, 2017, J NEUROPATH EXP NEUR, V76, P605, DOI 10.1093/jnen/nlx041; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Kovacs GG, 2011, ACTA NEUROPATHOL, V122, P205, DOI 10.1007/s00401-011-0819-x; Lee EB, 2019, ACTA NEUROPATHOL, V138, P389, DOI 10.1007/s00401-019-02030-y; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Ling HL, 2015, ACTA NEUROPATHOL, V130, P891, DOI 10.1007/s00401-015-1496-y; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Martland HS, 1929, ARCH NEURO PSYCHIATR, V22, P1001, DOI 10.1001/archneurpsyc.1929.02220050139008; MAWDSLEY C, 1963, LANCET, V2, P795; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Noy S, 2016, J NEUROPATH EXP NEUR, V75, P1145, DOI 10.1093/jnen/nlw092; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Oyanagi K, 2011, NEURODEGENERATION MO, P171, DOI [10.1002/9781444341256.ch18, DOI 10.1002/9781444341256.CH18]; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; ROBERTS GW, 1990, LANCET, V335, P918, DOI 10.1016/0140-6736(90)90520-F; SPILLANE J D, 1962, Br Med J, V2, P1205; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stewart W, 2016, QJM-INT J MED, V109, P11, DOI 10.1093/qjmed/hcv070; Tolnay M, 2004, NEUROPATHOLOGY, V24, P269, DOI 10.1111/j.1440-1789.2004.00591.x; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; Zanier ER, 2018, BRAIN, V141, P2685, DOI 10.1093/brain/awy193	55	19	19	1	1	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0022-3069	1554-6578		J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	MAR	2021	80	3					210	219		10.1093/jnen/nlab001			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	RJ0RQ	WOS:000637311200001	33611507	hybrid	Y	N	2022-02-06	
J	Leeper, CM; Yazer, MH; Triulzi, DJ; Neal, MD; Gaines, BA				Leeper, Christine M.; Yazer, Mark H.; Triulzi, Darrell J.; Neal, Matthew D.; Gaines, Barbara A.			Whole Blood is Superior to Component Transfusion for Injured Children A Propensity Matched Analysis	ANNALS OF SURGERY			English	Article						coagulopathy; pediatric; transfusion; trauma; whole blood	TRAUMATIC BRAIN-INJURY; MASSIVE TRANSFUSION; CELL TRANSFUSION; LOW-TITER; MORTALITY; PLASMA; FEASIBILITY; RATIO; AFGHANISTAN	Objective: To compare a propensity-matched cohort of injured children receiving conventional blood component transfusion to injured children receiving low-titer group O negative whole blood. Summary of Background Data: Transfusion of whole blood in pediatric trauma patients is feasible and safe. Effectiveness has not been evaluated. Methods: Injured children >= 1 years old can receive up to 40 mL/kg of cold-stored, uncrossmatched whole blood during initial hemostatic resuscitation. Whole blood recipients (2016-2019) were compared to a propensity-matched cohort who received at least 1 uncrossmatched red blood cell unit in the trauma bay (2013-2016). Cohorts were matched for age, hypotension, traumatic brain injury, injury mechanism, and need for emergent surgery. Outcomes included time to resolution of base deficit, product volumes transfused, and INR after resuscitation. Results: Twenty-eight children who received whole blood were matched to 28 children who received components. The whole blood group had faster time to resolution of base deficit [median (IQR) 2 (1-2.5) hours vs 6 (2-24) hours, respectively; P < 0.001]. The post-transfusion INR was decreased in whole blood vs component cohort [median (IQR) 1.4 (1.3-1.5) vs 1.6 (1.4-2.2); P = 0.01]. Lower plasma volumes [median (IQR) = 5 (0-15) mL/kg vs 11 (5-35) mL/kg; P = 0.04] and lower platelet volumes [median (IQR) = 0 (0-2) vs 3 (0- 8); P = 0.03] were administered to the whole blood group versus component group. Other clinical variables (in-hospital death, hospital length of stay, intensive care unit length of stay, and ventilator days) did not differ between groups. Conclusions: Compared to component transfusion, whole blood transfusion results in faster resolution of shock, lower post-transfusion INR, and decreased component product transfusion. Larger cohorts are required to support these findings.	[Leeper, Christine M.; Yazer, Mark H.; Triulzi, Darrell J.; Neal, Matthew D.; Gaines, Barbara A.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15260 USA		Leeper, CM (corresponding author), Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15260 USA.	leepercm@upmc.edu					Brown JB, 2015, J AM COLL SURGEONS, V220, P797, DOI 10.1016/j.jamcollsurg.2015.01.006; Brown JB, 2015, ANN SURG, V261, P997, DOI 10.1097/SLA.0000000000000674; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Chang R, 2017, SURGERY, V161, P538, DOI 10.1016/j.surg.2016.08.023; Drake SA, 2020, ANN SURG, V271, P375, DOI 10.1097/SLA.0000000000002999; Guyette FX, 2021, ANN SURG, V273, P358, DOI 10.1097/SLA.0000000000003324; Haltmeier T, 2018, INJURY, V49, P62, DOI 10.1016/j.injury.2017.07.035; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2015, PREHOSP EMERG CARE, V19, P1, DOI 10.3109/10903127.2014.923077; Jobes D, 2011, TRANSFUSION, V51, P43, DOI 10.1111/j.1537-2995.2010.02772.x; Karam Oliver, 2018, Pediatr Crit Care Med, V19, pS127, DOI 10.1097/PCC.0000000000001605; Leeper CM, 2019, J TRAUMA ACUTE CARE, V87, P49, DOI 10.1097/TA.0000000000002340; Leeper CM, 2018, J TRAUMA ACUTE CARE, V85, P674, DOI 10.1097/TA.0000000000001823; Leeper CM, 2018, JAMA PEDIATR, V172, P491, DOI 10.1001/jamapediatrics.2017.5238; Neff LP, 2015, J TRAUMA ACUTE CARE, V78, P22, DOI 10.1097/TA.0000000000000488; Pidcoke HF, 2013, TRANSFUSION, V53, p137S, DOI 10.1111/trf.12048; Pusateri AE, JAMA SURG; Seheult JN, 2017, TRANSFUSION MED, V27, P30, DOI 10.1111/tme.12372; Seheult JN, 2018, TRANSFUSION, V58, P2280, DOI 10.1111/trf.14771; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Shea SM, 2020, TRANSFUSION, V60, pS2, DOI 10.1111/trf.15696; Shroyer MC, 2017, J SURG RES, V208, P166, DOI 10.1016/j.jss.2016.09.039; Sperry JL, 2018, NEW ENGL J MED, V379, P315, DOI 10.1056/NEJMoa1802345; Strandenes G, 2015, J TRAUMA ACUTE CARE, V78, pS31, DOI 10.1097/TA.0000000000000628; Treml AB, 2017, ANESTH ANALG, V124, P277, DOI 10.1213/ANE.0000000000001610; Vanderspurt CK, 2019, TRANSFUSION, V59, P965, DOI 10.1111/trf.15086; Williams J, 2020, J TRAUMA ACUTE CARE, V88, P87, DOI 10.1097/TA.0000000000002498; Yazer MH, 2018, TRANSFUSION, V58, P2744, DOI 10.1111/trf.14869; Yazer MH, 2016, J TRAUMA ACUTE CARE, V81, P21, DOI 10.1097/TA.0000000000001100; Yazer MH., 2019, VOXS, V14, P276, DOI DOI 10.1111/VOXS.12495; Zhu CS, 2019, TRANSFUSION, V59, P1429, DOI 10.1111/trf.15264	32	19	20	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	OCT	2020	272	4					590	594		10.1097/SLA.0000000000004378			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	RM1CZ	WOS:000639399600020	32932312				2022-02-06	
J	Whiting, D; Deane, F; McLeod, H; Ciarrochi, J; Simpson, G				Whiting, Diane; Deane, Frank; McLeod, Hamish; Ciarrochi, Joseph; Simpson, Grahame			Can acceptance and commitment therapy facilitate psychological adjustment after a severe traumatic brain injury? A pilot randomized controlled trial	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Acceptance and commitment therapy; Randomized controlled trial; Depression; Anxiety; Stress; Traumatic brain injury; Psychological flexibility	COGNITIVE-BEHAVIORAL THERAPY; SCHEDULED TELEPHONE INTERVENTION; ANXIETY STRESS SCALES; DEPRESSIVE SYMPTOMS; EMOTIONAL DISTRESS; GOAL ATTAINMENT; 1ST YEAR; ACT; REHABILITATION; REINTEGRATION	This study i & x2060;nvestigated if an Acceptance and Commitment Therapy (ACT) intervention (ACT-Adjust) can facilitate psychological adjustment and reduce psychological distress following severe traumatic brain injury (TBI). The study design comprised a single centre, two-armed, Phase II pilot randomized controlled trial. Nineteen individuals with severe TBI (PTA >= 7 days) who met a clinical threshold for psychological distress (Depression Anxiety Stress Scales-21; DASS > 9) were randomly allocated to either ACT-Adjust (n = 10) or an active control, Befriending Therapy (n = 9), in conjunction with a holistic rehabilitation programme. Primary (psychological flexibility, rehabilitation participation) and secondary (depression, anxiety & stress) outcomes were measured at three-time points (pre, post and follow up). Significant decreases were found for DASS-depression (group by time interaction,F-1,F-17 = 5.35,p = .03) and DASS-stress (group by time interaction,F-1,F-17 = 5.69,p = .03) in comparison to the Befriending group, but not for the primary outcome measures. The reduction in stress post-treatment was classed as clinically significant, however interaction differences for stress and depression were not maintained at one month follow up. Preliminary investigations indicate potential for ACT in decreasing psychological distress for individuals with a severe TBI with further sessions required to maintain treatment gains. The pilot results suggest further investigation is warranted in a larger scale clinical trial.	[Whiting, Diane; Simpson, Grahame] Ingham Inst Appl Med Res, Brain Injury Rehabil Res Grp, 1 Campbell St Liverpool, Sydney, NSW 2170, Australia; [Whiting, Diane; Deane, Frank] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [McLeod, Hamish] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Ciarrochi, Joseph] Australian Catholic Univ, Inst Hlth & Wellbeing, Strathfield, Australia; [Simpson, Grahame] Univ Sydney, Kolling Inst Med Res, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia		Whiting, D (corresponding author), Ingham Inst Appl Med Res, 1 Campbell St, Liverpool, NSW 2170, Australia.	dwhiting@bigpond.net.au	Ciarrochi, Joseph/F-5823-2016; Whiting, Diane/AAN-2522-2021	Ciarrochi, Joseph/0000-0003-0471-8100; Simpson, Grahame/0000-0001-8156-9060; Whiting, Diane/0000-0003-1912-6626			Antonak R. F., 1993, J HEAD TRAUMA REHAB, V8, P87, DOI DOI 10.1097/00001199-199312000-00009; Ashman T, 2014, J HEAD TRAUMA REHAB, V29, P467, DOI 10.1097/HTR.0000000000000098; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E, 2009, BIOL RES NURS, V10, P213, DOI 10.1177/1099800408326453; Bedard M, 2014, J HEAD TRAUMA REHAB, V29, pE13, DOI 10.1097/HTR.0b013e3182a615a0; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bendall S, 2003, BEFRIENDING MANUAL; Bendall S, 2006, BEHAV COGN PSYCHOTH, V34, P277, DOI 10.1017/S1352465806002815; Blevins D, 2011, PROF PSYCHOL-RES PR, V42, P32, DOI 10.1037/a0022321; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bombardier CH, 2009, J HEAD TRAUMA REHAB, V24, P230, DOI 10.1097/HTR.0b013e3181ad65f0; Bomyea J, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000278; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Brenner LA, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000351; Brenner LA, 2012, J HEAD TRAUMA REHAB, V27, pE57, DOI 10.1097/HTR.0b013e318273414c; Brinkborg H, 2011, BEHAV RES THER, V49, P389, DOI 10.1016/j.brat.2011.03.009; Brown M, 2004, J HEAD TRAUMA REHAB, V19, P459, DOI 10.1097/00001199-200411000-00004; Chervinsky AB, 1998, ARCH CLIN NEUROPSYCH, V13, P433, DOI 10.1016/S0887-6177(97)00016-4; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; Ciarrochi J., 2008, CBT PRACTITIONERS GU; Ciarrochi J., 2010, ASSESSING MINDFULNES, P51; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Cumming G, 2013, AUST PSYCHOL, V48, P161, DOI 10.1111/ap.12018; Dahm J, 2013, J AFFECT DISORDERS, V151, P392, DOI 10.1016/j.jad.2013.06.011; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Eifert G. H., 2006, ACT LIFE NOT ANGER N; Fann JR, 2015, J NEUROTRAUM, V32, P45, DOI 10.1089/neu.2014.3423; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Freedland KE, 2011, PSYCHOSOM MED, V73, P323, DOI 10.1097/PSY.0b013e318218e1fb; Freeman A, 2015, NEUROPSYCHOL REHABIL, V25, P189, DOI 10.1080/09602011.2014.917686; Gallagher M, 2019, NEUROPSYCHOL REHABIL, V29, P1, DOI 10.1080/09602011.2016.1258367; Gertler P, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009871.pub2; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Gracey F., 2016, NEURO DISABILITY PSY, V3, P154; Graham CD, 2016, CLIN PSYCHOL REV, V46, P46, DOI 10.1016/j.cpr.2016.04.009; Hardy GE, 1999, PSYCHOL ASSESSMENT, V11, P159, DOI 10.1037/1040-3590.11.2.159; Hart T, 2008, NEUROPSYCHOL REHABIL, V18, P1, DOI 10.1080/09602010601082359; Hayes SC, 2006, BEHAV RES THER, V44, P1, DOI 10.1016/j.brat.2005.06.006; Hayes SC, 2003, ACCEPTANCE COMMITMEN; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; IBM Corp, 2013, SPSS STAT WIND VERS; Jackson HJ, 2008, PSYCHOL MED, V38, P725, DOI 10.1017/S0033291707002061; Kangas M, 2011, NEUROPSYCHOL REHABIL, V21, P250, DOI 10.1080/09602011.2010.540920; Karlovits T, 1999, BRAIN INJURY, V13, P845; Kashdan TB, 2010, CLIN PSYCHOL REV, V30, P865, DOI 10.1016/j.cpr.2010.03.001; Lang AJ, 2017, PSYCHOL TRAUMA-US, V9, P74, DOI 10.1037/tra0000127; Lang AJ, 2012, CONTEMP CLIN TRIALS, V33, P116, DOI 10.1016/j.cct.2011.08.007; Lovibond SH., 1995, MANUAL DEPRESSION AN; Malec JF, 1999, NEUROPSYCHOL REHABIL, V9, P253, DOI 10.1080/096020199389365; McHugh L, 2011, WORLD J BIOL PSYCHIA, V12, P76, DOI 10.3109/15622975.2011.603225; Mead N, 2010, BRIT J PSYCHIAT, V196, P96, DOI 10.1192/bjp.bp.109.064089; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Ponsford J, 2016, PSYCHOL MED, V46, P1079, DOI 10.1017/S0033291715002640; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Randall D, 2017, J HEAD TRAUMA REHAB, V32, P134, DOI 10.1097/HTR.0000000000000250; Randolph C., 1998, RBANS MANUAL REPEATA; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roundhill S. J., 2007, QUALITATIVE RES PSYC, V4, P241, DOI [DOI 10.1080/14780880701473540, 10.1080/14780880701473540]; Schonberger M, 2010, PSYCHIAT RES, V179, P342, DOI 10.1016/j.psychres.2009.07.003; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1186/1741-7015-8-18]; Shields C, 2016, NEUROPSYCHOL REHABIL, V26, P410, DOI 10.1080/09602011.2015.1037772; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Soo C, 2011, BRAIN IMPAIR, V12, P54, DOI 10.1375/brim.12.1.54; Sylvester M., 2011, THESIS U NEVADA; Tate RL, 2004, BRAIN IMPAIR, V5, P81, DOI [DOI 10.1375/BRIM.5.1.81.35408, 10.1375/brim.5.1.81.35408, DOI 10.1375/brim.5.1.81.35408]; Tate RL, 2011, J REHABIL MED, V43, P609, DOI 10.2340/16501977-0829; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Whiting DL, 2018, CLIN PSYCHOL-UK, V22, P230, DOI 10.1111/cp.12118; Whiting DL, 2017, NEUROPSYCHOL REHABIL, V27, P263, DOI 10.1080/09602011.2015.1062115; Whiting DL, 2015, PSYCHOL ASSESSMENT, V27, P415, DOI 10.1037/pas0000050; Whiting DL, 2012, BRAIN IMPAIR, V13, P360, DOI 10.1017/BrImp.2012.28; Wilson K.G., 2009, MINDFULNESS 2 ACCEPT; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	80	19	19	3	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 8	2020	30	7					1348	1371		10.1080/09602011.2019.1583582			24	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	MH9SO	WOS:000547060000007	30789059	Green Accepted			2022-02-06	
J	Buckley, TA; Howard, CM; Oldham, JR; Lynall, RC; Swanik, CB; Getchell, N				Buckley, Thomas A.; Howard, Caroline M.; Oldham, Jessie R.; Lynall, Robert C.; Swanik, C. Buz; Getchell, Nancy			No Clinical Predictors of Postconcussion Musculoskeletal Injury in College Athletes	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						MILD TRAUMATIC BRAIN INJURY; INJURY PREDICTION; BALANCE; NEUROCOGNITIVE	CONCUSSION-ASSESSMENT; SUBSEQUENT INJURY; CONTROL DEFICITS; ASSOCIATION; SPORT; RISK; SENSITIVITY; INCREASES; TRAINERS; HISTORY	Purpose This study aimed to identify clinical predictors of postconcussion subsequent musculoskeletal (MSK) injuries. Methods We recruited 66 National Collegiate Athletic Association intercollegiate student-athletes with a diagnosed concussion as well as 36 National Collegiate Athletic Association student-athletes without a concussion. All participants completed a multifaceted concussion baseline consisting of 1) 22-item 0-6 self-reported symptom checklist with outcomes including both the number of symptoms endorsed (0-22) and 2) total symptom score (0-132), 3) Standard Assessment of Concussion, 4) Balance Error Scoring System, 5) Immediate Post-Concussion Assessment and Cognitive Testing, 6) clinical reaction time, and 7) the King-Devick as well as demographic and injury characteristics. The concussion participants completed the same examination acutely postconcussion, and binary logistic regression was used to identify predictors of subsequent MSK from the change scores (acute minus baseline). From the 66 concussed student-athletes, a subset 36, matched with the healthy athletes, compared the risk of subsequent MSK in the year before and year after their concussion. Results The concussion participants were 1.78 times (95% confidence interval, 1.12-2.84; P = 0.015) more likely to suffer a lower extremity MSK in the year after their concussion than the control participants. The participant demographics and injury characteristics (P = 0.318) and concussion clinical outcomes (P = 0.461) did not predict subsequent MSK. Conclusion The concussion participants were 1.78 times more likely to sustain a subsequent MSK; however, no demographic, injury characteristic, or concussion assessments predicted the MSK. Thus, clinicians are not able to utilize common neurological measures or participant demographics to identify those at risk for subsequent lower extremity MSK. Injury prevention strategies should be considered for collegiate student-athletes upon premature return to participation after a concussion to reduce the subsequent MSK.	[Buckley, Thomas A.; Swanik, C. Buz; Getchell, Nancy] Univ Delaware, Dept Kinesiol & Appl Physiol, 349 STAR Tower,100 Discovery Blvd, Newark, DE 19716 USA; [Buckley, Thomas A.; Swanik, C. Buz; Getchell, Nancy] Univ Delaware, Interdisciplinary Program Biomech & Movement Sci, Newark, DE 19716 USA; [Howard, Caroline M.] Univ Delaware, Dept Intercollegiate Athlet, Newark, DE 19716 USA; [Oldham, Jessie R.] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Lynall, Robert C.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, 349 STAR Tower,100 Discovery Blvd, Newark, DE 19716 USA.	TBuckley@UDel.edu	Buckley, Thomas A/B-7525-2016; Getchell, Nancy/AAT-7985-2020; Lynall, Robert/M-2888-2014	Buckley, Thomas A/0000-0002-0515-0150; Getchell, Nancy/0000-0001-9230-9838; Lynall, Robert/0000-0002-0785-6640	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association; Department of DefenseUnited States Department of Defense; US Army Medical Research Acquisition Activity (Fort Detrick, MD); Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program [W81XWH-BA170608]; National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R03NS104371]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association and the Department of Defense. The US Army Medical Research Acquisition Activity (Fort Detrick, MD) is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program, endorsed by the Department of Defense under Award No. W81XWH-BA170608. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Office of the Assistant Secretary of Defense for Health Affairs. This project was also funded, in part, by a grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke (R03NS104371).	Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2019, SPORTS MED, V49, P1977, DOI 10.1007/s40279-019-01155-0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Buckley HL, 2017, J RENEW MATER, V5, P1, DOI 10.7569/JRM.2016.634109; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Finch CF, 2018, BRIT J SPORT MED, V52, P1077, DOI 10.1136/bjsports-2017-098225; Fino PC, 2019, CLIN J SPORT MED, V29, P218, DOI 10.1097/JSM.0000000000000502; Garcia GGP, 2019, J NEUROTRAUM, V36, P1571, DOI 10.1089/neu.2018.6098; Gilbert FC, 2016, SPORTS HEALTH, V8, P661, DOI 10.1177/1941738116666509; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Herman DC, 2015, CURR SPORT MED REP, V14, P194, DOI 10.1249/JSR.0000000000000157; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Houston MN, 2018, BRAIN INJURY, V32, P1353, DOI 10.1080/02699052.2018.1512718; Howell DR, 2018, J NEUROTRAUM, V35, P1630, DOI 10.1089/neu.2017.5570; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Lynall RC, 2017, J ATHL TRAINING, V52, P1028, DOI 10.4085/1062-6050-52.11.22; Lynall RC, 2017, J ATHL TRAINING, V52, P518, DOI 10.4085/1062-6050-52.2.03; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Mather RC, 2013, J BONE JOINT SURG AM, V95A, P1751, DOI 10.2106/JBJS.L.01705; McCrea M, 2020, BRIT J SPORT MED, V54, P102, DOI 10.1136/bjsports-2019-100579; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Misra A, COMMON SPORTS INJURI; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Turner S, 2017, SPORT EXERC PERFORM, V6, P277, DOI 10.1037/spy0000099; Weber ML, 2019, ANN BIOMED ENG, V47, P2136, DOI 10.1007/s10439-018-02151-7	40	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2020	52	6					1256	1262		10.1249/MSS.0000000000002269			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	LS2TN	WOS:000536241900003	31972629	Green Accepted			2022-02-06	
J	Xu, F; Huang, ZL; Yang, FF; Wang, D; Tsui, KL				Xu, Fan; Huang, Zhelin; Yang, Fangfang; Wang, Dong; Tsui, Kwok Leung			Constructing a health indicator for roller bearings by using a stacked auto-encoder with an exponential function to eliminate concussion	APPLIED SOFT COMPUTING			English	Article						Roller bearings; Deep learning; Stacked auto-encoder; Health indicator; Exponent function	ROTATING MACHINERY; FAULT-DIAGNOSIS; COULOMBIC EFFICIENCY; NEURAL-NETWORKS; LEARNING-METHOD; DEEP NETWORK; AUTOENCODER; DEGRADATION; PROGNOSIS; TOOL	Most deep-learning models, especially stacked auto-encoders (SAES), have been used in recent years for the diagnosis of faults in rotating machinery. However, very few studies have reported on health indicator (HI) construction by using SAES in deep learning. SAES have a good feature-extraction ability when several hidden layers are used to reconstruct the original input. In this study, we first introduce a method to reduce dependence on prior knowledge that is based on SAES and enables extraction of the preliminary degradation trend from the bearing's frequency domain directly. Second, to construct the final HI and improve the monotonicity of the indicators, an exponential function is used to eliminate global severe vibration after an SAE has extracted the preliminary degradation trend. To prove the effect of our presented method, some other HI construction models, such as root mean square, kurtosis, approximate entropy, permutations entropy, empirical mode decomposition-singular value decomposition, K-means/K-medoids, and various time-frequency fusion indicators are used for comparison. Moreover, to prove that the exponential-function effect exceeds other severe vibration-eliminating methods, examples of the latter methods such as exponentially weighted moving-average and outlier detection are used for comparative analysis. Finally, the results shows that our proposed model is better than the above-mentioned existing models. (C) 2020 Elsevier B.V. All rights reserved.	[Xu, Fan; Huang, Zhelin; Yang, Fangfang; Tsui, Kwok Leung] City Univ Hong Kong, Sch Data Sci, Kowloon, Tat Chee Ave, Hong Kong 990777, Peoples R China; [Huang, Zhelin] Shenzhen Univ, Sch Econ, Dept Stat, Shenzhen 518061, Peoples R China; [Wang, Dong] Shanghai Jiao Tong Univ, State Key Lab Mech Syst & Vibrat, Shanghai 200240, Peoples R China		Huang, ZL (corresponding author), City Univ Hong Kong, Sch Data Sci, Kowloon, Tat Chee Ave, Hong Kong 990777, Peoples R China.; Huang, ZL (corresponding author), Shenzhen Univ, Sch Econ, Dept Stat, Shenzhen 518061, Peoples R China.	fanxu8@cityu.edu.hk; zhuang44@cityu.edu.hk	Wang, Dong/K-8230-2018	Wang, Dong/0000-0003-4872-4860	Research Grants Council Theme-based Research Scheme [T32-101/15-R]; grant (RIF) from the Research Grants Council of the Hong Kong Special Administrative Region, China [R-5020-18]; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [51975355];  [CityU 11206417]	This research work was partly supported by the General Research Fund (Project No. CityU 11206417), the Research Grants Council Theme-based Research Scheme under Project T32-101/15-R, the grant (RIF) from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. R-5020-18). The Natural Science Foundation of China under Grant No. 51975355.	Affonso C, 2017, EXPERT SYST APPL, V85, P114, DOI 10.1016/j.eswa.2017.05.039; AP S. C., 2014, ADV NEURAL INFORM PR, P1853; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Chandola V., 2007, ACM COMPUT SURV CSUR, P1; Guo L, 2017, NEUROCOMPUTING, V240, P98, DOI 10.1016/j.neucom.2017.02.045; Gupta M, 2014, IEEE T KNOWL DATA EN, V26, P2250, DOI 10.1109/TKDE.2013.184; He Zhengjia, 2014, Journal of Mechanical Engineering, V50, P171, DOI 10.3901/JME.2014.02.171; Heng A, 2009, MECH SYST SIGNAL PR, V23, P1600, DOI 10.1016/j.ymssp.2008.12.006; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Javed K, 2015, IEEE T IND ELECTRON, V62, P647, DOI 10.1109/TIE.2014.2327917; Jia F, 2016, MECH SYST SIGNAL PR, V72-73, P303, DOI 10.1016/j.ymssp.2015.10.025; Kong ZM, 2019, IEEE T INF FOREN SEC, V14, P3151, DOI 10.1109/TIFS.2019.2908481; Kosasih B, 2014, APPL MECH MATER, V493, P343, DOI 10.4028/www.scientific.net/AMM.493.343; Lai JG, 2020, IEEE T CIRCUITS-II, V67, P2094, DOI 10.1109/TCSII.2019.2950764; Lai JG, 2019, IEEE T IND INFORM, V15, P5906, DOI 10.1109/TII.2019.2908666; Lei YG, 2016, IEEE T INSTRUM MEAS, V65, P2671, DOI 10.1109/TIM.2016.2601004; Li XQ, 2019, MECH MACH THEORY, V133, P229, DOI 10.1016/j.mechmachtheory.2018.11.005; Lu C, 2017, SIGNAL PROCESS, V130, P377, DOI 10.1016/j.sigpro.2016.07.028; Mansouri M, 2018, SOL ENERGY, V167, P125, DOI 10.1016/j.solener.2018.03.073; Qi YM, 2017, IEEE ACCESS, V5, P15066, DOI 10.1109/ACCESS.2017.2728010; Rai A, 2017, MECH SYST SIGNAL PR, V93, P16, DOI 10.1016/j.ymssp.2017.02.003; Ren L, 2017, J MANUF SYST, V43, P248, DOI 10.1016/j.jmsy.2017.02.013; Saufi SR, 2018, MEAS SCI TECHNOL, V29, DOI 10.1088/1361-6501/aae5b2; Shao HD, 2017, MECH SYST SIGNAL PR, V95, P187, DOI 10.1016/j.ymssp.2017.03.034; Shen CQ, 2018, ENG APPL ARTIF INTEL, V76, P170, DOI 10.1016/j.engappai.2018.09.010; Shen Zhongjie, 2013, Journal of Mechanical Engineering, V49, P183, DOI 10.3901/JME.2013.02.183; Sun SN, 2017, NEUROCOMPUTING, V257, P79, DOI 10.1016/j.neucom.2016.11.063; Sun WJ, 2016, MEASUREMENT, V89, P171, DOI 10.1016/j.measurement.2016.04.007; Tang RL, 2020, APPL ENERG, V259, DOI 10.1016/j.apenergy.2019.114183; Tang RL, 2018, ENERGY, V162, P697, DOI 10.1016/j.energy.2018.08.048; Tian Y, 2019, MECH SYST SIGNAL PR, V114, P658, DOI 10.1016/j.ymssp.2016.04.028; Tse PW, 2017, J VIB CONTROL, V23, P1925, DOI 10.1177/1077546315604522; Tse YL, 2019, MEASUREMENT, V139, P140, DOI 10.1016/j.measurement.2019.02.079; Varnier C., 2012, IEEE INT C PROGN HLT; Vincent P., P 25 INT C MACHINE L, DOI [DOI 10.1145/1390156.1390294, 10.1145/1390156.1390294]; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Wang D, 2018, IEEE ACCESS, V6, DOI 10.1109/ACCESS.2017.2774261; Wang YR, 2019, KNOWL-BASED SYST, V163, P438, DOI 10.1016/j.knosys.2018.09.005; Williams, 2002, COGNITIVE MODELING, P213; Williams T, 2001, MECH SYST SIGNAL PR, V15, P979, DOI 10.1006/mssp.2001.1418; Wu Z, 2020, IEEE T IND INFORM, V16, P4512, DOI 10.1109/TII.2019.2944627; Xu F, 2018, APPL SOFT COMPUT, V73, P898, DOI 10.1016/j.asoc.2018.09.037; Yan RQ, 2007, MECH SYST SIGNAL PR, V21, P824, DOI 10.1016/j.ymssp.2006.02.009; Yan RQ, 2012, MECH SYST SIGNAL PR, V29, P474, DOI 10.1016/j.ymssp.2011.11.022; Yang FF, 2019, ENERGY, V171, P1173, DOI 10.1016/j.energy.2019.01.083; Yang FF, 2018, ENERGY, V145, P486, DOI 10.1016/j.energy.2017.12.144	46	19	20	6	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1568-4946	1872-9681		APPL SOFT COMPUT	Appl. Soft. Comput.	APR	2020	89								106119	10.1016/j.asoc.2020.106119			15	Computer Science, Artificial Intelligence; Computer Science, Interdisciplinary Applications	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science	KU9KA	WOS:000520042200024					2022-02-06	
J	Ren, YZ; Zhang, BZ; Zhao, XJ; Zhang, ZY				Ren, Yi-Zhi; Zhang, Ben-Zheng; Zhao, Xiao-Jing; Zhang, Zhi-Yuan			Resolvin D1 ameliorates cognitive impairment following traumatic brain injury via protecting astrocytic mitochondria	JOURNAL OF NEUROCHEMISTRY			English	Article						astrocyte; cognitive impairment; mitochondrial protection; RvD1; traumatic brain injury	MACROPHAGE POLARIZATION; MICROGLIAL ACTIVATION; NLRP3 INFLAMMASOME; NEUROINFLAMMATION; DYSFUNCTION	Cognitive impairment is one of the most common and devastating neuropsychiatric sequelae after traumatic brain injury (TBI), and hippocampal neuronal survival plays a causal role in this pathological process. Resolvin D1 (RvD1), an important endogenous specialized pro-resolving mediator, has recently been reported to exert a potent protective effect on mitochondria. This suggests that RvD1 may suppress neuroinflammation and protect astrocytic mitochondria at the same time to play further neuroprotective roles. C57BL/6 mice subjected to TBI using a controlled cortical impact device were used for in vivo experiments. Cultured primary mouse astrocytes and an N2a mouse neuroblastoma cell line were used for in vitro experiments. In TBI mice, RvD1 significantly ameliorated cognitive impairment, suppressed gliosis and alleviated neuronal loss in the hippocampus. To explore the mechanism underlying this activity, we verified that RvD1 can induce a higher level of mitophagy to remove damaged mitochondria and eliminate extra mitochondria-derived reactive oxygen species (mitoROS) by activating ALX4/FPR2 receptors in astrocytes. In an in vitro model, we further confirmed that RvD1 can protect mitochondrial morphology and membrane potential in astrocytes and thereby enhance the survival of neurons. Meanwhile, RvD1 was also shown to increase the expression of brain-derived neurotrophic factor and glutamate aspartate transporter in the hippocampus following TBI, which indicates a possible way by which RvD1 increases the supportive function of astrocytes. These findings suggest that RvD1 may be a potent therapeutic option for ameliorating cognitive impairment following TBI by controlling neuroinflammation and protecting astrocytic mitochondria.	[Ren, Yi-Zhi; Zhang, Ben-Zheng; Zhao, Xiao-Jing; Zhang, Zhi-Yuan] Nanjing Med Univ, Dept Pathol, Longmian Ave 101, Nanjing 211166, Peoples R China; [Zhang, Zhi-Yuan] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Nanjing, Peoples R China; [Zhang, Zhi-Yuan] Nanjing Med Univ, Sir Run Run Hosp, Dept Neurol, Nanjing, Peoples R China		Zhang, ZY (corresponding author), Nanjing Med Univ, Dept Pathol, Longmian Ave 101, Nanjing 211166, Peoples R China.	zzy@njmu.edu.cn		Zhang, Zhi-Yuan/0000-0001-9067-0670; yizhi, ren/0000-0002-5762-1014	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571240, 81771171]; Jiangsu Provincial Innovation Team Program	National Natural Science Foundation of China, Grant/Award Number: 81571240 and 81771171; Jiangsu Provincial Innovation Team Program 2017	Abdolmaleki F, 2020, CLIN REV ALLERG IMMU, V58, P82, DOI 10.1007/s12016-019-08754-9; Alberini CM, 2018, GLIA, V66, P1244, DOI 10.1002/glia.23250; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Bisicchia E, 2018, MOL NEUROBIOL, V55, P6894, DOI 10.1007/s12035-018-0889-z; Bolanos JP, 2016, J NEUROCHEM, V139, P115, DOI 10.1111/jnc.13486; Carneiro CFD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196258; Chao HL, 2019, J NEUROSCI, V39, P1930, DOI 10.1523/JNEUROSCI.3415-17.2018; Chen XR, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1345-8; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cohen J, 2019, AGING CELL, V18, DOI 10.1111/acel.12937; Di Pietro V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09587-2; Du RH, 2016, REDOX BIOL, V9, P178, DOI 10.1016/j.redox.2016.08.006; Famenini S, 2017, FASEB J, V31, P148, DOI 10.1096/fj.201600677RR; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gerbatin RD, 2017, MOL NEUROBIOL, V54, P7585, DOI 10.1007/s12035-016-0238-z; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Higgins G, 2016, AM J PHYSIOL-LUNG C, V310, pL1053, DOI 10.1152/ajplung.00368.2015; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Ishii T, 2019, FREE RADICAL BIO MED, V133, P169, DOI 10.1016/j.freeradbiomed.2018.09.002; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jo M, 2017, J NEUROSCI, V37, P2878, DOI 10.1523/JNEUROSCI.2534-16.2017; Joshi AU, 2019, NAT NEUROSCI, V22, P1635, DOI 10.1038/s41593-019-0486-0; Kang JW, 2018, BRIT J PHARMACOL, V175, P2441, DOI 10.1111/bph.14212; Kang JW, 2016, BBA-MOL CELL BIOL L, V1861, P1025, DOI 10.1016/j.bbalip.2016.06.002; Kempuraj D, 2020, NEUROSCIENTIST, V26, P134, DOI 10.1177/1073858419848293; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Ladak AA, 2019, WORLD NEUROSURG, V131, P126, DOI 10.1016/j.wneu.2019.07.039; Lee JY, 2019, THERANOSTICS, V9, P1029, DOI 10.7150/thno.29868; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu YL, 2018, J NEUROTRAUM, V35, P2850, DOI 10.1089/neu.2017.5397; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Luo BW, 2016, J NEUROSCI, V36, P9590, DOI 10.1523/JNEUROSCI.0020-16.2016; Morganti JM, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1493-5; Moulin T. C., 2016, EVIDENCE BASED PRECL, V3; Murru S, 2019, GLIA, V67, P1526, DOI 10.1002/glia.23626; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Ohno Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113313; Prieto P, 2015, AUTOPHAGY, V11, P1729, DOI 10.1080/15548627.2015.1078958; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Rui Q, 2019, EXP NEUROL, V322, DOI 10.1016/j.expneurol.2019.113044; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Shalini SM, 2018, MOL NEUROBIOL, V55, P1537, DOI 10.1007/s12035-017-0413-x; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Shi KB, 2019, CELL MOL IMMUNOL, V16, P523, DOI 10.1038/s41423-019-0213-5; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Shoji H, 2014, JOVE-J VIS EXP, DOI 10.3791/50871; Sun LL, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0913-7; Terrando N, 2014, MOL MED, V20, P667, DOI 10.2119/molmed.2014.00143; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Viscomi MT, 2014, MOL NEUROBIOL, V50, P368, DOI 10.1007/s12035-013-8629-x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Xu X, 2018, NEUROBIOL DIS, V117, P15, DOI 10.1016/j.nbd.2018.05.016; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Xu ZZ, 2013, J NEUROIMMUNE PHARM, V8, P37, DOI 10.1007/s11481-012-9394-8; Hung YP, 2011, CELL METAB, V14, P545, DOI 10.1016/j.cmet.2011.08.012; Zhao QF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0835-7; Zheng LD, 2020, AUTOPHAGY, V16, P1366, DOI 10.1080/15548627.2019.1668228	61	19	19	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	SEP	2020	154	5					530	546		10.1111/jnc.14962		JAN 2020	17	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	NB8CL	WOS:000509824800001	31951012				2022-02-06	
J	Bland, ML; McNally, C; Zuby, DS; Mueller, BC; Rowson, S				Bland, Megan L.; McNally, Craig; Zuby, David S.; Mueller, Becky C.; Rowson, Steven			Development of the STAR Evaluation System for Assessing Bicycle Helmet Protective Performance	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Concussion; Cycling; Injury risk; Impact; Biomechanics	HEAD-INJURY; REAL-WORLD; CONCUSSION; RISK	Cycling is a leading cause of mild traumatic brain injury in the US. While bicycle helmets help protect cyclists who crash, limited biomechanical data exist differentiating helmet protective capabilities. This paper describes the development of a bicycle helmet evaluation scheme based in real-world cyclist accidents and brain injury mechanisms. Thirty helmet models were subjected to oblique impacts at six helmet locations and two impact velocities. The summation of tests for the analysis of risk (STAR) equation, which condenses helmet performance from a range of tests into a single value, was used to summarize measured linear and rotational head kinematics in the context of concussion risk. STAR values varied between helmets (10.9-25.3), with lower values representing superior protection. Road helmets produced lower STAR values than urban helmets. Helmets with slip planes produced lower STAR values than helmets without. This bicycle helmet evaluation protocol can educate consumers on the relative impact performance of various helmets and stimulate safer helmet design.	[Bland, Megan L.; McNally, Craig; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Ctr Injury Biomech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA; [Zuby, David S.; Mueller, Becky C.] Insurance Inst Highway Safety, 988 Dairy Rd, Ruckersville, VA 22968 USA		Bland, ML (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Ctr Injury Biomech, 440 Kelly Hall,325 Stanger St, Blacksburg, VA 24061 USA.	mbland27@vt.edu	Rowson, Steven/B-1270-2012	Rowson, Steven/0000-0002-3227-0596	Virginia Tech Institute for Critical Technology and Applied Science (Blacksburg, VA); Insurance Institute for Highway Safety (Ruckersville, VA)	The authors would like to thank the Virginia Tech Institute for Critical Technology and Applied Science (Blacksburg, VA) and the Insurance Institute for Highway Safety (Ruckersville, VA) for their funding and support.	Bland M.L., 2018, P IRCOBI C ATH GREEC; Bland ML, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040019; Bland ML, 2018, TRAFFIC INJ PREV, V19, pS158, DOI 10.1080/15389588.2017.1388915; Bonugli E., 2015, THESIS; Bourdet N, 2014, INT J CRASHWORTHINES, V19, P222, DOI 10.1080/13588265.2013.805293; Butz RC, 2015, J BIOMECH, V48, P3816, DOI 10.1016/j.jbiomech.2015.09.032; Cobb BR, 2018, P I MECH ENG P-J SPO, V232, P176, DOI 10.1177/1754337117708092; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; ECE, 1999, R2205 ECE UN EC COMM; Eckersley C. P., 2017, P IRCOBI C ANTW BELG, P685; European Committee for Standardization, 1997, 1078 CEN EUR COMM ST; Fahlstedt M., 2016, IR1664; Fischer P., 2017, RIGHT ROAD UNDERSTAN; Gaither TW, 2018, INJURY PREV, V24, P135, DOI 10.1136/injuryprev-2016-042281; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Laituri T. R., 2015, 2015011437 SAE; McIntosh AS, 2013, TRAFFIC INJ PREV, V14, P501, DOI 10.1080/15389588.2012.727217; Mertz Harold J, 2003, Stapp Car Crash J, V47, P155; Mills NJ, 2008, INT J IMPACT ENG, V35, P1075, DOI 10.1016/j.ijimpeng.2007.05.005; Mills NJ, 2010, INT J CRASHWORTHINES, V15, P331, DOI 10.1080/13588260903251000; Mills N J, 1990, Br J Sports Med, V24, P55; Milne G, 2014, INT J CRASHWORTHINES, V19, P323, DOI 10.1080/13588265.2013.859470; Nelson TS, 2010, TRAFFIC INJ PREV, V11, P309, DOI 10.1080/15389581003614870; Olivier J, 2017, INT J EPIDEMIOL, V46, P278, DOI [10.1093/ije/dyw153, 10.1093/ije/dyw360]; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Peng Y, 2012, SAFETY SCI, V50, P1749, DOI 10.1016/j.ssci.2012.03.005; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2016, SPORTS MED ARTHROSC, V24, P100, DOI 10.1097/JSA.0000000000000121; Rowson S, 2014, J NEUROSURG, V120, P919, DOI 10.3171/2014.1.JNS13916; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Sances A. J., BIOMED SCI INSTRUM, V38, P459; SMITH TA, 1994, ACCIDENT ANAL PREV, V26, P795, DOI 10.1016/0001-4575(94)90055-8; Stigson H., 2017, P INT RES COUNCIL BI, P13; Verschueren P., 2009, BIOMECHANICAL ANAL H; WILLIAMS M, 1991, ACCIDENT ANAL PREV, V23, P119, DOI 10.1016/0001-4575(91)90043-5; Yu HY, 2019, J BIOMECH ENG-T ASME, V141, DOI 10.1115/1.4040944; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	43	19	19	2	4	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	JAN	2020	48	1					47	57		10.1007/s10439-019-02330-0			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	KI8PN	WOS:000511620300007	31372859	Green Published, hybrid			2022-02-06	
J	Sandmo, SB; Andersen, TE; Koerte, IK; Bahr, R				Sandmo, Stian Bahr; Andersen, Thor Einar; Koerte, Inga Katharina; Bahr, Roald			Head impact exposure in youth football-Are current interventions hitting the target?	SCANDINAVIAN JOURNAL OF MEDICINE & SCIENCE IN SPORTS			English	Article						concussion; epidemiology; repetitive; soccer; subconcussive; TBI		Restrictions on heading in youth football have been implemented in some countries to limit head impact exposure. However, current interventions remain poorly guided by evidence. Our objective was to quantify heading exposure in youth football, assessing the effects of sex and age. Football matches played during an international youth football tournament with no heading restrictions were directly observed, including players from both sexes (11-19 years). The elite senior level was included for comparison, using video analysis. All heading events were registered, classified, and assigned to individual players. Heading rates were calculated for each sex and age group. We observed a total of 267 matches, corresponding to 4011 player hours (1927 player hours for females, 2083 player hours for males). Males headed more frequently than females (2.7 vs 1.8 headers/player hour; P < .001). Heading rates increased with age (ANOVA, P < .001), approaching the elite senior level for players 16 years and older. There was substantial variation within teams for all age and sex groups, with the widest range (1-18 headers) observed for girls aged 19. Girls younger than 12 years had the lowest exposure, with an average of <2 players per team heading the ball, each with 1-2 headers. In conclusion, age and sex influence head impact exposure in youth football, and warrants careful consideration when introducing injury prevention measures. Males are more frequently exposed than females, heading rates increase with age, and there is substantial variation between players. Heading is a rare event in the youngest age groups, especially among females.	[Sandmo, Stian Bahr; Andersen, Thor Einar; Bahr, Roald] Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, PB 4014 Ulleval Stad, NO-0806 Oslo, Norway; [Sandmo, Stian Bahr] Univ Oslo, Fac Med, Oslo, Norway; [Koerte, Inga Katharina] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Koerte, Inga Katharina] Harvard Med Sch, Brigham & Womens Hosp, Psychiat Neuroimaging Lab, Dept Psychiat, Boston, MA 02115 USA		Sandmo, SB (corresponding author), Norwegian Sch Sport Sci, Dept Sports Med, Oslo Sports Trauma Res Ctr, PB 4014 Ulleval Stad, NO-0806 Oslo, Norway.	s.b.sandmo@nih.no	Koerte, Inga Katharina/AAW-3031-2021	Andersen, Thor Einar/0000-0003-4172-4518	The Research Council of NorwayResearch Council of Norway Funding Source: Medline; ERA-NET NEURON Funding Source: Medline; The German Federal Ministry of Education and Research Funding Source: Medline		Andersen TE, 2004, BRIT J SPORT MED, V38, P690, DOI 10.1136/bjsm.2003.009357; Andersen TE, 2003, BRIT J SPORT MED, V37, P226, DOI 10.1136/bjsm.37.3.226; [Anonymous], [No title captured]; [Anonymous], IMPLEMENTATION GUIDE; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harris A, 2018, GENDER SEX HIST, P1, DOI 10.1007/978-3-319-70811-9_1; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2017, BRIT J SPORT MED, V51, P1118, DOI 10.1136/bjsports-2016-096276; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Sandmo SB, 2020, SCAND J MED SCI SPOR, V30, P193, DOI 10.1111/sms.13562; Sandmo SB, 2019, AM J SPORT MED, V47, P974, DOI 10.1177/0363546519826953; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; Straume-Naesheim TM, 2008, NEUROSURGERY, V62, P1297, DOI 10.1227/01.neu.0000333301.34189.3d; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	26	19	19	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-7188	1600-0838		SCAND J MED SCI SPOR	Scand. J. Med. Sci. Sports	JAN	2020	30	1					193	198		10.1111/sms.13562			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	PX7GZ	WOS:000611522400021	31584703	hybrid, Green Published			2022-02-06	
J	Broglio, SP; Harezlak, J; Katz, B; Zhao, S; McAllister, T; McCrea, M; Hazzard, J; Kelly, L; Campbell, D; Jackson, J; McGinty, G; O'Donnell, P; Cameron, K; Susmarski, A; Goldman, J; Giza, C; Buckley, T; Kaminski, T; Clugston, J; Schmidt, J; Feigenbaum, L; Eckner, JT; Anderson, S; Master, C; Kontos, A; Chrisman, S; Brooks, A				Broglio, Steven P.; Harezlak, Jaroslaw; Katz, Barry; Zhao, Shi; McAllister, Thomas; McCrea, Michael; Hazzard, Joseph; Kelly, Louise; Campbell, Darren; Jackson, Jonathan; McGinty, Gerald; O'Donnell, Patrick; Cameron, Kenneth; Susmarski, Adam; Goldman, Josh; Giza, Christopher; Buckley, Thomas; Kaminski, Thomas; Clugston, James; Schmidt, Julianne; Feigenbaum, Luis; Eckner, James T.; Anderson, Scott; Master, Christina; Kontos, Anthony; Chrisman, Sara; Brooks, Alison		CARE Consortium Investigators	Acute Sport Concussion Assessment Optimization: A Prospective Assessment from the CARE Consortium	SPORTS MEDICINE			English	Article							HIGH-SCHOOL; POSITION STATEMENT; RELIABILITY; MANAGEMENT; RECOVERY; VALIDITY	Background Numerous medical organizations recommend a multifaceted approach to the assessment of concussion occurring during sporting events. A number of tools are available to clinicians, with a wide breadth of sensitivity and specificity; however, little work has been done to evaluate the combined efficiency of these tools in concussed male and female athletes from a broad array of collegiate sports and with variable time from the pre-season baseline evaluation. Objective The aim of this study was to optimize the concussion assessment battery for application within the first 72 h of injury, and to identify the necessary baseline retesting frequency. Methods Between 2014 and 2017, a total of 1458 National Collegiate Athletic Association (NCAA) athletes sustaining 1640 diagnosed concussions completed a baseline assessment each year of the investigation and were evaluated up to three times within the first 72 h of injury using a standardized assessment protocol. Classification and regression tree analyses were implemented to identify the most efficient multifaceted assessment pathway to quantify concussion-related outcomes. Results were optimized for assessments occurring within 1 h post-injury, 1-24 h post-injury, and 24-72 h post-injury when using the raw post-injury assessment performance, difference scores from baseline evaluations occurring in the same year, and difference scores from baseline evaluations occurring the year prior. Results At each of the assessment time points, the analyses indicated that alone or in combination, a symptom evaluation, Balance Error Scoring System (BESS) scores collected on the firm surface, and Standardized Assessment of Concussion (SAC) total score offered the best overall performance when compared with pre-morbid performance captured in the same season. Optimized sensitivity of the multifaceted approach was 61% within 1 h of injury, 67% at the 1-24 h interval, and 55% at the 24-72 h interval when difference scores from the same-season baseline were available. Conclusions This investigation identified key concussion assessments in quantifying post-concussion performance among student athletes, that were maximized when same-season pre-morbid evaluations were available. Consistent with clinical recommendations, medical professionals should continue to focus on symptom reporting, postural control, and neurocognitive screening to support the clinical examination when making a concussion diagnosis.	[Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA; [Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Katz, Barry] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA; [Zhao, Shi] Eli Lilly & Co, Indianapolis, IN 46285 USA; [McAllister, Thomas] Indiana Univ, Dept Psychiat, Bloomington, IN USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Hazzard, Joseph] Bloomsburg Univ, Bloomsburg, PA USA; [Kelly, Louise] Calif Lutheran Univ, Thousand Oaks, CA USA; [Campbell, Darren; Jackson, Jonathan; McGinty, Gerald] US Air Force Acad, Washington, DC USA; [O'Donnell, Patrick] US Coast Guard Acad, New London, CT USA; [Cameron, Kenneth] US Mil Acad, West Point, NY 10996 USA; [Susmarski, Adam] US Naval Acad, Annapolis, MD 21402 USA; [Goldman, Josh; Giza, Christopher] Univ Calif Los Angeles, Los Angeles, CA USA; [Buckley, Thomas; Kaminski, Thomas] Univ Delaware, Newark, DE 19716 USA; [Clugston, James] Univ Florida, Gainesville, FL 32611 USA; [Schmidt, Julianne] Univ Georgia, Athens, GA 30602 USA; [Feigenbaum, Luis] Univ Miami, Coral Gables, FL 33124 USA; [Eckner, James T.] Univ Michigan, Ann Arbor, MI 48109 USA; [Anderson, Scott] Univ Oklahoma, Norman, OK 73019 USA; [Master, Christina] Univ Penn, Philadelphia, PA 19104 USA; [Kontos, Anthony] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Chrisman, Sara] Univ Washington, Seattle, WA 98195 USA; [Brooks, Alison] Univ Wisconsin, Madison, WI 53706 USA		Broglio, SP (corresponding author), Univ Michigan, Michigan Concuss Ctr, 401 Washtenaw Ave, Ann Arbor, MI 48109 USA.	broglio@umich.edu	Buckley, Thomas A/B-7525-2016; Harezlak, Jaroslaw/P-8557-2014	Buckley, Thomas A/0000-0002-0515-0150; Master, Christina/0000-0002-6717-4270; Clugston, James/0000-0002-2103-1039; Harezlak, Jaroslaw/0000-0002-3070-7686; Susmarski, Adam/0000-0003-3698-4163; Chrisman, Sara/0000-0001-5373-7223; Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance CARE Consortium - NCAA; Department of DefenseUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; US Army Medical Research Acquisition Activity, Chandler Street, Fort Detrick, MD, USA	This publication was made possible, in part, by support from the Grand Alliance CARE Consortium, funded by the NCAA and the Department of Defense. The US Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award no. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense (Defense Health Program funds).	[Anonymous], 2011, MED SCI SPORT EXER, V43, P2412, DOI 10.1249/MSS.0b013e3182342e64; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks BL, 2016, AM J SPORT MED, V44, P3243, DOI 10.1177/0363546516655095; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Garcia GGP, 2018, SPORTS MED, V48, P1739, DOI 10.1007/s40279-018-0880-x; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Harmon KG, 2019, BRIT J SPORT MED, V53, P213, DOI 10.1136/bjsports-2018-100338; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE., 2016, BMJ OPEN SPORT EXERC, V2, pe000012, DOI DOI 10.1136/BMJSEM-2015-000012; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Zimmer A, 2013, J ATHL TRAINING, V48, P659, DOI 10.4085/1062-6050-48.5.06	24	19	19	0	9	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	0112-1642	1179-2035		SPORTS MED	Sports Med.	DEC	2019	49	12					1977	1987		10.1007/s40279-019-01155-0			11	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JM2BT	WOS:000496026500012	31347086	Green Submitted			2022-02-06	
J	Rui, Q; Ni, HB; Lin, XL; Zhu, XJ; Li, D; Liu, HX; Chen, G				Rui, Qin; Ni, Haibo; Lin, Xiaolong; Zhu, Xiaojue; Li, Di; Liu, Huixiang; Chen, Gang			Astrocyte-derived fatty acid-binding protein 7 protects blood-brain barrier integrity through a caveolin-1/MMP signaling pathway following traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						FABP7; Caveolin-1; Astrocyte; Blood-brain barrier; Traumatic brain injury	MATRIX METALLOPROTEINASES; SPINAL-CORD; EXPRESSION; INCREASES; ISCHEMIA; FABP7; RATS	The astrocyte-endothelial cell interaction is crucial for normal brain homeostasis and blood-brain barrier (BBB) disruption in pathological conditions. However, the mechanism by which astrocytes control BBB integrity, especially after traumatic brain injury (TBI), remains unclear. Here, we present evidence that astrocyte-derived fatty acid-binding protein 7 (FABP7), a differentiation- and migration-associated molecule, may function as a modulator of BBB permeability in a rat weight-drop model of TBI. Immunohistochemical analysis revealed that TBI induced increased expression of FABP7 in astrocytes, accompanied by caveolin-1 (Cav-1) upregulation in endothelial cells. Administration of recombinant FABP7 significantly ameliorated TBI-induced neurological deficits, brain edema, and BBB permeability, concomitant with upregulation of endothelial Cav-1 and tight junction protein expression, while FABP7 knockdown resulted in the opposite effects. Furthermore, pretreatment with daidzein, a specific inhibitor of Cav-1, reversed the inhibitory effects of recombinant FABP7 on matrix metalloproteinase (MMP)-2/9 expression and abolished its BBB protection after TBI. Altogether, these findings suggest that astrocyte-derived FABP7 upregulation may represent an endogenous protective response to BBB disruption partly mediated through a Cav-1/MMP signaling pathway following TBI.	[Rui, Qin; Zhu, Xiaojue] Soochow Univ, Dept Lab, Affiliated Zhangjiagang Hosp, Suzhou 215006, Peoples R China; [Ni, Haibo; Liu, Huixiang] Soochow Univ, Dept Neurosurg, Affiliated Zhangjiagang Hosp, Suzhou 215006, Peoples R China; [Lin, Xiaolong] Soochow Univ, Dept Orthopaed, Affiliated Zhangjiagang Hosp, Suzhou 215006, Peoples R China; [Li, Di] Soochow Univ, Dept Translat Med Ctr, Affiliated Zhangjiagang Hosp, Suzhou 215006, Peoples R China; [Chen, Gang] Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China; [Chen, Gang] Soochow Univ, Brain & Nerve Res Lab, Affiliated Hosp 1, Suzhou 215006, Peoples R China		Liu, HX (corresponding author), Soochow Univ, Dept Neurosurg, Affiliated Hosp 1, 68 Jiyang Western Rd, Suzhou 215006, Peoples R China.	huixiangliu_zjg@163.com					Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Assis-Nascimento P, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0016-5; Badaut J, 2015, NEUROSCIENCE, V285, P215, DOI 10.1016/j.neuroscience.2014.10.035; Cheslow L, 2016, CURR OPIN PHARMACOL, V26, P39, DOI 10.1016/j.coph.2015.09.010; Choi KH, 2016, ONCOTARGET, V7, P67857, DOI 10.18632/oncotarget.12346; Choi KH, 2016, STROKE, V47, P1336, DOI 10.1161/STROKEAHA.116.013205; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Deng JM, 2012, J MOL NEUROSCI, V46, P677, DOI 10.1007/s12031-011-9629-9; Galliera E, 2015, CLIN CHEM LAB MED, V53, P349, DOI 10.1515/cclm-2014-0520; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Hong Sung-Ha, 2015, Exp Transl Stroke Med, V7, P3, DOI 10.1186/s13231-014-0012-0; Ikeshima-Kataoka H, 2016, NEUROREPORT, V27, P894, DOI 10.1097/WNR.0000000000000619; Jasmin JF, 2007, CIRC RES, V100, P721, DOI 10.1161/01.RES.0000260180.42709.29; Jha RM, 2019, NEUROPHARMACOLOGY, V145, P230, DOI 10.1016/j.neuropharm.2018.08.004; Jin XC, 2015, J NEUROCHEM, V132, P724, DOI 10.1111/jnc.13065; Kagawa Y, 2015, GLIA, V63, P780, DOI 10.1002/glia.22784; Kamizato K, 2019, NEUROSCIENCE, V409, P120, DOI 10.1016/j.neuroscience.2019.03.050; Kipp M, 2011, PHYSIOL RES, V60, pS49, DOI 10.33549/physiolres.932168; Kurauchi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113403; KURTZ A, 1994, DEVELOPMENT, V120, P2637; Lien CF, 2012, J BIOL CHEM, V287, P41374, DOI 10.1074/jbc.M112.400044; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Matsumata M, 2016, NEUROSCI RES, V102, P47, DOI 10.1016/j.neures.2014.08.012; Mizee MR, 2014, ACTA NEUROPATHOL, V128, P691, DOI 10.1007/s00401-014-1335-6; Nag S, 2009, NEUROPATH APPL NEURO, V35, P417, DOI 10.1111/j.1365-2990.2008.01009.x; Nag S, 2007, ACTA NEUROPATHOL, V114, P459, DOI 10.1007/s00401-007-0274-x; Nasser M, 2016, CNS NEUROL DISORD-DR, V15, P1030, DOI 10.2174/1871527315666160815093525; Ni HB, 2018, EXP NEUROL, V304, P102, DOI 10.1016/j.expneurol.2018.03.003; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Owada Y, 1996, MOL BRAIN RES, V42, P156, DOI 10.1016/S0169-328X(96)00182-9; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551; Robinson BD, 2018, J TRAUMA ACUTE CARE, V85, P968, DOI 10.1097/TA.0000000000002011; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Samaddar S, 2016, ADV NEUROBIOL, V12, P27, DOI 10.1007/978-3-319-28383-8_2; Sharifi K, 2011, HISTOCHEM CELL BIOL, V136, P501, DOI 10.1007/s00418-011-0865-4; Shin T, 2007, BRAIN RES, V1141, P228, DOI 10.1016/j.brainres.2007.01.009; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Virgintino D, 2002, NEUROSCIENCE, V115, P145, DOI 10.1016/S0306-4522(02)00374-3; Wang SS, 2019, CURR VASC PHARMACOL, V17, P41, DOI 10.2174/1570161116666180206112215; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Zhang WT, 2018, PROSTAG LEUKOTR ESS, V136, P35, DOI 10.1016/j.plefa.2017.04.004; Zhao YL, 2014, REV NEUROSCIENCE, V25, P247, DOI 10.1515/revneuro-2013-0039; Zhao Y, 2017, NEUROCHEM RES, V42, P389, DOI 10.1007/s11064-016-2081-z	49	19	20	2	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2019	322								113044	10.1016/j.expneurol.2019.113044			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JU1CS	WOS:000501416100005	31454490				2022-02-06	
J	Turcato, G; Zannoni, M; Zaboli, A; Zorzi, E; Ricci, G; Pfeifer, N; Maccagnani, A; Tenci, A; Bonora, A				Turcato, Gianni; Zannoni, Massimo; Zaboli, Arian; Zorzi, Elisabetta; Ricci, Giorgio; Pfeifer, Norbert; Maccagnani, Antonio; Tenci, Andrea; Bonora, Antonio			DIRECT ORAL ANTICOAGULANT TREATMENT AND MILD TRAUMATIC BRAIN INJURY: RISK OF EARLY AND DELAYED BLEEDING AND THE SEVERITY OF INJURIES COMPARED WITH VITAMIN K ANTAGONISTS	JOURNAL OF EMERGENCY MEDICINE			English	Article						mild traumatic brain injury; anticoagulation; direct oral anticoagulants; intracranial hemorrhage; warfarin	MINOR HEAD-INJURY; INTRACRANIAL HEMORRHAGE; ATRIAL-FIBRILLATION; WARFARIN; THERAPY	Background: The risk of intracranial hemorrhage (ICH) in patients taking direct oral anticoagulants (DOACs) after mild traumatic brain injury (MTBI) is unclear. Objectives: To assess the differences in the risk of developing early, delayed, and comprehensive bleeding after MTBI among patients treated with DOACs as compared with those treated with vitamin K antagonists (VKAs). Methods: All MTBI patients taking oral anticoagulants in our emergency department between June 2017 and August 2018 were included. All patients on oral anticoagulants underwent immediate cerebral computed tomography (CT) and a second CT scan after 24 h of clinical observation. Results: There were 451 patients enrolled: 268 were on VKAs and 183 on DOACs. Of the DOAC-treated patients, 7.7% (14/183) presented overall intracranial bleeding, compared with 14.9% (40/268) of VKA-treated patients (p = 0.026). Early bleeding was present in 5.5% (10/183) of DOAC-treated patients and in 11.6% (31/268) of VKA-treated patients (p = 0.030). Multivariable analysis showed that VKA therapy (odds ratio [OR] 2.327), high-energy impact (OR 11.229), amnesia (OR 2.814), loss of consciousness (OR 5.286), Glasgow Coma Scale score < 15 (OR 4.719), and the presence of lesion above the clavicles (OR 2.742) were associated with significantly higher risk of global ICH. A nomogram was constructed to predict ICH using these six variables. Discrimination of the nomogram revealed good predictive abilities (area under the receiver operating characteristic curve: 0.817). Conclusions: DOAC-treated patients seem to have lower risk of posttraumatic intracranial bleeding compared with VKA-treated patients. (C) 2019 Elsevier Inc. All rights reserved.	[Turcato, Gianni; Zaboli, Arian; Pfeifer, Norbert] Franz Tappeiner Hosp Merano, Azienda Sanitaria Alto Adige, Dept Emergency Med, Via Rossini, I-39012 Merano, Bolzano, Italy; [Zannoni, Massimo; Maccagnani, Antonio; Bonora, Antonio] Univ Verona, Dept Emergency Med, Verona, Italy; [Zorzi, Elisabetta; Ricci, Giorgio] Girolamo Fracastoro Hosp San Bonifacio, Dept Cardiol & Intens Care Cardiol, Azienda Osped Scaligera, Verona, Italy; [Tenci, Andrea] Girolamo Fracastoro Hosp San Bonifacio, Azienda Osped Scaligera, Dept Emergency Med, Verona, Italy		Turcato, G (corresponding author), Franz Tappeiner Hosp Merano, Azienda Sanitaria Alto Adige, Dept Emergency Med, Via Rossini, I-39012 Merano, Bolzano, Italy.			Turcato, Gianni/0000-0002-8890-4113; Zaboli, Arian/0000-0002-4204-8884			American College of Surgeons' Committee on Trauma, 2012, ADV TRAUM LIF SUPP M, P2; Bereczky Z, 2017, ORVOSI HETILAP, V158, P1930, DOI 10.1556/650.2017.30928; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Chauny JM, 2016, J EMERG MED, V51, P519, DOI 10.1016/j.jemermed.2016.05.045; Cipriano A, 2018, INTERN EMERG MED, V13, P1077, DOI 10.1007/s11739-018-1806-1; Cohn B, 2014, J EMERG MED, V46, P410, DOI 10.1016/j.jemermed.2013.08.107; Fuller GW, 2019, ANN EMERG MED, V73, P66, DOI 10.1016/j.annemergmed.2018.07.020; Galliazzo S, 2019, THROMB RES, V174, P113, DOI 10.1016/j.thromres.2018.12.015; Heidbuchel H, 2017, EUR HEART J, V38, P2137, DOI 10.1093/eurheartj/ehw058; Kim HM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211766; Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638; Min M, 2018, CONSULT PHARM, V33, P262, DOI [10.4140/TCP.n.2018.262., 10.4140/TCP.n.2018.262]; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Patti G, 2018, INT J CARDIOL, V265, P118, DOI 10.1016/j.ijcard.2018.02.066; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Sarrazin MSV, 2014, AM J MED, V127, P1179, DOI 10.1016/j.amjmed.2014.07.024; Spinola MB, 2019, AM J EMERG MED, V37, P1677, DOI 10.1016/j.ajem.2018.12.003; Tsivgoulis G, 2017, NEUROLOGY, V89, P1142, DOI 10.1212/WNL.0000000000004362; Uccella L, 2018, WORLD NEUROSURG, V110, pE339, DOI 10.1016/j.wneu.2017.10.173; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Verschoof MA, 2018, J NEUROL, V265, P315, DOI 10.1007/s00415-017-8701-y; Vos PE, 2002, EUR J NEUROL, V9, P207, DOI 10.1046/j.1468-1331.2002.00407.x; Zirlik A, 2017, J THROMB THROMBOLYS, V43, P365, DOI 10.1007/s11239-016-1446-0	25	19	19	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0736-4679	1090-1280		J EMERG MED	J. Emerg. Med.	DEC	2019	57	6					817	824		10.1016/j.jemermed.2019.09.007			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	JX8WZ	WOS:000504010500020	31648805				2022-02-06	
J	Bugay, V; Bozdemir, E; Vigil, FA; Chun, SH; Holstein, DM; Elliott, WR; Sprague, CJ; Cavazos, JE; Zamora, DO; Rule, G; Shapiro, MS; Lechleiter, JD; Brenner, R				Bugay, Vladislav; Bozdemir, Eda; Vigil, Fabio A.; Chun, Sang H.; Holstein, Deborah M.; Elliott, William R.; Sprague, Cassie J.; Cavazos, Jose E.; Zamora, David O.; Rule, Gregory; Shapiro, Mark S.; Lechleiter, James D.; Brenner, Robert			A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal Excitability	JOURNAL OF NEUROTRAUMA			English	Article						blast; epilepsy; mild traumatic brain injury; repetitive mTBI; seizure; traumatic brain injury	DENTATE GYRUS; EPILEPTIFORM ACTIVITY; TAU PHOSPHORYLATION; GABAERGIC INHIBITION; NERVOUS-SYSTEM; SERINE 396; EPILEPSY; INVOLVEMENT; INFLAMMATION; HIPPOCAMPUS	Repetitive blast traumatic brain injury (TBI) affects numerous soldiers on the battlefield. Mild TBI has been shown to have long-lasting effects with repeated injury. We have investigated effects on neuronal excitability after repetitive, mild TBI in a mouse model of blast-induced brain injury. We exposed mice to mild blast trauma of an average peak overpressure of 14.6 psi, repeated across three consecutive days. While a single exposure did not reveal trauma as indicated by the glial fibrillary acidic protein indicator, three repetitive blasts did show significant increases. As well, mice had an increased indicator of inflammation (Iba-1) and increased tau, tau phosphorylation, and altered cytokine levels in the spleen. Video-electroencephalographic monitoring 48 h after the final blast exposure demonstrated seizures in 50% (12/24) of the mice, most of which were non-convulsive seizures. Long-term monitoring revealed that spontaneous seizures developed in at least 46% (6/13) of the mice. Patch clamp recording of dentate gyrus hippocampus neurons 48 h post-blast TBI demonstrated a shortened latency to the first spike and hyperpolarization of action potential threshold. We also found that evoked excitatory postsynaptic current amplitudes were significantly increased. These findings indicate that mild, repetitive blast exposures cause increases in neuronal excitability and seizures and eventual epilepsy development in some animals. The non-convulsive nature of the seizures suggests that subclinical seizures may occur in individuals experiencing even mild blast events, if repeated.	[Bugay, Vladislav; Vigil, Fabio A.; Cavazos, Jose E.; Shapiro, Mark S.; Brenner, Robert] Univ Texas Hlth San Antonio, Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Bozdemir, Eda; Chun, Sang H.; Holstein, Deborah M.; Lechleiter, James D.] Univ Texas Hlth San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Cavazos, Jose E.] Univ Texas Hlth San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Elliott, William R.; Sprague, Cassie J.; Zamora, David O.] US Army, Sensory Trauma, Inst Surg Res, San Antonio, TX USA; [Rule, Gregory] Appl Res Associates, San Antonio, TX USA		Brenner, R (corresponding author), Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	brennerr@uthscsa.edu	Cavazos, Jose/J-4122-2016	Cavazos, Jose/0000-0001-5777-2608; Brenner, Robert/0000-0002-1036-8031; Vigil, Fabio Antonio/0000-0001-5302-0388	DoD CDMRPUnited States Department of Defense [W81XWH-15-1-0284, W81XWH-13-1-0284]; NSFNational Science Foundation (NSF) [1456862]; Morrison Trust Foundation grants	We would like to thank the following: Nameer B. Kirma and Nicholas D. Lucio from the Bioanalytics and Single-Cell Facility at UT Health San Antonio for the multiplex immunoassays. We also thank Brian J. Lund at the San Antonio Military Medical Center for advice on use of the blast facility, and Amy E. Pletz for her expert technical assistance. This study was supported by DoD CDMRP grants W81XWH-15-1-0284 (M.S.S. and R.B.) and W81XWH-13-1-0284 (J.D.L.), NSF grant 1456862 (R.B.) and the Morrison Trust Foundation grants (R.B. and M.S.S.)	ABOUD R, 1993, BRIT J PHARMACOL, V109, P80, DOI 10.1111/j.1476-5381.1993.tb13534.x; Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Arun P, 2013, NEUROSCI LETT, V552, P87, DOI 10.1016/j.neulet.2013.07.047; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Blume WT, 2006, EPILEPSIA, V47, P71, DOI 10.1111/j.1528-1167.2006.00665.x; Bolton-Hall AN, 2019, J NEUROTRAUM, V36, P1203, DOI 10.1089/neu.2018.6096; Bonaz B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01452; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Briones TL, 2015, ANNU REV NURS RES-SE, V33, P31, DOI 10.1891/0739-6686.33.31; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Buki A, 2015, ADV TECH STAND NEURO, V42, P147, DOI 10.1007/978-3-319-09066-5_8; Butler CR, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0134-17.2017; Butler CR, 2016, EXP NEUROL, V280, P30, DOI 10.1016/j.expneurol.2016.03.022; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Chen JWY, 2009, J REHABIL RES DEV, V46, P685, DOI 10.1682/JRRD.2008.09.0130; Denes A, 2013, DIS MODEL MECH, V6, P1043, DOI 10.1242/dmm.011601; Despres C, 2017, P NATL ACAD SCI USA, V114, P9080, DOI 10.1073/pnas.1708448114; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Du XP, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4159357; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; Edwards G, 2017, BIOCHEM BIOPH RES CO, V483, P1137, DOI 10.1016/j.bbrc.2016.07.123; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Evans DB, 2000, J BIOL CHEM, V275, P24977, DOI 10.1074/jbc.M000808200; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; FRIEDLANDER FG, 1946, PROC R SOC LON SER-A, V186, P356, DOI 10.1098/rspa.1946.0049; Ganti L, 2015, MIL MED, V180, P380, DOI 10.7205/MILMED-D-14-00316; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greene NT, 2018, HEARING RES, V365, P149, DOI 10.1016/j.heares.2018.05.014; Hammad A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1066-z; Hauser WA, 2002, PROG BRAIN RES, V135, P215; HEINEMANN U, 1992, EPILEPSY RES, P273; Holth JK, 2013, J NEUROSCI, V33, P1651, DOI 10.1523/JNEUROSCI.3191-12.2013; Horvath A, 2016, ALZ DIS ASSOC DIS, V30, P186, DOI 10.1097/WAD.0000000000000134; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Janigro D, 2013, EPILEPSIA, V54, P30, DOI 10.1111/epi.12271; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Johnston GR, 2009, BRIT J ANAESTH, V102, P453, DOI 10.1093/bja/aep037; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kenney MJ, 2014, COMPR PHYSIOL, V4, P1177, DOI 10.1002/cphy.c130051; Kim E, 2014, J CEREBR BLOOD F MET, V34, P1411, DOI 10.1038/jcbfm.2014.101; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lau KM, 2016, BRAIN INJURY, V30, P287, DOI 10.3109/02699052.2015.1089601; Li ZY, 2014, NEUROBIOL AGING, V35, P2617, DOI 10.1016/j.neurobiolaging.2014.05.001; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Lippmann K, 2017, J CEREBR BLOOD F MET, V37, P1803, DOI 10.1177/0271678X16652631; Liu X, 2013, NEUROSCI BULL, V29, P565, DOI 10.1007/s12264-013-1326-y; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; LOTHMAN EW, 1992, EPILEPSY RES, P301; Luheshi NM, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-186; Lund BJ, 2014, INVEST OPHTH VIS SCI, V55, P1348, DOI 10.1167/iovs.13-13337; McCrory P, 2012, CURR SPORT MED REP, V11, P21, DOI 10.1249/JSR.0b013e3182423bfd; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Murray KN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00018; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Rasouli J, 2011, Einstein J Biol Med, V27, P74; Regan P, 2015, J NEUROSCI, V35, P4804, DOI 10.1523/JNEUROSCI.2842-14.2015; Rhine T, 2016, BRAIN INJURY, V30, P1231, DOI 10.1080/02699052.2016.1178396; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Rowe RK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916647055; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sahota P, 2013, INT J STROKE, V8, P60, DOI 10.1111/ijs.12022; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Scott TE, 2017, BRIT J ANAESTH, V118, P311, DOI 10.1093/bja/aew385; Seifert HA, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1239-9; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; SmithSwintosky VL, 1997, J NEUROCHEM, V69, P1890; Su E, 2016, TRANSLATIONAL RES TR; Suppl e (U.S.). Committee on Gulf War and Health: Long term effects of blast exposures, 2014, GULF WAR HLTH LONG T; Sylvia FR, 2001, MIL MED, V166, P918, DOI 10.1093/milmed/166.10.918; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; TEASDALE G, 1974, LANCET, V2, P81; Terrone G, 2017, CURR PHARM DESIGN, V23, P5569, DOI 10.2174/1381612823666170926113754; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vogel EW, 2017, J NEUROTRAUM, V34, P1063, DOI 10.1089/neu.2016.4578; Vogel EW, 2016, J NEUROTRAUM, V33, P652, DOI 10.1089/neu.2015.4045; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Walilko T.J., 2016, MECH BIOL SYSTEMS MA, V6; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yan XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048782; Yang WJ, 2017, ACTA NEUROL SCAND, V135, P622, DOI 10.1111/ane.12644; Yokobori S, 2013, TRANSL STROKE RES, V4, P25, DOI 10.1007/s12975-012-0226-1; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zollman, 2016, MANUAL TRAUMATIC BRA	106	19	19	2	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					248	261		10.1089/neu.2018.6333		OCT 2019	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000492083900001	31025597	Green Published			2022-02-06	
J	Bryden, DW; Tilghman, JI; Hinds, SR				Bryden, Daniel W.; Tilghman, Jessica I.; Hinds, Sidney R., II			Blast-Related Traumatic Brain Injury: Current Concepts and Research Considerations	JOURNAL OF EXPERIMENTAL NEUROSCIENCE			English	Article						Blast; traumatic brain injury; concussion; biomarkers; radiation; biodosimetry	POSTTRAUMATIC-STRESS-DISORDER; SHELL-SHOCK; HEAD-INJURY; FUNCTIONAL OUTCOMES; COMT VAL(158)MET; ASSOCIATION; MILITARY; ACCOUNT; CONCUSSION; BIOMARKERS	Traumatic brain injury (TBI) is a well-known consequence of participation in activities such as military combat or collision sports. But the wide variability in eliciting circumstances and injury severities makes the study of TBI as a uniform disease state impossible. Military Service members are under additional, unique threats such as exposure to explosive blast and its unique effects on the body. This review is aimed toward TBI researchers, as it covers important concepts and considerations for studying blast-induced head trauma. These include the comparability of blast-induced head trauma to other mechanisms of TBI, whether blast overpressure induces measureable biomarkers, and whether a biodosimeter can link blast exposure to health outcomes, using acute radiation exposure as a corollary. This examination is contextualized by the understanding of concussive events and their psychological effects throughout the past century's wars, as well as the variables that predict sustaining a TBI and those that precipitate or exacerbate psychological conditions.	[Bryden, Daniel W.; Tilghman, Jessica I.] US Army, Booz Allen Hamilton, DoD Blast Injury Res Coordinating Off, Res & Dev Command, Ft Detrick, MD USA; [Hinds, Sidney R., II] US Army, DoD Blast Injury Res Coordinating Off, Med Res & Dev Command, Ft Detrick, MD 21702 USA		Hinds, SR (corresponding author), US Army, DoD Blast Injury Res Coordinating Off, Med Res & Dev Command, Ft Detrick, MD 21702 USA.	sidney.r.hinds.mil@mail.mil					Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Agoston DV, 2015, BRAIN NEUROTRAUMA MO, P307; [Anonymous], 2013, MSMR, V20, P9; [Anonymous], DOD WORLDW NUMB TBI; Armed Forces Health Surveillance Center, 2015, MSMR, V22, P12; Armed Forces Radiobiology Research Institute (AFFRI), ASS RAD INJ BIOD; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Azar S, 2017, METHODS MOL BIOL, V1598, P45, DOI 10.1007/978-1-4939-6952-4_3; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Bertisch H, 2019, J HEAD TRAUMA REHAB, V34, P36, DOI 10.1097/HTR.0000000000000399; Blakely WF, 2010, HEALTH PHYS, V99, pS184, DOI 10.1097/HP.0b013e3181f26895; BOGACZ T, 1989, J CONTEMP HIST, V24, P227, DOI 10.1177/002200948902400203; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2015, BRAIN NEUROTRAUMA MO, P629; Cernak I:, 2017, CONCUSSION, V2; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Courtney A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00221; Dainiak N, 2019, RADIAT PROT DOSIM, V186, P130, DOI 10.1093/rpd/ncy294; Davidson J, 2015, NEUROSCIENTIST, V21, P424, DOI 10.1177/1073858414543150; Davis LC, 2012, ARCH PHYS MED REHAB, V93, P1324, DOI 10.1016/j.apmr.2012.02.036; Defense and Veterans Brain Injury Center, CONC MILD TRAUM BRAI; Desmoulin GT, 2009, J TRAUMA, V67, P1113, DOI 10.1097/TA.0b013e3181bb8e84; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Elliott TR, 1914, BRIT MED J, V1914, P1005, DOI 10.1136/bmj.2.2815.1005; Engel CC, 2018, P FIND EXP REC 7 DEP; Friedlander FG, 1955, PROPAGATION PULSE IN; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; Goans RE, 2010, HEALTH PHYS, V99, pS192, DOI 10.1097/HP.0b013e3181ebcef7; Goldstein LE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0064-3; Greer N, 2018, J HEAD TRAUMA REHAB, V33, pE16, DOI 10.1097/HTR.0000000000000304; Gupta RK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00059; Howe LLS, 2009, CLIN NEUROPSYCHOL, V23, P1315, DOI 10.1080/13854040903266928; Isokuortti H, 2016, J NEUROTRAUM, V33, P232, DOI 10.1089/neu.2015.3888; Iverson KM, 2020, J INTERPERS VIOLENCE, V35, P2422, DOI 10.1177/0886260517702491; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Ivins BJ, 2003, J TRAUMA, V55, P617, DOI 10.1097/01.TA.0000052368.97573.D4; Johnson VE, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2014.241; Kamimori Gary H, 2018, Mil Med, V183, P28, DOI 10.1093/milmed/usx186; Kannus P, 1999, AM J EPIDEMIOL, V149, P143; Karibe H, 2017, NEUROL MED-CHIR, V57, P418, DOI 10.2176/nmc.st.2017-0058; Leggieri MJ, 2019, J ROY ARMY MED CORPS, V165, P7, DOI 10.1136/jramc-2018-000963; Lindquist LK, 2017, J NEUROPSYCH CLIN N, V29, P254, DOI 10.1176/appi.neuropsych.16050100; Lipsky RH, 2005, J NEUROPSYCH CLIN N, V17, P465, DOI 10.1176/appi.neuropsych.17.4.465; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Manchester J, 2017, MIL MED, V182, pE1726, DOI 10.7205/MILMED-D-16-00339; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McCrory PR, 2001, NEUROLOGY, V57, P2283, DOI 10.1212/WNL.57.12.2283; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McLellan TM, 2019, NUTR NEUROSCI, V22, P768, DOI 10.1080/1028415X.2018.1443996; Medical Effects of Ionizing Radiation (MEIR) Course, 2013, AC RAD SYNDR COMB IN; Merritt VC, 2019, ARCH CLIN NEUROPSYCH, V34, P706, DOI 10.1093/arclin/acy082; Merritt VC, 2018, J CLIN EXP NEUROPSYC, V40, P1050, DOI 10.1080/13803395.2018.1508555; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1917, BRIT MED J, V1917, P39, DOI 10.1136/bmj.2.2950.39; Mu WY, 2017, J HEAD TRAUMA REHAB, V32, P55, DOI 10.1097/HTR.0000000000000213; Myers CS, 1916, LANCET, V1, P65; Myers CS, 1916, LANCET, V2, P461; Myers CS, 1916, LANCET, V1, P608; Myers CS, 1919, LANCET, V1, P51; Myers CS, 1915, LANCET, V1, P316; Nauman EA, 2018, HAND CLINIC, V158, P245, DOI 10.1016/B978-0-444-63954-7.00024-0; Orgel J, 2019, J SYNCHROTRON RADIAT, V26, P89, DOI 10.1107/S1600577518015035; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Ponsford J, 2011, J NEUROTRAUM, V28, P1683, DOI 10.1089/neu.2010.1623; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Rafaels KA, 2015, J FORENSIC SCI, V60, P219, DOI 10.1111/1556-4029.12570; Regasa LE, 2019, J HEAD TRAUMA REHAB, V34, P21, DOI 10.1097/HTR.0000000000000417; Richmond DR., 1968, ESTIMATE MANS TOLERA; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Sandgren DJ, 2010, HEALTH PHYS, V99, pS171, DOI 10.1097/HP.0b013e3181f0fe6c; Seagly KS, 2018, BRAIN INJURY, V32, P78, DOI 10.1080/02699052.2017.1374467; Silver JM, 2019, TXB TRAUMATIC BRAIN; Simard JM, 2014, J NEUROTRAUM, V31, P1292, DOI 10.1089/neu.2013.3016; Strathmann FG, 2014, CLIN BIOCHEM, V47, P876, DOI 10.1016/j.clinbiochem.2014.01.028; Stuhmiller J.H., 1991, CONVENTIONAL WARFARE, P241; Stuhmiller JH, 2008, BLAST INJURY TRANSLA; Teasdale GM, 2005, BRAIN, V128, P2556, DOI 10.1093/brain/awh595; WALKER RI, 1989, MED CONSEQUENCES NUC; Wang YJ, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-017-0518-0; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Watts S, 2019, J ROY ARMY MED CORPS, V165, P38, DOI 10.1136/jramc-2018-000956; Weisenbach CA, 2018, MIL MED, V183, P287, DOI 10.1093/milmed/usx210; WHITE CS, 1968, ANN NY ACAD SCI, V152, P89, DOI 10.1111/j.1749-6632.1968.tb11969.x; Willmott C, 2014, J NEUROTRAUM, V31, P1507, DOI 10.1089/neu.2013.3308; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Winkler EA, 2016, NEUROGENETICS, V17, P31, DOI 10.1007/s10048-015-0467-8; Yamamoto S, 2018, MOLECULES, V23, DOI 10.3390/molecules23020245; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zhu F, 2013, J MECH MED BIOL, V13, DOI 10.1142/S0219519413500656; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	108	19	21	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1179-0695			J EXP NEUROSCI	J. Exp. Neurosci.	SEP 12	2019	13								1179069519872213	10.1177/1179069519872213			11	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	IY2QA	WOS:000486234700001	31548796	Green Published, gold			2022-02-06	
J	Wilhelmsson, U; Pozo-Rodrigalvarez, A; Kalm, M; de Pablo, Y; Widestrand, A; Pekna, M; Pekny, M				Wilhelmsson, Ulrika; Pozo-Rodrigalvarez, Andrea; Kalm, Marie; de Pablo, Yolanda; Widestrand, Asa; Pekna, Marcela; Pekny, Milos			The role of GFAP and vimentin in learning and memory	BIOLOGICAL CHEMISTRY			English	Article						astrocytes; hippocampus; hippocampal neurogenesis; intermediate filaments; nanofilaments; reactive gliosis	FIBRILLARY ACIDIC PROTEIN; ADULT HIPPOCAMPAL NEUROGENESIS; ASTROCYTE-SECRETED PROTEINS; INTERMEDIATE-FILAMENTS; MICE DEFICIENT; COGNITIVE FLEXIBILITY; REACTIVE ASTROCYTES; OBJECT RECOGNITION; RETINAL-DETACHMENT; MULLER CELLS	Intermediate filaments (also termed nanofilaments) are involved in many cellular functions and play important roles in cellular responses to stress. The upregulation of glial fibrillary acidic protein (GFAP) and vimentin (Vim), intermediate filament proteins of astrocytes, is the hallmark of astrocyte activation and reactive gliosis in response to injury, ischemia or neurodegeneration. Reactive gliosis is essential for the protective role of astrocytes at acute stages of neurotrauma or ischemic stroke. However, GFAP and Vim were also linked to neural plasticity and regenerative responses in healthy and injured brain. Mice deficient for GFAP and vimentin (GFAP(-/-)Vim(-/-)) exhibit increased post-traumatic synaptic plasticity and increased basal and post-traumatic hippocampal neurogenesis. Here we assessed the locomotor and exploratory behavior of GFAP(-/-)Vim(-/-) mice, their learning, memory and memory extinction, by using the open field, object recognition and Morris water maze tests, trace fear conditioning, and by recording reversal learning in IntelliCages. While the locomotion, exploratory behavior and learning of GFAP(-/-)Vim(-/-) mice, as assessed by object recognition, the Morris water maze, and trace fear conditioning tests, were comparable to wildtype mice, GFAP(-/-)Vim(-/-) mice showed more pronounced memory extinction when tested in IntelliCages, a finding compatible with the scenario of an increased rate of reorganization of the hippocampal circuitry.	[Wilhelmsson, Ulrika; Pozo-Rodrigalvarez, Andrea; de Pablo, Yolanda; Widestrand, Asa; Pekna, Marcela; Pekny, Milos] Univ Gothenburg, Sahlgrenska Acad, Lab Astrocyte Biol & CNS Regenerat, Ctr Brain Repair,Dept Clin Neurosci,Inst Neurosci, Box 440, S-40530 Gothenburg, Sweden; [Pekna, Marcela; Pekny, Milos] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Pekna, Marcela; Pekny, Milos] Univ Newcastle, Newcastle, NSW, Australia; [Kalm, Marie] Univ Gothenburg, Inst Neurosci & Physiol, Dept Pharmacol, Sahlgrenska Acad, S-40530 Gothenburg, Sweden		Pekny, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Lab Astrocyte Biol & CNS Regenerat, Ctr Brain Repair,Dept Clin Neurosci,Inst Neurosci, Box 440, S-40530 Gothenburg, Sweden.; Pekny, M (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.; Pekny, M (corresponding author), Univ Newcastle, Newcastle, NSW, Australia.	Milos.Pekny@neuro.gu.se	de Pablo, Yolanda/AAD-1642-2019; Pekna, Marcela/AAM-3261-2021; Pekna, Marcela/AAM-3249-2021	de Pablo, Yolanda/0000-0001-5208-2114; Pekna, Marcela/0000-0003-2734-8237; Pekna, Marcela/0000-0003-2734-8237; Kalm, Marie/0000-0002-0680-5040; Wilhelmsson, Ulrika/0000-0003-3227-2687	Swedish Medical Research CouncilSwedish Medical Research Council (SMRC)European Commission [2017-02255]; ALF Gothenburg [146051]; AFA Research Foundation; Soderbergs Foundations; Sten A. Olsson Foundation for Research and Culture; Amlov's Foundation; E. Jacobson's Donation Fund; VINNOVAVinnova; Swedish Stroke Foundation; NanoNet COST ActionEuropean Cooperation in Science and Technology (COST) [BM1002]; EU FP 7 Program EduGlia [237956]; EU FP 7 Program TargetBraIn [279017]; Hjarnfonden; Hagstromer's Foundation Millennium; EuroCellNet COST ActionEuropean Cooperation in Science and Technology (COST)	This work was supported by Swedish Medical Research Council (2017-02255), ALF Gothenburg (146051), AFA Research Foundation, Soderbergs Foundations, Sten A. Olsson Foundation for Research and Culture, Hjarnfonden, Hagstromer's Foundation Millennium, Amlov's Foundation, E. Jacobson's Donation Fund, VINNOVA, the Swedish Stroke Foundation, NanoNet COST Action (BM1002), EuroCellNet COST Action, EU FP 7 Program EduGlia (237956), and EU FP 7 Program TargetBraIn (279017). We thank Dr. Leke for teaching Dr. Pozo-Rodrigalvarez the open field and object recognition tests.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Allen NJ, 2012, NATURE, V486, P410, DOI 10.1038/nature11059; Anacker C, 2017, NAT REV NEUROSCI, V18, P335, DOI 10.1038/nrn.2017.45; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079395; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; de Pablo Y, 2013, HISTOCHEM CELL BIOL, V140, P81, DOI 10.1007/s00418-013-1110-0; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Engelmann M, 2011, NAT PROTOC, V6, P1152, DOI 10.1038/nprot.2011.353; Epp JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10838; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Galsworthy MJ, 2005, BEHAV BRAIN RES, V157, P211, DOI 10.1016/j.bbr.2004.06.021; Garber C, 2018, NAT IMMUNOL, V19, P151, DOI 10.1038/s41590-017-0021-y; Garthe A, 2016, HIPPOCAMPUS, V26, P261, DOI 10.1002/hipo.22520; Ge MY, 2019, CELL REP, V26, P2052, DOI 10.1016/j.celrep.2019.01.098; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Jarlestedt K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010397; Kalm M, 2013, EXP NEUROL, V247, P402, DOI 10.1016/j.expneurol.2013.01.006; Kamphuis W, 2015, GLIA, V63, P1036, DOI 10.1002/glia.22800; Karlsson N, 2011, RADIAT RES, V175, P336, DOI 10.1667/RR2231.1; Kinouchi R, 2003, NAT NEUROSCI, V6, P863, DOI 10.1038/nn1088; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; Kucukdereli H, 2011, P NATL ACAD SCI USA, V108, pE440, DOI 10.1073/pnas.1104977108; Labrie V, 2009, LEARN MEMORY, V16, P28, DOI 10.1101/lm.1112209; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Larsson A, 2004, NEUROCHEM RES, V29, P2069, DOI 10.1007/s11064-004-6880-2; Laterza C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192118; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Liu ZW, 2014, GLIA, V62, P2022, DOI 10.1002/glia.22723; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; Lu ZJ, 2010, FASEB J, V24, P1925, DOI 10.1096/fj.09-150573; Lundkvist A, 2004, J CELL SCI, V117, P3481, DOI 10.1242/jcs.01221; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; PEKNY M, 1995, EMBO J, V14, P1590, DOI 10.1002/j.1460-2075.1995.tb07147.x; Pekny M, 2007, EXP CELL RES, V313, P2244, DOI 10.1016/j.yexcr.2007.04.023; Pekny M, 2019, NEUROSCI LETT, V689, P45, DOI 10.1016/j.neulet.2018.07.021; Pekny M, 2016, BBA-MOL BASIS DIS, V1862, P483, DOI 10.1016/j.bbadis.2015.11.014; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Perez-Alcazar M, 2014, EXP NEUROL, V253, P154, DOI 10.1016/j.expneurol.2013.12.013; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stogsdill JA, 2017, NATURE, V551, P192, DOI 10.1038/nature24638; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swan AA, 2014, HIPPOCAMPUS, V24, P1581, DOI 10.1002/hipo.22337; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Verkhratsky A, 2018, PHYSIOL REV, V98, P239, DOI 10.1152/physrev.00042.2016; Widestrand A, 2007, STEM CELLS, V25, P2619, DOI 10.1634/stemcells.2007-0122; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2019, CEREB CORTEX, V29, P4050, DOI 10.1093/cercor/bhy284; Wilhelmsson U, 2012, STEM CELLS, V30, P2320, DOI 10.1002/stem.1196; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Wunderlich KA, 2015, FASEB J, V29, P4815, DOI 10.1096/fj.15-272963	76	19	22	0	7	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1431-6730	1437-4315		BIOL CHEM	Biol. Chem.	SEP	2019	400	9					1147	1156		10.1515/hsz-2019-0199			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IN5AB	WOS:000478687200007	31063456	Bronze			2022-02-06	
J	Zeiler, FA; Ercole, A; Beqiri, E; Cabeleira, M; Aries, M; Zoerle, T; Carbonara, M; Stocchetti, N; Smielewski, P; Czosnyka, M; Menon, DK; Anke, A; Beer, R; Bellander, BM; Buki, A; Chevallard, G; Chieregato, A; Citerio, G; Czeiter, E; Depreitere, B; Eapen, G; Frisvold, S; Helbok, R; Jankowski, S; Kondziella, D; Koskinen, LO; Meyfroidt, G; Moeller, K; Nelson, D; Piippo-Karjalainen, A; Radoi, A; Ragauskas, A; Raj, R; Rhodes, J; Rocka, S; Rossaint, R; Sahuquillo, J; Sakowitz, O; Stevanovic, A; Sundstrom, N; Takala, R; Tamosuitis, T; Tenovuo, O; Vajkoczy, P; Vargiolu, A; Vilcinis, R; Wolf, S; Younsi, A				Zeiler, Frederick A.; Ercole, Ari; Beqiri, Erta; Cabeleira, Manuel; Aries, Marcel; Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino; Smielewski, Peter; Czosnyka, Marek; Menon, David K.; Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Buki, Andras; Chevallard, Giorgio; Chieregato, Arturo; Citerio, Giuseppe; Czeiter, Endre; Depreitere, Bart; Eapen, George; Frisvold, Shirin; Helbok, Raimund; Jankowski, Stefan; Kondziella, Daniel; Koskinen, Lars-Owe; Meyfroidt, Geert; Moeller, Kirsten; Nelson, David; Piippo-Karjalainen, Anna; Radoi, Andreea; Ragauskas, Arminas; Raj, Rahul; Rhodes, Jonathan; Rocka, Saulius; Rossaint, Rolf; Sahuquillo, Juan; Sakowitz, Oliver; Stevanovic, Ana; Sundstrom, Nina; Takala, Riikka; Tamosuitis, Tomas; Tenovuo, Olli; Vajkoczy, Peter; Vargiolu, Alessia; Vilcinis, Rimantas; Wolf, Stefan; Younsi, Alexander		CENTER-TBI High Resolution ICU	Cerebrovascular reactivity is not associated with therapeutic intensity in adult traumatic brain injury: a CENTER-TBI analysis	ACTA NEUROCHIRURGICA			English	Article						Cerebrovascular reactivity; PRx; TBI; Therapeutic intensity; TIL	CEREBRAL PERFUSION-PRESSURE; MODERATE HYPOTHERMIA; AUTOREGULATION; ISOFLURANE; MANAGEMENT; SUPPRESSION	Background Impaired cerebrovascular reactivity in adult traumatic brain injury (TBI) is known to be associated with poor outcome. However, there has yet to be an analysis of the association between the comprehensively assessed intracranial hypertension therapeutic intensity level (TIL) and cerebrovascular reactivity. Methods Using the Collaborative European Neuro Trauma Effectiveness Research in TBI (CENTER-TBI) high-resolution intensive care unit (ICU) cohort, we derived pressure reactivity index (PRx) as the moving correlation coefficient between slow-wave in ICP and mean arterial pressure, updated every minute. Mean daily PRx, and daily % time above PRx of 0 were calculated for the first 7 days of injury and ICU stay. This data was linked with the daily TIL-Intermediate scores, including total and individual treatment sub-scores. Daily mean PRx variable values were compared for each TIL treatment score via mean, standard deviation, and the Mann U test (Bonferroni correction for multiple comparisons). General fixed effects and mixed effects models for total TIL versus PRx were created to display the relation between TIL and cerebrovascular reactivity. Results A total of 249 patients with 1230 ICU days of high frequency physiology matched with daily TIL, were assessed. Total TIL was unrelated to daily PRx. Most TIL sub-scores failed to display a significant relationship with the PRx variables. Mild hyperventilation (p < 0.0001), mild hypothermia (p = 0.0001), high levels of sedation for ICP control (p = 0.0001), and use vasopressors for CPP management (p < 0.0001) were found to be associated with only a modest decrease in mean daily PRx or % time with PRx above 0. Conclusions Cerebrovascular reactivity remains relatively independent of intracranial hypertension therapeutic intensity, suggesting inadequacy of current TBI therapies in modulating impaired autoregulation. These findings support the need for investigation into the molecular mechanisms involved, or individualized physiologic targets (ICP, CPP, or Co2) in order to treat dysautoregulation actively.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada; [Zeiler, Frederick A.; Beqiri, Erta; Cabeleira, Manuel; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England; [Aries, Marcel] Maastricht UMC, Dept Intens Care, Maastricht, Netherlands; [Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Dept Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Anke, Audny] Univ Hosp Northern Norway, Dept Phys Med & Rehabil, Tromso, Norway; [Beer, Ronny; Helbok, Raimund] Med Univ Innsbruck, Dept Neurol, Neurol Intens Care Unit, Innsbruck, Austria; [Bellander, Bo-Michael; Nelson, David] Karolinska Univ Hosp, Dept Neurosurg & Anesthesia & Intens Care Med, Stockholm, Sweden; [Buki, Andras; Czeiter, Endre] Univ Pecs, Dept Neurosurg, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Buki, Andras; Czeiter, Endre] Univ Pecs, Hungarian Brain Res Program, Janos Szentagothai Res Ctr, Pecs, Hungary; [Chevallard, Giorgio; Chieregato, Arturo] Osped Niguarda Ca Granda, NeuroIntens Care, Milan, Italy; [Citerio, Giuseppe; Vargiolu, Alessia] ASST Monza, Dept Anesthesia & Intens Care, NeuroIntens Care Unit, Monza, Italy; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Milan, Italy; [Depreitere, Bart] Univ Hosp Leuven, Dept Neurosurg, Leuven, Belgium; [Eapen, George; Frisvold, Shirin] Univ Hosp Northern Norway, Dept Anesthesiol & Intens Care, Tromso, Norway; [Jankowski, Stefan] Sheffield Teaching Hosp NHS Fdn Trust, Neurointens Care, Sheffield, S Yorkshire, England; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Neurol, Copenhagen, Denmark; [Kondziella, Daniel] Reg Hovedstaden Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Kondziella, Daniel; Moeller, Kirsten] Reg Hovedstaden Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Koskinen, Lars-Owe] Umea Univ Hosp, Dept Clin Neurosci, Neurosurg, Umea, Sweden; [Meyfroidt, Geert] Univ Hosp Leuven, Intens Care Med, Leuven, Belgium; [Piippo-Karjalainen, Anna; Raj, Rahul] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Radoi, Andreea; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Ragauskas, Arminas; Rocka, Saulius; Vilcinis, Rimantas] Kaunas Univ Technol, Dept Neurosurg, Vilnius, Lithuania; [Ragauskas, Arminas; Rocka, Saulius] Vilnius Univ, Vilnius, Lithuania; [Rhodes, Jonathan] NHS Lothian, Dept Anaesthesia Crit Care & Pain Med, Edinburgh, Midlothian, Scotland; [Rhodes, Jonathan] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rossaint, Rolf] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sakowitz, Oliver] Klinikum Ludwigsburg, Klin Neurochirurg, Ludwigsburg, Germany; [Sakowitz, Oliver; Younsi, Alexander] Univ Hosp Heidelberg, Dept Neurosurg, Heidelberg, Germany; [Stevanovic, Ana] Univ Hosp Aachen, Dept Anaesthesiol, Aachen, Germany; [Sundstrom, Nina] Umea Univ Hosp, Dept Radiat Sci, Biomed Engn, Umea, Sweden; [Takala, Riikka] Turku Univ, Cent Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka; Tenovuo, Olli] Univ Turku, Turku, Finland; [Tamosuitis, Tomas] Kaunas Univ Hlth Sci, Neurointens Care Unit, Kaunas, Lithuania; [Tenovuo, Olli] Turku Univ, Cent Hosp, Rehabil & Brain Trauma, Turku, Finland; [Vajkoczy, Peter] Charite Univ Med Berlin, Neurol Neurochirurg & Psychiat, Berlin, Germany; [Wolf, Stefan] Charite Univ Med Berlin, Interdisciplinary Neuro Intens Care Unit, Berlin, Germany		Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB R3A 1R9, Canada.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Brain Phys Lab,Div Neurosurg, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Dept Biomed Engn, Fac Engn, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca; ae105@cam.ac.uk; erta.beqiri@gmail.com; mc916@cam.ac.uk; marcel.aries@mumc.nl; tommaso.zoerle@policlinico.mi.it; marco.carbonara@gmail.com; nino.stocchetti@policlinico.mi.it; ps10011@cam.ac.uk; mc141@medschl.cam.ac.uk; dkm13@cam.ac.uk	Carbonara, Marco/N-3793-2015; Helbok, Raimund/AAA-8361-2021; Depreitere, Bart/AAA-9846-2020; Sahuquillo, Juan/B-3577-2008; Younsi, Alexander/AAW-7869-2020; Raj, Rahul/K-7693-2012; Koskinen, Lars-Owe/AAQ-8957-2020; Ercole, Ari/B-6288-2009; Moller, Kirsten/A-4751-2009	Carbonara, Marco/0000-0002-1431-8322; Depreitere, Bart/0000-0002-7458-0648; Sahuquillo, Juan/0000-0003-0713-5875; Younsi, Alexander/0000-0002-8218-9243; Raj, Rahul/0000-0003-4243-9591; Ercole, Ari/0000-0001-8350-8093; Moller, Kirsten/0000-0003-3058-1072; Zeiler, Frederick/0000-0003-1737-0510; Kondziella, Daniel/0000-0001-5562-9808; Nelson, David/0000-0003-2530-8207; Zoerle, Tommaso/0000-0001-8713-8085; Sakowitz, Oliver/0000-0003-3248-6335; Radoi, Andreea/0000-0002-0677-3544	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); National Institute for Health Research (NIHR, UK)National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; NIHR Clinical Research network; University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund; University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation Winnipeg	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA).; DKM was also supported by funding from the National Institute for Health Research (NIHR, UK) through a Senior Investigator award and the Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. The study also received additional support from the NIHR Clinical Research network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care, UK. FAZ has received salary support for dedicated research time, during which this project was completed.; FAZ receives research support from the University of Manitoba Thorlakson Chair in Surgical Research Establishment Fund, the University of Manitoba VPRI Research Investment Fund (RIF), the University of Manitoba Rudy Falk Clinician-Scientist Professorship, and the Health Sciences Centre Foundation Winnipeg.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Bisschops LLA, 2010, CRIT CARE MED, V38, P1542, DOI 10.1097/CCM.0b013e3181e2cc1e; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Fujita M, 2012, J NEUROTRAUM, V36, P1505, DOI [10.1089/neu.2018.6182, DOI 10.1089/NEU.2018.6182]; Irikura K, 1998, J CEREBR BLOOD F MET, V18, P1294, DOI 10.1097/00004647-199812000-00003; Koizumi H, 2016, ACTA NEUROCHIR SUPPL, V122, P193, DOI 10.1007/978-3-319-22533-3_39; Lavinio A, 2007, BRIT J ANAESTH, V99, P237, DOI 10.1093/bja/aem118; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; MCCULLOCH J, 1984, J CEREBR BLOOD F MET, V4, P129, DOI 10.1038/jcbfm.1984.21; McCulloch TJ, 2009, ANESTH ANALG, V108, P1284, DOI 10.1213/ane.0b013e318196728e; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Newell DW, 1996, NEUROSURGERY, V39, P35, DOI 10.1097/00006123-199607000-00008; Reinsfelt B, 2003, ANESTH ANALG, V97, P1246, DOI 10.1213/01.ANE.0000086732.97924.BE; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; VERHAEGEN MJJ, 1993, STROKE, V24, P407, DOI 10.1161/01.STR.24.3.407; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; Wettervik TS, 2019, J NEUROTRAUM, V36, P1818, DOI 10.1089/neu.2018.6157; WOODCOCK TE, 1987, ANESTHESIOLOGY, V67, P218, DOI 10.1097/00000542-198708000-00011; Zeiler F.A., 2018, J NEUROTRAUM; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2019, NAT REV NEUROL, V15, P25, DOI 10.1038/s41582-018-0105-9; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3224, DOI 10.1089/neu.2017.5086; Zuercher P, 2016, J NEUROTRAUM, V33, P1768, DOI 10.1089/neu.2015.4266	31	19	19	1	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	SEP	2019	161	9					1955	1964		10.1007/s00701-019-03980-8			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IS9FL	WOS:000482453900027	31240583	Green Published, Green Accepted, hybrid, Green Submitted			2022-02-06	
J	Steyerberg, EW; Nieboer, D; Debray, TPA; van Houwelingen, HC				Steyerberg, Ewout W.; Nieboer, Daan; Debray, Thomas P. A.; van Houwelingen, Hans C.			Assessment of heterogeneity in an individual participant data meta-analysis of prediction models: An overview and illustration	STATISTICS IN MEDICINE			English	Article						heterogeneity; meta-analysis; prediction; regression modeling	MULTILEVEL LOGISTIC-REGRESSION; TRAUMATIC BRAIN-INJURY; PROGNOSTIC MODELS; RISK MODELS; VALIDATION; IMPUTATION; CALIBRATION; SURVIVAL; VALIDITY	Clinical prediction models aim to provide estimates of absolute risk for a diagnostic or prognostic endpoint. Such models may be derived from data from various studies in the context of a meta-analysis. We describe and propose approaches for assessing heterogeneity in predictor effects and predictions arising from models based on data from different sources. These methods are illustrated in a case study with patients suffering from traumatic brain injury, where we aim to predict 6-month mortality based on individual patient data using meta-analytic techniques (15 studies, n = 11 022 patients). The insights into various aspects of heterogeneity are important to develop better models and understand problems with the transportability of absolute risk predictions.	[Steyerberg, Ewout W.; van Houwelingen, Hans C.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, NL-2300 RC Leiden, Netherlands; [Steyerberg, Ewout W.; Nieboer, Daan] Erasmus MC, Dept Publ Hlth, NL-3015 CN Rotterdam, Netherlands; [Debray, Thomas P. A.] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Debray, Thomas P. A.] Univ Med Ctr Utrecht, Cochrane Netherlands, Utrecht, Netherlands		Steyerberg, EW (corresponding author), Leiden Univ, Med Ctr, Dept Biomed Data Sci, NL-2300 RC Leiden, Netherlands.; Steyerberg, EW (corresponding author), Erasmus MC, Dept Publ Hlth, NL-3015 CN Rotterdam, Netherlands.	e.w.steyerberg@lumc.nl	van houwelingen, hans c/C-1872-2008; Debray, Thomas/J-7413-2012; Steyerberg, Ewout/C-1509-2018	van houwelingen, hans c/0000-0002-0494-4637; Debray, Thomas/0000-0002-1790-2719; Nieboer, Daan/0000-0002-4403-6537; Steyerberg, Ewout/0000-0002-7787-0122	Patient-Centered Outcomes Research InstitutePatient-Centered Outcomes Research Institute - PCORI [SA.Tufts.PARC.OSCO.2018.01.25, ME-1606-35555]; FORECEE (4C) Project Horizon 2020 [634570]; Movember Foundation [GAP3]; Netherlands Organization for Health Research and DevelopmentNetherlands Organization for Health Research and Development [91617050, 91810615]	Patient-Centered Outcomes Research Institute, Grant/Award Number: Predictive Analytics Resource Center (SA.Tufts.PARC.OSCO.2018.01.25) and Methods Award (ME-1606-35555); FORECEE (4C) Project Horizon 2020, Grant/Award Number: 634570; Movember Foundation, Grant/Award Number: GAP3; Netherlands Organization for Health Research and Development, Grant/Award Number: 91617050 and 91810615	Ahmed I, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-3; Ambler G, 2001, J STAT COMPUT SIM, V69, P89, DOI 10.1080/00949650108812083; Audigier V, 2018, STAT SCI, V33, P160, DOI 10.1214/18-STS646; Austin PC, 2017, STAT MED, V36, P3257, DOI 10.1002/sim.7336; Austin PC, 2016, J CLIN EPIDEMIOL, V79, P76, DOI 10.1016/j.jclinepi.2016.05.007; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Burke DL, 2017, STAT MED, V36, P855, DOI 10.1002/sim.7141; Cai TX, 2011, BIOMETRICS, V67, P436, DOI 10.1111/j.1541-0420.2010.01462.x; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; Debray TPA, 2014, STAT MED, V33, P2341, DOI 10.1002/sim.6080; Debray TPA, 2013, STAT MED, V32, P3158, DOI 10.1002/sim.5732; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Debray TPA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-121; Debray TPA, 2012, STAT MED, V31, P2697, DOI 10.1002/sim.5412; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Fiocco M, 2009, STAT MED, V28, P3782, DOI 10.1002/sim.3752; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Higgins J.P., 2011, COCHRANE HDB SYSTEMA; Jolani S, 2018, BIOMETRICAL J, V60, P333, DOI 10.1002/bimj.201600220; Jolani S, 2015, STAT MED, V34, P1841, DOI 10.1002/sim.6451; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kunkel D, 2017, STAT MED, V36, P3507, DOI 10.1002/sim.7388; MARTIN GP, 2017, BMC MED RES METHODOL, V17, DOI DOI 10.1186/S12874-016-0277-1; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; MILLER ME, 1991, STAT MED, V10, P1213, DOI 10.1002/sim.4780100805; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2008, J CLIN EPIDEMIOL, V61, P331, DOI 10.1016/j.jclinepi.2007.06.011; Nieboer D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148820; Perperoglou A, 2006, STAT MED, V25, P2831, DOI 10.1002/sim.2360; Putter H, 2015, BIOSTATISTICS, V16, P550, DOI 10.1093/biostatistics/kxv002; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Resche-Rigon M, 2018, STAT METHODS MED RES, V27, P1634, DOI 10.1177/0962280216666564; Resche-Rigon M, 2013, STAT MED, V32, P4890, DOI 10.1002/sim.5894; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; ROYSTON P, 2008, MULTIVARIABLE MODEL, DOI DOI 10.1177/0962280215604510; Sheng E, 2014, STAT MED, V33, P2567, DOI 10.1002/sim.6125; Snell KIE, 2018, STAT METHODS MED RES, V27, P3505, DOI 10.1177/0962280217705678; Steyerberg EW, 2007, J UROLOGY, V177, P107, DOI 10.1016/j.juro.2006.08.068; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2000, STAT MED, V19, P141, DOI 10.1002/(SICI)1097-0258(20000130)19:2<141::AID-SIM334>3.0.CO;2-O; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; STEYERBERG EW, 2009, CLIN PREDICTION MODE, DOI DOI 10.1002/SIM.5487; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Su TL, 2018, STAT METHODS MED RES, V27, P185, DOI 10.1177/0962280215626466; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van Houwelingen HC, 2008, LIFETIME DATA ANAL, V14, P447, DOI 10.1007/s10985-008-9099-8; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vergouwe Y, 2017, STAT MED, V36, P4529, DOI 10.1002/sim.7179; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wessler Benjamin S, 2017, Diagn Progn Res, V1, P20, DOI 10.1186/s41512-017-0021-2; Wynants L, 2018, STAT METHODS MED RES, V27, P1723, DOI 10.1177/0962280216668555	60	19	19	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	SEP 30	2019	38	22					4290	4309		10.1002/sim.8296		AUG 2019	20	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	IW4UC	WOS:000479892600001	31373722	hybrid, Green Published			2022-02-06	
J	Golz, C; Kirchhoff, FP; Westerhorstmann, J; Schmidt, M; Hirnet, T; Rune, GM; Bender, RA; Schafert, MKE				Goelz, Christina; Kirchhoff, Florian Paul; Westerhorstmann, Jana; Schmidt, Matthias; Hirnet, Tobias; Rune, Gabriele M.; Bender, Roland A.; Schaefert, Michael K. E.			Sex hormones modulate pathogenic processes in experimental traumatic brain injury	JOURNAL OF NEUROCHEMISTRY			English	Article						finasteride; letrozole; neuroprotection; neurotrophin; sex steroid hormones; traumatic brain injury	NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; RAT-BRAIN; NEUROPROTECTIVE ACTIONS; AROMATASE INHIBITORS; SYNAPTIC PLASTICITY; ESTROGEN-RECEPTORS; CEREBRAL-ISCHEMIA; MESSENGER-RNA; AXONAL INJURY	Clinical and animal studies have revealed sex-specific differences in histopathological and neurological outcome after traumatic brain injury (TBI). The impact of perioperative administration of sex steroid inhibitors on TBI is still elusive. Here, we subjected male and female C57Bl/6N mice to the controlled cortical impact (CCI) model of TBI and applied pharmacological inhibitors of steroid hormone synthesis, that is, letrozole (LET, inhibiting estradiol synthesis by aromatase) and finasteride (FIN, inhibiting dihydrotestosterone synthesis by 5 alpha-reductase), respectively, starting 72 h prior CCI, and continuing for a further 48 h after CCI. Initial gene expression analyses showed that androgen (Ar) and estrogen receptors (Esr1) were sex-specifically altered 72 h after CCI. When examining brain lesion size, we found larger lesions in male than in female mice, but did not observe effects of FIN or LET treatment. However, LET treatment exacerbated neurological deficits 24 and 72 h after CCI. On the molecular level, FIN administration reduced calpain-dependent spectrin breakdown products, a proxy of excitotoxicity and disturbed Ca2+ homeostasis, specifically in males, whereas LET increased the reactive astrocyte marker glial fibrillary acid protein specifically in females. Examination of neurotrophins (brain-derived neurotrophic factor, neuronal growth factor, NT-3) and their receptors (p75(NTR), TrkA, TrkB, TrkC) revealed CCI-induced down-regulation of TrkB and TrkC protein expression, which was reduced by LET in both sexes. Interestingly, FIN decreased neuronal growth factor mRNA expression and protein levels of its receptor TrkA only in males. Taken together, our data suggest a sex-specific impact on pathogenic processes in the injured brain after TBI. Sex hormones may thus modulate pathogenic processes in experimental TBI.	[Goelz, Christina; Kirchhoff, Florian Paul; Schmidt, Matthias; Hirnet, Tobias; Schaefert, Michael K. E.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Mainz, Germany; [Westerhorstmann, Jana; Rune, Gabriele M.; Bender, Roland A.] Univ Med Ctr, Inst Neuroanat, Hamburg, Germany; [Schaefert, Michael K. E.] Focus Program Translat Neurosci, Mainz, Germany; [Schaefert, Michael K. E.] Res Ctr Immunotherapy FZI, Mainz, Germany		Schafert, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.; Schafert, MKE (corresponding author), Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Langenbeckstr 1, D-55131 Mainz, Germany.	michael.schaefer@unimedizin-mainz.de	Schaefer, Michael K.E./S-1715-2019	Schaefer, Michael K.E./0000-0001-6055-6244	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [Be4107/3-1]; Focus Program Translational Neurosciences (FTN) Mainz	We thank Wiesia Bobkiewicz, Dana Pieter (Department of Anesthesiology, UMC Mainz, Germany) and Christiane Schrooder-Birkner (Institute of Anatomy, UMC Hamburg, Germany) for excellent technical assistance. The authors declare no conflicts of interest. Data presented in this manuscript are part of the doctoral theses of FK, MS, and JW (Faculties of Medicine, Johannes Gutenberg-University Mainz and the University of Hamburg, Germany, respectively). This work was supported by the Deutsche Forschungsgemeinschaft (Be4107/3-1 to RB) and the Focus Program Translational Neurosciences (FTN) Mainz to MS.	Allen KM, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0142-x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Baudry M, 2013, NEUROSCIENCE, V239, P280, DOI 10.1016/j.neuroscience.2012.10.051; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Lopez-Rodriguez AB, 2016, ENDOCRINOLOGY, V157, P3983, DOI 10.1210/en.2016-1316; Bender RA, 2017, J NEUROSCI, V37, P1532, DOI 10.1523/JNEUROSCI.1532-16.2016; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bhatnagar AS, 2007, BREAST CANCER RES TR, V105, P7, DOI 10.1007/s10549-007-9696-3; Bian C, 2014, J STEROID BIOCHEM, V141, P37, DOI 10.1016/j.jsbmb.2013.12.020; Bimonte-Nelson HA, 2004, NEUROREPORT, V15, P2659, DOI 10.1097/00001756-200412030-00021; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Bruna B, 2018, BIOCHEM BIOPH RES CO, V505, P201, DOI 10.1016/j.bbrc.2018.09.080; Carbone DL, 2013, NEUROSCIENCE, V239, P295, DOI 10.1016/j.neuroscience.2012.10.073; Castelli MP, 2013, PSYCHONEUROENDOCRINO, V38, P281, DOI 10.1016/j.psyneuen.2012.06.008; Cekic M, 2012, RESTOR NEUROL NEUROS, V30, P115, DOI 10.3233/RNN-2011-0628; Chakrabarti M, 2016, REV NEUROSCIENCE, V27, P271, DOI 10.1515/revneuro-2015-0032; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Chiaretti A, 2008, J TRAUMA, V65, P80, DOI 10.1097/TA.0b013e31805f7036; Choi S, 2014, NEUROSCIENCE, V257, P11, DOI 10.1016/j.neuroscience.2013.10.058; Choueiri TK, 2004, CLIN THER, V26, P1199, DOI 10.1016/S0149-2918(04)80017-1; Cooke PS, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00108; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; Dave N, 2013, CANCER CHEMOTH PHARM, V72, P349, DOI 10.1007/s00280-013-2205-y; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DEKOSKY ST, 1994, EXP NEUROL, V130, P173, DOI 10.1006/exnr.1994.1196; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Fanaei H, 2014, BRAIN RES, V1558, P74, DOI 10.1016/j.brainres.2014.02.028; Fester L, 2017, J NEUROCHEM, V140, P126, DOI 10.1111/jnc.13889; Finn DA, 2006, CNS DRUG REV, V12, P53, DOI 10.1111/j.1527-3458.2006.00053.x; Fullhase C, 2016, UROL CLIN N AM, V43, P325, DOI 10.1016/j.ucl.2016.04.003; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Hajszan T, 2008, HORM BEHAV, V53, P638, DOI 10.1016/j.yhbeh.2007.12.007; Harden Cynthia, 2005, Expert Rev Neurother, V5, P123, DOI 10.1586/14737175.5.1.123; Hicks RR, 1999, EXP NEUROL, V160, P469, DOI 10.1006/exnr.1999.7216; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00183; Huang CS, 2016, GLIA, V64, P507, DOI 10.1002/glia.22944; Kramer T, 2017, J NEUROCHEM, V143, P523, DOI 10.1111/jnc.14220; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEPHART ED, 1995, NEUROBIOL AGING, V16, P647, DOI 10.1016/0197-4580(95)98115-5; Ley EJ, 2013, J TRAUMA ACUTE CARE, V75, P682, DOI 10.1097/TA.0b013e31829d024f; Li CY, 2018, ARCH PHYS MED REHAB, V99, P1279, DOI 10.1016/j.apmr.2017.12.006; Li L, 2018, CNS NEUROSCI THER, V24, P115, DOI 10.1111/cns.12781; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu AL, 2012, ENDOCRINOLOGY, V153, P3747, DOI 10.1210/en.2012-1138; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Meirelles LD, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051082; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; MIRANDA RC, 1994, HORM BEHAV, V28, P367, DOI 10.1006/hbeh.1994.1033; Mladenovic D, 2014, AM J PHYSIOL-GASTR L, V307, pG931, DOI 10.1152/ajpgi.00463.2013; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; O'Brien EE, 2015, NEUROSCIENCE, V301, P235, DOI 10.1016/j.neuroscience.2015.06.009; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Park SY, 2007, NEUROSCIENCE, V144, P119, DOI 10.1016/j.neuroscience.2006.09.012; Pietranera L, 2010, J NEUROENDOCRINOL, V22, P1082, DOI 10.1111/j.1365-2826.2010.02058.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Prange-Kiel J, 2003, HIPPOCAMPUS, V13, P226, DOI 10.1002/hipo.10075; Prange-Kiel J, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/9802086; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saito K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041091; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Schafer MKE, 2018, MATRIX BIOL, V68-69, P571, DOI 10.1016/j.matbio.2017.10.002; Schafer M, 2014, CELL TISSUE RES, V357, P395, DOI 10.1007/s00441-014-1807-y; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Sebastiani A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00678; Sebastiani A, 2016, CRIT CARE MED, V44, pE70, DOI 10.1097/CCM.0000000000001284; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; Sethuraman KN, 2014, ACAD EMERG MED, V21, P1386, DOI 10.1111/acem.12536; Siddiqui AN, 2016, CNS NEUROSCI THER, V22, P342, DOI 10.1111/cns.12538; Simpson ER, 2005, ENDOCR REV, V26, P322, DOI 10.1210/er.2004-0020; Singh M, 1999, J NEUROSCI, V19, P1179; Soustiel JF, 2005, J NEUROTRAUM, V22, P345, DOI 10.1089/neu.2005.22.345; Spani CB, 2018, FRONT NEUROENDOCRIN, V50, P52, DOI 10.1016/j.yfrne.2018.03.006; Spencer JL, 2008, NEUROSCIENCE, V155, P1106, DOI 10.1016/j.neuroscience.2008.05.049; Styrke J, 2013, J REHABIL MED, V45, P749, DOI 10.2340/16501977-1215; Tabatadze N, 2015, J NEUROSCI, V35, P11252, DOI 10.1523/JNEUROSCI.1067-15.2015; Tanaka M, 2019, TRANSL STROKE RES, V10, P67, DOI 10.1007/s12975-018-0624-0; Uchida M, 2009, J CEREBR BLOOD F MET, V29, P1454, DOI 10.1038/jcbfm.2009.60; VANDERLEE S, 1955, ACTA PHYSIOL PHARM N, V4, P442; Vierk R, 2012, J NEUROSCI, V32, P8116, DOI 10.1523/JNEUROSCI.5319-11.2012; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; WHITTEN WK, 1959, J ENDOCRINOL, V18, P102, DOI 10.1677/joe.0.0180102; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200; Zhang M, 2017, NEUROCRIT CARE, V26, P292, DOI 10.1007/s12028-016-0342-y; Zhang QG, 2014, MOL CELL ENDOCRINOL, V389, P84, DOI 10.1016/j.mce.2013.12.019; Zhang WR, 2014, TRANSL STROKE RES, V5, P301, DOI 10.1007/s12975-013-0298-6; Zhang ZL, 2017, BRAIN RES, V1661, P15, DOI 10.1016/j.brainres.2017.02.004; Zhou L, 2010, ENDOCRINOLOGY, V151, P1153, DOI 10.1210/en.2009-0254; Zhu W, 2010, NEUROSCIENCE, V169, P758, DOI 10.1016/j.neuroscience.2010.05.038; Zhu XY, 2017, J NEUROSCI, V37, P10998, DOI 10.1523/JNEUROSCI.3874-16.2017	110	19	19	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUL	2019	150	2					173	187		10.1111/jnc.14678			15	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	II7WP	WOS:000475402700004	30790293	Bronze			2022-02-06	
J	Lepage, C; Muehlmann, M; Tripodis, Y; Hufschmidt, J; Stamm, J; Green, K; Wrobel, P; Schultz, V; Weir, I; Alosco, ML; Baugh, CM; Fritts, NG; Martin, BM; Chaisson, C; Coleman, MJ; Lin, AP; Pasternak, O; Makris, N; Stern, RA; Shenton, ME; Koerte, IK				Lepage, Christian; Muehlmann, Marc; Tripodis, Yorghos; Hufschmidt, Jakob; Stamm, Julie; Green, Katie; Wrobel, Pawel; Schultz, Vivian; Weir, Isabelle; Alosco, Michael L.; Baugh, Christine M.; Fritts, Nathan G.; Martin, Brett M.; Chaisson, Christine; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Stern, Robert A.; Shenton, Martha E.; Koerte, Inga K.			Limbic system structure volumes and associated neurocognitive functioning in former NFL players	BRAIN IMAGING AND BEHAVIOR			English	Article						Volumetric MRI; Chronic Traumatic Encephalopathy; Hippocampus; Limbic System; Repetitive Head Impacts	TRAUMATIC BRAIN-INJURY; HIPPOCAMPAL VOLUME; 1ST EXPOSURE; FOOTBALL; ENCEPHALOPATHY; CONCUSSION; HISTORY; NEUROCHEMISTRY; AMYGDALA; NETWORK	Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease associated with exposure to repetitive head impacts. CTE has been linked to disruptions in cognition, mood, and behavior. Unfortunately, the diagnosis of CTE can only be made post-mortem. Neuropathological evidence suggests limbic structures may provide an opportunity to characterize CTE in the living. Using 3T magnetic resonance imaging, we compared select limbic brain regional volumes - the amygdala, hippocampus, and cingulate gyrus - between symptomatic former National Football League (NFL) players (n=86) and controls (n=22). Moreover, within the group of former NFL players, we examined the relationship between those limbic structures and neurobehavioral functioning (n=75). The former NFL group comprised eighty-six men (mean age=55.2 +/- 8.0years) with at least 12years of organized football experience, at least 2years of active participation in the NFL, and self-reported declines in cognition, mood, and behavior within the last 6months. The control group consisted of men (mean age=57.0 +/- 6.6years) with no history of contact-sport involvement or traumatic brain injury. All control participants provided neurobehavioral data. Compared to controls, former NFL players exhibited reduced volumes of the amygdala, hippocampus, and cingulate gyrus. Within the NFL group, reduced bilateral cingulate gyrus volume was associated with worse attention and psychomotor speed (r=0.4 (right), r=0.42 (left); both p<0.001), while decreased right hippocampal volume was associated with worse visual memory (r=0.25, p=0.027). Reduced volumes of limbic system structures in former NFL players are associated with neurocognitive features of CTE. Volume reductions in the amygdala, hippocampus, and cingulate gyrus may be potential biomarkers of neurodegeneration in those at risk for CTE.	[Lepage, Christian; Muehlmann, Marc; Hufschmidt, Jakob; Stamm, Julie; Green, Katie; Wrobel, Pawel; Schultz, Vivian; Coleman, Michael J.; Lin, Alexander P.; Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.; Koerte, Inga K.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA; [Lepage, Christian] Univ Ottawa, Dept Psychol, Ottawa, ON, Canada; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Morphometr Anal, Boston, MA 02114 USA; [Muehlmann, Marc] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany; [Tripodis, Yorghos; Stamm, Julie; Alosco, Michael L.; Baugh, Christine M.; Fritts, Nathan G.; Chaisson, Christine; Stern, Robert A.] Boston Univ, BU Alzheimers Dis & CTE Ctr, Boston, MA 02215 USA; [Tripodis, Yorghos; Weir, Isabelle] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Hufschmidt, Jakob; Wrobel, Pawel; Schultz, Vivian; Koerte, Inga K.] Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany; [Stamm, Julie; Stern, Robert A.] Univ Wisconsin, Dept Kinesiol, Madison, WI USA; [Alosco, Michael L.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Martin, Brett M.; Chaisson, Christine] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA USA; [Lin, Alexander P.] Brigham & Womens Hosp, Ctr Clin Spect, 75 Francis St, Boston, MA 02115 USA; [Pasternak, Ofer; Makris, Nikos; Shenton, Martha E.] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Makris, Nikos] Massachusetts Gen Hosp, Ctr Neural Syst Invest, Boston, MA 02114 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Neurosurg, Boston, MA 02118 USA; [Stern, Robert A.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Shenton, Martha E.] VA Boston Healthcare Syst, Brockton Div, Brockton, MA USA		Koerte, IK (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA 02115 USA.; Koerte, IK (corresponding author), Ludwig Maximilians Univ Munchen, Dept Child & Adolescent Psychiat Psychosomat & Ps, Munich, Germany.	clepage@uottawa.ca; marc.muehlmann@med.lmu.de; yorghos@bu.edu; j.f.d.hufschmidt@web.de; jmstamm@bu.edu; katiefg@gmail.com; pwrob93@googlemail.com; vschultz@bwh.harvard.edu; iweir@bu.edu; malosco@bu.edu; cbaugh@g.harvard.edu; frittsn@ohsu.edu; brmartin@bu.edu; chaisson@bu.edu; mjc@bwh.harvard.edu; aplin@partners.org; ofer@bwh.harvard.edu; nikos@cma.mgh.harvard.edu; bobstern@bu.edu; shenton@bwh.harvard.edu; ikoerte@bwh.harvard.edu	Baugh, Christine/AAG-2324-2020; Shenton, Martha/V-8780-2019; Koerte, Inga Katharina/AAW-3031-2021; , Bob/ABA-8507-2020	Baugh, Christine/0000-0002-9340-6338; Tripodis, Yorghos/0000-0003-2190-7608	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS 078337, F31 NS 081957, 1F32NS096803-01, P30 AG13846, UL1-TR000157, P41 EB015902, T32GM074905, R01NS100952]; JetBlue Airlines; National Football League; NFL Players Association; Else Kroner-Fresenius Foundation, Germany; VA Merit AwardUS Department of Veterans Affairs; German Academic Exchange Service PROMOS award; Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral AwardCanadian Institutes of Health Research (CIHR); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM074905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100952, K23NS102399, F32NS096803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	The authors extend their appreciation to the study participants who make this work possible. This study was supported by the NIH (R01 NS 078337 (RAS, YT, CMB, NGF, BMM, CC); F31 NS 081957 (JMS); 1F32NS096803-01 (MLA), P30 AG13846 (RAS, YT, MLA, CMB, BMM, CC); UL1-TR000157 (RAS); P41 EB015902 (OP); T32GM074905 (IW); R01NS100952: IKK, APL), and participant travel was partially funded by JetBlue Airlines, the National Football League, and the NFL Players Association. This study was also partly supported by the Else Kroner-Fresenius Foundation, Germany (IK, MM) and by a VA Merit Award (MES, MC). VS was supported by the German Academic Exchange Service PROMOS award. CL was supported by the Canadian Institutes of Health Research Frederick Banting and Charles Best Doctoral Award. The sponsors had no role in the design and conduct of the study, the collection, analysis, or the interpretation of the data, nor in the preparation, review, or approval of the manuscript, or the decision of submission for publication. This work was completed in partial fulfillment of JH's Ph.D. dissertation.	Alosco Michael L, 2018, Alzheimers Dement (Amst), V10, P56, DOI 10.1016/j.dadm.2017.10.003; Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Amaral DG, 2003, NEUROPSYCHOLOGIA, V41, P235, DOI 10.1016/S0028-3932(02)00154-9; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Blaylock R. L., 2011, SURG NEUROLOGY INT, V2; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Drummond SPA, 2005, SLEEP, V28, P1059; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; Efron B., 1994, INTRO BOOTSTRAP; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Kilpatrick L, 2003, NEUROIMAGE, V20, P2091, DOI 10.1016/j.neuroimage.2003.08.006; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2015, J NEUROTRAUM, V32, P1287, DOI 10.1089/neu.2014.3715; Koerte IK, 2015, BRAIN PATHOL, V25, P318, DOI 10.1111/bpa.12249; Lin AP, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0094-5; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Robbins CA, 2014, OPEN ACCESS J SPORTS, V5, P99, DOI 10.2147/OAJSM.S58005; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sparks P, 2020, CLIN J SPORT MED, V30, pS1, DOI 10.1097/JSM.0000000000000541; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416	48	19	19	2	18	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2019	13	3					725	734		10.1007/s11682-018-9895-z			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IA1VV	WOS:000469351500014	29779184	Green Accepted			2022-02-06	
J	Wettervik, TS; Howells, T; Enblad, P; Lewen, A				Wettervik, Teodor Svedung; Howells, Timothy; Enblad, Per; Lewen, Anders			Temporal Neurophysiological Dynamics in Traumatic Brain Injury: Role of Pressure Reactivity and Optimal Cerebral Perfusion Pressure for Predicting Outcome	JOURNAL OF NEUROTRAUMA			English	Article						cerebral autoregulation; CPPopt; neurointensive care; traumatic brain injury	NEUROINTENSIVE CARE MANAGEMENT; DECOMPRESSIVE CRANIECTOMY; CEREBROVASCULAR REACTIVITY; INTRACRANIAL-PRESSURE; AUTOREGULATION; THRESHOLDS; GUIDELINES	Intracranial pressure (ICP), cerebral perfusion pressure (CPP), and the pressure reactivity index (PRx) have been shown to correlate with outcome after traumatic brain injury (TBI), but their temporal evolution is less studied. Optimal CPP (CPPopt; i.e., the CPP with the lowest [optimal] PRx value) has been proposed as a dynamic, individualized CPP target. Our aim was to map the temporal course of these parameters and their relation to outcome, in particular the extent and impact of CPP insults based both on fixed CPP thresholds and on divergence from CPPopt. Data from 362 TBI patients with ICP-monitoring treated at the neurointensive care unit of Uppsala University Hospital, Uppsala, Sweden, between 2008-2016 were retrospectively analyzed for the temporal course of ICP, mean arterial blood pressure, CPP, PRx, PRx55-15 (a variant of PRx), and CPPopt the first 10 days post-injury. PRx and PRx55-15 showed significantly lower/better values for those with favorable outcome, most pronounced on Days 2 to 5. PRx55-15 gave better separation between the two groups. In the univariate analysis, CPP insults (both fixed and CPPopt-thresholds) were significantly correlated with outcome on these days. Multi-variate logistic regression showed that age, Glasgow Coma Score Motor, pupillary abnormality at admission, CPP > CPPopt, and PRx55-15 were significant independent outcome predictors. PRx was significant when PRx55-15 was excluded. High PRx55-15 and high grade of monitoring time with CPP > CPPopt, but not the traditional fixed CPP thresholds, were strong predictors for worse clinical outcome. The study supports the concept that CPPopt is an important parameter in TBI management.	[Wettervik, Teodor Svedung; Howells, Timothy; Enblad, Per; Lewen, Anders] Uppsala Univ, Uppsala Univ Hosp, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden		Wettervik, TS (corresponding author), Uppsala Univ, Sect Neurosurg, Dept Neurosci, SE-75185 Uppsala, Sweden.	teodor.svedung-wettervik@neuro.uu.se	Wettervik, Teodor Mikael Svedung/S-5356-2017				Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2004, ACTA NEUROCHIR, V146, P131, DOI 10.1007/s00701-003-0187-y; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Fischerstrom A, 2014, ACTA NEUROCHIR, V156, P177, DOI 10.1007/s00701-013-1932-5; Ho CL, 2008, J NEUROSURG, V108, P943, DOI 10.3171/JNS/2008/108/5/0943; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Howells T, 2018, CRIT CARE MED, V46, pe235, DOI 10.1097/CCM.0000000000002930; Howells T, 2017, J CLIN MONIT COMPUT, V31, P469, DOI 10.1007/s10877-016-9863-3; Howells T, 2015, J CLIN MONIT COMPUT, V29, P97, DOI 10.1007/s10877-014-9573-7; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Miller J D, 1993, Acta Neurochir Suppl (Wien), V57, P152; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Nyholm L, 2013, UPSALA J MED SCI, V118, P169, DOI 10.3109/03009734.2013.806616; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257; Wettervik TS, 2018, ACTA NEUROCHIR, V160, P229, DOI 10.1007/s00701-017-3418-3; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	34	19	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1818	1827		10.1089/neu.2018.6157			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600012	30595128				2022-02-06	
J	Ocak, U; Ocak, PE; Wang, AN; Zhang, JH; Boling, W; Wu, P; Mo, J; Zhang, TY; Huang, L				Ocak, Umut; Ocak, Pinar Eser; Wang, Annie; Zhang, John H.; Boling, Warren; Wu, Pei; Mo, Jun; Zhang, Tongyu; Huang, Lei			Targeting mast cell as a neuroprotective strategy	BRAIN INJURY			English	Article						Mast cell; brain; neuroprotection; neuroinflammation; stroke; trauma; hypoxia	EARLY BRAIN-INJURY; NF-KAPPA-B; EXPERIMENTAL SUBARACHNOID HEMORRHAGE; EXPERIMENTAL ISCHEMIC-STROKE; CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; INTRACEREBRAL HEMORRHAGE; SIGNALING PATHWAY; HYPOXIA-ISCHEMIA; C-KIT	Background: Mast cells (MCs) are perivascularly located immune cells of haematopoietic origin. Emerging evidences suggest that the activation of MCs play important roles in the pathogenesis of blood brain barrier disruption, neuroinflammation, and neurodegeneration.Objectives: In this review, we aimed to discuss the detrimental effects of MCs in response to various types of brain injury, as well as the therapeutic potential and neuroprotective effects of targeting the activation and degranulation of MCs, particularly in the management of the acute phase.Methods: An extensive online literature search was conducted through Pubmed/Central on March 2018. Then, we comprehensively summarized the effects of the activation of brain MCs in acute brain injury along with current pharmacological strategies targeting at the activation of MCs.Results: The review of the current literature indicated that the activation and degranulation of brain MCs significantly contribute to the acute pathological process following different types of brain injury including focal and global cerebral ischaemia, intracerebral haemorrhage, subarachnoid haemorrhage, and traumatic brain injury.Conclusions: Brain MCs significantly contribute to the acute pathological processes following brain injury. In that regard, targeting brain MCs may provide a novel strategy for neuroprotection.	[Ocak, Umut; Ocak, Pinar Eser; Boling, Warren; Mo, Jun; Zhang, Tongyu; Huang, Lei] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92354 USA; [Wang, Annie; Zhang, John H.; Boling, Warren] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA 92354 USA; [Boling, Warren; Wu, Pei; Huang, Lei] Loma Linda Univ, Sch Med, Dept Neurosurg, Loma Linda, CA 92354 USA; [Mo, Jun] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin, Heilongjiang, Peoples R China; [Zhang, Tongyu] Zhejiang Univ, Sch Med, Affiliated Hosp 4, Dept Neurosurg, Yiwu, Zhejiang, Peoples R China		Huang, L (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Div Physiol, Loma Linda, CA 92354 USA.	lhuang@llu.edu	OCAK, UMUT/O-5167-2018; Eser, Pinar/AAI-2073-2021	OCAK, UMUT/0000-0002-6549-4246; Eser Ocak, Pinar/0000-0003-0132-9927			Ahmad A, 2012, BRAIN RES, V1477, P45, DOI 10.1016/j.brainres.2012.08.006; Akyol GY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15455-w; Aoki T, 2008, CURR NEUROVASC RES, V5, P37, DOI 10.2174/156720208783565663; Aoki T, 2007, CIRCULATION, V116, P2830, DOI 10.1161/CIRCULATIONAHA.107.728303; Aoki T, 2007, STROKE, V38, P162, DOI 10.1161/01.STR.0000252129.18605.c8; Aoki T, 2009, STROKE, V40, P942, DOI 10.1161/STROKEAHA.108.532556; Aoki T, 2009, NEUROSURGERY, V64, P357, DOI 10.1227/01.NEU.0000336764.92606.1D; Arac A, 2014, AM J PATHOL, V184, P2493, DOI 10.1016/j.ajpath.2014.06.003; Arsene D, 2011, ROM J MORPHOL EMBRYO, V52, P29; Arumugam TV, 2008, EXPERT OPIN THER TAR, V12, P19, DOI 10.1517/14728222.12.1.19; Ashman LK, 2013, EXPERT OPIN INV DRUG, V22, P103, DOI 10.1517/13543784.2013.740010; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Baba A, 2016, CELL PHYSIOL BIOCHEM, V38, P15, DOI 10.1159/000438605; BARONE FC, 1995, MOL CHEM NEUROPATHOL, V24, P13, DOI 10.1007/BF03160109; Beaven MA, 2009, EUR J IMMUNOL, V39, P11, DOI 10.1002/eji.200838899; Becker KJ, 1998, NEUROSURG CLIN N AM, V9, P435; Berger R, 1999, BRAIN RES REV, V30, P107, DOI 10.1016/S0165-0173(99)00009-0; Beridze M, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-41; Boddaert N, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.137; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; Bot I, 2007, CIRCULATION, V115, P2516, DOI 10.1161/CIRCULATIONAHA.106.660472; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Caltagirone C, 2016, TRANSL STROKE RES, V7, P54, DOI 10.1007/s12975-015-0440-8; Chen CH, 2010, NEUROSCIENCE, V169, P402, DOI 10.1016/j.neuroscience.2010.04.043; Chen S, 2015, TRANSL STROKE RES, V6, P4, DOI 10.1007/s12975-014-0384-4; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Chyatte D, 1997, STROKE, V28, P799, DOI 10.1161/01.STR.28.4.799; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; CUTZ E, 1978, NATURE, V275, P661, DOI 10.1038/275661a0; De Filippis D, 2013, CNS NEUROL DISORD-DR, V12, P78, DOI 10.2174/1871527311312010013; De Filippis D, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-3; Denes A, 2007, J CEREBR BLOOD F MET, V27, P1941, DOI 10.1038/sj.jcbfm.9600495; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Di Girolamo N, 2006, J IMMUNOL, V177, P2638, DOI 10.4049/jimmunol.177.4.2638; DIMITRIADOU V, 1990, NEUROSCIENCE, V39, P209, DOI 10.1016/0306-4522(90)90234-U; Dong HQ, 2014, MED SCI MONIT BASIC, V20, P200, DOI 10.12659/MSMBR.893093; DOYLE MP, 1994, AM J PHYSIOL, V266, pH2042, DOI 10.1152/ajpheart.1994.266.5.H2042; DROPP JJ, 1976, ACTA ANAT, V94, P1; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; DUX E, 1982, EXP BRAIN RES, V47, P252; EDVINSSON L, 1977, NEUROLOGY, V27, P878, DOI 10.1212/WNL.27.9.878; Erben P, 2014, ANN HEMATOL, V93, P81, DOI 10.1007/s00277-013-1964-1; Esposito E, 2014, PHARMACOL RES, V86, P26, DOI 10.1016/j.phrs.2014.05.009; FALEIRO LCM, 1981, J NEUROSURG, V54, P733, DOI 10.3171/jns.1981.54.6.0733; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Ferriero DM, 2002, DEV NEUROSCI-BASEL, V24, P349, DOI 10.1159/000069048; Finnie JW, 2002, VET PATHOL, V39, P679, DOI 10.1354/vp.39-6-679; Foerch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054203; Frank BT, 2001, J IMMUNOL, V166, P2783, DOI 10.4049/jimmunol.166.4.2783; Fujii M, 2014, J NEUROL SCI, V342, P101, DOI 10.1016/j.jns.2014.04.034; Fukuda S, 2000, CIRCULATION, V101, P2532, DOI 10.1161/01.CIR.101.21.2532; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Ganeshan K, 2012, J IMMUNOL, V188, P594, DOI 10.4049/jimmunol.1102389; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; GOLDSCHMIDT RC, 1984, BRAIN RES, V323, P209, DOI 10.1016/0006-8993(84)90291-9; GOLDSCHMIDT RC, 1985, J NEUROCHEM, V44, P1943, DOI 10.1111/j.1471-4159.1985.tb07191.x; GROSS PM, 1982, AM J PHYSIOL, V243, pH307, DOI 10.1152/ajpheart.1982.243.2.H307; Guo ZD, 2016, STROKE, V47, P490, DOI 10.1161/STROKEAHA.115.011223; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Hall NC, 2000, CELL MOL BIOL, V46, P673; Hallgren J, 2007, IMMUNOL REV, V217, P8, DOI 10.1111/j.1600-065X.2007.00502.x; He Y, 2015, STROKE, V46, P2277, DOI 10.1161/STROKEAHA.115.010088; Hedtjarn M, 2004, J CEREBR BLOOD F MET, V24, P1333, DOI 10.1097/01.WCB.0000141559.17620.36; Hei ZQ, 2008, BMC GASTROENTEROL, V8, DOI 10.1186/1471-230X-8-42; Hellings WE, 2008, JAMA-J AM MED ASSOC, V299, P547, DOI 10.1001/jama.299.5.547; Hendrikus E, 2017, NEUROSCI BIOBEHAV R, V83, P774, DOI 10.1016/j.neubiorev.2017.10.030; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hu WW, 2004, BRAIN RES, V1019, P275, DOI 10.1016/j.brainres.2004.05.109; Huang XP, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00398; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ibrahim MZM, 1996, J NEUROIMMUNOL, V70, P131, DOI 10.1016/S0165-5728(96)00102-6; IBRAHIM MZM, 1985, ACTA ANAT, V124, P149; Ishibashi R, 2010, CURR NEUROVASC RES, V7, P113, DOI 10.2174/156720210791184916; Itoh T, 2009, BIOCHEM BIOPH RES CO, V389, P651, DOI 10.1016/j.bbrc.2009.09.047; Jeong S, 2014, J NEUROIMMUNOL, V276, P112, DOI 10.1016/j.jneuroim.2014.08.626; Jin YX, 2007, DEV NEUROSCI-BASEL, V29, P373, DOI 10.1159/000105478; Jin YX, 2009, STROKE, V40, P3107, DOI 10.1161/STROKEAHA.109.549691; Jonsson F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00016; Johnson JL, 1998, ARTERIOSCL THROM VAS, V18, P1707, DOI 10.1161/01.ATV.18.11.1707; Kaptain GJ, 2000, DRUG AGING, V17, P183, DOI 10.2165/00002512-200017030-00003; Kasner SE, 2001, STROKE, V32, P2117, DOI 10.1161/hs0901.095719; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kempuraj D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00703; Kempuraj D, 2016, NEUROCHEM RES, V41, P1042, DOI 10.1007/s11064-015-1790-z; Khalil M, 2007, BRAIN RES, V1171, P18, DOI 10.1016/j.brainres.2007.07.034; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kim DY, 2010, J IMMUNOL, V185, P273, DOI 10.4049/jimmunol.1000991; King JT, 1997, NEUROIMAG CLIN N AM, V7, P659; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1993, AM J MED SCI, V306, P185, DOI 10.1097/00000441-199309000-00011; Kocic I, 2015, N-S ARCH PHARMACOL, V388, P79, DOI 10.1007/s00210-014-1061-6; Kulka M, 2009, J LEUKOCYTE BIOL, V86, P1217, DOI 10.1189/jlb.0908517; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Kuwabara A, 2017, NEUROSURGERY, V81, P1021, DOI 10.1093/neuros/nyx172; Laine P, 1999, CIRCULATION, V99, P361, DOI 10.1161/01.CIR.99.3.361; Lapchak PA, 2017, TRANSL STROKE RES, V8, P318, DOI 10.1007/s12975-017-0529-3; Lappalainen H, 2004, ARTERIOSCL THROM VAS, V24, P1880, DOI 10.1161/01.ATV.0000140820.51174.8d; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Li JR, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0959-6; Li X, 2018, TRANSL STROKE RES, V9, P549, DOI 10.1007/s12975-018-0664-5; Li XS, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00127; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; LISZCZAK TM, 1983, J NEUROSURG, V58, P18, DOI 10.3171/jns.1983.58.1.0018; Liu F, 2015, EXP NEUROL, V272, P120, DOI 10.1016/j.expneurol.2015.04.016; Liu FD, 2013, ACTA PHARMACOL SIN, V34, P1121, DOI 10.1038/aps.2013.89; Liu L, 2018, MOL NEUROBIOL, V55, P8346, DOI 10.1007/s12035-018-1006-z; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Lok J, 2011, ACTA NEUROCHIR SUPPL, V111, P63, DOI 10.1007/978-3-7091-0693-8_11; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Longley BJ, 1996, NAT GENET, V12, P312, DOI 10.1038/ng0396-312; Lozada A, 2005, NEUROPATH APPL NEURO, V31, P150, DOI 10.1111/j.1365-2990.2004.00622.x; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Manaenko A, 2013, CRIT CARE MED, V41, P1266, DOI 10.1097/CCM.0b013e31827711c9; MANNAIONI PF, 1991, INT J TISSUE REACT, V13, P271; Marinkovic I, 2014, J CEREBR BLOOD F MET, V34, P176, DOI 10.1038/jcbfm.2013.189; Mattila OS, 2011, STROKE, V42, P3600, DOI 10.1161/STROKEAHA.111.632224; Medic N, 2010, J NEUROIMMUNOL, V218, P57, DOI 10.1016/j.jneuroim.2009.10.011; Montaner J, 2010, TRANSL STROKE RES, V1, P261, DOI 10.1007/s12975-010-0038-0; Montecucco F, 2010, STROKE, V41, P1394, DOI 10.1161/STROKEAHA.110.578369; Moon TC, 2010, MUCOSAL IMMUNOL, V3, P111, DOI 10.1038/mi.2009.136; Moretti R, 2016, J NEUROSCI RES, V94, P1546, DOI 10.1002/jnr.23911; Moriwaki T, 2006, STROKE, V37, P900, DOI 10.1161/01.STR.0000204028.39783.d9; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Moura DS, 2014, IMMUNOL ALLERGY CLIN, V34, P407, DOI 10.1016/j.iac.2014.02.001; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Nautiyal KM, 2012, EUR J NEUROSCI, V36, P2347, DOI 10.1111/j.1460-9568.2012.08138.x; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Nelson KB, 2004, LANCET NEUROL, V3, P150, DOI 10.1016/S1474-4422(04)00679-9; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ollikainen E, 2014, J NEUROPATH EXP NEUR, V73, P855, DOI 10.1097/NEN.0000000000000105; ORR EL, 1984, J NEUROCHEM, V42, P727, DOI 10.1111/j.1471-4159.1984.tb02743.x; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Ottosson A, 1997, CEPHALALGIA, V17, P166, DOI 10.1046/j.1468-2982.1997.1703166.x; Parrella E, 2016, BRAIN RES, V1648, P409, DOI 10.1016/j.brainres.2016.07.014; Patkai J, 2001, PEDIATR RES, V50, P222, DOI 10.1203/00006450-200108000-00010; Peng YC, 2018, NEUROCHEM RES, V43, P785, DOI 10.1007/s11064-018-2480-4; Piette F, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt75; Qiao HM, 2012, NEUROCHEM RES, V37, P2014, DOI 10.1007/s11064-012-0822-1; Qiao HM, 2012, BRAIN RES, V1448, P71, DOI 10.1016/j.brainres.2012.02.003; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Ribatti D, 2008, ANN MED, V40, P606, DOI 10.1080/07853890802186913; RONNBERG AL, 1973, AGENTS ACTIONS, V3, P191; Rosell A, 2008, STROKE, V39, P1121, DOI 10.1161/STROKEAHA.107.500868; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Sadamasa N, 2003, STROKE, V34, P2980, DOI 10.1161/01.STR.0000102556.55600.3B; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Shanas U, 1998, J NEUROIMMUNOL, V90, P207, DOI 10.1016/S0165-5728(98)00137-4; Shepherd Rebecca K., 1995, Microcirculation (New York), V2, P363, DOI 10.3109/10739689509148280; Shepherd RK, 1996, CIRC RES, V78, P627, DOI 10.1161/01.RES.78.4.627; Silver R, 1996, TRENDS NEUROSCI, V19, P25, DOI 10.1016/0166-2236(96)81863-7; Silver RB, 2004, P NATL ACAD SCI USA, V101, P13607, DOI 10.1073/pnas.0403208101; Skaper SD, 2017, NEUROSCIENTIST, V23, P478, DOI 10.1177/1073858416687249; Skaper SD, 2014, IMMUNOLOGY, V141, P314, DOI 10.1111/imm.12170; Skaper SD, 2012, FASEB J, V26, P3103, DOI 10.1096/fj.11-197194; Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397; Strbian D, 2007, CIRCULATION, V116, P411, DOI 10.1161/CIRCULATIONAHA.106.655423; Strbian D, 2007, J CEREBR BLOOD F MET, V27, P795, DOI 10.1038/sj.jcbfm.9600387; Strbian D, 2006, J CEREBR BLOOD F MET, V26, P605, DOI 10.1038/sj.jcbfm.9600228; Strbian D, 2009, ANN MED, V41, P438, DOI 10.1080/07853890902887303; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Suzuki H, 2018, TRANSL STROKE RES, V9, P1, DOI 10.1007/s12975-017-0546-2; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Syvaranta S, 2010, ARTERIOSCL THROM VAS, V30, P1220, DOI 10.1161/ATVBAHA.109.198267; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Tashiro M, 2006, BRIT J CLIN PHARMACO, V61, P16, DOI 10.1111/j.1365-2125.2005.02514.x; Tchougounova E, 2005, J BIOL CHEM, V280, P9291, DOI 10.1074/jbc.M410396200; THEOHARIDES TC, 1990, LIFE SCI, V46, P607, DOI 10.1016/0024-3205(90)90129-F; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Theoharides TC, 2017, EXP DERMATOL, V26, P751, DOI 10.1111/exd.13288; Theoharides TC, 2015, NEW ENGL J MED, V373, P1885, DOI 10.1056/NEJMc1510021; Tore F, 2009, CURR PHARM DESIGN, V15, P3433, DOI 10.2174/138161209789105036; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2000, MAST CELLS BASOPHILS, P497; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; von Kummer R, 2001, RADIOLOGY, V219, P95, DOI 10.1148/radiology.219.1.r01ap0695; Woo D, 2002, NEUROSURG CLIN N AM, V13, P265, DOI 10.1016/S1042-3680(02)00011-6; Wu BH, 2011, NEUROCRIT CARE, V14, P109, DOI 10.1007/s12028-010-9372-z; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xie ZY, 2018, BRAIN BEHAV IMMUN, V69, P190, DOI 10.1016/j.bbi.2017.11.012; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yin J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00096; Yoshida GJ, 2015, NEW ENGL J MED, V373, P1884, DOI 10.1056/NEJMc1510021; ZHANG RL, 1994, J NEUROL SCI, V125, P3, DOI 10.1016/0022-510X(94)90234-8; Zhang X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0592-9	196	19	19	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	MAY 12	2019	33	6			SI		723	733		10.1080/02699052.2018.1556807			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IG0CN	WOS:000473458900005	30554528				2022-02-06	
J	Goetzl, EJ; Ledreux, A; Granholm, AC; Elahi, FM; Goetzl, L; Hiramoto, J; Kapogiannis, D				Goetzl, Edward J.; Ledreux, Aurelie; Granholm, Ann-Charlotte; Elahi, Fanny M.; Goetzl, Laura; Hiramoto, Jade; Kapogiannis, Dimitrios			Neuron-Derived Exosome Proteins May Contribute to Progression From Repetitive Mild Traumatic Brain Injuries to Chronic Traumatic Encephalopathy	FRONTIERS IN NEUROSCIENCE			English	Article						amyloid; cellular prion protein; phospho-tau; synaptogyrin-3; Alzheimer disease	BARRIER DISRUPTION; HEAD IMPACTS; BLOOD; ASSOCIATION; BIOMARKERS; DEMENTIA; INTERLEUKIN-6; EPIDEMIOLOGY; PATHOGENESIS; INFLAMMATION	The recent recognition that Alzheimer disease-like pathology may be found in chronic traumatic encephalopathy (CTE) even after acute mild traumatic brain injury (mTBI) has increased the urgency of elucidating mechanisms, identifying biomarkers predictive of high risk of development of CTE, and establishing biomarker profiles indicative of impactful effects of treatments. Of the many proteins that are loaded into neuron-derived exosomes (NDEs) from damaged neurons after acute TBI, the levels of prion cellular protein (PRPc), coagulation factor XIII (XIIIa), synaptogyrin-3, IL-6, and aquaporins remain elevated for months. Prolonged heightened expression of aquaporins and IL-6 may account for the persistent central nervous system edema and inflammation of CTE. PRPc, XIIIa and synaptogyrin-3 bind and concentrate neurotoxic forms of oligomeric amyloid beta peptides or P-tau for delivery into neurons at or distant from the site of trauma. Our progression factor hypothesis of CTE asserts that physiological neuronal proteins, such as PRPc, XIIIa, synaptogyrin-3, IL-6 and aquaporins, that increase in concentration in neurons and NDEs for months after acute TBI, are etiological contributors to CTE by either direct actions or by recruiting neurotoxic forms of A beta peptides or P-tau. Such progression factors also may be useful new targets for development of drugs to prevent CTE.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Ledreux, Aurelie; Granholm, Ann-Charlotte] Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA; [Elahi, Fanny M.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Laura] Univ Texas Hlth Sci Ctr Houston, Dept Obstet Gynecol & Reprod Sci, Houston, TX 77030 USA; [Hiramoto, Jade] Univ Calif San Francisco, Dept Surg, Div Vasc Surg, San Francisco, CA USA; [Kapogiannis, Dimitrios] NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA		Goetzl, EJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Ledreux, A (corresponding author), Univ Denver, Knoebel Inst Hlth Aging, Denver, CO 80208 USA.; Kapogiannis, D (corresponding author), NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA.	edward.goetzl@ucsf.edu; aurelie.ledreux@du.edu; kapogiannisd@nih.gov	Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Goetzl, Laura/0000-0003-4130-2809	Knoebel Institute for Healthy Aging; Intramural Program of the National Institute on Aging of the NIH; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG023481, ZIAAG000975] Funding Source: NIH RePORTER	The research described was supported by a pilot grant to Drs. Ledreux and Granholm-Bentley from the Knoebel Institute for Healthy Aging and by support of Drs. Mustapic and Kapogiannis from the Intramural Program of the National Institute on Aging of the NIH.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Blasko I, 2004, J NEURAL TRANSM, V111, P523, DOI 10.1007/s00702-003-0095-6; Blyth BJ, 2009, J NEUROTRAUM, V26, P1497, DOI 10.1089/neu.2008-0738; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Chua CEL, 2010, FEBS LETT, V584, P1, DOI 10.1016/j.febslet.2009.11.051; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Dailey NS, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00118; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fiandaca MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195318; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl L, 2018, ANN CLIN TRANSL NEUR, V5, P4, DOI 10.1002/acn3.499; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hiramoto JS, 2017, J VASC SURG, V65, P311, DOI 10.1016/j.jvs.2016.08.111; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hur WS, 2019, J BIOL CHEM, V294, P390, DOI 10.1074/jbc.RA118.005352; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Kiral FR, 2018, CURR BIOL, V28, pR471, DOI 10.1016/j.cub.2018.02.010; Kuriakose M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26813-7; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; Mettang M, 2018, FASEB J, V32, P1916, DOI 10.1096/fj.201700826R; Morita Y, 2014, J NEUROSCI, V34, P4929, DOI 10.1523/JNEUROSCI.1423-13.2014; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Roy D, 2017, J NEUROPSYCH CLIN N, V29, P334, DOI 10.1176/appi.neuropsych.16050088; Scharfman HE, 2013, NEUROCHEM INT, V63, P702, DOI 10.1016/j.neuint.2013.05.003; Simon DW, 2017, NAT REV NEUROL, V13, P572, DOI 10.1038/nrneurol.2017.116; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087	54	19	19	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	MAY 8	2019	13								452	10.3389/fnins.2019.00452			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HX4GW	WOS:000467354100001	31133789	Green Published, gold			2022-02-06	
J	Guley, NM; Del Mar, NA; Ragsdale, T; Li, CY; Perry, AM; Moor, BM; Honig, MG; Reiner, A				Guley, Natalie M.; Del Mar, Nobel A.; Ragsdale, Tyler; Li, Chunyan; Perry, Aaron M.; Moor, Bob M.; Honig, Marcia G.; Reiner, Anton			Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189	EXPERIMENTAL EYE RESEARCH			English	Article						TBI; Visual deficits; Microglia; CB2 receptors; Cannabinoid therapy	TRAUMATIC BRAIN-INJURY; OPTIC-NERVE HEAD; SPINAL-CORD; CB2 RECEPTOR; MICROGLIAL POLARIZATION; CELL RESPONSES; AXONAL INJURY; ACTIVATION; MOUSE; DYSFUNCTION	Mild TBI is often accompanied by visual system dysfunction and injury, which is at least partly caused by microglial neuroinflammatory processes initiated by the injury. Using our focal cranial blast mouse model of closed-skull mild TBI, we evaluated the ability of the cannabinoid type-2 (CB2) receptor inverse agonist SMM-189, which biases microglia from the harmful M1 state to the beneficial M2 state, to mitigate visual system dysfunction and injury after TBI. Male C57BL/6 or Thyl-EYFP reporter mice received a closed-head blast of either 0-psi (sham) or 50-psi to the left side of the cranium. Blast mice received vehicle or 6 mg/kg SMM-189 daily beginning 2 h after blast. Sham mice received vehicle. In some mice, retina and optic nerve/tract were assessed morphologically at 3-7 days after blast, while other mice were assessed functionally by Optomotry >= 30 days after blast and morphologically at >= 30 days after blast. Mice sacrificed at 3-7 days were treated daily until sacrificed, while those assessed 30 days after blast were treated daily for 2 weeks post blast. Axon damage was evident in the left optic nerve and its continuation as the right optic tract at 3 days post blast in vehicle-treated blast mice in the form of swollen axon bulbs, and was accompanied by a significant increase in the abundance of microglia. Testing at 30 days post blast revealed that the contrast sensitivity function was significantly reduced in both eyes in vehicle-treated blast mice compared to vehicle-treated sham blast mice, and axon counts at >= 30 days after blast revealed a similar to 10% loss in left optic nerve in vehicle-treated blast mice. Left optic nerve axon loss was highly correlated with the left eye deficit in contrast sensitivity. Immurtolabeling at 30 days post blast showed a significant increase in the abundance of microglia in the retinas of both eyes and in GFAP + Muller cell processes traversing the inner plexiform layer in the left eye of vehicle-treated blast mice. SMM-189 treatment reduced axon injury and microglial abundance at 3 days, and mitigated axon loss, contrast sensitivity deficits, microglial abundance, and Muller cell GFAP upregulation at >= 30 days after blast injury. Analysis of right optic tract microglia at 3 days post blast for Ml versus M2 markers revealed that SMM-189 biased microglia toward the M2 state, with this action of SMM-189 being linked to reduced axonal injury. Taken together, our results show that focal left side cranial blast resulted in impaired contrast sensitivity and retinal pathology bilaterally and optic nerve loss ipsilaterally. The novel cannabinoid drug SMM-189 significantly mitigated the functional deficit and the associated pathologies. Our findings suggest the value of combatting visual system injury after TBI by using CB2 inverse agonists such as SMM-189, which appear to target microglia and bias them away from the pro-inflammatory Ml state, toward the protective M2 state.	[Guley, Natalie M.; Del Mar, Nobel A.; Ragsdale, Tyler; Li, Chunyan; Perry, Aaron M.; Honig, Marcia G.; Reiner, Anton] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA; [Reiner, Anton] Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Moor, Bob M.] Univ Tennessee, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA		Reiner, A (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, 855 Monroe Ave, Memphis, TN 38163 USA.	areiner@uthsc.edu	Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232	University of Tennessee Neuroscience Institute; The Office of the Dean of the College of Medicine at The University of Tennessee Health Science Center; Office of the Dean of the College of Graduate Health Sciences at The University of Tennessee Health Science Center; Methodist Hospitals Endowed Professorship in Neuroscience; College of Pharmacy; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [EY-005298]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY005298] Funding Source: NIH RePORTER	This work was supported by The University of Tennessee Neuroscience Institute (AR, NMG), The Office of the Dean of the College of Medicine at The University of Tennessee Health Science Center (AR), The Office of the Dean of the College of Graduate Health Sciences at The University of Tennessee Health Science Center (NMG), The Methodist Hospitals Endowed Professorship in Neuroscience (AR), The College of Pharmacy (BMM), and NIH grant EY-005298 (AR). The funding sources played no role in the design or execution of the study, or in the choice of journal for publication.	Alvarez TL, 2012, OPTOMETRY VISION SCI, V89, P1740, DOI 10.1097/OPX.0b013e3182772dce; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Atwood BK, 2012, PROG NEURO-PSYCHOPH, V38, P16, DOI 10.1016/j.pnpbp.2011.12.001; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Bosco A, 2016, EXP EYE RES, V150, P34, DOI 10.1016/j.exer.2016.01.014; Bosco A, 2011, J COMP NEUROL, V519, P599, DOI 10.1002/cne.22516; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Bringmann A, 2012, OPHTHALMOLOGICA, V227, P1, DOI 10.1159/000328979; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Burgoyne CF, 2011, EXP EYE RES, V93, P120, DOI 10.1016/j.exer.2010.09.005; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Cao L, 2013, NEUROSCI BULL, V29, P189, DOI 10.1007/s12264-013-1324-0; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Pena-Philippides JC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0753-x; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Cockerham GC, 2013, OCUL SURF, V11, P25, DOI 10.1016/j.jtos.2012.09.004; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Das M., 2018, REV NEUROSCI; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; del Mar N, 2015, EXP NEUROL, V271, P53, DOI 10.1016/j.expneurol.2015.04.023; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Doble JE, 2010, PM&R, V2, P244, DOI 10.1016/j.pmrj.2010.01.011; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donat CK, 2014, ACTA NEUROBIOL EXP, V74, P197; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; Erkenstam NH, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00286; Evanson NK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197346; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Fujinaga M, 2010, BIOORG MED CHEM LETT, V20, P1565, DOI 10.1016/j.bmcl.2010.01.074; Gaucher D, 2007, VISION RES, V47, P612, DOI 10.1016/j.visres.2006.11.017; Gaudet AD, 2016, J NEUROSCI, V36, P8516, DOI 10.1523/JNEUROSCI.0735-16.2016; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hippert C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120415; Howell GR, 2007, J CELL BIOL, V179, P1523, DOI 10.1083/jcb.200706181; HUMPHREY MF, 1993, J COMP NEUROL, V334, P545, DOI 10.1002/cne.903340404; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jin H, 2010, INJURY, V41, P918, DOI 10.1016/j.injury.2010.03.007; Karlstetter M, 2010, IMMUNOBIOLOGY, V215, P685, DOI 10.1016/j.imbio.2010.05.010; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kimble TDH, 2006, EXP EYE RES, V83, P1017, DOI 10.1016/j.exer.2006.05.006; Kondo Y, 2013, J NEUROSCI, V33, P3514, DOI 10.1523/JNEUROSCI.4849-12.2013; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Levy C, 2015, J COMP NEUROL, V523, P629, DOI 10.1002/cne.23701; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2004, AM J PHYS MED REHAB, V83, P428, DOI 10.1097/00002060-200406000-00004; Liu Y, 2017, BMC BIOCHEM, V18, DOI 10.1186/s12858-017-0079-z; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Ohgidani M, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00676; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Peferoen LAN, 2015, J NEUROPATH EXP NEUR, V74, P48, DOI 10.1097/NEN.0000000000000149; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; SCHNITZER J, 1990, J COMP NEUROL, V302, P779, DOI 10.1002/cne.903020410; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Stempel AV, 2016, NEURON, V90, P795, DOI 10.1016/j.neuron.2016.03.034; STERNBERGER LA, 1982, P NATL ACAD SCI-BIOL, V79, P1326, DOI 10.1073/pnas.79.4.1326; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; Sun D, 2009, J COMP NEUROL, V516, P1, DOI 10.1002/cne.22058; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Walker DG, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0139-9; Wang JQ, 2011, J NEUROTRAUM, V28, P1185, DOI 10.1089/neu.2011.1756; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Xu FT, 2016, NEUROSCI LETT, V617, P6, DOI 10.1016/j.neulet.2016.01.038; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; 2006, J PHARMACOL EXP THER, V316, P780, DOI DOI 10.1124/JPET.105.093500; 2014, INVESTIG OPHTHALMOL, V55, P4853, DOI DOI 10.1167/IOVS.14-14353; 2008, ANESTHESIOLOGY, V108, P722; 2012, EXP NEUROL, V233, P364, DOI DOI 10.1016/J.EXPNEUROL.2011.10.030; 2015, INT J MOL SCI, V16, P758, DOI DOI 10.3390/IJMS16010758	94	19	19	0	4	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	MAY	2019	182						109	124		10.1016/j.exer.2019.03.013			16	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Ophthalmology	HY6RV	WOS:000468258300013	30922891	hybrid, Green Accepted			2022-02-06	
J	Monfort, SM; Pradarelli, JJ; Grooms, DR; Hutchison, KA; Onate, JA; Chaudhari, AMW				Monfort, Scott M.; Pradarelli, Jared J.; Grooms, Dustin R.; Hutchison, Keith A.; Onate, James A.; Chaudhari, Ajit M. W.			Visual-Spatial Memory Deficits Are Related to Increased Knee Valgus Angle During a Sport-Specific Sidestep Cut	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						cognition; dual task; knee valgus; ACL	CRUCIATE LIGAMENT INJURY; EXTREMITY MUSCULOSKELETAL INJURY; FEMALE TEAM HANDBALL; DECISION-MAKING; SOCCER PLAYERS; BIOMECHANICS; BASKETBALL; IMPACT; RISK; CONCUSSION	Background: Identifying athletes at an increased risk of injury is a promising approach to improve the effect of injury prevention interventions; however, it requires first identifying the potential athlete-specific risk factors. Cognitive ability was recently shown to correlate with noncontact anterior cruciate ligament injury rates and lower extremity mechanics, marking an underexplored area. A better understanding of how individuals' cognitive ability is associated with neuromuscular control during sport-specific tasks may improve injury prevention. Hypothesis: Athletes with lower cognitive performance on a standardized cognitive assessment would demonstrate greater increases in knee valgus angle and moment when performing a sidestep cut with soccer ball dribbling versus without. Visual-spatial memory was expected to demonstrate stronger relationships than reaction time or processing speed. Study Design: Descriptive laboratory study. Methods: Fifteen male collegiate club soccer players participated (mean +/- SD: 20.7 +/- 2.0 years, 1.78 +/- 0.07 m, 76.5 +/- 8.9 kg). Participants performed anticipated 45 degrees run-to-cut trials with and without a dual task of dribbling a soccer ball. Peak early-stance knee valgus angle and moment for the plant limb were calculated. Participants also completed a cognitive assessment to evaluate visual memory, verbal memory, reaction time, and processing speed. These composite scores were entered as candidate predictors for a stepwise regression analysis on the dual-task change scores in lower extremity biomechanical parameters (ie, ball handling -non-ball handling). Results: Visual memory composite score (a measure of visual-spatial memory) was the only cognitive outcome significantly associated with the change in biomechanical parameters. Each unit decrease in the visual memory composite score was associated with an increase of 0.21 degrees +/- 0.05 degrees in peak knee valgus angle during the ball-handling task as compared with the non-ball handling task (R-2 = 52%, P = .003). Conclusion: Visual-spatial memory was associated with neuromuscular control during a sidestep cutting task during soccer ball dribbling, with deficits in this cognitive domain being associated with increased peak knee valgus angle. Clinical Relevance: Assessing visual-spatial memory ability may provide useful information to better understand conditions associated with impaired neuromuscular control and to potentially identify athletes at an elevated risk for musculoskeletal injury.	[Monfort, Scott M.; Pradarelli, Jared J.; Grooms, Dustin R.; Hutchison, Keith A.; Onate, James A.; Chaudhari, Ajit M. W.] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Monfort, Scott M.] Montana State Univ, Dept Mech & Ind Engn, POB 173800, Bozeman, MT 59717 USA; [Pradarelli, Jared J.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Grooms, Dustin R.] Ohio Univ, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA; [Grooms, Dustin R.] Ohio Univ, Sch Appl Hlth Sci & Wellness, Coll Hlth Sci & Profess, Athens, OH 45701 USA; [Hutchison, Keith A.] Montana State Univ, Dept Psychol, Bozeman, MT 59717 USA; [Onate, James A.; Chaudhari, Ajit M. W.] Ohio State Univ, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Onate, James A.; Chaudhari, Ajit M. W.] Ohio State Univ, Sports Med Res Inst, Columbus, OH 43210 USA		Monfort, SM (corresponding author), Montana State Univ, Dept Mech & Ind Engn, POB 173800, Bozeman, MT 59717 USA.	scott.monfort@montana.edu	Chaudhari, Ajit/N-5831-2019	Chaudhari, Ajit/0000-0001-5071-7147; Hutchison, Keith/0000-0001-5189-2801	National Science FoundationNational Science Foundation (NSF) [DGE-1343012]; National Athletic Trainers' Association Foundation; National Strength and Conditioning Association Foundation; Ohio State College of Medicine	This work was supported by the National Science Foundation (grant DGE-1343012) as well as the National Athletic Trainers' Association Foundation, National Strength and Conditioning Association Foundation, and The Ohio State College of Medicine. AOSSM checks author disclosures against the Open Payments Database (OPD). AOSSM has not conducted an independent investigation on the OPD and disclaims any liability or responsibility relating thereto.	Agel J, 2005, AM J SPORT MED, V33, P524, DOI 10.1177/0363546504269937; Almonroeder TG, 2017, SPORTS BIOMECH, V13, P1; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Appelbaum LG, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00276; BELL AL, 1989, HUM MOVEMENT SCI, V8, P3, DOI 10.1016/0167-9457(89)90020-1; Besier TF, 2001, MED SCI SPORT EXER, V33, P1176; Bisseling RW, 2006, J BIOMECH, V39, P2438, DOI 10.1016/j.jbiomech.2005.07.021; Borotikar BS, 2008, CLIN BIOMECH, V23, P81, DOI 10.1016/j.clinbiomech.2007.08.008; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Brown TN, 2009, BRIT J SPORT MED, V43, P1049, DOI 10.1136/bjsm.2008.055954; Camomilla V, 2006, J BIOMECH, V39, P1096, DOI 10.1016/j.jbiomech.2005.02.008; Carey DP, 2001, J SPORT SCI, V19, P855, DOI 10.1080/026404101753113804; Chaudhari AM, 2006, J BIOMECH, V39, P330, DOI 10.1016/j.jbiomech.2004.11.013; Chaudhari AM, 2005, AM J SPORT MED, V33, P824, DOI 10.1177/0363546504270455; Collins JD, 2016, CLIN BIOMECH, V35, P62, DOI 10.1016/j.clinbiomech.2016.04.004; Cowley HR, 2006, J ATHL TRAINING, V41, P67; Dai BY, 2018, SPORT BIOMECH, V17, P192, DOI 10.1080/14763141.2016.1265579; Dyrby CO, 2004, J ORTHOP RES, V22, P794, DOI 10.1016/j.orthres.2003.11.003; Fedie R, 2010, SPORT BIOMECH, V9, P165, DOI 10.1080/14763141.2010.502241; Ford KR, 2005, J STRENGTH COND RES, V19, P394, DOI 10.1519/15834.1; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Grooms D, 2015, J ORTHOP SPORT PHYS, V45, P381, DOI 10.2519/jospt.2015.5549; Grooms DR, 2018, J ATHL TRAINING, V53, P486, DOI 10.4085/1062-6050-178-16; Grooms DR, 2017, J ORTHOP SPORT PHYS, V47, P180, DOI 10.2519/jospt.2017.7003; Harris KP, 2017, J ATHL TRAINING, V52, P507, DOI 10.4085/1062-6050-49.3.89; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Herman DC, 2016, AM J SPORT MED, V44, P2347, DOI 10.1177/0363546516657338; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jamison ST, 2012, J BIOMECH, V45, P1881, DOI 10.1016/j.jbiomech.2012.05.031; Kipp K, 2013, J APPL BIOMECH, V29, P756, DOI 10.1123/jab.29.6.756; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Kristianslund E, 2012, J BIOMECH, V45, P666, DOI 10.1016/j.jbiomech.2011.12.011; Krosshaug T, 2007, AM J SPORT MED, V35, P359, DOI 10.1177/0363546506293899; Landry SC, 2007, AM J SPORT MED, V35, P1901, DOI 10.1177/0363546507307400; Lohmander LS, 2004, ARTHRITIS RHEUM-US, V50, P3145, DOI 10.1002/art.20589; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; Mall NA, 2014, AM J SPORT MED, V42, P2363, DOI 10.1177/0363546514542796; Mandelbaum BR, 2005, AM J SPORT MED, V33, P1003, DOI 10.1177/0363546504272261; Marx RG, 2001, AM J SPORT MED, V29, P213, DOI 10.1177/03635465010290021601; Mclean SG, 2009, MED SCI SPORT EXER, V41, P1661, DOI 10.1249/MSS.0b013e31819ca07b; McLean SG, 2004, MED SCI SPORT EXER, V36, P1008, DOI 10.1249/01.MSS.0000128180.51443.83; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Mok KM, 2017, SCAND J MED SCI SPOR, V27, P161, DOI 10.1111/sms.12640; Monfort SM, 2015, AM J SPORT MED, V43, P802, DOI 10.1177/0363546514564541; Myklebust G, 2003, CLIN J SPORT MED, V13, P71, DOI 10.1097/00042752-200303000-00002; Petushek EJ, 2019, AM J SPORT MED, V47, P1744, DOI 10.1177/0363546518782460; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shultz SJ, 2010, J ATHL TRAINING, V45, P499, DOI 10.4085/1062-6050-45.5.499; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Zebis MK, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094776	56	19	19	1	12	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAY	2019	47	6					1488	1495		10.1177/0363546519834544			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	HY5ZT	WOS:000468208700026	30986095				2022-02-06	
J	Elia, LP; Mason, AR; Alijagic, A; Finkbeiner, S				Elia, Lisa P.; Mason, Amanda R.; Alijagic, Amela; Finkbeiner, Steven			Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway	JOURNAL OF NEUROSCIENCE			English	Article						AD; autophagy; FTD; lysosome; progranulin	PROTEIN 6 JMJD6; TRAUMATIC BRAIN-INJURY; MYOSIN VI; ACTIVATED MICROGLIA; ALZHEIMERS-DISEASE; CATHEPSIN-D; DYSFUNCTION; UBIQUITINATION; TRAFFICKING; BIOGENESIS	Deficient progranulin levels cause dose-dependent neurological syndromes: haploinsufficiency leads to frontotemporal lobar degeneration (FTLD) and nullizygosity produces adult-onset neuronal ceroid lipofuscinosis. Mechanisms controlling progranulin levels are largely unknown. To better understand progranulin regulation, we performed a genome-wide RNAi screen using an ELISA-based platform to discover genes that regulate progranulin levels in neurons. We identified 830 genes that raise or lower progranulin levels by at least 1.5-fold in Neuro2a cells. When inhibited by siRNA or some by submicromolar concentrations of small-molecule inhibitors, 33 genes of the druggable genome increased progranulin levels in mouse primary cortical neurons; several of these also raised progranulin levels in FTLD model mouse neurons. "Hit" genes regulated progranulin by transcriptional or posttranscriptional mechanisms. Pathway analysis revealed enrichment of hit genes from the autophagy-lysosome pathway (ALP), suggesting a key role for this pathway in regulating progranulin levels. Progranulin itself regulates lysosome function. We found progranulin deficiency in neurons increased autophagy and caused abnormally enlarged lysosomes and boosting progranulin levels restored autophagy and lysosome size to control levels. Our data link the ALP to neuronal progranulin: progranulin levels are regulated by autophagy and, in turn, progranulin regulates the ALP. Restoring progranulin levels by targeting genetic modifiers reversed FTLD functional deficits, opening up potential opportunities for future therapeutics development.	[Elia, Lisa P.; Finkbeiner, Steven] Koret Ctr Neurodegenerat Dis Res, Ctr Syst & Therapeut & Taube, San Francisco, CA 94117 USA; [Elia, Lisa P.; Alijagic, Amela; Finkbeiner, Steven] J David Gladstone Inst, San Francisco, CA 94158 USA; [Mason, Amanda R.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA		Elia, LP; Finkbeiner, S (corresponding author), Koret Ctr Neurodegenerat Dis Res, Ctr Syst & Therapeut & Taube, San Francisco, CA 94117 USA.; Elia, LP; Finkbeiner, S (corresponding author), J David Gladstone Inst, San Francisco, CA 94158 USA.; Finkbeiner, S (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.; Finkbeiner, S (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	lisa.elia@gladstone.ucsf.edu; steve.finkbeiner@gladstone.ucsf.edu		Mason, Amanda/0000-0001-6726-6311	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1R21NS093236-01A1, 1P01AG054407, 1RF1AG058476]; Consortium for Frontotemporal Dementia Research; Taube/Koret Center for Neurodegenerative Disease Research; J. David Gladstone InstitutesUniversity of California System; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR18928]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS083390, R21NS093236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG054407, RF1AG058476] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Grants 1R21NS093236-01A1, 1P01AG054407, and 1RF1AG058476), the Consortium for Frontotemporal Dementia Research, the Taube/Koret Center for Neurodegenerative Disease Research, and the J. David Gladstone Institutes. The Gladstone Institutes received support from the National Center for Research Resources (Grant RR18928). We thank Robert V. Farese (Harvard Medical School), Andrew D. Nguyen (Harvard Medical School), and Ping Zhou (Gladstone Institute of Cardiovascular Disease) for kindly providing the GRN<SUP>+/-</SUP> and GRN<SUP>R493X/+</SUP> mice and the progranulin rabbit polyclonal antibody; Laura Mitic (UCSF) and members of the Finkbeiner lab for discussion and comments on these experiments; Megan Laurance (UCSF) for assistance with Ingenuity Pathway Analysis; Hui Wang for animal husbandry; Gary Howard for editorial assistance; and Kelley Nelson for administrative assistance. PSA was a gift from R.G. Kalb (Mojsilovic-Petrovic et al., 2009).	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Albanesi J, 2015, AUTOPHAGY, V11, P2127, DOI 10.1080/15548627.2015.1093718; Almeida S, 2016, NEUROBIOL AGING, V42, P35, DOI 10.1016/j.neurobiolaging.2016.03.001; Almeida S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026454; Altieri DC, 2012, BBA-MOL CELL RES, V1823, P767, DOI 10.1016/j.bbamcr.2011.08.007; Amoroso MR, 2012, CELL DEATH DIFFER, V19, P592, DOI 10.1038/cdd.2011.128; Arrant AE, 2017, BRAIN, V140, P1447, DOI 10.1093/brain/awx060; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Barbosa IA, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12900; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Beel S, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0288-y; Beel S, 2017, HUM MOL GENET, V26, P2850, DOI 10.1093/hmg/ddx162; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bond LM, 2011, MOL BIOL CELL, V22, P54, DOI 10.1091/mbc.E10-06-0553; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Canuel M, 2008, BIOCHEM BIOPH RES CO, V373, P292, DOI 10.1016/j.bbrc.2008.06.021; Capell A, 2014, J BIOL CHEM, V289, P25879, DOI 10.1074/jbc.M114.560128; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chang MC, 2017, J EXP MED, V214, P2611, DOI 10.1084/jem.20160999; Chen YD, 2015, J NEUROL, V262, P814, DOI 10.1007/s00415-014-7630-2; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; Elrick MJ, 2013, AUTOPHAGY, V9, P234, DOI 10.4161/auto.22501; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Evers BM, 2017, CELL REP, V20, P2565, DOI 10.1016/j.celrep.2017.08.056; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Gross C, 2008, ONCOGENE, V27, P1333, DOI 10.1038/sj.onc.1210736; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Hong DS, 2013, CANCER TREAT REV, V39, P375, DOI 10.1016/j.ctrv.2012.10.001; Hosokawa M, 2015, J NEUROPATH EXP NEUR, V74, P158, DOI 10.1097/NEN.0000000000000158; Hsiung GYR, 2011, J NEUROL SCI, V300, P28, DOI 10.1016/j.jns.2010.10.009; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jenzer C, 2014, AUTOPHAGY, V10, P1868, DOI 10.4161/auto.29745; Liu JL, 2015, MOL ENDOCRINOL, V29, P528, DOI 10.1210/me.2014-1266; Liu Y, 2019, ONCOGENE, V38, P980, DOI 10.1038/s41388-018-0466-y; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Luo L, 2014, MOL MED REP, V9, P1675, DOI 10.3892/mmr.2014.2016; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Martens S, 2016, J CELL BIOL, V215, P761, DOI 10.1083/jcb.201611116; Matassa DS, 2012, AM J CANCER RES, V2, P235; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Mojsilovic-Petrovic J, 2009, J NEUROSCI, V29, P8236, DOI 10.1523/JNEUROSCI.1805-09.2009; Nagashima T, 2010, MOL PHARMACOL, V78, P961, DOI 10.1124/mol.110.065714; Nguyen AD, 2018, P NATL ACAD SCI USA, V115, pE2849, DOI 10.1073/pnas.1722344115; Osaka M, 2015, HUM MOL GENET, V24, P1617, DOI 10.1093/hmg/ddu575; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pacheco CD, 2007, AUTOPHAGY, V3, P487, DOI 10.4161/auto.4586; Park JH, 2016, BIOCHEM BIOPH RES CO, V477, P277, DOI 10.1016/j.bbrc.2016.06.057; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Perry DC, 2013, JAMA NEUROL, V70, P774, DOI 10.1001/2013.jamaneurol.393; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petoukhov E, 2013, J CELL SCI, V126, P5412, DOI 10.1242/jcs.132076; Picher-Martel V, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0162-6; Piscopo P, 2010, NEUROCHEM INT, V57, P893, DOI 10.1016/j.neuint.2010.09.008; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rabinovici GD, 2010, CNS DRUGS, V24, P375, DOI 10.2165/11533100-000000000-00000; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Riedl L, 2014, NEUROPSYCH DIS TREAT, V10, P297, DOI 10.2147/NDT.S38706; Ryan TA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01024; Semenchenko K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159531; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Takemoto K, 2011, NEUROCHEM INT, V58, P880, DOI 10.1016/j.neuint.2011.02.015; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Tanimoto R, 2017, MATRIX BIOL, V64, P27, DOI 10.1016/j.matbio.2017.04.001; Nguyen TN, 2016, J CELL BIOL, V215, P857, DOI 10.1083/jcb.201607039; Tsai WC, 2017, J BIOL CHEM, V292, P18886, DOI 10.1074/jbc.M117.800706; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/NCHEMBIO.1308, 10.1038/nchembio.1308]; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Tumbarello DA, 2013, J CELL SCI, V126, P2561, DOI 10.1242/jcs.095554; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Walport LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11974; Wang HZ, 2015, P NATL ACAD SCI USA, V112, P7015, DOI 10.1073/pnas.1507263112; Wang TL, 2010, TRAFFIC, V11, P1119, DOI 10.1111/j.1600-0854.2010.01098.x; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; Wasylyk C, 2008, CANCER RES, V68, P1275, DOI 10.1158/0008-5472.CAN-07-2674; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Xu HM, 2017, MOL NEUROBIOL, V54, P1187, DOI 10.1007/s12035-016-9698-4; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhang XN, 2015, J BIOL CHEM, V290, P20273, DOI 10.1074/jbc.M115.646554; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021023; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029; 2011, J NEUROSCI, V31, P1885, DOI DOI 10.1523/JNEUROSCI.5757-10.2011; 2013, J ALZHEIMERS DIS, V33, P23, DOI DOI 10.3233/JAD-2012-120946; 2014, ACTA NEUROPATHOL, V127, P845, DOI DOI 10.1007/S00401-014-1262-6	100	19	19	0	3	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	APR 24	2019	39	17					3332	3344		10.1523/JNEUROSCI.3498-17.2019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HU7VT	WOS:000465492300014	30696728	Green Published, Bronze			2022-02-06	
J	Abdollahzadeh, A; Belevich, I; Jokitalo, E; Tohka, J; Sierra, A				Abdollahzadeh, Ali; Belevich, Ilya; Jokitalo, Eija; Tohka, Jussi; Sierra, Alejandra			Automated 3D Axonal Morphometry of White Matter	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; SCANNING-ELECTRON-MICROSCOPY; MYELIN G-RATIO; UNMYELINATED AXONS; CORPUS-CALLOSUM; DIFFUSION; TISSUE; MODEL; RECONSTRUCTION; SEGMENTATION	Axonal structure underlies white matter functionality and plays a major role in brain connectivity. The current literature on the axonal structure is based on the analysis of two-dimensional (2D) cross-sections, which, as we demonstrate, is precarious. To be able to quantify three-dimensional (3D) axonal morphology, we developed a novel pipeline, called ACSON (AutomatiC 3D Segmentation and morphometry Of axoNs), for automated 3D segmentation and morphometric analysis of the white matter ultrastructure. The automated pipeline eliminates the need for time-consuming manual segmentation of 3D datasets. ACSON segments myelin, myelinated and unmyelinated axons, mitochondria, cells and vacuoles, and analyzes the morphology of myelinated axons. We applied the pipeline to serial block-face scanning electron microscopy images of the corpus callosum of sham-operated (n = 2) and brain injured (n = 3) rats 5 months after the injury. The 3D morphometry showed that cross-sections of myelinated axons were elliptic rather than circular, and their diameter varied substantially along their longitudinal axis. It also showed a significant reduction in the myelinated axon diameter of the ipsilateral corpus callosum of rats 5 months after brain injury, indicating ongoing axonal alterations even at this chronic time-point.	[Abdollahzadeh, Ali; Tohka, Jussi; Sierra, Alejandra] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, Kuopio, Finland; [Belevich, Ilya; Jokitalo, Eija] Univ Helsinki, Inst Biotechnol, Electron Microscopy Unit, Helsinki, Finland		Sierra, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Biomed Imaging Unit, Kuopio, Finland.	alejandra.sierralopez@uef.fi	Tohka, Jussi/D-2385-2013; Abdollahzadeh, Ali/AAD-5145-2021; Jokitalo, Eija/C-8375-2009	Tohka, Jussi/0000-0002-1048-5860; Abdollahzadeh, Ali/0000-0001-6234-2012; Sierra Lopez, Alejandra/0000-0001-5399-2056; Belevich, Ilya/0000-0003-2190-4909; Jokitalo, Eija/0000-0002-4159-6934	Academy of FinlandAcademy of FinlandEuropean Commission; Biocenter Finland; University of Helsinki	This work was supported by the Academy of Finland (J.T. and A.S.), and Biocenter Finland and University of Helsinki (I.B., E.J., and SBEM imaging). We would like to thank Maarit Pulkkinen for her help with the animal handling, and Mervi Lindman and Antti Salminen for help preparing the samples for SBEM.	Achanta R., 2010, 149300 EPFL; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Belevich I, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002340; Berning M, 2015, NEURON, V87, P1193, DOI 10.1016/j.neuron.2015.09.003; Blum H., 1967, MODELS PERCEPTION SP, P362; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; Deerinck T. J., 2010, MICROSC MICROANAL, V16, P1138; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Dorkenwald S, 2017, NAT METHODS, V14, P435, DOI 10.1038/nmeth.4206; Dowding I, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00103; Fieremans E, 2016, NEUROIMAGE, V129, P414, DOI 10.1016/j.neuroimage.2016.01.018; Funke J, 2012, PROC CVPR IEEE, P1004, DOI 10.1109/CVPR.2012.6247777; GREENBERG MM, 1990, J NEUROCYTOL, V19, P978, DOI 10.1007/BF01186825; Guillery R., 1970, CONT RES METHODS NEU, P77; Haralick R.M, 1992, COMPUTER ROBOT VISIO; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Hassouna MS, 2007, IEEE T PATTERN ANAL, V29, P1563, DOI 10.1109/TPAMI.2007.1154; Hayworth K, 2006, MICROSCOPY MICROA S2, V12, P86, DOI DOI 10.1017/S1431927606066268; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Hodneland E, 2009, IEEE T MED IMAGING, V28, P720, DOI 10.1109/TMI.2008.2011522; Jaccard P., 1908, BULL SOC VAUD SCI N, V44, P223, DOI 10.5169/seals-268384; Jain V., 2011, ADV NEURAL INFORM PR, P648; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Ju HW, 2016, SCI REP-UK, V6, DOI 10.1038/srep29686; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Kamiya K, 2017, NEUROIMAGE-CLIN, V14, P663, DOI 10.1016/j.nicl.2017.03.003; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kaynig V, 2015, MED IMAGE ANAL, V22, P77, DOI 10.1016/j.media.2015.02.001; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim JHY, 1997, DEV BRAIN RES, V102, P77, DOI 10.1016/S0165-3806(97)00080-1; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kuhn H. W., 1955, NAVAL RES LOGIST Q, V2, P83, DOI [10.1002/nav.3800020109, DOI 10.1002/nav.3800020109]; Lakovic K, 2014, J CEREBR BLOOD F MET, V34, P1837, DOI 10.1038/jcbfm.2014.154; Lee HH, 2019, BRAIN STRUCT FUNCT, V224, P1469, DOI 10.1007/s00429-019-01844-6; Liewald D, 2014, BIOL CYBERN, V108, P541, DOI 10.1007/s00422-014-0626-2; Liu T, 2012, PATT REC ICPR 2012 2, DOI [10.1097/MPG.0b013e3181a15ae8.Screening, DOI 10.1097/MPG.0B013E3181A15AE8.SCREENING]; Lucchi A, 2012, IEEE T MED IMAGING, V31, P474, DOI 10.1109/TMI.2011.2171705; Maggioni M, 2013, IEEE T IMAGE PROCESS, V22, P119, DOI 10.1109/TIP.2012.2210725; McDonald J. H, 2009, SPARKY HOUSE PUBL, V291, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Novikov DS, 2014, P NATL ACAD SCI USA, V111, P5088, DOI 10.1073/pnas.1316944111; Nunez-Iglesias J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071715; Palombo M, 2019, NEUROIMAGE, V188, P391, DOI 10.1016/j.neuroimage.2018.12.025; Parag T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125825; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rodriguez-Paez AC, 2005, ACTA NEUROPATHOL, V109, P603, DOI 10.1007/s00401-005-1010-z; ROSENFEL.A, 1966, J ACM, V13, P471; RUSHTON WAH, 1951, J PHYSIOL-LONDON, V115, P101, DOI 10.1113/jphysiol.1951.sp004655; Saalfeld S, 2009, BIOINFORMATICS, V25, P1984, DOI 10.1093/bioinformatics/btp266; Sethian JA, 1996, P NATL ACAD SCI USA, V93, P1591, DOI 10.1073/pnas.93.4.1591; Shepherd GMG, 2002, P NATL ACAD SCI USA, V99, P6340, DOI 10.1073/pnas.052151299; Sim KS, 2004, SCANNING, V26, P36; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Stikov N, 2015, NEUROIMAGE, V118, P397, DOI 10.1016/j.neuroimage.2015.05.023; Stikov N, 2015, DATA BRIEF, V4, P368, DOI 10.1016/j.dib.2015.05.019; Topgaard D, 2017, J MAGN RESON, V275, P98, DOI 10.1016/j.jmr.2016.12.007; Torrealba F, 2004, BRAIN RES REV, V47, P5, DOI 10.1016/j.brainresrev.2004.06.004; van Heekeren RJ, 2007, LECT NOTES COMPUT SC, V4522, P263; Van Uitert R, 2007, MED PHYS, V34, P627, DOI 10.1118/1.2409238; Vazquez-Reina A, 2011, IEEE I CONF COMP VIS, P177, DOI 10.1109/ICCV.2011.6126240; VIRTANEN J, 1984, ACTA OPHTHALMOL, V62, P577; Wake H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8844; Wang L, 2003, INVEST OPHTH VIS SCI, V44, P2, DOI 10.1167/iovs.02-0333; West KL, 2016, NEUROIMAGE, V125, P1155, DOI 10.1016/j.neuroimage.2015.08.017; Wilkins A, 2010, J NEUROPATH EXP NEUR, V69, P1256, DOI 10.1097/NEN.0b013e3181ffc317; Zaimi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22181-4	77	19	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 15	2019	9								6084	10.1038/s41598-019-42648-2			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HT3XF	WOS:000464495800008	30988411	Green Published, gold			2022-02-06	
J	Chen, ZH; Wang, H; Zhong, JJ; Yang, JQ; Darwazeh, R; Tian, XC; Huang, ZJ; Jiang, L; Cheng, CJ; Wu, Y; Guo, ZD; Sun, XC				Chen, Zhihao; Wang, Hong; Zhong, Jianjun; Yang, Junqing; Darwazeh, Rami; Tian, Xiaocui; Huang, Zhijian; Jiang, Li; Cheng, Chongjie; Wu, Yue; Guo, Zongduo; Sun, Xiaochuan			Significant changes in circular RNA in the mouse cerebral cortex around an injury site after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						TBI; Circular RNA; miRNA; CXCR2; RNA-seq	SPINAL-CORD-INJURY; LONG NONCODING RNA; CXCR2; INFLAMMATION; EXPRESSION; NEUROPROTECTION; IDENTIFICATION; ACTIVATION; BEXAROTENE; INDUCTION	Background and objective: Circular RNA (circRNA) is an important type of non-coding RNA that has not been widely researched in traumatic brain injury (TBI). The present study aimd to detect the altered circRNA expression around an injury site in the mouse cerebral cortex after TBI and explore its potential functions. Method: C57BL/6 mice were used to construct a controlled cortical impact (CCI) model to simulate TBI. At 24 h post-TBI, the cortex around the injury site was collected, and the total RNA was extracted to perform RNA sequencing (RNA-seq). The differentially expressed circRNAs were determined according to the following criteria: vertical bar log(2)((fold) (change))vertical bar > 1, P < .05 and FDR < 0.05. Among them, circRNA chr8_87,859,283-87,904,548 was preliminarily explored to determine its function. Results: A total of 8036 altered circRNAs were discovered, and among them, 16 were significantly changed (5 up-regulated and 11 down-regulated). The circRNA chr8_87,859,283-87,904,548 significantly increased by approximately 4 times in the cerebral cortex around the injury site after TBI and promoted neuro-inflammation through increasing the CXCR2 protein by sponging mmu-let-7a-5p. As a result, the increased circRNA chr8_87,859,283-87,904,548 blocked the restoration of neurological function after TBI. Conclusion: Many circRNAs are significantly up-regulated or down-regulated in the traumatic cerebral penumbra cortex after TBI. Among them, the circRNA chr8_87,859,283-87,904,548 potentially plays a pro-inflammatory role, which may have a deleterious effect on neurological restoration after TBI.	[Chen, Zhihao; Wang, Hong; Yang, Junqing; Tian, Xiaocui] Chongqing Med Univ, Dept Pharmacol, Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China; [Zhong, Jianjun; Darwazeh, Rami; Huang, Zhijian; Jiang, Li; Cheng, Chongjie; Wu, Yue; Guo, Zongduo; Sun, Xiaochuan] Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China		Zhong, JJ; Sun, XC (corresponding author), Chongqing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Chongqing 400016, Peoples R China.	zjjcom682161@126.com; sunxch1445@qq.com	Darwazeh, Rami/AAT-7891-2020	Darwazeh, Rami/0000-0003-3099-8257; Huang, Zhijian/0000-0002-8241-0761; sun, xiao chuan/0000-0001-6992-332X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571159]; Youth Fund of the National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81801230]	This work was supported by grants from the National Natural Science Foundation of China (grant No.: 81571159) and the Youth Fund of the National Natural Science Foundation of China (grant No.: 81801230). We express special acknowledgement to "Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology" for providing an experimental platform. We give special thanks to Rami Darwazeh from the First Affiliated Hospital of Chongqing Medical University for language modification.	Bai Y, 2018, J NEUROSCI, V38, P32, DOI 10.1523/JNEUROSCI.1348-17.2017; Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; Bhat SA, 2016, MOL NEUROBIOL, V53, P6950, DOI 10.1007/s12035-015-9584-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Donofrio G, 2006, MICROBES INFECT, V8, P898, DOI 10.1016/j.micinf.2005.10.016; Dubovicky Michal, 2014, Interdiscip Toxicol, V7, P201, DOI 10.2478/intox-2014-0029; Guo J, 2016, MOL NEUROBIOL, V53, P3154, DOI 10.1007/s12035-015-9222-2; Han B, 2018, AUTOPHAGY, V14, P1164, DOI 10.1080/15548627.2018.1458173; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Ho J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1555-3; Hsieh CY, 2014, J IMMUNOL, V193, P3693, DOI 10.4049/jimmunol.1400692; Hu JZ, 2015, BRAIN RES, V1608, P191, DOI 10.1016/j.brainres.2015.02.036; Huang JH, 2016, BRAIN RES, V1648, P35, DOI 10.1016/j.brainres.2016.07.023; Jiang YJ, 2019, J NEUROTRAUM, V36, P1018, DOI 10.1089/neu.2018.5647; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lerner CA, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2076.00391; Li JX, 2018, CELL PHYSIOL BIOCHEM, V45, P677, DOI 10.1159/000487161; Li ZY, 2015, NAT STRUCT MOL BIOL, V22, P256, DOI 10.1038/nsmb.2959; Lin SP, 2016, BIOCHEM BIOPH RES CO, V471, P52, DOI 10.1016/j.bbrc.2016.01.183; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P77, DOI [10.3389/fgene.2013.00077, 10.3389/fgene.2013.00307]; Marchelletta RR, 2015, J INFECT DIS, V212, P128, DOI 10.1093/infdis/jiu829; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Ranganathan P, 2013, AM J PHYSIOL-RENAL, V305, pF1422, DOI 10.1152/ajprenal.00319.2013; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Salvi A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5059043; Salzman J, 2016, TRENDS GENET, V32, P309, DOI 10.1016/j.tig.2016.03.002; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Song XF, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw075; Steele CW, 2015, J PATHOL, V237, P85, DOI 10.1002/path.4555; Szabo L, 2015, GENOME BIOL, V16, DOI [10.1186/s13059-016-1123-9, 10.1186/s13059-015-0690-5]; Teng ZP, 2016, STROKE, V47, P196, DOI 10.1161/STROKEAHA.115.011701; Tiwari N, 2016, AM J PHYSIOL-LUNG C, V310, pL496, DOI 10.1152/ajplung.00290.2015; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wu FJ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0316-6; Xia SY, 2017, BRIEF BIOINFORM, V18, P984, DOI 10.1093/bib/bbw081; Xie BS, 2018, J NEUROTRAUM, V35, P1659, DOI 10.1089/neu.2017.5468; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zhang Q, 2016, MOL NEUROBIOL, V53, P662, DOI 10.1007/s12035-014-9035-8; Zhang XJ, 2019, NEUROSCIENTIST, V25, P22, DOI 10.1177/1073858418769556; Zhang Y, 2013, MOL CELL, V51, P792, DOI 10.1016/j.molcel.2013.08.017; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhong JJ, 2016, BRAIN RES, V1646, P589, DOI 10.1016/j.brainres.2016.07.002; Zhou X, 2016, BRAIN RES, V1648, P136, DOI 10.1016/j.brainres.2016.07.034; Zhu LH, 2018, CELL PHYSIOL BIOCHEM, V49, P2264, DOI 10.1159/000493829	54	19	22	1	18	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2019	313						37	48		10.1016/j.expneurol.2018.12.003			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HK1HD	WOS:000457654700005	30529438				2022-02-06	
J	Ruet, A; Bayen, E; Jourdan, C; Ghout, I; Meaude, L; Lalanne, A; Pradat-Diehl, P; Nelson, G; Charanton, J; Aegerter, P; Vallat-Azouvi, C; Azouvi, P				Ruet, Alexis; Bayen, Eleonore; Jourdan, Claire; Ghout, Idir; Meaude, Layide; Lalanne, Astrid; Pradat-Diehl, Pascale; Nelson, Gaelle; Charanton, James; Aegerter, Philippe; Vallat-Azouvi, Claire; Azouvi, Philippe			A Detailed Overview of Long-Term Outcomes in Severe Traumatic Brain Injury Eight Years Post-injury	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; outcome; longitudinal study; adult; independence; return to work	QUALITY-OF-LIFE; PROGNOSTIC-FACTORS; HEAD-INJURY; FOLLOW-UP; PSYCHOSOCIAL ADJUSTMENT; WORK; RETURN; MODERATE; PREDICTORS; RECOVERY	Background and aims: Severe traumatic brain injury is a leading cause of acquired persistent disabilities, and represents an important health and economic burden. However, the determinants of long-term outcome have rarely been systematically studied in a prospective longitudinal study of a homogeneous group of patients suffering exclusively from severe TBI Methods: Prospective observational study of an inception cohort of adult patients with severe traumatic brain injury in the Parisian area (PariS-TBI). Outcome was assessed with face-to-face interview 8 years after Traumatic Brain Injury, focusing on impairments, activity limitations, and participation restriction. Results: Five hundred and four patients were included between 2005 and 2007. At 8-year follow-up, 261 patients were deceased, 128 were lost to follow-up, 22 refused to participate, and 86 were finally evaluated. Age, gender, initial injury severity did not significantly differ between evaluated patients and lost to follow-up, but the latter were more frequently students or unemployed. Mean age was 41.9 (SD 13.6), 79% were male, median initial Glasgow Coma Scale Score was 6. The most frequent somatic complaints concerned balance (47.5%), motricity (31%), and headaches (36%), but these were less frequent than cognitive complaints (Memory 71%, Slowness 68%, Concentration 67%). According to the Hospital Anxiety and Depression Scale (HADS), 25 % had a score >8 for anxiety and 23.7% for depression. According to the Extended Glasgow Outcome Scale, 19.8% remained severely disabled, 46.5% moderately disabled, 33.7% had a good recovery. Older age, longer education duration, lower functional status upon intensive care discharge, and more severe 8-year dysexecutive problems were significantly associated with a lower Extended Glasgow Outcome Scale score in multivariable analysis. At 8 years, 48.7% of patients were employed in a productive job. Of those, 38% declared a salary loss since traumatic brain injury. Unemployment was significantly associated with lower 1-year GOSE score and more severe 8-year dysexecutive problems. Conclusions: These results from an inception cohort study highlight the fact that long-term outcome after severe TBI is determined by a complex combination of injury-related, demographic and neuropsychological factors. Long after the injury, persisting impairments still interfere with social integration, and participation.	[Ruet, Alexis] CHRU, Dept Phys Med & Rehabil, Caen, France; [Ruet, Alexis; Vallat-Azouvi, Claire; Azouvi, Philippe] Univ Versailles St Quentin, Lab Rech Clin & Sante Publ Handicaps Psych Cognit, EA4047, Montigny Le Bretonneux, France; [Ruet, Alexis; Azouvi, Philippe] INSERM, U1077, EPHE, Neuropsychol & Imagerie Memoire Humaine, Caen, France; [Bayen, Eleonore; Pradat-Diehl, Pascale] Hop La Pitie Salpetriere, APHP, Phys Med & Rehabil Dept, Paris, France; [Bayen, Eleonore] Sorbonne Univ GRC18, Paris, France; [Jourdan, Claire] CHRU, Lapeyronie Hosp, Dept Phys Med & Rehabil, Montpellier, France; [Ghout, Idir; Meaude, Layide; Aegerter, Philippe] Ambroise Pare Hosp, APHP, Unite Rech Clin Paris Ile De France Ouest, Boulogne, France; [Lalanne, Astrid] Hop Raymond Poincare, APHP, Dept Phys Med & Rehabil, Garches, France; [Pradat-Diehl, Pascale] Sorbonne Univ GRC18, Lab Imagerie Biomed, INSERM, U1146, Paris, France; [Nelson, Gaelle; Charanton, James] CRFTC, Reg Reference Ctr Bain Injury Parisan Area, Paris, France; [Vallat-Azouvi, Claire] Hop Raymond Poincare, Antenne UEROS SAMSAH92 UGECAM IDF, Garches, France; [Vallat-Azouvi, Claire] Univ Paris 08, Lab Psychopathol & Neuropsychol, EA 2027, St Denis, France		Ruet, A (corresponding author), CHRU, Dept Phys Med & Rehabil, Caen, France.; Ruet, A (corresponding author), Univ Versailles St Quentin, Lab Rech Clin & Sante Publ Handicaps Psych Cognit, EA4047, Montigny Le Bretonneux, France.; Ruet, A (corresponding author), INSERM, U1077, EPHE, Neuropsychol & Imagerie Memoire Humaine, Caen, France.	ruet-a@chu-caen.fr	RUET, Alexis/L-8726-2015; AEGERTER, Philippe/AAY-6003-2021	RUET, Alexis/0000-0002-5080-5734; AEGERTER, Philippe/0000-0002-9156-5028	French Ministry of Health (Programme hospitalier de recherche clinique) [AOM04084]; AP-HP (Departement de la recherche clinique et du developpement) - Institut de recherche en sante publique (IRESP)	The authors thank all members of the CRFTC Steering Committee (Center ressource francilien des traumatises craniens) for their valuable help. The first part of this study and the 8 year evaluation was funded by a grant from the French Ministry of Health (Programme hospitalier de recherche clinique 2004 and 2012, AOM04084) and sponsored by AP-HP (Departement de la recherche clinique et du developpement). The second part of this study was funded by a grant from the Institut de recherche en sante publique (IRESP).	Agresti A., 2007, INTRO CATEGORICAL DA, V2nd; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1018; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Azouvi P, 2016, BRAIN INJURY, V30, P1665, DOI 10.1080/02699052.2016.1201593; Azouvi P, 2015, NEUROPSYCHOL REHABIL, V25, P864, DOI 10.1080/09602011.2014.990907; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bayen E, 2013, J HEAD TRAUMA REHAB, V28, P408, DOI 10.1097/HTR.0b013e31825413cf; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Chesnel C, 2018, CLIN REHABIL, V32, P692, DOI 10.1177/0269215517734294; Chien DK, 2017, ACCIDENT ANAL PREV, V98, P101, DOI 10.1016/j.aap.2016.09.025; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; DeGrauw X, 2018, EPILEPSY RES, V146, P41, DOI 10.1016/j.eplepsyres.2018.07.012; Diaz AP, 2014, REV BRAS PSIQUIATR, V36, P213, DOI 10.1590/1516-4446-2013-1303; DIKMEN S, 1990, J CLIN EXP NEUROPSYC, V12, P507, DOI 10.1080/01688639008400997; Dikmen S S, 1995, J Int Neuropsychol Soc, V1, P67; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; EDNA TH, 1987, ACTA NEUROCHIR, V85, P40, DOI 10.1007/BF01402368; Fayol P., 2004, Annales de Readaptation et de Medecine Physique, V47, P142, DOI 10.1016/j.annrmp.2004.01.004; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Forslund MV, 2013, J REHABIL MED, V45, P801, DOI 10.2340/16501977-1168; Foster M, 2000, BRAIN INJURY, V14, P1035; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Fraser R, 2006, J VOCAT REHABIL, V25, P141; HOLM S, 1979, SCAND J STAT, V6, P65; Jacobsson LJ, 2009, ACTA NEUROL SCAND, V120, P389, DOI 10.1111/j.1600-0404.2009.01238.x; Jaeger M., 2014, Annals of Physical and Rehabilitation Medicine, V57, P436, DOI 10.1016/j.rehab.2014.06.001; Jang SH, 2009, NEUROREHABILITATION, V24, P349, DOI 10.3233/NRE-2009-0489; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Jourdan C, 2015, BRAIN INJURY, V29, P701, DOI 10.3109/02699052.2015.1004646; Kostanjsek N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S3; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Odgaard L, 2017, J HEAD TRAUMA REHAB, V32, pE57, DOI 10.1097/HTR.0000000000000239; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Palm S, 2017, J REHABIL MED, V49, P228, DOI 10.2340/16501977-2190; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ruet A, 2018, DISABIL REHABIL, V40, P2200, DOI 10.1080/09638288.2017.1327992; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Scaratti C, 2017, DISABIL REHABIL, V39, P847, DOI 10.3109/09638288.2016.1162854; Sharpe D., 2015, PRACTICAL ASSESSMENT, V20, P10; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1995, J NEUROSURG, V82, P764, DOI 10.3171/jns.1995.82.5.0764; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Vallat-Azouvi C, 2018, J NEUROSCI RES, V96, P601, DOI 10.1002/jnr.24180; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; WEBB CR, 1995, ARCH PHYS MED REHAB, V76, P1113, DOI 10.1016/S0003-9993(95)80118-9; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	64	19	19	2	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 21	2019	10								120	10.3389/fneur.2019.00120			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HM2MG	WOS:000459297400001	30846966	Green Published, gold			2022-02-06	
J	Ojo, JO; Algamal, M; Leary, P; Abdullah, L; Mouzon, B; Evans, JE; Mullan, M; Crawford, F				Ojo, Joseph O.; Algamal, Moustafa; Leary, Paige; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Mullan, Michael; Crawford, Fiona			Converging and Differential Brain Phospholipid Dysregulation in the Pathogenesis of Repetitive Mild Traumatic Brain Injury and Alzheimer's Disease	FRONTIERS IN NEUROSCIENCE			English	Article						mild traumatic brain injury; Alzheimer's disease; preclinical models; lipidomics; brain phospholipids; sphingomyelin; omega-3 fatty acid; omega-6 fatty acid	N-3 FATTY-ACIDS; AMYLOID-PRECURSOR-PROTEIN; DOCOSAHEXAENOIC ACID; CEREBROSPINAL-FLUID; HEAD-INJURY; OLEIC-ACID; PLASMALOGEN DEFICIENCY; COGNITIVE DECLINE; RISK-FACTOR; RAT-BRAIN	Repetitive mild traumatic brain injury (rmTBI) is a major epigenetic risk factor for Alzheimer's disease (AD). The precise nature of how rmTBI leads to or precipitates AD pathology is currently unknown. Numerous neurological conditions have shown an important role for dysfunctional phospholipid metabolism as a driving factor for the pathogenesis of neurodegenerative diseases. However, the precise role in rmTBI and AD remains elusive. We hypothesized that a detailed phospholipid characterization would reveal profiles of response to injury in TBI that overlap with age-dependent changes in AD and thus provide insights into the TBI-AD relationship. We employed a lipidomic approach examining brain phospholipid profiles from mouse models of rmTBI and AD. Cortex and hippocampal tissue were collected at 24 h, 3, 6, 9, and 12 months post-rmTBI, and at ages representing 'pre', 'peri' and 'post' onset of amyloid pathology (i.e., 3, 9, 15 months-old). Total levels of phosphatidylcholine (PC), phosphatidylethanolamine (PE), LysoPE, and phosphatidylinositol (PI), including their monounsaturated, polyunsaturated and saturated fatty acid (FA) containing species were significantly increased at acute and/or chronic time points post-injury in both brain regions. However, levels of most phospholipid species in PS1/APP mice were nominal in the hippocampus, while in the cortex, levels were significantly decreased at ages post-onset of amyloid pathology. Sphingomyelin and LysoPC levels showed coincidental trends in our rmTBI and AD models within the hippocampus, an increase at acute and/or chronic time points examined. The ratio of arachidonic acid (omega-6 FA) to docosahexaenoic acid (omega-3 FA)-containing PE species was increased at early time points in the hippocampus of injured versus sham mice, and in PS1/APP mice there was a coincidental increase compared to wild type littermates at all time points. This study demonstrates some overlapping and diverse phospholipid profiles in rmTBI and AD models. Future studies are required to corroborate our findings in human post-mortem tissue. Investigation of secondary mechanisms triggered by aberrant downstream alterations in bioactive metabolites of these phospholipids, and their modulation at the appropriate time-windows of opportunity could help facilitate development of novel therapeutic strategies to ameliorate the neurodegenerative consequences of rmTBI or the potential triggering of AD pathogenesis by rmTBI.	[Ojo, Joseph O.; Algamal, Moustafa; Leary, Paige; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Ojo, Joseph O.; Abdullah, Laila; Mouzon, Benoit; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Ojo, Joseph O.; Algamal, Moustafa; Abdullah, Laila; Mouzon, Benoit; Mullan, Michael; Crawford, Fiona] Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England		Ojo, JO; Crawford, F (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Ojo, JO; Crawford, F (corresponding author), James A Haley Vet Hosp, Tampa, FL 33612 USA.; Ojo, JO; Crawford, F (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	jojo@roskampinstitute.org; fcrawford@roskampinstitute.org		Algamal, Moustafa/0000-0002-6215-0122	CDMRP awardUnited States Department of Defense [DOD/W81XWH-13-1-0253]; Roskamp Foundation	This project was supported by the CDMRP award to FC DOD/W81XWH-13-1-0253 and by the Roskamp Foundation. The content presented do not express the views of the Department of Defense or Veteran Affairs or the United States Government.	Abdullah L, 2017, AGING-US, V9, P964, DOI 10.18632/aging.101203; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2013, NEUROTOXICOL TERATOL, V40, P74, DOI 10.1016/j.ntt.2013.10.002; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x; Ariel A, 2007, TRENDS IMMUNOL, V28, P176, DOI 10.1016/j.it.2007.02.007; Bailes JE, 2014, MIL MED, V179, P112, DOI 10.7205/MILMED-D-14-00139; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bandaru VVR, 2009, NEUROBIOL AGING, V30, P591, DOI 10.1016/j.neurobiolaging.2007.07.024; Barnard ND, 2014, NEUROBIOL AGING, V35, pS65, DOI 10.1016/j.neurobiolaging.2014.02.030; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Beydoun MA, 2007, AM J CLIN NUTR, V85, P1103; Carrillo C, 2012, NUTR HOSP, V27, P978, DOI 10.3305/nh.2012.27.4.5783; Cherubini A, 2007, J GERONTOL A-BIOL, V62, P1120, DOI 10.1093/gerona/62.10.1120; Conquer JA, 2000, LIPIDS, V35, P1305, DOI 10.1007/s11745-000-0646-3; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freeman LR, 2012, J CEREBR BLOOD F MET, V32, P643, DOI 10.1038/jcbfm.2011.168; GEDYE A, 1989, J AM GERIATR SOC, V37, P970, DOI 10.1111/j.1532-5415.1989.tb07283.x; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Han XL, 2001, J NEUROCHEM, V77, P1168, DOI 10.1046/j.1471-4159.2001.00332.x; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; He XX, 2010, NEUROBIOL AGING, V31, P398, DOI 10.1016/j.neurobiolaging.2008.05.010; Heude B, 2003, AM J CLIN NUTR, V77, P803, DOI 10.1093/ajcn/77.4.803; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hsu TM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00088; Igarashi M, 2011, J ALZHEIMERS DIS, V24, P507, DOI 10.3233/JAD-2011-101608; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Jumpsen J, 1997, J NUTR, V127, P724, DOI 10.1093/jn/127.5.724; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kim HY, 2014, PROG LIPID RES, V56, P1, DOI 10.1016/j.plipres.2014.06.002; Kosicek M, 2012, NEUROSCI LETT, V516, P302, DOI 10.1016/j.neulet.2012.04.019; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Lohner K, 1996, CHEM PHYS LIPIDS, V81, P167, DOI 10.1016/0009-3084(96)02580-7; Mankidy R, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-62; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Medina JM, 2002, J PHYSIOL-PARIS, V96, P265, DOI 10.1016/S0928-4257(02)00015-3; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mulder C, 2003, J NEURAL TRANSM, V110, P949, DOI 10.1007/s00702-003-0007-9; NITSCH RM, 1992, P NATL ACAD SCI USA, V89, P1671, DOI 10.1073/pnas.89.5.1671; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Pallebage-Gamarallage MMS, 2010, ATHEROSCLEROSIS SUPP, V11, P49, DOI 10.1016/j.atherosclerosissup.2010.04.002; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Prasad MR, 1998, NEUROCHEM RES, V23, P81, DOI 10.1023/A:1022457605436; Sadowski M, 2004, J NEUROPATH EXP NEUR, V63, P418, DOI 10.1093/jnen/63.5.418; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Schofield PW, 1997, J NEUROL NEUROSUR PS, V62, P119, DOI 10.1136/jnnp.62.2.119; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; SPECTOR R, 1988, NEUROCHEM RES, V13, P785, DOI 10.1007/BF00971603; SPECTOR R, 1988, J NEUROCHEM, V50, P639, DOI 10.1111/j.1471-4159.1988.tb02958.x; STOKES CE, 1987, J NEUROCHEM, V48, P1018, DOI 10.1111/j.1471-4159.1987.tb05619.x; Takechi R, 2010, PROG LIPID RES, V49, P159, DOI 10.1016/j.plipres.2009.10.004; Takechi R, 2010, BRIT J NUTR, V103, P652, DOI 10.1017/S0007114509992194; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Tully AM, 2003, BRIT J NUTR, V89, P483, DOI 10.1079/BJN2002804; Walter A, 2004, NEUROBIOL AGING, V25, P1299, DOI 10.1016/j.neurobiolaging.2004.02.016; Wengenack TM, 2000, NEUROSCIENCE, V101, P939, DOI 10.1016/S0306-4522(00)00388-2; Wenk MR, 2010, CELL, V143, P888, DOI 10.1016/j.cell.2010.11.033; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Yuki D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07130	79	19	19	1	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	FEB 19	2019	13								103	10.3389/fnins.2019.00103			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HM0RH	WOS:000459154200001	30837829	gold, Green Accepted, Green Published			2022-02-06	
J	Popovitz, J; Mysore, SP; Adwanikar, H				Popovitz, Juliana; Mysore, Shreesh P.; Adwanikar, Hita			Long-Term Effects of Traumatic Brain Injury on Anxiety-Like Behaviors in Mice: Behavioral and Neural Correlates	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						traumatic brain injury; anxiety behaviors; basolateral amygdala; controlled cortical impact; GABA	CONTROLLED CORTICAL IMPACT; ELEVATED PLUS-MAZE; ANIMAL-MODELS; MILD; FEAR; DEFICITS; AMYGDALA; RATS; SYSTEM; MOTOR	Traumatic brain injury (TBI) has been frequently linked to affective disorders such as anxiety and depression. However, much remains to be understood about the underlying molecular and signaling mechanisms that mediate affective dysfunctions following injury. A lack of consensus in animal studies regarding what the affective sequelae of TBI are has been a major hurdle that has slowed progress, with studies reporting the full range of effects: increase, decrease, and no change in anxiety following injury. Here, we addressed this issue directly by investigating long-term anxiety outcomes in mice following a moderate to severe controlled cortical impact (CCI) injury using a battery of standard behavioral tests-the open field (OF), elevated zero maze (EZM), and elevated plus maze (EPM). Mice were tested on weeks 1, 3, 5 and 7 post-injury. Our results show that the effect of injury is time-and task-dependent. Early on-up to 3 weeks postinjury, there is an increase in anxiety-like behaviors in the elevated plus and zero mazes. However, after 5 weeks post-injury, anxiety-like behavior decreases, as measured in the OF and EZM. Immunostaining in the basolateral amygdala (BLA) for GAD, a marker for GABA, at the end of the behavioral testing showed the late decrease in anxiety behavior was correlated with upregulation of inhibition. The approach adopted in this study reveals a complex trajectory of affective outcomes following injury, and highlights the importance of comparing outcomes in different assays and time-points, to ensure that the affective consequences of injury are adequately assessed.	[Popovitz, Juliana; Mysore, Shreesh P.; Adwanikar, Hita] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Mysore, Shreesh P.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA		Adwanikar, H (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	hita@jhu.edu		Mysore, Shreesh/0000-0002-7781-8252	Johns Hopkins UniversityJohns Hopkins University	This research is funded by a start-up grant awarded to HA by Johns Hopkins University.	Adamec R, 2005, BEHAV BRAIN RES, V159, P73, DOI 10.1016/j.bbr.2004.10.004; Adwanikar H, 2011, NEUROMETHODS, V50, P237, DOI 10.1007/978-1-60761-883-6_10; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Amano T, 2011, J NEUROSCI, V31, P15481, DOI 10.1523/JNEUROSCI.3410-11.2011; Amoros-Aguilar L, 2015, BEHAV NEUROSCI, V129, P149, DOI 10.1037/bne0000046; Asada H, 1996, BIOCHEM BIOPH RES CO, V229, P891, DOI 10.1006/bbrc.1996.1898; Bertoglio LJ, 2000, BEHAV BRAIN RES, V108, P197, DOI 10.1016/S0166-4328(99)00148-5; Bolivar VJ, 2000, BEHAV GENET, V30, P285, DOI 10.1023/A:1026545316455; Buck PW, 2011, HEALTH SOC WORK, V36, P299, DOI 10.1093/hsw/36.4.299; Budinich CS, 2013, PHARMACOL BIOCHEM BE, V108, P66, DOI 10.1016/j.pbb.2013.04.001; Bueno CH, 2005, BRAZ J MED BIOL RES, V38, P1697, DOI 10.1590/S0100-879X2005001100019; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GRIEBEL G, 1993, BEHAV PROCESS, V29, P37, DOI 10.1016/0376-6357(93)90026-N; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Hong WZ, 2014, CELL, V158, P1348, DOI 10.1016/j.cell.2014.07.049; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; James LM, 2014, MIL MED, V179, P357, DOI 10.7205/MILMED-D-13-00241; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Logue SF, 1997, NEUROSCIENCE, V80, P1075, DOI 10.1016/S0306-4522(97)00164-4; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Nemeroff Charles B, 2003, Psychopharmacol Bull, V37, P133; Osborn AJ, 2016, NEUROPSYCHOLOGY, V30, P247, DOI 10.1037/neu0000221; Pandey DK, 2009, BEHAV BRAIN RES, V205, P436, DOI 10.1016/j.bbr.2009.07.027; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; RODGERS RJ, 1993, PSYCHOPHARMACOLOGY, V113, P237, DOI 10.1007/BF02245704; SANDERS SK, 1995, BIOL PSYCHIAT, V37, P473, DOI 10.1016/0006-3223(94)00183-4; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Schultz BA, 2011, NEUROREHABILITATION, V28, P309, DOI 10.3233/NRE-2011-0659; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Sierra-Mercado D, 2015, BRAIN RES, V1606, P133, DOI 10.1016/j.brainres.2015.02.031; Sonmez A, 2015, NEUROSCI LETT, V597, P137, DOI 10.1016/j.neulet.2015.05.001; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Thau-Zuchman O, 2019, J NEUROTRAUM, V36, P25, DOI 10.1089/neu.2017.5579; TREIT D, 1993, PHARMACOL BIOCHEM BE, V44, P463, DOI 10.1016/0091-3057(93)90492-C; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Wagner AK, 2007, J NEUROTRAUM, V24, P1308, DOI 10.1089/neu.2007.0274; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang YB, 2018, J NEUROTRAUM, V35, P105, DOI 10.1089/neu.2017.5024; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	66	19	19	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JAN 23	2019	13								6	10.3389/fnbeh.2019.00006			12	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	HI5WR	WOS:000456525400002	30728770	Green Published, gold			2022-02-06	
J	Fang, J; Zhu, YH; Wang, HD; Cao, BL; Fei, MX; Niu, WH; Zhou, Y; Wang, XL; Li, X; Zhou, ML				Fang, Jiang; Zhu, Yihao; Wang, Handong; Cao, Bailu; Fei, Maoxing; Niu, Wenhao; Zhou, Yuan; Wang, Xiaoliang; Li, Xiang; Zhou, Mengliang			Baicalin Protects Mice Brain From Apoptosis in Traumatic Brain Injury Model Through Activation of Autophagy	FRONTIERS IN NEUROSCIENCE			English	Article						Baicalin; traumatic brain injury; autophagy; apoptosis; mitochondrial apoptosis	CLOSED-HEAD INJURY; OXIDATIVE STRESS; NEUROPROTECTION; INFLAMMATION; INVOLVEMENT; MODULATION; MELATONIN; RAPAMYCIN; PATHWAYS; MOUSE	Autophagy is associated with secondary injury following traumatic brain injury (TBI) and is expected to be a therapeutic target. Baicalin, a neuroprotective agent, has been proven to exert multi-functional bioactive effects in brain injury diseases. However, it is unknown if Baicalin influences autophagy after TBI. In the present study, we aimed to explore the effects that Baicalin had on TBI in a mice model, focusing on autophagy as a potential mechanism. We found that Baicalin administration significantly improved motor function, reduced cerebral edema, and alleviated disruption of the blood-brain barrier (BBB) after TBI in mice. Besides, TBI-induced apoptosis was reversed by Baicalin evidenced by Nissl staining, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay, and the level of cleaved caspase-3. More importantly, Baicalin enhanced autophagy by detecting the autophagy markers (LC3, Beclin 1, and p62) using western blot and LC3 immunofluorescence staining, ameliorating mitochondrial apoptotic pathway evidenced by restoration of the TBI-induced translocation of Bax and cytochrome C. However, simultaneous treatment with 3-MA inhibited Baicalin-induced autophagy and abolished its protective effects on mitochondrial apoptotic pathway. In conclusion, we demonstrated that Baicalin enhanced autophagy, ameliorated mitochondrial apoptosis and protected mice brain in TBI mice model.	[Fang, Jiang; Zhu, Yihao; Wang, Handong; Fei, Maoxing; Niu, Wenhao; Zhou, Yuan; Wang, Xiaoliang; Zhou, Mengliang] Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Fang, Jiang; Wang, Handong; Niu, Wenhao] Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Yihao; Wang, Xiaoliang; Zhou, Mengliang] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Cao, Bailu; Fei, Maoxing; Zhou, Yuan] Nanjing Med Univ, Jinling Clin Med Coll, Nanjing, Jiangsu, Peoples R China; [Cao, Bailu] Jinling Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China; [Li, Xiang] Jiangsu Prov Second Chinese Med Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.; Wang, HD (corresponding author), Southeast Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.	njhdwang@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672503, 81571162, 81401026]; Military Medical Youth Training Program [16QNP042]; Project of Hospital Management of Nanjing General Hospital of Nanjing Military Region [2017013]	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81672503, 81571162, and 81401026), Military Medical Youth Training Program (Grant No. 16QNP042), and the Project of Hospital Management of Nanjing General Hospital of Nanjing Military Region (Grant No. 2017013).	Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cao YG, 2011, BRAIN RES BULL, V85, P396, DOI 10.1016/j.brainresbull.2011.05.002; Cavallucci V, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.511; Chen XR, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00117; Chen XR, 2017, J NEUROINFLAMM, V14, DOI [10.1186/s12974-017-0917-3, 10.1186/s12974-018-1151-3]; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Cortes CJ, 2019, NEUROBIOL DIS, V122, P83, DOI 10.1016/j.nbd.2018.05.012; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fang J, 2018, DRUG DES DEV THER, V12, P2497, DOI 10.2147/DDDT.S163951; Fernandez A, 2015, J PINEAL RES, V59, P292, DOI 10.1111/jpi.12264; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Fowler AJ, 2018, CNS DRUGS, V32, P1, DOI 10.1007/s40263-018-0497-5; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Hong C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10443-6; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.14; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Lee WS, 2015, CURR MOL MED, V15, P735, DOI 10.2174/1566524015666150921105453; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Lin CJ, 2013, INT J ONCOL, V42, P993, DOI 10.3892/ijo.2013.1791; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo SQ, 2013, AUTOPHAGY, V9, P104, DOI 10.4161/auto.22399; Ma AT, 2009, AM J CHINESE MED, V37, P85, DOI 10.1142/S0192415X09006709; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Shi XQ, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1401790; Tan XM, 2018, CELL TRANSPLANT, V27, P1753, DOI 10.1177/0963689718760486; Tarrago T, 2008, BIOORGAN MED CHEM, V16, P7516, DOI 10.1016/j.bmc.2008.04.067; Tu XK, 2009, NEUROCHEM RES, V34, P1626, DOI 10.1007/s11064-009-9953-4; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang CQ, 2017, NEUROSCIENCE, V343, P30, DOI 10.1016/j.neuroscience.2016.11.029; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhang QW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02142; Zhang XN, 2013, AUTOPHAGY, V9, P1321, DOI 10.4161/auto.25132; Zhang XJ, 2012, ONCOL REP, V27, P1128, DOI 10.3892/or.2011.1599; Zuo DY, 2016, NEUROTOX RES, V30, P159, DOI 10.1007/s12640-016-9611-y	52	19	22	1	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 9	2019	12								1006	10.3389/fnins.2018.01006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HG9MO	WOS:000455333000001	30686973	gold, Green Published			2022-02-06	
J	Baker, EW; Kinder, HA; Hutcheson, JM; Duberstein, KJJ; Platt, SR; Howerth, EW; West, FD				Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Duberstein, Kylee Jo J.; Platt, Simon R.; Howerth, Elizabeth W.; West, Franklin D.			Controlled Cortical Impact Severity Results in Graded Cellular, Tissue, and Functional Responses in a Piglet Traumatic Brain Injury Model	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; functional impairment; pig models; traumatic brain injury	GAIT CHARACTERISTICS; BALANCE ABILITIES; ANIMAL-MODEL; CHILDREN; RECOVERY; DEFICITS; PATHOPHYSIOLOGY; PLASTICITY; OUTCOMES; MOTOR	A number of pre-clinical rodent models have been developed in an effort to recapitulate injury mechanisms and identify potential therapeutics for traumatic brain injury (TBI), which is a major cause of death and long-term disability in the United States. The lack of restorative treatments for TBI, however, has led to considerable criticism of current pre-clinical therapeutic development strategies-namely, the translatability of widely used rodent models to human patients. The use of large animal models, such as the pig, with more brain anatomy and physiology comparable to humans may enhance the translational capacity of current pre-clinical animal models. The objective of this study was to develop and characterize a graded piglet TBI model with quantitative pathological features at the cellular, tissue, and functional level that become more prominent with increasing TBI severity. A graded TBI was produced by controlled cortical impact (CCI) in "toddler-aged" Landrace piglets by increasing impact velocity and/or depth of depression to 2 m/sec; 6 mm; 4 m/sec; 6 mm; 4 m/sec; 12 mm; or 4 m/sec; 15 mm, producing a range of neural injury responses that corresponded to injury severity. Quantitative gait analysis was performed pre-TBI and one, three, and seven days post-TBI, and piglets were sacrificed seven days post-TBI. Increasing impact parameters correlated to increases in lesion size with piglets that sustained a 6 mm depth of depression exhibiting significantly smaller lesions than piglets that sustained a depth of depression of 12 mm or 15 mm. Similarly, the extent of neuronal loss, astrogliosis/astrocytosis, and white matter damage became more prominent as CCI parameters were increased. These cellular and tissue-level changes correlated with motor function deficits including swing/stance time, stride velocity, and two- versus three-limb support. The piglet TBI model described here could serve as a translational platform for studying TBI sequelae across injury severities and identifying novel therapeutics.	[Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Duberstein, Kylee Jo J.; Platt, Simon R.; Howerth, Elizabeth W.; West, Franklin D.] Univ Georgia, Coll Vet Med, Regenerat Biosci Ctr, Athens, GA USA; [Baker, Emily W.; Kinder, Holly A.; Hutcheson, Jessica M.; Duberstein, Kylee Jo J.; West, Franklin D.] Univ Georgia, Coll Vet Med, Dept Anim & Dairy Sci, Athens, GA USA; [Platt, Simon R.] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Howerth, Elizabeth W.] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA		West, FD (corresponding author), Univ Georgia, Rhodes Ctr Anim & Dairy Sci, Dept Anim & Dairy Sci, Regenerat Biosci Ctr, 425 River Rd, Athens, GA 30602 USA.	westf@uga.edu		Kinder, Holly/0000-0001-8310-7265			Ahmad AS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00172; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Alessandri B, 2003, J NEUROTRAUM, V20, P1293, DOI 10.1089/089771503322686094; Allen KA, 2016, J NEUROSCI NURS, V48, P15, DOI 10.1097/JNN.0000000000000176; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2000, BRAIN INJURY, V14, P679; Anderson V, 2012, PEDIATRICS, V129, pE254, DOI 10.1542/peds.2011-0311; Beretta E, 2009, BRAIN INJURY, V23, P751, DOI 10.1080/02699050903133988; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Buritica E, 2009, J NEUROTRAUM, V26, P2145, DOI 10.1089/neu.2009.0894; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Coppoletta JM, 1933, AM J PATHOL, V9, P55; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Duberstein KJ, 2014, PHYSIOL BEHAV, V125, P8, DOI 10.1016/j.physbeh.2013.11.004; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Fairbairn L, 2011, J LEUKOCYTE BIOL, V89, P855, DOI 10.1189/jlb.1110607; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gaber ZB, 2011, NEURON, V69, P833, DOI 10.1016/j.neuron.2011.02.037; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Inness EL, 2011, PHYSIOTHER CAN, V63, P199, DOI 10.3138/ptc.2009-45; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kandel E.R., 2013, PRINCIPLES NEURAL SC, V5th; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Katz-Leurer M, 2011, NEUROREHABILITATION, V29, P45, DOI 10.3233/NRE-2011-0676; Katz-Leurer M, 2009, DEV NEUROREHABIL, V12, P100, DOI 10.1080/17518420902800928; King C, 2010, J NEUROTRAUM, V27, P1895, DOI 10.1089/neu.2009.1178; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li L, 2013, DEV MED CHILD NEUROL, V55, P37, DOI 10.1111/j.1469-8749.2012.04414.x; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Manley GT, 2006, J NEUROTRAUM, V23, P128, DOI 10.1089/neu.2006.23.128; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Meissner A, 2011, EUR SURG RES, V47, P141, DOI 10.1159/000330756; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Missios S, 2009, J NEUROTRAUM, V26, P1943, DOI [10.1089/neu.2009.0956, 10.1089/neu.2009-0956]; Mytar J, 2012, NEUROSURGERY, V71, P138, DOI 10.1227/NEU.0b013e318251795a; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Platt Simon R, 2014, Exp Transl Stroke Med, V6, P5, DOI 10.1186/2040-7378-6-5; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Sashindranath M, 2015, BEHAV BRAIN RES, V286, P33, DOI 10.1016/j.bbr.2015.02.038; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schwerin SC, 2017, J NEUROSCI METH, V285, P82, DOI 10.1016/j.jneumeth.2017.05.010; Sindelar B, 2017, J NEUROTRAUM, V34, P1703, DOI 10.1089/neu.2016.4648; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; THOMAS JM, 1971, GROWTH, V35, P259; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2010, DISCOV MED, V10, P434; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	82	19	19	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					61	73		10.1089/neu.2017.5551			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000453863000006	29916303				2022-02-06	
J	Clausen, F; Marklund, N; Hillered, L				Clausen, Fredrik; Marklund, Niklas; Hillered, Lars			Acute Inflammatory Biomarker Responses to Diffuse Traumatic Brain Injury in the Rat Monitored by a Novel Microdialysis Technique	JOURNAL OF NEUROTRAUMA			English	Article						diffuse axonal injury; inflammatory biomarkers; MD; rat; TBI	INTERLEUKIN-1 RECEPTOR ANTAGONIST; ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; AXONAL INJURY; EXPRESSION; CYTOKINES; CNS; QUANTIFICATION; ACTIVATION; CHEMOKINES	Neuroinflammation is a major contributor to the progressive brain injury process induced by traumatic brain injury (TBI), and may play an important role in the pathophysiology of axonal injury. The immediate neuroinflammatory cascade cannot be characterized in the human setting. Therefore, we used the midline fluid percussion injury model of diffuse TBI in rats and a novel microdialysis (MD) method providing stable diffusion-driven biomarker sampling. Immediately post-injury, bilateral amphiphilic tri-block polymer coated MD probes (100kDa cut off membrane) were inserted and perfused with Dextran 500kDa-supplemented artificial cerebrospinal fluid (CSF) to optimize protein capture. Six hourly samples were analyzed for 27 inflammatory biomarkers (9 chemokines, 13 cytokines, and 5 growth factors) using a commercial multiplex biomarker kit. TBI (n=6) resulted in a significant increase compared with sham-injured controls (n=6) for five chemokines (eotaxin/CCL11, fractalkine/CX3CL1, LIX/CXCL5, monocyte chemoattractant protein [MCP]1/CCL2, macrophage inflammatory protein [MIP]1 /CCL3), 10 cytokines (interleukin [IL]-1, IL-1, IL-4, IL-6, IL-10, IL-13, IL-17, IL-18, interferon [IFN]-, tumor necrosis factor [TNF]-), and four growth factors (epidermal growth factor [EGF], granulocyte-macrophage colony-stimulating factor [GM-CSF], leptin, vascular endothelial growth factor [VEGF]). Therefore, diffuse TBI was associated with an increased level of 18 of the 27 inflammatory biomarkers at one through six time points, during the observation period whereas the remaining 9 biomarkers were unaltered. The study shows that diffuse TBI induces an acute increase in a number of inflammatory biomarkers. The novel MD technique provides stable MD sampling suitable for further studies on the early neuroinflammatory cascade in TBI.	[Clausen, Fredrik; Marklund, Niklas; Hillered, Lars] Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden		Clausen, F (corresponding author), Uppsala Univ, Uppsala Univ Hosp, Dept Neurosci, Sect Neurosurg, Entrance 85,2nd Floor, S-75185 Uppsala, Sweden.	fredrik.clausen@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417	Swedish Research CouncilSwedish Research CouncilEuropean Commission; VINNOVA FoundationVinnova; Selander Foundation; Uppsala University Hospital	The authors thank the CMA division of Harvard Medical Apparatus for donating the microdialysis probes and co-funding the MilliPlex kits for this project; and the Swedish Research Council, VINNOVA Foundation, Uppsala University Hospital, and the Selander Foundation for supporting the work financially.	Abdul-Muneer P.M., 2016, MOL NEUROBIOL; Armstrong RC, 2016, EXP NEUROL, V275, P328, DOI 10.1016/j.expneurol.2015.02.011; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; CHAO CC, 1993, J IMMUNOL, V151, P1473; Chen WQ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0847-0; Chu JT, 2014, ANAL BIOANAL CHEM, V406, P7601, DOI 10.1007/s00216-014-8192-y; Clausen F, 2014, BRAIN RES, V1588, P37, DOI 10.1016/j.brainres.2014.08.043; Dahlin AP, 2014, ANAL CHEM, V86, P8671, DOI 10.1021/ac501880u; Dahlin AP, 2012, ANAL BIOANAL CHEM, V402, P2057, DOI 10.1007/s00216-011-5614-y; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Fassbender K, 2000, NEUROSCI LETT, V284, P135, DOI 10.1016/S0304-3940(00)00977-0; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Guglielmetti C, 2016, GLIA, V64, P2181, DOI 10.1002/glia.23053; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2014, J CEREBR BLOOD F MET, V34, P845, DOI 10.1038/jcbfm.2014.23; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Helmy A, 2009, J NEUROTRAUM, V26, P549, DOI 10.1089/neu.2008.0719; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillman J, 2005, NEUROSURGERY, V56, P1264, DOI 10.1227/01.NEU.0000159711.93592.8D; Hillman J, 2007, J NEUROSURG, V106, P820, DOI 10.3171/jns.2007.106.5.820; Hutchinson P.J., 2015, INTENSIVE CARE MED; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Hutchinson PJ, 2005, PHYSIOL MEAS, V26, P423, DOI 10.1088/0967-3334/26/4/008; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Keeler GD, 2014, EUR J PHARM SCI, V57, P60, DOI 10.1016/j.ejps.2013.11.005; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kozai TDY, 2016, BIOMATERIALS, V87, P157, DOI 10.1016/j.biomaterials.2016.02.013; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marklund N., 2009, J NEUROSURG; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mellergard P, 2008, NEUROSURGERY, V62, P151, DOI 10.1227/01.NEU.0000311072.33615.3A; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Purins K, 2011, CRIT CARE MED, V39, P512, DOI 10.1097/CCM.0b013e318206b824; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Szmydynger-Chodobska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167677; Tado M, 2014, J NEUROTRAUM, V31, P691, DOI 10.1089/neu.2013.2940; Thelin EP, 2018, J NEUROTRAUM, V35, P341, DOI 10.1089/neu.2017.5155; Tobin RP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0143-5; Truettner JS, 2005, MOL BRAIN RES, V138, P124, DOI 10.1016/j.molbrainres.2005.04.006; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Waisman A, 2015, ACTA NEUROPATHOL, V129, P625, DOI 10.1007/s00401-015-1402-7; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00331; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	75	19	21	2	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2019	36	2					201	211		10.1089/neu.2018.5636			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4LJ	WOS:000459444800003	29790398				2022-02-06	
J	Fehr, SD; Nelson, LD; Scharer, KR; Traudt, EA; Veenstra, JM; Tarima, SS; Liu, XC; Walter, KD				Fehr, Shayne D.; Nelson, Lindsay D.; Scharer, Kyle R.; Traudt, Elizabeth A.; Veenstra, Joshua M.; Tarima, Sergey S.; Liu, Xue-Cheng; Walter, Kevin D.			Risk Factors for Prolonged Symptoms of Mild Traumatic Brain Injury: A Pediatric Sports Concussion Clinic Cohort	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; mild traumatic brain injury; pediatric; child; adolescent; sports medicine; athlete; symptoms; female; loss of consciousness	PREDICT PROTRACTED RECOVERY; HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; SEX-DIFFERENCES; HEAD-INJURY; CHILDREN; AGE; EPIDEMIOLOGY; TRAJECTORIES; MANAGEMENT	Objective: To examine predictors of prolonged symptom duration from mild traumatic brain injury (mTBI) in a pediatric sports medicine specialty clinic cohort as these predictors may be distinct in this population. Design: Retrospective chart review. Setting: Outpatient specialty clinic. Patients: Charts of 549 patients (age range: 10-18 years) with concussions were reviewed in an outpatient clinic that predominantly managed sports-related injuries (77.3%). Patients (n = 431) included in the final analysis met the criteria for mTBI and were symptomatic at their first visit. Assessment of Risk Factors: Patient history, injury, and recovery variables were evaluated. Main Outcome Measures: Predictors of prolonged time to reach self-reported symptom recovery were evaluated using Cox proportional hazards. Results: Median time to symptom recovery of the 431 patients who presented to clinic with symptoms was 40 days (full clinic sample median = 34 days). Analyses identified 3 unique predictors of symptom recovery: loss of consciousness (LOC) [hazard ratio (HR) = 0.56, P < 0.0001], female sex (HR = 0.57, P < 0.0001), and concussion symptom score at first clinic visit (HR = 0.76, P < 0.0001). Conclusions: Prolonged duration of mTBI symptoms in patients who present to a pediatric sports-based concussion clinic is related to initial symptom severity, female sex, and LOC.	[Fehr, Shayne D.; Traudt, Elizabeth A.; Veenstra, Joshua M.; Liu, Xue-Cheng; Walter, Kevin D.] Med Coll Wisconsin, Dept Orthopaed Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Fehr, Shayne D.; Scharer, Kyle R.; Liu, Xue-Cheng; Walter, Kevin D.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Tarima, Sergey S.] Med Coll Wisconsin, Inst Hlth & Soc, Milwaukee, WI 53226 USA		Fehr, SD (corresponding author), Med Coll Wisconsin, Pediat Orthopaed, 9000 W Wisconsin Ave,POB 1997,Suite C360, Milwaukee, WI 53201 USA.	sfehr@mcw.edu			Department of Orthopaedic Surgery	The authors acknowledge Alexis Visotcky, MS; Ashley Ward, BS; and Heather Zhao, MS for their contributions to the study. Thanks to the Department of Orthopaedic Surgery for funding provided for the study.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Brooks BL, 2014, J HEAD TRAUMA REHAB, V29, P257, DOI 10.1097/HTR.0000000000000016; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Cantu RC, 2010, PM&R, V2, P1088, DOI 10.1016/j.pmrj.2010.07.483; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grady MF, 2010, CURR PROB PEDIATR AD, V40, P154, DOI 10.1016/j.cppeds.2010.06.002; Guskiewicz KM, 2011, PM&R, V3, P353, DOI 10.1016/j.pmrj.2010.12.006; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Iverson G, 2007, CLIN J SPORT MED, V17, P31; Karlin AM, 2011, PM&R, V3, pS369, DOI 10.1016/j.pmrj.2011.07.015; King NS, 2014, BRAIN INJURY, V28, P1639, DOI 10.3109/02699052.2014.954271; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Mannix R, 2013, NEUROSURGERY, V73, P129, DOI 10.1227/01.neu.0000429846.14579.41; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Nelson LD, 2013, NEUROPSYCHOL REV, V23, P285, DOI 10.1007/s11065-013-9240-7; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	50	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2019	29	1					11	17		10.1097/JSM.0000000000000494			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	IQ4PZ	WOS:000480734000005	29084034				2022-02-06	
J	Kerr, NA; Vaccari, JPD; Umland, O; Bullock, MR; Conner, GE; Dietrich, WD; Keane, RW				Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Umland, Oliver; Bullock, M. Ross; Conner, Gregory E.; Dietrich, W. Dalton; Keane, Robert W.			Human Lung Cell Pyroptosis Following Traumatic Brain Injury	CELLS			English	Article						pyroptosis; inflammasome; caspase-1; inflammation; brain injury; extracellular vesicles	EXTRACELLULAR VESICLES; ORGAN DYSFUNCTION; ENDOTHELIUM; MECHANISM; ASC	Approximately 30% of traumatic brain injured patients suffer from acute lung injury or acute respiratory distress syndrome. Our previous work revealed that extracellular vesicle (EV)-mediated inflammasome signaling plays a crucial role in the pathophysiology of traumatic brain injury (TBI)-induced lung injury. Here, serum-derived EVs from severe TBI patients were analyzed for particle size, concentration, origin, and levels of the inflammasome component, an apoptosis-associated speck-like protein containing a caspase-recruiting domain (ASC). Serum ASC levels were analyzed from EV obtained from patients that presented lung injury after TBI and compared them to EV obtained from patients that did not show any signs of lung injury. EVs were co-cultured with lung human microvascular endothelial cells (HMVEC-L) to evaluate inflammasome activation and endothelial cell pyroptosis. TBI patients had a significant increase in the number of serum-derived EVs and levels of ASC. Severe TBI patients with lung injury had a significantly higher level of ASC in serum and serum-derived EVs compared to individuals without lung injury. Only EVs isolated from head trauma patients with gunshot wounds were of neural origin. Delivery of serum-derived EVs to HMVEC-L activated the inflammasome and resulted in endothelial cell pyroptosis. Thus, serum-derived EVs and inflammasome proteins play a critical role in the pathogenesis of TBI-induced lung injury, supporting activation of an EV-mediated neural-respiratory inflammasome axis in TBI-induced lung injury.	[Kerr, Nadine A.; Vaccari, Juan Pablo de Rivero; Bullock, M. Ross; Dietrich, W. Dalton] Univ Miami, Dept Neurol Surg, Miami, FL 33136 USA; [Umland, Oliver] Univ Miami, Diabet Res Inst, Miami, FL 33136 USA; [Conner, Gregory E.] Univ Miami, Dept Cell Biol, Miami, FL 33136 USA; [Keane, Robert W.] Univ Miami, Dept Physiol & Biophys, Sch Med, 1600 NW 10th Ave RMSB 5054, Miami, FL 33136 USA		Keane, RW (corresponding author), Univ Miami, Dept Physiol & Biophys, Sch Med, 1600 NW 10th Ave RMSB 5054, Miami, FL 33136 USA.	N.Kerr@med.miami.edu; JDeRivero@med.miami.edu; oumland@med.miami.edu; RBullock@med.miami.edu; GConner@med.miami.edu; DDietrich@med.miami.edu; rkeane@miami.edu	de Rivero Vaccari, Juan Pablo/ABE-3248-2020; de Rivero Vaccari, Juan Pablo/H-5718-2019; Conner, Gregory/AAI-1285-2021	de Rivero Vaccari, Juan Pablo/0000-0002-5460-8834; Conner, Gregory/0000-0003-2217-2252; Keane, Robert/0000-0003-4068-9511	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R42NS086274, HL132425];  [RO1 NS042133];  [NS089443]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042133, R42NS086274, R01NS089443] Funding Source: NIH RePORTER	This project was supported in part with NIH grant R42NS086274 to RWK, NIH grant HL132425 to NAK, and RO1 NS042133 and NS089443 to WDD.	Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Brand FJ, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-016-0137-0; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Eppensteiner J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00190; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Garcia-Contreras M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05787-y; Gill SE, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0266-7; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Harrison EB, 2016, FEBS OPEN BIO, V6, P835, DOI 10.1002/2211-5463.12092; Hazelton I, 2018, J NEUROTRAUM, V35, P639, DOI 10.1089/neu.2017.5049; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Hoss F, 2017, CELL MOL LIFE SCI, V74, P1211, DOI 10.1007/s00018-016-2396-6; Jong AY, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1294368; Kerr NA, 2018, J NEUROTRAUM, V35, P2067, DOI 10.1089/neu.2017.5430; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Maniatis NA, 2008, CURR OPIN CRIT CARE, V14, P22, DOI 10.1097/MCC.0b013e3282f269b9; Montecalvo A, 2012, BLOOD, V119, P756, DOI 10.1182/blood-2011-02-338004; Moyron RB, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700061; Mrozek Segolene, 2015, World J Crit Care Med, V4, P163, DOI 10.5492/wjccm.v4.i3.163; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Ramtinfar S, 2016, INDIAN J CRIT CARE M, V20, P575, DOI 10.4103/0972-5229.192042; Razavi HM, 2004, AM J RESP CRIT CARE, V170, P227, DOI 10.1164/rccm.200306-846OC; Reategui E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02261-1; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Tao SC, 2018, ADV SCI, V5, DOI 10.1002/advs.201700449; Turturici G, 2014, AM J PHYSIOL-CELL PH, V306, pC621, DOI 10.1152/ajpcell.00228.2013; van der Merwe Yolandi, 2017, Curr Ophthalmol Rep, V5, P276, DOI 10.1007/s40135-017-0153-0; Vestad B, 2017, J EXTRACELL VESICLES, V6, P1, DOI 10.1080/20013078.2017.1344087; Villar J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006812; Wahlund CJE, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00039; Weber DJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009443; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Witwer KW, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1396823; Yang J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.274; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	36	19	21	1	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2073-4409		CELLS-BASEL	Cells	JAN	2019	8	1							69	10.3390/cells8010069			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	HM8PD	WOS:000459742400068	30669285	Green Submitted, Green Published, gold			2022-02-06	
S	Stern, Y; Barulli, D		Dekosky, ST; Asthana, S		Stern, Yaakov; Barulli, Daniel			Cognitive reserve	GERIATRIC NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; DEMENTIA RISK; HIPPOCAMPAL NEUROGENESIS; AMYLOID DEPOSITION; CONSTRUCT-VALIDITY; HEAD CIRCUMFERENCE; LEISURE ACTIVITIES; MEMORY DECLINE	Cognitive reserve is a latent construct theorized to account for the discrepancy between observed brain deterioration and ultimate clinical outcomes. This review outlines the theoretical development of the reserve concept and presents major trends within epidemiological and neuroimaging research literatures in support of such a construct. Particular focus is placed on the implications for cognitive aging and dementia.	[Stern, Yaakov] Columbia Univ Coll Phys & Surg, Dept Neurol, Psychiat, New York, NY 10032 USA; [Stern, Yaakov] Columbia Univ Coll Phys & Surg, Taub Inst, 630 W 168th St, New York, NY 10032 USA; [Barulli, Daniel] Columbia Univ, Dept Psychol, New York, NY 10027 USA		Stern, Y (corresponding author), Columbia Univ Coll Phys & Surg, Neuropsychol, 622 W 168th St,PH18-321, New York, NY 10032 USA.	ys11@columbia.edu					Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; Alexander GE, 1997, AM J PSYCHIAT, V154, P165; Arai JA, 2009, J NEUROSCI, V29, P1496, DOI 10.1523/JNEUROSCI.5057-08.2009; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Barulli DJ, 2013, J INT NEUROPSYCH SOC, V19, P841, DOI 10.1017/S1355617713000593; Bennett DA, 2003, NEUROLOGY, V60, P1909, DOI 10.1212/01.WNL.0000069923.64550.9F; Boyle PA, 2008, NEUROLOGY, V70, P1534, DOI 10.1212/01.wnl.0000304345.14212.38; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Brayne C, 2010, BRAIN, V133, P2210, DOI 10.1093/brain/awq185; Brickman AM, 2011, NEUROBIOL AGING, V32, P1588, DOI 10.1016/j.neurobiolaging.2009.10.013; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Butler SM, 1996, J AM GERIATR SOC, V44, P675, DOI 10.1111/j.1532-5415.1996.tb01831.x; Chodosh J, 2002, J AM GERIATR SOC, V50, P1051, DOI 10.1046/j.1532-5415.2002.50260.x; Christensen H, 1997, INT J GERIATR PSYCH, V12, P323, DOI 10.1002/(SICI)1099-1166(199703)12:3<323::AID-GPS492>3.0.CO;2-N; Clewett DV, 2016, NEUROBIOL AGING, V37, P117, DOI 10.1016/j.neurobiolaging.2015.09.019; Craik FIM, 2006, NEUROSCI BIOBEHAV R, V30, P885, DOI 10.1016/j.neubiorev.2006.06.010; Craik FIM, 2010, NEUROLOGY, V75, P1726, DOI 10.1212/WNL.0b013e3181fc2a1c; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Esiri MM, 2001, LANCET, V357, P169; Farinpour R, 2003, J CLIN EXP NEUROPSYC, V25, P654, DOI 10.1076/jcen.25.5.654.14577; Farmer Mary E., 1995, Annals of Epidemiology, V5, P1, DOI 10.1016/1047-2797(94)00047-W; Flicker L, 2011, BRIT J SPORT MED, V45, P465, DOI 10.1136/bjsm.2010.077446; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Garibotto V, 2008, NEUROLOGY, V71, P1342, DOI 10.1212/01.wnl.0000327670.62378.c0; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; Habeck C, 2017, CEREB CORTEX, V27, P3962, DOI 10.1093/cercor/bhw208; Hakansson K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2462; Hall CB, 2007, NEUROLOGY, V69, P1657, DOI 10.1212/01.wnl.0000278163.82636.30; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Harrison SL, 2015, J CLIN EXP NEUROPSYC, V37, P253, DOI 10.1080/13803395.2014.1002759; Jones RN, 2011, J INT NEUROPSYCH SOC, V17, P593, DOI 10.1017/S1355617710001748; Karp A, 2004, AM J EPIDEMIOL, V159, P175, DOI 10.1093/aje/kwh018; KATZMAN R, 1993, NEUROLOGY, V43, P13, DOI 10.1212/WNL.43.1_Part_1.13; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Kesler SR, 2003, APPL NEUROPSYCHOL, V10, P153, DOI 10.1207/S15324826AN1003_04; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lyketsos CG, 1999, AM J PSYCHIAT, V156, P58, DOI 10.1176/ajp.156.1.58; Mangialasche F, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt104; McNamara P., 2011, DEMENTIA HIST INCIDE, V1; Meng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038268; Mondini S, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00084; Morcom AM, 2015, J COGNITIVE NEUROSCI, V27, P1275, DOI 10.1162/jocn_a_00783; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Nithianantharajah J, 2009, PROG NEUROBIOL, V89, P369, DOI 10.1016/j.pneurobio.2009.10.001; Noble KG, 2015, NAT NEUROSCI, V18, P773, DOI 10.1038/nn.3983; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Oh H, 2015, NEUROBIOL AGING, V36, P3247, DOI 10.1016/j.neurobiolaging.2015.08.016; Paillard T, 2015, J CLIN NEUROL, V11, P212, DOI 10.3988/jcn.2015.11.3.212; Paillard-Borg S, 2009, DEMENT GERIATR COGN, V28, P136, DOI 10.1159/000235576; Piras F, 2011, HUM BRAIN MAPP, V32, P282, DOI 10.1002/hbm.21018; Qiu CX, 2001, ARCH NEUROL-CHICAGO, V58, P2034, DOI 10.1001/archneur.58.12.2034; Reed BR, 2010, BRAIN, V133, P2196, DOI 10.1093/brain/awq154; Rentz DM, 2010, ANN NEUROL, V67, P353, DOI 10.1002/ana.21904; Richards M, 2003, J CLIN EXP NEUROPSYC, V25, P614, DOI 10.1076/jcen.25.5.614.14581; Riley KP, 2002, ANN NEUROL, V51, P567, DOI 10.1002/ana.10161; Robertson IH, 2013, NEUROBIOL AGING, V34, P298, DOI 10.1016/j.neurobiolaging.2012.05.019; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; Roe CM, 2007, NEUROLOGY, V68, P223, DOI 10.1212/01.wnl.0000251303.50459.8a; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Sachdev PS, 2009, AM J GERIAT PSYCHIAT, V17, P175, DOI 10.1097/JGP.0b013e318196a661; Sandry J, 2014, J INT NEUROPSYCH SOC, V20, P868, DOI 10.1017/S1355617714000630; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Scarmeas N, 2003, ARCH NEUROL-CHICAGO, V60, P359, DOI 10.1001/archneur.60.3.359; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854; Schmand B, 1997, PSYCHOL MED, V27, P1337, DOI 10.1017/S0033291797005461; Schneider EB, 2014, NEUROLOGY, V82, P1636, DOI 10.1212/WNL.0000000000000379; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Schweizer TA, 2012, CORTEX, V48, P991, DOI 10.1016/j.cortex.2011.04.009; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Sole-Padulles C, 2009, NEUROBIOL AGING, V30, P1114, DOI 10.1016/j.neurobiolaging.2007.10.008; Steffener J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091196; Steffener J, 2012, BBA-MOL BASIS DIS, V1822, P467, DOI 10.1016/j.bbadis.2011.09.012; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; STERN Y, 1995, NEUROLOGY, V45, P55, DOI 10.1212/WNL.45.1.55; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 1999, NEUROLOGY, V53, P1942, DOI 10.1212/WNL.53.9.1942; Stern Y, 2008, CEREB CORTEX, V18, P959, DOI 10.1093/cercor/bhm134; Stern Y, 2014, NEUROIMAGE, V103, P139, DOI 10.1016/j.neuroimage.2014.09.029; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sumowski JF, 2009, J CLIN EXP NEUROPSYC, V31, P913, DOI 10.1080/13803390902740643; Valenzuela MJ, 2007, PSYCHOL MED, V37, P1015, DOI 10.1017/S003329170600938X; Valenzuela MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002598; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang HX, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.003; Whalley LJ, 2016, PSYCHIAT RES-NEUROIM, V247, P65, DOI 10.1016/j.pscychresns.2015.10.012; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1; Zahodne LB, 2014, NEUROPSYCHOLOGY, V28, P238, DOI 10.1037/neu0000014	99	19	19	4	5	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-805141-2; 978-0-12-804766-8	HAND CLINIC			2019	167						181	190		10.1016/B978-0-12-804766-8.00011-X			10	Geriatrics & Gerontology; Clinical Neurology	Book Citation Index – Science (BKCI-S)	Geriatrics & Gerontology; Neurosciences & Neurology	BQ8QQ	WOS:000621193100013	31753132				2022-02-06	
J	Xu, ZM; Fouda, AY; Lemtalsi, T; Shosha, E; Rojas, M; Liu, F; Patel, C; Caldwell, RW; Narayanan, SP; Caldwell, RB				Xu, Zhimin; Fouda, Abdelrahman Y.; Lemtalsi, Tahira; Shosha, Esraa; Rojas, Modesto; Liu, Fang; Patel, Chintan; Caldwell, R. William; Narayanan, Subhadra Priya; Caldwell, Ruth B.			Retinal Neuroprotection From Optic Nerve Trauma by Deletion of Arginase 2	FRONTIERS IN NEUROSCIENCE			English	Article						arginase 2; retina; neuroprotection; optic nerve crush; brain derived neurotrophic factor; retinal ganglion cells	GANGLION-CELLS; FUNCTIONAL-CHANGES; GAP-43; EXPRESSION; INJURY; MARKER; BDNF; RNA	Our previous studies have implicated expression of the mitochondrial isoform of the arginase enzyme arginase 2 (A2) in neurovascular injury during ischemic retinopathies. The aim of this study was to characterize the specific involvement of A2 in retinal injury following optic nerve crush (ONC). To accomplish this, wild-type (WT) or A2 knockout (A2(-/-)) mice were subjected to ONC injury. The contralateral eye served as sham control. Quantitative RT-PCR and western blot were used to evaluate mRNA and protein expression. Retinal ganglion cell (RGC) survival was assessed in retinal whole mounts. Axonal sprouting was determined by anterograde transport of Cholera Toxin B (CTB). These analyses showed increased A2 expression following ONC. Numbers of NeuN-positive neurons as well as Brn3a- and RBPMS-positive RGC were decreased in the WT retinas at 14 days after ONC as compared to the sham controls. This ONC-induced neuronal loss was diminished in the A2(-/-) retinas. Similarly, axonal degeneration was ameliorated by A2 deletion whereas axon sprouting was enhanced. Significant retinal thinning was also seen in WT retinas at 21 days after ONC, and this was blocked in A2(-/-) mice. Cell death studies showed an increase in TUNEL positive cells in the RGC layer at 5 days after ONC in the WT retinas, and this was attenuated by A2 deletion. ONC increased glial cell activation in WT retinas, and this was significantly reduced by A2 deletion. Western blotting showed a marked increase in the neurotrophin, brain derived neurotrophic factor (BDNF) and its downstream signaling in A2(-/-) retinas vs. WT after ONC. This was associated with increases in the axonal regeneration marker GAP-43 in A2(-/-) retinas. Furthermore, A2(-/-) retinas showed decreased NLRP3 inflammasome activation and lower interleukin (IL-) 1 beta/IL-18 levels as compared to WT retinas subjected to ONC. Collectively, our results show that deletion of A2 limits ONC-induced neurodegeneration and glial activation, and enhances axonal sprouting by a mechanism involving increases in BDNF and decreases in retinal inflammation. These data demonstrate that A2 plays an important role in ONC-induced retinal damage. Blockade of A2 activity may offer a therapeutic strategy for preventing vision loss induced by traumatic retinal injury.	[Xu, Zhimin; Fouda, Abdelrahman Y.; Lemtalsi, Tahira; Shosha, Esraa; Rojas, Modesto; Liu, Fang; Narayanan, Subhadra Priya; Caldwell, Ruth B.] Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA; [Xu, Zhimin; Fouda, Abdelrahman Y.; Lemtalsi, Tahira; Shosha, Esraa; Rojas, Modesto; Liu, Fang; Patel, Chintan; Narayanan, Subhadra Priya; Caldwell, Ruth B.] Augusta Univ, Vasc Biol Ctr, Augusta, GA 30904 USA; [Xu, Zhimin; Fouda, Abdelrahman Y.; Lemtalsi, Tahira; Shosha, Esraa; Rojas, Modesto; Liu, Fang; Caldwell, R. William; Narayanan, Subhadra Priya; Caldwell, Ruth B.] Augusta Univ, James & Jean Culver Vis Discovery Inst, Augusta, GA 30904 USA; [Rojas, Modesto; Caldwell, R. William] Augusta Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Liu, Fang; Narayanan, Subhadra Priya] Univ Georgia, Coll Pharm, Program Clin & Expt Therapeut, Augusta, GA USA; [Caldwell, Ruth B.] Augusta Univ, Dept Cell Biol & Anat, Augusta, GA 30904 USA; [Caldwell, Ruth B.] Augusta Univ, Dept Ophthalmol, Augusta, GA 30904 USA		Caldwell, RB (corresponding author), Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA.; Caldwell, RB (corresponding author), Augusta Univ, Vasc Biol Ctr, Augusta, GA 30904 USA.; Caldwell, RB (corresponding author), Augusta Univ, James & Jean Culver Vis Discovery Inst, Augusta, GA 30904 USA.; Caldwell, RB (corresponding author), Augusta Univ, Dept Cell Biol & Anat, Augusta, GA 30904 USA.; Caldwell, RB (corresponding author), Augusta Univ, Dept Ophthalmol, Augusta, GA 30904 USA.	rcaldwel@augusta.edu		Rojas, Modesto/0000-0002-9441-3302	National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R0I-EY11766]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and DevelopmentUS Department of Veterans Affairs [BX001233]; American Heart Association (AHA) postdoctoral fellowshipAmerican Heart Association [18POST34060036]; Culver Vision Discovery Institute at Augusta University; Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01EY011766] Funding Source: NIH RePORTER	This work was supported by grants from The National Institute of Health (NIH grant R0I-EY11766, the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development (BX001233) to RBC, American Heart Association (AHA) postdoctoral fellowship (18POST34060036) to AYF, and the Culver Vision Discovery Institute at Augusta University. RBC was the recipient of a Research Career Scientist Award from the Department of Veterans Affairs. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caldwell RW, 2018, PHYSIOL REV, V98, P641, DOI 10.1152/physrev.00037.2016; DOSTER SK, 1991, NEURON, V6, P635, DOI 10.1016/0896-6273(91)90066-9; Fouda AY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1051-6; Fournier AE, 1997, J NEUROSCI RES, V47, P561, DOI 10.1002/(SICI)1097-4547(19970315)47:6<561::AID-JNR1>3.0.CO;2-B; Gupta SK, 2009, CELL DEATH DIFFER, V16, P624, DOI 10.1038/cdd.2008.188; Holahan MR, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00266; Klocker N, 2001, NEUROBIOL DIS, V8, P103, DOI 10.1006/nbdi.2000.0329; Li HY, 2014, NEURAL REGEN RES, V9, P565, DOI 10.4103/1673-5374.130093; Li Y, 1999, INVEST OPHTH VIS SCI, V40, P1004; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Mac Nair CE, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0558-y; Mesentier-Louro LA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010098; Mysona BA, 2017, EXPERT REV OPHTHALMO, V12, P69, DOI 10.1080/17469899.2017.1259566; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Narayanan SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022460; Nuschke AC, 2015, EXP EYE RES, V141, P111, DOI 10.1016/j.exer.2015.06.006; Ratican SE, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/7108948; Rodriguez AR, 2014, J COMP NEUROL, V522, P1411, DOI 10.1002/cne.23521; Shosha E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.295; TANG ZS, 2011, JOVE J VIS EXP APR, DOI DOI 10.3791/2685; Wang JX, 2018, MOL VIS, V24, P174; Weber AJ, 2008, J PHYSIOL-LONDON, V586, P4393, DOI 10.1113/jphysiol.2008.156729; Yukita M, 2015, DOC OPHTHALMOL, V130, P149, DOI 10.1007/s10633-014-9478-2; Zhen PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20998	24	19	19	1	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	DEC 20	2018	12								970	10.3389/fnins.2018.00970			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HF0YP	WOS:000453891800001	30618589	Green Published, gold			2022-02-06	
J	Ko, J; Hemphill, M; Yang, Z; Sewell, E; Na, YJ; Sandsmark, DK; Haber, M; Fisher, SA; Torre, EA; Svane, KC; Omelchenko, A; Firestein, BL; Diaz-Arrastia, R; Kim, J; Meaney, DF; Issadore, D				Ko, J.; Hemphill, M.; Yang, Z.; Sewell, E.; Na, Y. J.; Sandsmark, D. K.; Haber, M.; Fisher, S. A.; Torre, E. A.; Svane, K. C.; Omelchenko, A.; Firestein, B. L.; Diaz-Arrastia, R.; Kim, J.; Meaney, D. F.; Issadore, D.			Diagnosis of traumatic brain injury using miRNA signatures in nanomagnetically isolated brain-derived extracellular vesicles	LAB ON A CHIP			English	Article							C-TERMINAL HYDROLASE; INTRACRANIAL LESIONS; CIRCULATING EXOSOMES; CEREBROSPINAL-FLUID; SERUM-LEVELS; BIOMARKERS; PROTEIN; MILD; DAMAGE; MICROVESICLES	The accurate diagnosis and clinical management of traumatic brain injury (TBI) is currently limited by the lack of accessible molecular biomarkers that reflect the pathophysiology of this heterogeneous disease. To address this challenge, we developed a microchip diagnostic that can characterize TBI more comprehensively using the RNA found in brain-derived extracellular vesicles (EVs). Our approach measures a panel of EV miRNAs, processed with machine learning algorithms to capture the state of the injured and recovering brain. Our diagnostic combines surface marker-specific nanomagnetic isolation of brain-derived EVs, biomarker discovery using RNA sequencing, and machine learning processing of the EV miRNA cargo to minimally invasively measure the state of TBI. We achieved an accuracy of 99% identifying the signature of injured vs. sham control mice using an independent blinded test set (N = 77), where the injured group consists of heterogeneous populations (injury intensity, elapsed time since injury) to model the variability present in clinical samples. Moreover, we successfully predicted the intensity of the injury, the elapsed time since injury, and the presence of a prior injury using independent blinded test sets (N = 82). We demonstrated the translatability in a blinded test set by identifying TBI patients from healthy controls (AUC = 0.9, N = 60). This approach, which can detect signatures of injury that persist across a variety of injury types and individual responses to injury, more accurately reflects the heterogeneity of human TBI injury and recovery than conventional diagnostics, opening new opportunities to improve treatment of traumatic brain injuries.	[Ko, J.; Hemphill, M.; Yang, Z.; Sewell, E.; Torre, E. A.; Meaney, D. F.; Issadore, D.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Na, Y. J.] Columbia Univ Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY 10032 USA; [Sandsmark, D. K.; Haber, M.; Diaz-Arrastia, R.] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Fisher, S. A.; Kim, J.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Kim, J.] Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA; [Issadore, D.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA; [Svane, K. C.; Omelchenko, A.; Firestein, B. L.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA; [Meaney, D. F.] Univ Penn, Dept Neurosurg, Perelman Sch Med, Philadelphia, PA 19104 USA		Issadore, D (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.; Issadore, D (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	daveissadore@gmail.com	Yang, Zijian/AAO-9763-2021	Meaney, David/0000-0002-0954-4122; Ko, Jina/0000-0002-4941-4234; Firestein, Bonnie/0000-0002-1679-3565; Omelchenko, Anton/0000-0001-7396-2815	New Jersey Commission on Brain Injury Research [CSCR14IRG005]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 088276]; Allen Foundation [U01 NS086090]; Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program, the National Institute of Health [1R21CA182336-01A1]; American Cancer Society - CEOs Against Cancer - CA Division Research Scholar GrantAmerican Cancer Society [RSG-15-227-01-CSM]; National Science Foundation's CAREER Award [1554200]; Hartwell Individual Research Award; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R21CA182336, R33CA206907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R21MH118170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	We thank Tawny Meredith-Duliba and Erika Silverman from the Diaz-Arrastia lab at Penn for collecting and processing clinical samples that were used for this study. Funding was provided by the New Jersey Commission on Brain Injury Research (CSCR14IRG005) to DI, DM, and BF, NIH NS 088276 to DM, Allen Foundation to DM and DI, U01 NS086090 to RDA, the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program, the National Institute of Health: 1R21CA182336-01A1 to DI and JK, and DI was supported by an American Cancer Society - CEOs Against Cancer - CA Division Research Scholar Grant, (RSG-15-227-01-CSM), the National Science Foundation's CAREER Award (#1554200), and The Hartwell Individual Research Award.	Adams JD, 2008, P NATL ACAD SCI USA, V105, P18165, DOI 10.1073/pnas.0809795105; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Battista D., 2015, FRONT NEUROL, V6, P110; Beamer M, 2016, EXP NEUROL, V283, P16, DOI 10.1016/j.expneurol.2016.05.025; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bruce ED, 2015, MOL CELL NEUROSCI, V66, P103, DOI 10.1016/j.mcn.2015.03.017; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Carrel D, 2009, J NEUROSCI, V29, P8248, DOI 10.1523/JNEUROSCI.5287-08.2009; Clayton A, 2001, J IMMUNOL METHODS, V247, P163, DOI 10.1016/S0022-1759(00)00321-5; De K., 2001, ACTA NEUROL SCAND, V103, P175; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Feldmann M., 2014, J BIOL METHODS, V1, pell; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Hadzimichalis NM, 2010, SCHIZOPHR RES, V124, P248, DOI 10.1016/j.schres.2010.05.009; Haun JB, 2010, WIRES NANOMED NANOBI, V2, P291, DOI 10.1002/wnan.84; He M, 2014, LAB CHIP, V14, P3773, DOI 10.1039/c4lc00662c; Hernandez K, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00006; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Hyun KA, 2016, ANALYST, V141, P382, DOI 10.1039/c5an01762a; Im H, 2014, NAT BIOTECHNOL, V32, P490, DOI 10.1038/nbt.2886; Jeong S, 2016, ACS NANO, V10, P1802, DOI 10.1021/acsnano.5b07584; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kanwar SS, 2014, LAB CHIP, V14, P1891, DOI 10.1039/c4lc00136b; Ko J, 2018, LAB CHIP, V18, P395, DOI 10.1039/c7lc00955k; Ko J, 2017, ACS NANO, V11, P11182, DOI 10.1021/acsnano.7b05503; Ko J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31215; Ko J, 2016, LAB CHIP, V16, P3049, DOI 10.1039/c6lc00487c; Ko J, 2016, ANALYST, V141, P450, DOI 10.1039/c5an01610j; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee JH, 2007, NAT MED, V13, P95, DOI 10.20659/jfp.13.1_95; Liong M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2745; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lusardi TA, 2004, J NEUROTRAUM, V21, P61, DOI 10.1089/089771504772695959; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Muller L, 2014, J IMMUNOL METHODS, V411, P55, DOI 10.1016/j.jim.2014.06.007; Muluneh M, 2014, ADV HEALTHC MATER, V3, P1078, DOI 10.1002/adhm.201300502; Muluneh M, 2014, ADV DRUG DELIVER REV, V66, P101, DOI 10.1016/j.addr.2013.09.013; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Patel TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00349; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Ping JL, 2016, ACS NANO, V10, P8700, DOI 10.1021/acsnano.6b04110; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Schreiber S, 2008, SMALL, V4, P270, DOI 10.1002/smll.200700116; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shao HL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7999; Shao HL, 2012, NAT MED, V18, P1835, DOI 10.1038/nm.2994; Sharma A., 2014, PLOS ONE, V9; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagner AK, 2004, J NEUROTRAUM, V21, P125, DOI 10.1089/089771504322778596; Willms E, 2016, SCI REP-UK, V6, DOI 10.1038/srep22519; Xia N, 2006, BIOMED MICRODEVICES, V8, P299, DOI 10.1007/s10544-006-0033-0; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Yuana Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.21494; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhao Z, 2016, LAB CHIP, V16, P489, DOI 10.1039/c5lc01117e	76	19	21	2	22	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1473-0197	1473-0189		LAB CHIP	Lab Chip	DEC 7	2018	18	23					3617	3630		10.1039/c8lc00672e			14	Biochemical Research Methods; Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience & Nanotechnology; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry; Science & Technology - Other Topics; Instruments & Instrumentation	HB0VS	WOS:000450737200005	30357245	Green Accepted			2022-02-06	
J	Briain, DO; Nickson, C; Pilcher, DV; Udy, AA				Briain, Diarmuid O.; Nickson, Christopher; Pilcher, David V.; Udy, Andrew A.			Early Hyperoxia in Patients with Traumatic Brain Injury Admitted to Intensive Care in Australia and New Zealand: A Retrospective Multicenter Cohort Study	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Oxygen exposure; Mortality	ARTERIAL HYPEROXIA; CARDIAC-ARREST; ASSOCIATION; OXYGEN; MORTALITY; OUTCOMES; HYPOXIA	BackgroundEarly hyperoxia may be an independent risk factor for mortality in critically ill traumatic brain injury (TBI) patients, although current data are inconclusive. Accordingly, we conducted a retrospective cohort study to determine the association between systemic oxygenation and in-hospital mortality, in critically ill mechanically ventilated TBI patients.MethodsData were extracted from the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation Adult Patient Database. All adult TBI patients receiving mechanical ventilation in 129 intensive care units between 2000 and 2016 were included in analysis. The following data were extracted: demographics, illness severity scores, physiological and laboratory measurements, institutional characteristics, and vital status at discharge. In-hospital mortality was used as the primary study outcome. The primary exposure variable was the worst' partial arterial pressure of oxygen (PaO2) recorded during the first 24h in ICU; hyperoxia was defined as>299mmHg. Adjustment for illness severity utilized multivariable logistic regression, the results of which are reported as the odds ratio (OR) 95% CI.ResultsData concerning 24,148 ventilated TBI patients were extracted. By category of worst PaO2, crude in-hospital mortality ranged from 27.1% (PaO2 40-49mmHg) to 13.3% (PaO2 140-159mmHg). When adjusted for patient and institutional characteristics, the only PaO2 category associated with a significantly greater risk of death was<40mmHg [OR 1.52, 1.03-2.25]. A total of 3117 (12.9%) patients were hyperoxic during the first 24h in ICU, with a crude in-hospital mortality rate of 17.8%. No association was evident in between hyperoxia and mortality in adjusted analysis [OR 0.97 (0.86-1.11)].ConclusionsIn this large multicenter cohort of TBI patients, hyperoxia in the first 24h after ICU admission was not independently associated with greater in-hospital mortality. Hypoxia remains associated with greater in-hospital mortality risk and should be avoided where possible.	[Briain, Diarmuid O.; Nickson, Christopher; Pilcher, David V.; Udy, Andrew A.] Alfred Intens Care Unit, 55 Commercial Rd, Melbourne, Vic 3004, Australia; [Nickson, Christopher; Pilcher, David V.; Udy, Andrew A.] Monash Univ, Sch Publ Hlth & Prevent Med, Australian & New Zealand Intens Care Res Ctr, 553 St Kilda Rd, Melbourne, Vic 3004, Australia; [Pilcher, David V.] Australian & New Zealand Intens Care Soc, Ctr Outcome & Resource Evaluat, 10 Ievers Terrace, Melbourne, Vic 3053, Australia		Udy, AA (corresponding author), Alfred Intens Care Unit, 55 Commercial Rd, Melbourne, Vic 3004, Australia.	a.udy@alfred.org.au		Nickson, Christopher Peter/0000-0002-6968-3087	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [GNT1124532]; State and Territory Health Departments of Australia; New Zealand Ministry of Health	Professor Andrew Udy gratefully acknowledges salary support from the National Health and Medical Research Council of Australia (Early Career Fellowship; GNT1124532). ANZICS CORE is funded by the State and Territory Health Departments of Australia and the New Zealand Ministry of Health to monitor performance and provide benchmarking services to ICUs and Health Departments throughout both countries.	Asfar P, 2015, INTENS CARE MED, V41, P1118, DOI 10.1007/s00134-015-3670-z; Asher SR, 2013, J NEUROSURG ANESTH, V25, P168, DOI 10.1097/ANA.0b013e318283d350; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Habre W, 2014, Br J Anaesth, V113 Suppl 2, pii26, DOI 10.1093/bja/aeu380; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Paul E, 2013, J CRIT CARE, V28, P935, DOI 10.1016/j.jcrc.2013.07.058; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Stub D, 2015, CIRCULATION, V131, P2143, DOI 10.1161/CIRCULATIONAHA.114.014494; Tan A, 2004, COCHRANE DB SYST REV, V3; von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040297, 10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]	23	19	19	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	DEC	2018	29	3					443	451		10.1007/s12028-018-0553-5			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HD4SH	WOS:000452517800016	29949002				2022-02-06	
J	Erdodi, LA; Kirsch, NL; Sabelli, AG; Abeare, CA				Erdodi, Laszlo A.; Kirsch, Ned L.; Sabelli, Alana G.; Abeare, Christopher A.			The Grooved Pegboard Test as a Validity Indicatora Study on Psychogenic Interference as a Confound in Performance Validity Research	PSYCHOLOGICAL INJURY & LAW			English	Article						Grooved Pegboard Test; Performance validity; Psychogenic interference; Manual dexterity; BDI-II; SCL-90-R	TRAUMATIC BRAIN-INJURY; PERSONALITY-ASSESSMENT INVENTORY; RECOGNITION MEMORY TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; FORCED-CHOICE RECOGNITION; VERBAL-LEARNING TEST; EXCESSIVE COGNITIVE SYMPTOMS; RELIABLE DIGIT SPAN; COMPLEX FIGURE TEST; CARD SORTING TEST	This study was designed to replicate an earlier report on the link between low scores on the Grooved Pegboard test (GPB), invalid responding, and elevated self-reported psychiatric symptoms. A fixed battery of neuropsychological tests was administered to 100 consecutively referred outpatients (M-Age=38.3, M-Education=13.6years) following traumatic brain injury at a Midwestern academic medical center. Classification accuracy of GPB validity cutoffs was computed against a free-standing PVT and three composite measures of embedded validity indicators. Previously suggested GPB validity cutoffs (T29 in either hand) produced good combinations of sensitivity (0.25-0.55) and specificity (0.89-0.98) to psychometrically defined invalid performance. Raising the cutoff to T31 resulted in a reasonable trade-off between increased sensitivity (0.36-0.55) and decreased specificity (0.84-0.94). T31 in both hands was highly specific (0.93-0.98) to noncredible responding. GPB validity cutoffs were unrelated to psychiatric symptoms or injury severity. Failing PVTs based on forced choice recognition was associated with elevated self-reported depression, somatic concerns, and overall symptomatology. Low scores on the GPB are reliable indicators of noncredible responding. Self-reported emotional distress has a complex relationship with performance validity. Psychogenic interference is a potential mechanism behind PVT failures, and its expression is likely mediated by instrumentation and sampling artifacts. Further research on the topic is clearly needed to advance current understanding of psychogenic interference as a confound in cognitive testing.	[Erdodi, Laszlo A.; Abeare, Christopher A.] Univ Windsor, Neuropsychol Track, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Kirsch, Ned L.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Sabelli, Alana G.] Univ Windsor, Brain Cognit Neurosci Program, Windsor, ON, Canada		Erdodi, LA (corresponding author), Univ Windsor, Neuropsychol Track, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434			An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Arnold G, 2007, ASSESSMENT FEIGNED C; Ashendorf L, 2003, CLIN NEUROPSYCHOL, V17, P255, DOI 10.1076/clin.17.2.255.16502; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Bearden CE, 2006, PSYCHIAT RES, V142, P139, DOI 10.1016/j.psychres.2005.08.010; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bell-Sprinkel TL, 2013, CLIN NEUROPSYCHOL, V27, P516, DOI 10.1080/13854046.2012.744853; Berry DTR, 1996, J PERS ASSESS, V67, P26, DOI 10.1207/s15327752jpa6701_2; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; BINDER LM, 1991, PSYCHOL ASSESSMENT J, V3, P175, DOI DOI 10.1037/1040-3590.3.2.175; Boone D, 1998, J CLIN PSYCHOL, V54, P839, DOI 10.1002/(SICI)1097-4679(199810)54:6<839::AID-JCLP12>3.0.CO;2-M; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2007, ARCH CLIN NEUROPSYCH, V22, P675, DOI 10.1016/j.acn.2007.07.005; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; Conners, 2004, CONNERS CONTINUOUS P; Considine CM, 2011, ARCH CLIN NEUROPSYCH, V26, P445, DOI 10.1093/arclin/acr041; Costabile T, 2018, PSYCHIAT CLIN NEUROS, V72, P189, DOI 10.1111/pcn.12630; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; DeFilippis NA, 1997, MANUAL BOOKLET CATEG; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; Derogatis L. R., 1994, SCL 90 R ADM SCORING, VThird; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dunn, 2007, PPVT 4 PEABODY PICTU; Egeland J, 2005, ACTA PSYCHIAT SCAND, V112, P434, DOI 10.1111/j.1600-0447.2005.00599.x; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L. A., 2017, ARCH CLIN NEUROPSYCH, DOI [10. 1093/arclin/acx110, DOI 10.1093/ARCLIN/ACX110]; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Green P., 2008, GREENS NONVERBAL MED; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF, 2008, CLIN NEUROPSYCHOL, V22, P565, DOI 10.1080/13854040701377810; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Grote CL, 2000, J CLIN EXP NEUROPSYC, V22, P709, DOI 10.1076/jcen.22.6.709.958; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; Hopwood CJ, 2007, J NERV MENT DIS, V195, P266, DOI 10.1097/01.nmd.0000253747.44836.61; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Johnson JL, 1997, ARCH CLIN NEUROPSYCH, V12, P231, DOI 10.1016/S0887-6177(96)00040-6; JOHNSON RW, 1989, J COUNS PSYCHOL, V36, P110; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kalfon TBO, 2016, J PSYCHOSOM RES, V87, P30, DOI 10.1016/j.jpsychores.2016.06.004; Karlin BE, 2005, J CLIN PSYCHOL, V61, P1571, DOI 10.1002/jclp.20209; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Kiewel NA, 2012, CLIN NEUROPSYCHOL, V26, P965, DOI 10.1080/13854046.2012.694478; Kim MS, 2010, ARCH CLIN NEUROPSYCH, V25, P60, DOI 10.1093/arclin/acp088; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kjaergaard M, 2014, SCAND J PSYCHOL, V55, P83, DOI 10.1111/sjop.12090; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lafayette Instrument, 2015, GROOV PERGB US MAN; Lange RT, 2017, CLIN NEUROPSYCHOL, V31, P1015, DOI 10.1080/13854046.2017.1335438; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Langenecker SA, 2005, J CLIN EXP NEUROPSYC, V27, P320, DOI 10.1080/13803390490490515720; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P813, DOI 10.1080/13854040701625846; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Leighton A, 2014, J INT NEUROPSYCH SOC, V20, P873, DOI 10.1017/S135561771400085X; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; MacAllister WS, 2009, CHILD NEUROPSYCHOL, V15, P521, DOI 10.1080/09297040902748226; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McGuire BE, 2001, J CLIN PSYCHOL, V57, P1589, DOI 10.1002/jclp.1121; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey, 1991, PERSONALITY ASSESSME; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOLUTIONS W; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Rees LM, 2001, ARCH CLIN NEUROPSYCH, V16, P501, DOI 10.1016/S0887-6177(00)00064-0; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rohling ML, 2002, ARCH CLIN NEUROPSYCH, V17, P205, DOI 10.1016/S0887-6177(01)00109-3; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Siefert CJ, 2009, ASSESSMENT, V16, P373, DOI 10.1177/1073191109333756; Sims JA, 2013, J PERS ASSESS, V95, P495, DOI 10.1080/00223891.2013.775137; Sinclair SJ, 2015, B MENNINGER CLIN, V79, P305, DOI 10.1521/bumc.2015.79.4.305; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Sprinkle SD, 2002, J COUNS PSYCHOL, V49, P381, DOI 10.1037//0022-0167.49.3.381; Storch EA, 2004, DEPRESS ANXIETY, V19, P187, DOI 10.1002/da.20002; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr J, 1997, J CLIN EXP NEUROPSYC, V19, P500, DOI 10.1080/01688639708403740; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sullivan K, 2010, PSYCHIAT RES, V176, P75, DOI 10.1016/j.psychres.2008.07.013; Sussman Z. W., 2017, APPL NEUROPSYCHOLOGY; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882; Wechsler D., 2008, WECHSLER ADULT INTEL; Westcott MC, 2005, BRAIN INJURY, V19, P1261, DOI 10.1080/02699050500150104; Whiteside DM, 2015, J CLIN EXP NEUROPSYC, V37, P220, DOI 10.1080/13803395.2014.1002758; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Zenisek R, 2016, ARCH CLIN NEUROPSYCH, V31, P426, DOI 10.1093/arclin/acw025; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	147	19	19	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	DEC	2018	11	4					307	324		10.1007/s12207-018-9337-7			18	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	HA8UB	WOS:000450568200001					2022-02-06	
J	Vieira, E; Guimaraes, TC; Faquini, IV; Silva, JL; Saboia, T; Andrade, RVCL; Gemir, TL; Neri, VC; Almeida, NS; Azevedo, HRC				Vieira, Eduardo; Guimaraes, Thiago C.; Faquini Jr, Igor, V; Silva, Jose L.; Saboia, Tammy; Andrade, Rodrigo V. C. L.; Gemir, Thais L.; Neri, Valesca C.; Almeida, Nivaldo S.; Azevedo-Filho, Hildo R. C.			Randomized controlled study comparing 2 surgical techniques for decompressive craniectomy: with watertight duraplasty and without watertight duraplasty	JOURNAL OF NEUROSURGERY			English	Article						decompressive craniectomy; traumatic brain injury; brain edema; duraplasty	TRAUMATIC BRAIN-INJURY; CRANIOTOMY; EFFICACY; FLAP	OBJECTIVE Decompressive craniectomy (DC) is a widely used procedure in neurosurgery; however, few studies focus on the best surgical technique for the procedure. The authors' objective was to conduct a prospective randomized controlled trial comparing 2 techniques for performing DC: with watertight duraplasty and without watertight duraplasty (rapid-closure DC). METHODS The study population comprised patients ranging in age from 18 to 60 years who were admitted to the Neurotrauma Service of the Hospital da Restauracao with a clinical indication for unilateral decompressive craniectomy. Patients were randomized by numbered envelopes into 2 groups: with watertight duraplasty (control group) and without watertight duraplasty (test group). After unilateral DC was completed, watertight duraplasty was performed in the control group, while in the test group, no watertight duraplasty was performed and the exposed parenchyma was covered with Surgicel and the remaining dura mater. Patients were then monitored daily from the date of surgery until hospital discharge or death. The primary end point was the incidence of surgical complications (CSF leak, wound infection, brain abscess, or subgaleal fluid collections). The following were analyzed as secondary end points: clinical outcome (analyzed using the Glasgow Outcome Scale [GOS]), surgical time, and hospital costs. RESULTS Fifty-eight patients were enrolled, 29 in each group. Three patients were excluded, leaving 27 in the test group and 28 in the control group. There were no significant differences between groups regarding age, Glasgow Coma Scale score at the time of surgery, GOS score, and number of postoperative follow-up days. There were 9 surgical complications (5 in the control group and 4 in the test group), with no significant differences between the groups. The mean surgical time in the control group was 132 minutes, while in the test group the average surgical time was 101 minutes, a difference of 31 minutes (p = 0.001). The mean reduction in total cost was $420.00 USD (a 23.4% reduction) per procedure in the test group. CONCLUSIONS Rapid-closure DC without watertight duraplasty is a safe procedure. It is not associated with a higher incidence of surgical complications (CSF leak, wound infection, brain abscess, or subgaleal fluid collections), and it decreased surgical time by 31 minutes on average. There was also a hospital cost reduction of $420.00 USD (23.4% reduction) per procedure.	[Vieira, Eduardo; Guimaraes, Thiago C.; Faquini Jr, Igor, V; Silva, Jose L.; Saboia, Tammy; Andrade, Rodrigo V. C. L.; Gemir, Thais L.; Neri, Valesca C.; Almeida, Nivaldo S.; Azevedo-Filho, Hildo R. C.] Hosp Restauracao, Dept Neurol Surg, Ave Agamenon Magalhaes SN, BR-52010040 Recife, PE, Brazil		Vieira, E (corresponding author), Hosp Restauracao, Dept Neurol Surg, Ave Agamenon Magalhaes SN, BR-52010040 Recife, PE, Brazil.	evcj2005@gmail.com	Faquini, Igor/S-4936-2019	Faquini, Igor/0000-0002-1538-396X			Barth M, 2008, NEUROSURGERY, V63, P352, DOI 10.1227/01.NEU.0000310696.52302.99; Csokay A, 2002, SURG NEUROL, V57, P126, DOI 10.1016/S0090-3019(01)00686-3; Cushing H., 1908, SURGERY ITS PRINCIPL, P17; Goettler CE, 2007, J TRAUMA, V62, P777, DOI 10.1097/TA.0b013e31802ee55e; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Holland M, 2004, OPER TECH NEUROSURG, V7, P10, DOI DOI 10.1053/J.OTNS.2004.04.006; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kempe LK, 2004, KEMPES OPERATIVE NEU, V1, P170; Kenning TJ, 2012, J NEUROSURG, V116, P1289, DOI 10.3171/2012.2.JNS111772; Kenning TJ, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0960; KHOO JCM, 1976, J NEUROSURG, V45, P589, DOI 10.3171/jns.1976.45.5.0589; Ko K, 2007, NEUROSURGERY, V60, P255, DOI 10.1227/01.NEU.0000255380.64969.81; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Peethambaran AK, 2012, NEUROL INDIA, V60, P672, DOI 10.4103/0028-3886.105221; Ragel BT, NEUROSURG FOCUS, V28, pE2; Sade B, 2011, J NEUROSURG, V114, P714, DOI 10.3171/2010.7.JNS10460; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Valenca MM, 2010, J NEUROSURG, V113, P982, DOI 10.3171/2009.11.JNS09674; Zumkeller M, 1996, NEUROSURGERY, V39, P708, DOI 10.1097/00006123-199610000-00011	20	19	20	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	OCT	2018	129	4					1017	1023		10.3171/2017.4.JNS152954			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GV4QL	WOS:000446085200020	29148904	Bronze			2022-02-06	
J	Huie, JR; Diaz-Arrastia, R; Yue, JK; Sorani, MD; Puccio, AM; Okonkwo, DO; Manley, GT; Ferguson, AR				Huie, J. Russell; Diaz-Arrastia, Ramon; Yue, John K.; Sorani, Marco D.; Puccio, Ava M.; Okonkwo, David O.; Manley, Geoffrey T.; Ferguson, Adam R.		TRACK-TBI Investigators	Testing a Multivariate Proteomic Panel for Traumatic Brain Injury Biomarker Discovery: A TRACK-TBI Pilot Study	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; proteomics; TBI	COMMON DATA ELEMENTS; SERUM NEUROFILAMENT LIGHT; C-TERMINAL HYDROLASE-L1; MILD HEAD-INJURY; TRANSFORMING RESEARCH; INTRACRANIAL LESIONS; CLINICAL KNOWLEDGE; IMPACT MODELS; ACUTE-PHASE; S100B	The complex and heterogeneous nature of traumatic brain injury (TBI) has rendered the identification of diagnostic and prognostic biomarkers elusive. A single acute biomarker may not be sufficient to categorize injury severity and/or predict outcome. Using multivariate dimension reduction analyses, we tested the sensitivity and specificity of a multi-analyte panel of proteins as an ensemble biomarker for TBI. Serum was collected within 24h of injury in a cohort of 130 patients enrolled in the multi-center prospective Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study and run on an array that measured 72 proteins. Using unsupervised principal components analysis, we first identified the subset of protein changes accounting for the most variance across patients. This yielded a group of 21 proteins that reflected an inverse relationship between inflammatory cytokines and regulators of anti-inflammation, and generated an individual inflammatory profile score for each patient. We then tested the association between these scores and computed tomography (CT) findings at hospital admission, as well as their prognostic association with functional recovery at 3 and 6 months (Glasgow Outcome Scale-Extended), and cognitive recovery at 6 months (California Verbal Learning Test, Second Edition) after injury. Inflammatory signatures were significantly increased in patients with positive CT findings, as well as in those who showed poor or incomplete recovery. Inflammation biomarker scores also showed significant sensitivity and specificity as a discriminator of these outcome measures (all areas under the curve [AUCs] >0.62). This proof of concept for the feasibility of multivariate biomarker identification demonstrates the prognostic validity of using a proteomic panel as a potential biomarker for TBI.	[Huie, J. Russell; Yue, John K.; Manley, Geoffrey T.; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Zuckerberg San Francisco Gen Hosp, San Francisco, CA USA; [Huie, J. Russell; Yue, John K.; Manley, Geoffrey T.; Ferguson, Adam R.] Univ Calif San Francisco, Ctr Trauma, San Francisco, CA 94143 USA; [Huie, J. Russell; Yue, John K.; Manley, Geoffrey T.; Ferguson, Adam R.] Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Huie, J. Russell; Yue, John K.; Sorani, Marco D.; Manley, Geoffrey T.; Ferguson, Adam R.] Univ Calif San Francisco, Dept Neurol Surg, Weill Inst Neurosci, San Francisco, CA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Puccio, Ava M.] Univ Pittsburgh, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15260 USA; [Okonkwo, David O.; Ferguson, Adam R.] San Francisco VA Med Ctr, Dept Vet Affairs, San Francisco, CA USA		Ferguson, AR (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	Adam.ferguson@ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Hemphill, Claude/0000-0003-4019-7525; Sergot, Paulina/0000-0003-0796-8009; Ferguson, Adam/0000-0001-7102-1608; Huie, J. Russell/0000-0001-5594-4277	Department of Defense (DoD)United States Department of Defense [W81XWH-13-1-0441]; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS069409, NS069409-02S1, NS086090, NS106899, NS088475]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088475, U01NS086090, UG3NS106899] Funding Source: NIH RePORTER	This work was supported by Department of Defense (DoD) grant W81XWH-13-1-0441 (G.T.M.), and NIH/NINDS grants NS069409 (G.T.M.), NS069409-02S1 (G.T.M.), NS086090 (G.T.M.), NS106899 (A.R.F.), and NS088475 (A.R.F.). TRACK-TBI investigators include (in alphabetical order): Opeolu M. Adeoye, MD, University of Cincinnati; Neeraj Badjatia, MD, University of Maryland, Baltimore; Kimberly D. Boase, BA, University of Washington; Yelena Bodien-Guller, PhD, Harvard/Spaulding Rehabilitation Hospital; Malcolm R. Bullock, MD, PhD, University of Miami; Randall M. Chesnut, MD, FCCM, FACS, University of Washington; John D. Corrigan, PhD, Ohio State University; Karen L. Crawford, MILS, University of Southern California; Ramon Diaz-Arrastia, MD, University of Pennsylvania; Sureyya S. Dikmen, PhD, University of Washington; Ann-Christine Duhaime, MD, Harvard/Massachusetts General Hospital; Richard G. Ellenbogen, MD, FACS, University of Washington; Frank Ezekiel, University of California, San Francisco; Venkata R. Feeser, MD, Virginia Commonwealth University; Joseph T. Giacino, PhD, Harvard/Spaulding Rehabilitation Hospital; Dana P. Goldman, PhD, University of Southern California; Luis Gonzales, BA, TIRR Memorial Hermann; Shankar P. Gopinath, MD, Baylor College of Medicine; Rao P. Gullapalli, PhD, MBA, University of Maryland, Baltimore; Jesse C. Hemphill, MD, University of California, San Francisco; Gillian A. Hotz, PhD, University of Miami; Joel H. Kramer, PsyD, University of California, San Francisco; Harvey Levin, PhD, Baylor College of Medicine; Christopher J. Lindsell, PhD, Vanderbilt University; Joan Machamer, MA, University of Washington; Christopher Madden, MD, UT Southwestern; Amy J. Markowitz, JD, University of California, San Francisco; Alastair Martin, PhD, University of California, San Francisco; Bruce E. Mathern, MD, Virginia Commonwealth University; Thomas W. McAllister, MD, Indiana University; Michael A. McCrea, PhD, Medical College of Wisconsin; Randall E. Merchant, PhD, Virginia Commonwealth University; Florence Noel, PhD, Baylor College of Medicine; Daniel P. Perl, MD, Uniformed Services University of the Health Sciences; Ava M. Puccio, RN, PhD, University of Pittsburgh; Miri Rabinowitz, PhD, University of Pittsburgh; Claudia S. Robertson, MD, Baylor College of Medicine; Jonathan Rosand, MD, MSC, Harvard/Massachusetts General Hospital; Angelle M. Sander, PhD, Baylor College of Medicine; Gabriela Satris, MSc, University of California, San Francisco; David M. Schnyer, PhD, University of Texas at Austin; Seth A. Seabury, PhD, University of Southern California; Paulina Sergot, MD, FACEP, Baylor College of Medicine; Mark Sherer, PhD, TIRR Memorial Hermann; Deborah M. Stein, MD, MPH, University of Maryland, Baltimore; Murray B. Stein, MD, MPH, FRCPC, University of California, San Diego; Sabrina R. Taylor, PhD, University of California, San Francisco; Nancy R. Temkin, PhD, University of Washington; Arthur W. Toga, PhD, University of Southern California; L. Christine Turtzo, MD, PhD, Uniformed Services University of the Health Sciences; Paul M. Vespa, MD, University of California, Los Angeles; Kevin K. Wang, PhD, University of Florida; Ross Zafonte, DO, Harvard/ Spaulding Rehabilitation Hospital; Zhiqun Zhang, MD, University of Florida. The authors also give special thanks to Amy J. Markowitz, JD for editorial assistance.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Barber RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142360; Bazarian JJ, 2013, J NEUROTRAUM, V30, P1747, DOI 10.1089/neu.2013.2853; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; CATTELL RB, 1969, J GERONTOL, V24, P348, DOI 10.1093/geronj/24.3.348; Cervellin G, 2012, CLIN BIOCHEM, V45, P408, DOI 10.1016/j.clinbiochem.2012.01.006; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ferguson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059712; Ferguson AR, 2011, TRANSL STROKE RES, V2, P438, DOI 10.1007/s12975-011-0121-1; Glabinski AR, 1996, J IMMUNOL, V156, P4363; Ho L, 2012, J ALZHEIMERS DIS, V31, P301, DOI 10.3233/JAD-2012-120598; Korley FK, 2019, J NEUROTRAUM, V36, P182, DOI 10.1089/neu.2017.5623; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Maas AIR, 2008, ACTA NEUROCHIR SUPPL, V101, P119; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nielson JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169490; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; O'Bryant SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028092; O'Bryant SE, 2010, ARCH NEUROL-CHICAGO, V67, P1077, DOI 10.1001/archneurol.2010.215; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Reith FCM, 2017, NEUROSURGERY, V80, P829, DOI 10.1093/neuros/nyw178; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Saatman K.E., 2008, CLASSIFICATION TRAUM; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Stevens JP, 2012, APPL MULTIVARIATE ST; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; Thurman D, 1999, TRAUMATIC BRAIN INJU, DOI http://www.cdc.gov/ncipc/tbi/tbi_congress/TBI_in_the_US.PDF; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yang F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30168; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	52	19	20	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					100	110		10.1089/neu.2017.5449		SEP 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000445769900001	30084741	Green Published			2022-02-06	
J	Maneshi, MM; Ziegler, L; Sachs, F; Hua, SZ; Gottlieb, PA				Maneshi, Mohammad M.; Ziegler, Lynn; Sachs, Frederick; Hua, Susan Z.; Gottlieb, Philip A.			Enantiomeric A beta peptides inhibit the fluid shear stress response of PIEZO1	SCIENTIFIC REPORTS			English	Article							ION-CHANNEL PIEZO1; AMYLOID-BETA; MECHANOSENSITIVE CHANNELS; ALZHEIMERS-DISEASE; CELL; FORCE; PROTEIN; GSMTX4; ORIENTATION; MUTATIONS	Traumatic brain injury (TBI) elevates Abeta (A beta) peptides in the brain and cerebral spinal fluid. A beta peptides are amphipathic molecules that can modulate membrane mechanics. Because the mechanosensitive cation channel PIEZO1 is gated by membrane tension and curvature, it prompted us to test the effects of A beta on PIEZO1. Using precision fluid shear stress as a stimulus, we found that A beta monomers inhibit PIEZO1 at femtomolar to picomolar concentrations. The A beta oligomers proved much less potent. The effect of A beta s on Piezo gating did not involve peptide-protein interactions since the D and L enantiomers had similar effects. Incubating a fluorescent derivative of A beta and a fluorescently tagged PIEZO1, we showed that A beta can colocalize with PIEZO1, suggesting that they both had an affinity for particular regions of the bilayer. To better understand the PIEZO1 inhibitory effects of A beta, we examined their effect on wound healing. We observed that over-expression of PIEZO1 in HEK293 cells increased cell migration velocity similar to 10-fold, and both enantiomeric A beta peptides and GsMTx4 independently inhibited migration, demonstrating involvement of PIEZO1 in cell motility. As part of the motility study we examined the correlation of PIEZO1 function with tension in the cytoskeleton using a genetically encoded fluorescent stress probe. A beta peptides increased resting stress in F-actin, and is correlated with A beta block of PIEZO1-mediated Ca2+ influx. A beta inhibition of PIEZO1 in the absence of stereospecific peptide-protein interactions shows that A beta peptides modulate both cell membrane and cytoskeletal mechanics to control PIEZO1-triggered Ca2+ influx.	[Maneshi, Mohammad M.; Ziegler, Lynn; Sachs, Frederick; Hua, Susan Z.; Gottlieb, Philip A.] SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14214 USA; [Maneshi, Mohammad M.; Hua, Susan Z.] SUNY Buffalo, Dept Mech & Aerosp Engn, 340 Jarvis Hall, Buffalo, NY 14260 USA; [Maneshi, Mohammad M.] Feinberg Sch Med, 745 N Fairbanks,Tarry 7-718, Chicago, IL 60611 USA		Gottlieb, PA (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 302 Cary Hall, Buffalo, NY 14214 USA.	philgott@buffalo.edu	Gottlieb, Philip/C-3113-2019	Gottlieb, Philip/0000-0003-3764-9885; sachs, frederick/0000-0002-4324-2240	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL054887]; National Institute of Health grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085517]; National Science FoundationNational Science Foundation (NSF) [CMMI-1537239]	This work was supported by National Institutes of Health (HL054887) to F.S., and the National Institute of Health grant (NS085517) and National Science Foundation (CMMI-1537239) to S.Z.H. We thank Seth Alper and Olaf Andersen for their thoughtful comments, and Shermali Gunawardena (SUNY at Buffalo) for the APP-YFP clone. We also thank Wade Sigurdson and the UB confocal imaging facility for assistance with high resolution imaging.	Anishkin A, 2013, P NATL ACAD SCI USA, V110, P4886, DOI 10.1073/pnas.1302018110; Bae C, 2015, J BIOL CHEM, V290, P5167, DOI 10.1074/jbc.M114.604033; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Bavi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11984; Beaven AH, 2017, BIOPHYS J, V112, P1185, DOI 10.1016/j.bpj.2017.01.028; Besch SR, 2002, PFLUG ARCH EUR J PHY, V445, P161, DOI 10.1007/s00424-002-0903-0; Blumenthal NR, 2014, P NATL ACAD SCI USA, V111, P16124, DOI 10.1073/pnas.1412740111; Cox CD, 2017, CURR TOP MEMBR, V79, P59, DOI 10.1016/bs.ctm.2016.09.001; Cox CD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10366; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Gnanasambandam R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125503; Gnanasambandam R, 2013, BIOPHYS J, V104, p467A, DOI 10.1016/j.bpj.2012.11.2583; Gottlieb PA, 2012, CHANNELS, V6, P282, DOI 10.4161/chan.21064; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guo J, 2014, P NATL ACAD SCI USA, V111, pE5252, DOI 10.1073/pnas.1411683111; Guo YSR, 2017, ELIFE, V6, DOI 10.7554/eLife.33660; HIJMANS W, 1979, CLIN EXP IMMUNOL, V35, P96; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Koser DE, 2016, NAT NEUROSCI, V19, P1592, DOI 10.1038/nn.4394; Lewis AH, 2015, ELIFE, V4, DOI 10.7554/eLife.12088; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Maneshi MM, 2017, CURR TOP MEMBR, V79, P309, DOI 10.1016/bs.ctm.2016.11.005; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Markin V S, 2015, Open J Biophys, V5, P80; McHugh BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040346; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Meng F., 2018, BIOPHYS J; Meng FJ, 2012, J CELL SCI, V125, P743, DOI 10.1242/jcs.093104; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nishizawa K, 2015, BBA-BIOMEMBRANES, V1848, P2767, DOI 10.1016/j.bbamem.2015.09.003; Nourse JL, 2017, SEMIN CELL DEV BIOL, V71, P3, DOI 10.1016/j.semcdb.2017.06.018; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Pathak MM, 2014, P NATL ACAD SCI USA, V111, P16148, DOI 10.1073/pnas.1409802111; Pearson HA, 2006, J PHYSIOL-LONDON, V575, P5, DOI 10.1113/jphysiol.2006.111203; Poole K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4520; Qi YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9512; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Sachs F, 2018, BIOPHYS J, V114, P3, DOI 10.1016/j.bpj.2017.10.035; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Suchyna TM, 2009, BIOPHYS J, V97, P738, DOI 10.1016/j.bpj.2009.05.018; Suchyna TM, 2004, NATURE, V430, P235, DOI 10.1038/nature02743; Syeda R, 2016, CELL REP, V17, P1739, DOI 10.1016/j.celrep.2016.10.033; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x	48	19	19	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 24	2018	8								14267	10.1038/s41598-018-32572-2			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU5OL	WOS:000445336600035	30250223	Green Published, gold			2022-02-06	
J	Huang, WH; Bai, XS; Stopper, L; Catalin, B; Cartarozzi, LP; Scheller, A; Kirchhoff, F				Huang, Wenhui; Bai, Xianshu; Stopper, Laura; Catalin, Bogdan; Cartarozzi, Luciana Politti; Scheller, Anja; Kirchhoff, Frank			During Development NG2 Glial Cells of the Spinal Cord are Restricted to the Oligodendrocyte Lineage, but Generate Astrocytes upon Acute Injury	NEUROSCIENCE			English	Article						NG2 glia; differentiation; spinal cord; oligodendrocytes; astrocytes; spinal cord injury	CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; PROGENITOR CELLS; ADULT CNS; NG2-GLIA; FATE; MICE; DIFFERENTIATION; PLASTICITY; PRODUCE	NG2 glia are self-renewal cells widely populating the entire central nervous system (CNS). The differentiation potential of NG2 glia in the brain has been systematically studied. However, the fate of NG2 glia in the spinal cord during development and after injury is still unclear. Here, we took advantage of faithful expression of Cre in NG2-CreERT2 knock-in mice to demonstrate that spinal NG2 glia remain committed to the oligodendrocyte (OL) lineage and generate OLs, but not astrocytes or neurons, during development. However, we found significant age- and region dependent differences in differentiation into OLs. Embryonic or neonatal NG2 glia generated more than 90% of the white matter OLs, but only 50% (embryonic) or 75% (neonatal) of gray matter OLs. Such differences disappeared after myelin completion coinciding with a decrease in the differentiation rate. While we never detected the generation of astrocytes from NG2 glia during spinal cord development, we found a small portion of NG2 glia could generate astrocytes in adult spinal cord upon acute traumatic injury. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.	[Huang, Wenhui; Bai, Xianshu; Stopper, Laura; Catalin, Bogdan; Cartarozzi, Luciana Politti; Scheller, Anja; Kirchhoff, Frank] Univ Saarland, CIPMM, Mol Physiol, D-66421 Homburg, Germany; [Catalin, Bogdan] Univ Med & Pharm Craiova, Expt Res Ctr Normal & Pathol Aging, Craiova 200349, Romania; [Cartarozzi, Luciana Politti] Univ Estadual Campinas, UNICAMP, Lab Nerve Regenerat, Cidade Univ Zeferino Vaz, BR-13083862 Campinas, SP, Brazil		Huang, WH; Kirchhoff, F (corresponding author), Univ Saarland, CIPMM, Mol Physiol, D-66421 Homburg, Germany.	wenhui.huang@uks.eu; frank.kirchhoff@uks.eu	Cartarozzi, Luciana P/S-5717-2018; Catalin, Bogdan/M-6683-2019; Scheller, Anja/B-8577-2018; Catalin, Bogdan/G-2565-2013; Bai, Xianshu/AAN-8029-2021; Kirchhoff, Frank/B-9335-2008; Huang, Wenhui/M-6227-2013	Cartarozzi, Luciana P/0000-0003-1942-800X; Scheller, Anja/0000-0001-8955-2634; Catalin, Bogdan/0000-0002-5706-8722; Bai, Xianshu/0000-0002-4758-1645; Kirchhoff, Frank/0000-0002-2324-2761; Huang, Wenhui/0000-0001-9865-0375	Deutsche Forschungsgemeinschaft DFGGerman Research Foundation (DFG) [SFB 894, SPP 1757, FOR 2289]; European Commission EC-H2020 MSCA-ITN EU-GliaPhD; EC-H2020 FET ProAct Neurofibers; University of Saarland	This work was supported by grants from Deutsche Forschungsgemeinschaft DFG SFB 894, SPP 1757 and FOR 2289 to F.K., from European Commission EC-H2020 MSCA-ITN EU-GliaPhD; and EC-H2020 FET ProAct Neurofibers to F.K.. A.S. W.H. and X.B. were supported by HOMFOR 2015, HOMFORexzellenz2016 and 2017 from the University of Saarland, respectively.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Assinck P, 2017, J NEUROSCI, V37, P8635, DOI 10.1523/JNEUROSCI.2409-16.2017; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Clarke LE, 2012, J NEUROSCI, V32, P8173, DOI 10.1523/JNEUROSCI.0928-12.2012; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; Garcia-Marques J, 2014, J NEUROSCI, V34, P2305, DOI 10.1523/JNEUROSCI.3060-13.2014; Guo FZ, 2009, J NEUROSCI, V29, P7256, DOI 10.1523/JNEUROSCI.5653-08.2009; Hesp ZC, 2018, J NEUROSCI, V38, P1366, DOI 10.1523/JNEUROSCI.3953-16.2017; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Horner PJ, 2002, J NEUROCYTOL, V31, P469, DOI 10.1023/A:1025739630398; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nishiyama A, 2016, BRAIN RES, V1638, P116, DOI 10.1016/j.brainres.2015.08.013; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Richardson WD, 2006, NAT REV NEUROSCI, V7, P11, DOI 10.1038/nrn1826; Richardson WD, 2011, NEURON, V70, P661, DOI 10.1016/j.neuron.2011.05.013; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Sakry D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001993; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Tognatta R, 2016, GLIA; Tripathi RB, 2011, J NEUROSCI, V31, P6809, DOI 10.1523/JNEUROSCI.6474-10.2011; Vigano F, 2016, BRAIN RES, V1638, P129, DOI 10.1016/j.brainres.2015.09.012; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	34	19	20	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 10	2018	385						154	165		10.1016/j.neuroscience.2018.06.015			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GM6VW	WOS:000438316600014	29913244				2022-02-06	
J	Molina, B; Segura, A; Serrano, JP; Alonso, FJ; Molina, L; Perez-Borrego, YA; Ugarte, MI; Oliviero, A				Molina, B.; Segura, A.; Serrano, J. P.; Alonso, F. J.; Molina, L.; Perez-Borrego, Y. A.; Ugarte, M., I; Oliviero, A.			Cognitive performance of people with traumatic spinal cord injury: a cross-sectional study comparing people with subacute and chronic injuries	SPINAL CORD			English	Article							QUALITY-OF-LIFE; LONGITUDINAL ANALYSIS; BRAIN-INJURY; DEPRESSION; FATIGUE; ANXIETY; DEFICITS; ALCOHOL; IMPACT; MOOD	Study design Cross-sectional study. Objectives To assess the impact of spinal cord injury (SCI) on cognitive function in individuals with subacute and chronic SCI. Setting National Hospital for SCI patients (Spain). Methods The present investigation was designed to determine the nature, pattern, and extent of cognitive deficits in a group of participants with subacute (n = 32) and chronic (n = 34) SCI, using a comprehensive battery of reliable and validated neuropsychological assessments to study a broad range of cognitive functions. Twenty-seven able-bodied subjects matched to the groups with SCI for age and educational level formed the control group. Results The neuropsychological assessment showed alterations in the domain of attention, processing speed, memory and learning, executive functions, and in recognition in participants with SCI. The prevalence of cognitive dysfunction in the chronic stage was also confirmed at the individual level. The comparison of the neuropsychological assessment between the groups with subacute and chronic SCI showed a worsening of cognitive functions in those with chronic SCI compared to the group with subacute SCI. Conclusions In participants with SCI, cognitive dysfunctions are present in the subacute stage and worsen over time. From a clinical point of view, we confirmed the presence of cognitive dysfunction that may interfere with the first stage of rehabilitation which is the most intense and important. Moreover, cognitive dysfunction may be important beyond the end of the first stage of rehabilitation as it can affect an individual's quality of life and possible integration to society.	[Molina, B.; Perez-Borrego, Y. A.; Oliviero, A.] SESCAM, Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain; [Molina, B.] SESCAM, Hosp Nacl Paraplejicos, Nursing Dept, Toledo, Spain; [Segura, A.] Castilla La Mancha Govt, Dept Hlth & Social Affairs, Hlth Sci Inst, Talavera De La Reina, Spain; [Serrano, J. P.] Univ Castilla La Mancha, Dept Psychol, Fac Med, Albacete, Spain; [Alonso, F. J.] Ctr Salud Silleria, Dept Primary Hlth Care, Toledo, Spain; [Molina, L.] SESCAM, Hosp Mancha Ctr, Nursing Dept, Ciudad Real, Spain; [Ugarte, M., I] Univ Castilla La Mancha, Nursing Dept, Toledo, Spain		Oliviero, A (corresponding author), SESCAM, Hosp Nacl Paraplejicos, FENNSI Grp, Toledo, Spain.	antonioo@sescam.jccm.es	Segura, Antonio a/Q-5696-2017; Oliviero, Antonio/ABH-4485-2020; Fragoso, Antonio Segura/AAM-7995-2020	Segura, Antonio a/0000-0003-4884-2242; Oliviero, Antonio/0000-0001-7723-0478; Fragoso, Antonio Segura/0000-0003-4884-2242			Benedet M., 1998, TEST APRENDIZAJE VER; Cotter I, 2008, PSYCHOL ASPECTS ASS, P175; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; CRAIG AR, 1994, PARAPLEGIA, V32, P675, DOI 10.1038/sc.1994.109; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Craig A, 2015, ARCH PHYS MED REHAB, V96, P1426, DOI 10.1016/j.apmr.2015.02.027; Craig A, 2013, J PAIN, V14, P911, DOI 10.1016/j.jpain.2013.03.002; Craig A, 2012, J PSYCHOSOM RES, V73, P205, DOI 10.1016/j.jpsychores.2012.07.005; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Engels AS, 2010, COGN AFFECT BEHAV NE, V10, P141, DOI 10.3758/CABN.10.1.141; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; JUDD FK, 1991, PARAPLEGIA, V29, P91, DOI 10.1038/sc.1991.12; Kennedy P, 2000, SPINAL CORD, V38, P498, DOI 10.1038/sj.sc.3101021; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Kurylo M, 2001, REHABIL PSYCHOL, V46, P247, DOI 10.1037/0090-5550.46.3.247; McDermott LM, 2009, J AFFECT DISORDERS, V119, P1, DOI 10.1016/j.jad.2009.04.022; Pena-Casanova J, 1997, Neurologia, V12, P99; Pena-Casanova J., 2005, NORMALIDAD SEMIOLOGI; Pollard C, 2007, BRIT J HEALTH PSYCH, V12, P347, DOI 10.1348/135910707X197046; RICHARDS JS, 1988, AM J PHYS MED REHAB, V67, P211, DOI 10.1097/00002060-198810000-00005; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sanz J., 2003, CLIN SALUD, V14, P249, DOI DOI 10.1016/S1130-5474(14)70025-8; Tolonen A, 2007, J REHABIL MED, V39, P622, DOI 10.2340/16501977-0101; Tun CG, 1997, REHABIL PSYCHOL, V42, P163, DOI 10.1037/0090-5550.42.3.163; Wechsler D., 2004, ESCALA MEMORIA WECHS; Wijesuriya N, 2012, ARCH PHYS MED REHAB, V93, P319, DOI 10.1016/j.apmr.2011.09.008; Williams R, 2015, ARCH PHYS MED REHAB, V96, P133, DOI 10.1016/j.apmr.2014.08.016; Wingfield A, 2003, AM J PHYS MED REHAB, V82, P547, DOI 10.1097/00002060-200307000-00009; Wu JF, 2014, J NEUROSCI, V34, P10989, DOI 10.1523/JNEUROSCI.5110-13.2014; YOUNG ME, 1995, ARCH PHYS MED REHAB, V76, P525, DOI 10.1016/S0003-9993(95)80506-0	33	19	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	AUG	2018	56	8					796	805		10.1038/s41393-018-0076-0			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GP8JN	WOS:000441156700010	29472608	Bronze			2022-02-06	
J	Algamal, M; Ojo, JO; Lungmus, CP; Muza, P; Cammarata, C; Owens, MJ; Mouzono, BC; Diamond, DM; Mullan, M; Crawford, F				Algamal, Moustafa; Ojo, Joseph O.; Lungmus, Carlyn P.; Muza, Phillip; Cammarata, Constance; Owens, Margaret J.; Mouzono, Benoit C.; Diamond, David M.; Mullan, Michael; Crawford, Fiona			Chronic Hippocampal Abnormalities and Blunted HPA Axis in an Animal Model of Repeated Unpredictable Stress	FRONTIERS IN BEHAVIORAL NEUROSCIENCE			English	Article						PTSD; animal model; stress; HPA axis; corticosterone	TRAUMATIC BRAIN-INJURY; ELEVATED PLUS-MAZE; SOCIAL DEFEAT STRESS; NEUROTROPHIC FACTOR; PREFRONTAL CORTEX; MAJOR DEPRESSION; DISORDER; ANXIETY; VOLUME; MICE	Incidence of post-traumatic stress disorder (PTSD) ranges from 3 to 30% in individuals exposed to traumatic events, with the highest prevalence in groups exposed to combat, torture, or rape. To date, only a few FDA approved drugs are available to treat PTSD, which only offer symptomatic relief and variable efficacy. There is, therefore, an urgent need to explore new concepts regarding the biological responses causing PTSD. Animal models are an appropriate platform for conducting such studies. Herein, we examined the chronic behavioral and neurobiological effects of repeated unpredictable stress (RUS) in a mouse model. 12 weeks-old C57BL/6J male mice were exposed to a 21-day RUS paradigm consisting of exposures to a predator odor (TMT) whilst under restraint, unstable social housing, inescapable footshocks and social isolation. Validity of the model was assessed by comprehensive examination of behavioral outcomes at an acute timepoint, 3 and 6 months post-RUS; and molecular profiling was also conducted on brain and plasma samples at the acute and 6 months timepoints. Stressed mice demonstrated recall of traumatic memories, passive stress coping behavior, acute anxiety, and weight gain deficits when compared to control mice. Immunoblotting of amygdala lysates showed a dysregulation in the p75NTR/ProBDNF, and glutamatergic signaling in stressed mice at the acute timepoint. At 6 months after RUS, stressed mice had lower plasma corticosterone, reduced hippocampal CA1 volume and reduced brain-derived neurotrophic factor levels. In addition, glucocorticoid regulatory protein FKBP5 was downregulated in the hypothalamus of stressed mice at the same timepoint, together implicating an impaired hypothalamus-pituitary-adrenal-axis. Our model demonstrates chronic behavioral and neurobiological outcomes consistent with those reported in human PTSD cases and thus presents a platform through which to understand the neurobiology of stress and explore new therapeutic interventions.	[Algamal, Moustafa; Ojo, Joseph O.; Lungmus, Carlyn P.; Muza, Phillip; Cammarata, Constance; Owens, Margaret J.; Mouzono, Benoit C.; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL 34243 USA; [Algamal, Moustafa; Ojo, Joseph O.; Mullan, Michael; Crawford, Fiona] Open Univ, Life Hearth & Chem Sci, Milton Keynes, Bucks, England; [Lungmus, Carlyn P.; Mouzono, Benoit C.; Crawford, Fiona] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Diamond, David M.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Diamond, David M.] Univ S Florida, Dept Mol Pharmacol & Physiol, Tampa, FL USA		Algamal, M (corresponding author), Roskamp Inst, Sarasota, FL 34243 USA.; Algamal, M (corresponding author), Open Univ, Life Hearth & Chem Sci, Milton Keynes, Bucks, England.	maigamal@roskampinstitute.net		Algamal, Moustafa/0000-0002-6215-0122	Roskamp Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 MH109655-0]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH109655] Funding Source: NIH RePORTER	We thank Dr. Tanja Emmerich and Dr. Laila Abdullah (Roskamp Institute) for helpful discussions. This project was funded by The Roskamp Foundation. FC is a VA research career scientist. DD was supported by NIH grant R01 MH109655-0.	Abd El Wahab MG, 2018, AM J ALZHEIMERS DIS, V33, P221, DOI 10.1177/1533317518755993; Ahmed-Leitao F, 2016, PSYCHIAT RES-NEUROIM, V256, P33, DOI 10.1016/j.pscychresns.2016.09.008; Angelucci F, 2014, BRAIN COGNITION, V84, P118, DOI 10.1016/j.bandc.2013.11.012; Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; Assocation AP., 2013, DIAGN STAT MAN MENT, V5th edn; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Ballachey EL, 1932, U CALIFORNIA PUBLICA, V6, P1; Balu DT, 2018, BIOL PSYCHIAT, V83, P273, DOI 10.1016/j.biopsych.2017.08.012; Beitia G, 2005, BRAIN BEHAV IMMUN, V19, P530, DOI 10.1016/j.bbi.2004.11.002; Berridge C. W., 2009, BRAIN RES, V75, P1781; Bonne O, 2004, NEUROSCI BIOBEHAV R, V28, P65, DOI 10.1016/j.neubiorev.2003.12.001; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Breslau N, 1999, PSYCHOL MED, V29, P813, DOI 10.1017/S0033291799008612; Brooks SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082707; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Cooper O, 2017, J ENDOCR SOC, V1, P577, DOI 10.1210/js.2017-00069; Deslauriers J, 2018, BIOL PSYCHIAT, V83, P895, DOI 10.1016/j.biopsych.2017.11.019; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Endres T, 2009, J EXP BIOL, V212, P2324, DOI 10.1242/jeb.028498; Flandreau E. I., 2017, CURR TOP BEHAV NEURO, DOI [10.1007/7854-2016-65, DOI 10.1007/7854-2016-65]; Fragkaki I, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30915; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Gill JM, 2009, PERSPECT PSYCHIATR C, V45, P262, DOI 10.1111/j.1744-6163.2009.00229.x; Girgenti MJ, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0841-3; Gold PW, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/581976; Grassi-Oliveira R, 2008, BIOL PSYCHIAT, V64, P281, DOI 10.1016/j.biopsych.2008.02.023; Griffin GD, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.26; Harris RBS, 2015, AM J PHYSIOL-REG I, V308, pR250, DOI 10.1152/ajpregu.00361.2014; Hartmann J, 2012, NEUROPHARMACOLOGY, V62, P332, DOI 10.1016/j.neuropharm.2011.07.041; Harvey BH, 2006, PHYSIOL BEHAV, V87, P881, DOI 10.1016/j.physbeh.2006.01.033; Holmes SE, 2017, P NATL ACAD SCI USA, V114, P8390, DOI 10.1073/pnas.1701749114; Hussin AT, 2012, NEUROPHARMACOLOGY, V63, P883, DOI 10.1016/j.neuropharm.2012.06.033; Janitzky K, 2015, BRAIN RES, V1599, P1, DOI 10.1016/j.brainres.2014.12.030; Ji JZ, 2008, LEARN MEMORY, V15, P244, DOI 10.1101/lm.794808; Johnson PL, 2012, PROG BRAIN RES, V198, P133, DOI 10.1016/B978-0-444-59489-1.00009-4; Johnson PL, 2010, NAT MED, V16, P111, DOI 10.1038/nm.2075; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kim EJ, 2015, LEARN MEMORY, V22, P411, DOI 10.1101/lm.037291.114; Koelsch S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23008; Krystal JH, 2017, BIOL PSYCHIAT, V82, pE51, DOI 10.1016/j.biopsych.2017.03.007; Lee BH, 2010, PSYCHIAT INVEST, V7, P231, DOI 10.4306/pi.2010.7.4.231; Levy-Gigi E, 2013, BIOL PSYCHIAT, V74, P793, DOI 10.1016/j.biopsych.2013.05.017; Liberzon I, 1997, PSYCHONEUROENDOCRINO, V22, P443, DOI 10.1016/S0306-4530(97)00044-9; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; Maren S, 2000, BEHAV BRAIN RES, V110, P97, DOI 10.1016/S0166-4328(99)00188-6; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Monteiro S, 2015, FRONT PSYCHIATRY, V6, DOI [10.3389/fpsyt.2015.00006, 10.3389/fpsyt.2015.0006]; Morey RA, 2016, NEUROPSYCHOPHARMACOL, V41, P791, DOI 10.1038/npp.2015.205; O'Doherty DCM, 2015, PSYCHIAT RES-NEUROIM, V232, P1, DOI 10.1016/j.pscychresns.2015.01.002; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00213; Palazidou E, 2012, BRIT MED BULL, V101, P127, DOI 10.1093/bmb/lds004; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PHILLIPS C, 2017, NEURAL PLAST, DOI DOI 10.1155/2017/7260130; Roth MK, 2012, NEUROPHARMACOLOGY, V63, P1118, DOI 10.1016/j.neuropharm.2012.07.034; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Schneider P, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00043; Schoner J, 2017, J CELL MOL MED, V21, P2248, DOI 10.1111/jcmm.13161; Schoenfeld TJ, 2017, BIOL PSYCHIAT, V82, P914, DOI 10.1016/j.biopsych.2017.05.013; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Spivak B, 1997, BIOL PSYCHIAT, V42, P345, DOI 10.1016/S0006-3223(96)00375-7; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Strohle A, 2008, J PSYCHIATR RES, V42, P1185, DOI 10.1016/j.jpsychires.2008.01.015; Touma C, 2011, BIOL PSYCHIAT, V70, P928, DOI 10.1016/j.biopsych.2011.07.023; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; van Rooij SJH, 2015, PSYCHOL MED, V45, P2737, DOI 10.1017/S0033291715000707; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang ZW, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00222; Whitaker AM, 2014, BEHAV PHARMACOL, V25, P398, DOI 10.1097/FBP.0000000000000069; Yasmin F, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.13002; YEHUDA R, 1993, AM J PSYCHIAT, V150, P83; Yehuda R, 2001, J CLIN PSYCHIAT, V62, P41; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Young KA, 2015, NEUROBIOL STRESS, V2, P67, DOI 10.1016/j.ynstr.2015.07.002; Yu H, 2011, ACTA PHARMACOL SIN, V32, P3, DOI 10.1038/aps.2010.184; Zhou JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094075; Zoladz PR, 2015, PHYSIOL BEHAV, V147, P183, DOI 10.1016/j.physbeh.2015.04.032; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	82	19	19	2	15	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5153			FRONT BEHAV NEUROSCI	Front. Behav. Neurosci.	JUL 20	2018	12								150	10.3389/fnbeh.2018.00150			16	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GN8EU	WOS:000439392100001	30079015	gold, Green Published			2022-02-06	
J	Mugon, J; Struk, A; Danckert, J				Mugon, Jhotisha; Struk, Andriy; Danckert, James			A Failure to Launch: Regulatory Modes and Boredom Proneness	FRONTIERS IN PSYCHOLOGY			English	Article						boredom; assessment; locomotion; goal-pursuit; self-regulation	TRAUMATIC BRAIN-INJURY; PSYCHOMETRIC PROPERTIES; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; SCALE; EXPERIENCE; LAPSES; CONSEQUENCES; DEPRESSION; CHILDHOOD	Boredom is a ubiquitous human experience characterized as a state of wanting but failing to engage with the world. Individuals prone to the experience of boredom demonstrate lower levels of self-control which may be at the heart of their failures to engage in goal-directed, meaningful behaviors. Here we develop the hypothesis that distinct self-regulatory profiles, which in turn differentially influence modes of goal pursuit, are at the heart of boredom proneness. Two specific regulatory modes are addressed: Locomotion, the desire to 'just do it,' an action oriented mode of goal-pursuit, and Assessment, the desire to 'do the right thing,' an evaluative orientation toward goal pursuit. We present data from a series of seven large samples of undergraduates showing that boredom proneness is negatively correlated with Locomotion, as though getting on with things acts as a prophylactic against boredom. This 'failure to launch' that we suggest is prevalent in the highly boredom prone individual, could be due to an inability to appropriately discriminate value (i.e., everything is tarred with the same gray brush), an unwillingness to put in the required effort to engage, or simply a failure to get started. In contrast, boredom proneness was consistently positively correlated with the Assessment mode of self-regulation. We suggest that this association reflects a kind of rumination that hampers satisfying goal pursuit.	[Mugon, Jhotisha; Struk, Andriy; Danckert, James] Univ Waterloo, Dept Psychol, Waterloo, ON, Canada		Mugon, J (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON, Canada.	jmugon@uwaterloo.ca			Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	This work was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grant to JD.	ABRAMSON EE, 1977, ADDICT BEHAV, V2, P181, DOI 10.1016/0306-4603(77)90015-6; AHMED SMS, 1990, PERCEPT MOTOR SKILL, V71, P963, DOI 10.2466/pms.1990.71.3.963; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Anderson VA, 2001, DEV NEUROPSYCHOL, V20, P385, DOI 10.1207/S15326942DN2001_5; Baumeister RF, 2003, HANDBOOK OF SELF AND IDENTITY, P197; Brankovic S, 2015, PSYCHIAT DANUB, V27, P126; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; DAMRADFRYE R, 1989, J PERS SOC PSYCHOL, V57, P315; Danckert J., 2013, SCI AM MIND, V24, P54, DOI DOI 10.1038/SCIENTIFICAMERICANMIND0713-54; Dockree PM, 2006, EXP BRAIN RES, V168, P218, DOI 10.1007/s00221-005-0079-x; Dockree PM, 2004, COGNITIVE BRAIN RES, V20, P403, DOI 10.1016/j.cogbrainres.2004.03.019; Eastwood, 2010, INT GAMBL STUD, V10, P91, DOI [10.1080/14459791003754414, DOI 10.1080/14459791003754414, 10.1080/1445979100 3754414]; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; Fahlman SA, 2013, ASSESSMENT, V20, P68, DOI 10.1177/1073191111421303; FARMER R, 1986, J PERS ASSESS, V50, P4, DOI 10.1207/s15327752jpa5001_2; Ferrari JR, 2000, J SOC BEHAV PERS, V15, P185; Goetz T, 2014, MOTIV EMOTION, V38, P401, DOI 10.1007/s11031-013-9385-y; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; Hunter A, 2018, EXP BRAIN RES, V236, P2483, DOI 10.1007/s00221-016-4749-7; Isacescu J, 2018, EXP BRAIN RES, V236, P2493, DOI 10.1007/s00221-016-4674-9; Isacescu J, 2017, COGNITION EMOTION, V31, P1741, DOI 10.1080/02699931.2016.1259995; Joireman J, 2003, J PERS SOC PSYCHOL, V84, P1287, DOI 10.1037/0022-3514.84.6.1287; Keating DP, 2012, ENFANCE, V3, P267, DOI [10.4074/S0013754512003035, DOI 10.4074/S0013754512003035, 10.4074/ S0013754512003035]; Kruglanski AW, 2000, J PERS SOC PSYCHOL, V79, P793, DOI 10.1037/0022-3514.79.5.793; Lee CM, 2007, ADDICT BEHAV, V32, P1384, DOI 10.1016/j.addbeh.2006.09.010; Malkovsky E, 2012, EXP BRAIN RES, V221, P59, DOI 10.1007/s00221-012-3147-z; Massen JJM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01735; Melton AMA, 2009, J PSYCHOL, V143, P493, DOI 10.3200/JRL.143.5.493-508; Merrifield C, 2014, EXP BRAIN RES, V232, P481, DOI 10.1007/s00221-013-3755-2; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Newell SE, 2012, INT J SOC PSYCHIATR, V58, P488, DOI 10.1177/0020764011408655; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; O'Keeffe FM, 2007, EXP BRAIN RES, V180, P59, DOI 10.1007/s00221-006-0832-9; Ohsuga M, 2001, INT J PSYCHOPHYSIOL, V40, P211, DOI 10.1016/S0167-8760(00)00189-6; Pierro A, 2011, J PERS SOC PSYCHOL, V101, P1317, DOI 10.1037/a0025943; Poletti M, 2009, CLIN NEUROPSYCHIATR, V6, P155; Posner J, 2005, DEV PSYCHOPATHOL, V17, P715, DOI 10.1017/S0954579405050340; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Sommers J, 2000, J CLIN PSYCHOL, V56, P149, DOI 10.1002/(SICI)1097-4679(200001)56:1<149::AID-JCLP14>3.0.CO;2-Y; Stickney MI, 1999, INT J EAT DISORDER, V26, P195, DOI 10.1002/(SICI)1098-108X(199909)26:2&lt;195::AID-EAT9&gt;3.0.CO;2-2; Struk AA, 2016, COGNITION EMOTION, V30, P1388, DOI 10.1080/02699931.2015.1064363; Struk AA, 2017, ASSESSMENT, V24, P346, DOI 10.1177/1073191115609996; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Thackray RI, 1977, VIGILANCE THEORY OPE, P203; Todman M, 2003, PSYCHIATRY, V66, P146, DOI 10.1521/psyc.66.2.146.20623; Vodanovich SJ, 2005, J PERS ASSESS, V85, P295, DOI 10.1207/s15327752jpa8503_05; Vodanovich SJ, 1999, SOC BEHAV PERSONAL, V27, P11, DOI 10.2224/sbp.1999.27.1.11; VODANOVICH SJ, 1990, J PERS ASSESS, V55, P115, DOI 10.1207/s15327752jpa5501&2_11; Westgate E. C., 2017, PSYCHOL REV	51	19	19	2	12	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-1078			FRONT PSYCHOL	Front. Psychol.	JUL 17	2018	9								1126	10.3389/fpsyg.2018.01126			7	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	GN4JH	WOS:000438987600001	30065675	Green Published, gold			2022-02-06	
J	Wu, YC; Mustafi, SM; Harezlak, J; Kodiweera, C; Flashman, LA; McAllister, TW				Wu, Yu-Chien; Mustafi, Sourajit M.; Harezlak, Jaroslaw; Kodiweera, Chandana; Flashman, Laura A.; McAllister, Thomas W.			Hybrid Diffusion Imaging in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal density; clinical outcomes; hybrid diffusion imaging; mild traumatic brain injury; NODDI; q-space imaging	NEURITE ORIENTATION DISPERSION; WHITE-MATTER MICROSTRUCTURE; HIGH B-VALUE; FREE-WATER ELIMINATION; PROPAGATOR MAP MRI; AXONAL INJURY; MULTIPLE-SCLEROSIS; WEIGHTED MRI; NODDI; MODEL	Mild traumatic brain injury (mTBI) is an important public health problem. Although conventional medical imaging techniques can detect moderate-to-severe injuries, they are relatively insensitive to mTBI. In this study, we used hybrid diffusion imaging (HYDI) to detect white matter alterations in 19 patients with mTBI and 23 other trauma control patients. Within 15 days (standard deviation=10) of brain injury, all subjects underwent magnetic resonance HYDI and were assessed with a battery of neuropsychological tests of sustained attention, memory, and executive function. Tract-based spatial statistics (TBSS) was used for voxel-wise statistical analyses within the white matter skeleton to study between-group differences in diffusion metrics, within-group correlations between diffusion metrics and clinical outcomes, and between-group interaction effects. The advanced diffusion imaging techniques, including neurite orientation dispersion and density imaging (NODDI) and q-space analyses, appeared to be more sensitive then classic diffusion tensor imaging. Only NODDI-derived intra-axonal volume fraction (V-ic) demonstrated significant group differences (i.e., 5-9% lower in the injured brain). Within the mTBI group, V-ic and a q-space measure, P-0, correlated with 6 of 10 neuropsychological tests, including measures of attention, memory, and executive function. In addition, the direction of correlations differed significantly between groups (R-2>0.71 and p(interation) < 0.03). Specifically, in the control group, higher V-ic and P-0 were associated with better performances on clinical assessments, whereas in the mTBI group, higher V-ic and P-0 were associated with worse performances with correlation coefficients >0.83. In summary, the NODDI-derived axonal density index and q-space measure for tissue restriction demonstrated superior sensitivity to white matter changes shortly after mTBI. These techniques hold promise as a neuroimaging biomarker for mTBI.	[Wu, Yu-Chien; Mustafi, Sourajit M.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, 355 West 16th St,Suite 4100, Indianapolis, IN 46202 USA; [Harezlak, Jaroslaw] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Kodiweera, Chandana] Dartmouth Coll, Dartmouth Brain Imaging Ctr, Hanover, NH 03755 USA; [Flashman, Laura A.] Geisel Sch Med Dartmouth, Dept Psychiat, Lebanon, NH USA; [Flashman, Laura A.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Wu, YC (corresponding author), Indiana Univ Sch Med, Dept Radiol & Imaging Sci, 355 West 16th St,Suite 4100, Indianapolis, IN 46202 USA.	yucwu@iu.edu	Harezlak, Jaroslaw/P-8557-2014	Harezlak, Jaroslaw/0000-0002-3070-7686	Indiana University-Purdue University Indianapolis ITDP; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 NS075791, R01 R01AG053993]; NCAA-DoD Grand Alliance [W81XWH-14-2-0151]; Project Development Team within the ICTSI NIH/NCRR Grant [UL1TR001108]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG053993] Funding Source: NIH RePORTER	The authors thank Mary L. Hynes and Marcia A. Davis for assistance with data collection. This study was supported by institutional grants from Indiana University-Purdue University Indianapolis ITDP to YCW and TWM, National Institutes of Health grant R21 NS075791 to YCW and TWM, R01 R01AG053993 to YCW, the NCAA-DoD Grand Alliance W81XWH-14-2-0151 to TWM, and a Project Development Team within the ICTSI NIH/NCRR Grant Number UL1TR001108.	Albi A, 2017, HUM BRAIN MAPP, V38, P12, DOI 10.1002/hbm.23350; Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; Assaf Y, 2005, MAGN RESON IMAGING, V23, P703, DOI 10.1016/j.mri.2005.04.008; Assaf Y, 2002, MAGNET RESON MED, V47, P115, DOI 10.1002/mrm.10040; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avram AV, 2016, NEUROIMAGE, V127, P422, DOI 10.1016/j.neuroimage.2015.11.027; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beck AT, 1987, BECK DEPRESSION INVE; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; Biton IE, 2006, MAGN RESON IMAGING, V24, P161, DOI 10.1016/j.mri.2005.10.029; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Callaghan P.T., 1991, PRINCIPLES NUCL MAGN; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; First M.B., 1996, STRUCTURED CLIN INTE; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Guerrero J.M., 2016, ISMRM 24 ANN M EXH 2; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hosseinbor AP, 2013, NEUROIMAGE, V64, P650, DOI 10.1016/j.neuroimage.2012.08.072; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones DK, 2008, CORTEX, V44, P936, DOI 10.1016/j.cortex.2008.05.002; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kodiweera C, 2016, DATA BRIEF, V7, P1131, DOI 10.1016/j.dib.2016.03.063; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Lally P., 2014, ARCH DIS CHILD FE S1, V99, pA14; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; Levin B, 2014, NEUROCRIT CARE, V20, P334, DOI 10.1007/s12028-013-9931-1; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mustafi S.M., 2015, ISMRM 23 ANN M EXH 2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ozarslan E, 2013, NEUROIMAGE, V78, P16, DOI 10.1016/j.neuroimage.2013.04.016; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Radiological Society of North America, 2017, RSNA POS STAT TRAUM; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Simon CM, 2009, J NEUROTRAUM, V26, P563, DOI 10.1089/neu.2008.0523; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Spielberger CD., 1983, STATE TRAIT ANXIETY; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; Timmers I, 2015, J INHERIT METAB DIS, V38, P295, DOI 10.1007/s10545-014-9780-x; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wallister TW, 2008, WORLD PSYCHIATRY, V7, P3; Wen Q., 2017, ALZH ASS INT C UNPUB; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wintermark M, 2015, AJNR Am J Neuroradiol, V36, pE1, DOI 10.3174/ajnr.A4181; Wu Y.C., 2016, DIFFUSION MRI TENSOR, P150; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Wu YC, 2011, NEUROIMAGE, V58, P829, DOI 10.1016/j.neuroimage.2011.06.067; Wu YC, 2011, NEUROIMAGE, V54, P1840, DOI 10.1016/j.neuroimage.2010.09.067; Yamada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112411; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	103	19	20	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2377	2390		10.1089/neu.2017.5566		JUL 2018	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437869100001	29786463	Green Submitted, Green Published, hybrid			2022-02-06	
J	Nolan, A; Hennessy, E; Krukowski, K; Guglielmetti, C; Chaumeil, MM; Sohal, VS; Rosi, S				Nolan, Amber; Hennessy, Edel; Krukowski, Karen; Guglielmetti, Caroline; Chaumeil, Myriam M.; Sohal, Vikaas S.; Rosi, Susanna			Repeated Mild Head Injury Leads to Wide-Ranging Deficits in Higher-Order Cognitive Functions Associated with the Prefrontal Cortex	JOURNAL OF NEUROTRAUMA			English	Article						disinhibition; prefrontal cortex; repetitive mild traumatic brain injury; social memory; working memory	TRAUMATIC BRAIN-INJURY; ENGINEERED ROTATIONAL ACCELERATION; WORKING-MEMORY; IMPACT MODEL; NEUROBEHAVIORAL CHANGES; PYRAMIDAL NEURONS; SOCIAL COGNITION; RISK; SEVERITY; CONCUSSION	Traumatic brain injury (TBI) has long been identified as a precipitating risk factor for higher-order cognitive deficits associated with the frontal and prefrontal cortices (PFC). In addition, mild repetitive TBI (rTBI), in particular, is being steadily recognized to increase the risk of neurodegenerative disease. Thus, further understanding of how mild rTBI changes the pathophysiology of the brain to lead to cognitive impairment is warranted. The current models of rTBI lack knowledge regarding chronic higher-order cognitive functions and the underlying neuronal physiology, especially functions involving the PFC. Here, we establish that five repeated mild hits, allowing rotational acceleration of the head, lead to chronic deficits in PFC-dependent functions such as social behavior, spatial working memory, and environmental response with concomitant microgliosis and a small decrease in the adaptation rate of layer V pyramidal neurons in the medial PFC (mPFC). However, structural damage is not seen on in vivo T2-weighted magnetic resonance imaging (MRI), and extensive intrinsic excitability changes in layer V pyramidal neurons of the mPFC are not observed. Thus, this rTBI animal model can recapitulate chronic higher-order cognitive impairments without structural damage on MR imaging as observed in humans.	[Nolan, Amber; Hennessy, Edel; Krukowski, Karen; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Nolan, Amber; Hennessy, Edel; Krukowski, Karen; Guglielmetti, Caroline; Chaumeil, Myriam M.; Rosi, Susanna] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Nolan, Amber] Univ Calif San Francisco, Dept Anat Pathol, San Francisco, CA 94143 USA; [Guglielmetti, Caroline; Chaumeil, Myriam M.] Univ Calif San Francisco, Surbeck Lab Adv Imaging, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Sohal, Vikaas S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA		Rosi, S (corresponding author), Zuckerberg San Francisco Gen Hosp, Bldg 1,Room 101,1001 Potrero Ave, San Francisco, CA 94110 USA.	susanna.rosi@ucsf.edu	Hennessy, Edel/H-4438-2019	Hennessy, Edel/0000-0003-4024-0802; Chaumeil, Myriam/0000-0002-2110-4613	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096718, R21NS087458, R01NS095831]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056770]; David Mahoney Neuroimaging Grant from the Dana Foundation [CA-0114728];  [CalBRAIN349087]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG056770] Funding Source: NIH RePORTER	This work was supported by research grants: NIH/NINDS R21NS096718, NIH/NINDS R21NS087458, NIH/NIA R01AG056770, CalBRAIN349087, NIH/NINDS R01NS095831, and a David Mahoney Neuroimaging Grant from the Dana Foundation (CA-0114728).	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chen HZ, 2017, J NEUROTRAUM, V34, P2291, DOI 10.1089/neu.2016.4870; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Chou A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151418; Cohen J., 2013, STAT POWER ANAL BEHA; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; de la Plata CDM, 2011, ARCH NEUROL-CHICAGO, V68, P74, DOI 10.1001/archneurol.2010.342; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng X, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2389; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gilmartin MR, 2013, J NEUROSCI, V33, P10910, DOI 10.1523/JNEUROSCI.0144-13.2013; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Haber M, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0164-17.2017; Hall ANB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159442; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Juengst SB, 2014, BRAIN BEHAV IMMUN, V41, P134, DOI 10.1016/j.bbi.2014.05.020; Kang JH, 2012, J NEUROTRAUM, V29, P90, DOI 10.1089/neu.2011.1936; Kim EJ, 2015, NEURON, V88, P1253, DOI 10.1016/j.neuron.2015.11.002; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Lee AT, 2014, NEURON, V81, P61, DOI 10.1016/j.neuron.2013.10.031; Leo L.M., 2014, BIOPROTOCOL, V9, DOI [10.21769/BioProtoc.1211, DOI 10.21769/BIOPROTOC.1211]; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Manktelow AE, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00058; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Martins AT, 2012, NEURAL REGEN RES, V7, P101, DOI 10.3969/j.issn.1673-5374.2012.02.004; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mouzon BC, 2018, ANN CLIN TRANSL NEUR, V5, P64, DOI 10.1002/acn3.510; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Riga D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00230; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Sekerli M, 2004, IEEE T BIO-MED ENG, V51, P1665, DOI 10.1109/TBME.2004.827531; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Ubukata S, 2014, NEUROPSYCH DIS TREAT, V10, P2061, DOI 10.2147/NDT.S68156; VILKKI J, 1994, J CLIN EXP NEUROPSYC, V16, P325, DOI 10.1080/01688639408402643; Wallesch CW, 2001, J NEUROTRAUM, V18, P11, DOI 10.1089/089771501750055730; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wu X, 2016, RADIOLOGY, V279, P693, DOI 10.1148/radiol.16142535; Xiao H, 2017, BRAIN INJURY, V31, P1331, DOI 10.1080/02699052.2017.1319576; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zelikowsky M, 2014, J NEUROSCI, V34, P8462, DOI 10.1523/JNEUROSCI.3624-13.2014; Zhang J, 2015, J CEREBR BLOOD F MET, V35, P706, DOI 10.1038/jcbfm.2014.247	71	19	19	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2425	2434		10.1089/neu.2018.5731		JUL 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000437230700001	29732949	Green Published			2022-02-06	
J	Cooksley, R; Maguire, E; Lannin, NA; Unsworth, CA; Farquhar, M; Galea, C; Mitra, B; Schmidt, J				Cooksley, Rebecca; Maguire, Emma; Lannin, Natasha A.; Unsworth, Carolyn A.; Farquhar, Michelle; Galea, Claire; Mitra, Biswadev; Schmidt, Julia			Persistent symptoms and activity changes three months after mild traumatic brain injury	AUSTRALIAN OCCUPATIONAL THERAPY JOURNAL			English	Article						neurology; rehabilitation services; traumatic brain injury	HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; CONCUSSION SYMPTOMS; FOLLOW-UP; CHILDREN; OUTCOMES; DISABILITY; RECOVERY; SPORT; SCALE	Background/aimApproximately, 80% of traumatic brain injuries are considered mild in severity. Mild traumatic brain injury (mTBI) may cause temporary or persisting impairments that can adversely affect an individual's ability to participate in daily occupations and life roles. This study aimed to identify symptoms, factors predicting level of symptoms and functional and psycho-social outcomes for participants with mTBI three months following injury. MethodPatients discharged from the Emergency Department of a major metropolitan hospital with a diagnosis of mTBI were contacted by telephone three months after injury. An interview with two questionnaires was administered: The Concussion Symptom Inventory (CSI) Scale and the Rivermead Head Injury Follow-Up Questionnaire (RHIFUQ). Data obtained were used to determine the type and prevalence of post-concussion symptoms and their impact on activity change. ResultsSixty-three people with mTBI participated in the study. The majority of participants (81%) reported that all symptoms had resolved within the three-month time frame. Of those still experiencing symptoms, workplace fatigue (22%) and an inability to maintain previous workload/standards (17%) were reported. ConclusionThere is a small, but clinically significant, subgroup of patients who continue to experience symptoms three-month post-mTBI. Symptoms experienced beyond the expected three-month recovery timeframe have the potential to adversely affect an individual's ability to participate in daily occupation and return to work.	[Cooksley, Rebecca; Lannin, Natasha A.; Unsworth, Carolyn A.; Schmidt, Julia] La Trobe Univ, Coll Sci Hlth & Engn, Sch Allied Hlth, Occupat Therapy, Melbourne, Vic, Australia; [Maguire, Emma; Lannin, Natasha A.; Farquhar, Michelle; Mitra, Biswadev] Alfred Hlth, Melbourne, Vic, Australia; [Mitra, Biswadev] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic, Australia; [Unsworth, Carolyn A.] Cent Queensland Univ, Sch Hlth Med & Appl Sci, Occupat Therapy, Melbourne, Vic, Australia; [Galea, Claire] Univ Sydney, Cerebral Palsy Alliance, Sydney, NSW, Australia; [Schmidt, Julia] Univ British Columbia, Fac Med, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada		Schmidt, J (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, 212-2177 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	julia.schmidt@ubc.ca	Lannin, Natasha A/A-4195-2013; Mitra, Biswadev/AAC-3724-2019	Lannin, Natasha A/0000-0002-2066-8345; Mitra, Biswadev/0000-0002-0508-2450; Unsworth, Carolyn/0000-0001-6430-2823; Schmidt, Julia/0000-0003-2004-4871	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	NAL was supported by a fellowship from the National Health and Medical Research Council. No funding for this research was provided.	AIHW, 2007, DIS AUSTR ACQ BRAIN; Anderson V, 2001, J CLIN EXP NEUROPSYC, V23, P705, DOI 10.1076/jcen.23.6.705.1015; Baker A, 2015, ACCIDENT ANAL PREV, V79, P50, DOI 10.1016/j.aap.2015.03.014; Berrigan L, 2011, BRAIN INJURY, V25, P742, DOI 10.3109/02699052.2011.580317; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Blostein PA, 1997, J NEUROTRAUM, V14, P171, DOI 10.1089/neu.1997.14.171; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Crawford S, 1996, J NEUROL NEUROSUR PS, V60, P510, DOI 10.1136/jnnp.60.5.510; Helps Y. L. M., 2008, HOSP SEPERATIONS DUE; Iverson G.L, 2007, BRAIN INJURY MED PRI, P373; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; Kraus J. F., 1999, REHABILITATION ADULT, P3; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; McCrea M., 2008, MILD TRAUMATIC BRAIN; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLean SA, 2009, AM J EMERG MED, V27, P182, DOI 10.1016/j.ajem.2008.01.054; Meares S, 2006, J INT NEUROPSYCH SOC, V12, P792, DOI 10.1017/S1355617706060978; Monash University, 2015, VICT STAT TRAUM OUTC; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Motor Accidents Authority of NSW (MAA NSW), 2008, GUID MILD TRAUM BRAI; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Ponsford JL, 2016, J NEUROTRAUM, V33, P997, DOI 10.1089/neu.2015.4025; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Saini NS, 2012, INDIAN J NEUROTRAUM, V9, P45, DOI 10.1016/j.ijnt.2012.04.009; Scaffa, 2013, WILLARD SPACKMANS OC; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stuart B, 2012, J EMERG NURS, V38, P435, DOI 10.1016/j.jen.2011.04.006; Tiller J. W. G., 2001, MJA OPEN S4, V1, P28, DOI [10. 5694/mjao12. 10628, DOI 10.5694/MJA012.10628]; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yeates KO, 1999, J HEAD TRAUMA REHAB, V14, P337, DOI 10.1097/00001199-199908000-00003	39	19	20	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0045-0766	1440-1630		AUST OCCUP THER J	Aust. Occup. Ther. J.	JUN	2018	65	3					168	175		10.1111/1440-1630.12457			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	GK5SQ	WOS:000436237700002	29498077				2022-02-06	
J	Evers, KS; Atkinson, A; Barro, C; Fisch, U; Pfister, M; Huhn, EA; Lapaire, O; Kuhle, J; Wellmann, S				Evers, Katrina Suzanne; Atkinson, Andrew; Barro, Christian; Fisch, Urs; Pfister, Marc; Huhn, Evelyn A.; Lapaire, Olav; Kuhle, Jens; Wellmann, Sven			Neurofilament as Neuronal Injury Blood Marker in Preeclampsia	HYPERTENSION			English	Article						biomarker; blood-brain barrier; hypertension; preeclampsia; pregnancy	TRAUMATIC BRAIN-INJURY; LIGHT-CHAIN; CEREBROSPINAL-FLUID; CSF NEUROFILAMENT; CEREBRAL HEMODYNAMICS; PLASMA-LEVELS; PREGNANCY; BIOMARKER; HYPERTENSION; DIAGNOSIS	Preeclampsia has been shown to be associated with changes in cerebral structure and cognitive function later in life. Nf (neurofilaments) are specific scaffolding proteins of neurons, and their quantification in serum has been proposed as a biomarker for neuroaxonal injury. We performed a prospective, longitudinal, single-center study at the University Hospital of Basel to determine scrum Nf concentrations in pregnant women with singleton pregnancies and with high risk of preeclampsia or with early signs of preeclampsia. Enrollment started at 21 weeks of gestation, followed up with multiple visits until delivery, Sixty out of 197 women developed preeclampsia (30.5%), NIL (Nf light chain) was measured with a highly sensitive single molecule array (Simon) assay, in addition to the established preeclampsia markers sFlt-1 (soluble fins-like tyrosine kinase-1) and PIGF (placental growth factor). The most important independent predictors of Nit were maternal age, number of pregnancies, and proteinuria, NIL levels increased during pregnancy and were significantly higher in women developing preeclampsia. The discriminatory accuracy of NfL, PIGF, and sFlt-1 in receiver operating characteristic curves analysis (area under the curve) of the overall group was 0.68, 0.81, and 0,84, respectively, and in women older than 36 years 0.7, 0,62, and 0.79, respectively. We conclude that increased axonal injury serum marker NfL predicts preeclampsia particularly in older women, with an accuracy similar to the established angiogenic factors. NIL may serve as an early indicator of preeclampsia-induced changes in cerebral structure and may help to stratify disease management.	[Evers, Katrina Suzanne; Wellmann, Sven] Univ Basel, Childrens Hosp UKBB, Div Neonatol, Basel, Switzerland; [Atkinson, Andrew; Pfister, Marc] Univ Basel, Childrens Hosp UKBB, Div Paediat Pharmacol & Pharmacometr, Basel, Switzerland; [Atkinson, Andrew] Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Barro, Christian; Fisch, Urs; Kuhle, Jens] Univ Basel, Neurol Clin & Policlin, Dept Med, Basel, Switzerland; [Barro, Christian; Fisch, Urs; Kuhle, Jens] Univ Basel, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland; [Barro, Christian; Fisch, Urs; Kuhle, Jens] Univ Basel, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland; [Huhn, Evelyn A.; Lapaire, Olav] Univ Basel, Univ Hosp Basel, Div Obstet & Gynecol, Basel, Switzerland		Wellmann, S (corresponding author), Spitalstr 33, CH-4056 Basel, Switzerland.	sven.wellmann@ukbb.ch	Evers, Katrina/ABF-4388-2020; Pfister, Marc/ABC-6438-2021; Huhn, Evelyn/AAG-7095-2020; Barro, Christian/AAO-3567-2021	Pfister, Marc/0000-0003-2597-1228; Huhn, Evelyn/0000-0001-5382-1353; Barro, Christian/0000-0002-7795-7383; Fisch, Urs/0000-0003-1557-9062; Evers, Katrina/0000-0002-0572-8709	Gottfried und Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland; Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [320030_160221]	This work was supported by the Gottfried und Julia Bangerter-Rhyner-Stiftung, Bern, Switzerland and the Swiss National Science Foundation (320030_160221).	Amburgey OA, 2010, HYPERTENSION, V56, P1003, DOI 10.1161/HYPERTENSIONAHA.110.158931; Axelsson M, 2011, J NEUROL, V258, P882, DOI 10.1007/s00415-010-5863-2; Bacioglu M, 2016, NEURON, V91, P56, DOI 10.1016/j.neuron.2016.05.018; Bergman L, 2016, AM J HYPERTENS, V29, P1374, DOI 10.1093/ajh/hpw097; Bergman L, 2014, AM J HYPERTENS, V27, P1105, DOI 10.1093/ajh/hpu020; Block H Steven, 2014, Handb Clin Neurol, V121, P1595, DOI 10.1016/B978-0-7020-4088-7.00105-X; Burman J, 2014, ACTA NEUROL SCAND, V130, P81, DOI 10.1111/ane.12239; Bushnell C, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/858134; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Disanto G, 2017, ANN NEUROL, V81, P857, DOI 10.1002/ana.24954; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Fields JA, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.03.008; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Hakansson I, 2017, EUR J NEUROL, V24, P703, DOI 10.1111/ene.13274; Hammer ES, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0575-8; Karumanchi SA, 2016, HYPERTENSION, V67, P1072, DOI 10.1161/HYPERTENSIONAHA.116.06421; Khalil M, 2013, MULT SCLER J, V19, P436, DOI 10.1177/1352458512458010; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Kuhle J, 2015, NEUROLOGY, V84, P1639, DOI 10.1212/WNL.0000000000001491; Kuhle J, 2015, J NEUROL NEUROSUR PS, V86, P273, DOI 10.1136/jnnp-2013-307454; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Lu CH, 2015, NEUROLOGY, V84, P2247, DOI 10.1212/WNL.0000000000001642; Malmestrom C, 2003, NEUROLOGY, V61, P1720, DOI 10.1212/01.WNL.0000098880.19793.B6; Martinez-Morillo E, 2015, CLIN CHEM LAB MED, V53, P1575, DOI 10.1515/cclm-2014-0908; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; Meeter LH, 2016, ANN CLIN TRANSL NEUR, V3, P623, DOI 10.1002/acn3.325; Modvig S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077163; Oehm E, 2003, ULTRASOUND OBST GYN, V22, P395, DOI 10.1002/uog.183; Oehm E, 2006, CEREBROVASC DIS, V22, P204, DOI 10.1159/000093810; Petzold A, 2005, J NEUROL SCI, V233, P183, DOI 10.1016/j.jns.2005.03.015; Petzold A, 2011, BRAIN, V134, P464, DOI 10.1093/brain/awq360; PHILLIPS SJ, 1992, ARCH INTERN MED, V152, P938, DOI 10.1001/archinte.152.5.938; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Rojas JC, 2016, ANN CLIN TRANSL NEUR, V3, P216, DOI 10.1002/acn3.290; ROYBURT M, 1991, Obstetrical and Gynecological Survey, V46, P656, DOI 10.1097/00006254-199110000-00002; Schoknecht K, 2015, SEMIN CELL DEV BIOL, V38, P35, DOI 10.1016/j.semcdb.2014.10.004; Schreurs MPH, 2013, FASEB J, V27, P1254, DOI 10.1096/fj.12-222216; Schwartz RB, 2000, RADIOLOGY, V217, P371, DOI 10.1148/radiology.217.2.r00nv44371; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Siepmann T, 2017, NEUROLOGY, V88, P1256, DOI 10.1212/WNL.0000000000003765; Singh P, 2011, J NEUROL SCI, V304, P117, DOI 10.1016/j.jns.2011.01.025; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stepan H, 2015, ULTRASOUND OBST GYN, V45, P241, DOI 10.1002/uog.14799; Teunissen CE, 2012, MULT SCLER J, V18, P552, DOI 10.1177/1352458512443092; Traenka C, 2015, CEREBROVASC DIS, V40, P222, DOI 10.1159/000440774; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; Vettorazzi J, 2012, PREGNANCY HYPERTENS, V2, P101, DOI 10.1016/j.preghy.2011.11.004; Wellmann S, 2014, FETAL DIAGN THER, V36, P202, DOI 10.1159/000361016; Weydt P, 2016, ANN NEUROL, V79, P152, DOI 10.1002/ana.24552; Wikstrom AK, 2012, PREGNANCY HYPERTENS, V2, P398, DOI 10.1016/j.preghy.2012.03.001; Wilke C, 2016, J NEUROL NEUROSUR PS, V87, P1270, DOI 10.1136/jnnp-2015-312972; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zunker P, 2000, ULTRASOUND OBST GYN, V16, P179, DOI 10.1046/j.1469-0705.2000.00194.x	62	19	20	2	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0194-911X	1524-4563		HYPERTENSION	Hypertension	JUN	2018	71	6					1178	1184		10.1161/HYPERTENSIONAHA.117.10314			7	Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	GP6TZ	WOS:000441020300040	29686016	Bronze			2022-02-06	
J	Frames, CW; Soangra, R; Lockhart, TE; Lach, J; Ha, DS; Roberto, KA; Lieberman, A				Frames, Christopher W.; Soangra, Rahul; Lockhart, Thurmon E.; Lach, John; Ha, Dong Sam; Roberto, Karen A.; Lieberman, Abraham			Dynamical Properties of Postural Control in Obese Community-Dwelling Older Adults	SENSORS			English	Article						obesity; postural control; nonlinear	TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; UNITED-STATES; BODY-WEIGHT; CEREBRAL CONCUSSION; PHYSICAL-ACTIVITY; BALANCE CONTROL; SWAY; RISK; MEN	Postural control is a key aspect in preventing falls. The aim of this study was to determine if obesity affected balance in community-dwelling older adults and serve as an indicator of fall risk. The participants were randomly assigned to receive a comprehensive geriatric assessment followed by a longitudinal assessment of their fall history. The standing postural balance was measured for 98 participants with a Body Mass Index (BMI) ranging from 18 to 63 kg/m(2), using a force plate and an inertial measurement unit affixed at the sternum. Participants' fall history was recorded over 2 years and participants with at least one fall in the prior year were classified as fallers. The results suggest that body weight/BMI is an additional risk factor for falling in elderly persons and may be an important marker for fall risk. The linear variables of postural analysis suggest that the obese fallers have significantly higher sway area and sway ranges, along with higher root mean square and standard deviation of time series. Additionally, it was found that obese fallers have lower complexity of anterior-posterior center of pressure time series. Future studies should examine more closely the combined effect of aging and obesity on dynamic balance.	[Frames, Christopher W.; Lockhart, Thurmon E.] Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA; [Frames, Christopher W.; Lieberman, Abraham] St Josephs Hosp, Barrow Neurol Inst, MAPC, Phoenix, AZ 85013 USA; [Soangra, Rahul] Chapman Univ, Dept Phys Therapy, Crean Coll Hlth & Behav Sci, Orange, CA 92866 USA; [Lach, John] Univ Virginia, Dept Elect & Comp Engn, Charlottesville, VA 22904 USA; [Ha, Dong Sam] Virginia Polytech Inst & State Univ, Bradley Dept Elect & Comp Engn, Blacksburg, VA 24061 USA; [Roberto, Karen A.] Virginia Polytech Inst & State Univ, Ctr Gerontol, Blacksburg, VA 24061 USA		Lockhart, TE (corresponding author), Arizona State Univ, Sch Biol & Hlth Syst Engn, Tempe, AZ 85281 USA.	cframes@asu.edu; soangra@chapman.edu; Thurmon.Lockhart@asu.edu; jlach@virginia.edu; ha@vt.edu; kroberto@vt.edu; abraham.lieberman@dignityhealth.org	Roberto, Karen A./AAC-1805-2019; SOANGRA, RAHUL/C-9625-2014; Lockhart, Thurmon/R-9964-2019	Roberto, Karen A./0000-0003-1153-1811; SOANGRA, RAHUL/0000-0001-9836-1549; Lockhart, Thurmon/0000-0002-7008-5711; Lach, John/0000-0002-7105-9996; Ha, Dong/0000-0003-4838-1773	National Science Foundation-Information and Intelligent Systems (IIS) [1065442, 1547466, 1065262]; National Science Foundation-Smart and Connected Health [1065442, 1547466, 1065262]	This research was supported by the National Science Foundation-Information and Intelligent Systems (IIS) and Smart and Connected Health (1065442, and 1547466, and secondary 1065262).	BALOH RW, 1994, J AM GERIATR SOC, V42, P405, DOI 10.1111/j.1532-5415.1994.tb07489.x; BARTLETT SA, 1986, MED BIOL ENG COMPUT, V24, P219, DOI 10.1007/BF02443942; Blaszczyk JW, 2009, J BIOMECH, V42, P1295, DOI 10.1016/j.jbiomech.2009.03.006; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; CARROLL JP, 1993, J BIOMECH, V26, P409, DOI 10.1016/0021-9290(93)90004-X; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Compston JE, 2011, AM J MED, V124, P1043, DOI 10.1016/j.amjmed.2011.06.013; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Dutil M, 2013, AGE, V35, P883, DOI 10.1007/s11357-012-9386-x; Duvigneaud N, 2008, J SPORT MED PHYS FIT, V48, P201; ERA P, 1985, J GERONTOL, V40, P287, DOI 10.1093/geronj/40.3.287; FERNIE GR, 1982, AGE AGEING, V11, P11, DOI 10.1093/ageing/11.1.11; Ferraro KF, 2002, AM J PUBLIC HEALTH, V92, P834, DOI 10.2105/AJPH.92.5.834; Fjeldstad Cecilie, 2008, Dyn Med, V7, P4, DOI 10.1186/1476-5918-7-4; Flegal KM, 2004, AM J PUBLIC HEALTH, V94, P1486, DOI 10.2105/AJPH.94.9.1486; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Handrigan GA, 2010, J BIOMECH, V43, P383, DOI 10.1016/j.jbiomech.2009.08.041; Harbourne RT, 2003, DEV PSYCHOBIOL, V42, P368, DOI 10.1002/dev.10110; HASSELKUS BR, 1975, J GERONTOL, V30, P661, DOI 10.1093/geronj/30.6.661; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; Hurley MV, 1998, AGE AGEING, V27, P55, DOI 10.1093/ageing/27.1.55; Jenkins KR, 2004, GERONTOLOGIST, V44, P206, DOI 10.1093/geront/44.2.206; Khandoker AH, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-4; Ko SU, 2010, J BIOMECH, V43, P1104, DOI 10.1016/j.jbiomech.2009.12.004; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LIPSITZ LA, 1992, JAMA-J AM MED ASSOC, V267, P1806, DOI 10.1001/jama.267.13.1806; Lockhart T., 2014, FALL RISK PREDICTION; Loughlin PJ, 2003, IEEE ENG MED BIOL, V22, P69, DOI 10.1109/MEMB.2003.1195699; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; MAKI BE, 1994, J GERONTOL, V49, pM72, DOI 10.1093/geronj/49.2.M72; Manor B, 2010, J APPL PHYSIOL, V109, P1786, DOI 10.1152/japplphysiol.00390.2010; Melzer I, 2016, OBES RES CLIN PRACT, V10, P151, DOI 10.1016/j.orcp.2015.05.016; Messier SP, 2011, OSTEOARTHR CARTILAGE, V19, P272, DOI 10.1016/j.joca.2010.11.010; Metzger JS, 2008, MED SCI SPORT EXER, V40, P630, DOI 10.1249/MSS.0b013e3181620ebc; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; MURRAY MP, 1980, PHYS THER, V60, P412, DOI 10.1093/ptj/60.4.412; Naugle KM, 2012, ARCH GERONTOL GERIAT, V54, pE134, DOI 10.1016/j.archger.2011.10.017; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Owusu W, 1998, OBES RES, V6, P12, DOI 10.1002/j.1550-8528.1998.tb00309.x; Peeters A, 2004, OBES RES, V12, P1145, DOI 10.1038/oby.2004.143; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PINCUS S, 1995, CHAOS, V5, P110, DOI 10.1063/1.166092; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pincus SM, 2006, BIPOLAR DISORD, V8, P430, DOI 10.1111/j.1399-5618.2006.00375.x; Pincus Steven M., 1995, METH NEUROSCI, V28, P336; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rossi-Izquierdo M, 2016, AGING CLIN EXP RES, V28, P423, DOI 10.1007/s40520-015-0414-4; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Teasdale N, 2007, INT J OBESITY, V31, P153, DOI 10.1038/sj.ijo.0803360; Vaillancourt DE, 2000, CLIN NEUROPHYSIOL, V111, P2046, DOI 10.1016/S1388-2457(00)00467-3; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wu XF, 2014, NEUROSCI LETT, V583, P49, DOI 10.1016/j.neulet.2014.09.029	59	19	19	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1424-8220		SENSORS-BASEL	Sensors	JUN	2018	18	6							1692	10.3390/s18061692			15	Chemistry, Analytical; Engineering, Electrical & Electronic; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Chemistry; Engineering; Instruments & Instrumentation	GL0KD	WOS:000436774300026	29794998	Green Published, gold, Green Submitted			2022-02-06	
J	Martin, G; Shah, D; Elson, N; Boudreau, R; Hanseman, D; Pritts, TA; Makley, AT; Foreman, B; Goodman, MD				Martin, Grace; Shah, Dhavan; Elson, Nora; Boudreau, Ryan; Hanseman, Dennis; Pritts, Timothy A.; Makley, Amy T.; Foreman, Brandon; Goodman, Michael D.			Relationship of Coagulopathy and Platelet Dysfunction to Transfusion Needs After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Coagulopathy; Platelet function assays; Thromboelastography; Transfusion	SEVERE HEAD-INJURY; INTRACRANIAL HEMORRHAGE; ANTIPLATELET THERAPY; FUNCTION TESTS; CLOPIDOGREL; ASPIRIN; RESPONSIVENESS; VARIABILITY; REVERSAL; ASSAY	Coagulopathy and platelet dysfunction commonly develop after traumatic brain injury (TBI). Thromboelastography (TEG) and platelet function assays (PFAs) are often performed at the time of admission; however, their roles in assessing post-TBI coagulopathy have not been investigated. We hypothesized that compared to blunt TBI, penetrating TBI would (1) demonstrate greater coagulopathy by TEG, (2) be associated with abnormal PFA results, and (3) require more blood product transfusions. We performed a retrospective study of patients admitted to the neuroscience intensive care unit of a level 1 trauma center from 2013 to 2015 with head Abbreviated Injury Scale ae<yen>3. Patients were compared by mechanism of injury (blunt vs. penetrating). Admission demographics, injury characteristics, and laboratory parameters were evaluated. VerifyNow(A (R)) Aspirin and P2Y12 tests were used for platelet function analysis. Five hundred and thirty-four patients were included in the analysis. There were no differences between groups in platelet count or international normalized ratio; however, patients with penetrating TBI were more coagulopathic by TEG, with all of the TEG parameters being significantly different except for R time. Patients with penetrating head trauma were not more likely than their blunt counterparts to have abnormal PFA results, and PFA results did not correlate with any TEG parameter in either group. The penetrating cohort received more units of blood products in the first 4 and 24 h than the blunt cohort. Patients presenting with penetrating TBI demonstrated increased coagulopathy compared to those with blunt TBI as measured by TEG and need for transfusion. PFA results did not correlate with TEG findings in this population.	[Martin, Grace; Shah, Dhavan; Elson, Nora; Boudreau, Ryan; Hanseman, Dennis; Pritts, Timothy A.; Makley, Amy T.; Goodman, Michael D.] Univ Cincinnati, Div Trauma Crit Care, Dept Surg, Coll Med, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA; [Foreman, Brandon] Univ Cincinnati, Div Neurocrit Care, Dept Neurol, Coll Med, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA		Goodman, MD (corresponding author), Univ Cincinnati, Div Trauma Crit Care, Dept Surg, Coll Med, 231 Albert Sabin Way,ML 0558, Cincinnati, OH 45267 USA.	goodmamd@ucmail.uc.edu		Foreman, Brandon/0000-0002-5418-674X; Pritts, Timothy/0000-0003-2495-3255; Elson, Nora/0000-0001-6038-4761; Shah, Dhavan/0000-0001-5034-2816			Abdelfattah K, 2016, INT J SURG, V33, P196, DOI 10.1016/j.ijsu.2015.09.036; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; Bansal V, 2011, J TRAUMA, V70, P65, DOI 10.1097/TA.0b013e318204fdae; Ben-Dor I, 2009, AM J CARDIOL, V104, P227, DOI 10.1016/j.amjcard.2009.03.022; Boto GR, 2006, J NEUROL NEUROSUR PS, V77, P1054, DOI 10.1136/jnnp.2005.087056; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Centers for Disease Control and Prevention, TRAUMATIC BRAIN INJU; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Hans GA, 2016, BRIT J HAEMATOL, V173, P37, DOI 10.1111/bjh.13930; Harrison P, 2005, STROKE, V36, P1001, DOI 10.1161/01.STR.0000162719.11058.bd; Jeong YH, 2012, AM HEART J, V164, P35, DOI 10.1016/j.ahj.2012.03.022; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; KEARNEY TJ, 1992, J TRAUMA, V32, P608, DOI 10.1097/00005373-199205000-00012; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Oestreich JH, 2009, CORONARY ARTERY DIS, V20, P207, DOI 10.1097/MCA.0b013e328329924b; Paniccia R, 2015, VASC HEALTH RISK MAN, V11, P133, DOI 10.2147/VHRM.S44469; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Serebruany VL, 2005, J AM COLL CARDIOL, V45, P246, DOI 10.1016/j.jacc.2004.09.067; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor G, 2013, J TRAUMA ACUTE CARE, V74, P1367, DOI 10.1097/TA.0b013e31828cca61; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	28	19	19	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2018	28	3					330	337		10.1007/s12028-017-0485-5			8	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK8EB	WOS:000436449800010	29313313				2022-02-06	
J	Sarnaik, A; Ferguson, NM; O'Meara, AMI; Agrawal, S; Deep, A; Buttram, S; Bell, MJ; Wisniewski, SR; Luther, JF; Hartman, AL; Vavilala, MS				Sarnaik, Ajit; Ferguson, Nikki Miller; O'Meara, A. M. Iqbal; Agrawal, Shruti; Deep, Akash; Buttram, Sandra; Bell, Michael J.; Wisniewski, Stephen R.; Luther, James F.; Hartman, Adam L.; Vavilala, Monica S.		ADAPT Trial	Age and Mortality in Pediatric Severe Traumatic Brain Injury: Results from an International Study	NEUROCRITICAL CARE			English	Article						Pediatric traumatic brain injury; Age; Comparative effectiveness research; Pediatric neurocritical care; Secondary injuries	SEVERE HEAD-INJURY; YOUNG-CHILDREN; PREDICTIVE FACTORS; LESIONS; HYPOTHERMIA; PLASTICITY; RECOVERY; RATS; VULNERABILITY; MECHANISMS	Although small series have suggested that younger age is associated with less favorable outcome after severe traumatic brain injury (TBI), confounders and biases have limited our understanding of this relationship. We hypothesized that there would be an association between age and mortality in children within an ongoing observational, cohort study. The first 200 subjects from the Approaches and Decisions for Acute Pediatric TBI trial were eligible for this analysis (inclusion criteria: severe TBI (Glasgow Coma Scale [GCS] score ae<currency> 8], age 18 years, and intracranial pressure (ICP) monitor placed; exclusion: pregnancy). Children with suspected abusive head trauma (AHT) were excluded to avoid bias related to the association between AHT and mortality. Demographics, and prehospital and resuscitation events were collected/analyzed, and children were stratified based on age at time of injury (< 5, 5-< 11, 11-18 years) and presented as mean +/- standard error of the mean (SEM). Analyses of variance were used to test the equality of the means across the group for continuous variable, and Chi-square tests were used to compare percentages for discrete variables (post hoc comparisons were made using t test and Bonferroni corrections, as needed). Kaplan-Meier curves were generated for each age subgroup describing the time of death, and log-rank was used to compare the curves. Cox proportional hazards regression models were used to assess the effect of age on time to death while controlling for covariates. In the final cohort (n = 155, 45 excluded for AHT), overall age was 9.2 years +/- 0.4 and GCS was 5.3 +/- 0.1. Mortality was similar between strata (14.0, 20.0, 20.9%, respectively, p = 0.58). Motor vehicle accidents were the most common mechanism across all strata, while falls tended to be more common in the youngest stratum (p = 0.08). The youngest stratum demonstrated increased incidence of spontaneous hypothermia at presentation and decreased hemoglobin concentrations and coagulopathies, while the oldest demonstrated lower platelet counts. In contrast to previous reports, we failed to detect mortality differences across age strata in children with severe TBI. We have discerned novel associations between age and various markers of injury-unrelated to AHT-that may lead to testable hypotheses in the future.	[Sarnaik, Ajit] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Ferguson, Nikki Miller; O'Meara, A. M. Iqbal] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA; [Agrawal, Shruti] Addenbrookes Hosp, Dept Pediat, Cambridge, England; [Deep, Akash] Kings Coll Hosp London, Dept Pediat, London, England; [Buttram, Sandra] Phoenix Childrens Hosp, Dept Pediat, Phoenix, AZ USA; [Bell, Michael J.] Univ Pittsburgh, Crit Care Med Neurol Surg & Pediat, 3434 Fifth Ave, Pittsburgh, PA 15260 USA; [Wisniewski, Stephen R.; Luther, James F.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98195 USA; [Hartman, Adam L.] NINDS, Off Clin Res, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Bell, MJ (corresponding author), Univ Pittsburgh, Crit Care Med Neurol Surg & Pediat, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	bellmj4@upmc.edu	Hartman, Adam/W-9782-2019; Ferguson, Nikki Miller/AAA-4548-2020	Hartman, Adam/0000-0001-5672-3409; Figaji, Anthony/0000-0002-3357-6490; , Alia Marie/0000-0003-3158-7943; Kilbaugh, Todd/0000-0002-4959-3092; Bennett, Tellen/0000-0003-1483-4236; Edwards, Richard/0000-0001-8415-2180	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 NS081041]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS081041] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number U01 NS081041. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CDC, TRAUM BRAIN INJ US; Center for Disease Control and Prevention (CDC), TRAUMATIC BRAIN INJU; Crowe LM, 2012, J PEDIATR PSYCHOL, V37, P745, DOI 10.1093/jpepsy/jss070; Davies FC, 2015, EMERG MED J, V32, P921, DOI 10.1136/emermed-2015-205285; Dean NP, 2007, J NEUROSURG, V107, P387, DOI 10.3171/PED-07/11/387; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; GOLDMAN PS, 1978, BRAIN RES, V152, P451, DOI 10.1016/0006-8993(78)91103-4; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Hymel KP, 2007, PEDIATRICS, V119, P922, DOI 10.1542/peds.2006-3111; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kennard MA, 1936, AM J PHYSIOL, V115, P138, DOI 10.1152/ajplegacy.1936.115.1.138; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037/0735-7044.107.5.799; Kolb B, 2000, BRAIN RES, V882, P62, DOI 10.1016/S0006-8993(00)02828-6; KOLB B, 1994, BRAIN RES, V645, P85, DOI 10.1016/0006-8993(94)91641-1; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; Moran LM, 2016, J INT NEUROPSYCH SOC, V22, P512, DOI 10.1017/S1355617716000175; Morrison Wynne E, 2004, Pediatr Crit Care Med, V5, P145, DOI 10.1097/01.PCC.0000112373.71645.2A; Prasad MR, 2002, PEDIATR NEUROSURG, V36, P64, DOI 10.1159/000048355; Sifringer M, 2007, NEUROBIOL DIS, V25, P526, DOI 10.1016/j.nbd.2006.10.019; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Treble-Barna A, 2016, DEV PSYCHOL, V52, P1777, DOI 10.1037/dev0000208; Melo JRT, 2010, NEUROSURGERY, V67, P1542, DOI 10.1227/NEU.0b013e3181fa7049; Villablanca JR, 1998, DEV BRAIN RES, V105, P309, DOI 10.1016/S0165-3806(97)00187-9	37	19	19	1	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2018	28	3					302	313		10.1007/s12028-017-0480-x			12	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK8EB	WOS:000436449800007	29476389				2022-02-06	
J	Lilja-Cyron, A; Kelsen, J; Andresen, M; Fugleholm, K; Juhler, M				Lilja-Cyron, Alexander; Kelsen, Jesper; Andresen, Morten; Fugleholm, Kare; Juhler, Marianne			Feasibility of Telemetric Intracranial Pressure Monitoring in the Neuro Intensive Care Unit	JOURNAL OF NEUROTRAUMA			English	Article						decompressive craniectomy; ICP; TBI; telemetric; telemetry	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; DECOMPRESSIVE CRANIECTOMY; INTRACEREBRAL HEMORRHAGE; MANAGEMENT; TRIAL; COMPLICATIONS; MULTICENTER; REACTIVITY; HYDROCEPHALUS	Intracranial pressure (ICP) monitoring is crucial in the management of acute neurosurgical conditions such as traumatic brain injury (TBI). However, pathological ICP may persist beyond the admission to the neuro intensive care unit (NICU). We investigated the feasibility of telemetric ICP monitoring in the NICU, as this technology provides the possibility of long-term ICP assessment beyond NICU discharge. In this prospective investigation, we implanted telemetric ICP sensors (Raumedic Neurovent-P-tel) instead of conventional, cabled ICP sensors in patients undergoing decompressive craniectomy. We recorded ICP curves, duration of ICP monitoring, signal quality, and complications. Seventeen patients were included (median age 55 years) and diagnoses were: severe TBI (8), malignant middle cerebral artery infarction (8), and spontaneous intracerebral hemorrhage (1). In total, 3015 h of ICP monitoring were performed, and the median duration of ICP monitoring was 188 h (interquartile range [IQR] 54-259). The ICP signal was lost 613 times (displacement of the reader unit on the skin) for a median of 1.5 min, corresponding to 0.8% of the total monitoring period. When the signal was lost, it could always be restored by realignment of the reader unit on the skin above the telemetric sensor. Sixteen of 17 patients survived the NICU admission, and ICP gradually decreased from 10.7mm Hg (IQR 7.5-13.6) during the first postoperative day to 6.3mm Hg (IQR 4.0-8.3) after 1 week in the NICU. All 17 implanted telemetric sensors functioned throughout the NICU admission, and no wound infections were observed. Therefore, telemetric ICP monitoring in an acute neurosurgical setting is feasible. Signal quality and stability are sufficient for clinical decision making based on mean ICP. The low sampling frequency (5 Hz) does not permit analysis of intracranial pulse wave morphology, but resolution is sufficient for calculation of derived indices such as the pressure reactivity index (PRx).	[Lilja-Cyron, Alexander; Andresen, Morten; Fugleholm, Kare; Juhler, Marianne] Rigshosp, Dept Neurosurg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark; [Kelsen, Jesper] Rigshosp, Dept Orthoped Surg, Spine Sect, Copenhagen, Denmark		Lilja-Cyron, A (corresponding author), Rigshosp, Dept Neurosurg, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	alexander.lilja-cyron@regionh.dk	Fugleholm, Kare/AAW-5086-2021; Kelsen, Jesper/AAH-7372-2020	Lilja-Cyron, Alexander/0000-0003-2915-249X; Andresen, Morten/0000-0002-3802-6033; Fugleholm, Kare/0000-0002-1520-7122	The Council of the Danish Victims Fund	This project was supported by The Council of the Danish Victims Fund through a research grant to M.J., to improve treatment of patients with severe TBI.	Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Andresen M, 2013, J NEUROSURG, V119, P1119, DOI 10.3171/2013.7.JNS13506; Antes S, 2016, WORLD NEUROSURG, V91, P133, DOI 10.1016/j.wneu.2016.03.096; Antes S, 2014, ACTA NEUROCHIR, V156, P1009, DOI 10.1007/s00701-013-1991-7; Antes S, 2014, CHILD NERV SYST, V30, P331, DOI 10.1007/s00381-013-2269-3; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Arroyo-Palacios J, 2016, NEUROCRIT CARE, V25, P424, DOI 10.1007/s12028-016-0268-4; ATKINSON JR, 1967, J NEUROSURG, V27, P428, DOI 10.3171/jns.1967.27.5.0428; Beez T, 2016, J CRANIOFAC SURG, V27, P1032, DOI 10.1097/SCS.0000000000002556; Bor-Seng-Shu E, 2012, J NEUROSURG, V117, P589, DOI 10.3171/2012.6.JNS101400; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Citerio G, 2008, NEUROSURGERY, V63, P1152, DOI 10.1227/01.NEU.0000335148.87042.D7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Eide PK, 2007, NEUROL RES, V29, P578, DOI 10.1179/016164107X172167; Eide PK, 2011, NEUROSURGERY, V69, P1105, DOI 10.1227/NEU.0b013e318227e0e1; Fenoy AJ, 2014, J NEUROSURG, V120, P132, DOI 10.3171/2013.10.JNS131225; Freimann FB, 2014, CHILD NERV SYST, V30, P689, DOI 10.1007/s00381-013-2324-0; Freimann FB, 2013, PEDIATR NEUROSURG, V49, P29, DOI 10.1159/000355561; Fung C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149169; Gelabert-Gonzalez M, 2006, ACTA NEUROCHIR, V148, P435, DOI 10.1007/s00701-005-0683-3; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holm S, 2009, MED ENG PHYS, V31, P601, DOI 10.1016/j.medengphy.2008.12.001; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Hu X, 2008, ACTA NEUROCHIR SUPPL, V102, P131, DOI 10.1007/978-3-211-85578-2_27; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jamjoom AAB, 2018, J NEUROL NEUROSUR PS, V89, P120, DOI 10.1136/jnnp-2017-316415; Kammersgaard LP, 2013, NEUROREHABILITATION, V33, P473, DOI 10.3233/NRE-130980; Kiefer Michael, 2012, Acta Neurochir Suppl, V114, P111, DOI 10.1007/978-3-7091-0956-4_20; Koskinen LOD, 2013, ACTA NEUROCHIR, V155, P2141, DOI 10.1007/s00701-013-1856-0; Kurland DB, 2015, NEUROCRIT CARE, V23, P292, DOI 10.1007/s12028-015-0144-7; Lazaridis C, 2016, NEUROSURG CLIN N AM, V27, P509, DOI 10.1016/j.nec.2016.05.010; Lilja A, 2014, CLIN NEUROL NEUROSUR, V120, P36, DOI 10.1016/j.clineuro.2014.02.010; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Magneli S, 2016, CHILD NERV SYST, V32, P1311, DOI 10.1007/s00381-016-3023-4; Mansson PK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013389; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; Picetti E, 2017, ACTA NEUROCHIR, V159, P615, DOI 10.1007/s00701-017-3118-z; Quinn TM, 2011, ACTA NEUROL SCAND, V123, P239, DOI 10.1111/j.1600-0404.2010.01397.x; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Schmitt M, 2012, ACTA NEUROCHIR SUPPL, V113, P109, DOI 10.1007/978-3-7091-0923-6_22; Smielewski P, 2005, ACT NEUR S, V95, P43; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Tavakoli S, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.8.FOCUS17450; Timofeev I, 1800, Adv Tech Stand Neurosurg, V38, P115, DOI 10.1007/978-3-7091-0676-1_6; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Welschehold S, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e31822dda12; Wijdicks EFM, 2014, STROKE, V45, P1222, DOI 10.1161/01.str.0000441965.15164.d6; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9	55	19	19	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1578	1586		10.1089/neu.2017.5589		MAY 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000431464200001	29648985				2022-02-06	
J	Murdaugh, DL; Ono, KE; Reisner, A; Burns, TG				Murdaugh, Donna L.; Ono, Kim E.; Reisner, Andrew; Burns, Thomas G.			Assessment of Sleep Quantity and Sleep Disturbances During Recovery From Sports-Related Concussion in Youth Athletes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Adolescent; Brain injury; Child; Rehabilitation; Sleep	HIGH-SCHOOL; COLLEGE-STUDENTS; ACADEMIC-PERFORMANCE; DAYTIME SLEEPINESS; FOOTBALL PLAYERS; SCALE PDSS; IMPACT; PATTERNS; HABITS; SPECIFICITY	Objective: To determine the relation between sleep quantity and sleep disturbances on symptoms and neurocognitive ability during the acute phase (<7d) and after sports-related concussion (SRC; >21d). Design: Prospective inception cohort study. Setting: General community setting of regional middle and high schools. Participants: A sample (N=971) including youth athletes with SRC (n=528) and controls (n=443) (age, 10-18y). Interventions: Not applicable. Main Outcome Measures: Athletes completed the Immediate Post-Concussion Assessment and Cognitive Testing battery. Partial correlation analyses and independent t tests were conducted to assess sleep quantity the night before testing. Multivariate analysis of covariance was used to assess sleep disturbances and their interaction with age. Results: Less sleep quantity was correlated with greater report of cognitive (P=.001) and neuropsychological (P=.024) symptoms specific to prolonged recovery from SRC. Sleep disturbances significantly affect each migraine, cognitive, and neuropsychological symptoms (P<.001). A significant interaction was found between sleep disturbances and age (P=.04) at >21 days post-SRC. Conclusions: Findings emphasize that the continued presence of low sleep quantity and sleep disturbances in youth athletes with SRC should be a specific indicator to health professionals that these athletes are at an increased risk of protracted recovery. Further research should identify additional factors that may interact with sleep to increase the risk of protracted recovery. (C) 2018 by the American Congress of Rehabilitation Medicine	[Murdaugh, Donna L.; Ono, Kim E.; Reisner, Andrew; Burns, Thomas G.] Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA		Murdaugh, DL (corresponding author), Childrens Healthcare Atlanta, 1547 Clifton Rd NE,Suite 200, Atlanta, GA 30322 USA.	dlmurdaugh@gmail.com		Murdaugh, Donna/0000-0001-8550-8353			Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Buboltz WC, 2001, J AM COLL HEALTH, V50, P131, DOI 10.1080/07448480109596017; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Drake C, 2003, SLEEP, V26, P455; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Hung Ryan, 2014, Arch Phys Med Rehabil, V95, pS174, DOI 10.1016/j.apmr.2013.08.301; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kelly WE, 2001, COLL STUD J, V35, P84; Kostyun RO, 2014, AM J SPORTS MED, V133, P1; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mah CD, 2008, SLEEP, V31, pA128; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Mous SE, 2017, APPL NEUROPSYCH-CHIL, V6, P22, DOI 10.1080/21622965.2015.1067214; Neveus T, 2001, ACTA PAEDIATR, V90, P1450; Ohayon MM, 2000, J AM ACAD CHILD PSY, V39, P1549, DOI 10.1097/00004583-200012000-00019; Perez-Chada D, 2007, SLEEP, V30, P1698, DOI 10.1093/sleep/30.12.1698; Pilcher JJ, 1997, J PSYCHOSOM RES, V42, P583, DOI 10.1016/S0022-3999(97)00004-4; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Short MA, 2013, NAT SCI SLEEP, V5, P23, DOI 10.2147/NSS.S38369; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Trockel MT, 2000, J AM COLL HEALTH, V49, P125, DOI 10.1080/07448480009596294; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3	38	19	19	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2018	99	5					960	966		10.1016/j.apmr.2018.01.005			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GE7CG	WOS:000431387000019	29425698				2022-02-06	
J	Watanitanon, A; Lyons, VH; Lele, AV; Krishnamoorthy, V; Chaikittisilpa, N; Chandee, T; Vavilala, MS				Watanitanon, Arraya; Lyons, Vivian H.; Lele, Abhijit V.; Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Chandee, Theerada; Vavilala, Monica S.			Clinical Epidemiology of Adults With Moderate Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						adult; facility; moderate; trauma designation; traumatic brain injury	HEAD-INJURY; DIAGNOSIS; OUTCOMES; CLASSIFICATION; TALK; AGE	Objectives: To characterize admission patterns, treatments, and outcomes among patients with moderate traumatic brain injury. Design: Retrospective cohort study. Setting: National Trauma Data Bank. Patients: Adults (age > 18 yr) with moderate traumatic brain injury (International Classification of Diseases, Ninth revision codes and admission Glasgow Coma Scale score of 9-13) in the National Trauma Data Bank between 2007 and 2014. Interventions: None. Measurement and Main Results: Demographics, mechanism of injury, hospital course, and facility characteristics were examined. Admission characteristics associated with discharge outcomes were analyzed using multivariable Poisson regression models. Of 114,066 patients, most were white (62%), male (69%), and had median admission Glasgow Coma Scale score of 12 (interquartile range, 10-13). Seventy-seven percent had isolated traumatic brain injury. Concussion, which accounted for 25% of moderate traumatic brain injury, was the most frequent traumatic brain injury diagnosis. Fourteen percent received mechanical ventilation, and 66% were admitted to ICU. Over 50% received care at a community hospital. Seven percent died, and 32% had a poor outcome, including those with Glasgow Coma Scale score of 13. Compared with patients 18-44 years, patients 45-64 years were twice as likely (adjusted relative risk, 1.97; 95% CI, 1.92-2.02) and patients over 80 years were five times as likely (adjusted relative risk, 4.66; 95% CI, 4.55-4.76) to have a poor outcome. Patients with a poor discharge outcome were more likely to have had hypotension at admission (adjusted relative risk, 1.10; 95% CI, 1.06-1.14), lower admission Glasgow Coma Scale (adjusted relative risk, 1.37; 95% CI, 1.34-1.40), higher Injury Severity Score (adjusted relative risk, 2.97; 95% CI, 2.86-3.09), and polytrauma (adjusted relative risk, 1.05; 95% CI, 1.02-1.07), compared with those without poor discharge outcomes. Conclusions: Many patients with moderate traumatic brain injury deteriorate, require neurocritical care, and experience poor outcomes. Optimization of care and outcomes for this vulnerable group of patients are urgently needed.	[Watanitanon, Arraya; Lele, Abhijit V.; Chaikittisilpa, Nophanan; Chandee, Theerada; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA; [Watanitanon, Arraya; Lyons, Vivian H.; Krishnamoorthy, Vijay; Chaikittisilpa, Nophanan; Chandee, Theerada; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Lyons, Vivian H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Krishnamoorthy, Vijay] Duke Univ, Dept Anesthesiol, Durham, NC USA		Watanitanon, A (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA 98195 USA.; Watanitanon, A (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	arrayawat@gmail.com			National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	Dr. Lele's institution received funding from the National Institutes of Health (NIH). Dr. Vavilala received support for article research from the NIH. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Godoy DA, 2016, NEUROCRIT CARE, V25, P306, DOI 10.1007/s12028-016-0253-y; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Cnossen MC, 2017, CRIT CARE MED, V45, P660, DOI 10.1097/CCM.0000000000002263; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P122, DOI 10.1097/HTR.0000000000000012; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Johnson WD, 2017, LANCET NEUROL, V16, P949, DOI 10.1016/S1474-4422(17)30362-9; Joseph B, 2017, J TRAUMA ACUTE CARE, V82, P575, DOI 10.1097/TA.0000000000001329; Leo P, 2016, TRANSLATIONAL RES TR; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lund SB, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0269-5; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Peterson EC, 2011, J TRAUMA, V71, P1588, DOI 10.1097/TA.0b013e31822b791d; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Scott MS, 2011, GUIDELINES FIELD TRI; Shafiei E, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.29729; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stein SC, 2001, J TRAUMA, V50, P759, DOI 10.1097/00005373-200104000-00032; Stein SC, 2010, J NEUROSURG, V112, P1105, DOI 10.3171/2009.8.JNS09738; TEASDALE G, 1974, LANCET, V2, P81; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1	28	19	19	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	MAY	2018	46	5					781	787		10.1097/CCM.0000000000002991			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GN9ZK	WOS:000439573700039	29369057	Green Accepted			2022-02-06	
J	Kenzie, ES; Parks, EL; Bigler, ED; Wright, DW; Lim, MM; Chesnutt, JC; Hawryluk, GWJ; Gordon, W; Wakeland, W				Kenzie, Erin S.; Parks, Elle L.; Bigler, Erin D.; Wright, David W.; Lim, Miranda M.; Chesnutt, James C.; Hawryluk, Gregory W. J.; Gordon, Wayne; Wakeland, Wayne			The Dynamics of concussion: Mapping Pathophysiology, Persistence, and recovery With causal-loop Diagramming	FRONTIERS IN NEUROLOGY			English	Article						concussion; traumatic brain injury; systems science; complexity; recovery; causal-loop diagram; models of injury; systems medicine	TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; DIFFUSE AXONAL INJURY; DEFAULT MODE NETWORK; SYSTEMS SCIENCE; COMPLEX WORLD; RESTING-STATE; CONNECTIVITY; SYMPTOMS; MILITARY	Despite increasing public awareness and a growing body of literature on the subject of concussion, or mild traumatic brain injury, an urgent need still exists for reliable diagnostic measures, clinical care guidelines, and effective treatments for the condition. Complexity and heterogeneity complicate research efforts and indicate the need for innovative approaches to synthesize current knowledge in order to improve clinical outcomes. Methods from the interdisciplinary field of systems science, including models of complex systems, have been increasingly applied to biomedical applications and show promise for generating insight for traumatic brain injury. The current study uses causal-loop diagramming to visualize relationships between factors influencing the pathophysiology and recovery trajectories of concussive injury, including persistence of symptoms and deficits. The primary output is a series of preliminary systems maps detailing feedback loops, intrinsic dynamics, exogenous drivers, and hubs across several scales, from micro-level cellular processes to social influences. Key system features, such as the role of specific restorative feedback processes and cross-scale connections, are examined and discussed in the context of recovery trajectories. This systems approach integrates research findings across disciplines and allows components to be considered in relation to larger system influences, which enables the identification of research gaps, supports classification efforts, and provides a framework for interdisciplinary collaboration and communication-all strides that would benefit diagnosis, prognosis, and treatment in the clinic.	[Kenzie, Erin S.; Parks, Elle L.; Wakeland, Wayne] Portland State Univ, Syst Sci Program, Portland, OR 97207 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, Provo, UT 84602 USA; [Wright, David W.] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA USA; [Lim, Miranda M.] VA Portland Hlth Care Syst, Res Serv, Div Hosp & Specialty Med, Sleep Disorders Clin, Portland, OR USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Neurol, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Med, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Lim, Miranda M.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Oregon Inst Occupat Hlth Sci, Portland, OR 97201 USA; [Chesnutt, James C.] Oregon Hlth & Sci Univ, TBI Concuss Program, Orthoped & Rehabil, Neurol & Family Med, Portland, OR 97201 USA; [Hawryluk, Gregory W. J.] Univ Utah, Dept Neurosurg, Salt Lake City, UT USA; [Gordon, Wayne] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA		Kenzie, ES (corresponding author), Portland State Univ, Syst Sci Program, Portland, OR 97207 USA.	erin.kenzie@pdx.edu			US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division [W911QY-14-C-0086]; VA Career Development Award [IK2 BX002712]; Portland VA Research Foundation; Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0095]	This material is based upon work supported by the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, through a contract awarded to Stanford University (W911QY-14-C-0086), and a subcontract awarded to the Brain Trauma Foundation. This material is in part the result of work supported with resources and the use of facilities at the VA Portland Health Care System, the VA Career Development Award #IK2 BX002712, and Portland VA Research Foundation (MML). In part, the Brain Imaging and Behavior Lab that EB directs was supported by the Army Medical Research and Material Command under Award No. W81XWH-13-2-0095 (Chronic Effects of Neurotrauma Consortium). Also, EB co-directs the Neuropsychological Assessment and Research Laboratory at Brigham Young University which includes forensic consultation. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the US Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division, Stanford University, the Brain Trauma Foundation, U.S. Department of Veterans Affairs or the United States Government.	[Anonymous], 2007, THINKING SYSTEMS PRI; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; Astafiev SV, 2016, NEUROIMAGE-CLIN, V11, P10, DOI 10.1016/j.nicl.2016.01.004; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Barbey AK, 2015, CURR OPIN BEHAV SCI, V4, P92, DOI 10.1016/j.cobeha.2015.04.002; Bassett DS, 2017, NAT NEUROSCI, V20, P353, DOI 10.1038/nn.4502; Bigler ED, 2016, BRAIN, V139, P3054, DOI 10.1093/brain/aww277; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2010, J NEUROL NEUROSUR PS, V81, pE12, DOI 10.1136/jnnp.2010.217554.28; Chen Y, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00119; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cohen JR, 2016, J NEUROSCI, V36, P12083, DOI 10.1523/JNEUROSCI.2965-15.2016; Crossley NA, 2016, PSYCHOL MED, V46, P897, DOI 10.1017/S0033291715002895; Crowe Louise M, 2015, Handb Clin Neurol, V128, P661, DOI 10.1016/B978-0-444-63521-1.00041-8; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dougherty Joseph D, 2017, Curr Opin Syst Biol, V3, P67, DOI 10.1016/j.coisb.2017.04.011; Dulla CG, 2016, NEUROSCIENTIST, V22, P295, DOI 10.1177/1073858415585108; Fisher JAN, 2016, IEEE T NEUR SYS REH, V24, P1003, DOI 10.1109/TNSRE.2016.2529663; Fonzo GA, 2017, DIALOGUES CLIN NEURO, V19, P169; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Ghajar J, 2008, NEUROREHAB NEURAL RE, V22, P217, DOI 10.1177/1545968308315600; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gordon Wayne A, 2015, Handb Clin Neurol, V127, P423, DOI 10.1016/B978-0-444-52892-6.00027-1; Hack D., 2016, BRIDGE NATL ACAD ENG, V46, P34; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Heine L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00295; Hemphill MA, 2015, NEURON, V85, P1177, DOI 10.1016/j.neuron.2015.02.041; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hladky SB, 2019, HANDB EXP PHARMACOL, V253, P385, DOI 10.1007/164_2017_37; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Hwang K, 2017, J NEUROSCI, V37, P5594, DOI 10.1523/JNEUROSCI.0067-17.2017; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Insel TR, 2015, SCIENCE, V348, P499, DOI 10.1126/science.aab2358; Jackson CE, 2017, BRAIN INJURY, V31, P485, DOI 10.1080/02699052.2017.1280740; Jiang HD, 2017, CEREB CORTEX, V27, P4083, DOI 10.1093/cercor/bhw220; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnston LM, 2014, AM J PUBLIC HEALTH, V104, P1270, DOI 10.2105/AJPH.2014.301884; Jones NA, 2011, ECOL SOC, V16; Katz Douglas I, 2015, Handb Clin Neurol, V127, P131, DOI 10.1016/B978-0-444-52892-6.00009-X; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King LA, 2014, ARCH PHYS MED REHAB, V95, P353, DOI 10.1016/j.apmr.2013.10.015; Kurowski BG, 2017, J NEUROTRAUM, V34, P2280, DOI 10.1089/neu.2016.4856; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Lee SW, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00843; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lippa SM, 2018, ARCH CLIN NEUROPSYCH, V33, P606, DOI 10.1093/arclin/acx098; Logsdon AF, 2015, COMPR PHYSIOL, V5, P1147, DOI 10.1002/cphy.c140057; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Mabry PL, 2013, HEALTH EDUC BEHAV, V40, p9S, DOI 10.1177/1090198113503469; Malhotra RK, 2017, NEUROL CLIN, V35, P547, DOI 10.1016/j.ncl.2017.03.002; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McAllister TW, 2002, NEUROREHABILITATION, V17, P265; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Muresanu DF, 2012, J CELL MOL MED, V16, P2861, DOI 10.1111/j.1582-4934.2012.01605.x; Oehr L, 2017, ARCH PHYS MED REHAB, V98, P2308, DOI 10.1016/j.apmr.2017.03.019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raskin SA, 2014, UNDERSTANDING TRAUMA, P370; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Reynolds Erin, 2014, Neurosurgery, V75 Suppl 4, pS71, DOI 10.1227/NEU.0000000000000471; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sacher J, 2012, J AFFECT DISORDERS, V140, P142, DOI 10.1016/j.jad.2011.08.001; Seung S., 2013, CONNECTOME BRAINS WI; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Smith Douglas H, 2016, Bridge (Wash D C), V46, P79; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sporns O, 2016, ANNU REV PSYCHOL, V67, P613, DOI 10.1146/annurev-psych-122414-033634; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Sterman JD, 2006, AM J PUBLIC HEALTH, V96, P505, DOI 10.2105/AJPH.2005.066043; Sterman JD, 2001, CALIF MANAGE REV, V43, P8, DOI 10.2307/41166098; Stone JR, 2016, BRAIN INJURY, V30, P1458, DOI 10.1080/02699052.2016.1222080; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Waljas M, 2014, J NEUROTRAUM, V31, P108, DOI 10.1089/neu.2013.2941; Wakeland W, 2015, AM J DRUG ALCOHOL AB, V41, P508, DOI 10.3109/00952990.2015.1043435; Waljas M, 2015, J NEUROTRAUM, V32, P534, DOI 10.1089/neu.2014.3339; Wittenborn AK, 2016, PSYCHOL MED, V46, P551, DOI 10.1017/S0033291715002044; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamawaki S, 2012, INT J NEUROPSYCHOPH, V15, P681, DOI 10.1017/S1461145711000757; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	113	19	19	1	9	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 4	2018	9								203	10.3389/fneur.2018.00203			16	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GB6KY	WOS:000429179300002	29670568	Green Published, gold			2022-02-06	
J	Becker, RE; Kapogiannis, D; Greig, NH				Becker, Robert E.; Kapogiannis, Dimitrios; Greig, Nigel H.			Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?	ALZHEIMERS & DEMENTIA			English	Article						Concussion; Alzheimer's disease; Neuropathology; Anecrotic cell death; Preprogrammed cell death; Timing of therapeutic interventions; Drug targets	AMYLOID PRECURSOR PROTEIN; CLINICAL-TRIALS; RISK-FACTOR; COGNITIVE IMPAIRMENT; CEREBROSPINAL-FLUID; PATHOLOGICAL LINK; PIFITHRIN-ALPHA; BLOOD EXOSOMES; DOUBLE-BLIND; EARLIER AGE	Introduction: Neurodegenerative disorders have been a graveyard for hundreds of well-intentioned efforts at drug discovery and development. Concussion and other traumatic brain injuries (TBIs) and Alzheimer's disease (AD) share many overlapping pathologies and possible clinical links. Methods: We searched the literature since 1995 using MEDLINE and Google Scholar for the terms concussion, AD, and shared neuropathologies. We also studied a TBI animal model as a supplement to transgenic (Tg) mouse AD models for evaluating AD drug efficacy by preventing neuronal losses. To evaluate TBI/AD pathologies and neuronal self-induced cell death (apoptosis), we are studying brain extracellular vesicles in plasma and (-)-phenserine pharmacology to probe, in animal models of AD and humans, apoptosis and pathways common to concussion and AD. Results: Neuronal cell death and a diverse and significant pathological cascade follow TBIs. Many of the developing pathologies are present in early AD. The use of an animal model of concussion as a supplement to Tg mice provides an indication of an AD drug candidate's potential for preventing apoptosis and resulting progression toward dementia in AD. This weight drop supplementation to Tg mouse models, the experimental drug (-)-phenserine, and plasma-derived extracellular vesicles enriched for neuronal origin to follow biomarkers of neurodegenerative processes, each and in combination, show promise as tools useful for probing the progression of disease in AD, TBI/AD pathologies, apoptosis, and drug effects on rates of apoptosis both preclinically and in humans. (-)-Phenserine both countered many subacute post-TBI pathologies that could initiate clinical AD and, in the concussion and other animal models, showed evidence consistent with direct inhibition of neuronal preprogrammed cell death in the presence of TBI/AD pathologies. Discussion: These findings may provide support for expanding preclinical Tg mouse studies in AD with a TBI weight drop model, insights into the progression of pathological targets, their relations to apoptosis, and timing of interventions against these targets and apoptosis. Such studies may demonstrate the potential for drugs to effectively and safely inhibit preprogrammed cell death as a new drug development strategy for use in the fight to defeat AD. Published by Elsevier Inc. on behalf of the Alzheimer's Association.	[Becker, Robert E.] Aristea Translat Med Corp, Park City, UT 84098 USA; [Kapogiannis, Dimitrios] NIA, Lab Neurosci, Intramural Res Program, Baltimore, MD 21224 USA; [Becker, Robert E.; Greig, Nigel H.] NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program, Baltimore, MD 21224 USA		Becker, RE (corresponding author), Aristea Translat Med Corp, Park City, UT 84098 USA.; Becker, RE (corresponding author), NIA, Drug Design & Dev Sect, Translat Gerontol Branch, Intramural Res Program, Baltimore, MD 21224 USA.	rebecker@aristeatm.com; greign@nih.gov	Kapogiannis, Dimitrios/AAW-4934-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118	Intramural Research Program of the National Institute on Aging, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000311, ZIAAG000975] Funding Source: NIH RePORTER	The authors appreciate the comments and observations of the Editors, Alzheimer's & Dementia. These assisted greatly in the preparation of this article. The authors thank Lauren Brick, Visual Media Services, Intramural Research Program, National Institute on Aging, NIH, in relation to Figure 1. R.E.B. is the president of Aristea Translational Medicine Corporation and an inventor on a patent pending on a method to treat concussion and prevent Alzheimer's disease assigned to Aristea Translational Medicine Corporation. N.H.G. and D.K. have no conflicts of interest to declare and are supported by the Intramural Research Program of the National Institute on Aging, NIH.	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Becker R, 2000, CLIN DRUG INVEST, V19, P33, DOI 10.2165/00044011-200019010-00005; Becker RE, 2010, CURR ALZHEIMER RES, V7, P642; Becker RE, 1998, ALZ DIS ASSOC DIS, V12, P54, DOI 10.1097/00002093-199803000-00009; Becker RE, 1996, ALZ DIS ASSOC DIS, V10, P124, DOI 10.1097/00002093-199601030-00003; Becker RE, 2001, CLIN DRUG INVEST, V21, P727, DOI 10.2165/00044011-200121100-00007; Becker RE., 2016, J PATIENT SAF; Becker RE, 2008, J ALZHEIMERS DIS, V15, P303; Becker RE, 2015, LANCET PSYCHIAT, V2, P756, DOI 10.1016/S2215-0366(15)00214-X; Becker RE, 2014, CURR ALZHEIMER RES, V11, P215, DOI 10.2174/156720501103140329210642; Becker RE, 2014, NAT REV DRUG DISCOV, V13, P157, DOI 10.1038/nrd3842-c2; Becker RE, 2013, ALZHEIMERS DEMENT, V9, P50, DOI 10.1016/j.jalz.2012.01.007; Becker RE, 2012, CURR ALZHEIMER RES, V9, P1174; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Chang CF, 2017, BRAIN RES, V1677, P118, DOI 10.1016/j.brainres.2017.09.015; Chang JR, 2012, NEURODEGENER DIS, V9, P68, DOI 10.1159/000329999; Checler F, 2014, PHARMACOL THERAPEUT, V142, P99, DOI 10.1016/j.pharmthera.2013.11.009; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cummings JL, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0173-2; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Esquerda-Canals G, 2017, J ALZHEIMERS DIS, V57, P1171, DOI 10.3233/JAD-170045; Eve DJ, 2016, NEUROPSYCH DIS TREAT, V12, P2689, DOI 10.2147/NDT.S110126; Fargo KN, 2016, ALZHEIMERS DEMENT, V12, P1113, DOI 10.1016/j.jalz.2016.10.001; Feynman R. P., 1974, ENG SCI, V37, P10; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Giza CC, 2001, J ATHL TRAINING, V36, P228; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greig Nigel H., 2005, Current Alzheimer Research, V2, P483, DOI 10.2174/156720505774330564; Greig Nigel H., 2005, Current Alzheimer Research, V2, P281, DOI 10.2174/1567205054367829; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; Hardy J, 2017, FEBS J, V284, P1040, DOI 10.1111/febs.14004; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hoffer BJ, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0377-1; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Itoh T, 2009, MOL CELL BIOCHEM, V324, P191, DOI 10.1007/s11010-008-0013-1; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kamat P.K., 2014, THER TARGETS NEUROL, V1; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Khachaturian ZS, 2012, ADV BIOL PSYCH-KARG, V28, P179; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kwak YD, 2014, BIOCHEM BIOPH RES CO, V447, P394, DOI 10.1016/j.bbrc.2014.03.139; Lahiri DK, 2007, J PHARMACOL EXP THER, V320, P386, DOI 10.1124/jpet.106.112102; Lilja AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054887; Lipska K, 2016, NY TIMES; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Lobue C, 2016, J ALZHEIMERS DIS, V51, P727, DOI 10.3233/JAD-150895; Luukinen H, 2005, EUR J NEUROL, V12, P86, DOI 10.1111/j.1468-1331.2004.00953.x; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Mikkilineni S, 2012, PARKINSONS DIS, V2012, P5; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Moyron RB, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700095; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nigro A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00017; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Sambamurti K., 2007, ALZHEIMERS DIS NEW A, P571; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Shahaduzzaman M, 2013, MED HYPOTHESES, V81, P675, DOI 10.1016/j.mehy.2013.07.025; Shimohama S, 2000, APOPTOSIS, V5, P9, DOI 10.1023/A:1009625323388; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Supramaniam V, 2013, PEDIATR RES, V73, P301, DOI 10.1038/pr.2012.186; Sutphen CL, 2015, JAMA NEUROL, V72, P1029, DOI 10.1001/jamaneurol.2015.1285; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Taylor DD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0503; Tweedie D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156493; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vella MA, 2017, SURG CLIN N AM, V97, P1015, DOI 10.1016/j.suc.2017.06.003; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yang LY, 2016, NEUROBIOL DIS, V96, P216, DOI 10.1016/j.nbd.2016.08.012; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134; Zhu XW, 2013, J ALZHEIMERS DIS, V33, pS253, DOI 10.3233/JAD-2012-129005	95	19	19	1	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	APR	2018	14	4					431	443		10.1016/j.jalz.2017.11.007			13	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC6LN	WOS:000429903200001	29245000	Green Accepted			2022-02-06	
J	Galindo, LT; Mundim, MTVV; Pinto, AS; Chiarantin, GMD; Almeida, MES; Lamers, ML; Horwitz, AR; Santos, MF; Porcionatto, M				Galindo, Layla T.; Mundim, Mayara T. V. V.; Pinto, Agnes S.; Chiarantin, Gabrielly M. D.; Almeida, Maira E. S.; Lamers, Marcelo L.; Horwitz, Alan R.; Santos, Marinilce F.; Porcionatto, Marimelia			Chondroitin Sulfate Impairs Neural Stem Cell Migration Through ROCK Activation	MOLECULAR NEUROBIOLOGY			English	Article						Neural stem cell; Cell migration; Chondroitin sulfate; Traumatic brain injury; RhoA; Rock	SPINAL-CORD-INJURY; FOCAL CEREBRAL-ISCHEMIA; FUNCTIONAL RECOVERY; NEURITE OUTGROWTH; RHO/ROCK PATHWAY; NERVOUS-SYSTEM; GLIAL SCAR; REGENERATION; PROTEOGLYCANS; PHOSPHATASE	Brain injuries such as trauma and stroke lead to glial scar formation by reactive astrocytes which produce and secret axonal outgrowth inhibitors. Chondroitin sulfate proteoglycans (CSPG) constitute a well-known class of extracellular matrix molecules produced at the glial scar and cause growth cone collapse. The CSPG glycosaminoglycan side chains composed of chondroitin sulfate (CS) are responsible for its inhibitory activity on neurite outgrowth and are dependent on RhoA activation. Here, we hypothesize that CSPG also impairs neural stem cell migration inhibiting their penetration into an injury site. We show that DCX+ neuroblasts do not penetrate a CSPG-rich injured area probably due to Nogo receptor activation and RhoA/ROCK signaling pathway as we demonstrate in vitro with neural stem cells cultured as neurospheres and pull-down for RhoA. Furthermore, CS-impaired cell migration in vitro induced the formation of large mature adhesions and altered cell protrusion dynamics. ROCK inhibition restored migration in vitro as well as decreased adhesion size.	[Galindo, Layla T.; Mundim, Mayara T. V. V.; Pinto, Agnes S.; Chiarantin, Gabrielly M. D.; Porcionatto, Marimelia] Univ Fed Sao Paulo, Dept Biochem, Neurobiol Lab, Rua Pedro de Toledo 669,3 Andar, BR-04039032 Sao Paulo, SP, Brazil; [Almeida, Maira E. S.] Butantan Inst, Physiopathol Lab, BR-05503900 Sao Paulo, Brazil; [Lamers, Marcelo L.] Univ Fed Rio Grande do Sul, Dept Morphol Sci, BR-90050170 Porto Alegre, RS, Brazil; [Horwitz, Alan R.] Univ Virginia, Dept Cell Biol, Sch Med, Charlottesville, VA 22903 USA; [Santos, Marinilce F.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, BR-05508000 Sao Paulo, Brazil		Porcionatto, M (corresponding author), Univ Fed Sao Paulo, Dept Biochem, Neurobiol Lab, Rua Pedro de Toledo 669,3 Andar, BR-04039032 Sao Paulo, SP, Brazil.	marimelia.porcionatto@unifesp.br	Santos, Marinilce F/G-9548-2011; Mundim, Mayara V/N-9985-2015; Araujo Sardinha Pinto, Agnes/ABB-4851-2021; Porcionatto, Marimelia/C-3322-2012; LAMERS, MARCELO/A-5291-2013	Santos, Marinilce F/0000-0002-3257-3327; Araujo Sardinha Pinto, Agnes/0000-0002-5895-7353; Porcionatto, Marimelia/0000-0001-6287-916X; LAMERS, MARCELO/0000-0001-5296-5662; Mundim, Mayara/0000-0002-9771-977X	Fundacao de Amparo a Pesquisa de Sao Paulo - FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/00526-7, 2012/00652]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPqConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [404,646/2012-3]; National Institute of General Medical SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [GM23244]	This work was supported by Fundacao de Amparo a Pesquisa de Sao Paulo - FAPESP (2011/00526-7; 2012/00652 to MP), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (404,646/2012-3 to MP), and National Institute of General Medical Sciences (GM23244 to ARH).	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Ayoub E, 2013, J BIOL CHEM, V288, P25739, DOI 10.1074/jbc.M113.501007; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Chiba S, 2004, J NEUROL SCI, V219, P107, DOI 10.1016/j.jns.2004.01.006; Coulson-Thomas YA, 2008, J NEUROSCI METH, V171, P19, DOI 10.1016/j.jneumeth.2008.01.030; Dickendesher TL, 2012, NAT NEUROSCI, V15, P703, DOI 10.1038/nn.3070; Dyck SM, 2015, STEM CELLS, V33, P2550, DOI 10.1002/stem.1979; Filippo TRM, 2013, STEM CELL RES, V11, P913, DOI 10.1016/j.scr.2013.06.003; Fisher D, 2011, J NEUROSCI, V31, P14051, DOI 10.1523/JNEUROSCI.1737-11.2011; Fonseca AV, 2010, J BIOL CHEM, V285, P31661, DOI 10.1074/jbc.M110.145037; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Galindo LT, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/564089; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gandham VD, 2013, CLIN EXP DERMATOL, V38, P782, DOI 10.1111/ced.12067; Garcia-Alias G, 2009, NAT NEUROSCI, V12, P1145, DOI 10.1038/nn.2377; Garwood J, 2003, J BIOL CHEM, V278, P24164, DOI 10.1074/jbc.M211721200; Garwood J, 1999, J NEUROSCI, V19, P3888; Goetsch KP, 2014, J CELL BIOCHEM, V115, P1299, DOI 10.1002/jcb.24784; Gu WL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-128; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Jaerve A, 2012, CELL TISSUE RES, V349, P229, DOI 10.1007/s00441-012-1427-3; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kojima T, 2010, STEM CELLS, V28, P545, DOI 10.1002/stem.306; Laabs T, 2005, CURR OPIN NEUROBIOL, V15, P116, DOI 10.1016/j.conb.2005.01.014; Leong SY, 2011, NEUROCHEM INT, V59, P382, DOI 10.1016/j.neuint.2010.12.024; Leong SY, 2011, STEM CELLS, V29, P332, DOI 10.1002/stem.577; Li X, 2011, NEUROCHEM RES, V36, P2363, DOI 10.1007/s11064-011-0562-7; Lin R, 2008, J NEUROCHEM, V104, P400, DOI 10.1111/j.1471-4159.2007.05066.x; Llorens F, 2011, FASEB J, V25, P463, DOI 10.1096/fj.10-162792; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Monnier PP, 2003, MOL CELL NEUROSCI, V22, P319, DOI 10.1016/S1044-7431(02)00035-0; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Siebert JR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/845323; Siebzehnrubl FA, 2011, METHODS MOL BIOL, V750, P61, DOI 10.1007/978-1-61779-145-1_4; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; Tanaka M, 2003, J NEUROSCI, V23, P2804, DOI 10.1523/jneurosci.23-07-02804.2003; Vicente-Manzanares M, 2011, J CELL BIOL, V193, P381, DOI 10.1083/jcb.201012159; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; Wang D, 2014, NEURAL REGEN RES, V9, P2189, DOI 10.4103/1673-5374.147952; Wang F, 2008, NEUROSCIENCE, V151, P74, DOI 10.1016/j.neuroscience.2007.10.034; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Yan YP, 2007, J CEREBR BLOOD F MET, V27, P1213, DOI 10.1038/sj.jcbfm.9600432; Zhou CX, 2010, CELL MOL BIOENG, V3, P76, DOI 10.1007/s12195-010-0106-2	60	19	20	2	9	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2018	55	4					3185	3195		10.1007/s12035-017-0565-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY8EX	WOS:000427097500037	28477140	Green Published, hybrid			2022-02-06	
J	Georgoff, PE; Nikolian, VC; Higgins, G; Chtraklin, K; Eidy, H; Ghandour, MH; Williams, A; Athey, B; Alam, HB				Georgoff, Patrick E.; Nikolian, Vahagn C.; Higgins, Gerald; Chtraklin, Kiril; Eidy, Hassan; Ghandour, Mohamed H.; Williams, Aaron; Athey, Brian; Alam, Hasan B.			Valproic acid induces prosurvival transcriptomic changes in swine subjected to traumatic injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Valproic acid; histone deacetylase inhibitor; genomics; RNA sequencing; trauma; hemorrhage; traumatic brain injury	HISTONE DEACETYLASE INHIBITORS; GENE-EXPRESSION PROFILES; BRAIN-INJURY; PHARMACOLOGICAL RESUSCITATION; CHROMATIN-STRUCTURE; LESION SIZE; MODEL; MECHANISMS; BIOCONDUCTOR; INFLAMMATION	BACKGROUND: Valproic acid (VPA) is a histone deacetylase inhibitor that improves outcomes in large animal models of trauma. However, its protective mechanism of action is not completely understood. We sought to characterize the genetic changes induced by VPA treatment following traumatic injuries. METHODS: Six female Yorkshire swine were subjected to traumatic brain injury (controlled cortical impact), polytrauma (liver and splenic laceration, rib fracture, rectus crush), and hemorrhagic shock (HS, 40% total blood volume). Following 2 hours of HS, animals were randomized to resuscitation with normal saline (NS) or NS + 150 mg/kg of intravenous VPA (n = 3/cohort, 18 samples total). Blood samples were collected for isolation of peripheral blood mononuclear cells at three distinct time points: baseline, 6 hours following injuries, and on postinjury day 1. RNA was extracted from peripheral blood mononuclear cells and sequenced. Differential expression analysis (false discovery rate < 0.001 and p value <0.001) and gene set enrichment (Panther Gene Ontology and Ingenuity Pathway Analysis) was used to compare VPA to non-VPA-treated animals. RESULTS: A total of 628 differentially expressed RNA transcripts were identified, 412 of which were used for analysis. There was no difference between treatment groups at baseline. The VPA-induced genetic changes were similar at 6 hours and on postinjury day 1. Upregulated genes were associated with gene expression (p 2.13E-34), cellular development (1.19E-33), cellular growth and proliferation (1.25E-30), and glucocorticoid receptor signaling (8.6E-21). Downregulated genes were associated with cell cycle checkpoint regulation (3.64E-22), apoptosis signaling (6.54E-21), acute phase response signaling (5.84E-23), and the inflammasome pathway (1.7E-19). CONCLUSION: In injured swine, VPA increases the expression of genes associated with cell survival, proliferation, and differentiation and decreases those associated with cell death and inflammation. These genetic changes could explain the superior clinical outcomes in VPA-treated animals, including smaller brain lesion size and improved neurologic recovery. (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Georgoff, Patrick E.; Nikolian, Vahagn C.; Chtraklin, Kiril; Eidy, Hassan; Ghandour, Mohamed H.; Williams, Aaron; Alam, Hasan B.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Higgins, Gerald; Athey, Brian] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu		Higgins, Gerry/0000-0002-0434-1465	US Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0520]; Massey Foundation	Funded by research grants from the US Army Medical Research and Material Command (W81XWH-09-1-0520) to HBA and the Massey Foundation to HBA and PEG.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bose P, 2014, PHARMACOL THERAPEUT, V143, P323, DOI 10.1016/j.pharmthera.2014.04.004; BOYUM A, 1977, LYMPHOLOGY, V10, P71; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chen YF, 2016, BIOINFORMATICS, V32, P1832, DOI 10.1093/bioinformatics/btw074; Dekker SE, 2014, J TRAUMA ACUTE CARE, V77, P906, DOI 10.1097/TA.0000000000000345; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Felisbino MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029144; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Gao LY, 2011, BIOINFORMATICS, V27, P662, DOI 10.1093/bioinformatics/btr005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georgoff PE, 2017, J NEUROTRAUM, V34, P2167, DOI 10.1089/neu.2016.4859; Georgoff PE, 2016, J TRAUMA ACUTE CARE, V81, P1020, DOI 10.1097/TA.0000000000001249; Georgoff PE, 2017, CLIN PHARMACOKINET; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Gray SG, 2004, INT J ONCOL, V24, P773; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Halaweish I, 2015, J TRAUMA ACUTE CARE, V79, P911, DOI 10.1097/TA.0000000000000789; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Higgins GA, 2017, PHARM RES-DORDR, V34, P1658, DOI 10.1007/s11095-017-2130-6; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Jepsen CH, 2014, J TRAUMA ACUTE CARE, V77, P292, DOI 10.1097/TA.0000000000000333; Jin G, 2012, J TRAUMA ACUTE CARE, V73, P1461, DOI 10.1097/TA.0b013e3182782641; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Li YQ, 2010, SURGERY, V148, P246, DOI 10.1016/j.surg.2010.05.003; Liu XS, 2012, NEUROSCIENCE, V220, P313, DOI 10.1016/j.neuroscience.2012.06.012; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lv L, 2011, BRAIN RES, V1396, P60, DOI 10.1016/j.brainres.2011.03.040; Maier RV, 2014, J TRAUMA ACUTE CARE, V77, P912; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Nikolian VC, 2016, J AM COLL SURGEONS, V223, pS83, DOI 10.1016/j.jamcollsurg.2016.06.162; Nueda MJ, 2014, BIOINFORMATICS, V30, P2598, DOI 10.1093/bioinformatics/btu333; Peart MJ, 2003, CANCER RES, V63, P4460; Perucca E, 2002, CNS DRUGS, V16, P695, DOI 10.2165/00023210-200216100-00004; Sauaia A, 2017, CRIT CARE CLIN, V33, P167, DOI 10.1016/j.ccc.2016.08.006; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Sillesen M, 2016, J TRAUMA ACUTE CARE, V80, P26, DOI 10.1097/TA.0000000000000896; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhao T, 2013, SURGERY, V154, P206, DOI 10.1016/j.surg.2013.04.003	48	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	APR	2018	84	4					642	649		10.1097/TA.0000000000001763			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GE4IT	WOS:000431179700013	29251706				2022-02-06	
J	Goodrich-Hunsaker, NJ; Abildskov, TJ; Black, G; Bigler, ED; Cohen, DM; Mihalov, LK; Bangert, BA; Taylor, HG; Yeates, KO				Goodrich-Hunsaker, Naomi J.; Abildskov, Tracy J.; Black, Garrett; Bigler, Erin D.; Cohen, Daniel M.; Mihalov, Leslie K.; Bangert, Barbara A.; Taylor, H. Gerry; Yeates, Keith O.			Age- and sex-related effects in children with mild traumatic brain injury on diffusion magnetic resonance imaging properties: A comparison of voxelwise and tractography methods	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						diffusion tensor imaging; mild traumatic brain injury; pediatric; development; white matter integrity	WHITE-MATTER TRACTS; CORTICAL THICKNESS; MRI; DTI; SEGMENTATION; PARAMETERIZATION; MICROSTRUCTURE; REGISTRATION; ADOLESCENCE; RELIABILITY	Although there are several techniques to analyze diffusion-weighted imaging, any technique must be sufficiently sensitive to detect clinical abnormalities. This is especially critical in disorders like mild traumatic brain injury (mTBI), where pathology is likely to be subtle. mTBI represents a major public health concern, especially for youth under 15 years of age. However, the developmental period from birth to 18 years is also a time of tremendous brain changes. Therefore, it is important to establish the degree of age-and sex-related differences. Participants were children aged 8-15 years with mTBI or mild orthopedic injuries. Imaging was obtained within 10 days of injury. We performed tract-based spatial statistics (TBSS), deterministic tractography using Automated Fiber Quantification (AFQ), and probabilistic tractography using TRACULA (TRActs Constrained by UnderLying Anatomy) to evaluate whether any method provided improved sensitivity at identifying group, developmental, and/or sex-related differences. Although there were no group differences from any of the three analyses, many of the tracts, but not all, revealed increases of fractional anisotropy and decreases of axial, radial, and mean diffusivity with age. TBSS analyses resulted in age-related changes across all white matter tracts. AFQ and TRACULA revealed age-related changes within the corpus callosum, cingulum cingulate, corticospinal tract, inferior and superior longitudinal fasciculus, and uncinate fasciculus. The results are in many ways consistent across all three methods. However, results from the tractography methods provided improved sensitivity and better tract-specific results for identifying developmental and sex-related differences within the brain.	[Goodrich-Hunsaker, Naomi J.; Abildskov, Tracy J.; Bigler, Erin D.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Black, Garrett] Ohio State Univ, Fisher Coll Business, Columbus, OH 43210 USA; [Cohen, Daniel M.; Mihalov, Leslie K.] Nationwide Childrens Hosp, Div Emergency Med, Columbus, OH USA; [Bangert, Barbara A.] Case Western Reserve Univ, Sch Med, Dept Radiol, Cleveland, OH USA; [Taylor, H. Gerry] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Yeates, Keith O.] Univ Calgary, Dept Psychol, 2500 Univ Dr NW,AD254, Calgary, AB T2N 1N4, Canada		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, 2500 Univ Dr NW,AD254, Calgary, AB T2N 1N4, Canada.	kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury [1R01HD076885]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD076885] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Predicting Outcomes in Children with Mild Traumatic Brain Injury, 1R01HD076885.	Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Bookstein F. L, 2001, WORKSH BIOM STAT; Chen Z, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00009; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Concha L, 2012, NEUROLOGY, V79, P455, DOI 10.1212/WNL.0b013e31826170b6; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Drakesmith M, 2016, JAMA PSYCHIAT, V73, P396, DOI 10.1001/jamapsychiatry.2015.3375; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Fink AZ, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150753; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Goodrich-Hunsaker N., 2017, AUTOMATED FIBER QUAN; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Herting MM, 2012, CEREB CORTEX, V22, P1979, DOI 10.1093/cercor/bhr246; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnson CP, 2015, NEUROIMAGE-CLIN, V9, P668, DOI 10.1016/j.nicl.2015.10.009; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Kodiweera C, 2016, NEUROIMAGE, V128, P180, DOI 10.1016/j.neuroimage.2015.12.033; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lin FC, 2006, NEUROIMAGE, V33, P154, DOI 10.1016/j.neuroimage.2006.03.055; Mirzaalian H, 2016, NEUROIMAGE, V135, P311, DOI 10.1016/j.neuroimage.2016.04.041; Myall NJ, 2013, J CHILD NEUROL, V28, P771, DOI 10.1177/0883073812449693; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Robinson Emma C, 2013, Inf Process Med Imaging, V23, P475, DOI 10.1007/978-3-642-38868-2_40; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schmithorst VJ, 2008, HUM BRAIN MAPP, V29, P696, DOI 10.1002/hbm.20431; Schwehm A, 2016, NEUROPSYCHOPHARMACOL, V41, P2473, DOI 10.1038/npp.2016.47; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stephens R, 2009, NEUROREPORT, V20, P1056, DOI 10.1097/WNR.0b013e32832e64b1; Toth A, 2018, BEHAV BRAIN RES, V340, P106, DOI 10.1016/j.bbr.2017.02.039; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; Uda S, 2015, DEV NEUROSCI-BASEL, V37, P182, DOI 10.1159/000373885; van Hemmen J, 2017, CEREB CORTEX, V27, P2994, DOI 10.1093/cercor/bhw156; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Walker L, 2016, NEUROIMAGE, V124, P1125, DOI 10.1016/j.neuroimage.2015.05.083; Wang YY, 2012, BRAIN RES, V1478, P1, DOI 10.1016/j.brainres.2012.08.038; Wassermann D, 2011, LECT NOTES COMPUT SC, V6801, P320, DOI 10.1007/978-3-642-22092-0_27; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xue R, 1999, MAGNET RESON MED, V42, P1123, DOI 10.1002/(SICI)1522-2594(199912)42:6<1123::AID-MRM17>3.0.CO;2-H; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023	62	19	19	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	APR	2018	96	4			SI		626	641		10.1002/jnr.24142			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV2DK	WOS:000424374300013	28984377	Green Accepted			2022-02-06	
J	Sieber, M; Dressler, J; Franke, H; Pohlers, D; Ondruschka, B				Sieber, Monique; Dressler, Jan; Franke, Heike; Pohlers, Dirk; Ondruschka, Benjamin			Post-mortem biochemistry of NSE and S100B: A supplemental tool for detecting a lethal traumatic brain injury?	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						Autopsy; Cerebrospinal fluid; NSE; Post-mortem biochemistry; S100B; Traumatic brain injury	NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; S-100B PROTEIN; SERUM; BIOMARKERS; MARKER; HEMOLYSIS; BLOOD; TIME; CSF	Purpose: Traumatic brain injury (TBI) is a very common entity that leads to numerous fatalities all over the world. Therefore, forensic pathologists are in desperate need of supplemental methodological tools for the diagnosis of TBI in everyday practice besides the standard autopsy. The present study determined post-mortem neuron specific enolase (NSE) and S100 calcium-binding protein B (S100B) levels as biological markers of an underlying TBI in autopsy cases. Methods: Paired serum and CSF samples of 92 fatalities were collected throughout routine autopsies. Afterwards, the marker levels were assessed using commercially available immunoassays (ECLIA, Roche Diagnostics). For statistical analysis, we compared the TBI cases to three control groups (sudden natural death by acute myocardial infarction, traumatic death without impact on the head, cerebral hypoxia). Moreover, the TBI cases were subdivided according to their survival time of the trauma. Brain specimens have been collected and stained immunohistochemically against the aforementioned proteins to illustrate their typical cellular staining patterns with an underlying TBI compared to non-TBI fatalities. Principal results: CSF NSE and S100B levels were elevated after TBI compared to all control groups (p < 0.001). Although this finding can already be investigated among the TBI cases dying immediately subsequent to the trauma, the marker levels in CSF increase with longer survival times until a peak level within the first three days after trauma. There is a strong correlation between both marker levels in CSF (r=0.67). The presence or absence of cerebral tissue contusion following the initial trauma does not seem to affect the CSF levels of both proteins (p > 0.05). Post-mortem serum levels of both proteins were not elevated in TBI cases compared to controls (p > 0.05). Former elaborated cut-off values in CSF were confirmed and were only exceeded when a TBI survival time of at least 30 min was reached. Major conclusions: The present results report that post-mortem NSE and S100B CSF levels are significantly elevated subsequent to a fatal TBI.	[Sieber, Monique; Dressler, Jan; Ondruschka, Benjamin] Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany; [Pohlers, Dirk] Klinikum Chemnitz, Ctr Diagnost GmbH, Chemnitz, Germany		Ondruschka, B (corresponding author), Univ Leipzig, Inst Legal Med, Johannisallee 28, D-04103 Leipzig, Germany.	benjamin.ondruschka@medizinuni-leipzig.de					Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; BARGER SW, 1992, J BIOL CHEM, V267, P9689; Beaudeux JL, 2000, CLIN CHEM, V46, P989; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Franke H, 2012, PURINERG SIGNAL, V8, P629, DOI 10.1007/s11302-012-9300-0; Gao F, 1997, PERFUSION-UK, V12, P171, DOI 10.1177/026765919701200305; Goede A, 2015, RECHTSMEDIZIN, V25, P261, DOI 10.1007/s00194-015-0040-7; HAIMOTO H, 1985, LAB INVEST, V52, P257; Hajdukova L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/379071; Hanrieder J, 2009, J NEUROSCI METH, V177, P469, DOI 10.1016/j.jneumeth.2008.10.038; Hausmann R, 2000, INT J LEGAL MED, V113, P288, DOI 10.1007/s004149900126; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Krohn M, 2015, J NEUROTRAUM, V32, P430, DOI 10.1089/neu.2014.3524; Lamers KJB, 2003, BRAIN RES BULL, V61, P261, DOI 10.1016/S0361-9230(03)00089-3; Li Dong-Ri, 2006, Legal Medicine, V8, P71, DOI 10.1016/j.legalmed.2005.07.004; Li Dong-Ri, 2009, Leg Med (Tokyo), V11 Suppl 1, pS273, DOI 10.1016/j.legalmed.2009.02.042; Lorente L, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7110142; Maeda H, 2009, LEG MED, V11, P46, DOI DOI 10.1016/J.LEGALMED.2009.01.048; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Oehmichen Manfred, 2003, Leg Med (Tokyo), V5, P190, DOI 10.1016/S1344-6223(03)00077-4; Ogata M, 1999, INT J LEGAL MED, V113, P19, DOI 10.1007/s004140050273; Olczak M, 2017, FORENSIC SCI INT, V280, P1, DOI 10.1016/j.forsciint.2017.09.008; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Ondruschka B, 2017, ROM J LEG MED, V25, P301, DOI 10.4323/rjlm.2017.301; Ondruschka B, 2013, J NEUROTRAUM, V30, P1862, DOI 10.1089/neu.2013.2895; OSUNA E, 1992, FORENSIC SCI INT, V52, P193, DOI 10.1016/0379-0738(92)90107-8; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Pelinka LE, 2005, SHOCK, V24, P119, DOI 10.1097/01.shk.0000168876.68154.43; Penkowa M, 1999, GLIA, V25, P343; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Raabe A, 2003, CLIN CHEM LAB MED, V41, P700, DOI 10.1515/CCLM.2003.106; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Schiavi Paolo, 2012, Acta Biomed, V83, P5; SCHMECHEL D, 1978, NATURE, V276, P834, DOI 10.1038/276834a0; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wojtczak-Soska K, 2010, CARDIOL J, V17, P532; Wolf H, 2013, J NEUROSURG, V118, P1298, DOI 10.3171/2013.1.JNS121181; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	52	19	20	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	APR	2018	55						65	73		10.1016/j.jflm.2018.02.016			9	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	FZ6AH	WOS:000427677700010	29471249				2022-02-06	
J	Wright, AD; Smirl, JD; Bryk, K; Fraser, S; Jakovac, M; van Donkelaar, P				Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; Fraser, Sarah; Jakovac, Michael; van Donkelaar, Paul			Sport-Related Concussion Alters Indices of Dynamic Cerebral Autoregulation	FRONTIERS IN NEUROLOGY			English	Article						cerebral blood flow; autoregulation; blood pressure; autonomic dysfunction; transfer function analysis; repetitive head impact exposure	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL DOPPLER ULTRASOUND; ARTERIAL-BLOOD GASES; SUBARACHNOID HEMORRHAGE; VASCULAR INJURY; FLOW VELOCITY; HEAD-INJURY; PRESSURE; REACTIVITY; RESPONSES	Sport-related concussion is known to affect a variety of brain functions. However, the impact of this brain injury on cerebral autoregulation (CA) is poorly understood. Thus, the goal of the current study was to determine the acute and cumulative effects of sport-related concussion on indices of dynamic CA. Toward this end, 179 elite, junior-level (age 19.6 +/- 1.5 years) contact sport (ice hockey, American football) athletes were recruited for preseason testing, 42 with zero prior concussions and 31 with three or more previous concussions. Eighteen athletes sustained a concussion during that competitive season and completed follow-up testing at 72 h, 2 weeks, and 1 month post injury. Beat-bybeat arterial blood pressure (BP) and middle cerebral artery blood velocity (MCAv) were recorded using finger photoplethysmography and transcranial Doppler ultrasound, respectively. Five minutes of repetitive squat-stand maneuvers induced BP oscillations at 0.05 and 0.10 Hz (20- and 10-s cycles, respectively). The BP-MCAv relationship was quantified using transfer function analysis to estimate Coherence (correlation), Gain (amplitude ratio), and Phase (timing offset). At a group level, repeated-measures ANOVA indicated that 0.10 Hz Phase was significantly reduced following an acute concussion, compared to preseason, by 23% (-0.136 +/- 0.033 rads) at 72 h and by 18% (-0.105 +/- 0.029 rads) at 2 weeks post injury, indicating impaired autoregulatory functioning; recovery to preseason values occurred by 1 month. Athletes were cleared to return to competition after a median of 14 days (range 7-35), implying that physiologic dysfunction persisted beyond clinical recovery in many cases. When comparing dynamic pressure buffering between athletes with zero prior concussions and those with three or more, no differences were observed. Sustaining an acute sport-related concussion induces transient impairments in the capabilities of the cerebrovascular pressure-buffering system that may persist beyond 2 weeks and may be due to a period of autonomic dysregulation. Athletes with a history of three or more concussions did not exhibit impairments relative to those with zero prior concussions, suggesting recovery of function over time. Findings from this study support the potential need to consider physiological recovery in deciding when patients should return to play following a concussion.	[Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC, Canada; [Wright, Alexander D.; Fraser, Sarah; Jakovac, Michael] Univ British Columbia Okanagan, Southern Med Program, Reichwald Hlth Sci Ctr, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Expt Med Program, Fac Med, Vancouver, BC, Canada; [Wright, Alexander D.; Smirl, Jonathan D.; Bryk, Kelsey; van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada		van Donkelaar, P (corresponding author), Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada.	paul.vandonkelaar@ubc.ca		Smirl, Jonathan/0000-0003-1054-0038	CIHRCanadian Institutes of Health Research (CIHR) [183304]; CFICanada Foundation for Innovation [30979]; Vanier Canada Graduate Scholarships program; Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship; O'Brien Foundation Fellowship; Innovations in Wellness post-doctoral fellowship	This research was funded by grants from CIHR (183304) and CFI (30979) awarded to PD. AW was supported by the Vanier Canada Graduate Scholarships program, a Vancouver Coastal Health-CIHR-UBC MD/PhD Studentship, and an O'Brien Foundation Fellowship. JS was supported by the Innovations in Wellness post-doctoral fellowship.	Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Ainslie PN, 2007, EXP PHYSIOL, V92, P769, DOI 10.1113/expphysiol.2006.036814; Ainslie PN, 2014, J APPL PHYSIOL, V117, P1081, DOI 10.1152/japplphysiol.00854.2014; Allen B, 2015, PSYCHOPHYSIOLOGY, V52, P277, DOI 10.1111/psyp.12321; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Barlow KM, 2017, J NEUROTRAUM, V34, P996, DOI 10.1089/neu.2016.4634; Becelewski Janusz, 2003, Neurol Neurochir Pol, V37, P339; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Brothers RM, 2016, J PHYSIOL-LONDON, V594, P4077, DOI 10.1113/JP271884; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Budohoski KP, 2015, NEUROCRIT CARE, V22, P65, DOI 10.1007/s12028-014-0032-6; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Claassen JAHR, 2016, J CEREBR BLOOD F MET, V36, P665, DOI 10.1177/0271678X15626425; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Edvinsson L, 1975, Acta Physiol Scand Suppl, V427, P1; Gabler LF, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4038357; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gardner AJ, 2015, BRIT J SPORT MED, V49, P1050, DOI 10.1136/bjsports-2014-093901; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hamner JW, 2014, STROKE, V45, P1771, DOI 10.1161/STROKEAHA.114.005293; Hamner JW, 2012, J PHYSIOL-LONDON, V590, P6343, DOI 10.1113/jphysiol.2012.245100; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Hamner JW, 2004, J PHYSIOL-LONDON, V559, P965, DOI 10.1113/jphysiol.2004.066969; Hilz MJ, 2016, J NEUROL SCI, V365, P181, DOI 10.1016/j.jns.2016.04.022; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2004, J NEUROL, V251, P564, DOI 10.1007/s00415-004-0364-9; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Hoiland RL, 2016, J PHYSIOL-LONDON, V594, P4073, DOI 10.1113/JP271981; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; KAWAI Y, 1993, J APPL PHYSIOL, V74, P3046, DOI 10.1152/jappl.1993.74.6.3046; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; Kirkness C J, 2001, Biol Res Nurs, V2, P175, DOI 10.1177/109980040100200303; Lam JMK, 1997, J NEUROSURG, V86, P438, DOI 10.3171/jns.1997.86.3.0438; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Mandera M, 2002, CHILD NERV SYST, V18, P124, DOI 10.1007/s00381-002-0572-5; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; OPPENHEIMER S, 1993, STROKE, V24, pI3; OPPENHEIMER SM, 1992, BRAIN RES, V581, P133, DOI 10.1016/0006-8993(92)90352-A; Otite F, 2014, STROKE, V45, P677, DOI 10.1161/STROKEAHA.113.002630; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; Purkayastha S, 2014, J CEREBR BLOOD F MET, V34, P228, DOI 10.1038/jcbfm.2013.180; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Santos GA, 2016, NEUROLOGY, V86, P1950, DOI 10.1212/WNL.0000000000002696; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Smirl JD, 2015, J APPL PHYSIOL, V119, P487, DOI 10.1152/japplphysiol.00264.2015; Sorond FA, 2010, J ULTRAS MED, V29, P1017, DOI 10.7863/jum.2010.29.7.1017; Strebel S, 1997, SURG NEUROL, V47, P128, DOI 10.1016/S0090-3019(96)00459-4; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tan CO, 2014, NEUROLOGY, V83, P1665, DOI 10.1212/WNL.0000000000000944; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Wright AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150215; ZAMRINI EY, 1990, NEUROLOGY, V40, P1408, DOI 10.1212/WNL.40.9.1408; Zhang R, 1998, J APPL PHYSIOL, V85, P1113, DOI 10.1152/jappl.1998.85.3.1113	68	19	19	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 27	2018	9								196	10.3389/fneur.2018.00196			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GA6EQ	WOS:000428426100001	29636724	Green Published, gold			2022-02-06	
J	Hocke, LM; Duszynski, CC; Debert, CT; Dleikan, D; Dunn, JF				Hocke, Lia M.; Duszynski, Chris C.; Debert, Chantel T.; Dleikan, Diane; Dunn, Jeff F.			Reduced Functional Connectivity in Adults with Persistent Post-Concussion Symptoms: A Functional Near-Infrared Spectroscopy Study	JOURNAL OF NEUROTRAUMA			English	Article						concussion; DLPFC; fNIRS; functional connectivity; mTBI; working memory task	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; HEAD-INJURY; MILD; ACTIVATION; NETWORK; STATE; MRI; ABNORMALITIES; DYSFUNCTION	Concussion, or mild traumatic brain injury (mTBI), accounts for approximate to 80% of all TBIs across North America. The majority of mTBI patients recover within days to weeks; however, 14-36% of the time, acute mTBI symptoms persist for months or even years and develop into persistent post-concussion symptoms (PPCS). There is a need to find biomarkers in patients with PPCS, to improve prognostic ability and to provide insight into the pathophysiology underlying chronic symptoms. Recent research has pointed toward impaired network integrity and cortical communication as a biomarker. In this study we investigated functional near-infrared spectroscopy (fNIRS) as a technique to assess cortical communication deficits in adults with PPCS. Specifically, we aimed to identify cortical communication patterns in prefrontal and motor areas during rest and task, in adult patients with persistent symptoms. We found that (1) the PPCS group showed reduced connectivity compared with healthy controls, (2) increased symptom severity correlated with reduced coherence, and (3) connectivity differences were best distinguishable during task and in particular during the working memory task (n-back task) in the right and left dorsolateral prefrontal cortex (DLPFC). These data show that reduced brain communication may be associated with the pathophysiology of mTBI and that fNIRS, with a relatively simple acquisition paradigm, may provide a useful biomarker of this injury.	[Hocke, Lia M.; Duszynski, Chris C.; Debert, Chantel T.; Dleikan, Diane; Dunn, Jeff F.] Hotchkiss Brain Inst, Calgary, AB, Canada; [Hocke, Lia M.; Duszynski, Chris C.; Dleikan, Diane; Dunn, Jeff F.] Expt Imaging Lab, Dept Radiol, Calgary, AB, Canada; [Hocke, Lia M.; Duszynski, Chris C.; Debert, Chantel T.; Dleikan, Diane; Dunn, Jeff F.] Foothills Med Ctr, Dept Clin Neurosci, Calgary, AB, Canada; [Hocke, Lia M.; Duszynski, Chris C.; Debert, Chantel T.; Dleikan, Diane; Dunn, Jeff F.] Cumming Sch Med Calgary, Calgary, AB, Canada		Dunn, JF (corresponding author), Expt Imaging Lab, 3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	dunnj@ucalgary.ca	Hocke, Lia/AAE-3454-2020	Hocke, Lia/0000-0003-3157-8801; Debert, Chantel/0000-0002-2704-0438	Collaborative Health Research Program (CHRP) through the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [CIHR - CPG-140174]; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [NSERC - CHRP/478476-2015]; NSERC CREATE (Collaborative Research and Training Experience) I3T (International and Industrial Imaging Training) Program	We thank the patients who volunteered. This work was funded by the Collaborative Health Research Program (CHRP) through the Canadian Institutes of Health Research (CIHR - CPG-140174) and Natural Sciences and Engineering Research Council of Canada (NSERC - CHRP/478476-2015) as well as the NSERC CREATE (Collaborative Research and Training Experience) I3T (International and Industrial Imaging Training) Program.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boas DA, 2014, NEUROIMAGE, V85, P1, DOI 10.1016/j.neuroimage.2013.11.033; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; CHANCE B, 1993, P NATL ACAD SCI USA, V90, P3770, DOI 10.1073/pnas.90.8.3770; Chen JK, 2008, CLIN J SPORT MED, V18, P241, DOI 10.1097/JSM.0b013e318170b59d; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Dean PJA, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.292; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fekete T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024322; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gosselin N, 2011, J NEUROTRAUM, V28, P329, DOI 10.1089/neu.2010.1493; Helmich I, 2016, MED SCI SPORT EXER, V48, P2362, DOI 10.1249/MSS.0000000000001028; Helmich I, 2015, J NEUROPSYCH CLIN N, V27, P287, DOI 10.1176/appi.neuropsych.14100276; Hockey A, 2004, INTELLIGENCE, V32, P591, DOI 10.1016/j.intell.2004.07.009; Hoshi Y, 1998, NEUROSCI LETT, V245, P147, DOI 10.1016/S0304-3940(98)00197-9; HOSHI Y, 1993, NEUROSCI LETT, V150, P5, DOI 10.1016/0304-3940(93)90094-2; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Jimenez JJ, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.076008; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; KATO T, 1993, J CEREBR BLOOD F MET, V13, P516, DOI 10.1038/jcbfm.1993.66; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; Lannsjo M, 2013, EUR J NEUROL, V20, P124, DOI 10.1111/j.1468-1331.2012.03813.x; Lovell MR, 2007, NEUROSURGERY, V61, P352, DOI 10.1227/01.NEU.0000279985.94168.7F; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Pardini JE, 2010, NEUROSURGERY, V67, P1020, DOI 10.1227/NEU.0b013e3181ee33e2; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Sasai S, 2011, NEUROIMAGE, V56, P252, DOI 10.1016/j.neuroimage.2010.12.075; Sato H, 2004, NEUROIMAGE, V21, P1554, DOI 10.1016/j.neuroimage.2003.12.017; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Sun FT, 2004, NEUROIMAGE, V21, P647, DOI 10.1016/j.neuroimage.2003.09.056; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Varshney VP, 2012, J EUR OPT SOC-RAPID, V7, DOI 10.2971/jeos.2012.12047; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	64	19	19	3	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN	2018	35	11					1224	1232		10.1089/neu.2017.5365		MAR 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GG7EW	WOS:000428446000001	29373947	Bronze, Green Published			2022-02-06	
J	Zhang, WQ; Cui, Y; Gao, JL; Li, R; Jiang, XH; Tian, YX; Wang, KJ; Cui, JZ				Zhang, Wenqian; Cui, Ying; Gao, Junling; Li, Ran; Jiang, Xiaohua; Tian, Yanxia; Wang, Kaijie; Cui, Jianzhong			Recombinant Osteopontin Improves Neurological Functional Recovery and Protects Against Apoptosis via PI3K/Akt/GSK-3 beta Pathway Following Intracerebral Hemorrhage	MEDICAL SCIENCE MONITOR			English	Article						Apoptosis; Cerebral Hemorrhage; Osteopontin; Phosphatidylinositol 3-Kinases	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; GLYCOGEN-SYNTHASE KINASE-3; PI3K/AKT/GSK3-BETA PATHWAY; CELL-SURVIVAL; MOUSE MODEL; INHIBITION; EXPRESSION; STROKE; CANCER	Background: This study aimed to investigate the potential neuroprotective effect of recombinant osteopontin (r-OPN) on apoptotic changes via modulating phosphoinositide-3-kinase/Akt/glycogen synthase kinase 3 beta (PI3K/Akt/GSK-3 beta) signaling in a rat model of intracerebral hemorrhage (ICH). Material/Methods: We subjected 10-12-week-old Sprague-Dawley male rats (n=120) to injection of autologous blood into the right basal ganglia to induce ICH or sham surgery. ICH animals received vehicle administration, r-OPN (4 mu L/pup), or r-OPN combined with phosphatidylinositol 3-kinase (PI3K) inhibitor wortmannin (86 ng/pup) at 30 min after injury. Neurological scores and rotarod latencies were evaluated on days 1-5 post-ICH. Brain water content was evaluated on days 1-3 post-ICH. The number of apoptotic cells changes were evaluated by terminal deoxynucleotidyl transferase-mediated 2-deoxyuridine 5-triphosphate-biotin nick-end labeling (TUNEL) and hematoxylin staining. Apoptosis-related proteins Bcl-2, Bax, and cleaved caspase-3 (CC3), and the phosphorylation levels of Akt and GSK-3 beta were assayed by Western blot. Results: Neurological deficits, rotarod latencies, and brain water content following ICH were reduced in the r-OPN group compared to the vehicle group. r-OPN also attenuated cell death in ICH. Furthermore, treatment with r-OPN significantly increased p-Akt expression and decreased p-GSK-3 beta. These effects were associated with a decrease in the Bax/Bcl-2 ratio and the suppression of CC3 at 24 h after ICH. Importantly, all the beneficial effects of r-OPN in ICH were abrogated by the PI3K inhibitor wortmannin. Conclusions: r-OPN may provide a wide range of neuroprotection by suppressing apoptosis through the PI3K/Akt/GSK-3 beta signaling pathway after ICH.	[Zhang, Wenqian; Cui, Jianzhong] Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China; [Cui, Ying; Wang, Kaijie; Cui, Jianzhong] Tangshan Gongren Hosp, Dept Neurosurg, Tangshan, Hebei, Peoples R China; [Gao, Junling; Li, Ran; Jiang, Xiaohua; Tian, Yanxia] North China Univ Sci & Technol, Sch Basic Med Sci, Tangshan, Hebei, Peoples R China; [Gao, Junling; Li, Ran; Jiang, Xiaohua; Tian, Yanxia] Tangshan Key Lab Preclin & Basic Res Chron Dis, Hebei Key Lab Chron Dis, Tangshan, Hebei, Peoples R China		Cui, JZ (corresponding author), Hebei Med Univ, Dept Surg, Shijiazhuang, Hebei, Peoples R China.; Cui, JZ (corresponding author), Tangshan Gongren Hosp, Dept Neurosurg, Tangshan, Hebei, Peoples R China.	jianzhongcuidoctor@163.com		, Wenqian Zhang/0000-0002-4757-5253	Natural Science Foundation of Hebei, ChinaNatural Science Foundation of Hebei Province [H2012401071, H2014105079]	This study was supported by a grant from the Natural Science Foundation of Hebei, China (grant no. H2012401071 and H2014105079)	Belur PK, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1317; Broderick JP, 1999, STROKE, V30, P905, DOI 10.1161/01.STR.30.4.905; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen L, 2014, NEUROCHEM INT, V66, P27, DOI 10.1016/j.neuint.2014.01.006; Chen L, 2013, NEUROCHEM RES, V38, P2268, DOI 10.1007/s11064-013-1135-8; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Garwood ER, 2010, BREAST CANCER RES TR, V119, P137, DOI 10.1007/s10549-009-0507-x; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; He JC, 2015, BRAIN RES, V1611, P74, DOI 10.1016/j.brainres.2015.03.015; Hua Y, 2009, STROKE, V40, pS88, DOI 10.1161/STROKEAHA.108.533281; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Lee SH, 2017, MED SCI MONITOR, V23, P1401, DOI 10.12659/MSM.899309; Lu QH, 2016, MED SCI MONITOR, V22, P1716, DOI 10.12659/MSM.898642; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Matusan-Ilijas K, 2008, PATHOL ONCOL RES, V14, P293, DOI 10.1007/s12253-008-9058-4; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Ola MS, 2011, MOL CELL BIOCHEM, V351, P41, DOI 10.1007/s11010-010-0709-x; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Qureshi AI, 2003, NEUROSURGERY, V52, P1041, DOI 10.1227/01.NEU.0000057694.96978.BC; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Reis CR, 2015, EMBO J, V34, P2132, DOI 10.15252/embj.201591518; Robertson BW, 2010, EXP CELL RES, V316, P1, DOI 10.1016/j.yexcr.2009.10.012; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Spencer RL, 2000, BRAIN RES, V868, P275, DOI 10.1016/S0006-8993(00)02341-6; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Toyoshima A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127302; Valerio A, 2011, J NEUROCHEM, V116, P1148, DOI 10.1111/j.1471-4159.2011.07171.x; Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Wu BH, 2011, NEUROCRIT CARE, V14, P109, DOI 10.1007/s12028-010-9372-z; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xie YS, 2001, KIDNEY INT, V60, P1645, DOI 10.1046/j.1523-1755.2001.00032.x; Yang DM, 2011, J NEUROSURG, V114, P1110, DOI 10.3171/2010.6.JNS091856; Yang JT, 2011, ACTA NEUROCHIR, V153, P2197, DOI 10.1007/s00701-011-1122-2; Zhang S, 2013, NEUROCHEM INT, V63, P522, DOI 10.1016/j.neuint.2013.08.008; Zhu H, 2018, MED SCI MONITOR, V24, P366	46	19	20	0	8	INT SCIENTIFIC LITERATURE, INC	SMITHTOWN	361 FOREST LANE, SMITHTOWN, NY 11787 USA	1643-3750			MED SCI MONITOR	Med. Sci. Monitor	MAR 18	2018	24						1588	1596		10.12659/MSM.905700			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	GA1PV	WOS:000428090200001	29550832	Green Published, Green Submitted			2022-02-06	
J	Bedi, SS; Aertker, BM; Liao, GP; Caplan, HW; Bhattarai, D; Mandy, F; Mandy, F; Fernandez, LG; Zelnick, P; Mitchell, MB; Schiffer, W; Johnson, M; Denson, E; Prabhakara, K; Xue, H; Smith, P; Uray, K; Olson, SD; Mays, RW; Cox, CS				Bedi, Supinder S.; Aertker, Benjamin M.; Liao, George P.; Caplan, Henry W.; Bhattarai, Deepa; Mandy, Fanni; Mandy, Franciska; Fernandez, Luis G.; Zelnick, Pamela; Mitchell, Matthew B.; Schiffer, Walter; Johnson, Margaret; Denson, Emma; Prabhakara, Karthik; Xue, Hasen; Smith, Philippa; Uray, Karen; Olson, Scott D.; Mays, Robert W.; Cox, Charles S., Jr.			Therapeutic time window of multipotent adult progenitor therapy after traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Microglia; Neuroinflammation; Spatial learning and blood-brain barrier	ACTIVATED MICROGLIAL/MACROPHAGE RESPONSE; CONTROLLED CORTICAL IMPACT; MICROGLIAL ACTIVATION; CELLS; RATS; RECRUITMENT; NEUROINFLAMMATION; TRANSPLANTATION; EXPRESSION; INFARCTION	Background: Traumatic brain injury (TBI) is a major cause of death and disability. TBI results in a prolonged secondary central neuro-inflammatory response. Previously, we have demonstrated that multiple doses (2 and 24 h after TBI) of multipotent adult progenitor cells (MAPC) delivered intravenously preserve the blood-brain barrier (BBB), improve spatial learning, and decrease activated microglia/macrophages in the dentate gyrus of the hippocampus. In order to determine if there is an optimum treatment window to preserve the BBB, improve cognitive behavior, and attenuate the activated microglia/macrophages, we administered MAPC at various clinically relevant intervals. Methods: We administered two injections intravenously of MAPC treatment at hours 2 and 24 (2/24), 6 and 24 (6/24), 12 and 36 (12/36), or 36 and 72 (36/72) post cortical contusion injury (CCI) at a concentration of 10 million/kg. For BBB experiments, animals that received MAPC at 2/24, 6/24, and 12/36 were euthanized 72 h post injury. The 36/72 treated group was harvested at 96 h post injury. Results: Administration of MAPC resulted in a significant decrease in BBB permeability when administered at 2/24 h after TBI only. For behavior experiments, animals were harvested post behavior paradigm. There was a significant improvement in spatial learning (120 days post injury) when compared to cortical contusion injury (CCI) in groups when MAPC was administered at or before 24 h. In addition, there was a significant decrease in activated microglia/macrophages in the dentate gyrus of hippocampus of the treated group (2/24) only when compared to CCI. Conclusions: Intravenous injections of MAPC at or before 24 h after CCI resulted in improvement of the BBB, improved cognitive behavior, and attenuated activated microglia/macrophages in the dentate gyrus.	[Bedi, Supinder S.; Aertker, Benjamin M.; Liao, George P.; Caplan, Henry W.; Bhattarai, Deepa; Mandy, Fanni; Mandy, Franciska; Fernandez, Luis G.; Zelnick, Pamela; Mitchell, Matthew B.; Schiffer, Walter; Johnson, Margaret; Denson, Emma; Prabhakara, Karthik; Xue, Hasen; Smith, Philippa; Uray, Karen; Olson, Scott D.; Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA; [Cox, Charles S., Jr.] Michael E DeBakey Inst Comparat Cardiovasc Sci &, Cleveland, OH USA; [Cox, Charles S., Jr.] Athersys Inc, Cleveland, OH USA		Bedi, SS (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Pediat Surg, Houston, TX 77030 USA.	Supinder.Bedi@uth.tmc.edu		Olson, Scott/0000-0001-8032-3755; Caplan, Henry/0000-0003-0012-1606; Cardenas, Fanni/0000-0002-2026-5351; Zelnick, Pamela/0000-0002-2781-9791	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [4U44NS077511-03, 2T32 GM0879201-11A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U44NS077511] Funding Source: NIH RePORTER	d This study is supported by NIH grants 4U44NS077511-03 (Cox/Mays) and 2T32 GM0879201-11A1 (Cox).	Aertker BM, 2016, EXP NEUROL, V275, P411, DOI 10.1016/j.expneurol.2015.01.008; Aloisi F, 2001, ANN MED, V33, P510, DOI 10.3109/07853890108995960; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bannerman DM, 2012, NAT NEUROSCI, V15, P1153, DOI 10.1038/nn.3166; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Bedi SS, 2013, J TRAUMA ACUTE CARE, V75, P410, DOI 10.1097/TA.0b013e31829617c6; Bedi SS, 2013, J NEUROSCI METH, V219, P176, DOI 10.1016/j.jneumeth.2013.07.017; Belarbi K, 2012, BRAIN BEHAV IMMUN, V26, P18, DOI 10.1016/j.bbi.2011.07.225; Boozer Sherry, 2009, J Stem Cells, V4, P17, DOI jsc.2009.4.1.17; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Burrows GG, 2013, STEM CELL TRANSL MED, V2, P745, DOI 10.5966/sctm.2013-0031; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kalla R, 2001, J COMP NEUROL, V436, P182; Kota DJ, 2016, STEM CELL TRANSL MED, V5, P33, DOI 10.5966/sctm.2015-0065; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Liao GP, 2014, J SURG RES, V190, P628, DOI 10.1016/j.jss.2014.05.011; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Ma Y., 2016, PROG NEUROBIOL; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rekha J, 2009, BEHAV NEUROSCI, V123, P1197, DOI 10.1037/a0017655; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Smith HS, 2010, PAIN PHYSICIAN, V13, P295; Soares HD, 1995, J NEUROSCI, V15, P8223; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Terry AV, 2009, FRONT NEUROSCI, P267; Walker PA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-228; Walker Peter A, 2011, World J Stem Cells, V3, P9, DOI 10.4252/wjsc.v3.i2.9; Walker PA, 2010, EXP NEUROL, V225, P341, DOI 10.1016/j.expneurol.2010.07.005	48	19	21	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAR 16	2018	15								84	10.1186/s12974-018-1122-8			13	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FZ9BN	WOS:000427904700001	29548333	gold, Green Published			2022-02-06	
J	Amick, MM; Meterko, M; Fortier, CB; Fonda, JR; Milberg, WP; McGlinchey, RE				Amick, Melissa M.; Meterko, Mark; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.			The Deployment Trauma Phenotype and Employment Status in Veterans of the Wars in Iraq and Afghanistan	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; employment; mTBI; PTSD; veterans	BRAIN-INJURY; TEST-PERFORMANCE; US MILITARY; UNEMPLOYMENT; ASSOCIATION; SERVICES	Objectives: To determine the prevalence of comorbid mild traumatic brain injury (mTBI), posttraumatic stress disorder (PTSD), and depression, termed the deployment trauma phenotype (DTP), and its constituent diagnoses' impact on unemployment status in a national cohort of veterans. Setting: Retrospective analysis of the comprehensive TBI evaluation, a Veterans Affairs-wide protocol for assessing TBI, employment status, and psychiatric impressions. Participants: The final data set consisted of 48 821 veterans. Main Outcomes and Measures: Frequency of mTBI, PTSD, and depression in isolation and combinations and their association with unemployment status. Results: Age- and education-adjusted risk ratios (RRs) showed that the mTBI-only group was the least likely to be unemployed, RR = 0.65 (0.59-0.71). By contrast, the greatest likelihood of unemployment was associated with membership in the DTP group, RR = 1.45 (1.36-1.56), and the comorbid PTSD and depression group, RR = 1.39 (1.27-1.52). Furthermore, the DTP was nearly 3 times more prevalent (16.4%) in this sample compared with comorbid PTSD and depression (5.7%), indicating that the DTP conveys risk for unemployment to a significantly greater number of individuals. Conclusions and Relevance: The comorbid and interactive conditions of PTSD, depression, and mTBI, rather than mTBI in isolation, were linked to significant risk for unemployment in this veteran cohort. These findings suggest that multifaceted assessments and interventions to improve postdeployment reintegration are needed.	[Amick, Melissa M.; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.] Translat Res Ctr TBI & Stress Disorders, Boston, MA USA; [Amick, Melissa M.; Fortier, Catherine B.; Fonda, Jennifer R.; Milberg, William P.; McGlinchey, Regina E.] Ctr Geriatr Res Educ & Clin, Boston, MA USA; [Meterko, Mark] VA Boston Healthcare Syst, HSR&D Ctr Healthcare Org & Implementat Res, Boston, MA USA; [Amick, Melissa M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Meterko, Mark] Boston Univ, Sch Publ Hlth, Dept Hlth Law Policy & Management, Boston, MA USA; [Fonda, Jennifer R.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Fortier, Catherine B.; Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Amick, MM (corresponding author), VA Boston Healthcare Syst, 150 South Huntington Ave, Boston, MA 02130 USA.	Melissa.Amick@Va.gov	Fortier, Catherine/AAS-2163-2021; Fonda, Jennifer R./ABG-2890-2021	Fortier, Catherine/0000-0002-8953-9904; Fonda, Jennifer R./0000-0001-9482-2918	Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B9254-C]; NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258]; VA CSR&D Merit Review Award; VA HSRD [IIR 11-358]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG034258] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001327, I50RX003001] Funding Source: NIH RePORTER	This study was supported in part by the Translational Research Center for TBI and Stress Disorders (TRACTS) VA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (B9254-C, McGlinchey); NIH NIA K23AG034258 (Fortier); VA CSR&D Merit Review Award (McGlinchey); and VA HSR&D IIR 11-358 (Meterko).	Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; ATKINSON T, 1986, J HEALTH SOC BEHAV, V27, P317, DOI 10.2307/2136947; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Erbes CR, 2011, J REHABIL RES DEV, V48, P1159, DOI 10.1682/JRRD.2010.11.0212; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Jurick SM, 2016, J REHABIL RES DEV, V53, P571, DOI 10.1682/JRRD.2015.05.0094; Kleylamp M, 2013, SOC SCI RES, V42, P836, DOI 10.1016/j.ssresearch.2012.12.017; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Pietrzak RH, 2009, PSYCHIAT SERV, V60, P1118, DOI 10.1176/ps.2009.60.8.1118; Pittman JOE, 2012, QUAL LIFE RES, V21, P99, DOI 10.1007/s11136-011-9918-3; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Sayer NA, 2010, PSYCHIAT SERV, V61, P589, DOI 10.1176/ps.2010.61.6.589; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Storzbach D, 2015, J INT NEUROPSYCH SOC, V21, P353, DOI 10.1017/S1355617715000326; Sturm R, 1999, PSYCHIATR SERV, V50, P1407, DOI 10.1176/ps.50.11.1407; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; U.S. Bureau of Labor Statistics, EMPL STAT CIV NON PO; US Bureau of Labor Statistics, 2009, EMPL STAT VET AG RAC; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Vanneman ME, 2015, MIL MED, V180, P1052, DOI 10.7205/MILMED-D-14-00682; World Health Organization, 2010, MEAS HLTH DIS MAN WH	30	19	19	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E30	E40		10.1097/HTR.0000000000000308			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200004	28422901	Green Accepted			2022-02-06	
J	Deng, QJ; Xu, XF; Ren, J				Deng, Quan-Jun; Xu, Xiao-Feng; Ren, Jing			Effects of SDF-1/CXCR4 on the Repair of Traumatic Brain Injury in Rats by Mediating Bone Marrow Derived Mesenchymal Stem Cells	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						SDF-1; CXCR4; Traumatic brain injury; Bone mesenchymal stem cells and cell transplantation	GASTRIC-CANCER; AXIS; MIGRATION; CXCR4; TRANSPLANTATION; BDNF; ANGIOGENESIS; CONTRIBUTES; INHIBITION; SECRETION	Our study aims to investigate the effects of the SDF-1/CXCR4 axis on the repair of traumatic brain injury (TBI) in rats by mediating bone marrow derived from mesenchymal stem cells (BMSCs). Healthy male SD rats were collected, their tibiofibulars were removed, cultured, and BMSCs were collected. The expression of cell-surface molecular proteins was examined using flow cytometry. The mRNA and protein expression of CXCR4 in cells were tested using qRT-PCR and western blotting analysis. An electronic brain injury instrument was utilized to build TBI rat models and each rat was assigned into the experiment, positive control and control groups (10 rats in each group). The morris water maze was used to calculate the escape latency and number of times rats in each group crossed the platform. Neurological severity scores (NSS) was calculated to evaluate the recovery of neurological functioning. The distribution of neuronal nuclear antigens was detected using double-labeling immunohistochemistry. The morphological changes in the hippocampal neuronal and the number of BrdU-positive cells were observed through Nissl's staining and high magnification. The mRNA and protein expressions of CXCR4 were gradually increased as SDF-1 concentration increased. NGF and BDNF positive cells were expressed in each group. The distribution of neuronal nuclear antigens in the experiment group was elevated compared to the control and positive control groups. Among the three groups, the experimental group had the shortest escape latency and the highest number platform crossings. The difference in NSS among the three groups was significant. The experimental group had better cell morphology and a higher number of BrdU-positive cells than the other groups. The present study demonstrates that transplanting BMSCs with SDF-1-induced CXCR4 expression can promote the repair of TBI. This is expected to become a new treatment regimen for TBI.	[Deng, Quan-Jun] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin 300052, Peoples R China; [Xu, Xiao-Feng] Fudan Univ, Dept Clin Lab, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Xu, Xiao-Feng] Fudan Univ, Dept Oncol, Shanghai Med Coll, Shanghai 200032, Peoples R China; [Ren, Jing] Tianjin Med Univ Gen Hosp, Dept Med Lab, 154 Anshan Rd, Tianjin 300052, Peoples R China		Ren, J (corresponding author), Tianjin Med Univ Gen Hosp, Dept Med Lab, 154 Anshan Rd, Tianjin 300052, Peoples R China.	renjingzyy@126.com		Deng, Quanjun/0000-0002-8718-1857			Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; Crowley MG, 2016, J NEUROSURG SCI; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Du ZY, 2013, LIVER TRANSPLANT, V19, P215, DOI 10.1002/lt.23577; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hu CJ, 2013, J SURG RES, V183, P427, DOI 10.1016/j.jss.2013.01.019; Huang MZ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-80; Jiang JD, 2012, NEURAL REGEN RES, V7, P46, DOI 10.3969/j.issn.1673-5374.2012.01.008; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Jones GN, 2012, STEM CELL TRANSL MED, V1, P70, DOI 10.5966/sctm.2011-0007; Kawakami Y, 2015, J BONE MINER RES, V30, P95, DOI 10.1002/jbmr.2318; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Lavezzi AM, 2013, J NEUROL SCI, V329, P45, DOI 10.1016/j.jns.2013.03.012; Lee HJ, 2012, HISTOL HISTOPATHOL, V27, P1155, DOI 10.14670/HH-27.1155; Lee HJ, 2011, EXP THER MED, V2, P499, DOI 10.3892/etm.2011.228; Lewin Gary R, 2014, Handb Exp Pharmacol, V220, P251, DOI 10.1007/978-3-642-45106-5_10; Liu NM, 2013, J CELL BIOCHEM, V114, P2677, DOI 10.1002/jcb.24615; Liu XL, 2011, PROTEIN CELL, V2, P845, DOI 10.1007/s13238-011-1097-z; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maleki Masoud, 2014, International Journal of Stem Cells, V7, P118, DOI 10.15283/ijsc.2014.7.2.118; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Park SA, 2011, INT J ONCOL, V38, P97, DOI 10.3892/ijo_00000828; Penn MS, 2012, GENE THER, V19, P583, DOI 10.1038/gt.2012.32; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Vanden Berg-Foels WS, 2014, TISSUE ENG PART B-RE, V20, P28, DOI 10.1089/ten.TEB.2013.0100; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wang YL, 2014, BRAIN RES, V1575, P78, DOI 10.1016/j.brainres.2014.05.035; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Xia GZ, 2010, J PERINAT MED, V38, P215, DOI [10.1515/JPM.2010.021, 10.1515/jpm.2010.021]; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xiong Y, 2011, J NEUROSURG, V114, P102, DOI 10.3171/2010.4.JNS10118; Xuan WJ, 2015, J BIOPHOTONICS, V8, P502, DOI 10.1002/jbio.201400069; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Zhao BC, 2011, WORLD J GASTROENTERO, V17, P2389, DOI 10.3748/wjg.v17.i19.2389	42	19	19	0	11	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2018	38	2					467	477		10.1007/s10571-017-0490-4			11	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FX4WL	WOS:000426079300007	28484859				2022-02-06	
J	Ma, MW; Wang, J; Dhandapani, KM; Brann, DW				Ma, Merry W.; Wang, Jing; Dhandapani, Krishnan M.; Brann, Darrell W.			Deletion of NADPH oxidase 4 reduces severity of traumatic brain injury	FREE RADICAL BIOLOGY AND MEDICINE			English	Article						NADPH oxidase; NOX4; Traumatic brain injury; TBI; Oxidative stress	CONTROLLED CORTICAL IMPACT; OXIDATIVE STRESS; NOX FAMILY; ANTIOXIDANT THERAPIES; CLINICAL-TRIALS; NOX/DUOX FAMILY; NEURODEGENERATION; ACTIVATION; EXPRESSION; NEUROPROTECTION	Traumatic brain injury (TBI) contributes to over 30% of injury-related deaths and is a major cause of disability without effective clinical therapies. Oxidative stress contributes to neurodegeneration, neuroinflammation, and neuronal death to amplify the primary injury after TBI. NADPH oxidase (NOX) is a major source of reactive oxygen species following brain injury. Our current study addresses the functional role of the NOX4 isoform in the damaged cortex following TBI. Adult male C57BL/6 J and NOX4(-/-) mice received a controlled cortical impact and lesion size, NOX4 expression, oxidative stress, neurodegeneration, and cell death were assessed in the injured cerebral cortex. The results revealed that NOX4 mRNA and protein expression were significantly upregulated at 1-7 days post-TBI in the injured cerebral cortex. Expression of the oxidative stress markers, 8-OHdG, 4-HNE, and nitrotyrosine was upregulated at 2 and 4 days post-TBI in the WT injured cerebral cortex, and nitrotyrosine primarily colocalized with neurons. In the NOX4(-/-) mice, expression of these oxidative stress markers, 8-OHdG, 4-HNE, and nitrotyrosine were significantly attenuated at both timepoints. In addition, examination of NOX4(-/-) mice revealed a reduced number of apoptotic (TUNEL+) and degenerating (FJB(+)) cells in the perilesional cortex after TBI, as well as a smaller lesion size compared with the WT group. The results of this study implicate a functional role for NOX4 in TBI induced oxidative damage and neurodegeneration and raise the possibility that targeting NOX4 may have therapeutic efficacy in TBI.	[Ma, Merry W.; Wang, Jing; Dhandapani, Krishnan M.; Brann, Darrell W.] Charlie Norwood VA Med Ctr, One Freedom Way, Augusta, GA 30904 USA; [Ma, Merry W.; Wang, Jing; Brann, Darrell W.] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA 30912 USA; [Dhandapani, Krishnan M.] Augusta Univ, Med Coll Georgia, Dept Neurosurg, Augusta, GA 30912 USA		Brann, DW (corresponding author), Augusta Univ, Dept Neurosci & Regenerat Med, 1120 15th St,CA-4004, Augusta, GA 30912 USA.	dbrann@augusta.edu		Dhandapani, Krishnan/0000-0001-7044-1117	VA Merit Review Award from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development ServiceUS Department of Veterans Affairs [5l101BX001117]	The research presented in this article was conducted in partial fulfillment of the Ph.D. degree requirements set forth for Merry W. Ma and was supported by a VA Merit Review Award (5l101BX001117) from the United States Department of Veteran's Affairs, Biomedical Laboratory Research and Development Service.	Altenhofer S, 2012, CELL MOL LIFE SCI, V69, P2327, DOI 10.1007/s00018-012-1010-9; Angeloni C, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/370312; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barrett JP, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0843-4; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Boque M C, 2000, Semin Respir Infect, V15, P280; BRIDGES RA, 1959, AMA J DIS CHILD, V97, P387, DOI 10.1001/archpedi.1959.02070010389004; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Buetler TM, 2004, NEWS PHYSIOL SCI, V19, P120, DOI 10.1152/nips.01514.2003; Cachat J, 2015, CLIN SCI, V128, P635, DOI 10.1042/CS20140635; Choi BY, 2012, BRAIN RES, V1481, P49, DOI 10.1016/j.brainres.2012.08.032; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Dziedzic T, 2004, CRIT CARE, V8, P266, DOI 10.1186/cc2828; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hoover RC, 2004, J NEUROTRAUM, V21, P501, DOI 10.1089/089771504774129847; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Inatomi Y, 2006, INTERNAL MED, V45, P253, DOI 10.2169/internalmedicine.45.1423; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Kim GH, 2015, EXP NEUROBIOL, V24, P325, DOI 10.5607/en.2015.24.4.325; Kleinschnitz C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000479; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Laird MD, 2010, J NEUROCHEM, V113, P637, DOI 10.1111/j.1471-4159.2010.06630.x; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Li Z, 2015, NEUROL SCI, V36, P61, DOI 10.1007/s10072-014-1909-z; Liu Z., 2016, J NEUROINTERVENTIONA; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Lucke-Wold B.P., 2015, TRANSL RES, V166; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Ma MW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0150-7; McCord JM, 2005, BIOMED PHARMACOTHER, V59, P139, DOI 10.1016/j.biopha.2005.03.005; Miller DM, 2014, J NEUROTRAUM, V31, P1194, DOI 10.1089/neu.2013.3218; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; NELSON SK, 1994, FREE RADICAL BIO MED, V16, P195, DOI 10.1016/0891-5849(94)90143-0; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Ferreira APO, 2013, NEUROCHEM INT, V63, P583, DOI 10.1016/j.neuint.2013.09.012; Pendyala S, 2010, RESP PHYSIOL NEUROBI, V174, P265, DOI 10.1016/j.resp.2010.09.016; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Schiavone S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09202-4; Scott P, 1996, STROKE, V27, P1453; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Shirley R, 2014, ANTIOXIDANTS-BASEL, V3, P472, DOI 10.3390/antiox3030472; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Sirokmany G, 2016, TRENDS PHARMACOL SCI, V37, P318, DOI 10.1016/j.tips.2016.01.006; Thompson HJ, 2006, EUR J NEUROSCI, V24, P3063, DOI 10.1111/j.1460-9568.2006.05197.x; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; Uzan M, 2006, ACTA NEUROCHIR, V148, P1157, DOI 10.1007/s00701-006-0887-1; von Leden RE, 2017, J NEUROTRAUM, V34, P755, DOI 10.1089/neu.2016.4486; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Wang J, 2017, FREE RADICAL BIO MED, V113, P119, DOI 10.1016/j.freeradbiomed.2017.09.017; Wang RM, 2009, BRAIN RES, V1255, P32, DOI 10.1016/j.brainres.2008.12.011; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Whitaker-Lea WA, 2017, PHYS MED REH CLIN N, V28, P227, DOI 10.1016/j.pmr.2016.12.002; Yamaguchi T, 1998, STROKE, V29, P12, DOI 10.1161/01.STR.29.1.12; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	80	19	19	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0891-5849	1873-4596		FREE RADICAL BIO MED	Free Radic. Biol. Med.	MAR	2018	117						66	75		10.1016/j.freeradbiomed.2018.01.031			10	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	FZ2PA	WOS:000427420600008	29391196	hybrid			2022-02-06	
J	Zhao, HL; Wang, YY; Chen, LY; Shi, J; Ma, K; Tang, LH; Xu, DG; Yao, JQ; Feng, H; Chen, TN				Zhao, Hengli; Wang, Yuye; Chen, Linyu; Shi, Jia; Ma, Kang; Tang, Longhuang; Xu, Degang; Yao, Jianquan; Feng, Hua; Chen, Tunan			High-sensitivity terahertz imaging of traumatic brain injury in a rat model	JOURNAL OF BIOMEDICAL OPTICS			English	Article						traumatic brain injury; terahertz imaging; terahertz spectroscopy	CEREBRAL EDEMA; PATHOPHYSIOLOGY; IMPACT; DEVICE	We demonstrated that different degrees of experimental traumatic brain injury (TBI) can be differentiated clearly in fresh slices of rat brain tissues using transmission-type terahertz (THz) imaging system. The high absorption region in THz images corresponded well with the injured area in visible images and magnetic resonance imaging results. The THz image and absorption characteristics of dehydrated paraffin-embedded brain slices and the hematoxylin and eosin (H&E)-stained microscopic images were investigated to account for the intrinsic differences in the THz images for the brain tissues suffered from different degrees of TBI and normal tissue aside from water. The THz absorption coefficients of rat brain tissues showed an increase in the aggravation of brain damage, particularly in the high-frequency range, whereas the cell density decreased as the order of mild, moderate, and severe TBI tissues compared with the normal tissue. Our results indicated that the different degrees of TBI were distinguishable owing to the different water contents and probable hematoma components distribution rather than intrinsic cell intensity. These promising results suggest that THz imaging has great potential as an alternative method for the fast diagnosis of TBI. (C) 2018 Society of Photo-Optical Instrumentation Engineers (SPIE)	[Zhao, Hengli; Wang, Yuye; Ma, Kang; Feng, Hua; Chen, Tunan] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China; [Zhao, Hengli; Wang, Yuye; Ma, Kang; Feng, Hua; Chen, Tunan] Key Lab Neurotrauma, Chongqing, Peoples R China; [Wang, Yuye; Chen, Linyu; Shi, Jia; Tang, Longhuang; Xu, Degang; Yao, Jianquan] Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Inst Laser & Optoelect, Tianjin, Peoples R China; [Wang, Yuye; Chen, Linyu; Shi, Jia; Tang, Longhuang; Xu, Degang; Yao, Jianquan] Tianjin Univ, Minist Educ, Key Lab Optoelect Informat Technol, Tianjin, Peoples R China		Feng, H; Chen, TN (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China.; Feng, H; Chen, TN (corresponding author), Key Lab Neurotrauma, Chongqing, Peoples R China.; Xu, DG (corresponding author), Tianjin Univ, Sch Precis Instrument & Optoelect Engn, Inst Laser & Optoelect, Tianjin, Peoples R China.; Xu, DG (corresponding author), Tianjin Univ, Minist Educ, Key Lab Optoelect Informat Technol, Tianjin, Peoples R China.	xudegang@tju.edu.cn; fenghua8888@vip.163.com; ctn@tmmu.edu.cn	Yuye, Wang/AAT-9799-2020; Feng, Hua/AAX-4121-2021; Shi, Jia/T-6002-2017	Feng, Hua/0000-0003-4489-9217; Shi, Jia/0000-0001-7563-9982	National Basic Research Program of China (973)National Basic Research Program of China [2015CB755400]; National Key Research and Development Projects [2016YFC0101000]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61775160]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M602954]; Postdoctoral Science Foundation of Chongqing [Xm2016021]; Joint Incubation Project of Southwest Hospital [SWH2016LHJC04, SWH2016LHJC01]	This work was supported by the National Basic Research Program of China (973) (2015CB755400), the National Key Research and Development Projects (2016YFC0101000), the National Natural Science Foundation of China (61775160), China Postdoctoral Science Foundation (2016M602954), Postdoctoral Science Foundation of Chongqing (Xm2016021), and Joint Incubation Project of Southwest Hospital (SWH2016LHJC04, SWH2016LHJC01).	Bajwa N, 2017, BIOMED OPT EXPRESS, V8, P460, DOI 10.1364/BOE.8.000460; Bin Ji Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep36040; Brabazon F, 2017, J NEUROTRAUM, V34, P1074, DOI 10.1089/neu.2016.4540; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Grootendorst MR, 2017, BIOMED OPT EXPRESS, V8, P2932, DOI 10.1364/BOE.8.002932; Joseph CS, 2014, J BIOPHOTONICS, V7, P295, DOI 10.1002/jbio.201200111; Kang DG, 2012, SPINE J, V12, P849, DOI 10.1016/j.spinee.2011.11.014; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lu M, 2003, J NEUROSCI METH, V128, P183, DOI 10.1016/S0165-0270(03)00188-2; Masson JB, 2006, P NATL ACAD SCI USA, V103, P4808, DOI 10.1073/pnas.0510945103; Meng K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.077001; Oh SJ, 2014, BIOMED OPT EXPRESS, V5, P2837, DOI 10.1364/BOE.5.002837; Reid CB, 2013, IEEE J BIOMED HEALTH, V17, P774, DOI 10.1109/JBHI.2013.2255306; Reid CB, 2011, PHYS MED BIOL, V56, P4333, DOI 10.1088/0031-9155/56/14/008; Reilly P, 2007, PROG BRAIN RES, V161, P3, DOI 10.1016/S0079-6123(06)61001-7; Rong L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08445; Ruggiero MT, 2015, PHYS CHEM CHEM PHYS, V17, P9326, DOI 10.1039/c5cp01195g; Ryu JH, 2013, NEUROCRIT CARE, V19, P222, DOI 10.1007/s12028-013-9824-3; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Shi J., 2016, 41 INT C INFR MILL T; Shi LY, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.1.015014; Sim YC, 2013, BIOMED OPT EXPRESS, V4, P1413, DOI 10.1364/BOE.4.001413; Wang YY, 2011, PHYS MED BIOL, V56, P4517, DOI 10.1088/0031-9155/56/14/018; Wang YY, 2010, OPT EXPRESS, V18, P15504, DOI 10.1364/OE.18.015504; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Winkler EA, 2016, NEUROSURG CLIN N AM, V27, P473, DOI 10.1016/j.nec.2016.05.008; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yamaguchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30124; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang CC, 2015, MOL MED REP, V12, P7351, DOI 10.3892/mmr.2015.4372; Zou Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05554-z	32	19	22	7	19	SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668	1560-2281		J BIOMED OPT	J. Biomed. Opt.	MAR	2018	23	3							036015	10.1117/1.JBO.23.3.036015			7	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	GB7IT	WOS:000429248800029	29595016	gold			2022-02-06	
J	Clough, M; Mutimer, S; Wright, DK; Tsang, A; Costello, DM; Gardner, AJ; Stanwell, P; Mychasiuk, R; Sun, MJ; Brady, RD; McDonald, SJ; Webster, KM; Johnstone, MR; Semple, BD; Agoston, DV; White, OB; Frayne, R; Fielding, J; O'Brien, TJ; Shultz, SR				Clough, Meaghan; Mutimer, Steven; Wright, David K.; Tsang, Adrian; Costello, Daniel M.; Gardner, Andrew J.; Stanwell, Peter; Mychasiuk, Richelle; Sun, Mujun; Brady, Rhys D.; McDonald, Stuart J.; Webster, Kyria M.; Johnstone, Maddison R.; Semple, Bridgette D.; Agoston, Denes V.; White, Owen B.; Frayne, Richard; Fielding, Joanne; O'Brien, Terence J.; Shultz, Sandy R.			Oculomotor Cognitive Control Abnormalities in Australian Rules Football Players with a History of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						cavum septum pellucidum; cognition; DTI; functional MRI; ocular motor; mild TBI	CAVUM SEPTUM PELLUCIDUM; APPARENT FIBER DENSITY; OCULAR MOTOR MEASURES; FUNCTIONAL CONNECTIVITY; RECURRENT CONCUSSION; SWITCH-COST; TASK; ROBUST; DYSFUNCTION; DEPRESSION	This study used oculomotor, cognitive, and multi-modal magnetic resonance imaging (MRI) measures to assess for neurological abnormalities in current asymptomatic amateur Australian rules footballers (i.e., Australia's most participated collision sport) with a history of sports-related concussion (SRC). Participants were 15 male amateur Australian rules football players with a history of SRC greater than 6 months previously, and 15 sex-, age-, and education-matched athlete control subjects that had no history of neurotrauma or participation in collision sports. Participants completed a clinical interview, neuropsychological measures, and oculomotor measures of cognitive control. MRI investigation involved structural imaging, as well as diffusion tensor imaging and resting-state functional MRI sequences. Despite no group differences on conventional neuropsychological tests and multi-modal MRI measures, Australian rules football players with a history of SRC performed significantly worse on an oculomotor switch task: a measure of cognitive control that interleaves the response of looking towards a target (i.e., a prosaccade) with the response of looking away from a target (i.e., an antisaccade). Specifically, Australian footballers performed significantly shorter latency prosaccades and found changing from an antisaccade trial to a prosaccade trial (switch cost) significantly more difficult than control subjects. Poorer switch cost was related to poorer performance on a number of neuropsychological measures of inhibitory control. Further, when comparing performance on the cognitively more demanding switch task with performance on simpler, antisaccade/prosaccades tasks which require a single response, Australian footballers demonstrated a susceptibility to increased cognitive load, compared to the control group who were unaffected. These initial results suggest that current asymptomatic amateur Australian rules football players with a history of SRC may have persisting, subtle, cognitive changes, which are demonstrable on oculomotor cognitive measures. Future studies are required in order to further elucidate the full nature and clinical relevance of these findings.	[Clough, Meaghan; Fielding, Joanne] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Mutimer, Steven; Costello, Daniel M.; Sun, Mujun; Brady, Rhys D.; Webster, Kyria M.; Semple, Bridgette D.; White, Owen B.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Dept Med, Parkville, Vic, Australia; [Wright, David K.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Tsang, Adrian; Frayne, Richard] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Tsang, Adrian; Frayne, Richard] Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB, Canada; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Stanwell, Peter] Univ Newcastle, Sch Hlth Sci, Callaghan, NSW, Australia; [Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [McDonald, Stuart J.; Johnstone, Maddison R.] La Trobe Univ, Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Agoston, Denes V.] Uniformed Serv Univ Hlth Sci, Anat Physiol & Genet, Bethesda, MD USA; [O'Brien, Terence J.; Shultz, Sandy R.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia		Shultz, SR (corresponding author), Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013; Frayne, Richard/AAA-9217-2021; Stanwell, Peter/F-9136-2012	Frayne, Richard/0000-0003-0358-1210; Stanwell, Peter/0000-0002-4780-0393; Wright, David/0000-0002-7535-8651; Sun, Mujun/0000-0002-9923-9913; McDonald, Stuart/0000-0001-5190-3179; White, Owen/0000-0002-2836-7344; O'Brien, Terence/0000-0002-7198-8621; Gardner, Andrew/0000-0001-5031-5586	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Royal Melbourne Hospital Neuroscience Foundation; Melbourne Neuroscience Institute; La Trobe University (Sport, Exercise, and Rehabilitation RFA); University of MelbourneUniversity of Melbourne; NHMRCNational Health and Medical Research Council of Australia; Berlin-Burns Fellowship; Hotchkiss Brain Institute (HBI), University of Calgary	S.R.S., S.J.M., and T.O.B. acknowledge the Australian National Health and Medical Research Council, the Royal Melbourne Hospital Neuroscience Foundation, the Melbourne Neuroscience Institute, La Trobe University (Sport, Exercise, and Rehabilitation RFA), and the University of Melbourne for funding this study. A.G. and B.S. are supported by NHMRC Early Career Fellowships. A.T. was supported by the Berlin-Burns Fellowship and a travel award provided by the Hotchkiss Brain Institute (HBI), University of Calgary. R.F. is the Hopewell Professor of Brain Imaging, HBI. The authors also thank the staff of the Department of Radiology, The Royal Melbourne Hospital for their assistance with MRI data collection.	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; [Anonymous], 2013, Br J Sports Med, V47, P259; Beck AT, 1987, MANUAL REVISED BECK; Burgess P.W., 1997, HAYLING BRIXTON TEST; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Clough M, 2015, J NEUROL, V262, P1130, DOI 10.1007/s00415-015-7645-3; Clough M, 2015, J NEUROL, V262, P1138, DOI 10.1007/s00415-015-7644-4; DeSimone JC, 2014, VISION RES, V96, P17, DOI 10.1016/j.visres.2013.12.005; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Golden CJ, 1978, STROOP COLOR WORD TE; GRONWALL DMA, 1977, PACED AUDITORY SERIA; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Herd SA, 2014, NEUROPSYCHOLOGIA, V62, P375, DOI 10.1016/j.neuropsychologia.2014.04.014; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Jamadar SD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00653; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nelson HE, 1991, REVISED NATL ADULT R; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Raffelt D, 2011, NEUROIMAGE, V56, P1171, DOI 10.1016/j.neuroimage.2011.02.014; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Shelton AL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.250; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Silk T, 2013, PSYCHIAT RES-NEUROIM, V213, P186, DOI 10.1016/j.pscychresns.2013.03.001; Smith, 1973, SYMBOL DIGIT MODALIT; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sussman ES, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15610; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tsang A, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00144; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiler J, 2014, J NEUROPHYSIOL, V112, P2176, DOI 10.1152/jn.00352.2014; Weiler J, 2012, NEUROSCI LETT, V530, P150, DOI 10.1016/j.neulet.2012.10.007; Wright DK, 2017, CEREB CORTEX, V27, P4503, DOI 10.1093/cercor/bhw254; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	54	19	19	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					730	738		10.1089/neu.2017.5204		FEB 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000424836000001	29228862				2022-02-06	
J	Nishijima, DK; Gaona, SD; Waechter, T; Maloney, R; Blitz, A; Elms, AR; Farrales, RD; Montoya, J; Bair, T; Howard, C; Gilbert, M; Trajano, RP; Hatchel, KM; Faul, M; Bell, JM; Coronado, VC; Vinson, DR; Ballard, DW; Tancredi, DJ; Garzon, H; Mackey, KE; Shahlaie, K; Holmes, JF				Nishijima, Daniel K.; Gaona, Samuel D.; Waechter, Trent; Maloney, Ric; Blitz, Adam; Elms, Andrew R.; Farrales, Roel D.; Montoya, James; Bair, Troy; Howard, Calvin; Gilbert, Megan; Trajano, Renee P.; Hatchel, Kaela M.; Faul, Mark; Bell, Jeneita M.; Coronado, Victor C.; Vinson, David R.; Ballard, Dustin W.; Tancredi, Daniel J.; Garzon, Hernando; Mackey, Kevin E.; Shahlaie, Kiarash; Holmes, James F.		Sacramento Cty Prehosp Res Consort	The Incidence of Traumatic Intracranial Hemorrhage in Head-Injured Older Adults Transported by EMS with and without Anticoagulant or Antiplatelet Use	JOURNAL OF NEUROTRAUMA			English	Article						anticoagulants; field triage; head injuries; older adults	BRAIN-INJURY; PREINJURY WARFARIN; CLOPIDOGREL; RULE; CRITERIA; DEATHS; TRIAGE; AGENTS; RISK; CARE	Field triage guidelines recommend transport of head-injured patients on anticoagulants or antiplatelets to a higher-level trauma center based on studies suggesting a high incidence of traumatic intracranial hemorrhage (tICH). We compared the incidence of tICH in older adults transported by emergency medical services (EMS) with and without anticoagulation or antiplatelet use and evaluated the accuracies of different sets of field triage criteria to identify tICH. This was a prospective, observational study at five EMS agencies and 11 hospitals. Older adults (55 years) with head trauma and transported by EMS from August 2015 to September 2016 were eligible. EMS providers completed standardized data forms and patients were followed through emergency department (ED) or hospital discharge. We enrolled 1304 patients; 1147 (88%) received a cranial computed tomography (CT) scan and were eligible for analysis. Four hundred thirty-four (33%) patients had anticoagulant or antiplatelet use and 112 (10%) had tICH. The incidence of tICH in patients with (11%, 95% confidence interval [CI] 8%-14%) and without (9%, 95% CI 7%-11%) anticoagulant or antiplatelet use was similar. Anticoagulant or antiplatelet use was not predictive of tICH on adjusted analysis. Steps 1-3 criteria alone were not sensitive in identifying tICH (27%), whereas the addition of anticoagulant or antiplatelet criterion improved sensitivity (63%). Other derived sets of triage criteria were highly sensitive (>98%) but poorly specific (<11%). The incidence of tICH was similar between patients with and without anticoagulant or antiplatelet use. Use of anticoagulant or antiplatelet medications was not a risk factor for tICH. We were unable to identify a set of triage criteria that was accurate for trauma center need.	[Nishijima, Daniel K.; Gaona, Samuel D.; Gilbert, Megan; Trajano, Renee P.; Hatchel, Kaela M.; Tancredi, Daniel J.; Garzon, Hernando; Holmes, James F.] UC Davis Sch Med, Dept Emergency Med, Sacramento, CA USA; [Shahlaie, Kiarash] UC Davis Sch Med, Dept Neurol Surg, Sacramento, CA USA; [Waechter, Trent] City Sacramento Fire Dept, Sacramento, CA USA; [Maloney, Ric] Sacramento Metropolitan Fire Dept, Sacramento, CA USA; [Blitz, Adam] Amer Med Response, Sacramento, CA USA; [Elms, Andrew R.; Mackey, Kevin E.] Kaiser Permanente South Sacramento Med Ctr, Sacramento, CA USA; [Vinson, David R.] Kaiser Permanente Sacramento Med Ctr, Sacramento, CA USA; [Farrales, Roel D.] Mercy Gen Hosp, Sacramento, CA USA; [Montoya, James] Sutter Community Hosp, Sacramento, CA USA; [Bair, Troy] Cosumnes Community Serv Dist, Fire Dept, Elk Grove, CA USA; [Howard, Calvin] City Folsom Fire Dept, Folsom, CA USA; [Faul, Mark; Bell, Jeneita M.; Coronado, Victor C.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Vinson, David R.; Ballard, Dustin W.] Kaiser Permanente Div Res, Oakland, CA USA; [Ballard, Dustin W.] Kaiser Permanente San Rafael Med Ctr, San Rafael, CA USA; [Coronado, Victor C.] Bridge Heath, Atlanta, GA USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, 4150 St,PSSB 2100, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Tancredi, Daniel J/O-3381-2013; Vinson, David R/AAK-3227-2020	Tancredi, Daniel J/0000-0002-3884-7907; Vinson, David R/0000-0001-6559-1858; Faul, Mark/0000-0002-7683-0348	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA	This work was funded by the Centers for Disease Control and Prevention (CDC), grant number U01CE002177. The findings and conclusion of this research are those of the authors and do not represent the official views of the U.S. Department of Health and Human Services (DHHS) and the CDC. The inclusion of individuals, programs, or organizations in this article does not constitute endorsement by the U.S. federal government, DHHS, or CDC.; Dr. Nishijima was supported through Mentored Clinical Research Training Program Award (Grant Number UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	*AM COLL SURG COMM, 2006, RES OPT CAR INJ PAT; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Brieman L., 1984, CLASSIFICATION REGRE; Chisholm KM, 2010, AM J FOREN MED PATH, V31, P350, DOI 10.1097/PAF.0b013e3181f69c87; Finkelstein E., 2006, INCIDENCE EC BURDEN; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Haukoos JS, 2007, ACAD EMERG MED, V14, P662, DOI 10.1197/j.aem.2006.11.037; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Lemeshow S, 2000, APPL LOGISTIC REGRES; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Newgard CD, 2014, PREHOSP EMERG CARE, V18, P461, DOI 10.3109/10903127.2014.912707; Newgard CD, 2013, J TRAUMA ACUTE CARE, V74, P1298, DOI 10.1097/TA.0b013e31828b7848; Newgard CD, 2011, J TRAUMA, V70, P1345, DOI 10.1097/TA.0b013e3182191a1b; Nishijima DK, 2017, ANN EMERG MED, V70, P127, DOI 10.1016/j.annemergmed.2016.12.018; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Starke RM, 2015, NEUROSURGERY, V77, pN11, DOI 10.1227/01.neu.0000473806.53232.3e; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thibault N., 2016, AM J THER; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Zehtabchi S, 2011, ACAD EMERG MED, V18, P637, DOI 10.1111/j.1553-2712.2011.01083.x	38	19	19	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					750	759		10.1089/neu.2017.5232		FEB 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000424834300001	29108469	Green Published			2022-02-06	
J	Sangobowale, MA; Grin'kina, NM; Whitney, K; Nikulina, E; St Laurent-Ariot, K; Ho, JS; Bayzan, N; Bergold, PJ				Sangobowale, Michael A.; Grin'kina, Natalia M.; Whitney, Kristen; Nikulina, Elena; St. Laurent-Ariot, Karrah; Ho, Johnson S.; Bayzan, Narek; Bergold, Peter J.			Minocycline plus N-Acetylcysteine Reduce Behavioral Deficits and Improve Histology with a Clinically Useful Time Window	JOURNAL OF NEUROTRAUMA			English	Article						animal behavior; drug synergy; hippocampus; mouse closed head injury; myelin; pre-clinical testing; rat controlled cortical impact; time to first dose	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; COGNITIVE IMPAIRMENT; SPATIAL INFORMATION; MEMORY; MILD; ACTIVATION; AVOIDANCE; DAMAGE; PLACE	There are no drugs to manage traumatic brain injury (TBI) presently. A major problem in developing therapeutics is that drugs to manage TBI lack sufficient potency when dosed within a clinically relevant time window. Previous studies have shown that minocycline (MINO, 45mg/kg) plus N-acetylcysteine (NAC, 150mg/kg) synergistically improved cognition and memory, modulated inflammation, and prevented loss of oligodendrocytes that remyelinated damaged white matter when first dosed 1h after controlled cortical impact (CCI) in rats. We show that MINO (45mg/kg) plus NAC (150mg/kg) also prevent brain injury in a mouse closed head injury (CHI) TBI model. Using the CHI model, the concentrations of MINO and NAC were titrated to determine that MINO (22.5mg/kg) plus NAC (75mg/kg) was more potent than the original formulation. MINO (22.5mg/kg) plus NAC (75mg/kg) also limited injury in the rat CCI model. The therapeutic time window of MINO plus NAC was then tested in the CHI and CCI models. Mice and rats could acquire an active place avoidance task when MINO plus NAC was first dosed at 12h post-injury. A first dose at 12h also limited gray matter injury in the hippocampus and preserved myelin in multiple white matter tracts. Mice and rats acquired Barnes maze when MINO plus NAC was first dosed at 24h post-injury. These data suggest that MINO (22.5mg/kg) plus NAC (75mg/kg) remain potent when dosed at clinically useful time windows. Both MINO and NAC are drugs approved by the Food and Drug Administration and have been administered safely to patients in clinical trials at the doses in the new formulation. This suggests that the drug combination of MINO plus NAC may be effective in treating patients with TBI.	[Sangobowale, Michael A.; Whitney, Kristen] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Grin'kina, Natalia M.; Nikulina, Elena; St. Laurent-Ariot, Karrah; Ho, Johnson S.; Bayzan, Narek; Bergold, Peter J.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11203 USA; [Bergold, Peter J.] Suny Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Sangobowale, Michael A.] Penn Presbyterian Med Ctr, Philadelphia, PA USA		Bergold, PJ (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Box 29,450 Clarkson Ave, Brooklyn, NY 11203 USA.	pbergold@downstate.edu		Whitney, Kristen/0000-0002-1578-6339	USAMRCC [09127004]	This work was supported by an award from the USAMRCC (09127004) to P.J.B.	Abdel Baki SG, 2010, PLOS ONE, V5; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bridges RJ, 2012, BRIT J PHARMACOL, V165, P20, DOI 10.1111/j.1476-5381.2011.01480.x; Burghardt NS, 2012, HIPPOCAMPUS, V22, P1795, DOI 10.1002/hipo.22013; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Deepmala, 2015, NEUROSCI BIOBEHAV R, V55, P294, DOI 10.1016/j.neubiorev.2015.04.015; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Garrido-Mesa N, 2013, PHARMACOL RES, V67, P18, DOI 10.1016/j.phrs.2012.10.006; Grin'kina NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161053; Grin'kina NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053775; Haber M., 2017, J CEREB BLOOD FLOW M; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hylin MJ, 2013, J NEUROTRAUM, V30, P716, DOI 10.1089/neu.2012.2717; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lante F, 2008, HIPPOCAMPUS, V18, P602, DOI 10.1002/hipo.20421; Li M, 2016, GEN MED OPEN ACCESS, V4, P1, DOI [10.4172/2327-5146.1000275, DOI 10.4172/2327-5146.1000275]; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Shinohara Y, 2012, HIPPOCAMPUS, V22, P117, DOI 10.1002/hipo.20886; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Siopi E, 2012, J NEUROTRAUM, V29, P354, DOI 10.1089/neu.2011.2055; Siopi E, 2011, J NEUROTRAUM, V28, P2135, DOI 10.1089/neu.2010.1738; Sunyer B., 2007, NAT PROTOC, P390; Thomale UW, 2006, INTENS CARE MED, V32, P149, DOI 10.1007/s00134-005-2845-4; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067	40	19	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2018	35	7					907	917		10.1089/neu.2017.5348		FEB 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GC0NF	WOS:000424831700001	29187031				2022-02-06	
J	Dillahunt-Aspillaga, C; Pugh, MJ; Cotner, BA; Silva, MA; Haskin, A; Tang, XY; Saylors, ME; Nakase-Richardson, R				Dillahunt-Aspillaga, Christina; Pugh, Mary Jo; Cotner, Bridget A.; Silva, Marc A.; Haskin, Adam; Tang, Xinyu; Saylors, Marie E.; Nakase-Richardson, Risa			Employment Stability in Veterans and Service Members With Traumatic Brain Injury: A Veterans Administration Traumatic Brain Injury Model Systems Study	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries, traumatic; Employment; Rehabilitation; Veterans	NEUROBEHAVIORAL SYMPTOM INVENTORY; POSTTRAUMATIC-STRESS-DISORDER; FUNCTIONAL INDEPENDENCE MEASURE; UNITED-STATES; NEUROPSYCHOLOGICAL OUTCOMES; GALVESTON ORIENTATION; LIFE SATISFACTION; FREEDOM VETERANS; ACUTE PREDICTORS; AMNESIA TEST	Objective: To examine incidence and predictors of employment stability in veterans and military service members with traumatic brain injury (TBI) who return to work. Design: Prospective observational cohort study. Setting: Four rehabilitation centers. Participants: Veterans and military service members (N=110) with mild (26%), moderate (22%), or severe (52%) TBI enrolled in the Department of Veterans Affairs Polytrauma Rehabilitation Centers TBI Model Systems database within 2 years of injury who were discharged between January 2009 and June 2015. Interventions: Not applicable. Main Outcome Measure: Employment stability as reflected by competitive employment at 1- and/or 2-year follow-up. Results: Over half (n=61, 55%) of the participants had stable employment at the time the first competitive employment date was recorded. Individuals with stable employment were more likely to be white (79%) and to have slightly higher cognitive and motor discharge scores on the FIM. Based on univariate analysis, more severe TBI and higher FIIVI motor scores at discharge were significantly associated with employment stability. At follow-up, compared with veterans and military service members who had unstable employment, those with stable employment had higher scores on motor and cognitive FIIVI and lower scores of self-report symptoms on the Neurobehavioral Symptom Inventory, the 9-item Patient Health Questionnaire-Depression, the 7-item Generalized Anxiety Disorder Questionnaire, and the PTSD Checklist-Civilian version. Conclusions: A number of unique factors affect employment stability in veterans and military service members with TBI. Study findings identify veterans and military service members who have stable employment and predictors of employment stability. Published by Elsevier Inc. on behalf of the American Congress of Rehabilitation Medicine	[Dillahunt-Aspillaga, Christina] Univ S Florida, Dept Child & Family Studies, Rehabil & Mental Hlth Counseling Program, Tampa, FL USA; [Dillahunt-Aspillaga, Christina; Cotner, Bridget A.; Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Hlth Serv Res & Dev Serv Ctr Innovat Disabil & Re, Tampa, FL USA; [Pugh, Mary Jo] South Texas Vet Healthcare Syst, Audie L Murphy Vet Affairs Hosp, San Antonio, TX USA; [Cotner, Bridget A.] Univ S Florida, Dept Anthropol, Tampa, FL USA; [Silva, Marc A.; Haskin, Adam; Nakase-Richardson, Risa] Def & Vet Brain Injury Ctr, Def Ctr Excellence Psychol Hlth & Traumat Brain I, Tampa, FL USA; [Silva, Marc A.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci Serv, Tampa, FL USA; [Silva, Marc A.] Univ S Florida, Dept Psychol, Tampa, FL USA; [Haskin, Adam] Gen Dynam Hlth Solut, Tampa, FL USA; [Tang, Xinyu; Saylors, Marie E.] Univ Arkansas Med Sci, Dept Pediat, Biostat Program, Little Rock, AR 72205 USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA		Cotner, BA (corresponding author), Hlth Serv Res & Dev Serv Ctr Innovat Disabil & Re, 8900 Grand Oak Circle, Tampa, FL 33637 USA.	Bridget.Cotner@va.gov	Pugh, Mary Jo/K-5336-2019; Silva, Marc A./J-1874-2019	Pugh, Mary Jo/0000-0003-4196-7763; Silva, Marc A./0000-0002-3879-6054; Dillahunt-Aspillaga, Christina/0000-0002-1231-2023	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VATBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center [W91YTZ-13-C-0015]; U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Department of Veterans AffairsUS Department of Veterans Affairs [1 I50 HX001233-01, W81XWH-13-2-0095]; U.S. Department of Defense Congressionally Directed Medical Research Programs; American Congress of Rehabilitation Medicine	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by the VHA Central Office VATBI Model System Program of Research and a subcontract from General Dynamics Health Solutions (contract no. W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, U.S. Army Medical Research and Material Command, U.S. Department of Veterans Affairs grants (grant nos. 1 I50 HX001233-01 and W81XWH-13-2-0095), and U.S. Department of Defense Congressionally Directed Medical Research Programs.; Publication of this article was supported by the American Congress of Rehabilitation Medicine.	Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2009, PM&R, V1, P41, DOI 10.1016/j.pmrj.2008.07.001; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Cohen SI, 2013, WORK, V44, P213, DOI 10.3233/WOR-2012-1417; Coronado VG, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P84; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dillahunt-Aspillaga C, 2017, J HEAD TRAUMA REHAB, V32, P271, DOI 10.1097/HTR.0000000000000275; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Donaghy S, 1998, ARCH PHYS MED REHAB, V79, P1231, DOI 10.1016/S0003-9993(98)90267-2; DVBIC, 2017, DOD WORLDW NUMB TBI; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Forslund MV, 2014, BRAIN INJURY, V28, P980, DOI 10.3109/02699052.2014.888770; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gary KW, 2010, J VOCAT REHABIL, V33, P65, DOI 10.3233/JVR-2010-0516; Geiling J, 2012, MIL MED, V177, P1235, DOI 10.7205/MILMED-D-12-00031; Gordon W, 1993, J HEAD TRAUMA REHAB, V8, P26; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Guerrero JL, 2000, BRAIN INJURY, V14, P181, DOI 10.1080/026990500120827; Hankins AB, 2015, J OCCUP REHABIL, P1; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Hobart JC, 2001, NEUROLOGY, V57, P639, DOI 10.1212/WNL.57.4.639; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; JENNETT B, 1977, LANCET, V1, P878; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kupersmith J, 2009, J REHABIL RES DEV, V46, P1; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Novack TA, 2000, J HEAD TRAUMA REHAB, V15, P957, DOI 10.1097/00001199-200006000-00008; O'Neil M., 2014, J INT NEUROPSYCH SOC, V1, P24; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Pogoda TK, 2016, J HEAD TRAUMA REHAB, V31, P191, DOI 10.1097/HTR.0000000000000092; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Possl O, 2001, BRAIN INJURY, V15, P15; Prigerson HG, 2002, AM J PUBLIC HEALTH, V92, P59, DOI 10.2105/AJPH.92.1.59; Rehabilitation UDS, 1997, GUID UN DAT SET MED; Reid MW, 2015, MOL CELL NEUROSCI, V66, P123, DOI 10.1016/j.mcn.2015.03.014; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sayer NA, 2014, SOC ISS POLICY REV, V8, P33, DOI 10.1111/sipr.12001; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Silva MA, 2013, CLIN NEUROPSYCHOL, V27, P601; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tsaousides T, 2008, REHABIL PSYCHOL, V53, P456, DOI 10.1037/a0012579; Twamley EW, 2013, J REHABIL RES DEV, V50, P663, DOI 10.1682/JRRD.2012.08.0137; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Vasterling JJ, 2012, PTSD MILD TRAUM BRAI; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weathers FW, TEH PTSD CHECKLIST D; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williamson MLC, 2016, J HEAD TRAUMA REHAB, V31, P167, DOI 10.1097/HTR.0000000000000111; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	94	19	19	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	FEB	2018	99	2		1			S23	S32		10.1016/j.apmr.2017.05.012			10	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	FU7YY	WOS:000424069900004	28629990				2022-02-06	
J	Fitzpatrick, AC; Naylor, AS; Myler, P; Robertson, C				Fitzpatrick, Anna C.; Naylor, Adam S.; Myler, Peter; Robertson, Colin			A three-year epidemiological prospective cohort study of rugby league match injuries from the European Super League	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Epidemiology; Sports injuries; Injury incidence; Injury severity	DATA-COLLECTION PROCEDURES; CONSENSUS STATEMENT; TRAINING INJURIES; TEAM SPORTS; DEFINITIONS; FOOTBALL; SURVEILLANCE; DEBATE; UNION; RATES	Objectives: Conduct a comprehensive epidemiological study of match injury characteristics (incidence, severity, causes, diagnostics, and temporal trends) in professional rugby league. Design: Prospective cohort design. Methods: Data was captured over the 2013, '14, and '15 seasons, collected via an online-reporting survey tool, and underpinned by nominal group technique-agreed definitions. Injury details were provided by club medical staff in accordance to the survey fields from all European Super League teams (e.g. injury occurrence/return dates, diagnosis, mechanism, recurrence). All time-loss injuries have been reported. Results: Injury incidence of 57 injuries/1000 h has been observed over the three-year period, with an average of 34 days missed per injury. The final 20-min period was the most significant period for injury occurrence, and higher incidence of injury/1000 h played was during the start of the season in February, although an absolute injury risk for injury frequency was shown in April due to the greatest playing time. Forward positions reported the highest injury incidence whilst tackle activities were the most frequent mechanism of injury. Concussions and hamstring strains (5 injuries/1000 h) were the most commonly diagnosed injuries, although the knee joint region (10 injuries/1000 H) was the most frequently injured area. Conclusions: In light of the most common injury diagnoses, mechanisms, identified seasonal risk, and time of match, the data should look to inform player preparation in terms of physical conditioning and tackle technique in order to optimise player welfare and availability for participation. (C) 2017 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Fitzpatrick, Anna C.; Naylor, Adam S.; Myler, Peter; Robertson, Colin] Univ Bolton, Sch Sport & Biomed Sci, Bolton, England		Fitzpatrick, AC (corresponding author), Univ Bolton, Sch Sport & Biomed Sci, Bolton, England.	A.Fitzpatrick@bolton.ac.uk	Myler, Peter/AAR-9535-2021	Fitzpatrick, Anna/0000-0002-4200-2886; Myler, Peter/0000-0003-3611-1979; Robertson, Colin/0000-0002-6186-8466; Naylor, Adam/0000-0002-7340-8109	Rugby Football League	Part funded by the Rugby Football League.	Brooks JHM, 2006, SPORTS MED, V36, P459, DOI 10.2165/00007256-200636060-00001; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; England professional rugby injury surveillance steering group (RFU), 201516 RFU; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Fuller CW, 2007, CLIN J SPORT MED, V17, P177, DOI 10.1097/JSM.0b013e31803220b3; Fuller CW, 2006, SCAND J MED SCI SPOR, V16, P83, DOI 10.1111/j.1600-0838.2006.00528.x; Gabbett TJ, 2011, J SCI MED SPORT, V14, P210, DOI 10.1016/j.jsams.2011.01.002; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gissane C, 2003, OCCUP MED-OXFORD, V53, P512, DOI 10.1093/occmed/kqg103; Gissane C, 1998, BRIT J SPORT MED, V32, P149, DOI 10.1136/bjsm.32.2.149; Gissane C, 2003, AM J SPORT MED, V31, P954, DOI 10.1177/03635465030310063501; Gissane C, 2001, CLEVE MED J, V4, P147; Hodgson L, 2007, CLIN J SPORT MED, V17, P188, DOI 10.1097/JSM.0b013e3180547513; Hodgson L, 2006, CLIN J SPORT MED, V16, P305, DOI 10.1097/00042752-200607000-00004; Hoskins W, 2006, J SCI MED SPORT, V9, P46, DOI 10.1016/j.jsams.2006.03.013; King DA, 2009, J SCI MED SPORT, V12, P12, DOI 10.1016/j.jsams.2007.12.001; King D, 2014, INT J SPORTS SCI COA, V9, P417, DOI 10.1260/1747-9541.9.2.417; King DA, 2010, SPORTS MED, V40, P163, DOI 10.2165/11319740-000000000-00000; McKay CD, 2014, BRIT J SPORT MED, V48, P57, DOI 10.1136/bjsports-2013-092860; O'Connor D., 2011, SPORT HLTH, V29, P17; Orchard J, 2002, BRIT J SPORT MED, V36, P39, DOI 10.1136/bjsm.36.1.39; Orchard J., 2004, SPORT HLTH, V22, P11; Orchard J, 2007, CLIN J SPORT MED, V17, P192, DOI 10.1097/JSM.0b013e3180547527; Orchard JW, 2013, AM J SPORT MED, V41, P734, DOI 10.1177/0363546513476270; Phillips LH, 2000, BRIT J SPORT MED, V34, P133, DOI 10.1136/bjsm.34.2.133; Twist C, 2014, INT J SPORT PHYSIOL, V9, P925, DOI 10.1123/ijspp.2013-0270; Williams S, 2013, SPORTS MED, V43, P1043, DOI 10.1007/s40279-013-0078-1	27	19	19	1	15	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	FEB	2018	21	2					160	165		10.1016/j.jsams.2017.08.012			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FX5TZ	WOS:000426144600011	28866109				2022-02-06	
J	Hughes, JM; Ulmer, CS; Gierisch, JM; Hastings, SN; Howard, MO				Hughes, Jaime M.; Ulmer, Christi S.; Gierisch, Jennifer M.; Hastings, S. Nicole; Howard, Matthew O.			Insomnia in United States military veterans: An integrated theoretical model	CLINICAL PSYCHOLOGY REVIEW			English	Article						Insomnia; Sleep; Stress; Coping; Resilience; Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS; SLEEP-DEPRIVATION; PSYCHIATRIC-DISORDERS; BEHAVIORAL TREATMENT; LIFE-COURSE; HEALTH; RESILIENCE; DISTURBANCE; DEPRESSION	Marked by difficulty falling or staying asleep and/or poor sleep leading to daytime dysfunction, insomnia contributes to functional impairment, poor health, and increased healthcare utilization when left untreated. As many as two-thirds of Iraq and Afghanistan military veterans complain of insomnia. Older veterans of prior conflicts report insomnia occurring since initial service, suggesting a chronic nature to insomnia in this population. Despite insomnia's high prevalence and severe consequences, there is no theoretical model to explain either the onset or chronicity of insomnia in this growing patient population. Existing theories view insomnia as an acute, unidirectional phenomenon and do little to elucidate long-term consequences of such problems. Existing theories also fail to address mechanisms by which acute insomnia becomes chronic. This paper presents an original, integrated theoretical model that draws upon constructs from several prominent behavioral medicine theories to reconceptualize insomnia as a chronic, cyclical problem that is both a consequence and predictor of stress. Additional research examining the relationships between stress, sleep, resilience, and outcomes of interest could inform clinical and research practices. Addressing sleep problems early could potentially enhance adaptive capacity, thereby reducing the risk for subsequent negative outcomes.	[Hughes, Jaime M.; Ulmer, Christi S.; Gierisch, Jennifer M.; Hastings, S. Nicole] Durham VA Hlth Care Syst, Hlth Serv Res & Dev, 508 Fulton St 152, Durham, NC 27705 USA; [Ulmer, Christi S.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Gierisch, Jennifer M.] Duke Univ, Dept Populat Hlth Sci, Durham, NC USA; [Hastings, S. Nicole] Durham VA Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Durham, NC USA; [Hastings, S. Nicole] Duke Univ, Dept Med, Durham, NC USA; [Hastings, S. Nicole] Duke Univ, Ctr Study Aging & Human Dev, Durham, NC USA; [Howard, Matthew O.] Univ North Carolina Chapel Hill, Sch Social Work, Chapel Hill, NC USA		Hughes, JM (corresponding author), Durham VA Hlth Care Syst, Hlth Serv Res & Dev, 508 Fulton St 152, Durham, NC 27705 USA.	jane.hughes@va.gov		Hughes, Jaime/0000-0001-6410-0068	Office of Academic Affiliations, VA Health Services Research Development [TPH 21-000]; VA Research Career Development Award Program [CDA 09-218]; University of North Carolina Program on Integrative Medicine [NIH/NCCIH T32AT003378]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32AT003378] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2HX000845] Funding Source: NIH RePORTER	This work was supported by facilities and resources at the Center of Innovation for Health Services Research in Primary Care at the Durham VAMC (CIN 13-410); Office of Academic Affiliations, VA Health Services Research & Development (Hughes: TPH 21-000); VA Research Career Development Award Program (Ulmer: CDA 09-218); and University of North Carolina Program on Integrative Medicine (Hughes: NIH/NCCIH T32AT003378). None of the funding sources had a role in developing this material, writing the manuscript, or the decision to submit the paper for publication.	Ahn S, 2014, FAM COMMUNITY HEALTH, V37, P327, DOI 10.1097/FCH.0000000000000045; American Psychiatric Association, 2013, DESK REF DIAGN CRIT; Amin MM, 2010, MIL MED, V175, P155; [Anonymous], 2009, DEPRESS ANXIETY, V26, P493, DOI 10.1002/da.20581; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Benight CC, 2004, BEHAV RES THER, V42, P1129, DOI 10.1016/j.brat.2003.08.008; Blosnich JR, 2014, JAMA PSYCHIAT, V71, P1041, DOI 10.1001/jamapsychiatry.2014.724; Bramoweth AD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0401-4; Breslau N, 1996, BIOL PSYCHIAT, V39, P411, DOI 10.1016/0006-3223(95)00188-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cabrera OA, 2007, AM J PREV MED, V33, P77, DOI 10.1016/j.amepre.2007.03.019; Campbell J, 2015, 29 ANN M ASS PROF SL; Castro C. A., 2015, TRAUMATOLOGY, V221, P299; Charles ST, 2013, PSYCHOL SCI, V24, P733, DOI 10.1177/0956797612462222; DeLongis A., 1982, HEALTH PSYCHOL, V1, P119, DOI [DOI 10.1037/0278-6133.1.2.119, 10.1037/0278-6133.1.2.119]; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Drake C, 2004, SLEEP, V27, P285, DOI 10.1093/sleep/27.2.285; Drake CL, 2014, SLEEP, V37, P1295, DOI 10.5665/sleep.3916; Drake CL, 2011, SLEEP, V34, P1179, DOI 10.5665/SLEEP.1234; Fernandez-Mendoza J, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0418-8; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Ford ES, 2015, SLEEP MED, V16, P372, DOI 10.1016/j.sleep.2014.12.008; GARMEZY N, 1971, AM J ORTHOPSYCHIAT, V41, P101, DOI 10.1111/j.1939-0025.1971.tb01111.x; Gehrman P, 2013, SLEEP, V36, P1009, DOI 10.5665/sleep.2798; Germain A, 2007, BEHAV RES THER, V45, P627, DOI 10.1016/j.brat.2006.04.009; Hamilton NA, 2007, HEALTH PSYCHOL, V26, P288, DOI 10.1037/0278-6133.26.3.288; Haynes P. L., 2013, SLEEP S, V36, pA232; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge EA, 2007, DEPRESS ANXIETY, V24, P139, DOI 10.1002/da.20175; Hughes JM, 2015, BEHAV SLEEP MED, V13, P197, DOI 10.1080/15402002.2013.855212; Ilgen M. A., 2013, VETERAN SUICIDE PUBL, P278; Institute of Medicine, 2013, RET HOM IRAQ AFGH AS; Irwin MR, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0009; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Karlin BE, 2015, INT J GERIATR PSYCH, V30, P308, DOI 10.1002/gps.4143; Katz DA, 2002, J FAM PRACTICE, V51, P229; Killgore WDS, 2006, J SLEEP RES, V15, P7, DOI 10.1111/j.1365-2869.2006.00487.x; Killgore WDS, 2008, SLEEP MED, V9, P517, DOI 10.1016/j.sleep.2007.07.003; Koffel E., 2015, SLEEP S, V38, pA326; Kripke DF, 2002, ARCH GEN PSYCHIAT, V59, P131, DOI 10.1001/archpsyc.59.2.131; Lavretsky H, 2014, Resilience and Aging: Research and Practice, P1; Lohr JB, 2015, AM J GERIAT PSYCHIAT, V23, P709, DOI 10.1016/j.jagp.2015.04.001; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Manber R, 2005, CLIN PSYCHOL REV, V25, P535, DOI 10.1016/J.CPR.2005.04.002; Marmar CR, 2015, JAMA PSYCHIAT, V72, P875, DOI 10.1001/jamapsychiatry.2015.0803; Masten AS, 2007, DEV PSYCHOPATHOL, V19, P921, DOI 10.1017/S0954579407000442; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; McAlister A. L., 2008, HLTH BEHAV HLTH ED T, P169; McEwen B. S, 2006, METABOLISM CLIN E S2, V55; McEwen BS, 2015, SLEEP MED CLIN, V10, P1, DOI 10.1016/j.jsmc.2014.11.007; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Morin C, 1993, INSOMNIA PYSCHOL ASS; Morin CM, 2006, SLEEP, V29, P1398, DOI 10.1093/sleep/29.11.1398; Morin CM, 2003, PSYCHOSOM MED, V65, P259, DOI 10.1097/01.PSY.0000030391.09558.A3; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; National Institutes of Health, 2005, NIH STAT SCI C STAT; Ong JC, 2014, SLEEP, V37, P1553, DOI 10.5665/sleep.4010; Pearlin LI, 1996, GERONTOLOGIST, V36, P239, DOI 10.1093/geront/36.2.239; Pearlin LI, 2005, J HEALTH SOC BEHAV, V46, P205, DOI 10.1177/002214650504600206; Perlis Michael L, 2006, Behav Sleep Med, V4, P104, DOI 10.1207/s15402010bsm0402_3; Perlis ML, 1997, J SLEEP RES, V6, P179, DOI 10.1046/j.1365-2869.1997.00045.x; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Pigeon WR, 2008, SLEEP, V31, P481, DOI 10.1093/sleep/31.4.481; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Roth Thomas, 2007, J Clin Sleep Med, V3, pS7; Ryden A. M., 2015, SLEEP S, V38, pA396; Schnurr PP, 2000, HEALTH PSYCHOL, V19, P91, DOI 10.1037/0278-6133.19.1.91; Seelig AD, 2016, SLEEP, V39, P1111, DOI 10.5665/sleep.5766; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; Sharma M, 2014, J EVID-BASED INTEGR, V19, P271, DOI 10.1177/2156587214543143; Shippee ND, 2012, J CLIN EPIDEMIOL, V65, P1041, DOI 10.1016/j.jclinepi.2012.05.005; Southwick SM, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.25338; Spielman AJ, 1991, CASE STUDIES INSOMNI; Stanley EA, 2011, COGN BEHAV PRACT, V18, P566, DOI 10.1016/j.cbpra.2010.08.002; Taylor DJ, 2007, SLEEP, V30, P213, DOI 10.1093/sleep/30.2.213; Trockel M, 2014, BEHAV RES THER, V53, P41, DOI 10.1016/j.brat.2013.11.006; Troxel WM, 2015, SLEEP MILITARY PROMO; Ulmer CS, 2015, J CLIN SLEEP MED, V11, P995, DOI 10.5664/jcsm.5012; Vaughan C. C., 1999, PROMISE SLEEP PIONEE; Viswanath K., 2008, HLTH BEHAV HLTH ED T, P211; WERNER EE, 1995, CURR DIR PSYCHOL SCI, V4, P81, DOI 10.1111/1467-8721.ep10772327; Wolf EJ, 2016, PSYCHONEUROENDOCRINO, V63, P155, DOI 10.1016/j.psyneuen.2015.09.020; Wright KM, 2011, J CLIN PSYCHOL, V67, P1240, DOI 10.1002/jclp.20845; Yoon J, 2011, POPUL HEALTH MANAG, V14, P293, DOI 10.1089/pop.2010.0079; Young-McCaughan S., 2011, ROLE SLEEP HLTH RESI; Yu W, 2003, MED CARE RES REV, V60, p146S, DOI 10.1177/1077558703257000; Zullig LL, 2016, J GEN INTERN MED, V31, P329, DOI 10.1007/s11606-015-3512-2	90	19	19	1	20	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0272-7358	1873-7811		CLIN PSYCHOL REV	Clin. Psychol. Rev.	FEB	2018	59						118	125		10.1016/j.cpr.2017.11.005			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FT9VD	WOS:000423499600009	29180102	Bronze, Green Accepted			2022-02-06	
J	Li, X; Wang, HD; Wen, GD; Li, LW; Gao, YY; Zhuang, Z; Zhou, ML; Mao, L; Fan, YW				Li, Xiang; Wang, Handong; Wen, Guodao; Li, Liwen; Gao, Yongyue; Zhuang, Zong; Zhou, Mengliang; Mao, Lei; Fan, Youwu			Neuroprotection by quercetin via mitochondrial function adaptation in traumatic brain injury: PGC-1 alpha pathway as a potential mechanism	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						quercetin; mitochondria; PGC-1 alpha; traumatic brain injury; neuroprotection	EXPERIMENTAL STROKE; OXIDATIVE STRESS; APOPTOSIS; PROTECTS; DYSFUNCTION; BIOGENESIS; RATS; ERYTHROPOIETIN; EXPRESSION; DISEASE	The aim of this study was to investigate the neuroprotective effects of quercetin in mouse models of traumatic brain injury (TBI) and the potential role of the PGC-1 alpha pathway in putative neuroprotection. Wild-type mice were randomly assigned to four groups: the sham group, the TBI group, the TBI+ vehicle group and the TBI+ quercetin group. Quercetin, a dietary flavonoid used as a food supplement, significantly reduced TBI-induced neuronal apoptosis and ameliorated mitochondrial lesions. It significantly accelerated the translocation of PGC-1 alpha protein from the cytoplasm to the nucleus. In addition, quercetin restored the level of cytochrome c, malondialdehyde and superoxide dismutase in mitochondria. Therefore, quercetin administration can potentially attenuate brain injury in a TBI model by increasing the activities of mitochondrial biogenesis via the mediation of the PGC-1 alpha pathway.	[Li, Xiang; Wang, Handong; Wen, Guodao; Li, Liwen; Gao, Yongyue; Zhuang, Zong; Zhou, Mengliang; Mao, Lei; Fan, Youwu] Nanjing Univ, Med Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD; Fan, YW (corresponding author), Nanjing Univ, Med Sch Med, Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	njhdwang@hotmail.com; njywfan@163.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371357]; Nanjing Military Region Foundation, PLA Grant [14MS104, 15MS126]	This work was supported by grants from the National Natural Science Foundation of China (81371357) and the Nanjing Military Region Foundation, PLA Grant (14MS104, 15MS126).	Baburamani AA, 2015, INT J MOL SCI, V16, P22509, DOI 10.3390/ijms160922509; Chen SD, 2011, INT J MOL SCI, V12, P7199, DOI 10.3390/ijms12107199; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Egger A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031272; Escobales N, 2014, J MOL CELL CARDIOL, V77, P136, DOI 10.1016/j.yjmcc.2014.10.009; Fan YW, 2012, BRAIN INJURY, V26, P1267, DOI 10.3109/02699052.2012.672789; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gloryy A, 2014, INT J HYPERTHER, V30, P502, DOI 10.3109/02656736.2014.968641; Go KL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/183469; Greco T, 2016, J CEREBR BLOOD F MET, V36, P1603, DOI 10.1177/0271678X15610584; Halder S, 2016, BIOL TRACE ELEM RES, V171, P391, DOI 10.1007/s12011-015-0544-8; Hang CH, 2007, J SURG RES, V137, P53, DOI 10.1016/j.jss.2006.06.026; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Kilbaugh TJ, 2016, MITOCHONDRION, V26, P19, DOI 10.1016/j.mito.2015.11.001; Li L, 2015, NEUROCHEM RES, V40, P1555, DOI 10.1007/s11064-015-1623-0; Liu HC, 2012, BRAIN RES, V1474, P73, DOI 10.1016/j.brainres.2012.07.028; Liu P, 2015, RESTOR NEUROL NEUROS, V33, P143, DOI 10.3233/RNN-140446; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Ma SB, 2014, CELL DEATH DIFFER, V21, P1925, DOI 10.1038/cdd.2014.119; McMeekin LJ, 2016, SCHIZOPHRENIA BULL, V42, P1009, DOI 10.1093/schbul/sbv184; Millet A, 2016, J NEUROTRAUM, V33, P1625, DOI 10.1089/neu.2015.4160; Pena-Salazar C, 2014, J NEUROPSYCH CLIN N, V26, pE23, DOI 10.1176/appi.neuropsych.13100276; Peng WJ, 2014, J NEUROSURG, V121, P653, DOI 10.3171/2014.6.JNS132577; Petzold A, 2007, NEUROL RES, V29, P691, DOI 10.1179/016164107X240080; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Senoo N, 2015, J LIPID RES, V56, P2286, DOI 10.1194/jlr.M060533; Sharma DR, 2015, NEUROTOXICOLOGY, V51, P116, DOI 10.1016/j.neuro.2015.10.002; Simonyan L, 2016, FEBS LETT, V590, P13, DOI 10.1002/1873-3468.12030; Su XM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134087; Viswanatha GL, 2013, EUR J PHARMACOL, V720, P286, DOI 10.1016/j.ejphar.2013.10.016; Vlodavsky E, 2017, J CEREBR BLOOD F MET, V37, P166, DOI 10.1177/0271678X15621068; Wang RS, 2013, CELL METAB, V17, P685, DOI 10.1016/j.cmet.2013.03.016; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Zhu HR, 2010, NEUROPHARMACOLOGY, V59, P70, DOI 10.1016/j.neuropharm.2010.03.017; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	39	19	22	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	FEB	2018	22	2					883	891		10.1111/jcmm.13313			9	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	FT7VO	WOS:000423361500018	29205806	Green Published, gold			2022-02-06	
J	Lu, HH; Ma, K; Jin, LW; Zhu, H; Cao, RQ				Lu, Huaihai; Ma, Kun; Jin, Liwei; Zhu, He; Cao, Ruiqi			17-estradiol rescues damages following traumatic brain injury from molecule to behavior in mice	JOURNAL OF CELLULAR PHYSIOLOGY			English	Article						17beta-estradiol; neuroprotection; NR2B; traumatic brain injury	LONG-TERM POTENTIATION; ESTRADIOL-INDUCED INCREASE; CLOSED-HEAD INJURY; NMDA RECEPTORS; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; 17-BETA-ESTRADIOL; MODEL; RAT; NEUROPROTECTION	Traumatic brain injury (TBI) is a public health concern, and causes cognitive dysfunction, emotional disorders, and neurodegeration, as well. The currently available treatments are all symptom-oriented with unsatifying efficacy. It is highly demanded to understand its underlying mechanisms. Controlled cortical impact (CCI) was used to induce TBI in aged female mice subjected to ovariectomy. Brain damages were assessed with neurological severity score, brain infarction and edema. Morris water maze and elevated plus maze were applied to evaluate the levels of anxiety. Apoptosis in the hippocampus was assayed with Fluoro-Jade B staining and TUNEL staining. Western blot was employed to measure the expression of NMDA receptor subunits and phosphorylation of ERK1/2, and biochemical assays were used to estimate oxidative stress. 17beta-Estradiol (E2) was intraperitoneally administered at 10-80g/kg once per day for 7 consecutive days before or after CCI. Chronic administration of E2 both before and immediately after CCI conferred neuroprotection, reducing neurological severity score, brain infarction, and edema in TBI mice. Additionally, E2 improved many aspects of deleterious effects of TBI on the hippocampus, including neuronal apoptosis, dysfunction in spatial memory, reduction in NR2B, enhancement of oxidative stress, and activation of ERK1/2 pathway. The present study provides clue for the notion that E2 has therapeutic potential for both prevention and intervention of TBI-induced brain damages.	[Lu, Huaihai; Cao, Ruiqi] Hebei Med Univ, Intens Care Unit, Dept Anesthesiol, Hosp 2, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China; [Ma, Kun] Fourth Hosp Shijiazhuang, Dept Anesthesiol, Shijiazhuang, Hebei, Peoples R China; [Jin, Liwei] Youfu Hosp Hebei Prov, Dept Geratol, Shijiazhuang, Hebei, Peoples R China; [Zhu, He] Tianjin Cent Hosp Gyecol & Obstet, Dept Anesthesiol, Tianjin, Peoples R China		Cao, RQ (corresponding author), Hebei Med Univ, Intens Care Unit, Dept Anesthesiol, Hosp 2, 215 Heping West Rd, Shijiazhuang 050000, Hebei, Peoples R China.	caoruiqilhlh@163.com					Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Bi RF, 2001, P NATL ACAD SCI USA, V98, P13391, DOI 10.1073/pnas.241507698; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Brinton RD, 1997, NEUROCHEM RES, V22, P1339, DOI 10.1023/A:1022015005508; Buhmann CB, 2014, DAN MED J, V61; Chen W, 2017, RESTOR NEUROL NEUROS, V35, P217, DOI 10.3233/RNN-160705; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Clayton DA, 2002, J NEUROSCI, V22, P3628; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Galvin C, 2014, NEUROPSYCHOPHARMACOL, V39, P2086, DOI 10.1038/npp.2014.56; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Groger M, 2014, BRAIN RES, V1589, P61, DOI 10.1016/j.brainres.2014.08.029; HATASHITA S, 1988, J CEREBR BLOOD F MET, V8, P552, DOI 10.1038/jcbfm.1988.96; Heron P, 2001, METAB BRAIN DIS, V16, P187, DOI 10.1023/A:1012593027961; Hilton GD, 2006, EUR J NEUROSCI, V24, P3008, DOI 10.1111/j.1460-9568.2006.05189.x; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Krishnamurthy K, 2016, TRANSLATIONAL RES TR; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Lesniak A, 2016, NEUROPHARMACOLOGY, V101, P506, DOI 10.1016/j.neuropharm.2015.10.014; Lewis MC, 2008, BEHAV NEUROSCI, V122, P716, DOI 10.1037/0735-7044.122.3.716; Lopez-Grueso R, 2014, ANTIOXID REDOX SIGN, V20, P236, DOI 10.1089/ars.2012.5112; Mollayeva T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005917; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Romeo RD, 2005, NEUROENDOCRINOLOGY, V81, P391, DOI 10.1159/000089557; Romine J, 2014, JOVE-J VIS EXP, DOI 10.3791/51781; Schaible EV, 2014, J NEUROCHEM, V129, P940, DOI 10.1111/jnc.12708; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shohami E, 2014, CNS NEUROL DISORD-DR, V13, P567, DOI 10.2174/18715273113126660196; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Smith CC, 2016, HIPPOCAMPUS, V26, P110, DOI 10.1002/hipo.22495; Smith Caroline C, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS130, DOI 10.1016/j.psyneuen.2009.06.003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Snyder MA, 2011, HIPPOCAMPUS, V21, P398, DOI 10.1002/hipo.20756; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Spampinato SF, 2012, ENDOCRINOLOGY, V153, P5940, DOI 10.1210/en.2012-1799; Vedder LC, 2013, HIPPOCAMPUS, V23, P108, DOI 10.1002/hipo.22068; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6; Xiao C, 2016, NEURON, V90, P333, DOI 10.1016/j.neuron.2016.03.028; Zamani MR, 2000, J NEUROPHYSIOL, V84, P1800, DOI 10.1152/jn.2000.84.4.1800; Zhou C, 2014, EUR J PAIN, V18, P649, DOI 10.1002/j.1532-2149.2013.00416.x	52	19	20	0	36	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9541	1097-4652		J CELL PHYSIOL	J. Cell. Physiol.	FEB	2018	233	2					1712	1722		10.1002/jcp.26083			11	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	FL9RB	WOS:000414593500086	28681915				2022-02-06	
J	Slowik, A; Lammerding, L; Hoffmann, S; Beyer, C				Slowik, A.; Lammerding, L.; Hoffmann, S.; Beyer, C.			Brain inflammasomes in stroke and depressive disorders: Regulation by oestrogen	JOURNAL OF NEUROENDOCRINOLOGY			English	Article; Proceedings Paper	9th International Meeting on Steroids and Nervous System	FEB 11-15, 2017	Torino, ITALY			depressive disorder; oestrogen; inflammasome; ischaemia; neuroinflammation	POLYUNSATURATED FATTY-ACIDS; SPINAL-CORD-INJURY; FACTOR-KAPPA-B; NLRP3 INFLAMMASOME; CEREBRAL-ISCHEMIA; FRONTAL-CORTEX; RECEPTOR BETA; CELL-DEATH; MAJOR DEPRESSION; DORSAL RAPHE	Neuroinflammation is a devastating pathophysiological process that results in brain damage and neuronal death. Pathogens, cell fragments and cellular dysfunction trigger inflammatory responses. Irrespective of the cause, inflammasomes are key intracellular multiprotein signalling platforms that sense neuropathological conditions. The activation of inflammasomes leads to the auto-proteolytic cleavage of caspase-1, resulting in the proteolysis of the pro-inflammatory cytokines interleukin (IL)1 and IL18 into their bioactive forms. It also initiates pyroptosis, a type of cell death. The two cytokines contribute to the pathogenesis in acute and chronic brain diseases and also play a central role in human aging and psychiatric disorders. Sex steroids, in particular oestrogens, are well-described neuroprotective agents in the central nervous system. Oestrogens improve the functional outcome after ischaemia and traumatic brain injury, reduce neuronal death in Parkinsons and Alzheimers disease, as well as in amyotrophic lateral sclerosis, attenuate glutamate excitotoxicity and the formation of radical oxygen species, and lessen the spread of oedema after damage. Moreover, oestrogens alleviate menopause-related depressive symptoms and have a positive influence on depressive disorders probably by influencing growth factor production and serotonergic brain circuits. Recent evidence also suggests that inflammasome signalling affects anxiety- and depressive-like behaviour and that oestrogen ameliorates depression-like behaviour through the suppression of inflammasomes. In the present review, we highlight the most recent findings demonstrating that oestrogens selectively suppress the activation of the neuroinflammatory cascade in the brain in acute and chronic brain disease models. Furthermore, we aim to describe putative regulatory signalling pathways involved in the control of inflammasomes. Finally, we consider that psychiatric disorders such as depression also contain an inflammatory component that could be modulated by oestrogen.	[Slowik, A.; Lammerding, L.; Beyer, C.] Rhein Westfal TH Aachen, Med Fac, Inst Neuroanat, Aachen, Germany; [Hoffmann, S.] Rhein Westfal TH Aachen, Med Fac, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Hoffmann, S.; Beyer, C.] JARA Translat Brain Med, Aachen, Germany		Beyer, C (corresponding author), Rhein Westfal TH Aachen, Inst Neuroanat, Aachen, Germany.	cbeyer@ukaachen.de		Dr. Slowik, Alexander/0000-0001-9907-2263	START grant of the Medical Faculty of the RWTH Aachen, Germany	START grant (A. Slowik) of the Medical Faculty of the RWTH Aachen, Germany	Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Alcocer-Gomez E, 2014, BRAIN BEHAV IMMUN, V36, P111, DOI 10.1016/j.bbi.2013.10.017; Barrington J, 2017, BRAIN PATHOL, V27, P205, DOI 10.1111/bpa.12476; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bethea CL, 2006, J PSYCHIATR NEUROSCI, V31, P105; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Broughton BRS, 2009, STROKE, V40, pE331, DOI 10.1161/STROKEAHA.108.531632; Chakrabarti M, 2016, REV NEUROSCIENCE, V27, P271, DOI 10.1515/revneuro-2015-0032; Chen S, 2013, NEUROBIOL DIS, V58, P296, DOI 10.1016/j.nbd.2013.06.011; Choi AJS, 2014, MOL CELLS, V37, P441, DOI 10.14348/molcells.2014.0104; Chuang SY, 2013, P NATL ACAD SCI USA, V110, P16079, DOI 10.1073/pnas.1306556110; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dambal S, 2015, NUCLEIC ACIDS RES, V43, P7173, DOI 10.1093/nar/gkv703; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; de Freitas GR, 2001, EUR J NEUROL, V8, P1, DOI 10.1046/j.1468-1331.2001.00150.x; De Nicola AF, 2013, J NEUROENDOCRINOL, V25, P1095, DOI 10.1111/jne.12043; Debye B, 2016, BRAIN PATHOL; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Fann D. Y., 2017, MOL NEUROBIOL; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Fann DYW, 2014, EXP NEUROL, V257, P114, DOI 10.1016/j.expneurol.2014.04.017; Farooq RK, 2017, BIOMED REP, V6, P15, DOI 10.3892/br.2016.807; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Gao L, 2017, INFLAMM RES, V66, P17, DOI 10.1007/s00011-016-0981-7; Giatti S, 2012, J MOL ENDOCRINOL, V49, pR125, DOI 10.1530/JME-12-0127; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Lopez MG, 2015, IMMUNOPHARM IMMUNOT, V37, P343, DOI 10.3109/08923973.2015.1059439; Gordon JL, 2015, AM J PSYCHIAT, V172, P227, DOI 10.1176/appi.ajp.2014.14070918; Guarda G, 2011, J IMMUNOL, V186, P2529, DOI 10.4049/jimmunol.1002720; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Habib P, 2013, J STEROID BIOCHEM, V138, P195, DOI 10.1016/j.jsbmb.2013.06.003; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Harraz MM, 2012, P NATL ACAD SCI USA, V109, P18962, DOI 10.1073/pnas.1121288109; Heitzer M, 2016, MOL NEUROBIOL; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Herzog R, 2017, J STEROID BIOCHEM, V167, P126, DOI 10.1016/j.jsbmb.2016.11.018; Hodes GE, 2017, J NEUROSCI RES, V95, P692, DOI 10.1002/jnr.23876; Hu W, 2016, BRAIN BEHAV IMMUN, V52, P58, DOI 10.1016/j.bbi.2015.09.019; Ishrat T, 2015, MOL NEUROBIOL, V51, P766, DOI 10.1007/s12035-014-8766-x; Iwata M, 2013, BRAIN BEHAV IMMUN, V31, P105, DOI 10.1016/j.bbi.2012.12.008; Jeon SW, 2016, WORLD J PSYCHIATR, V6, P283, DOI 10.5498/wjp.v6.i3.283; Jin Y, 2015, J NUTR BIOCHEM, V26, P970, DOI 10.1016/j.jnutbio.2015.04.005; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Johnson AB, 2005, NEUROBIOL AGING, V26, P1365, DOI 10.1016/j.neurobiolaging.2004.12.006; Kajta M, 2006, BRAIN RES, V1116, P64, DOI 10.1016/j.brainres.2006.07.105; Kaufmann FN, 2017, BRAIN BEHAV IMMUN, V64, P367, DOI 10.1016/j.bbi.2017.03.002; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kim HK, 2016, J PSYCHIATR RES, V72, P43, DOI 10.1016/j.jpsychires.2015.10.015; Kim MJ, 2016, BMB REP, V49, P529, DOI 10.5483/BMBRep.2016.49.10.115; Kipp M, 2016, NEUROSCI BIOBEHAV R, V67, P125, DOI 10.1016/j.neubiorev.2015.11.016; Kipp M, 2009, FRONT NEUROENDOCRIN, V30, P188, DOI 10.1016/j.yfrne.2009.04.004; Kiss A, 2012, BEHAV BRAIN RES, V227, P100, DOI 10.1016/j.bbr.2011.10.047; Klinge CM, 2009, CURR GENOMICS, V10, P169, DOI 10.2174/138920209788185289; Kong X, 2016, J NEUROSCI RES; Koo JW, 2010, P NATL ACAD SCI USA, V107, P2669, DOI 10.1073/pnas.0910658107; Kuppers E, 2008, PSYCHONEUROENDOCRINO, V33, P832, DOI 10.1016/j.psyneuen.2008.03.007; Lammerding L, 2016, NEUROENDOCRINOLOGY, V103, P460, DOI 10.1159/000439435; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li Y, 2015, TOXICOL APPL PHARM, V286, P53, DOI 10.1016/j.taap.2015.03.010; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lommatzsch M, 2006, PSYCHONEUROENDOCRINO, V31, P388, DOI 10.1016/j.psyneuen.2005.09.003; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu SJ, 2013, COMPR PSYCHIAT, V54, P953, DOI 10.1016/j.comppsych.2013.03.026; Lunov O, 2011, ACS NANO, V5, P9648, DOI 10.1021/nn203596e; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; May M, 2016, NAT MED, V22, P1370, DOI 10.1038/nm1216-1370; Michelsen KA, 2007, BRAIN RES REV, V55, P329, DOI 10.1016/j.brainresrev.2007.01.002; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Mohamed IN, 2015, ANTIOXID REDOX SIGN, V22, P1188, DOI 10.1089/ars.2014.6126; Munding C, 2006, CELL DEATH DIFFER, V13, P1938, DOI 10.1038/sj.cdd.4401896; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Numakawa T, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00136; Pace TWW, 2006, AM J PSYCHIAT, V163, P1630, DOI 10.1176/appi.ajp.163.9.1630; Pan Y, 2014, BRAIN BEHAV IMMUN, V41, P90, DOI 10.1016/j.bbi.2014.04.007; Panchanathan R, 2015, MOL CELL ENDOCRINOL, V415, P45, DOI 10.1016/j.mce.2015.08.003; Peeri M, 2015, MED HYPOTHESES, V85, P707, DOI 10.1016/j.mehy.2015.10.026; Peng H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030344; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Rao YS, 2013, ENDOCRINOLOGY, V154, P2795, DOI 10.1210/en.2013-1230; Rim HK, 2013, INDIAN J MED RES, V137, P142; Sahin C, 2016, BASIC CLIN PHARMACOL, V119, P367, DOI 10.1111/bcpt.12604; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Savage CD, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00288; Sayeed I, 2009, PROG BRAIN RES, V175, P219, DOI 10.1016/S0079-6123(09)17515-5; Shelton RC, 2011, MOL PSYCHIATR, V16, P751, DOI 10.1038/mp.2010.52; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Slowik A, 2015, J STEROID BIOCHEM, V153, P135, DOI 10.1016/j.jsbmb.2015.02.013; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Suzuki S, 2009, FRONT NEUROENDOCRIN, V30, P201, DOI 10.1016/j.yfrne.2009.04.007; Tan MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.348; Tan MS, 2013, MOL NEUROBIOL, V48, P875, DOI 10.1007/s12035-013-8475-x; Thakkar R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8309031; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Trendelenburg G, 2014, J CEREBR BLOOD F MET, V34, P1857, DOI 10.1038/jcbfm.2014.159; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vaccari JPD, 2016, J NEUROCHEM, V136, P492, DOI 10.1111/jnc.13404; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Vegeto E, 2008, FRONT NEUROENDOCRIN, V29, P507, DOI 10.1016/j.yfrne.2008.04.001; Vinuesa CG, 2009, INT REV IMMUNOL, V28, P112, DOI 10.1080/08830180902934909; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang Y, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-77; Wang YJ, 2016, BEHAV BRAIN RES, V307, P18, DOI 10.1016/j.bbr.2016.03.044; Wei Q, 2015, LAB INVEST, V95, P804, DOI 10.1038/labinvest.2015.63; Wohleb ES, 2016, NAT REV NEUROSCI, V17, P497, DOI 10.1038/nrn.2016.69; Wu WF, 2013, P NATL ACAD SCI USA, V110, P3543, DOI 10.1073/pnas.1300313110; Xu YJ, 2016, BRAIN BEHAV IMMUN, V56, P175, DOI 10.1016/j.bbi.2016.02.022; Xu YJ, 2015, BEHAV BRAIN RES, V288, P71, DOI 10.1016/j.bbr.2015.04.017; Yao X, 2014, AM J PHYSIOL-HEART C, V306, pH882, DOI 10.1152/ajpheart.00475.2013; Yin Y, 2009, INT J IMMUNOPATH PH, V22, P311, DOI 10.1177/039463200902200208; Zendedel A, 2017, MOL NEUROBIOL; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zendedel A, 2015, J NEUROIMMUNOL, V278, P200, DOI 10.1016/j.jneuroim.2014.11.007; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.11772/j.issn.1001-9081.2014.07.1929, 10.1523/JNEUROSCI.1860-14.2014]; Zhang Y, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv006; Zhang Y, 2014, CNS NEUROSCI THER, V20, P119, DOI 10.1111/cns.12170; Zhao QQ, 2017, CURR PHARM DESIGN, V23, P522, DOI 10.2174/1381612822666161208142617; Zhong Z, 2016, CLIN EXP RHEUMATOL, V34, pS12; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	133	19	20	0	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-8194	1365-2826		J NEUROENDOCRINOL	J. Neuroendocrinol.	FEB	2018	30	2			SI				e12482	10.1111/jne.12482			11	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Endocrinology & Metabolism; Neurosciences & Neurology	FW7RG	WOS:000425521300001	28477436				2022-02-06	
J	Katsumoto, A; Miranda, AS; Butovsky, O; Teixeira, AL; Ransohoff, RM; Lamb, BT				Katsumoto, Atsuko; Miranda, Aline S.; Butovsky, Oleg; Teixeira, Antonio L.; Ransohoff, Richard M.; Lamb, Bruce T.			Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model	JOURNAL OF NEUROINFLAMMATION			English	Article						Laquinimod; Microglia; Peripherally derived monocytes; Traumatic brain injury	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED TRIAL; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; ORAL LAQUINIMOD; MICE; DISEASE; CELLS; MILD; MICROGLIA	Background: Traumatic brain injury (TBI) is a critical public health and socio-economic problem worldwide. A growing body of evidence supports the involvement of inflammatory events in TBI. It has been reported that resident microglia and infiltrating monocytes promote an inflammatory reaction that leads to neuronal death and eventually behavioral and cognitive impairment. Currently, there is no effective treatment for TBI and the development of new therapeutic strategies is a scientific goal of highest priority. Laquinimod, an orally administered neuroimmunomodulator initially developed for the treatment of multiple sclerosis, might be a promising neuroprotective therapy for TBI. Herein, we aim to investigate the hypothesis that laquinimod will reduce the central nervous system (CNS) damage caused by TBI. Methods: To test our hypothesis, Ccr2(rfp/+) Cx3cr1(gfp/+) mice were submitted to a moderate TBI induced by fluid percussion. Sham controls were submitted only to craniotomy. Mice were treated daily by oral gavage with laquinimod (25 mg/kg) 7 days before and 3 days after TBI. The brains of mice treated or not treated with laquinimod were collected at 3 and 120 days post injury, and brain morphological changes, axonal injury, and neurogenesis were evaluated by microscopy analysis. We also isolated microglia from infiltrating monocytes, and the expression of immune gene mRNAs were analyzed by employing a quantitative NanoString nCounter technique. Results: Laquinimod prevented ventricle enlargement caused by TBI in the long term. Immunohistochemical analyses revealed decreased axonal damage and restored neurogenesis in the laquinimod-treated TBI group at early stage (3 days post injury). Notably, laquinimod inhibited the monocytes infiltration to the brain. Hierarchial clustering demonstrated that the microglial gene expression from the TBI group treated with laquinimod resembles the sham group more than the TBI-water control group. Conclusions: Administration of laquinimod reduced lesion volume and axonal damage and restored neurogenesis after TBI. Laquinimod might be a potential therapy strategy to improve TBI long-term prognosis.	[Katsumoto, Atsuko; Miranda, Aline S.; Ransohoff, Richard M.; Lamb, Bruce T.] Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Katsumoto, Atsuko; Lamb, Bruce T.] Indiana Univ Sch Med, Stark Neurosci Res Inst, 320 W 15th St, Indianapolis, IN 46202 USA; [Miranda, Aline S.] Univ Fed Minas Gerais, Dept Morphol, Lab Neurobiol, Belo Horizonte, MG, Brazil; [Butovsky, Oleg] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Teixeira, Antonio L.] Univ Fed Minas Gerais, Sch Med, Interdisciplinary Lab Med Invest, Belo Horizonte, MG, Brazil		Katsumoto, A; Lamb, BT (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave, Cleveland, OH 44195 USA.	chiwawan-atsuko@hotmail.co.jp; btlamb@iu.edu	Teixeira, Antonio L/N-3315-2014; Butovsky, Oleg/ABG-9086-2020	Teixeira, Antonio L/0000-0002-9621-5422; Butovsky, Oleg/0000-0003-0186-8867; Katsumoto, Atsuko/0000-0002-5582-3050	Teva Pharmaceuticals, Ltd. Netanya Israel; CNPq SWO scholar-ship	This work was supported by the Teva Pharmaceuticals, Ltd. Netanya Israel to BTL and OB. ASM was a CNPq SWO scholar-ship recipient.	Aharoni R, 2012, J NEUROIMMUNOL, V251, P14, DOI 10.1016/j.jneuroim.2012.06.005; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Butovsky O, 2015, ANN NEUROL, V77, P75, DOI 10.1002/ana.24304; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Comi G, 2012, NEW ENGL J MED, V366, P1000, DOI 10.1056/NEJMoa1104318; D'Haens G, 2015, GUT, V64, P1227, DOI 10.1136/gutjnl-2014-307118; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dobson L, 2016, J NEUROCHEM, V137, P782, DOI 10.1111/jnc.13553; Downes CE, 2010, BRIT J PHARMACOL, V160, P1872, DOI 10.1111/j.1476-5381.2010.00864.x; Febinger HY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0386-5; Filippi M, 2014, J NEUROL NEUROSUR PS, V85, P852, DOI 10.1136/jnnp-2013-306132; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hawthorne G, 2009, J NEUROTRAUM, V26, P1623, DOI [10.1089/neu.2008.0735, 10.1089/neu.2008-0735]; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jolivel V, 2013, BRAIN, V136, P1048, DOI 10.1093/brain/awt023; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Lourenco EV, 2014, ARTHRITIS RHEUMATOL, V66, P674, DOI 10.1002/art.38259; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; McCauley SR, 2010, J NEUROTRAUM, V27, P991, DOI 10.1089/neu.2009.1195; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mishra MK, 2012, AM J PATHOL, V181, P642, DOI 10.1016/j.ajpath.2012.05.011; Mishra MK, 2014, ANN CLIN TRANSL NEUR, V1, P409, DOI 10.1002/acn3.67; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Ono K, 2010, NEUROSCI LETT, V473, P146, DOI 10.1016/j.neulet.2010.02.041; Poca MA, 2005, J NEUROTRAUM, V22, P1303, DOI 10.1089/neu.2005.22.1303; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Vollmer TL, 2014, J NEUROL, V261, P773, DOI 10.1007/s00415-014-7264-4; Wegner C, 2010, J NEUROIMMUNOL, V227, P133, DOI 10.1016/j.jneuroim.2010.07.009; Woiciechowsky C, 2002, J TRAUMA, V52, P339, DOI 10.1097/00005373-200202000-00021; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yang HS, 2004, J NEUROIMMUNOL, V156, P3, DOI 10.1016/j.jneuroim.2004.02.016; Yang SH, 2013, SHOCK, V40, P471, DOI 10.1097/SHK.0000000000000037; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041	49	19	19	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 30	2018	15									10.1186/s12974-018-1075-y			11	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	FU2XB	WOS:000423712200001	29382353	gold, Green Published			2022-02-06	
J	Cnossen, MC; van Essen, TA; Ceyisakar, IE; Polinder, S; Andriessen, TM; van der Naalt, J; Haitsma, L; Horn, J; Franschman, G; Vos, PE; Peul, WC; Menon, DK; Maas, AIR; Steyerberg, EW; Lingsma, HF				Cnossen, Maryse C.; van Essen, Thomas A.; Ceyisakar, Iris E.; Polinder, Suzanne; Andriessen, Teuntje M.; van der Naalt, Joukje; Haitsma, Lain; Horn, Janneke; Franschman, Gaby; Vos, Pieter E.; Peul, Wilco C.; Menon, David K.; Maas, Andrew I. R.; Steyerberg, Ewout W.; Lingsma, Hester F.			Adjusting for confounding by indication in observational studies: a case study in traumatic brain injury	CLINICAL EPIDEMIOLOGY			English	Article						confounding; observational studies; traumatic brain injury; instrumental variable analysis; comparative effectiveness research	ACUTE SUBDURAL-HEMATOMA; PROPENSITY SCORE; HEAD-INJURY; MORTALITY; MANAGEMENT; CARE; BIAS; CLASSIFICATION; HEMORRHAGE; GUIDELINES	Introduction: Observational studies of interventions are at risk for confounding by indication. The objective of the current study was to define the circumstances for the validity of methods to adjust for confounding by indication in observational studies. Patients and methods: We performed post hoc analyses of data prospectively collected from three European and North American traumatic brain injury studies including 1,725 patients. The effects of three interventions (intracranial pressure [ICP] monitoring, intracranial operation and primary referral) were estimated in a proportional odds regression model with the Glasgow Outcome Scale as ordinal outcome variable. Three analytical methods were compared: classical covariate adjustment, propensity score matching and instrumental variable (IV) analysis in which the percentage exposed to an intervention in each hospital was added as an independent variable, together with a random intercept for each hospital. In addition, a simulation study was performed in which the effect of a hypothetical beneficial intervention (OR 1.65) was simulated for scenarios with and without unmeasured confounders. Results: For all three interventions, covariate adjustment and propensity score matching resulted in negative estimates of the treatment effect (OR ranging from 0.80 to 0.92), whereas the IV approach indicated that both ICP monitoring and intracranial operation might be beneficial (OR per 10% change 1.17, 95% CI 1.01-1.42 and 1.42, 95% CI 0.95-1.97). In our simulation study, we found that covariate adjustment and propensity score matching resulted in an invalid estimate of the treatment effect in case of unmeasured confounders (OR ranging from 0.90 to 1.03). The IV approach provided an estimate in the similar direction as the simulated effect (OR per 10% change 1.04-1.05) but was statistically inefficient. Conclusion: The effect estimation of interventions in observational studies strongly depends on the analytical method used. When unobserved confounding and practice variation are expected in observational multicenter studies, IV analysis should be considered.	[Cnossen, Maryse C.; Ceyisakar, Iris E.; Polinder, Suzanne; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [van Essen, Thomas A.; Peul, Wilco C.] Leiden Univ, Med Ctr, Dept Neurosurg, Neurosurg Cooperat Holland, Leiden, Netherlands; [van Essen, Thomas A.; Peul, Wilco C.] Haaglanden Med Ctr, Dept Neurosurg, The Hague, Netherlands; [Andriessen, Teuntje M.] RIVAS Healthcare Grp, Dept Psychol, Gorinchem, Netherlands; [van der Naalt, Joukje] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Haitsma, Lain] Erasmus MC, Dept Neurosurg, Rotterdam, Netherlands; [Horn, Janneke] Univ Amsterdam, Acad Med Ctr, Dept Intens Care Med, Amsterdam, Netherlands; [Franschman, Gaby] VU Univ Med Ctr Amsterdam, Dept Anesthesiol, Amsterdam, Netherlands; [Vos, Pieter E.] Slingeland Hosp, Dept Neurol, Doetinchem, Netherlands; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands		Cnossen, MC (corresponding author), Erasmus MC, Dept Publ Hlth, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl	Maas, Andrew IR/C-5584-2013	Maas, Andrew IR/0000-0003-1612-1264; Van Essen, Thomas/0000-0003-4657-5283; van der Naalt, Joukje/0000-0001-9873-2418	European Union PF 7th Framework Program [602150]; Dutch Brain Foundation (Hersenstichting Nederland)	This work was funded by the European Union PF 7th Framework Program (grant 602150) - CENTER TBI. In addition, the author TvE was funded by a grant from the Dutch Brain Foundation (Hersenstichting Nederland) for the Neurotraumatology Quality Registry (Net-QuRe) study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agoritsas T, 2017, JAMA-J AM MED ASSOC, V317, P748, DOI 10.1001/jama.2016.20029; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Arthur KR, 2013, AM SURGEON, V79, P909; Austin PC, 2005, STAT MED, V24, P1563, DOI 10.1002/sim.2053; Basch E, 2012, JAMA-J AM MED ASSOC, V307, P1636, DOI 10.1001/jama.2012.466; Bates DM, 2015, PACKAGE VERSION 1 18; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bosco JLF, 2010, J CLIN EPIDEMIOL, V63, P64, DOI 10.1016/j.jclinepi.2009.03.001; Brain Trauma Foundation, 2007, GUID MAN SEV TRAUM B; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2015, J NEUROTRAUM, V32, P1722, DOI 10.1089/neu.2015.3976; Cnossen MC, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1816-9; Davies NM, 2013, EPIDEMIOLOGY, V24, P363, DOI 10.1097/EDE.0b013e31828abafb; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Frieden TR, 2017, NEW ENGL J MED, V377, P465, DOI 10.1056/NEJMra1614394; Greenland S, 2017, EUR J EPIDEMIOL, V32, P3, DOI 10.1007/s10654-017-0230-6; Gregson BA, 2015, HEALTH TECHNOL ASSES, V19, DOI 10.3310/hta19700; Halpern EF, 2014, RADIOLOGY, V271, P625, DOI 10.1148/radiol.14140035; Harrell F.E, 2017, PACKAGE RMS; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Heinze G, 2011, EUR HEART J, V32, P1704, DOI 10.1093/eurheartj/ehr031; Hernan MA, 2006, EPIDEMIOLOGY, V17, P360, DOI 10.1097/01.ede.0000222409.00878.37; Hlatky MA, 2013, HEART FAIL CLIN, V9, P29, DOI 10.1016/j.hfc.2012.09.007; Ioannidis JPA, 2011, SCIENCE, V334, P1230, DOI 10.1126/science.1211811; Laborde-Casterot H, 2015, J CLIN EPIDEMIOL, V68, P1232, DOI 10.1016/j.jclinepi.2015.04.003; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mendelow AD, 2015, J NEUROTRAUM, V32, P1312, DOI 10.1089/neu.2014.3644; Moodie EEM, 2011, INT J PUBLIC HEALTH, V56, P117, DOI 10.1007/s00038-010-0198-4; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; National Institute for Health and Care Excellence (NICE), 2014, HEAD INJ ASS MAN CLI; Normand SLT, 2010, STAT MED, V29, P1985, DOI 10.1002/sim.3933; Pezzin LE, 2015, MED CARE, V53, P1033, DOI 10.1097/MLR.0000000000000439; Rayan N, 2012, J TRAUMA ACUTE CARE, V72, P585, DOI 10.1097/TA.0b013e318243da4d; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Sanwald A, 2017, HEALTH SERV RES, V52, P16, DOI 10.1111/1475-6773.12509; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Signorello Lisa B, 2002, Am J Ther, V9, P199, DOI 10.1097/00045391-200205000-00005; Sjoding MW, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0923-8; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Van Essen TA, 2016, J NEUROTRAUM, V33, pA20; van Essen TA, 2017, J NEUROTRAUM, V34, P881, DOI 10.1089/neu.2016.4495; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; Xu JC, 2016, BRAIN INJURY, V30, P1054, DOI 10.3109/02699052.2016.1170882; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460	58	19	19	1	5	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1179-1349			CLIN EPIDEMIOL	Clin. Epidemiol.		2018	10						841	852		10.2147/CLEP.S154500			12	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health	GN6LN	WOS:000439196400001	30050328	Green Published, gold			2022-02-06	
J	Downey, RI; Hutchison, MG; Comper, P				Downey, Rachel I.; Hutchison, Michael G.; Comper, Paul			Determining sensitivity and specificity of the Sport Concussion Assessment Tool 3 (SCAT3) components in university athletes	BRAIN INJURY			English	Article						Sport-related concussion; Balance Error Scoring System (BESS); Standardized Assessment of Concussion (SAC); Post Concussion Symptom Scale (PCSS); Sport Concussion Assessment Tool (SCAT-3)	BASE-LINE VALUES; HIGH-SCHOOL; INTERNATIONAL-CONFERENCE; POSTURAL STABILITY; FOOTBALL PLAYERS; STATEMENT; ASSOCIATION; HISTORY	Objective: To examine the clinical utility of the Sport Concussion Assessment Tool-3 (SCAT3) in university athletes with concussion in the absence and presence of baseline data over time. Methods: Athletes with concussion (n = 23) and uninjured controls (n = 22) were prospectively evaluated at three time-points (baseline, 3-5 days, 3 weeks post-injury) with the SCAT3 components: (1) Post-Concussion Symptom Scale (PCSS); (2) Standardized Assessment of Concussion (SAC); and (3) modified Balance Error Scoring System (m-BESS). Sensitivity and specificity were calculated using reliable change indices and normative data from 458 athletes who completed baseline testing. Results: The PCSS total symptom score yielded highest sensitivity (47.4-72.2%) and specificity (78.6-91.7%) 3-5 days post-injury, with the SAC and m-BESS demonstrating little discriminative ability when used more than 3 days post-concussion. The utility of the SCAT3 was comparable when baseline or normative data was used for predicting concussion. Conclusion: The SCAT is a clinically useful tool for assessing concussion in the absence or presence of baseline data within the first 3-5 days post-injury. Clinical utility of the SCAT3 was driven by symptoms, which remains consistent in the SCAT5. Future research should explore whether additional cognitive elements in the SCAT5 improve utility beyond this timeframe.	[Downey, Rachel I.; Comper, Paul] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Hutchison, Michael G.; Comper, Paul] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Comper, Paul] Toronto Rehabil Inst, Neuropsychol Dept, Toronto, ON, Canada		Downey, RI (corresponding author), Concordia Univ, Dept Psychol, 7141 Sherbrooke St West, Montreal, PQ H4B 1R6, Canada.	downeyr01@gmail.com			Canadian Institutes of Military and Veterans Health (CIMVHR) [W7714-145967]	This work was supported by the Canadian Institutes of Military and Veterans Health (CIMVHR) [grant number W7714-145967].	Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jinguji TM, 2012, BRIT J SPORT MED, V46, P365, DOI 10.1136/bjsports-2011-090526; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McCrory PR, 2017, BRIT J SPORT MED, V51; McLeod TCV, 2012, AM J SPORT MED, V40, P927, DOI 10.1177/0363546511431573; Okonkwo David O, 2014, Neurosurgery, V75 Suppl 4, pS82, DOI 10.1227/NEU.0000000000000493; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Register-Mihalik JK, 2009, SPORTS HEALTH, V1, P61, DOI 10.1177/1941738108325920; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Snyder AR, 2014, CLIN NEUROPSYCHOL, V28, P1091, DOI 10.1080/13854046.2014.952667; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	21	19	19	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	11					1345	1352		10.1080/02699052.2018.1484166			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GZ6GX	WOS:000449534000005	29902070				2022-02-06	
J	Gray, JC; MacKillop, J; Weafer, J; Hernandez, KM; Gao, JJ; Palmer, AA; de Wit, H				Gray, Joshua C.; MacKillop, James; Weafer, Jessica; Hernandez, Kyle M.; Gao, Jianjun; Palmer, Abraham A.; de Wit, Harriet			Genetic analysis of impulsive personality traits: Examination of a priori candidates and genome-wide variation	PSYCHIATRY RESEARCH			English	Article						Impulsivity; Genetics; Endophenotype; Personality traits; Serotonin	TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SEROTONIN TRANSPORTER POLYMORPHISM; ALCOHOL-DEPENDENT PATIENTS; DRUG-USE DISORDERS; SENSATION SEEKING; ENDOPHENOTYPE CONCEPT; DECISION-MAKING; ASSOCIATION; BEHAVIOR	Impulsive personality traits are heritable risk factors and putative endophenotypes for addiction and other psychiatric disorders involving disinhibition. This study examined the genetic basis of impulsive personality traits, defined as scores on the Barratt Impulsiveness Scale (BIS-11) and the UPPS-P Impulsive Behavior Scale (UPPS-P). In 983 healthy young adults of European ancestry, the study examined genetic variation in relation to a combined phenotype of seven subscales based on high phenotypic intercorrelations. The study first tested 14 a priori loci that have previously been associated impulsive personality traits or closely related constructs. Second, the study included an exploratory genome-wide scan (i.e., GWAS), acknowledging that only relatively large effects would be detectable in a sample size of similar to 1000. A priori SNP analyses revealed a significant association between the combined impulsivity phenotype and two SNPs within the 5-HT2a receptor gene (HTR2A; rs6313 and rs6311). Follow-up analyses suggested that the effects were specific to the Motor and Non-planning sub scales on the BIS-11, and also that the two loci were in linkage disequilibrium. The GWAS yielded no statistically significant findings. This study further implicates loci within HTR2A with certain forms of self-reported impulsivity and identifies candidates for future investigation from the genome-wide analyses.	[Gray, Joshua C.] Uniformed Serv Univ Hlth Sci, Ctr Deployment Psychol, Bethesda, MD 20814 USA; [Gray, Joshua C.] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [MacKillop, James] McMaster Univ, Peter Boris Ctr Addict Res, Hamilton, ON L8S 4L8, Canada; [MacKillop, James] Homewood Hlth Ctr, Homewood Res Inst, Guelph, ON N1E 6K9, Canada; [Weafer, Jessica; Gao, Jianjun; Palmer, Abraham A.; de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA; [Hernandez, Kyle M.] Univ Chicago, Ctr Res Informat, Chicago, IL 60637 USA; [Gao, Jianjun; Palmer, Abraham A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92103 USA; [Gao, Jianjun; Palmer, Abraham A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92103 USA		Gray, JC (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Deployment Psychol, Bethesda, MD 20814 USA.	jgray7700@gmail.com	, James/ABI-3641-2020; Gray, Joshua/AAE-7733-2019; Hernandez, Kyle/K-2536-2019	, James/0000-0002-8695-1071; Gray, Joshua/0000-0002-5351-561X; Hernandez, Kyle/0000-0001-8267-644X	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01DA032015]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [K01AA024519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA032015] Funding Source: NIH RePORTER	Funding for this study was provided by NIH Grant R01DA032015. JM is the holder of the Peter Boris Chair in Addictions Research, which partially supported his role.	Agrawal A, 2008, ADDICTION, V103, P1069, DOI 10.1111/j.1360-0443.2008.02213.x; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amlung M, 2017, ADDICTION, V112, P51, DOI 10.1111/add.13535; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benko A, 2010, AM J MED GENET B, V153B, P592, DOI 10.1002/ajmg.b.31025; Berg JM, 2015, PSYCHOL ASSESSMENT, V27, P1129, DOI 10.1037/pas0000111; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; Bevilacqua L, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0380; Cao J, 2014, HUM GENET, V133, P357, DOI 10.1007/s00439-013-1388-y; Carver CS, 2014, SOC PSYCHOL PERS SCI, V5, P730, DOI 10.1177/1948550614527116; Carver CS, 2011, PSYCHOL SCI, V22, P589, DOI 10.1177/0956797611404085; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chester DS, 2015, BEHAV BRAIN RES, V283, P97, DOI 10.1016/j.bbr.2015.01.034; Congdon E, 2008, AM J MED GENET B, V147B, P27, DOI 10.1002/ajmg.b.30557; Coskunpinar A, 2013, DRUG ALCOHOL DEPEN, V133, P1, DOI 10.1016/j.drugalcdep.2013.05.008; Coskunpinar A, 2013, ALCOHOL CLIN EXP RES, V37, P1441, DOI 10.1111/acer.12131; Cyders MA, 2007, PSYCHOL ASSESSMENT, V19, P107, DOI 10.1037/1040-3590.19.1.107; de Wit H, 2009, ADDICT BIOL, V14, P22, DOI 10.1111/j.1369-1600.2008.00129.x; Dick DM, 2015, PERSPECT PSYCHOL SCI, V10, P37, DOI 10.1177/1745691614556682; Dick DM, 2013, TWIN RES HUM GENET, V16, P661, DOI 10.1017/thg.2013.20; Distel MA, 2008, PSYCHOL MED, V38, P1219, DOI 10.1017/S0033291707002024; Doran N, 2013, J PSYCHOACTIVE DRUGS, V45, P379, DOI 10.1080/02791072.2013.844380; Eisenberg DTA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001216; Ersche KD, 2010, BIOL PSYCHIAT, V68, P770, DOI 10.1016/j.biopsych.2010.06.015; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Flint J, 2007, PSYCHOL MED, V37, P163, DOI 10.1017/S0033291706008750; Forbes EE, 2009, MOL PSYCHIATR, V14, P60, DOI 10.1038/sj.mp.4002086; Galesloot TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095923; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Gustavson DE, 2014, PSYCHOL SCI, V25, P1178, DOI 10.1177/0956797614526260; Hadamitzky M, 2009, BEHAV PHARMACOL, V20, P415, DOI 10.1097/FBP.0b013e3283305e11; Hart AB, 2013, NEUROPSYCHOPHARMACOL, V38, P802, DOI 10.1038/npp.2012.245; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hutchison KE, 2004, PSYCHOL BULL, V130, P66, DOI 10.1037/0033-2909.130.1.66; Jackson Jacob N S, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P316; Jakubczyk A, 2012, J PSYCHIATR RES, V46, P44, DOI 10.1016/j.jpsychires.2011.09.001; Jepsen JRM, 2018, PSYCHOL MED, V48, P604, DOI 10.1017/S0033291717001921; Jimenez E, 2014, EUR NEUROPSYCHOPHARM, V24, P510, DOI 10.1016/j.euroneuro.2014.01.005; Laas K, 2015, J PSYCHOPHARMACOL, V29, P878, DOI 10.1177/0269881115573803; Limosin F, 2003, PSYCHIAT GENET, V13, P127, DOI 10.1097/01.ypg.0000066963.66429.00; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; MacKillop J, 2016, PSYCHOPHARMACOLOGY, V233, P3361, DOI 10.1007/s00213-016-4372-0; MacKillop J, 2013, GENETIC INFLUENCES ON ADDICTION: AN INTERMEDIATE PHENOTYPE APPROACH, P1; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; Munafo MR, 2004, PSYCHIAT RES, V129, P39, DOI 10.1016/j.psychres.2004.06.011; Nemeth N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084207; Niv S, 2012, BEHAV GENET, V42, P378, DOI 10.1007/s10519-011-9518-6; Paaver M, 2007, PSYCHOPHARMACOLOGY, V194, P545, DOI 10.1007/s00213-007-0867-z; Paloyelis Y, 2010, NEUROPSYCHOPHARMACOL, V35, P2414, DOI 10.1038/npp.2010.124; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Pfeifer P., 2015, ALCOHOL ALCOHOLISM; Preuss UW, 2001, NEUROPSYCHOBIOLOGY, V43, P186, DOI 10.1159/000054888; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quinn PD, 2013, DEV PSYCHOPATHOL, V25, P223, DOI 10.1017/S0954579412000284; Quinn PD, 2011, J ABNORM PSYCHOL, V120, P543, DOI 10.1037/a0023159; Racine SE, 2009, J PSYCHIATR RES, V43, P1278, DOI 10.1016/j.jpsychires.2009.05.002; Reynolds B, 2006, PERS INDIV DIFFER, V40, P305, DOI 10.1016/j.paid.2005.03.024; Robinson ESJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2398, DOI 10.1038/sj.npp.1301636; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ruble CL, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0325-6; Sakado K, 2003, AM J MED GENET B, V121B, P71, DOI 10.1002/ajmg.b.20063; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schilling C, 2014, PSYCHIAT GENET, V24, P82, DOI 10.1097/YPG.0000000000000005; Schuckit MA, 2014, J STUD ALCOHOL DRUGS, P59, DOI 10.15288/jsads.2014.s17.59; Seroczynski AD, 1999, PSYCHIAT RES, V86, P41, DOI 10.1016/S0165-1781(99)00013-X; Smith JL, 2014, DRUG ALCOHOL DEPEN, V145, P1, DOI 10.1016/j.drugalcdep.2014.08.009; Smith RM, 2014, AUTISM RES, V7, P459, DOI 10.1002/aur.1383; Smith RM, 2013, BIOL PSYCHIAT, V73, P546, DOI 10.1016/j.biopsych.2012.09.028; Soeiro-De-Souza MG, 2013, MOL MED REP, V7, P1067, DOI 10.3892/mmr.2013.1336; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Stoltenberg Scott F, 2011, Drug Alcohol Depend, V119, pe31, DOI 10.1016/j.drugalcdep.2011.05.025; Su H, 2014, NEUROSCI LETT, V582, P16, DOI 10.1016/j.neulet.2014.08.030; Varga G, 2012, AM J MED GENET B, V159B, P281, DOI 10.1002/ajmg.b.32025; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wischhof L, 2011, BEHAV PHARMACOL, V22, P805, DOI 10.1097/FBP.0b013e32834d6279; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X; Wrzosek M, 2014, MOL BIOL REP, V41, P7223, DOI 10.1007/s11033-014-3607-6; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	84	19	19	3	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	JAN	2018	259						398	404		10.1016/j.psychres.2017.10.047			7	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	FU1ZT	WOS:000423648700062	29120849	Green Accepted			2022-02-06	
J	Jiang, Y; Xie, H; Tu, W; Fang, H; Ji, CX; Yan, TF; Huang, HM; Yu, C; Hu, Q; Gao, ZY; Lv, SG				Jiang, Yuan; Xie, Huan; Tu, Wei; Fang, Hua; Ji, Chenxing; Yan, Tengfeng; Huang, Hongming; Yu, Cong; Hu, Qing; Gao, Ziyun; Lv, Shigang			Exosomes secreted by HUVECs attenuate hypoxia/reoxygenation-induced apoptosis in neural cells by suppressing miR-21-3p	AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH			English	Article						ATG12; autophagy; exosome; hypoxia/reoxygenation; microarray; miR-21-3p	TRAUMATIC BRAIN-INJURY; INHIBITION; REPERFUSION; MYOCARDIUM; ISCHEMIA; PROTECTS; DAMAGE	Background: Remote ischemic postconditioning (RIPostC) is an effective strategy for preventing key organs from becoming impaired due to an ischemia/reperfusion injury. In the current study, we investigated how remote exosome transfer of microRNAs (miRs) may contribute to the treatment effect of RIPostC on the central nerve system (CNS). Methods: Human umbilical vein endothelial cells (HUVECs) were subjected to hypoxia/reoxygenation (H/R) and their miR expression profiles were investigated using the microarray method. The pathways associated with dysregulated miRs were analyzed by gene ontology (GO) annotation of the target genes and a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. The role played by the most significantly down-regulated miR (miR-21-3p) in the protective effect of HUVEC-derived exosomes on H/R-treated neural cells was further investigated. The pathway mediating the effect of miR-21-3p was then explored by focusing on activity of autophagy-related 12 (ATG12) protein. Results: The miR expression profile of HUVECs significantly changed after H/R administration, with 104 miRs becoming upregulated and 249 miRs becoming downregulated. Based on the GO and KEGG analyses, the target genes of 8 selected miRs were involved in multiple biological pathways, including the hippo signaling pathway and longevity regulating pathway. Further studies showed that inhibition of miR-21-3p by HUVEC-derived exosomes or a specific inhibitor could the block apoptotic process in H/R-treated neural cells. Molecular level studies showed that the effect of miR-21-3p inhibition depended on the restored function of ATG12, which resulted in the activation of autophagy and suppression of apoptosis. Conclusion: Taken together, these results suggest that H/R caused significant changes of miR expression in exosomes derived from H/R-treated HUVECs, and the exosomes protect neurons against H/R-induced injuries by suppressing miR-21-3p.	[Jiang, Yuan; Xie, Huan; Tu, Wei; Fang, Hua; Ji, Chenxing; Yan, Tengfeng; Huang, Hongming; Yu, Cong; Hu, Qing; Gao, Ziyun; Lv, Shigang] Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China		Gao, ZY; Lv, SG (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Neurosurg, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China.	gaozy999@qq.com; lvsg1982@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81660420]; Construction Plan of the Superior Science and Technology Innovation Team of Jiangxi Province [20161BCB24-009]; Foreign Science and Technology Cooperation Plan of Jiangxi Province [20151BDH80009]; Key Projects of Natural Science Foundation of Jiangxi Province [20171ACB20035]	This work was supported by the National Natural Science Foundation of China (No. 81660420), the Construction Plan of the Superior Science and Technology Innovation Team of Jiangxi Province (No. 20161BCB24-009), the Foreign Science and Technology Cooperation Plan of Jiangxi Province (No. 20151BDH80009), and the Key Projects of Natural Science Foundation of Jiangxi Province (No. 20171ACB20035).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Barteneva NS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00049; Baskin YK, 2003, J NEUROSCI METH, V129, P87, DOI 10.1016/S0165-0270(03)00212-7; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Ge XT, 2014, SCI REP, V4, P1; Hess DC, 2013, STROKE, V44, P1191, DOI 10.1161/STROKEAHA.112.678482; Kalani A, 2014, MOL NEUROBIOL, V49, P590, DOI 10.1007/s12035-013-8544-1; Kerendi F, 2005, BASIC RES CARDIOL, V100, P404, DOI 10.1007/s00395-005-0539-2; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pan JR, 2016, REV NEUROSCIENCE, V27, P501, DOI 10.1515/revneuro-2015-0043; Peng B, 2012, BRAIN RES, V1445, P92, DOI 10.1016/j.brainres.2012.01.033; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Ren CH, 2011, NEUROL RES, V33, P514, DOI 10.1179/016164111X13007856084241; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Rubinstein AD, 2011, MOL CELL, V44, P698, DOI 10.1016/j.molcel.2011.10.014; Slagsvold KH, 2014, CIRC RES, V114, P851, DOI 10.1161/CIRCRESAHA.114.302751; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yamaguchi T, 2015, INT J CARDIOL, V178, P239, DOI 10.1016/j.ijcard.2014.10.144; Yang JL, 2017, MOL THER-NUCL ACIDS, V7, P278, DOI 10.1016/j.omtn.2017.04.010; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002; Zong YH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0235-6	24	19	21	0	5	E-CENTURY PUBLISHING CORP	MADISON	40 WHITE OAKS LN, MADISON, WI 53711 USA	1943-8141			AM J TRANSL RES	Am. J. Transl. Res.		2018	10	11					3529	+					16	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	HC2VM	WOS:000451660000019	30662605				2022-02-06	
J	Wu, LY; Ye, ZN; Zhuang, Z; Gao, Y; Tang, C; Zhou, CH; Wang, CX; Zhang, XS; Xie, GB; Liu, JP; Zhou, ML; Hang, CH; Shi, JX				Wu, Ling-yun; Ye, Zhen-nan; Zhuang, Zong; Gao, Yongyue; Tang, Chao; Zhou, Chen-hui; Wang, Chun-xi; Zhang, Xiang-sheng; Xie, Guang-bin; Liu, Jing-peng; Zhou, Meng-liang; Hang, Chun-hua; Shi, Ji-xin			Biochanin A Reduces Inflammatory Injury and Neuronal Apoptosis following Subarachnoid Hemorrhage via Suppression of the TLRs/TIRAP/MyD88/NF-kappa B Pathway	BEHAVIOURAL NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; NF-KAPPA-B; POSSIBLE INVOLVEMENT; SIGNALING PATHWAY; RATS; CELLS; DAMAGE; RECEPTOR; MICE; DIFFERENTIATION	Inflammatory injury and neuronal apoptosis participate in the period of early brain injury (EBI) after subarachnoid hemorrhage (SAH). Suppression of inflammation has recently been shown to reduce neuronal death and neurobehavioral dysfunction post SAH. Biochanin A (BCA), a natural bioactive isoflavonoid, has been confirmed to emerge the anti-inflammatory pharmacological function. This original study was aimed at evaluating and identifying the neuroprotective role of BCA and the underlying molecular mechanism in an experimental Sprague-Dawley rat SAH model. Neurobehavioral function was evaluated via the modified water maze test and modified Garcia neurologic score system. Thus, we confirmed that BCA markedly decreased the activated level of TLRs/TIRAP/MyD88/NF-kappa B pathway and the production of cytokines. BCA also significantly ameliorated neuronal apoptosis which correlated with the improvement of neurobehavioral dysfunction post SAH. These results indicated that BCA may provide neuroprotection against EBI through the inhibition of inflammatory injury and neuronal apoptosis partially via the TLRs/TIRAP/MyD88/NF-kappa B signal pathway.	[Wu, Ling-yun; Zhuang, Zong; Gao, Yongyue; Tang, Chao; Zhou, Chen-hui; Wang, Chun-xi; Zhang, Xiang-sheng; Xie, Guang-bin; Zhou, Meng-liang; Hang, Chun-hua; Shi, Ji-xin] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East ZhongShan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Ye, Zhen-nan] Guangzhou Med Univ, Affiliated Hosp 2, Dept Neurosurg, Guangzhou 510260, Guangdong, Peoples R China; [Ye, Zhen-nan; Liu, Jing-peng; Hang, Chun-hua] Southern Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China		Hang, CH; Shi, JX (corresponding author), Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, 305 East ZhongShan Rd, Nanjing 210002, Jiangsu, Peoples R China.; Hang, CH (corresponding author), Southern Med Univ Guangzhou, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com; shijx52@hotmail.com		Zhou, Meng-liang/0000-0002-1165-5489	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271297, 81371294, 81400980, 81571162, 81501022]	The authors acknowledge the support for this research by grants from the National Natural Science Foundation of China (no. 81271297 for Ji-xin Shi, no. 81371294 for Chun-hua Hang, no. 81400980 for Zong Zhuang, no. 81571162 for Meng-liang Zhou, and no. 81501022 for Xiang-sheng Zhang).	Ascenzi P, 2005, IUBMB LIFE, V57, P749, DOI 10.1080/15216540500380871; Biradar SM, 2014, HUM EXP TOXICOL, V33, P369, DOI 10.1177/0960327113497772; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Chen J, 2015, CELL PHYSIOL BIOCHEM, V35, P639, DOI 10.1159/000369725; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Fadakar K, 2014, REV NEUROSCIENCE, V25, P699, DOI 10.1515/revneuro-2013-0069; Gao C, 2009, AUTON NEUROSCI-BASIC, V147, P70, DOI 10.1016/j.autneu.2009.01.010; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Guo ZD, 2016, STROKE, V47, P490, DOI 10.1161/STROKEAHA.115.011223; Jain A, 2015, ANTI-CANCER DRUG, V26, P323, DOI 10.1097/CAD.0000000000000189; Jalaludeen AM, 2015, ENVIRON TOXICOL PHAR, V39, P1221, DOI 10.1016/j.etap.2015.04.020; Jeon H, 2010, NEUROSCIENCE, V169, P1805, DOI 10.1016/j.neuroscience.2010.06.039; Kole L, 2011, EUR J PHARMACOL, V653, P8, DOI 10.1016/j.ejphar.2010.11.026; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee KH, 2005, BIOL PHARM BULL, V28, P1948, DOI 10.1248/bpb.28.1948; Li H, 2017, MOL NEUROBIOL, V54, P755, DOI 10.1007/s12035-016-9703-y; Li H, 2014, BRAIN RES, V1543, P315, DOI 10.1016/j.brainres.2013.11.023; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Ming XD, 2015, LIFE SCI, V136, P36, DOI 10.1016/j.lfs.2015.06.015; Mishra P, 2008, MOL CELL BIOCHEM, V312, P1, DOI 10.1007/s11010-008-9714-8; Oh JS, 2016, BIOCHEM BIOPH RES CO, V477, P723, DOI 10.1016/j.bbrc.2016.06.126; Piegholdt S, 2014, FREE RADICAL BIO MED, V70, P255, DOI 10.1016/j.freeradbiomed.2014.02.025; Pradilla G, 2010, NEUROSURG CLIN N AM, V21, P365, DOI 10.1016/j.nec.2009.10.008; Sercombe R, 2002, JPN J PHARMACOL, V88, P227, DOI 10.1254/jjp.88.227; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Szyndler J, 2006, PHARMACOL REP, V58, P75; Wang CX, 2015, BRAIN RES, V1594, P245, DOI 10.1016/j.brainres.2014.10.014; Wang J, 2016, NEUROTOX RES, V30, P486, DOI 10.1007/s12640-016-9648-y; Wang WZ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/501401; Wang Z, 2013, J PINEAL RES, V55, P399, DOI 10.1111/jpi.12087; Wu LY, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00175; Wu WY, 2015, INT J MOL MED, V35, P391, DOI 10.3892/ijmm.2014.2020; Youssef MM, 2016, SCI REP-UK, V6, DOI 10.1038/srep30717; Zhang HS, 2016, BRAIN RES, V1643, P130, DOI 10.1016/j.brainres.2016.05.003; Zhong W, 2016, TURKISH NEUROSURGERY, V27; Zhou CH, 2015, BRAIN RES, V1629, P250, DOI 10.1016/j.brainres.2015.10.016; Zhou CH, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0415-4	38	19	20	0	6	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	0953-4180	1875-8584		BEHAV NEUROL	Behav. Neurol.		2018	2018								1960106	10.1155/2018/1960106			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK1QT	WOS:000435894200001	29971136	Green Submitted, gold, Green Published			2022-02-06	
J	Guglielmetti, C; Chou, A; Krukowski, K; Najac, C; Feng, X; Riparip, LK; Rosi, S; Chaumeil, MM				Guglielmetti, Caroline; Chou, Austin; Krukowski, Karen; Najac, Chloe; Feng, Xi; Riparip, Lara-Kirstie; Rosi, Susanna; Chaumeil, Myriam M.			In vivo metabolic imaging of Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							C-13-LABELED MICRODIALYSIS; MACROPHAGE POLARIZATION; CEREBRAL METABOLISM; LACTATE; NEUROINFLAMMATION; INHIBITION; INCREASE	Complex alterations in cerebral energetic metabolism arise after traumatic brain injury (TBI). To date, methods allowing for metabolic evaluation are highly invasive, limiting our understanding of metabolic impairments associated with TBI pathogenesis. We investigated whether C-13 MRSI of hyperpolarized (HP) [1-C-13] pyruvate, a non-invasive metabolic imaging method, could detect metabolic changes in controlled cortical injury (CCI) mice (n = 57). Our results show that HP [1-C-13] lactate-to-pyruvate ratios were increased in the injured cortex at acute (12/24 hours) and sub-acute (7 days) time points after injury, in line with decreased pyruvate dehydrogenase (PDH) activity, suggesting impairment of the oxidative phosphorylation pathway. We then used the colony-stimulating factor-1 receptor inhibitor PLX5622 to deplete brain resident microglia prior to and after CCI, in order to confirm that modulations of HP [1-C-13] lactate-to-pyruvate ratios were linked to microglial activation. Despite CCI, the HP [1-C-13] lactate-to-pyruvate ratio at the injury cortex of microglia-depleted animals at 7 days post-injury remained unchanged compared to contralateral hemisphere, and PDH activity was not affected. Altogether, our results demonstrate that HP [1-C-13] pyruvate has great potential for in vivo non-invasive detection of cerebral metabolism post-TBI, providing a new tool to monitor the effect of therapies targeting microglia/macrophages activation after TBI.	[Guglielmetti, Caroline; Chou, Austin; Krukowski, Karen; Feng, Xi; Riparip, Lara-Kirstie; Rosi, Susanna; Chaumeil, Myriam M.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Guglielmetti, Caroline; Najac, Chloe; Chaumeil, Myriam M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Surbeck Lab Adv Imaging, San Francisco, CA 94143 USA; [Chou, Austin; Krukowski, Karen; Feng, Xi; Riparip, Lara-Kirstie; Rosi, Susanna] Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Rosi, Susanna] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Rosi, Susanna] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA		Rosi, S; Chaumeil, MM (corresponding author), Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA.; Chaumeil, MM (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, Surbeck Lab Adv Imaging, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA.; Rosi, S (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94143 USA.	susanna.rosi@ucsf.edu; myriam.chaumeil@ucsf.edu	; Feng, Xi/N-7160-2016	Chou, Austin/0000-0003-4328-5811; Najac, Chloe/0000-0002-7804-2281; Chaumeil, Myriam/0000-0002-2110-4613; Feng, Xi/0000-0002-6920-1519	NMSSNational Multiple Sclerosis Society [FG-1507-05297]; NIH Hyperpolarized MRI Technology Resource CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P41EB013598]; NIH/NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA172845, R01CA1972254];  [ABTA BRF1700006];  [NIH/NINDS R21NS096718];  [NIH/NINDS R01NS102156];  [Cal-BRAIN349087]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R01CA172845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB013598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS102156, R21NS096718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [F32AG054126] Funding Source: NIH RePORTER	This work was supported by research grants: NIH/NINDS R21NS096718, NIH/NINDS R01NS102156, Cal-BRAIN349087, NIH Hyperpolarized MRI Technology Resource Center #P41EB013598, fellowship from the NMSS (FG-1507-05297), NIH/NCI R01CA172845, NIH/NCI R01CA1972254, ABTA BRF1700006.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Carpenter KLH, 2014, EUR J PHARM SCI, V57, P87, DOI 10.1016/j.ejps.2013.12.012; Chaumeil MM, 2015, METHOD ENZYMOL, V561, P1, DOI 10.1016/bs.mie.2015.04.001; Chou A, 2017, P NATL ACAD SCI USA, V114, pE6420, DOI 10.1073/pnas.1707661114; Daniels CJ, 2016, NMR BIOMED, V29, P387, DOI 10.1002/nbm.3468; DeVience SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01736-x; Dienel GA, 2014, J CEREBR BLOOD F MET, V34, P1736, DOI 10.1038/jcbfm.2014.153; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Feng X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0671-y; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; Galvan-Pena S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00420; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Guglielmetti C, 2017, P NATL ACAD SCI USA, V114, pE6982, DOI 10.1073/pnas.1613345114; Hanrahan F, 2016, TRANSLATIONAL RES TR; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hillary FG, 2007, BRAIN INJURY, V21, P981, DOI 10.1080/02699050701426964; Jalloh I, 2013, J NEUROTRAUM, V30, P2031, DOI 10.1089/neu.2013.2947; Jha MK, 2015, J NEUROSCI, V35, P14353, DOI 10.1523/JNEUROSCI.1910-15.2015; Kettunen MI, 2010, MAGN RESON MED, V63, P872, DOI 10.1002/mrm.22276; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Makoroff KL, 2005, PEDIATR RADIOL, V35, P668, DOI 10.1007/s00247-005-1441-7; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Tisdall MM, 2007, BRIT J ANAESTH, V99, P61, DOI 10.1093/bja/aem143; Vallez Garcia D, 2016, J NEUROTRAUM, V33, P1855, DOI 10.1089/neu.2015.4230; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	45	19	19	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 13	2017	7								17525	10.1038/s41598-017-17758-4			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP7FR	WOS:000417796000045	29235509	gold, Green Published			2022-02-06	
J	Caswell, SV; Lincoln, AE; Stone, H; Kelshaw, P; Putukian, M; Hepburn, L; Higgins, M; Cortes, N				Caswell, Shane V.; Lincoln, Andrew E.; Stone, Hannah; Kelshaw, Patricia; Putukian, Margot; Hepburn, Lisa; Higgins, Michael; Cortes, Nelson			Characterizing Verified Head Impacts in High School Girls' Lacrosse	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head impacts; female; lacrosse; wearable sensors; verification; video analysis	ICE HOCKEY PLAYERS; COLLEGIATE FOOTBALL PLAYERS; WOMENS LACROSSE; EYE INJURIES; EPIDEMIOLOGY; CONCUSSION; SOCCER; MENS; BIOMECHANICS; EXPOSURE	Background: Girls' high school lacrosse players have higher rates of head and facial injuries than boys. Research indicates that these injuries are caused by stick, player, and ball contacts. Yet, no studies have characterized head impacts in girls' high school lacrosse. Purpose: To characterize girls' high school lacrosse game-related impacts by frequency, magnitude, mechanism, player position, and game situation. Study Design: Descriptive epidemiology study. Methods: Thirty-five female participants (mean age, 16.2 +/- 1.2 years; mean height, 1.66 +/- 0.05 m; mean weight, 61.2 +/- 6.4 kg) volunteered during 28 games in the 2014 and 2015 lacrosse seasons. Participants wore impact sensors affixed to the right mastoid process before each game. All game-related impacts recorded by the sensors were verified using game video. Data were summarized for all verified impacts in terms of frequency, peak linear acceleration (PLA), and peak rotational acceleration (PRA). Descriptive statistics and impact rates were calculated. Results: Fifty-eight verified game-related impacts >= 20g were recorded (median PLA, 33.8g; median PRA, 6151.1 rad/s(2)) during 467 player-games. The impact rate for all game-related verified impacts was 0.12 per athlete-exposure (AE) (95% CI, 0.09-0.16), equivalent to 2.1 impacts per team game, indicating that each athlete suffered fewer than 2 head impacts per season 20g. Of these impacts, 28 (48.3%) were confirmed to directly strike the head, corresponding with an impact rate of 0.05 per AE (95% CI, 0.00-0.10). Overall, midfielders (n = 28, 48.3%) sustained the most impacts, followed by defenders (n = 12, 20.7%), attackers (n = 11, 19.0%), and goalies (n = 7, 12.1%). Goalies demonstrated the highest median PLA and PRA (38.8g and 8535.0 rad/s(2), respectively). The most common impact mechanisms were contact with a stick (n = 25, 43.1%) and a player (n = 17, 29.3%), followed by the ball (n = 7, 12.1%) and the ground (n = 7, 12.1%). One hundred percent of ball impacts occurred to goalies. Most impacts occurred to field players within the attack area of the field (n = 32, 55.2%) or the midfield (n = 18, 31.0%). Most (95%) impacts did not result in a penalty. Conclusion: The incidence of verified head impacts in girls' high school lacrosse was quite low. Ball to head impacts were associated with the highest impact magnitudes. While stick and body contacts are illegal in girls' high school lacrosse, rarely did such impacts to the head result in a penalty. The verification of impact mechanisms using video review is critical to collect impact sensor data.	[Caswell, Shane V.; Lincoln, Andrew E.; Stone, Hannah; Kelshaw, Patricia; Putukian, Margot; Hepburn, Lisa; Higgins, Michael; Cortes, Nelson] George Mason Univ, SMART Lab, Sports Med Assessment Res & Testing, 10900 Univ Blvd,MS4E5, Manassas, VA 20110 USA; [Lincoln, Andrew E.; Hepburn, Lisa] MedStar Sports Med, Baltimore, MD USA; [Putukian, Margot] Princeton Univ, Princeton, NJ 08544 USA; [Higgins, Michael] Univ Virginia, Charlottesville, VA USA		Caswell, SV (corresponding author), George Mason Univ, SMART Lab, Sports Med Assessment Res & Testing, 10900 Univ Blvd,MS4E5, Manassas, VA 20110 USA.	scaswell@gmu.edu	Kelshaw, Patricia/AAC-7220-2021	Cortes, Nelson/0000-0001-8762-3144			[Anonymous], 2013 14 HIGH SCH ATH; ASTM International, F313715 ASTM; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Carter EA, 2010, INT J INJ CONTROL SA, V17, P111, DOI 10.1080/17457300903524888; Caswell SV, 2012, AM J SPORT MED, V40, P756, DOI 10.1177/0363546512436647; Clark JM, 2016, AM J SPORT MED, V44, P1047, DOI 10.1177/0363546515623272; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2015, J APPL BIOMECH, V31, P122, DOI [10.1123/jab.2014-0102, 10.1123/JAB.2014-0102]; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; De Lench B, ASTM STANDARD WOMENS; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P262; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hall C, 2013, RES SPORTS MED, V21, P229, DOI 10.1080/15438627.2013.792085; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; King D, 2014, SPORTS MED, V44, P449, DOI 10.1007/s40279-013-0134-x; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2012, AM J SPORT MED, V40, P611, DOI 10.1177/0363546511428873; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; Mihalik JP, 2011, CLIN J SPORT MED, V21, P416, DOI 10.1097/JSM.0B013E31822C8A5C; Miyashita T, 2016, ATHLETIC TRAINING SP, V8, P202, DOI DOI 10.3928/19425864-20160503-01; Morse JD, 2014, ANN BIOMED ENG, V42, P2501, DOI 10.1007/s10439-014-1091-8; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Otago L, 2007, Int J Inj Contr Saf Promot, V14, P259, DOI 10.1080/17457300701602381; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reed N, 2010, INT J SPORTS MED, V31, P826, DOI 10.1055/s-0030-1263103; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rodowicz KA, 2015, ANN BIOMED ENG, V43, P949, DOI 10.1007/s10439-014-1154-x; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; US Lacrosse, 2016 WOM RUL; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	39	19	19	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	DEC	2017	45	14					3374	3381		10.1177/0363546517724754			8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FO4OH	WOS:000416823600023	28918649				2022-02-06	
J	Howell, DR; Brilliant, A; Berkstresser, B; Wang, F; Fraser, J; Meehan, WP				Howell, David R.; Brilliant, Anna; Berkstresser, Brant; Wang, Francis; Fraser, Joana; Meehan, William P., III			The Association between Dual-Task Gait after Concussion and Prolonged Symptom Duration	JOURNAL OF NEUROTRAUMA			English	Article						attention; mild traumatic brain injury; postural balance; sports; symptoms	SPORT-RELATED CONCUSSION; TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTION; BALANCE CONTROL; HIGH-SCHOOL; POSTCONCUSSION SYNDROME; HOCKEY PLAYERS; RECOVERY; ADOLESCENTS; PREDICTORS	Quantitative gait measurements can identify persistent postconcussion impairments. However, their prognostic utility after injury to identify the likelihood of prolonged concussion symptoms remains unknown. Our objective was to examine if dual-task gait performance measures are independently associated with persistent (> 28 days) concussion symptoms among a sample of athletes. Sixty individuals diagnosed with a sport-related concussion were assessed within 10 days of their injury. Each participant completed a postconcussion symptom scale, an injury history questionnaire, and a single/dual-task gait examination. They were followed until they no longer reported symptoms, and the duration of time required for symptom resolution was calculated. A binary multivariable logistic regression model determined the independent association between dual-task gait and symptom duration (<= 28 days vs. >28 days) while controlling for the effect of gender, age, symptom severity, injury-to-examination time, and history of concussion. Seventeen (28%) participants reported a symptom duration > 28 days. The dual-task cost for average gait speed (-25.9 +/- 9.5% vs. -19.8 +/- 8.9%; p = 0.027) and cadence (-18.0 +/- 2.9% vs. -12.0 +/- 7.7%; p = 0.029) was significantly greater among participants who experienced symptoms for > 28 days. After adjusting for potential confounding variables, greater dual-task average gait speed costs were independently associated with prolonged symptom duration (aOR = 0.908; 95% CI = 0.835-0.987). Examinations of dual-task gait may provide useful information during multifaceted concussion examinations. Quantitative assessments that simultaneously test multiple domains, such as dual tasks, may be clinically valuable after a concussion to identify those more likely to experience symptoms for >28 days after injury.	[Howell, David R.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.; Brilliant, Anna; Fraser, Joana; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Howell, David R.; Brilliant, Anna; Fraser, Joana; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Dept Orthopaed, Boston, MA USA; [Berkstresser, Brant; Wang, Francis] Harvard Univ, Hlth Serv, Cambridge, MA 02138 USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA USA		Howell, DR (corresponding author), Univ Colorado, Sch Med, Colorado Childrens Hosp, Dept Orthopaed,Sports Med Ctr, 13123 E 16th Ave,B060, Aurora, CO 80045 USA.	David.Howell@ucdenver.edu			ElMinda Ltd.; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; Football Players Health Study at Harvard University - NFL Players Association	This research was funded, in part, by ElMinda Ltd. Dr. Howell and Ms. Brilliant received research support from ElMinda Ltd. Dr. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A Guide for Coaches and Parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in the Young Athlete; and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association. The remaining authors have no disclosures related to this study.	Al-Yahya E, 2011, NEUROSCI BIOBEHAV R, V35, P715, DOI 10.1016/j.neubiorev.2010.08.008; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Buckley TA, 2013, GAIT POSTURE, V38, P549, DOI 10.1016/j.gaitpost.2013.02.008; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Cossette I, 2016, BRAIN INJURY, V30, P1648, DOI 10.1080/02699052.2016.1200143; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Fino PC, 2016, J BIOMECH, V49, P1983, DOI 10.1016/j.jbiomech.2016.05.004; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Heyer GL, 2016, J PEDIATR-US, V174, P33, DOI 10.1016/j.jpeds.2016.03.014; Howel DR, 2017, J APPL BIOMECH, V33, P24, DOI 10.1123/jab.2015-0323; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2017, GAIT POSTURE, V54, P284, DOI 10.1016/j.gaitpost.2017.03.034; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2015, MED SCI SPORT EXER, V47, P673, DOI 10.1249/MSS.0000000000000462; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kriz PK, 2016, J PEDIATR-US, V171, P234, DOI 10.1016/j.jpeds.2015.12.006; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lax ID, 2015, BRAIN INJURY, V29, P1409, DOI 10.3109/02699052.2015.1043344; Mancini M., 2011, J BIOENG BIOMED S S1, V1, P7, DOI DOI 10.4172/2155-9538.S1-007; Mannix R, 2014, ANN CLIN TRANSL NEUR, V1, P433, DOI 10.1002/acn3.70; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2017, BR J SPORTS MED; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Nishiguchi S, 2012, TELEMED E-HEALTH, V18, P292, DOI 10.1089/tmj.2011.0132; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Plummer P, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00225; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Sufrinko AM, 2017, AM J SPORT MED, V45, P1187, DOI 10.1177/0363546516685061; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yogev-Seligmann G, 2008, MOVEMENT DISORD, V23, P329, DOI 10.1002/mds.21720; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	50	19	19	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3288	3294		10.1089/neu.2017.5191			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000416341700010	28895490				2022-02-06	
J	Ramos-Hryb, AB; Pazini, FL; Kaster, MP; Rodrigues, ALS				Ramos-Hryb, Ana B.; Pazini, Francis L.; Kaster, Manuella P.; Rodrigues, Ana Lucia S.			Therapeutic Potential of Ursolic Acid to Manage Neurodegenerative and Psychiatric Diseases	CNS DRUGS			English	Article							EARLY BRAIN-INJURY; TRIPLE REUPTAKE INHIBITORS; INDUCED COGNITIVE DEFICITS; ORIGANUM-MAJORANA L.; OLEANOLIC ACID; OXIDATIVE STRESS; MITOCHONDRIAL-FUNCTION; MONOAMINE-OXIDASE; NEXT-GENERATION; OFFICINALIS L.	Ursolic acid is a pentacyclic triterpenoid found in several plants. Despite its initial use as a pharmacologically inactive emulsifier in pharmaceutical, cosmetic and food industries, several biological activities have been reported for this compound so far, including anti-tumoural, anti-diabetic, cardioprotective and hepatoprotective properties. The biological effects of ursolic acid have been evaluated in vitro, in different cell types and against several toxic insults (i.e. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, amyloid-beta peptides, kainic acid and others); in animal models of brain-related disorders (Alzheimer disease, Parkinson disease, depression, traumatic brain injury) and ageing; and in clinical studies with cancer patients and for muscle atrophy. Most of the protective effects of ursolic acid are related to its ability to prevent oxidative damage and excessive inflammation, common mechanisms associated with multiple brain disorders. Additionally, ursolic acid is capable of modulating the monoaminergic system, an effect that might be involved in its ability to prevent mood and cognitive dysfunctions associated with neurodegenerative and psychiatric conditions. This review presents and discusses the available evidence of the possible beneficial effects of ursolic acid for the management of neurodegenerative and psychiatric disorders. We also discuss the chemical features, major sources and potential limitations of the use of ursolic acid as a pharmacological treatment for brain-related diseases.	[Ramos-Hryb, Ana B.; Pazini, Francis L.; Kaster, Manuella P.; Rodrigues, Ana Lucia S.] Univ Fed Santa Catarina, Dept Biochem, Ctr Biol Sci, BR-88040900 Florianopolis, SC, Brazil		Ramos-Hryb, AB (corresponding author), Univ Fed Santa Catarina, Dept Biochem, Ctr Biol Sci, BR-88040900 Florianopolis, SC, Brazil.	alsrodri@gmail.com	Hryb, Ana Belen B R-H Ramos/P-3615-2014; Rodrigues, Ana Lucia/P-6869-2015; Kaster, Manuella P/D-5028-2013	Hryb, Ana Belen B R-H Ramos/0000-0003-3376-5977; Rodrigues, Ana Lucia/0000-0001-6285-8780; Kaster, Manuella P/0000-0003-0258-6204	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [308723/2013-9, 449436/2014-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, NENASC Project (PRONEX-FAPESC/CNPq) [1262/2012-9]	The authors acknowledge funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), #308723/2013-9 and #449436/2014-4, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, NENASC Project (PRONEX-FAPESC/CNPq) #1262/2012-9. Manuella P. Kaster and Ana Lucia S. Rodrigues are CNPq Research Fellows.	Aarsland D, 2017, NAT REV NEUROL, V13, P217, DOI 10.1038/nrneurol.2017.27; Anderson KN, 2013, NAT SCI SLEEP, V5, P61, DOI 10.2147/NSS.S34842; Bahadori MB, 2016, S AFR J BOT, V106, P1, DOI 10.1016/j.sajb.2015.12.003; Bang HS, 2014, KOREAN J PHYSIOL PHA, V18, P441, DOI 10.4196/kjpp.2014.18.5.441; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Beer B, 2004, J CLIN PHARMACOL, V44, P1360, DOI 10.1177/0091270004269560; Birks J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005593; Bodkin JA, 1997, J CLIN PSYCHIAT, V58, P137, DOI 10.4088/JCP.v58n0401; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; Brooks SP, 2009, NAT REV NEUROSCI, V10, P519, DOI 10.1038/nrn2652; Caligiani A, 2013, FOOD CHEM, V136, P735, DOI 10.1016/j.foodchem.2012.08.011; Chandramu C, 2003, PHYTOTHER RES, V17, P129, DOI 10.1002/ptr.1088; Chapman K, 2013, PHYSIOL REV, V93, P1139, DOI 10.1152/physrev.00020.2012; Chattopadhyay D, 2003, J ETHNOPHARMACOL, V85, P99, DOI 10.1016/S0378-8741(02)00379-3; Chen QH, 2011, ANAL BIOANAL CHEM, V399, P2877, DOI 10.1007/s00216-011-4651-x; Chen XP, 2012, NEURAL REGEN RES, V7, P376, DOI 10.3969/j.issn.1673-5374.2012.05.009; Chin JH, 2014, NEUROLOGY, V83, P349, DOI 10.1212/WNL.0000000000000610; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; Chung YK, 2001, MOL CELLS, V11, P137; Colla ARS, 2015, EUR J PHARMACOL, V758, P171, DOI 10.1016/j.ejphar.2015.03.077; Colla ARS, 2014, PHARMACOL BIOCHEM BE, V124, P108, DOI 10.1016/j.pbb.2014.05.015; Coraci IS, 2002, AM J PATHOL, V160, P101, DOI 10.1016/S0002-9440(10)64354-4; Culhaoglu B, 2013, NAT PROD RES, V27, P438, DOI 10.1080/14786419.2012.734820; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Dar BA, 2016, EUR J MED CHEM, V111, P26, DOI 10.1016/j.ejmech.2016.01.026; De Angel RE, 2010, NUTR CANCER, V62, P1074, DOI 10.1080/01635581.2010.492092; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Ennaceur A, 2014, PHYSIOL BEHAV, V135, P55, DOI 10.1016/j.physbeh.2014.05.032; Esch T, 2002, NEUROENDOCRINOL LETT, V23, P199; Falkenburger BH, 2016, J NEUROCHEM, V139, P121, DOI 10.1111/jnc.13618; Gao LP, 2005, PHARMAZIE, V60, P62; Gonzalez-Cortazar M, 2013, MOLECULES, V18, P13260, DOI 10.3390/molecules181113260; Gonzalez-Trujano ME, 2012, PLANTA MED, V78, P793, DOI 10.1055/s-0031-1298416; Hane FT, 2017, J ALZHEIMERS DIS, V57, P1, DOI 10.3233/JAD-160882; Heo HJ, 2002, MOL CELLS, V13, P5; Hettema JM, 2008, AM J MED GENET C, V148C, P140, DOI 10.1002/ajmg.c.30171; Hong SY, 2012, MOLECULES, V17, P10831, DOI 10.3390/molecules170910831; Hussain H, 2017, EXPERT OPIN THER PAT, V27, P1061, DOI 10.1080/13543776.2017.1344219; Ibarra A, 2010, PHYTOMEDICINE, V17, P397, DOI 10.1016/j.phymed.2010.01.012; Jager S, 2009, MOLECULES, V14, P2016, DOI 10.3390/molecules14062016; Jeon SJ, 2015, EUR J PHARMACOL, V762, P443, DOI 10.1016/j.ejphar.2015.06.037; Jetter R, 2001, PLANT PHYSIOL, V126, P1725, DOI 10.1104/pp.126.4.1725; Kashyap D, 2016, LIFE SCI, V146, P201, DOI 10.1016/j.lfs.2016.01.017; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Kim JH, 2012, BIOMOL THER, V20, P214, DOI 10.4062/biomolther.2012.20.2.214; Kowalski R, 2007, J AGR FOOD CHEM, V55, P656, DOI 10.1021/jf0625858; Krishnan V, 2011, CURR TOP BEHAV NEURO, V7, P121, DOI 10.1007/7854_2010_108; Leal AS, 2012, BIOORGAN MED CHEM, V20, P5774, DOI 10.1016/j.bmc.2012.08.010; Lee S, 2002, ARCH PHARM RES, V25, P280, DOI 10.1007/BF02976626; Leung A. Y., 1996, ENCY COMMON NATURAL; LEVIN EY, 1960, J BIOL CHEM, V235, P2080; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Liang WN, 2016, ARQ NEURO-PSIQUIAT, V74, P482, DOI 10.1590/0004-282X20160065; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Liu H, 2005, J ETHNOPHARMACOL, V100, P92, DOI 10.1016/j.jep.2005.05.024; Lu J, 2007, BIOCHEM PHARMACOL, V74, P1078, DOI 10.1016/j.bcp.2007.07.007; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Lu J, 2010, CEREB CORTEX, V20, P2540, DOI 10.1093/cercor/bhq002; Machado DG, 2012, PHARMACOL BIOCHEM BE, V103, P204, DOI 10.1016/j.pbb.2012.08.016; Machado DG, 2013, FOOD CHEM, V136, P999, DOI 10.1016/j.foodchem.2012.09.028; Marks DM, 2008, CURR NEUROPHARMACOL, V6, P338, DOI 10.2174/157015908787386078; Monteiro MC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2949102; Moon HS, 2013, METABOLISM, V62, P1131, DOI 10.1016/j.metabol.2013.04.007; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Mortiboys H, 2008, ANN NEUROL, V64, P555, DOI 10.1002/ana.21492; NITTA A, 1994, NEUROSCI LETT, V170, P63, DOI 10.1016/0304-3940(94)90239-9; Novotny L, 2003, J PHARMACEUT BIOMED, V31, P961, DOI 10.1016/S0731-7085(02)00706-9; Nyola A, 2010, CURR OPIN STRUC BIOL, V20, P415, DOI 10.1016/j.sbi.2010.05.007; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Popoli M, 2000, J NEUROCHEM, V74, P21, DOI 10.1046/j.1471-4159.2000.0740021.x; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Prediger RDS, 2008, J ETHNOPHARMACOL, V120, P465, DOI 10.1016/j.jep.2008.09.018; Qian ZZ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/809714; Rai SN, 2016, J CHEM NEUROANAT, V71, P41, DOI 10.1016/j.jchemneu.2015.12.002; Ramos-Hryb AB, 2017, PHARMACOL REP, V69, P1240, DOI 10.1016/j.pharep.2017.05.009; Richard EJ, 2016, PHYTOTHER RES, V30, P805, DOI 10.1002/ptr.5584; Rollinger JM, 2010, BIOORGAN MED CHEM, V18, P1507, DOI 10.1016/j.bmc.2010.01.010; ROWE EJ, 1949, J AM PHARM ASSOC SCI, V38, P122, DOI 10.1002/jps.3030380303; Santos Claudia Y, 2017, Alzheimers Dement (Amst), V7, P69, DOI 10.1016/j.dadm.2017.01.005; Shan JZ, 2011, CHIN J INTEGR MED, V17, P607, DOI 10.1007/s11655-011-0815-y; Shanmugam MK, 2013, BIOCHEM PHARMACOL, V85, P1579, DOI 10.1016/j.bcp.2013.03.006; Shanmugam MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032476; Shanmugam MK, 2011, INT J CANCER, V129, P1552, DOI 10.1002/ijc.26120; Sharma H, 2015, FUTURE MED CHEM, V7, P2385, DOI 10.4155/fmc.15.134; Shen DD, 2011, J FOOD SCI, V76, pC900, DOI 10.1111/j.1750-3841.2011.02281.x; Shih YH, 2004, NEUROSCI LETT, V362, P136, DOI 10.1016/j.neulet.2004.03.011; Shimohama S, 2003, TRENDS MOL MED, V9, P360, DOI 10.1016/S1471-4914(03)00117-5; Singla RK, 2016, CURR NEUROPHARMACOL; Skolnick P, 2006, CNS DRUG REV, V12, P123, DOI 10.1111/j.1527-3458.2006.00123.x; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Snow WM, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00118; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Szakiel A, 2012, PHYTOCHEM REV, V11, P263, DOI 10.1007/s11101-012-9241-9; Szakiel A, 2012, J AGR FOOD CHEM, V60, P11839, DOI 10.1021/jf3046895; Takanishi R, 2017, PROMOTING THE EDUCATIONAL SUCCESS OF CHILDREN AND YOUTH LEARNING ENGLISH: PROMISING FUTURES, P1, DOI 10.1111/pin.12520; Takeda S, 2009, BRAIN RES, V1280, P137, DOI 10.1016/j.brainres.2009.05.035; Tang Siu W, 2017, Mod Trends Pharmacopsychiatry, V31, P107, DOI 10.1159/000470811; Tapondjou LA, 2003, ARCH PHARM RES, V26, P143, DOI 10.1007/BF02976660; Taviano MF, 2007, PHYTOTHER RES, V21, P382, DOI 10.1002/ptr.2076; TOKUDA H, 1986, CANCER LETT, V33, P279, DOI 10.1016/0304-3835(86)90067-4; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Tsai SJ, 2008, J FOOD SCI, V73, pH174, DOI 10.1111/j.1750-3841.2008.00864.x; Vasconcelos MAL, 2006, Z NATURFORSCH C, V61, P477, DOI 10.1515/znc-2006-7-803; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Verano J, 2013, PHARMACOL BIOCHEM BE, V110, P255, DOI 10.1016/j.pbb.2013.07.020; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Wang XH, 2013, EXPERT OPIN DRUG MET, V9, P117, DOI 10.1517/17425255.2013.738667; Wang YZ, 2016, DRUG DES DEV THER, V10, DOI 10.2147/DDDT.S103829; Wang YJ, 2011, NEUROBIOL LEARN MEM, V96, P156, DOI 10.1016/j.nlm.2011.03.010; Wei HF, 2005, BEHAV BRAIN RES, V157, P245, DOI 10.1016/j.bbr.2004.07.003; Whiteford HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116820; Wilkinson K, 2011, J BIOL CHEM, V286, P34914, DOI 10.1074/jbc.M111.232116; Wojciak-Kosior M, 2007, J PHARMACEUT BIOMED, V45, P337, DOI 10.1016/j.jpba.2007.05.011; Wozniak L, 2015, MOLECULES, V20, P20614, DOI 10.3390/molecules201119721; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Wu DM, 2013, TOXICOL APPL PHARM, V271, P127, DOI 10.1016/j.taap.2013.04.038; Xia YY, 2011, J CHROMATOGR B, V879, P219, DOI 10.1016/j.jchromb.2010.11.037; Yealland G, 2016, NEUROSCI LETT, V630, P23, DOI 10.1016/j.neulet.2016.06.065; Yoon JH, 2014, J AGR FOOD CHEM, V62, P4911, DOI 10.1021/jf501314g; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Youn K, 2012, PHYTOTHER RES, V26, P1714, DOI 10.1002/ptr.4638; Zhang TT, 2014, INT IMMUNOPHARMACOL, V23, P585, DOI 10.1016/j.intimp.2014.10.009; Zhang TT, 2014, NEUROSCI LETT, V579, P12, DOI 10.1016/j.neulet.2014.07.005; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079; Zhu ZL, 2013, INT J NANOMED, V8, P129, DOI 10.2147/IJN.S38271	126	19	19	0	14	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1172-7047	1179-1934		CNS DRUGS	CNS Drugs	DEC	2017	31	12					1029	1041		10.1007/s40263-017-0474-4			13	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	FR4FN	WOS:000419021200001	29098660				2022-02-06	
J	Navarro, SM; Sokunbi, OF; Haeberle, HS; Schickendantz, MS; Mont, MA; Figler, RA; Ramkumar, PN				Navarro, Sergio M.; Sokunbi, Olumide F.; Haeberle, Heather S.; Schickendantz, Mark S.; Mont, Michael A.; Figler, Richard A.; Ramkumar, Prem N.			Short-term Outcomes Following Concussion in the NFL: A Study of Player Longevity, Performance, and Financial Loss	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						concussion; NFL; football; performance; economic and decision analysis	FOOTBALL LEAGUE PLAYERS; BASKETBALL ASSOCIATION PLAYERS; PROFESSIONAL FOOTBALL; TIME; DEPRESSION; RETURN	Background: A short-term protocol for evaluation of National Football League (NFL) athletes incurring concussion has yet to be fully defined and framed in the context of the short-term potential team and career longevity, financial risk, and performance. Purpose: To compare the short-term career outcomes for NFL players with concussions by analyzing the effect of concussions on (1) franchise release rate, (2) career length, (3) salary, and (4) performance. Study Design: Cohort study; Level of evidence, 3. Methods: NFL player transaction records and publicly available injury reports from August 2005 to January 2016 were analyzed. All players sustaining documented concussions were evaluated for a change to inactive or DNP (did not participate) status. A case-control design compared franchise release rates and remaining NFL career span. Career length was analyzed via survival analysis. Salary and performance differences were analyzed with publicly available contract data and a performance-scoring algorithm based on position/player level. Results: Of the 5894 eligible NFL players over the 11-year period, 307 sustained publicly reported concussions resulting in the DNP injury protocol. Analysis of the probability of remaining in the league demonstrated a statistically significantly shorter career length for the concussion group at 3 and 5 years after concussion. The year-over-year change in contract value for the concussion group resulted in a mean overall salary reduction of $300,000 $1,300,000 per year (interquartile range, -$723,000 to $450,000 per year). The performance score reduction for all offensive scoring players sustaining concussions was statistically significant. Conclusion: This retrospective study demonstrated that NFL players who sustain a concussion face a higher overall franchise release rate and shorter career span. Players who sustained concussions may incur significant salary reductions and perform worse after concussion. Short-term reductions in longevity, performance, and salary after concussion exist and deserve additional consideration.	[Navarro, Sergio M.; Sokunbi, Olumide F.; Haeberle, Heather S.; Schickendantz, Mark S.; Mont, Michael A.; Figler, Richard A.; Ramkumar, Prem N.] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Navarro, Sergio M.; Sokunbi, Olumide F.; Haeberle, Heather S.] Baylor Coll Med, Dept Orthoped Surg, Houston, TX 77030 USA; [Schickendantz, Mark S.; Mont, Michael A.; Figler, Richard A.; Ramkumar, Prem N.] Cleveland Clin, Dept Orthoped Surg, Cleveland, OH USA		Ramkumar, PN (corresponding author), 2049 E 100th St, Cleveland, OH 44195 USA.	premramkumar@gmail.com	Navarro, Sergio M/B-4287-2019; Navarro, Sergio M/K-8923-2019	Navarro, Sergio M/0000-0003-3455-1567; Navarro, Sergio M/0000-0003-3455-1567; Haeberle, Heather/0000-0001-8341-8389			American Academy of Neurology website, STUD MOR 40 PERC RET; [Associated Press Goodell issues memo changing return to play rules for concussions National Football League website], GOODELL ISSUES MEMO; Bradley B, NEW NFL RULES CROWNO; Bradley B., NFLS 2013 PROTOCOL P; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Izraelski Jason, 2014, J Can Chiropr Assoc, V58, P346; Kontos AP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1633; Kuhn AW, 2016, AM J SPORT MED, V44, P2152, DOI 10.1177/0363546516638327; Kumar NS, 2014, AM J SPORT MED, V42, P2050, DOI 10.1177/0363546514539449; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; National Football League, NEL PLAY HLTH SAF FA; National Football League, NFL ANN NEW SID CONC; National Football League . NFL, NFL NFLPA ANN POL EN; National Football League website, NFL MOV KICK 35 YARD; NFL Head Neck and Spine Committee, NEL HEAD NECK SPIN C; Padaki AS, 2016, AM J SPORT MED, V44, P2263, DOI 10.1177/0363546516634679; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Plancher KD, 2014, ORTHOP J SPORTS MED, V2, DOI 10.1177/2325967114550623; Reams N, 2017, INT J SPORT PHYSIOL, V12, P1100, DOI 10.1123/ijspp.2016-0508; Secrist ES., 2016, ORTHOP J SPORTS MED, V4; Stites A, DOES NFLS CONCUSSION; Teramoto M, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115620365; Wasserman EB, 2015, AM J SPORT MED, V43, P1127, DOI 10.1177/0363546515576130; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; Yengo-Kahn AM, 2016, PHYSICIAN SPORTSMED, V44, P297, DOI 10.1080/00913847.2016.1200956	28	19	19	0	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	NOV 27	2017	5	11							2325967117740847	10.1177/2325967117740847			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	FN9MP	WOS:000416361900001	29226164	gold, Green Published			2022-02-06	
J	Cohen, ML; Tulsky, DS; Holdnack, JA; Carlozzi, NE; Wong, A; Magasi, S; Heaton, RK; Heinemann, AW				Cohen, Matthew L.; Tulsky, David S.; Holdnack, James A.; Carlozzi, Noelle E.; Wong, Alex; Magasi, Susan; Heaton, Robert K.; Heinemann, Allen W.			Cognition Among Community-Dwelling Individuals With Spinal Cord Injury	REHABILITATION PSYCHOLOGY			English	Article						spinal cord injuries; cognition; neuropsychological tests	TRAUMATIC BRAIN-INJURY; NIH TOOLBOX COGNITION; CLOSED HEAD-INJURY; QUALITY-OF-LIFE; EXECUTIVE FUNCTION; CHRONIC PAIN; BATTERY; CB; DEPRESSION; PREVALENCE	Purpose/Objective: To compare the cognitive profiles of a well-characterized sample of adults with and without spinal cord injury (SCI) using the NIH Toolbox Cognition Battery NIHTB-CB. Research Method/Design: Participants were 156 community-dwelling individuals with SCI recruited from 3 academic medical centers, and 156 individuals without SCI selected from the NIHTB-CB normative database (N = 312). The main outcome measures were the demographically adjusted NIHTB-CB subtest and composite scores. Results: Individuals with and without SCI performed equivalently on the NIHTB-CB crystallized composite score, suggesting comparable premorbid functioning. Individuals with SCI produced lower scores on the NIHTB-CB fluid composite score by an average of 4.5 T-score points (Cohen's d = 0.50; a medium effect size). As a group, individuals with SCI had the most difficulty on tests of processing speed and executive functions, and some difficulty on a test of episodic memory, although effect sizes were small. These differences remained even after accounting for fine motor speed and dexterity. Individuals with tetraplegia produced lower scores than individuals with paraplegia on tests of processing speed and executive functioning. Conclusion/Implications: Community-dwelling individuals with SCI are at elevated risk of mild cognitive difficulties, particularly on tasks that rely on processing speed and executive functions. The NIHTB-CB is relatively brief, samples important cognitive domains, has good normative data, and is appropriate for some individuals with SCI (those who have functional use of one hand). The battery has standardized accommodations for individuals with minor motor limitations, but timed tests are inaccessible for individuals who are unable to perform rapid button presses.	[Cohen, Matthew L.; Tulsky, David S.; Holdnack, James A.] Univ Delaware, Ctr Hlth Assessment Res & Translat, Newark, DE 19713 USA; [Cohen, Matthew L.] Univ Delaware, Dept Commun Sci & Disorders, 540 South Coll Ave, Newark, DE 19713 USA; [Tulsky, David S.] Kessler Fdn, E Hanover, NJ USA; [Holdnack, James A.] Pearson Assessment, San Antonio, TX USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA; [Wong, Alex] Washington Univ, Program Occupat Therapy, St Louis, MO USA; [Wong, Alex] Washington Univ, Dept Neurol, St Louis, MO USA; [Magasi, Susan] Univ Illinois, Dept Occupat Therapy, Chicago, IL 60680 USA; [Heaton, Robert K.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Heinemann, Allen W.] Shirley Ryan AbilityLab, Ctr Rehabil Outcomes Res, Chicago, IL USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Evanston, IL 60208 USA		Cohen, ML (corresponding author), Univ Delaware, Dept Commun Sci & Disorders, 540 South Coll Ave, Newark, DE 19713 USA.	mlcohen@udel.edu	Cohen, Mathew/W-3982-2019; Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Cohen, Matthew/0000-0001-9609-2461; Tulsky, David/0000-0002-4335-4509	United States Department of Health and Human Services [H133B090024]; National Institutes of Health (NIH), National Institute on Disability, Independent Living, and Research Rehabilitation (NIDILRR); Psychosocial Research Postdoctoral Fellowships from Craig H. Neilsen Foundation [290474, 364962]; Institutional Development Award (IDeA) from NIH, National Institute of General Medical Sciences [U54-GM104941]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U54GM104941] Funding Source: NIH RePORTER	An abstract based on earlier data was accepted for presentation as a poster at the 2016 Annual Conference of the International Spinal Cord Society. These data were also presented at the 2017 Annual Conference of the American Psychological Association's Division 22 (Rehabilitation Psychology). This research was supported by Grant H133B090024, Principal Investigator (PI): Allen W. Heinemann, from the United States Department of Health and Human Services, National Institutes of Health (NIH), National Institute on Disability, Independent Living, and Research Rehabilitation (NIDILRR), as well as Psychosocial Research Postdoctoral Fellowships from the Craig H. Neilsen Foundation (Grant 290474, PI: Alex Wong and Grant 364962, PI: Matthew L. Cohen). Salary support for Matthew L. Cohen was also provided by an Institutional Development Award (IDeA) from the NIH, National Institute of General Medical Sciences, Grant U54-GM104941 (PI: Binder-Macleod). We thank their talented and dedicated research staff: Ana Miskovic, Arielle Goldsmith, Sara Jerousek, Sue Tucker, Jessica Dashner, Cathy Crawley, Ben Aziz, Julie Grech, Livia Vanden Belt, and Angela Miciura.	Akshoomoff N, 2013, MONOGR SOC RES CHILD, V78, P119, DOI 10.1111/mono.12038; American Psychological Association, 2014, STAND ED PSYCH TEST; Avluk OC, 2014, ANN SAUDI MED, V34, P211, DOI 10.5144/0256-4947.2014.211; Baum CM, 2008, AM J OCCUP THER, V62, P446, DOI 10.5014/ajot.62.4.446; Bazarian JJ, 2006, ACAD EMERG MED, V13, P31, DOI 10.1197/j.aem.2005.07.038; Block C. K., 2016, PM&R, V8, pe4; Block C, 2014, J HEAD TRAUMA REHAB, V29, P76, DOI 10.1097/HTR.0b013e3182886d78; Block CK, 2016, PM&R, V8, P58, DOI 10.1016/j.pmrj.2015.05.022; Bonanno GA, 2012, REHABIL PSYCHOL, V57, P236, DOI 10.1037/a0029256; Boyer B., 2000, TOP SPINAL CORD INJ, V6, P125, DOI [10.1310/4FJ8-3VCH-EE0N-HNCD, DOI 10.1310/4FJ8-3VCH-EE0N-HNCD]; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS77, DOI 10.1016/j.apmr.2008.07.008; Carlozzi NE, 2014, J INT NEUROPSYCH SOC, V20, P630, DOI 10.1017/S1355617714000319; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; CRAWFORD JR, 1988, BRIT J PSYCHIAT, V153, P178, DOI 10.1192/bjp.153.2.178; Cullum CM, 2001, NEUROPSY NEUROPSY BE, V14, P103; DAVIDOFF G, 1988, ARCH PHYS MED REHAB, V69, P869; DAVIDOFF G, 1985, ARCH PHYS MED REHAB, V66, P489; DAVIDOFF GN, 1992, ARCH PHYS MED REHAB, V73, P275; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; Dijkers M, 2009, J REHABIL RES DEV, V46, P13, DOI 10.1682/JRRD.2008.04.0053; Dikmen SS, 2014, J INT NEUROPSYCH SOC, V20, P611, DOI 10.1017/S1355617714000460; Dowler R N, 1995, Appl Neuropsychol, V2, P124, DOI 10.1207/s15324826an0203&4_4; Dowler RN, 1997, J INT NEUROPSYCH SOC, V3, P464, DOI 10.1017/S1355617797004645; Dryden DM, 2005, NEUROEPIDEMIOLOGY, V25, P55, DOI 10.1159/000086284; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Franzen MD, 1997, ARCH CLIN NEUROPSYCH, V12, P711, DOI 10.1016/S0887-6177(97)00046-2; Gershon RC, 2014, J INT NEUROPSYCH SOC, V20, P642, DOI 10.1017/S1355617714000411; Gershon RC, 2013, MONOGR SOC RES CHILD, V78, P49, DOI 10.1111/mono.12034; Ghobrial GM, 2014, CLIN NEUROL NEUROSUR, V123, P174, DOI 10.1016/j.clineuro.2014.05.013; Hagen EM, 2010, ACTA NEUROL SCAND, V122, P51, DOI 10.1111/j.1600-0404.2010.01376.x; Hassanijirdehi M, 2015, KOREAN J PAIN, V28, P129, DOI 10.3344/kjp.2015.28.2.129; HEINEMANN AW, 1988, ARCH PHYS MED REHAB, V69, P619; HERRICK S, 1994, J CLIN PSYCHOL MED S, V1, P269, DOI 10.1007/BF01989628; Hess DW, 2003, REHABIL PSYCHOL, V48, P151, DOI 10.1037/0090-5550.48.3.151; Inoue T, 2013, EXP NEUROL, V248, P136, DOI 10.1016/j.expneurol.2013.06.006; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Krause JS, 2010, ARCH PHYS MED REHAB, V91, P1182, DOI 10.1016/j.apmr.2010.05.012; Kushner DS, 2014, PHYS MED REH CLIN N, V25, P681, DOI 10.1016/j.pmr.2014.04.005; Lazzaro I, 2013, J CLIN NEUROPHYSIOL, V30, P59, DOI 10.1097/WNP.0b013e31827edb0c; Macciocchi SN, 2004, AM J PHYS MED REHAB, V83, P22, DOI 10.1097/01.PHM.0000104661.86307.91; Macciocchi S, 2008, ARCH PHYS MED REHAB, V89, P1350, DOI 10.1016/j.apmr.2007.11.055; Macciocchi S, 2012, ARCH PHYS MED REHAB, V93, P1788, DOI 10.1016/j.apmr.2012.01.022; Macciocchi SN, 2013, ARCH CLIN NEUROPSYCH, V28, P684, DOI 10.1093/arclin/act049; Magasi S., 2017, TEST ACCOMMODA UNPUB; Masri R, 2012, ADV EXP MED BIOL, V760, P74; Mckinlay A, 2011, BRAIN INJURY, V25, P761, DOI 10.3109/02699052.2011.579935; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Migliorini C, 2015, INTERN MED J, V45, P1014, DOI 10.1111/imj.12825; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; ROTH E, 1989, PARAPLEGIA, V27, P480, DOI 10.1038/sc.1989.75; Sharma B, 2014, J REHABIL MED, V46, P370, DOI 10.2340/16501977-1261; Slotkin J., 2012, TECHNICAL MANUAL NIH; Spreen O., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [10.1080/13854048908403285, DOI 10.1080/13854048908403285]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tulsky DS, 2015, J SPINAL CORD MED, V38, P257, DOI [10.1179/2045772315Y.0000000023, 10.1179/2045772315Y.0000000035]; United States Department of Health and Human Services National Institutes of Health, 2012, NIH TOOLB REAS ACC G; Weintraub S, 2014, J INT NEUROPSYCH SOC, V20, P567, DOI 10.1017/S1355617714000320; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WILMOT CB, 1985, ARCH PHYS MED REHAB, V66, P227, DOI 10.1016/0003-9993(85)90148-0; Zelazo PD, 2014, J INT NEUROPSYCH SOC, V20, P620, DOI 10.1017/S1355617714000472; Zelazo PD, 2013, MONOGR SOC RES CHILD, V78, P16, DOI 10.1111/mono.12032	63	19	20	0	2	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2017	62	4					425	434		10.1037/rep0000140			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT1CK	WOS:000422871400003	29265863	Green Accepted, Bronze			2022-02-06	
J	Rau, CS; Wu, SC; Chen, YC; Chien, PC; Hsieh, HY; Kuo, PJ; Hsieh, CH				Rau, Cheng-Shyuan; Wu, Shao-Chun; Chen, Yi-Chun; Chien, Peng-Chen; Hsieh, Hsiao-Yun; Kuo, Pao-Jen; Hsieh, Ching-Hua			Stress-Induced Hyperglycemia, but Not Diabetic Hyperglycemia, Is Associated with Higher Mortality in Patients with Isolated Moderate and Severe Traumatic Brain Injury: Analysis of a Propensity Score-Matched Population	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury (TBI); stress-induced hyperglycemia (SIH); diabetic hyperglycemia (DH); diabetes mellitus (DM); mortality	SURGICAL-SITE INFECTION; ADMISSION HYPERGLYCEMIA; INSULIN-RESISTANCE; GLYCEMIC CONTROL; GLUCOSE	Background: Admission hyperglycemia is associated with higher morbidity and mortality in patients with traumatic brain injury (TBI). Stress-induced hyperglycemia (SIH), a form of hyperglycemia induced by the stress response, is associated with increased patient mortality following TBI. However, admission hyperglycemia occurs not only in SIH but also in patients with diabetic hyperglycemia (DH). Current information regarding whether trauma patients with SIH represent a distinct group with differential outcomes compared to those with DH remains limited. Methods: Serum glucose concentration 200 mg/dL upon arrival at the emergency department was defined as hyperglycemia. Presence of diabetes mellitus (DM) was determined by patient history and/or admission glycated hemoglobin (HbA1c) level 6.5%. In the present study, the patient cohort included those with moderate and severe TBI, as defined by an Abbreviated Injury Scale (AIS) score 3 points in the head, and excluded those who had additional AIS scores 3 points in any other region of the body. A total of 1798 adult patients with isolated moderate to severe TBI were allocated into four groups: SIH (n = 140), DH (n = 187), diabetic normoglycemia (DN, n = 186), and non-diabetic normoglycemia (NDN, n = 1285). Detailed patient information was retrieved from the Trauma Registry System at a level I trauma center between 1 January 2009, and 31 December 2015. Unpaired Student's t- and Mann-Whitney U-tests were used to analyze normally and non-normally distributed continuous data, respectively. Categorical data were compared using the Pearson chi-square or two-sided Fisher's exact tests. Matched patient populations were allocated in a 1:1 ratio according to propensity scores calculated by NCSS software. Logistic regression was used to evaluate the effect of SIH and DH on the adjusted mortality outcome. Results: In patients with isolated moderate to severe TBI, the presence of SIH and DH led to 9.1-fold and 2.3-fold higher odds of mortality, respectively, than patients with NDN. After adjusting for confounding factors, including sex and age, pre-existing co-morbidities, existence of different kinds of intracerebral hemorrhage, and injury severity, patients with SIH still had 6.6-fold higher odds of mortality than those with NDN; however, DH did not present significantly higher adjusted mortality odds. SIH and DH presented different effects on outcomes after TBI. The results also suggested that the pathophysiological effect associated with SIH was different from that of DH. Conclusions: This study demonstrated that patients with SIH and DH had significantly higher mortality than patients with NDN. However, the adjusted mortality was significantly higher only in the selected propensity score-matched patients with SIH and not in those with DH.	[Rau, Cheng-Shyuan] Chang Gung Univ, Coll Med, Dept Neurosurg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan; [Wu, Shao-Chun] Chang Gung Univ, Coll Med, Dept Anesthesiol, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan; [Chen, Yi-Chun; Chien, Peng-Chen; Hsieh, Hsiao-Yun; Kuo, Pao-Jen; Hsieh, Ching-Hua] Chang Gung Univ, Coll Med, Dept Plast Surg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan		Hsieh, CH (corresponding author), Chang Gung Univ, Coll Med, Dept Plast Surg, Kaohsiung Chang Gung Mem Hosp, Kaohsiung 833, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; libe320@yahoo.com.tw; VENU_CHIEN@hotmail.com; sylvia19870714@hotmail.com; bow110470@gmail.com; m93chinghua@gmail.com		WU, Shaochun/0000-0002-0984-6921; Hsieh, Ching-Hua/0000-0002-0945-2746	 [CMRPG8F0261]	We appreciated the Biostatistics Center, Kaohsiung Chang Gung Memorial Hospital for statistics work. This research was supported by a grant from CMRPG8F0261 for Ching-Hua Hsieh.	Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS62, DOI [10.2337/dc09-S062, 10.2337/dc11-S011, 10.2337/dc12-S064]; Bonizzoli M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-69; Bosarge PL, 2015, J TRAUMA ACUTE CARE, V79, P289, DOI 10.1097/TA.0000000000000716; Bosarge Patrick L, 2013, Adv Surg, V47, P287; Butcavage K, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e3182527656; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Cherian L, 1998, J NEUROTRAUM, V15, P307, DOI 10.1089/neu.1998.15.307; Gauglitz GG, 2008, J BURN CARE RES, V29, P683, DOI 10.1097/BCR.0b013e31818481ce; Hill J, 2010, J NEUROTRAUM, V27, P1439, DOI 10.1089/neu.2010.1328; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Kerby JD, 2012, ANN SURG, V256, P446, DOI 10.1097/SLA.0b013e3182654549; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC11, DOI 10.7860/JCDR/2016/17208.7686; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kramer AH, 2012, CRIT CARE, V16, DOI 10.1186/cc11812; Leto R, 2015, EUR J EMERG MED, V22, P99, DOI 10.1097/MEJ.0000000000000119; Marik PE, 2013, CRIT CARE MED, V41, pE93, DOI 10.1097/CCM.0b013e318283d124; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; Mraovic Boris, 2011, J Diabetes Sci Technol, V5, P412; Oddo M, 2008, CURR OPIN CLIN NUTR, V11, P134, DOI 10.1097/MCO.0b013e3282f37b43; Patrone C, 2014, LANCET DIABETES ENDO, V2, P256, DOI 10.1016/S2213-8587(13)70125-6; Prisco L, 2012, J NEUROSURG SCI, V56, P131; Rau CS, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101161; Ray B, 2017, WORLD NEUROSURG, V100, P208, DOI 10.1016/j.wneu.2017.01.008; Richards JE, 2013, J ORTHOP TRAUMA, V27, P16, DOI 10.1097/BOT.0b013e31825d60e5; Richards JE, 2012, J BONE JOINT SURG AM, V94A, P1181, DOI 10.2106/JBJS.K.00193; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Rovlias A, 2000, NEUROSURGERY, V46, P335, DOI 10.1097/00006123-200002000-00015; Salim A, 2009, AM SURGEON, V75, P25; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Scalea TM, 2007, ANN SURG, V246, P605, DOI 10.1097/SLA.0b013e318155a789; Smit JWA, 2006, SEMIN CARDIOTHORAC V, V10, P215, DOI 10.1177/1089253206291153; Sung J, 2005, J TRAUMA, V59, P80, DOI 10.1097/01.TA.0000171452.96585.84; Yang CJ, 2017, AM J EMERG MED, V35, P1240, DOI 10.1016/j.ajem.2017.03.049; YOUNG B, 1989, ANN SURG, V210, P466, DOI 10.1097/00000658-198910000-00007; Zygun DA, 2004, NEUROSURGERY, V55, P877, DOI 10.1227/01.NEU.0000137658.14906.E4	37	19	21	0	3	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1660-4601		INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2017	14	11							1340	10.3390/ijerph14111340			10	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FO1SQ	WOS:000416545200056	29099813	Green Published, gold, Green Submitted			2022-02-06	
J	Hellstrom, T; Westlye, LT; Kaufmann, T; Doan, NT; Soberg, HL; Sigurdardottir, S; Nordhoy, W; Helseth, E; Andreassen, OA; Andelic, N				Hellstrom, Torgeir; Westlye, Lars T.; Kaufmann, Tobias; Nhat Trung Doan; Soberg, Helene L.; Sigurdardottir, Solrun; Nordhoy, Wibeke; Helseth, Eirik; Andreassen, Ole A.; Andelic, Nada			White matter microstructure is associated with functional, cognitive and emotional symptoms 12 months after mild traumatic brain injury	SCIENTIFIC REPORTS			English	Article							MINOR HEAD-INJURY; POSTCONCUSSIVE SYNDROME; SPATIAL STATISTICS; DIFFUSION MRI; IMPAIRMENT; IMAGES; SCALE; NEUROPATHOLOGY; ABNORMALITIES; REGISTRATION	Identifying patients at risk of poor outcome after mild traumatic brain injury (MTBI) is essential to aid prognostics and treatment. Diffuse axonal injury (DAI) may be the primary pathologic feature of MTBI but is normally not detectable by conventional imaging technology. This lack of sensitivity of clinical imaging techniques has impeded a pathophysiologic understanding of the long-term cognitive and emotional consequences of MTBI, which often remain unnoticed and are attributed to factors other than the injury. Diffusion tensor imaging (DTI) is sensitive to microstructural properties of brain tissue and has been suggested to be a promising candidate for the detection of DAI in vivo. In this study, we report strong associations between brain white matter DTI and self-reported cognitive, somatic and emotional symptoms at 12 months post-injury in 134 MTBI patients. The anatomical distribution suggested global associations, in line with the diffuse symptomatology, although the strongest effects were found in frontal regions including the genu of the corpus callosum and the forceps minor. These findings support the hypothesis that DTI may provide increased sensitivity to the diffuse pathophysiology of MTBI and suggest an important role of advanced Magnetic Resonance Imaging (MRI) in trauma care.	[Hellstrom, Torgeir; Soberg, Helene L.; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway; [Hellstrom, Torgeir; Helseth, Eirik; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Westlye, Lars T.; Kaufmann, Tobias; Nhat Trung Doan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Westlye, Lars T.; Kaufmann, Tobias; Nhat Trung Doan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Westlye, Lars T.] Univ Oslo, Dept Psychol, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Nesoddtangen, Norway; [Nordhoy, Wibeke] Oslo Univ Hosp, Dept Diagnost Phys, Clin Radiol & Nucl Med, Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, Oslo, Norway; [Andelic, Nada] Univ Oslo, Inst Hlth & Soc, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Fac Med, Oslo, Norway		Hellstrom, T (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, Oslo, Norway.; Hellstrom, T (corresponding author), Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway.	torgeir.hellstrom@ous-hf.no	Helseth, Eirik/AAH-2466-2020; Hellstrom, Torgeir/AAY-6043-2021; Kaufmann, Tobias/M-8972-2017; Hellstrom, Torgeir/AAW-4301-2021; Andreassen, Ole A./AAY-7531-2020	Hellstrom, Torgeir/0000-0003-0831-3274; Kaufmann, Tobias/0000-0002-4003-1018; Andelic, Nada/0000-0002-3719-4406; Westlye, Lars T./0000-0001-8644-956X	Department of Physical Medicine and Rehabilitation, Oslo University Hospital; Research Council of NorwayResearch Council of Norway [204966/F20, 249795/F20]; South-Eastern Norway Regional Health Authority [2014097]; European Community's 7th Framework Programme (IMAGEMEND) [602450]	The authors thank all of the patients who participated in the study. We also thank radiographer Anne-Hilde Farstad for practical MRI assistance and the Department of Physical Medicine and Rehabilitation, Oslo University Hospital for institutional and financial support. The study was supported by research funding from Research Council of Norway (204966/F20, 249795/F20), the South-Eastern Norway Regional Health Authority (2014097), and European Community's 7th Framework Programme (602450, IMAGEMEND).	Andersson JLR, 2016, NEUROIMAGE, V141, P556, DOI 10.1016/j.neuroimage.2016.06.058; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; [Anonymous], 2014, R LANG ENV STAT COMP; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Bjornebekk A, 2013, NEUROIMAGE, V65, P194, DOI 10.1016/j.neuroimage.2012.10.009; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dikmen S, 2016, J NEUROTRAUMA; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Donovan J, 2014, CHIROPR MAN THER, V22, DOI 10.1186/s12998-014-0038-3; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Hellstrom T, 2016, BRAIN INJURY, V30, P1683, DOI 10.1080/02699052.2016.1199905; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lingsma HF, 2014, J NEUROTRAUMA; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Newcombe VFJ, 2015, NEUROREHABILITATION; Doan NT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45131; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Roalf DR, 2016, NEUROIMAGE, V125, P903, DOI 10.1016/j.neuroimage.2015.10.068; Sexton CE, 2014, J NEUROSCI, V34, P15425, DOI 10.1523/JNEUROSCI.0203-14.2014; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Spitz G., 2016, J NEUROTRAUMA; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; TEASDALE G, 1974, LANCET, V2, P81; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Westlye LT, 2011, ARCH GEN PSYCHIAT, V68, P369, DOI 10.1001/archgenpsychiatry.2011.24; Westlye LT, 2010, CEREB CORTEX, V20, P2055, DOI 10.1093/cercor/bhp280; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	72	19	19	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	OCT 23	2017	7								13795	10.1038/s41598-017-13628-1			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FK3QH	WOS:000413400500070	29061970	gold, Green Published			2022-02-06	
J	Kannan, G; Kambhampati, SP; Kudchadkar, SR				Kannan, Gokul; Kambhampati, Siva P.; Kudchadkar, Sapna R.			Effect of anesthetics on microglial activation and nanoparticle uptake: Implications for drug delivery in traumatic brain injury	JOURNAL OF CONTROLLED RELEASE			English	Article; Proceedings Paper	14th International Nanomedicine and Drug Delivery Symposium (NanoDDS)	SEP 16-18, 2016	Johns Hopkins Univ, Baltimore, MD		Johns Hopkins Univ		PENTOBARBITAL COMA; DENDRIMERS; CLEARANCE; NANOMEDICINE; THERAPY; PATHWAY; ADULT	Traumatic brain injury (TBI) is a serious public health problem, often with devastating consequences for patients and their families. Affordable and timely therapies can have a substantial impact on outcomes in severe TBI. Despite the common use of sedatives and anesthetics in the acute phase of TBI management, their effect on glial cells is not well understood. We investigated the effect of a commonly used sedative, pentobarbital, on glial cells and their uptake of nanoparticles. First, we studied how pentobarbital affects BV2 mouse microglial cells in culture. The cell morphology was imaged by confocal microscopy and analyzed. Our results suggest that microglia change to a more swollen, 'activated' shape with pentobarbital (cell area increased by approximately 20%, p < 0.001). Such glial activation may have negative implications for the ability of the injured brain to clear edema. Second, we investigated how pentobarbital treatment affected nanoparticle uptake. BV-2 mouse microglial cells in the presence and absence of pentobarbital were treated with fluorescently-labeled, hydroxyl-functionalized poly(amidoamine) dendrimer nanoparticles (Dendrimer-Cy5). We demonstrated that the presence of pentobarbital increased the dendrimer nanoparticle uptake significantly (similar to 2-fold both 2 and 6 h following treatment). This semi-quantitative fluorescence assessment was broadly consistent among confocal image analysis, flow cytometry, and fluorescence quantification of cell-extracted dendrimer-Cy5. Although anesthetics appear to activate microglia, the increased uptake of dendrimer nanoparticles in their presence can be exploited to deliver drug-loaded nanoparticles directly to microglia after TBI. These drugs could restore glial and glymphatic function, enabling efficient drainage of waste and fluid from the brain and effectively improving recovery after TBI. A key future direction is to validate these findings in TBI models.	[Kannan, Gokul] River Hill High Sch, Columbia, MD 21029 USA; [Kannan, Gokul; Kambhampati, Siva P.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Ctr Nanomed,Wilmer Eye Inst, Baltimore, MD 21205 USA; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA		Kudchadkar, SR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA.; Kudchadkar, SR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA.	skudcha1@jhmi.edu	Kudchadkar, Sapna R./AAT-2855-2020	Kudchadkar, Sapna R./0000-0003-3089-0318			Balakrishnan B, 2013, INT J NANOMED, V8, P4183, DOI 10.2147/IJN.S35979; Burd I, 2016, ADV PHARMACOL, V76, P85, DOI 10.1016/bs.apha.2016.02.003; Carney N, 2016, NEUROSURGERY; Cho Y, 2012, EXP NEUROL, V233, P126, DOI 10.1016/j.expneurol.2011.09.028; Cormio M, 1999, J NEUROTRAUM, V16, P927, DOI 10.1089/neu.1999.16.927; Dai H, 2010, NANOMEDICINE-UK, V5, P1317, DOI 10.2217/NNM.10.89; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Faul M, 2010, TRAUMATIC BRAIN INJU; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010; Iliff JJ, 2015, LANCET NEUROL, V14, P977, DOI 10.1016/S1474-4422(15)00221-5; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Impellizzeri D, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00458; Kambhampati SP, 2015, INVEST OPHTH VIS SCI, V56, P4413, DOI 10.1167/iovs.14-16250; Kambhampati SP, 2015, EUR J PHARM BIOPHARM, V95, P239, DOI 10.1016/j.ejpb.2015.02.013; Kannan RM, 2014, J INTERN MED, V276, P579, DOI 10.1111/joim.12280; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Koob A., 2009, ROOT THOUGHT UNLOCKI; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Lescot T., 2006, PRESSE MED PARIS FRA, V36, P1117; Lesniak WG, 2013, MOL PHARMACEUT, V10, P4560, DOI 10.1021/mp400371r; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Mastorakos P, 2015, NANOSCALE, V7, P3845, DOI 10.1039/c4nr04284k; Mendelsohn AR, 2013, REJUV RES, V16, P518, DOI 10.1089/rej.2013.1530; Mishra MK, 2014, ACS NANO, V8, P2134, DOI 10.1021/nn404872e; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Nakki R, 1996, EXP NEUROL, V137, P234, DOI 10.1006/exnr.1996.0022; Nance E, 2016, BIOMATERIALS, V101, P96, DOI 10.1016/j.biomaterials.2016.05.044; Nance E, 2015, J CONTROL RELEASE, V214, P112, DOI 10.1016/j.jconrel.2015.07.009; Nedergaard M, 2013, SCIENCE, V340, P1529, DOI 10.1126/science.1240514; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Remsen LG, 1999, ANESTH ANALG, V88, P559, DOI 10.1097/00000539-199903000-00018; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Tanaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082930; Tanaka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029378; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vutskits L, 2014, CURR PHARM DESIGN, V20, P4203; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yang LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-107	44	19	19	2	28	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-3659	1873-4995		J CONTROL RELEASE	J. Control. Release	OCT 10	2017	263				SI		192	199		10.1016/j.jconrel.2017.03.032			8	Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Chemistry; Pharmacology & Pharmacy	FH5JQ	WOS:000411202400020	28336376				2022-02-06	
J	Chari, A; Dasgupta, D; Smedley, A; Craven, C; Dyson, E; Matloob, S; Thompson, S; Thorne, L; Toma, AK; Watkins, L				Chari, Aswin; Dasgupta, Debayan; Smedley, Alexander; Craven, Claudia; Dyson, Edward; Matloob, Samir; Thompson, Simon; Thorne, Lewis; Toma, Ahmed K.; Watkins, Laurence			Intraparenchymal intracranial pressure monitoring for hydrocephalus and cerebrospinal fluid disorders	ACTA NEUROCHIRURGICA			English	Article						Intracranial pressure; Hydrocephalus; Cerebrospinal fluid dynamics	CHIARI MALFORMATION TYPE-1; SINGLE-CENTER EXPERIENCE; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; PULSATILE; HYPERTENSION; ADULTS; TRIAL	Elective intraparenchymal intracranial pressure (ICP) monitoring is useful for the diagnosis and treatment of hydrocephalus and cerebrospinal fluid (CSF) disorders. This retrospective study analyzes median ICP and pulse amplitude (PA) recordings in neurosurgically na < ve patients undergoing elective ICP monitoring for suspected CSF disorders. Retrospective review of prospectively collated database of neurosurgically na < ve patients undergoing elective ICP monitoring for suspected hydrocephalus and CSF disorders. Following extraction of the median ICP and PA values (separated into all, day and night time recordings), principal component analysis (PCA) was performed to identify the principal factors determining the spread of the data. Exploratory comparisons and correlations of ICP and PA values were explored, including by post hoc diagnostic groupings and age. A total of 198 patients were identified in six distinct diagnostic groups (n = 21-47 in each). The PCA suggested that there were two main factors accounting for the spread in the data, with 61.4% of the variance determined largely by the PA and 33.0% by the ICP recordings. Exploratory comparisons of PA and ICP between the diagnostic groups showed significant differences between the groups. Specifically, significant differences were observed in PA between a group managed conservatively and the Chiari/syrinx, IIH, and NPH/LOVA groups and in the ICP between the conservatively managed group and high-pressure, IIH, and low-pressure groups. Correlations between ICP and PA revealed some interesting trends in the different diagnostic groups and correlations between ICP, PA, and age revealed a decreasing ICP and increasing PA with age. This study provides insights into hydrodynamic disturbances in different diagnostic groups of patients with CSF hydrodynamic disorders. It highlights the utility of analyzing both median PA and ICP recordings, stratified into day and night time recordings.	[Chari, Aswin; Dasgupta, Debayan; Smedley, Alexander; Craven, Claudia; Dyson, Edward; Matloob, Samir; Thompson, Simon; Thorne, Lewis; Toma, Ahmed K.; Watkins, Laurence] Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England; [Chari, Aswin] Imperial Coll London, Fac Med, Div Brain Sci, London, England		Chari, A (corresponding author), Natl Hosp Neurol & Neurosurg, Victor Horsley Dept Neurosurg, Queen Sq, London WC1N 3BG, England.; Chari, A (corresponding author), Imperial Coll London, Fac Med, Div Brain Sci, London, England.	aswinchari@gmail.com	Watkins, Laurence/AAH-6973-2021	Watkins, Laurence/0000-0003-0678-3774; CRAVEN, CLAUDIA/0000-0002-6199-0090; Dasgupta, Debayan/0000-0002-1064-0541; Thompson, Simon/0000-0001-9575-9711; Thorne, Lewis/0000-0002-7692-0378			Andresen M, 2016, ACTA NEUROCHIR SUPPL, V122, P45, DOI 10.1007/978-3-319-22533-3_9; Andresen M, 2015, ACTA NEUROCHIR, V157, P109, DOI 10.1007/s00701-014-2250-2; Andresen M, 2014, J NEUROSURG, V121, P797, DOI 10.3171/2014.2.JNS132209; Chari A, 2015, FLUIDS BARRIERS CNS, V12, pO14, DOI DOI 10.1186/2045-8118-12-S1-O14; Chari A, 2014, J NEUROSURG, V120, P697, DOI 10.3171/2013.11.JNS121895; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Eide PK, 2016, WORLD NEUROSURG, V86, P186, DOI 10.1016/j.wneu.2015.09.067; Eide PK, 2011, CLIN NEUROL NEUROSUR, V113, P123, DOI 10.1016/j.clineuro.2010.10.008; Eide PK, 2010, NEUROSURGERY, V66, P80, DOI 10.1227/01.NEU.0000363408.69856.B8; Eide PK, 2003, ACTA NEUROL SCAND, V108, P381, DOI 10.1034/j.1600-0404.2003.00163.x; Fric R, 2016, J NEUROSURG, V24, P1, DOI DOI 10.3171/2016.4.JNS152862; Fric R, 2016, ACTA NEUROCHIR, V158, P2295, DOI 10.1007/s00701-016-2979-x; Fric R, 2016, ACTA NEUROCHIR, V158, P341, DOI 10.1007/s00701-015-2669-0; Fric R, 2015, ACTA NEUROCHIR, V157, P1411, DOI 10.1007/s00701-015-2465-x; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Matloob SA, 2015, FLUIDS BARRIERS CNS, V12, pO62; Matloob SA, 2015, ACTA NEUROCHIR, V157, P2099, DOI 10.1007/s00701-015-2600-8; Thompson SD, 2017, ACTA NEUROCHIR; Toma AK, 2010, J NEUROSURG, V113, P1326, DOI 10.3171/2010.8.JNS1067; Toma AK, 2010, BRIT J NEUROSURG, V24, P584, DOI 10.3109/02688697.2010.495169	21	19	19	2	8	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	OCT	2017	159	10					1967	1978		10.1007/s00701-017-3281-2			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FG2GK	WOS:000409907500020	28799016	hybrid, Green Published			2022-02-06	
J	Heneghan, JA; Pollack, MM				Heneghan, Julia A.; Pollack, Murray M.			Morbidity Changing the Outcome Paradigm for Pediatric Critical Care	PEDIATRIC CLINICS OF NORTH AMERICA			English	Article						Morbidity; Functional status; Quality; Outcomes; Outcomes research; Critical care; Pediatric critical care; Pediatric intensive care	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; FUNCTIONAL STATUS SCALE; RANDOMIZED CONTROLLED-TRIAL; CHILD HEALTH QUESTIONNAIRE; ADAPTIVE-BEHAVIOR SCALES; INTENSIVE-CARE; CRITICAL ILLNESS; PERFORMANCE CATEGORY; SURVEY FORM	The focus of critical care has evolved from saving lives to preservation of function. Morbidity rates in pediatric critical care are approximately double mortality rates. Morbidity includes complications of disease and medical care. In pediatric critical care, functional status morbidity is an intermediate outcome in the progression toward death and is the result of the same factors associated with mortality, including physiologic profiles and case-mix factors. The Functional Status Scale developed by Collaborative Pediatric Critical Care Research Network is a validated, granular, age-independent measure of functional status that has proved valuable and practical even in large outcome studies.	[Heneghan, Julia A.; Pollack, Murray M.] Childrens Natl Hlth Syst, Crit Care Med, 111 Michigan Ave Northwest, Washington, DC 20010 USA; [Pollack, Murray M.] George Washington Univ, Crit Care Med, Childrens Natl Hlth Syst, Sch Med & Hlth Sci,Dept Pediat, 111 Michigan Ave Northwest, Washington, DC 20010 USA		Pollack, MM (corresponding author), Childrens Natl Hlth Syst, Crit Care Med, 111 Michigan Ave Northwest, Washington, DC 20010 USA.; Pollack, MM (corresponding author), George Washington Univ, Crit Care Med, Childrens Natl Hlth Syst, Sch Med & Hlth Sci,Dept Pediat, 111 Michigan Ave Northwest, Washington, DC 20010 USA.	mpollack@childrensnational.org			NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [UG1 HD049981, U10 HD063114, U10 HD049981] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [UG1HD049981, U10HD049981, U10HD063114] Funding Source: NIH RePORTER		Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Als LC, 2015, CRIT CARE MED, V43, pE312, DOI 10.1097/CCM.0000000000001075; Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Amer Coll of Surgeon, 2015, AM COLL SURGEON; Aspesberro F, 2015, INTENS CARE MED, V41, P1235, DOI 10.1007/s00134-015-3780-7; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bennett TD, 2016, PEDIATR CRIT CARE ME, V17, P1147, DOI 10.1097/PCC.0000000000000934; Berger JT, 2017, J THORAC CARDIOVASC; Bone MF, 2014, PEDIATR CRIT CARE ME, V15, P640, DOI 10.1097/PCC.0000000000000199; Boyd JM, 2016, ANN SURG; Committee on the future of emergency care, 2006, FUT EM CAR EM CAR CH; Davydow DS, 2010, ARCH PEDIAT ADOL MED, V164, P377, DOI 10.1001/archpediatrics.2010.10; Drotar D, 2006, J PEDIATR PSYCHOL, V31, P127, DOI 10.1093/jpepsy/jsi078; Dumas Helene M, 2004, Pediatr Phys Ther, V16, P157, DOI 10.1097/01.PEP.0000136004.69289.01; Ebrahim S, 2013, PEDIATR CRIT CARE ME, V14, P10, DOI 10.1097/PCC.0b013e31825b64b3; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Gabbe BJ, 2011, J TRAUMA, V70, P1532, DOI 10.1097/TA.0b013e31820e8546; Harrison P.L., 2003, ABAS 2 ADAPTIVE BEHA, V2nd ed.; Jacobs ML, 2013, J THORAC CARDIOV SUR, V145, P1046, DOI 10.1016/j.jtcvs.2012.06.029; Jardine J, 2014, PEDIATRICS, V134, pE1129, DOI 10.1542/peds.2014-0352; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kronman MP, 2008, PEDIATRICS, V121, pE1653, DOI 10.1542/peds.2007-2831; Larsen GY, 2016, NEUROCRIT CARE, V24, P353, DOI 10.1007/s12028-015-0218-6; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; Moler FW, 2015, NEW ENGL J MED, V372, P1898, DOI 10.1056/NEJMoa1411480; Namachivayam P, 2010, PEDIATR CRIT CARE ME, V11, P549, DOI 10.1097/PCC.0b013e3181ce7427; Ong C, 2016, PEDIATR CRIT CARE ME, V17, pE247, DOI 10.1097/PCC.0000000000000706; Pinto NP, 2017, PEDIATR CRIT CARE ME, V18, pE122, DOI 10.1097/PCC.0000000000001070; Polinder S, 2005, PEDIATRICS, V116, pE810, DOI 10.1542/peds.2005-1035; POLLACK MM, 1987, NEW ENGL J MED, V316, P134, DOI 10.1056/NEJM198701153160304; Pollack MM, 2016, PEDIATR CRIT CARE ME, V17, P2, DOI 10.1097/PCC.0000000000000558; Pollack MM, 2015, CRIT CARE MED, V43, P1699, DOI 10.1097/CCM.0000000000001081; Pollack MM, 2014, PEDIATR CRIT CARE ME, V15, P821, DOI 10.1097/PCC.0000000000000250; Pollack MM, 2014, JAMA PEDIATR, V168, P671, DOI 10.1001/jamapediatrics.2013.5316; Pollack MM, 2009, PEDIATRICS, V124, pE18, DOI 10.1542/peds.2008-1987; Raat H, 2002, J CLIN EPIDEMIOL, V55, P67, DOI 10.1016/S0895-4356(01)00411-5; RAGGIO DJ, 1993, PERCEPT MOTOR SKILL, V77, P931, DOI 10.2466/pms.1993.77.3.931; RAGGIO DJ, 1994, PERCEPT MOTOR SKILL, V79, P203, DOI 10.2466/pms.1994.79.1.203; Ridgeon EE, 2016, CRIT CARE MED, V44, P1278, DOI 10.1097/CCM.0000000000001670; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sparrow SS., 2005, VINELAND 2 VINELAND; Varni JW, 2011, QUAL LIFE RES, V20, P45, DOI 10.1007/s11136-010-9730-5; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812	47	19	20	0	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0031-3955	1557-8240		PEDIATR CLIN N AM	Pediatr. Clin. N. Am.	OCT	2017	64	5					1147	+		10.1016/j.pcl.2017.06.011			20	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	FL5KI	WOS:000414275300014	28941541	Green Accepted			2022-02-06	
J	Mountney, A; Boutte, AM; Cartagena, CM; Flerlage, WF; Johnson, WD; Rho, C; Lu, XC; Yarnell, A; Marcsisin, S; Sousa, J; Vuong, C; Zottig, V; Leung, LY; Deng-Bryant, Y; Gilsdorf, J; Tortella, FC; Shear, DA				Mountney, Andrea; Boutte, Angela M.; Cartagena, Casandra M.; Flerlage, William F.; Johnson, Wyane D.; Rho, Chanyang; Lu, Xi-Chu; Yarnell, Angela; Marcsisin, Sean; Sousa, Jason; Chau Vuong; Zottig, Victor; Leung, Lai-Yee; Deng-Bryant, Ying; Gilsdorf, Janice; Tortella, Frank C.; Shear, Deborah A.			Functional and Molecular Correlates after Single and Repeated Rat Closed-Head Concussion: Indices of Vulnerability after Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ataxia; CatWalk; chronic traumatic encephalopathy; concussion; GFAP; mild TBI; Neurobehavioral Severity Scale-Revised; quantitative electroencephalography; rodent gait; tau	TRANSIENT FOCAL ISCHEMIA; COLLEGIATE FOOTBALL PLAYERS; US MILITARY PERSONNEL; CEREBROSPINAL-FLUID; MOUSE MODEL; MATRIX METALLOPROTEINASES; INTRACRANIAL LESIONS; MICRORNA EXPRESSION; GAIT ABNORMALITIES; BALANCE ASSESSMENT	Closed-head concussive injury is one of the most common causes of traumatic brain injury (TBI). Isolated concussions frequently produce acute neurological impairments, and individuals typically recover spontaneously within a short time frame. In contrast, brain injuries resulting from multiple concussions can result in cumulative damage and elevated risk of developing chronic brain pathologies. Increased attention has focused on identification of diagnostic markers that can prognostically serve as indices of brain health after injury, revealing the temporal profile of vulnerability to a second insult. Such markers may demarcate adequate recovery periods before concussed patients can return to required activities. We developed a noninvasive closed-head impact model that captures the hallmark symptoms of concussion in the absence of gross tissue damage. Animals were subjected to single or repeated concussive impact and examined using a battery of neurological, vestibular, sensorimotor, and molecular metrics. A single concussion induced transient, but marked, acute neurological impairment, gait alterations, neuronal death, and increased glial fibrillary acidic protein (GFAP) expression in brain tissue. As expected, repeated concussions exacerbated sensorimotor dysfunction, prolonged gait abnormalities, induced neuroinflammation, and upregulated GFAP and tau. These animals also exhibited chronic functional neurological impairments with sustained astrogliosis and white matter thinning. Acute changes in molecular signatures correlated with behavioral impairments, whereas increased times to regaining consciousness and balance impairments were associated with higher GFAP and neuroinflammation. Overall, behavioral consequences of either single or repeated concussive impact injuries appeared to resolve more quickly than the underlying molecular, metabolic, and neuropathological abnormalities. This observation, which is supported by similar studies in other mTBI models, underscores the critical need to develop more objective prognostic measures for guiding return-to-play decisions.	[Mountney, Andrea; Boutte, Angela M.; Cartagena, Casandra M.; Flerlage, William F.; Johnson, Wyane D.; Rho, Chanyang; Lu, Xi-Chu; Leung, Lai-Yee; Deng-Bryant, Ying; Gilsdorf, Janice; Tortella, Frank C.; Shear, Deborah A.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Yarnell, Angela] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Behav Biol Branch, Silver Spring, MD USA; [Marcsisin, Sean; Sousa, Jason; Chau Vuong; Zottig, Victor] Walter Reed Army Inst Res, Mil Malaria Res, Div Expt Therapeut, Silver Spring, MD USA		Mountney, A (corresponding author), Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	andrea.mountney.mil@mail.mil	Sousa, Jason/A-9177-2011		United States Army grants [W81XWH-12-2-0134, H_024_2014_WRAIR]	This research was supported by United States Army grants W81XWH-12-2-0134 and H_024_2014_WRAIR. The authors are grateful to Weihong Yang, Ying Cao, Matthew Wise, and the Walter Reed Army Institute of Research Pathology Department for their technical assistance. This material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting true views of Department of the Army or Department of Defense.	Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Allison L., 1999, NEUROL REP, V23, P14; Almeida-Suhett CP, 2014, J NEUROTRAUM, V31, P683, DOI 10.1089/neu.2013.3029; [Anonymous], 1995, GAIT POSTURE; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; Benedetti MG, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-64; Bey T, 2009, WEST J EMERG MED, V10, P6; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chen ZY, 2012, J NEUROTRAUM, V29, P268, DOI 10.1089/neu.2011.2057; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Deng-Bryant Y, 2016, METHODS MOL BIOL, V1462, P539, DOI 10.1007/978-1-4939-3816-2_29; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fischer H., 2014, GUIDE US MILITARY CA, P1; Freilich RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079416; Gao HB, 2017, BRAIN RES, V1657, P1, DOI 10.1016/j.brainres.2016.11.028; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; Huang L, 2013, BRAIN RES, V1499, P109, DOI 10.1016/j.brainres.2012.12.038; Iverson D, 2010, J OCCUP ENVIRON MED, V52, P1206, DOI 10.1097/JOM.0b013e3181fd276a; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jia LH, 2015, CELL BIOCHEM FUNCT, V33, P314, DOI 10.1002/cbf.3116; Johnson D, 2015, J NEUROTRAUM, V32, pA36; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Katayama T, 2009, J PHARMACOL SCI, V109, P88, DOI 10.1254/jphs.08298FP; Khalin I, 2016, NEURAL REGEN RES, V11, P630, DOI 10.4103/1673-5374.180749; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Lee MA, 1999, BRAIN, V122, P191, DOI 10.1093/brain/122.2.191; Leung LY, 2014, ANN BIOMED ENG, V42, P1618, DOI 10.1007/s10439-014-1014-8; Lorenzl S, 2003, J NEUROL SCI, V207, P71, DOI 10.1016/S0022-510X(02)00398-2; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; Madathil SK, 2011, BIOESSAYS, V33, P21, DOI 10.1002/bies.201000069; Maier B, 2006, SHOCK, V26, P122, DOI 10.1097/01.shk.0000223127.41641.f4; Mancini M, 2010, EUR J PHYS REHAB MED, V46, P239; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McAteer KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160220; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miyauchi T, 2014, J NEUROTRAUM, V31, P773, DOI 10.1089/neu.2013.3181; Modarres M, 2016, NEUROBIOL SLEEP CIRC, V1; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Phillips DJ, 2006, J NEUROTRAUM, V23, P1283, DOI 10.1089/neu.2006.23.1283; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; Rubenstein R, 2015, J NEUROTRAUM, V32, P342, DOI 10.1089/neu.2014.3548; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; SWASH M, 1988, J NEUROL NEUROSUR PS, V51, P785, DOI 10.1136/jnnp.51.6.785; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; TEBANO MT, 1988, ELECTROEN CLIN NEURO, V70, P185, DOI 10.1016/0013-4694(88)90118-6; TERASHIMA T, 1995, NEUROSCI RES, V22, P139, DOI 10.1016/0168-0102(95)00895-9; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thatcher RW, 1998, NEUROIMAGE, V8, P307, DOI 10.1006/nimg.1998.0365; Thompson J, 2005, NEUROSCI LETT, V377, P158, DOI 10.1016/j.neulet.2004.11.090; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tsai MC, 2008, SURG NEUROL, V70, P19, DOI 10.1016/j.surneu.2007.09.033; Underwood E, 2013, SCIENCE, V339, P1367, DOI 10.1126/science.339.6126.1367; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Watts RP, 2013, J TRANSPLANT, V2013, DOI 10.1155/2013/521369; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Weil ZM, 2014, NEUROBIOL DIS, V70, P108, DOI 10.1016/j.nbd.2014.06.016; Weinstein E, 2013, J NEUROSURG-PEDIATR, V11, P331, DOI 10.3171/2012.11.PEDS12343; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Yarnell Angela M, 1800, Curr Protoc Neurosci, V75, DOI 10.1002/cpns.10; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zemlan FP, 2002, BRAIN RES, V947, P131, DOI 10.1016/S0006-8993(02)02920-7; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zheng KB, 2013, NEUROL INDIA, V61, P606, DOI 10.4103/0028-3886.125258; Zuckerman SL, 2015, WORLD NEUROSURG, V83, P1098, DOI 10.1016/j.wneu.2014.12.030	133	19	19	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2017	34	19					2768	2789		10.1089/neu.2016.4679			22	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI1DZ	WOS:000411672700012	28326890				2022-02-06	
J	Quinn, T; Moskowitz, J; Khan, MW; Shutter, L; Goldberg, R; Col, N; Mazor, KM; Muehlschlegel, S				Quinn, Thomas; Moskowitz, Jesse; Khan, Muhammad W.; Shutter, Lori; Goldberg, Robert; Col, Nananda; Mazor, Kathleen M.; Muehlschlegel, Susanne			What Families Need and Physicians Deliver: Contrasting Communication Preferences Between Surrogate Decision-Makers and Physicians During Outcome Prognostication in Critically Ill TBI Patients	NEUROCRITICAL CARE			English	Article						Shared decision making; Goals-of-care decisions; Decision aid; Qualitative research; Traumatic brain injury; Critical care; Surrogate decision-maker	TRAUMATIC BRAIN-INJURY; CARE; AIDS; WITHDRAWAL; FRAMEWORK; MEMBERS	Surrogate decision-makers ("surrogates") and physicians of incapacitated patients have different views of prognosis and how it should be communicated, but this has not been investigated in neurocritically ill patients. We examined surrogates' communication preferences and physicians' practices during the outcome prognostication for critically ill traumatic brain injury (ciTBI) patients in two level-1 trauma centers and seven academic medical centers in the USA. We used qualitative content analysis and descriptive statistics of transcribed interviews to identify themes in surrogates (n = 16) and physicians (n = 20). The majority of surrogates (82%) preferred numeric estimates describing the patient's prognosis, as they felt it would increase prognostic certainty, and limit the uncertainty perceived as frustrating. Conversely, 75% of the physicians reported intentionally omitting numeric estimates during prognostication meetings due to low confidence in family members' abilities to appropriately interpret probabilities, worry about creating false hope, and distrust in the accuracy and data quality of existing TBI outcome models. Physicians felt that these models are for research only and should not be applied to individual patients. Surrogates valued compassion during prognostication discussions, and acceptance of their goals-of-care decision by clinicians. Physicians and surrogates agreed on avoiding false hope. We identified fundamental differences in the communication preferences of prognostic information between ciTBI patient surrogates and physicians. These findings inform the content of a future decision aid for goals-of-care discussions in ciTBI patients. If validated, these findings may have important implications for improving communication practices in the neurointensive care unit independent of whether a formal decision aid is used.	[Quinn, Thomas; Moskowitz, Jesse; Khan, Muhammad W.; Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Neurol Neurocrit Care, 55 Lake Ave North,S-5, Worcester, MA 01655 USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Goldberg, Robert] Univ Massachusetts, Med Sch, Dept Quantitat Hlth Sci, Worcester, MA USA; [Col, Nananda] Shared Decis Making Resources, Georgetown, ME USA; [Mazor, Kathleen M.] Univ Massachusetts, Med Sch, Meyers Primary Care Inst, Worcester, MA USA; [Mazor, Kathleen M.] Univ Massachusetts, Med Sch, Dept Internal Med, Worcester, MA USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Anesthesiol Crit Care, Worcester, MA 01655 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Med Sch, Dept Surg, Worcester, MA 01655 USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Neurol Neurocrit Care, 55 Lake Ave North,S-5, Worcester, MA 01655 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Anesthesiol Crit Care, Worcester, MA 01655 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Med Sch, Dept Surg, Worcester, MA 01655 USA.	susanne.muehlschlegel@umassmemorial.org	Col, Nananda/AAE-3445-2019; Shutter, Lori A/G-2957-2013	Muehlschlegel, Susanne/0000-0002-5717-9246; Shutter, Lori/0000-0002-1390-0628; Col, Nananda/0000-0001-7106-662X	NIH/NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [5K23HD080971]; University of Massachusetts Medical School Center for Clinical and Translational Science - NIH Clinical and Translational Science Award [UL1TR000161]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000161] Funding Source: NIH RePORTER	Funded by NIH/NICHD Grant 5K23HD080971 (PI Muehlschlegel). This project was additionally supported by the University of Massachusetts Medical School Center for Clinical and Translational Science which is funded by the NIH Clinical and Translational Science Award to the University of Massachusetts Medical School (UL1TR000161).	Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Boyd EA, 2010, CRIT CARE MED, V38, P1270, DOI 10.1097/CCM.0b013e3181d8a217; Char SJL, 2010, AM J RESP CRIT CARE, V182, P905, DOI 10.1164/rccm.201002-0262OC; Col N., 2011, SHARED DECISION MAKI; Cox CE, 2012, CRIT CARE MED, V40, P2327, DOI 10.1097/CCM.0b013e3182536a63; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Fagerlin A, 2007, MED DECIS MAKING, V27, P672, DOI 10.1177/0272989x07304449; Gerteis M, 1993, PATIENTS EYES UNDERS, V1st; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Kon AA, 2016, CRIT CARE MED, V44, P188, DOI 10.1097/CCM.0000000000001396; Legare F, 2006, CAN FAM PHYSICIAN, V52, P476; Legare F, 2006, MED DECIS MAKING, V26, P373, DOI 10.1177/0272989X06290492; McAdam JL, 2012, AM J CRIT CARE, V21, P386, DOI 10.4037/ajcc2012582; Muehlschlegel S, 2015, NEUROCRIT CARE, V23, P127, DOI 10.1007/s12028-014-0097-2; O'Connor AM, 2007, HEALTH AFFAIR, V26, P716, DOI 10.1377/hlthaff.26.3.716; OHRI Ottawa Hospital Research Institute, DEC DEV TOOLK; Ottawa Hospital Research Institute, 2014, DDEC AID IMPL TOOLK; Skrobik Y, 2006, CAN J ANAESTH, V53, P432, DOI 10.1007/BF03022613; Stacey D, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub4, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub2]; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; White DB, 2010, MED DECIS MAKING, V30, P76, DOI 10.1177/0272989X08317012	24	19	19	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2017	27	2					154	162		10.1007/s12028-017-0427-2			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FJ4VC	WOS:000412739900002	28685395	Green Accepted			2022-02-06	
J	Wong, AWK; Ng, S; Dashner, J; Baum, MC; Hammel, J; Magasi, S; Lai, JS; Carlozzi, NE; Tulsky, DS; Miskovic, A; Goldsmith, A; Heinemann, AW				Wong, Alex W. K.; Ng, Sheryl; Dashner, Jessica; Baum, M. Carolyn; Hammel, Joy; Magasi, Susan; Lai, Jin-Shei; Carlozzi, Noelle E.; Tulsky, David S.; Miskovic, Ana; Goldsmith, Arielle; Heinemann, Allen W.			Relationships between environmental factors and participation in adults with traumatic brain injury, stroke, and spinal cord injury: a cross-sectional multi-center study	QUALITY OF LIFE RESEARCH			English	Article						Environment; Participation; Stroke; Spinal cord injury; Traumatic brain injury	INSIDER PERSPECTIVE; AFFECTING PERSONS; UNITED-STATES; NIH TOOLBOX; DISABILITIES; PEOPLE; BARRIERS; CLASSIFICATION; INFORMATION; STANDARDS	To develop and evaluate a model of environmental factors-participation relationships for persons with traumatic brain injury (TBI), stroke, and spinal cord injury (SCI), and test whether this model differed across three diagnostic groups, as well as other demographic and clinical characteristics. A cross-sectional observational study included 545 community-dwelling adults with neurological disorders (TBI = 166; stroke = 189; SCI = 190) recruited at three academic medical centers. Participants completed patient-reported measures of environmental factors and participation. The final structural equation model had acceptable fit to the data (CFI = 0.923; TLI = 0.898; RMSEA = 0.085; SRMR = 0.053), explaining 63% of the variance in participation in social roles and activities. Systems, services, and policies had an indirect influence on participation and this relation was mediated by social attitudes and the built and natural environment. Access to information and technology was associated with the built and natural environment which in turn influence on participation (ps < 0.001). The model was consistent across sex, diagnosis, severity/type of injury, education, race, age, marital status, years since injury, wheelchairs use, insurance coverage, personal or household income, and crystallized cognition. Social and physical environments appear to mediate the influence of systems, services, and policies on participation after acquired neurological disorders. These relations are stable across three diagnostic groups and many personal and clinical factors. Our findings inform health and disability policy, and provide guidance for implementing the initiatives in Healthy People 2020 in particular for people with acquired neurological disorders.	[Wong, Alex W. K.; Ng, Sheryl; Dashner, Jessica] Washington Univ, Sch Med, Program Occupat Therapy, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA; [Wong, Alex W. K.; Dashner, Jessica] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Ng, Sheryl] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Baum, M. Carolyn] Washington Univ, Dept Neurol, Program Occupat Therapy, St Louis, MO USA; [Baum, M. Carolyn] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO 63130 USA; [Hammel, Joy; Magasi, Susan] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Hammel, Joy] Univ Illinois, Dept Disabil & Human Dev, Chicago, IL USA; [Lai, Jin-Shei] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Lai, Jin-Shei] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA; [Carlozzi, Noelle E.] Univ Michigan, Dept Phys Med & Rehabil, Sch Med, Ann Arbor, MI 48109 USA; [Tulsky, David S.] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Miskovic, Ana; Goldsmith, Arielle; Heinemann, Allen W.] Rehabil Inst Chicago, Ctr Rehabil Outcomes Res, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Dept Phys Med & Rehabil, Feinberg Sch Med, Chicago, IL 60611 USA		Wong, AWK (corresponding author), Washington Univ, Sch Med, Program Occupat Therapy, 4444 Forest Pk Ave,Campus Box 8505, St Louis, MO 63108 USA.; Wong, AWK (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wongal@wustl.edu; ephsnhx@nus.edu.sg; dashnerj@wustl.edu; baumc@wustl.edu; hammel@uic.edu; smagas1@uic.edu; js-lai@northwestern.edu; carlozzi@med.umich.edu; dtulsky@udel.edu; amiskovic@ric.org; agoldsmith@ric.org; a-heinemann@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326; Wong, Alex/0000-0002-4423-2685; Ng, Sheryl/0000-0001-5046-2666; Tulsky, David/0000-0002-4335-4509	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services; Administration on Community Living; U.S. Department of Health and Human Services [H133B090024, H133F140037]; Craig H. Neilsen Foundation [290474]	This study was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, the Administration on Community Living, the U.S. Department of Health and Human Services to the Rehabilitation Institute of Chicago (Grant No. H133B090024) and to Washington University in St. Louis (Grant No. H133F140037), and by the Craig H. Neilsen Foundation to Washington University in St. Louis (Grant No. 290474).	ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; BAILEY IL, 1976, AM J OPTOM PHYS OPT, V53, P740; Berkman LF., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI [10.1016/S0277-9536(00)00065-4, DOI 10.4135/9781412952576.N192]]; Bricout JC, 2006, SCAND J DISABIL RES, V8, P1, DOI 10.1080/15017410500335229; Bronfenbrenner U., 1999, MEASURING ENV LIFE S, P3, DOI [DOI 10.1037/10317-001, 10.1037/10317-001]; Browne MW, 1993, SAGE FOCUS EDITIONS, V154, P136, DOI DOI 10.1177/0049124192021002005; Casaletto KB, 2015, J INT NEUROPSYCH SOC, V21, P378, DOI 10.1017/S1355617715000351; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Enderby PM, 1986, DISABIL REHABIL, V8, P166, DOI DOI 10.3109/03790798709166209; Field M.J., 2007, FUTURE DISABILITY AM; Garcia SF, 2015, ARCH PHYS MED REHAB, V96, P596, DOI 10.1016/j.apmr.2014.06.019; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P2231, DOI 10.1001/jama.2015.6405; Gray JA, 2012, DISABIL HEALTH J, V5, P87, DOI 10.1016/j.dhjo.2011.12.002; Hahn EA, 2016, ARCH PHYS MED REHAB, V97, P1284, DOI 10.1016/j.apmr.2016.01.027; Hahn EA, 2010, QUAL LIFE RES, V19, P1035, DOI 10.1007/s11136-010-9654-0; Hammel J, 2008, DISABIL REHABIL, V30, P1445, DOI 10.1080/09638280701625534; Hammel J, 2006, TOP STROKE REHABIL, V13, P43, DOI 10.1310/5X2G-V1Y1-TBK7-Q27E; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Heinemann AW, 2016, ARCH PHYS MED REHAB, V97, P2113, DOI 10.1016/j.apmr.2016.05.021; Heinemann AW, 2016, QUAL LIFE RES, V25, P2775, DOI 10.1007/s11136-016-1314-6; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Hobart JC, 2007, LANCET NEUROL, V6, P1094, DOI 10.1016/S1474-4422(07)70290-9; Hollingsworth H, 2010, ARCH PHYS MED REHAB, V91, P1174, DOI 10.1016/j.apmr.2010.04.019; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iezzoni LI, 2008, JAMA-J AM MED ASSOC, V299, P332, DOI 10.1001/jama.299.3.332; Keysor JJ, 2005, J REHABIL MED, V37, P37, DOI 10.1080/16501970410014830; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; Lai JS, 2016, ARCH PHYS MED REHAB, V97, P2102, DOI 10.1016/j.apmr.2016.06.010; Lawson, 2006, SYRACUSE J INT LAW C, V34, P563; Magasi S, 2015, ARCH PHYS MED REHAB, V96, P569, DOI 10.1016/j.apmr.2014.12.002; National Council on Disability, 2015, US CEL 25 ANN AM DIS; National Spinal Cord Injury Statistical Center, 2016, FACTS FIG GLANC FACTS FIG GLANC; Office of Disease Prevention and Health Promotion, 2014, HLTH PEOPL 2020; Schulz A, 2004, HEALTH EDUC BEHAV, V31, P455, DOI 10.1177/1090198104265598; Stiens SA, 2002, ARCH PHYS MED REHAB, V83, pS72, DOI 10.1053/apmr.2002.32178; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Traumatic Brain Injury Model Systems National Data Center, 2006, TRAUM BRAIN INJ MOD; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; W.H. Organization, 2006, NEUR DIS PUBL HLTH C; Wang J., 2020, STRUCTURAL EQUATION, V2nd; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Weltgesundheitsorganisation, 2015, WHO GLOB DIS ACT PLA; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; Whiteneck GG, 2004, J HEAD TRAUMA REHAB, V19, P191, DOI 10.1097/00001199-200405000-00001; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; World Health Organization, 2007, INT CLASS FUNCT DIS	50	19	20	1	17	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	OCT	2017	26	10					2633	2645		10.1007/s11136-017-1586-5			13	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	FH1MS	WOS:000410904700005	28444554				2022-02-06	
J	Westerhof-Evers, HJ; Visser-Keizer, AC; Fasotti, L; Schonherr, MC; Vink, M; van der Naalt, J; Spikman, JM				Westerhof-Evers, Herma J.; Visser-Keizer, Annemarie C.; Fasotti, Luciano; Schonherr, Marleen C.; Vink, Martie; van der Naalt, Joukje; Spikman, Jacoba M.			Effectiveness of a Treatment for Impairments in Social Cognition and Emotion Regulation (T-ScEmo) After Traumatic Brain Injury: A Randomized Controlled Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affect recognition; emotion perception; social behavior; social cognition; social skills; TBI; ToM	ECOLOGICALLY VALID TEST; PERCEPTION DEFICITS; RECOGNITION; LIFE; HEALTH; ADULTS; SKILLS; MIND; METAANALYSIS; MARRIAGE	Objective: To evaluate the effects of a multifaceted Treatment for Social cognition and Emotion regulation (T-ScEmo) in patients with a traumatic brain injury. Participants: Sixty-one patients with moderate to severe traumatic brain injury randomly assigned to an experimental T-ScEmo intervention or a Cogniplus control condition. Interventions: T-ScEmo is a compensatory strategy training for impairments in emotion recognition, theory of mind, and social behavioral skills. Cogniplus is a computerized cognitive function training. Both interventions were given in 16 to 20 weekly 1-hour sessions. Main Measures: Social cognition tests and questionnaires for social behavior (self-and proxy-rated) administered at baseline, immediately posttreatment, and at 3 to 5 months of follow-up. Results: Compared with the Cogniplus group, the T-ScEmo group improved significantly on facial affect recognition, theory of mind, proxy-rated empathic behavior, societal participation, and treatment goal attainment, which lasted up to 5 months after treatment. At follow-up, the T-ScEmo group also reported higher quality of life and their life partners rated relationship quality to be higher than the Cogniplus group. Conclusion: This study shows that impairments in social cognition can be effectively dealt with by using a comprehensive treatment protocol, leading to improvements in everyday life social functioning.	[Westerhof-Evers, Herma J.; Spikman, Jacoba M.] Univ Groningen, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands; [Westerhof-Evers, Herma J.; Schonherr, Marleen C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands; [Visser-Keizer, Annemarie C.; van der Naalt, Joukje; Spikman, Jacoba M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Fasotti, Luciano] Klimmendaal Rehabil Ctr, Arnhem, Netherlands; [Vink, Martie] Reade Rehabil Ctr, Amsterdam, Netherlands		Westerhof-Evers, HJ (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Grote Kruisstr 2-1, NL-9712 TS Groningen, Netherlands.	h.j.evers@rug.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418			Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Beck R, 1998, COGNITIVE THER RES, V22, P63, DOI 10.1023/A:1018763902991; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Bookwala J, 2005, J AGING HEALTH, V17, P85, DOI 10.1177/0898264304272794; Bornhofen C, 2008, J HEAD TRAUMA REHAB, V23, P103, DOI 10.1097/01.HTR.0000314529.22777.43; Brooks N., 1984, HEAD INJURY FAMILY, P148; Burgess P, 1996, BEHAV ASSESSMENT DYS; Cantagallo, 2003, Z NEUROPSYCHOL, V14, P283, DOI [10.1024/1016-264X.14.4.283, DOI 10.1024/1016-264X.14.4.283]; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Deelman B, 1980, NEUROPSYCHOLOGIE NED; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; DYWAN J, 1995, J INT NEUROPSYCH SOC, V1, P121; Emmanouel A, 2014, BRAIN INJURY, V28, P1581, DOI 10.3109/02699052.2014.942371; ERNST E, 1995, BMJ-BRIT MED J, V311, P551, DOI 10.1136/bmj.311.7004.551; FALLOWFIELD L, 1990, QUALITY LIFE MISSING; Felmingham KL, 2001, ARCH PHYS MED REHAB, V82, P435, DOI 10.1053/apmr.2001.21985; Gabbatore I, 2015, J HEAD TRAUMA REHAB, V30, pE14, DOI 10.1097/HTR.0000000000000087; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Guercio JM, 2004, BRAIN INJURY, V18, P593, DOI 10.1080/02699050310001646116; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Harwood MD, 2006, BRIT J DEV PSYCHOL, V24, P401, DOI 10.1348/026151005X50302; HELFFENSTEIN DA, 1982, INT J CLIN NEUROPSYC, V4, P139; Hoofien D, 2001, BRAIN INJURY, V15, P189; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Kiecolt-Glaser JK, 2001, PSYCHOL BULL, V127, P472, DOI 10.1037//0033-2909.127.4.472; Lamberts KF, 2010, J CLIN EXP NEUROPSYC, V32, P56, DOI 10.1080/13803390902806550; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Neumann D, 2015, J HEAD TRAUMA REHAB, V30, pE12, DOI 10.1097/HTR.0000000000000054; Radice-Neumann D, 2009, J HEAD TRAUMA REHAB, V24, P313, DOI 10.1097/HTR.0b013e3181b09160; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RIGGIO RE, 1989, PERS INDIV DIFFER, V10, P93, DOI 10.1016/0191-8869(89)90184-0; Robertson I., 1994, TEST EVERYDAY ATTENT; Saxton ME, 2013, NEUROREHABILITATION, V33, P263, DOI 10.3233/NRE-130954; Schmand BL., 1992, NEDERLANDSE LEESLIJS NEDERLANDSE LEESTEST; Spikman JM, 2016, J NEUROTRAUM, V33, P22, DOI 10.1089/neu.2014.3788; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Struchen MA, 2014, HDB NEUROPSYCHOLOGY, P213, DOI DOI 10.1007/978; TURNER JA, 1994, JAMA-J AM MED ASSOC, V271, P1609, DOI 10.1001/jama.271.20.1609; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; Westerhof-Evers HJ, 2014, J CLIN EXP NEUROPSYC, V36, P1031, DOI 10.1080/13803395.2014.966661; Winegardner J, 2016, NEUROREHABILITATION, V39, P153, DOI 10.3233/NRE-161347; Ylvisaker M, 2007, BRAIN INJURY, V21, P769, DOI 10.1080/02699050701482470; Ylvisaker Mark, 2005, Seminars in Speech and Language, V26, P256, DOI 10.1055/s-2005-922104; Young A., 2002, FACIAL EXPRESSIONS E	54	19	19	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2017	32	5					296	307		10.1097/HTR.0000000000000332			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FG2DW	WOS:000409893800010	28786854	Green Published			2022-02-06	
J	Portbury, SD; Hare, DJ; Finkelstein, DI; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.			Trehalose improves traumatic brain injury-induced cognitive impairment	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CONTROLLED CORTICAL IMPACT; CELLULAR STRESS RESPONSES; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEAD-INJURY; RAT MODEL; SUBVENTRICULAR ZONE; MEMORY FORMATION	Traumatic brain Injury (TBI) is a significant cause of death and long-term disability for which there are currently no effective pharmacological treatment options. In this study then, we utilized a mouse model of TBI to assess the therapeutic potential of the stable disaccharide trehalose, which is known to protect against oxidative stress, increase levels of chaperone molecules and enhance autophagy. Furthermore, trehalose has demonstrated neuroprotective properties in numerous animal models and has been proposed as a potential treatment for neurodegeneration. As TBI (and associated neurodegenerative disorders) is complicated by a sudden and dramatic change in brain metal concentrations, including iron (Fe) and zinc (Zn), the collective accumulation and translocation of which has been hypothesized to contribute to the pathogenesis of TBI, then we also sought to determine whether trehalose modulated the metal dyshomeostasis associated with TBI. In this study three-monthold C57Bl/6 wildtype mice received a controlled cortical impact TBI, and were subsequently treated for one month with trehalose. During this time animals were assessed on multiple behavioral tasks prior to tissue collection. Results showed an overall significant improvement in the Morris water maze, Y-maze and open field behavioral tests in trehalose-treated mice when compared to controls. These functional benefits occurred in the absence of any change in lesion volume or any significant modulation of biometals, as assessed by laser ablation inductively coupled plasma mass spectrometry. Western blot analysis, however, revealed an upregulation of synaptophysin, doublecortin and brain derived neurotrophic factor protein in trehalose treated mice in the contralateral cortex. These results indicate that trehalose may be efficacious in improving functional outcomes following TBI by a previously undescribed mechanism of action that has relevance to multiple disorders of the central nervous system.	[Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging, Sydney, NSW, Australia		Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	paul.adlard@florey.edu.au	Hare, Dominic/H-2481-2011; Finkelstein, David/B-9617-2009	Hare, Dominic/0000-0002-5922-7643; Finkelstein, David/0000-0002-8167-4917	Australian Research Council Future FellowshipAustralian Research Council [FT120100030]; Australian Research CouncilAustralian Research Council; Agilent Technologies [LP140100095]	P.A.A. is supported by an Australian Research Council Future Fellowship (FT120100030). D.J.H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095).	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Calabrese EJ, 2016, PHARMACOL RES, V110, P242, DOI 10.1016/j.phrs.2015.12.021; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Du J, 2013, J PHARM PHARMACOL, V65, P1753, DOI 10.1111/jphp.12108; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Holler CJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0114-3; Ikeda S, 2013, EXCLI J, V12, P641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Liu MY, 2013, FOOD CHEM, V136, P485, DOI 10.1016/j.foodchem.2012.09.031; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tanji K, 2015, BIOCHEM BIOPH RES CO, V465, P746, DOI 10.1016/j.bbrc.2015.08.076; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	88	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183683	10.1371/journal.pone.0183683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	WOS:000408365000102	28837626	Green Published, gold, Green Submitted			2022-02-06	
J	Wylie, GR; Dobryakova, E; DeLuca, J; Chiaravalloti, N; Essad, K; Genova, H				Wylie, G. R.; Dobryakova, E.; DeLuca, J.; Chiaravalloti, N.; Essad, K.; Genova, H.			Cognitive fatigue in individuals with traumatic brain injury is associated with caudate activation	SCIENTIFIC REPORTS			English	Article							WORKING-MEMORY LOAD; MULTIPLE-SCLEROSIS; BASAL GANGLIA; PREFRONTAL CORTEX; MENTAL FATIGUE; NEURAL-NETWORK; REWARD; RESPONSES; TASK; CONSCIOUSNESS	We investigated differences in brain activation associated with cognitive fatigue between persons with traumatic brain injury (TBI) and healthy controls (HCs). Twenty-two participants with moderatesevere TBI and 20 HCs performed four blocks of a difficult working memory task and four blocks of a control task during fMRI imaging. Cognitive fatigue, assessed before and after each block, was used as a covariate to assess fatigue-related brain activation. The TBI group reported more fatigue than the HCs, though their performance was comparable. Regarding brain activation, the TBI group showed a Task X Fatigue interaction in the caudate tail resulting from a positive correlation between fatigue and brain activation for the difficult task and a negative relationship for the control task. The HC group showed the same Task X Fatigue interaction in the caudate head. Because we had prior hypotheses about the caudate, we performed a confirmatory analysis of a separate dataset in which the same subjects performed a processing speed task. A relationship between Fatigue and brain activation was evident in the caudate for this task as well. These results underscore the importance of the caudate nucleus in relation to cognitive fatigue.	[Wylie, G. R.; Dobryakova, E.; DeLuca, J.; Chiaravalloti, N.; Genova, H.] Kessler Fdn, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA; [Wylie, G. R.; Dobryakova, E.; DeLuca, J.; Chiaravalloti, N.; Genova, H.] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07101 USA; [Wylie, G. R.] New Jersey Healthcare Syst, Dept Vet Affairs, War Related Illness & Injury Study Ctr, East Orange Campus, E Orange, NJ 07018 USA; [DeLuca, J.] Rutgers State Univ, New Jersey Med Sch, Dept Neurol, Newark, NJ 07101 USA; [Essad, K.] Dartmouth Coll Med Sch, Dartmouth Coll, Hanover, NH 03755 USA		Wylie, GR (corresponding author), Kessler Fdn, 120 Eagle Rock Ave,Suite 100, E Hanover, NJ 07936 USA.; Wylie, GR (corresponding author), Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07101 USA.; Wylie, GR (corresponding author), New Jersey Healthcare Syst, Dept Vet Affairs, War Related Illness & Injury Study Ctr, East Orange Campus, E Orange, NJ 07018 USA.	gwylie@kesslerfoundation.org	Dobryakova, Ekaterina/ABD-2853-2021	Dobryakova, Ekaterina/0000-0002-6005-2115; Chiaravalloti, Nancy/0000-0003-2943-7567	New Jersey Commission for Brain Injury Research [10.005.BIR1]; Kessler Foundation Research Center	The authors would like to acknowledge grant support from The New Jersey Commission for Brain Injury Research (10.005.BIR1 to GW and HG), and The Kessler Foundation Research Center.	Akhlaghpour H, 2016, ELIFE, V5, DOI 10.7554/eLife.19507; [Anonymous], 2005, FATIGUE WINDOW BRAIN; Blockmans Daniel, 2006, Am J Med, V119, DOI 10.1016/j.amjmed.2005.07.047; Boksem MAS, 2006, BIOL PSYCHOL, V72, P123, DOI 10.1016/j.biopsycho.2005.08.007; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Das A, 2012, NEUROLOGY, V79, P2146, DOI 10.1212/WNL.0b013e3182752cdb; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; DeLuca J, 2009, PHYS MED REH CLIN N, V20, P325, DOI 10.1016/j.pmr.2008.12.007; Dobryakova E., 2013, J INT NEUROPSYCH SOC, V19, P1; Dobryakova E, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00052; Dobryakova E, 2013, COGN AFFECT BEHAV NE, V13, P725, DOI 10.3758/s13415-013-0182-6; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Genova HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078811; Gibbs SEB, 2005, COGN AFFECT BEHAV NE, V5, P212, DOI 10.3758/CABN.5.2.212; Gillis MM, 2015, BRAIN IMAGING BEHAV, V9, P801, DOI 10.1007/s11682-014-9337-5; Harel Y, 2009, J NEUROL SCI, V276, P38, DOI 10.1016/j.jns.2008.08.025; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Johansson B, 2014, BRAIN INJURY, V28, P304, DOI 10.3109/02699052.2013.865267; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Lorist MM, 2009, BRAIN RES, V1270, P95, DOI 10.1016/j.brainres.2009.03.015; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; MCCORMACK HM, 1988, PSYCHOL MED, V18, P1007, DOI 10.1017/S0033291700009934; Mendonca DA, 2007, MOVEMENT DISORD, V22, P2070, DOI 10.1002/mds.21656; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; NAKAGAWA S, 2016, SCI REP UK, V6; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Pardini M, 2015, MULT SCLER J, V21, P442, DOI 10.1177/1352458514546791; Pardini M, 2010, BEHAV NEUROSCI, V124, P329, DOI 10.1037/a0019585; Pardini M, 2010, NEUROLOGY, V74, P749, DOI 10.1212/WNL.0b013e3181d25b6b; Perlstein WM, 2004, J INT NEUROPSYCH SOC, V10, P724, DOI 10.1017/S1355617704105110; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ryan NP, 2016, CORTEX, V83, P222, DOI 10.1016/j.cortex.2016.07.020; Sandry J., 2014, FRONT NEUROL, V5, P1; Schneider W., 2002, E PRIME REFERENCE GU; Schoedel ALA, 2008, PAIN, V135, P131, DOI 10.1016/j.pain.2007.05.014; Schonberger M, 2017, NEUROPSYCHOL REHABIL, V27, P1056, DOI 10.1080/09602011.2016.1154875; SCHULTZ W, 1993, J NEUROSCI, V13, P900; TEASDALE G, 1974, LANCET, V2, P81; Tricomi E, 2008, NEUROIMAGE, V41, P1154, DOI 10.1016/j.neuroimage.2008.02.066; Wanger AK, 2009, J NEUROCHEM, V110, P801, DOI 10.1111/j.1471-4159.2009.06155.x; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Wylie GR, 2014, HUM BRAIN MAPP, V35, P1, DOI 10.1002/hbm.22150	57	19	20	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	AUG 21	2017	7								8973	10.1038/s41598-017-08846-6			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE3HM	WOS:000408107000107	28827779	Green Published, gold			2022-02-06	
J	Bagnato, S; Grimaldi, LME; Di Raimondo, G; Sant'Angelo, A; Boccagni, C; Virgilio, V; Andriolo, M				Bagnato, Sergio; Grimaldi, Luigi M. E.; Di Raimondo, Giorgio; Sant'Angelo, Antonino; Boccagni, Cristina; Virgilio, Vittorio; Andriolo, Maria			Prolonged Cerebrospinal Fluid Neurofilament Light Chain Increase in Patients with Post-Traumatic Disorders of Consciousness	JOURNAL OF NEUROTRAUMA			English	Article						Alzheimer's disease; axonal injury; neurofilaments; traumatic brain injury; vegetative state	TRAUMATIC BRAIN-INJURY; UNRESPONSIVE WAKEFULNESS SYNDROME; INFLAMMATION; AD	The mechanisms involved in secondary brain injury after the acute phase of severe traumatic brain injury (TBI) are largely unknown. Ongoing axonal degeneration, consequent to the initial trauma, may lead to secondary brain injury. To test this hypothesis, we evaluated the cerebrospinal fluid (CSF) level of neurofilament light chain (NF-L), a proposed marker of axonal degeneration, in 10 patients who developed a severe disorder of consciousness after a TBI, including 7 in a minimally conscious state and 3 with unresponsive wakefulness syndrome (time since brain injury, 309 - 169 days). CSF NF-L level was measured with a commercially available NF-L enzyme-linked immunosorbent assay. CSF NF-L level was very high in all 10 patients, ranging from 2.4- to 60.5-fold the upper normal limit (median value, 4458 pg/mL; range, 695 - 23,000). Moreover, NF-L level was significantly higher after a severe TBI than in a reference group of 9 patients with probable Alzheimer's disease, a population with elevated levels of CSF NF-L attributed to neuronal degeneration (median value, 1173 pg/mL; range, 670-3643; p < 0.01). CSF NF-L level was correlated with time post-TBI (p = 0.04). These results demonstrate prolonged secondary brain injury, suggesting that patients exhibit ongoing axonal degeneration up to 19 months after a severe TBI.	[Bagnato, Sergio; Sant'Angelo, Antonino; Boccagni, Cristina] Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Neurophysiol, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Bagnato, Sergio; Sant'Angelo, Antonino; Boccagni, Cristina] Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy; [Grimaldi, Luigi M. E.; Di Raimondo, Giorgio] Fdn Ist Giuseppe Giglio, Dept Neurol, Cefalu, PA, Italy; [Virgilio, Vittorio] Fdn Ist Giuseppe Giglio, Strateg Direct, Cefalu, PA, Italy; [Andriolo, Maria] Fdn Ist Giuseppe Giglio, Clin Pathol & Microbiol Lab, Cefalu, PA, Italy		Bagnato, S (corresponding author), Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Neurophysiol, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.; Bagnato, S (corresponding author), Fdn Ist Giuseppe Giglio, Rehabil Dept, Unit Severe Acquired Brain Injuries, Viale Giuseppe Giardina, I-90015 Cefalu, PA, Italy.	sergiobagnato@gmail.com	Grimaldi, Luigi/L-2614-2019; Bagnato, Sergio/H-6842-2013	Bagnato, Sergio/0000-0002-6289-1887; Boccagni, Cristina/0000-0002-6317-015X; Sant'Angelo, Antonino/0000-0001-9972-3679			Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bagnato S, 2017, ARCH PHYS MED REHAB, V98, P665, DOI 10.1016/j.apmr.2016.09.132; Bagnato S, 2013, NEUROSCI BIOBEHAV R, V37, P2721, DOI 10.1016/j.neubiorev.2013.09.007; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hall GF, 2000, CELL MOTIL CYTOSKEL, V46, P166, DOI 10.1002/1097-0169(200007)46:3<166::AID-CM2>3.0.CO;2-8; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Laser-Azogui A, 2015, CURR OPIN CELL BIOL, V32, P92, DOI 10.1016/j.ceb.2015.01.003; Marmarou CR, 2006, EXP NEUROL, V197, P353, DOI 10.1016/j.expneurol.2005.10.003; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Zetterberg H, 2016, JAMA NEUROL, V73, P60, DOI 10.1001/jamaneurol.2015.3037; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	16	19	19	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2017	34	16					2475	2479		10.1089/neu.2016.4837			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FC6RI	WOS:000406968400010	28385104				2022-02-06	
J	Nishijima, DK; Gaona, SD; Waechter, T; Maloney, R; Bair, T; Blitz, A; Elms, AR; Farrales, RD; Howard, C; Montoya, J; Bell, JM; Faul, M; Vinson, DR; Garzon, H; Holmes, JF; Ballard, DW				Nishijima, Daniel K.; Gaona, Samuel D.; Waechter, Trent; Maloney, Ric; Bair, Troy; Blitz, Adam; Elms, Andrew R.; Farrales, Roel D.; Howard, Calvin; Montoya, James; Bell, Jeneita M.; Faul, Mark; Vinson, David R.; Garzon, Hernando; Holmes, James F.; Ballard, Dustin W.		Sacramento County Prehosp Res	Out-of-Hospital Triage of Older Adults With Head Injury: A Retrospective Study of the Effect of Adding "Anticoagulation or Antiplatelet Medication Use" as a Criterion	ANNALS OF EMERGENCY MEDICINE			English	Article; Proceedings Paper	National Annual Meeting of the Society-for-Academic-Emergency-Medicine	MAY 10-13, 2016	New Orleans, LA	Soc Acad Emergency Med			TRAUMATIC BRAIN-INJURY; INTRACRANIAL HEMORRHAGE; STATISTICAL-METHODS; PREINJURY WARFARIN; STANDARD; OUTCOMES; IMPACT; CARE; REHABILITATION; MANAGEMENT	Study objective: Field triage guidelines recommend that emergency medical services (EMS) providers consider transport of head-injured older adults with anticoagulation use to trauma centers. However, the triage patterns and the incidence of intracranial hemorrhage or neurosurgery in these patients are unknown. Our objective is to describe the characteristics and outcomes of older adults with head trauma who are transported by EMS, particularly for patients who do not meet physiologic, anatomic, or mechanism-of-injury (steps 1 to 3) field triage criteria but are receiving anticoagulant or antiplatelet medications. Methods: This was a retrospective study at 5 EMS agencies and 11 hospitals (4 trauma centers, 7 nontrauma centers). Patients aged 55 years or older with head trauma who were transported by EMS were included. The primary outcome was the presence of intracranial hemorrhage. The secondary outcome was a composite measure of inhospital death or neurosurgery. Results: Of the 2,110 patients included, 131 (6%) had intracranial hemorrhage and 41 (2%) had inhospital death or neurosurgery. There were 162 patients (8%) with steps 1 to 3 criteria. Of the remaining 1,948 patients without steps 1 to 3 criteria, 566 (29%) had anticoagulant or antiplatelet use. Of these patients, 52 (9%) had traumatic intracranial hemorrhage and 15 (3%) died or had neurosurgery. The sensitivity (adjusted for clustering by EMS agency) of steps 1 to 3 criteria was 19.8% (26/131; 95% confidence interval [CI] 5.5% to 51.2%) for identifying traumatic intracranial hemorrhage and 34.1% (14/41; 95% CI 9.9% to 70.1%) for death or neurosurgery. The additional criterion of anticoagulant or antiplatelet use improved the sensitivity for intracranial hemorrhage (78/131; 59.5%; 95% CI 42.9% to 74.2%) and death or neurosurgery (29/41; 70.7%; 95% CI 61.0% to 78.9%). Conclusion: Relatively few patients met steps 1 to 3 triage criteria. For individuals who did not have steps 1 to 3 criteria, nearly 30% had anticoagulant or antiplatelet use. A relatively high proportion of these patients had intracranial hemorrhage, but a much smaller proportion died or had neurosurgery during hospitalization. Use of steps 1 to 3 triage criteria alone is not sufficient in identifying intracranial hemorrhage and death or neurosurgery in this patient population. The additional criterion of anticoagulant or antiplatelet use improves the sensitivity of the instrument, with only a modest decrease in specificity.	[Nishijima, Daniel K.; Gaona, Samuel D.; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Waechter, Trent] City Sacramento Fire Dept, Sacramento, CA USA; [Maloney, Ric] Sacramento Metropolitan Fire Dept, Sacramento, CA USA; [Bair, Troy] Cosumnes Community Serv, Dist Fire Dept, Elk Grove, CA USA; [Blitz, Adam] Amer Med Response, Sacramento, CA USA; [Elms, Andrew R.] Kaiser Permanente South Sacramento Med Ctr, Sacramento, CA USA; [Farrales, Roel D.] Mercy Gen Hosp, Sacramento, CA USA; [Howard, Calvin] City Folsom Fire Dept, Folsom, CA USA; [Montoya, James] Sutter Community Hosp, Sacramento, CA USA; [Bell, Jeneita M.; Faul, Mark] Ctr Dis Control & Prevent, Atlanta, GA USA; [Vinson, David R.; Garzon, Hernando] Kaiser Permanente Sacramento Med Ctr, Sacramento, CA USA; [Ballard, Dustin W.] Kaiser Permanente San Rafael Med Ctr, San Rafael, CA USA		Nishijima, DK (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA.	dnishijima@ucdavis.edu	Vinson, David R/AAK-3227-2020	Vinson, David R/0000-0001-6559-1858; Faul, Mark/0000-0002-7683-0348	Centers for Disease Control and Prevention (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177]; Mentored Clinical Research Training Program Award from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH) [UL1TR000002, KL2TR000134]; NIH Roadmap for Medical ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000002, UL1TR001860, KL2TR000134] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002177] Funding Source: NIH RePORTER	Annals policy, all authors are required to disclose any and all commercial, financial, and other relationships in any way related to the subject of this article as per ICMJE conflict of interest guidelines (see www.icmje.org). The authors have stated that no such relationships exist. This work was funded by the Centers for Disease Control and Prevention (CDC), grant U01CE002177. Dr. Nishijima was supported through a Mentored Clinical Research Training Program Award (grant UL1TR000002 and linked award KL2TR000134) from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	American Trauma Society, TRAUM CTR LEV EXPL; Berlot G, 2009, EUR J EMERG MED, V16, P312, DOI 10.1097/MEJ.0b013e32832d3aa1; Boulis NM, 1999, NEUROSURGERY, V45, P1113, DOI 10.1097/00006123-199911000-00020; California EMS Authority, RETR REG NETW WORKGR; Caterino JM, 2016, J AM GERIATR SOC, V64, P1944, DOI 10.1111/jgs.14376; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Faul M, 2010, TRAUMATIC BRAIN INJU; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Flanagan SR, 2006, CLIN GERIATR MED, V22, P449, DOI 10.1016/j.cger.2005.12.011; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Graham P, 1998, J CLIN EPIDEMIOL, V51, P763, DOI 10.1016/S0895-4356(98)00048-1; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hill AD, J TRAUMA; Jakobsson U, 2005, SCAND J CARING SCI, V19, P427, DOI 10.1111/j.1471-6712.2005.00368.x; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Joosse P, 2012, J TRAUMA ACUTE CARE, V72, P487, DOI 10.1097/TA.0b013e318226ed59; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Kawamata T, 1995, SURG NEUROL, V44, P438, DOI 10.1016/0090-3019(95)00249-9; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Lerner EB, 2014, J TRAUMA ACUTE CARE, V76, P1157, DOI 10.1097/TA.0000000000000189; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Miller SL, 2008, ANN EMERG MED, V52, P483, DOI 10.1016/j.annemergmed.2008.03.021; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Newgard CD, 2012, J TRAUMA ACUTE CARE, V72, P1239, DOI 10.1097/TA.0b013e3182468b51; Newgard CD, 2011, J TRAUMA, V70, P1345, DOI 10.1097/TA.0b013e3182191a1b; Nishijima DK, 2013, ACAD EMERG MED, V20, P140, DOI 10.1111/acem.12074; Nishijima DK, 2012, INJURY, V43, P1827, DOI 10.1016/j.injury.2011.07.020; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Nishijima DK, 2016, PREHOSP EMERG CARE; Patel PA, 2015, CIRC-CARDIOVASC QUAL, V8, P383, DOI 10.1161/CIRCOUTCOMES.114.000907; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Platts-Mills TF, 2016, J AM GERIATR SOC, V64, P1941, DOI 10.1111/jgs.14405; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; Sasser Scott M, 2012, MMWR Recomm Rep, V61, P1; Siracuse JJ, 2010, SURGERY, V148, P724, DOI 10.1016/j.surg.2010.07.014; Starke RM, 2015, NEUROSURGERY, V77, pN11, DOI 10.1227/01.neu.0000473806.53232.3e; Tepas JJ, 2009, J PEDIATR SURG, V44, P368, DOI 10.1016/j.jpedsurg.2008.10.089; Thibault N., 2016, AM J THER; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Viera AJ, 2005, FAM MED, V37, P360; Wears RL, 2002, ACAD EMERG MED, V9, P330, DOI 10.1197/aemj.9.4.330; Willenbring BD, 2016, PREHOSP EMERG CARE, V20, P1, DOI 10.3109/10903127.2015.1056896; Yasuda CL, 2003, ARQ NEURO-PSIQUIAT, V61, P1011, DOI 10.1590/S0004-282X2003000600023	50	19	19	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0196-0644	1097-6760		ANN EMERG MED	Ann. Emerg. Med.	AUG	2017	70	2					127	138		10.1016/j.annemergmed.2016.12.018			12	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Emergency Medicine	FD1OI	WOS:000407306200002	28238499	Green Accepted, Bronze			2022-02-06	
J	Olkowski, BF; Shah, SO				Olkowski, Brian F.; Shah, Syed Omar			Early Mobilization in the Neuro-ICU: How Far Can We Go?	NEUROCRITICAL CARE			English	Article						Early mobilization; Rehabilitation; Acute ischemic stroke; Aneurysmal subarachnoid hemorrhage; Intracerebral hemorrhage; Neurotrauma	INTENSIVE-CARE-UNIT; ACUTE ISCHEMIC-STROKE; RANDOMIZED CONTROLLED-TRIAL; BLOOD-FLOW-VELOCITY; EARLY REHABILITATION; SUBARACHNOID HEMORRHAGE; CRITICALLY-ILL; ORTHOSTATIC HYPOTENSION; INTRACRANIAL-PRESSURE; PHASE-II	Immobility that is frequently encountered in the intensive care unit (ICU) can lead to patient complications. Early mobilization of patients in the ICU has been shown to reduce the complications associated with critical illness; however, early mobilization in the neurological intensive care unit (NICU) presents a unique challenge for the multidisciplinary team. The early mobilization of patients with acute neurologic injuries such as acute ischemic stroke, aneurysmal subarachnoid hemorrhage, intracerebral hemorrhage, and neurotrauma varies because of differing disease processes and management. When developing an early mobility program in the NICU, the following should be considered: the effect of positional changes and exercise, the time from symptom onset to the initiation of early mobilization, and the type and intensity of the exercise prescribed.	[Olkowski, Brian F.] Capital Hlth Reg Med Ctr, Dept Rehabil, Trenton, NJ 08638 USA; [Shah, Syed Omar] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA; [Shah, Syed Omar] Jefferson Hosp Neurosci, Div Crit Care & Neurotrauma, Philadelphia, PA USA		Olkowski, BF (corresponding author), Capital Hlth Reg Med Ctr, Dept Rehabil, Trenton, NJ 08638 USA.	bolkowski@capitalhealth.org	Shah, Syed/E-4083-2013	Shah, Syed/0000-0003-4760-5229			[Anonymous], 2016, CER HEM ORTH RESP UP; Arnold SM, 2015, J STROKE CEREBROVASC, V24, P1168, DOI 10.1016/j.jstrokecerebrovasdis.2015.01.007; Awad AJ, 2016, WORLD NEUROSURG, V87, P474, DOI 10.1016/j.wneu.2016.01.043; Balas MC, 2013, CRIT CARE MED, V41, pS116, DOI 10.1097/CCM.0b013e3182a17064; Baltz MJ, 2013, J NEUROL PHYS THER, V37, P9, DOI 10.1097/NPT.0b013e318282a1f0; Barer D, 2015, LANCET, V386, P1734, DOI 10.1016/S0140-6736(15)00691-1; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; Bernhardt J, 2008, STROKE, V39, P390, DOI 10.1161/STROKEAHA.107.492363; Bernhardt J, 2015, LANCET, V386, P46, DOI 10.1016/S0140-6736(15)60690-0; Bernhardt J, 2015, STROKE, V46, P1141, DOI 10.1161/STROKEAHA.114.007434; Brimioulle S, 1997, PHYS THER, V77, P1682, DOI 10.1093/ptj/77.12.1682; Brunser AM, 2016, INT J STROKE, V11, P253, DOI 10.1177/1747493015620808; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Claydon VE, 2006, SPINAL CORD, V44, P341, DOI 10.1038/sj.sc.3101855; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Consortium Spinal Cord Med, 2008, J SPINAL CORD MED, V31, P403; Cumming TB, 2008, J REHABIL MED, V40, P609, DOI 10.2340/16501977-0226; Cumming TB, 2011, STROKE, V42, P153, DOI 10.1161/STROKEAHA.110.594598; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Dubb R, 2016, ANN AM THORAC SOC, V13, P724, DOI 10.1513/AnnalsATS.201509-586CME; Fletcher SN, 2003, CRIT CARE MED, V31, P1012, DOI 10.1097/01.CCM.0000053651.38421.D9; Frazzitta G, 2015, J HEAD TRAUMA REHAB, V30, P290, DOI 10.1097/HTR.0000000000000135; Guidelines for the Management of Cervical Spine and Spinal Cord Injuries, 2002, CLIN NEUROSURG, V49, P407; Hanekom S, 2011, CLIN REHABIL, V25, P771, DOI 10.1177/0269215510397677; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Helbok R, 2012, CRIT CARE, V16, DOI 10.1186/cc11880; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Herter KR, 2016, ARCH PHYS MED REHAB, V97, P1620, DOI 10.1016/j.apmr.2016.05.009; Hester JM, 2015, NEUROCRIT CARE, V23, pS63; Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kamdar BB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1433-z; Karic T, 2016, J NEUROSURG, P1; Karic T, 2016, J REHABIL MED, V48, P676, DOI 10.2340/16501977-2121; Karic T, 2015, DISABIL REHABIL, V37, P1446, DOI 10.3109/09638288.2014.966162; Kawamoto S, 2004, J NEUROSURG, V100, P236, DOI 10.3171/jns.2004.100.2.0236; Kayambu G, 2013, CRIT CARE MED, V41, P1543, DOI 10.1097/CCM.0b013e31827ca637; Klein K, 2015, CRIT CARE MED, V43, P865, DOI 10.1097/CCM.0000000000000787; Klein KE, 2015, NEUROCRIT CARE, V23, pS269; Koch SM, 1996, J CRIT CARE, V11, P176, DOI 10.1016/S0883-9441(96)90028-3; Krassioukov A, 2009, ARCH PHYS MED REHAB, V90, P876, DOI 10.1016/j.apmr.2009.01.009; Kuznetsov AN, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/946056; Langhorne P, 2010, CEREBROVASC DIS, V29, P352, DOI 10.1159/000278931; Lantigua H, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1036-0; Li ZQ, 2013, ARCH PHYS MED REHAB, V94, P551, DOI 10.1016/j.apmr.2012.10.023; Liu N, 2014, STROKE, V45, P3502, DOI 10.1161/STROKEAHA.114.005661; Lord RK, 2013, CRIT CARE MED, V41, P717, DOI 10.1097/CCM.0b013e3182711de2; Luft AR, 2016, STROKE, V47, P291, DOI 10.1161/STROKEAHA.115.010483; Ma ZX, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008346.pub2; Martin Niels D, 2015, J Emerg Trauma Shock, V8, P94, DOI 10.4103/0974-2700.155507; Mills PB, 2015, ARCH PHYS MED REHAB, V96, P366, DOI 10.1016/j.apmr.2014.09.028; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Nakagomi T, 2011, ACTA NEUROCHIR SUPPL, V110, P105, DOI 10.1007/978-3-7091-0356-2_19; Needham DM, 2008, JAMA-J AM MED ASSOC, V300, P1685, DOI 10.1001/jama.300.14.1685; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Needham DM, 2010, ARCH PHYS MED REHAB, V91, P536, DOI 10.1016/j.apmr.2010.01.002; Oddo M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1294-5; Olavarria VV, 2014, CEREBROVASC DIS, V37, P401, DOI 10.1159/000362533; Olkowski BF, 2015, J ACUTE CARE PHYS TH, V6, P47, DOI 10.1097/JAT.0000000000000008; Olkowski BF, 2013, PHYS THER, V93, P208, DOI 10.2522/ptj.20110334; Pandharipande P, 2010, CRIT CARE, V14, DOI 10.1186/cc8999; Riordan MA, 2014, ACTA NEUROCHIR, V120, pS55; Saciri BM, 2002, J NEUROL NEUROSUR PS, V72, P334, DOI 10.1136/jnnp.72.3.334; Schmidt A, 2014, STROKE, V45, P239, DOI 10.1161/STROKEAHA.113.002048; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Shimamura N, 2014, WORLD NEUROSURG, V81, P330, DOI 10.1016/j.wneu.2012.12.007; Sundseth A, 2012, STROKE, V43, P2389, DOI 10.1161/STROKEAHA.111.646687; SUZUKI I, 1991, SURG CEREB STROKE, V19, P295; Tay-Teo K, 2008, CEREBROVASC DIS, V26, P475, DOI 10.1159/000155984; Thomsen GE, 2008, CRIT CARE MED, V36, P1119, DOI 10.1097/CCM.0b013e318168f986; Titsworth WL, 2012, J NEUROSURG, V116, P1379, DOI 10.3171/2012.2.JNS111881; Tyedin K, 2010, DISABIL REHABIL, V32, P875, DOI 10.3109/09638280903349552; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; Wojner-Alexander AW, 2005, NEUROLOGY, V64, P1354, DOI 10.1212/01.WNL.0000158284.41705.A5; Zhang Y, 2011, NEUROCRIT CARE, V14, P73, DOI 10.1007/s12028-010-9444-0	83	19	21	1	26	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2017	27	1					141	150		10.1007/s12028-016-0338-7			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FB7GX	WOS:000406310200020	28000130				2022-02-06	
J	Fonda, JR; Fredman, L; Brogly, SB; McGlinchey, RE; Milberg, WP; Gradus, JL				Fonda, Jennifer R.; Fredman, Lisa; Brogly, Susan B.; McGlinchey, Regina E.; Milberg, William P.; Gradus, Jaimie L.			Traumatic Brain Injury and Attempted Suicide Among Veterans of the Wars in Iraq and Afghanistan	AMERICAN JOURNAL OF EPIDEMIOLOGY			English	Article						attempted suicide; cohort studies; traumatic brain injury; veterans	POSTTRAUMATIC-STRESS-DISORDER; OPERATIONS ENDURING FREEDOM; POSTCONCUSSIVE SYMPTOMS; SOLDIERS; PAIN; ASSOCIATION; POLYTRAUMA; DEPRESSION; DEPLOYMENT; SERVICES	Studies of the association between traumatic brain injury (TBI) and suicide attempt have yielded conflicting results. Furthermore, no studies have examined the possible mediating role of common comorbid psychiatric conditions in this association. This study used Veterans Affairs registry data to evaluate the associations between deployment-related TBI, psychiatric diagnoses, and attempted suicide among 273,591 veterans deployed in support of Operation Enduring Freedom, Operation Iraqi Freedom, and Operation New Dawn, and who received care from the Department of Veterans Affairs during 2007-2012. We performed Cox proportional hazards regression analyses, adjusting for demographic characteristics. Mediation analyses were conducted to quantify the impact of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and substance abuse) on this association. The sample was predominantly male (84%); mean age = 28.7 years. Veterans with TBI (16%) were more likely to attempt suicide than those without (0.54% vs. 0.14%): adjusted hazards ratio = 3.76, 95% confidence interval: 3.15, 4.49. This association was attenuated in mediation analyses (adjusted hazards ratio = 1.25, 95% confidence interval: 1.07, 1.46), with 83% of the association of TBI with attempted suicide mediated by co-occurring psychiatric conditions and with posttraumatic stress disorder having the largest impact. These results suggest that veterans with these conditions should be closely monitored for suicidal behavior.	[Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA; [Fonda, Jennifer R.; McGlinchey, Regina E.; Milberg, William P.] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA; [Fonda, Jennifer R.; Fredman, Lisa; Brogly, Susan B.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Brogly, Susan B.] Queens Univ, Dept Med, Kingston, ON, Canada; [Brogly, Susan B.] Queens Univ, Dept Surg, Kingston, ON, Canada; [McGlinchey, Regina E.; Milberg, William P.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Gradus, Jaimie L.] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Gradus, Jaimie L.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA		Fonda, JR (corresponding author), VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA.; Fonda, JR (corresponding author), VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, 150 South Huntington Ave 182 JP, Boston, MA 02130 USA.	jennifer.fonda@va.gov	Fonda, Jennifer R./ABG-2890-2021	Fonda, Jennifer R./0000-0001-9482-2918; Brogly, Susan/0000-0002-2339-3287	Translational Research Center for TBI and Stress Disorders (TRACTS)-aVA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center [B6796-C]	This study was performed without financial support. VA Boston Healthcare System and the Translational Research Center for TBI and Stress Disorders (TRACTS)-aVA Rehabilitation Research and Development Traumatic Brain Injury National Network Research Center (grant B6796-C)-provided overall and infrastructural support.	Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Brenner LA, 2011, SUICIDE LIFE-THREAT, V41, P416, DOI 10.1111/j.1943-278X.2011.00041.x; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Eber S, 2013, MIL MED, V178, P966, DOI 10.7205/MILMED-D-13-00175; Epidemiology Program Post-Deployment Health Group, 2001, AN VA HLTH CAR UT OP; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Gironda RJ, 2006, PAIN MED, V7, P339, DOI 10.1111/j.1526-4637.2006.00146.x; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Lange T, 2014, AM J EPIDEMIOL, V179, P513, DOI 10.1093/aje/kwt270; Lew HL, 2005, J REHABIL RES DEV, V42, pXIII, DOI 10.1682/JRRD.2005.07.0124; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Management of Concussion/mTBI Working Group, 2009, CLIN PRACT GUID MAN; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Miller EA, 2012, SOC WORK PUBLIC HLTH, V27, P379, DOI 10.1080/19371910903176197; Oquendo MA, 2004, J NERV MENT DIS, V192, P430, DOI 10.1097/01.nmd.0000126706.53615.7b; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rochon J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-9; Schneider AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00059; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; US Department of Defense and US Department of Veterans Affairs, DOD VA COMM DEF TBI; US Department of Veterans Affairs, SCREEN EV POSS TRAUM; US Department of Veterans Affairs National Center for Veterans Analysis and Statistics, UN VET US REP FY 201; VanderWeele T J, 2014, Epidemiol Methods, V2, P95; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	35	19	19	0	12	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0002-9262	1476-6256		AM J EPIDEMIOL	Am. J. Epidemiol.	JUL 15	2017	186	2					220	226		10.1093/aje/kwx044			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	FB0XV	WOS:000405869200011	28472407	hybrid			2022-02-06	
J	MacManus, DB; Pierrat, B; Murphy, JG; Gilchrist, MD				MacManus, David B.; Pierrat, Baptiste; Murphy, Jeremiah G.; Gilchrist, Michael D.			Protection of cortex by overlying meninges tissue during dynamic indentation of the adolescent brain	ACTA BIOMATERIALIA			English	Article						Dura mater; Traumatic brain injury; Viscoelasticity; Indentation; Characterization	P56 MOUSE-BRAIN; MECHANICAL-PROPERTIES; DURA-MATER; INJURY; HEAD; VISCOELASTICITY; BIOMECHANICS	Traumatic brain injury (TBI) has become a recent focus of biomedical research with a growing international effort targeting material characterization of brain tissue and simulations of trauma using computer models of the head and brain to try to elucidate the mechanisms and pathogenesis of TBI. The meninges, a collagenous protective tri-layer, which encloses the entire brain and spinal cord has been largely overlooked in these material characterization studies. This has resulted in a lack of accurate constitutive data for the cranial meninges, particularly under dynamic conditions such as those experienced during head impacts. The work presented here addresses this lack of data by providing for the first time, in situ large deformation material properties of the porcine dura-arachnoid mater composite under dynamic indentation. It is demonstrated that this tissue is substantially stiffer (shear modulus, mu = 19.10 +/- 8.55 kPa) and relaxes at a slower rate (tau(1) = 0.034 +/- 0.008 s, tau(2) = 0.336 +/- 0.077 s) than the underlying brain tissue (mu = 6.97 +/- 2.26 kPa, tau(1) = 0.021 +/- 0.007 s, tau(2) = 0.199 +/- 0.036 s), reducing the magnitudes of stress by 250% and 65% for strains that arise during indentation-type deformations in adolescent brains. Statement of Significance We present the first mechanical analysis of the protective capacity of the cranial meninges using in situ micro-indentation techniques. Force-relaxation tests are performed on in situ meninges and cortex tissue, under large strain dynamic micro-indentation. A quasi-linear viscoelastic model is used subsequently, providing time-dependent mechanical properties of these neural tissues under loading conditions comparable to what is experienced in TBI. The reported data highlights the large differences in mechanical properties between these two tissues. Finite element simulations of the indentation experiments are also performed to investigate the protective capacity of the meninges. These simulations show that the meninges protect the underlying brain tissue by reducing the overall magnitude of stress by 250% and up to 65% for strains. (C) 2017 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.	[MacManus, David B.; Pierrat, Baptiste; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Murphy, Jeremiah G.] Dublin City Univ, Dept Mech & Mfg Engn, Dublin, Ireland; [Pierrat, Baptiste] Ecole Natl Super Mines, CIS EMSE, SAINBIOSE, F-42023 St Etienne, France; [Pierrat, Baptiste] INSERM, U1059, F-42000 St Etienne, France		Gilchrist, MD (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.	david.mac-manus@ucdconnect.ie; pierrat@emse.fr; jeremiah.murphy@dcu.ie; michael.gilchrist@ucd.ie		Pierrat, Baptiste/0000-0001-8064-8496; MacManus, David/0000-0003-2959-698X	Science Foundation IrelandScience Foundation IrelandEuropean Commission [12/IP/1732]	The authors would like to acknowledge Dawn Pork & Bacon, Waterford, for supplying the porcine specimens. This work was made possible by Science Foundation Ireland (Grant No. 12/IP/1732).	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Antona-Makoshi J, 2012, P 2012 INT IRCOBI C, V2012, P441; Budday S, 2017, ACTA BIOMATER, V48, P319, DOI 10.1016/j.actbio.2016.10.036; Budday S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00257; Budday S, 2014, J MECH PHYS SOLIDS, V72, P75, DOI 10.1016/j.jmps.2014.07.010; Budday S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05644; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; El Sayed T, 2008, COMPUT METHOD APPL M, V197, P4692, DOI 10.1016/j.cma.2008.06.006; Elkin B S, 2010, J BIOMECHANICAL ENG, V132, P1; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; England M.A., 1996, COLOUR ATLAS BRAIN S; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiford RJ, 2005, J BIOMECH, V38, P1509, DOI 10.1016/j.jbiomech.2004.07.009; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P10976, DOI 10.1073/pnas.1309690110; Fratzl P, 1998, J STRUCT BIOL, V122, P119, DOI 10.1006/jsbi.1998.3966; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Haimann MCJ, 1998, J ANAT, V192, P99; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P911, DOI 10.1007/s00401-016-1565-x; Lejeune E, 2016, SOFT MATTER, V12, P5613, DOI 10.1039/c6sm00526h; Libertiaux V, 2011, J MECH BEHAV BIOMED, V4, P1177, DOI 10.1016/j.jmbbm.2011.03.028; Maas S., 2015, FEBIO THEORY MANUAL, P94; MacManus DB, 2015, J BIOMECH, V48, P3213, DOI 10.1016/j.jbiomech.2015.06.028; MacManus DB, 2017, ACTA BIOMATER, V48, P309, DOI 10.1016/j.actbio.2016.10.029; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mao H., J BIOMECH ENG, P135; Menard, 2008, DYNAMIC MECH ANAL PR; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Olivero WC, 2016, PEDIATR NEUROSURG, V51, P257, DOI 10.1159/000445900; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; PATIN DJ, 1993, ANESTH ANALG, V76, P535; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Pervin F, 2011, NEUROIMAGE, V54, pS98, DOI 10.1016/j.neuroimage.2010.03.077; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Puso MA, 1998, J BIOMECH ENG-T ASME, V120, P62, DOI 10.1115/1.2834308; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; REILAND S, 1978, ACTA RADIOL DIAGN, P15; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sacks MS, 1998, J BIOMECH ENG-T ASME, V120, P541, DOI 10.1115/1.2798027; Shearer T, 2015, J BIOMECH, V48, P3017, DOI 10.1016/j.jbiomech.2015.07.032; Shetye SS, 2014, J MECH BEHAV BIOMED, V34, P146, DOI 10.1016/j.jmbbm.2014.02.014; Sim A., 2012, J NEUROSURG, V116, P511; Streitberger K., 2016, EUR RADIOL; Thibault KL, 1998, J BIOMECH, V31, P1119, DOI 10.1016/S0021-9290(98)00122-5; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Wadsworth JDF, 2011, ACTA NEUROPATHOL, V121, P69, DOI 10.1007/s00401-010-0735-5; Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192; Willinger R, 1999, CR ACAD SCI II B, V327, P125, DOI 10.1016/S1287-4620(99)80021-0; Zhang HT, 2016, C PROC SOC EXP MECH, P99, DOI 10.1007/978-3-319-21455-9_11; Zhang M, 1997, MED ENG PHYS, V19, P512, DOI 10.1016/S1350-4533(97)00017-9	60	19	20	1	17	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1742-7061	1878-7568		ACTA BIOMATER	Acta Biomater.	JUL 15	2017	57						384	394		10.1016/j.actbio.2017.05.022			11	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EZ9HY	WOS:000405041900033	28501711				2022-02-06	
J	Guo, S; Zhou, D; Zhang, M; Li, TJ; Liu, YJ; Xu, YP; Chen, TJ; Li, ZL				Guo, Shuai; Zhou, Dan; Zhang, Mo; Li, Tiejun; Liu, Yujie; Xu, Yupin; Chen, Tianjing; Li, Zhili			Monitoring changes of docosahexaenoic acid-containing lipids during the recovery process of traumatic brain injury in rat using mass spectrometry imaging	SCIENTIFIC REPORTS			English	Article							DESORPTION ELECTROSPRAY-IONIZATION; SPRAY IONIZATION; FATTY-ACIDS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; ENCEPHALOPATHY; EPIDEMIOLOGY; METABOLITES; COMPLEXES; PHASE	Brain lipid homoeostasis is critical during recovery process after traumatic brain injury (TBI). In this study, we integrated liquid extraction and electrosonic spray ionization technology to develop an ionization device coupled with a Fourier transform ion cyclotron resonance mass spectrometer for imaging of docosahexaenoic acid (DHA)-containing lipids on rat brain tissues. The ion images of the brain tissue sections from the normal rats and the rats after TBI at acute phase (0 and 1 day) and chronic phase (3, 5, and 7 days) were obtained. The imaging results indicate that the levels of DHA and lysophosphatidylethanolamine (22:6) in the injury area of TBI rats increased significantly at the acute phase and subsequently decreased at the chronic phase. But the levels of DHA-containing phospholipids including phosphatidylethanolamine (PE)(P-18:0/22:6), PE(18:0/22:6), and phosphatidylserine (18:0/22:6) decreased at the acute phase and gradually increased at the chronic phase in the injury area accompanied by the morphogenesis and wound healing. These findings indicate that the DHA may participate in the recovery process of brain injury. This is the first report to in situ detect the changes in the levels of DHA and DHA-containing lipids in the TBI model.	[Guo, Shuai; Zhou, Dan; Zhang, Mo; Liu, Yujie; Xu, Yupin; Chen, Tianjing; Li, Zhili] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing, Peoples R China; [Guo, Shuai; Zhou, Dan; Zhang, Mo; Liu, Yujie; Xu, Yupin; Chen, Tianjing; Li, Zhili] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China; [Li, Tiejun] Second Mil Med Univ, Sch Pharm, Shanghai, Peoples R China		Li, ZL (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biophys & Struct Biol, Beijing, Peoples R China.; Li, ZL (corresponding author), Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China.	lizhili@ibms.pumc.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [91542101]	This study was funded by the National Natural Science Foundation of China (Grant No. 91542101) to Z.Li.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Barrett EC, 2014, ADV NUTR, V5, P268, DOI 10.3945/an.113.005280; Chen SM, 2015, NAT NANOTECHNOL, V10, P176, DOI [10.1038/NNANO.2014.282, 10.1038/nnano.2014.282]; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Guo S, 2015, ANAL CHEM, V87, P5860, DOI 10.1021/ac504761t; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Guo S, 2014, ANAL BIOANAL CHEM, V406, P4357, DOI 10.1007/s00216-014-7846-0; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hanrieder J, 2013, ACS CHEM NEUROSCI, V4, P666, DOI 10.1021/cn400053c; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hasadsri L, 2013, J NEUROTRAUM, V30, P897, DOI 10.1089/neu.2012.2672; Heijs B, 2015, ANAL CHEM, V87, P11978, DOI 10.1021/acs.analchem.5b03610; Ifa DR, 2010, ANALYST, V135, P669, DOI 10.1039/b925257f; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Lanekoff I, 2012, ANAL CHEM, V84, P8351, DOI 10.1021/ac301909a; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laskin J, 2016, ANAL CHEM, V88, P52, DOI 10.1021/acs.analchem.5b04188; Laskin J, 2012, ANAL CHEM, V84, P141, DOI 10.1021/ac2021322; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Lopez-Vales R, 2010, J NEUROSCI, V30, P3220, DOI 10.1523/JNEUROSCI.5770-09.2010; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Mills JD, 2011, J NEUROSURG, V114, P77, DOI 10.3171/2010.5.JNS08914; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Nefliu M, 2006, CHEM COMMUN, P888, DOI 10.1039/b514057a; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Pan HC, 2009, J NUTR BIOCHEM, V20, P715, DOI 10.1016/j.jnutbio.2008.06.014; Pan N, 2014, ANAL CHEM, V86, P9376, DOI 10.1021/ac5029038; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Shariatgorji M, 2014, NEUROPSYCHOPHARMACOL, V39, P34, DOI 10.1038/npp.2013.215; Singh Meharban, 2005, Indian Journal of Pediatrics, V72, P239, DOI 10.1007/BF02859265; Soltwisch J, 2015, SCIENCE, V348, P211, DOI 10.1126/science.aaa1051; Takats Z, 2004, ANAL CHEM, V76, P4050, DOI 10.1021/ac049848m; Takats Z, 2004, SCIENCE, V306, P471, DOI 10.1126/science.1104404; Tur JA, 2012, BRIT J NUTR, V107, pS23, DOI 10.1017/S0007114512001456; Van Berkel GJ, 2008, J MASS SPECTROM, V43, P500, DOI 10.1002/jms.1340; van Hove ERA, 2010, J CHROMATOGR A, V1217, P3946, DOI 10.1016/j.chroma.2010.01.033; Wang XD, 2015, CHEM SCI, V6, P729, DOI 10.1039/c4sc01850h; Wiseman JM, 2005, ANGEW CHEM INT EDIT, V44, P913, DOI 10.1002/anie.200461672; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Wu CP, 2013, MASS SPECTROM REV, V32, P218, DOI 10.1002/mas.21360; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	49	19	19	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 11	2017	7								5054	10.1038/s41598-017-05446-2			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA1BI	WOS:000405172600021	28698592	Green Published, gold			2022-02-06	
J	Szot, P; Franklin, A; Figlewicz, DP; Beuca, TP; Bullock, K; Hansen, K; Banks, WA; Raskind, MA; Peskind, ER				Szot, Patricia; Franklin, Allyn; Figlewicz, Dianne P.; Beuca, Timothy Petru; Bullock, Kristin; Hansen, Kim; Banks, William A.; Raskind, Murray A.; Peskind, Elaine R.			MULTIPLE LIPOPOLYSACCHARIDE (LPS) INJECTIONS ALTER INTERLEUKIN 6 (IL-6), IL-7, IL-10 AND IL-6 AND IL-7 RECEPTOR MRNA IN CNS AND SPLEEN	NEUROSCIENCE			English	Article						Neuroinflammation; LPS; spleen; interleukin-6; interleukin-10; IL receptor	CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; TRANSCRIPTIONAL ACTIVATION; PROINFLAMMATORY CYTOKINE; PARKINSONS-DISEASE; EXPRESSION; MICE; LOCALIZATION; INFLAMMATION; HIPPOCAMPUS	Neuroinflammation is proposed to be an important component in the development of several central nervous system (CNS) disorders including depression, Alzheimer's disease, Parkinson's disease, and traumatic brain injury. However, exactly how neuroinflammation leads to, or contributes to, these central disorders is unclear. The objective of the study was to examine and compare the expression of mRNAs for interleukin-6 (IL-6), IL-7, IL-10 and the receptors for IL-6 (IL-6R) and IL-7 (IL-7R) using in situ hybridization in discrete brain regions and in the spleen after multiple injections of 3 mg/kg lipopolysaccharide (LPS), a model of neuroinflammation. In the spleen, LPS significantly elevated IL-6 mRNA expression, then IL-10 mRNA, with no effect on IL-7 or IL-7R mRNA, while significantly decreasing IL-6R mRNA expression. In the CNS, LPS administration had the greatest effect on IL-6 and IL-6R mRNA. LPS increased IL-6 mRNA expression only in non neuronal cells throughout the brain, but significantly elevated IL-6R mRNA in neuronal populations, where observed, except the cerebellum. LPS resulted in variable effects on IL-10 mRNA, and had no effect on IL-7 or IL-7R mRNA expression. These studies indicate that LPS-induced neuroinflammation has substantial but variable effects on the regional and cellular patterns of CNS IL-6, IL-7 and IL-10, and for IL-6R and IL-7R mRNA expression. It is apparent that administration of LPS can affect non-neuronal and neuronal cells in the brain. Further research is required to determine how CNS inflammatory changes associated with IL-6, IL-10 and IL-6R could in turn contribute to the development of CNS neurological disorders. Published by Elsevier Ltd on behalf of IBRO.	[Szot, Patricia; Franklin, Allyn; Beuca, Timothy Petru; Raskind, Murray A.; Peskind, Elaine R.] Mental Illness Res Educ & Clin Ctr, Seattle, WA USA; [Bullock, Kristin; Hansen, Kim; Banks, William A.] Univ Washington, Sch Med, Geriatr Res Educ & Clin Ctr, Seattle, WA USA; [Bullock, Kristin; Hansen, Kim; Banks, William A.] Univ Washington, Sch Med, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; [Bullock, Kristin; Hansen, Kim; Banks, William A.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Figlewicz, Dianne P.] Vet Affairs Puget Sound Hlth Care Syst, BSR&D, Seattle, WA USA; [Figlewicz, Dianne P.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA		Szot, P (corresponding author), VA Puget Sound Hlth Care Syst, MIRECC, 1660 S Columbian Way, Seattle, WA 98108 USA.	szot@uw.edu	Banks, William A/K-1330-2017	Banks, William A/0000-0002-0496-3619	Department of Veterans Affairs VISN 20 Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC); Geriatric Research, Education, and Clinical Center (University of Washington Department of Psychiatry and Behavioral Sciences)	This work was supported by Department of Veterans Affairs VISN 20 Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC; Patricia Szot, Allyn Franklin, Murray A. Raskind and Elaine R. Peskind) and Geriatric Research, Education, and Clinical Center (University of Washington Department of Psychiatry and Behavioral Sciences (Patricia Szot, Murray A. Raskind and Elaine R. Peskind). Dianne Figlewicz Lattemann is a Senior Research Career Scientist, Biomedical Laboratory Research Program, Department of Veterans Affairs Puget Sound Health Care System, Seattle, Washington.	Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Banks WA, 1999, EXP NEUROL, V156, P165, DOI 10.1006/exnr.1998.7011; Brown MA, 1994, ANN NY ACAD SCI, V840, P21; Cazareth J, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-132; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Elenkov IJ, 1999, CYTOKINE, V6, P300; Erickson MA, 2011, BRAIN BEHAV IMMUN, V25, P1637, DOI 10.1016/j.bbi.2011.06.006; Francois A, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0056-z; Gadient RA, 1995, ANN NY ACAD SCI, V762, P403; GADIENT RA, 1994, BRAIN RES, V637, P10, DOI 10.1016/0006-8993(94)91211-4; GADIENT RA, 1994, NEUROSCI LETT, V182, P243, DOI 10.1016/0304-3940(94)90807-9; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Harden LM, 2014, PFLUG ARCH EUR J PHY, V466, P1451, DOI 10.1007/s00424-013-1371-4; Konsman JP, 2004, J COMP NEUROL, V472, P113, DOI 10.1002/cne.20052; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kuper DF, 2002, HDB TOXICOLOGICAL PA, V2, P586; Lebel E, 2000, ENDOCRINOLOGY, V141, P3749, DOI 10.1210/en.141.10.3749; Macia L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009953; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; O'Brien SM, 2004, HUM PSYCHOPHARM CLIN, V19, P397, DOI 10.1002/hup.609; Orr CF, 2002, PROG NEUROBIOL, V68, P325, DOI 10.1016/S0301-0082(02)00127-2; Paxinos G., 2013, MOUSE BRAIN STEREOTA, VFourth; Quan N, 2014, BRAIN BEHAV IMMUN, V40, P1, DOI 10.1016/j.bbi.2014.02.006; Ramsey CP, 2014, EXP NEUROL, V256, P126, DOI 10.1016/j.expneurol.2013.05.014; Rhodes JKJ, 2002, NEUROSCI LETT, V335, P1, DOI 10.1016/S0304-3940(02)00811-X; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Roth J, 2004, J THERM BIOL, V29, P383, DOI 10.1016/j.jtherbio.2004.08.002; Roth J, 2004, FRONT BIOSCI-LANDMRK, V9, P290, DOI 10.2741/1241; Rummel C, 2005, J COMP NEUROL, V491, P1, DOI 10.1002/cne.20653; Rummel C, 2008, J COMP NEUROL, V511, P373, DOI 10.1002/cne.21850; Rummel C, 2016, BRAIN BEHAV IMMUN, V54, P1, DOI 10.1016/j.bbi.2015.09.003; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Schaper F, 2015, CYTOKINE GROWTH F R, V26, P475, DOI 10.1016/j.cytogfr.2015.07.004; Schneiders J, 2015, BRAIN BEHAV IMMUN, V48, P147, DOI 10.1016/j.bbi.2015.03.008; SCHOBITZ B, 1992, NEUROSCI LETT, V136, P189, DOI 10.1016/0304-3940(92)90046-A; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; SCHOBITZ B, 1993, ENDOCRINOLOGY, V132, P1569, DOI 10.1210/en.132.4.1569; Smith EM, 1999, J NEUROIMMUNOL, V100, P140, DOI 10.1016/S0165-5728(99)00206-4; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Stoll G, 2000, J NEURAL TRANSM-SUPP, P81; Strle K, 2001, CRIT REV IMMUNOL, V21, P427; Szelenyi J, 2007, ANN NY ACAD SCI, V1113, P311, DOI 10.1196/annals.1391.026; Szot P, 1996, MOL BRAIN RES, V43, P233, DOI 10.1016/S0169-328X(96)00184-2; Vallieres L, 1999, ENDOCRINOLOGY, V140, P3890, DOI 10.1210/en.140.9.3890; Vallieres L, 1997, J NEUROCHEM, V69, P1668, DOI 10.1046/j.1471-4159.1997.69041668.x; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; Williamson LL, 2013, BRAIN BEHAV IMMUN, V30, P186, DOI 10.1016/j.bbi.2013.01.077	51	19	19	0	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUL 4	2017	355						9	21		10.1016/j.neuroscience.2017.04.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY6EQ	WOS:000404075700002	28456715				2022-02-06	
J	Byom, L; Turkstra, LS				Byom, Lindsey; Turkstra, Lyn S.			Cognitive task demands and discourse performance after traumatic brain injury	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						traumatic brain injury; social communication; theory of mind; executive function; speech-language pathology	SOCIAL COMMUNICATION; EXECUTIVE FUNCTION; EMOTION RECOGNITION; STORY NARRATIVES; HEAD-INJURY; MIND; ADULTS; LANGUAGE; ADOLESCENTS; DEFICITS	BackgroundSocial communication problems are common in adults with traumatic brain injury (TBI), particularly problems in spoken discourse. Social communication problems are thought to reflect underlying cognitive impairments. AimsTo measure the contribution of two cognitive processes, executive functioning (EF) and theory of mind (ToM), to the communication of adults with TBI, and to investigate the relationships between discourse performance and potential communication partners' perceptions. Methods & ProceduresTwenty-one adults with moderate-to-severe TBI and 23 uninjured adults completed a discourse task in which EF and ToM demands were manipulated across three conditions: baseline, high-EF and high-ToM. Dependent variables were fluency (for EFs), number of mental state terms (MSTs; for ToM) and speech rate. Discourse from high-EF/ToM conditions was judged by naive raters for social acceptability. Outcomes & ResultsThe TBI group produced significantly fewer MSTs than the comparison group across conditions and also spoke at a slower rate, and there were significant effects of condition on both measures (MST: high-EF < baseline = high-ToM; speech rate: high-EF < high-ToM < baseline). There were no significant between-groups differences in fluency or interaction of fluency with condition. MST use and fluency were associated with social acceptability ratings. Conclusions & ImplicationsResults added further evidence of social communication problems in adults with TBI and demonstrated that discourse behaviours may negatively affect how a speaker is perceived. Results also indicated that task manipulations can affect discourse performance, suggesting that general cognitive demands may influence social communication after TBI.	[Byom, Lindsey; Turkstra, Lyn S.] William S Middleton Mem Vet Adm Med Ctr, GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA; [Byom, Lindsey] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI USA		Byom, L (corresponding author), William S Middleton Mem Vet Adm Med Ctr, GRECC, 2500 Overlook Terrace, Madison, WI 53705 USA.	lindsey.byom@va.gov	Turkstra, Lyn/ABC-5831-2021; Byom, Lindsey/AAC-5095-2019	Turkstra, Lyn/0000-0002-6948-6921; Byom, Lindsey/0000-0002-2457-1735	Wisconsin Alumni Research Foundation; Walker Foundation; NIDCDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F31DC012481]; University of Wisconsin-Madison Department of Communication Sciences and Disorders Interdisciplinary training grant NIDCD [T32DC005259]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R56DC005259, F31DC012481, R01DC005259] Funding Source: NIH RePORTER	This manuscript was prepared at the William S. Middleton Memorial Veteran Affairs Hospital in Madison, WI; GRECC manuscript #2015-014. The views and content expressed in this article are solely the responsibility of the authors and do not necessarily reflect the position, policy, or official views of the Department of Veteran Affairs or the U.S. government. This work was supported in part by funds from the Wisconsin Alumni Research Foundation and the Walker Foundation, as well as through fellowship support to the first author from NIDCD F31DC012481 and from the University of Wisconsin-Madison Department of Communication Sciences and Disorders Interdisciplinary training grant NIDCD T32DC005259. The authors thank Professor Skye McDonald for comments made on an earlier version of the manuscript; and Sarah Riedeman and Rachel Solomon for assistance with data analysis. The authors also thank the participants and their families for participation in this study.	Adrian JE, 2005, J CHILD LANG, V32, P673, DOI 10.1017/S0305000905006963; Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; BATES E, 1983, CAN J PSYCHOL, V37, P59, DOI 10.1037/h0080695; Beddeley AD., 1974, PSYCHOL LEARN MOTIV, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Breau LM, 2015, J CHILD NEUROL, V30, P588, DOI 10.1177/0883073814528282; BRETHERTON I, 1982, DEV PSYCHOL, V18, P906, DOI 10.1037/0012-1649.18.6.906; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Byom Lindsey J, 2013, Front Hum Neurosci, V7, P413, DOI 10.3389/fnhum.2013.00413; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; CAMPBELL TF, 1995, J SPEECH HEAR RES, V38, P864, DOI 10.1044/jshr.3804.864; Channon Shelley, 2003, Cogn Neuropsychiatry, V8, P243, DOI 10.1080/135468000344000002; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho C, 2013, AM J SPEECH-LANG PAT, V22, pS438, DOI 10.1044/1058-0360(2013/12-0076); Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2001, DKEFS DELIS KAPLAN E; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); FAGAN WT, 1982, RES TEACH ENGL, V16, P85; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Ghayoumi Z, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.21473; IBM, 2013, SPSS STAT MAC VERS 2; Jones CA, 2011, BRAIN INJURY, V25, P844, DOI 10.3109/02699052.2011.585507; Kertesz A., 1982, W APHASIA BATTERY; KOWAL S, 1975, J PSYCHOLINGUIST RES, V4, P195, DOI 10.1007/BF01066926; Le K, 2014, AM J SPEECH-LANG PAT, V23, P271, DOI 10.1044/2014_AJSLP-13-0095; MacWhinney B., 2000, CHILDES PROJECT; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moran C, 2012, LANG SPEECH HEAR SER, V43, P264, DOI 10.1044/0161-1461(2011/10-0114); Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; NICHOLAS LE, 1993, J SPEECH HEAR RES, V36, P338, DOI 10.1044/jshr.3602.338; Powell J., 2000, COGNITIVE NEUROPSYCH, V5, P175, DOI [DOI 10.1080/13546800050083520, 10.1080/13546800050083520]; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Prigatano G. P., 1985, LANG SCI, V7, P217, DOI [10.1016/S0388-0001(85)80020-6, DOI 10.1016/S0388-0001(85)80020-6]; QUALTRICS, 2013, QUALTR SURV SUIT VER; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Sainson C., 2014, Annals of Physical and Rehabilitation Medicine, V57, P664, DOI 10.1016/j.rehab.2014.08.011; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Sedikides C., 1999, REPRESENTATIVE RES S, V23, P1; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Togher L, 1998, APHASIOLOGY, V12, P755, DOI 10.1080/02687039808249571; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Turkstra Lyn S, 2004, Acta Neuropsychol, V2, P70; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Ybarra O, 2008, PERS SOC PSYCHOL B, V34, P248, DOI 10.1177/0146167207310454	55	19	19	1	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	JUL-AUG	2017	52	4					501	513		10.1111/1460-6984.12289			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	EZ7VK	WOS:000404933600011	27891725	Green Accepted			2022-02-06	
J	Rokad, D; Ghaisas, S; Harischandra, DS; Jin, HJ; Anantharam, V; Kanthasamy, A; Kanthasamy, AG				Rokad, Dharmin; Ghaisas, Shivani; Harischandra, Dilshan S.; Jin, Huajun; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.			Role of neurotoxicants and traumatic brain injury in alpha-synuclein protein misfolding and aggregation	BRAIN RESEARCH BULLETIN			English	Article						Alpha-synuclein; Pesticides; Metals; Protein aggregation; Traumatic brain injury; Oxidative stress; Parkinson disease; Neurodegenerative disease	ENVIRONMENTAL RISK-FACTORS; KINASE-C-DELTA; PARKINSONS-DISEASE; OXIDATIVE STRESS; LEWY BODIES; CELL-DEATH; IN-VITRO; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; DOPAMINERGIC DEGENERATION	Protein misfolding and aggregation are key pathological features of many neurodegenerative diseases including Parkinson's disease (PD) and other forms of human Parkinsonism. PD is a complex and multifaceted disorder whose etiology is not fully understood. However, several lines of evidence support the multiple hit hypothesis that genetic vulnerability and environmental toxicants converge to trigger PD pathology. Alpha-synuclein (alpha-Syn) aggregation in the brain is an important pathophysiological characteristic of synucleinopathies including PD. Epidemiological and experimental studies have shown that metals and pesticides play a crucial role in alpha-Syn aggregation leading to the onset of various neurodegenerative diseases including PD. In this review, we will emphasize key findings of several epidemiological as well as experimental studies of metal- and pesticide-induced alpha-Syn aggregation and neurodegeneration. We will also discuss other factors such as traumatic brain injury and oxidative insult in the context of alpha-Syn-related neurodegenerative processes. (C) 2016 Elsevier Inc. All rights reserved.	[Rokad, Dharmin; Ghaisas, Shivani; Harischandra, Dilshan S.; Jin, Huajun; Anantharam, Vellareddy; Kanthasamy, Arthi; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neuroroxicol, Parkinson Disorders Res Program, Ames, IA 50011 USA; [Harischandra, Dilshan S.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Parkinson Disorders Res Lab, 1222 Vet Med Bldg, Ames, IA 50011 USA.	akanthas@iastate.edu	Ghaisas, Shivani/AAO-7105-2020	Ghaisas, Shivani/0000-0001-7827-8190; Kanthasamy, Anumantha/0000-0002-6454-4264; Harischandra, Dilshan/0000-0003-3220-8765	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ES19267, ES26892, NS074443, ES10586, N5088206]; Linda Lloyd Endowed Chair; Syngenta Fellowship Award in Human Health Applications of New TechnologiesSyngenta; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [R01ES019267, R01ES010586, R01ES026892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088206, R01NS074443] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health RO1 grants ES19267, ES26892, NS074443 and ES10586 awarded to A.G.K, and N5088206 to A.K. The W. Eugene and Linda Lloyd Endowed Chair to A.G.K, the Dean Endowed Professorship to AK and the Syngenta Fellowship Award in Human Health Applications of New Technologies to D.S.H. are also acknowledged. We also thank Mr. Gary Zenitsky for assistance in preparing this manuscript.	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Askanas V, 2000, J NEUROPATH EXP NEUR, V59, P592, DOI 10.1093/jnen/59.7.592; Babadi VY, 2014, J TOXICOL-US, V2014, DOI 10.1155/2014/946372; Bates CA, 2015, ADMET DMPK, V3, P15, DOI 10.5599/admet.3.1.159; Bayer TA, 1999, NEUROSCI LETT, V266, P213, DOI 10.1016/S0304-3940(99)00311-0; Betarbet R, 2006, NEUROBIOL DIS, V22, P404, DOI 10.1016/j.nbd.2005.12.003; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Biasiotto G, 2016, MOL NEUROBIOL, V53, P5542, DOI 10.1007/s12035-015-9473-y; Bihaqi SW, 2013, NEUROTOXICOLOGY, V39, P95, DOI 10.1016/j.neuro.2013.07.010; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Binolfi Q. L., 2014, J BACTERIOL, V196, P3980; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Cai TJ, 2010, BRAIN RES, V1359, P201, DOI 10.1016/j.brainres.2010.08.055; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Carboni E, 2015, METALLOMICS, V7, P395, DOI 10.1039/c4mt00339j; Chatterjee S, 2014, CHEM RES TOXICOL, V27, P1887, DOI 10.1021/tx500264s; Chen P., 2016, METALS NEURODEGENERA; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chun HS, 2001, J NEUROCHEM, V76, P1010, DOI 10.1046/j.1471-4159.2001.00096.x; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.0.CO;2-E; Cook C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009423; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Corrigan FM, 1996, HUM EXP TOXICOL, V15, P262, DOI 10.1177/096032719601500314; Corrigan FM, 1998, EXP NEUROL, V150, P339, DOI 10.1006/exnr.1998.6776; Corrigan FM, 2000, J TOXICOL ENV HEAL A, V59, P229, DOI 10.1080/009841000156907; Couraud PO, 1998, PATHOL BIOL, V46, P176; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Culvenor JG, 1999, AM J PATHOL, V155, P1173, DOI 10.1016/S0002-9440(10)65220-0; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Dick FD, 2007, OCCUP ENVIRON MED, V64, P666, DOI 10.1136/oem.2006.027003; Drew SC, 2008, J AM CHEM SOC, V130, P7766, DOI 10.1021/ja800708x; Du HN, 2006, FEBS LETT, V580, P3657, DOI 10.1016/j.febslet.2006.05.050; Dunning CJR, 2013, PRION, V7, P92, DOI 10.4161/pri.23806; Eid Aseel, 2016, Alzheimers Dement (Amst), V2, P123, DOI 10.1016/j.dadm.2016.02.002; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; ENZENAUER RW, 1989, JAMA-J AM MED ASSOC, V261, P1463, DOI 10.1001/jama.261.10.1463; Fares MB, 2014, HUM MOL GENET, V23, P4491, DOI 10.1093/hmg/ddu165; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Febbraro F, 2012, NEUROREPORT, V23, P576, DOI 10.1097/WNR.0b013e328354a1f0; Feng LR, 2011, NEUROTOX RES, V20, P387, DOI 10.1007/s12640-011-9255-x; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Fukushima T, 2011, NEUROEPIDEMIOLOGY, V36, P240, DOI 10.1159/000328253; George W., 2002, GENOME BIOL, V3; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Golts N, 2002, J BIOL CHEM, V277, P16116, DOI 10.1074/jbc.M107866200; Gorell JM, 1999, NEUROTOXICOLOGY, V20, P239; Gorell JM, 1997, NEUROLOGY, V48, P650, DOI 10.1212/WNL.48.3.650; Gorojod RM, 2015, FREE RADICAL BIO MED, V87, P237, DOI 10.1016/j.freeradbiomed.2015.06.034; Ha Y, 2014, J NEUROSCI RES, V92, P359, DOI 10.1002/jnr.23323; Harischandra DS, 2015, TOXICOL SCI, V143, P454, DOI 10.1093/toxsci/kfu247; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hashimoto M, 2003, NEUROMOL MED, V4, P21, DOI 10.1385/NMM:4:1-2:21; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hatcher JM, 2007, EXP NEUROL, V204, P619, DOI 10.1016/j.expneurol.2006.12.020; He Q, 2013, INT J BIOCHEM CELL B, V45, P1019, DOI 10.1016/j.biocel.2013.02.012; Horning KJ, 2015, ANNU REV NUTR, V35, P71, DOI 10.1146/annurev-nutr-071714-034419; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Ibanez P, 2009, ARCH NEUROL-CHICAGO, V66, P102, DOI 10.1001/archneurol.2008.555; Jackson MS, 2009, INORG CHEM, V48, P9303, DOI 10.1021/ic901157w; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jensen PH, 1998, J BIOL CHEM, V273, P26292, DOI 10.1074/jbc.273.41.26292; Ji HJ, 1997, CANCER RES, V57, P759; Jin HJ, 2011, J NEUROSCI, V31, P2035, DOI 10.1523/JNEUROSCI.5634-10.2011; Jorgenson JL, 2001, ENVIRON HEALTH PERSP, V109, P113, DOI 10.2307/3434852; Kanthasamy AG, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-12; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kitazawa M, 2003, NEUROSCIENCE, V119, P945, DOI 10.1016/S0306-4522(03)00226-4; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kwakye GF, 2015, INT J ENV RES PUB HE, V12, P7519, DOI 10.3390/ijerph120707519; Kwik-Uribe C, 2006, J NEUROSCI RES, V83, P1601, DOI 10.1002/jnr.20836; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lazaro DF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004741; Lechpammer M, 2014, ANN NEUROL, V75, P608, DOI 10.1002/ana.24131; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2002, J BIOL CHEM, V277, P48976, DOI 10.1074/jbc.M208192200; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li WX, 2005, P NATL ACAD SCI USA, V102, P2162, DOI 10.1073/pnas.0406976102; Li Y, 2010, BRAIN RES BULL, V81, P428, DOI 10.1016/j.brainresbull.2009.11.007; Liang GQ, 2015, FOOD CHEM TOXICOL, V83, P261, DOI 10.1016/j.fct.2015.07.005; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez-Finley EJ, 2013, FREE RADICAL BIO MED, V62, P65, DOI 10.1016/j.freeradbiomed.2013.01.032; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Michalke B, 2014, J TRACE ELEM MED BIO, V28, P106, DOI 10.1016/j.jtemb.2013.08.005; Mondello S, 2013, NEUROLOGY, V80, P1662, DOI 10.1212/WNL.0b013e3182904d43; More SV, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/952375; Navarro-Otano J, 2013, PARKINSONISM RELAT D, V19, P27, DOI 10.1016/j.parkreldis.2012.07.005; Negro A, 2001, FASEB J, V15, P210, DOI 10.1096/fj.01-0517fje; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pan-Montojo F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00898; Petty MA, 2002, PROG NEUROBIOL, V68, P311, DOI 10.1016/S0301-0082(02)00128-4; Povlishock JT, 2008, J NEUROTRAUM, V25, P717, DOI 10.1089/neu.2008.9964; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Pyatigorskaya N, 2015, MOVEMENT DISORD, V30, P1077, DOI 10.1002/mds.26218; Rasia RM, 2005, P NATL ACAD SCI USA, V102, P4294, DOI 10.1073/pnas.0407881102; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Roth JA, 2014, NEUROTOXICOLOGY, V44, P314, DOI 10.1016/j.neuro.2014.08.006; RYBICKI BA, 1993, MOVEMENT DISORD, V8, P87, DOI 10.1002/mds.870080116; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saberzadeh J, 2016, BRAIN RES, V1635, P153, DOI 10.1016/j.brainres.2016.01.037; Sanchez-Ramos J, 1998, EXP NEUROL, V150, P263, DOI 10.1006/exnr.1997.6770; Schildknecht S, 2005, FASEB J, V19, P1169, DOI 10.1096/fj.04-3465fje; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Sheftel AD, 2012, BBA-GEN SUBJECTS, V1820, P161, DOI 10.1016/j.bbagen.2011.08.002; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s10059-000-0065-x; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; SPILLANTINI MG, 1995, GENOMICS, V27, P379, DOI 10.1006/geno.1995.1063; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sun F, 2005, J PHARMACOL EXP THER, V315, P69, DOI 10.1124/jpet.105.084632; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tavassoly O, 2014, FEBS J, V281, P2738, DOI 10.1111/febs.12817; TOBE T, 1992, J NEUROCHEM, V59, P1624, DOI 10.1111/j.1471-4159.1992.tb10991.x; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; TOKUDA T, 1991, ACTA NEUROPATHOL, V82, P280, DOI 10.1007/BF00308813; Tsunemi T, 2014, HUM MOL GENET, V23, P2791, DOI 10.1093/hmg/ddt572; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Uversky VN, 2001, FEBS LETT, V500, P105, DOI 10.1016/S0014-5793(01)02597-2; Valensin D, 2016, J INORG BIOCHEM, V163, P292, DOI 10.1016/j.jinorgbio.2016.04.012; Verina T, 2013, TOXICOL LETT, V217, P177, DOI 10.1016/j.toxlet.2012.12.006; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Visanji Naomi P, 2013, Acta Neuropathol Commun, V1, P2, DOI 10.1186/2051-5960-1-2; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; White AR, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00127; Wills J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030745; Xiang W, 2013, MOL CELL NEUROSCI, V54, P71, DOI 10.1016/j.mcn.2013.01.004; Xu B, 2013, TOXICOLOGY, V305, P71, DOI 10.1016/j.tox.2013.01.006; Yuan YH, 2015, TOXICOL LETT, V233, P163, DOI 10.1016/j.toxlet.2014.11.029; Zarbiv Y, 2014, NEUROBIOL DIS, V70, P90, DOI 10.1016/j.nbd.2014.05.031; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang HY, 2013, BIOPHYS J, V104, P2706, DOI 10.1016/j.bpj.2013.04.050; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	151	19	19	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUL	2017	133				SI		60	70		10.1016/j.brainresbull.2016.12.003			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH0ZR	WOS:000410869700007	27993598	Green Accepted			2022-02-06	
J	Yeates, KO; Beauchamp, M; Craig, W; Doan, Q; Zemek, R; Bjornson, BH; Gravel, J; Mikrogianakis, A; Goodyear, B; Abdeen, N; Beaulieu, C; Dehaes, M; Deschenes, S; Harris, A; Lebel, C; Lamont, R; Williamson, T; Barlow, KM; Bernier, F; Brooks, BL; Emery, C; Freedman, SB; Kowalski, K; Mrklas, K; Tomfohr-Madsen, L; Schneider, KJ				Yeates, Keith Owen; Beauchamp, Miriam; Craig, William; Doan, Quynh; Zemek, Roger; Bjornson, Bruce H.; Gravel, Jocelyn; Mikrogianakis, Angelo; Goodyear, Bradley; Abdeen, Nishard; Beaulieu, Christian; Dehaes, Mathieu; Deschenes, Sylvain; Harris, Ashley; Lebel, Catherine; Lamont, Ryan; Williamson, Tyler; Barlow, Karen Maria; Bernier, Francois; Brooks, Brian L.; Emery, Carolyn; Freedman, Stephen B.; Kowalski, Kristina; Mrklas, Kelly; Tomfohr-Madsen, Lianne; Schneider, Kathryn J.		Pediat Emergency Res Canada PERC	Advancing Concussion Assessment in Pediatrics (A-CAP): a prospective, concurrent cohort, longitudinal study of mild traumatic brain injury in children: study protocol	BMJ OPEN			English	Article							FUNCTIONAL DISABILITY INVENTORY; FAMILY ASSESSMENT DEVICE; SERIOUS MENTAL-ILLNESS; SYMPTOM VALIDITY TEST; EMERGENCY-DEPARTMENT; POSTCONCUSSIVE SYMPTOMS; POSTURAL STABILITY; GENERAL-POPULATION; OUTCOME SCALE; HEAD TRAUMA	Introduction Paediatric mild traumatic brain injury (mTBI) is a public health burden. Clinicians urgently need evidence-based guidance to manage mTBI, but gold standards for diagnosing and predicting the outcomes of mTBI are lacking. The objective of the Advancing Concussion Assessment in Pediatrics (A-CAP) study is to assess a broad pool of neurobiological and psychosocial markers to examine associations with postinjury outcomes in a large sample of children with either mTBI or orthopaedic injury (OI), with the goal of improving the diagnosis and prognostication of outcomes of paediatric mTBI. Methods and analysis A-CAP is a prospective, longitudinal cohort study of children aged 8.00-16.99 years with either mTBI or OI, recruited during acute emergency department (ED) visits at five sites from the Pediatric Emergency Research Canada network. Injury information is collected in the ED; follow-up assessments at 10 days and 3 and 6 months postinjury measure a variety of neurobiological and psychosocial markers, covariates/confounders and outcomes. Weekly postconcussive symptom ratings are obtained electronically. Recruitment began in September 2016 and will occur for approximately 24 months. Analyses will test the major hypotheses that neurobiological and psychosocial markers can: (1) differentiate mTBI from OI and (2) predict outcomes of mTBI. Models initially will focus within domains (eg, genes, imaging biomarkers, psychosocial markers), followed by multivariable modelling across domains. The planned sample size (700 mTBI, 300 OI) provides adequate statistical power and allows for internal cross-validation of some analyses. Ethics and dissemination The ethics boards at all participating institutions have approved the study and all participants and their parents will provide informed consent or assent. Dissemination will follow an integrated knowledge translation plan, with study findings presented at scientific conferences and in multiple manuscripts in peer-reviewed journals.	[Yeates, Keith Owen; Kowalski, Kristina; Tomfohr-Madsen, Lianne] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen; Goodyear, Bradley; Harris, Ashley; Emery, Carolyn; Schneider, Kathryn J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Yeates, Keith Owen; Mikrogianakis, Angelo; Harris, Ashley; Lebel, Catherine; Lamont, Ryan; Barlow, Karen Maria; Bernier, Francois; Brooks, Brian L.; Emery, Carolyn; Freedman, Stephen B.; Kowalski, Kristina; Tomfohr-Madsen, Lianne; Schneider, Kathryn J.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Beauchamp, Miriam] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Beauchamp, Miriam; Gravel, Jocelyn; Dehaes, Mathieu; Deschenes, Sylvain] Ste Justine Hosp, Montreal, PQ, Canada; [Craig, William] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Craig, William] Stollery Childrens Hosp, Edmonton, AB, Canada; [Doan, Quynh; Bjornson, Bruce H.] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Doan, Quynh; Bjornson, Bruce H.] BC Childrens Hosp, Vancouver, BC, Canada; [Zemek, Roger] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat & Emergency Med, Ottawa, ON, Canada; [Gravel, Jocelyn] Univ Montreal, Dept Pediat, Montreal, PQ, Canada; [Goodyear, Bradley; Harris, Ashley; Lebel, Catherine] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Abdeen, Nishard] Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; [Abdeen, Nishard] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Beaulieu, Christian] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Dehaes, Mathieu; Deschenes, Sylvain] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ, Canada; [Lamont, Ryan] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Lamont, Ryan; Barlow, Karen Maria; Bernier, Francois; Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada; [Williamson, Tyler] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Barlow, Karen Maria; Brooks, Brian L.; Freedman, Stephen B.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Barlow, Karen Maria; Brooks, Brian L.] Univ Calgary, Dept Pediat, Calgary, AB, Canada; [Bernier, Francois] Univ Calgary, Dept Med Genet, Calgary, AB, Canada; [Emery, Carolyn; Schneider, Kathryn J.] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; [Mrklas, Kelly] Alberta Hlth Serv, Res Innovat & Analyt, Calgary, AB, Canada		Yeates, KO (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.; Yeates, KO (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; Yeates, KO (corresponding author), Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada.	kyeates@ucalgary.ca	Yeates, Keith/AAJ-4223-2020; Emery, Carolyn/AAI-2761-2020; Bernier, Francois/AAP-2174-2020; Mikrogianakis, Angelo/AAW-5929-2021; Doan, Quynh/AAJ-6023-2021; Beaulieu, Christian/E-9796-2011; Bernier, Francois/V-7150-2018; Barlow, Karen/I-6492-2019; Zemek, Roger/H-1039-2018; Barlow, Karen/C-1323-2014; Bjornson, Bruce Hal/A-8616-2010; Freedman, Stephen/H-9102-2012; Lebel, Catherine/B-4298-2015	Mikrogianakis, Angelo/0000-0002-8854-0620; Doan, Quynh/0000-0002-8435-7837; Beaulieu, Christian/0000-0002-2342-3298; Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Bjornson, Bruce Hal/0000-0002-1465-6196; Craig, William/0000-0002-4804-194X; Freedman, Stephen/0000-0003-2319-6192; Tomfohr-Madsen, Lianne/0000-0002-0860-5392; Yeates, Keith/0000-0001-7680-2892; Schneider, Kathryn/0000-0002-5951-5899; Lebel, Catherine/0000-0002-0344-4032	Canadian Institute of Health Research (CIHR) Foundation Grant [FDN143304]; Alberta Children's Hospital Foundation; Alberta Children's Hospital Research Institute	This work is supported by a Canadian Institute of Health Research (CIHR) Foundation Grant (FDN143304) to KY, as well as by funds from the Alberta Children's Hospital Foundation and Alberta Children's Hospital Research Institute.	Allen JL, 2012, J PSYCHOPATHOL BEHAV, V34, P204, DOI 10.1007/s10862-011-9270-5; *AM ASS AUT MED, 1990, ABBR INJ SCAL AIS 19; ANDERSEN MB, 1988, J SPORT EXERCISE PSY, V10, P294, DOI 10.1123/jsep.10.3.294; [Anonymous], 1999, WECHSLER ABBREVIATED; ASHER SR, 1984, CHILD DEV, V55, P1456, DOI 10.2307/1130015; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Becker SP, 2015, SLEEP MED, V16, P79, DOI 10.1016/j.sleep.2014.09.008; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Bornbaum CC, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0351-9; Brooks BL, 2016, J NEUROTRAUM, V33, P2091, DOI 10.1089/neu.2015.4301; Brooks BL, 2016, J INT NEUROPSYCH SOC, V22, P379, DOI 10.1017/S1355617715001368; Brooks BL, 2014, J NEUROTRAUM, V31, P1744, DOI 10.1089/neu.2014.3356; BURCHINAL MR, 1994, J EARLY INTERVENTION, V18, P403, DOI 10.1177/105381519401800409; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Canadian Health Services Research Foundation, 2003, THEOR PRACT KNOWL BR; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chevignard M, 2015, ANN PHYS REHABIL MED, V58, pe138; Claar RL, 2006, PAIN, V121, P77, DOI 10.1016/j.pain.2005.12.002; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Ebesutani C, 2012, J PERS ASSESS, V94, P427, DOI 10.1080/00223891.2012.662188; Ewing-Cobbs L, 2014, J PEDIATR PSYCHOL, V39, P653, DOI 10.1093/jpepsy/jsu018; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1111/1469-7610.00494; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Green P., 2004, MANUAL GREENS MED SY; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haug E, 2009, INT J PUBLIC HEALTH, V54, P167, DOI 10.1007/s00038-009-5408-6; Hewitt PL, 2002, PERS INDIV DIFFER, V32, P1049, DOI 10.1016/S0191-8869(01)00109-X; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Kessler RC, 2010, INT J METH PSYCH RES, V19, P4, DOI 10.1002/mpr.310; Khetani AM, PED EMERG C IN PRESS; Kirkwood MW, 2012, PSYCHOL ASSESSMENT, V24, P36, DOI 10.1037/a0024628; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LeBourgeois MK, 2005, PEDIATRICS, V115, P257, DOI 10.1542/peds.2004-0815H; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Malecki CK, 2002, PSYCHOL SCHOOLS, V39, P1; McAllister TW, 2010, PM&R, V2, pS241, DOI 10.1016/j.pmrj.2010.10.005; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Mittenberg W, 1997, NEUROPSYCHOLOGY, V11, P447, DOI 10.1037/0894-4105.11.3.447; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37; Noel M, 2015, J PAIN, V16, P31, DOI 10.1016/j.jpain.2014.10.005; Novak Z, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2900; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Reynolds C. R., 2004, BEHAV ASSESSMENT SYS, V2nd; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sinharay S, 2001, PSYCHOL METHODS, V6, P317, DOI 10.1037//1082-989X.6.4.317; Speranza M, 2012, CAN J PSYCHIAT, V57, P570, DOI 10.1177/070674371205700908; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2009, PEDIATR CLIN N AM, V56, P843, DOI 10.1016/j.pcl.2009.05.016; von Baeyer CL, 2009, PAIN, V143, P223, DOI 10.1016/j.pain.2009.03.002; WALKER LS, 1991, J PEDIATR PSYCHOL, V16, P39, DOI 10.1093/jpepsy/16.1.39; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Yeates KO, 2012, ARCH PEDIAT ADOLESC, V166, P585; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zemek R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003550	76	19	19	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open	JUL	2017	7	7							e017012	10.1136/bmjopen-2017-017012			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FG4HQ	WOS:000410203700218	28710227	Green Published, Green Submitted, gold			2022-02-06	
J	Taylor, JA; Rodgers, KM; Bercum, FM; Booth, CJ; Dudek, FE; Barth, DS				Taylor, Jeremy A.; Rodgers, Krista M.; Bercum, Florencia M.; Booth, Carmen J.; Dudek, F. Edward; Barth, Daniel S.			Voluntary Control of Epileptiform Spike-Wave Discharges in Awake Rats	JOURNAL OF NEUROSCIENCE			English	Article						absence; epilepsy; SWD	SPRAGUE-DAWLEY RATS; PHOTOTHROMBOTIC BRAIN INFARCTION; FLUID PERCUSSION INJURY; TEMPORAL-LOBE EPILEPSY; LONG-EVANS RATS; POSTTRAUMATIC EPILEPSY; ABSENCE SEIZURES; ANIMAL-MODELS; COMMON; EPILEPTOGENESIS	Genetically inherited absence epilepsy in humans is typically characterized by brief (seconds) spontaneous seizures, which involve spike-wave discharges (SWDs) in the EEG and interruption of consciousness and ongoing behavior. Genetic (inbred) models of this disorder in rats have been used to examine mechanisms, comorbidities, and antiabsence drugs. SWDs have also been proposed as models of complex partial seizures (CPSs) following traumatic brain injury (post-traumatic epilepsy). However, the ictal characteristics of these rat models, including SWDs and associated immobility, are also prevalent in healthy outbred laboratory rats. We therefore hypothesized that SWDs are not always associated with classically defined absence seizures or CPSs. To test this hypothesis, we used operant conditioning in male rats to determine whether outbred strains, Sprague Dawley and Long-Evans, and/or the inbred WAG/Rij strain (a rat model of heritable human absence epilepsy) could exercise voluntary control over these epileptiform events. We discovered that both inbred and outbred rats could shorten the duration of SWDs to obtain a reward. These results indicate that SWD and associated immobility in rats may not reflect the obvious cognitive/behavioral interruption classically associated with absence seizures or CPSs in humans. One interpretation of these results is that human absence seizures and perhaps CPSs could permit a far greater degree of cognitive capacity than often assumed and might be brought under voluntary control in some cases. However, these results also suggest that SWDs and associated immobility may be nonepileptic in healthy outbred rats and reflect instead voluntary rodent behavior unrelated to genetic manipulation or to brain trauma.	[Taylor, Jeremy A.; Rodgers, Krista M.; Bercum, Florencia M.; Barth, Daniel S.] Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA; [Booth, Carmen J.] Yale Univ, Dept Comparat Med, Sch Med, New Haven, CT 06520 USA; [Dudek, F. Edward] Univ Utah, Dept Neurosurg, Sch Med, Salt Lake City, UT 84108 USA		Barth, DS (corresponding author), Univ Colorado, Dept Psychol & Neurosci, Campus Box 345, Boulder, CO 80309 USA.	daniel.barth@colorado.edu	Rodgers, Krista/AAC-5063-2020	BARTH, DANIEL/0000-0001-5474-1320; Booth, Carmen Jane/0000-0002-2153-738X; RODGERS, KRISTA/0000-0003-4393-6389	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [PR100040, EP150033]; Citizens United for Research in Epilepsy [7153]; Rugen Biomedical and Neurona Therapeutics; Epitel	This work was supported by the U.S. Army Medical Research and Material Command (Grants PR100040 and EP150033) and by Citizens United for Research in Epilepsy (Grant #7153).; F.E. Dudek has received consulting fees from Rugen Biomedical and Neurona Therapeutics. He has equity interest in and receives consultant fees from Epitel, a company that makes telemetric recording devices; however, this work did not use these devices. The other authors declare no competing financial interests.	ALDINIO C, 1985, METHOD FIND EXP CLIN, V7, P563; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Blumenfeld H, 2005, PROG BRAIN RES, V150, P271, DOI 10.1016/S0079-6123(05)50020-7; Blumenfeld H, 2012, LANCET NEUROL, V11, P814, DOI 10.1016/S1474-4422(12)70188-6; BUZSAKI G, 1990, NEUROSCIENCE, V36, P1, DOI 10.1016/0306-4522(90)90345-5; BUZSAKI G, 1990, NEUROSCIENCE, V38, P323, DOI 10.1016/0306-4522(90)90031-X; Chipaux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058180; Coenen AML, 2003, BEHAV GENET, V33, P635, DOI 10.1023/A:1026179013847; D'Ambrosio R, 2004, BRAIN, V127, P304, DOI 10.1093/brain/awh038; D'Ambrosio R, 2010, EPILEPSY CURR, V10, P61, DOI 10.1111/j.1535-7511.2010.01358.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Hughes JR, 2009, EPILEPSY BEHAV, V15, P404, DOI 10.1016/j.yebeh.2009.06.007; KAPLAN BJ, 1985, EXP NEUROL, V88, P425, DOI 10.1016/0014-4886(85)90204-3; Kelly KM, 2006, EXP NEUROL, V201, P495, DOI 10.1016/j.expneurol.2006.05.006; Kelly Kevin M, 2004, Epilepsy Curr, V4, P176, DOI 10.1111/j.1535-7597.2004.04503.x; Kelly KM, 2001, EPILEPSY RES, V47, P189, DOI 10.1016/S0920-1211(01)00294-7; Kharlamov EA, 2003, EPILEPSY RES, V56, P185, DOI 10.1016/j.eplepsyres.2003.09.005; KLEINLOGEL H, 1985, NEUROPSYCHOBIOLOGY, V13, P206, DOI 10.1159/000118189; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P37; Nandan M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036001; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Osterhagen L, 2010, EPILEPSY RES, V90, P75, DOI 10.1016/j.eplepsyres.2010.03.010; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Reid AY, 2016, EPILEPSIA, V57, P1558, DOI 10.1111/epi.13486; ROBINSON PF, 1980, BRAIN RES, V201, P452, DOI 10.1016/0006-8993(80)91052-5; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Sarkisova K, 2011, PROG NEURO-PSYCHOPH, V35, P854, DOI 10.1016/j.pnpbp.2010.11.010; SEMBA K, 1980, BRAIN RES, V195, P281, DOI 10.1016/0006-8993(80)90065-7; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Stefan H, 2008, EPILEPSY COMPREHANSI, P537; VANDERWOLF CH, 1975, J COMP PHYSIOL PSYCH, V88, P300, DOI 10.1037/h0076211; VANLUIJTELAAR ELJM, 1991, ELECTROEN CLIN NEURO, V79, P430, DOI 10.1016/0013-4694(91)90208-L; VERGNES M, 1982, NEUROSCI LETT, V33, P97, DOI 10.1016/0304-3940(82)90136-7; Wiest MC, 2003, NAT NEUROSCI, V6, P913, DOI 10.1038/nn1107	37	19	19	1	5	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUN 14	2017	37	24					5861	5869		10.1523/JNEUROSCI.3235-16.2017			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX4VC	WOS:000403232000008	28522734	Green Published, Bronze			2022-02-06	
J	Yeh, CY; Bulas, AM; Moutal, A; Saloman, JL; Hartnett, KA; Anderson, CT; Tzounopoulos, T; Sun, DD; Khanna, R; Aizenman, E				Yeh, Chung-Yang; Bulas, Ashlyn M.; Moutal, Aubin; Saloman, Jami L.; Hartnett, Karen A.; Anderson, Charles T.; Tzounopoulos, Thanos; Sun, Dandan; Khanna, Rajesh; Aizenman, Elias			Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke	JOURNAL OF NEUROSCIENCE			English	Article						apoptosis; ischemia; neuroprotection; potassium channel; syntaxin; zinc	RAT CORTICAL-NEURONS; RECEPTOR-MEDIATED NEUROTOXICITY; TRAUMATIC BRAIN-INJURY; IN-VITRO; NMDA RECEPTOR; HIPPOCAMPAL-NEURONS; K+ CURRENTS; INTRACELLULAR ZINC; APOPTOTIC SURGE; KV2.1 CHANNEL	The voltage-gated K+ channel Kv2.1 has been intimately linked with neuronal apoptosis. After ischemic, oxidative, or inflammatory insults, Kv2.1 mediates a pronounced, delayed enhancement of K+ efflux, generating an optimal intracellular environment for caspase and nuclease activity, key components of programmed cell death. This apoptosis-enabling mechanism is initiated via Zn2+-dependent dual phosphorylation of Kv2.1, increasing the interaction between the channel's intracellular C-terminus domain and the SNARE(soluble N-ethylmaleimide-sensitive factor activating protein receptor) protein syntaxin 1A. Subsequently, an upregulation of de novo channel insertion into the plasma membrane leads to the critical enhancement of K+ efflux in damaged neurons. Here, we investigated whether a strategy designed to interfere with the cell death-facilitating properties of Kv2.1, specifically its interaction with syntaxin 1A, could lead to neuroprotection following ischemic injury in vivo. The minimal syntaxin 1A-binding sequence of Kv2.1 C terminus (C1aB) was first identified via a far-Western peptide screen and used to create a protherapeutic product by conjugating C1aB to a cell-penetrating domain. The resulting peptide (TAT-C1aB) suppressed enhanced whole-cell K+ currents produced by a mutated form of Kv2.1 mimicking apoptosis in a mammalian expression system, and protected cortical neurons from slow excitotoxic injury in vitro, without influencing NMDA-induced intracellular calcium responses. Importantly, intraperitoneal administration of TAT-C1aB in mice following transient middle cerebral artery occlusion significantly reduced ischemic stroke damage and improved neurological outcome. These results provide strong evidence that targeting the proapoptotic function of Kv2.1 is an effective and highly promising neuroprotective strategy.	[Yeh, Chung-Yang; Bulas, Ashlyn M.; Saloman, Jami L.; Hartnett, Karen A.; Tzounopoulos, Thanos; Aizenman, Elias] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; [Yeh, Chung-Yang; Bulas, Ashlyn M.; Hartnett, Karen A.; Sun, Dandan; Aizenman, Elias] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15261 USA; [Anderson, Charles T.; Tzounopoulos, Thanos] Univ Pittsburgh, Sch Med, Dept Otolaryngol, Pittsburgh, PA 15261 USA; [Sun, Dandan] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Moutal, Aubin; Khanna, Rajesh] Univ Arizona, Coll Med, Dept Pharmacol, Dept Anesthesiol, Tucson, AZ 85724 USA; [Moutal, Aubin; Khanna, Rajesh] Univ Arizona, Coll Med, Dept Grad Interdisciplinary Program Neuro, Tucson, AZ 85724 USA		Aizenman, E (corresponding author), Dept Neurobiol, 3501 Fifth Ave,BST3-7020, Pittsburgh, PA 15261 USA.; Aizenman, E (corresponding author), Pittsburgh Inst Neurodegenerat Dis, 3501 Fifth Ave,BST3-7020, Pittsburgh, PA 15261 USA.	redox@pitt.edu		Tzounopoulos, Thanos/0000-0003-4583-145X; Moutal, Aubin/0000-0003-4268-1206; Anderson, Charles/0000-0003-3353-0182; Saloman, Jami/0000-0001-6093-6511; Yeh, Chung-Yang/0000-0002-0970-1300; Khanna, Rajesh/0000-0002-9066-2969; Aizenman, Elias/0000-0001-9610-4194	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS043277, DC007905, 5T32NS007433-18]; American Heart AssociationAmerican Heart Association [16PRE29170009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R56NS043277, T32NS007433, R01NS043277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [R01DC007905] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants NS043277 (E.A.) and DC007905 (T.T.). C-Y.Y. was supported by the National Institutes of Health Training Grant 5T32NS007433-18 and the American Heart Association individual predoctoral Fellowship 16PRE29170009. We thank J. Trimmer (University of California Davis) for providing the WT Kv2.1 plasmid and R. Di Maio (University of Pittsburgh) and J. Justice (University of Pittsburgh) for expert advice. We also thank E. Levitan (University of Pittsburgh) and I. Lotan (Tel Aviv University, Israel) for encouragement and advice throughout this project, as well as B. Davis (University of Pittsburgh) for allowing us access to his equipment to complete this work.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; Aras M.A., 2008, CURR PROTOC NEUROSCI; Aras MA, 2005, NEUROSCI LETT, V387, P136, DOI 10.1016/j.neulet.2005.06.024; Aras MA, 2009, J NEUROCHEM, V110, P106, DOI 10.1111/j.1471-4159.2009.06106.x; Bach A, 2012, P NATL ACAD SCI USA, V109, P3317, DOI 10.1073/pnas.1113761109; Batey AJ, 2002, BRIT J PHARMACOL, V135, P1003, DOI 10.1038/sj.bjp.0704550; Bierbower SM, 2015, J NEUROSCI, V35, P2101, DOI 10.1523/JNEUROSCI.3805-14.2015; Blitzblau R, 1996, EUR J NEUROSCI, V8, P1840, DOI 10.1111/j.1460-9568.1996.tb01328.x; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Bret ~on RR, 2012, ACUTE ISCHEMIC STROK, V200, P29, DOI [10.5772/64991, DOI 10.5772/64991]; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; FUETA Y, 1993, DEV BRAIN RES, V72, P51, DOI 10.1016/0165-3806(93)90158-7; GRAHAM AJP, 1950, BMJ-BRIT MED J, V2, P321, DOI 10.1136/bmj.2.4674.321; Granzotto A, 2015, NEUROBIOL DIS, V81, P25, DOI 10.1016/j.nbd.2015.04.010; Hartnett KA, 1997, J NEUROCHEM, V68, P1836; He K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129498; Hill MD, 2012, LANCET NEUROL, V11, P942, DOI 10.1016/S1474-4422(12)70225-9; Hughes FM, 1999, ADV ENZYME REGUL, V39, P157, DOI 10.1016/S0065-2571(98)00010-7; IWAKI M, 1987, CARDIOVASC RES, V21, P130, DOI 10.1093/cvr/21.2.130; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kikuchi K, 2014, CNS DRUGS, V28, P929, DOI 10.1007/s40263-014-0199-6; Kilic E, 2006, FRONT BIOSCI-LANDMRK, V11, P1716, DOI 10.2741/1917; Knoch ME, 2008, GLIA, V56, P89, DOI 10.1002/glia.20592; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Leary S., 2013, AVMA GUIDELINES EUTH; Leist M, 1998, EXP CELL RES, V239, P183, DOI 10.1006/excr.1997.4026; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; McCord MC, 2014, J PHYSIOL-LONDON, V592, P3511, DOI 10.1113/jphysiol.2014.276964; McCord MC, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00077; McCord MC, 2013, P NATL ACAD SCI USA, V110, P13988, DOI 10.1073/pnas.1306238110; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Medvedeva YV, 2017, J NEUROSCI, V37, P726, DOI [10.1523/JNEUROSCI.3270-16.2016, 10.1523/JNEUROSCI.3270-16.2017]; MELDRUM BS, 1987, MED BIOL, V65, P153; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nattel S, 2008, J PHYSIOL-LONDON, V586, P5849, DOI 10.1113/jphysiol.2008.163089; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Redman PT, 2006, NEUROSCIENCE, V143, P1, DOI 10.1016/j.neuroscience.2006.08.039; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Redman PT, 2009, J PHYSIOL-LONDON, V587, P4393, DOI 10.1113/jphysiol.2009.176321; REYNOLDS IJ, 1990, BRIT J PHARMACOL, V101, P178, DOI 10.1111/j.1476-5381.1990.tb12109.x; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sesti F, 2016, AGING DIS, V7, P130, DOI 10.14336/AD.2015.0901; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shen QJ, 2009, J NEUROSCI RES, V87, P3153, DOI 10.1002/jnr.22136; Shepherd AJ, 2012, J NEUROSCI, V32, P17725, DOI 10.1523/JNEUROSCI.3029-12.2012; Singer-Lahat D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001381; Singer-Lahat D, 2007, J NEUROSCI, V27, P1651, DOI 10.1523/JNEUROSCI.4006-06.2007; Sinor JD, 2000, J NEUROSCI, V20, P8831; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Stalmans S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139652; Stas JI, 2016, SCI REP-UK, V6, DOI 10.1038/srep35080; Thrift AG, 2017, INT J STROKE, V12, P13, DOI 10.1177/1747493016676285; Tymianski M, 2014, NAT REV NEUROL, V10, P66, DOI 10.1038/nrneurol.2013.271; Tymianski M, 2013, STROKE, V44, P2942, DOI 10.1161/STROKEAHA.113.000731; Wang GJ, 1998, EUR J NEUROSCI, V10, P2523, DOI 10.1046/j.1460-9568.1998.t01-1-00256.x; Wang MZ, 2016, APPL MICROBIOL BIOT, V100, P5353, DOI 10.1007/s00253-015-7251-4; Wei L, 2003, STROKE, V34, P1281, DOI 10.1161/01.STR.0000065828.18661.FE; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Wu KW, 2015, NEUROSCIENCE, V298, P94, DOI 10.1016/j.neuroscience.2015.04.015; Xia CF, 2006, HYPERTENSION, V47, P752, DOI 10.1161/01.HYP.0000214867.35632.0e; Yao HL, 2009, J NEUROCHEM, V108, P909, DOI 10.1111/j.1471-4159.2008.05834.x; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Yu SP, 1998, J NEUROSCI RES, V52, P612, DOI 10.1002/(SICI)1097-4547(19980601)52:5<612::AID-JNR13>3.3.CO;2-N; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Yuan H, 2011, EUR J PHARMACOL, V657, P76, DOI 10.1016/j.ejphar.2011.01.054; Zou LL, 2013, CURR NEUROPHARMACOL, V11, P197, DOI 10.2174/1570159X11311020006	77	19	19	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	JUN 7	2017	37	23					5648	5658		10.1523/JNEUROSCI.3811-16.2017			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EX0JS	WOS:000402907200008	28483976	Bronze, Green Published			2022-02-06	
J	Christie, SA; Kornblith, LZ; Howard, BM; Conroy, AS; Kunitake, RC; Nelson, MF; Hendrickson, CM; Calfee, CS; Callcut, RA; Cohen, MJ				Christie, S. Ariane; Kornblith, Lucy Z.; Howard, Benjamin M.; Conroy, Amanda S.; Kunitake, Ryan C.; Nelson, Mary F.; Hendrickson, Carolyn M.; Calfee, Carolyn S.; Callcut, Rachael A.; Cohen, Mitchell Jay			Characterization of distinct coagulopathic phenotypes in injury: Pathway-specific drivers and implications for individualized treatment	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Phenotype; precision medicine; resuscitation; traumatic coagulopathy	ACUTE TRAUMATIC COAGULOPATHY; ORGAN FAILURE; BRAIN-INJURY; COAGULATION; MANAGEMENT; MORTALITY; EFFICACY; SAFETY; CARE	BACKGROUND: International normalized ratio (INR) and partial thromboplastin time (PTT) are used interchangeably to diagnose acute traumatic coagulopathy but reflect disparate activation pathways. In this study, we identified injury/patient characteristics and coagulation factors that drive contact pathway, tissue factor pathway (TF), and common pathway dysfunction by examining injured patients with discordant coagulopathies. We hypothesized that patients with INR/PTT discordance reflect differing phenotypes representing contact versus tissue factor pathway perturbations and that characterization will provide targets to guide individualized resuscitation. METHODS: Plasma samples were prospectively collected from 1,262 critically injured patients at a single Level I trauma center. Standard coagulation measures and an extensive panel of procoagulant and anticoagulant factors were assayed and analyzed with demographic and outcome data. RESULTS: Fourteen percent of patients were coagulopathic on admission. Among these, 48% had abnormal INR and PTT (BOTH), 43% had isolated prolonged PTT (PTT-CONTACT), and 9% had isolated elevated INR (INR-TF). PTT-CONTACT and BOTH had lower Glasgow Coma Scale score than INR-TF (p < 0.001). INR-TF had decreased factor VII activity compared with PTT-CONTACT, whereas PTT-CONTACT had decreased factor VIII activity compared with INR-TF. All coagulopathic patients had factor V deficits, but activity was lowest in BOTH, suggesting an additive downstream effect of disordered activation pathways. Patients with PTT-CONTACT received half as much packed red blood cell and fresh frozen plasma as did the other groups (p < 0.001). Despite resuscitation, mortality was higher for coagulopathic patients; mortality was highest in BOTH and higher in PTT-CONTACT than in INR-TF (71%, 60%, 41%; p = 0.04). CONCLUSIONS: Discordant phenotypes demonstrate differential factor deficiencies consistent with dysfunction of contact versus tissue factor pathways with additive effects from common pathway dysfunction. Recognition and treatment of pathway-specific factor deficiencies driving different coagulopathic phenotypes in injured patients may individualize resuscitation and improve outcomes. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.	[Christie, S. Ariane; Kornblith, Lucy Z.; Howard, Benjamin M.; Conroy, Amanda S.; Kunitake, Ryan C.; Nelson, Mary F.; Hendrickson, Carolyn M.; Calfee, Carolyn S.; Callcut, Rachael A.] San Francisco Gen Hosp, Dept Surg, San Francisco, CA 94110 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cohen, Mitchell Jay] Denver Hlth Med Ctr, 777 Bannock St MC 0206, Denver, CO 80204 USA; [Cohen, Mitchell Jay] Univ Colorado, Denver, CO 80202 USA		Cohen, MJ (corresponding author), Denver Hlth Med Ctr, 777 Bannock St MC 0206, Denver, CO 80204 USA.	Mitchell.Cohen@dhha.org	Callcut, Rachael/ABE-1484-2021		PCORIPatient-Centered Outcomes Research Institute - PCORI [R-IMC-1306-02735]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01ES026834]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [K23HL133495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER	This study was supported by PCORI R-IMC-1306-02735 (to M.J.C.), NIH #K01ES026834 (to R.A.C.).	Acharya SS, 2013, PEDIATRICS, V132, P882, DOI 10.1542/peds.2012-3662; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; Downes KA, 2001, TRANSFUSION, V41, P570, DOI 10.1046/j.1537-2995.2001.41040570.x; Dunbar NM, 2009, TRANSFUSION, V49, P2652, DOI 10.1111/j.1537-2995.2009.02335.x; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Hulka F, 1996, ARCH SURG-CHICAGO, V131, P923; Knudson MM, 2011, J AM COLL SURGEONS, V212, P87, DOI 10.1016/j.jamcollsurg.2010.08.020; KNUDSON MM, 1992, J TRAUMA, V32, P2, DOI 10.1097/00005373-199201000-00002; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P9; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Levi M, 2005, CRIT CARE MED, V33, P883, DOI 10.1097/01.CCM.0000159087.85970.38; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; McLaughlin DF, 2008, J TRAUMA, V64, pS57, DOI 10.1097/TA.0b013e318160a566; MILLER RS, 1994, J TRAUMA, V37, P442, DOI 10.1097/00005373-199409000-00019; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Sauaia A, 2009, SHOCK, V31, P438, DOI 10.1097/SHK.0b013e31818ba4c6; Schrieber M, 2007, J TRAUMA, V63, P1261; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; SUCHMAN AL, 1986, ANN INTERN MED, V104, P810, DOI 10.7326/0003-4819-104-6-810; TEASDALE G, 1974, LANCET, V2, P81	29	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2017	82	6					1055	1062		10.1097/TA.0000000000001423			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EV5MV	WOS:000401811900016	28338598	Green Accepted			2022-02-06	
J	Hides, JA; Smith, MMF; Mendis, MD; Smith, NA; Cooper, AJ; Treleaven, J; Leung, F; Gardner, AJ; McCrory, P; Choy, NLL				Hides, Julie A.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Smith, Nigel A.; Cooper, Andrew J.; Treleaven, Julia; Leung, Felix; Gardner, Andrew J.; McCrory, Paul; Choy, Nancy L. Low			A prospective investigation of changes in the sensorimotor system following sports concussion. An exploratory study	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Motor control; Vestibular system; Balance; Cervical proprioception; Trunk muscles; Rugby	LOW-BACK-PAIN; PAROXYSMAL POSITIONAL VERTIGO; LUMBAR MULTIFIDUS MUSCLE; TRAUMATIC BRAIN-INJURY; AUSTRALIAN RULES FOOTBALL; MILD HEAD-INJURY; MOTOR CONTROL; NECK-PAIN; POSTURAL STABILITY; VESTIBULAR REHABILITATION	Background: Sports concussion is a risk for players involved in high impact, collision sports. Postconcussion, the majority of symptoms subside within 7e10 days, but can persist in 10e20% of athletes. Understanding the effects of sports concussion on sensorimotor systems could inform physiotherapy treatment. Objective: To explore changes in sensorimotor function in the acute phase following sports concussion. Design: Prospective cohort study. Methods: Fifty-four players from elite rugby union and league teams were assessed at the start of the playing season. Players who sustained a concussion were assessed three to five days later. Measures included assessments of balance (sway velocity), vestibular system function (vestibular ocular reflex gain; right-left asymmetry), cervical proprioception (joint position error) and trunk muscle size and function. Results: During the playing season, 14 post-concussion assessments were performed within 3-5 days of injury. Significantly decreased sway velocity and increased size/contraction of trunk muscles, were identified. Whilst not significant overall, large inter-individual variation of test results for cervical proprioception and the vestibular system was observed. Limitations: The number of players who sustained a concussion was not large, but numbers were comparable with other studies in this field. There was missing baseline data for vestibular and cervical proprioception testing for some players. Conclusions: Preliminary findings post-concussion suggest an altered balance strategy and trunk muscle control with splinting/over-holding requiring consideration as part of the development of appropriate physiotherapy management strategies. (C) 2017 Elsevier Ltd. All rights reserved.	[Hides, Julie A.; Smith, Melinda M. Franettovich; Mendis, M. Dilani; Smith, Nigel A.; Cooper, Andrew J.; Leung, Felix] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Ctr Musculoskeletal Res, Brisbane, Qld 4102, Australia; [Mendis, M. Dilani] Mater Hlth Serv, Physiotherapy Dept, South Brisbane, Qld 4101, Australia; [Treleaven, Julia] Univ Queensland, Sch Hlth & Rehabil Sci, Div Physiotherapy, Brisbane, Qld 4072, Australia; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW 2310, Australia; [Gardner, Andrew J.] John Hunter Hosp, Hunter New England Local Hlth Dist Sports Concuss, New Lambton Hts, NSW 2305, Australia; [McCrory, Paul] Florey Inst Neurosci & Mental Hlth, Heidelberg, Vic, Australia; [Choy, Nancy L. Low] Australian Catholic Univ, Sch Physiotherapy, Brisbane, Qld 4014, Australia		Hides, JA (corresponding author), Level 1,631 Stanley St, Woolloongabba, Qld 4102, Australia.	Julie.hides@acu.edu	Treleaven, Julia/N-1379-2019; Hides, Julie Anne/F-2141-2011; Smith, Melinda Franettovich/AAK-1568-2021; McCrory, Paul/Q-8688-2019; Treleaven, Julia M/F-8734-2010	Treleaven, Julia/0000-0002-6258-3972; Hides, Julie Anne/0000-0002-1830-8121; Smith, Melinda Franettovich/0000-0002-0098-7656; Treleaven, Julia M/0000-0002-6258-3972; Gardner, Andrew/0000-0001-5031-5586; McCrory, Paul/0000-0003-4850-0568	Collaborative Research Network/Australian Catholic University Research Fund [2013000523]	This work was funded by a Collaborative Research Network/Australian Catholic University Research Fund [Grant number: 2013000523].	Ahn SK, 2011, J TRAUMA, V70, P442, DOI 10.1097/TA.0b013e3181d0c3d9; Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bhattacharyya N, 2008, OTOLARYNG HEAD NECK, V139, pS47, DOI 10.1016/j.otohns.2008.08.022; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Carpenter MG, 2010, NEUROSCIENCE, V171, P196, DOI 10.1016/j.neuroscience.2010.08.030; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chen XQ, 2013, MANUAL THER, V18, P562, DOI 10.1016/j.math.2013.05.015; Cullen KE, 2012, TRENDS NEUROSCI, V35, P185, DOI 10.1016/j.tins.2011.12.001; Davisson C, 2014, TEST RETEST RELIABIL; Dubois JD, 2011, J ELECTROMYOGR KINES, V21, P774, DOI 10.1016/j.jelekin.2011.05.004; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Falla D, 2007, MANUAL THER, V12, P139, DOI 10.1016/j.math.2006.06.003; Faux S, 2011, BRAIN INJURY, V25, P14, DOI 10.3109/02699052.2010.531686; Field S, 2008, MANUAL THER, V13, P183, DOI 10.1016/j.math.2006.12.005; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fu S, 2009, CLIMACTERIC, V12, P165, DOI 10.1080/13697130802506614; Furman JM, 1999, NEW ENGL J MED, V341, P1590, DOI 10.1056/NEJM199911183412107; Ganti L, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0031-6; Gardner A, 2015, BRIT J SPORT MED, V49, P495, DOI 10.1136/bjsports-2013-093102; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; HAIN TC, 1987, AM J OTOLARYNG, V8, P36, DOI 10.1016/S0196-0709(87)80017-0; Hain TC, 2011, NEUROREHABILITATION, V29, P127, DOI 10.3233/NRE-2011-0687; Hall Courtney D, 2006, J Neurol Phys Ther, V30, P74; HALMAGYI GM, 1988, ARCH NEUROL-CHICAGO, V45, P737, DOI 10.1001/archneur.1988.00520310043015; Hides J., 2016, SCAND J MED SCI SPOR; Hides J. A., 2015, EUR SPINE J; HIDES JA, 1995, SPINE, V20, P54, DOI 10.1097/00007632-199501000-00010; Hides J, 2012, J ATHL TRAINING, V47, P314, DOI 10.4085/1062-6050-47.3.03; Hides JA, 2007, J ORTHOP SPORT PHYS, V37, P480, DOI 10.2519/jospt.2007.2416; Hides JA, 2016, MANUAL THER, V24, P46, DOI 10.1016/j.math.2016.05.001; Hides JA, 2012, MED SCI SPORT EXER, V44, P1141, DOI 10.1249/MSS.0b013e318244a321; Hodges PW, 2003, J ELECTROMYOGR KINES, V13, P361, DOI 10.1016/S1050-6411(03)00042-7; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Hynes LM, 2006, BRAIN INJURY, V20, P179, DOI 10.1080/02699050500443707; Jacobs JV, 2009, BEHAV NEUROSCI, V123, P455, DOI 10.1037/a0014479; JACOBSON GP, 1990, ARCH OTOLARYNGOL, V116, P424; Jorns-Haderli M, 2007, J NEUROL NEUROSUR PS, V78, P1113, DOI 10.1136/jnnp.2006.109512; Karayannis NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067779; Khan S, 2013, NEUROREHABILITATION, V32, P437, DOI 10.3233/NRE-130866; L'Heureux-Lebeau B, 2014, OTOL NEUROTOL, V35, P1858, DOI 10.1097/MAO.0000000000000506; Lanska DJ, 1997, NEUROLOGY, V48, P1167, DOI 10.1212/WNL.48.5.1167; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lee PJ, 2006, J ELECTROMYOGR KINES, V16, P51, DOI 10.1016/j.jelekin.2005.06.006; Makdissi M, 2009, AM J SPORT MED, V37, P877, DOI 10.1177/0363546508328118; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McDevitt J, 2016, BRAIN INJURY, V30, P494; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Miller EM, 2013, J BIOMECH, V46, P801, DOI 10.1016/j.jbiomech.2012.11.023; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; Mossman B, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0081-7; Murnaghan CD, 2011, NEUROSCIENCE, V195, P54, DOI 10.1016/j.neuroscience.2011.08.020; Murnaghan CD, 2013, GAIT POSTURE, V38, P734, DOI 10.1016/j.gaitpost.2013.03.012; Nilssen RM, 1999, PAIN, V83, P477, DOI 10.1016/S0304-3959(99)00153-0; Nitz J. C., 2004, AGE AGEING, V33; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Perez N, 2003, OTOL NEUROTOL, V24, P913, DOI 10.1097/00129492-200311000-00016; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Petrak M. R., 2013, VIDEO HEAD IMPULSE T; Pinsault N, 2010, PHYS THER SPORT, V11, P66, DOI 10.1016/j.ptsp.2010.02.004; Pinsault N, 2010, SPINE, V35, P294, DOI 10.1097/BRS.0b013e3181b0c889; Radebold A, 2000, SPINE, V25, P947, DOI 10.1097/00007632-200004150-00009; REVEL M, 1994, ARCH PHYS MED REHAB, V75, P895, DOI 10.1016/0003-9993(94)90115-5; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roren A, 2009, MANUAL THER, V14, P270, DOI 10.1016/j.math.2008.03.002; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Slobounov S, 2006, NEUROSURGERY, V59, P134, DOI 10.1227/01.NEU.0000219197.33182.3F; Smith M, 2005, EXP BRAIN RES, V166, P109, DOI 10.1007/s00221-005-2352-4; Swait G, 2007, SPINE, V32, pE692, DOI 10.1097/BRS.0b013e31815a5a1b; van Dieen JH, 2003, SPINE, V28, P834, DOI 10.1097/00007632-200304150-00018; van Dieen JH, 2003, J ELECTROMYOGR KINES, V13, P333, DOI 10.1016/S1050-6411(03)00041-5; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wallwork TL, 2007, J ORTHOP SPORT PHYS, V37, P608, DOI 10.2519/jospt.2007.2418; Wallwork TL, 2009, MANUAL THER, V14, P496, DOI 10.1016/j.math.2008.09.006; Whitney SL, 2004, OTOL NEUROTOL, V25, P139, DOI 10.1097/00129492-200403000-00010; Wilder DG, 1996, SPINE, V21, P2628, DOI 10.1097/00007632-199611150-00013; Yang CJ, 2016, CLIN OTOLARYNGOL, V41, P532, DOI 10.1111/coa.12558	87	19	19	1	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	JUN	2017	29						7	19		10.1016/j.msksp.2017.02.003			13	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FO9WZ	WOS:000417250400009	28259770	Green Accepted			2022-02-06	
J	Balanca, B; Meiller, A; Bezin, L; Dreier, JP; Marinesco, S; Lieutaud, T				Balanca, Baptiste; Meiller, Anne; Bezin, Laurent; Dreier, Jens P.; Marinesco, Stephane; Lieutaud, Thomas			Altered hypermetabolic response to cortical spreading depolarizations after traumatic brain injury in rats	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Biosensors; brain trauma; brain metabolism; cerebral blood flow; energy metabolism; spreading depression; spreading depolarization	CEREBRAL-BLOOD-FLOW; ISCHEMIC NEUROLOGICAL DEFICITS; LOW EXTRACELLULAR MAGNESIUM; IN-VIVO; PERIINFARCT DEPOLARIZATIONS; ENERGY-METABOLISM; LACTATE LEVELS; SUBARACHNOID HEMORRHAGE; ANOXIC DEPOLARIZATION; EPILEPTIFORM ACTIVITY	Spreading depolarizations are waves of near-complete breakdown of neuronal transmembrane ion gradients, free energy starving, and mass depolarization. Spreading depolarizations in electrically inactive tissue are associated with poor outcome in patients with traumatic brain injury. Here, we studied changes in regional cerebral blood flow and brain oxygen (PbtO(2)), glucose ([Glc] b), and lactate ([Lac] b) concentrations in rats, using minimally invasive real-time sensors. Rats underwent either spreading depolarizations chemically triggered by KCl in naive cortex in absence of traumatic brain injury or spontaneous spreading depolarizations in the traumatic penumbra after traumatic brain injury, or a cluster of spreading depolarizations triggered chemically by KCl in a remote window from which spreading depolarizations invaded penumbral tissue. Spreading depolarizations in noninjured cortex induced a hypermetabolic response characterized by a decline in [Glc] b and monophasic increases in regional cerebral blood flow, PbtO(2), and [Lac] b, indicating transient hyperglycolysis. Following traumatic brain injury, spontaneous spreading depolarizations occurred, causing further decline in [Glc] b and reducing the increase in regional cerebral blood flow and biphasic responses of PbtO(2) and [Lac] b, followed by prolonged decline. Recovery of PbtO(2) and [Lac] b was significantly delayed in traumatized animals. Prespreading depolarization [Glc] b levels determined the metabolic response to clusters. The results suggest a compromised hypermetabolic response to spreading depolarizations and slower return to physiological conditions following traumatic brain injury-induced spreading depolarizations.	[Balanca, Baptiste; Bezin, Laurent; Marinesco, Stephane; Lieutaud, Thomas] INSERM, CNRS, Lyon Neurosci Res Ctr, U1028,UMR 5292,Team TIGER, Lyon, France; [Balanca, Baptiste] CHU Lyon, Lyon, France; [Meiller, Anne; Marinesco, Stephane] Univ Claude Bernard Lyon I, AniRA Neurochem Technol Platform, Lyon Neuroscience Res Ctr, Lyon, France; [Dreier, Jens P.] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Dreier, Jens P.] Charite Univ Med Berlin, Dept Expt Neurol, Berlin, Germany		Balanca, B (corresponding author), Univ Claude Bernard, Lyon Neurosci Res Ctr CRNL, Team TIGER, 8 Ave, F-69373 Lyon 08, France.	baptiste.balanca@gmail.com	Marinesco, Stephane/M-6694-2017; balanca, baptiste/ABG-2847-2020; balanca, baptiste/W-2261-2018	Marinesco, Stephane/0000-0003-2712-6263; balanca, baptiste/0000-0001-7917-9645; balanca, baptiste/0000-0001-7917-9645	Hospices Civils de Lyon, Inserm; Fondation Gueules cassees sourire quand meme [FGC11-2013]; Ecole de l'INSERM Bettencourt Schueller; Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [323/6-1]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)Federal Ministry of Education & Research (BMBF) [01 EO 0801]; Era-Net Neuron [01EW1212]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Supported by the Hospices Civils de Lyon, Inserm and the Fondation Gueules cassees sourire quand meme (FGC11-2013 to SM), BB was supported by a PhD fellowship from Ecole de l'INSERM Bettencourt Schueller, Deutsche Forschungsgemeinschaft (DFG DR 323/6-1), the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 0801) and Era-Net Neuron 01EW1212 to JPD.	ADACHI K, 1995, J CEREBR BLOOD F MET, V15, P97, DOI 10.1038/jcbfm.1995.11; Agarwal B, 2014, BBA-BIOENERGETICS, V1837, P354, DOI 10.1016/j.bbabio.2013.11.006; AVOLI M, 1991, ANN NEUROL, V30, P589, DOI 10.1002/ana.410300412; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Balanc B, 2016, J NEUROSCI RES, V94, P39, DOI 10.1002/jnr.23676; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; BAUGHMAN VL, 1990, ANESTHESIOLOGY, V72, P85, DOI 10.1097/00000542-199001000-00016; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bere Z, 2014, J CEREBR BLOOD F MET, V34, P1695, DOI 10.1038/jcbfm.2014.136; Boretius S, 2013, NEUROIMAGE, V69, P244, DOI 10.1016/j.neuroimage.2012.12.020; Claassen J, 2013, ANN NEUROL, V74, P53, DOI 10.1002/ana.23859; CORTEZ SC, 1989, BRAIN RES, V482, P271, DOI 10.1016/0006-8993(89)91190-6; Cruz NF, 1999, J CEREBR BLOOD F MET, V19, P380, DOI 10.1097/00004647-199904000-00004; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2007, EXP BIOL MED, V232, P204; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2002, BRAIN, V125, P102, DOI 10.1093/brain/awf007; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Farkas E, 2008, J CEREBR BLOOD F MET, V28, P251, DOI 10.1038/sj.jcbfm.9600569; Feuerstein D, 2016, J CEREBR BLOOD F MET, V36, P1965, DOI 10.1177/0271678X15612779; Feuerstein D, 2014, J CEREBR BLOOD F MET, V34, P1117, DOI 10.1038/jcbfm.2014.53; Feuerstein D, 2010, J CEREBR BLOOD F MET, V30, P1343, DOI 10.1038/jcbfm.2010.17; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Gobatto CA, 2001, COMP BIOCHEM PHYS A, V130, P21, DOI 10.1016/S1095-6433(01)00362-2; Goodman JC, 1999, CRIT CARE MED, V27, P1965, DOI 10.1097/00003246-199909000-00041; Gramsbergen JB, 2004, J NEUROSCI METH, V140, P93, DOI 10.1016/j.jneumeth.2004.03.027; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hopwood SE, 2005, J CEREBR BLOOD F MET, V25, P391, DOI 10.1038/sj.jcbfm.9600050; Horn T, 2010, NEUROCHEM INT, V57, P940, DOI 10.1016/j.neuint.2010.09.014; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hyder F, 2000, J CEREBR BLOOD F MET, V20, P485, DOI 10.1097/00004647-200003000-00007; KRUGERS HJ, 1992, J NEUROCHEM, V58, P826, DOI 10.1111/j.1471-4159.1992.tb09331.x; KUBOTA M, 1989, Neurosurgical Review, V12, P393, DOI 10.1007/BF01790681; KUHR WG, 1988, J CEREBR BLOOD F MET, V8, P848, DOI 10.1038/jcbfm.1988.142; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Linde R, 1999, ACTA PHYSIOL SCAND, V165, P395; Magistretti PJ, 1996, CEREB CORTEX, V6, P50, DOI 10.1093/cercor/6.1.50; Makaryus R, 2011, J CEREBR BLOOD F MET, V31, P1432, DOI 10.1038/jcbfm.2011.1; Mayevsky A, 1996, BRAIN RES, V740, P268, DOI 10.1016/S0006-8993(96)00874-8; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MODY I, 1987, J NEUROPHYSIOL, V57, P869, DOI 10.1152/jn.1987.57.3.869; NILSSON P, 1993, J CEREBR BLOOD F MET, V13, P183, DOI 10.1038/jcbfm.1993.22; Offenhauser N, 2011, ACTA NEUROCHIR SUPPL, V110, P119, DOI [10.1007/978-3-7091-0353-1_21, 10.1007/978-3-7091-0353-1_2l]; Ostergaard L, 2015, STROKE, V46, P1392, DOI 10.1161/STROKEAHA.114.008077; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Poulsen PH, 1997, J NEUROSCI METH, V77, P199, DOI 10.1016/S0165-0270(97)00127-1; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Sahuquillo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102540; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082891; Shin HK, 2006, J CEREBR BLOOD F MET, V26, P1018, DOI 10.1038/sj.jcbfm.9600252; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Somjen GG., 2004, IONS IN THE BRAIN, P338; Sonn J, 2012, Open Neurol J, V6, P6, DOI 10.2174/1874205X01206010006; Strong AJ, 2007, BRAIN, V130, P995, DOI 10.1093/brain/awl392; Sukhotinsky I, 2008, J CEREBR BLOOD F MET, V28, P1369, DOI 10.1038/jcbfm.2008.35; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vasylieva N, 2013, ANAL CHEM, V85, P2507, DOI 10.1021/ac3035794; VERHAEGEN MJ, 1992, J CEREBR BLOOD F MET, V12, P230, DOI 10.1038/jcbfm.1992.33; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; von Bornstadt D, 2015, NEURON, V85, P1117, DOI 10.1016/j.neuron.2015.02.007; von Oettingen G, 2002, NEUROSURGERY, V50, P781, DOI 10.1097/00006123-200204000-00019; Wei YN, 2014, J NEUROSCI, V34, P11733, DOI 10.1523/JNEUROSCI.0516-14.2014; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Wolf T, 1997, J CEREBR BLOOD F MET, V17, P950, DOI 10.1097/00004647-199709000-00004; Wu HM, 2013, J NEUROTRAUM, V30, P352, DOI 10.1089/neu.2012.2610; Yang Y, 2017, MOL NEUROBIOL, V54, P1101, DOI 10.1007/s12035-016-9710-z; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang FY, 2002, J NEUROSURG, V97, P963, DOI 10.3171/jns.2002.97.4.0963; Zhu XH, 2002, P NATL ACAD SCI USA, V99, P13194, DOI 10.1073/pnas.202471399	88	19	19	0	9	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1670	1686		10.1177/0271678X16657571			17	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200009	27356551	Green Published			2022-02-06	
J	Kenardy, J; Heron-Delaney, M; Hendrikz, J; Warren, J; Edmed, SL; Brown, E				Kenardy, Justin; Heron-Delaney, Michelle; Hendrikz, Joan; Warren, Jacelle; Edmed, Shannon L.; Brown, Erin			Recovery trajectories for long-term health-related quality of life following a road traffic crash injury: Results from the UQ SuPPORT study	JOURNAL OF AFFECTIVE DISORDERS			English	Article						Quality of life; Road traffic crash; Posttraumatic stress disorder	INTERNATIONAL DIAGNOSTIC INTERVIEW; TRAUMATIC BRAIN-INJURY; WHIPLASH INJURY; SEVERITY SCORE; MENTAL-HEALTH; ESPARR COHORT; 1ST YEAR; OUTCOMES; PREDICTORS; EMERGENCY	Background: Diminished physical and mental health-related quality of life (HRQoL) is a common consequence of road traffic crash (RTC) injury. This study aimed to (a) determine the probable recovery trajectories in physical and mental HRQoL; (b) examine the impact of posttraumatic stress disorder (PTSD) on HRQoL scores within these trajectory groups; and (c) examine the influence of predictor covariates on trajectory group membership. Methods: 336 (63% female, M-age = 44.72; SD = 14.77) injured RTC survivors completed the SF-36v2 at approximately 6, 12, and 24 months after sustaining a RTC injury. Participants also completed telephone interviews to assess prior history of psychological disorder and current PTSD at each wave. Results: Three trajectories were identified for SF-36v2 Physical Component Score (PCS): "gradual recovery" (27.3%);"low but improving" (54.7%); and "severe and chronic" (17.9%). Four trajectories were defined for SF36v2 Mental Component Score (MCS): "unaffected" (19.1%);"severe but improving" (24.1%);"severe and declining" (17.3%); and"low but improving" (39.5%). A PTSD diagnosis significantly reduced SF36v2 component scores only in trajectories associated with poorer outcome. Age was predictive of trajectory group membership for PCS, whereas injury severity was predictive of trajectory group membership for MCS. Limitations: Use of a compensation seeking sample affects generalizability to the general RTC population. Conclusions: This study identified a concerning subgroup of individuals who have chronic and/or declining physical and mental HRQoL that can be impacted by a diagnosis of PTSD. The development of interventions with a special focus on associated psychological injury is needed to improve the HRQoL of at-risk individuals following RTC injury.	[Kenardy, Justin; Hendrikz, Joan; Warren, Jacelle; Edmed, Shannon L.; Brown, Erin] Univ Queensland, Recover Injury Res Ctr, Brisbane, Qld, Australia; [Kenardy, Justin] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Heron-Delaney, Michelle] Australian Catholic Univ, Sch Psychol, Brisbane, Qld, Australia		Kenardy, J (corresponding author), UQ Oral Hlth Ctr, Level 7,288 Herston Rd, Herston, Qld 4006, Australia.	j.kenardy@uq.edu.au	Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014; Warren, Jacelle/G-2125-2010; Heron-Delaney, Michelle/M-7540-2014	Kenardy, Justin A/0000-0001-9475-8450; Warren, Jacelle/0000-0002-2273-1846; Heron-Delaney, Michelle/0000-0003-1332-9385	Motor Accident Insurance Commission (MAIC)	This research was funded by the Motor Accident Insurance Commission (MAIC), however, the views in this paper do not necessarily reflect those of the funder.	Alghnam S, 2014, QUAL LIFE RES, V23, P119, DOI 10.1007/s11136-013-0444-3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Andrews G, 1998, SOC PSYCH PSYCH EPID, V33, P80, DOI 10.1007/s001270050026; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BRESLAU N, 1998, INT J METHODS PSYCHI, V0007, P00121, DOI [DOI 10.1002/mpr.41, DOI 10.1002/MPR.41]; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Connelly LB, 2006, ACCIDENT ANAL PREV, V38, P1087, DOI 10.1016/j.aap.2006.04.015; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Economic Commission for Europe, 1995, STAT ROAD TRAFF ACC; Fitzharris M, 2010, AUST NZ J PUBL HEAL, V34, P153, DOI 10.1111/j.1753-6405.2010.00500.x; Fort E, 2011, J REHABIL MED, V43, P283, DOI 10.2340/16501977-0670; Gopinath B, 2015, INJURY, V46, P909, DOI 10.1016/j.injury.2015.01.002; Hawthorne G, 2007, QUAL LIFE RES, V16, P661, DOI 10.1007/s11136-006-9154-4; Heron-Delaney M, 2013, INJURY, V44, P1413, DOI 10.1016/j.injury.2013.07.011; Nhac-Vu HT, 2014, TRAFFIC INJ PREV, V15, P138, DOI 10.1080/15389588.2013.804180; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Hours M, 2014, J RHEUMATOL, V41, P528, DOI 10.3899/jrheum.130406; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kenardy J, 2015, INJURY, V46, P883, DOI 10.1016/j.injury.2014.11.006; Kenardy J, 2015, ARCH PHYS MED REHAB, V96, P410, DOI 10.1016/j.apmr.2014.10.007; Kenardy J, 2014, EUR J PSYCHOTRAUMATO, V5, DOI 10.3402/ejpt.v5.22612; Khati I, 2013, J TRAUMA ACUTE CARE, V74, P301, DOI 10.1097/TA.0b013e318270d967; Littleton SM, 2011, INJURY, V42, P927, DOI 10.1016/j.injury.2010.02.011; Mayou R, 2002, PSYCHOL MED, V32, P671, DOI 10.1017/S0033291702005470; Mayou R, 2001, BRIT J PSYCHIAT, V179, P528, DOI 10.1192/bjp.179.6.528; McLean SA, 2014, PAIN, V155, P309, DOI 10.1016/j.pain.2013.10.016; Moergeli H, 2012, PSYCHOTHER PSYCHOSOM, V81, P305, DOI 10.1159/000330887; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Organization W. H., 2013, WHO GLOB STAT REP RO; Peters L, 1996, INT J METHOD PSYCH, V6, P167, DOI 10.1002/(SICI)1234-988X(199610)6:3<167::AID-MPR159>3.3.CO;2-Z; Read KM, 2004, J TRAUMA, V57, P815, DOI 10.1097/01.TA.0000136289.15303.44; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Smith B, 2007, COUNS PSYCHOL Q, V20, P149, DOI 10.1080/09515070701403679; Sterling M, 2003, PAIN, V106, P481, DOI 10.1016/j.pain.2003.09.013; Ware J., 2000, SCORE VERSION 2 SF 3; WARE JE, 1993, SF 36 HLTH SURV MAN	38	19	20	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0327	1573-2517		J AFFECT DISORDERS	J. Affect. Disord.	MAY	2017	214						8	14		10.1016/j.jad.2017.02.031			7	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	ET1NY	WOS:000400037300002	28260620	Green Accepted			2022-02-06	
J	Khor, D; Inaba, K; Aiolfi, A; Delapena, S; Benjamin, E; Matsushima, K; Strumwasser, AM; Demetriades, D				Khor, Desmond; Inaba, Kenji; Aiolfi, Alberto; Delapena, Samantha; Benjamin, Elizabeth; Matsushima, Kazuhide; Strumwasser, Aaron M.; Demetriades, Demetrios			The impact of helmet use on outcomes after a motorcycle crash	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Helmet; Cervical spine; Motorcyclist; Motorcycle collisions; Trauma	CERVICAL-SPINE INJURY; SOCIETY; BURDEN; NECK; HEAD; LAWS	Background: Helmet use in a motorcycle collision has been shown to reduce head injury and death. Its protective effect on the cervical spine (C-spine), however, remains unclear. The objective of this study was to explore the relationship between helmet use and C-spine injuries. Method: Retrospective National Trauma Data Bank (NTDB) study. All motorcycle collisions between 2007 and 2014 involving either a driver or passenger were included. Data collected included demographics, vital signs, Abbreviated Injury Scale (AIS), Injury Severity Score (ISS) and specific injuries. The primary outcome was the prevalence of C-spine injuries. Secondary outcomes included were overall mortality, ventilation days, intensive care unit length of stay (LOS), total hospital LOS, and in-hospital complications. Results: A total of 270,525 patients were included. Helmets were worn by 57.6% of motorcyclists. The non-helmeted group was found to have a higher incidence of head injury with head AIS > 2 (27.6% vs 14.8%, p < 0.001). Univariate analysis showed a higher prevalence of C-spine injuries in the non-helmeted group (10.4% vs 9.4%, p < 0.001), with a higher proportion of severe C-spine injuries with AIS > 2 (3.2% vs 2.6%, p < 0.001). Additionally, traumatic brain injury (TBI) was found to be two times higher in the nonhelmeted group (20.7% vs 10.9%, p < 0.001). Multiple logistic regression showed helmet use to be an independent protective factor against mortality (OR = 0.832, 95% CI 0.781-0.887, p < 0.001). Although statistically significant in univariate analysis, helmet use was not associated with C-spine injuries after adjusting for relevant covariates. However, helmet use reduced the risk of severe head injuries by almost 50% (OR = 0.488, 95% CI 0.475-0.500, p < 0.001). Conclusions: Helmet use reduces the risk of head injury and death among motorcyclists; however, no association with C-spine injuries could be detected. (C) 2017 Elsevier Ltd. All rights reserved.	[Khor, Desmond; Inaba, Kenji; Aiolfi, Alberto; Delapena, Samantha; Benjamin, Elizabeth; Matsushima, Kazuhide; Strumwasser, Aaron M.; Demetriades, Demetrios] LAC USC Med Ctr, Div Acute Care Surg & Surg Crit Care, Los Angeles, CA 90033 USA		Inaba, K (corresponding author), Univ Southern Calif, LAC USC Med Ctr, Div Trauma & Surg Crit Care, 2051 Marengo St,Inpatient Tower,C5L100, Los Angeles, CA 90033 USA.	kenji.inaba@med.usc.edu	INABA, KENJI/AAC-8532-2020; Aiolfi, Alberto/ABA-7242-2020; Benjamin, Elizabeth/AAD-2457-2020	Aiolfi, Alberto/0000-0002-7764-6075			Croce MA, 2009, ANN SURG, V250, P390, DOI 10.1097/SLA.0b013e3181b365a2; Crompton JG, 2011, J AM COLL SURGEONS, V212, P295, DOI 10.1016/j.jamcollsurg.2010.09.032; Dao H, 2012, J TRAUMA ACUTE CARE, V72, P638, DOI 10.1097/TA.0b013e318243d9ca; Duane TM, 2012, J TRAUMA ACUTE CARE, V72, P641; GOLDSTEIN JP, 1986, EVALUATION REV, V10, P355, DOI 10.1177/0193841X8601000306; Hooten KG, 2014, J NEUROTRAUM, V31, P1329, DOI 10.1089/neu.2013.3253; Hundley JC, 2004, J TRAUMA, V57, P944, DOI 10.1097/01.TA.0000149497.20065.F4; Lam C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/487985; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Mazzeo AT, 2006, J NEUROTRAUM, V23, P962, DOI 10.1089/neu.2006.23.962; O'Connor Peter J, 2005, Traffic Inj Prev, V6, P60, DOI 10.1080/15389580590903195; Ooi SS, 2011, ASIA-PAC J PUBLIC HE, V23, P608, DOI 10.1177/1010539511413750; Rice TM, 2016, ACCIDENT ANAL PREV, V91, P200, DOI 10.1016/j.aap.2016.03.002; Vaca F, 2006, ANN EMERG MED, V47, P204, DOI 10.1016/j.annemergmed.2005.12.007; Van Camp L A, 1998, Eur J Emerg Med, V5, P207; WAGLE VG, 1993, J TRAUMA, V34, P120, DOI 10.1097/00005373-199301000-00022; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808	18	19	20	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2017	48	5					1093	1097		10.1016/j.injury.2017.02.006			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EW4QG	WOS:000402485400023	28242065				2022-02-06	
J	Stocker, RPJ; Khan, H; Henry, L; Germain, A				Stocker, Ryan P. J.; Khan, Hassen; Henry, Luke; Germain, Anne			Effects of Sleep Loss on Subjective Complaints and Objective Neurocognitive Performance as Measured by the Immediate Post-Concussion Assessment and Cognitive Testing	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Sleep; Sleep Loss; ImPACT; Neurocognitive Performance; Subjective Symptoms	TRAUMATIC BRAIN-INJURY; TEST-RETEST RELIABILITY; COMPUTERIZED NEUROPSYCHOLOGICAL ASSESSMENT; BRIEF BEHAVIORAL TREATMENT; DEFAULT-MODE NETWORK; IMPACT TEST BATTERY; FUNCTIONAL CONNECTIVITY; RESPONSE-INHIBITION; CHRONIC INSOMNIA; ONLINE VERSION	Objective: This study examined the effects of total and partial sleep deprivation on subjective symptoms and objective neurocognitive performance, as measured by the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) in a sample of healthy adults. Method: One-hundred and two, right-handed, healthy participants (between ages 18 and 30 years old) completed three consecutive nights in the sleep laboratory with concurrent continuous polysomnography monitoring. Night 1 served as a baseline night. Prior to Night 2, they were randomly assigned to one of three sleep conditions: undisrupted normal sleep (N = 34), sleep restriction (50% of habitual sleep, N = 37), or total sleep deprivation (N = 31). Participants slept undisturbed on Night 3. ImPACT was administered on three separate occasions. Results: Sleep loss was associated with increased severity of subjectively reported affective, cognitive, physical, and sleep symptoms. Although objective neurocognitive task scores derived from the ImPACT battery did not corroborate subjective complaints, sleep loss was associated with significant differences on tasks of visual memory, reaction time, and visual motor speed over time. Conclusions: While self-report measures suggested marked impairments following sleep loss, deficits in neurocognitive performance were observed only on three domains measured with ImPACT. ImPACT may capture subtle changes in neurocognitive performance following sleep loss; however, independent and larger validation studies are needed to determine its sensitivity to acute sleep loss and recovery sleep. Neurocognitive screening batteries may be useful for detecting the effects of more severe or chronic sleep loss under high-stress conditions that mimic high-risk occupations.	[Stocker, Ryan P. J.; Germain, Anne] Univ Pittsburgh, Sch Med, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA; [Khan, Hassen] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Henry, Luke] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA		Stocker, RPJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 3811 OHara St, Pittsburgh, PA 15213 USA.	stockerrp@upmc.edu			Department of DefenseUnited States Department of Defense [11293006]	This work was supported by the Department of Defense as this was an ancillary study included in a larger sleep study focused on the effects of sleep loss of positive and negative affect in healthy individuals (Log#11293006).	Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Banks Martha E, 2002, Adolesc Med, V13, P643; Barr T, 2015, ANNU REV NURS RES-SE, V33, P249, DOI 10.1891/0739-6686.33.249; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Bauer RM, 2012, CLIN NEUROPSYCHOL, V26, P177, DOI 10.1080/13854046.2012.663001; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Buysse DJ, 2011, ARCH INTERN MED, V171, P887, DOI 10.1001/archinternmed.2010.535; Buysse DJ, 2008, SLEEP, V31, P1673, DOI 10.1093/sleep/31.12.1673; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chee MWL, 2007, P NATL ACAD SCI USA, V104, P9487, DOI 10.1073/pnas.0610712104; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dinges D. F., 1992, SLEEP AROUSAL PERFOR, P177; Dinges DF, 1997, SLEEP, V20, P267; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Drummond SPA, 2006, J SLEEP RES, V15, P261, DOI 10.1111/j.1365-2869.2006.00535.x; Drummond SPA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035653; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 2004, SLEEP, V27, P445; Drummond SPA, 2000, NATURE, V403, P655, DOI 10.1038/35001068; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; First M.B., 1996, STRUCTURED CLIN INTE; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Germain A, 2005, J ANXIETY DISORD, V19, P233, DOI 10.1016/j.janxdis.2004.02.001; Germain A, 2006, J CLIN SLEEP MED, V2, P403; Germain A, 2012, J PSYCHOSOM RES, V72, P89, DOI 10.1016/j.jpsychores.2011.11.010; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Hampson M, 2010, MAGN RESON IMAGING, V28, P1051, DOI 10.1016/j.mri.2010.03.021; Harrison Y, 2000, J EXP PSYCHOL-APPL, V6, P236, DOI 10.1037//1076-898X.6.3.236; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horovitz SG, 2009, P NATL ACAD SCI USA, V106, P11376, DOI 10.1073/pnas.0901435106; Iverson G. L., 2003, 23 ANN M NAT AC NEUR; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kertzman S, 2008, ISR J PSYCHIATR REL, V45, P114; Kleitman, 1963, SLEEP WAKEFULNESS; Kribbs N.B., 1994, HARSH RDOJR SLEEP ON, P113; Leposavic I, 2010, PSYCHIAT DANUB, V22, P149; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell M.R.C.M., 2003, IMMEDIATE POSTCONCUS; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lynch WJ, 2002, J HEAD TRAUMA REHAB, V17, P66, DOI 10.1097/00001199-200202000-00009; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Mayers LB, 2012, J CLIN EXP NEUROPSYC, V34, P235, DOI 10.1080/13803395.2011.630655; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Patrick GTW, 1896, PSYCHOL REV, V3, P469, DOI [10.1037/h0075739, DOI 10.1037/H0075739]; Pilcher J.J., 1996, SLEEP J SLEEP RES SL; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schmaal L, 2013, BIOL PSYCHIAT, V73, P789, DOI 10.1016/j.biopsych.2012.12.025; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; SPIELMAN AJ, 1987, SLEEP, V10, P45; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V720; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Troyanskaya M, 2015, MIL MED, V180, P285, DOI 10.7205/MILMED-D-14-00256; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wesensten NJ, 2012, DRUG DISCOV TODAY, V8, P139; WILKINSON RT, 1968, PROGRESS CLINICAL PS, V8, P28; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075	89	19	19	1	19	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	MAY	2017	32	3					349	368		10.1093/arclin/acx003			20	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EU2WN	WOS:000400890700010	28431034	Bronze			2022-02-06	
J	Alhilali, LM; Delic, J; Fakhran, S				Alhilali, L. M.; Delic, J.; Fakhran, S.			Differences in Callosal and Forniceal Diffusion between Patients with and without Postconcussive Migraine	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; WHITE-MATTER; POSTTRAUMATIC MIGRAINE; HEADACHE; ASSOCIATIONS; SUMATRIPTAN; RECOVERY	BACKGROUND AND PURPOSE: Posttraumatic migraines are common after mild traumatic brain injury. The purpose of this study was to determine if a specific axonal injury pattern underlies posttraumatic migraines after mild traumatic brain injury utilizing Tract-Based Spatial Statistics analysis of diffusion tensor imaging. MATERIALS AND METHODS: DTI was performed in 58 patients with mild traumatic brain injury with posttraumatic migraines. Controls consisted of 17 patients with mild traumatic brain injury without posttraumatic migraines. Fractional anisotropy and diffusivity maps were generated to measure white matter integrity and were evaluated by using Tract-Based Spatial Statistics regression analysis with a general linear model. DTI findings were correlated with symptom severity, neurocognitive test scores, and time to recovery with the Pearson correlation coefficient. RESULTS: Patients with mild traumatic brain injury with posttraumatic migraines '' were not significantly different from controls in terms of age, sex, type of injury, or neurocognitive test performance. Patients with posttraumatic migraines had higher initial symptom severity (P =.01) than controls. Compared with controls, patients with mild traumatic brain injury with posttraumatic migraines had decreased fractional anisotropy in the corpus callosum (P =.03) and fornix/septohippocampal circuit (P =.045). Injury to the fornix/septohippocampal circuit correlated with decreased visual memory (r = 0.325, P =.01). Injury to corpus callosum trended toward inverse correlation with recovery (r = -0.260, P =.05). CONCLUSIONS: Injuries to the corpus callosum and fornix/septohippocampal circuit were seen in patients with mild traumatic brain injury with posttraumatic migraines, with injuries in the fornix/septohippocampal circuit correlating with decreased performance on neurocognitive testing.	[Alhilali, L. M.] Barrow Neurol Inst, Dept Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA; [Delic, J.] Univ Pittsburgh, Med Ctr, Div Neuroradiol, Dept Radiol, Pittsburgh, PA USA; [Fakhran, S.] Banner Hlth & Hosp Syst, East Valley Diagnost Imaging, Mesa, AZ USA		Alhilali, LM (corresponding author), Barrow Neurol Inst, Dept Neuroradiol, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	lalhilali@sniweb.net		Alhilali, Lea/0000-0002-9059-2454			Abend NS, 2008, J CHILD NEUROL, V23, P438, DOI 10.1177/0883073807309772; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Bartsch T, 2003, Curr Pain Headache Rep, V7, P371, DOI 10.1007/s11916-003-0036-y; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Carlson KF, 2013, HEADACHE, V53, P1573, DOI 10.1111/head.12216; Caspers S, 2013, CEREB CORTEX, V23, P615, DOI 10.1093/cercor/bhs048; D'Onofrio F, 2014, NEUROL SCI, V35, pS203, DOI 10.1007/s10072-014-1771-z; Fakhran S, 2013, RADIOLOGY, V269, P249, DOI 10.1148/radiol.13122343; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Hamel E, 2007, CEPHALALGIA, V27, P1295; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hawthorne AL, 2011, J NEUROSCI, V31, P5605, DOI 10.1523/JNEUROSCI.6663-10.2011; Kontos AP, 2016, BRAIN IMAGING BEHAV, V10, P594, DOI 10.1007/s11682-015-9412-6; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Li XL, 2011, HEADACHE, V51, P237, DOI 10.1111/j.1526-4610.2010.01774.x; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McCrory P, 2005, BRIT J SPORT MED, V39, P552, DOI 10.1136/bjsm.2004.014878; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Murphy DL, 1998, J CLIN PSYCHIAT, V59, P4; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Packard RC, 2008, CURR PAIN HEADACHE R, V12, P67, DOI 10.1007/s11916-008-0013-6; Rocca MA, 2008, CEPHALALGIA, V28, P1061, DOI 10.1111/j.1468-2982.2008.01655.x; Sarmento E, 2009, HEADACHE, V49, P1345, DOI 10.1111/j.1526-4610.2009.01494.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Yu DH, 2013, CEPHALALGIA, V33, P34, DOI 10.1177/0333102412466964	30	19	19	0	4	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2017	38	4					691	695		10.3174/ajnr.A5073			5	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	EQ9UD	WOS:000398429800005	28126745	Green Published, hybrid			2022-02-06	
J	Jiang, L; Xia, QJ; Dong, XJ; Hu, Y; Chen, ZW; Chen, K; Wang, KH; Liu, J; Wang, TH				Jiang, Ling; Xia, Qing-jie; Dong, Xiu-juan; Hu, Yue; Chen, Zhi-wei; Chen, Kang; Wang, Kun-hua; Liu, Jia; Wang, Ting-hua			Neuroprotective effect of breviscapine on traumatic brain injury in rats associated with the inhibition of GSK3 beta signaling pathway	BRAIN RESEARCH			English	Article						Breviscapine; Traumatic brain injury; Neuroprotection; Glycogen synthase kinase 3 beta; Apoptosis; Synapse growth	GLYCOGEN-SYNTHASE KINASE-3-BETA; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE DAMAGE; PC12 CELLS; PKC-ALPHA; ACTIVATION; SCUTELLARIN; EXPRESSION; APOPTOSIS; ISCHEMIA	Breviscapine, a standardized Chinese herbal medicine extracted from Erigeron breviscapine, has been widely used to treat cerebrovascular diseases. However, there are no reports about the neuroprotective effects and underlying molecular mechanisms of breviscapine on traumatic brain injury (TBI). Therefore, this study was aimed to investigate the effects of breviscapine on rats with TBI insult and illuminate the underlying mechanism. We created a traumatic brain-injured model with breviscapine lateral ventricle injection and evaluated the expressional changes of glycogen synthase kinase 3 beta (GSK3I3) as well as the GSK3p-involved signaling pathways including apoptosis and axonal growth. At 7, 14, 21 days after injection, we found a great reduction of motor disability in TBI rats following breviscapine treatment, which was accompanied with a notably increased expression of phospho-Ser9-GSK313(p-Ser9-GSK3(3) and decreased expression of phosphor-Try216-GSK313 (p-Try216-GSK3(3) at 7 days after injection. Concomitantly, an enhanced expression of synaptic marker synaptophysin (SYP) together with a weakened expression of pro-apoptotic caspase3 was observed after TBI rats were treated with breviscapine. Terminal deoxynucleotidyl transferase deoxy-UTP-nick end labeling (TUNEL) immunohistochemical assay and SYP immunofluorescence staining also confirmed the result. This study suggests that breviscapine inhibits the GSK3p signaling pathway to promote neurobehavioral function following neurotrauma. These events may provide a new insight into the mechanism of breviscapine treating brain injury. (C) 2017 Elsevier B.V. All rights reserved.	[Jiang, Ling; Xia, Qing-jie; Hu, Yue; Wang, Ting-hua] Sichuan Univ, Inst Neurol Dis, West China Hosp, Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China; [Dong, Xiu-juan; Chen, Zhi-wei; Wang, Ting-hua] Kunming Med Univ, Inst Neurosci, Kunming, Yunnan Province, Peoples R China; [Dong, Xiu-juan; Chen, Zhi-wei; Wang, Ting-hua] Yunnan Normal Univ, Key Lab Natl Phys Fitness & Altitude Training Ada, Inst Phys Educ, Kunming 650000, Yunnan, Peoples R China; [Chen, Kang; Wang, Kun-hua] Kunming Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 1, Kunming 650032, Yunnan, Peoples R China; [Liu, Jia; Wang, Ting-hua] Kunming Med Univ, Dept Expt Zool, Kunming 650031, Yunnan, Peoples R China		Liu, J; Wang, TH (corresponding author), Kunming Med Univ, Dept Anesthesiol, Inst Neurol Dis, West China Hosp,Translat Neurosci Ctr, Chengdu 610041, Sichuan, Peoples R China.	liujiaaixuexi@126.com; tinghua_neuron@263.net			plan for Natinional Science and Technology support [2014BAI01B00]; Program for Innovation Resarch Team (In Science and Technology) in Yunnan Province; Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471268]	This study was supported by a plan for Natinional Science and Technology support (No. 2014BAI01B00), and by Program for Innovation Resarch Team (In Science and Technology) in Yunnan Province, 2016, together with the Grant of Natural Science Foundation of China (No. 81471268).	Agrawal R, 2015, BBA-MOL BASIS DIS, V1852, P862, DOI 10.1016/j.bbadis.2015.01.018; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Endo H, 2006, STROKE, V37, P2140, DOI 10.1161/01.STR.0000229888.55078.72; Erdem Y, 2015, TURK NEUROSURG, V25, P85, DOI 10.5137/1019-5149.JTN.10359-14.2; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Forde JE, 2007, CELL MOL LIFE SCI, V64, P1930, DOI 10.1007/s00018-007-7045-7; Guo C, 2014, J ETHNOPHARMACOL, V151, P660, DOI 10.1016/j.jep.2013.11.026; Hong H, 2004, PLANTA MED, V70, P427, DOI 10.1055/s-2004-818970; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Jia JH, 2008, ACTA CARDIOL, V63, P757, DOI 10.2143/AC.63.6.2033394; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Jope RS, 2007, NEUROCHEM RES, V32, P577, DOI 10.1007/s11064-006-9128-5; Kaytor MD, 2002, CURR OPIN NEUROBIOL, V12, P275, DOI 10.1016/S0959-4388(02)00320-3; Kukreti V, 2014, J PEDIATR NEUROSCI, V9, P207, DOI 10.4103/1817-1745.147572; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; ladecola C., 1995, AM J PHYSIOL, V268, pR286; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Li YF, 2015, J CHROMATOGR A, V1425, P8, DOI 10.1016/j.chroma.2015.10.062; Lin LL, 2007, J CARDIOVASC PHARM, V50, P327, DOI 10.1097/FJC.0b013e3180cbd0e7; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Liu H, 2005, PHARMACOL RES, V51, P205, DOI 10.1016/j.phrs.2004.09.001; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Mao X, 2015, BRAIN INJURY, V29, P86, DOI 10.3109/02699052.2014.968621; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; Park SM, 2015, BIOL PHARM BULL, V38, P184, DOI 10.1248/bpb.b14-00430; Piper DR, 2005, J BIOL CHEM, V280, P7206, DOI 10.1074/jbc.M411042200; Pop V, 2011, TRANSL STROKE RES, V2, P533, DOI 10.1007/s12975-011-0126-9; Romanova G A, 2015, Patol Fiziol Eksp Ter, V59, P112; Seira O, 2014, MOL NEUROBIOL, V49, P931, DOI 10.1007/s12035-013-8571-y; Tong N, 2001, EUR J NEUROSCI, V13, P1913, DOI 10.1046/j.0953-816x.2001.01572.x; Wang JM, 2000, BRAIN RES, V859, P381, DOI 10.1016/S0006-8993(00)02008-4; Wang J, 2015, PHARMAZIE, V70, P593, DOI 10.1691/ph.2015.5552; Wang M, 2010, ACTA DIABETOL, V47, pS209, DOI 10.1007/s00592-009-0164-x; Wu XM, 2013, INT J CLIN EXP PATHO, V6, P1282; Wu Y, 2007, APOPTOSIS, V12, P1365, DOI 10.1007/s10495-007-0065-9; Xu JG, 2014, BRAIN RES, V1582, P237, DOI 10.1016/j.brainres.2014.07.042; Yan L, 2010, J CELL BIOCHEM, V109, P1158, DOI 10.1002/jcb.22495; Zhang H, 2011, WORLD J GASTROENTERO, V17, P1825, DOI 10.3748/wjg.v17.i14.1825; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025; Zhu D, 2009, NEUROL RES, V31, P200, DOI 10.1179/174313209X393915	44	19	23	1	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	APR 1	2017	1660						1	9		10.1016/j.brainres.2017.01.031			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EQ3XA	WOS:000398006100001	28143715				2022-02-06	
J	Sahn, JJ; Hodges, TR; Chan, JZ; Martin, SF				Sahn, James J.; Hodges, Timothy R.; Chan, Jessica Z.; Martin, Stephen F.			Norbenzomorphan Scaffold: Chemical Tool for Modulating Sigma Receptor-Subtype Selectivity	ACS MEDICINAL CHEMISTRY LETTERS			English	Article						Sigma receptor; norbenzomorphan; neuroprotection; Alzheimer's disease; traumatic brain injury	MEMBRANE COMPONENT 1; PGRMC1 PROTEIN; BINDING; ANTAGONISTS; LIGANDS; DIVERSE	Some norbenzomorphans exhibit high affinity for sigma 1 and sigma 2 receptors, and varying the position of substituents on the aromatic ring of this scaffold has a significant effect on subtype selectivity. In particular, compounds bearing several different substituents at C7 of the norbenzomorphan ring system exhibit a general preference for the sigma 1 receptor, whereas the corresponding C8-substituted analogues preferentially bind at the sigma 2 receptor. These findings suggest that the norbenzomorphan scaffold may be a unique chemical template that can be easily tuned to prepare small molecules for use as tool compounds to study the specific biological effects arising from preferential binding at either sigma receptor subtype. In the absence of structural characterization data for the sigma 2 receptor, such compounds will be useful toward refining the pharmacophore model of its binding site.	[Sahn, James J.; Hodges, Timothy R.; Chan, Jessica Z.; Martin, Stephen F.] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA		Martin, SF (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	sfrnartin@mail.utexas.edu	Martin, Stephen/U-4676-2019	Hodges, Timothy/0000-0003-1216-9551	The Robert A. Welch FoundationThe Welch Foundation [F-0652]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM 86192]; ADR; BrightFocus FoundationBrightFocus Foundation; Dell Medical School's Texas Health Catalyst program	Generous funding for this research was provided by The Robert A. Welch Foundation (F-0652), the National Institutes of Health (GM 86192), the donors of the ADR, a program of the BrightFocus Foundation, and the Dell Medical School's Texas Health Catalyst program.	Abate C, 2015, EUR J PHARMACOL, V758, P16, DOI 10.1016/j.ejphar.2015.03.067; Bai SP, 2014, J MED CHEM, V57, P4239, DOI 10.1021/jm5001453; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; CHEN YL, 1994, J MED CHEM, V37, P1996, DOI 10.1021/jm00039a013; Chu UB, 2015, EBIOMEDICINE, V2, P1806, DOI 10.1016/j.ebiom.2015.10.017; Cobos EJ, 2005, SYNAPSE, V55, P192, DOI 10.1002/syn.20103; Guo L, 2015, CURR MED CHEM, V22, P989, DOI 10.2174/0929867322666150114163607; Hayashi T., 2005, Current Neuropharmacology, V3, P267, DOI 10.2174/157015905774322516; Huang YS, 2014, MED RES REV, V34, P532, DOI 10.1002/med.21297; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111898; Izzo NJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111899; JACOBSON AE, 1970, J MED CHEM, V13, P7, DOI 10.1021/jm00295a002; Jasper A, 2009, EUR J MED CHEM, V44, P4306, DOI 10.1016/j.ejmech.2009.07.017; Kabe Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11030; Laurini E, 2010, BIOORG MED CHEM LETT, V20, P2954, DOI 10.1016/j.bmcl.2010.03.009; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mach RH, 2013, J MED CHEM, V56, P7137, DOI 10.1021/jm301545c; Manohar M, 2015, AUST J CHEM, V68, P600, DOI 10.1071/CH14590; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Matsumoto Rae R., 2007, P1, DOI 10.1007/978-0-387-36514-5_1; Moller HJ, 2001, J CLIN PSYCHOPHARM, V21, P59, DOI 10.1097/00004714-200102000-00011; Narayanan S, 2011, FUTURE MED CHEM, V3, P79, DOI 10.4155/FMC.10.279; Narita N, 1996, EUR J PHARMACOL, V307, P117, DOI 10.1016/0014-2999(96)00254-3; Pati ML, 2017, PHARMACOL RES, V117, P67, DOI 10.1016/j.phrs.2016.12.023; Sahn J. J., 2016, TARGETING SIG2 RPGRM; Sahn JJ, 2016, CHEMMEDCHEM, V11, P556, DOI 10.1002/cmdc.201500551; Sahn JJ, 2014, ORG BIOMOL CHEM, V12, P7659, DOI 10.1039/c4ob00835a; Sahn JJ, 2012, ACS COMB SCI, V14, P496, DOI 10.1021/co300068a; Sahn JJ, 2011, ORG LETT, V13, P2590, DOI 10.1021/ol200709h; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; Sun H, 2016, J MED CHEM, V59, P6329, DOI 10.1021/acs.jmedchem.6b00571; Sunderhaus JD, 2007, ORG LETT, V9, P4223, DOI 10.1021/ol7018357; Sunderhaus JD, 2009, TETRAHEDRON, V65, P6454, DOI 10.1016/j.tet.2009.05.009; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vela JM, 2015, EXPERT OPIN INV DRUG, V24, P883, DOI 10.1517/13543784.2015.1048334; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386; Yi BN, 2017, J NEUROCHEM, V140, P561, DOI 10.1111/jnc.13917; Zeng CB, 2016, MOL IMAGING BIOL, V18, P172, DOI 10.1007/s11307-015-0891-z; Zeng CB, 2014, ANAL BIOCHEM, V448, P68, DOI 10.1016/j.ab.2013.12.008	39	19	19	0	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1948-5875			ACS MED CHEM LETT	ACS Med. Chem. Lett.	APR	2017	8	4					455	460		10.1021/acsmedchemlett.7b00066			6	Chemistry, Medicinal	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Pharmacology & Pharmacy	ES3NG	WOS:000399435700015	28435536	Green Published			2022-02-06	
J	Zhang, M; Wu, JY; Ding, HJ; Wu, WT; Xiao, GM				Zhang, Mei; Wu, Jianyue; Ding, Haojun; Wu, Wentian; Xiao, Guomin			Progesterone Provides the Pleiotropic Neuroprotective Effect on Traumatic Brain Injury Through the Nrf2/ARE Signaling Pathway	NEUROCRITICAL CARE			English	Article						Progesterone; Nrf2/ARE signaling pathway; Traumatic brain injury; Neuroprotection; Nrf2 gene knockout; In vivo	SPINAL-CORD; CELL-DEATH; CEREBRAL-ISCHEMIA; GENE-EXPRESSION; RAT-BRAIN; IN-VIVO; ACTIVATION; NEUROSTEROIDS; MECHANISMS; RECEPTOR	This study was to investigate the role of Nrf2/ARE signaling pathway in the pleiotropic neuroprotective effect of progesterone (PROG) on traumatic brain injury (TBI). The Nrf2-knockout (Nrf2-/-) and C57 mice were respectively subjected to a lateral cortical impact injury caused by a free-falling object and randomly divided into three groups: sham-operated, trauma, and trauma + PROG treatment group. The PROG treatment group was given PROG (32 mg/kg of body weight, intraperitoneal injection) immediately after injury. For all groups, a series of brain samples were obtained after trauma at 24 and 72 h, respectively. The cerebral edema was evaluated; the expression of IL-1 beta, IL-6, and TNF-alpha was measured using ELISA array, and the apoptosis index was detected by TUNEL. Flow cytometry was used to detect the intracellular calcium concentration. The water content, the apoptosis index, the levels of inflammatory cytokine, and the intracellular calcium ion were significantly decreased with the PROG treatment in C57 mice with TBI model. However, the effect of PROG on TBI was not found in the Nrf2-/- mouse model of TBI. PROG reduced cerebral edema, apoptosis, inflammatory reaction, and intracellular calcium ion overload effects after TBI. These beneficial effects were not seen in the Nrf2-/- mouse model of TBI. The results from this study suggested that the Nrf2/ARE signal pathway may be involved in the pleiotropic neuroprotective effect of PROG on TBI.	[Zhang, Mei; Wu, Jianyue; Ding, Haojun; Wu, Wentian; Xiao, Guomin] Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, Hangzhou 310015, Zhejiang, Peoples R China		Xiao, GM (corresponding author), Hangzhou Normal Univ, Affiliated Hosp, Dept Neurosurg, Hangzhou 310015, Zhejiang, Peoples R China.	xiao_gm@126.com			Zhejiang provincial natural science foundationNatural Science Foundation of Zhejiang Province; Hangzhou science and technology development plans; Zhejiang provincial and Hangzhou medical and health science and technology project; Zhejiang key laboratory of organ development and regeneration, China	This work was supported by Grants from Zhejiang provincial natural science foundation; Hangzhou science and technology development plans; Zhejiang provincial and Hangzhou medical and health science and technology project; and Zhejiang key laboratory of organ development and regeneration, China.	Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; Chen PC, 2009, P NATL ACAD SCI USA, V106, P2933, DOI 10.1073/pnas.0813361106; COLLADO ML, 1985, PHARMACOL BIOCHEM BE, V23, P501, DOI 10.1016/0091-3057(85)90408-3; De Nicola AF, 2006, J MOL NEUROSCI, V28, P3, DOI 10.1385/JMN:28:1:3; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gonzalez SL, 2004, NEUROSCIENCE, V125, P605, DOI 10.1016/j.neuroscience.2004.02.024; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hong YA, 2010, ACTA PHARMACOL SIN, V31, P1421, DOI 10.1038/aps.2010.101; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; KATO J, 1994, HORM BEHAV, V28, P454, DOI 10.1006/hbeh.1994.1043; Labombarda F, 2006, J NEUROTRAUM, V23, P181, DOI 10.1089/neu.2006.23.181; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Limmroth V, 1996, BRIT J PHARMACOL, V117, P99, DOI 10.1111/j.1476-5381.1996.tb15160.x; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; McIntosh TK, 1996, LAB INVEST, V74, P315; Migliaccio A, 1998, EMBO J, V17, P2008, DOI 10.1093/emboj/17.7.2008; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Pan DS, 2007, BIOMED ENVIRON SCI, V20, P432; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Roof RL, 1997, MOL CHEM NEUROPATHOL, V31, P1, DOI 10.1007/BF02815156; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Schumacher M, 1996, DEV NEUROSCI-BASEL, V18, P6, DOI 10.1159/000111391; Shen H, 2005, NEUROPHARMACOLOGY, V49, P573, DOI 10.1016/j.neuropharm.2005.04.026; Shih AY, 2005, J NEUROSCI, V25, P10321, DOI 10.1523/JNEUROSCI.4014-05.2005; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; SMITH SS, 1991, NEUROSCIENCE, V42, P309, DOI 10.1016/0306-4522(91)90377-Z; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Stein DG, 2010, EXPERT OPIN INV DRUG, V19, P847, DOI 10.1517/13543784.2010.489549; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yan W, 2008, NEUROSCI LETT, V431, P150, DOI 10.1016/j.neulet.2007.11.060; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zhao J, 2006, NEUROSCI LETT, V393, P108, DOI 10.1016/j.neulet.2005.09.065; Zhao XR, 2007, STROKE, V38, P3280, DOI 10.1161/STROKEAHA.107.486506	45	19	22	0	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2017	26	2					292	300		10.1007/s12028-016-0342-y			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN5EV	WOS:000396029300019	27995513	Green Published, hybrid			2022-02-06	
J	Rodriguez-Millan, M; Tan, LB; Tse, KM; Lee, HP; Miguelez, MH				Rodriguez-Millan, M.; Tan, L. B.; Tse, K. M.; Lee, H. P.; Miguelez, M. H.			Effect of full helmet systems on human head responses under blast loading	MATERIALS & DESIGN			English	Article						Combat helmet design; Mandibular guard; Visor; Blast simulation; Head modeling; Traumatic brain injury (TBI); Intracranial pressure (ICP)	TRAUMATIC BRAIN-INJURY; FINITE-ELEMENT MODEL; METHODOLOGY; VALIDATION	This paper focuses on helmet design for head protection under blast threats. It is presented a numerical investigation of the head response accruing to blast loads on helmet protective systems. Various combinations of the helmet, visor and mandible guard were numerically analyzed for a given mass of TNT at a distance to the target representing an anti-vehicle buried mine threat. Limited published articles on the subject are available in the scientific literature. In this paper, a 3D head helmet numerical model for blast analyses is developed in the finite element code ABAQUS/Explicit. The results showed that individual protective systems are not effective enough to mitigate the damage caused by blast loading. The complete protective equipment reduces the pressures on the brain by up to 5 times and ensures that no fracture in the skull appears. This numerical study aims to provide helmet manufacturers and users with some insight in what possible brain injuries are to be expected in various blast scenarios so as to help in better diagnosis of unsuspected brain injury. (C) 2016 Elsevier Ltd. All rights reserved.	[Rodriguez-Millan, M.; Miguelez, M. H.] Univ Carlos III Madrid, Dept Mech Engn, Avda Univ 30, Madrid 28917, Spain; [Tan, L. B.; Tse, K. M.; Lee, H. P.] Natl Univ Singapore, Dept Mech Engn, 9 Engn Dr 1, Singapore 117576, Singapore; [Tse, K. M.] Univ Melbourne, Dept Mech Engn, Biomech Res Grp, Parkville, Vic 3010, Australia		Rodriguez-Millan, M (corresponding author), Univ Carlos III Madrid, Dept Mech Engn, Avda Univ 30, Madrid 28917, Spain.	mrmillan@ing.uc3m.es	Tse, Kwong Ming/D-8669-2011; Millan, Marcos Rodriguez/A-3945-2012; Miguelez, Maria Henar/L-3097-2014; Lee, Heow Pueh/I-7834-2014	Tse, Kwong Ming/0000-0002-8170-0775; Millan, Marcos Rodriguez/0000-0002-9081-8425; Miguelez, Maria Henar/0000-0001-5227-1425; Lee, Heow Pueh/0000-0002-4380-3888; Tan, Long Bin/0000-0002-3897-7365	Ministry of Economy and Competitiveness of SpainSpanish Government [RTC-2015-3887-8]; FEDER programEuropean Commission [RTC-2015-3887-8]	The authors acknowledge the Ministry of Economy and Competitiveness of Spain and FEDER program under the Project RTC-2015-3887-8 for the financial support of the work.	Bin Tan L, 2012, INT J IMPACT ENG, V50, P99, DOI 10.1016/j.ijimpeng.2012.06.003; Binder M. D. Sue, 2003, REP C MILD TRAUM BRA; Casem, 2012, MECH RESPONSE POLYCA; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Coelho RM, 2013, MATER DESIGN, V43, P384, DOI 10.1016/j.matdes.2012.07.020; Dassault Systernes, 2012, AB V6 12 DOC ABAQUS; Domont A., 1992, P 36 STAPP CAR CRASH, DOI [10.4271/922527, DOI 10.4271/922527]; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fallah AS, 2014, INT J IMPACT ENG, V73, P91, DOI 10.1016/j.ijimpeng.2014.06.014; Friedlander FG, 1976, WAVE EQUATION CURVED; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gong SW, 2008, COMPUT STRUCT, V86, P758, DOI 10.1016/j.compstruc.2007.06.003; Grujicic M, 2010, MULTIDISCIP MODEL MA, V6, P335, DOI 10.1108/15736101011080097; Grujicic M, 2010, MATER DESIGN, V31, P4050, DOI 10.1016/j.matdes.2010.05.002; Hardy W N, 2001, Stapp Car Crash J, V45, P337; HASHIN Z, 1980, J APPL MECH-T ASME, V47, P329, DOI 10.1115/1.3153664; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kleiven S., 2008, MTBI PREC S LISB POR; Kulkarni SG, 2013, COMPOS STRUCT, V101, P313, DOI 10.1016/j.compstruct.2013.02.014; Lee HP, 2010, COMPUT METHOD BIOMEC, V13, P537, DOI 10.1080/10255840903337848; MCELHANEY JH, 1970, J BIOMECH, V3, P495, DOI 10.1016/0021-9290(70)90059-X; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Mott, 2014, 52 AER SCI M, V11, P9142; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pinnoji PK, 2010, MATER DESIGN, V31, P3716, DOI 10.1016/j.matdes.2010.03.011; Pintar FA, 2013, MED ENG PHYS, V35, P1682, DOI 10.1016/j.medengphy.2013.04.015; Risling M., 2012, FRONT NEUROL, P1; Millan MR, 2016, J REINF PLAST COMP, V35, P124, DOI 10.1177/0731684415608004; Rodriguez-Millan M, 2016, MATER DESIGN, V110, P391, DOI 10.1016/j.matdes.2016.08.015; Ruan J. S., 1994, IMPACT BIOMECHANICS; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Santiuste C, 2014, COMPOS STRUCT, V116, P423, DOI 10.1016/j.compstruct.2014.05.031; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Singh D, 2014, INT J NUMER METH BIO, V30, P470, DOI 10.1002/cnm.2612; Stuhmiller J.H., 2008, TXB MILITARY MED; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tan L. B., 2014, INT J NUMER METHODS, P1; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tinard V, 2012, MATER DESIGN, V37, P79, DOI 10.1016/j.matdes.2011.12.005; Tse K. M., 2016, MED BIOL ENG COMPUT, P1; Tse K.M., 2014, AM J ENG TECHNOL SOC, V1, P28; Tse KM, 2014, INT J NUMER METH BIO, V30, P397, DOI 10.1002/cnm.2609; Wang CZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113264; Ward C., 1980, STAPP CAR CRASH J, P163; Willinger R, 1999, ANN BIOMED ENG, V27, P403, DOI 10.1114/1.165; WOOD JL, 1971, J BIOMECH, V4, P1, DOI 10.1016/0021-9290(71)90010-8; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhu F, 2012, BIOMECH MODEL MECHAN, V11, P341, DOI 10.1007/s10237-011-0314-2	55	19	20	1	23	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0264-1275	1873-4197		MATER DESIGN	Mater. Des.	MAR 5	2017	117						58	71		10.1016/j.matdes.2016.12.081			14	Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	EK6XG	WOS:000394068800007		Green Accepted			2022-02-06	
J	Emmerich, T; Abdullah, L; Ojo, J; Mouzon, B; Nguyen, T; Laco, GS; Crynen, G; Evans, JE; Reed, J; Mullan, M; Crawford, F				Emmerich, Tanja; Abdullah, Laila; Ojo, Joseph; Mouzon, Benoit; Thinh Nguyen; Laco, Gary S.; Crynen, Gogce; Evans, James E.; Reed, Jon; Mullan, Michael; Crawford, Fiona			Mild TBI Results in a Long-Term Decrease in Circulating Phospholipids in a Mouse Model of Injury	NEUROMOLECULAR MEDICINE			English	Article						Mild traumatic brain injury (mTBI); Phospholipids (PL); Plasma biomarkers; Lipidomics; Mouse model	TRAUMATIC BRAIN-INJURY; FATTY-ACIDS; HIGH-SCHOOL; PROTEIN; LIPIDS; LIPOPROTEINS; CONCUSSION; MECHANISMS; BIOMARKERS; RECOVERY	Neurophysiological and neurological dysfunction is usually experienced for a short period of time in patients with mild traumatic brain injury (mTBI). However, around 15 % of patients exhibit symptoms months after TBI. Phospholipid (PL) changes have been observed in plasma from mTBI patients at chronic stages, suggesting a role in TBI pathology. We examined long-term plasma phospholipid profiles in a mouse model of mTBI to determine their translational value in reproducing PL changes observed in mTBI patients. Plasma samples were collected at an acute timepoint (24 h post-injury) and at several chronic stages (3, 6, 12 and 24 months post-injury) from injured mice and sham controls. Phospholipids were identified and quantified using liquid chromatography/mass spectrometry analysis. In accordance with human data, we observed significantly lower levels of several major PL classes in mTBI mice compared to controls at chronic timepoints. Saturated, monounsaturated and polyunsaturated fatty acids (PUFAs) were differently regulated over time. As PUFA levels were decreased at 3 months, we measured levels of malondialdehyde to assess lipid peroxidation, which we found to be elevated at this timepoint. Ether-containing PE species were elevated at 24 h post-injury and decreased relative to controls at chronic stages. Arachidonic acid and docosahexaenoic acid-containing species were significantly decreased within all PL classes at the chronic stages. Our findings are similar to changes in PL levels observed in human mTBI subjects. Chronic TBI biomarkers have received little attention, even though disabilities at this stage can be of major importance. Our study provides information on biochemical abnormalities that persist long after the initial injury; these abnormalities may provide useful insight into the continuing pathogenesis and serve as diagnostic biomarkers.	[Emmerich, Tanja; Abdullah, Laila; Ojo, Joseph; Mouzon, Benoit; Thinh Nguyen; Laco, Gary S.; Crynen, Gogce; Evans, James E.; Reed, Jon; Mullan, Michael; Crawford, Fiona] Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA; [Emmerich, Tanja; Abdullah, Laila; Ojo, Joseph; Mouzon, Benoit; Crynen, Gogce; Crawford, Fiona] Open Univ, Walton Hall, Milton Keynes MK7 6AA, Bucks, England; [Emmerich, Tanja; Abdullah, Laila; Mouzon, Benoit; Evans, James E.; Reed, Jon; Crawford, Fiona] James A Haley Vet Hosp, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA		Emmerich, T (corresponding author), Roskamp Inst, 2040 Whitfield Ave, Sarasota, FL 34243 USA.; Emmerich, T (corresponding author), Open Univ, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.; Emmerich, T (corresponding author), James A Haley Vet Hosp, 13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	temmerich@roskampinstitute.net; labdullah@roskampinsitute.net; bojo@roskampinstitute.net; bmouzon@rfdn.org; tnguyen@roskampinstitute.net; glaco@roskampinstitute.net; gkayihan@rfdn.org; jevans@roskampinstitute.net; jreed@rfdn.org; mmullan@rfdn.org; fcrawford@rfdn.org		Emmerich, Tanja/0000-0001-5064-7150	Department of DefenseUnited States Department of Defense [W81XWH-10-1-0759, W81XWH-13-1-0253]; VA Research Award [RX-16-007]; Roskamp Foundation	This research was funded by Department of Defense Awards (W81XWH-10-1-0759 and W81XWH-13-1-0253) and VA Research Award (RX-16-007) to VA Research Career scientist Dr. Fiona Crawford and by the Roskamp Foundation. The contents do not represent the views of the Department of Veterans Affairs, or the US Government.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Abdullah L, 2012, NEUROMOL MED, V14, P349, DOI 10.1007/s12017-012-8192-z; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Begum H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19139; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Chaurio RA, 2009, MOLECULES, V14, P4892, DOI 10.3390/molecules14124892; Coronado V., 2009, EPIDEMIOLOGY; Crawford F, 2012, J NEUROTRAUM, V29, P246, DOI 10.1089/neu.2011.1789; Dalleau S, 2013, CELL DEATH DIFFER, V20, P1615, DOI 10.1038/cdd.2013.138; Emmerich T., 2015, J NEUROTRAUMA; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Fischer H., 2015, DOD NUMBERS TRAUMATI, P1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fredman G, 2011, BIOCHEM J, V437, P185, DOI 10.1042/BJ20110327; Frisardi V, 2011, PROG LIPID RES, V50, P313, DOI 10.1016/j.plipres.2011.06.001; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Jackson Laboratories, 2007, PHYSL DAT SUMM C57BL, V6 J; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim Seungwoo, 2014, Osong Public Health Res Perspect, V5, P345, DOI 10.1016/j.phrp.2014.10.002; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kosicek M, 2013, INT J MOL SCI, V14, P1310, DOI 10.3390/ijms14011310; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Norman AB, 2011, SYNAPSE, V65, P404, DOI 10.1002/syn.20858; Ovsepian L M, 2012, Adv Gerontol, V25, P250; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Polozova A, 2007, J MOL NEUROSCI, V33, P56, DOI 10.1007/s12031-007-0039-y; Purdon AD, 2002, NEUROCHEM RES, V27, P1641, DOI 10.1023/A:1021635027211; Raabe A, 1998, J NEUROL NEUROSUR PS, V65, P930, DOI 10.1136/jnnp.65.6.930; Reno F, 1998, HISTOCHEM CELL BIOL, V110, P467, DOI 10.1007/s004180050308; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Vance DE, 2008, N COMP BIOC, P1; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442	46	19	19	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1535-1084	1559-1174		NEUROMOL MED	Neuromol. Med.	MAR	2017	19	1					122	135		10.1007/s12017-016-8436-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN5EX	WOS:000396029500012	27540748				2022-02-06	
J	Gardner, RC; Langa, KM; Yaffe, K				Gardner, Raquel C.; Langa, Kenneth M.; Yaffe, Kristine			Subjective and objective cognitive function among older adults with a history of traumatic brain injury: A population-based cohort study	PLOS MEDICINE			English	Article							ALZHEIMERS-DISEASE; HEAD-INJURY; RISK-FACTOR; DEMENTIA; RELIABILITY; ASSOCIATION; VALIDITY; HEALTH; INDIVIDUALS; IMPAIRMENT	Background Traumatic brain injury (TBI) is extremely common across the lifespan and is an established risk factor for dementia. The cognitive profile of the large and growing population of older adults with prior TBI who do not have a diagnosis of dementia, however, has not been well described. Our aim was to describe the cognitive profile associated with prior TBI exposure among community-dwelling older adults without dementia-an understudied but potentially vulnerable population. Methods and findings In this population-based cohort study, we studied 984 community-dwelling older adults (age 51 y and older and their spouses) without dementia who had been randomly selected from respondents to the 2014 wave of the Health and Retirement Study to participate in a comprehensive TBI survey and who either reported no prior TBI (n = 737) or prior symptomatic TBI resulting in treatment in a hospital (n = 247). Mean time since first TBI was 38 +/- 19 y. Outcomes assessed included measures of global cognitive function, verbal episodic memory, semantic fluency, and calculation as well as a measure of subjective memory ("How would you rate your memory at the present time?"). We compared outcomes between the two TBI groups using regression models adjusting for demographics, medical comorbidities, and depression. Sensitivity analyses were performed stratified by TBI severity (no TBI, TBI without loss of consciousness [LOC], and TBI with LOC). Respondents with TBI were younger (mean age 64 +/- 10 y versus 68 +/- 11 y), were less likely to be female, and had higher prevalence of medical comorbidities and depression than respondents without TBI. Respondents with TBI did not perform significantly differently from respondents without TBI on any measure of objective cognitive function in either raw or adjusted models (fully adjusted: global cognitive function score 15.4 versus 15.2, p = 0.68; verbal episodic memory score 4.4 versus 4.3, p = 0.79; semantic fluency score 15.7 versus 14.0, p = 0.21; calculation impairment 22% versus 26%, risk ratio [RR] [95% CI] = 0.86 [0.67 +/- 1.11], p = 0.24). Sensitivity analyses stratified by TBI severity produced similar results. TBI was associated with significantly increased risk for subjective memory impairment in models adjusted for demographics and medical comorbidities (29% versus 24%; RR [95% CI]: 1.26 [1.02 +/- 1.57], p = 0.036). After further adjustment for active depression, however, risk for subjective memory impairment was no longer significant (RR [95% CI]: 1.18 [0.95 +/- 1.47], p = 0.13). Sensitivity analyses revealed that risk of subjective memory impairment was increased only among respondents with TBI with LOC and not among those with TBI without LOC. Furthermore, the risk of subjective memory impairment was significantly greater among those with TBI with LOC versus those without TBI even after adjustment for depression (RR [95% CI]: partially adjusted, 1.38 [1.09 +/- 1.74], p = 0.008; fully adjusted, 1.28 [1.01 +/- 1.61], p = 0.039). Conclusions In this population-based study of community-dwelling older adults without dementia, those with prior TBI with LOC were more likely to report subjective memory impairment compared to those without TBI even after adjustment for demographics, medical comorbidities, and active depression. Lack of greater objective cognitive impairment among those with versus without TBI may be due to poor sensitivity of the cognitive battery or survival bias, or may suggest that post-TBI cognitive impairment primarily affects executive function and processing speed, which were not rigorously assessed in this study. Our findings show that among community-dwelling non-demented older adults, history of TBI is common but may not preferentially impact cognitive domains of episodic memory, attention, working memory, verbal semantic fluency, or calculation.	[Gardner, Raquel C.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Gardner, Raquel C.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Langa, Kenneth M.] Univ Michigan Hlth Syst, Div Gen Med, Ann Arbor, MI USA; [Langa, Kenneth M.] Vet Affairs Ctr Practice Management & Outcomes Re, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Langa, Kenneth M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA		Gardner, RC (corresponding author), Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94143 USA.; Gardner, RC (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	raquel.gardner@ucsf.edu		Langa, Kenneth/0000-0002-2798-1836; Gardner, Raquel C./0000-0003-4028-440X	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS095755]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24 AG031155, U01 AG009740]; American Federation for Aging Research [K23 NS095755]; Weill Institute for Neurosciences; Departments of Defense and Veterans Affairs [W81XWH-12-1-0581, W81XWH-12-PHTBI-CENC]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG044281, P30AG053760, K24AG031155, U01AG009740] Funding Source: NIH RePORTER	This work was supported by the National Institute of Neurological Disorders and Stroke (Beeson K23 NS095755 to RCG), National Institute on Aging (K24 AG031155 to KY); the American Federation for Aging Research (K23 NS095755 to RCG); the Weill Institute for Neurosciences (to RCG), and the Departments of Defense and Veterans Affairs (W81XWH-12-1-0581 and W81XWH-12-PHTBI-CENC to KY). The Health and Retirement Study is funded by the National Institute on Aging (U01 AG009740), and performed at the Institute for Social Research, University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruszkow H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-26; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brown AW, 2011, J NEUROTRAUM, V28, P167, DOI 10.1089/neu.2010.1400; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Cuthbert JP, 2016, J HEAD TRAUMA REHAB, V31, pE36, DOI 10.1097/HTR.0000000000000075; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Dams-O'Connor K, 2016, NEURODEGENER DIS MAN, V6, P417, DOI 10.2217/nmt-2016-0017; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROL NEUROSUR PS, V84, P177, DOI 10.1136/jnnp-2012-303938; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Farfel JM, 2013, NEUROLOGY, V81, P650, DOI 10.1212/WNL.0b013e3182a08f1b; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frieden T., 2014, REPORT C TRAUMATIC B; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Godbolt Alison K, 2014, Arch Phys Med Rehabil, V95, pS245, DOI 10.1016/j.apmr.2013.06.036; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hedden T, 2013, NEUROLOGY, V80, P1341, DOI 10.1212/WNL.0b013e31828ab35d; Helmes E, 2011, BRAIN INJURY, V25, P338, DOI 10.3109/02699052.2011.556104; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kaup AR, 2015, NEUROLOGY, V85, P1852, DOI 10.1212/WNL.0000000000002153; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; McKinlay A, 2016, DISABIL REHABIL 0626; Mehta KM, 1999, NEUROLOGY, V53, P1959, DOI 10.1212/WNL.53.9.1959; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; National Institute of Neurological Disorders and Stroke, 2017, COMM DAT EL TRAUM BR; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Russell LM, 2013, AM J PUBLIC HEALTH, V103, pS211, DOI 10.2105/AJPH.2013.301485; Salib E, 1997, INT J GERIATR PSYCH, V12, P363, DOI 10.1002/(SICI)1099-1166(199703)12:3<363::AID-GPS515>3.0.CO;2-F; Sayed N, 2013, J NEUROTRAUM, V30, P1117, DOI 10.1089/neu.2012.2638; Silverberg ND, 2017, J NEUROTRAUM, V34, P363, DOI 10.1089/neu.2016.4443; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; StataCorp, 2013, STATA STAT SOFTW REL; Suhanov AV, 2006, EUR J NEUROL, V13, P990, DOI 10.1111/j.1468-1331.2006.01391.x; Turvey C L, 1999, Int Psychogeriatr, V11, P139, DOI 10.1017/S1041610299005694; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wechsler, 1997, WECHSLER ADULT INTEL; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE43, DOI 10.1097/HTR.0000000000000141	59	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1549-1277	1549-1676		PLOS MED	PLos Med.	MAR	2017	14	3							e1002246	10.1371/journal.pmed.1002246			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ2NJ	WOS:000397906100004	28267747	gold, Green Submitted, Green Published			2022-02-06	
J	Lagraoui, M; Sukumar, G; Latoche, JR; Maynard, SK; Dalgard, CL; Schaefer, BC				Lagraoui, Mouna; Sukumar, Gauthaman; Latoche, Joseph R.; Maynard, Sean K.; Dalgard, Clifton L.; Schaefer, Brian C.			Salsalate treatment fallowing traumatic brain injury reduces inflammation and promotes a neuroprotective and neurogenic transcriptional response with concomitant functional recovery	BRAIN BEHAVIOR AND IMMUNITY			English	Article						TBI; Myeloid cells; Microglia; NF-kappaB; Salicylate; Neuroprotection; Neuroregeneration; Oxytocin; Motor function; NSAID	NF-KAPPA-B; ACID RECEPTOR-BETA; NEURONAL DEGENERATION; REACTIVE ASTROCYTES; INSULIN-RESISTANCE; NEURODEGENERATION; SALICYLATE; EXPRESSION; OXYTOCIN; GENES	Neuroinflammation plays a critical role in the pathogenesis of traumatic brain injury (TBI). TBI induces rapid activation of astrocytes and microglia, infiltration of peripheral leukocytes, and secretion of inflammatory cytokines. In the context of modest or severe TBI, such inflammation contributes to tissue destruction and permanent brain damage. However, it is clear that the inflammatory response is also necessary to promote post-injury healing. To date, anti-inflammatory therapies, including the broad class of non-steroidal anti-inflammatory drugs (NSAIDs), have met with little success in treatment of TBI, perhaps because these drugs have inhibited both the tissue-damaging and repair-promoting aspects of the inflammatory response, or because inhibition of inflammation alone is insufficient to yield therapeutic benefit. Salsalate is an unacetylated salicylate with long history of use in limiting inflammation. This drug is known to block activation of NF-KB, and recent data suggest that salsalate has a number of additional biological activities, which may also contribute to its efficacy in treatment of human disease. Here, we show that salsalate potently blocks pro-inflammatory gene expression and nitrite secretion by microglia in vitro. Using the controlled cortical impact (CCI) model in mice, we find that salsalate has a broad antiinflammatory effect on in vivo TBI-induced gene expression, when administered post-injury. Interestingly, salsalate also elevates expression of genes associated with neuroprotection and neurogenesis, including the neuropeptides, oxytocin and thyrotropin releasing hormone. Histological analysis reveals salsalate-dependent decreases in numbers and activation-associated morphological changes in microglia/macrophages, proximal to the injury site. Flow cytometry data show that salsalate changes the kinetics of CCI-induced accumulation of various populations of CD11b-positive myeloid cells in the injured brain. Behavioral assays demonstrate that salsalate treatment promotes significant recovery of function following CCI. These pre-clinical data suggest that salsalate may show promise as a TBI therapy with a multifactorial mechanism of action to enhance functional recovery.	[Lagraoui, Mouna; Latoche, Joseph R.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Lagraoui, Mouna; Sukumar, Gauthaman; Latoche, Joseph R.; Maynard, Sean K.; Dalgard, Clifton L.; Schaefer, Brian C.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD USA; [Sukumar, Gauthaman; Dalgard, Clifton L.] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, Bethesda, MD USA; [Latoche, Joseph R.] Windber Res Inst, Integrat Cardiac & Metab Hlth Program, 620 7th St, Windber, PA 15963 USA; [Maynard, Sean K.] MedImmune, One MedImmune Way,2214F, Gaithersburg, MD 20878 USA		Schaefer, BC (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	brian.schaefer@usuhs.edu	Sukumar, Gauthaman/A-1697-2018	Maynard, Sean/0000-0002-0953-4362; Dalgard, Clifton/0000-0003-2025-8239; Sukumar, Gauthaman/0000-0003-3129-4171	Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [GM109887]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [U01GM109887] Funding Source: NIH RePORTER	The authors thank A. Fu and L. Tucker for help with design and execution of TBI surgeries and behavior assays; C. Olsen for statistical consultation; D. McDaniel for help with microscopy analyses; and A. Kashyap and C. Huaman for excellent technical assistance. This work was supported by grants from the Center for Neuroscience and Regenerative Medicine and the NIH (GM109887) to B.C.S. The opinions or assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Department of Defense, the Uniformed Services University or any other agency of the U.S. Government. The authors declare no competing financial interests.	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Appolloni I, 2008, CEREB CORTEX, V18, P553, DOI 10.1093/cercor/bhm092; Betts-Henderson J, 2010, HUM MOL GENET, V19, P342, DOI 10.1093/hmg/ddp500; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; Calabresi P, 2013, MOVEMENT DISORD, V28, P51, DOI 10.1002/mds.25096; Cao YG, 2012, BIOPHARM DRUG DISPOS, V33, P285, DOI 10.1002/bdd.1797; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; de Vries EM, 2016, ENDOCRINOLOGY, V157, P2947, DOI 10.1210/en.2016-1027; DeLegge MH, 2008, NUTR CLIN PRACT, V23, P35, DOI 10.1177/011542650802300135; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Flandin P, 2011, NEURON, V70, P939, DOI 10.1016/j.neuron.2011.04.020; Fu TS, 2016, CAN J NEUROL SCI, V43, P238, DOI 10.1017/cjn.2015.320; Gainer H, 2012, J NEUROENDOCRINOL, V24, P528, DOI 10.1111/j.1365-2826.2011.02236.x; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Gumus B, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0301-x; HARRISON LI, 1981, J CLIN PHARMACOL, V21, P401, DOI 10.1002/j.1552-4604.1981.tb01740.x; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hedner T, 1998, CLIN RHEUMATOL, V17, P17, DOI 10.1007/BF01450953; Hellewell S, 2015, BRAIN RES; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Karelina K, 2011, STROKE, V42, P3606, DOI 10.1161/STROKEAHA.111.628008; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Knudsen SH, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0642-1; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Lewis M. M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P345, DOI 10.2174/187152706777452245; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marin I. A., 2016, NEUROPSYCHOPHARMACOL; Marnett LJ, 2009, ANNU REV PHARMACOL, V49, P265, DOI 10.1146/annurev.pharmtox.011008.145638; McLarren KW, 2003, DEV BIOL, V259, P34, DOI 10.1016/S0012-1606(03)00177-5; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Paintlia MK, 2013, J BIOL CHEM, V288, P3831, DOI 10.1074/jbc.M112.405654; Perera M, 2004, MOL CELL NEUROSCI, V25, P153, DOI 10.1016/j.mcn.2003.10.004; Pierce JW, 1996, J IMMUNOL, V156, P3961; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078898; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Rataj-Baniowska M, 2015, J NEUROSCI, V35, P14467, DOI 10.1523/JNEUROSCI.1278-15.2015; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Serpente P, 2005, DEVELOPMENT, V132, P503, DOI 10.1242/dev.01593; Shirakawa K, 2016, ELIFE, V5, DOI 10.7554/eLife.11156; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Soares HD, 1995, J NEUROSCI, V15, P8223; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; SWEENEY JD, 1991, THROMB RES, V61, P23, DOI 10.1016/0049-3848(91)90165-S; Szmydynger-Chodobska J, 2010, J NEUROTRAUM, V27, P1449, DOI 10.1089/neu.2010.1331; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; Tay T.L., 2016, J PHYSL; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; Wynshaw-Boris A, 2010, SEMIN CELL DEV BIOL, V21, P823, DOI 10.1016/j.semcdb.2010.07.008; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	76	19	19	0	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	MAR	2017	61						96	109		10.1016/j.bbi.2016.12.005			14	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EM5PZ	WOS:000395365900012	27939247	Green Accepted, Bronze, Green Published			2022-02-06	
J	Palm, S; Ronnback, L; Johansson, B				Palm, Samuel; Ronnback, Lars; Johansson, Birgitta			LONG-TERM MENTAL FATIGUE AFTER TRAUMATIC BRAIN INJURY AND IMPACT ON EMPLOYMENT STATUS	JOURNAL OF REHABILITATION MEDICINE			English	Article						mental fatigue; traumatic brain injury; employment status; post-concussion	FOLLOW-UP; HEAD-INJURY; SYMPTOMS; RECOVERY; RETURN; METHYLPHENIDATE; DISABILITY; COMPLAINTS; FREQUENCY; QUALITY	Objective: Long-term mental fatigue following traumatic brain injury is endorsed as one of the most distressing symptoms, interfering considerably with return to work and social life. The objective of this cross-sectional study was to estimate the prevalence of long-term mental fatigue after traumatic brain injury and to evaluate its association with employment status. Methods: All patients (age range 19-65 years) diagnosed with traumatic brain injury irrespective of severity at Kungalv Hospital, Kungalv, Sweden, over a period of 5 years (n = 613) were invited by post to respond to questions about their injury, employment status and complete a questionnaire about mental fatigue, the Mental Fatigue Scale (MFS). Results: A response rate of 38% was achieved. Among respondents, 39% scored above the MFS cutoff of 10.5. Higher MFS scores were associated with decreased employment status (p < 0.001). Rating on the MFS was higher for women, for those with a longer initial duration of acute post-traumatic brain injury symptoms, and for those who had previously experienced a traumatic brain injury. No association was found between mental fatigue and age, severity of injury, or time since injury. Conclusion: Long-term mental fatigue was frequent among people who had experienced a traumatic brain injury, and a higher rating on the MFS was associated with decreased employment status.	[Palm, Samuel; Ronnback, Lars; Johansson, Birgitta] Univ Gothenburg, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden		Johansson, B (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Clin Neurosci & Rehabil, Bla Str 7, SE-41345 Gothenburg, Sweden.	birgitta.johansson@neuro.gu.se		, Birgitta/0000-0003-0240-1142	Health & Medical Care Committee of the Region, Vastra Gotaland	The study was funded by grants from The Health & Medical Care Committee of the Region, Vastra Gotaland.	Andersson EH, 2003, ACTA NEUROL SCAND, V107, P256, DOI 10.1034/j.1600-0404.2003.00112.x; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Benedictus MR, 2010, ARCH PHYS MED REHAB, V91, P1436, DOI 10.1016/j.apmr.2010.06.019; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P25, DOI 10.1097/01.HTR.0000308718.88214.bb; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2014, J HEAD TRAUMA REHAB, V29, P490, DOI 10.1097/HTR.0000000000000102; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Johansson B, 2017, ACTA NEUROL SCAND, V135, P100, DOI 10.1111/ane.12587; Johansson B, 2015, BRAIN INJURY, V29, P758, DOI 10.3109/02699052.2015.1004747; Johansson B, 2012, BRAIN INJURY, V26, P1621, DOI 10.3109/02699052.2012.700082; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2014, INT J PHYS MED REHAB, V2, P1, DOI [10.4172/2329-9096.1000182, DOI 10.4172/2329-9096.1000182]; Johansson B, 2015, MINDFULNESS, V6, P1356, DOI 10.1007/s12671-015-0406-7; Johansson B, 2012, ACTA NEUROPSYCHIATR, V24, P266, DOI 10.1111/j.1601-5215.2012.00678.x; Johansson B, 2010, BRAIN INJURY, V24, P2, DOI 10.3109/02699050903452961; Juengst S, 2013, ARCH PHYS MED REHAB, V94, P74, DOI 10.1016/j.apmr.2012.07.025; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Mollayeva T, 2014, NEUROSCI BIOBEHAV R, V47, P684, DOI 10.1016/j.neubiorev.2014.10.024; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; O'Connor C, 2005, PSYCHOL REP, V97, P169, DOI 10.2466/PR0.97.5.169-179; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ponsford J, 2015, J HEAD TRAUMA REHAB, V30, P277, DOI 10.1097/HTR.0000000000000049; Reitan RM, 1999, ARCH CLIN NEUROPSYCH, V14, P191, DOI 10.1016/S0887-6177(98)00012-2; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Willmott C, 2014, J HEAD TRAUMA REHAB, V29, P248, DOI 10.1097/HTR.0000000000000014; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	42	19	20	0	7	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAR	2017	49	3					228	233		10.2340/16501977-2190			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EQ4MA	WOS:000398050300006	28150857	gold			2022-02-06	
J	Sell, SL; Johnson, K; DeWitt, DS; Prough, DS				Sell, Stacy L.; Johnson, Kathia; DeWitt, Douglas S.; Prough, Donald S.			Persistent Behavioral Deficits in Rats after Parasagittal Fluid Percussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						behavior; chronic brain injury; reference memory; TBI; working memory	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; WORKING-MEMORY; WATER MAZE; SPATIAL LOCALIZATION; HIPPOCAMPAL-LESIONS; HEAD-INJURY; MODEL; OUTCOMES; CONCUSSION	Although traumatic brain injury (TBI) is now considered a chronic disease, few studies have investigated the long-term behavioral deficits elicited by a well-established rodent model of injury. Here we evaluate behavioral measures, commonly used in TBI research, to determine which tests are useful for studying long-term effects of brain injury in rats. Male Sprague-Dawley rats were handled and pre-trained to neurological, balance, and motor coordination tests prior to receiving parasagittal fluid-percussion injury (FPI), sham injury, or maintenance as naive cohorts. Rats underwent neuroscore, beam-balance, and beam-walk tests for 3 days after injury. Subsequently, in separate groups at 3, 6, or 12 months, they were re-tested on the same tasks followed by a working memory version of the Morris water maze. On post-injury days (PIDs) 1-3, significant effects of injury on neuroscore, beam-balance, and beam-walk were observed. Differences in the beam-walk task were not detectable at any of the later time-points. However, deficits persisted in beam-balance out to 3 months and neuroscore out to 6 months. Working memory deficits persisted out to 12 months, at which time a reference memory deficit was also evident. These data suggest that balance and motor coordination recovered more quickly than neurological deficits. Furthermore, while deficits in working memory remained stable over the 12-month period, the late onset of the reference memory deficit points to the progressive nature of the injury, or an age/TBI interaction. In conclusion, standard behavioral tests are useful measures of persistent behavioral deficits after parasagittal FPI and provide evidence that TBI is a chronic condition that can change over time and worsen with age.	[Sell, Stacy L.; Johnson, Kathia; DeWitt, Douglas S.; Prough, Donald S.] Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA		Sell, SL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 301 Univ Blvd, Galveston, TX 77555 USA.	slsell@utmb.edu	Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X; DeWitt, Douglas/0000-0001-9810-8156	Moody Project for Translational Traumatic Brain Injury Research	These studies were completed as part of a team funded by The Moody Project for Translational Traumatic Brain Injury Research.	AGGLETON JP, 1986, BEHAV BRAIN RES, V19, P133, DOI 10.1016/0166-4328(86)90011-2; Arnold JL, 2004, ANN EMERG MED, V43, P263, DOI 10.1016/S0196-0644(03)00723-6; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Casson IR, 2009, PHYS MED REH CLIN N, V20, P195, DOI 10.1016/j.pmr.2008.10.006; Choi SH, 2006, J NEUROSCI METH, V156, P182, DOI 10.1016/j.jneumeth.2006.03.002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eskridge SL, 2012, INJURY, V43, P1678, DOI 10.1016/j.injury.2012.05.027; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Franklin M, 2015, 2015 WOUNDED WARRIOR; FRICK KM, 1995, NEUROBIOL AGING, V16, P149, DOI 10.1016/0197-4580(94)00155-3; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; Jung J., 2016, J NEUROL SCI-TURK, V30, P617; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Long JB, 1996, J NEUROTRAUM, V13, P149, DOI 10.1089/neu.1996.13.149; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Perez-Polo JR, 2015, J NEUROSCI RES, V93, P549, DOI 10.1002/jnr.23513; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Rimel R W, 1981, J Neurosurg Nurs, V13, P132; Risdall JE, 2011, PHILOS T R SOC B, V366, P241, DOI 10.1098/rstb.2010.0230; Risling Marten, 2012, Front Neurol, V3, P30, DOI 10.3389/fneur.2012.00030; RUTHERFORD WH, 1977, LANCET, V1, P1; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sharpe W, 1922, CAN MED ASSOC J, V7, P761; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Weicker J, 2016, NEUROPSYCHOLOGY, V30, P190, DOI 10.1037/neu0000227; Ziebell J. M., 2016, BRAIN BEHAV IMMUN	56	19	19	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1086	1096		10.1089/neu.2016.4616			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200013	27650266				2022-02-06	
J	Ulndreaj, A; Tzekou, A; Mothe, AJ; Siddiqui, AM; Dragas, R; Tator, CH; Torlakovic, EE; Fehlings, MG				Ulndreaj, Antigona; Tzekou, Apostolia; Mothe, Andrea J.; Siddiqui, Ahad M.; Dragas, Rachel; Tator, Charles H.; Torlakovic, Emina E.; Fehlings, Michael G.			Characterization of the Antibody Response after Cervical Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						antibody-secreting cells (ASCs); astrocytes; autoantibodies; cervical spinal cord injury (cSCI); IgG/IgM immunoglobulins	FIBRILLARY ACIDIC PROTEIN; AUTOIMMUNE-DISEASE; IMMUNE SUPPRESSION; NERVOUS-SYSTEM; NATURAL IGM; T-CELLS; SERUM; NEURONS; BRAIN; SCI	The immune system plays a critical and complex role in the pathobiology of spinal cord injury (SCI), exerting both beneficial and detrimental effects. Increasing evidence suggests that there are injury level-dependent differences in the immune response to SCI. Patients with traumatic SCI have elevated levels of circulating autoantibodies against components of the central nervous system, but the role of these antibodies in SCI outcomes remains unknown. In rodent models of mid-thoracic SCI, antibody-mediated autoimmunity appears to be detrimental to recovery. However, whether autoantibodies against the spinal cord are generated following cervical SCI (cSCI), the most common level of injury in humans, remains undetermined. To address this knowledge gap, we investigated the antibody responses following cSCI in a rat model of injury. We found increased immunoglobulin G (IgG) and IgM antibodies in the spinal cord in the subacute phase of injury (2 weeks), but not in more chronic phases (10 and 20 weeks). At 2 weeks post-cSCI, antibodies were detected at the injury epicenter and co-localized with the astroglial scar and neurons of the ventral horn. These increased levels of antibodies corresponded with enhanced activation of immune responses in the spleen. Higher counts of antibody secreting cells were observed in the spleen of injured rats. Further, increased levels of secreted IgG antibodies and enhanced proliferation of T-cells in splenocyte cultures from injured rats were found. These findings suggest the potential development of autoantibody responses following cSCI in the rat. The impact of the post-traumatic antibody responses on functional outcomes of cSCI is a critical topic that requires further investigation.	[Ulndreaj, Antigona; Tzekou, Apostolia; Mothe, Andrea J.; Siddiqui, Ahad M.; Dragas, Rachel; Tator, Charles H.; Fehlings, Michael G.] Univ Hlth Network, Toronto Western Res Inst, Div Genet & Dev, Toronto, ON, Canada; [Ulndreaj, Antigona; Tzekou, Apostolia; Mothe, Andrea J.; Siddiqui, Ahad M.; Dragas, Rachel; Tator, Charles H.; Fehlings, Michael G.] Univ Hlth Network, Univ Toronto Spinal Program, Krembil Neurosci Ctr, Toronto, ON, Canada; [Ulndreaj, Antigona; Dragas, Rachel; Tator, Charles H.; Fehlings, Michael G.] Univ Toronto, Fac Med, Inst Med Sci, 100 Coll St, Toronto, ON, Canada; [Tator, Charles H.; Fehlings, Michael G.] Univ Toronto, Dept Surg, 100 Coll St, Toronto, ON, Canada; [Tator, Charles H.; Fehlings, Michael G.] Univ Toronto, Univ Toronto Spine Program, 100 Coll St, Toronto, ON, Canada; [Tator, Charles H.] Univ Toronto, Dept Lab Hematol, 100 Coll St, Toronto, ON, Canada		Fehlings, MG (corresponding author), Toronto Western Hosp, 399 Bathurst St,Suite 4W449, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.ca		Fehlings, Michael/0000-0002-5722-6364	Stem Cell Network; Halbert Chair in Neural Repair and Regeneration; DeZwirek Foundation	We are thankful to Stem Cell Network for supporitng AU with a bursary to learn flow cytometry at the University of British Columbia Flow Cytometry Facility. We also thank Drs. Joan Wither and Tania Watts for their constructive feedback throughout the course of this study, Drs. Pia Vidal and Nicole Forgione for their feedback during the preparation of this manuscript, and Dr. Madeleine O' Higgins for copyediting this manuscript. MGF is supported by the Halbert Chair in Neural Repair and Regeneration and the DeZwirek Foundation.	ADIB M, 1990, J IMMUNOL, V145, P3807; AIHARA N, 1994, J COMP NEUROL, V342, P481, DOI 10.1002/cne.903420402; Anderson DK, 2005, SPINAL CORD, V43, P453, DOI 10.1038/sj.sc.3101746; Ankeny DP, 2006, J NEUROCHEM, V99, P1073, DOI 10.1111/j.1471-4159.2006.04147.x; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Baumgarth N, 2015, ANN NY ACAD SCI, V1362, P188, DOI 10.1111/nyas.12804; BENNER R, 1981, IMMUNOBIOLOGY, V158, P225, DOI 10.1016/S0171-2985(81)80072-1; BERNSTEIN JJ, 1987, BRAIN RES, V426, P112, DOI 10.1016/0006-8993(87)90430-6; BERNSTEIN JJ, 1993, INT J DEV NEUROSCI, V11, P117, DOI 10.1016/0736-5748(93)90072-L; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Boes M, 2000, MOL IMMUNOL, V37, P1141, DOI 10.1016/S0161-5890(01)00025-6; BRIGHTMA.MW, 1970, J NEUROL SCI, V10, P215, DOI 10.1016/0022-510X(70)90151-6; BRINDEL I, 1994, NEUROSCI LETT, V181, P103, DOI 10.1016/0304-3940(94)90570-3; Carnini Anna, 2010, Prion, V4, P80; Davies AL, 2007, ARCH PHYS MED REHAB, V88, P1384, DOI 10.1016/j.apmr.2007.08.004; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Nguyen DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-224; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; FABIAN RH, 1990, NEUROLOGY, V40, P419, DOI 10.1212/WNL.40.3_Part_1.419; FABIAN RH, 1986, J NEUROL SCI, V73, P257, DOI 10.1016/0022-510X(86)90150-4; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; FEHLINGS MG, 1995, EXP NEUROL, V132, P220, DOI 10.1016/0014-4886(95)90027-6; Figley SA, 2014, J NEUROTRAUM, V31, P541, DOI 10.1089/neu.2013.3034; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Forgione N, 2014, J NEUROTRAUM, V31, P1776, DOI 10.1089/neu.2014.3388; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Hayes KC, 2002, J NEUROTRAUM, V19, P753, DOI 10.1089/08977150260139129; Holodick NE, 2010, EUR J IMMUNOL, V40, P3007, DOI 10.1002/eji.201040545; Ibarra A, 2007, SPINAL CORD, V45, P380, DOI 10.1038/sj.sc.3101972; Iversen PO, 2000, BLOOD, V96, P2081; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Jones TB, 2002, J NEUROSCI, V22, P2690, DOI 10.1523/JNEUROSCI.22-07-02690.2002; Kopp MA, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-168; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucin KM, 2007, EXP NEUROL, V207, P75, DOI 10.1016/j.expneurol.2007.05.019; Lucin KM, 2009, J NEUROCHEM, V110, P1409, DOI 10.1111/j.1471-4159.2009.06232.x; Marques CP, 2011, J VIROL, V85, P6136, DOI 10.1128/JVI.00202-11; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mori A, 2014, J NEUROL SCI, V337, P215, DOI 10.1016/j.jns.2013.11.026; Mothe AJ, 2011, SPINAL CORD, V49, P967, DOI 10.1038/sc.2011.46; National Spinal Cord Injury Statistics C, 2015, SPIN CORD INJ FACTS; Niebroj-Dobosz I, 2004, EUR J NEUROL, V11, P13, DOI 10.1046/j.1351-5101.2003.00697.x; NOBLE LJ, 1989, BRAIN RES, V482, P57, DOI 10.1016/0006-8993(89)90542-8; Oropallo MA, 2012, J IMMUNOL, V188, P5257, DOI 10.4049/jimmunol.1101934; Petzold A, 2015, BRAIN RES, V1600, P17, DOI 10.1016/j.brainres.2014.12.027; Popovich PG, 2001, J NEUROTRAUM, V18, P957, DOI 10.1089/089771501750451866; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Riegger T, 2009, NEUROSCIENCE, V158, P1194, DOI 10.1016/j.neuroscience.2008.08.021; Riegger T, 2007, EUR J NEUROSCI, V25, P1743, DOI 10.1111/j.1460-9568.2007.05447.x; Saltzman JW, 2013, J NEUROTRAUM, V30, P434, DOI 10.1089/neu.2012.2501; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sengupta MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110885; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Tzekou A, 2014, J CLIN IMMUNOL, V34, pS132, DOI 10.1007/s10875-014-0021-8; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; Watzlawik JO, 2013, EXPERT REV NEUROTHER, V13, P1017, DOI 10.1586/14737175.2013.835601; Wu B, 2012, EXP NEUROL, V237, P274, DOI 10.1016/j.expneurol.2012.07.016; YAMAMOTO T, 1987, NEUROLOGY, V37, P843, DOI 10.1212/WNL.37.5.843; Yoshimi K, 2002, BRAIN RES, V956, P53, DOI 10.1016/S0006-8993(02)03479-0; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8; Zhang Y, 2013, J NEUROSCI, V33, P12970, DOI 10.1523/JNEUROSCI.1974-13.2013	70	19	19	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2017	34	6					1209	1226		10.1089/neu.2016.4498			18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN7ZR	WOS:000396221200009	27775474	Green Published			2022-02-06	
J	Young, AMH; Guilfoyle, MR; Donnelly, J; Scoffings, D; Fernandes, H; Garnett, M; Agrawal, S; Hutchinson, PJ				Young, Adam M. H.; Guilfoyle, Mathew R.; Donnelly, Joseph; Scoffings, Daniel; Fernandes, Helen; Garnett, Mathew; Agrawal, Shruti; Hutchinson, Peter J.			Correlating optic nerve sheath diameter with opening intracranial pressure in pediatric traumatic brain injury	PEDIATRIC RESEARCH			English	Article							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; SCAN; ULTRASONOGRAPHY; HYPERTENSION; ULTRASOUND	INTRODUCTION: The use of clinical markers to predict intracranial pressure (ICP) is desirable as a first-line measure to assist in decision making as to whether invasive monitoring is required. Correlations between ICP and optic nerve sheath diameter (ONSD) using CT and MRI have been observed in adult populations. However, data on this modality in children is less well documented. METHODS: ONSD was measured by independent observers and correlated with opening ICP at insertion of invasive monitoring probes in pediatric traumatic brain injury patients admitted to Addenbrookes Hospital between January 2009 and December 2013. RESULTS: Thirty-six patients with a mean age of 8.2 y were admitted to the Pediatric Intensive Care Unit (PICU) with a traumatic head injury and required invasive neurosurgical monitoring. The median ICP was 18 +/- 10 mmHg (median +/- IQR), the median right ONSD was 5.6 +/- 2.5 mm and the left was 5.9 +/- 3.2 mm. The Intraclass correlation between observers was 0.91 (P < 0.0001). The correlation of mean ONSD and max ONSD with ICP was 0.712 (P < 0.0001) and 0.713 (P < 0.0001), respectively. Area under ROC curve for both mean and max ONSD is 0.85 (95% CI: 0.73-0.98). CONCLUSION: Where pediatric patients present with an ONSD of over 6.1 mm following a traumatic brain injury (TBI), ICP monitoring should be implemented.	[Young, Adam M. H.; Guilfoyle, Mathew R.; Donnelly, Joseph; Fernandes, Helen; Garnett, Mathew; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Dept Clin Neurosci, Cambridge, England; [Scoffings, Daniel] Univ Cambridge, Addenbrookes Hosp, Dept Neuroradiol, Cambridge, England; [Agrawal, Shruti] Univ Cambridge, Addenbrookes Hosp, Dept Pediat Intens Care, Cambridge, England		Young, AMH (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Acad Neurosurg, Dept Clin Neurosci, Cambridge, England.	ay276@cam.ac.uk	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Scoffings, Daniel/AAA-1649-2022	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; 	Medical Research-Council (MRC)UK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986 ID79068, G1002277 ID98489]; National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G1002277, G0601025] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0601025, G1002277] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [ACF-2014-14-005, 12/35/57, NIHR-RP-R3-12-013] Funding Source: researchfish	We gratefully acknowledge financial support as follows. Research support: the Medical Research-Council (MRC, Grant Nos. G0600986 ID79068 and G1002277 ID98489) and the National Institute for Health Research Biomedical Research Centre (NIHR BRC) Cambridge (Neuroscience Theme; Brain Injury and Repair Theme). Authors' support: P.J.H.-NIHR Research Professorship, Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship and NIHR Cambridge BRC. J.D. is supported by a Woolf Fisher Scholarship. MC-NIHR BRC.	Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Geeraerts T, 2008, CRIT CARE, V12, DOI 10.1186/cc7006; Hansen HC, 1997, J NEUROSURG, V87, P34, DOI 10.3171/jns.1997.87.1.0034; Harrison D, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17030; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Helmke K, 1996, PEDIATR RADIOL, V26, P701, DOI 10.1007/BF01383383; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kalantari H, 2013, AM J EMERG MED, V31, P1595, DOI 10.1016/j.ajem.2013.07.028; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Launey Y, 2014, J NEUROTRAUM, V31, P984, DOI 10.1089/neu.2012.2829; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Miller MT, 2004, J TRAUMA, V56, P967, DOI 10.1097/01.TA.0000123699.16465.8B; Moretti R, 2011, ACTA ANAESTH SCAND, V55, P644, DOI 10.1111/j.1399-6576.2011.02432.x; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Tsung JW, 2005, PEDIATR EMERG CARE, V21, P94, DOI 10.1097/01.pec.0000159052.64930.64; Wang D, 2004, J TRAUMA, V56, P972; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	31	19	19	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0031-3998	1530-0447		PEDIATR RES	Pediatr. Res.	MAR	2017	81	3					443	447		10.1038/pr.2016.165			5	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	EN9BZ	WOS:000396297000014	27513519	Bronze			2022-02-06	
J	Baugh, CM; Kroshus, E; Kiernan, PT; Mendel, D; Meehan, WP				Baugh, Christine M.; Kroshus, Emily; Kiernan, Patrick T.; Mendel, David; Meehan, William P., III			Football Players' Perceptions of Future Risk of Concussion and Concussion-Related Health Outcomes	JOURNAL OF NEUROTRAUMA			English	Article						American football; brain injury; chronic traumatic encephalopathy; concussion; risk	TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL FOOTBALL; STATES HIGH-SCHOOL; RECURRENT CONCUSSION; UNITED-STATES; HEAD-INJURY; ILLNESS PERCEPTIONS; NCAA CONCUSSION; FEAR APPEALS; ICE HOCKEY	Concussion is increasingly recognized as a risk of participation in contact and collision sports. There have been few examinations of athletes' perceptions of their susceptibility to concussion or concussion-related health consequences. We examine college football players' perceptions of their risk of sustaining a concussion and concussion-related health consequences in their future, whether these perceptions change over time, and how concussion history is related to perceived future risk of concussion and concussion-related health consequences. A survey was administered to National Collegiate Athletic Association Division I Football Championship Series athletes on 10 teams in 2013 and to nine of those teams in 2014. Athletes answered questions assessing their perceptions of concussion and potential concussion-related health consequences. Approximately 40% of athletes believed there was a strong possibility that they would sustain a concussion in the future, while approximately one-in-four thought a concussion would make them miss a few games. About one-in-10 athletes predicted dementia, Alzheimer's disease, or chronic traumatic encephalopathy would develop from concussions. These beliefs were stronger among athletes who had sustained previous concussions. Across the two years studied, athletes' perceptions of the risk of concussion and missing a few games because of concussion decreased significantly. Overall, a substantial proportion of college football players believe they will have long-term health consequences as a result of sustaining sport-related concussions. The true incidence and prevalence of many of these outcomes are unknown. Further research is needed to determine whether athletes have an accurate perception of the risks of these outcomes developing.	[Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA; [Baugh, Christine M.; Mendel, David; Meehan, William P., III] Boston Childrens Hosp, Micheli Ctr Sports Injury Prevent, Boston, MA USA; [Baugh, Christine M.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Kroshus, Emily] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kroshus, Emily] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Kiernan, Patrick T.] Boston Univ, Chron Traumat Encephalopathy Ctr, Boston, MA 02215 USA; [Meehan, William P., III] Boston Childrens Hosp, Brain Injury Ctr, Boston, MA USA		Baugh, CM (corresponding author), Harvard Univ, Interfac Initiat Hlth Policy, 14 Story St,Fourth Floor, Cambridge, MA 02138 USA.	cbaugh@g.harvard.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; Edmond J. Safra Center for Ethics at Harvard University; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	C.M.B. is supported by the National Institute of Mental Health of Award Number T32MH019733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This study was funded, in part, by a grant from the Edmond J. Safra Center for Ethics at Harvard University. The authors would like to thank the athletes who contributed to this research and to the sports medicine providers and coaches who fostered the athletes' participation.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.10.FOCUS10222; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Houck Z, 2016, AM J SPORTS MED; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kaut KP, 2003, CLIN J SPORT MED, V13, P213, DOI 10.1097/00042752-200307000-00004; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kerr ZY, 2015, AM J SPORT MED, V43, P606, DOI 10.1177/0363546514562180; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kristman VL, 2008, CLIN J SPORT MED, V18, P322, DOI 10.1097/JSM.0b013e31817e6f3e; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Langburt W, 2001, J CHILD NEUROL, V16, P83, DOI 10.1177/088307380101600203; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leventhal H, 1980, MED PSYCHOL, P7; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moreau M. S., 2014, INT J EXERC SCI, V7, P8; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Rothman Alexander J., 1999, Journal of the National Cancer Institute Monographs, P44; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Seichepine DR, 2013, J NEUROTRAUM, V30, P1299, DOI 10.1089/neu.2012.2690; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Snell DL, 2010, BRAIN INJURY, V24, P1595, DOI 10.3109/02699052.2010.523048; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wiebe DJ, 2011, INJURY PREV, V17, P69, DOI 10.1136/ip.2010.031211; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	60	19	19	5	25	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					790	797		10.1089/neu.2016.4585			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200005	27526721	Green Published			2022-02-06	
J	Kunitake, RC; Howard, BM; Kornblith, LZ; Christie, SA; Conroy, AS; Cohen, MJ; Callcut, RA				Kunitake, Ryan C.; Howard, Benjamin M.; Kornblith, Lucy Z.; Christie, Sabrinah A.; Conroy, Amanda S.; Cohen, Mitchell J.; Callcut, Rachael A.			Individual clotting factor contributions to mortality following trauma	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Clotting factors; hemorrhage; trauma-related mortality	PRINCIPAL COMPONENT ANALYSIS; ACTIVATED PROTEIN-C; TISSUE FACTOR; ORGAN FAILURE; COAGULOPATHY; COAGULATION; INJURY; HEMOSTASIS; HYPOPERFUSION; HEMORRHAGE	BACKGROUND: Acute traumatic coagulopathy affects 20% to 30% of trauma patients, but the extensive collinearity of the coagulation cascade complicates attempts to clarify global clotting factor dysfunction. This study aimed to characterize phenotypes of clotting factor dysfunction and their contributions to mortality after major trauma. METHODS: This prospective cohort study examines all adult trauma patients of the highest activation level presenting to San Francisco General Hospital between February 2005 and February 2015. Factors II, V, VII, VIII, IX, and X and protein C activity on admission and mortality status at 28 days were assessed. Predictors of 28-day mortality in univariate analysis were included in multiple logistic regression controlling for traumatic brain injury (TBI), acidosis, age, and mechanism of injury. Principal component analysis was utilized to identify phenotypic coagulation. RESULTS: Complete coagulation factor data were available for 876 (61%) of 1,429 patients. In multiple logistic regression, factors V (odds ratio [OR], 0.86; 95% confidence interval [CI], 0.76-0.97), VIII (OR, 0.97; 95% CI, 0.95-0.99), and X (OR, 0.79; 95% CI, 0.68-0.92) and protein C (OR, 1.17; 95% CI, 1.05-1.30) significantly predicted 28-day mortality after controlling for age, base deficit, mechanism of injury, and TBI. Principal component analysis identified two significant principal components (Phenotypes 1 and 2) that accounted for 66.3% of the total variance. Phenotype 1 (factors II, VII, IX, and X and protein C abnormalities) explained 49.3% and was associated with increased injury, coagulopathy, TBI, and mortality. Phenotype 2 (factors V and VIII abnormalities) explained 17.0% and was associated with increased coagulopathy, blunt injury, and mortality. Only Phenotype 2 remained significantly associated with 28-day mortality in multiple logistic regression. CONCLUSIONS: Principal component analysis identified two distinct phenotypes within the entirety of global clotting factor abnormalities, and these findings substantiate the crucial association of factors Vand VIII on mortality following trauma. This may be the first step toward identifying unique phenotypes after injury and personalizing hemostatic resuscitation. (Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Kunitake, Ryan C.; Howard, Benjamin M.; Kornblith, Lucy Z.; Christie, Sabrinah A.; Conroy, Amanda S.; Cohen, Mitchell J.; Callcut, Rachael A.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Kunitake, Ryan C.; Howard, Benjamin M.; Kornblith, Lucy Z.; Christie, Sabrinah A.; Conroy, Amanda S.; Cohen, Mitchell J.; Callcut, Rachael A.] Zuckerberg San Francisco Gen Hosp, Dept Surg, 1001 Potrero Ave,Ward 3A, San Francisco, CA 94110 USA		Callcut, RA (corresponding author), Zuckerberg San Francisco Gen Hosp, Dept Surg, 1001 Potrero Ave,Ward 3A, San Francisco, CA 94110 USA.	Rachael.Callcut@ucsf.edu	Callcut, Rachael/ABE-1484-2021		National Center for Advancing Translational Sciences, National Institutes of Health (NIH) via the University of California San Francisco Clinical and Translational Institute [TL1 TR000144]; career development award from the National Institute of Environmental Health Sciences, National Institute of Health Big Data to Knowledge Initiative [K01ES026834]; Department of DefenseUnited States Department of Defense [W81XWH-10-1-0509]; NIH Tactic Grant [1UM1HL120877]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000144] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [UM1HL120877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER	R.C.K. is supported by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH) via the University of California San Francisco Clinical and Translational Institute (TL1 TR000144). R.A.C. is supported with a career development award from the National Institute of Environmental Health Sciences, National Institute of Health Big Data to Knowledge Initiative (K01ES026834). Additional funding was provided by the Department of Defense (W81XWH-10-1-0509) and NIH Tactic Grant (1UM1HL120877).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Chin TL, 2014, SURGERY, V156, P570, DOI 10.1016/j.surg.2014.04.030; Christiaans SC, 2013, AM J PHYSIOL-LUNG C, V305, pL455, DOI 10.1152/ajplung.00093.2013; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Dobson GP, 2015, J TRAUMA ACUTE CARE, V79, P301, DOI 10.1097/TA.0000000000000729; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Dunteman George H., 1989, PRINCIPAL COMPONENTS; Esmon CT, 2012, SEMIN IMMUNOPATHOL, V34, P127, DOI 10.1007/s00281-011-0284-6; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Hauser CJ, 2010, J TRAUMA, V69, P489, DOI 10.1097/TA.0b013e3181edf36e; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Jansen JO, 2011, J TRAUMA, V71, pS435, DOI 10.1097/TA.0b013e318232e5cb; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kerlin BA, 2003, BLOOD, V102, P3085, DOI 10.1182/blood-2003-06-1789; Kutcher ME, 2015, J TRAUMA ACUTE CARE, V78, P516, DOI 10.1097/TA.0000000000000545; Kutcher ME, 2013, J TRAUMA ACUTE CARE, V74, P1223, DOI 10.1097/TA.0b013e31828b7fa1; Liang HPH, 2015, BLOOD, V126, P2415, DOI 10.1182/blood-2015-05-644401; Lu Rommel P, 2013, J Trauma Acute Care Surg, V74, P1474, DOI 10.1097/TA.0b013e3182923193; Mackman N, 2009, ANESTH ANALG, V108, P1447, DOI 10.1213/ane.0b013e31819bceb1; Oshiro A, 2014, CRIT CARE, V18, DOI 10.1186/cc13816; Peltan ID, 2015, CRIT CARE MED, V43, P1429, DOI 10.1097/CCM.0000000000000981; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rizoli S, 2013, J TRAUMA ACUTE CARE, V74, P1229; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Utter GH, 2002, J TRAUMA, V52, P1071, DOI 10.1097/00005373-200206000-00008; Zulian MC, 2015, LANGENBECK ARCH SURG, V400, P589, DOI 10.1007/s00423-015-1290-2	29	19	20	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2017	82	2					302	308		10.1097/TA.0000000000001313			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	EJ8GO	WOS:000393463600014	27906868	Green Accepted			2022-02-06	
J	Martin, M; Cook, F; Lobo, D; Vermersch, C; Attais, A; Ait-Mamar, B; Plaud, B; Mounier, R; Dhonneur, G				Martin, Mathieu; Cook, Fabrice; Lobo, David; Vermersch, Charlotte; Attais, Arie; Ait-Mamar, Bouziane; Plaud, Benoit; Mounier, Roman; Dhonneur, Gilles			Secondary Insults and Adverse Events During Intrahospital Transport of Severe Traumatic Brain-Injured Patients	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Head computed tomography; Intrahospital transport	CRITICALLY-ILL PATIENTS; HEAD COMPUTED-TOMOGRAPHY; HEMORRHAGE; UTILITY; SAFETY	Our aim was to assess the occurrence of secondary insults (SIs) or adverse events (AEs) during intrahospital transport (IHT) of severe traumatic brain injury (TBI) patients for head computed tomography (CT) scanning. A prospective study based on severe TBI patients admitted from June 2011 through June 2013 in a level I trauma center. Patients received an IHT to perform a control CT scan in the first 3 days following trauma. The occurrence of SIs and AEs was assessed during the IHT for a control CT scan. The frequency of SIs was compared to the periods "before," "during," and "after" IHT. SI was defined by an intracranial pressure (ICP) > 30 mmHg, a cerebral perfusion pressure (CPP) < 50 mmHg, systolic blood pressure (SBP) < 90 mmHg, or saturation pulse O-2 (SpO(2)) < 90 % for more than five consecutive minutes. An AE was defined as failures of hardware or ventilator asynchrony requiring therapeutic intervention during transport. In addition, we assessed the therapeutic benefit of a CT scan control. The final analysis included 31 patients and 31 IHTs. The median duration of IHT was 29 min [25;37]. SIs occurred in 16 patients (52 %) during transport, whereas it was observed in 4 patients (13 %) before (p = 0.002) and 4 patients (13 %) after IHT (p = 0.001). Twenty-four AEs occurred during transport of 19 patients (61 %). One patient benefited from hematoma evacuation after implementation of control CT. IHT carries significant SIs and AEs in severe TBI patients. To improve a risk/benefit ratio favorable for patients, a program focusing on IHT complications regarding therapeutic impact of control CT scan is needed.	[Martin, Mathieu; Cook, Fabrice; Lobo, David; Vermersch, Charlotte; Attais, Arie; Ait-Mamar, Bouziane; Mounier, Roman; Dhonneur, Gilles] Paris Est Creteil Univ, Dept Anaesthesiol & Crit Care Med, Ctr Trauma, Surg Intens Care Unit, Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France; [Martin, Mathieu; Cook, Fabrice; Lobo, David; Vermersch, Charlotte; Attais, Arie; Ait-Mamar, Bouziane; Mounier, Roman; Dhonneur, Gilles] Henri Mondor Univ Hosp, AP HP, Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France; [Plaud, Benoit] Paris Diderot Univ, Dept Anaesthesiol & Surg Intens Care, 1 Ave Claude Vellefaux, F-75010 Paris, France; [Plaud, Benoit] St Louis Univ Hosp, AP HP, 1 Ave Claude Vellefaux, F-75010 Paris, France		Martin, M (corresponding author), Paris Est Creteil Univ, Dept Anaesthesiol & Crit Care Med, Ctr Trauma, Surg Intens Care Unit, Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.; Martin, M (corresponding author), Henri Mondor Univ Hosp, AP HP, Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	mathieu.martin@hmn.aphp.fr		Lobo, David/0000-0002-7906-6023			ANDREWS PJD, 1990, LANCET, V335, P327, DOI 10.1016/0140-6736(90)90614-B; Beckmann U, 2004, INTENS CARE MED, V30, P1579, DOI 10.1007/s00134-004-2177-9; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Damm C, 2005, ANN FR ANESTH, V24, P24, DOI 10.1016/j.annfar.2004.10.026; Evans A, 1995, Am J Crit Care, V4, P106; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mathe JF, 2005, ANN FR ANESTH, V24, P688, DOI 10.1016/j.annfar.2005.03.029; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Schwebel C, 2013, CRIT CARE MED, V41, P1919, DOI 10.1097/CCM.0b013e31828a3bbd; Shackford SR, 2004, J TRAUMA, V56, P480; Sherren PB, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0041-7; Sinson G, 2001, J TRAUMA, V51, P875; SMITH I, 1990, CRIT CARE MED, V18, P278, DOI 10.1097/00003246-199003000-00006; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; SZEM JW, 1995, CRIT CARE MED, V23, P1660, DOI 10.1097/00003246-199510000-00009; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; WAYDHAS C, 1995, INTENS CARE MED, V21, P784, DOI 10.1007/BF01700959	22	19	20	0	3	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2017	26	1					87	95		10.1007/s12028-016-0291-5			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EI2AI	WOS:000392287900013	27601068				2022-02-06	
J	Tapper, A; Gonzalez, D; Roy, E; Niechwiej-Szwedo, E				Tapper, Anthony; Gonzalez, Dave; Roy, Eric; Niechwiej-Szwedo, Ewa			Executive function deficits in team sport athletes with a history of concussion revealed by a visual-auditory dual task paradigm	JOURNAL OF SPORTS SCIENCES			English	Article						Concussions; athletes; mild traumatic brain injury; dividing attention	WORKING-MEMORY; NEUROPSYCHOLOGICAL FUNCTION; NEUROCOGNITIVE PERFORMANCE; SEX-DIFFERENCES; GAIT STABILITY; HIGH-SCHOOL; ATTENTION; SYMPTOMS; LOCOMOTOR; RECOVERY	The purpose of this study was to examine executive functions in team sport athletes with and without a history of concussion. Executive functions comprise many cognitive processes including, working memory, attention and multi-tasking. Past research has shown that concussions cause difficulties in vestibular-visual and vestibular-auditory dual-tasking, however, visual-auditory tasks have been examined rarely. Twenty-nine intercollegiate varsity ice hockey athletes (age=19.13, SD=1.56; 15 females) performed an experimental dual-task paradigm that required simultaneously processing visual and auditory information. A brief interview, event description and self-report questionnaires were used to assign participants to each group (concussion, no-concussion). Eighteen athletes had a history of concussion and 11 had no concussion history. The two tests involved visuospatial working memory (i.e., Corsi block test) and auditory tone discrimination. Participants completed both tasks individually, then simultaneously. Two outcome variables were measured, Corsi block memory span and auditory tone discrimination accuracy. No differences were shown when each task was performed alone; however, athletes with a history of concussion had a significantly worse performance on the tone discrimination task in the dual-task condition. In conclusion, long-term deficits in executive functions were associated with a prior history of concussion when cognitive resources were stressed. Evaluations of executive functions and divided attention appear to be helpful in discriminating participants with and without a history concussion.	[Tapper, Anthony; Gonzalez, Dave; Roy, Eric; Niechwiej-Szwedo, Ewa] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada		Tapper, A (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	atapper@uwaterloo.ca			PROPEL Centre for Population Health Impact, University of Waterloo	This research was supported by funding from the PROPEL Centre for Population Health Impact, University of Waterloo.	Anderson V, 2010, STUD NEUROPSYCHOL NE, P1; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; Bernstein DM, 2002, J INT NEUROPSYCH SOC, V8, P673, DOI 10.1017/S1355617702801400; Beurskens R, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/131608; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Chein JM, 2003, J NEUROLINGUIST, V16, P315, DOI 10.1016/S0911-6044(03)00021-6; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Corsi PM, 1972, HUMAN MEMORY MEDIAL; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Dziemianowicz MS, 2012, CURR NEUROL NEUROSCI, V12, P547, DOI 10.1007/s11910-012-0299-y; Fait P, 2013, J HEAD TRAUMA REHAB, V28, P293, DOI 10.1097/HTR.0b013e3182407ace; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Locklin J, 2010, SPORTS MED, V40, P183, DOI 10.2165/11319440-000000000-00000; Lovell M. R, 2011, IMMEDIATE POSTCONCUS; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Notebaert AJ, 2005, J ATHL TRAINING, V40, P320; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Sauseng P, 2005, INT J PSYCHOPHYSIOL, V57, P97, DOI 10.1016/j.ijpsycho.2005.03.018; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Vandierendonck A, 2004, BRIT J PSYCHOL, V95, P57, DOI 10.1348/000712604322779460; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255	45	19	19	3	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0264-0414	1466-447X		J SPORT SCI	J. Sports Sci.	FEB	2017	35	3					231	240		10.1080/02640414.2016.1161214			10	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	EG2BT	WOS:000390848200004	26999459				2022-02-06	
J	Xiong, M; Jones, OD; Peppercorn, K; Ohline, SM; Tate, WP; Abraham, WC				Xiong, Monica; Jones, Owen D.; Peppercorn, Katie; Ohline, Shane M.; Tate, Warren P.; Abraham, Wickliffe C.			Secreted amyloid precursor protein-alpha can restore novel object location memory and hippocampal LTP in aged rats	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Aging; Memory; Long-term potentiation; Hippocampus; Secreted amyloid precursor protein	LONG-TERM POTENTIATION; CEREBROSPINAL-FLUID LEVELS; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; SIGNALING PATHWAY; SPATIAL MEMORY; APPS-ALPHA; IN-VITRO; SYNAPTIC PLASTICITY; LEARNING-CAPACITY	Secreted amyloid precursor protein-a (sAPP alpha) is a neurotrophic and neuroprotective molecule which can enhance learning and synaptic plasticity. Aging is associated with memory decline and impaired long-term potentiation (LTP). SAPP alpha therefore has potential as a nootropic agent which could be used to offset age-related cognitive decline. In this study we investigated the effects of sAPPa on spatial memory tasks and LTP in aged and young Long-Evans rats. Two hippocampus-dependent tasks were employed to measure spatial memory that is susceptible to impairments during aging. Aged rats showed a mild deficit in the novel object location task, but memory was significantly enhanced by bilateral intrahippocampal injections of sAPPa. There was no effect on the performance of young animals. In the watermaze task, however, sAPPa did not alleviate age-related decline in spatial memory. In subsequent electrophysiological experiments, LTP was impaired in slices from aged animals, but plasticity was rescued in a concentration-dependent manner by exogenous sAPPa administration. In contrast, LTP was impaired in young animals by sAPPa. Overall, these data support the hypothesis that sAPPa has therapeutic potential as a treatment for age-related cognitive decline. (C) 2016 Elsevier Inc. All rights reserved.	[Xiong, Monica; Jones, Owen D.; Ohline, Shane M.; Abraham, Wickliffe C.] Univ Otago, Brain Res New Zealand, Brain Hlth Res Ctr, Dept Psychol, Dunedin, New Zealand; [Peppercorn, Katie; Tate, Warren P.] Univ Otago, Brain Res New Zealand, Brain Hlth Res Ctr, Dept Biochem, Dunedin, New Zealand		Abraham, WC (corresponding author), Univ Otago, Dept Psychol, Box 56, Dunedin 9054, New Zealand.	cabraham@psy.otago.ac.nz		Abraham, Wickliffe/0000-0001-9919-0622; Tate, Warren/0000-0002-6971-7734; Ohline, Shane/0000-0001-7716-5055	Health Research Council of New ZealandHealth Research Council of New Zealand; University of Otago Research Committee, New Zealand; Fulbright Foundation, U.S.A.	This research was supported by grants from the Health Research Council of New Zealand and the University of Otago Research Committee, New Zealand to W.C.A. and W.P.T, and by a Fulbright Foundation, U.S.A. scholarship to M.X. We thank Ms B. Logan for assistance with the surgical procedures.	Almkvist O, 1997, ARCH NEUROL-CHICAGO, V54, P641, DOI 10.1001/archneur.1997.00550170111022; Anderson JJ, 1999, NEUROSCIENCE, V93, P1409, DOI 10.1016/S0306-4522(99)00244-4; Bach ME, 1999, P NATL ACAD SCI USA, V96, P5280, DOI 10.1073/pnas.96.9.5280; BARGER SW, 1995, J NEUROCHEM, V64, P2087; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Burke SN, 2010, BEHAV NEUROSCI, V124, P559, DOI 10.1037/a0020893; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Cheng GJ, 2002, EXP NEUROL, V175, P407, DOI 10.1006/exnr.2002.7920; Claasen AM, 2009, NEUROSCI LETT, V460, P92, DOI 10.1016/j.neulet.2009.05.040; Corrigan F, 2012, J NEUROCHEM, V122, P208, DOI 10.1111/j.1471-4159.2012.07761.x; Corrigan F, 2012, NEUROSCI LETT, V515, P50, DOI 10.1016/j.neulet.2012.03.017; DEUPREE DL, 1991, BRAIN RES, V554, P1, DOI 10.1016/0006-8993(91)90164-Q; Deyts C, 2016, TRENDS PHARMACOL SCI, V37, P390, DOI 10.1016/j.tips.2016.01.005; Eckert MJ, 2010, LEARN MEMORY, V17, P480, DOI 10.1101/lm.1822610; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fellgiebel A, 2009, J GERIATR PSYCH NEUR, V22, P3, DOI 10.1177/0891988708327810; Fol R, 2016, ACTA NEUROPATHOL, V131, P247, DOI 10.1007/s00401-015-1498-9; GEINISMAN Y, 1995, PROG NEUROBIOL, V45, P223, DOI 10.1016/0301-0082(94)00047-L; Greifzu F, 2014, P NATL ACAD SCI USA, V111, P1150, DOI 10.1073/pnas.1313385111; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Hu YS, 2010, FASEB J, V24, P1667, DOI 10.1096/fj.09-136945; Huber G, 1997, NEUROSCIENCE, V80, P313, DOI 10.1016/S0306-4522(97)00120-6; Ishida A, 1997, NEUROREPORT, V8, P2133, DOI 10.1097/00001756-199707070-00009; Jankowsky JL, 2005, J NEUROSCI, V25, P5217, DOI 10.1523/JNEUROSCI.5080-04.2005; Kobayashi S, 2002, J NEUROSCI RES, V70, P340, DOI 10.1002/jnr.10442; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Kumar A, 2004, J NEUROPHYSIOL, V91, P2437, DOI 10.1152/jn.01148.2003; LANDFIELD PW, 1978, BRAIN RES, V150, P85, DOI 10.1016/0006-8993(78)90655-8; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Luo JJ, 2001, J NEUROSCI RES, V63, P410, DOI 10.1002/1097-4547(20010301)63:5<410::AID-JNR1036>3.0.CO;2-B; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mileusnic R, 2004, EUR J NEUROSCI, V19, P1933, DOI 10.1111/j.1460-9568.2004.03276.x; MookJung I, 1997, NEUROSCI LETT, V235, P1, DOI 10.1016/S0304-3940(97)00631-9; Moreno L, 2015, J ALZHEIMERS DIS, V48, P927, DOI 10.3233/JAD-150297; Okamoto M, 2001, NEUROSCIENCE, V104, P653, DOI 10.1016/S0306-4522(01)00124-5; Olsson A, 2003, EXP NEUROL, V183, P74, DOI 10.1016/S0014-4886(03)00027-X; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Ryan MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-376; Sokol DK, 2011, NEUROLOGY, V76, P1344, DOI 10.1212/WNL.0b013e3182166dc7; Speisman RB, 2013, NEUROBIOL AGING, V34, P263, DOI 10.1016/j.neurobiolaging.2012.05.023; SQUIRE LR, 1980, SCIENCE, V209, P836, DOI 10.1126/science.7190729; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Thornton E, 2006, BRAIN RES, V1094, P38, DOI 10.1016/j.brainres.2006.03.107; TONKISS J, 1992, DEV PSYCHOBIOL, V25, P567, DOI 10.1002/dev.420250804; Turner PR, 2007, J NEUROSCI METH, V164, P68, DOI 10.1016/j.jneumeth.2007.04.001; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Wallace WC, 1997, MOL BRAIN RES, V52, P213, DOI 10.1016/S0169-328X(97)00259-3	56	19	20	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	FEB	2017	138				SI		291	299		10.1016/j.nlm.2016.08.002			9	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	EN4HU	WOS:000395969400028	27521248				2022-02-06	
J	Adams, J; Alipio-Jocson, V; Inoyama, K; Bartlett, V; Sandhu, S; Oso, J; Barry, JJ; Loring, DW; Meador, K				Adams, Jesse; Alipio-Jocson, Valerie; Inoyama, Katherine; Bartlett, Victoria; Sandhu, Saira; Oso, Jemima; Barry, John J.; Loring, David W.; Meador, Kimford			Methylphenidate, cognition, and epilepsy A double-blind, placebo-controlled, single-dose study	NEUROLOGY			English	Article							DEFICIT-HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; ATTENTION-DEFICIT; PEDIATRIC-PATIENTS; PERFORMANCE; SEIZURES; INDIVIDUALS; EFFICACY; SAFETY; RISK	Objective: To evaluate the potential efficacy of immediate-release methylphenidate (MPH) for treating cognitive deficits in epilepsy. Methods: This was a double-blind, randomized, single-dose, 3-period crossover study in patients with epilepsy and chronic cognitive complaints comparing the effects of placebo and MPH 10 and 20 mg given 1 week apart. Cognitive outcome was evaluated on the basis of an omnibus z score calculated from performance on the Conners Continuous Performance Test 3 (ability to discriminate between target and nontarget stimuli [d'] and hit reaction time standard deviation), Symbol-Digit Modalities Test, and Medical College of Georgia Paragraph Memory Test. Adverse events and seizure frequency were monitored. An open-label follow-up is reported elsewhere. Results: Thirty-five adult patients with epilepsy participated, of whom 31 finished. Demographics included the following: mean age = 35.3 years (range 20-62 years), 13 men and 18 women, and baseline seizure frequency of 2.8 per month. Epilepsy types were focal (n = 24), generalized (n = 6), or unclassified (n = 1). Mean epilepsy duration was 12.5 years. A statistically significant performance benefit was present at both 10-mg (p = 0.030) and 20-mg (p = 0.034) MPH doses. No seizures were associated with either MPH dose. Adverse effects leading to withdrawal included cognitive "fogginess" (n = 1 on 20 mg), anxiety/agitation (n = 1 on 10 mg), and tachycardia (n = 1). One participant was lost to follow-up after one 20-mg dose without side effect. Conclusions: This single-dose study suggests that MPH may be effective in ameliorating some cognitive deficits in patients with epilepsy. Additional studies are required.	[Adams, Jesse; Alipio-Jocson, Valerie; Sandhu, Saira; Oso, Jemima; Barry, John J.] Stanford Univ, Psychiat & Behav Sci, Stanford, CA 94305 USA; [Inoyama, Katherine; Bartlett, Victoria; Meador, Kimford] Stanford Univ, Neurol & Neurol Sci, Stanford, CA 94305 USA; [Loring, David W.] Emory Univ, Neurol, Atlanta, GA 30322 USA		Adams, J (corresponding author), Stanford Univ, Psychiat & Behav Sci, Stanford, CA 94305 USA.	jadamsmd@uw.edu	Meador, Kimford/W-6167-2019	Loring, David/0000-0003-2497-1074	Stanford University's Department of Neurology	This study was funded entirely by Stanford University's Department of Neurology.	Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Aldenkamp AP, 2001, J CHILD NEUROL, V16, P119, DOI 10.1177/088307380101600210; Aldenkamp AP, 1999, J CHILD NEUROL, V14, P795, DOI 10.1177/088307389901401205; [Anonymous], 2004, EP COGN FUNCT SURV; [Anonymous], 2007, PHYS DESK REFERENCE; BABINGTON R G, 1973, Pharmacology Biochemistry and Behavior, V1, P461, DOI 10.1016/0091-3057(73)90013-0; Baptista-Neto L, 2008, EXPERT OPIN INV DRUG, V17, P77, DOI 10.1517/13543784.17.1.77; Ben-Itzhak R, 2008, J AM GERIATR SOC, V56, P695, DOI 10.1111/j.1532-5415.2007.01623.x; BRUERA E, 1992, PAIN, V48, P163, DOI 10.1016/0304-3959(92)90053-E; CHAMBERL.RW, 1974, PEDIATRICS, V54, P658; Coghill DR, 2014, BIOL PSYCHIAT, V76, P603, DOI 10.1016/j.biopsych.2013.10.005; Conners C., 2014, CONNERS CONTINUOUS P; Epstein JN, 2003, J ABNORM CHILD PSYCH, V31, P543, DOI 10.1023/A:1025405216339; Feeney DJ, 1997, J AM ACAD CHILD PSY, V36, P1018, DOI 10.1097/00004583-199708000-00007; Gonzalez-Heydrich J, 2010, EPILEPSY BEHAV, V18, P229, DOI 10.1016/j.yebeh.2010.02.022; GrossTsur V, 1997, J PEDIATR-US, V130, P670, DOI 10.1016/S0022-3476(97)70258-0; Gucuyener K, 2003, J CHILD NEUROL, V18, P109, DOI 10.1177/08830738030180020601; Harel Y, 2009, J NEUROL SCI, V276, P38, DOI 10.1016/j.jns.2008.08.025; Hinkin CH, 2001, J NEUROPSYCH CLIN N, V13, P248, DOI 10.1176/appi.neuropsych.13.2.248; Holtmann M, 2003, EPILEPSIA, V44, P1241, DOI 10.1046/j.1528-1157.2003.13403.x; Kim YH, 2006, CLIN REHABIL, V20, P24, DOI 10.1191/0269215506cr927oa; Klein-Schwartz W, 2002, CURR OPIN PEDIATR, V14, P219, DOI 10.1097/00008480-200204000-00013; Koneski JAS, 2010, ARQ NEURO-PSIQUIAT, V68, P107, DOI 10.1590/S0004-282X2010000100023; Koneski JAS, 2011, EPILEPSY BEHAV, V21, P228, DOI 10.1016/j.yebeh.2011.02.029; MEADOR KJ, 1993, EPILEPSIA, V34, pS34, DOI 10.1111/j.1528-1157.1993.tb05914.x; Mendonca DA, 2007, MOVEMENT DISORD, V22, P2070, DOI 10.1002/mds.21656; Meyers CA, 1998, J CLIN ONCOL, V16, P2522, DOI 10.1200/JCO.1998.16.7.2522; Moore JL, 2002, EPILEPSY BEHAV, V3, P92, DOI 10.1006/ebeh.2001.0313; Perrine K, 1999, NEUROLOGY, V53, pS39; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; Rhodes SM, 2006, J CHILD PSYCHOL PSYC, V47, P1184, DOI 10.1111/j.1469-7610.2006.01633.x; Smith A., 1982, SYMBOL DIGIT MODALIT; Swanson J, 2011, NEUROPSYCHOPHARMACOL, V36, P207, DOI 10.1038/npp.2010.160; Tan M, 2005, ARCH DIS CHILD, V90, P57, DOI 10.1136/adc.2003.048504; Tavakoli SA, 2003, PSYCHOSOMATICS, V44, P262, DOI 10.1176/appi.psy.44.3.262; Torres AR, 2008, EPILEPSY BEHAV, V12, P217, DOI 10.1016/j.yebeh.2007.08.001; Van der Feltz-Cornelis CM, 2006, EPILEPSY BEHAV, V8, P659, DOI 10.1016/j.yebeh.2006.01.015; Wernicke JF, 2007, DEV MED CHILD NEUROL, V49, P498, DOI 10.1111/j.1469-8749.2007.00498.x; Willmott C, 2009, J NEUROL NEUROSUR PS, V80, P552, DOI 10.1136/jnnp.2008.159632; Wolraich ML, 2004, CNS DRUGS, V18, P243, DOI 10.2165/00023210-200418040-00004	40	19	19	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	JAN 31	2017	88	5					470	476		10.1212/WNL.0000000000003564			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EP4HE	WOS:000397340800013	28031390	Green Published			2022-02-06	
J	Tao, XG; Shi, JH; Hao, SY; Chen, XT; Liu, BY				Tao, Xiao-Gang; Shi, Jing-Hua; Hao, Shu-Yu; Chen, Xue-Tao; Liu, Bai-Yun			Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-kappa B-related Inflammation during Traumatic Brain Injury in Mice	CHINESE MEDICAL JOURNAL			English	Article						Calpain; Inflammation; Neurovascular Unit; Nuclear Factor-kappa B; Traumatic Brain Injury	IN-VIVO MODEL; BARRIER DISRUPTION; PHARMACOLOGICAL ANALYSIS; CEREBRAL-ISCHEMIA; AXONAL-TRANSPORT; RAT MODEL; MDL-28170; IMPACT; INVOLVEMENT; DYSFUNCTION	Background: In addition to neurons, all components of the neurovascular unit (NVU), such as glial, endothelial, and basal membranes, are destroyed during traumatic brain injury (TBI). Previous studies have shown that excessive stimulation of calpain is crucial for cerebral injury after traumatic insult. The objective of this study was to investigate whether calpain activation participated in NVU disruption and edema formation in a mouse model of controlled cortical impact (CCI). Methods: One hundred and eight mice were divided into three groups: the sham group, the control group, and the MDL28170 group. MDL28170 (20 mg/ kg), an efficient calpain inhibitor, was administered intraperitoneally at 5 min, 3 h, and 6 h after experimental CCI. We then measured neurobehavioral deficits, calpain activity, inflammatory mediator levels, blood-brain barrier (BBB) disruption, and NVU deficits using electron microscopy and histopathological analysis at 6 h and 24 h after CCI. Results: The MDL28170 treatment significantly reduced the extent of both cerebral contusion (MDL28170 vs. vehicle group, 16.90 +/- 1.01 mm(3) and 17.20 +/- 1.17 mm(3) vs. 9.30 +/- 1.05 mm(3) and 9.90 +/- 1.17 mm(3), both P < 0.001) and edema (MDL28170 vs. vehicle group, 80.76 +/- 1.25% and 82.00 +/- 1.84% vs. 82.55 +/- 1.32% and 83.64 +/- 1.25%, both P < 0.05), improved neurological scores (MDL28170 vs. vehicle group, 7.50 +/- 0.45 and 6.33 +/- 0.38 vs. 12.33 +/- 0.48 and 11.67 +/- 0.48, both P < 0.001), and attenuated NVU damage resulting (including tight junction (TJ), basement membrane, BBB, and neuron) from CCI at 6 h and 24 h. Moreover, MDL28170 markedly downregulated nuclear factor-kappa B-related inflammation (tumor necrosis factor-alpha [ TNF-alpha]: MDL28170 vs. vehicle group, 1.15 +/- 0.07 and 1.62 +/- 0.08 vs. 1.59 +/- 0.10 and 2.18 +/- 0.10, both P < 0.001; inducible nitric oxide synthase: MDL28170 vs. vehicle group, 4.51 +/- 0.23 vs. 6.23 +/- 0.12, P < 0.001 at 24 h; intracellular adhesion molecule-l: MDL28170 vs. vehicle group, 1.45 +/- 0.13 vs. 1.70 +/- 0.12, P < 0.01 at 24 h) and lessened both myeloperoxidase activity (MDL28170 vs. vehicle group, 0.016 +/- 0.001 and 0.016 +/- 0.001 vs. 0.024 +/- 0.001 and 0.023 +/- 0.001, P < 0.001 and 0.01, respectively) and matrix metalloproteinase-9 (MMP-9) levels (MDL28170 vs. vehicle group, 0.87 +/- 0.13 and 1.10 +/- 0.10 vs. 1.17 +/- 0.13 and 1.25 +/- 0.12, P < 0.001 and 0.05, respectively) at 6 h and 24 h after CCI. Conclusions: These findings demonstrate that MDL28170 can protect the structure of the NVU by inhibiting the inflammatory cascade, reducing the expression of MMP-9, and supporting the integrity of TJ during acute TBI.	[Tao, Xiao-Gang; Hao, Shu-Yu; Chen, Xue-Tao; Liu, Bai-Yun] Capital Med Univ, Beijing Tian Tan Hosp, Dept Neurosurg, Beijing 100050, Peoples R China; [Shi, Jing-Hua] Capital Med Univ, Beijing Tian Tan Hosp, Dept Otolaryngol, Beijing 100050, Peoples R China; [Liu, Bai-Yun] Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing 100050, Peoples R China		Liu, BY (corresponding author), Capital Med Univ, Beijing Neurosurg Inst, Dept Neurotrauma, Beijing 100050, Peoples R China.	liubaiyun1963@163.com					Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ai JL, 2007, J NEUROTRAUM, V24, P960, DOI 10.1089/neu.2006.0224; Bains M, 2013, J NEUROCHEM, V125, P125, DOI 10.1111/jnc.12118; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Barakat R, 2016, MED PRIN PRACT, V25, P3, DOI 10.1159/000435858; Blanc F, 2016, AM J PHYSIOL-LUNG C, V310, pL689, DOI 10.1152/ajplung.00314.2015; Bralic M, 2012, COLLEGIUM ANTROPOL, V36, P1319; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Calderon-Garciduenas L, 2016, ENVIRON RES, V146, P404, DOI 10.1016/j.envres.2015.12.031; Chen G, 2009, EXP NEUROL, V216, P398, DOI 10.1016/j.expneurol.2008.12.019; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Cuzzocrea S, 2001, GUT, V48, P478, DOI 10.1136/gut.48.4.478; Cuzzocrea S, 2000, AM J PATHOL, V157, P2065, DOI 10.1016/S0002-9440(10)64845-6; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fontana ACK, 2016, J NEUROTRAUM, V33, P1073, DOI 10.1089/neu.2015.4079; Gao M, 2010, J ASIAN NAT PROD RES, V12, P407, DOI 10.1080/10286020.2010.485129; Glushakov AV, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-132; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Jasinska M, 2006, ACTA NEUROBIOL EXP, V66, P99; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lacoste B, 2015, MECH DEVELOP, V138, P43, DOI 10.1016/j.mod.2015.06.003; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Lin MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124558; Liu Y, 2016, J MOL NEUROSCI, V58, P254, DOI 10.1007/s12031-015-0670-y; Liu YQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0177-4; Lo EH, 2009, STROKE, V40, pS2, DOI 10.1161/STROKEAHA.108.534404; Ma M, 2012, J NEUROTRAUM, V29, P2555, DOI 10.1089/neu.2012.2473; Ma MR, 2012, J NEUROTRAUM, V29, P445, DOI 10.1089/neu.2011.2060; Marzocco S, 2004, SHOCK, V21, P38, DOI 10.1097/01.shk.0000095056.62263.b2; McDonald MC, 2001, FASEB J, V15, P171, DOI 10.1096/fj.99-0645com; Pan JH, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0808-z; Ponnappan Subramaniam, 2005, Immun Ageing, V2, P15, DOI 10.1186/1742-4933-2-15; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Ringger NC, 2004, J NEUROTRAUM, V21, P829, DOI 10.1089/0897715041526177; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Simard M, 2003, J NEUROSCI, V23, P9254; Sozen T, 2009, STROKE, V40, P2519, DOI 10.1161/STROKEAHA.109.549592; Sun M, 2008, CELL MOL NEUROBIOL, V28, P593, DOI 10.1007/s10571-007-9183-8; Tao X, 2015, NEUROSCIENCE, V291, P26, DOI 10.1016/j.neuroscience.2015.01.070; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Trager N, 2014, J NEUROCHEM, V130, P268, DOI 10.1111/jnc.12659; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Won S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122821; Wu CH, 2015, SCI REP-UK, V5, DOI 10.1038/srep16151; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	58	19	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0366-6999			CHINESE MED J-PEKING	Chin. Med. J.	JAN 20	2017	130	2					187	198		10.4103/0366-6999.198001			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EK5MV	WOS:000393971400011	28091411				2022-02-06	
J	Bennett, KS; DeWitt, PE; Harlaar, N; Bennett, TD				Bennett, Kimberly Statler; DeWitt, Peter E.; Harlaar, Nicole; Bennett, Tellen D.			Seizures in Children With Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						child abuse; seizures; subdural hematoma; traumatic brain injury	EARLY POSTTRAUMATIC SEIZURES; HEAD-INJURY; HYPOTHERMIA; EPILEPSY; CONSEQUENCES; PREDICTORS; MECHANISMS; OUTCOMES; INFANTS; TRIAL	Objective: Traumatic brain injury causes substantial morbidity and mortality in children. Posttraumatic seizures may worsen outcomes after traumatic brain injury. Posttraumatic seizures risk factors are not completely understood. Our objective was to clarify posttraumatic seizures risk factors in a large cohort of children with severe traumatic brain injury. Design: Retrospective cohort study of a probabilistically linked dataset from the National Trauma Data Bank and the Pediatric Health Information Systems database, 2007-2010. Setting: Twenty-nine U.S. children's hospitals. Patients: A total of 2,122 children (age, < 18 yr old at admission) with linked National Trauma Data Bank and Pediatric Health Information Systems records, severe (emergency department Glasgow Coma Scale, < 8) traumatic brain injury, hospital length of stay more than 24 hours, and nonmissing disposition. Interventions: None. Measurements and Main Results: The outcome was posttraumatic seizures, identified using validated International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes. Prespecified candidate predictors of posttraumatic seizures included age, injury mechanism, emergency department Glasgow Coma Scale, intracranial hemorrhage type, hypoxia, hypotension, and cardiac arrest. Posttraumatic seizures were diagnosed in 25.2% of children with severe traumatic brain injury. In those without abuse/assault or subdural hemorrhage, the posttraumatic seizures rate varied between 36.6% in those less than 2 years old and 16.4% in those 14-17 years old. Age, abusive mechanism, and subdural hemorrhage are each significant predictors of posttraumatic seizures. The risk of posttraumatic seizures has a complex relationship with these predictors. The estimated odds of posttraumatic seizures decrease with advancing age, odds ratio equal to 0.929 (0.905-0.954) per additional year of age with no abuse/assault and no subdural hemorrhage; odds ratio equal to 0.820 (0.730-0.922) per additional year of age when abuse and subdural hemorrhage are present. An infant with accidental traumatic brain injury and subdural hemorrhage has approximately the same estimated probability of posttraumatic seizures as an abused infant without subdural hemorrhage (47% [95% CI, 39-55%] vs 50% [95% CI, 41-58%]; p = 0.69). The triad of young age, injury by abuse/assault, and subdural hemorrhage confers the greatest estimated probability for posttraumatic seizures (60% [95% CI, 53-66%]). Conclusions: Posttraumatic seizures risk in children with severe traumatic brain injury is greatest with a triad of younger age, injury by abuse/assault, and subdural hemorrhage. However, posttraumatic seizures are common even in the absence of these factors.	[Bennett, Kimberly Statler; Bennett, Tellen D.] Univ Colorado, Childrens Hosp Colorado, Pediat Crit Care Sect, Dept Pediat,Sch Med, Aurora, CO 80045 USA; [DeWitt, Peter E.] Univ Colorado Denver, Dept Bioinformat & Biostat, Aurora, CO USA; [Harlaar, Nicole] Univ Colorado, Kempe Ctr Prevent & Treatment Child Abuse & Negle, Childrens Hosp Colorado, Dept Pediat,Sch Med, Aurora, CO USA; [Bennett, Tellen D.] Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA		Bennett, TD (corresponding author), Univ Colorado, Childrens Hosp Colorado, Pediat Crit Care Sect, Dept Pediat,Sch Med, Aurora, CO 80045 USA.; Bennett, TD (corresponding author), Adult & Child Consortium Hlth Outcomes Res & Deli, Aurora, CO USA.	tell.bennett@ucdenver.edu		DeWitt, Peter/0000-0002-6391-0795; Bennett, Tellen/0000-0003-1483-4236	Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health [K23HD074620]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD074620] Funding Source: NIH RePORTER	Supported, in part, by the grant from Eunice Kennedy Shriver National Institute for Child Health and Human Development at the National Institutes of Health (grant K23HD074620 to Dr. Tellen D. Bennett).; Dr. Bennett received support for article research from the National Institutes of Health (NIH); his institution received funding from the NICHD. Dr. Harlaar received support for article research from the NIH and her institution received funding from the NIH NICHD. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Adamo MA, 2009, J NEUROSURG-PEDIATR, V4, P414, DOI 10.3171/2009.6.PEDS0939; Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; American College of Surgeons Committee on Trauma, 2010, NAT TRAUM DAT BANK R; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Ates O, 2006, CHILD NERV SYST, V22, P279, DOI 10.1007/s00381-005-1177-6; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barlow KM, 2000, DEV MED CHILD NEUROL, V42, P591, DOI 10.1017/S0012162200001110; Beca J, 2015, CRIT CARE MED, V43, P1458, DOI 10.1097/CCM.0000000000000947; Bennett TD, 2015, METHOD INFORM MED, V54, P328, DOI 10.3414/ME14-01-0093; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Centers for Disease Control and Prevention, 2013, CONV TABL NEW ICD 9; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P1; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, P740; Chiaretti A, 2002, CHILD NERV SYST, V18, P109, DOI 10.1007/s00381-002-0561-8; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Conway PH, 2009, J PEDIATR-US, V154, P789, DOI 10.1016/j.jpeds.2009.01.010; Faul M, 2010, TRAUMATIC BRAIN INJU; Frieden T.R., 2014, C TRAUM BRAIN INJ US; Gerber JS, 2010, PEDIATRICS, V126, P1067, DOI 10.1542/peds.2010-1275; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Hernandez TD, 1997, NEUROLOGY, V48, P803, DOI 10.1212/WNL.48.4.803; Hooft A, 2013, J PEDIATR-US, V162, P80, DOI 10.1016/j.jpeds.2012.06.037; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Kee VR, 2012, PHARMACOEPIDEM DR S, V21, P183, DOI 10.1002/pds.2329; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; LEWIS RJ, 1993, ANN EMERG MED, V22, P1114, DOI 10.1016/S0196-0644(05)80974-6; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Ong LC, 1996, J PAEDIATR CHILD H, V32, P173, DOI 10.1111/j.1440-1754.1996.tb00917.x; Slonim AD, 2010, PEDIATRICS, V125, P1208, DOI 10.1542/peds.2009-1451; Statler KD, 2006, DEV NEUROSCI-BASEL, V28, P354, DOI 10.1159/000094162; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380; Walker WC, 2015, J HEAD TRAUMA REHAB, V30, P231, DOI 10.1097/HTR.0000000000000127; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zebrack M, 2009, PEDIATRICS, V124, P56, DOI 10.1542/peds.2008-1006	40	19	20	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	JAN	2017	18	1					54	63		10.1097/PCC.0000000000000948			10	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	EI1PJ	WOS:000392249300007	27654815	Green Accepted			2022-02-06	
S	Brouwer, MC; van de Beek, D		Wijdicks, EFM; Kramer, AH		Brouwer, M. C.; van de Beek, D.			Management of bacterial central nervous system infections	CRITICAL CARE NEUROLOGY, PT I	Handbook of Clinical Neurology		English	Article; Book Chapter							INVASIVE MENINGOCOCCAL DISEASE; RANDOMIZED CONTROLLED TRIAL; REAL-TIME PCR; PNEUMOCOCCAL MENINGITIS; BRAIN-ABSCESS; STREPTOCOCCUS-PNEUMONIAE; LISTERIA-MONOCYTOGENES; NEISSERIA-MENINGITIDIS; DIFFERENTIAL-DIAGNOSIS; HAEMOPHILUS-INFLUENZAE	Bacterial infections of the central nervous system present as a medical emergency, thus requiring rapid diagnosis and immediate treatment. The most prevalent bacterial infections seen in the intensive care unit can be summarized as acute bacterial meningitis, subdural empyema, intracerebral abscess, and ventriculitis, which all commonly involve the brain parenchyma. The infections can either be community-acquired or hospital-acquired, e.g., after neurosurgical intervention, as a complication of severe neurotrauma or related to indwelling cerebrospinal fluid drains. Community-acquired bacterial meningitis is most commonly caused by the pneumococcus (Streptococcus pneumoniae) and meningococcus (Neisseria meningtidis), and is often complicated by hearing loss, cerebrovascular complications, and seizures. Brain abscesses are frequently associated with contiguous or metastatic foci of infection such as otitis, sinusitis, pneumonia, or endocarditis which need to be detected and treated early during disease course. Despite optimal treatment, many patients are at risk for both major systemic and neurologic complications, leading to a substantial mortality and risk of major disability in survivors. Empiric treatment depends on regional antibiotic resistance patterns of common pathogens. For subdural empyema and brain abscesses, neurosurgical drainage of the infection is required alongside prolonged antibiotic treatment.	[Brouwer, M. C.; van de Beek, D.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, Dept Neurol, Amsterdam, Netherlands		van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.	D.vandeBeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X			Abulhasan YB, 2013, NEUROCRIT CARE, V19, P199, DOI 10.1007/s12028-013-9853-y; Ajdukiewicz KMB, 2011, LANCET INFECT DIS, V11, P293, DOI 10.1016/S1473-3099(10)70317-0; Al Masalma M, 2012, CLIN INFECT DIS, V54, P202, DOI 10.1093/cid/cir797; Aronin SI, 1998, ANN INTERN MED, V129, P862, DOI 10.7326/0003-4819-129-11_Part_1-199812010-00004; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Bijlsma MW, 2014, LANCET INFECT DIS, V14, P805, DOI 10.1016/S1473-3099(14)70806-0; Blaser C, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-84; Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2016, INTENS CARE MED, V42, P415, DOI 10.1007/s00134-015-4057-x; Brouwer MC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub5; Brouwer MC, 2015, CLIN INFECT DIS, V61, P664, DOI 10.1093/cid/civ328; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Castelblanco RL, 2014, LANCET INFECT DIS, V14, P813, DOI 10.1016/S1473-3099(14)70805-9; Choi SH, 2013, INFECT CHEMOTHER, V45, P308, DOI 10.3947/ic.2013.45.3.308; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; de Louvois J, 2000, BRIT J NEUROSURG, V14, P525; Dubos F, 2008, ARCH PEDIAT ADOL MED, V162, P1157, DOI 10.1001/archpedi.162.12.1157; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Edberg M, 2011, ACTA ANAESTH SCAND, V55, P732, DOI 10.1111/j.1399-6576.2011.02460.x; Edmond K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031239; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Hasbun R, 2001, NEW ENGL J MED, V345, P1727, DOI 10.1056/NEJMoa010399; Heckenberg SGB, 2012, CLIN MICROBIOL INFEC, V18, P849, DOI 10.1111/j.1469-0691.2011.03668.x; Heinsbroek E, 2013, J INFECTION, V67, P385, DOI 10.1016/j.jinf.2013.06.007; Hoen B, 1993, Eur J Med, V2, P28; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Jim KK, 2012, NEUROLOGY, V79, P2133, DOI 10.1212/WNL.0b013e3182752d0e; Kasanmoentalib ES, 2013, CURR OPIN NEUROL, V26, P282, DOI 10.1097/WCO.0b013e328360415c; Kasanmoentalib ES, 2010, NEUROLOGY, V75, P918, DOI 10.1212/WNL.0b013e3181f11e10; Koomen I, 2004, ACTA PAEDIATR, V93, P1378, DOI 10.1080/08035250410033349; Koopmans MM, 2013, CLIN INFECT DIS, V57, P247, DOI 10.1093/cid/cit250; Le Monnier A, 2011, J CLIN MICROBIOL, V49, P3917, DOI 10.1128/JCM.01072-11; Liu S, 2011, CRIT CARE MED, V39, P1467, DOI 10.1097/CCM.0b013e3182120d13; Lucas MJ, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000009; Lucas MJ, 2013, CIRCULATION, V127, P2056, DOI 10.1161/CIRCULATIONAHA.113.001545; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Mitja O, 2009, J ANTIMICROB CHEMOTH, V64, P416, DOI 10.1093/jac/dkp180; Moisi JC, 2009, CLIN INFECT DIS, V48, pS49, DOI 10.1086/596481; Molyneux EM, 2014, PEDIATR INFECT DIS J, V33, P214, DOI 10.1097/INF.0000000000000122; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mourvillier B, 2013, JAMA-J AM MED ASSOC, V310, P2174, DOI 10.1001/jama.2013.280506; Munoz-Almagro C, 2009, DIAGN MICR INFEC DIS, V63, P148, DOI 10.1016/j.diagmicrobio.2008.10.008; Munoz-Gomez S, 2015, HEART LUNG, V44, P158, DOI 10.1016/j.hrtlng.2015.01.003; Mylonakis E, 1998, MEDICINE, V77, P313, DOI 10.1097/00005792-199809000-00002; Nathoo N, 1999, NEUROSURGERY, V44, P529, DOI 10.1097/00006123-199903000-00055; Nau R, 1999, J NEUROPATH EXP NEUR, V58, P265, DOI 10.1097/00005072-199903000-00006; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Nigrovic LE, 2004, PEDIATR INFECT DIS J, V23, P786, DOI 10.1097/01.inf.0000135679.98790.14; Nigrovic LE, 2008, PEDIATRICS, V122, P726, DOI 10.1542/peds.2007-3275; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Pelkonen T, 2011, LANCET INFECT DIS, V11, P613, DOI 10.1016/S1473-3099(11)70055-X; Peltola H, 2007, CLIN INFECT DIS, V45, P1277, DOI 10.1086/522534; Pfausler B, 2003, J NEUROSURG, V98, P1040, DOI 10.3171/jns.2003.98.5.1040; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; Read RC, 2014, LANCET, V384, P2123, DOI 10.1016/S0140-6736(14)60842-4; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; Saha SK, 2005, PEDIATR INFECT DIS J, V24, P1093, DOI 10.1097/01.inf.0000190030.75892.78; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Schmand B, 2010, J INFECTION, V61, P330, DOI 10.1016/j.jinf.2010.07.006; Schut ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034311; Schut ES, 2012, NEUROCRIT CARE, V16, P421, DOI 10.1007/s12028-011-9634-4; Sormunen P, 1999, J PEDIATR-US, V134, P725, DOI 10.1016/S0022-3476(99)70288-X; SPANOS A, 1989, JAMA-J AM MED ASSOC, V262, P2700, DOI 10.1001/jama.262.19.2700; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; Tunkel A, 2010, PRINCIPLES PRACTICE; Tzanakaki G, 2005, CLIN MICROBIOL INFEC, V11, P386, DOI 10.1111/j.1469-0691.2005.01109.x; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2016, CLIN MICROBIOL INFEC, V22, pS37, DOI 10.1016/j.cmi.2016.01.007; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Vergouwen MDI, 2010, NEUROCRIT CARE, V13, P217, DOI 10.1007/s12028-010-9387-5; Vinchon M, 2006, CHILD NERV SYST, V22, P692, DOI 10.1007/s00381-005-0037-8; Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216; Wong AM, 2004, AM J NEURORADIOL, V25, P1016; Wong GKC, 2002, J NEUROL NEUROSUR PS, V73, P759, DOI 10.1136/jnnp.73.6.759; Worsoe L, 2010, CLIN INFECT DIS, V51, P917, DOI 10.1086/656409; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169; Zoons E, 2008, NEUROLOGY, V70, P2109, DOI 10.1212/01.wnl.0000288178.91614.5d	89	19	22	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0072-9752		978-0-12-803563-4; 978-0-44-463600-3	HAND CLINIC			2017	140						349	364		10.1016/B978-0-444-63600-3.00019-2			16	Critical Care Medicine; Clinical Neurology	Book Citation Index – Science (BKCI-S)	General & Internal Medicine; Neurosciences & Neurology	BJ3DL	WOS:000422931500021	28187809				2022-02-06	
J	Chandran, R; Sharma, A; Bhomia, M; Balakathiresan, NS; Knollmann-Ritschel, BE; Maheshwari, RK				Chandran, Raghavendar; Sharma, Anuj; Bhomia, Manish; Balakathiresan, Nagaraja S.; Knollmann-Ritschel, Barbara E.; Maheshwari, Radha K.			Differential expression of microRNAs in the brains of mice subjected to increasing grade of mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury; brain; microRNA (miRNA); weight-drop injury; closed head injury	NEURONAL CELL-DEATH; COGNITIVE DEFICITS; GENE-EXPRESSION; HIPPOCAMPUS; PATHWAYS; MODEL; FEAR; ACTIVATION; DIAGNOSIS; MEDIATORS	Objective: To investigate the effect of heterogeneity in mTBI on miRNA expression in mouse brain and to identify molecular pathways targeted' by the modulated miRNAs. Methods: A weight drop device was used to induce four, increasing grades of mTBI. MiRNA expression was evaluated using TaqMan rodent miRNA arrays. Bioinformatics analysis was done using the DIANA miRPath tool and Ingenuity Pathway Analysis software. Histology of brain sections was evaluated using H&E staining. Results: No histologic lesions were observed in the brains of injured mice; however, significant modulation in miRNA expression profile was observed. Global miRNA profiling, indicated a trend Of decrease in the number of modulated' miRNAs from 24 hours to day 7 post-injury, except for the most severe grade of mTBI. Canonical pathways like calcium signalling, synaptic pathways and axon guidance pathway were the major targets of the modulated miRNAs. Network correlation analyses indicated an interaction between the modulated miRNAs and putative protein biomarkers of TBI. Conclusions: The data demonstrated that varying intensities of mTBI induced a differential miRNA expression profile in the brain post-injury. Pathways such as calcium and synaptic signalling, were major targets of modulated miRNAs and may play a role in the pathophysiology of mTBI.	[Chandran, Raghavendar; Sharma, Anuj; Bhomia, Manish; Balakathiresan, Nagaraja S.; Knollmann-Ritschel, Barbara E.; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Chandran, Raghavendar] Birla Inst Technol & Sci, Biol Sci Grp, Pilani, Rajasthan, India		Sharma, A (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	anuj.sharma.ctr@usuhs.edu	Balakathiresan, Nagaraja Sethuraman/O-3213-2019; Bhomia, Manish/C-7683-2015; Chandran, Raghavendar/AAB-9402-2019	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070; Bhomia, Manish/0000-0003-2808-9927; Chandran, Raghavendar/0000-0002-7915-2810; Sharma, Anuj/0000-0001-6906-190X	Defense Medical Research and Development Program (DMRDP)	The authors report no conflicts of interest. This work was supported by a grant from the Defense Medical Research and Development Program (DMRDP). The opinions expressed herein are that of the author(s) and are not necessarily representative of those of the Uniformed Services University of the Health Sciences (USUHS), the Defense Medical Research and Development Program, Birla Institute of Technology and Science, Pilani, the Department of Defense (DOD), the United States Army, Navy; or Air Force.	Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Atkins CM, 2006, J CEREBR BLOOD F MET, V26, P1507, DOI 10.1038/sj.jcbfm.9600301; Bajwa NM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146886; Balakathiresan NS, 2014, J PSYCHIATR RES, V57, P65, DOI 10.1016/j.jpsychires.2014.05.020; Bao TH, 2014, J MOL NEUROSCI, V54, P622, DOI 10.1007/s12031-014-0344-1; Bhalala OG, 2013, NAT REV NEUROL, V9, P328, DOI 10.1038/nrneurol.2013.67; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; Camkurt MA, 2015, J PSYCHIATR RES, V69, P67, DOI 10.1016/j.jpsychires.2015.07.023; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chen RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050957, 10.1371/journal.pone.0051246]; Cheng G, 2013, MED HYPOTHESES, V80, P115, DOI 10.1016/j.mehy.2012.11.004; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Giza CC, 2002, J NEUROTRAUM, V19, P387, DOI 10.1089/08977150252932352; Henry LC, 2014, PROG NEUROL SURG, V28, P63, DOI 10.1159/000358763; Jayakumar AR, 2016, NEUROCHEM RES, V41, P307, DOI 10.1007/s11064-015-1801-0; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kekesi KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050532; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lagraoui Mouna, 2012, Front Neurol, V3, P155, DOI 10.3389/fneur.2012.00155; Langham J, 2003, COCHRANE DB SYST REV; Lee DJ, 2008, NEUROSURGERY, V63, P1004, DOI 10.1227/01.NEU.0000327685.90800.F7; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Li H, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00164; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Marshall KR, 2012, MIL MED, V177, P67, DOI 10.7205/MILMED-D-12-00110; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miao W, 2015, BRAZ J MED BIOL RES, V48, P433, DOI [10.1590/1414-431X20144012, 10.1590/1414-431x20144012]; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nakamoto M, 2005, HUM MOL GENET, V14, P3813, DOI 10.1093/hmg/ddi397; Natale JE, 2003, J NEUROTRAUM, V20, P907, DOI 10.1089/089771503770195777; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Oliveros JC, 2007, VENNY INTERACTIVE TO; Rapp PE, 2012, J TRAUMA ACUTE CARE, V73, pS13, DOI 10.1097/TA.0b013e318260604b; Redell JB, 2013, J NEUROTRAUM, V30, P752, DOI 10.1089/neu.2012.2437; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Schober K, 2014, INT J LEGAL MED, V29, P29; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Sherin Jonathan E, 2011, Dialogues Clin Neurosci, V13, P263; Shimada R, 2014, NEUROL RES, V36, P239, DOI 10.1179/1743132813Y.0000000289; Sun E, 2014, EXPT NEUROLOGY, V13; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang WX, 2015, EXP NEUROL, V265, P84, DOI 10.1016/j.expneurol.2014.12.018; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Wei J, 2013, ACTA PHARMACOL SIN, V34, P1485, DOI 10.1038/aps.2013.160; Wen Y, 2015, MOL MED, V21, P197, DOI 10.2119/molmed.2014.00199; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu GZ, 2013, BRAIN RES BULL, V99, P41, DOI 10.1016/j.brainresbull.2013.09.011; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	74	19	19	2	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	1					106	119		10.1080/02699052.2016.1213420			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EJ5KT	WOS:000393257600014	27819514	hybrid			2022-02-06	
J	Forslund, MV; Roe, C; Perrin, PB; Sigurdardottir, S; Lu, J; Berntsen, S; Andelic, N				Forslund, Marit V.; Roe, Cecilie; Perrin, Paul B.; Sigurdardottir, Solrun; Lu, Juan; Berntsen, Svein; Andelic, Nada			The trajectories of overall disability in the first 5 years after moderate and severe traumatic brain injury	BRAIN INJURY			English	Article						Traumatic brain injury; disability; outcome measures; GOSE	GLASGOW OUTCOME SCALE; LONG-TERM DISABILITY; HEAD-INJURY; NATIONAL INSTITUTE; GENDER-DIFFERENCES; PROSPECTIVE COHORT; PRACTICAL SCALE; MODEL SYSTEMS; UNITED-STATES; HEALTH	Primary objectives: To assess longitudinal trajectories of overall disability after moderate-to-severe traumatic brain injury (TBI) and to examine whether those trajectories could be predicted by sociodemographic and injury characteristics. Methods: Demographics and injury characteristics of 105 individuals with moderate-to-severe TBI were extracted from medical records. At the 1-, 2-, and 5-year follow-ups, TBI-related disability was assessed by the GOSE. A hierarchical linear model (HLM) was used to examine-functional outcomes up to 5 years following injury and whether those outcomes could be predicted by: time, gender, age, relationship, education, employment pre-injury, occupation, GCS, cause of injury, length of post-traumatic amnesia (PTA), CT findings and injury severity score, as well as the interactions between each of these predictors and time. Results: Higher GOSE trajectories (lower disability) were predicted by younger age at injury and shorter PTA, as well as by the interaction terms of time*PTA and time*employment. Those who had been employed at injury decreased in disability over time, while those who had been unemployed increased in disability. Conclusion: The study results support the view that individual factors generally outweigh injury-related factors as predictors of disability after TBI, except for PTA.	[Forslund, Marit V.; Roe, Cecilie; Andelic, Nada] Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway; [Roe, Cecilie] Univ Oslo, Fac Med, Oslo, Norway; [Perrin, Paul B.] Virginia Commonwealth Univ, Dept Psychol, Box 2018, Richmond, VA 23284 USA; [Sigurdardottir, Solrun; Andelic, Nada] Univ Oslo, CHARM Res Ctr Habilitat & Rehabil Models & Serv, Fac Med, Oslo, Norway; [Sigurdardottir, Solrun] Sunnaas Rehabil Hosp, Dept Res, Nesoddtangen, Norway; [Lu, Juan] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA USA; [Berntsen, Svein] Sorlandet Hosp, Dept Phys Med & Rehabil, Kristiansand, Norway		Andelic, N (corresponding author), Oslo Univ Hosp, Dept Phys Med & Rehabil, PB 4950 Nydalen, N-0424 Oslo, Norway.	nadand@ous-hf.no	; Perrin, Paul/L-5373-2015	Andelic, Nada/0000-0002-3719-4406; Lu, Juan/0000-0002-5389-7603; Perrin, Paul/0000-0003-2070-215X	Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo	The authors report no conflicts of interest. This study was funded by grant from The Institute of Health and Society, CHARM (Research Centre for Habilitation and Rehabilitation Models and Services), Faculty of Medicine, University of Oslo.	Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andelic N, 2016, J NEUROTRAUM, V33, P95, DOI 10.1089/neu.2014.3844; Andelic N, 2014, PM&R, V6, P1013, DOI 10.1016/j.pmrj.2014.05.005; Andelic N, 2012, BRAIN INJURY, V26, P261, DOI 10.3109/02699052.2012.654589; Arango-Lasprilla JC, 2010, J HEAD TRAUMA REHAB, V25, P128, DOI 10.1097/HTR.0b013e3181d36ca3; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bilbao A, 2003, NEUROREHABILITATION, V18, P239; Connelly J, 2006, DISABIL REHABIL, V28, P629, DOI 10.1080/09638280500276513; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Dams-O'Connor K, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000073; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Forslund MV, 2014, NEUROREHABILITATION, V34, P781, DOI 10.3233/NRE-141084; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Huang SJ, 2010, BRAIN INJURY, V24, P1606, DOI 10.3109/02699052.2010.523056; JENNETT B, 1975, LANCET, V1, P480; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Mellick D, 2003, BRAIN INJURY, V17, P55, DOI 10.1080/0269905021000010159; Niemeier JP, 2014, J WOMENS HEALTH, V23, P573, DOI 10.1089/jwh.2013.4535; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P2486, DOI 10.1016/j.apmr.2013.06.021; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; Roe C, 2012, J NEUROL RES, V2, P134, DOI DOI 10.4021/JNR133W; Sandhaug M, 2015, BRAIN INJURY, V29, P1431, DOI 10.3109/02699052.2015.1063692; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Shafi S, 2007, J TRAUMA, V63, P1263, DOI 10.1097/TA.0b013e31815b8f00; Sigurdardottir S, 2009, J INT NEUROPSYCH SOC, V15, P740, DOI 10.1017/S1355617709990452; Skandsen T, CLIN REHABILITATION, P653; Son AHPWV, 2007, CLIN REHABIL, V21, P1024, DOI 10.1177/0269215507077603; TEASDALE G, 1974, LANCET, V2, P81; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Whitnall L, 2006, J NEUROL NEUROSUR PS, V77, P640, DOI 10.1136/jnnp.2005.078246; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	38	19	19	0	15	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	3					329	335		10.1080/02699052.2016.1255778			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EQ3WY	WOS:000398005900007	28095032	Green Submitted			2022-02-06	
J	Malec, JF; Van Houtven, CH; Tanielian, T; Atizado, A; Dorn, MC				Malec, James F.; Van Houtven, Courtney Harold; Tanielian, Terri; Atizado, Adrian; Dorn, Michael C.			Impact of TBI on caregivers of veterans with TBI: Burden and interventions	BRAIN INJURY			English	Article						Caregivers; Brain Injury; Veterans	TRAUMATIC BRAIN-INJURY; RANDOMIZED CONTROLLED-TRIAL; COPING SKILLS GROUP; MULTIFAMILY GROUP TREATMENT; US SERVICE MEMBERS; FAMILY-MEMBERS; CARE; DEMENTIA; IMPLEMENTATION; PREVALENCE	Objectives: Describe State-of-the-Art in practice and research in caregiving with individuals, specifically, Veterans with traumatic brain injury (TBI) and the implications for current practice and future research. Sources: Professional literature and personal experience of review panel. Main Outcomes: Unpaid caregiving for individuals with TBI is most often provided by a spouse, parent or other blood relative; the majority of caregivers are women. Although caregiving can be rewarding, it also may create financial burden and psychological stress. Depression among family caregivers occurs four times more frequently than in the general population. Positive coping can help reduce the impact of stress, and Department of Veterans Affairs (VA) programmes are available to ease financial burden. Group interventions show promise in reinforcing and improving positive coping for both family caregivers and Veterans with TBI. Conclusions: Identifying the specific needs of caregivers and families of Veterans with TBI and other traumatic injuries, including post-traumatic stress syndrome (PTSD), will require further longitudinal research. Currently available group interventions and programmes appear to benefit injured Veterans and their family caregivers financially and psychologically. Increased understanding of characteristics of quality family caregiving and its long term costs and benefits is likely to lead to additional improvements in these interventions and programmes.	[Malec, James F.] Indiana Univ, Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46077 USA; [Malec, James F.] Rehabil Hosp Indiana, Indianapolis, IN USA; [Malec, James F.] Mayo Clin, Psychol, Rochester, MN USA; [Van Houtven, Courtney Harold] Durham VA Med Ctr, HSR&D, Durham, NC USA; [Van Houtven, Courtney Harold] Duke Univ, Dept Med, Durham, NC USA; [Tanielian, Terri] RAND Corp, Arlington, VA USA; [Atizado, Adrian] DAV Natl Serv & Legislat Headquarters, Washington, DC USA		Malec, JF (corresponding author), Indiana Univ, Sch Med, Dept Phys Med & Rehabil, 4141 Shore Dr, Indianapolis, IN 46077 USA.	jmalec@rhin.com		Van Houtven, Courtney/0000-0002-0783-1611	Department of Veterans AffairsUS Department of Veterans Affairs; Caregiver Support Program; Quality Enhancement Research Initiative [PEC 14-272]; Durham VA Center for Health Services Research in Primary Care	Dr. Van Houtven's work on this project was partially funded by the Department of Veterans Affairs, Caregiver Support Program and Quality Enhancement Research Initiative (PEC 14-272). She also received support from the Durham VA Center for Health Services Research in Primary Care.	Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Backhaus S, 2016, BRAIN INJURY, V30, P975, DOI 10.3109/02699052.2016.1147601; Backhaus S, 2016, ARCH PHYS MED REHAB, V97, P281, DOI 10.1016/j.apmr.2015.10.097; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Coe NB, 2009, HEALTH ECON, V18, P991, DOI 10.1002/hec.1512; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Epstein NB, 2006, J MARITAL FAM THER, V20, P575; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Feinberg L., 2013, HOM COMM BAS SERV C; FEINBERG L., 2011, VALUING INVALUABLE 2; Ford JH, 2014, J REHABIL RES DEV, V51, P1311, DOI 10.1682/JRRD.2014.03.0066; Godwin EE, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1329; Griffin JM, AM J ORTHOP IN PRESS; Griffin JM, 2012, J HEAD TRAUMA REHAB, V27, P3, DOI 10.1097/HTR.0b013e3182274260; Ibarra, 2012, BRAIN INJURY COPING; Implementation of Caregiver Assistance, 2011, IMPL CAR ASS MOV FOR; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Lo Sasso A.T.(, 2000, TRADE OFF HOURS PAID; MADRIAN BC, 1994, Q J ECON, V109, P27, DOI 10.2307/2118427; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McLaughlin KA, 2013, J HEAD TRAUMA REHAB, V28, P341, DOI 10.1097/HTR.0b013e31824e1d43; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Nichols LO, 2011, ARCH INTERN MED, V171, P353, DOI 10.1001/archinternmed.2010.548; Ory MG, 1999, GERONTOLOGIST, V39, P177, DOI 10.1093/geront/39.2.177; Perlick DA, 2013, PSYCHIAT SERV, V64, P534, DOI 10.1176/appi.ps.001622012; Ramchand R, 2014, RR499TEDF RAND CORP; Rietdijk R, 2012, J REHABIL MED, V44, P913, DOI 10.2340/16501977-1058; Sander AM, 2003, ARCH PHYS MED REHAB, V84, P197, DOI 10.1053/apmr.2003.50105; Schonberger M, 2010, NEUROPSYCHOL REHABIL, V20, P813, DOI 10.1080/09602011003620077; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Schulz R, 2014, CLIN GERONTOLOGIST, V37, P347, DOI 10.1080/07317115.2014.907594; Skira MM, 2015, INT ECON REV, V56, P63, DOI 10.1111/iere.12095; Stevens LF, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/185941; Straits-Troster K, 2013, PSYCHIAT SERV, V64, P541, DOI 10.1176/appi.ps.001632012; Thompson HJ, 2009, J NEUROSCI NURS, V41, P148, DOI 10.1097/JNN.0b013e3181a23eda; Thompson L., 2004, ISSUE BRIEF LONG TER; Van Houtven CH, 2004, J HEALTH ECON, V23, P1159, DOI 10.1016/j.jhealeco.2004.04.008; Van Houtven CH, 2016, VA CARES EVALUATION, P1; Van Houtven CH, 2012, INQUIRY-J HEALTH CAR, V49, P339, DOI 10.5034/inquiryjrnl_49.04.01; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080	42	19	19	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1235	1245		10.1080/02699052.2016.1274778			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600009	28981343	hybrid, Green Published			2022-02-06	
J	Rowley, DA; Rogish, M; Alexander, T; Riggs, KJ				Rowley, Dane A.; Rogish, Miles; Alexander, Timothy; Riggs, Kevin J.			Cognitive correlates of pragmatic language comprehension in adult traumatic brain injury: A systematic review and meta-analyses	BRAIN INJURY			English	Article						Cognition; communication; language; pragmatics; traumatic brain injury	DIFFUSE AXONAL INJURY; CLOSED-HEAD INJURY; NEUROPSYCHOLOGICAL EVIDENCE; EXECUTIVE DYSFUNCTION; SOCIAL-PERCEPTION; WORKING-MEMORY; INFORMATION; MIND; DISCOURSE; IMPAIRMENT	Effective pragmatic comprehension of language is critical for successful communication and interaction, but this ability is routinely impaired following Traumatic Brain Injury (TBI) (1,2). Individual studies have investigated the cognitive domains associated with impaired pragmatic comprehension, but there remains little understanding of the relative importance of these domains in contributing to pragmatic comprehension impairment following TBI. This paper presents a systematic meta-analytic review of the observed correlations between pragmatic comprehension and cognitive processes following TBI. Five meta-analyses were computed, which quantified the relationship between pragmatic comprehension and five key cognitive constructs (declarative memory; working memory; attention; executive functions; social cognition). Significant moderate-to-strong correlations were found between all cognitive measures and pragmatic comprehension, where declarative memory was the strongest correlate. Thus, our findings indicate that pragmatic comprehension in TBI is associated with an array of domain general cognitive processes, and as such deficits in these cognitive domains may underlie pragmatic comprehension difficulties following TBI. The clinical implications of these findings are discussed.	[Rowley, Dane A.; Alexander, Timothy] Univ Hull, Clin Psychol Programme, Kingston Upon Hull, N Humberside, England; [Rogish, Miles] Disabil Trust, Brain Injury Rehabil Trust, Wakefield, W Sussex, England; [Riggs, Kevin J.] Univ Hull, Dept Psychol, Fenner Bldg, Kingston Upon Hull HU6 7RX, N Humberside, England		Riggs, KJ (corresponding author), Univ Hull, Dept Psychol, Fenner Bldg, Kingston Upon Hull HU6 7RX, N Humberside, England.	k.riggs@hull.ac.uk					ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; [Anonymous], 1983, CAMBRIDGE TXB LINGUI; Apperly IA, 2005, TRENDS COGN SCI, V9, P572, DOI 10.1016/j.tics.2005.10.004; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braun C M, 1989, Brain Inj, V3, P345, DOI 10.3109/02699058909004559; BROOKSHIRE RH, 1984, BRAIN LANG, V21, P21, DOI 10.1016/0093-934X(84)90033-6; Bryan KL., 1996, RIGHT HEMISPHERE LAN; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Channon S, 2005, BRAIN LANG, V93, P123, DOI 10.1016/j.bandl.2004.09.002; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Erez ABH, 2009, AM J OCCUP THER, V63, P634; Evans K, 2011, BRAIN INJURY, V25, P767, DOI 10.3109/02699052.2011.576307; Faust ME, 1996, BRAIN LANG, V53, P234, DOI 10.1006/brln.1996.0046; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Fork M, 2005, BRAIN INJURY, V19, P101, DOI 10.1080/02699050410001726086; Gernsbacher MA, 2001, J MEM LANG, V45, P433, DOI 10.1006/jmla.2000.2782; GLOSSER G, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P191; Grice H. P., 1975, SYNTAX SEMANTICS; Hagen C, 1984, LANGUAGE DISORDERS A, P245; Havet-Thomassin V, 2006, BRAIN INJURY, V20, P83, DOI 10.1080/02699050500340655; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Holland A., 1982, CLIN APH P C, P345; Holliday R, 2005, BRAIN LANG, V95, P74, DOI 10.1016/j.bandl.2005.07.041; Huang Y, 2007, OXFORD TXB LINGUISTI; Joanette Y, 2004, PROTOCOLE MONTREAL E; Johnson JE, 2012, BRAIN INJURY, V26, P1118, DOI 10.3109/02699052.2012.666370; LeBlanc J, 2014, INT J SPEECH-LANG PA, V16, P582, DOI 10.3109/17549507.2013.871335; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Marini A, 2014, NEUROPSYCHOLOGIA, V64, P282, DOI 10.1016/j.neuropsychologia.2014.09.042; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Martin I, 2003, BRAIN LANG, V85, P451, DOI 10.1016/S0093-934X(03)00070-1; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Matsuoka K, 2012, BRAIN INJURY, V26, P1723, DOI 10.3109/02699052.2012.698789; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOLOGY, V18, P572, DOI 10.1037/0894-4105.18.3.572; McDonald S, 2017, J NEUROPSYCHOL, V11, P291, DOI 10.1111/jnp.12086; McDonald S, 2014, NEUROPSYCHOLOGY, V28, P801, DOI 10.1037/neu0000089; McDonald S, 2011, J CLIN EXP NEUROPSYC, V33, P17, DOI 10.1080/13803391003761967; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; MENTIS M, 1991, J SPEECH HEAR RES, V34, P583, DOI 10.1044/jshr.3403.583; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Mozeiko J, 2011, APHASIOLOGY, V25, P826, DOI 10.1080/02687038.2010.543983; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Peach RK, 2013, AM J SPEECH-LANG PAT, V22, pS285, DOI 10.1044/1058-0360(2013/12-0081); Ponsford JL, 2014, J NEUROTRAUM, V31, P64, DOI 10.1089/neu.2013.2997; Powell GE, 2001, BRAIN DAM B, P65; R Core Team, 2012, R LANG ENV STAT COMP; Rios M, 2004, BRAIN INJURY, V18, P257, DOI 10.1080/02699050310001617442; Scheid R, 2006, ARCH NEUROL-CHICAGO, V63, P418, DOI 10.1001/archneur.63.3.418; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; The Psychological Corporation, 2008, WAIS 4 TECHN MAN; Wallesch CW, 2001, BRAIN INJURY, V15, P401, DOI 10.1080/02699050010005959; Wechsler D, 1997, WMS 3 ADM SCORING MA; Wilson D, 2005, LINGUA, V115, P1129, DOI 10.1016/j.lingua.2004.02.005; Wood RL, 2008, J INT NEUROPSYCH SOC, V14, P289, DOI 10.1017/S1355617708080326; Yang FG, 2010, NEUROPSYCHOLOGIA, V48, P1923, DOI 10.1016/j.neuropsychologia.2010.03.011; Youse KM, 2005, BRAIN INJURY, V19, P1001, DOI 10.1080/02699050500109951	79	19	19	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	12					1564	1574		10.1080/02699052.2017.1341645			11	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FN4KB	WOS:000415973200002	28901780	Green Accepted			2022-02-06	
J	Hossfeld, B; Bein, B; Boettiger, BW; Bohn, A; Fischer, M; Graesner, JT; Hinkelbein, J; Kill, C; Lott, C; Popp, E; Roessler, M; Schaumberg, A; Wenzel, V; Bernhard, M				Hossfeld, Bjoern; Bein, Bertold; Boettiger, Bernd W.; Bohn, Andreas; Fischer, Matthias; Graesner, Jan-Thorsten; Hinkelbein, Jochen; Kill, Clemens; Lott, Carsten; Popp, Erik; Roessler, Markus; Schaumberg, Alin; Wenzel, Volker; Bernhard, Michael			Recommended practice for out-of-hospital emergency anaesthesia in adults: Statement from the Out-of-Hospital Emergency Anaesthesia Working Group of the Emergency Medicine Research Group of the German Society of Anaesthesiology and Intensive Care	EUROPEAN JOURNAL OF ANAESTHESIOLOGY			English	Article							RAPID-SEQUENCE INTUBATION; PREHOSPITAL AIRWAY-MANAGEMENT; TRAUMATIC BRAIN-INJURY; ENDOTRACHEAL INTUBATION; VIDEO LARYNGOSCOPES; TRACHEAL INTUBATION; SUCCESS RATES; ETOMIDATE; INDUCTION; MULTICENTER	Emergency anaesthesia is an important therapeutic measure in out-of-hospital emergency medicine. The associated risks are considerably higher than those of in-hospital anaesthesia. The primary objectives of emergency anaesthesia are hypnosis, analgesia, oxygenation and ventilation through airway management. The secondary objectives of emergency anaesthesia are amnesia, anxiolysis, the reduction of oxygen consumption and respiratory work, the protection of vital organs and the avoidance of secondary myocardial and cerebral damage. A critical evaluation of the indications for outof- hospital emergency anaesthesia must take into consideration patient, case and provider-related factors. Rapid sequence induction of emergency anaesthesia includes standard monitoring, preoxygenation, standardised preparation of emergency anaesthesia, drug administration, manual in-line stabilisation during intubation (if necessary), airway management and checking of correct tube placement. Spontaneously breathing casualties should receive preoxygenation for at least 3 to 4 min with a tight-fitting facemask with reservoir using 12 to 15 l min_1 of oxygen or with a demand valve providing 100% oxygen. As an alternative, preoxygenation may be performed as noninvasive ventilation with 100% oxygen. Standardised anaesthesia preparation comprises filling drugs into syringes and labelling them, checking ventilation equipment, preparing endotracheal tube and syringe for inflating the cuff and the introducer, stethoscope and fixation material, preparing alternative instruments for airway management as well as checking suction, ventilation and standard monitoring devices, including capnography. Standard monitoring for out-of-hospital emergency anaesthesia comprises ECG, blood pressure measurement and pulse oximetry. Continuous capnography is always and exclusively performed to check the placement of airway devices, as well as to indirectly monitor haemodynamics.	[Hossfeld, Bjoern] Armed Forces Hosp, Sect Emergency Med, Dept Anaesthesiol & Intens Care Med, Oberer Eselsberg 40, D-89081 Ulm, Germany; [Bein, Bertold] ASKLEPIOS Hosp St Georg, Dept Anaesthesiol, Intens Care Med, Emergency Med,Pain Serv, Hamburg, Germany; [Boettiger, Bernd W.; Hinkelbein, Jochen] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Cologne, Germany; [Bohn, Andreas] City Munster Fire Dept, Munster, Germany; [Fischer, Matthias] Hosp Eichert, Dept Anaesthesiol, Intens Care Med, Emergency Med,Pain Serv, Goeppingen, Germany; [Graesner, Jan-Thorsten] Univ Schleswig Holstein, Dept Emergency Med, Kiel, Germany; [Kill, Clemens] Univ Giessen & Marburg, Dept Emergency Med, Campus Marburg, Marburg, Germany; [Lott, Carsten] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Mainz, Germany; [Popp, Erik] Heidelberg Univ, Dept Anesthesiol, Heidelberg, Germany; [Roessler, Markus] Univ Med Ctr Gottingen, Dept Anesthesiol, Gottingen, Germany; [Schaumberg, Alin] Univ Giessen & Marburg, Dept Anaesthesiol & Intens Care Med, Campus Giessen, Giessen, Germany; [Wenzel, Volker] Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria; [Bernhard, Michael] Univ Leipzig, Emergency Dept, Leipzig, Germany		Hossfeld, B (corresponding author), Armed Forces Hosp, Sect Emergency Med, Dept Anaesthesiol & Intens Care Med, Oberer Eselsberg 40, D-89081 Ulm, Germany.	bjoern.hossfeld@extern.uni-ulm.de	Hinkelbein, Jochen/AAA-8801-2021; Roessler, Markus Soeren/I-7834-2013				Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Barnard EBG, 2015, EMERG MED J, V32, P449, DOI 10.1136/emermed-2014-203740; Benumof JL, 1997, ANESTHESIOLOGY, V87, P979, DOI 10.1097/00000542-199710000-00034; Bernhard M, 2006, ANAESTHESIST, V55, P1157, DOI 10.1007/s00101-006-1106-4; Bernhard M, 2014, ANAESTHESIST, V63, P589, DOI 10.1007/s00101-014-2348-1; Bernhard M, 2011, NOTFALL RETTUNGSMED, V14, P554, DOI 10.1007/s10049-010-1402-z; Bernhard M, 2010, ANASTH INTENSIVMED, V51, pS615; Braun P, 2010, CURR OPIN ANESTHESIO, V23, P500, DOI 10.1097/ACO.0b013e32833bc135; Breckwoldt J, 2012, RESUSCITATION, V83, P434, DOI 10.1016/j.resuscitation.2011.10.011; Bretschneider I, 2011, NOTARZT, V27, P270, DOI 10.1055/s-0031-1276960; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chi JH, 2006, J TRAUMA, V61, P1134, DOI 10.1097/01.ta.0000196644.64653.d8; Christ M., 2010, Intensivmedizin und Notfallmedizin, V47, P83, DOI 10.1007/s00390-009-0140-2; Connor CW, 2014, ANESTH ANALG, V118, P419, DOI 10.1213/ANE.0000000000000012; Cook T, 2012, CURR OPIN ANESTHESIO, V25, P461, DOI 10.1097/ACO.0b013e32835528b1; Cotton BA, 2008, ARCH SURG-CHICAGO, V143, P62, DOI 10.1001/archsurg.143.1.62; Cowan GM, 2012, EMERG MED J, V29, P136, DOI 10.1136/emj.2010.105304; Easby J, 2004, J TRAUMA, V6, P217; Edlow JA, 2014, LANCET, V384, P2064, DOI 10.1016/S0140-6736(13)62184-4; Eich C, 2009, RESUSCITATION, V80, P1371, DOI 10.1016/j.resuscitation.2009.09.004; El-Orbany M, 2010, ANESTH ANALG, V110, P1318, DOI 10.1213/ANE.0b013e3181d5ae47; ELBEHEIRY H, 1995, CAN J ANAESTH, V42, P875, DOI 10.1007/BF03011034; Grasner JT, 2007, NOTFALLMEDIZIN UP2DA, V2, P197; Gries A, 2006, ANAESTHESIST, V55, P1080, DOI 10.1007/s00101-006-1051-2; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Hasler RM, 2012, RESUSCITATION, V83, P476, DOI 10.1016/j.resuscitation.2011.10.018; Hedenstierna G, 2005, INTENS CARE MED, V31, P1327, DOI 10.1007/s00134-005-2761-7; Helm M, 2006, BRIT J ANAESTH, V96, P67, DOI 10.1093/bja/aei275; Helm M, 2013, ACTA ANAESTH SCAND, V57, P199, DOI 10.1111/aas.12032; Helm M, 2010, ANAESTHESIST, V59, P896, DOI 10.1007/s00101-010-1759-x; Helm M, 2005, BEST PRACT RES-CLIN, V19, P623, DOI 10.1016/j.bpa.2005.06.002; Henderson JJ, 2004, ANAESTHESIA, V59, P675, DOI 10.1111/j.1365-2044.2004.03831.x; Herff H, 2009, ANESTH ANALG, V109, P303, DOI 10.1213/ane.0b013e3181ad8a1e; Heuer JF, 2012, ANAESTH INTENS CARE, V40, P120, DOI 10.1177/0310057X1204000113; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P15, DOI 10.1007/s10049-010-1355-2; Hossfeld B, 2011, NOTFALL RETTUNGSMED, V14, P10, DOI 10.1007/s10049-010-1354-3; HUGG CJ, 1993, ANESTH ANALG       S, V25, P77; Innerklinische Akutversorgung des Patienten mit Schadel-Hirn-Trauma, 2009, ANASTH INTENSIVMED, V50, pS489; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Jacoby J, 2006, ANN EMERG MED, V47, P525, DOI 10.1016/j.annemergmed.2005.12.009; Kheterpal S, 2013, ANESTHESIOLOGY, V119, P1360, DOI 10.1097/ALN.0000435832.39353.20; Koenig SJ, 2015, J INTENSIVE CARE MED, V30, P499, DOI 10.1177/0885066614523100; Liccardi G, 2009, CURR MED RES OPIN, V25, P1621, DOI 10.1185/03007990903010474; Lockey D, 2009, 2009 AAGBI SAFETY GU; Luxen J, 2014, ANAESTHESIST, V63, P331, DOI 10.1007/s00101-014-2303-1; Mayglothling J, 2012, J TRAUMA ACUTE CARE, V73, pS333, DOI 10.1097/TA.0b013e31827018a5; MOULTON C, 1994, LANCET, V343, P1261, DOI 10.1016/S0140-6736(94)92155-5; MRUGALLA H, 2003, NOTFALL RETTUNGSMED, V6, P233; Neumayr A, 2014, NOTFALL RETTUNGSMED, V17, P25, DOI 10.1007/s10049-013-1816-5; Newton A, 2008, J TRAUMA, V64, P487, DOI 10.1097/TA.0b013e31802e7476; Niven AS, 2013, CURR OPIN CRIT CARE, V19, P9, DOI 10.1097/MCC.0b013e32835c6014; Paal P, 2010, RESUSCITATION, V81, P148, DOI 10.1016/j.resuscitation.2009.10.023; Patanwala AE, 2014, ACAD EMERG MED, V21, P87, DOI 10.1111/acem.12292; Pehbock D, 2010, ANESTHESIOLOGY, V113, P593, DOI 10.1097/ALN.0b013e3181e73f07; Perry JJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002788.pub2; Reinhart K, 2010, ANAESTHESIST, V59, P347, DOI 10.1007/s00101-010-1719-5; Rortgen D, 2011, ANAESTHESIST, V60, P312, DOI 10.1007/s00101-010-1812-9; Rognas L, 2014, EUR J EMERG MED, V21, P418, DOI 10.1097/MEJ.0000000000000103; Rognas L, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-58; Sakles JC, 2013, ACAD EMERG MED, V20, P71, DOI 10.1111/acem.12055; Schlechtriemen T, 2004, NOTFALL RETTUNGSMED, V7, P231; Schmidt J, 2007, ANASTH INTENSIVMED, V48, pS88; Sefrin P, 2014, NOTARZT, V30, P73, DOI 10.1055/s-0034-1369910; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Springer Zollinger A, 2012, ANASTHESIOLOGIE; Steinmann D, 2009, ANAESTHESIST, V58, P695, DOI 10.1007/s00101-009-1548-6; Stollings JL, 2014, ANN PHARMACOTHER, V48, P62, DOI 10.1177/1060028013510488; Swanson Eric R, 2004, Prehosp Emerg Care, V8, P273; Thierbach A, 2004, ANAESTHESIST, V53, P543, DOI 10.1007/s00101-004-0679-z; Timmermann A, 2012, ANASTH INTENSIVMED, V53, P294; Timmermann A, 2009, ANAESTHESIST, V58, P663, DOI 10.1007/s00101-009-1570-8; van den Heuvel I, 2013, CURR OPIN ANESTHESIO, V26, P404, DOI 10.1097/ACO.0b013e328362a84c; VANDERWALT J, 1995, PAEDIATR ANAESTH, V5, P257; Voelckel WG, 2004, ANAESTHESIST, V53, P1151, DOI 10.1007/s00101-004-0771-4; von Goedecke A, 2007, ANESTH ANALG, V104, P481, DOI 10.1213/01.ane.0000255964.86086.63; Weingart SD, 2012, ANN EMERG MED, V59, P165, DOI 10.1016/j.annemergmed.2011.10.002; WELLER D, 2006, AKTUEL NEUROL, V33, P532; Werdan K, 2011, KARDIOLOGE, V5, P166, DOI 10.1007/s12181-011-0349-8; Wetsch WA, 2013, EUR J ANAESTH, V30, P537, DOI 10.1097/EJA.0b013e3283614119; Wetsch WA, 2011, EUR J ANAESTH, V28, P849, DOI 10.1097/EJA.0b013e32834c7c7f; Wilbur K, 2001, CJEM, V3, P302; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x	83	19	20	1	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0265-0215	1365-2346		EUR J ANAESTH	Eur. J. Anaesth.	DEC	2016	33	12					881	897		10.1097/EJA.0000000000000533			17	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EB3OR	WOS:000387275500003	27635954				2022-02-06	
J	Karout, M; Miesch, M; Geoffroy, P; Kraft, S; Hofmann, HD; Mensah-Nyagan, AG; Kirsch, M				Karout, Mona; Miesch, Michel; Geoffroy, Philippe; Kraft, Stephanie; Hofmann, Hans-Dieter; Mensah-Nyagan, Ayikoe Guy; Kirsch, Matthias			Novel analogs of allopregnanolone show improved efficiency and specificity in neuroprotection and stimulation of proliferation	JOURNAL OF NEUROCHEMISTRY			English	Article						allopregnanolone; hippocampus; neural stem cells; neurogenesis; neuroprotection; -amyloid	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; NEURAL STEM; 3-ALPHA-HYDROXYSTEROID OXIDOREDUCTASE; PROGESTERONE-RECEPTORS; NEUROPATHIC PAIN; PROGENITOR CELLS; GABA-RECEPTOR; NERVE INJURY; MOUSE MODEL	The natural neurosteroid allopregnanolone exerts beneficial effects in animal models of neurodegenerative diseases, nervous system injury and peripheral neuropathies. It not only has anti-apoptotic activity, but also promotes proliferation of progenitor cells. With respect to using it as a therapeutic tool, such pleiotropic actions might create unwanted side effects. Therefore, we have synthesized allopregnanolone analogs and analyzed their neuroprotective and proliferative effects to identify compounds with higher efficiency and less ambiguous biological actions. Proliferation-promoting effects of 3 and 3 isomers of 3-O-allyl-allopregnanolone and 12 oxo-allopregnanolone were studied in adult subventricular zone stem cell cultures and in primary hippocampal cultures by measuring 5-ethynyl-2-deoxyuridine incorporation. Neuroprotective activity against amyloid beta 42-induced cell death was determined by quantifying caspase 3/7 activity. The 3 isomers significantly stimulated proliferation in all culture systems, whereas the 3 isomers were ineffective. The stimulatory effect of 3-O-allyl-allopregnanolone was significantly higher than that of allopregnanolone. In neural stem cell cultures, 3-O-allyl-allopregnanolone specifically enhanced proliferation of Nestin-positive progenitors. In addition, it promoted the differentiation of doublecortin-positive neurons. In neural stem cell cultures treated with amyloid beta 42, both the and isomers of O-allyl- allopregnanolone showed increased neuroprotective activity as compared to allopregnanolone, completely preventing amyloid-induced caspase 3/7 activation. The 12 oxo-allopregnanolone analogs were ineffective. These results identify structural allopregnanolone analogs with higher anti-apoptotic and proliferation-promoting activity than the natural neurosteroid. Interestingly, stereoisomers of the analogs were found to have distinct profiles of activity raising the possibility of exploiting the neuroprotective properties of neurosteroids with or without simultaneously stimulating neurogenesis.	[Karout, Mona; Kraft, Stephanie; Hofmann, Hans-Dieter; Kirsch, Matthias] Univ Freiburg, Inst Anat & Cell Biol, Fac Med, Dept Neuroanat,ZfN, Albertstr 23, D-79104 Freiburg, Germany; [Karout, Mona; Mensah-Nyagan, Ayikoe Guy] Univ Strasbourg, FMTS, INSERM U1119, Biopathol Myeline Neuroprotect & Strategies Thera, Strasbourg, France; [Miesch, Michel; Geoffroy, Philippe] Univ Strasbourg, Inst Chim, UMR 7177, Lab Chim Organ Synth, Strasbourg, France		Kirsch, M (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Fac Med, Dept Neuroanat,ZfN, Albertstr 23, D-79104 Freiburg, Germany.; Mensah-Nyagan, AG (corresponding author), Univ Strasbourg, INSERM U1119, Fac Med, Batiment 3,11 Rue Humann, F-67000 Strasbourg, France.	gmensah@unistra.fr; matthias.kirsch@zfn.uni-freiburg.de	Mensah-Nyagan, Ayikoe G/D-5951-2011; Kirsch, Matthias/G-7227-2015	Mensah-Nyagan, Ayikoe G/0000-0003-4454-511X; Kirsch, Matthias/0000-0002-2090-8556; Karout, Mona/0000-0002-5087-3673	INTERREG IV Program (European Fund for Regional Development) in the Upper Rhine Region; Offensive Science Call	This work was funded by INTERREG IV Program (European Fund for Regional Development) in the Upper Rhine Region and the Offensive Science Call 2012. We thank Gaby Kaiser and Birgit Egle for excellent technical support. Authors declare that AGMN, PG and MM are the owners of Patent number WO 2012127176 A1 and US 2014/0058079 A1.	Afrazi S, 2014, J STEROID BIOCHEM, V139, P98, DOI 10.1016/j.jsbmb.2013.10.010; Agis-Balboa RC, 2006, P NATL ACAD SCI USA, V103, P14602, DOI 10.1073/pnas.0606544103; AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Antoine JC, 2007, LANCET NEUROL, V6, P75, DOI 10.1016/S1474-4422(06)70679-2; BAULIEU EE, 1991, BIOL CELL, V71, P3, DOI 10.1016/0248-4900(91)90045-O; BAULIEU EE, 1990, J STEROID BIOCHEM, V37, P395, DOI 10.1016/0960-0760(90)90490-C; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Chen SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024293; Deleyrolle Loic P., 2009, V549, P91, DOI 10.1007/978-1-60327-931-4_7; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Eckert A, 2008, NEURODEGENER DIS, V5, P157, DOI 10.1159/000113689; Faroni Alessandro, 2011, Front Endocrinol (Lausanne), V2, P103, DOI 10.3389/fendo.2011.00103; Gotz J, 2011, CELL MOL LIFE SCI, V68, P3359, DOI 10.1007/s00018-011-0750-2; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Grimm A, 2014, BBA-MOL BASIS DIS, V1842, P2427, DOI 10.1016/j.bbadis.2014.09.013; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Heinitz K, 2006, J NEUROCHEM, V98, P1930, DOI 10.1111/j.1471-4159.2006.04015.x; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Irwin RW, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00203; Irwin RW, 2014, PROG NEUROBIOL, V113, P40, DOI 10.1016/j.pneurobio.2013.08.004; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Keller EA, 2004, DEV BRAIN RES, V153, P13, DOI 10.1016/j.devbrainres.2004.07.009; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; MAJEWSKA MD, 1986, SCIENCE, V232, P1004, DOI 10.1126/science.2422758; Melcangi RC, 2014, PROG NEUROBIOL, V113, P1, DOI 10.1016/j.pneurobio.2013.09.005; Mellon SH, 2001, INT REV NEUROBIOL, V46, P33; Meyer L, 2008, NEUROBIOL DIS, V30, P30, DOI 10.1016/j.nbd.2007.12.001; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moore A, 2009, PEDIATR BLOOD CANCER, V53, P1180, DOI 10.1002/pbc.22161; Noorbakhsh F, 2011, BRAIN, V134, P2703, DOI 10.1093/brain/awr200; Pang YF, 2013, ENDOCRINOLOGY, V154, P283, DOI 10.1210/en.2012-1772; Patte-Mensah C, 2005, P NATL ACAD SCI USA, V102, P9044, DOI 10.1073/pnas.0502968102; Patte-Mensah C, 2014, PROG NEUROBIOL, V113, P70, DOI 10.1016/j.pneurobio.2013.07.004; Patte-Mensah C, 2003, J NEUROCHEM, V86, P1233, DOI 10.1046/j.1471-4159.2003.01935.x; Patte-Mensah C, 2010, PAIN, V150, P522, DOI 10.1016/j.pain.2010.06.004; Pelletier G, 2010, PROG BRAIN RES, V181, P193, DOI 10.1016/S0079-6123(08)81011-4; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; PURDY RH, 1990, J MED CHEM, V33, P1572, DOI 10.1021/jm00168a008; Reddy D S, 2000, Prog Med Chem, V37, P135, DOI 10.1016/S0079-6468(08)70059-6; Reddy Doodipala Samba, 2003, Critical Reviews in Neurobiology, V15, P197; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Singh C, 2012, NEUROBIOL AGING, V33, P1493, DOI 10.1016/j.neurobiolaging.2011.06.008; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Suzuki M, 2004, P NATL ACAD SCI USA, V101, P3202, DOI 10.1073/pnas.0307325101; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wang JM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S11; Wang Mingde, 2011, Front Endocrinol (Lausanne), V2, P44, DOI 10.3389/fendo.2011.00044; Young SZ, 2009, PHYSIOLOGY, V24, P171, DOI 10.1152/physiol.00002.2009; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	55	19	19	0	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2016	139	5					782	794		10.1111/jnc.13693			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	ED8QA	WOS:000389134800010	27256158	Bronze			2022-02-06	
J	Kim, N; Krasner, A; Kosinski, C; Wininger, M; Qadri, M; Kappus, Z; Danish, S; Craelius, W				Kim, Nam; Krasner, Alex; Kosinski, Colin; Wininger, Michael; Qadri, Maria; Kappus, Zachary; Danish, Shabbar; Craelius, William			Trending autoregulatory indices during treatment for traumatic brain injury	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Traumatic brain injury; TBI; Autoregulation; Informatics SICU; ABP; ICP; PRx	CEREBRAL PERFUSION-PRESSURE; INTRACRANIAL-PRESSURE; WAVE-FORM; CEREBROVASCULAR AUTOREGULATION; ONLINE ANALYSIS; INTENSIVE-CARE; CHALLENGES; SOFTWARE	Our goal is to use automatic data monitoring for reliable prediction of episodes of intracranial hypertension in patients with traumatic brain injury. Here we test the validity of our method on retrospective patient data. We developed the Continuous Hemodynamic Autoregulatory Monitor (CHARM), that siphons and stores signals from existing monitors in the surgical intensive care unit (SICU), efficiently compresses them, and standardizes the search for statistical relationships between any proposed index and adverse events. CHARM uses an automated event detector to reliably locate episodes of elevated intracranial pressure (ICP), while eliminating artifacts within retrospective patient data. A graphical user interface allowed data scanning, selection of criteria for events, and calculating indices. The pressure reactivity index (PRx), defined as the least square linear regression slope of intracranial pressure versus arterial BP, was calculated for a single case that spanned 259 h. CHARM collected continuous records of ABP, ICP, ECG, SpO2, and ventilation from 29 patients with TBI over an 18-month period. Analysis of a single patient showed that PRx data distribution in the single hours immediately prior to all 16 intracranial hypertensive events, significantly differed from that in the 243 h that did not precede such events (p < 0.0001). The PRx index, however, lacked sufficient resolution as a real-time predictor of IH in this patient. CHARM streamlines the search for reliable predictors of intracranial hypertension. We report statistical evidence supporting the predictive potential of the pressure reactivity index.	[Kim, Nam; Krasner, Alex; Kosinski, Colin; Qadri, Maria; Kappus, Zachary; Craelius, William] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA; [Wininger, Michael] Univ Hartford, Rehabil Sci, Hartford, CT 06117 USA; [Danish, Shabbar] Rutgers RWJ Med Sch, Rutgers Canc Inst, Dept Neurosurg, New Brunswick, NJ 08901 USA		Craelius, W (corresponding author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.	craelius@rci.rutgers.edu	Wininger, Michael/K-8985-2012	Wininger, Michael/0000-0002-7871-3292; Qadri, Maria/0000-0002-4921-6924	New Jersey Commission on Traumatic Brain Injury	Drs. Nicki Newby and Min-ge Xie for statistical help, and Dr. Lloyd Marks for clinical guidance. The New Jersey Commission on Traumatic Brain Injury for support.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Bellazzi R, 2014, Yearb Med Inform, V9, P8, DOI 10.15265/IY-2014-0024; Bellazzi R, 2011, WIRES DATA MIN KNOWL, V1, P416, DOI 10.1002/widm.23; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burykin A, 2011, COMPUT METH PROG BIO, V103, P151, DOI 10.1016/j.cmpb.2010.10.004; Cohen MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc8864; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dias C, 2014, J NEUROTRAUM, V31, P1872, DOI 10.1089/neu.2014.3376; Feigin V, 2009, NEUROEPIDEMIOLOGY, V33, P296, DOI 10.1159/000252942; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Guendling K, 2006, ACTA NEUROCHIR SUPPL, V96, P108; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Halpern NA, 2014, CHEST, V145, P903, DOI 10.1378/chest.13-0005; Hu X, 2006, IEEE T BIO-MED ENG, V53, P195, DOI 10.1109/TBME.2005.862546; Hu X, 2010, IEEE T BIO-MED ENG, V57, P1070, DOI 10.1109/TBME.2009.2037607; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kirkman MA, 2014, BRIT J ANAESTH, V112, P35, DOI 10.1093/bja/aet418; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS3, DOI 10.1097/PCC.0b013e31823f437e; Lazaridis C, 2014, J NEUROSURG, V120, P892; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Le Roux P, 2014, CURR OPIN CRIT CARE, V20, P141, DOI 10.1097/MCC.0000000000000078; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Liu J, 2010, PHYSIOL MEAS, V31, P1291, DOI 10.1088/0967-3334/31/10/001; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; Marmarelis Vz, 2012, Open Biomed Eng J, V6, P42, DOI 10.2174/1874230001206010042; Miller RA, 2009, ADV HEALTH SCI EDUC, V14, P89, DOI 10.1007/s10459-009-9186-y; Narayanan N, 2008, J APPL PHYSIOL, V105, P152, DOI 10.1152/japplphysiol.00988.2007; Neamatullah I, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-32; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Sivaganesan A, 2014, NEUROCRIT CARE, V20, P132, DOI 10.1007/s12028-013-9872-8; Smielewski P, 2005, ACT NEUR S, V95, P43; Stein PK, 2013, CRIT CARE MED, V41, P666, DOI 10.1097/CCM.0b013e318270e6f0; Stylianides N, 2011, IEEE T INF TECHNOL B, V15, P26, DOI 10.1109/TITB.2010.2091141; von Mises R., 1964, MATH THEORY PROBABIL; Wakeland W, 2009, CRIT CARE MED, V37, P1079, DOI 10.1097/CCM.0b013e31819b629d; WARNER HR, 1961, JAMA-J AM MED ASSOC, V177, P177, DOI 10.1001/jama.1961.03040290005002; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	42	19	19	2	8	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	DEC	2016	30	6					821	831		10.1007/s10877-015-9779-3			11	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	EB2YV	WOS:000387229400010	26446002				2022-02-06	
J	Muehlschlegel, S; Ayturk, D; Ahlawat, A; Izzy, S; Scalea, TM; Stein, DM; Emhoff, T; Sheth, KN				Muehlschlegel, Susanne; Ayturk, Didem; Ahlawat, Aditi; Izzy, Saef; Scalea, Thomas M.; Stein, Deborah M.; Emhoff, Timothy; Sheth, Kevin N.			Predicting survival after acute civilian penetrating brain injuries The SPIN score	NEUROLOGY			English	Article							GLASGOW COMA SCALE; GUNSHOT WOUNDS; HEAD; PROGESTERONE; IMPACT; WITHDRAWAL; TRAUMA; CARE	Objective: To identify predictors associated with survival in civilian penetrating traumatic brain injury (pTBI) utilizing a contemporary, large, diverse 2-center cohort, and to develop a parsimonious survival prediction score for pTBI. Methods: Our cohort comprised 413 pTBI patients retrospectively identified from the local trauma registries at 2 US level 1 trauma centers, of which one was predominantly urban and the other predominantly rural. Predictors of in-hospital and 6-month survival identified in univariate and multivariable logistic regression were used to develop the simple Surviving Penetrating Injury to the Brain (SPIN) score. Results: The mean age was 33 6 16 years and patients were predominantly male (87%). Survival at hospital discharge as well as 6 months post pTBI was 42.4%. Higher motor Glasgow Coma Scale subscore, pupillary reactivity, lack of self-inflicted injury, transfer from other hospital, female sex, lower Injury Severity Score, and lower international normalized ratio were independently associated with survival (all p < 0.001; model area under the curve 0.962). Important radiologic factors associated with survival were also identified but their addition to the full multivariable would have resulted in model overfitting without much gain in the area under the curve. Conclusions: The SPIN score, a logistic regression-based clinical risk stratification scale estimating survival after pTBI, was developed in this large, diverse 2-center cohort. While this preliminary clinical survival prediction tool does not include radiologic factors, it may support clinical decision-making after civilian pTBI if external validation confirms the probability estimates.	[Muehlschlegel, Susanne; Ahlawat, Aditi] Univ Massachusetts, Sch Med, Dept Neurol Neurocrit Care, Worcester, MA 01655 USA; [Muehlschlegel, Susanne; Ayturk, Didem; Emhoff, Timothy] Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA 01655 USA; [Muehlschlegel, Susanne] Univ Massachusetts, Sch Med, Dept Anesthesia Crit Care, Worcester, MA 01655 USA; [Izzy, Saef] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Div Neurocrit Care, Boston, MA USA; Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Scalea, Thomas M.; Stein, Deborah M.] Univ Maryland, R Adams Cowley Shock Trauma Ctr, Dept Surg, Baltimore, MD USA; [Sheth, Kevin N.] Yale Univ, Dept Neurol Neurocrit Care & Emergency Neurol, New Haven, CT USA; [Sheth, Kevin N.] Yale Univ, Dept Neurosurg, New Haven, CT USA		Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol Neurocrit Care, Worcester, MA 01655 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Surg, Worcester, MA 01655 USA.; Muehlschlegel, S (corresponding author), Univ Massachusetts, Sch Med, Dept Anesthesia Crit Care, Worcester, MA 01655 USA.	susanne.muehlschlegel@umassmemorial.org		Stein, Deborah/0000-0003-3683-3963	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001863] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23 HD080971] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD080971] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER		Aarabi B, 2014, J NEUROSURG, V120, P1138, DOI 10.3171/2014.1.JNS131869; ALDRICH EF, 1992, SURG NEUROL, V38, P418, DOI 10.1016/0090-3019(92)90109-Z; [Anonymous], 2001, J TRAUMA, V51, pS12; [Anonymous], 2001, J Trauma, V51, pS3; [Anonymous], 2001, J TRAUMA, V51, pS16; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Carney N, 2016, NEUROSURGERY; CDC, FAST STATS INJ; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Giffords G., 2011, GABBY STORY COURAGE; Gressot LV, 2014, J NEUROSURG, V121, P645, DOI 10.3171/2014.5.JNS131872; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Joseph B, 2014, J AM COLL SURGEONS, V218, P58, DOI 10.1016/j.jamcollsurg.2013.08.018; Kim KA, 2005, NEUROSURGERY, V57, P737, DOI [10.1227/01.NEU.0000175727.76530.94, 10.1227/01.NEU.0000164174.07281.F9]; Lin DJ., 2012, SURG NEUROL INT, V3, P98, DOI [DOI 10.4103/2152-7806, 10.4103/2152-7806.100187, DOI 10.4103/2152-7806.100187]; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Martins RS, 2003, SURG NEUROL, V60, P98, DOI 10.1016/S0090-3019(03)00302-1; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Muehlschlegel S, 2013, NEUROCRIT CARE, V18, P318, DOI 10.1007/s12028-013-9817-2; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304	28	19	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	NOV 22	2016	87	21					2244	2253		10.1212/WNL.0000000000003355			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EI1LE	WOS:000392238000017	27784772	Green Published			2022-02-06	
J	Briggs, DI; Angoa-Perez, M; Kuhn, DM				Briggs, Denise I.; Angoa-Perez, Mariana; Kuhn, Donald M.			Prolonged Repetitive Head Trauma Induces a Singular Chronic Traumatic Encephalopathy-Like Pathology in White Matter Despite Transient Behavioral Abnormalities	AMERICAN JOURNAL OF PATHOLOGY			English	Article							PROFESSIONAL FOOTBALL PLAYERS; DIFFUSE AXONAL INJURY; MILD STRESS MODEL; BRAIN-INJURY; MOUSE MODEL; RECURRENT CONCUSSION; MEMORY DEFICITS; OPTIC-NERVE; GRAY-MATTER; IMPACT	Repetitive mild traumatic brain injury (rmTBI), resulting from insults caused by an external mechanical force that disrupts normal brain function, has been linked to the development of neurodegenerative diseases, such as chronic traumatic encephalopathy and Alzheimer disease; however, neither the severity nor frequency of head injury required to trigger adverse behavioral outcomes is well understood. In this study, the administration of 30 head impacts using two different weights to tightly anesthetized, completely unrestrained mice established a paradigm that simulates the highly repetitive nature of sports- and military-related head injury. As the number of head impacts increases, the time to recover consciousness diminishes; however, both the sensorimotor function and behavioral outcomes of impacted mice evolve during the ensuing weeks. Postmortem analyses reveal robust Alzheimer disease and chronic traumatic encephalopathy like conditions that manifest in a singular manner throughout the white matter concomitant with evidence of chronic oligoden-drogenesis. Our data suggest that latency to recover the righting reflex may be an inadequate measure of injury severity and imply that exposure to repeated head impacts may mask the severity of an underlying and developing neuropathologic condition that does not manifest itself until long after head collisions cease. In addition, our data indicate that there is a cumulative and dose-dependent effect of repetitive head impacts that induces the neurobehavioral and neuropathologic outcomes seen in humans with a history of rmTBI.	[Briggs, Denise I.; Angoa-Perez, Mariana; Kuhn, Donald M.] John D Dingell VA Med Ctr, Res & Dev Serv, 4646 John R St, Detroit, MI 48201 USA; [Briggs, Denise I.; Angoa-Perez, Mariana; Kuhn, Donald M.] Wayne State Univ, Dept Psychiat & Behav Neurosci, Sch Med, Detroit, MI 48207 USA		Briggs, DI (corresponding author), John D Dingell VA Med Ctr, Res & Dev Serv, 4646 John R St, Detroit, MI 48201 USA.	dbriggs@med.wayne.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Briggs, Denise/0000-0002-4824-3947	Department of Veterans Affairs grantUS Department of Veterans Affairs [5IO1RX000375]; New Investigator grant from the Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine; Veterans AffairsUS Department of Veterans Affairs [IK6RX002419, I01RX000375] Funding Source: NIH RePORTER	Supported by Department of Veterans Affairs grant 5IO1RX000375 (D.M.K.); and a New Investigator grant from the Department of Psychiatry and Behavioral Neurosciences, Wayne State University School of Medicine (D.I.B.).	Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P737, DOI 10.1249/MSS.0b013e3182792ed7; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brann DW, 2007, STEROIDS, V72, P381, DOI 10.1016/j.steroids.2007.02.003; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Deacon R. M. J., 2013, JOVE-J VIS EXP, V76, P2610, DOI [10.3791/2610, DOI 10.3791/2610]; Denny-Brown Russell WR, 1940, J PHYSL, V99, P153; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Di Bello IC, 1999, J NEUROCYTOL, V28, P365, DOI 10.1023/A:1007069815302; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fleminger S, 2008, EUR J ANAESTH, V25, P123, DOI 10.1017/S0265021507003250; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Holbourn AHS, 1943, LANCET, V2, P438; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Mannix R, 2014, J NEUROSURG, V121, P1342, DOI 10.3171/2014.7.JNS14272; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Maxwell WL, 2015, J NEUROTRAUM, V32, P780, DOI 10.1089/neu.2014.3369; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Paxinos G., 2008, MOUSE BRAIN STEREOTA; Perunovic B, 2001, J NEUROL SCI, V185, P55, DOI 10.1016/S0022-510X(01)00463-4; Petraglia Anthony L, 2014, Surg Neurol Int, V5, P184, DOI 10.4103/2152-7806.147566; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Piato AL, 2008, J ETHNOPHARMACOL, V118, P300, DOI 10.1016/j.jep.2008.04.018; Reith FCM, 2016, J NEUROTRAUM, V33, P89, DOI 10.1089/neu.2014.3843; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2011, NEUROSURGERY, V68, P1562, DOI 10.1227/NEU.0b013e31820e382e; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Szabo AJ, 2013, J ATHL TRAINING, V48, P851, DOI 10.4085/1062-6050-48.6.20; Tan AM, 2005, J ANAT, V207, P717, DOI 10.1111/j.1469-7580.2005.00452.x; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Thomas DM, 2008, J NEUROCHEM, V105, P605, DOI 10.1111/j.1471-4159.2007.05155.x; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Walker AK, 2014, J NEUROSCI, V34, P6448, DOI 10.1523/JNEUROSCI.0248-14.2014; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xu LY, 2015, EXP NEUROL, V273, P168, DOI 10.1016/j.expneurol.2015.08.014; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Yalcin I, 2007, BEHAV PHARMACOL, V18, P623, DOI 10.1097/FBP.0b013e3282eff109	84	19	19	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	NOV	2016	186	11					2869	2886		10.1016/j.ajpath.2016.07.013			18	Pathology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pathology	EA9TG	WOS:000386987000010	27662795	Bronze			2022-02-06	
J	Dahdah, MN; Barnes, S; Buros, A; Dubiel, R; Dunklin, C; Callender, L; Harper, C; Wilson, A; Diaz-Arrastia, R; Bergquist, T; Sherer, M; Whiteneck, G; Pretz, C; Vanderploeg, RD; Shafi, S				Dahdah, Marie N.; Barnes, Sunni; Buros, Amy; Dubiel, Rosemary; Dunklin, Cynthia; Callender, Librada; Harper, Caryn; Wilson, Amy; Diaz-Arrastia, Ramon; Bergquist, Thomas; Sherer, Mark; Whiteneck, Gale; Pretz, Christopher; Vanderploeg, Rodney D.; Shafi, Shahid			Variations in Inpatient Rehabilitation Functional Outcomes Across Centers in the Traumatic Brain Injury Model Systems Study and the Influence of Demographics and Injury Severity on Patient Outcomes	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Inpatients; Rehabilitation; Treatment outcome	LENGTH-OF-STAY; LOCALIZED PROSTATE-CANCER; OLDER-ADULTS; DIFFERENTIAL OUTCOMES; COMMUNITY INTEGRATION; CARE INDICATORS; HEAD-INJURY; STROKE; IMPACT; VARIABLES	Objective: To compare patient functional outcomes across Traumatic Brain Injury Model Systems (TBIMS) rehabilitation centers using an enhanced statistical model and to determine factors that influence those outcomes. Design: Multicenter observational cohort study. Setting: TBIMS centers. Participants: Patients with traumatic brain injury (TBI) admitted to 19 TBIMS rehabilitation centers from 2003-2012 (N=5505). Interventions: Not applicable. Main Outcome Measures: Functional outcomes of patients with TBI. Results: Individuals with lower functional status at the time of admission, longer duration of posttraumatic amnesia, and higher burden of medical comorbidities continued to have worse functional outcomes at discharge from inpatient rehabilitation and at the 1-year follow-up, whereas those who were employed at the time of injury had better outcomes at both time periods. Risk-adjusted patient functional outcomes for patients in most TBIMS centers were consistent with previous research. However, there were wide performance differences for a few centers even after using more recently collected data, improving on the regression models by adding predictors known to influence functional outcomes, and using bootstrapping to eliminate confounds. Conclusions: Specific patient, injury, and clinical factors are associated with differences in functional outcomes within and across TBIMS rehabilitation centers. However, these factors did not explain all the variance in patient outcomes, suggesting a role of some other predictors that remain unknown. (C) 2016 by the American Congress of Rehabilitation Medicine	[Dahdah, Marie N.; Dubiel, Rosemary; Wilson, Amy] Baylor Inst Rehabil, Dallas, TX USA; [Dahdah, Marie N.; Dubiel, Rosemary; Dunklin, Cynthia; Callender, Librada; Harper, Caryn; Diaz-Arrastia, Ramon; Shafi, Shahid] North Texas Traumat Brain Injury Model Syst Ctr, Dallas, TX USA; [Dahdah, Marie N.] Baylor Reg Med Ctr Plano, Ctr Med Psychol, Plano, TX USA; [Barnes, Sunni; Buros, Amy; Shafi, Shahid] Baylor Inst Hlth Care Res & Improvement, 8080 North Cent Expressway,Suite 900, Dallas, TX 75206 USA; [Diaz-Arrastia, Ramon] Univ Texas Southwestern, Dept Neurol & Neurotherapeut, Dallas, TX USA; [Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Bergquist, Thomas] Mayo Clin Traumat Brain Injury Model Syst, Rochester, MN USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Whiteneck, Gale] Rocky Mt Reg Brain Injury Syst, Englewood, CO USA; [Pretz, Christopher] Craig Hosp, Natl Data & Stat Ctr, Englewood, CO USA; [Vanderploeg, Rodney D.] James A Haley Vet Hosp, Tampa, FL USA		Shafi, S (corresponding author), Baylor Inst Hlth Care Res & Improvement, 8080 North Cent Expressway,Suite 900, Dallas, TX 75206 USA.	shahid.shafi@baylorhealth.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133A120098-11]	Supported by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (grant no H133A120098-11). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, or HHS, and you should not assume endorsement by the federal government.	Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Borkar SA, 2011, INDIAN J NEUROTRAUM, V8, P77, DOI 10.1016/S0973-0508(11)80004-3; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Corrigan J, PROBLEMATIC SUBSTANC; Corrigan JA, 2008, ARCH PHYS MED REHAB, V89, P912, DOI 10.1016/j.apmr.2007.12.027; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Dahdah MN, 2014, J HEAD TRAUMA REHAB, V29, P451, DOI 10.1097/HTR.0b013e3182a61983; DeJong G, 2011, PHYS THER, V91, P1826, DOI 10.2522/ptj.20100424; Deshpande AA, 1997, ARCH PHYS MED REHAB, V78, P350, DOI 10.1016/S0003-9993(97)90224-0; Dijkers MP, 2010, J HEAD TRAUMA REHAB, V25, P81, DOI 10.1097/HTR.0b013e3181cd3528; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Frankel JE, 2006, ARCH PHYS MED REHAB, V87, P57, DOI 10.1016/j.apmr.2005.07.309; HAHN B, 1994, MED CARE, V32, P227, DOI 10.1097/00005650-199403000-00004; Hawkins ML, 2005, AM SURGEON, V71, P920; Hawkins ML, 2005, AM SURGEON, V71, P9; High WM, 2006, ARCH PHYS MED REHAB, V87, P334, DOI 10.1016/j.apmr.2005.11.028; Hoenig H, 2001, HEALTH SERV RES, V35, P1293; Horn SD, 2005, ARCH PHYS MED REHAB, V86, pS101, DOI 10.1016/j.apmr.2005.09.016; Horn SD, 2015, ARCH PHYS MED REHAB, V96, pS304, DOI 10.1016/j.apmr.2014.11.030; Irdesel J, 2007, NEUROCIRUGIA, V18, P5; JOHNSTON M V, 1991, Brain Injury, V5, P155, DOI 10.3109/02699059109008086; Kennedy RL, 2002, J TRAUMA, V52, P660, DOI 10.1097/00005373-200204000-00008; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Kuhne CA, 2007, UNFALLCHIRURG, V110, P341, DOI 10.1007/s00113-007-1244-4; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lew HL, 2002, AM J PHYS MED REHAB, V81, P830, DOI 10.1097/00002060-200211000-00005; Mayer SA, 2011, CRIT CARE MED, V39, P2330, DOI 10.1097/CCM.0b013e3182227238; Mazurek M, 2011, INT J THER REHABIL, V18, P551, DOI 10.12968/ijtr.2011.18.10.551; McNaughton H, 2005, ARCH PHYS MED REHAB, V86, pS115, DOI 10.1016/j.apmr.2005.08.115; *MEDPAC, 2001, REP C MED RUR AM; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Pasquale MD, 2005, CRIT CARE MED, V33, pA40, DOI 10.1097/00003246-200512002-00148; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Semlyen JK, 1998, ARCH PHYS MED REHAB, V79, P678, DOI 10.1016/S0003-9993(98)90044-2; Shafi S, 2009, J AM COLL SURGEONS, V209, P521, DOI 10.1016/j.jamcollsurg.2009.07.001; Tewari A, 2006, UROLOGY, V68, P1268, DOI 10.1016/j.urology.2006.08.1059; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, RES GERONTOL NURS, V5, P17, DOI 10.3928/19404921-20111206-02; Treadwell J, 2012, SURG OPTIONS INGUINA; Wagner AK, 2000, J TRAUMA, V49, P411, DOI 10.1097/00005373-200009000-00005; Wertheimer JC, 2008, ARCH PHYS MED REHAB, V89, P1983, DOI 10.1016/j.apmr.2008.04.010; Winchell RJ, 1996, ARCH SURG-CHICAGO, V131, P533; Wood RI, 1998, BRAIN INJURY, V13, P69; Wudhikarn K, 2014, J COMP EFFECT RES, V3, P95, DOI 10.2217/cer.13.86; Zumsteg JM, 2012, ARCH PHYS MED REHAB, V93, P386, DOI 10.1016/j.apmr.2011.08.018	58	19	19	1	6	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2016	97	11					1821	1831		10.1016/j.apmr.2016.05.005			11	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EB8IK	WOS:000387634500001	27246623				2022-02-06	
J	Mohammed, HS				Mohammed, Haitham S.			Transcranial low-level infrared laser irradiation ameliorates depression induced by reserpine in rats	LASERS IN MEDICAL SCIENCE			English	Article						Low-level infrared laser; Depression; FST; ECoG; Rat	LIGHT; MODEL; MICE; PHOTOBIOMODULATION; SYMPTOMS	Transcranial low-level infrared laser is a modality of therapy based on the principle of photons delivered in a non-invasive manner through the skull for the treatment of some neurological conditions such as psychological disorders, traumatic brain injuries, and neurodegenerative diseases among others. In the present study, effects of low-level infrared laser irradiation with different radiation powers (80, 200, and 400 mW, continuous wave) were investigated on normal animals subjected to forced swimming test (FST). Results indicated that there are changes in FST parameters in animals irradiated with laser; the lowest dose provoked a significant increase in animal activity (swimming and climbing) and a significant decrease in animal's immobility, while the highest laser dose resulted in a complete inverse action by significantly increasing animal immobility and significantly decreasing animal activity with respect to control animals. The lowest dose (80 mW) of transcranial laser irradiation has then utilized on animals injected with a chronic dose of reserpine (0.2 mg/kg i.p. for 14 days) served as an animal model of depression. Laser irradiation has successfully ameliorated depression induced by reserpine as indicated by FST parameters and electrocorticography (ECoG) spectral analysis in irradiated animals. The findings of the present study emphasized the beneficial effects of low-level infrared laser irradiation on normal and healthy animals. Additionally, it indicated the potential antidepressant activity of the low dose of infrared laser irradiation.	[Mohammed, Haitham S.] Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt		Mohammed, HS (corresponding author), Cairo Univ, Dept Biophys, Fac Sci, Giza, Egypt.	Haitham@sci.cu.edu.eg	Sharaf, Haitham/AAU-7472-2021; mohammed, haitham/AAY-2237-2021	Sharaf, Haitham/0000-0002-6055-9514; 			Antkiewicz-Michaluk L, 2014, NEUROTOX RES, V26, P85, DOI 10.1007/s12640-013-9454-8; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Blasco-Serra A, 2015, PHYSIOL BEHAV, V151, P456, DOI 10.1016/j.physbeh.2015.07.033; Cassano Paolo, 2015, Psychiatry J, V2015, P352979, DOI 10.1155/2015/352979; Cassano P, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031404; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; El-Ghazaly MA, 2015, TOXICOL IND HEALTH, V31, P1128, DOI 10.1177/0748233713487251; Huang QJ, 2004, ACTA PHARMACOL SIN, V25, P293; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Hunter AM, 2010, ACTA PSYCHIAT SCAND, V122, P461, DOI 10.1111/j.1600-0447.2010.01560.x; Leuchter AF, 2009, PSYCHIAT RES, V169, P132, DOI 10.1016/j.psychres.2009.04.004; Li JY, 2014, J NEUROPHYSIOL, V111, P2061, DOI 10.1152/jn.00475.2013; MAINA G, 1974, BIOCHIM BIOPHYS ACTA, V333, P481, DOI 10.1016/0005-2728(74)90132-7; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Mohammed HS, 2011, BEHAV BRAIN RES, V225, P39, DOI 10.1016/j.bbr.2011.06.018; Mrazek DA, 2014, PSYCHIAT SERV, V65, P977, DOI 10.1176/appi.ps.201300059; Nagakura Y, 2009, PAIN, V146, P26, DOI 10.1016/j.pain.2009.05.024; Olvera-Cortes E, 2002, BRAIN RES BULL, V58, P261, DOI 10.1016/S0361-9230(02)00769-4; OSUBOR CC, 1994, RES EXP MED, V194, P109, DOI 10.1007/BF02576371; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; Robbins TW, 1998, ANN NY ACAD SCI, V846, P222, DOI 10.1111/j.1749-6632.1998.tb09740.x; Rojas JC, 2013, BIOCHEM PHARMACOL, V86, P447, DOI 10.1016/j.bcp.2013.06.012; Rojas-Corrales MO, 2004, J PSYCHOPHARMACOL, V18, P404, DOI 10.1177/026988110401800305; Schiffer F, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-46; Shumake J, 2003, Behav Cogn Neurosci Rev, V2, P198, DOI 10.1177/1534582303259057; Tian FH, 2016, LASER SURG MED, V48, P343, DOI 10.1002/lsm.22471; Vakalopoulos C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00063; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Zwierzynska E, 2015, AM J DRUG ALCOHOL AB, V41, P153, DOI 10.3109/00952990.2014.987349	31	19	20	0	12	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	NOV	2016	31	8					1651	1656		10.1007/s10103-016-2033-5			6	Engineering, Biomedical; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Surgery	EA1QW	WOS:000386367900017	27437987				2022-02-06	
J	Zafardoost, P; Ghasemi, AA; Salehpour, F; Piroti, C; Ziaeii, E				Zafardoost, Peyman; Ghasemi, Amir Abbas; Salehpour, Firooz; Piroti, Chia; Ziaeii, Ehsan			Evaluation of the Effect of Glibenclamide in Patients With Diffuse Axonal Injury Due to Moderate to Severe Head Trauma	TRAUMA MONTHLY			English	Article						Diffuse Axonal Injury; Traumatic Brain Injury; Glibenclamide; Outcome	VASOGENIC EDEMA; BRAIN-INJURY; RAT MODEL; EPIDEMIOLOGY; GLYBURIDE; FLUX	Background: Traumatic brain injury (TBI) is a major health problem worldwide. Secondary injuries after TBI, including diffuse axonal injury (DAI) often occur, and proper treatments are needed in this regard. It has been shown that glibenclamide could reduce secondary brain damage after experimental TBI and improve outcomes. Objectives: We aim to evaluate the role of glibenclamide on the short-term outcome of patients with DAI due to moderate to severe TBI. Patients and Methods: In this controlled randomized clinical trial, 40 patients with moderate to severe TBI were assigned to glibenclamide (n = 20) and control (n = 20) groups. Six hours after admission the intervention group received 1.25 mg glibenclamide every 12 hours. The Glasgow coma scale (GCS) was administered at admission, in the first 24 and 48 hours, at one week post-trauma and at discharge. The Glasgow outcome scale (GOS) was also administered at discharge. All results were evaluated and compared between groups. Results: Patients treated with glibenclamide compared to the control group had a significantly better GCS score one week post-trauma (P = 0.003) and at discharge (P = 0.004), as well as a better GOS score at discharge (P = 0.001). The glibenclamide group also had a shorter length of hospital stay compared to the control group (P = 0.03). In the control group, two patients (10%) died during the first week post-trauma, but there was no mortality in the glibenclamide group (P = 0.48). Conclusions: Treatment with glibenclamide in patients with DAI due to moderate to severe TBI significantly improves short-term outcomes.	[Zafardoost, Peyman; Ghasemi, Amir Abbas; Salehpour, Firooz; Piroti, Chia; Ziaeii, Ehsan] Urmia Univ Med Sci, Dept Neurosurg, Orumiyeh, Iran		Zafardoost, P (corresponding author), Urmia Univ Med Sci, Dept Neurosurg, Orumiyeh, Iran.	peyman_z_2002@yahoo.com	Ziaee, Ehsan/AAP-2112-2021; Heidari, Mohammad/D-1287-2018; Ghasemi, Amir abbas/C-9574-2018	Heidari, Mohammad/0000-0002-7159-4809; Ghasemi, Amir abbas/0000-0002-7159-4809	Urmia University of Medical Sciences, Iran	This research was financially supported by vice chancellor for research, Urmia University of Medical Sciences, Iran.	Ahmed I., 2012, NEUROLOGY, V78; Bartnik BL, 2007, J NEUROTRAUM, V24, P181, DOI 10.1089/neu.2006.0038; Ding J, 2013, CLIN NEUROL NEUROSUR, V115, P2166, DOI 10.1016/j.clineuro.2013.08.010; Dusick JR, 2007, J CEREBR BLOOD F MET, V27, P1593, DOI 10.1038/sj.jcbfm.9600458; Hassan STS, 2013, TRAUMA MON, V18, P56, DOI 10.5812/traumamon.11522; Hattori N, 2004, J NUCL MED, V45, P775; Ingebrigtsen T, 1998, NEUROEPIDEMIOLOGY, V17, P139, DOI 10.1159/000026165; Kimberly WT, 2014, NEUROCRIT CARE, V20, P193, DOI 10.1007/s12028-013-9917-z; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; Patel AD, 2010, J NEUROPATH EXP NEUR, V69, P1177, DOI 10.1097/NEN.0b013e3181fbf6d6; Rambiritch V, 2014, CLIN PHARMACOL-ADV A, V6, P63, DOI 10.2147/CPAA.S54809; Robles JF, 2009, INT J ENDOCRINOL MET, V7, P72; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Sheth KN, 2014, NEUROCRIT CARE, V21, P43, DOI 10.1007/s12028-014-9970-2; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Simard JM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000522; Simard JM, 2010, STROKE, V41, P531, DOI 10.1161/STROKEAHA.109.572644; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Simard JM, 2009, J CEREBR BLOOD F MET, V29, P317, DOI 10.1038/jcbfm.2008.120; Zhou YL, 2009, BRAIN RES, V1270, P131, DOI 10.1016/j.brainres.2009.03.010; Zweckberger K, 2014, NEUROSCIENCE, V272, P199, DOI 10.1016/j.neuroscience.2014.04.040	23	19	19	0	4	NATL CENTER TRAUMA RESEARCH	TEHRAN	NATL CENTER TRAUMA RESEARCH, TEHRAN, IRAN	2251-7464	2251-7472		TRAUMA MON	Trauma Mon.	NOV	2016	21	5							e25113	10.5812/traumamon.25113			4	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	ED7QM	WOS:000389064100006	28184360	Green Published, Green Submitted			2022-02-06	
J	Ostergard, T; Sweet, J; Kusyk, D; Herring, E; Miller, J				Ostergard, Thomas; Sweet, Jennifer; Kusyk, Dorian; Herring, Eric; Miller, Jonathan			Animal models of post-traumatic epilepsy	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Epilepsy; Traumatic brain injury; Animal models	LATERAL FLUID-PERCUSSION; TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; RAT; SEIZURES; MOUSE; RISK	Post-traumatic epilepsy (PTE) is defined as the development of unprovoked seizures in a delayed fashion after traumatic brain injury (TBI). PTE lies at the intersection of two distinct fields of study, epilepsy and neurotrauma. TBI is associated with a myriad of both focal and diffuse anatomic injuries, and an ideal animal model of epilepsy after TBI must mimic the characteristics of human PTE. The three most commonly used models of TBI are lateral fluid percussion, controlled cortical injury, and weight drop. Much of what is known about PTE has resulted from use of these models. In this review, we describe the most commonly used animal models of TBI with special attention to their advantages and disadvantages with respect to their use as a model of PTE. (C) 2016 Elsevier B.V. All rights reserved.	[Ostergard, Thomas; Sweet, Jennifer; Kusyk, Dorian; Herring, Eric; Miller, Jonathan] Case Western Reserve Univ, Sch Med, Neurol Inst, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA		Miller, J (corresponding author), Univ Hosp Case Med Ctr, Dept Neurol Surg, 11100 Euclid Ave, Cleveland, OH 44106 USA.	Jonathan.Miller@UHHospitals.org					Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Campbell John N, 2014, Int J Neurol Brain Disord, V1, P1; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Heise T, 2010, J HEALTH CARE POOR U, V21, P401; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kitano H, 2007, J CEREBR BLOOD F MET, V27, P1108, DOI 10.1038/sj.jcbfm.9600410; Kovacs SK, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00047; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDGREN S, 1966, BIOPHYSIK, V3, P174, DOI 10.1007/BF01191611; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Messori A, 2005, EPILEPSIA, V46, P1472, DOI 10.1111/j.1528-1167.2005.34004.x; Nemes A., 2016, J NEUROTRAUMA; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496	30	19	20	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		50	55		10.1016/j.jneumeth.2016.03.023			6	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000006	27044802				2022-02-06	
J	Shibahashi, K; Doi, T; Tanaka, S; Hoda, H; Chikuda, H; Sawada, Y; Takasu, Y; Chiba, K; Nozaki, T; Hamabe, Y; Ogata, T				Shibahashi, Keita; Doi, Toru; Tanaka, Sakae; Hoda, Hidenori; Chikuda, Hirotaka; Sawada, Yasuhiro; Takasu, Yuichi; Chiba, Kentaro; Nozaki, Toshiki; Hamabe, Yuichi; Ogata, Toru			The Serum Phosphorylated Neurofilament Heavy Subunit as a Predictive Marker for Outcome in Adult Patients after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; assessment tool; traumatic brain injury	NF-H; PNF-H; BIOMARKER; SEVERITY; DAMAGE	The serum phosphorylated neurofilament heavy subunit (pNF-H) is a nervous system-specific protein that is released from damaged neural tissue after traumatic brain injury (TBI). The aim of this study was to elucidate the usefulness of serum pNF-H as a predictive marker for the outcome of patients after TBI. Patients with TBI (Glasgow Coma Scale score of 13 or less on admission) were included. Patients who were younger than age 18, dependent on others for daily activities before injury, pregnant, or who were not likely to survive for more than 24h after injury were excluded. The outcome was assessed using the Glasgow Outcome Scale at 6 months after injury. Blood was collected from subjects (n=32), and the serum pNF-H value was assessed at 24 and 72h after TBI. The optimal cutoff value and usefulness of the serum pNF-H value for predicting the long-term outcome were investigated. We found that the serum pNF-H value at 24h after injury was a good predictive marker of death at 6 months (p<0.001) after injury. The optimal cutoff value was 240pg/mL, and the area under the curve in the receiver operating characteristic analysis was 0.930. The serum pNF-H value at 72h after injury was correlated with an unfavorable outcome (vegetative state or death) at 6 months (p<0.01) with a cutoff value of 80pg/mL. Collectively, the results of this study indicate that the serum pNF-H value is a useful predictive marker for patient outcome after TBI.	[Shibahashi, Keita; Hoda, Hidenori; Chikuda, Hirotaka; Takasu, Yuichi; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Tokyo, Japan; [Shibahashi, Keita; Hoda, Hidenori; Chikuda, Hirotaka; Takasu, Yuichi; Hamabe, Yuichi] Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Tokyo, Japan; [Doi, Toru; Sawada, Yasuhiro; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Saitama, Japan; [Doi, Toru; Tanaka, Sakae] Univ Tokyo, Dept Orthoped Surg, Fac Med, Tokyo, Japan; [Chiba, Kentaro] Tokyo Womens Med Univ, Dept Neurosurg, Tokyo, Japan; [Nozaki, Toshiki] Nippon Med Sch, Dept Neurol Surg, Tokyo, Japan		Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Dept Emergency, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.; Shibahashi, K (corresponding author), Tokyo Metropolitan Bokutoh Hosp, Intens Care Ctr, Sumida Ku, 4-23-15 Kotobashi, Tokyo 1308575, Japan.	kshibahashi@yahoo.co.jp	Sawada, Yasuhiro/H-8044-2012; Tanaka, Sakae/Y-3061-2019; Doi, Toru/AAC-3441-2020	Sawada, Yasuhiro/0000-0003-0625-3335; Tanaka, Sakae/0000-0001-9210-9414; Doi, Toru/0000-0001-8833-2437; Nozaki, Toshiki/0000-0002-6941-4645	Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [15H04966] Funding Source: KAKEN		Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; [Anonymous], 2008, BMJ-BRIT MED J, V336, P336; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; De Guise E, 2005, BRAIN INJURY, V19, P1087, DOI 10.1080/02699050500149882; Gatson JW, 2014, J NEUROSURG, V121, P1232, DOI 10.3171/2014.7.JNS132474; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hayakawa K, 2012, SPINAL CORD, V50, P493, DOI 10.1038/sc.2011.184; Kato S, 2015, J CLIN NEUROSCI, V22, P1638, DOI 10.1016/j.jocn.2015.03.047; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Natori A, 2015, CLIN CANCER RES, V21, P1348, DOI 10.1158/1078-0432.CCR-14-2775; Pelinka LE, 2003, BRIT J ANAESTH, V91, P595, DOI 10.1093/bja/aeg225; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Zurek J, 2011, BRAIN INJURY, V25, P221, DOI 10.3109/02699052.2010.541895	15	19	20	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1826	1833		10.1089/neu.2015.4237			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300003	27098610				2022-02-06	
J	Kamal, VK; Agrawal, D; Pandey, RM				Kamal, Vineet Kumar; Agrawal, Deepak; Pandey, Ravindra Mohan			Epidemiology, clinical characteristics and outcomes of traumatic brain injury: Evidences from integrated level 1 trauma center in India	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Epidemiology; Glasgow Outcome Scale; mortality; outcome; traumatic brain injury	HEAD-INJURIES; MODERATE	Introduction: Traumatic brain injury (TBI) is a leading cause of mortality, morbidity, disability, and socioeconomic losses in the Indian subcontinent. However, for policymaking and research, there is a lack of reliable and larger data in our settings. Aims and Objectives: To evaluate and describe the epidemiological, clinical characteristics, and outcomes of patients with TBI in a Level 1 Trauma Center in India. Materials and Methods: In this retrospective study, all patients with moderate or severe TBI, based on emergency department Glasgow Coma Scale, admitted to neurosurgery Intensive Care Unit (ICU) during May 2010-July 2012 were evaluated to provide detailed information on TBI-related variables and outcomes using descriptive statistics. Results: Among the 1527 patients with moderate or severe TBI patients with mean age 32.15 +/- 16.76 years (range: 1-90) and male: female ratio 6.5: 1, 1281 (83.89%) had severe TBI. The majority of cases took place in the age group of 21-40 years (50.24%) with the most common mode of injury as road traffic accidents (RTAs) (64.96%). Surgical intervention (craniotomy) was done in 49.12% of patients. About 34.58% (n = 528) patients died in hospital, and 67.21% (n = 701) had unfavorable outcome at 6 months. Conclusions: This is the first study of its kind from the Indian subcontinent that gives data on the admission characteristics, mortality, and 6 months outcome of such patients. Most of the injuries occurred due to RTAs, more common among the economic productive age groups and mostly in males with a high rate of mortality and unfavorable outcome.	[Kamal, Vineet Kumar; Pandey, Ravindra Mohan] All India Inst Med Sci, Dept Biostat, JPN Apex Trauma Ctr, New Delhi, India; [Agrawal, Deepak] All India Inst Med Sci, Dept Neurosurg, JPN Apex Trauma Ctr, New Delhi, India		Pandey, RM (corresponding author), All India Inst Med Sci, Dept Biostat, New Delhi 110029, India.	rmpandey@yahoo.com	GARG, RAKESH/H-4591-2011; /AAG-3032-2021	GARG, RAKESH/0000-0001-5842-8024; /0000-0002-5499-0746; Kamal, Vineet Kumar/0000-0002-7295-1644	ICMR, New DelhiIndian Council of Medical Research (ICMR)	ICMR, New Delhi.	Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bajracharya A, 2010, J NEUROSCI RURAL PRA, V1, P2, DOI 10.4103/0976-3147.63092; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; COLOHAN ART, 1989, J NEUROSURG, V71, P202, DOI 10.3171/jns.1989.71.2.0202; Compagnone C, 2009, NEUROSURGERY, V64, P690, DOI 10.1227/01.NEU.0000340796.18738.F7; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Gururaj G, 2002, NEUROL RES, V24, P24, DOI 10.1179/016164102101199503; Gururaj G., 2005, BACKGROUND PAPERS BU, P325; Gururaj G, 2005, USITC PUBL, V61; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Lopez A.D., 1996, GLOBAL BURDEN DIS CO; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray C. J., 1996, GLOBAL HLTH STAT COM; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Murthy TVSP, 2005, INDIAN J NEUROTRAUM, V2, P99; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; WHO, 2003, WORLD HLTH REP 2003	23	19	19	0	6	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	OCT-DEC	2016	7	4					515	525		10.4103/0976-3147.188637			11	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DW7BS	WOS:000383806800009	27695230	Green Published, gold			2022-02-06	
J	Llompart-Pou, JA; Chico-Fernandez, M; Sanchez-Casado, M; Alberdi-Odriozola, F; Guerrero-Lopez, F; Mayor-Garcia, MD; Gonzalez-Robledo, J; Ballesteros-Sanz, MA; Herran-Mongei, R; Leon-Lopez, R; Lopez-Amork, L; Bueno-Gonzalez, A				Antonio Llompart-Pou, Juan; Chico-Fernandez, Mario; Sanchez-Casado, Marcelino; Alberdi-Odriozola, Fermin; Guerrero-Lopez, Francisco; Dolores Mayor-Garcia, Maria; Gonzalez-Robledo, Javier; Angeles Ballesteros-Sanz, Maria; Herran-Mongei, Ruben; Leon-Lopez, Rafael; Lopez-Amork, Lucia; Bueno-Gonzalez, Ana		Trauma & Neurointensive Care	Age-related injury patterns in Spanish trauma ICU patients. Results from the RETRAUCI	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Intensive care unit; Elderly; Injury patterns; Trauma registry	BRAIN-INJURY; GERIATRIC TRAUMA; MORTALITY; CARE; EPIDEMIOLOGY; MANAGEMENT; REGISTRIES; COMPLICATIONS; PREDICTORS; OUTCOMES	Background: Injury patterns may differ in trauma patients when age is considered. This information is relevant in the management of trauma patients and for planning preventive measures. Methods: We included in the study all patients admitted for traumatic disease in the participating ICUs from November 23rd, 2012 to July 31st, 2015 with complete records. Data on epidemiology, injury patterns, severity scores, acute management, resources utilisation and outcome were recorded and compared in the following groups of age: <= 55 years (young adults), 56-65 years (adults), 66-75 years (elderly), > 75 years (very elderly). Quantitative datawere reported as median (Interquartile Range (IQR) 25-75) and categorical data as number and percentage. Comparison between groups of age with quantitative variables was performed using the analysis of variance (ANOVA) test. Differences between groups with categorical variables were compared using the chi-square test. A value of p < 0.05 was considered significant. Results: We included 2700 patients (78.9% male). Median age was 46 (31-62) years. Blunt trauma was present in 93.7% of the patients. Median RTS was 7.55 (5.97-7.84). Median ISS was 20 (13-26). High-energy trauma secondary to motor-vehicle accident with rhabdomyolysis and drugs abuse showed an inverse linear association with ageing, whilst pedestrian falls with isolated brain injury, being run-over and pre-injury antiplatelets or anticoagulant treatment increased with age (in all cases p < 0.001). Multiple injurieswere more common in young adults (p < 0.001). Acute kidney injury prevalence was higher in elderly and very elderly patients (p < 0.001). ICU Mortality increased with age in spite of similar severity scores in all groups (p < 0.001). The main cause of death in all groups was intracranial hypertension. Conclusions: Different injury patterns exist in relation with ageing in trauma ICU patients. Adult patients were more likely to present high-energy trauma with significant injuries in different areas whilst elderly patients were prone to low-energy falls, complicated by antiplatelets or anticoagulants use, resulting in severe brain injury and increased mortality. (C) 2016 Elsevier Ltd. All rights reserved.	[Antonio Llompart-Pou, Juan] Hosp Univ Son Espases, Serv Med Intens, Palma De Mallorca, Spain; [Chico-Fernandez, Mario] Hosp Univ 12 Octubre, Serv Med Intens, UCI Trauma & Emergencias, Ave Andalucia S-N, Madrid 28041, Spain; [Sanchez-Casado, Marcelino] Hosp Virgen Salud, Serv Med Intens, Toledo, Spain; [Alberdi-Odriozola, Fermin] Hosp Univ Donostia, Serv Med Intens, San Sebastian, Spain; [Guerrero-Lopez, Francisco] Hosp Univ Virgen Nieves, Serv Med Intens, Granada, Spain; [Dolores Mayor-Garcia, Maria] Complejo Hosp Torrecardenas, Serv Med Intens, Almeria, Spain; [Gonzalez-Robledo, Javier] Complejo Asistencial Univ Salamanca, Serv Med Intens, Salamanca, Spain; [Angeles Ballesteros-Sanz, Maria] Hosp Univ Marques de Valdecilla, Serv Med Intens, Santander, Spain; [Herran-Mongei, Ruben] Hosp Univ Rio Hortega, Serv Med Intens, Valladolid, Spain; [Leon-Lopez, Rafael] Ciudad Sanitaria Reina Sofia, Serv Med Intens, Cordoba, Spain; [Lopez-Amork, Lucia] Hosp Univ Cent Asturias, Serv Med Intens, Asturias, Spain; [Bueno-Gonzalez, Ana] Hosp Gen Univ Ciudad Real, Serv Med Intens, Ciudad Real, Spain		Chico-Fernandez, M (corresponding author), Hosp Univ 12 Octubre, Serv Med Intens, UCI Trauma & Emergencias, Ave Andalucia S-N, Madrid 28041, Spain.	murgchico@yahoo.es		Ballesteros, Maria A/0000-0002-4032-9973	Fundacion Mutua Madrilena, Trauma and Neurointensive Care Working Group of the Spanish Society of Intensive Care Medicine (SEMICYUC) [AP117892013]	RETRAUCI received funding from the Fundacion Mutua Madrilena during 3 years for the development of a web-based database granted to Dr. Chico-Fernandez (reference AP117892013), on behalf of Trauma and Neurointensive Care Working Group of the Spanish Society of Intensive Care Medicine (SEMICYUC)	Adams SD, 2012, J TRAUMA ACUTE CARE, V72, P112, DOI 10.1097/TA.0b013e318241f073; Alberdi F, 2014, MED INTENSIVA, V38, P580, DOI 10.1016/j.medin.2014.06.012; Beynon C, 2015, CLIN NEUROL NEUROSUR, V136, P73, DOI 10.1016/j.clineuro.2015.05.035; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Chang DC, 2008, ARCH SURG-CHICAGO, V143, P776, DOI 10.1001/archsurg.143.8.776; Fernandez MC, 2013, MED INTENSIVA, V37, P284, DOI 10.1016/j.medin.2013.01.010; Chico-Fernandez M, 2015, MED INTENSIVA; Clement ND, 2010, SCAND J TRAUMA RESUS, V18, DOI 10.1186/1757-7241-18-26; Demetriades D, 2002, BRIT J SURG, V89, P1319, DOI 10.1046/j.1365-2168.2002.02210.x; Egea-Guerrero JJ, 2015, MED INTENSIVA, V39, P167, DOI 10.1016/j.medin.2014.09.008; Gibson AA, 2014, INJURY, V45, P1066, DOI 10.1016/j.injury.2014.02.037; Grant PT, 2000, INJURY, V31, P519, DOI 10.1016/S0020-1383(00)00038-3; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; Hashmi A, 2014, J TRAUMA ACUTE CARE, V76, P894, DOI 10.1097/TA.0b013e3182ab0763; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Lee H, 2015, ANZ J SURG, V85, P230, DOI 10.1111/ans.12676; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Min LL, 2013, J TRAUMA ACUTE CARE, V74, P1125, DOI 10.1097/TA.0b013e31828273a0; Moore L, 2008, INJURY, V39, P686, DOI 10.1016/j.injury.2008.02.023; Oliver M, 2012, INJURY, V43, P1296, DOI 10.1016/j.injury.2012.04.021; Sanchez FIP, 2015, MED INTENSIVA, V39, P114, DOI 10.1016/j.medin.2014.06.008; Schaefer JH, 2014, J CEREBR BLOOD F MET, V34, P870, DOI 10.1038/jcbfm.2014.31; Skinner DL, 2014, INJURY, V45, P259, DOI 10.1016/j.injury.2013.07.013; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Willis CD, 2007, INJURY, V38, P527, DOI 10.1016/j.injury.2006.06.018	25	19	19	0	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2016	47			3			S61	S65		10.1016/S0020-1383(16)30608-8			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	EF7VW	WOS:000390538400011	27692109				2022-02-06	
J	Chen, CH; Chen, NF; Feng, CW; Cheng, SY; Hung, HC; Tsui, KH; Hsu, CH; Sung, PJ; Chen, WF; Wen, ZH				Chen, Chun-Hong; Chen, Nan-Fu; Feng, Chien-Wei; Cheng, Shu-Yu; Hung, Han-Chun; Tsui, Kuan-Hao; Hsu, Chi-Hsin; Sung, Ping-Jyun; Chen, Wu-Fu; Wen, Zhi-Hong			A Coral-Derived Compound Improves Functional Recovery after Spinal Cord Injury through Its Antiapoptotic and Anti-Inflammatory Effects	MARINE DRUGS			English	Article						Sinularia flexibilis; marine natural compound; 11-dehydrosinulariolide; microglia; neuroprotection; spinal cord injury; anti-inflammation	NECROSIS-FACTOR-ALPHA; ACTIVATED PROTEIN-KINASE; FOCAL CEREBRAL-ISCHEMIA; COLONY-STIMULATING FACTOR; MARINE NATURAL-PRODUCTS; ELEMENT-BINDING PROTEIN; SIGNAL-REGULATED KINASE; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; AMP RESPONSE ELEMENT	Background: Our previous in vitro results demonstrated that 11-dehydrosinulariolide significantly reduced 6-hydroxydopamine-induced cytotoxicity and apoptosis in a human neuroblastoma cell line, SH-SY5Y, and suppressed the expression of inducible NO synthase (iNOS) and cyclooxygenase 2 in lipopolysaccharide-stimulated macrophage cells. The neuroprotective and anti-inflammatory effects of 11-dehydrosinulariolide may be suitable for treating spinal cord injury (SCI). Methods: In the present study, Wistar rats were pretreated with 11-dehydrosinulariolide or saline through intrathecal injection after a thoracic spinal cord contusion injury induced using a New York University (NYU) impactor. The apoptotic cells were assessed using the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. The expression and localization of proinflammatory, apoptosis-associated and cell survival-related pathway proteins were examined through immunoblotting and immunohistochemistry. Results: 11-Dehydrosinulariolide attenuated SCI-induced cell apoptosis by upregulating the antiapoptotic protein Bcl-2 and cell survival-related pathway proteins p-Akt and p-ERK, 8 h after SCI. Furthermore, the transcription factor p-CREB, which regulates Bcl-2 expression, was upregulated after 11-dehydrosinulariolide treatment. On day 7 after SCI, 11-dehydrosinulariolide exhibited an anti-inflammatory effect, attenuating SCI-induced upregulation of the inflammatory proteins iNOS and tumor necrosis factor-. 11-Dehydrosinulariolide also induced an increase in the expression of arginase-1 and CD206, markers of M2 microglia, in the injured spinal cord on day 7 after SCI. Thus, the anti-inflammatory effect of 11-dehydrosinulariolide may be related to the promotion of an alternative pathway of microglia activation. Conclusion: The results show that 11-dehydrosinulariolide exerts antiapoptotic effects at 8 h after SCI and anti-inflammatory effects at 7 days after SCI. We consider that this compound may be a promising therapeutic agent for SCI.	[Chen, Chun-Hong; Feng, Chien-Wei; Cheng, Shu-Yu; Hung, Han-Chun; Hsu, Chi-Hsin; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan; [Chen, Chun-Hong; Feng, Chien-Wei; Cheng, Shu-Yu; Hung, Han-Chun] Acad Sinica, Doctoral Degree Program Marine Biotechnol, Taipei 11529, Taiwan; [Chen, Nan-Fu] Kaohsiung Armed Forces Gen Hosp, Div Neurosurg, Dept Surg, Kaohsiung 80284, Taiwan; [Chen, Nan-Fu] Triserv Gen Hosp, Dept Neurol Surg, Natl Def Med Ctr, Taipei 11490, Taiwan; [Tsui, Kuan-Hao] Kaohsiung Vet Gen Hosp, Dept Obstet & Gynecol, Kaohsiung 81362, Taiwan; [Tsui, Kuan-Hao] Natl Yang Ming Univ, Dept Obstet & Gynecol, Taipei 11221, Taiwan; [Tsui, Kuan-Hao] Natl Yang Ming Univ, Inst Clin Med, Taipei 11221, Taiwan; [Tsui, Kuan-Hao] Tajen Univ, Dept Pharm, Yanpu Township 90741, Pingtung County, Taiwan; [Tsui, Kuan-Hao] Tajen Univ, Grad Inst Pharmaceut Technol, Yanpu Township 90741, Pingtung County, Taiwan; [Hsu, Chi-Hsin; Sung, Ping-Jyun; Chen, Wu-Fu; Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Sung, Ping-Jyun] Natl Museum Marine Biol & Aquarium, Pingtung 94450, Taiwan; [Sung, Ping-Jyun] Natl Dong Hwa Univ, Grad Inst Marine Biol, Pingtung 94450, Taiwan; [Chen, Wu-Fu] Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Chen, Wu-Fu] Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan		Wen, ZH (corresponding author), Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan.; Chen, WF; Wen, ZH (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan.; Chen, WF (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan.; Chen, WF (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung 83301, Taiwan.	chen06688@gmail.com; chen06688@gmail.com; qscjuejuejue@gmail.com; joygetit@gmail.com; hanchun25@gmail.com; khtsui60@gmail.com; hsuch@mail.nsysu.edu.tw; pjsung@nmmba.gov.tw; ma4949@cgmh.org.tw; wzh@mail.nsysu.edu.tw	Wen, Zhi-Hong/AAG-8034-2019; Sung, Ping-Jyun/Z-4162-2019	Wen, Zhi-Hong/0000-0003-4411-044X; Sung, Ping-Jyun/0000-0002-6644-9236; Cheng, Shu Yu/0000-0002-7175-7989	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [104-2325-B-110-001, 103-2314-B-182A-076, 104-2314-B-182A-038]; Chang Gung Memorial HospitalChang Gung Memorial Hospital [CMRPG8A0151-3]	The study was supported, in part, by grants from the Ministry of Science and Technology, Taiwan (104-2325-B-110-001, 103-2314-B-182A-076, and 104-2314-B-182A-038) and Chang Gung Memorial Hospital (CMRPG8A0151-3).	Abe K, 2000, DEV BRAIN RES, V122, P81, DOI 10.1016/S0165-3806(00)00054-7; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bartholdi D, 1997, EUR J NEUROSCI, V9, P1422, DOI 10.1111/j.1460-9568.1997.tb01497.x; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bhat NR, 1998, J NEUROSCI, V18, P1633; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Busch SA, 2009, J NEUROSCI, V29, P9967, DOI 10.1523/JNEUROSCI.1151-09.2009; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; Chen KB, 2011, SPINE, V36, P1350, DOI 10.1097/BRS.0b013e3181f014ec; Chen NF, 2014, MAR DRUGS, V12, P3792, DOI 10.3390/md12073792; Chen WF, 2008, NEUROSCIENCE, V153, P31, DOI 10.1016/j.neuroscience.2008.01.062; Chen WF, 2015, CNS NEUROSCI THER, V21, P698, DOI 10.1111/cns.12429; Chen WF, 2015, BIOMATERIALS, V53, P1, DOI 10.1016/j.biomaterials.2015.02.069; Chen WF, 2012, N-S ARCH PHARMACOL, V385, P265, DOI 10.1007/s00210-011-0710-2; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; CORRALIZA IM, 1995, BIOCHEM BIOPH RES CO, V206, P667, DOI 10.1006/bbrc.1995.1094; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Culbert AA, 2006, J BIOL CHEM, V281, P23658, DOI 10.1074/jbc.M513646200; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Emery E, 1998, J NEUROSURG, V89, P911, DOI 10.3171/jns.1998.89.6.0911; Endo H, 2006, J CEREBR BLOOD F MET, V26, P1479, DOI 10.1038/sj.jcbfm.9600303; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Figueroa JD, 2012, J NEUROTRAUM, V29, P551, DOI 10.1089/neu.2011.2141; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Freeland K, 2001, MOL BRAIN RES, V92, P98, DOI 10.1016/S0169-328X(01)00158-9; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gao K, 2016, J NEUROCHEM, V138, P139, DOI 10.1111/jnc.13382; Ghosh M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0463-9; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Guo Y, 2013, NEUROSCIENCE, V238, P1, DOI 10.1016/j.neuroscience.2013.01.047; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hayashi M, 2000, J NEUROTRAUM, V17, P203, DOI 10.1089/neu.2000.17.203; HERIN M, 1976, B SOC CHIM BELG, V85, P801; Howitt J, 2012, J CELL BIOL, V196, P29, DOI 10.1083/jcb.201105009; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang SY, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0280-1; Inukai T, 2009, SPINE, V34, P2848, DOI 10.1097/BRS.0b013e3181b0d078; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kim BJ, 2009, J NEUROL SCI, V279, P70, DOI 10.1016/j.jns.2008.12.025; Kim SS, 2013, J CELL BIOCHEM, V114, P1115, DOI 10.1002/jcb.24452; Kobayashi K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.54; Koistinaho M, 2002, GLIA, V40, P175, DOI 10.1002/glia.10151; Kong DX, 2010, DRUG DISCOV TODAY, V15, P884, DOI 10.1016/j.drudis.2010.09.002; Lan WB, 2014, BRAIN RES, V1562, P100, DOI 10.1016/j.brainres.2014.03.020; Leal MC, 2013, TRENDS BIOTECHNOL, V31, P555, DOI 10.1016/j.tibtech.2013.06.004; Lee JY, 2010, ENDOCRINOLOGY, V151, P3815, DOI 10.1210/en.2009-1416; Li M, 2000, NEUROSCIENCE, V99, P333, DOI 10.1016/S0306-4522(00)00173-1; Li YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19869; Lin YY, 2015, MAR DRUGS, V13, P2559, DOI 10.3390/md13052559; Liu W, 2011, LIFE SCI, V89, P141, DOI 10.1016/j.lfs.2011.05.011; Liu XZ, 1997, J NEUROSCI, V17, P5395; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martins A, 2014, MAR DRUGS, V12, P1066, DOI 10.3390/md12021066; Montaser R, 2011, FUTURE MED CHEM, V3, P1475, DOI [10.4155/FMC.11.118, 10.4155/fmc.11.118]; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Munder M, 1999, J IMMUNOL, V163, P3771; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Paintlia MK, 2011, J NEUROCHEM, V116, P508, DOI 10.1111/j.1471-4159.2010.07136.x; Pawate S, 2006, ANTIOXID REDOX SIGN, V8, P903, DOI 10.1089/ars.2006.8.903; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Prewitt CMF, 1997, EXP NEUROL, V148, P433, DOI 10.1006/exnr.1997.6694; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rapalino O, 1998, NAT MED, V4, P814, DOI 10.1038/nm0798-814; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Sato A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-65; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Streit WJ, 1998, EXP NEUROL, V152, P74, DOI 10.1006/exnr.1998.6835; Sury MD, 2011, NEUROBIOL DIS, V41, P201, DOI 10.1016/j.nbd.2010.09.007; Tian HP, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-139; Tian W, 2013, NEUROCHEM RES, V38, P772, DOI 10.1007/s11064-013-0976-5; Toborek M, 2007, J CELL BIOCHEM, V100, P279, DOI 10.1002/jcb.21013; Walker CL, 2012, PLOS ONE, V7, P315, DOI 10.1371/journal.pone.0030012; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Xie GL, 2013, EXP THER MED, V5, P1593, DOI 10.3892/etm.2013.1030; Xing J, 1998, MOL CELL BIOL, V18, P1946, DOI 10.1128/MCB.18.4.1946; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xu L, 2007, ANESTH ANALG, V105, P1838, DOI 10.1213/01.ane.0000287660.29297.7b; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yang Y, 2014, NEUROSCI LETT, V568, P44, DOI 10.1016/j.neulet.2014.03.037; Yu FS, 2005, NEUROBIOL DIS, V20, P491, DOI 10.1016/j.nbd.2005.04.004; Yune TY, 2008, J NEUROTRAUM, V25, P1121, DOI 10.1089/neu.2008.0544; Yune TY, 2003, J NEUROTRAUM, V20, P207, DOI 10.1089/08977150360547116; Zhang C, 2014, BRAIN RES, V1555, P1, DOI 10.1016/j.brainres.2014.01.051; Zhang Q, 2016, MOL NEUROBIOL, V53, P662, DOI 10.1007/s12035-014-9035-8; Zhou J, 2015, ASN NEURO, V7, DOI 10.1177/1759091415602463; Zhu HL, 2016, SCI REP-UK, V6, DOI 10.1038/srep26859; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	107	19	19	0	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	SEP	2016	14	9							160	10.3390/md14090160			19	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DZ0LH	WOS:000385529900004	27598175	Green Published, gold, Green Submitted			2022-02-06	
J	Desai, B; Hsu, Y; Schneller, B; Hobbs, JG; Mehta, AI; Linninger, A				Desai, Bhargav; Hsu, Ying; Schneller, Benjamin; Hobbs, Jonathan G.; Mehta, Ankit I.; Linninger, Andreas			Hydrocephalus: the role of cerebral aquaporin-4 channels and modeling considerations of cerebrospinal fluid	NEUROSURGICAL FOCUS			English	Article						hydrocephalus; aquaporin-4; AQP4; computational modeling; reconstruction; pharmaceutical; therapy; treatment; diagnosis	NORMAL-PRESSURE HYDROCEPHALUS; INDUCED SALIVARY HYPOFUNCTION; OSMOTIC WATER PERMEABILITY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; PROTEIN-KINASE-C; INTRAVENTRICULAR HEMORRHAGE; RAT-BRAIN; NEUROLOGICAL DISORDERS; ACCELERATED RESOLUTION	Aquaporin-4 (AQP4) channels play an important role in brain water homeostasis. Water transport across plasma membranes has a critical role in brain water exchange of the normal and the diseased brain. AQP4 channels are implicated in the pathophysiology of hydrocephalus, a disease of water imbalance that leads to CSF accumulation in the ventricular system. Many molecular aspects of fluid exchange during hydrocephalus have yet to be firmly elucidated, but review of the literature suggests that modulation of AQP4 channel activity is a potentially attractive future pharmaceutical therapy. Drug therapy targeting AQP channels may enable control over water exchange to remove excess CSF through a molecular intervention instead of by mechanical shunting. This article is a review of a vast body of literature on the current understanding of AQP4 channels in relation to hydrocephalus, details regarding molecular aspects of AQP4 channels, possible drug development strategies, and limitations. Advances in medical imaging and computational modeling of CSF dynamics in the setting of hydrocephalus are summarized. Algorithmic developments in computational modeling continue to deepen the understanding of the hydrocephalus disease process and display promising potential benefit as a tool for physicians to evaluate patients with hydrocephalus.	[Desai, Bhargav; Mehta, Ankit I.; Linninger, Andreas] Univ Illinois, Dept Neurosurg, Chicago, IL USA; [Hsu, Ying; Schneller, Benjamin; Linninger, Andreas] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Hobbs, Jonathan G.] Univ Chicago, Neurosurg Sect, Chicago, IL 60637 USA		Linninger, A (corresponding author), Univ Illinois, 912 South Wood St,M-C 799 4N NPI, Chicago, IL 60612 USA.	linninge@uic.edu	Mehta, Ankit/AAL-3851-2020		Hydrocephalus Association	Partial support through an Innovator Award (P.I. Andreas Linninger) by the Hydrocephalus Association (directed by Dr. J. Koschnitzky) is gratefully acknowledged.	Abe Y, 2012, J NEUROCHEM, V120, P899, DOI 10.1111/j.1471-4159.2012.07652.x; Aghayev K, 2012, ACTA NEUROCHIR, V154, P753, DOI 10.1007/s00701-011-1241-9; Agre P, 2004, NEUROSCIENCE, V129, P849, DOI 10.1016/j.neuroscience.2004.10.001; AIMARD G, 1990, REV NEUROL, V146, P437; Alikina TY, 2002, P 3 INT C BIOINF GEN; Ambarki K, 2012, AM J NEURORADIOL, V33, P1951, DOI 10.3174/ajnr.A3067; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Assentoft M, 2013, GLIA, V61, P1101, DOI 10.1002/glia.22498; Badaut J, 2011, J CEREBR BLOOD F MET, V31, P819, DOI 10.1038/jcbfm.2010.163; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Baum BJ, 2006, BBA-BIOMEMBRANES, V1758, P1071, DOI 10.1016/j.bbamem.2005.11.006; Baum BJ, 2012, P NATL ACAD SCI USA, V109, P19403, DOI 10.1073/pnas.1210662109; Bloch Orin, 2007, Neurosurg Focus, V22, pE3; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; BROWN PN, 1985, PHYS MED BIOL, V30, P1113, DOI 10.1088/0031-9155/30/10/010; Buishas J, 2014, CROAT MED J, V55, P481, DOI 10.3325/cmj.2014.55.481; CABANES J, 1983, J NEUROSURG, V59, P311, DOI 10.3171/jns.1983.59.2.0311; CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455; Carmosino M, 2007, BIOL CELL, V99, P25, DOI 10.1042/BC200600068; Castaneyra-Ruiz L, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-18; Cheng S., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P151, DOI 10.1080/10255840601124753; Clarke Michelle J, 2007, Neurosurg Focus, V22, pE3, DOI 10.3171/foc.2007.22.4.4; CUTLER RWP, 1968, BRAIN, V91, P707, DOI 10.1093/brain/91.4.707; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; De Bellis M, 2014, MOL BIOL CELL, V25, P470, DOI 10.1091/mbc.E13-06-0331; Del Bigio MR, 2008, FLUIDS BARRIERS CNS, V5, DOI 10.1186/1743-8454-5-12; Del Bigio MR, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0025-2; Del Bigio MR, 2010, DEV DISABIL RES REV, V16, P16, DOI 10.1002/ddrr.94; Dey M, 2015, NEUROSURGERY, V76, P291, DOI 10.1227/NEU.0000000000000624; Diringer MN, 1998, STROKE, V29, P1352, DOI 10.1161/01.STR.29.7.1352; Dombrowski SM, 2006, J CEREBR BLOOD F MET, V26, P1298, DOI 10.1038/sj.jcbfm.9600282; Engel A, 2008, CURR OPIN STRUC BIOL, V18, P229, DOI 10.1016/j.sbi.2007.11.003; Feng XC, 2009, J NEUROSCI RES, V87, P1150, DOI 10.1002/jnr.21927; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Ferreira Cesar Biselli, 2015, Rev Bras Ter Intensiva, V27, P315, DOI 10.5935/0103-507X.20150055; Filippidis AS, 2011, CHILD NERV SYST, V27, P27, DOI 10.1007/s00381-010-1227-6; Fryclenlund DS, 2006, P NATL ACAD SCI USA, V103, P13532, DOI 10.1073/pnas.0605796103; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Galarza M, 2014, CHILD NERV SYST, V30, P105, DOI 10.1007/s00381-013-2226-1; Gao F, 2016, ACTA NEUROCHIR SUPPL, V121, P373, DOI 10.1007/978-3-319-18497-5_64; Gao F, 2014, J CEREBR BLOOD F MET, V34, P489, DOI 10.1038/jcbfm.2013.225; Gao R, 2011, GENE THER, V18, P38, DOI 10.1038/gt.2010.128; GOMEZ DG, 1981, ACTA ANAT, V111, P247; Gunnarson E, 2005, NEUROSCIENCE, V136, P105, DOI 10.1016/j.neuroscience.2005.07.027; Gunnarson E, 2008, GLIA, V56, P587, DOI 10.1002/glia.20627; HAYDEN PW, 1968, PEDIATRICS, V41, P955; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Hodel J, 2014, EUR RADIOL, V24, P136, DOI 10.1007/s00330-013-2990-z; Hodel J, 2013, EUR RADIOL, V23, P1450, DOI 10.1007/s00330-012-2732-7; Hsu C.-Y., 2016, MAGN RESON MED; Hsu MS, 2011, NEUROSCIENCE, V178, P21, DOI 10.1016/j.neuroscience.2011.01.020; Hsu Y, 2015, CROAT MED J, V56, P401, DOI 10.3325/cmj.2015.56.401; Huber VJ, 2007, BIOORG MED CHEM LETT, V17, P1270, DOI 10.1016/j.bmcl.2006.12.010; Huber VJ, 2009, BIOORGAN MED CHEM, V17, P418, DOI 10.1016/j.bmc.2007.12.038; Igarashi H, 2014, NEUROREPORT, V25, P39, DOI 10.1097/WNR.0000000000000042; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ishii K, 2013, DEMENT GER COGN D EX, V3, P489, DOI 10.1159/000357329; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Ivkovic M, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0004-z; Kadohira I, 2008, BIOCHEM BIOPH RES CO, V377, P463, DOI 10.1016/j.bbrc.2008.09.155; Kamali-Zare P, 2013, BASIC CLIN NEUROSCI, V4, P282; Kato J, 2013, BIOCHEM J, V454, P275, DOI 10.1042/BJ20130046; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; KIMELBERG HK, 1995, J NEUROSURG, V83, P1051, DOI 10.3171/jns.1995.83.6.1051; Kitchen P, 2015, J BIOL CHEM, V290, P16873, DOI 10.1074/jbc.M115.646034; Klarica M, 2013, NEUROSCIENCE, V248, P278, DOI 10.1016/j.neuroscience.2013.06.022; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758; Krishnamurthy S, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-13; Krishnamurthy S, 2009, FLUIDS BARRIERS CNS, V6, DOI 10.1186/1743-8454-6-16; Kuwahara-Otani S, 2013, J VET MED SCI, V75, P1081, DOI 10.1292/jvms.13-0083; Lee P, 2013, NEUROSURGERY, V73, pN13, DOI 10.1227/01.neu.0000438332.72566.f5; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; Linninger AA, 2016, ANNU REV FLUID MECH, V48, P219, DOI 10.1146/annurev-fluid-122414-034321; Linninger AA, 2009, J MATH BIOL, V59, P729, DOI 10.1007/s00285-009-0250-2; Linninger AA, 2009, ANN BIOMED ENG, V37, P1434, DOI 10.1007/s10439-009-9691-4; Luciano Mark, 2007, Cleve Clin J Med, V74 Suppl 1, pS128; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Mao XY, 2006, EUR J NEUROSCI, V23, P2929, DOI 10.1111/j.1460-9568.2006.04829.x; MEALEY J, 1968, J PEDIATR-US, V72, P257, DOI 10.1016/S0022-3476(68)80319-1; MERCURI E, 1994, ACTA PAEDIATR, V83, P1319, DOI 10.1111/j.1651-2227.1994.tb13028.x; Migliati E, 2009, MOL PHARMACOL, V76, P105, DOI 10.1124/mol.108.053744; MINER ME, 1986, CHILD NERV SYST, V2, P105; Mobasheri A, 2007, CHANNELS, V1; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Moeller HB, 2009, NEUROSCIENCE, V164, P1674, DOI 10.1016/j.neuroscience.2009.09.072; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Neely JD, 2001, P NATL ACAD SCI USA, V98, P14108, DOI 10.1073/pnas.241508198; Nicchia GP, 2003, FASEB J, V17, P1508, DOI 10.1096/fj.02-1183fje; Nielsen S, 1997, J NEUROSCI, V17, P171; Niemietz CM, 2002, FEBS LETT, V531, P443, DOI 10.1016/S0014-5793(02)03581-0; Oku H, 2015, OPHTHALMIC RES, V54, P212, DOI 10.1159/000440846; Oshio K, 2004, FASEB J, V18, P76, DOI 10.1096/fj.04-1711fje; Oshio K, 2003, ACT NEUR S, V86, P525; Pan CF, 2010, CHINESE MED J-PEKING, V123, P1888, DOI 10.3760/cma.j.issn.0366-6999.2010.14.011; Papadopoulos MC, 2008, PROG BRAIN RES, V170, P589, DOI 10.1016/S0079-6123(08)00446-9; Park EH, 2010, J NEUROSURG-PEDIATR, V6, P159, DOI 10.3171/2010.5.PEDS09142; Paul L, 2011, NEUROSURGERY, V68, P462, DOI 10.1227/NEU.0b013e3182011860; Penn RD, 2011, J NEUROSURG, V115, P159, DOI 10.3171/2010.12.JNS10926; Piper RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003434.pub3; Pisani F, 2011, GLIA, V59, P1923, DOI 10.1002/glia.21234; Poca MA, 2005, EXPERT OPIN PHARMACO, V6, P1525, DOI 10.1517/14656566.6.9.1525; Qi LL, 2011, LIFE SCI, V88, P50, DOI 10.1016/j.lfs.2010.10.025; Ramakrishna R, 2010, NEUROSURGERY, V67, P110, DOI 10.1227/01.NEU.0000370920.44359.91; Rash JE, 2004, NEUROSCIENCE, V129, P915, DOI 10.1016/j.neuroscience.2004.06.076; Ratelade J, 2012, INT J BIOCHEM CELL B, V44, P1519, DOI 10.1016/j.biocel.2012.06.013; Reddy GK, 2014, WORLD NEUROSURG, V81, P404, DOI 10.1016/j.wneu.2013.01.096; Ribeiro MD, 2006, J NEUROSCI RES, V83, P1231, DOI 10.1002/jnr.20819; Rossi A, 2012, TRAFFIC, V13, P43, DOI 10.1111/j.1600-0854.2011.01299.x; Rossi A, 2011, GLIA, V59, P1056, DOI 10.1002/glia.21177; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Saehle T, 2015, J NEUROSURG, V122, P1076, DOI 10.3171/2014.12.JNS141029; Salminen LE, 2016, TECHNOL INNOV, V18, P5, DOI 10.21300/18.1.2016.5; Shen XQ, 2006, J NEUROSURG, V105, P459, DOI 10.3171/ped.2006.105.6.459; Shoesmith CL, 2000, NEUROL RES, V22, P111; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Skjolding AD, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-20; SMITH QR, 1980, J PHARMACOL EXP THER, V215, P673; Solenov E, 2004, AM J PHYSIOL-CELL PH, V286, pC426, DOI 10.1152/ajpcell.00298.2003; Spector R, 2015, EXP NEUROL, V267, P78, DOI 10.1016/j.expneurol.2015.02.032; Supuran CT, 2015, EXPERT REV NEUROTHER, V15, P851, DOI 10.1586/14737175.2015.1066675; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Swenson ER, 2016, J APPL PHYSIOL, V120, P204, DOI 10.1152/japplphysiol.00443.2015; Tait MJ, 2008, TRENDS NEUROSCI, V31, P37, DOI 10.1016/j.tins.2007.11.003; Tarkowski E, 2003, NEUROBIOL AGING, V24, P707, DOI 10.1016/S0197-4580(02)00187-2; Thrane AS, 2011, P NATL ACAD SCI USA, V108, P846, DOI 10.1073/pnas.1015217108; Tomas-Camardiel M, 2005, J NEUROSCI RES, V80, P235, DOI 10.1002/jnr.20443; Tourdias T, 2009, NEUROIMAGE, V47, P659, DOI 10.1016/j.neuroimage.2009.04.070; Umenishi F, 1998, GENOMICS, V50, P373, DOI 10.1006/geno.1998.5337; van Meer G, 2005, EMBO REP, V6, P418, DOI 10.1038/sj.embor.7400410; Venero JL, 2004, CURR PHARM DESIGN, V10, P2153, DOI 10.2174/1381612043384150; Venero JL, 2001, PROG NEUROBIOL, V63, P321, DOI 10.1016/S0301-0082(00)00035-6; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Verkman AS, 2014, NAT REV DRUG DISCOV, V13, P259, DOI 10.1038/nrd4226; Wen H, 1999, EUR J NEUROSCI, V11, P935, DOI 10.1046/j.1460-9568.1999.00502.x; WINNING RS, 1991, NUCLEIC ACIDS RES, V19, P3709, DOI 10.1093/nar/19.13.3709; Wu Y, 2007, NEUROSURGERY, V61, P557, DOI 10.1227/01.NEU.0000290903.07943.AF; Yool AJ, 2007, NEUROSCIENTIST, V13, P470, DOI 10.1177/1073858407303081; Zelenin S, 2000, PEDIATR RES, V48, P335, DOI 10.1203/00006450-200009000-00012; Zelenina M, 2002, AM J PHYSIOL-RENAL, V283, pF309, DOI 10.1152/ajprenal.00260.2001; Zhang H, 2008, J MOL BIOL, V382, P1136, DOI 10.1016/j.jmb.2008.07.089; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649; Zheng GQ, 2010, NEUROCHEM INT, V56, P651, DOI 10.1016/j.neuint.2010.01.014; Ziai WC, 2014, INT J STROKE, V9, P536, DOI 10.1111/ijs.12097	145	19	22	2	13	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	SEP	2016	41	3							E8	10.3171/2016.7.FOCUS16191			17	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DW1ZK	WOS:000383442500008	27581320	gold			2022-02-06	
J	Lopez, MC; Efron, PA; Ozrazgat-Baslanti, T; Zhang, JY; Cuschieri, J; Maier, RV; Minei, JP; Baker, HV; Moore, FA; Moldawer, LL; Brakenridge, SC				Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Cuschieri, Joseph; Maier, Ronald V.; Minei, Joseph P.; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.			Sex-based differences in the genomic response, innate immunity, organ dysfunction, and clinical outcomes after severe blunt traumatic injury and hemorrhagic shock	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Sex; trauma; hemorrhagic shock; leukocyte; genomics	INSTITUTE PROSPECTIVE EVALUATION; MATCHED-PAIR-ANALYSIS; PERSISTENT INFLAMMATION; HORMONE ENVIRONMENT; CATABOLISM SYNDROME; VENTILATOR BUNDLE; GENDER DIMORPHISM; BRAIN-INJURY; EXPRESSION; IMMUNOSUPPRESSION	INTRODUCTION The effect of sex on posttraumatic pathophysiology and outcomes after severe traumatic injury remains debated. We sought to determine the relationship of sex to the genomic and inflammatory responses, and clinical outcomes after hemorrhagic shock. METHODS We analyzed blunt trauma patients in hemorrhagic shock from a prospective multi-institutional cohort study to assess for sex-based differences in the genomic response and clinical outcomes. Serially drawn blood samples were analyzed to evaluate peripheral leukocyte genomewide expression and circulating inflammatory mediators at intervals between 0.5 and 28 days after injury. Multivariate logistic regression models were developed to assess the effect of sex on outcomes after controlling for age, injury and shock severity, blood transfusion, and comorbidities. RESULTS The cohort consisted of 1,285 (67%) male and 643 (33%) female blunt trauma patients. Injury and shock severity were similar between the two groups. There were small but statistically significant differences between males and females regarding their age, body mass index, and 12-hour blood and crystalloid administration. Organ failure was more severe in males, with slower recovery (9.0 vs. 6.5 days) in males compared to females (p < 0.01). However, there were no differences between males and females in plasma levels of IL-6, IL-8, IL-10, IL-1, tumor necrosis factor alpha, and monocyte chemoattractant protein 1. Multivariate analysis revealed that sex was not a significant independent risk factor for complicated recovery or 28-day mortality. Transcriptomic analysis revealed 333 genes with significant differential expression patterns between males and females (FDR, <0.001), including genes associated with general inflammation, innate immunity, cell adhesion, and cell signaling. None of the former genes were directly associated with sex hormones or X/Y chromosomes. CONCLUSION There are sex-specific differences in the leukocyte genomic response to severe injury that are associated with more robust and longer-duration organ dysfunction. However, these expression patterns do not seem to be associated with sex-linked genes or circulating cytokine level differences, and do not translate to worsened sex-specific organ failure outcomes or inpatient mortality. LEVEL OF EVIDENCE Prognostic/epidemiologic study, level III.	[Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.] Univ Florida, Dept Surg, Gainesville, FL USA; [Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.] Univ Florida, Dept Anesthesiol, Gainesville, FL USA; [Lopez, Maria-Cecilia; Efron, Philip A.; Ozrazgat-Baslanti, Tezcan; Zhang, Jianyi; Baker, Henry V.; Moore, Frederick A.; Moldawer, Lyle L.; Brakenridge, Scott C.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Cuschieri, Joseph; Maier, Ronald V.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Minei, Joseph P.] Univ Texas Southwestern, Dept Surg, Dallas, TX USA		Brakenridge, SC (corresponding author), Univ Florida, Dept Surg, Div Acute Care Surg, 1600 SW Archer Rd, Gainesville, FL 32610 USA.	Scott.Brakenridge@surgery.ufl.edu	Brakenridge, Scott/AAD-6691-2019	Brakenridge, Scott/0000-0002-7327-3718; Zhang, Jianyi/0000-0002-1501-4822	National Institutes of Health, National Institute for General Medical Sciences, including the Inflammation and Host Response to Injury Large-Scale Collaborative Research Program (NIH/NIGMS) [U54 GM062119]; University of Florida Sepsis and Critical Illness Research Center (NIH/NIGMS) [P50 GM111152-01]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32 GM-08431, R01 GM-40586-24, R01 GM-081923-06]; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [NIH GM-113945]; University of Florida Claude D. Pepper Older Americans Independence Center [2P30AG028740]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008721, U54GM062119, R01GM081923, R01GM104481, R01GM113945, R01GM040586, P50GM111152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG028740] Funding Source: NIH RePORTER	This project was supported by funding from the National Institutes of Health, National Institute for General Medical Sciences, including the Inflammation and Host Response to Injury Large-Scale Collaborative Research Program (NIH/NIGMS, U54 GM062119), awarded to Dr Ronald G Tompkins. SCB, TB, JZ, HVB, FA, LLM, and PAE were additionally supported by funding awarded to the University of Florida Sepsis and Critical Illness Research Center (NIH/NIGMS, P50 GM111152-01), awarded to Dr Frederick A Moore. This work was also supported by NIH grants T32 GM-08431, R01 GM-40586-24, R01 GM-081923-06, and NIH GM-113945 awarded by the NIGMS. Additionally, SCB was funded with support from the University of Florida Claude D. Pepper Older Americans Independence Center (2P30AG028740).	Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Cuenca AG, 2013, CRIT CARE MED, V41, P1175, DOI 10.1097/CCM.0b013e318277131c; Cuschieri J, 2012, ANN SURG, V255, P993, DOI 10.1097/SLA.0b013e31824f1ebc; Dossett LA, 2008, J TRAUMA, V64, P580, DOI 10.1097/TA.0b013e31816543dd; Doucet D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009421; Efron PA, 2015, J LEUKOCYTE BIOL, V98, P945, DOI 10.1189/jlb.5MR0315-127R; Feezor RJ, 2004, PHYSIOL GENOMICS, V19, P247, DOI 10.1152/physiolgenomics.00020.2004; Frink M, 2007, SHOCK, V27, P151, DOI 10.1097/01.shk.0000239767.64786.de; Gentile LF, 2014, CRIT CARE MED, V42, P1406, DOI 10.1097/CCM.0000000000000222; Gentile LF, 2012, J TRAUMA ACUTE CARE, V72, P1491, DOI 10.1097/TA.0b013e318256e000; Haider AH, 2009, SURGERY, V146, P308, DOI 10.1016/j.surg.2009.05.006; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Moore F, 2013, J TRAUMA ACUTE CARE, V74, P360; Nacionales DC, 2015, J IMMUNOL, V195, P2396, DOI 10.4049/jimmunol.1500984; Schoeneberg C, 2013, CRIT CARE, V17, DOI 10.1186/cc13132; Sharpe JP, 2014, J TRAUMA ACUTE CARE, V77, P161, DOI 10.1097/TA.0000000000000251; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Sperry JL, 2008, J LEUKOCYTE BIOL, V83, P499, DOI 10.1189/jlb.0607360; Sperry JL, 2008, CRIT CARE MED, V36, P1838, DOI 10.1097/CCM.0b013e3181760c14; Sperry JL, 2008, J TRAUMA, V64, P572, DOI 10.1097/TA.0b013e3181650fdf; Sperry JL, 2014, ANN SURG, V260, P698, DOI 10.1097/SLA.0000000000000918; Sperry JL, 2012, J AM COLL SURGEONS, V214, P973, DOI 10.1016/j.jamcollsurg.2012.02.020; Summers JI, 2014, J BURN CARE RES, V35, P484, DOI 10.1097/BCR.0000000000000018; Tominaga GT, 2008, J TRAUMA, V64, P578; Trentzsch H, 2015, ANN SURG, V261, P774, DOI 10.1097/SLA.0000000000000789; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Vanzant EL, 2014, J TRAUMA ACUTE CARE, V76, P21, DOI 10.1097/TA.0b013e3182ab1ab5; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Yang KC, 2014, SHOCK, V42, P11, DOI 10.1097/SHK.0000000000000168; Zolin SJ, 2015, J TRAUMA ACUTE CARE, V78, P451, DOI 10.1097/TA.0000000000000550	32	19	19	1	12	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	SEP	2016	81	3					478	485		10.1097/TA.0000000000001113			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DW8MX	WOS:000383911200011	27306446	Green Accepted			2022-02-06	
J	Mc Fie, S; Brown, J; Hendricks, S; Posthumus, M; Readhead, C; Lambert, M; September, AV; Viljoen, W				Mc Fie, Sarah; Brown, James; Hendricks, Sharief; Posthumus, Michael; Readhead, Clint; Lambert, Mike; September, Alison V.; Viljoen, Wayne			Incidence and Factors Associated With Concussion Injuries at the 2011 to 2014 South African Rugby Union Youth Week Tournaments	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; rugby union; youth; epidemiology	TRAUMATIC BRAIN-INJURY; CONSENSUS STATEMENT; HEAD-INJURIES; UNITED-STATES; RISK-FACTORS; HIGH-SCHOOL; PLAYERS; EPIDEMIOLOGY; SPORTS; COHORT	Objective:To determine the concussion incidence and to identify factors associated with concussion in South African youth rugby union players.Design:Prospective cohort study.Setting:Injury surveillance was completed at the South African Rugby Union Youth Week tournaments (under-13, under-16, and under-18 age groups).Participants:South African youth rugby union players. A total of 7216 players participated in 531 matches between 2011 and 2014.Interventions:None.Main Outcome Measures:Concussion incidence was calculated per 1000 player-match-hours with 95% CIs. Poisson regression was used to calculate the incidence rate ratio (IRR) between factors (age, time period, playing position, and activity at the time of concussion) potentially associated with concussions.Results:The concussion incidence was 6.8/1000 player-match-hours (95% CI, 5.5-8.1) across all age groups. Under-13s (IRR, 1.5; P = 0.09) and under-16s (IRR, 1.7; P = 0.03) had higher concussion incidence rates than the under-18 age group. The incidence was higher in the third (IRR, 2.1; P = 0.04) and fourth (IRR, 2.5; P = 0.01) quarters of matches compared with the first quarter. Sixty-two percent of concussions occurred in the tackle situation. The tackler had a 4-fold greater concussion rate (IRR, 4.3; P < 0.001) compared with the ball carrier. The hooker and loose forwards had higher incidence rates than several other player positions (P < 0.05).Conclusions:The reported concussion incidence falls within the broad range previously reported in youth rugby. The evidence highlighted in this study may contribute to targeted concussion prevention strategies and provide a baseline against which the effectiveness of future interventions can be measured.	[Mc Fie, Sarah; Brown, James; Hendricks, Sharief; Posthumus, Michael; Readhead, Clint; Lambert, Mike; September, Alison V.; Viljoen, Wayne] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa; [Readhead, Clint; Viljoen, Wayne] South African Rugby Football Union, Dept Med, Cape Town, South Africa		Viljoen, W (corresponding author), SARU House,163 Uys Krige Dr,Tygerberg Pk, ZA-7500 Cape Town, South Africa.	waynev@sarugby.co.za	Hendricks, Sharief/U-3278-2019; Brown, James Craig/H-7637-2019	Hendricks, Sharief/0000-0002-3416-6266; Brown, James Craig/0000-0002-7778-7783; Viljoen, Wayne/0000-0002-9432-6153; September, Alison V/0000-0003-0950-286X	South African National Research FoundationNational Research Foundation - South Africa; University of Cape Town; Thembakazi Trust	S.M. was funded by the South African National Research Foundation and the University of Cape Town. M.P. was funded by the Thembakazi Trust. W.V. and C.R. are full-time employees of SARU.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; AMERICAN_COLLEGE_OF_SPORTS_MEDICINE, 2014, ACSMS HLTH REL PHYS; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Brown JC, 2012, S AFR J SPORTS MED, V24, P49; Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; Deutsch MU, 2007, J SPORT SCI, V25, P461, DOI 10.1080/02640410600631298; Deutsch MU, 1998, J SPORT SCI, V16, P561, DOI 10.1080/026404198366524; Fuller CW, 2007, BRIT J SPORT MED, V41, P862, DOI 10.1136/bjsm.2007.037499; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Haseler CM, 2010, BRIT J SPORT MED, V44, P1093, DOI 10.1136/bjsm.2010.074021; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hollis SJ, 2011, BRIT J SPORT MED, V45, P997, DOI 10.1136/bjsm.2010.079707; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kemp SPT, 2008, CLIN J SPORT MED, V18, P227, DOI 10.1097/JSM.0b013e31816a1c9a; Kerr HA, 2008, BRIT J SPORT MED, V42, P595, DOI 10.1136/bjsm.2007.035881; King D, 2014, J SCI MED SPORT, V17, P250, DOI 10.1016/j.jsams.2013.05.007; Koh JO, 2003, BRAIN INJURY, V17, P901, DOI 10.1080/0269905031000088869; Kontos AP, 2005, FDN SPORT RELAT BRAI, P315; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Roberts S, 2014, BRIT J SPORT MED, V48, P654; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Viljoen W., 2008, S AFR J SPORTS MED, V20, P64, DOI [10.17159/2078-516X/2008/v20i3a633, DOI 10.17159/2078-516X/2008/V20I3A633]; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5	40	19	19	0	17	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2016	26	5					398	404		10.1097/JSM.0000000000000276			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	DW8LH	WOS:000383906800011	27604072				2022-02-06	
J	Millet, A; Bouzat, P; Trouve-Buisson, T; Batandier, C; Pernet-Gallay, K; Gaide-Chevronnay, L; Barbier, EL; Debillon, T; Fontaine, E; Payen, JF				Millet, Anne; Bouzat, Pierre; Trouve-Buisson, Thibaut; Batandier, Cecile; Pernet-Gallay, Karin; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Debillon, Thierry; Fontaine, Eric; Payen, Jean-Francois			Erythropoietin and Its Derivates Modulate Mitochondrial Dysfunction after Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain edema; erythropoietin; mitochondrial permeability; transition pore; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; POSITRON-EMISSION-TOMOGRAPHY; PERMEABILITY TRANSITION PORE; CYCLOSPORINE-A; CARBAMYLATED ERYTHROPOIETIN; AXONAL INJURY; ATP SYNTHASE; CELL-DEATH; RATS; MODEL	Inhibiting the opening of mitochondrial permeability transition pore (mPTP), thereby maintaining the mitochondrial membrane potential and calcium homeostasis, could reduce the induction of cell death. Although recombinant human erythropoietin (rhEpo) and carbamylated erythropoietin (Cepo) were shown to prevent apoptosis after traumatic brain injury (TBI), their impact on mPTP is yet unknown. Thirty minutes after diffuse TBI (impact-acceleration model), rats were intravenously administered a saline solution (TBI-saline), 5000 UI/kg rhEpo (TBI-rhEpo) or 50 lg/kg Cepo (TBI-Cepo). A fourth group received no TBI insult (sham-operated) (n = 11 rats per group). Post-traumatic brain edema was measured using magnetic resonance imaging. A first series of experiments was conducted 2 h after TBI (or equivalent) to investigate the mitochondrial function with the determination of thresholds for mPTP opening and ultrastructural mitochondrial changes. In addition, the intramitochondrial calcium content [Ca-im] was measured. In a second series of experiments, brain cell apoptosis was assessed at 24 h post-injury. TBI-rhEpo and TBI-Cepo groups had a reduced brain edema compared with TBI-saline. They had higher threshold for mPTP opening with succinate as substrate: 120 (120-150) (median, interquartiles) and 100 (100-120) versus 80 (60-90) nmol calcium/mg protein in TBI-saline, respectively (p < 0.05). Similar findings were shown with glutamate-malate as substrate. TBI-rhEpo and Cepo groups had less morphological mitochondrial disruption in astrocytes. The elevation in [Ca-im] after TBI was not changed by rhEpo and Cepo treatment. Finally, rhEpo and Cepo reduced caspase-3 expression at 24 h post-injury. These results indicate that rhEpo and Cepo could modulate mitochondrial dysfunction after TBI. The mechanisms involved are discussed.	[Millet, Anne; Bouzat, Pierre; Trouve-Buisson, Thibaut; Pernet-Gallay, Karin; Gaide-Chevronnay, Lucie; Barbier, Emmanuel L.; Payen, Jean-Francois] INSERM, U1216, Grenoble, France; [Millet, Anne; Bouzat, Pierre; Trouve-Buisson, Thibaut; Pernet-Gallay, Karin; Gaide-Chevronnay, Lucie; Payen, Jean-Francois] Univ Grenoble Alpes, Grenoble Inst Neurosci, Grenoble, France; [Millet, Anne; Debillon, Thierry] Hop Couple Enfant, Dept Reanimat Pediat & Neonatale, Grenoble, France; [Bouzat, Pierre; Trouve-Buisson, Thibaut; Gaide-Chevronnay, Lucie; Payen, Jean-Francois] CHU Grenoble Alpes, Pole Anesthesie Reanimat, Grenoble, France; [Batandier, Cecile; Fontaine, Eric] Univ Grenoble 1, INSERM, U1055, Lab Biol Fondamentale & Appl, Grenoble, France; [Fontaine, Eric] CHU Grenoble Alpes, Unite Nutr Parenterale, Pole Med Aigue Specialisee, Grenoble, France		Payen, JF (corresponding author), Univ Grenoble 1, INSERM, U836, Grenoble Inst Neurosci,Equipe 5, Site Sante Tronche,BP 170, F-38042 Grenoble 9, France.	jfpayen@ujf-grenoble.fr	Payen, Jean-Francois/L-6667-2014; Bouzat, Pierre/AAC-4105-2019; Fontaine, Eric/ABA-8853-2020; Bouzat, Pierre/L-6881-2014; Barbier, Emmanuel/E-6302-2011	Bouzat, Pierre/0000-0003-4667-6738; Fontaine, Eric/0000-0002-5204-9477; Barbier, Emmanuel/0000-0002-4952-1240; PERNET GALLAY, Karin/0000-0003-3468-3316			Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Bouzat P, 2011, CRIT CARE MED, V39, P2099, DOI 10.1097/CCM.0b013e31821cb7b2; Buki A, 2000, J NEUROSCI, V20, P2825; Cernak I, 2002, J CLIN NEUROSCI, V9, P565, DOI 10.1054/jocn.2002.1132; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Galluzzi L, 2009, BBA-BIOENERGETICS, V1787, P402, DOI 10.1016/j.bbabio.2008.09.006; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Hammond J B, 1988, Methods Mol Biol, V3, P25, DOI 10.1385/0-89603-126-8:25; Hansson MJ, 2011, J NEUROTRAUM, V28, P143, DOI 10.1089/neu.2010.1613; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Kobayashi H, 2008, CLIN EXP PHARMACOL P, V35, P812, DOI 10.1111/j.1440-1681.2008.04925.x; Lablanche S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.15; Liao ZB, 2008, EUR J NEUROL, V15, P140, DOI 10.1111/j.1468-1331.2007.02013.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Mahmood A, 2007, J NEUROSURG, V107, P392, DOI 10.3171/JNS-07/08/0392; Mammis A, 2009, SURG NEUROL, V71, P527, DOI 10.1016/j.surneu.2008.02.040; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mazzeo AT, 2009, EXP NEUROL, V218, P363, DOI 10.1016/j.expneurol.2009.05.026; Merenda A, 2006, CURR OPIN CRIT CARE, V12, P90, DOI 10.1097/01.ccx.0000216573.26686.27; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Okonkwo DO, 2003, NEUROREPORT, V14, P463, DOI 10.1097/01.wnr.0000058958.85541.d3; Rasola A, 2010, FEBS LETT, V584, P1989, DOI 10.1016/j.febslet.2010.02.022; Sala N, 2013, J CEREBR BLOOD F MET, V33, P1815, DOI 10.1038/jcbfm.2013.142; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Sullivan PG, 1999, EXP NEUROL, V160, P226, DOI 10.1006/exnr.1999.7197; Valable S, 2010, J CEREBR BLOOD F MET, V30, P361, DOI 10.1038/jcbfm.2009.222; Velly L, 2010, PHARMACOL THERAPEUT, V128, P445, DOI 10.1016/j.pharmthera.2010.08.002; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Wang Y, 2007, BRIT J PHARMACOL, V151, P1377, DOI 10.1038/sj.bjp.0707285; Wenker SD, 2013, FEBS J, V280, P1630, DOI 10.1111/febs.12172; Xie ZY, 2012, BRAIN RES, V1472, P113, DOI 10.1016/j.brainres.2012.06.053; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2009, NEUROL RES, V31, P496, DOI 10.1179/174313208X353703; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zauner A, 1997, NEUROL RES, V19, P265, DOI 10.1080/01616412.1997.11740812; Zhao JB, 2011, CYTOKINE, V56, P343, DOI 10.1016/j.cyto.2011.07.018; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	44	19	21	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1625	1633		10.1089/neu.2015.4160			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300008	26530102				2022-02-06	
J	Johnson, U; Engquist, H; Howells, T; Nilsson, P; Ronne-Engstrom, E; Lewen, A; Rostami, E; Enblad, P				Johnson, Ulf; Engquist, Henrik; Howells, Tim; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Lewen, Anders; Rostami, Elham; Enblad, Per			Bedside Xenon-CT Shows Lower CBF in SAH Patients with Impaired CBF Pressure Autoregulation as Defined by Pressure Reactivity Index (PRx)	NEUROCRITICAL CARE			English	Article						Cerebrovascular pressure reactivity; Xenon-CT; Cerebral blood flow; Subarachnoid; Hemorrhage; Monitoring	ANEURYSMAL SUBARACHNOID HEMORRHAGE; DELAYED CEREBRAL-ISCHEMIA; CASE-FATALITY RATES; BLOOD-FLOW; CEREBROVASCULAR AUTOREGULATION; PERFUSION-PRESSURE; VASOSPASM; INFARCTION; TIME; METAANALYSIS	Subarachnoid hemorrhage (SAH) is a disease with a high rate of unfavorable outcome, often related to delayed cerebral ischemia (DCI), i.e., ischemic injury that develops days-weeks after onset, with a multifactorial etiology. Disturbances in cerebral pressure autoregulation, the ability to maintain a steady cerebral blood flow (CBF), despite fluctuations in systemic blood pressure, have been suggested to play a role in the development of DCI. Pressure reactivity index (PRx) is a well-established measure of cerebral pressure autoregulation that has been used to study traumatic brain injury, but not extensively in SAH. To study the relation between PRx and CBF in SAH patients, and to examine if PRx can be used to predict DCI. Retrospective analysis of prospectively collected data. PRx was calculated as the correlation coefficient between mean arterial blood pressure (MABP) and intracranial pressure (ICP) in a 5 min moving window. CBF was measured using bedside Xenon-CT (Xe-CT). DCI was diagnosed clinically. 47 poor-grade mechanically ventilated patients were studied. Patients with disturbed pressure autoregulation (high PRx values) had lower CBF, as measured by bedside Xe-CT; both in the early (day 0-3) and late (day 4-14) acute phase of the disease. PRx did not differ significantly between patients who developed DCI or not. In mechanically ventilated and sedated SAH patients, high PRx (more disturbed CBF pressure autoregulation) is associated with low CBF, both day 0-3 and day 4-14 after onset. The role of PRx as a monitoring tool in SAH patients needs further studying.	[Johnson, Ulf; Engquist, Henrik; Howells, Tim; Nilsson, Pelle; Ronne-Engstrom, Elisabeth; Lewen, Anders; Rostami, Elham; Enblad, Per] Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden; [Johnson, Ulf] Uppsala Univ, Dept Surg Sci Radiol, Uppsala, Sweden; [Engquist, Henrik] Uppsala Univ, Dept Surg Sci Anesthesia & Intens Care, Uppsala, Sweden		Johnson, U (corresponding author), Uppsala Univ, Dept Neurosci Neurosurg, Uppsala, Sweden.; Johnson, U (corresponding author), Uppsala Univ, Dept Surg Sci Radiol, Uppsala, Sweden.	ulf.johnson@neuro.uu.se	Lewen, Anders/A-5156-2013; Engquist, Henrik/S-1890-2016	Lewen, Anders/0000-0003-4925-1348; Engquist, Henrik/0000-0002-9826-1422; Johnson, Ulf/0000-0002-3879-6476			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ALLCOCK JM, 1963, J NEUROSURG, V20, P752, DOI 10.3171/jns.1963.20.9.0752; Aries MJH, 2015, NEUROCRIT CARE, V23, P347, DOI 10.1007/s12028-015-0107-z; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; BAMFORD J, 1990, J NEUROL NEUROSUR PS, V53, P16, DOI 10.1136/jnnp.53.1.16; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Bijlenga P, 2010, NEUROCRIT CARE, V13, P17, DOI 10.1007/s12028-010-9362-1; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Calviere L, 2015, NEUROCRIT CARE, V23, P253, DOI 10.1007/s12028-015-0125-x; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; DOCZI T, 1985, ACTA NEUROCHIR, V77, P110, DOI 10.1007/BF01476215; Dupont SA, 2009, NEUROCRIT CARE, V11, P172, DOI 10.1007/s12028-009-9247-3; ECKER A, 1951, J NEUROSURG, V8, P660, DOI 10.3171/jns.1951.8.6.0660; Eide PK, 2012, J NEUROSURG, V116, P961, DOI 10.3171/2012.1.JNS111313; Enblad P, 1997, J NEUROL NEUROSUR PS, V62, P512, DOI 10.1136/jnnp.62.5.512; Etminan N, 2011, J CEREBR BLOOD F MET, V31, P1443, DOI 10.1038/jcbfm.2011.7; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Fontana J, 2016, J NEUROIMAGING, V26, P339, DOI 10.1111/jon.12295; Friedman JA, 2003, NEUROSURGERY, V52, P1025, DOI 10.1227/01.NEU.0000058222.59289.F1; HARDERS AG, 1987, J NEUROSURG, V66, P718, DOI 10.3171/jns.1987.66.5.0718; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Kaufmann AM, 1999, STROKE, V30, P93, DOI 10.1161/01.STR.30.1.93; Koffijberg H, 2008, J NEUROL NEUROSUR PS, V79, P294, DOI 10.1136/jnnp.2007.123901; KONTOS HA, 1978, AM J PHYSIOL, V234, pH371, DOI 10.1152/ajpheart.1978.234.4.H371; Lam JMK, 2000, NEUROSURGERY, V47, P819, DOI 10.1097/00006123-200010000-00004; LASSEN NA, 1964, CIRC RES, V15, P201; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Rostami E, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00089; Ryttlefors M, 2007, NEUROSURGERY, V61, P704, DOI 10.1227/01.NEU.0000298898.38979.E3; Sarrafzadeh A, 2013, ACTA NEUROCHIR SUPPL, V115, P143, DOI 10.1007/978-3-7091-1192-5_28; Soehle M, 2004, STROKE, V35, P1393, DOI 10.1161/01.STR.0000128411.07036.a9; Stein SC, 2006, NEUROSURGERY, V59, P787; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; YONAS H, 1989, NEUROSURGERY, V24, P368, DOI 10.1227/00006123-198903000-00010; Yundt KD, 1998, J CEREBR BLOOD F MET, V18, P419, DOI 10.1097/00004647-199804000-00010; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73	45	19	19	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	AUG	2016	25	1					47	55		10.1007/s12028-016-0240-3			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DR8LZ	WOS:000380150700007	26842717				2022-02-06	
J	Masgutov, RF; Masgutova, GA; Zhuravleva, MN; Salafutdinov, II; Mukhametshina, RT; Mukhamedshina, YO; Lima, LM; Reis, HJ; Kiyasov, AP; Palotas, A; Rizvanov, AA				Masgutov, Ruslan F.; Masgutova, Galina A.; Zhuravleva, Margarita N.; Salafutdinov, Ilnur I.; Mukhametshina, Regina T.; Mukhamedshina, Yana O.; Lima, Luciana M.; Reis, Helton J.; Kiyasov, Andrey P.; Palotas, Andras; Rizvanov, Albert A.			Human adipose-derived stem cells stimulate neuroregeneration	CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Autonerve graft; Human adipose-derived stem cell (hADSC); Xenotransplantation; Peripheral nerve injury; Regenerative medicine; Repair	DORSAL-ROOT GANGLIA; PERIPHERAL-NERVE REGENERATION; SENSORY NEURONS; MICROGLIA; REPAIR; MACROPHAGES; APOPTOSIS; SYSTEM; GROWTH; MOUSE	Traumatic brain injuries and degenerative neurological disorders such as Alzheimer's dementia, Parkinson's disease, amyotrophic lateral sclerosis and many others are characterized by loss of brain cells and supporting structures. Restoring microanatomy and function using stem cells is a promising therapeutic approach. Among the many various sources, adipose-derived stem cells (ADSCs) are one of the most easily harvested alternatives, they multiply rapidly, and they demonstrate low immunogenicity with an ability to differentiate into several cell types. The objective of this study was to evaluate the effect of xenotransplanted human ADSCs on post-traumatic regeneration of rat sciatic nerve. Peripheral reconstruction following complete sciatic transection and autonerve grafting was complemented by intra-operative injection of hADSCs into the proximal and distal stumps. The injury caused gliosis and apoptosis of sensory neurons in the lumbar 5 (L5) ganglia in the control rodents; however, animals treated with hADSCs demonstrated a smaller amount of cellular loss. Formation of amputation neuroma, which hinders axonal repair, was less prominent in the experimental group, and immunohistochemical analysis of myelin basic protein showed good myelination 65 days after surgery. At this point, control groups still exhibited high levels of microglia/macrophage-specific marker Iba-1 and proliferating cell nuclear antigen, the mark of an ongoing inflammation and incomplete axonal growth 2 months after the injury. This report demonstrates that hADSCs promote neuronal survival in the spinal ganglion, fuel axonal repair and stimulate the regeneration of peripheral nerves.	[Masgutov, Ruslan F.; Masgutova, Galina A.; Zhuravleva, Margarita N.; Salafutdinov, Ilnur I.; Mukhametshina, Regina T.; Mukhamedshina, Yana O.; Kiyasov, Andrey P.; Palotas, Andras; Rizvanov, Albert A.] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Masgutov, Ruslan F.; Salafutdinov, Ilnur I.] Republ Clin Hosp, Kazan, Russia; [Lima, Luciana M.] Univ Fed Vicosa, Vicosa, MG, Brazil; [Reis, Helton J.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Palotas, Andras] Asklepios Med Private Med Practice & Res Ctr, Kossuth Lajos Sgt 23, H-6722 Szeged, Hungary		Palotas, A; Rizvanov, AA (corresponding author), Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.; Palotas, A (corresponding author), Asklepios Med Private Med Practice & Res Ctr, Kossuth Lajos Sgt 23, H-6722 Szeged, Hungary.	palotas@asklepios-med.eu; albert.rizvanov@kpfu.ru	Lima, Luciana Moreira/X-7039-2018; Reis, Helton/AAD-4337-2020; Rizvanov, Albert/H-4486-2013; Kiassov, Andrey/L-1976-2015	Lima, Luciana Moreira/0000-0001-5349-1577; Reis, Helton/0000-0002-4055-701X; Rizvanov, Albert/0000-0002-9427-5739; Kiassov, Andrey/0000-0003-4460-4140	Russian Foundation for Basic ResearchRussian Foundation for Basic Research (RFBR) [13-04-12035]; Russian FederationRussian Federation [4020.2015.7]; Ministry of Education of Russia [RFMEFI59414X0003]; Interdisciplinary center for analytical microscopy; Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia	The study was supported by Grant 13-04-12035 from Russian Foundation for Basic Research. This work was performed in accordance with Program of Competitive Growth of Kazan Federal University and subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities. Yana O. Mukhamedshina was supported by Presidential grant for government support of young scientists (PhD) from the Russian Federation (4020.2015.7). Some of the experiments were conducted using equipment at the Interdisciplinary center for collective use of Kazan Federal University supported by Ministry of Education of Russia (ID RFMEFI59414X0003), Interdisciplinary center for analytical microscopy, and Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia. The authors are also indebted to Drs. Gallyamov and Bogov for their assistance in animal handling.	Abram SE, 2006, ANESTHESIOLOGY, V105, P146, DOI 10.1097/00000542-200607000-00024; Arkhipova S S, 2010, Neurosci Behav Physiol, V40, P609, DOI 10.1007/s11055-010-9303-7; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079395; Chen LK, 2014, J NANOSCI NANOTECHNO, V14, P969, DOI 10.1166/jnn.2014.9126; Cheng C, 2003, DIABETES, V52, P2363, DOI 10.2337/diabetes.52.9.2363; Cheutin T, 2004, MOL CELL BIOL, V24, P3157, DOI 10.1128/MCB.24.8.3157-3167.2004; Dezawa Mari, 2005, Current Neuropharmacology, V3, P257, DOI 10.2174/157015905774322507; Dubovy Petr, 2004, Anatomical Science International, V79, P198, DOI 10.1111/j.1447-073x.2004.00090.x; Faroni A, 2013, INT REV NEUROBIOL, V108, P121, DOI 10.1016/B978-0-12-410499-0.00005-8; Ginhoux F, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00045; Goldberg JL, 2000, NATURE, V403, P369, DOI 10.1038/35000309; Gordon T, 2011, J NEUROSCI, V31, P5325, DOI 10.1523/JNEUROSCI.6156-10.2011; Kalinina NI, 2011, ACTA NATURAE, V3, P30, DOI 10.32607/20758251-2011-3-4-30-37; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; LO DC, 1995, NEURON, V15, P979, DOI 10.1016/0896-6273(95)90085-3; Marconi S, 2012, TISSUE ENG PT A, V18, P1264, DOI [10.1089/ten.tea.2011.0491, 10.1089/ten.TEA.2011.0491]; Masgutov R, 2011, CELL TRANSPLANT TISS, V6, P67; MCKAY HA, 2002, EXP BRAIN RES, V142, P308; Momeni HR, 2013, CELL J, V15, P212; Otoshi K, 2010, SPINE, V35, P264, DOI 10.1097/BRS.0b013e3181b8b04f; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Radtke C, 2011, CELL TRANSPLANT, V20, P145, DOI 10.3727/096368910X522081; Raginov I S, 2003, Morfologiia, V124, P47; Reid AJ, 2011, NEUROSCIENCE, V199, P515, DOI 10.1016/j.neuroscience.2011.09.064; Ribeiro-Resende VT, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-34; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Shachpazyan NR, 2012, CELL TRANSPLANT TISS, V7, P23; Solovyeva V.V., 2013, WORLD APPL SCI J, V26, P968, DOI [10.5829/idosi.wasj.2013.26.07.13539, DOI 10.5829/idosi.wasj.2013.26.07.13539]; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Vigneswara V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057861; Weerasuriya A, 2011, METHODS MOL BIOL, V686, P149, DOI 10.1007/978-1-60761-938-3_6; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008	34	19	20	0	32	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1591-8890	1591-9528		CLIN EXP MED	Clin. Exper. Med.	AUG	2016	16	3					451	461		10.1007/s10238-015-0364-3			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	DS3FM	WOS:000380668500025	26047869	Green Published			2022-02-06	
J	Schmidt, JD; Guskiewicz, KM; Mihalik, JP; Blackburn, JT; Siegmund, GP; Marshall, SW				Schmidt, Julianne D.; Guskiewicz, Kevin M.; Mihalik, Jason P.; Blackburn, J. Troy; Siegmund, Gunter P.; Marshall, Stephen W.			Head Impact Magnitude in American High School Football	PEDIATRICS			English	Article							STATES HIGH-SCHOOL; PROFESSIONAL FOOTBALL; CONCUSSION; BIOMECHANICS; PLAYERS; INJURY; EXPOSURE; EPIDEMIOLOGY; POSITION; SPORTS	OBJECTIVES: To describe determinants of head impact magnitudes between various play aspects in high school football. METHODS: Thirty-two high school American football players wore Head Impact Telemetry System instrumented helmets to capture head impact magnitude (linear acceleration, rotational acceleration, and Head Impact Technology severity profile [HITsp]). We captured and analyzed video from 13 games (n = 3888 viewable head impacts) to determine the following play aspects: quarter, impact cause, play type, closing distance, double head impact, player's stance, player's action, direction of gaze, athletic readiness, level of anticipation, player stationary, ball possession, receiving ball, and snapping ball. We conducted random intercepts general linear mixed models to assess the differences in head impact magnitude between play aspects (alpha = 0.05). RESULTS: The following aspects resulted in greater head impact magnitude: impacts during the second quarter (HITsp: P =.03); contact with another player (linear, rotational, HITsp: P < .001); initial head impact when the head is struck twice (linear, rotational, HITsp: P < .001); longer closing distances, especially when combined with a 3-point stance or when being struck in the head (linear: P = .03); the 2-point stance (linear, rotational, HITsp: P < .001); and offensive linemen not snapping the ball compared with those snapping the ball (rotational: P = .02, HITsp: P = .02). CONCLUSIONS: Preventing head impacts caused by contact with another player may reduce head impact magnitude in high school football. Rule or coaching changes that reduce collisions after long closing distances, especially when combined with the 3-point stance or when a player is being struck in the head, should be considered.	[Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA; [Schmidt, Julianne D.] Univ Georgia, Concuss Res Lab, Athens, GA 30602 USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Matthew A Gfeller Sport Related Traumat Brain Inj, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.; Blackburn, J. Troy] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.; Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Blackburn, J. Troy] Univ N Carolina, Neuromuscular Res Lab, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Siegmund, Gunter P.] MEA Forens Engineers & Scientists, Richmond, BC, Canada; [Siegmund, Gunter P.] Univ British Columbia, Sch Kinesiol, Vancouver, BC, Canada		Schmidt, JD (corresponding author), 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Siegmund, Gunter P/B-7003-2013				Allison MA, MED SCI SPORTS EXERC; [Anonymous], 2013, HEADACHE, V53, P817; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Bonnechere B, 2014, J SPORT SCI MED, V13, P423; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; DeLamielleure J, 2014, J LAW MED ETHICS, V42, P133, DOI 10.1111/jlme.12127; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Eckner JT, J NEUROTRAUMA; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Harpham JA, 2014, ANN BIOMED ENG, V42, P1, DOI 10.1007/s10439-013-0881-8; Harrison EA, 2014, AM J PUBLIC HEALTH, V104, P822, DOI 10.2105/AJPH.2013.301840; Jadischke R, 2013, J BIOMECH, V46, P2310, DOI 10.1016/j.jbiomech.2013.05.030; King D, 2012, RES SPORTS MED, V20, P86, DOI 10.1080/15438627.2012.660824; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Mihalik JP, 2010, PEDIATRICS, V125; Mihalik JP, 2012, 2012 ASTM SPECIAL TE; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Ocwieja KE, 2012, ANN BIOMED ENG, V40, P90, DOI 10.1007/s10439-011-0401-7; Siegmund GP, 2016, ANN BIOMED ENG, V44, P1257, DOI 10.1007/s10439-015-1420-6; Stevens Sean T, 2008, Res Sports Med, V16, P68, DOI 10.1080/15438620701879020; van der Kamp J, 2011, MOTOR CONTROL, V15, P342, DOI 10.1123/mcj.15.3.342; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Viera AJ, 2005, FAM MED, V37, P360; Wilcox BJ, 2014, J ATHL TRAINING, V49, P514, DOI 10.4085/1062-6050-49.3.19	32	19	19	0	17	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2016	138	2							e20154231	10.1542/peds.2015-4231			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DS7ZP	WOS:000381002500015	27432843	Bronze, Green Published			2022-02-06	
J	Siracusa, R; Paterniti, I; Bruschetta, G; Cordaro, M; Impellizzeri, D; Crupi, R; Cuzzocrea, S; Esposito, E				Siracusa, Rosalba; Paterniti, Irene; Bruschetta, Giuseppe; Cordaro, Marika; Impellizzeri, Daniela; Crupi, Rosalia; Cuzzocrea, Salvatore; Esposito, Emanuela			The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury	MOLECULAR NEUROBIOLOGY			English	Article						Neuroprotection; Anti-inflammatory; Anti-oxidant; Autophagy; Spinal compression	BRAIN-INJURY; CELL-DEATH; NEURONS; PATHOGENESIS; LIFE; LC3	Spinal cord injury (SCI) is a devastating condition of the central nervous system (CNS) often resulting in severe functional impairment and for which there are not yet restorative therapies. In the present study, we performed a widely used model of SCI to determine the neuroprotective propriety of palmitoylethanolamide (PEA) and the antioxidant effect of a flavonoid luteolin (Lut), given as a co-ultramicronized compound co-ultraPEALut. In particular, by western blot analysis and immunofluorescence staining, we investigated whether this compound (at the dose of 1 mg/kg) was able to modulate autophagy. Our results showed that treatment with co-ultraPEALut after SCI reduced the expression of proteins promoter of autophagy such as Beclin-1 and microtubule-associated protein 1A/1B-light chain 3 (MAP-LC3). In contrast, this compound decreased the levels of mammalian target of rapamycin (mTOR), p-Akt, and p-70S6K which are proteins that inhibit autophagy. These data confirmed that the protective role of co-ultraPEALut is associated with inhibition of excessive autophagy and regulation of protein degradation. Therefore, treatment with co-ultraPEALut could be considered as a possible therapeutic approach in an acute traumatic lesion like SCI.	[Siracusa, Rosalba; Paterniti, Irene; Bruschetta, Giuseppe; Cordaro, Marika; Impellizzeri, Daniela; Crupi, Rosalia; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA		Esposito, E (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres 31, I-98166 Messina, Italy.	eesposito@unime.it	Cordaro, Marika/K-7329-2016; Crupi, Rosalia/U-4364-2019; Siracusa, Rosalba/AAC-3110-2022	Cordaro, Marika/0000-0002-3980-0043; Siracusa, Rosalba/0000-0001-7868-2505; Crupi, Rosalia/0000-0002-7629-3132; Impellizzeri, Daniela/0000-0001-9492-3161; Cuzzocrea, Salvatore/0000-0001-6131-3690	PON [01_02512]	The authors would like to thank Maria Antonietta Medici for her excellent technical assistance during this study and Mr Francesco Soraci for his secretarial and administrative assistance and Miss Valentina Malvagni for her editorial assistance with the manuscript. This study was supported by PON 01_02512.	Amar AP, 1999, NEUROSURGERY, V44, P1027, DOI 10.1097/00006123-199905000-00052; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Carloni S, 2008, NEUROBIOL DIS, V32, P329, DOI 10.1016/j.nbd.2008.07.022; Chen HC, 2012, SPINE, V37, P470, DOI 10.1097/BRS.0b013e318221e859; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Esposito E, 2011, BRAIN BEHAV IMMUN, V25, P1099, DOI 10.1016/j.bbi.2011.02.006; Esposito E, 2011, TRENDS PHARMACOL SCI, V32, P107, DOI 10.1016/j.tips.2010.11.009; Ferraro E, 2007, ARCH BIOCHEM BIOPHYS, V462, P210, DOI 10.1016/j.abb.2007.02.006; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Kanno H, 2011, SPINE, V36, pE1427, DOI 10.1097/BRS.0b013e3182028c3a; Kwon Brian K, 2004, Spine J, V4, P451, DOI 10.1016/j.spinee.2003.07.007; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu G, 2012, EXP NEUROL, V233, P447, DOI 10.1016/j.expneurol.2011.11.018; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Park JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100819; Park JM, 2013, CANCER BIOL THER, V14, P100, DOI 10.4161/cbt.22954; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Reef S, 2006, MOL CELL, V22, P463, DOI 10.1016/j.molcel.2006.04.014; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	34	19	22	0	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2016	53	6					3783	3792		10.1007/s12035-015-9328-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR2AO	WOS:000379707600023	26143261	Green Published, hybrid			2022-02-06	
J	Wei, X; Hu, CC; Zhang, YL; Yao, SL; Mao, WK				Wei, Xin; Hu, Chen-chen; Zhang, Ya-li; Yao, Shang-long; Mao, Wei-ke			Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury	JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES			English	Article						telmisartan; traumatic brain injury; cerebral edema; NLRP3 inflammasome; inflammation	RECEPTOR ANTAGONIST TELMISARTAN; INTRACEREBRAL HEMORRHAGE; OXIDATIVE STRESS; ISCHEMIC-STROKE; ANGIOTENSIN-II; PPAR-GAMMA; RAT MODEL; INTERLEUKIN-1-BETA; TRAUMA; PATHOGENESIS	The aim of this study was to investigate the possible beneficial role of telmisartan in cerebral edema after traumatic brain injury (TBI) and the potential mechanisms related to the nucleotide-binding oligomerization domain (NOD)-like receptor (NLR) pyrin domain-containing 3 (NLRP3) inflammasome activation. TBI model was established by cold-induced brain injury. Male C57BL/6 mice were randomly assigned into 3, 6, 12, 24, 48 and 72 h survival groups to investigate cerebral edema development with time and received 0, 5, 10, 20 and 40 mg/kg telmisartan by oral gavage, 1 h prior to TBI to determine the efficient anti-edemic dose. The therapeutic window was identified by post-treating 30 min, 1 h, 2 h and 4 h after TBI. Blood-brain barrier (BBB) integrity, the neurological function and histological injury were assessed, at the same time, the mRNA and protein expression levels of NLRP3 inflammasome, IL-1 beta and IL-18 concentrations in peri-contused brain tissue were measured 24 h post TBI. The results showed that the traumatic cerebral edema occurred from 6 h, reached the peak at 24 h and recovered to the baseline 72 h after TBI. A single oral dose of 5, 10 and 20 mg/kg telmisartan could reduce cerebral edema. Post-treatment up to 2 h effectively limited the edema development. Furthermore, prophylactic administration of telmisartan markedly inhibited BBB impairment, NLRP3, apoptotic speck-containing protein (ASC) and Caspase-1 activation, as well as IL-1 beta and IL-18 maturation, subsequently improved the neurological outcomes. In conclusion, telmisartan can reduce traumatic cerebral edema by inhibiting the NLRP3 inflammasome-regulated IL-1 beta and IL-18 accumulation.	[Wei, Xin; Hu, Chen-chen; Zhang, Ya-li; Yao, Shang-long; Mao, Wei-ke] Huazhong Univ Sci & Technol, Union Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430022, Peoples R China		Mao, WK (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Dept Anesthesiol, Tongji Med Coll, Wuhan 430022, Peoples R China.	1004500126@qq.com; mweike@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81270239]; Natural Science Foundation of Hubei Province of ChinaNatural Science Foundation of Hubei Province [2014CFB200]	This project was supported by grants from the National Natural Science Foundation of China (No. 81270239) and the Natural Science Foundation of Hubei Province of China (No. 2014CFB200).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Billecke SS, 2013, VASC HEALTH RISK MAN, V9, P95, DOI 10.2147/VHRM.S40963; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Fann DYW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.326; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Gohlke P, 2001, J PHARMACOL EXP THER, V298, P62; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Huang LQ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-102; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Jung KH, 2007, J PHARMACOL EXP THER, V322, P1051, DOI 10.1124/jpet.107.120097; Kahle KT, 2013, J CLIN NEUROSCI, V20, P30, DOI 10.1016/j.jocn.2012.10.004; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kimbler DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041229; Kono S, 2015, J STROKE CEREBROVASC, V24, P537, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.037; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Michinaga S, 2015, INT J MOL SCI, V16, P9949, DOI 10.3390/ijms16059949; Morita-Fujimura Y, 1999, NEUROSCIENCE, V93, P1465, DOI 10.1016/S0306-4522(99)00231-6; Panahpour H, 2014, IRAN J MED SCI, V39, P536; Panahpour Hamdollah, 2014, Iranian Biomedical Journal, V18, P232, DOI 10.6091/ibj.13672.2014; Pang T, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-102; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Tan CC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0233-0; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Timaru-Kast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043829; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; V H Pushpa, 2014, J Clin Diagn Res, V8, pHC08, DOI 10.7860/JCDR/2014/9455.5061; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang J, 2014, NEUROPHARMACOLOGY, V79, P249, DOI 10.1016/j.neuropharm.2013.11.022; Yang Z, 2015, MOL IMMUNOL, V65, P267, DOI 10.1016/j.molimm.2014.12.018; Zeynalov E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136121; Zhang B, 2015, KOREAN J PHYSIOL PHA, V19, P491, DOI 10.4196/kjpp.2015.19.6.491	35	19	19	3	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1672-0733	1993-1352		J HUAZHONG U SCI-MED	J. Huazhong Univ. Sci. Tech.-Med.	AUG	2016	36	4					576	583		10.1007/s11596-016-1628-1			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DS3ZA	WOS:000380720000018	27465336				2022-02-06	
J	Young, JY; Duhaime, AC; Caruso, PA; Rincon, SP				Young, Joseph Yeen; Duhaime, Ann-Christine; Caruso, Paul Albert; Rincon, Sandra Patricia			Comparison of non-sedated brain MRI and CT for the detection of acute traumatic injury in children 6 years of age or less	EMERGENCY RADIOLOGY			English	Article						Rapid MRI; CT; Brain; Pediatric; Trauma	HEAD-INJURY; EVENTS	CT is considered the first-line study for acute intracranial injury in children because of its availability, detection of acute hemorrhage, and lack of sedation. An MRI study with rapidly acquired sequences can obviate the need for sedation and radiation. We compared the detection rate of rapid non-sedated brain MRI to CT for traumatic head injury in young children. We reviewed a series of children 6 years of age or less who presented to our ED during a 5-year period with head trauma and received a non-sedated brain MRI and CT within 24 h of injury. Most MRI studies were limited to triplane T2 and susceptibility sequences. Two neuroradiologists reviewed the MRIs and CTs and assessed the following findings: fracture, epidural hematoma (EDH)/subdural hematoma (SDH), subarachnoid hemorrhage (SAH), intraventricular hemorrhage (IVH), and parenchymal injury. Thirty of 33 patients had radiologically identified traumatic injuries. There was an overall agreement of 82 % between the two modalities. Skull fracture was the only injury subtype which had a statistically significant difference in detection between CT and MRI (p = 0.0001), with MRI missing 14 of 21 fractures detected on CT. While not statistically significant, MRI had a higher detection rate of EDH/SDH (p = 0.34), SAH (p = 0.07), and parenchymal injuries (p = 0.50). Non-sedated MRI has similar detection rates to CT for intracranial injury in young children presenting with acute head trauma and may be an alternative to CT in select patients.	[Young, Joseph Yeen; Caruso, Paul Albert; Rincon, Sandra Patricia] Massachusetts Gen Hosp, Neuroradiol Sect, Dept Radiol, 55 Fruit St,Gray 273A, Boston, MA 02114 USA; [Duhaime, Ann-Christine] Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St,Gray 273A, Boston, MA 02114 USA		Young, JY (corresponding author), Massachusetts Gen Hosp, Neuroradiol Sect, Dept Radiol, 55 Fruit St,Gray 273A, Boston, MA 02114 USA.	joseph.y.young@gmail.com					Arrey EN, 2015, J NEUROSURG-PEDIATR, V16, P703, DOI 10.3171/2015.4.PEDS1545; Ashley WW, 2005, J NEUROSURG, V103, P124, DOI 10.3171/ped.2005.103.2.0124; Buttram Sandra D W, 2015, Hosp Pediatr, V5, P79, DOI 10.1542/hpeds.2014-0094; Cohen AR, 2015, AM J EMERG MED, V33, P887, DOI 10.1016/j.ajem.2015.03.052; Cote CJ, 2000, PEDIATRICS, V106, P633, DOI 10.1542/peds.106.4.633; Faul M, 2010, TRAUMATIC BRAIN INJU; Foerster BR, 2009, J PEDIATR-US, V154, P573, DOI 10.1016/j.jpeds.2008.09.051; Kemp AM, 2009, CLIN RADIOL, V64, P473, DOI 10.1016/j.crad.2008.11.011; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Malviya S, 2000, BRIT J ANAESTH, V84, P743, DOI 10.1093/oxfordjournals.bja.a013586; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mehta H, 2016, AM J NEURORADIOL, V37, P11, DOI 10.3174/ajnr.A4464; Missios S, 2008, J NEUROS-PEDIATR, V2, P438, DOI 10.3171/PED.2008.2.12.438; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; O'Neill BR, 2013, WORLD NEUROSURG, V80, pE307, DOI 10.1016/j.wneu.2012.10.066; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Roguski M, 2015, J NEUROSURG-PEDIATR, V15, P529, DOI 10.3171/2014.10.PEDS14128; Ryan ME, 2014, J AM COLL RADIOL, V11, P939, DOI 10.1016/j.jacr.2014.07.017; SATO Y, 1989, RADIOLOGY, V173, P653, DOI 10.1148/radiology.173.3.2813768; Sigmund GA, 2007, PEDIATR NEUROL, V36, P217, DOI 10.1016/j.pediatrneurol.2007.01.003; Wang X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096299, 10.1371/journal.pone.0085760]; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	22	19	19	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1070-3004	1438-1435		EMERG RADIOL	Emerg. Radiol.	AUG	2016	23	4					325	331		10.1007/s10140-016-1392-3			7	Radiology, Nuclear Medicine & Medical Imaging	Emerging Sources Citation Index (ESCI)	Radiology, Nuclear Medicine & Medical Imaging	DR1BQ	WOS:000379641400002	27166965				2022-02-06	
J	Hong, CT; Huang, YH; Liu, HY; Chiou, HY; Chan, L; Chien, LN				Hong, Chien Tai; Huang, Yao Hsien; Liu, Hung Yi; Chiou, Hung-Yi; Chan, Lung; Chien, Li-Nien			Newly Diagnosed Anemia Increases Risk of Parkinson's disease: A Population-Based Cohort Study	SCIENTIFIC REPORTS			English	Article							RED-BLOOD-CELLS; PROPENSITY-SCORE; IRON CONTENT; POTENTIAL BIOMARKER; ALPHA-SYNUCLEIN; BRAIN; ERYTHROCYTE; NEUROPROTECTION; SYMPTOMS; PREMOTOR	Anemia and low hemoglobin have been identified to increase Parkinson's disease (PD) risk. This population-based cohort study investigated PD risk in newly diagnosed anemic patients by using data from the Taiwan National Health Insurance Research Database. All newly diagnosed anemic patients (n = 86,334) without a history of stroke, neurodegenerative diseases, traumatic brain injury, major operations, or blood loss diseases were enrolled. A cohort of nonanemic controls, 1: 1 matched with anemic patients on the basis of the demographics and pre-existing medical conditions, was also included. Competing risk analysis was used to evaluate PD risk in anemic patients compared with that in their matched controls. The adjusted hazard ratio (aHR) of PD risk in the anemic patients was 1.36 (95% confidence interval [CI]: 1.22-1.52, p < 0.001). Iron deficiency anemia (IDA) patients tended to exhibit a higher PD risk (aHR: 1.49; 95% CI: 1.24-1.79, p < 0.001). Furthermore, Iron supplement did not significantly affect the PD risk: the aHRs for PD risk were 1.32 (95% CI: 1.07-1.63, p < 0.01) and 1.86 (95% CI: 1.46-2.35, p < 0.001) in IDA patients with and without iron supplementation, respectively. The population-based cohort study indicated newly diagnosed anemia increases PD risk.	[Hong, Chien Tai; Huang, Yao Hsien; Chan, Lung] Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan; [Hong, Chien Tai; Huang, Yao Hsien; Chan, Lung] Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan; [Liu, Hung Yi; Chiou, Hung-Yi] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Chien, Li-Nien] Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan		Chan, L (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Neurol, Taipei, Taiwan.; Chan, L (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Neurol, Taipei, Taiwan.; Chien, LN (corresponding author), Taipei Med Univ, Coll Management, Sch Hlth Care Adm, Taipei, Taiwan.	cjustinmd@gmail.com; lnchien@tmu.edu.tw	Chan, Lung/AAI-6349-2020; Chan, Lung/AAM-3231-2021	Chan, Lung/0000-0001-5795-4460; Chiou, Hung Yi/0000-0002-4545-9697	Health and Clinical Data Research Center, Taipei Medical University; Ministry of Health and WelfareMinistry of Health, Labour and Welfare, Japan [MOHW104-TDU-B-212-113001]; Taipei Medical University [TMU101-AE1-B57]	We appreciate the support from the Health and Clinical Data Research Center, Taipei Medical University. This study was also supported by grants from the Ministry of Health and Welfare (MOHW104-TDU-B-212-113001) and Taipei Medical University (TMU101-AE1-B57).	Adler CH, 2011, INT J NEUROSCI, V121, P3, DOI 10.3109/00207454.2011.620192; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Braak H, 2007, ACTA NEUROPATHOL, V113, P421, DOI 10.1007/s00401-007-0193-x; Cabantchik ZI, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00167; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112; Guo Shenyang, 2010, PROPENSITY SCORE ANA; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; JOHANNSEN P, 1991, J NEUROL NEUROSUR PS, V54, P679, DOI 10.1136/jnnp.54.8.679; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kaneko J.J., 1980, CLIN BIOCH DOMESTIC; Kieburtz K, 2013, MOVEMENT DISORD, V28, P8, DOI 10.1002/mds.25150; KILINC A, 1988, NEUROSCI LETT, V87, P307, DOI 10.1016/0304-3940(88)90467-3; Lang F, 2014, ANTIOXID REDOX SIGN, V21, P138, DOI 10.1089/ars.2013.5747; Lee YC, 2013, NEUROLOGY, V81, P410, DOI 10.1212/WNL.0b013e31829d873c; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Miyake Y, 2011, J NEUROL SCI, V306, P98, DOI 10.1016/j.jns.2011.03.035; Nelson C, 1997, J NUTR, V127, P2282, DOI 10.1093/jn/127.12.2282; Noyce AJ, 2016, J NEUROL NEUROSUR PS, V87, P871, DOI 10.1136/jnnp-2015-311890; Olanow CW, 2008, ANN NEUROL, V64, pS101, DOI 10.1002/ana.21461; Pearce N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i969; Pichler I, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001462; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Pretorius E, 2014, AGING-US, V6, P788, DOI 10.18632/aging.100695; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008454.pub2; Roberts KM, 2013, IUBMB LIFE, V65, P350, DOI 10.1002/iub.1144; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Savica R, 2009, NEUROLOGY, V73, P1381, DOI 10.1212/WNL.0b013e3181bd80c1; Savica R, 2010, ARCH NEUROL-CHICAGO, V67, P798, DOI 10.1001/archneurol.2010.135; Schapira AHV, 2008, EUR J NEUROL, V15, P5, DOI 10.1111/j.1468-1331.2008.02055.x; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; URAKAMI K, 1992, JPN J PSYCHIAT NEUR, V46, P933; Wang XM, 2015, NEUROSCI LETT, V599, P115, DOI 10.1016/j.neulet.2015.05.030; Zhou BQ, 2011, BIOMETRICS, V67, P661, DOI 10.1111/j.1541-0420.2010.01493.x	42	19	19	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 14	2016	6								29651	10.1038/srep29651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR0CX	WOS:000379576700001	27412825	Green Published, gold			2022-02-06	
J	Scultetus, AH; Haque, A; Chun, SJ; Hazzard, B; Mahon, RT; Harssema, MJ; Auker, CR; Moon-Massat, P; Malone, DL; McCarron, RM				Scultetus, Anke H.; Haque, Ashraful; Chun, Steve J.; Hazzard, Brittany; Mahon, Richard T.; Harssema, Martin J.; Auker, Charles R.; Moon-Massat, Paula; Malone, Debra L.; McCarron, Richard M.			Brain hypoxia is exacerbated in hypobaria during aeromedical evacuation in swine with traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Aeromedical evacuation; altitude; hypobaria; cerebral oxygenation; traumatic brain injury; swine	DECOMPRESSION-SICKNESS; HIGH-ALTITUDE; MODEL	BACKGROUND: There is inadequate information on the physiologic effects of aeromedical evacuation on wounded war fighters with traumatic brain injury (TBI). At altitudes of 8,000 ft, the inspired oxygen is lower than standard sea level values. In troops experiencing TBI, this reduced oxygen may worsen or cause secondary brain injury. We tested the hypothesis that the effects of prolonged aeromedical evacuation on critical neurophysiologic parameters (i.e., brain oxygenation [PbtO2]) of swine with a fluid percussion injury/TBI would be detrimental compared with ground (normobaric) transport. METHODS: Yorkshire swine underwent fluid percussion injury/TBI with pretransport stabilization before being randomized to a 4-hour aeromedical transport at simulated flight altitude of 8,000 ft (HYPO, n = 8) or normobaric ground transport (NORMO, n = 8). Physiologic measurements (i.e., PbtO2], cerebral perfusion pressure, intracranial pressure, regional cerebral blood flow, mean arterial blood pressure, and oxygen transport variables) were analyzed. RESULTS: Survival was equivalent between groups. Measurements were similar in both groups at all phases up to and including onset of flight. During the flight, PbtO2], cerebral perfusion pressure, and mean arterial blood pressure were significantly lower in the HYPO than in the NORMO group. At the end of flight, regional cerebral blood flow was lower in the HYPO than in the NORMO group. Other parameters such as intracranial pressure, cardiac output, and mean pulmonary artery pressure were not significantly different between the two groups. CONCLUSION: A 4-hour aeromedical evacuation at a simulated flight altitude of 8,000 ft caused a notable reduction in neurophysiologic parameters compared with normobaric conditions in this TBI swine model. Results suggest that hypobaric conditions exacerbate cerebral hypoxia and may worsen TBI in casualties already in critical condition. (J Trauma Acute Care Surg. 2016; 81: 101-107. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.)	[Scultetus, Anke H.; Haque, Ashraful; Chun, Steve J.; Hazzard, Brittany; Mahon, Richard T.; Auker, Charles R.; Moon-Massat, Paula; McCarron, Richard M.] NMRC, Silver Spring, MD 20910 USA; [Scultetus, Anke H.; Malone, Debra L.; McCarron, Richard M.] USU, Dept Surg, Bethesda, MD USA; [Chun, Steve J.; Malone, Debra L.] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Harssema, Martin J.] Joint Base Andrews, Crit Care Air Transport Team, Med Grp 79, Bethesda, MD USA		Scultetus, AH (corresponding author), Naval Med Res Ctr, NeuroTrauma Dept, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	anke.h.scultetus2.ctr@mail.mil					Auten JD, 2010, AVIAT SPACE ENVIR MD, V81, P427, DOI 10.3357/ASEM.2406.2010; Chesnut RM, 2004, CRIT CARE CLIN, V20, P25, DOI 10.1016/S0749-0704(03)00090-3; Cotton BA, 2011, ANN SURG, V254, P598, DOI 10.1097/SLA.0b013e318230089e; Dukes SF, 2013, MIL MED, V178, P11, DOI 10.7205/MILMED-D-12-00177; Fang R, 2010, J TRAUMA, V69, pS140, DOI 10.1097/TA.0b013e3181e452a2; Goodman MD, 2011, J SURG RES, V165, P30, DOI 10.1016/j.jss.2010.05.055; Hu SL, 2010, NEUROL RES, V32, P173, DOI 10.1179/174313209X414524; Hurd WW, 2003, AEROMEDICAL EVACUATI; Johannigman Jay, 2015, J Trauma Acute Care Surg, V79, pS216, DOI 10.1097/TA.0000000000000736; Joshi M C, 2010, Med J Armed Forces India, V66, P63, DOI 10.1016/S0377-1237(10)80097-8; Kannan N, 1998, AVIAT SPACE ENVIR MD, V69, P965; Kragh John F Jr, 2011, US Army Med Dep J, P38; MAROTTE H, 1990, AVIAT SPACE ENVIR MD, V61, P690; Mongan PD, 2009, J TRAUMA, V67, P51, DOI 10.1097/TA.0b013e3181838030; Pilmanis AA, 1996, AVIAT SPACE ENVIR MD, V67, P1092; Ran Y, 2011, MIL MED, V176, P647, DOI 10.7205/MILMED-D-10-00390; Skovira JW, 2016, J NEUROTRAUMA; STAPP JP, 1986, AVIAT SPACE ENVIR MD, V57, pA32; Yu AY, 2014, NEUROREPORT, V25, P1272, DOI 10.1097/WNR.0000000000000259	19	19	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUL	2016	81	1					101	107		10.1097/TA.0000000000001048			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DS5BV	WOS:000380796400016	26998778				2022-02-06	
J	Xiong, C; Martin, T; Sravanapudi, A; Colantonio, A; Mollayeva, T				Xiong, Chen; Martin, Tickalyn; Sravanapudi, Aneesha; Colantonio, Angela; Mollayeva, Tatyana			Factors associated with return to work in men and women with work-related traumatic brain injury	DISABILITY AND HEALTH JOURNAL			English	Article						Occupational injury; Head trauma; Sex differences; Occupational outcomes	GENDER-DIFFERENCES; MILD; PREDICTION; MODERATE; HOSPITALIZATION; MULTICENTER; VARIABLES; TBI	Background: Symptoms that persist subsequent to a work-related traumatic brain injury (wrTBI) influence the ability to return to work (RTW) and indicate areas of functional disability, as classified in the International Classification of Functioning, Disability and Health (ICF) framework. Objective: The purpose of this study was to describe the relationship between RTW status and ICF framework domains in men and women with a wrTBI. Methods: A retrospective chart review of 209 consecutive workers with TBI (mild TBI: 71.8%; mean age: 40.2 +/- 11.1, men: 71.3%) was conducted. Workers were assessed during the chronic post-injury phase, at the neurology service of a large rehabilitation hospital in Ontario, Canada in 2003. Frequency distributions were calculated and chi-square tests performed. Results: At the point of assessment, 78.0% of workers were in receipt of disability benefits, while the remainder had returned to work on a full-or part-time basis. Significant differences were observed in the Body Functions and Structures domain of the ICF model, specifically clinical diagnoses of depression, anxiety, pain disorders; self-perceived cognitive disturbance, and certain psychosocial factors (p < 0.05), between workers who had returned to work and those who had not. When stratified according to sex, these associations remained significant only in men. Conclusions: The factors outlined above should be subject to further TBI research, as indicators for RTW. The lack of significant findings in women warrants further exploration of variables within the physical and social environmental domains of the ICF. (C) 2015 Elsevier Inc. All rights reserved.	[Xiong, Chen; Colantonio, Angela; Mollayeva, Tatyana] Univ Toronto, Rehabil Sci Inst, Rehabil Sci Bldg,500 Univ Ave,Room 260, Toronto, ON M5G 1V7, Canada; [Martin, Tickalyn; Sravanapudi, Aneesha; Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Colantonio, Angela; Mollayeva, Tatyana] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada		Xiong, C (corresponding author), Univ Toronto, Rehabil Sci Inst, Rehabil Sci Bldg,500 Univ Ave,Room 260, Toronto, ON M5G 1V7, Canada.	chen.xiong@mail.utoronto.ca	, Mollayeva/A-4522-2018	Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848	Frederick Banting and Charles Best Graduate Scholarship from the Canadian Institutes of Health Research; Frederick Banting and Charles Best Doctoral Research Award; Work Disability Prevention Fellowship from the Canadian Institutes of Health Research; Saunderson Family Chair in Acquired Brain Injury Research; Canadian Institutes for Health Research Grant - Institute for Gender and Health [CGW-126580]	Role of the funding source: Our study had no external funding source. Chen Xiong was supported by the 2015/2016 Frederick Banting and Charles Best Graduate Scholarship from the Canadian Institutes of Health Research. Tatyana Mollayeva was supported by the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award and the Work Disability Prevention Fellowship from the Canadian Institutes of Health Research. Angela Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research and the Canadian Institutes for Health Research Grant - Institute for Gender and Health (#CGW-126580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Bootes Kylie, 2002, Work, V19, P255; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cicerone KD, 1996, BRAIN INJURY, V10, P277, DOI 10.1080/026990596124458; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Colantonio A, 2012, WORK, V43, P195, DOI 10.3233/WOR-2012-1377; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, CAN J PUBLIC HEALTH, V101, pS58, DOI 10.1007/BF03403848; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Engel L, 2009, EVAL HEALTH PROF, V32, P281, DOI 10.1177/0163278709338561; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; FRASER RT, 1994, TOP LANG DISORD, V15, P55, DOI 10.1097/00011363-199411000-00006; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hanlon RE, 1999, BRAIN INJURY, V13, P873; Health Canada, 2010, HLTH PORTF SEX GEND; Hoefsmit N, 2014, WORK, V48, P203, DOI 10.3233/WOR-131657; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kim H, 2006, NEUROREHABILITATION, V21, P269; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nolin P, 2006, J HEAD TRAUMA REHAB, V21, P514, DOI 10.1097/00001199-200611000-00006; O'Connell MJ, 2000, REHABIL PSYCHOL, V45, P212, DOI 10.1037/0090-5550.45.2.212; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Stergiou-Kita M, 2011, J OCCUP REHABIL, V21, P374, DOI 10.1007/s10926-010-9282-0; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Workplace Safety Insurance Board of Ontario, 2013, NUMB 2012 WSIB STAT; World Health Organization, 2002, COMM LANG FUNCT DIS; Yasuda S, 2001, AM J PHYS MED REHAB, V80, P852, DOI 10.1097/00002060-200111000-00011	40	19	19	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1936-6574	1876-7583		DISABIL HEALTH J	Disabil. Health J.	JUL	2016	9	3					439	448		10.1016/j.dhjo.2015.12.002			10	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	DN9RP	WOS:000377418100011	26817582				2022-02-06	
J	Couch, JR; Stewart, KE				Couch, James R.; Stewart, Kenneth E.			Headache Prevalence at 4-11 Years After Deployment-Related Traumatic Brain Injury in Veterans of Iraq and Afghanistan Wars and Comparison to Controls: A Matched Case-Controlled Study	HEADACHE			English	Article						traumatic brain injury; headache; chronic daily headache; migraine; veterans; tension-type headache	CHRONIC POSTTRAUMATIC HEADACHES; US SOLDIERS; MIGRAINE; CONCUSSION; PERSONNEL; SEVERITY; SYMPTOMS; BURDEN; RISK	ObjectiveEvaluate the extent and severity of headache following deployment-related TBI (D-TBI) in veterans of the Iraq (OIF) and Afghanistan (OEF) wars over a follow-up period of 4-11 years with comparison to age, sex, race, and time of deployment matched controls. BackgroundTBI has been recognized as the signature Injury of the OEF/OIF campaigns occurring in 14-20% of deployed soldiers. Currently, there are very few data on the longer term follow-up of soldiers with D-TBI. This study deals with prevalence and severity of headache and headache burden at 4-11 years following D-TBI for OEF/OIF veterans with comparison to controls without D-TBI. MethodsThis is a matched case controlled-study. All subjects were recruited from Operation New Dawn (OND), a voluntary program for OEF/OIF Veterans at the Oklahoma VAMC designed to assist with re-integrating into civilian life. On entry into OND a medical questionnaire was administered that included a brief screen for D-TBI, and those with a possible D-TBI were referred to a TBI clinic, For this study, the first 500 TBI clinic patients who were found to have had a D-TBI (TBIS) were matched by age, sex, race, and time of deployment to control subjects (CS), drawn from the 4411 OND program members with no D-TBI, creating a pool of 500 TBIS/CS pairs. From this pool, 55 pairs (11%) were randomly selected for this study. Data were collected from both TBIS and CS by telephone interview with questionnaires regarding the DTBI, headache, depression, and PTSD. TBI severity was measured by duration of loss of consciousness (LOC) as: [a] Very Mild (VMTBI, dazed only, no LOC), [b] Mild (MTBI, LOC 1-30 minutes), and [c] Moderate-Severe (MSTBI, LOC>30 minutes). Intensity for individual headaches was measured by disability produced by the headache as: [a] Disabling (must be in bed), [b] Severe (50-90% decrease in activity), or [c] Mild-Moderate (>50% of usual activity possible). Statistical analysis employed Fisher's exact test and odds ratio. ResultsThe 55 TBIS/CS pairs were segregated by severity of TBI for the TBIS. For the TBIS there were no significant differences among these three subgroups as to mechanism producing the TBI (blast injury or direct head trauma). Comparing TBIS vs CS for phenotypic classification of headaches, for TBIS - 89% had migraine, 2% probable migraine, 9% had tension, and 0% had no headaches, while for CS - 36% had migraine, 15% probable migraine, 27% tension, and 22% no headache (P<.0001). Migraine with aura occurred in 38% of TBIS and 6% of CS (P<.0001). As to headache frequency, for TBIS - chronic daily headache (CDH) occurred in 44%, frequent headache in 33%, and infrequent or no headache in 23%, while for CS - CDH occurred in 7%, frequent headache in 13%, and infrequent or no headache in 80% (P<.0001). For TBIS, 54% had severe or disabling headache 2 days/week as opposed to only 16% of CS (OR 6.13 [2.5-14.9]). As to onset of most severe and frequent headaches, this occurred shortly after TBI in 89% of TBIS while only 27% of CS reported most severe headaches starting during deployment. There was no correlation of severity of headache problem with severity of TBI. Comparing TBIS at 4-7 vs 8-11 years after injury, there was no difference in frequency or severity of headache between these groups. ConclusionsAt 4-11 years after D-TBI for TBIS, or after deployment for CS, the TBIS as compared to CS suffered much more frequent and severe headaches. For TBIS, there was no relation of headache intensity or phenotype to severity or cause of the TBI, and the Headache Burden has not improved over time up to 11 years after D-TBI. The process initiated by the D-TBI that relates to the headache has a prolonged effect up to and beyond 11 years.	[Couch, James R.] Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, 920 Stanton L Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA; [Stewart, Kenneth E.] Univ Oklahoma, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK USA		Couch, JR (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Neurol, 920 Stanton L Young Blvd,Suite 2040, Oklahoma City, OK 73104 USA.	james-couch@ouhsc.edu			Education and Research Fund of the Oklahoma City Veterans Affairs Medical Center	This study was funded, in part, by the Education and Research Fund of the Oklahoma City Veterans Affairs Medical Center.	Alves W. M., 1986, J HEAD TRAUMA REHAB, V1, P1; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Brenner C, 1944, J NEUROSURG, V1, P379, DOI 10.3171/jns.1944.1.6.0379; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Cartlidge NEF, 1981, HEAD INJURY, P95; Couch James R., 2003, Curr Treat Options Neurol, V5, P467, DOI 10.1007/s11940-996-0015-9; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; Couch JR, 2011, HEADACHE, V51, P33, DOI 10.1111/j.1526-4610.2010.01800.x; COUCH JR, 1979, ARCH NEUROL-CHICAGO, V36, P695, DOI 10.1001/archneur.1979.00500470065013; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Couch JR, 2007, DRUG DEVELOP RES, V68, P1; Couch JR, 2004, HEADACHE, V44, P512; COUCH JR, 2012, HEADACHE, V52, P907; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Fear NT, 2009, PSYCHOL MED, V39, P1379, DOI 10.1017/S0033291708004595; Finkel AG, 2012, HEADACHE, V52, P957, DOI 10.1111/j.1526-4610.2012.02167.x; Guttmann E, 1943, LANCET, V1, P10; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; KAY DWK, 1971, LANCET, V2, P1052; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lieba-Samal D, 2011, CEPHALALGIA, V31, P1618, DOI 10.1177/0333102411428954; Lipton RB, 2001, HEADACHE, V41, P646, DOI 10.1046/j.1526-4610.2001.041007646.x; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; MILLER H, 1961, BRIT MED J, V1, P919, DOI 10.1136/bmj.1.5230.919; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Olesen J, 2013, CEPHALALGIA, V33, P627, DOI 10.1177/0333102413487610; RASKIN NH, 1987, HEADACHE, V27, P416, DOI 10.1111/j.1526-4610.1987.hed2708416.x; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; RUTHERFORD WH, 1977, LANCET, V1, P1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; SPEED WG, 1989, HEADACHE, V29, P643, DOI 10.1111/j.1526-4610.1989.hed2910643.x; Stovner LJ, 2009, EUR J NEUROL, V16, P112, DOI 10.1111/j.1468-1331.2008.02363.x; Streel S, 2015, REV NEUROL-FRANCE, V171, P707, DOI 10.1016/j.neurol.2015.04.009; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; Walker WC, 2005, ARCH PHYS MED REHAB, V86, P1793, DOI 10.1016/j.apmr.2004.12.042; WEILLER C, 1995, NAT MED, V1, P658, DOI 10.1038/nm0795-658; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Wilk JE, 2010, J HEAD TRAUMA REHAB, V25, P9, DOI 10.1097/HTR.0b013e3181bd090f; YAMAGUCHI M, 1992, HEADACHE, V32, P427, DOI 10.1111/j.1526-4610.1992.hed3209427.x	52	19	19	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0017-8748	1526-4610		HEADACHE	Headache	JUN	2016	56	6					1004	1021		10.1111/head.12837			18	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DQ4DO	WOS:000379154300009	27237921				2022-02-06	
J	Dhaliwal, SS; Sowerby, LJ; Rotenberg, BW				Dhaliwal, Sandeep S.; Sowerby, Leigh J.; Rotenberg, Brian W.			Timing of endoscopic surgical decompression in traumatic optic neuropathy: a systematic review of the literature	INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY			English	Article; Proceedings Paper	61st Annual Meeting of the American-Rhinologic-Society (ARS) during the Annual Meeting of the American-Academy-of-Otolaryngology-Head-and-Neck-Surgery-Foundation (AAO-HNS) / Annual Meeting of the American-Academy-of-Otolaryngic-Allergy	SEP 25-30, 2015	Dallas, TX	Amer Rhinol Soc, Amer Acad Otolaryngol Head & Neck Surg Fdn, Amer Acad Otolaryng Allergy		optic neuropathy; optic nerve injury; optic nerve decompression; surgical decompression; endoscopic sinus surgery	NERVE DECOMPRESSION; SURGERY	BackgroundTraumatic optic neuropathy (TON) represents a rare but devastating complication of closed head injuries. No accepted guidelines are available for medical and surgical management algorithms. A systematic review of the literature was performed to determine the optimal timing and candidacy for endoscopic surgical intervention. MethodsA systematic review of multiple databases was performed including Medline-Ovid, EMBASE, and PubMed. Data was extracted and patients stratified based on surgical delay from trauma (3 days, >3 days, 7 days, or >7 days) as well as preoperative and postoperative vision testing (no light perception [NLP]; light perception [LP]; hand motion [HM]; or finger counting [FC] or better). ResultsThe literature review identified 24 studies meeting inclusion criteria. In the group of patients receiving surgery 3 days after the antecedent event, 57% (105/183) had visual improvement, whereas in the >7-days group 51% (145/283) of patients improved. In those with NLP preoperatively, 41% (172/411) saw improvement, whereas those with LP (89%), HM (93%), or FC (85%) fared better. ConclusionThe literature suggests that surgical intervention for TON is indicated despite delayed presentation, and is a better choice than no intervention at all. Patients with complete blindness on presentation (NLP) tend to have a poorer surgical outcome.	[Dhaliwal, Sandeep S.; Sowerby, Leigh J.; Rotenberg, Brian W.] Western Univ, Dept Otolaryngol Head & Neck Surg, London, ON, Canada		Rotenberg, BW (corresponding author), St Josephs Hosp, Room B2-501,268 Grosvenor St, London, ON N6A 4V2, Canada.	brian.rotenberg@sjhc.london.on.ca					Chen C, 2006, OTOLARYNG HEAD NECK, V135, P155, DOI 10.1016/j.otohns.2005.03.056; Chen FH, 2014, N AM J MED SCI, V6, P270, DOI 10.4103/1947-2714.134372; Cook MW, 1996, ARCH OTOLARYNGOL, V122, P389; De Ganseman A, 2000, Acta Otorhinolaryngol Belg, V54, P175; Emanuelli E, 2015, EUR ARCH OTO-RHINO-L, V272, P3301, DOI 10.1007/s00405-014-3408-5; FUJITANI T, 1986, JPN J OPHTHALMOL, V30, P125; HAMEED AS, 2014, J EVIDENCE BASED MED, V1, P696; Horiguchi K, 2010, NEUROL MED-CHIR, V50, P518, DOI 10.2176/nmc.50.518; Jiang RS, 2001, RHINOLOGY, V39, P71; Kong DS, 2011, J CLIN NEUROSCI, V18, P1541, DOI 10.1016/j.jocn.2011.02.042; Kountakis SE, 2000, OTOLARYNG HEAD NECK, V123, P34, DOI 10.1067/mhn.2000.106007; Kountakis SE, 1997, OTOLARYNG HEAD NECK, V116, P652, DOI 10.1016/S0194-5998(97)70243-2; Krings JG, 2014, LARYNGOSCOPE, V124, P838, DOI 10.1002/lary.24401; Kuppersmith RB, 1997, LARYNGOSCOPE, V107, P311, DOI 10.1097/00005537-199703000-00006; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; Li H, 2008, J LARYNGOL OTOL, V122, P1325, DOI 10.1017/S0022215108002296; Li HB, 2007, CLIN OTOLARYNGOL, V32, P447, DOI 10.1111/j.1749-4486.2007.01560.x; Luxenberger W, 1998, LARYNGOSCOPE, V108, P873, DOI 10.1097/00005537-199806000-00016; Mabuchi F, 2003, INVEST OPHTH VIS SCI, V44, P4321, DOI 10.1167/iovs.03-0138; Maurer J, 1999, EUR ARCH OTO-RHINO-L, V256, P341, DOI 10.1007/s004050050160; Mine S, 1999, ACTA NEUROCHIR, V141, P27, DOI 10.1007/s007010050262; Moher D, 2016, REV ESP NUTR HUM DIE, V20, P148, DOI 10.14306/renhyd.20.2.223; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; NAYAK SR, 1991, J LARYNGOL OTOL, V105, P205, DOI 10.1017/S0022215100115361; Nazir SA, 2010, AM J OTOLARYNG, V31, P193, DOI 10.1016/j.amjoto.2008.11.015; Peng AQ, 2011, INT J PEDIATR OTORHI, V75, P992, DOI 10.1016/j.ijporl.2011.05.004; Rajiniganth MG, 2003, ARCH OTOLARYNGOL, V129, P1203, DOI 10.1001/archotol.129.11.1203; Ropposch T, 2013, LARYNGOSCOPE, V123, P1082, DOI 10.1002/lary.23845; SOFFERMAN RA, 1981, LARYNGOSCOPE, V91, P184; Song YX, 2013, ACTA OTO-LARYNGOL, V133, P1196, DOI 10.3109/00016489.2013.822556; Thakar A, 2003, LARYNGOSCOPE, V113, P112, DOI 10.1097/00005537-200301000-00021; Wang DH, 2008, ORL-J OTO-RHIN-LARYN, V70, P130, DOI 10.1159/000114537; Wu WC, 2011, OPHTHAL PLAST RECONS, V27, pE13, DOI 10.1097/IOP.0b013e3181dc8323; Xu R, 2014, ORL J OTO-RHINO-LARY, V76, P44, DOI 10.1159/000358305; Yang QT, 2012, J TRAUMA ACUTE CARE, V72, P1350, DOI 10.1097/TA.0b013e3182493c70; Yu-Wai-Man P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006032.pub2	36	19	21	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2042-6976	2042-6984		INT FORUM ALLERGY RH	Int. Forum Allergy Rhinol.	JUN	2016	6	6					661	667		10.1002/alr.21706			7	Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Otorhinolaryngology	DR1YL	WOS:000379700700016	26782715				2022-02-06	
J	Hifumi, T; Kuroda, Y; Kawakita, K; Yamashita, S; Oda, Y; Dohi, K; Maekawa, T				Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya; Yamashita, Susumu; Oda, Yasutaka; Dohi, Kenji; Maekawa, Tsuyoshi		Brain Hypothermia B-HYPO Study Grp	Fever Control Management Is Preferable to Mild Therapeutic Hypothermia in Traumatic Brain Injury Patients with Abbreviated Injury Scale 3-4: A Multi-Center, Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						Abbreviated Injury Scale; heterogeneous pathophysiology; multi-center randomized controlled trial; therapeutic hypothermia; traumatic brain injury	GLASGOW COMA SCALE; INTRACRANIAL-PRESSURE; TEMPERATURE; MORTALITY; SEVERITY; BLOOD	In our prospective, multi-center, randomized controlled trial (RCT)the Brain Hypothermia (B-HYPO) studywe could not show any difference on neurological outcomes in patients probably because of the heterogeneity in the severity of their traumatic condition. We therefore aimed to clarify and compare the effectiveness of the two therapeutic temperature management regimens in severe (Abbreviated Injury Scale [AIS] 3-4) or critical trauma patients (AIS 5). In the present post hoc B-HYPO study, we re-evaluated data based on the severity of trauma as AIS 3-4 or AIS 5 and compared Glasgow Outcome Scale score and mortality at 6 months by per-protocol analyses. Consequently, 135 patients were enrolled. Finally, 129 patients, that is, 47 and 31 patients with AIS 3-4 and 36 and 15 patients with AIS 5 were allocated to the mild therapeutic hypothermia (MTH) and fever control groups, respectively. No significant intergroup differences were observed with regard to age, gender, scores on head computed tomography (CT) scans, and surgical operation for traumatic brain injury (TBI), except for Injury Severity Score (ISS) in AIS 5. The fever control group demonstrated a significant reduction of TBI-related mortality compared with the MTH group (9.7% vs. 34.0%, p=0.02) and an increase of favorable neurological outcomes (64.5% vs. 51.1%, p=0.26) in patients with AIS 3-4, although the latter was not statistically significant. There was no difference in mortality or favorable outcome in patients with AIS 5. Fever control may be considered instead of MTH in patients with TBI (AIS 3-4).	[Hifumi, Toru; Kuroda, Yasuhiro; Kawakita, Kenya] Kagawa Univ Hosp, Dept Emergency Disaster & Crit Care Med, Miki, Kagawa, Japan; [Yamashita, Susumu] Tokuyama Cent Hosp, Dept Emergency Med, Yamaguchi, Japan; [Oda, Yasutaka] Yamaguchi Univ, Sch Med, Adv Med Emergency & Crit Care Ctr, Yamaguchi, Japan; [Dohi, Kenji] Jikei Univ, Sch Med, Dept Emergency Med, Tokyo, Japan; [Maekawa, Tsuyoshi] Yamaguchi Prefectural Grand Med Ctr, Yamaguchi, Japan		Hifumi, T (corresponding author), Dept Emergency Disaster & Crit Care Med, Kita Ku, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	hifumitoru@gmail.com		dohi, kenji/0000-0002-4451-0382	Japanese Ministry of Health, Labor and WelfareMinistry of Health, Labour and Welfare, Japan [H-14-shinkin-005, H-15-shinkin-001, H-16-shinkin-001]; Japanese Human Science Association	This study was supported by research project grants from the Japanese Ministry of Health, Labor and Welfare (H-14-shinkin-005, H-15-shinkin-001, and H-16-shinkin-001) and by the Japanese Human Science Association, 2002-2004.	CIVIL ID, 1988, J TRAUMA, V28, P87, DOI 10.1097/00005373-198801000-00012; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Foreman BP, 2007, J TRAUMA, V62, P946, DOI 10.1097/01.ta.0000229796.14717.3a; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gando S, 2011, ANN SURG, V254, P10, DOI 10.1097/SLA.0b013e31821221b1; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; Lobo SMA, 2003, CHEST, V123, P2043, DOI 10.1378/chest.123.6.2043; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Medicine T. A. f. t. A. o. A., 2015, ABBR INJ SCAL PHIL; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Oda Y, 2009, RESUSCITATION, V80, P189, DOI 10.1016/j.resuscitation.2008.10.001; Saxena M, 2014, COCHRANE DB SYST REV, V8; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suehiro E, 2004, J NEUROTRAUM, V21, P1706, DOI 10.1089/0897715042664957; The Japan Society of Neurotraumatology, 2001, GUID MAN SEV HEAD IN; Timmons SD, 2011, J TRAUMA, V71, P1172, DOI 10.1097/TA.0b013e31822b0f4b; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Tokutomi T, 2009, J TRAUMA, V66, P166, DOI 10.1097/TA.0b013e318157dbec; WALDER AD, 1995, INTENS CARE MED, V21, P606, DOI 10.1007/BF01700170; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80	26	19	20	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1047	1053		10.1089/neu.2015.4033			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600008	26413933	Green Published			2022-02-06	
J	Huang, CJ; Zhao, LX; Gu, J; Nie, DK; Chen, YN; Zuo, H; Huan, W; Shi, JL; Chen, J; Shi, W				Huang, Chuanjun; Zhao, Longxiang; Gu, Jun; Nie, Dekang; Chen, Yinan; Zuo, Hao; Huan, Wei; Shi, Jinlong; Chen, Jian; Shi, Wei			The migration and differentiation of hUC-MSCsCXCR4/GFP encapsulated in BDNF/chitosan scaffolds for brain tissue engineering	BIOMEDICAL MATERIALS			English	Article						traumatic brain injury; hUC-MSCs; CXCR4/SDF-1 alpha axis; migration; neuronal differentiation	MESENCHYMAL STEM-CELLS; BONE-MARROW; INJURY; TRAFFICKING; EXPRESSION; THERAPY; MODEL	We previously developed a biomaterial scaffold that could effectively provide seed cells to a lesion cavity resulting from traumatic brain injury. However, we subsequently found that few transplanted human umbilical cord mesenchymal stem cells (hUC-MSCs) are able to migrate from the scaffold to the lesion boundary. Stromal derived-cell factor-1 alpha and its receptor chemokine (C-X-C motif) receptor (CXCR) 4 are chemotactic factors that control cell migration and stem cell recruitment to target areas. Given the low expression level of CXCR4 on the hUC-MSC membrane, lentiviral vectors were used to generate hUC-MSCs stably expressing CXCR4 fused to green fluorescent protein (GFP) (hUC-MSCsCXCR4/GFP). We constructed a scaffold in which recombinant human brain-derived neurotrophic factor (BDNF) was linked to chitosan scaffolds with the crosslinking agent genipin (CGB scaffold). The scaffold containing hUC-MSCsCXCR4/GFP was transplanted into the lesion cavity of a rat brain, providing exogenous hUC-MSCs to both lesion boundary and cavity. These results demonstrate a novel strategy for inducing tissue regeneration after traumatic brain injury.	[Huang, Chuanjun; Zhao, Longxiang; Gu, Jun; Chen, Yinan; Zuo, Hao; Huan, Wei; Shi, Jinlong; Chen, Jian; Shi, Wei] Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China; [Nie, Dekang] Nantong Univ, Affiliated Hosp 4, Dept Neurosurg, YanCheng City Peoples Hosp 1, Yancheng, Peoples R China		Shi, W (corresponding author), Nantong Univ, Affiliated Hosp, Dept Neurosurg, Nantong, Peoples R China.	ntshiwei123@163.com			National Nature Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271368]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2012654]	The authors thank the Surgical Comprehensive Laboratory at the Affiliated Hospital of Nantong University for technical assistance and equipment support. This work was supported by the National Nature Science Foundation of China (grant no. 81271368) and the Natural Science Foundation of Jiangsu Province (grant no. BK2012654).	Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Brooke G, 2008, STEM CELLS DEV, V17, P929, DOI 10.1089/scd.2007.0156; Cao ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082949; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Dazzi F, 2007, CURR OPIN ONCOL, V19, P650, DOI 10.1097/CCO.0b013e3282f0e116; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415; Jiang QS, 2011, CHINESE MED J-PEKING, V124, P1540, DOI 10.3760/cma.j.issn.0366-6999.2011.10.019; Jiang Q, 2011, NMR BIOMED, V24, P1119, DOI 10.1002/nbm.1667; Keilhoff G, 2006, CELL MOL NEUROBIOL, V26, P1235, DOI 10.1007/s10571-006-9029-9; Kim Ju-Yeon, 2010, World J Stem Cells, V2, P34, DOI 10.4252/wjsc.v2.i2.34; Lee JH, 2011, J NEUROL SCI, V300, P86, DOI 10.1016/j.jns.2010.09.025; Liang J, 2013, NEUROSCI LETT, V532, P59, DOI 10.1016/j.neulet.2012.11.014; Lim JY, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt79; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2008, MINIM INVASIV THER, V17, P119, DOI 10.1080/13645700801970087; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiu YY, 2012, CYTOTHERAPY, V14, P285, DOI 10.3109/14653249.2011.651532; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Wang KZ, 2014, FLEX SERV MANUF J, V26, P387, DOI 10.1007/s10696-012-9153-4	28	19	20	3	18	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1748-6041	1748-605X		BIOMED MATER	Biomed. Mater.	JUN	2016	11	3								10.1088/1748-6041/11/3/035004			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	DP0GQ	WOS:000378167700005	27147644	hybrid			2022-02-06	
J	Valko, PO; Gavrilov, YV; Yamamoto, M; Noain, D; Reddy, H; Haybaeck, J; Weis, S; Baumann, CR; Scammell, TE				Valko, Philipp O.; Gavrilov, Yuri V.; Yamamoto, Mihoko; Noain, Daniela; Reddy, Hasini; Haybaeck, Johannes; Weis, Serge; Baumann, Christian R.; Scammell, Thomas E.			Damage to Arousal-Promoting Brainstem Neurons with Traumatic Brain Injury	SLEEP			English	Article						traumatic brain injury; arousal; coma; locus coeruleus; raphe nucleus	DIFFUSE AXONAL INJURY; HEAD-INJURY; DAYTIME SLEEPINESS; STATE; COMA	Study Objectives: Coma and chronic sleepiness are common after traumatic brain injury (TBI). Here, we explored whether injury to arousal-promoting brainstem neurons occurs in patients with fatal TBI. Methods: Postmortem examination of 8 TBI patients and 10 controls. Results: Compared to controls, TBI patients had 17% fewer serotonergic neurons in the dorsal raphe nucleus (effect size: 1.25), but the number of serotonergic neurons did not differ in the median raphe nucleus. TBI patients also had 29% fewer noradrenergic neurons in the locus coeruleus (effect size: 0.96). The number of cholinergic neurons in the pedunculopontine and laterodorsal tegmental nuclei (PPT/LDT) was similar in TBI patients and controls. Conclusions: TBI injures arousal-promoting neurons of the mesopontine tegmentum, but this injury is less severe than previously observed in hypothalamic arousal-promoting neurons. Most likely, posttraumatic arousal disturbances are not primarily caused by damage to these brainstem neurons, but arise from an aggregate of injuries, including damage to hypothalamic arousal nuclei and disruption of other arousal-related circuitries.	[Valko, Philipp O.; Gavrilov, Yuri V.; Yamamoto, Mihoko; Baumann, Christian R.; Scammell, Thomas E.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Valko, Philipp O.; Gavrilov, Yuri V.; Noain, Daniela; Baumann, Christian R.] Univ Zurich, Univ Zurich Hosp, Dept Neurol, CH-8006 Zurich, Switzerland; [Gavrilov, Yuri V.] Russian Acad Med Sci, Inst Expt Med, Dept Gen Pathol & Pathol Physiol, St Petersburg P-22, Russia; [Reddy, Hasini] Beth Israel Deaconess Med Ctr, Dept Neuropathol, Boston, MA 02215 USA; [Haybaeck, Johannes] Med Univ Graz, Dept Neuropathol, Inst Pathol, Graz, Austria; [Haybaeck, Johannes] Johannes Kepler Univ Linz, Dept Neuropathol, State Neuropsychiat Hosp Wagner, Jauregg Kepler Univ Hosp, Linz, Austria		Valko, PO (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.; Valko, PO (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	philipp.valko@usz.ch	Gavrilov, Yury/AAA-2915-2019	Baumann, Christian/0000-0003-3417-1978; Gavrilov, Yury/0000-0003-1409-7686; Noain, Daniela/0000-0001-5482-7933	Swiss National Science FoundationSwiss National Science Foundation (SNSF)European Commission [32003B-125504]; Clinical Research Priority Program "Sleep and Health" of the University of Zurich; EisaiEisai Co Ltd	This was not an industry supported study. This study was supported by the Swiss National Science Foundation (grant No. 32003B-125504) and the Clinical Research Priority Program "Sleep and Health" of the University of Zurich. Dr. Scammell has received research support from Eisai and has consulted for Merck, Symphony, Prexa, Jazz, Cereve, Purdue Pharma, Ferrer, Heptares, and Synageva. The other authors have indicated no financial conflicts of interest.	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Arciniegas David B, 2003, Curr Psychiatry Rep, V5, P391, DOI 10.1007/s11920-003-0074-5; Carter ME, 2012, P NATL ACAD SCI USA, V109, pE2635, DOI 10.1073/pnas.1202526109; CROMPTON MR, 1971, LANCET, V1, P669; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Kaiser PR, 2010, NEUROLOGY, V75, P1780, DOI 10.1212/WNL.0b013e3181fd62a2; Murdoch I, 1998, J NEUROTRAUM, V15, P295, DOI 10.1089/neu.1998.15.295; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Valko PO, 2013, ANN NEUROL, V74, P794, DOI 10.1002/ana.24019	17	19	19	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA		1550-9109		SLEEP	Sleep	JUN 1	2016	39	6					1249	1252	PII sp-00640-15	10.5665/sleep.5844			4	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP7JO	WOS:000378675200012	27091531	Green Submitted, Green Published, Bronze, Green Accepted			2022-02-06	
J	Weimer, JM; Nowacki, AS; Frontera, JA				Weimer, Jonathan M.; Nowacki, Amy S.; Frontera, Jennifer A.			Withdrawal of Life-Sustaining Therapy in Patients With Intracranial Hemorrhage: Self-Fulfilling Prophecy or Accurate Prediction of Outcome?	CRITICAL CARE MEDICINE			English	Article						intracranial hemorrhage; palliative care; withdrawal of life-sustaining therapy	SPONTANEOUS INTRACEREBRAL HEMORRHAGE; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; SUBARACHNOID HEMORRHAGE; ISCHEMIC-STROKE; RECOVERY; SCALE; MORTALITY; SUPPORT; IMPACT	Objectives: Withdrawal of life-sustaining therapy may lead to premature limitations of life-saving treatments among patients with intracranial hemorrhage, representing a self-fulfilling prophecy. We aimed to determine whether our algorithm for the withdrawal of life-sustaining therapy decision would accurately identify patients with a high probability of poor outcome, despite aggressive treatment. Design: Retrospective analysis of prospectively collected data. Setting: Tertiary-care Neuro-ICU. Patients: Intraparenchymal, subdural, and subarachnoid hemorrhage patients. Interventions: Baseline demographics, clinical status, and hospital course were assessed to determine the predictors of in-hospital mortality and 12-month death/severe disability among patients receiving maximal therapy. Multivariable logistic regression models developed on maximal therapy patients were applied to patients who underwent withdrawal of life-sustaining therapy to predict their probable outcome had they continued maximal treatment. A validation cohort of propensity score-matched patients was identified from the maximal therapy cohort, and their predicted and actual outcomes compared. Measurements and Main Results: Of 383 patients enrolled, there were 128 subarachnoid hemorrhage (33.4%), 134 subdural hematoma (35.0%), and 121 intraparenchymal hemorrhage (31.6%). Twenty-six patients (6.8%) underwent withdrawal of life-sustaining therapy and died, 41 (10.7%) continued maximal therapy and died in hospital, and 316 (82.5%) continued maximal therapy and survived to discharge. The median predicted probability of in-hospital death among withdrawal of life-sustaining therapy patients was 35% had they continued maximal therapy, whereas the median predicted probability of 12-month death/severe disability was 98%. In the propensity-matched validation cohort, 16 of 20 patients had greater than or equal to 80% predicted probability of death/severe disability at 12 months, matching the observed outcomes and supporting the strength and validity of our prediction models. Conclusions: The withdrawal of life-sustaining therapy decision may contribute to premature in-hospital death in some patients who may otherwise have been expected to survive to discharge. However, based on probability models, nearly all of the patients who underwent withdrawal of life-sustaining therapy would have died or remained severely disabled at 12 months had maximal therapy been continued. Withdrawal of life-sustaining therapy may not represent a self-fulfilling prophecy.	[Weimer, Jonathan M.; Frontera, Jennifer A.] Cleveland Clin, Neurol Inst, Ctr Cardiovasc, Lerner Coll Med, Cleveland, OH 44106 USA; [Nowacki, Amy S.] Cleveland Clin, Quantitat Hlth Sci Dept, Cleveland, OH 44106 USA		Frontera, JA (corresponding author), Cleveland Clin, Neurol Inst, Ctr Cardiovasc, Lerner Coll Med, Cleveland, OH 44106 USA.	frontej@ccf.org	Viani, Rafael/V-1196-2018				Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Brizzi M, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-36; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Christakis NA, 1999, DEATH FORETOLD; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Frontera JA, 2011, CRIT CARE MED, V39, P1619, DOI 10.1097/CCM.0b013e3182186ed6; Frontera JA, 2011, NEUROCRIT CARE, V14, P260, DOI 10.1007/s12028-010-9418-2; Frontera JA, 2009, STROKE, V40, P1963, DOI 10.1161/STROKEAHA.108.544700; Hankey GJ, 2007, NEUROLOGY, V68, P1583, DOI 10.1212/01.wnl.0000260967.77422.97; HARTLEY C, 1995, BRIT J NEUROSURG, V9, P179, DOI 10.1080/02688699550041520; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; Jain A, 2013, NEUROCRIT CARE, V19, P342, DOI 10.1007/s12028-013-9878-2; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kong KH, 2014, NEUROREHABILITATION, V35, P221, DOI 10.3233/NRE-141110; Kowalski RG, 2013, NEUROCRIT CARE, V19, P269, DOI 10.1007/s12028-013-9929-8; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Naidech AM, 2009, NEUROCRIT CARE, V11, P45, DOI 10.1007/s12028-009-9186-z; Qureshi AI, 2014, WORLD NEUROSURG, V82, pE579, DOI 10.1016/j.wneu.2014.07.008; Rost NS, 2008, STROKE, V39, P2304, DOI 10.1161/STROKEAHA.107.512202; Scheunemann LP, 2012, AM J RESP CRIT CARE, V186, P480, DOI 10.1164/rccm.201204-0710CP; TEASDALE G, 1974, LANCET, V2, P81; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Varelas PN, 2009, J NEUROSURG, V111, P396, DOI 10.3171/2009.3.JNS08493; Varelas PN, 2008, SEMIN NEUROL, V28, P726, DOI 10.1055/s-0028-1105969; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Wijdicks EFM, 2004, CRIT CARE MED, V32, P2332, DOI 10.1097/01.CCM.0000145949.34618.E1; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72	35	19	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2016	44	6					1161	1172		10.1097/CCM.0000000000001570			12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL9EK	WOS:000375944200045	26807687				2022-02-06	
J	Kasprowicz, M; Burzynska, M; Melcer, T; Kuebler, A				Kasprowicz, Magdalena; Burzynska, Malgorzata; Melcer, Tomasz; Kuebler, Andrzej			A comparison of the Full Outline of UnResponsiveness (FOUR) score and Glasgow Coma Score (GCS) in predictive modelling in traumatic brain injury	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Full Outline of UnResponsiveness score; Glasgow Coma Score; predictive modelling; traumatic brain injury	SCALE; VALIDATION; CONSCIOUSNESS; PROGNOSIS; MORTALITY	Objectives: To compare the performance of multivariate predictive models incorporating either the Full Outline of UnResponsiveness (FOUR) score or Glasgow Coma Score (GCS) in order to test whether substituting GCS with the FOUR score in predictive models for outcome in patients after TBI is beneficial. Material and methods: A total of 162 TBI patients were prospectively enrolled in the study. Stepwise logistic regression analysis was conducted to compare the prediction of (1) in-ICU mortality and (2) unfavourable outcome at 3 months post-injury using as predictors either the FOUR score or GCS along with other factors that may affect patient outcome. The areas under the ROC curves (AUCs) were used to compare the discriminant ability and predictive power of the models. The internal validation was performed with bootstrap technique and expressed as accuracy rate (AcR). Results: The FOUR score, age, the CT Rotterdam score, systolic ABP and being placed on ventilator within day one (model 1: AUC: 0.906 +/- 0.024; AcR: 80.3 +/- 4.8%) performed equally well in predicting in-ICU mortality as the combination of GCS with the same set of predictors plus pupil reactivity (model 2: AUC: 0.913 +/- 0.022; AcR: 81.1 +/- 4.8%). The CT Rotterdam score, age and either the FOUR score (model 3) or GCS (model 4) equally well predicted unfavourable outcome at 3 months post-injury (AUC: 0.852 +/- 0.037 vs. 0.866 +/- 0.034; AcR: 72.3 +/- 6.6% vs. 71.9%+/- 6.6%, respectively). Adding the FOUR score or GCS at discharge from ICU to predictive models for unfavourable outcome increased significantly their performances (AUC: 0.895 +/- 0.029, p=0.05; AcR: 76.1 +/- 6.5%; p<0.004 when compared with model 3; and AUC: 0.918 +/- 0.025, p<0.05; AcR: 79.6 +/- 7.2%, p<0.009 when compared with model 4), but there was no benefit from substituting GCS with the FOUR score. Conclusion: Results showed that FOUR score and GCS perform equally well in multivariate predictive modelling in TBI.	[Kasprowicz, Magdalena; Melcer, Tomasz] Wroclaw Univ Technol, Dept Biomed Engn, PL-50370 Wroclaw, Poland; [Burzynska, Malgorzata; Kuebler, Andrzej] Wroclaw Med Univ, Dept Anaesthesiol, Borowska 213, PL-50556 Wroclaw, Poland; [Burzynska, Malgorzata; Kuebler, Andrzej] Wroclaw Med Univ, Intens Care Unit, Borowska 213, PL-50556 Wroclaw, Poland		Kuebler, A (corresponding author), Wroclaw Med Univ, Dept Anaesthesiol, Borowska 213, PL-50556 Wroclaw, Poland.; Kuebler, A (corresponding author), Wroclaw Med Univ, Intens Care Unit, Borowska 213, PL-50556 Wroclaw, Poland.	andrzej.kubler@anest.am.wroc.pl		Kasprowicz, Magdalena/0000-0002-2271-7737; Burzynska, Malgorzata/0000-0003-2318-7130	National Science Centre (Poland) [2013/09/B/NZ4/01343]	This study was partially supported by National Science Centre (Poland) Grant no. 2013/09/B/NZ4/01343.	Akavipat P, 2009, NEUROL MED-CHIR, V49, P565, DOI 10.2176/nmc.49.565; Bruno MA, 2011, NEUROCRIT CARE, V15, P447, DOI 10.1007/s12028-011-9547-2; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; Chen BX, 2013, ACTA NEUROCHIR, V155, P2133, DOI 10.1007/s00701-013-1854-2; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Heidegger CP, 2005, INTENS CARE MED, V31, P1676, DOI 10.1007/s00134-005-2831-x; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; JENNETT B, 1975, LANCET, V1, P480; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; Okasha AS, 2014, NEUROCRIT CARE, V21, P496, DOI 10.1007/s12028-014-9995-6; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Sadaka F, 2012, NEUROCRIT CARE, V16, P95, DOI 10.1007/s12028-011-9617-5; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wijdicks EFM, 2015, CRIT CARE MED, V43, P439, DOI 10.1097/CCM.0000000000000707; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolf CA, 2007, MAYO CLIN PROC, V82, P435, DOI 10.4065/82.4.435	30	19	22	0	13	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	MAY 3	2016	30	2					211	220		10.3109/02688697.2016.1161173			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3LK	WOS:000373399900010	27001246				2022-02-06	
J	Bick, SKB; Eskandar, EN				Bick, Sarah K. B.; Eskandar, Emad N.			Neuromodulation for restoring memory	NEUROSURGICAL FOCUS			English	Article						deep brain stimulation; memory; Alzheimer disease; traumatic brain injury	DEEP-BRAIN-STIMULATION; INTRACRANIAL SELF-STIMULATION; NUCLEUS BASALIS MAGNOCELLULARIS; TRANSCRANIAL MAGNETIC STIMULATION; ACTIVE-AVOIDANCE RETENTION; HIGH-FREQUENCY STIMULATION; VAGUS NERVE-STIMULATION; TEMPORAL-LOBE EPILEPSY; ALZHEIMERS-DISEASE; ELECTRICAL-STIMULATION	Disorders of learning and memory have a large social and economic impact in today's society. Unfortunately, existing medical treatments have shown limited clinical efficacy or potential for modification of the disease course. Deep brain stimulation is a successful treatment for movement disorders and has shown promise in a variety of other diseases including psychiatric disorders. The authors review the potential of neuromodulation for the treatment of disorders of learning and memory. They briefly discuss learning circuitry and its involvement in Alzheimer disease and traumatic brain injury. They then review the literature supporting various targets for neuromodulation to improve memory in animals and humans. Multiple targets including entorhinal cortex, fornix, nucleus basalis of Meynert, basal ganglia, and pedunculopontine nucleus have shown a promising potential for improving dysfunctional memory by mechanisms such as altering firing patterns in neuronal networks underlying memory and increasing synaptic plasticity and neurogenesis. Significant work remains to be done to translate these findings into durable clinical therapies.	[Bick, Sarah K. B.; Eskandar, Emad N.] Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St, Boston, MA 02114 USA		Bick, SKB (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, 55 Fruit St, Boston, MA 02114 USA.	sbick@partners.org					Aldavert-Vera L, 2013, BEHAV BRAIN RES, V250, P46, DOI 10.1016/j.bbr.2013.04.025; Arrieta-Cruz I, 2010, TRANSL NEUROSCI, V1, P188, DOI 10.2478/v10134-010-0023-x; Bari A, 2014, NEUROSURG CLIN N AM, V25, P137, DOI 10.1016/j.nec.2013.08.004; Berger TW, 2012, IEEE PULSE, V3, P17, DOI 10.1109/MPUL.2012.2205775; Berger TW, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046017; Boggio PS, 2012, BRAIN STIMUL, V5, P223, DOI 10.1016/j.brs.2011.06.006; Boix-Trelis N, 2006, LEARN MEMORY, V13, P783, DOI 10.1101/lm.305306; Chen N, 2014, CHINESE MED J-PEKING, V127, P125, DOI 10.3760/cma.j.issn.0366-6999.20131025; Costa A, 2010, PARKINSONISM RELAT D, V16, P64, DOI 10.1016/j.parkreldis.2009.05.009; Cotelli M, 2012, NEUROCASE, V18, P217, DOI 10.1080/13554794.2011.588176; Custodio JCD, 2013, BRAIN STIMUL, V6, P261, DOI 10.1016/j.brs.2012.07.004; Dhaliwal SK, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00119; Encinas JM, 2011, J COMP NEUROL, V519, P6, DOI 10.1002/cne.22503; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2013, BRAIN STIMUL, V6, P270, DOI 10.1016/j.brs.2012.08.001; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fisher R, 2010, EPILEPSIA, V51, P899, DOI 10.1111/j.1528-1167.2010.02536.x; Fontaine D, 2013, J ALZHEIMERS DIS, V34, P315, DOI 10.3233/JAD-121579; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Freund HJ, 2009, ARCH NEUROL-CHICAGO, V66, P781, DOI 10.1001/archneurol.2009.102; Gondard E, 2015, BRAIN STIMUL, V8, P1058, DOI 10.1016/j.brs.2015.07.044; Gonzalez MMC, 2013, J NEUROTRAUM, V30, P119, DOI 10.1089/neu.2012.2499; Gratwicke J, 2013, NEUROSCI BIOBEHAV R, V37, P2676, DOI 10.1016/j.neubiorev.2013.09.003; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Guo Yi, 2001, Frontiers of Medical and Biological Engineering, V11, P237, DOI 10.1163/156855701321138905; Hamani C, 2008, ANN NEUROL, V63, P119, DOI 10.1002/ana.21295; Hamani C, 2011, EXP NEUROL, V232, P100, DOI 10.1016/j.expneurol.2011.08.023; Hamani C, 2010, EXP NEUROL, V225, P154, DOI 10.1016/j.expneurol.2010.06.007; Hanell A, 2015, J NEUROTRAUM, V32, P1590, DOI 10.1089/neu.2014.3592; Hansen N, 2014, FRONT NEUROL, V5, DOI [10.3389/fpsyg.2014.01052, 10.3389/fneur.2014.00080]; Hao S, 2015, NATURE, V526, P430, DOI 10.1038/nature15694; Hardenacke Katja, 2013, Front Psychiatry, V4, P159, DOI 10.3389/fpsyt.2013.00159; Hardenacke K, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.12.005; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hescham S, 2015, BEHAV BRAIN RES, V292, P353, DOI 10.1016/j.bbr.2015.06.032; Hescham S, 2013, NEUROSCI BIOBEHAV R, V37, P2666, DOI 10.1016/j.neubiorev.2013.09.002; Hescham S, 2013, BRAIN STIMUL, V6, P72, DOI 10.1016/j.brs.2012.01.008; Hotta H, 2007, J PHYSIOL SCI, V57, P383, DOI 10.2170/physiolsci.SC008107; Hotta H, 2009, NEUROSCI RES, V63, P122, DOI 10.1016/j.neures.2008.11.004; Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273; Hu R, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0975; Huguet G, 2009, NEUROSCIENCE, V162, P359, DOI 10.1016/j.neuroscience.2009.04.074; Jausovec N, 2014, BIOL PSYCHOL, V96, P42, DOI 10.1016/j.biopsycho.2013.11.006; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; Jeong DU, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/568587; Kadar E, 2011, GENES BRAIN BEHAV, V10, P69, DOI 10.1111/j.1601-183X.2010.00609.x; Kadar E, 2014, BEHAV BRAIN RES, V274, P43, DOI 10.1016/j.bbr.2014.07.050; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knowlton B, 2012, NEW ENGL J MED, V366, P502; Kohler S, 2004, J COGNITIVE NEUROSCI, V16, P178, DOI 10.1162/089892904322984490; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Koubeissi MZ, 2013, ANN NEUROL, V74, P223, DOI 10.1002/ana.23915; Lacruz ME, 2010, NEUROSCIENCE, V170, P623, DOI 10.1016/j.neuroscience.2010.06.042; Laxton Adrian W, 2013, Handb Clin Neurol, V116, P307, DOI 10.1016/B978-0-444-53497-2.00025-5; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lee DJ, 2013, J NEUROTRAUM, V30, P131, DOI 10.1089/neu.2012.2646; Lee H, 2013, TRENDS COGN SCI, V17, P574, DOI 10.1016/j.tics.2013.09.002; Liu A, 2015, ELIFE, V4, DOI 10.7554/eLife.04803; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lyketsos Constantine G, 2012, Innov Clin Neurosci, V9, P10; Mair RG, 2008, J NEUROSCI, V28, P14293, DOI 10.1523/JNEUROSCI.3301-08.2008; Mannu P, 2011, CLIN INTERV AGING, V6, P207, DOI 10.2147/CIA.S23394; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McLachlan RS, 2010, EPILEPSIA, V51, P304, DOI 10.1111/j.1528-1167.2009.02332.x; McLin DE, 2002, P NATL ACAD SCI USA, V99, P4002, DOI 10.1073/pnas.062057099; McNaughton N, 2006, HIPPOCAMPUS, V16, P1102, DOI 10.1002/hipo.20235; Merrill CA, 2006, J CLIN PSYCHIAT, V67, P1171, DOI 10.4088/JCP.v67n0801; Miatton M, 2011, EPILEPSY BEHAV, V22, P759, DOI 10.1016/j.yebeh.2011.09.016; Miller JP, 2015, BRAIN, V138, P1833, DOI 10.1093/brain/awv095; Mollion H, 2011, MOVEMENT DISORD, V26, P2019, DOI 10.1002/mds.23769; Montero-Pastor A, 2004, BEHAV BRAIN RES, V154, P41, DOI 10.1016/j.bbr.2004.01.017; Montero-Pastor A, 2001, BRAIN RES, V900, P337, DOI 10.1016/S0006-8993(01)02325-3; Mure H, 2012, J NEUROSCI, V32, P2804, DOI 10.1523/JNEUROSCI.4331-11.2012; Neren D, 2015, NEUROCRIT CARE; Obeso JA, 2001, NEW ENGL J MED, V345, P956, DOI 10.1056/nejmoa000827; Oh YS, 2012, SEIZURE-EUR J EPILEP, V21, P183, DOI 10.1016/j.seizure.2011.12.003; OJEMANN GA, 1971, BRAIN, V94, P225, DOI 10.1093/brain/94.2.225; Pachalska M, 2011, MED SCI MONITOR, V17, pCS120, DOI 10.12659/MSM.881970; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Parikh S, 2007, INT ANESTHESIOL CLIN, V45, P119, DOI 10.1097/AIA.0b013e318078cfe7; Paterno R, 2016, J NEUROTRAUMA; Pereira Julio Leonardo Barbosa, 2014, Surg Neurol Int, V5, pS385, DOI 10.4103/2152-7806.140191; Plassman BL, 2007, NEUROEPIDEMIOLOGY, V29, P125, DOI 10.1159/000109998; RASMUSSON DD, 1992, BRAIN RES, V594, P150, DOI 10.1016/0006-8993(92)91041-C; Ruiz-Medina J, 2008, NEUROBIOL LEARN MEM, V89, P574, DOI 10.1016/j.nlm.2007.11.005; Salviati M, 2014, BRAIN STIMUL, V7, P492, DOI 10.1016/j.brs.2014.02.005; Sankar T, 2015, BRAIN STIMUL, V8, P645, DOI 10.1016/j.brs.2014.11.020; Scherder EJA, 1998, BIOL PSYCHIAT, V43, P417, DOI 10.1016/S0006-3223(97)00208-4; Schumacher A, 2011, BEHAV BRAIN RES, V222, P368, DOI 10.1016/j.bbr.2011.04.001; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Sharma Mayur, 2015, J Clin Med Res, V7, P501, DOI 10.14740/jocmr2127w; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Sjogren MJC, 2002, J CLIN PSYCHIAT, V63, P972, DOI 10.4088/JCP.v63n1103; Smith GS, 2012, ARCH NEUROL-CHICAGO, V69, P1141, DOI 10.1001/archneurol.2012.590; Sole-Padulles C, 2006, CEREB CORTEX, V16, P1487, DOI 10.1093/cercor/bhj083; Soriano-Mas C, 2005, BEHAV BRAIN RES, V160, P141, DOI 10.1016/j.bbr.2004.11.025; Soriano-Mas C, 2007, BRAIN RES BULL, V74, P51, DOI 10.1016/j.brainresbull.2007.05.003; Stefani A, 2010, CLIN EEG NEUROSCI, V41, P82, DOI 10.1177/155005941004100207; Stone SSD, 2011, J NEUROSCI, V31, P13469, DOI 10.1523/JNEUROSCI.3100-11.2011; Stone SSD, 2011, HIPPOCAMPUS, V21, P1348, DOI 10.1002/hipo.20845; Suthana N, 2014, NEUROIMAGE, V85, P996, DOI 10.1016/j.neuroimage.2013.07.066; Sweeney-Reed CM, 2014, ELIFE, V3, DOI 10.7554/eLife.05352; Sweet JA, 2014, HIPPOCAMPUS, V24, P1592, DOI 10.1002/hipo.22338; Toda H, 2008, J NEUROSURG, V108, P132, DOI 10.3171/JNS/2008/108/01/0132; TURNBULL IM, 1985, APPL NEUROPHYSIOL, V48, P216; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Vignal JP, 2007, BRAIN, V130, P88, DOI 10.1093/brain/awl329; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Zhang C, 2015, CHINESE MED J-PEKING, V128, P1190, DOI 10.4103/0366-6999.156114	113	19	20	5	28	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	MAY	2016	40	5							E5	10.3171/2016.3.FOCUS162			12	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	DK7PX	WOS:000375119300007	27132526	gold			2022-02-06	
J	Cunha, MP; Lieberknecht, V; Ramos-Hryb, AB; Olescowicz, G; Ludka, FK; Tasca, CI; Gabilan, NH; Rodrigues, ALS				Cunha, Mauricio P.; Lieberknecht, Vicente; Ramos-Hryb, Ana Belen; Olescowicz, Gislaine; Ludka, Fabiana K.; Tasca, Carla I.; Gabilan, Nelson H.; Rodrigues, Ana Lucia S.			Creatine affords protection against glutamate-induced nitrosative and oxidative stress	NEUROCHEMISTRY INTERNATIONAL			English	Article						Cellular viability; Creatine; Glutamate; Hydrogen peroxide; Nitric oxide	CENTRAL-NERVOUS-SYSTEM; PENTYLENETETRAZOL-INDUCED SEIZURES; NEUROBLASTOMA SH-SY5Y CELLS; NITRIC-OXIDE PRODUCTION; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; REACTIVE OXYGEN; IN-VITRO; ANTIOXIDANT PROPERTIES; NEURONAL CELLS	Creatine has been reported to exert beneficial effects in several neurodegenerative diseases in which glutamatergic excitotoxicity and oxidative stress play an etiological role. The purpose of this study was to investigate the protective effects of creatine, as compared to the N-Methyl-D-Aspartate (NMDA) receptor antagonist dizocilpine (MK-801), against glutamate or hydrogen peroxide (H2O2)-induced injury in human neuroblastoma SH-SY5Y cells. Exposure of cells to glutamate (60-80 mM) or H2O2 (200-300 mu M) for 24 h decreased cellular viability and increased dichlorofluorescein (DCF) fluorescence (indicative of increased reactive oxygen species, ROS) and nitric oxide (NO) production (assessed by mono-nitrogen oxides, NOx, levels). Creatine (1-10 mM) or MK-801 (0.1-10 mu M) reduced glutamate- and H2O2-induced toxicity. The protective effect of creatine against glutamate-induced toxicity involves its antioxidant effect, since creatine, similar to MK-801, prevented the increase on DCF fluorescence induced by glutamate or H2O2. Furthermore, creatine or MK-801 blocked gltitamate- and H2O2-induced increases in NOx levels. In another set of experiments, the repeated, but not acute, administration of creatine (300 mg/kg, po) in mice prevented the decreases on cellular viability and mitochondrial membrane potential (assessed by tetramethylrhodamine ethyl ester, TMRE, probe) of hippocampal slices incubated with glutaihate (10 mM). Creatine concentration-dependent decreased the amount of nitrite formed in the reaction of oxygen with NO produced from sodium nitroprusside solution, suggesting that its protective effect against glutamate or H2O2-induced toxicity might be due to its scavenger activity. Overall, the results suggest that creatine may be useful as adjuvant therapy for neurodegenerative disease treatments. (C) 2016 Elsevier Ltd. All rights reserved.	[Cunha, Mauricio P.; Lieberknecht, Vicente; Ramos-Hryb, Ana Belen; Olescowicz, Gislaine; Ludka, Fabiana K.; Tasca, Carla I.; Gabilan, Nelson H.; Rodrigues, Ana Lucia S.] Univ Fed Santa Catarina, Ctr Biol Sci, Dept Biochem, Campus Univ, BR-88040900 Florianopolis, SC, Brazil		Cunha, MP (corresponding author), Univ Fed Santa Catarina, Ctr Biol Sci, Dept Biochem, Campus Univ, BR-88040900 Florianopolis, SC, Brazil.	mauricio.personal@gmail.com	Rodrigues, Ana Lucia/P-6869-2015; Lieberknecht, Vicente/L-2121-2017; Cunha, Mauricio/J-7135-2013; Lieberknecht, Vicente/AAC-6952-2019; Hryb, Ana Belen B R-H Ramos/P-3615-2014; Tasca, Carla Ines/AAB-8287-2019	Rodrigues, Ana Lucia/0000-0001-6285-8780; Lieberknecht, Vicente/0000-0002-8418-2352; Cunha, Mauricio/0000-0002-0269-7521; Lieberknecht, Vicente/0000-0002-8418-2352; Hryb, Ana Belen B R-H Ramos/0000-0003-3376-5977; Tasca, Carla Ines/0000-0002-3414-6150; Olescowicz, Gislaine/0000-0002-7462-3150	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [308723/2013-9, 449436/2014-4]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Apoio a Pesquisa Cientifica e Tecnologica do Estado de Santa Catarina (FAPESC)Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA; Rede Instituto Brasileiro de Neurociencia (IBN-Net/CNPq); Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC) Project/PRONEX Program (CNPq/FAPESC) [1262/2012-9]	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, #308723/2013-9, #449436/2014-4), Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior (CAPES), Fundacao de Apoio a Pesquisa Cientifica e Tecnologica do Estado de Santa Catarina (FAPESC), Rede Instituto Brasileiro de Neurociencia (IBN-Net/CNPq), Nucleo de Excelencia em Neurociencias Aplicadas de Santa Catarina (NENASC) Project/PRONEX Program (CNPq/FAPESC, # 1262/2012-9).	Andres RH, 2008, BRAIN RES BULL, V76, P329, DOI 10.1016/j.brainresbull.2008.02.035; ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Ballaz S, 2013, J NEUROSCI RES, V91, P1609, DOI 10.1002/jnr.23276; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; Beister A, 2004, J NEURAL TRANSM-SUPP, P117; Blandini F, 1996, MOL NEUROBIOL, V12, P73, DOI 10.1007/BF02740748; Blandini F, 1996, FUNCT NEUROL, V11, P3; BREDT DS, 1992, NEURON, V8, P3, DOI 10.1016/0896-6273(92)90104-L; Brewer GJ, 2000, J NEUROCHEM, V74, P1968, DOI 10.1046/j.1471-4159.2000.0741968.x; Cacabelos R, 1999, INT J GERIATR PSYCH, V14, P3, DOI 10.1002/(SICI)1099-1166(199901)14:1<3::AID-GPS897>3.0.CO;2-7; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Capone C, 2013, FREE RADICAL BIO MED, V63, P99, DOI 10.1016/j.freeradbiomed.2013.05.007; CARTER AJ, 1995, J NEUROCHEM, V64, P2691; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Cheng YH, 2014, BIOTECHNOL LETT, V36, P1615, DOI 10.1007/s10529-014-1521-6; Coco M, 2012, J SPORT MED PHYS FIT, V52, P165; Colle D, 2012, PHARM BIOL, V50, P883, DOI 10.3109/13880209.2011.641981; Colle D, 2012, J MED FOOD, V15, P549, DOI 10.1089/jmf.2011.0282; Contestabile A, 2000, BRAIN RES REV, V32, P476, DOI 10.1016/S0165-0173(00)00018-7; Contestabile A, 2003, CURR MED CHEM, V10, P2147, DOI 10.2174/0929867033456792; Cooper R, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-33; Cunha MP, 2013, NEUROSCIENCE, V238, P185, DOI 10.1016/j.neuroscience.2013.02.030; Cunha MP, 2015, AMINO ACIDS, V47, P795, DOI 10.1007/s00726-014-1910-0; Cunha MP, 2012, J PSYCHOPHARMACOL, V26, P1489, DOI 10.1177/0269881112447989; Deminice R, 2014, EUR J NUTR, V53, P1355, DOI 10.1007/s00394-013-0636-1; Deminice R, 2009, BRIT J NUTR, V102, P110, DOI 10.1017/S0007114508162985; DIGUISEPPI J, 1984, CRC CR REV TOXICOL, V12, P315, DOI 10.3109/10408448409044213; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Dong XX, 2009, ACTA PHARMACOL SIN, V30, P379, DOI 10.1038/aps.2009.24; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Esplugues JV, 2002, BRIT J PHARMACOL, V135, P1079, DOI 10.1038/sj.bjp.0704569; Fimognari C, 2009, MUTAT RES-FUND MOL M, V670, P59, DOI 10.1016/j.mrfmmm.2009.07.005; Forman HJ, 2015, FREE RADICAL BIO MED, V78, P233, DOI 10.1016/j.freeradbiomed.2014.10.504; Royes LF, 2008, NEUROCHEM INT, V53, P33, DOI 10.1016/j.neuint.2008.04.008; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Genius J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030554; Gualano B, 2012, AMINO ACIDS, V43, P519, DOI 10.1007/s00726-011-1132-7; Guerrero-Ontiveros ML, 1998, MOL CELL BIOCHEM, V184, P427, DOI 10.1023/A:1006895414925; Guidi C, 2008, BBA-GEN SUBJECTS, V1780, P16, DOI 10.1016/j.bbagen.2007.09.018; Hosamani R, 2010, NEUROCHEM RES, V35, P1402, DOI 10.1007/s11064-010-0198-z; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/728342; Hu Y, 2014, J MOL NEUROSCI, V53, P600, DOI 10.1007/s12031-013-0226-y; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Iadarola ND, 2015, THER ADV CHRONIC DIS, V6, P97, DOI 10.1177/2040622315579059; Juravleva E, 2005, J NEUROSCI RES, V79, P224, DOI 10.1002/jnr.20291; Juravleva E, 2003, NATO SCI SERIES LIFE, V343, P113; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; KERWIN JF, 1995, J MED CHEM, V38, P4343, DOI 10.1021/jm00022a001; Kingsley MIC, 2009, OXID MED CELL LONGEV, V2, P247, DOI 10.4161/oxim.2.4.9415; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V290, P47, DOI 10.1006/bbrc.2001.6164; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lin Y, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1928; Saraiva ALL, 2012, BRAIN RES BULL, V87, P180, DOI 10.1016/j.brainresbull.2011.10.010; Lorrio S, 2013, NEUROPHARMACOLOGY, V67, P403, DOI 10.1016/j.neuropharm.2012.12.001; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mailly F, 1999, J NEUROCHEM, V73, P1181, DOI 10.1046/j.1471-4159.1999.0731181.x; Malcon C, 2000, BRAIN RES, V860, P195, DOI 10.1016/S0006-8993(00)02038-2; Manosso LM, 2013, FOOD FUNCT, V4, P1776, DOI 10.1039/c3fo60246j; MARCOCCI L, 1994, BIOCHEM MOL BIOL INT, V34, P531; Matthews RT, 1999, EXP NEUROL, V157, P142, DOI 10.1006/exnr.1999.7049; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mikati MA, 2004, BRAIN INJURY, V18, P1229, DOI 10.1080/02699050410001719880; Molz S, 2008, NEUROCHEM RES, V33, P27, DOI 10.1007/s11064-007-9402-1; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURPHY ME, 1991, P NATL ACAD SCI USA, V88, P10860, DOI 10.1073/pnas.88.23.10860; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nciri R, 2013, INT J NEUROPSYCHOPH, V16, P365, DOI 10.1017/S1461145712000132; Neukirchen M, 2012, BRIT J ANAESTH, V109, P887, DOI 10.1093/bja/aes303; Parada E, 2010, FREE RADICAL BIO MED, V49, P1815, DOI 10.1016/j.freeradbiomed.2010.09.017; Parodi M, 2003, BRAIN RES, V963, P197, DOI 10.1016/S0006-8993(02)03976-8; Cunha MP, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554945; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; Pereira CMF, 1997, FREE RADICAL BIO MED, V23, P637, DOI 10.1016/S0891-5849(97)00020-8; Persky AM, 2001, PHARMACOL REV, V53, P161; Petroni D, 2013, ENVIRON TOXICOL, V28, P700, DOI 10.1002/tox.20765; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; Quincozes-Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064372; Rae CD, 2015, NEUROCHEM INT, V89, P249, DOI 10.1016/j.neuint.2015.08.010; Rahimi R, 2011, J STRENGTH COND RES, V25, P3448, DOI 10.1519/JSC.0b013e3182162f2b; Rambo LM, 2013, AMINO ACIDS, V44, P857, DOI 10.1007/s00726-012-1408-6; Rambo LM, 2009, NEUROCHEM INT, V55, P333, DOI 10.1016/j.neuint.2009.04.007; Reisberg B, 2003, NEW ENGL J MED, V348, P1333, DOI 10.1056/NEJMoa013128; Royes LFF, 2006, PHARMACOL BIOCHEM BE, V83, P136, DOI 10.1016/j.pbb.2005.12.017; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Sartini S, 2012, J NEUROSCI RES, V90, P435, DOI 10.1002/jnr.22762; Schubert D, 2001, J NEUROSCI, V21, P7455, DOI 10.1523/JNEUROSCI.21-19-07455.2001; Sestili P, 2006, FREE RADICAL BIO MED, V40, P837, DOI 10.1016/j.freeradbiomed.2005.10.035; Sestili P, 2011, AMINO ACIDS, V40, P1385, DOI 10.1007/s00726-011-0875-5; Sestili P, 2009, MOL NUTR FOOD RES, V53, P1187, DOI 10.1002/mnfr.200800504; Siegel S, 2012, PHARMACOL BIOCHEM BE, V100, P653, DOI 10.1016/j.pbb.2011.11.002; Sonsalla PK, 1998, AMINO ACIDS, V14, P69, DOI 10.1007/BF01345245; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; Sulkowski G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113954; Sullivan PG, 2000, ANN NEUROL, V48, P723, DOI 10.1002/1531-8249(200011)48:5&lt;723::AID-ANA5&gt;3.0.CO;2-W; Sun DD, 1998, AM J PHYSIOL-CELL PH, V275, pC772, DOI 10.1152/ajpcell.1998.275.3.C772; Sun HZ, 2010, CHINESE MED J-PEKING, V123, P1052, DOI 10.3760/cma.j.issn.0366-6999.2010.08.014; Sun ZW, 2010, NEUROSCI BULL, V26, P8, DOI 10.1007/s12264-010-0813-7; Swaminathan A, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00282; Taveira M, 2014, J STEROID BIOCHEM, V140, P106, DOI 10.1016/j.jsbmb.2013.12.013; Tian JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095777; Torreilles F, 1999, BRAIN RES REV, V30, P153, DOI 10.1016/S0165-0173(99)00014-4; Tzschentke TM, 2002, AMINO ACIDS, V23, P147, DOI 10.1007/s00726-001-0120-8; van Marum RJ, 2009, NEUROPSYCH DIS TREAT, V5, P237; Vielhaber S, 2001, EXP NEUROL, V172, P377, DOI 10.1006/exnr.2001.7797; Wei TT, 2000, BBA-MOL CELL RES, V1498, P72, DOI 10.1016/S0167-4889(00)00078-1; Wyss M, 2002, NEUROSCIENCE, V112, P243, DOI 10.1016/S0306-4522(02)00088-X; Xu MF, 2012, ACTA PHARMACOL SIN, V33, P578, DOI 10.1038/aps.2012.3; Yamamoto M, 2004, NEUROSCIENCE, V128, P163, DOI 10.1016/j.neuroscience.2004.06.026; Young JF, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-9; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhu XH, 2009, TOXICOL APPL PHARM, V240, P286, DOI 10.1016/j.taap.2009.06.020	117	19	20	0	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAY	2016	95						4	14		10.1016/j.neuint.2016.01.002			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DL3EB	WOS:000375515900002	26804444	hybrid			2022-02-06	
J	Heyer, GL; Young, JA; Rose, SC; McNally, KA; Fischer, AN				Heyer, Geoffrey L.; Young, Julie A.; Rose, Sean C.; McNally, Kelly A.; Fischer, Anastasia N.			Post-traumatic headaches correlate with migraine symptoms in youth with concussion	CEPHALALGIA			English	Article						Concussion; post-traumatic headache; migraine; pediatric; adolescent; traumatic brain injury	TRAUMATIC BRAIN-INJURY; TENSION-TYPE HEADACHE; NECK PAIN; RECOVERY; ATTACKS; PREVALENCE; VALIDITY; SPORT	Objective The term post-traumatic migraine (PTM) has been used to describe post-traumatic headaches (PTHs) that have associated migraine features, but studies of this relationship are lacking. The objective of the present study was to determine whether PTH correlates strongly with migraine symptoms among youth with concussion. Methods Twenty-three symptoms were analyzed from a retrospective cohort of 1953 pediatric patients with concussion. A principal component analysis (PCA) with oblique Promax rotation was conducted to explore underlying symptom relationships in the full cohort and in subcohorts stratified by the presence (n=414) or absence (n=1526) of premorbid headache. Results The mean patient age was 14.1 years; 63% were male. Headache was the most common postconcussion symptom, acknowledged by 69.4% of patients. When considering the full cohort, the PCA demonstrated clustering of headache with photophobia, phonophobia, nausea, dizziness, and neck pain. Similar clustering was present among patients without premorbid headaches. Repeating the analysis in the patients with preconcussion headaches led to elimination of neck pain from the cluster. Conclusions PTH correlates strongly with other migraine symptoms among youth with concussion, regardless of premorbid headaches. This clustering of migraine symptoms supports the existence of PTM as a distinct clinical entity in some patients.	[Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Neurol, Columbus, OH 43205 USA; [Heyer, Geoffrey L.; Rose, Sean C.] Ohio State Univ, Dept Neurol, Columbus, OH 43205 USA; [Young, Julie A.; Fischer, Anastasia N.] Nationwide Childrens Hosp, Div Sports Med, Columbus, OH 43205 USA; [McNally, Kelly A.] Ohio State Univ, Nationwide Childrens Hosp, Div Pediat Psychol & Neuropsychol, Columbus, OH 43205 USA; [McNally, Kelly A.] Ohio State Univ, Dept Pediat, Columbus, OH 43205 USA		Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Pediat, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Nationwide Childrens Hosp, Dept Neurol, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.; Heyer, GL (corresponding author), Ohio State Univ, 700 Childrens Dr,ED-5, Columbus, OH 43205 USA.	geoffrey.heyer@nationwidechildrens.org		Rose, Sean/0000-0001-5177-7715; Heyer, Geoffrey/0000-0001-9334-3739			Aaltonen K, 2000, CEPHALALGIA, V20, P580, DOI 10.1046/j.1468-2982.2000.00089.x; Ashina S, 2015, CEPHALALGIA, V35, P211, DOI 10.1177/0333102414535110; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Blaschek A, 2014, CEPHALALGIA, V34, P895, DOI 10.1177/0333102414523338; BURKE EC, 1956, AMA J DIS CHILD, V92, P330, DOI 10.1001/archpedi.1956.02060030324002; Calhoun AH, 2011, HEADACHE, V51, P1388, DOI 10.1111/j.1526-4610.2011.01970.x; ESPIR MLE, 1972, BRIT MED J, V3, P352, DOI 10.1136/bmj.3.5822.352; Florencio LL, 2014, HEADACHE, V54, P1203, DOI 10.1111/head.12393; HAAS DC, 1969, J NEUROL NEUROSUR PS, V32, P548, DOI 10.1136/jnnp.32.6.548; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; HAYES RL, 1994, SEMIN NEUROL, V14, P25, DOI 10.1055/s-2008-1041055; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jolliffe I. T., 1986, PRINCIPAL COMPONENTS, DOI DOI 10.1007/978-1-4757-1904-8; Joyce AS, 2015, MED SCI SPORT EXER, V47, P1119, DOI 10.1249/MSS.0000000000000534; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McIntosh T K, 1986, NIDA Res Monogr, V75, P527; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MICHAEL MI, 1952, J PEDIATR-US, V41, P18, DOI 10.1016/S0022-3476(52)80024-1; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Piland SG, 2006, MED SCI SPORT EXER, V38, P27, DOI 10.1249/01.mss.0000183186.98212.d5; Piland SG, 2003, J ATHL TRAINING, V38, P104; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Radanov BP, 2001, EUR SPINE J, V10, P403, DOI 10.1007/s005860000227; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; VINK R, 1987, BIOCHEM BIOPH RES CO, V149, P594, DOI 10.1016/0006-291X(87)90409-8; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	40	19	19	2	13	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	APR	2016	36	4					309	316		10.1177/0333102415590240			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ2DS	WOS:000374014500002	26054363				2022-02-06	
J	Hughes, J; Maguire, S; Jones, M; Theobald, P; Kemp, A				Hughes, Jonathon; Maguire, Sabine; Jones, Michael; Theobald, Peter; Kemp, Alison			Biomechanical characteristics of head injuries from falls in children younger than 48 months	ARCHIVES OF DISEASE IN CHILDHOOD			English	Article							TRAUMATIC BRAIN-INJURY; LOW-HEIGHT FALLS; SKULL FRACTURES; INFANTS; CHILDHOOD; IMPACTS; BED; AGE	Background A fall-height threshold is important when evaluating the likelihood of structural head injury or abusive head trauma. This study investigates witnessed falls to correlate the fall characteristics with the extent of injury. Method Case-control study of children aged <= 48 months who attended one hospital following a fall from < 3 m (10 ft), comparing cases who sustained a skull fracture or intracranial injury (ICI) with controls, who had minor head injuries. Characteristics included: the mechanism of injury, surface of impact, site of impact to the head and fall height. Results Forty-seven children had a skull fracture or ICI, while 416 children had minor head injuries. The mean fall height for minor head injuries was significantly lower than that causing skull fracture/ICI (p< 0.001). No skull fracture/ICI was recorded in children who fell < 0.6 m (2 ft), based on the height of the head centre of gravity. Skull fractures/ICI were more likely in children aged <= 12 months (p< 0.001) from impacts to the temporal/ parietal or occipital region (p< 0.001), impacts onto wood (p= 0.004) and falls from a carer's arms, particularly when on stairs (p< 0.001). No significant difference was reported between the mean fall heights of children who had a simple skull fracture (n= 17) versus those who had a complex fracture or ICI (n= 30). Conclusions An infant is more likely to sustain a skull fracture/ICI from a fall above a 0.6 m (2 ft) threshold, based on the height of the head centre of gravity, or with a parietal/temporal or occipital impact. These variables should be recorded when evaluating the likelihood of skull fracture/ICI.	[Hughes, Jonathon; Jones, Michael; Theobald, Peter] Cardiff Univ, Cardiff Sch Engn, Inst Med Engn & Med Phys, Cardiff CF10 3AX, S Glam, Wales; [Maguire, Sabine; Kemp, Alison] Cardiff Sch Med, Inst Primary Care & Publ Hlth, Heath Pk, Cardiff CF14 4YS, S Glam, Wales		Kemp, A (corresponding author), Cardiff Sch Med, Inst Primary Care & Publ Hlth, Heath Pk, Cardiff CF14 4YS, S Glam, Wales.	KempAM@cf.ac.uk	Theobald, Peter S/C-2490-2013	Theobald, Peter S/0000-0002-3227-7130	Schools of Engineering and Medicine (Cardiff University)	JH received a doctoral scholarship to support this study, funded equally by the Schools of Engineering and Medicine (Cardiff University).	[Anonymous], 2004, INT CLASS EXT CAUS I; Chadwick DL, 2008, PEDIATRICS, V121, P1213, DOI 10.1542/peds.2007-2281; CHADWICK DL, 1991, J TRAUMA, V31, P1353, DOI 10.1097/00005373-199110000-00006; Coats B, 2008, J NEUROSURG-PEDIATR, V2, P321, DOI 10.3171/PED.2008.2.11.321; Cory CZ, 2006, FORENSIC SCI INT, V163, P102, DOI 10.1016/j.forsciint.2005.11.014; Crowe LM, 2012, INJURY, V43, P2141, DOI 10.1016/j.injury.2012.07.195; DUHAIME AC, 1992, PEDIATRICS, V90, P179; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; HALL JR, 1989, J TRAUMA, V29, P1273, DOI 10.1097/00005373-198909000-00015; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; HELFER RE, 1977, PEDIATRICS, V60, P533; Hettler J, 2003, PEDIATRICS, V111, P602, DOI 10.1542/peds.111.3.602; Ibrahim NG, 2012, INT J DEV NEUROSCI, V30, P201, DOI 10.1016/j.ijdevneu.2011.10.007; Ibrahim NG, 2010, J NEUROSURG-PEDIATR, V6, P57, DOI 10.3171/2010.3.PEDS09357; IDB, 2005, INJ DAT IDB VERS 1 1; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEVENTHAL JM, 1993, AM J DIS CHILD, V147, P87, DOI 10.1001/archpedi.1993.02160250089028; Loyd Andre M, 2010, Stapp Car Crash J, V54, P167; LYONS TJ, 1993, PEDIATRICS, V92, P125; Nakahira Y, 2000, COMBINED EVALUATION, P147; NICE, HEAD INJ TRIAG ASS I; Park SH, 2004, YONSEI MED J, V45, P229, DOI 10.3349/ymj.2004.45.2.229; Parslow RC, 2005, ARCH DIS CHILD, V90, P1182, DOI 10.1136/adc.2005.072405; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Prange Michael T, 2004, Stapp Car Crash J, V48, P279; Prange MT, 2003, J NEUROSURG, V99, P143, DOI 10.3171/jns.2003.99.1.0143; Reece RM, 2000, ARCH PEDIAT ADOL MED, V154, P11; Schneider LW, 1986, SIZE SHAPE HEAD NECK; SCHUTZMAN SA, 1993, ANN EMERG MED, V22, P535, DOI 10.1016/S0196-0644(05)81938-9; Snyder R.G., 1975, PHYS CHARACTERISTICS; Tarantino CA, 1999, PEDIATR EMERG CARE, V15, P5, DOI 10.1097/00006565-199902000-00002; Thomas AG, 2013, ARCH DIS CHILD, V98, P787, DOI 10.1136/archdischild-2013-304267; Thompson AK, 2011, ACCIDENT ANAL PREV, V43, P143, DOI 10.1016/j.aap.2010.07.020; Van Ee C, 2009, EVALUATION REFINEMEN; WEBER W, 1985, Z RECHTSMED, V94, P93; WEBER W, 1984, Z RECHTSMED, V92, P87, DOI 10.1007/BF02116216; WILLIAMS RA, 1991, J TRAUMA, V31, P1350, DOI 10.1097/00005373-199110000-00005	37	19	20	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-9888	1468-2044		ARCH DIS CHILD	Arch. Dis. Child.	APR	2016	101	4					310	315		10.1136/archdischild-2014-306803			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DH0VS	WOS:000372502800005	26384509				2022-02-06	
J	Jin, YC; Lei, J; Lin, YY; Gao, GY; Jiang, JY				Jin, Yichao; Lei, Jin; Lin, Yingying; Gao, Guo-yi; Jiang, Ji-yao			Autophagy Inhibitor 3-MA Weakens Neuroprotective Effects of Posttraumatic Brain Injury Moderate Hypothermia	WORLD NEUROSURGERY			English	Article						Apoptosis; Autophagy; Behavioral assessment; Moderate hypothermia; Traumatic brain injury	CONTROLLED CORTICAL IMPACT; REDUCES SECONDARY INJURY; ANTI-APOPTOTIC FUNCTION; HIPPOCAMPAL CELL-DEATH; FLUID-PERCUSSION MODEL; THERAPEUTIC HYPOTHERMIA; BEHAVIORAL DEFICITS; NEUROVASCULAR UNIT; BH3-ONLY PROTEIN; MILD HYPOTHERMIA	OBJECTIVE: The role of autophagy in moderate hypothermia in posttraumatic brain injury (post-TBI) remains elusive. In this study, we evaluated the protective role of autophagy in post-TBI moderate hypothermia. METHODS: Adult male Sprague-Dawley rats were randomly divided into 3 groups (n = 36/group): TBI with hypothermia group (sham), TBI with hypothermia and a single intracerebroventricular injection of saline (saline, 5 mu L), and TBI with hypothermia and a single intracerebroventricular injection of 3-methyladenine (600 nmol, diluted in 0.9% saline to a final volume of 5 mu L). All rats, except those in the behavioral tests, were killed at 24 hours after fluid percussion TBI. Immunohistochemistry staining, western blot, and transmission electron microscopy were performed to assess changes in apoptosis and autophagy after injection of 3-methyladenine. Motor function (beam-walk test) and spatial learning/memory (Morris water maze) were assessed on postoperative days 1-5 and 11-15, respectively. RESULTS: Our results showed downregulation of the expression level of microtubule-associated protein 1 light chain 3 and Beclin-1, aggravation of behavioral outcome, and increase of apoptosis. CONCLUSION: Our results suggest that the autophagy pathway is involved in the neuroprotective effect of post-TBI hypothermia and negative modulation of apoptosis may be 1 possible mechanism.	[Jin, Yichao; Lei, Jin; Lin, Yingying; Gao, Guo-yi; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China.	jiyaojiangrenji@126.com			National Science and Nature Grant [81271381]; National Key Project Grant [2012CB518100]	This work was supported by National Science and Nature Grant (No. 81271381), and National Key Project Grant (No. 2012CB518100).	Ahmad A, 2012, BRAIN BEHAV IMMUN, V26, P1310, DOI 10.1016/j.bbi.2012.07.021; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Celik SE, 2006, J NEUROTRAUM, V23, P1355, DOI 10.1089/neu.2006.23.1355; Ciechomska IA, 2009, ONCOGENE, V28, P2128, DOI 10.1038/onc.2009.60; Ciechomska IA, 2009, AUTOPHAGY, V5, P880, DOI 10.4161/auto.9096; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Crotzer VL, 2005, P NATL ACAD SCI USA, V102, P7779, DOI 10.1073/pnas.0503088102; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eldadah BA, 2000, J NEUROTRAUM, V17, P811, DOI 10.1089/neu.2000.17.811; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Heckmann BL, 2013, BRIT J PHARMACOL, V168, P163, DOI 10.1111/j.1476-5381.2012.02110.x; Huang XJ, 2014, J NEUROTRAUM, V31, P346, DOI 10.1089/neu.2013.2899; Jia F, 2014, J NEUROTRAUM, V31, P1225, DOI 10.1089/neu.2013.3230; Jia F, 2014, J NEUROTRAUM, V31, P387, DOI 10.1089/neu.2008.0814; Jia F, 2009, J NEUROTRAUM, V26, P243, DOI 10.1089/neu.2008.0670; Jiang JY, 2009, J NEUROTRAUM, V26, P399, DOI 10.1089/neu.2008.0525; Jin YC, 2015, WORLD NEUROSURG, V84, P420, DOI 10.1016/j.wneu.2015.03.039; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Liu D, 2002, J CEREBR BLOOD F MET, V22, P431, DOI 10.1097/00004647-200204000-00007; Logue SE, 2008, BIOCHEM SOC T, V36, P1, DOI 10.1042/BST0360001; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Mao Q, 2010, NEUROSURGERY, V66, P1134, DOI 10.1227/01.NEU.0000369612.31946.A2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Moore EM, 2011, INJURY, V42, P843, DOI 10.1016/j.injury.2011.03.027; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zhou CC, 2010, CHEMOTHERAPY, V56, P393, DOI 10.1159/000317750	54	19	22	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2016	88						433	446		10.1016/j.wneu.2015.10.055			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DK1CI	WOS:000374649700059	26547006				2022-02-06	
J	Sung, CW; Lee, HC; Chiang, YH; Chiu, WT; Chu, SF; Ou, JC; Tsai, SH; Liao, KH; Lin, CM; Lin, JW; Chen, GS; Li, WJ; Wang, JY				Sung, Chih-Wei; Lee, Hsin-Chien; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Chu, Shu-Fen; Ou, Ju-Chi; Tsai, Shin-Han; Liao, Kuo-Hsing; Lin, Chien-Min; Lin, Jia-Wei; Chen, Gunng-Shinng; Li, Wei-Jiun; Wang, Jia-Yi			Early dysautonomia detected by heart rate variability predicts late depression in female patients following mild traumatic brain injury	PSYCHOPHYSIOLOGY			English	Article						mTBI; Depression; Heart rate variability; Dysautonomia; Autonomic dysfunction	PROFESSIONAL FOOTBALL PLAYERS; CORONARY-ARTERY-DISEASE; MAJOR DEPRESSION; PSYCHIATRIC OUTPATIENTS; RECURRENT CONCUSSION; GENDER DIFFERENCES; SPECTRAL-ANALYSIS; INVENTORY-II; RISK FACTOR; SYMPTOMS	Depression is one of the frequent complications following a mild traumatic brain injury (mTBI). Recent research indicated that abnormalities in the autonomic nervous system (ANS) can be evaluated by a noninvasive power spectral analysis of the heart rate variability (HRV). In this study, we investigated whether a frequency-domain analysis of HRV was correlated with late depression in mTBI patients. In total, 181 patients diagnosed with mTBI and 83 volunteers as healthy controls were recruited in 2010-2014. Beck Depression Inventory (BDI) scores were used to evaluate depression in the 1st week of assessment and at 1.5-, 3-, 6-, 12-, and 18-month follow-ups. Correlation and logistic regression analyses of the 1st week HRV parameters with BDI scores at 18 months were performed in individual female mTBI patients. Female mTBI patients were more vulnerable to depression accompanied by reduced HRV compared to healthy controls. Over time, depression was aggravated in female mTBI patients but was alleviated in male mTBI patients. A significantly lower parasympathetic proportion of the ANS was noted at 18 months with respect to the 1st week in female mTBI patients. In addition, depression in female mTBI patients at 18 months after injury was significantly correlated with a decrease in the parasympathetic proportion of the ANS in the 1st week (=-0.411; p<.05). Dysautonomia resulted in higher risks of depression in female mTBI patients. We concluded that early dysautonomia following an mTBI contributes to late depression in female mTBI patients.	[Sung, Chih-Wei; Chen, Gunng-Shinng; Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan; [Sung, Chih-Wei; Li, Wei-Jiun] Taipei Med Univ, Coll Med, Sch Med, Taipei 110, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, New Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Grad Program Neuroregenerat, Taipei 110, Taiwan; [Chiu, Wen-Ta; Chu, Shu-Fen; Tsai, Shin-Han] Taipei Med Univ, Coll Publ Hlth, Grad Inst Injury & Prevent, Taipei 110, Taiwan; [Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency, New Taipei, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Lin, Chien-Min; Lin, Jia-Wei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei, Taiwan; [Chen, Gunng-Shinng] Tri Serv Gen Hosp, Dept Dent, Div Orthodont & Dentofacial Orthoped & Pedodont, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei 110, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		Sung, Chih-Wei/0000-0003-3312-2752; lee, hsin-chien/0000-0002-7557-8259; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology [MOST-103-2321-B-038-002, MOST-104-2320-B-038-057-MY3, MOST-103-2815-C-038-016-B]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC 98-2321-B-038-003-MY3, NSC102-2632-B-038-001-MY3]	This work was supported in part by grants from the Ministry of Science and Technology (MOST-103-2321-B-038-002 and MOST-104-2320-B-038-057-MY3) to JYW, from the National Science Council (NSC 98-2321-B-038-003-MY3) to WTC and NSC102-2632-B-038-001-MY3 to HCL, and from the Ministry of Science and Technology (MOST-103-2815-C-038-016-B) to CWS.	Akdemir A, 2001, COMPR PSYCHIAT, V42, P161, DOI 10.1053/comp.2001.19756; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; ATTEBERRYBENNETT J, 1986, INT J CLIN NEUROPSYC, V8, P114; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Barton DA, 2008, ARCH GEN PSYCHIAT, V65, P38, DOI 10.1001/archgenpsychiatry.2007.11; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Bjornelv S, 2011, SOC PSYCH PSYCH EPID, V46, P353, DOI 10.1007/s00127-010-0197-z; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; BRYER JB, 1992, J NEUROPSYCH CLIN N, V4, P440; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Cameron O, 1996, PSYCHOSOM MED, V58, P111, DOI 10.1097/00006842-199603000-00002; Carney RM, 2005, PSYCHOSOM MED, V67, pS29, DOI 10.1097/01.psy.0000162254.61556.d5; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; CARNEY RM, 1995, ANN BEHAV MED, V17, P142, DOI 10.1007/BF02895063; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; DAVIDSON J, 1986, BRIT J PSYCHIAT, V148, P442, DOI 10.1192/bjp.148.4.442; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou CL, 2006, BRAIN RES, V1095, P154, DOI 10.1016/j.brainres.2006.04.026; Hughes JW, 2000, PSYCHOSOM MED, V62, P796, DOI 10.1097/00006842-200011000-00009; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; KLIKS BR, 1975, AM J CARDIOL, V36, P45, DOI 10.1016/0002-9149(75)90866-8; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Mancilla-Diaz JM, 2009, EAT WEIGHT DISORD-ST, V14, pE169, DOI 10.1007/BF03325113; MILLS V M, 1992, Brain Injury, V6, P219, DOI 10.3109/02699059209029663; Nestler EJ, 2014, JAMA PSYCHIAT, V71, P454, DOI 10.1001/jamapsychiatry.2013.4291; Nishizawa S, 1997, P NATL ACAD SCI USA, V94, P5308, DOI 10.1073/pnas.94.10.5308; Nolen-Hoeksema S, 1999, J PERS SOC PSYCHOL, V77, P1061, DOI 10.1037/0022-3514.77.5.1061; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Ownsworth TL, 1998, BRAIN INJURY, V12, P735, DOI 10.1080/026990598122133; PODRID PJ, 1990, CIRCULATION, V82, P103; RABINS PV, 1985, J AFFECT DISORDERS, V9, P165, DOI 10.1016/0165-0327(85)90096-5; Rapoport MJ, 2006, J AFFECT DISORDERS, V92, P273, DOI 10.1016/j.jad.2005.05.022; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; del Paso GAR, 2013, PSYCHOPHYSIOLOGY, V50, P477, DOI 10.1111/psyp.12027; Rhee H, 2000, HEADACHE, V40, P528, DOI 10.1046/j.1526-4610.2000.00084.x; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; RUTHERFORD WH, 1977, LANCET, V1, P1; SANTORELLI G, 1964, Osp Psichiatr, V32, P69; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; SCHWARTZ PJ, 1981, J CARDIOVASC PHARM, V3, P1251, DOI 10.1097/00005344-198111000-00012; Sheffield D, 1998, INT J BEHAV MED, V5, P31, DOI 10.1207/s15327558ijbm0501_3; Sosin DM, 1996, BRAIN INJURY, V10, P47; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Sund AM, 2011, SOC PSYCH PSYCH EPID, V46, P431, DOI 10.1007/s00127-010-0208-0; Sung CW, 2016, CLIN NEUROPHYSIOL, V127, P1629, DOI 10.1016/j.clinph.2015.08.006; TEASDALE G, 1974, LANCET, V2, P81; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; Wilhelm K, 2002, ACTA PSYCHIAT SCAND, V106, P45, DOI 10.1034/j.1600-0447.2002.02094.x; Williams WH, 2003, NEUROPSYCHOL REHABIL, V13, P1, DOI [10.1016/S0960-9822(02)01374-X, 10.1080/09602010244000444]; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011; Zheng A, 2008, J NUTR SCI VITAMINOL, V54, P148, DOI 10.3177/jnsv.54.148	70	19	20	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0048-5772	1469-8986		PSYCHOPHYSIOLOGY	Psychophysiology	APR	2016	53	4					455	464		10.1111/psyp.12575			10	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	DH6GN	WOS:000372889100004	26560198				2022-02-06	
J	Tajiri, N; De La Pena, I; Acosta, SA; Kaneko, Y; Tamir, S; Landesman, Y; Carlson, R; Shacham, S; Borlongan, CV				Tajiri, Naoki; De La Pena, Ike; Acosta, Sandra A.; Kaneko, Yuji; Tamir, Sharon; Landesman, Yosef; Carlson, Robert; Shacham, Sharon; Borlongan, Cesar V.			A Nuclear Attack on Traumatic Brain Injury: Sequestration of Cell Death in the Nucleus	CNS NEUROSCIENCE & THERAPEUTICS			English	Article						Cell death protein trafficking; Neuroinflammation; Nuclear export inhibitor; Secondary cell death	SELECTIVE INHIBITORS; PRECLINICAL MODELS; EXPORT INHIBITORS; DRUG-RESISTANCE; CRM1; RATS; ACTIVATION; EXPRESSION; APOPTOSIS; PROTEINS	BackgroundExportin 1 (XPO1/CRM1) plays prominent roles in the regulation of nuclear protein export. Selective inhibitors of nuclear export (SINE) are small orally bioavailable molecules that serve as drug-like inhibitors of XPO1, with potent anti-cancer properties. Traumatic brain injury (TBI) presents with a secondary cell death characterized by neuroinflammation that is putatively regulated by nuclear receptors. Aims and ResultsHere, we report that the SINE compounds (KPT-350 or KPT-335) sequestered TBI-induced neuroinflammation-related proteins (NF-B-k, AKT, FOXP1) within the nucleus of cultured primary rat cortical neurons, which coincided with protection against TNF- (20ng/mL)-induced neurotoxicity as shown by at least 50% and 100% increments in preservation of cell viability and cellular enzymatic activity, respectively, compared to non-treated neuronal cells (P's<0.05). In parallel, using an invivo controlled cortical impact (CCI) model of TBI, we demonstrate that adult Sprague-Dawley rats treated post-injury with SINE compounds exhibited significant reductions in TBI-induced behavioral and histological deficits. Animals that received KPT-350 orally starting at 2h post-TBI and once a day thereafter over the next 4days exhibited significantly better motor coordination, and balance in the rotorod test and motor asymmetry test by 100-200% improvements, as early as 4h after initial SINE compound injection that was sustained during subsequent KPT-350 dosing, and throughout the 18-day post-TBI study period compared to vehicle treatment (P's<0.05). Moreover, KPT-350 reduced cortical core impact area and peri-impact cell death compared to vehicle treatment (P's<0.05). ConclusionsBoth invitro and invivo experiments revealed that KPT-350 increased XPO1, AKT, and FOXP1 nuclear expression and relegated NF-B-k expression within the neuronal nuclei. Altogether, these findings advance the utility of SINE compounds to stop trafficking of cell death proteins within the nucleus as an efficacious treatment for TBI.	[Tajiri, Naoki; De La Pena, Ike; Acosta, Sandra A.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Tampa, FL USA; [Tamir, Sharon; Landesman, Yosef; Carlson, Robert; Shacham, Sharon] Karyopharm Therapeut Inc, Newton, MA USA		Borlongan, CV (corresponding author), Univ S Florida, Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA.	cborlong@health.usf.edu	Kaneko, Yuji/J-6447-2012		Karyopharm Inc	This study was funded by Karyopharm Inc. The authors thank the excellent technical assistance of Mr. Quinn Colburn in final preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Azmi AS, 2013, GASTROENTEROLOGY, V144, P447, DOI 10.1053/j.gastro.2012.10.036; Bachstetter AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010496; Bell E, 2003, DIABETES, V52, P2731, DOI 10.2337/diabetes.52.11.2731; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Campolo M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0196-1; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; Cheng Y, 2014, MOL CANCER THER, V13, P675, DOI 10.1158/1535-7163.MCT-13-0416; Cooper G. M., 2000, CELL MOL APPROACH, P1; Das M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-148; Draetta GF, 2011, J CLIN ONCOL, V29; Etchin J, 2013, BRIT J HAEMATOL, V161, P117, DOI 10.1111/bjh.12231; Fang YS, 2012, ANNU REV CELL DEV BI, V28, P575, DOI 10.1146/annurev-cellbio-101011-155836; Gatson JW, 2012, J NEUROTRAUM, V29, P2209, DOI 10.1089/neu.2011.2274; Guttler T, 2011, EMBO J, V30, P3457, DOI 10.1038/emboj.2011.287; Hadass O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076904; Haines JD, 2015, NAT NEUROSCI, V18, P511, DOI 10.1038/nn.3953; Kaneko Y, 2016, MOL NEUROBIOL, V53, P1874, DOI 10.1007/s12035-015-9126-1; Kaneko Y, 2014, CNS NEUROSCI THER, V20, P275, DOI 10.1111/cns.12208; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kojima K, 2013, BLOOD, V121, P4166, DOI 10.1182/blood-2012-08-447581; Kou ZF, 2014, GLIA, V62, P1831, DOI 10.1002/glia.22690; Kudo N, 1997, J BIOL CHEM, V272, P29742, DOI 10.1074/jbc.272.47.29742; Landesman Y, 2012, CANCER RES, V72, DOI 10.1158/1538-7445.AM2012-3775; Lapalombella R, 2012, BLOOD, V120, P4621, DOI 10.1182/blood-2012-05-429506; Li AH, 2013, J MOL NEUROSCI, V51, P208, DOI 10.1007/s12031-013-9994-7; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; London CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087585; McCauley D, 2012, J CLIN ONCOL S, V30; Mendonca J, 2014, ONCOTARGET, V5, P6102, DOI 10.18632/oncotarget.2174; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Nguyen Kevin T, 2012, Int J Biochem Mol Biol, V3, P137; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Owen T, 2012, ARTHRITIS RHEUM S, V64; Owen T, 2013, 13 ACR ARHP ANN M OC; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Tajiri N, 2014, CELL TRANSPLANT, V23, P785; Tajiri N, 2014, 10 WORLD C BRAIN INJ; Tajiri N, 2014, BRAIN RES, V1559, P65, DOI 10.1016/j.brainres.2014.02.041; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Takahashi K, 2008, BRAIN RES, V1234, P172, DOI 10.1016/j.brainres.2008.07.086; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Zhang K, 2013, EXP HEMATOL, V41	55	19	20	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-5930	1755-5949		CNS NEUROSCI THER	CNS Neurosci. Ther.	APR	2016	22	4			SI		306	315		10.1111/cns.12501			10	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DH7QO	WOS:000372989100009	26842647	Green Published, hybrid			2022-02-06	
J	Klapal, L; Igelhorst, BA; Dietzel-Meyer, ID				Klapal, Lars; Igelhorst, Birte A.; Dietzel-Meyer, Irmgard D.			Changes in Neuronal Excitability by Activated Microglia: Differential Na+ Current Upregulation in Pyramid-Shaped and Bipolar Neurons by TNF-alpha and IL-18	FRONTIERS IN NEUROLOGY			English	Article						voltage-activated sodium currents; microglia; hippocampal neurons; interleukin-18; tumor necrosis factor-alpha; lipopolysaccharide; transforming growth factor-beta; glial cells	TUMOR-NECROSIS-FACTOR; TRANSFORMING-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; ROOT GANGLION NEURONS; TRAUMATIC BRAIN-INJURY; GATED SODIUM-CHANNELS; FACTOR-BETA; HIPPOCAMPAL-NEURONS; INNATE IMMUNITY; GLIAL-CELLS	Microglia are activated during pathological events in the brain and are capable of releasing various types of inflammatory cytokines. Here, we demonstrate that the addition of 5% microglia activated by 1 mu g/ml lipopolysaccharides (LPS) to hippocampal cultures upregulates Na current densities (I-NavD) of bipolar as well as pyramid-shaped neurons, thereby increasing their excitability. Deactivation of microglia by the addition of 10 ng/ml transforming growth factor-beta (TGF-beta) decreases I-NavD below control levels suggesting that the residual activated microglial cells influence neuronal excitability in control cultures. Preincubation of hippocampal cultures with 10 ng/ml tumor necrosis factor-alpha (TNF-alpha), a major cytokine released by activated microglia, upregulated I-NavD significantly by similar to 30% in bipolar cells, whereas in pyramid shaped cells, the upregulation only reached an increase of similar to 14%. Incubation of the cultures with antibodies against either TNF-receptor 1 or 2 blocked the upregulation of I-NavD in bipolar cells, whereas in pyramid-shaped cells, increases in I-NavD were exclusively blocked by antibodies against TNF-receptor 2, suggesting that both cell types respond differently to TNIF-alpha exposure. Since additional cytokines, such as interleukin-18 (IL-18), are released from activated microglia, we tested potential effects of IL-18 on I-NavD in both cell types. Exposure to 5-10 ng/ml IL-18 for 4 days increased I-NavD in both pyramid-shaped as well as bipolar neurons, albeit the dose response curves were shifted to lower concentrations in bipolar cells. Our results suggest that by secretion of cytokines, microglial cells upregulate Na+ current densities in bipolar and pyramid shaped neurons to some extent differentially. Depending on the exact cytokine composition and concentration released, this could change the balance between the activity of inhibitory bipolar and excitatory pyramid-shaped cells. Since bipolar cells show a larger upregulation of I-NavD in response to TNF-alpha as well as respond to smaller concentrations of IL-18, our results offer an explanation for the finding, that in certain conditions of brain inflammations periods of dizziness are followed by epileptic seizures.	[Klapal, Lars; Igelhorst, Birte A.; Dietzel-Meyer, Irmgard D.] Ruhr Univ Bochum, Dept Biochem 2, Univ Str 150, Bochum, Germany		Klapal, L; Dietzel-Meyer, ID (corresponding author), Ruhr Univ Bochum, Dept Biochem 2, Univ Str 150, Bochum, Germany.	lars.klapal@rub.de; Irmgard.D.Dietzel-Meyer@rub.de		Dietzel-Meyer, Irmgard/0000-0003-4009-6249			Aloisi F, 2000, IMMUNOL TODAY, V21, P141, DOI 10.1016/S0167-5699(99)01512-1; Amrani Y, 1996, AM J RESP CELL MOL, V15, P55, DOI 10.1165/ajrcmb.15.1.8679222; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BARRALNETTO M, 1992, SCIENCE, V257, P545, DOI 10.1126/science.1636092; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; BRODIE C, 1989, ENDOCRINOLOGY, V125, P842, DOI 10.1210/endo-125-2-842; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; Canolle B, 2004, J NEUROCHEM, V88, P1521, DOI 10.1046/j.1471-4159.2003.02301.x; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Chen X, 2011, EXP NEUROL, V227, P279, DOI 10.1016/j.expneurol.2010.11.017; CHIZHMAKOV IV, 1994, NEUROSCIENCE, V59, P285, DOI 10.1016/0306-4522(94)90596-7; Coma G, 2006, CLIN EXP IMMUNOL, V145, P535, DOI 10.1111/j.1365-2249.2006.03145.x; CONSTAM DB, 1992, J IMMUNOL, V148, P1404; CZARNIECKI CW, 1988, J IMMUNOL, V140, P4217; DACUNHA A, 1993, J NEUROIMMUNOL, V42, P71, DOI 10.1016/0165-5728(93)90214-J; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; DING A, 1990, J IMMUNOL, V145, P940; Djouhri L, 1999, J PHYSIOL-LONDON, V520, P565, DOI 10.1111/j.1469-7793.1999.t01-1-00565.x; FANGER GR, 1993, J NEUROCHEM, V61, P1977, DOI 10.1111/j.1471-4159.1993.tb09844.x; FEUERSTEIN GZ, 1994, CEREBROVAS BRAIN MET, V6, P341; Forge A, 2002, BRIT MED BULL, V63, P5, DOI 10.1093/bmb/63.1.5; Franceschetti S, 2000, J PHYSIOL-LONDON, V528, P291, DOI 10.1111/j.1469-7793.2000.00291.x; French AR, 2006, CYTOKINE, V35, P229, DOI 10.1016/j.cyto.2006.08.006; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1987, J NEUROSCI RES, V18, P132, DOI DOI 10.1002/JNR.490180123; Gould HJ, 2000, BRAIN RES, V854, P19, DOI 10.1016/S0006-8993(99)02216-7; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226; Guo LH, 2007, CELL MOL LIFE SCI, V64, P1128, DOI 10.1007/s00018-007-6494-3; Haas E, 1999, J BIOL CHEM, V274, P18107, DOI 10.1074/jbc.274.25.18107; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; He XH, 2010, PAIN, V151, P266, DOI 10.1016/j.pain.2010.06.005; HETIER E, 1990, EUR J NEUROSCI, V2, P762, DOI 10.1111/j.1460-9568.1990.tb00466.x; Hoffmann G, 2004, NEUROSCIENCE, V125, P369, DOI 10.1016/j.neuroscience.2004.01.047; Hudmon A, 2008, J NEUROSCI, V28, P3190, DOI 10.1523/JNEUROSCI.4403-07.2008; HUGHES JR, 1977, DIS NERV SYST, V38, P431; Igelhorst BA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0194; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jack CS, 2005, J IMMUNOL, V175, P4320, DOI 10.4049/jimmunol.175.7.4320; Jin XC, 2006, J NEUROSCI, V26, P246, DOI 10.1523/JNEUROSCI.3858-05.2006; Jones LL, 1998, BRAIN RES, V795, P301, DOI 10.1016/S0006-8993(98)00325-4; Joshi SK, 2006, PAIN, V123, P75, DOI 10.1016/j.pain.2006.02.011; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KEHRL JH, 1986, J IMMUNOL, V137, P3855; Kerr BJ, 2001, NEUROREPORT, V12, P3077, DOI 10.1097/00001756-200110080-00019; Kim WK, 2004, J IMMUNOL, V172, P7015, DOI 10.4049/jimmunol.172.11.7015; Kleinsimlinghaus K, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00277; KORNBLUTH RS, 1986, J IMMUNOL, V137, P2585; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; Lai J, 2004, ANNU REV PHARMACOL, V44, P371, DOI 10.1146/annurev.pharmtox.44.101802.121627; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lancman ME, 1996, EPILEPSY RES, V25, P285, DOI 10.1016/S0920-1211(96)00086-1; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Leo M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/124942; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Lodge PA, 1996, J LEUKOCYTE BIOL, V60, P502, DOI 10.1002/jlb.60.4.502; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Magnus T, 2012, BRAIN, V135, P1850, DOI 10.1093/brain/aws090; MARTIN DL, 1992, GLIA, V5, P81, DOI 10.1002/glia.440050202; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McGowan E, 2009, ANESTH ANALG, V109, P951, DOI 10.1213/ane.0b013e3181b01b02; Najjar S, 2011, NEUROLOGIST, V17, P249, DOI 10.1097/NRL.0b013e31822aad04; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; Nakamura Y, 1999, NEUROSCI RES, V35, P95, DOI 10.1016/S0168-0102(99)00071-1; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Niederkinkhaus V, 2009, MOL ENDOCRINOL, V23, P1494, DOI 10.1210/me.2009-0132; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Opp MR, 2005, SLEEP MED REV, V9, P355, DOI 10.1016/j.smrv.2005.01.002; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Potthoff O, 1997, P ROY SOC B-BIOL SCI, V264, P367, DOI 10.1098/rspb.1997.0053; Rath PC, 1999, J CLIN IMMUNOL, V19, P350, DOI 10.1023/A:1020546615229; Richter F, 2014, ANN NEUROL, V76, P43, DOI 10.1002/ana.24176; Rolfe M, 1997, CARCINOGENESIS, V18, P2277, DOI 10.1093/carcin/18.11.2277; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; Schilling T, 2000, AM J PHYSIOL-CELL PH, V279, pC1123, DOI 10.1152/ajpcell.2000.279.4.C1123; Schilling T, 2001, EUR J NEUROSCI, V14, P463, DOI 10.1046/j.0953-816x.2001.01661.x; Singhi P, 2011, DEV MED CHILD NEUROL, V53, P600, DOI 10.1111/j.1469-8749.2011.03928.x; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; STREIT WJ, 1988, GLIA, V1, P301, DOI 10.1002/glia.440010502; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; TAKEMURA R, 1984, AM J PHYSIOL, V246, pC1, DOI 10.1152/ajpcell.1984.246.1.C1; Tamura R, 2014, ANESTH ANALG, V118, P318, DOI 10.1213/ANE.0000000000000085; Tang P, 1996, BIOCHEMISTRY-US, V35, P8216, DOI 10.1021/bi952182t; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Wheeler RD, 2000, MOL BRAIN RES, V77, P290, DOI 10.1016/S0169-328X(00)00069-3; Wheeler RD, 2003, J NEUROCHEM, V85, P1412, DOI 10.1046/j.1471-4159.2003.01787.x; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Yuhas Y, 2003, INFECT IMMUN, V71, P2288, DOI 10.1128/IAI.71.4.2288-2291.2003	98	19	19	0	7	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 30	2016	7								44	10.3389/fneur.2016.00044			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DH7GW	WOS:000372961600001	27065940	Green Published, gold			2022-02-06	
J	Li, CY; Limnuson, K; Wu, ZZ; Amin, A; Narayan, A; Golanov, EV; Ahn, CH; Hartings, JA; Narayan, RK				Li, Chunyan; Limnuson, Kanokwan; Wu, Zhizhen; Amin, Aseer; Narayan, Anjali; Golanov, Eugene V.; Ahn, Chong H.; Hartings, Jed A.; Narayan, Raj K.			Single probe for real-time simultaneous monitoring of neurochemistry and direct-current electrocorticography	BIOSENSORS & BIOELECTRONICS			English	Article						Neurochemical; Direct-current electrocorticography; Spreading depolarization; Iridium oxide reference electrode; Real-time monitoring	CORTICAL SPREADING DEPRESSION; OXIDE REFERENCE ELECTRODE; BRAIN GLUCOSE; EXTRACELLULAR GLUTAMATE; ONLINE MICRODIALYSIS; CEREBRAL-CORTEX; MICROELECTRODE; DEPOLARIZATIONS; LACTATE; OXYGEN	We report a novel single neural probe for real-time simultaneous monitoring of multiple neurochemicals and direct-current electrocorticography (DC-ECoG). A major advance of this probe is the inclusion of two iridium oxide reference electrodes to improve sensor accuracy. The ECoG reference electrode is identical to the ECoG recording electrodes to significantly improve DC stability, while the reference for electrochemical sensors has 10-fold lower polarization rate to minimize the small current-induced drift in the reference electrode potential. In vi, the single probe selectively measured oxygen (r(2)=0.985 +/- 0.01, concentration range=0-60 mmHg, limit of detection=0.4 +/- 0.07 mmHg) and glucose (r(2)=0.989 +/- 0.009, concentration range=0-4 mM, limit of detection=31 +/- 8 mu Mu) in a linear fashion. The performance of the single probe was assessed in an in vivo needle prick model to mimic sequelae of traumatic brain injury. It successfully monitored the theoretically expected transient brain oxygen, glucose, and DC potential changes during the passage of spreading depolarization (SD) waves. We envision that the developed probe can be used to decipher the cause-effect relationships between multiple variables of brain pathophysiology with the high temporal and spatial resolutions that it provides. (C) 2015 Elsevier B.V. All rights reserved.	[Li, Chunyan; Limnuson, Kanokwan; Amin, Aseer; Golanov, Eugene V.; Narayan, Raj K.] Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY 11030 USA; [Li, Chunyan; Narayan, Anjali; Narayan, Raj K.] Hofstra North Shore LIJ Sch Med, Dept Neurosurg, Hempstead, NY 11549 USA; [Wu, Zhizhen; Ahn, Chong H.] Univ Cincinnati, Microsyst & BioMEMS Lab, Cincinnati, OH 45221 USA; [Hartings, Jed A.] Univ Cincinnati, Coll Med, Neurosci Inst, Dept Neurosurg, Cincinnati, OH 45219 USA		Li, CY (corresponding author), Feinstein Inst Med Res, Cushing Neuromonitoring Lab, Manhasset, NY 11030 USA.	cli11@nshs.edu	Golanov, Eugene/B-6462-2011	Golanov, Eugene/0000-0003-0220-822X; Hartings, Jed/0000-0001-8583-3471	U.S. Department of Defense CDMRP PH/TBI Research Program [PT090526P4 (W81XWH-10-1-0978)]	This research was supported by the U.S. Department of Defense CDMRP PH/TBI Research Program under Project no. PT090526P4 (W81XWH-10-1-0978).	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Chase Alex, 2014, Nat Rev Neurol, V10, P547, DOI 10.1038/nrneurol.2014.169; Cordeiro CA, 2015, BIOSENS BIOELECTRON, V67, P677, DOI 10.1016/j.bios.2014.09.101; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fekete Z, 2015, SENSOR ACTUAT B-CHEM, V215, P300, DOI 10.1016/j.snb.2015.03.055; Ges IA, 2005, BIOSENS BIOELECTRON, V21, P248, DOI 10.1016/j.bios.2004.09.021; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hashemi P, 2009, J CEREBR BLOOD F MET, V29, P166, DOI 10.1038/jcbfm.2008.108; Hinzman JM, 2015, BIOSENS BIOELECTRON, V74, P512, DOI 10.1016/j.bios.2015.06.074; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Johnson MD, 2008, J NEUROSCI METH, V174, P62, DOI 10.1016/j.jneumeth.2008.06.036; Kealy J, 2013, J NEUROSCI METH, V215, P110, DOI 10.1016/j.jneumeth.2013.02.016; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Lewitus D, 2011, ACTA BIOMATER, V7, P2483, DOI 10.1016/j.actbio.2011.02.027; Li CY, 2007, BIOSENS BIOELECTRON, V22, P1988, DOI 10.1016/j.bios.2006.08.043; Li CY, 2009, BIOSENS BIOELECTRON, V25, P173, DOI 10.1016/j.bios.2009.06.032; Li CY, 2009, LAB CHIP, V9, P1988, DOI 10.1039/b900651f; Marzouk SAM, 1998, ANAL CHEM, V70, P5054, DOI 10.1021/ac980608e; Morales-Villagran A, 2008, J NEUROSCI METH, V168, P48, DOI 10.1016/j.jneumeth.2007.09.005; Muthuswamy J, 2005, J NEUROSCI METH, V142, P45, DOI 10.1016/j.jneumeth.2004.07.017; Naylor E, 2011, J ELECTROANAL CHEM, V656, P106, DOI 10.1016/j.jelechem.2010.12.031; Odijk M, 2015, SENSOR ACTUAT B-CHEM, V207, P945, DOI 10.1016/j.snb.2014.06.138; Parkin MC, 2005, J CEREBR BLOOD F MET, V25, P402, DOI 10.1038/sj.jcbfm.9600051; Peteu SF, 1996, BIOSENS BIOELECTRON, V11, P1059, DOI 10.1016/0956-5663(96)87665-2; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Rocchitta G, 2013, ANAL CHEM, V85, P10282, DOI 10.1021/ac402071w; Rogers ML, 2013, ACS CHEM NEUROSCI, V4, P799, DOI 10.1021/cn400047x; Shinwari MW, 2010, SENSORS-BASEL, V10, P1679, DOI 10.3390/s100301679; Song YL, 2012, BIOSENS BIOELECTRON, V38, P416, DOI 10.1016/j.bios.2012.05.011; STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Thomas TC, 2009, NEUROPSYCHOPHARMACOL, V34, P436, DOI 10.1038/npp.2008.74; Tolosa VM, 2013, BIOSENS BIOELECTRON, V42, P256, DOI 10.1016/j.bios.2012.10.061; Tseng TTC, 2012, J ELECTROANAL CHEM, V682, P141, DOI 10.1016/j.jelechem.2012.07.014; Wassum KM, 2012, J NEUROSCI, V32, P2734, DOI 10.1523/JNEUROSCI.5780-11.2012; Wei WJ, 2015, MICROSYST NANOENG, V1, DOI 10.1038/micronano.2015.2; Wei WJ, 2014, BIOSENS BIOELECTRON, V55, P66, DOI 10.1016/j.bios.2013.11.048; Weltin A, 2014, BIOSENS BIOELECTRON, V61, P192, DOI 10.1016/j.bios.2014.05.014; Wise KD, 2008, P IEEE, V96, P1184, DOI 10.1109/JPROC.2008.922564; Yang HS, 2004, LAB CHIP, V4, P42, DOI 10.1039/b309899k	44	19	19	1	67	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663	1873-4235		BIOSENS BIOELECTRON	Biosens. Bioelectron.	MAR 15	2016	77						62	68		10.1016/j.bios.2015.09.021			7	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	CZ0AG	WOS:000366766900011	26386904	Bronze			2022-02-06	
J	Wong, TH; Krishnaswamy, G; Nadkarni, NV; Nguyen, HV; Lim, GH; Bautista, DCT; Chiu, MT; Chow, KY; Ong, MEH				Wong, Ting Hway; Krishnaswamy, Gita; Nadkarni, Nivedita Vikas; Nguyen, Hai V.; Lim, Gek Hsiang; Bautista, Dianne Carrol Tan; Chiu, Ming Terk; Chow, Khuan Yew; Ong, Marcus Eng Hock			Combining the new injury severity score with an anatomical polytrauma injury variable predicts mortality better than the new injury severity score and the injury severity score: a retrospective cohort study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Trauma; Injury severity score; New injury severity score; Polytrauma; Mortality; Outcome prediction	TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; BODY REGIONS; VALIDATION; DEFINITION; CARE; AGE; CLASSIFICATION; PERFORMANCE; ADMISSION	Background: Anatomy-based injury severity scores are commonly used with physiological scores for reporting severity of injury in a standardized manner. However, there is lack of consensus on choice of scoring system, with the commonly used injury severity score (ISS) performing poorly for certain sub-groups, eg head-injured patients. We hypothesized that adding a dichotomous variable for polytrauma (yes/no for Abbreviated Injury Scale (AIS) scores of 3 or more in at least two body regions) to the New Injury Severity Score (NISS) would improve the prediction of in-hospital mortality in injured patients, including head-injured patients-a subgroup that has a disproportionately high mortality. Our secondary hypothesis was that the ISS over-estimates the risk of death in polytrauma patients, while the NISS under-estimates it. Methods: Univariate and multivariable analysis was performed on retrospective cohort data of blunt injured patients aged 18 and over with an ISS over 9 from the Singapore National Trauma Registry from 2011-2013. Model diagnostics were tested using discrimination (c-statistic) and calibration (Hosmer-Lemeshow goodness-of-fit statistic). All models included age, gender, and comorbidities. Results: Our results showed that the polytrauma and NISS model outperformed the other models (polytrauma and ISS, NISS alone or ISS alone) in predicting 30-day and in-hospital mortality. The NISS underestimated the risk of death for patients with polytrauma, while the ISS overestimated the risk of death for these patients. When used together with the NISS and polytrauma, categorical variables for deranged physiology (systolic blood pressure of 90 mmHg or less, GCS of 8 or less) outperformed the traditional 'ISS and RTS (Revised Trauma Score)' model, with a c-statistic of greater than 0.90. This could be useful in cases when the RTS cannot be scored due to missing respiratory rate. Discussion: The NISS and polytrauma model is superior to current scores for prediction of 30-day and in-hospital mortality. We propose that this score replace the ISS or NISS in institutions using AIS-based scores. Conclusions: Adding polytrauma to the NISS or ISS improves prediction of 30-day mortality. The superiority of the NISS or ISS depends on the proportion of polytrauma and head-injured patients in the study population.	[Wong, Ting Hway] Singapore Gen Hosp, Dept Gen Surg, Outram Rd, Singapore 169608, Singapore; [Wong, Ting Hway; Krishnaswamy, Gita; Nadkarni, Nivedita Vikas; Nguyen, Hai V.; Bautista, Dianne Carrol Tan; Ong, Marcus Eng Hock] Duke Natl Univ Singapore, Singapore, Singapore; [Lim, Gek Hsiang; Chow, Khuan Yew] Hlth Promot Board, Singapore, Singapore; [Chiu, Ming Terk] Tan Tock Seng Hosp, Singapore, Singapore; [Ong, Marcus Eng Hock] Singapore Gen Hosp, Dept Emergency Med, Singapore 169608, Singapore		Wong, TH (corresponding author), Singapore Gen Hosp, Dept Gen Surg, Outram Rd, Singapore 169608, Singapore.; Wong, TH (corresponding author), Duke Natl Univ Singapore, Singapore, Singapore.	wong.ting.hway@singhealth.com.sg			Ministry of Health, SingaporeMinistry of Health-Singapore	The authors received no specific individual funding for this work. The collection and management of data for the National Trauma Registry is funded by the Ministry of Health, Singapore.	Agency for Healthcare Research and Quality R MD, 2012, HCUP CCS FACT SHEET; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Balogh ZJ, 2003, J ORTHOP TRAUMA, V17, P508, DOI 10.1097/00005131-200308000-00006; Bouamra O, 2006, INJURY, V37, P1092, DOI 10.1016/j.injury.2006.07.029; Butcher N, 2012, INJURY, V43, P196, DOI 10.1016/j.injury.2011.06.029; Butcher NE, 2014, J TRAUMA ACUTE CARE, V77, P620, DOI 10.1097/TA.0000000000000404; Caterino JM, 2010, AM J EMERG MED, V28, P151, DOI 10.1016/j.ajem.2008.10.027; Centers for Disease Control and Prevention and others, 2013, INT CLASS DIS 9 REV; Champion HR, 1996, J TRAUMA, V40, P42, DOI 10.1097/00005373-199601000-00009; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; COOKE RS, 1995, INJURY, V26, P399, DOI 10.1016/0020-1383(95)00064-G; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Di Bartolomeo S, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-26; Dillon B, 2006, EUR J TRAUMA, V32, P538; Gabbe BJ, 2003, ANZ J SURG, V73, P944, DOI 10.1046/j.1445-1433.2003.02833.x; Groven S, 2011, J TRAUMA, V70, P569, DOI 10.1097/TA.0b013e31820d1a9b; Haider AH, 2012, J AM COLL SURGEONS, V214, P756, DOI 10.1016/j.jamcollsurg.2011.12.013; Hannan EL, 2005, J TRAUMA, V58, P244, DOI 10.1097/01.TA.0000141995.44721.44; Harwood PJ, 2006, J TRAUMA, V60, P334, DOI 10.1097/01.ta.0000197148.86271.13; Ho AFW, 2015, PREHOSP EMERG CARE, V19, P409, DOI 10.3109/10903127.2014.980477; Jacobs DG, 2003, J TRAUMA, V54, P391, DOI 10.1097/01.TA.0000042015.54022.BE; Jones JM, 2014, ACTA ANAESTH SCAND, V58, P303, DOI 10.1111/aas.12256; Lavoie A, 2004, J TRAUMA, V56, P1312, DOI 10.1097/01.TA.0000075342.36072.EF; Lefering R, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0476-2; Lim J., 2013, MYTH MAGIC SINGAPORE; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Meredith JW, 2002, J TRAUMA, V53, P621, DOI 10.1097/00005373-200210000-00001; MILZMAN DP, 1992, J TRAUMA, V32, P236, DOI 10.1097/00005373-199202000-00021; (MOH) MoH, 2014, POP VIT STAT; Moore L, 2006, J TRAUMA, V60, P802, DOI 10.1097/01.ta.0000200838.55420.ad; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; National Registry of Diseases Office (NRDO) HPB Singapore, 2014, SING NAT TRAUM REG A; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pape HC, 2014, J TRAUMA ACUTE CARE, V77, P780, DOI 10.1097/TA.0000000000000453; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Raj R, 2015, INJURY, V46, P86, DOI 10.1016/j.injury.2014.08.026; Ringdal KG, 2008, SCAND J TRAUMA RESUS, V16, DOI 10.1186/1757-7241-16-7; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Samin OA, 1999, P ANN C ASS, P1; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tohira H, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-63; Whitaker Iveth Y, 2003, Annu Proc Assoc Adv Automot Med, V47, P301; Wong TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137127; Wong TH, 2013, J TRAUMA ACUTE CARE, V74, P780, DOI 10.1097/TA.0b013e3182826d5f	48	19	23	1	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	MAR 8	2016	24								25	10.1186/s13049-016-0215-6			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DF8FI	WOS:000371592400002	26955863	gold, Green Published			2022-02-06	
J	Huang, ZJ; Cheng, CJ; Jiang, L; Yu, ZY; Cao, F; Zhong, JJ; Guo, ZD; Sun, XC				Huang, Zhijian; Cheng, Chongjie; Jiang, Li; Yu, Zhanyang; Cao, Fang; Zhong, Jianjun; Guo, Zongduo; Sun, Xiaochuan			Intraventricular apolipoprotein ApoJ infusion acts protectively in Traumatic Brain Injury	JOURNAL OF NEUROCHEMISTRY			English	Article						ApoJ; complement cascade; oxidative stress; TBI	SPINAL-CORD-INJURY; NEURONAL MAINTENANCE; UP-REGULATION; COMPLEMENT ACTIVATION; CLUSTERIN EXPRESSION; ADULT-RAT; MICE; ISCHEMIA; ASTROCYTES; MOUSE	Traumatic brain injury (TBI) is the leading cause of mortality and morbidity in youth, but to date, effective therapies are still lacking. Previous studies revealed a marked response of apolipoprotein J (ApoJ) expression to the brain injury. The aim of this study was to determine the potential roles of ApoJ in functional recovery following TBI. After controlled cortex impact (CCI), a TBI model, in adult wild-type mice, ApoJ expression was up-regulated since 6h post-injury and sustained for 5days. Animals infused with recombinant human ApoJ intraventricularly at 30min prior to CCI showed significantly reduced oxidative stress (3-nitrotyrosine, 4-hydroxynonenal) and complement activation (C5b-9). In addition, ApoJ treatment was shown to suppress the inflammatory response (glial activation, cytokine expression), blood-brain barrier disruption (Evans blue extravasation), and cerebral edema (water content) induced by CCI. Concomitantly, improved neuronal maintenance and neurological behavioral performance were observed in ApoJ-treated mice compared with the vehicle group. These findings support a neuroprotective role of ApoJ via multifunctional pathways, providing a novel and encouraging treatment strategy for TBI.	[Huang, Zhijian; Cheng, Chongjie; Jiang, Li; Zhong, Jianjun; Guo, Zongduo; Sun, Xiaochuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China; [Yu, Zhanyang] Harvard Univ, Sch Med, Neuroprotect Res Lab, Dept Neurol & Radiol, Cambridge, MA 02138 USA; [Cao, Fang] Zunyi Med Coll, Affiliated Hosp, Dept Cerebrovasc, Zunyi, Guizhou, Peoples R China		Sun, XC (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China.	sunxch1445@qq.com		sun, xiao chuan/0000-0001-6992-332X; Huang, Zhijian/0000-0002-8241-0761	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371378]; National Construction Project for Clinical Key Specialty [(2011)170]; Guizhou Science and Technology Department [(2013)2332]	The authors thank the following funding agencies for their support: National Natural Science Foundation of China (No. 81371378), National Construction Project for Clinical Key Specialty (No. (2011)170), and Guizhou Science and Technology Department (No. (2013)2332). We acknowledge the service provided by Chongqing Key Laboratory of Ophthalmology. We thank Gilbert Wan for his help in language. All experiments were conducted in compliance with the ARRIVE guidelines. The authors have no conflict of interest to declare.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Ali YO, 2013, TRENDS NEUROSCI, V36, P632, DOI 10.1016/j.tins.2013.07.002; Anderson AJ, 2005, J NEUROTRAUM, V22, P382, DOI 10.1089/neu.2005.22.382; Arent AM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/723060; Bellander BM, 1996, J NEUROSURG, V85, P468, DOI 10.3171/jns.1996.85.3.0468; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Charnay Y, 2008, NEUROSCIENCE, V155, P714, DOI 10.1016/j.neuroscience.2008.06.022; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Crehan H., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/983640; Davoust N, 1999, GLIA, V27, P162, DOI 10.1002/(SICI)1098-1136(199908)27:2<162::AID-GLIA6>3.0.CO;2-K; Ducruet AF, 2009, EXP NEUROL, V219, P398, DOI 10.1016/j.expneurol.2009.07.018; Ferguson S, 2010, NEUROSCIENCE, V168, P811, DOI 10.1016/j.neuroscience.2010.01.031; Hayashi H, 2011, BIOL PHARM BULL, V34, P453, DOI 10.1248/bpb.34.453; Holtzman DM, 2001, NAT MED, V7, P977, DOI 10.1038/nm0901-977; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; JENNE DE, 1989, P NATL ACAD SCI USA, V86, P7123, DOI 10.1073/pnas.86.18.7123; Kim N, 2012, ALCOHOL CLIN EXP RES, V36, P72, DOI 10.1111/j.1530-0277.2011.01588.x; KIM SH, 1987, J IMMUNOL, V138, P1530; Koltai T, 2014, ONCOTARGETS THER, V7, P447, DOI 10.2147/OTT.S58622; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Koscielska-Kasprzak K, 2014, ARCH IMMUNOL THER EX, V62, P47, DOI 10.1007/s00005-013-0254-x; Lee YN, 2012, BIOCHEM BIOPH RES CO, V420, P851, DOI 10.1016/j.bbrc.2012.03.087; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Ohlsson M, 2003, J NEUROTRAUM, V20, P895, DOI 10.1089/089771503322385827; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; Storini C, 2005, NEUROBIOL DIS, V19, P10, DOI 10.1016/j.nbd.2004.11.001; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Walker DG, 1998, BRAIN RES, V809, P31, DOI 10.1016/S0006-8993(98)00811-7; Wang D, 2013, CELL MOL LIFE SCI, V70, P2919, DOI 10.1007/s00018-012-1201-4; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; Yasuda Y, 2004, BRAIN RES, V1021, P20, DOI 10.1016/j.brainres.2004.06.015; Zhuang JL, 2015, GENE, V555, P150, DOI 10.1016/j.gene.2014.10.056	42	19	23	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2016	136	5					1017	1025		10.1111/jnc.13491			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DE5BT	WOS:000370646500012	26670094				2022-02-06	
J	Lee, S; Yang, M; Kim, J; Son, Y; Kim, J; Kang, S; Ahn, W; Kim, SH; Kim, JC; Shin, T; Wang, H; Moon, C				Lee, Sueun; Yang, Miyoung; Kim, Juhwan; Son, Yeonghoon; Kim, Jinwook; Kang, Sohi; Ahn, Wooseok; Kim, Sung-Ho; Kim, Jong-Choon; Shin, Taekyun; Wang, Hongbing; Moon, Changjong			Involvement of BDNF/ERK signaling in spontaneous recovery from trimethyltin-induced hippocampal neurotoxicity in mice	BRAIN RESEARCH BULLETIN			English	Article						Trimethyltin; Hippocampus; BDNF; ERK; Spontaneous recovery	REGULATED KINASE ACTIVATION; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; DENTATE GYRUS; MAP KINASE; IN-VITRO; MURINE HIPPOCAMPUS; MOUSE HIPPOCAMPUS	Trimethyltin (TMT) toxicity causes histopathological damage in the hippocampus and induces seizure behaviors in mice. The lesions and symptoms recover spontaneously over time; however, little is known about the precise mechanisms underlying this recovery from TMT toxicity. We investigated changes in the brain-derived neurotrophic factor/extracellular signal-regulated kinases (BDNF/ERK) signaling pathways in the mouse hippocampus following TMT toxicity. Mice (7 weeks old, C57BL/6) administered TMT (2.6 mg/kg intraperitoneally) showed acute and severe neurodegeneration with increased TUNEL-positive cells in the dentate gyrus (DG) of the hippocampus. The mRNA and protein levels of BDNF in the hippocampus were elevated by TMT treatment. Immunohistochemical analysis showed that TMT treatment markedly increased phosphorylated ERK1/2 expression in the mouse hippocampus 1-4 days after TMT treatment, although the intensity of ERK immunoreactivity in mossy fiber decreased at 1-8 days post-treatment. In addition, ERK-immunopositive cells were localized predominantly in doublecortin-positive immature progenitor neurons in the DG. In primary cultured immature hippocampal neurons (4 days in vitro), BDNF treatment alleviated TMT-induced neurotoxicity, via activation of the ERK signaling pathway. Thus, we suggest that BDNF/ERK signaling pathways may be associated with cell differentiation and survival of immature progenitor neurons, and will eventually lead to spontaneous recovery in TMT-induced hippocampal neurodegeneration. (C) 2016 Elsevier Inc. All rights reserved.	[Lee, Sueun; Kim, Juhwan; Son, Yeonghoon; Kim, Jinwook; Kang, Sohi; Ahn, Wooseok; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea; [Lee, Sueun; Kim, Juhwan; Son, Yeonghoon; Kim, Jinwook; Kang, Sohi; Ahn, Wooseok; Kim, Sung-Ho; Kim, Jong-Choon; Moon, Changjong] Chonnam Natl Univ, Plus Project Team BK21, Kwangju 500757, South Korea; [Yang, Miyoung] Wonkwang Univ, Sch Med, Dept Anat, Iksan 570740, Jeonbuk, South Korea; [Yang, Miyoung; Wang, Hongbing] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Yang, Miyoung; Wang, Hongbing] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Shin, Taekyun] Jeju Natl Univ, Coll Vet Med, Jeju 690756, South Korea		Wang, H (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.; Wang, H (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Moon, C (corresponding author), Chonnam Natl Univ, Coll Vet Med, Dept Vet Anat, Kwangju 500757, South Korea.	wangho@msu.edu; moonc@chonnam.ac.kr	Moon, Changjong/AAI-2005-2020	Moon, Changjong/0000-0003-2451-0374; SHIN, Taekyun/0000-0002-9851-4354	Animal Medical Institute of Chonnam National University; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2012R1A1B4001262]; NIH grant, U.S.A. [R01MH093445]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH093445] Funding Source: NIH RePORTER	The animal experiment in this study was supported by the Animal Medical Institute of Chonnam National University. This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning, Republic of Korea (NRF-2012R1A1B4001262 to CM) and NIH grant, U.S.A. (R01MH093445 to HW).	Adderley SR, 1999, J BIOL CHEM, V274, P5038, DOI 10.1074/jbc.274.8.5038; Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; Berkeley JL, 2002, J NEUROCHEM, V82, P192, DOI 10.1046/j.1471-4159.2002.00977.x; BESSER R, 1987, NEUROLOGY, V37, P945, DOI 10.1212/WNL.37.6.945; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Blaiss CA, 2011, J NEUROSCI, V31, P4906, DOI 10.1523/JNEUROSCI.5265-10.2011; Casalbore P, 2010, J CELL PHYSIOL, V224, P710, DOI 10.1002/jcp.22170; CHANG LW, 1987, BIOL TRACE ELEM RES, V13, P77, DOI 10.1007/BF02796623; Choi YS, 2008, GLIA, V56, P791, DOI 10.1002/glia.20653; Corvino V, 2013, NEUROCHEM RES, V38, P240, DOI 10.1007/s11064-012-0932-9; DOCTOR SV, 1982, TOXICOLOGY, V25, P213, DOI 10.1016/0300-483X(82)90031-2; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Dudek F Edward, 2004, Epilepsy Curr, V4, P184, DOI 10.1111/j.1535-7597.2004.04507.x; Fabrizi C, 2016, NEUROTOXICOLOGY, V52, P12, DOI 10.1016/j.neuro.2015.10.004; Fiedorowicz A, 2001, BRAIN RES, V912, P116, DOI 10.1016/S0006-8993(01)02675-0; Garcia J, 2002, EMBO J, V21, P5151, DOI 10.1093/emboj/cdf488; Geloso MC, 2011, NEUROCHEM INT, V58, P729, DOI 10.1016/j.neuint.2011.03.009; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Harry GJ, 2004, NEUROTOX RES, V5, P623; Hetman M, 2004, EUR J BIOCHEM, V271, P2050, DOI 10.1111/j.1432-1033.2004.04133.x; Hossain MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083508; Houser CR, 2008, NEUROSCIENCE, V156, P222, DOI 10.1016/j.neuroscience.2008.07.010; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jaffe DB, 2007, PROG BRAIN RES, V163, P109, DOI 10.1016/S0079-6123(07)63006-4; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim DJ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/729509; Kim J., 2015, INT J DEV NEUROSCI; Kim J, 2014, INT J DEV NEUROSCI, V38, P68, DOI 10.1016/j.ijdevneu.2014.08.001; Kim J, 2014, ACTA HISTOCHEM, V116, P1490, DOI 10.1016/j.acthis.2014.09.003; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070356; Kulich SM, 2001, J NEUROCHEM, V77, P1058, DOI 10.1046/j.1471-4159.2001.00304.x; Lannuzel A, 1997, ANN NEUROL, V42, P847, DOI 10.1002/ana.410420605; Lee S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.16; Lee S, 2014, ACTA HISTOCHEM, V116, P1276, DOI 10.1016/j.acthis.2014.07.009; Li Y, 2010, EXP NEUROL, V224, P133, DOI 10.1016/j.expneurol.2010.03.003; Liu Y, 2010, NEUROSCIENCE, V166, P241, DOI 10.1016/j.neuroscience.2009.12.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matsumoto J, 2006, J PHARMACOL EXP THER, V318, P982, DOI 10.1124/jpet.106.104562; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; NAALSUND LU, 1985, NEUROTOXICOLOGY, V6, P145; Nakazawa T, 2002, INVEST OPHTH VIS SCI, V43, P3319; Ogita K, 2005, J NEUROSCI RES, V82, P609, DOI 10.1002/jnr.20678; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; Piacentini R, 2008, J NEUROCHEM, V105, P2109, DOI 10.1111/j.1471-4159.2008.05297.x; Pignataro G, 2013, NEUROBIOL DIS, V54, P105, DOI 10.1016/j.nbd.2013.02.008; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Qing Y, 2013, ARCH TOXICOL, V87, P1273, DOI 10.1007/s00204-013-1021-9; Rapoport M, 2000, J NEUROCHEM, V74, P125, DOI 10.1046/j.1471-4159.2000.0740125.x; Sanchez A, 2012, NEUROSCI RES, V72, P1, DOI 10.1016/j.neures.2011.09.003; Sathanoori M, 2004, MOL BRAIN RES, V130, P170, DOI 10.1016/j.molbrainres.2004.08.002; Schenk U, 2005, J NEUROSCI, V25, P1654, DOI 10.1523/JNEUROSCI.3074-04.2005; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; Sindreu C, 2011, P NATL ACAD SCI USA, V108, P3366, DOI 10.1073/pnas.1019166108; Slevin M, 2000, NEUROREPORT, V11, P2759, DOI 10.1097/00001756-200008210-00030; Son Y, 2015, NEUROBIOL LEARN MEM, V121, P12, DOI 10.1016/j.nlm.2015.03.002; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Vanhoutte P, 1999, MOL CELL BIOL, V19, P136; Vara H, 2009, P NATL ACAD SCI USA, V106, P9872, DOI 10.1073/pnas.0900077106; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Wachter B, 2010, CELL TISSUE RES, V342, P147, DOI 10.1007/s00441-010-1061-x; Wuhanqimuge, 2013, FEBS OPEN BIO, V3, P243, DOI 10.1016/j.fob.2013.05.003; Yang M, 2012, NEUROCHEM INT, V61, P955, DOI 10.1016/j.neuint.2012.09.015; Yang M, 2011, BIOCHEM PHARMACOL, V82, P72, DOI 10.1016/j.bcp.2011.03.020; Yoneyama M, 2008, NEUROCHEM INT, V52, P761, DOI 10.1016/j.neuint.2007.09.003; Yun MS, 2005, J CELL SCI, V118, P313, DOI 10.1242/jcs.01601; Zhou XJ, 2009, J NEUROSCI RES, V87, P2632, DOI 10.1002/jnr.22103	72	19	19	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	MAR	2016	121						48	58		10.1016/j.brainresbull.2016.01.002			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DI3SN	WOS:000373418900006	26772626	Green Accepted			2022-02-06	
J	Logue, OC; Cramer, NP; Xu, XF; Perl, DP; Galdzicki, Z				Logue, Omar C.; Cramer, Nathan P.; Xu, Xiufen; Perl, Daniel P.; Galdzicki, Zygmunt			Alterations of functional properties of hippocampal networks following repetitive closed-head injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Hippocampus; Long-term potentiation; Neuroplasticity; Electrophysiology; Spontaneous excitatory currents; Spontaneous inhibitory currents, fear-conditioning context and cued	TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; TS65DN MOUSE MODEL; SYNAPTIC PLASTICITY; AMPA RECEPTOR; DOWN-SYNDROME; CORTICAL-NEURONS; GLUR2 ENDOCYTOSIS; CELL SYNAPSES; CA1 AREA	Traumatic brain injury (TBI) is the leading cause of death for persons under the age of 45. Military service members who have served on multiple combat deployments and contact-sport athletes are at particular risk of sustaining repetitive TBI (rTBI). Cognitive and behavioral deficits resulting from rTBI are well documented. Optimal associative LTP, occurring in the CA1 hippocampal Schaffer collateral pathway, is required for both memory formation and retrieval. Surprisingly, ipsilateral Schaffer collateral CA1 LIP evoked by 100 Hz tetanus was enhanced in mice from the 3 x closed head injury (3 x CHI) treatment group in comparison to LTP in contralateral or 3 x Sham CA1 area, and in spite of reduced freezing during contextual fear conditioning at one week following 3 x CHI. Electrophysiological activity of CA1 neurons was evaluated with whole-cell patch-clamp recordings. 3 x CHI ipsilateral CA1 neurons exhibited significant increases in action potential amplitude and maximum rise and decay slope while the action potential duration was decreased. Recordings of CA1 neuron postsynaptic currents were conducted to detect spontaneous excitatory and inhibitory postsynaptic currents (sEPSCs/sIPSCs) and respective miniature currents (mEPSCs and mIPSCs). In the 3 x CHI mice, sEPSCs and sIPSCs in ipsilateral CA1 neurons had an increased frequency of events but decreased amplitudes. In addition, 3 x CHI altered the action potential-independent miniature postsynaptic currents. The mEPSCs of ipsilateral CA1 neurons exhibited both an increased frequency of events and larger amplitudes. Moreover, the effect of 3 x CHI on mIPSCs was opposite to that of the sIPSCs. Specifically, the frequency of the mIPSCs was decreased while the amplitudes were increased. These results are consistent with a mechanism in which repetitive closed-head injury affects CA1 hippocampal function by promoting a remodeling of excitatory and inhibitory synaptic inputs leading to impairment in hippocampal-dependent tasks. Published by Elsevier Inc.	[Logue, Omar C.] Uniformed Serv Univ Hlth Sci, Sch Med, Grad Program Neurosci, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Logue, Omar C.; Cramer, Nathan P.; Xu, Xiufen; Galdzicki, Zygmunt] Uniformed Serv Univ Hlth Sci, Sch Med, Ctr Neurosci & Regenerat Med, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Sch Med, Ctr Neurosci & Regenerat Med, Dept Pathol, Bethesda, MD 20814 USA		Galdzicki, Z (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Ctr Neurosci & Regenerat Med, Dept Anat Physiol & Genet,Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Galdzicki, Z (corresponding author), Uniformed Serv Univ Hlth Sci, Sch Med, Ctr Neurosci & Regenerat Med, MCB Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	zygmunt.galdzicki@usuhs.edu		Logue, Omar/0000-0002-9919-7688; Cramer, Nathan/0000-0001-6146-3664	USUHS [T070B013]; CNRMUnited States Department of Defense [PAT-74-2333, G17030, G1702577]; DMRDP [D61_I_10_J6_214]	This research was supported by USUHS grant T070B013 (OL), CNRM grants PAT-74-2333 (DP), G17030 and G1702577 (ZG) and DMRDP grant D61_I_10_J6_214 (ZG).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Almeida-Suhett CP, 2015, EXP NEUROL, V273, P11, DOI 10.1016/j.expneurol.2015.07.028; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Avital A, 2003, HIPPOCAMPUS, V13, P826, DOI 10.1002/hipo.10135; Bang S.A., 2015, J NEUROTRAUMA; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Belanger HG, 2015, J HEAD TRAUMA REHABI; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Bell JD, 2007, BRAIN, V130, P2528, DOI 10.1093/brain/awm164; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; BERBERIAN BJ, 1990, CUTIS, V46, P46; Best TK, 2012, EXP NEUROL, V233, P749, DOI 10.1016/j.expneurol.2011.11.033; Bourtchouladze R, 2006, LEARN MEMORY, V13, P745, DOI 10.1101/lm.354106; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Buccafusco JJ, 2009, FRONT NEUROSCI, P1; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chakrabarti L, 2010, NAT NEUROSCI, V13, P927, DOI 10.1038/nn.2600; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Di Filippo M, 2008, TRENDS PHARMACOL SCI, V29, P402, DOI 10.1016/j.tips.2008.06.005; Di Filippo M, 2013, NEUROBIOL DIS, V52, P229, DOI 10.1016/j.nbd.2012.12.009; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Drummond JB, 2012, NEUROREPORT, V23, P1031, DOI 10.1097/WNR.0b013e32835ad229; Dutra RC, 2013, BRAIN BEHAV IMMUN, V33, P90, DOI 10.1016/j.bbi.2013.06.002; Faul M, 2010, TRAUMATIC BRAIN INJU; Ferrario CR, 2013, J NEUROPHYSIOL, V110, P131, DOI 10.1152/jn.01011.2012; FORSCHER P, 1985, J GEN PHYSIOL, V85, P743, DOI 10.1085/jgp.85.5.743; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hauss-Wegrzyniak B, 2002, EXP NEUROL, V176, P336, DOI 10.1006/exnr.2002.7966; He SJ, 2014, NEUROPHARMACOLOGY, V77, P379, DOI 10.1016/j.neuropharm.2013.10.016; Hoge CW, 2010, ARCH PHYS MED REHAB, V91, P963, DOI 10.1016/j.apmr.2010.02.005; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holopainen IE, 2003, NEUROSCIENCE, V118, P967, DOI 10.1016/S0306-4522(03)00046-0; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Imbrosci B, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/614329; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kandel ER, 2014, CELL, V157, P163, DOI 10.1016/j.cell.2014.03.001; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Kharlamov EA, 2011, EPILEPSY RES, V95, P20, DOI 10.1016/j.eplepsyres.2011.02.008; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kirischuk S, 2000, NEUROREPORT, V11, P3709, DOI 10.1097/00001756-200011270-00024; Klausberger T, 2009, EUR J NEUROSCI, V30, P947, DOI 10.1111/j.1460-9568.2009.06913.x; Klemenhagen KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074510; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lucke-Wold BP, 2014, J NEUROTRAUM, V31, P1129, DOI 10.1089/neu.2013.3303; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Marion DW, 2011, J NEUROTRAUM, V28, P517, DOI 10.1089/neu.2010.1638; Martin LJ, 2010, J NEUROSCI, V30, P5269, DOI 10.1523/JNEUROSCI.4209-09.2010; McMillan R, 1990, Transfus Med Rev, V4, P136, DOI 10.1016/S0887-7963(90)70258-1; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Min SS, 2009, NEUROSCI LETT, V456, P20, DOI 10.1016/j.neulet.2009.03.079; Mitterdorfer J, 2002, J NEUROSCI, V22, P10106; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Nistico R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0162; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Ojo JO, 2016, EXP NEUROL, V275, P389, DOI 10.1016/j.expneurol.2015.06.003; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Penn AC, 2012, NEURON, V76, P503, DOI 10.1016/j.neuron.2012.08.010; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Phillips LL, 2001, RESTOR NEUROL NEUROS, V19, P213; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Reeves TM, 1997, BRAIN RES, V757, P119, DOI 10.1016/S0006-8993(97)00170-4; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Rozov Andrei, 2012, Front Synaptic Neurosci, V4, P4, DOI 10.3389/fnsyn.2012.00004; Rozov A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00022; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schwarzbach E, 2006, HIPPOCAMPUS, V16, P541, DOI 10.1002/hipo.20183; Semple BD, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00069; Shen H, 2007, NAT NEUROSCI, V10, P469, DOI 10.1038/nn1868; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; Siarey RJ, 1999, NEUROPHARMACOLOGY, V38, P1917, DOI 10.1016/S0028-3908(99)00083-0; Siarey RJ, 2005, NEUROPHARMACOLOGY, V49, P122, DOI 10.1016/j.neuropharm.2005.02.012; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Soares C, 2013, J NEUROSCI, V33, P13547, DOI 10.1523/JNEUROSCI.1873-13.2013; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; Tsuzuki K, 2001, J NEUROCHEM, V77, P1650, DOI 10.1046/j.1471-4159.2001.00388.x; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vargas-Caballero M, 2010, NEUROPHARMACOLOGY, V58, P668, DOI 10.1016/j.neuropharm.2009.11.005; Viosca J, 2009, LEARN MEMORY, V16, P198, DOI 10.1101/lm.1220309; Vithlani M, 2011, PHYSIOL REV, V91, P1009, DOI 10.1152/physrev.00015.2010; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Warren KM, 2012, J NEUROTRAUM, V29, P1922, DOI 10.1089/neu.2012.2383; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Whitehead G, 2013, BRAIN, V136, P3753, DOI 10.1093/brain/awt293; Wiltgen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012818; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yokoi N, 2012, INT REV CEL MOL BIO, V297, P1, DOI 10.1016/B978-0-12-394308-8.00001-7; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Yurdakoc A, 2008, ACTA ANAESTH SCAND, V52, P658, DOI 10.1111/j.1399-6576.2008.01635.x; Zhang L, 1996, SCIENCE, V274, P1921, DOI 10.1126/science.274.5294.1921	123	19	20	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2016	277						227	243		10.1016/j.expneurol.2015.12.019			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF2ST	WOS:000371194800023	26730521	hybrid			2022-02-06	
J	McCredie, VA; Alali, AS; Xiong, W; Rubenfeld, GD; Cuthbertson, BH; Scales, DC; Nathens, AB				McCredie, Victoria A.; Alali, Aziz S.; Xiong, Wei; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Scales, Damon C.; Nathens, Avery B.			Timing of withdrawal of life-sustaining therapies in severe traumatic brain injury: Impact on overall mortality	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; critical care; mortality; withdrawal of life-sustaining therapies; trauma centers	QUALITY IMPROVEMENT PROGRAM; HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; LOGISTIC-REGRESSION; AMERICAN-COLLEGE; UNITED-STATES; CARE; MANAGEMENT; VARIABLES; OUTCOMES	BACKGROUND The care of patients with severe traumatic brain injury (TBI) is complex and confounded by uncertainty in prognoses. Studies have demonstrated significant unexplained variation in mortality between centers. Possible explanations include differences in the quality and intensity of care across centers, including the appropriateness and timing of withdrawal of life-sustaining therapies. We postulated that centers with a preponderance of early deaths might have a more pessimistic approach to the TBI patient, which would be reflected in an increased hospital TBI-related mortality. METHODS This is a retrospective cohort study. Time to death was used as a proxy for time to withdrawal of life-sustaining therapies. Centers were classified as early or late based on when the majority (75th percentile) of their TBI-related deaths occurred. We evaluated the association between adjusted mortality and center classification using a hierarchical multivariable model. Two hundred trauma centers contributing data to the American College of Surgeons Trauma Quality Improvement Program from 2010 through 2013 were involved. The cohort included 17,505 patients with severe isolated TBI. RESULTS One hundred eight centers were classified as early centers. The 75th percentile for time to death was 4 days among early centers versus 7 days in late centers. Mortality was 34% and 33%, respectively. After adjustment for case mix, care in an early center was not associated with increased odds of death (adjusted odds ratio, 0.95; 95% confidence interval, 0.83-1.09). Higher odds of death were independently associated with age, Glasgow Coma Scale (GCS) score, head Abbreviated Injury Scale (AIS) score, multiple comorbidities, traumatic subarachnoid hemorrhage, intracerebral mass lesions, brainstem lesions, and signs of compressed or absent basal cisterns. CONCLUSION Centers rendering early decisions related to withdrawal of life-sustaining therapies in TBI patients, as measured by time until death, do not have worse outcomes than those making later decisions. How and when these decisions are made requires further exploration to balance an opportunity for clinical improvement with appropriate resource use. LEVEL OF EVIDENCE Prognostic and epidemiologic study, level III.	[McCredie, Victoria A.; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Alali, Aziz S.; Xiong, Wei; Rubenfeld, Gordon D.; Cuthbertson, Brian H.; Scales, Damon C.; Nathens, Avery B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Surg, Toronto, ON M4N 3M5, Canada; [Cuthbertson, Brian H.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada		McCredie, VA (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	Victoria.McCredie@sunnybrook.ca		McCredie, Victoria/0000-0002-1590-2846			Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; American College of Surgeons, 2016, RES OPT CAR INJ PAT; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Becker KJ, 2001, NEUROLOGY, V56, P766, DOI 10.1212/WNL.56.6.766; Bennett TD, 2012, ARCH PEDIAT ADOL MED, V166, P641, DOI 10.1001/archpediatrics.2012.322; Boucher KM, 1998, J CLIN EPIDEMIOL, V51, P1223, DOI 10.1016/S0895-4356(98)00129-2; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Can-ada, 2010, TRI COUNC POL STAT E; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Hukkelhoven CWPM, 2006, J CLIN EPIDEMIOL, V59, P132, DOI 10.1016/j.jclinepi.2005.06.009; Khan S, 2002, BRAIN INJURY, V16, P537, DOI 10.1080/02699050110119862; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kozar RA, 2014, J TRAUMA ACUTE CARE, V76, P634, DOI 10.1097/TA.0000000000000130; Lingsma HF, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-201; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Meldon SW, 2002, J TRAUMA, V52, P79, DOI 10.1097/00005373-200201000-00014; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Mittlbock M, 1996, STAT MED, V15, P1987, DOI 10.1002/(SICI)1097-0258(19961015)15:19<1987::AID-SIM318>3.0.CO;2-9; Moore Lynne, 2009, J Emerg Trauma Shock, V2, P73, DOI 10.4103/0974-2700.44774; Moore L, 2009, J AM COLL SURGEONS, V209, P572, DOI 10.1016/j.jamcollsurg.2009.07.004; Naidech AM, 2009, NEUROCRIT CARE, V11, P45, DOI 10.1007/s12028-009-9186-z; Newgard CD, 2013, J AM COLL SURGEONS, V216, P147, DOI 10.1016/j.jamcollsurg.2012.08.017; Pillai SV, 2003, NEUROL INDIA, V51, P345; Plaisier BR, 2002, AM SURGEON, V68, P159; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schaan M, 2002, J TRAUMA, V52, P667, DOI 10.1097/00005373-200204000-00009; Schreiber MA, 2002, ARCH SURG-CHICAGO, V137, P285, DOI 10.1001/archsurg.137.3.285; Shafi S, 2009, J AM COLL SURGEONS, V209; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	39	19	19	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAR	2016	80	3					484	491		10.1097/TA.0000000000000922			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DF7XT	WOS:000371571900027	26595711				2022-02-06	
J	Dziewas, R; Glahn, J; Helfer, C; Ickenstein, G; Keller, J; Ledl, C; Lindner-Pfleghar, B; Nabavi, DG; Prosiegel, M; Riecker, A; Lapa, S; Stanschus, S; Warnecke, T; Busse, O				Dziewas, Rainer; Glahn, Joerg; Helfer, Christine; Ickenstein, Guntram; Keller, Jochen; Ledl, Christian; Lindner-Pfleghar, Beate; Nabavi, Darius G.; Prosiegel, Mario; Riecker, Axel; Lapa, Sriramya; Stanschus, Soenke; Warnecke, Tobias; Busse, Otto			Flexible endoscopic evaluation of swallowing (FEES) for neurogenic dysphagia: training curriculum of the German Society of Neurology and the German stroke society	BMC MEDICAL EDUCATION			English	Article						Nervous system diseases; Flexible Endoscopic Evaluation of Swallowing; Muscular diseases; Stroke; Clinical competence	TRAUMATIC BRAIN-INJURY; LATERAL-SCLEROSIS; COMPLICATIONS; ASPIRATION; DISORDERS; SAFETY; VIDEOFLUOROSCOPY; DIAGNOSIS; DEMENTIA; DISEASE	Background: Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. In spite of the huge demand for qualified dysphagia diagnostics in neurology, a systematic FEES education has not yet been established. Results: The structured training curriculum presented in this article aims to close this gap and intends to enforce a robust and qualified FEES service. As management of neurogenic dysphagia is not confined to neurologists, this educational programme is applicable to other clinicians and speech-language therapists with expertise in dysphagia as well. Conclusion: The systematic education in carrying out FEES across a variety of different professions proposed by this curriculum will help to spread this instrumental approach and to improve dysphagia management.	[Dziewas, Rainer; Warnecke, Tobias] Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany; [Glahn, Joerg] Johannes Wesling Klinikum Minden, Dept Neurol, Minden, Germany; [Helfer, Christine] Vivantes Klinikum Neukolln, ENT Dept, Berlin, Germany; [Helfer, Christine; Nabavi, Darius G.] Vivantes Klinikum Neukolln, Dept Neurol, Berlin, Germany; [Ickenstein, Guntram] HELIOS Klinikum Aue, Dept Neurol, Aue, Germany; [Ickenstein, Guntram] HELIOS Klinikum Aue, Stroke Unit, Aue, Germany; [Keller, Jochen] St Martinus Hosp, Clin Acute Geriatr, Dusseldorf, Germany; [Ledl, Christian] Schon Klin Bad Aibling, Bad Aibling, Germany; [Lindner-Pfleghar, Beate; Riecker, Axel] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Prosiegel, Mario] German Soc Dysphagia, Munich, Germany; [Riecker, Axel] Reha Nova, Clin Neurol & Neurosurg Rehabil, Cologne, Germany; [Lapa, Sriramya] Goethe Univ Frankfurt, Dept Neurol, ZNN, D-60054 Frankfurt, Germany; [Stanschus, Soenke] Hosp Zum Heiligen Geist, Kempen, Germany; [Busse, Otto] DSG & DGN Off, D-10117 Berlin, Germany		Dziewas, R (corresponding author), Univ Hosp Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	dziewas@uni-muenster.de	Dziewas, Rainer/AAX-9505-2020	Dziewas, Rainer/0000-0003-1592-8461	DSG; DGN	Travel expenses of the meetings of the FEES task force were covered by the DGN and DSG.	[Anonymous], FIBR END EV SWALL FE; Aviv JE, 2000, DYSPHAGIA, V15, P39, DOI 10.1007/s004559910008; Aviv JE., 2001, ENDOSCOPIC EVALUATIO, P235; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Cohen MA, 2003, LARYNGOSCOPE, V113, P21, DOI 10.1097/00005537-200301000-00004; Deutschmann MW, 2013, HEAD NECK-J SCI SPEC, V35, P974, DOI 10.1002/hed.23066; Dziewas, 2013, NEUROGENE DYSPHAGIEN; Dziewas R, 2003, J NEUROL NEUROSUR PS, V74, P1429, DOI 10.1136/jnnp.74.10.1429; Dziewas R, 2008, CEREBROVASC DIS, V26, P41, DOI 10.1159/000135652; GROB D, 1987, ANN NY ACAD SCI, V505, P472; Hafner G, 2008, EUR ARCH OTO-RHINO-L, V265, P441, DOI 10.1007/s00405-007-0507-6; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; HORNER J, 1994, ALZ DIS ASSOC DIS, V8, P177; Kelly AM, 2006, CLIN OTOLARYNGOL, V31, P425, DOI 10.1111/j.1749-4486.2006.01292.x; Kelly AM, 2007, LARYNGOSCOPE, V117, P1723, DOI 10.1097/MLG.0b013e318123ee6a; Kuhnlein P, 2008, NAT CLIN PRACT NEURO, V4, P366, DOI 10.1038/ncpneuro0853; Langmore S E, 1988, Dysphagia, V2, P216, DOI 10.1007/BF02414429; Langmore S. E., 2001, ENDOSCOPIC EVALUATIO; Langmore SE, 2007, ARCH NEUROL-CHICAGO, V64, P58, DOI 10.1001/archneur.64.1.58; Langmore Susan E, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P485, DOI 10.1097/00020840-200312000-00014; Leder SB, 2004, DYSPHAGIA, V19, P177, DOI 10.1007/s00455-004-0009-2; Leder SB, 1999, J HEAD TRAUMA REHAB, V14, P448, DOI 10.1097/00001199-199910000-00005; Leder SB, 1998, DYSPHAGIA, V13, P19, DOI 10.1007/PL00009544; Leder SB, 1997, DYSPHAGIA, V12, P52; Macht M, 2011, CRIT CARE, V15, DOI 10.1186/cc10472; Mackay LE, 1999, J HEAD TRAUMA REHAB, V14, P435, DOI 10.1097/00001199-199910000-00004; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; McCullough GH, 2005, J SPEECH LANG HEAR R, V48, P1280, DOI 10.1044/1092-4388(2005/089); Miller N, 2006, AGE AGEING, V35, P614, DOI 10.1093/ageing/afl105; Morgan AS, 1999, J HEAD TRAUMA REHAB, V14, P454, DOI 10.1097/00001199-199910000-00006; Mulcahy KP, 2012, DYSPHAGIA, V27, P64, DOI 10.1007/s00455-011-9338-0; Muller J, 2001, ARCH NEUROL-CHICAGO, V58, P259, DOI 10.1001/archneur.58.2.259; O'Donoghue S, 1999, FOLIA PHONIATR LOGO, V51, P158, DOI 10.1159/000021494; Scheel R, 2016, ANN OTO RHINOL LARYN, V125, P43, DOI 10.1177/0003489415596755; Suh MK, 2009, ALZ DIS ASSOC DIS, V23, P178, DOI 10.1097/WAD.0b013e318192a539; Suntrup S, 2012, NERVENARZT, V83, P1619, DOI 10.1007/s00115-012-3611-9; Suntrup S, 2012, J NEUROL, V259, P93, DOI 10.1007/s00415-011-6129-3; Tolep K, 1996, CHEST, V109, P167, DOI 10.1378/chest.109.1.167; Warnecke T, 2010, MOVEMENT DISORD, V25, P1239, DOI 10.1002/mds.23060; Warnecke T, 2009, NEUROMUSCULAR DISORD, V19, P704, DOI 10.1016/j.nmd.2009.06.371; Warnecke T, 2009, STROKE, V40, P482, DOI 10.1161/STROKEAHA.108.520775; Willging J Paul, 2005, Curr Gastroenterol Rep, V7, P240, DOI 10.1007/s11894-005-0041-x; Wu CH, 1997, LARYNGOSCOPE, V107, P396	43	19	21	0	11	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1472-6920			BMC MED EDUC	BMC Med. Educ.	FEB 25	2016	16								70	10.1186/s12909-016-0587-3			9	Education & Educational Research; Education, Scientific Disciplines	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research	DF1VE	WOS:000371126500001	26911194	Green Published, gold			2022-02-06	
J	Guldenmund, P; Soddu, A; Baquero, K; Vanhaudenhuyse, A; Bruno, MA; Gosseries, O; Laureys, S; Gomez, F				Guldenmund, Pieter; Soddu, Andrea; Baquero, Katherine; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Laureys, Steven; Gomez, Francisco			Structural brain injury in patients with disorders of consciousness: A voxel-based morphometry study	BRAIN INJURY			English	Article						Vegetative state/unresponsive wakefulness syndrome; voxel-based morphometry; structural brain injury; minimally conscious state	UNRESPONSIVE WAKEFULNESS SYNDROME; RESTING-STATE NETWORKS; DEFAULT MODE NETWORK; VEGETATIVE STATE; GRAY-MATTER; THALAMIC NUCLEI; CONNECTIVITY; MRI; NEUROPATHOLOGY; COMA	Main objective: Disorders of consciousness (DOC; encompassing coma, vegetative state/unresponsive wakefulness syndrome (VS/UWS) and minimally conscious state minus/plus (MCS-/+)) are associated with structural brain injury. The extent of this damage remains poorly understood and merits a detailed examination using novel analysis techniques. Research design/methods and procedures: This study used voxel-based morphometry (VBM) on structural magnetic resonance imaging scans of 61 patients with DOC to examine grey and white matter injury associated with DOC, time spent in DOC, aetiology and diagnosis. Main outcomes and results: DOC and time spent in DOC were found to be associated with widespread structural brain injury, although the latter did not correlate strongly with injury in the right cerebral hemisphere. Traumatic, as compared to non-traumatic aetiology, was related to more injury in the brainstem, midbrain, thalamus, hypothalamus, basal forebrain, cerebellum, and posterior corpus callosum. Potential structural differences were found between VS/UWS and MCS and between MCS- and MCS+, but need further examination. Conclusions: The findings indicate that both traumatic and non-traumatic DOC are associated with widespread structural brain injury, although differences exist that could lead to aetiology-specific treatment strategies. Furthermore, the high degree of atrophy occurring after initial brain injury prompts the development and use of neuroprotective techniques to potentially increase patients' chances of recovery.	[Guldenmund, Pieter; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Laureys, Steven; Gomez, Francisco] Univ Liege, Cyclotron Res Ctr, Coma Sci Grp, Liege, Belgium; [Guldenmund, Pieter; Vanhaudenhuyse, Audrey; Bruno, Marie-Aurelie; Gosseries, Olivia; Laureys, Steven; Gomez, Francisco] Univ Liege, Univ Hosp Liege, Liege, Belgium; [Soddu, Andrea] Univ Western Ontario, Dept Phys & Astron, Brain & Mind Inst, London, ON, Canada; [Baquero, Katherine] Univ Nacl Colombia, Comp Imaging & Med Applicat Lab, Bogota, Colombia; [Baquero, Katherine] Univ Liege, Cyclotron Res Ctr, MoVeRe Grp, Liege, Belgium; [Vanhaudenhuyse, Audrey] Univ Liege, Univ Hosp Liege, Algol Palliat Care Dept, Liege, Belgium; [Gomez, Francisco] Cent Univ Colombia, Dept Comp Sci, Bogota, Colombia		Guldenmund, P; Laureys, S (corresponding author), Cyclotron Res Ctr, Coma Sci Grp, B30,Allee 6 Aout, B-4000 Liege, Belgium.	guldenmund@hotmail.com; steven.laureys@ulg.ac.be	Gosseries, Olivia/AAB-6469-2020; Soddu, Andrea/K-7087-2014; Laureys, Steven/A-3349-2011; Laureys, Steven/AAN-2097-2021; Vanhaudenhuyse, Audrey/AAP-2455-2020	Gosseries, Olivia/0000-0001-9011-7496; Soddu, Andrea/0000-0001-6833-745X; Laureys, Steven/0000-0002-3096-3807; 	Belgian National Funds for Scientific Research (Brussels, Belgium)Fonds de la Recherche Scientifique - FNRS; European Commission (Brussels, Belgium)European CommissionEuropean Commission Joint Research Centre; James McDonnell Foundation (Saint Louis, MO, USA); Mind Science Foundation (San Antonio, TX, USA); French Speaking Community Concerted Research Action (ARC, Brussels, Belgium) [06/11-340]; Fondation Medicale Reine Elisabeth (Brussels, Belgium); University of Liege (Liege, Belgium)University of Liege; University Hospital of Liege (Liege, Belgium)	This research was funded by the Belgian National Funds for Scientific Research (Brussels, Belgium), the European Commission (Brussels, Belgium), the James McDonnell Foundation (Saint Louis, MO, USA), the Mind Science Foundation (San Antonio, TX, USA), the French Speaking Community Concerted Research Action (ARC, 06/11-340, Brussels, Belgium), the Fondation Medicale Reine Elisabeth (Brussels, Belgium), the University of Liege (Liege, Belgium) and the University Hospital of Liege (Liege, Belgium). The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	Adams JH, 1999, J CLIN PATHOL, V52, P804, DOI 10.1136/jcp.52.11.804; Adams JH, 2000, BRAIN, V123, P1327, DOI 10.1093/brain/123.7.1327; Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Braga B, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/481378; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Can DD, 2013, BRAIN LANG, V124, P34, DOI 10.1016/j.bandl.2012.10.007; Chu Nai-Shin, 1993, Journal of the Formosan Medical Association, V92, P697; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Edlow BL, 2013, J NEUROPATH EXP NEUR, V72, P505, DOI 10.1097/NEN.0b013e3182945bf6; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Fernandez-Espejo D, 2012, ANN NEUROL, V72, P335, DOI 10.1002/ana.23635; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giraud AL, 2004, CEREB CORTEX, V14, P247, DOI 10.1093/cercor/bhg124; Gitelman DR, 2001, NEUROIMAGE, V13, P623, DOI 10.1006/nimg.2000.0734; Goldfine AM, 2011, NEUROL CLIN, V29, P723, DOI 10.1016/j.ncl.2011.08.001; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gosseries O, 2014, CURR PHARM DESIGN, V20, P4167; Graham DI, 2005, PROG BRAIN RES, V150, P445, DOI 10.1016/S0079-6123(05)50031-1; Guldenmund P, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/624724; Guldenmund P, 2012, ARCH ITAL BIOL, V150, P107, DOI 10.4449/aib.v150i2.1373; Guldenmund P, 2013, BRAIN CONNECT, V3, P273, DOI 10.1089/brain.2012.0117; Hattingen E, 2010, CLIN NEURORADIOL, V20, P81, DOI 10.1007/s00062-010-0009-6; Heine L, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00295; Hellewell SC, 2010, J NEUROTRAUM, V27, P1997, DOI 10.1089/neu.2009.1245; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Henley SMD, 2010, AM J NEURORADIOL, V31, P711, DOI 10.3174/ajnr.A1939; Hertz L, 2008, NEUROPHARMACOLOGY, V55, P289, DOI 10.1016/j.neuropharm.2008.05.023; Ho AK, 2004, NEUROREPORT, V15, P1061, DOI 10.1097/00001756-200404290-00026; Jellinger KA, 2013, BRAIN INJURY, V27, P917, DOI 10.3109/02699052.2013.793395; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Juengling FD, J NEUROLOGICAL SCI, V228, P179; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101; Laureys S, 2005, PROG BRAIN RES, V150, P495, DOI 10.1016/S0079-6123(05)50034-7; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lingor P, 2012, CELL TISSUE RES, V349, P289, DOI 10.1007/s00441-012-1362-3; Lull N, 2010, NEUROLOGIA, V25, P174; Lull N, 2010, BRAIN INJURY, V24, P1098, DOI 10.3109/02699052.2010.494592; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Monti MM, 2012, ANNU REV CLIN PSYCHO, V8, P431, DOI 10.1146/annurev-clinpsy-032511-143050; Moreau OK, 2012, J NEUROTRAUM, V29, P81, DOI 10.1089/neu.2011.2048; Mura E, 2014, CURR PHARM DESIGN, V20, P4121; Newcombe VFJ, 2010, J NEUROL NEUROSUR PS, V81, P552, DOI 10.1136/jnnp.2009.196246; Nugent AC, 2006, NEUROIMAGE, V30, P485, DOI 10.1016/j.neuroimage.2005.09.029; Peelle JE, 2012, NEUROIMAGE, V60, P1503, DOI 10.1016/j.neuroimage.2011.12.086; Phillips CL, 2011, NEUROIMAGE, V56, P797, DOI 10.1016/j.neuroimage.2010.05.083; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Ripolles P, 2012, NEUROIMAGE, V60, P1296, DOI 10.1016/j.neuroimage.2012.01.094; Rosenblum WI, 2015, J NEUROPATH EXP NEUR, V74, P198, DOI 10.1097/NEN.0000000000000170; Rousseau MC, 2008, BRAIN INJURY, V22, P123, DOI 10.1080/02699050801895415; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Saleh A, 2004, BRAIN, V127, P1670, DOI 10.1093/brain/awh191; Salmond CH, 2002, NEUROIMAGE, V17, P1027, DOI 10.1006/nimg.2002.1153; Sato H, 2012, AM J FOREN MED PATH, V33, P341, DOI 10.1097/PAF.0b013e318273b823; Scott SK, 2012, J COMMUN DISORD, V45, P419, DOI 10.1016/j.jcomdis.2012.06.007; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; Soderfeldt B, 1997, NEUROLOGY, V49, P82, DOI 10.1212/WNL.49.1.82; Takahashi R, 2010, AM J NEURORADIOL, V31, P1873, DOI 10.3174/ajnr.A2200; Toyama Yoshihiro, 2005, Radiat Med, V23, P309; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Vanhaudenhuyse A, 2011, J COGNITIVE NEUROSCI, V23, P570, DOI 10.1162/jocn.2010.21488; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vorobyev VA, 2004, COGNITIVE BRAIN RES, V20, P309, DOI 10.1016/j.cogbrainres.2004.03.011; Weibull A, 2008, NEUROIMAGE, V41, P346, DOI 10.1016/j.neuroimage.2008.02.015; Weiss N, 2008, J NEUROL, V255, P217, DOI 10.1007/s00415-008-0658-4; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404	86	19	20	0	12	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	FEB 23	2016	30	3					343	352		10.3109/02699052.2015.1118765			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DG9QM	WOS:000372418900012	26890670	Green Published			2022-02-06	
J	Lancaster, MA; McCrea, MA; Nelson, LD				Lancaster, Melissa A.; McCrea, Michael A.; Nelson, Lindsay D.			Psychometric properties and normative data for the Brief Symptom Inventory-18 (BSI-18) in high school and collegiate athletes	CLINICAL NEUROPSYCHOLOGIST			English	Article						Brief Symptom Inventory-18; sport-related concussion; concussion; emotional functioning; psychometric properties	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; LIFE-SCALE; CONCUSSION; OUTCOMES; SATISFACTION; DEPRESSION; RECOVERY; RELIABILITY; DISTRESS	Objective: Assessment of emotional functioning is important in sport-related concussion (SRC) management, although few standardized measures have been validated in this population, and appropriate normative data are lacking. We investigated the psychometric properties of the Brief Symptom Inventory-18 (BSI-18) in high school and collegiate athletes at risk of SRC and compiled normative data.Method: Athletes (n=2,031) completed the BSI-18 and other measures of concussion symptoms, cognition, and psychological functioning. A subset of healthy individuals was re-evaluated at approximately 7, 30, 45, and 165days. Psychometric analyses of test-retest reliability, internal consistency reliability, and concurrent validity were performed. Given significant differences between sexes and education levels (high school or college student) on the BSI-18 Global Severity Index and all subscales, normative conversion tables were produced after stratifying by these variables.Results: The BSI-18 showed good internal consistency, fair to poor test-retest reliability, and good convergent validity with other measures of emotional functioning.Conclusions: These data indicate that the BSI-18 may be a valuable measure of emotional state in concussed athletes and may provide unique information beyond post-concussive symptoms for research on the role of psychological factors in SRC recovery. The limited divergent validity of the BSI-18 depression and anxiety scales implies that they tap into general distress more so than specific mood or anxiety symptoms; therefore, BSI-18 scores should be not relied upon for differential diagnosis of mood and anxiety disorders. Normative data provided can be readily applied to clinical cases with high school and collegiate athletes.	[Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Lancaster, Melissa A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA		Lancaster, MA (corresponding author), Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA.; Lancaster, MA (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	mlancaster@mcw.edu			NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR000055] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR031973] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000055] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR031973] Funding Source: NIH RePORTER		Arrindell W. A., 1986, HANDLEIDING BIJEEN M; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Buchanan K M, 2001, Axone, V22, P16; BURLINGAME GM, 1995, J MENT HEALTH ADMIN, V22, P226, DOI 10.1007/BF02521118; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Derogatis L. R., 1977, SCL 90 MANUAL 1 SCOR; Derogatis LR., 1982, BRIEF SYMPTOM INVENT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Green P., 2003, GREENS MED SYMPTOM V; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P160; KELLEY MJ, 1990, J SPORT MED PHYS FIT, V30, P202; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Mooney G, 2005, BRAIN INJURY, V19, P975, DOI 10.1080/02699050500110264; Oler M J, 1994, Arch Fam Med, V3, P781, DOI 10.1001/archfami.3.9.781; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Rocke C, 2009, PSYCHOL AGING, V24, P863, DOI 10.1037/a0016276; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Slaughter J, 1999, BRAIN INJURY, V13, P125, DOI 10.1080/026990599121782; Tellegen A., 1985, ANXIETY ANXIETY DISO, P681; Vangel SJ, 2011, J HEAD TRAUMA REHAB, V26, P20, DOI 10.1097/HTR.0b013e318204a70d; WechslerD, 2001, WECHSLER TEST ADULT; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Yang JZ, 2014, RES SPORTS MED, V22, P147, DOI 10.1080/15438627.2014.881818	36	19	20	1	58	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.	FEB 17	2016	30	2					321	333		10.1080/13854046.2016.1138504			13	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DI3LQ	WOS:000373400600011	26924037	Green Accepted			2022-02-06	
J	Nieboer, D; van der Ploeg, T; Steyerberg, EW				Nieboer, Daan; van der Ploeg, Tjeerd; Steyerberg, Ewout W.			Assessing Discriminative Performance at External Validation of Clinical Prediction Models	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; ADMISSION CHARACTERISTICS; IMPACT; REGRESSION; FRAMEWORK	Introduction External validation studies are essential to study the generalizability of prediction models. Recently a permutation test, focusing on discrimination as quantified by the c-statistic, was proposed to judge whether a prediction model is transportable to a new setting. We aimed to evaluate this test and compare it to previously proposed procedures to judge any changes in c-statistic from development to external validation setting. Methods We compared the use of the permutation test to the use of benchmark values of the c-statistic following from a previously proposed framework to judge transportability of a prediction model. In a simulation study we developed a prediction model with logistic regression on a development set and validated them in the validation set. We concentrated on two scenarios: 1) the case-mix was more heterogeneous and predictor effects were weaker in the validation set compared to the development set, and 2) the case-mix was less heterogeneous in the validation set and predictor effects were identical in the validation and development set. Furthermore we illustrated the methods in a case study using 15 datasets of patients suffering from traumatic brain injury. Results The permutation test indicated that the validation and development set were homogenous in scenario 1 (in almost all simulated samples) and heterogeneous in scenario 2 (in 17%-39% of simulated samples). Previously proposed benchmark values of the c-statistic and the standard deviation of the linear predictors correctly pointed at the more heterogeneous case-mix in scenario 1 and the less heterogeneous case-mix in scenario 2. Conclusion The recently proposed permutation test may provide misleading results when externally validating prediction models in the presence of case-mix differences between the development and validation population. To correctly interpret the c-statistic found at external validation it is crucial to disentangle case-mix differences from incorrect regression coefficients.	[Nieboer, Daan; Steyerberg, Ewout W.] Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [van der Ploeg, Tjeerd] Inholland Univ, Med Ctr Alkmaar, Dept Sci, Alkmaar, Netherlands		Nieboer, D (corresponding author), Erasmus MC Univ Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands.	d.nieboer@erasmusmc.nl		van der Ploeg, Tjeerd/0000-0003-0429-6753	Netherlands Organization for Scientific Research (ZonMw)Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development [ZonMw 9120.8004 (TOP)]	This work was funded by The Netherlands Organization for Scientific Research (ZonMw 9120.8004 (TOP)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; Debray TPA, 2015, J CLIN EPIDEMIOL, V68, P280, DOI 10.1016/j.jclinepi.2014.06.018; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Moons KGM, 2012, HEART, V98, P691, DOI 10.1136/heartjnl-2011-301247; R Development Core Team, 2008, R LANG ENV STAT COMP; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, CLIN PREDICTION MODE; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116957; Wessler BS, 2015, CIRC-CARDIOVASC QUAL, V8, P368, DOI 10.1161/CIRCOUTCOMES.115.001693	20	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2016	11	2							e0148820	10.1371/journal.pone.0148820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3BP	WOS:000371219000026	26881753	Green Published, gold, Green Submitted			2022-02-06	
J	Chauvette, S; Soltani, S; Seigneur, J; Timofeev, I				Chauvette, Sylvain; Soltani, Sara; Seigneur, Josee; Timofeev, Igor			In vivo models of cortical acquired epilepsy	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Epilepsy; Epileptogenesis; Seizure; Trauma; Kindling; Undercut	TRAUMATIC BRAIN-INJURY; EXTRACELLULAR POTASSIUM ACTIVITY; SPIKE-WAVE COMPLEXES; PAROXYSMAL FAST RUNS; V PYRAMIDAL NEURONS; POSTTRAUMATIC EPILEPSY; NEOCORTICAL NEURONS; SEIZURE ACTIVITY; GAP-JUNCTIONS; ELECTRICAL-STIMULATION	The neocortex is the site of origin of several forms of acquired epilepsy. Here we provide a brief review of experimental models that were recently developed to study neocortical epileptogenesis as well as some major results obtained with these methods. Most of neocortical seizures appear to be nocturnal and it is known that neuronal activities reveal high levels of synchrony during slow-wave sleep. Therefore, we start the review with a description of mechanisms of neuronal synchronization and major forms of synchronized normal and pathological activities. Then, we describe three experimental models of seizures and epileptogenesis: ketamine-xylazine anesthesia as feline seizure triggered factor, cortical undercut as cortical penetrating wound model and neocortical kindling. Besides specific technical details describing these models we also provide major features of pathological brain activities recorded during epileptogenesis and seizures. The most common feature of all models of neocortical epileptogenesis is the increased duration of network silent states that up-regulates neuronal excitability and eventually leads to epilepsy. (C) 2015 Elsevier B.V. All rights reserved.	[Chauvette, Sylvain; Soltani, Sara; Seigneur, Josee; Timofeev, Igor] CRIUSMQ, Local F-6500,2601 Canardiere, Quebec City, PQ G1J2G3, Canada; [Soltani, Sara; Timofeev, Igor] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada		Timofeev, I (corresponding author), CRIUSMQ, Local F-6500,2601 Canardiere, Quebec City, PQ G1J2G3, Canada.	igor.timofeev@fmed.ulaval.ca	Timofeev, Igor/AAP-7529-2021; Timofeev, Igor/E-8828-2012	Timofeev, Igor/0000-0002-1389-5857	CIHRCanadian Institutes of Health Research (CIHR) [MOP-325213, MOP-324941, MOP-37862, MOP-67175]; NIH-NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01-NS060870, 1R01-NS059740]; NSERCNatural Sciences and Engineering Research Council of Canada (NSERC) [298475]; FRQ-S, FRQ-NT; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS059740, R01NS060870] Funding Source: NIH RePORTER	In recent years, our work was supported by CIHR (MOP-325213, MOP-324941, MOP-37862 and MOP-67175), NIH-NINDS (1R01-NS060870 and 1R01-NS059740), NSERC (Grant 298475), and FRQ-S, FRQ-NT. We are thankful to Sergiu Ftomov for his excellent technical assistance.	Adami C, 2013, SCHWEIZ ARCH TIERH, V155, P569, DOI 10.1024/0036-7281/a000513; AGMON A, 1989, NEUROSCI LETT, V99, P137, DOI 10.1016/0304-3940(89)90278-4; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Amzica F, 2002, J NEUROSCI, V22, P1042, DOI 10.1523/JNEUROSCI.22-03-01042.2002; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Avramescu S, 2008, CELLULAR HOMEOSTATIC, P253; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; BABA H, 1982, EPILEPSIA, V23, P663, DOI 10.1111/j.1528-1157.1982.tb05082.x; BARKAI E, 1994, J NEUROPHYSIOL, V72, P72, DOI 10.1152/jn.1994.72.1.72; Bazhenov M, 2004, J NEUROPHYSIOL, V92, P1116, DOI 10.1152/jn.00529.2003; Beltramo R, 2013, NAT NEUROSCI, V16, P227, DOI 10.1038/nn.3306; Blake H, 1937, AM J PHYSIOL, V119, P692, DOI 10.1152/ajplegacy.1937.119.4.692; Boucetta S, 2008, EPILEPSIA, V49, P1925, DOI 10.1111/j.1528-1167.2008.01707.x; Boucetta S, 2013, EXP NEUROL, V245, P5, DOI 10.1016/j.expneurol.2012.12.001; Carlen PL, 2000, BRAIN RES REV, V32, P235, DOI 10.1016/S0165-0173(99)00084-3; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Chauvette S., 2007, MECH SPONTANEOUS ACT, P73; Chauvette S, 2012, NEURON, V75, P1105, DOI 10.1016/j.neuron.2012.08.034; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chen JY, 2012, J PHYSIOL-LONDON, V590, P3987, DOI 10.1113/jphysiol.2012.227462; Christe KL, 2013, COMPARATIVE MED, V63, P445; Christensen J, 2012, EPILEPSIA, V53, P43, DOI 10.1111/j.1528-1167.2012.03612.x; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Crochet S, 2005, EUR J NEUROSCI, V21, P1030, DOI 10.1111/j.1460-9568.2005.03932.x; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; D'Ambrosio R, 2004, CURR OPIN NEUROL, V17, P731, DOI 10.1097/00019052-200412000-00014; David F, 2013, J NEUROSCI, V33, P19599, DOI 10.1523/JNEUROSCI.3169-13.2013; DEFELIPE J, 1985, J COMP NEUROL, V231, P364, DOI 10.1002/cne.902310307; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; Derchansky M, 2006, NEUROBIOL DIS, V23, P312, DOI 10.1016/j.nbd.2006.03.014; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; Dinner Dudley S., 1993, P654; Eccles J, 1964, PHYSL SYNAPSES; Eftekhar B, 2009, J NEUROSURG, V110, P319, DOI 10.3171/2008.4.17519; FEENEY DM, 1979, ARCH NEUROL-CHICAGO, V36, P8, DOI 10.1001/archneur.1979.00500370038005; Ferguson PL, 2010, EPILEPSIA, V51, P891, DOI 10.1111/j.1528-1167.2009.02384.x; FREUND TF, 1983, J COMP NEUROL, V221, P263, DOI 10.1002/cne.902210303; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Frohlich F, 2006, J NEUROSCI, V26, P6153, DOI 10.1523/JNEUROSCI.5509-05.2006; Frohlich Flavio, 2005, Thalamus & Related Systems, V3, P147, DOI 10.1017/S1472928807000155; FUKUSHIMA J, 1987, EPILEPSIA, V28, P651, DOI 10.1111/j.1528-1157.1987.tb03696.x; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GODDARD GV, 1967, NATURE, V214, P1020, DOI 10.1038/2141020a0; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Gorji A, 2001, EPILEPSIA, V42, P1228, DOI 10.1046/j.1528-1157.2001.01301.x; Grand L, 2013, J NEUROSCI METH, V212, P237, DOI 10.1016/j.jneumeth.2012.10.008; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Grenier FO, 2001, J NEUROPHYSIOL, V86, P1884, DOI 10.1152/jn.2001.86.4.1884; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Haltiner AM, 1997, ARCH PHYS MED REHAB, V78, P835, DOI 10.1016/S0003-9993(97)90196-9; HEDLER L, 1981, EUR J PHARMACOL, V70, P43, DOI 10.1016/0014-2999(81)90430-1; HEINEMANN U, 1977, EXP BRAIN RES, V27, P237; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Hughes S, 2013, NAT NEUROSCI, V16, P115, DOI 10.1038/nn.3313; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; JOY RM, 1983, PHARMACOL BIOCHEM BE, V19, P345, DOI 10.1016/0091-3057(83)90063-1; Kandratavicius L, 2014, NEUROPSYCH DIS TREAT, V10, P1693, DOI 10.2147/NDT.S50371; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kazemi H, 2012, INJURY, V43, P2132, DOI 10.1016/j.injury.2012.06.007; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kollevold T, 1976, J OSLO CITY HOSP, V26, P99; Kusmierczak M, 2015, NEUROSCIENCE, V284, P153, DOI 10.1016/j.neuroscience.2014.09.079; Lemieux M, 2014, J NEUROSCI, V34, P5689, DOI 10.1523/JNEUROSCI.1156-13.2014; LEVITON A, 1981, EPIDEMIOL REV, V3, P67, DOI 10.1093/oxfordjournals.epirev.a036240; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; MAJKOWSKI J, 1981, EPILEPSIA, V22, P275, DOI 10.1111/j.1528-1157.1981.tb04110.x; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Massimini M, 2001, J NEUROPHYSIOL, V85, P1346, DOI 10.1152/jn.2001.85.3.1346; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; McCormick DA, 2001, ANNU REV PHYSIOL, V63, P815, DOI 10.1146/annurev.physiol.63.1.815; MCNAMARA JO, 1980, PROG NEUROBIOL, V15, P139, DOI 10.1016/0301-0082(80)90006-4; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Midzyanovskaya IS, 2004, PHARMACOL BIOCHEM BE, V79, P83, DOI 10.1016/j.pbb.2004.06.007; MOODY WJ, 1974, EXP NEUROL, V42, P248, DOI 10.1016/0014-4886(74)90023-5; Mugnaini E, 1986, CELL JUCTIONS ASTROC; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nelson SB, 1998, NAT NEUROSCI, V1, P539, DOI 10.1038/2775; NICHOLAS AP, 1993, J COMP NEUROL, V328, P575, DOI 10.1002/cne.903280409; Nita D, 2007, MECH SPONTANEOUS ACT, P135; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; Nita DA, 2008, EPILEPSIA, V49, P705, DOI 10.1111/j.1528-1167.2007.01431.x; Nita DA, 2008, EXP NEUROL, V211, P518, DOI 10.1016/j.expneurol.2008.02.028; Nita DA, 2008, EXP NEUROL, V211, P456, DOI 10.1016/j.expneurol.2008.02.010; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; Okamoto M, 1982, Seishin Shinkeigaku Zasshi, V84, P48; ONO K, 1981, INT J NEUROSCI, V12, P53, DOI 10.3109/00207458108990672; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; PRINCE DA, 1973, BRAIN RES, V50, P489, DOI 10.1016/0006-8993(73)90758-0; Pumain R, 1981, Adv Biochem Psychopharmacol, V29, P53; PUMAIN R, 1983, SCIENCE, V222, P177, DOI 10.1126/science.6623068; Racine R, 1975, Can J Neurol Sci, V2, P395; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P269, DOI 10.1016/0013-4694(72)90176-9; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Salin P, 1995, J NEUROSCI, V15, P8234; Sanchez-Vives M.V., 2007, MECH SPONTANEOUS ACT, P23; Sanchez-Vives MV, 2008, CEREB CORTEX, V18, P1179, DOI 10.1093/cercor/bhm152; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Sayin U, 2003, J NEUROSCI, V23, P2759; Seigneur J, 2011, EPILEPSIA, V52, P132, DOI 10.1111/j.1528-1167.2010.02784.x; Sharma AV, 2010, J NEUROPHYSIOL, V104, P932, DOI 10.1152/jn.01065.2009; Sheroziya M, 2014, J NEUROSCI, V34, P8875, DOI 10.1523/JNEUROSCI.4460-13.2014; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Steriade M, 1998, J NEUROPHYSIOL, V79, P483, DOI 10.1152/jn.1998.79.1.483; Steriade M, 1998, J NEUROPHYSIOL, V80, P1456, DOI 10.1152/jn.1998.80.3.1456; STERIADE M, 1994, J NEUROPHYSIOL, V72, P2051, DOI 10.1152/jn.1994.72.5.2051; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Steriade M., 2003, NEURONAL SUBSTRATES; Synowiec AS, 2013, EPILEPSY RES, V105, P183, DOI 10.1016/j.eplepsyres.2013.01.007; Szentagothai J, 1974, Neurosci Res Program Bull, V12, P305; TASKER JG, 1991, NEUROCHEM RES, V16, P251, DOI 10.1007/BF00966088; Temkin N R, 1995, New Horiz, V3, P518; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Temkin NR, 2003, EPILEPSIA, V44, P18, DOI 10.1046/j.1528-1157.44.s10.6.x; Teskey GC, 2002, CEREB CORTEX, V12, P98, DOI 10.1093/cercor/12.1.98; Teskey GC, 1999, CEREB CORTEX, V9, P675, DOI 10.1093/cercor/9.7.675; Thimm J, 2005, J BIOL CHEM, V280, P10646, DOI 10.1074/jbc.M412749200; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Timofeev I, 1996, J NEUROPHYSIOL, V76, P4152, DOI 10.1152/jn.1996.76.6.4152; Timofeev I, 2004, J NEUROPHYSIOL, V92, P1133, DOI 10.1152/jn.00523.2003; Timofeev I, 2004, NEUROSCIENCE, V123, P299, DOI 10.1016/j.neuroscience.2003.08.051; Timofeev I, 2002, NEUROSCIENCE, V114, P1115, DOI 10.1016/S0306-4522(02)00300-7; Timofeev I, 1998, J NEUROPHYSIOL, V80, P1495, DOI 10.1152/jn.1998.80.3.1495; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; Timofeev I, 2012, JASPERS BASIC MECH E; Timofeev I, 2014, INT REV NEUROBIOL, V114, P9, DOI 10.1016/B978-0-12-418693-4.00002-9; Timofeev I, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00154; Timofeev I, 2011, INHIBITORY SYNAPTIC PLASTICITY, P107, DOI 10.1007/978-1-4419-6978-1_8; Timofeev I, 2010, ATLAS OF EPILEPSIES, VOL 1-3, P203, DOI 10.1007/978-1-84882-128-6_27; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, CEREB CORTEX, V13, P883, DOI 10.1093/cercor/13.8.883; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Traub RD, 1996, EPILEPSIA, V37, P879, DOI 10.1111/j.1528-1157.1996.tb00042.x; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Valentine PA, 2004, CEREB CORTEX, V14, P827, DOI 10.1093/cercor/bhh041; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Volman V, 2011, J NEUROPHYSIOL, V106, P1933, DOI 10.1152/jn.00458.2011; WADA Y, 1989, JPN J PSYCHIAT NEUR, V43, P245; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wester JC, 2012, J NEUROSCI, V32, P5454, DOI 10.1523/JNEUROSCI.5006-11.2012; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong WH, 2011, JOVE-J VIS EXP, DOI 10.3791/2840	172	19	19	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	FEB 15	2016	260				SI		185	201		10.1016/j.jneumeth.2015.08.030			17	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DE7QN	WOS:000370831900019	26343530	Green Accepted			2022-02-06	
